Citrus Sinensis ID: 001275

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------1080------1090------1100------111
Protein Sequence
MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKYV
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHccccccccccccccccccccccccEEEEccccccEEEEEcccccccEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEcccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccHHccccccccEEEccccEEEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHcccccccccccccccccccccHHccccccccEEEcccccccccccHHHHccccccEEEccccccEEcccccccccccccEEEccccEEEEEccHHHHccccccEEEccccEEEEEccccccccccccEEEcccccccccccccccccccccEEEccccccEEccccccccccccEEEccccEEEEcccccccccccccEEEcccccccccccHHHHcccccccEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHcccccccccccccccccccHHHHHHHHHcccccccccccccccccHHHHcccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHcccccccEEccccccEEEEEEEccccEEEEEEEcccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccHHHHHccccccccccHHHHHHHHHHHHHHHcccccccccccEEcccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccEEHHHHHHHHHHccccccccccccccHHHHHHHHHcccccccccccccccHHHccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHcHccccHHHHHHHHHHHHccccccccccccccccccccccEEEEEcccccEEEEEEcccccccccccHHHcccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEccccccccccHHHHcccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEcccccccccccHHHccccccEEEEEccccccccccccccccccEEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccccccEEEccccEEEEEccHHHHHccHccEEEccccccccccccHHHccccEEEEEEcccccccccccccHHccccHHHHccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHcccccccEEEccccEEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccEEccccccccccccEEccccccccHHcEEEEEcccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHcccccHHHHccHHHccccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRhwnsvppliisswnssdstpcqwvgiecdddahnvVSFNlssygvsgqlgpeighlsklqtidlssnnfsgnippklgncsaleyldlstngftgdipdnfenlqNLQYLNLYgnlldgeipepLFRILGLQYVFLnnnslsgsiprnvgdlKEVEALWLFSNrlsgtipesigncYRLQELYLNEnklmgflpeslsnlenlvyldvgdnnlegrinfgsekcknltfldlsynrfsggispnlgncsslthldivgskltgsipssfGLLARLSsldlsenqlsgkippelgkckyLTVLHLYANQlegeipdelgqlsnlqdlelfdnrltgefpvSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLknislynnqfsgvipqslginsslmqldfinnsftgeippnlcfgkQLRVLNmgqnqfhgpipsllgscpTLWRVILKQnqltgalpefsknpvlshldvsrnnisgaipssignsinltsidfssnkfsglmpqelGNLVSLVTLNISlnhvegslpsqlskcknlevFDVSFnllngsipsslrSWKSLSILKlsenhftggIPTFISELEKLLELQlggnqlggeippsigALQDLSYALNlskngltgripsdleklskleqldissnnltgtlsplsnIHSLVEVNVsynlftgpvpetlmnllgpspssfsgnpslcvkclsstdsscfgtsnlrpcdyhsshqqglNKVKIVVIALGSSLLTVLVMLGLVSCClfrrrskqdleipaqegpsYLLKQVIEATENLNAKHVIGRGAHGivykaslgpnavFAVKKLAFRghkrgslsmKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMengslrdvlhsitppptlewnVRYKIALGAAHALAYlhydcdppivhrdikpenilldsemephisdfgiaklldkspasttsisvvgtigyiapenafttakskesdvySYGVVLLELITRKkaldpsykertdiVGWVrsvwsdteeinDIVDLSLMEEMLVSSIRDQVIDVLLVALRCtekkpsnrpnmRDVVRQLVDAsvpmtskyv
Flexible Loop (DISEMBL)
MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSnrlsgtipeSIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQlsgkippelgkCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRrskqdleipaqegpsYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFrghkrgslsmkreiqtigkirhrnlvrledfwLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENafttakskesdVYSYGVVLLELItrkkaldpsykertdivgwvrsvwsdteeiNDIVDLSLMEEMLVSSIRDQVIDVLLVALrctekkpsnrpnmrdvVRQLvdasvpmtskyv
Low Complexity Region (SEG)
MKflfchflllfssfvalslRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFEnlqnlqylnlygnllDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASleyllvynnnllgklPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISelekllelqlggnqlggeIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMnllgpspssfsgnpslCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIalgaahalaylhyDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKYV
Disordered region (IsUnstruct)
**FLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDL****LSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGR*******************NLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLL***********SLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCT*****************************
Disordered Region (DISOPRED)
MKFLFCHFLLLFSSFVALSLRS****NGDGVALLSLMRHWNS*PPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDS*************************IVVIALGSSLLTVLVMLGLVSCC*******************YLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHK*GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP***TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV*******
Disordered Region (DISEMBL)
MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKYV
Disordered Region (DISPRO)
*KFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTD**********PCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSC*********DLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKYV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1109	2.2.26 [Sep-21-2011]
P93194	1109	Receptor-like protein kin	N/A	no	0.994	0.994	0.562	0.0
Q9SSL9	1123	Leucine-rich repeat recep	yes	no	0.968	0.956	0.562	0.0
Q9FZ59	1088	Leucine-rich repeat recep	no	no	0.950	0.968	0.519	0.0
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.908	0.914	0.384	0.0
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.945	0.952	0.373	0.0
O49318	1124	Probable leucine-rich rep	no	no	0.944	0.931	0.359	1e-176
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.941	0.835	0.341	1e-170
Q9LHP4	1141	Receptor-like protein kin	no	no	0.866	0.842	0.375	1e-168
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.929	0.823	0.343	1e-167
C0LGV1	1135	LRR receptor-like serine/	no	no	0.923	0.902	0.349	1e-159

>sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2

 Score = 1171 bits (3029), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 624/1110 (56%), Positives = 784/1110 (70%), Gaps = 7/1110 (0%)

Query: 1    MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQ 60
            MK     FLL   S    S+ +  ALN DG ALLSL RHW S+P  I  SWN+SDSTPC 
Sbjct: 1    MKVAVNTFLLFLCS--TSSIYAAFALNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCS 58

Query: 61   WVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSA 120
            W+G+ECD     V + NLSSYG+SG+ GPEI HL  L+ + LS N F G+IP +LGNCS 
Sbjct: 59   WLGVECDRRQF-VDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSL 117

Query: 121  LEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLS 180
            LE++DLS+N FTG+IPD    LQNL+ L+L+ N L G  PE L  I  L+ V+   N L+
Sbjct: 118  LEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLN 177

Query: 181  GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
            GSIP N+G++ E+  LWL  N+ SG +P S+GN   LQELYLN+N L+G LP +L+NLEN
Sbjct: 178  GSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLEN 237

Query: 241  LVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT 300
            LVYLDV +N+L G I      CK +  + LS N+F+GG+ P LGNC+SL         L+
Sbjct: 238  LVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALS 297

Query: 301  GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSN 360
            G IPS FG L +L +L L+ N  SG+IPPELGKCK +  L L  NQLEGEIP ELG LS 
Sbjct: 298  GPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQ 357

Query: 361  LQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
            LQ L L+ N L+GE P+SIW+I SL+ L +Y NNL G+LP++MTELKQL +++LY N F+
Sbjct: 358  LQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFT 417

Query: 421  GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT 480
            GVIPQ LG NSSL  LD   N FTG IPPNLC  K+L+ L +G N   G +PS LG C T
Sbjct: 418  GVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCST 477

Query: 481  LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
            L R+IL++N L G LP+F +   L   D+S NN +G IP S+GN  N+T+I  SSN+ SG
Sbjct: 478  LERLILEENNLRGGLPDFVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSG 537

Query: 541  LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL 600
             +P ELG+LV L  LN+S N ++G LPS+LS C  L   D S NLLNGSIPS+L S   L
Sbjct: 538  SIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTEL 597

Query: 601  SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT 660
            + L L EN F+GGIPT + +  KLL LQLGGN L G+IPP +GALQ L  +LNLS N L 
Sbjct: 598  TKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPP-VGALQALR-SLNLSSNKLN 655

Query: 661  GRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGP 720
            G++P DL KL  LE+LD+S NNL+GTL  LS I SL  +N+S+NLF+GPVP +L   L  
Sbjct: 656  GQLPIDLGKLKMLEELDVSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNS 715

Query: 721  SPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHS-SHQQGLNKVKIVVIALGSSLLTV 779
            SP+SFSGN  LC+ C  +   +C  +S LRPC+  S + + GL+ + I +I LG+ L  +
Sbjct: 716  SPTSFSGNSDLCINC-PADGLACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFII 774

Query: 780  LVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS 839
             + L      L  ++S Q++ I AQEG   LL +V+EATENLN K+VIG+GAHG +YKA+
Sbjct: 775  CLFLFSAFLFLHCKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKAT 834

Query: 840  LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME 899
            L P+ V+AVKKL F G K GS+SM REI+TIGK+RHRNL++LE+FWLRK+ G+I+Y YME
Sbjct: 835  LSPDKVYAVKKLVFTGIKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYME 894

Query: 900  NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM 959
            NGSL D+LH   PP  L+W+ R+ IA+G AH LAYLH+DCDP IVHRDIKP NILLDS++
Sbjct: 895  NGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDL 954

Query: 960  EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            EPHISDFGIAKLLD+S  S  S +V GTIGY+APENAFTT KS+ESDVYSYGVVLLELIT
Sbjct: 955  EPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELIT 1014

Query: 1020 RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRC 1079
            RKKALDPS+   TDIVGWVRSVW+ T EI  IVD SL++E++ SS+ +QV + L +ALRC
Sbjct: 1015 RKKALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRC 1074

Query: 1080 TEKKPSNRPNMRDVVRQLVDASVPMTSKYV 1109
             EK+   RP MRDVV+QL   S+   S  V
Sbjct: 1075 AEKEVDKRPTMRDVVKQLTRWSIRSYSSSV 1104

Possible role in short-day photoperiod floral induction.
Ipomoea nil (taxid: 35883)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1

 Score = 1147 bits (2968), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 614/1091 (56%), Positives = 788/1091 (72%), Gaps = 17/1091 (1%)

Query: 22   SVNALNGDGVALLSLMRHWNSVPPLIISSW--NSSDSTPCQWVGIECDDDAHNVVSFNLS 79
            SV+ LN DG+ LLSL++H + VPP + S+W  N+S++TPC W GI CDD + NV S N +
Sbjct: 25   SVSCLNSDGLTLLSLLKHLDRVPPQVTSTWKINASEATPCNWFGITCDD-SKNVASLNFT 83

Query: 80   SYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNF 139
               VSGQLGPEIG L  LQ +DLS+NNFSG IP  LGNC+ L  LDLS NGF+  IPD  
Sbjct: 84   RSRVSGQLGPEIGELKSLQILDLSTNNFSGTIPSTLGNCTKLATLDLSENGFSDKIPDTL 143

Query: 140  ENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF 199
            ++L+ L+ L LY N L GE+PE LFRI  LQ ++L+ N+L+G IP+++GD KE+  L ++
Sbjct: 144  DSLKRLEVLYLYINFLTGELPESLFRIPKLQVLYLDYNNLTGPIPQSIGDAKELVELSMY 203

Query: 200  SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS 259
            +N+ SG IPESIGN   LQ LYL+ NKL+G LPESL+ L NL  L VG+N+L+G + FGS
Sbjct: 204  ANQFSGNIPESIGNSSSLQILYLHRNKLVGSLPESLNLLGNLTTLFVGNNSLQGPVRFGS 263

Query: 260  EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLS 319
              CKNL  LDLSYN F GG+ P LGNCSSL  L IV   L+G+IPSS G+L  L+ L+LS
Sbjct: 264  PNCKNLLTLDLSYNEFEGGVPPALGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLS 323

Query: 320  ENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI 379
            EN+LSG IP ELG C  L +L L  NQL G IP  LG+L  L+ LELF+NR +GE P+ I
Sbjct: 324  ENRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPSALGKLRKLESLELFENRFSGEIPIEI 383

Query: 380  WRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFI 439
            W+  SL  LLVY NNL G+LP+EMTE+K+LK  +L+NN F G IP  LG+NSSL ++DFI
Sbjct: 384  WKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFI 443

Query: 440  NNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFS 499
             N  TGEIPPNLC G++LR+LN+G N  HG IP+ +G C T+ R IL++N L+G LPEFS
Sbjct: 444  GNKLTGEIPPNLCHGRKLRILNLGSNLLHGTIPASIGHCKTIRRFILRENNLSGLLPEFS 503

Query: 500  KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISL 559
            ++  LS LD + NN  G IP S+G+  NL+SI+ S N+F+G +P +LGNL +L  +N+S 
Sbjct: 504  QDHSLSFLDFNSNNFEGPIPGSLGSCKNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSR 563

Query: 560  NHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFIS 619
            N +EGSLP+QLS C +LE FDV FN LNGS+PS+  +WK L+ L LSEN F+GGIP F+ 
Sbjct: 564  NLLEGSLPAQLSNCVSLERFDVGFNSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLP 623

Query: 620  ELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDIS 679
            EL+KL  LQ+  N  GGEIP SIG ++DL Y L+LS NGLTG IP+ L  L KL +L+IS
Sbjct: 624  ELKKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNIS 683

Query: 680  SNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSST 739
            +NNLTG+LS L  + SL+ V+VS N FTGP+P+ L   L   PSSFSGNP+LC+    S 
Sbjct: 684  NNNLTGSLSVLKGLTSLLHVDVSNNQFTGPIPDNLEGQLLSEPSSFSGNPNLCIP--HSF 741

Query: 740  DSSCFGTSNLRPC-DYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQD 798
             +S    S L+ C D   S + GL+  +IV+IA+ SSLL ++V+L LV  CL RR+ + +
Sbjct: 742  SASNNSRSALKYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPE 801

Query: 799  LE---IPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG 855
             +      +EGPS LL +V+ AT+NLN K+ IGRGAHGIVY+ASLG   V+AVK+L F  
Sbjct: 802  KDAYVFTQEEGPSLLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFAS 861

Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPP- 914
            H R + SM REI TIGK+RHRNL++LE FWLRKD G+++YRYM  GSL DVLH ++P   
Sbjct: 862  HIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKEN 921

Query: 915  TLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK 974
             L+W+ RY +ALG AH LAYLHYDC PPIVHRDIKPENIL+DS++EPHI DFG+A+LLD 
Sbjct: 922  VLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDD 981

Query: 975  SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
            S  ST   +V GT GYIAPENAF T + +ESDVYSYGVVLLEL+TRK+A+D S+ E TDI
Sbjct: 982  STVSTA--TVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDI 1039

Query: 1035 VGWVRSVWSDT-----EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN 1089
            V WVRS  S +     + +  IVD  L++E+L SS+R+QV+ V  +AL CT++ P+ RP 
Sbjct: 1040 VSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPT 1099

Query: 1090 MRDVVRQLVDA 1100
            MRD V+ L D 
Sbjct: 1100 MRDAVKLLEDV 1110

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1

 Score = 1053 bits (2722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 572/1101 (51%), Positives = 755/1101 (68%), Gaps = 47/1101 (4%)

Query: 10   LLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSW--NSSDSTPCQ--WVGIE 65
            LL S FV   + SV++LN DG+ALLSL++H++ VP  + S+W  N+S++TPC   W G+ 
Sbjct: 11   LLCSLFVYFRIDSVSSLNSDGLALLSLLKHFDKVPLEVASTWKENTSETTPCNNNWFGVI 70

Query: 66   CDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLD 125
            CD   + V + NLS+ G+SGQLG EIG L  L T                        LD
Sbjct: 71   CDLSGNVVETLNLSASGLSGQLGSEIGELKSLVT------------------------LD 106

Query: 126  LSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPR 185
            LS N F+G +P    N  +L+YL+L  N   GE+P+    +  L +++L+ N+LSG IP 
Sbjct: 107  LSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIPA 166

Query: 186  NVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLD 245
            +VG L E+  L +  N LSGTIPE +GNC +L+ L LN NKL G LP SL  LENL  L 
Sbjct: 167  SVGGLIELVDLRMSYNNLSGTIPELLGNCSKLEYLALNNNKLNGSLPASLYLLENLGELF 226

Query: 246  VGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS 305
            V +N+L GR++FGS  CK L  LDLS+N F GG+ P +GNCSSL  L +V   LTG+IPS
Sbjct: 227  VSNNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPS 286

Query: 306  SFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLE 365
            S G+L ++S +DLS+N+LSG IP ELG C  L  L L  NQL+GEIP  L +L  LQ LE
Sbjct: 287  SMGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLE 346

Query: 366  LFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQ 425
            LF N+L+GE P+ IW+I SL  +LVYNN L G+LP+E+T+LK LK ++L+NN F G IP 
Sbjct: 347  LFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPM 406

Query: 426  SLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVI 485
            SLG+N SL ++D + N FTGEIPP+LC G++LR+  +G NQ HG IP+ +  C TL RV 
Sbjct: 407  SLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVR 466

Query: 486  LKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQE 545
            L+ N+L+G LPEF ++  LS++++  N+  G+IP S+G+  NL +ID S NK +GL+P E
Sbjct: 467  LEDNKLSGVLPEFPESLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPE 526

Query: 546  LGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKL 605
            LGNL SL  LN+S N++EG LPSQLS C  L  FDV  N LNGSIPSS RSWKSLS L L
Sbjct: 527  LGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVL 586

Query: 606  SENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPS 665
            S+N+F G IP F++EL++L +L++  N  GG+IP S+G L+ L Y L+LS N  TG IP+
Sbjct: 587  SDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPT 646

Query: 666  DLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSF 725
             L  L  LE+L+IS+N LTG LS L ++ SL +V+VSYN FTGP+P   +NLL  S S F
Sbjct: 647  TLGALINLERLNISNNKLTGPLSVLQSLKSLNQVDVSYNQFTGPIP---VNLLSNS-SKF 702

Query: 726  SGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSL-LTVLVMLG 784
            SGNP LC++  +S   S       + C      Q  L+  KI +IA GSSL +  L+   
Sbjct: 703  SGNPDLCIQ--ASYSVSAIIRKEFKSC----KGQVKLSTWKIALIAAGSSLSVLALLFAL 756

Query: 785  LVSCCLFRRRSK-QDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPN 843
             +  C  +R +K +D  I A+EG S LL +V+ AT+NL+ K++IGRGAHG+VY+ASLG  
Sbjct: 757  FLVLCRCKRGTKTEDANILAEEGLSLLLNKVLAATDNLDDKYIIGRGAHGVVYRASLGSG 816

Query: 844  AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL 903
              +AVKKL F  H R + +MKREI+TIG +RHRNL+RLE FW+RK+ G+++Y+YM NGSL
Sbjct: 817  EEYAVKKLIFAEHIRANQNMKREIETIGLVRHRNLIRLERFWMRKEDGLMLYQYMPNGSL 876

Query: 904  RDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH 962
             DVLH        L+W+ R+ IALG +H LAYLH+DC PPI+HRDIKPENIL+DS+MEPH
Sbjct: 877  HDVLHRGNQGEAVLDWSARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMDSDMEPH 936

Query: 963  ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKK 1022
            I DFG+A++LD S  ST   +V GT GYIAPENA+ T +SKESDVYSYGVVLLEL+T K+
Sbjct: 937  IGDFGLARILDDSTVSTA--TVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELVTGKR 994

Query: 1023 ALDPSYKERTDIVGWVRSVWSDTEEIND----IVDLSLMEEMLVSSIRDQVIDVLLVALR 1078
            ALD S+ E  +IV WVRSV S  E+ +D    IVD  L++E+L + +R+Q I V  +ALR
Sbjct: 995  ALDRSFPEDINIVSWVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTDLALR 1054

Query: 1079 CTEKKPSNRPNMRDVVRQLVD 1099
            CT+K+P NRP+MRDVV+ L D
Sbjct: 1055 CTDKRPENRPSMRDVVKDLTD 1075

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  648 bits (1671), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/1079 (38%), Positives = 591/1079 (54%), Gaps = 71/1079 (6%)

Query: 48   ISSWNSSDSTPCQWVGIECDDDAHN--VVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSN 105
            + +WNS+DS PC W G+ C + + +  V+S NLSS  +SG+L P I              
Sbjct: 48   LRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSI-------------- 93

Query: 106  NFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFR 165
                      G    L+ LDLS NG +G IP    N  +L+ L L  N  DGEIP  + +
Sbjct: 94   ----------GGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGK 143

Query: 166  ILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNEN 225
            ++ L+ + + NN +SGS+P  +G+L  +  L  +SN +SG +P SIGN  RL      +N
Sbjct: 144  LVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQN 203

Query: 226  KLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGN 285
             + G LP  +   E+LV L +  N L G +       K L+ + L  N FSG I   + N
Sbjct: 204  MISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN 263

Query: 286  CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
            C+SL  L +  ++L G IP   G L  L  L L  N L+G IP E+G   Y   +    N
Sbjct: 264  CTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSEN 323

Query: 346  QLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTE 405
             L GEIP ELG +  L+ L LF+N+LTG  PV +  + +L  L +  N L G +PL    
Sbjct: 324  ALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQY 383

Query: 406  LKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQN 465
            L+ L  + L+ N  SG IP  LG  S L  LD  +N  +G IP  LC    + +LN+G N
Sbjct: 384  LRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTN 443

Query: 466  QFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGN 524
               G IP+ + +C TL ++ L +N L G  P    K   ++ +++ +N   G+IP  +GN
Sbjct: 444  NLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGN 503

Query: 525  SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN 584
               L  +  + N F+G +P+E+G L  L TLNIS N + G +PS++  CK L+  D+  N
Sbjct: 504  CSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCN 563

Query: 585  LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGA 644
              +G++PS + S   L +LKLS N+ +G IP  +  L +L ELQ+GGN   G IP  +G+
Sbjct: 564  NFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGS 623

Query: 645  LQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHSLVEVNVSY 703
            L  L  ALNLS N LTG IP +L  L  LE L +++NNL+G + S  +N+ SL+  N SY
Sbjct: 624  LTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSY 683

Query: 704  NLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLN 763
            N  TGP+P  L N+   S SSF GN  LC   L    + C  T    P    +    G+ 
Sbjct: 684  NSLTGPIP-LLRNI---SMSSFIGNEGLCGPPL----NQCIQTQPFAPSQ-STGKPGGMR 734

Query: 764  KVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQ---------------DLEIPAQEGPS 808
              KI+ I   + +  V +ML  +   L RR  +                D+  P +EG  
Sbjct: 735  SSKIIAIT-AAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG-- 791

Query: 809  YLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGS-----LSM 863
            +  + ++ AT+N +   V+GRGA G VYKA L      AVKKLA   H+ G+      S 
Sbjct: 792  FTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLA-SNHEGGNNNNVDNSF 850

Query: 864  KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
            + EI T+G IRHRN+V+L  F   +   +++Y YM  GSL ++LH   P   L+W+ R+K
Sbjct: 851  RAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD--PSCNLDWSKRFK 908

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            IALGAA  LAYLH+DC P I HRDIK  NILLD + E H+ DFG+AK++D  P S +  +
Sbjct: 909  IALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-PHSKSMSA 967

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043
            + G+ GYIAPE A+T   +++SD+YSYGVVLLEL+T K  + P   +  D+V WVRS   
Sbjct: 968  IAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIR 1026

Query: 1044 DTEEINDIVD--LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
                 + ++D  L+L +E +VS     ++ VL +AL CT   P  RP+MR VV  L+++
Sbjct: 1027 RDALSSGVLDARLTLEDERIVS----HMLTVLKIALLCTSVSPVARPSMRQVVLMLIES 1081

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  636 bits (1641), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 421/1126 (37%), Positives = 602/1126 (53%), Gaps = 77/1126 (6%)

Query: 1    MKFLFCHF-LLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPC 59
            M+   C   +++  SF  + +RS   LN +G  LL      N     + +SWN  DS PC
Sbjct: 1    MRGRICFLAIVILCSFSFILVRS---LNEEGRVLLEFKAFLNDSNGYL-ASWNQLDSNPC 56

Query: 60   QWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCS 119
             W GI C      V S +L+   +SG L P I  L  L+ +++S+N  SG IP  L  C 
Sbjct: 57   NWTGIACTH-LRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCR 115

Query: 120  ALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSL 179
            +LE LDL TN F                         G IP  L  I+ L+ ++L  N L
Sbjct: 116  SLEVLDLCTNRF------------------------HGVIPIQLTMIITLKKLYLCENYL 151

Query: 180  SGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLE 239
             GSIPR +G+L  ++ L ++SN L+G IP S+    +L+ +    N   G +P  +S  E
Sbjct: 152  FGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCE 211

Query: 240  NLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKL 299
            +L  L + +N LEG +    EK +NLT L L  NR SG I P++GN S L  L +  +  
Sbjct: 212  SLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYF 271

Query: 300  TGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLS 359
            TGSIP   G L ++  L L  NQL+G+IP E+G       +    NQL G IP E G + 
Sbjct: 272  TGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHIL 331

Query: 360  NLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQF 419
            NL+ L LF+N L G  P  +  +  LE L +  N L G +P E+  L  L ++ L++NQ 
Sbjct: 332  NLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQL 391

Query: 420  SGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCP 479
             G IP  +G  S+   LD   NS +G IP + C  + L +L++G N+  G IP  L +C 
Sbjct: 392  EGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCK 451

Query: 480  TLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKF 538
            +L +++L  NQLTG+LP E      L+ L++ +N +SG I + +G   NL  +  ++N F
Sbjct: 452  SLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNF 511

Query: 539  SGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWK 598
            +G +P E+GNL  +V  NIS N + G +P +L  C  ++  D+S N  +G I   L    
Sbjct: 512  TGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLV 571

Query: 599  SLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNG 658
             L IL+LS+N  TG IP    +L +L+ELQLGGN L   IP  +G L  L  +LN+S N 
Sbjct: 572  YLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNN 631

Query: 659  LTGRIPSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
            L+G IP  L  L  LE L ++ N L+G + + + N+ SL+  N+S N   G VP+T +  
Sbjct: 632  LSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAV-F 690

Query: 718  LGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQ--------QGLNKVKIVV 769
                 S+F+GN  LC    +S  S C      +P   HS  +        Q    + I  
Sbjct: 691  QRMDSSNFAGNHGLC----NSQRSHC------QPLVPHSDSKLNWLINGSQRQKILTITC 740

Query: 770  IALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGP-----------SYLLKQVIEAT 818
            I +GS  L  +  LGL  C   +RR    + +  Q  P            +  + +++AT
Sbjct: 741  IVIGSVFL--ITFLGL--CWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDAT 796

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRN 877
             N +   V+GRGA G VYKA +    V AVKKL  RG    S  S + EI T+GKIRHRN
Sbjct: 797  RNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRN 856

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            +V+L  F   ++  +++Y YM  GSL + L        L+WN RY+IALGAA  L YLH+
Sbjct: 857  IVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHH 916

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            DC P IVHRDIK  NILLD   + H+ DFG+AKL+D S + + S +V G+ GYIAPE A+
Sbjct: 917  DCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS-AVAGSYGYIAPEYAY 975

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057
            T   +++ D+YS+GVVLLELIT K  + P  ++  D+V WVR         N I  + + 
Sbjct: 976  TMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIR-----NMIPTIEMF 1029

Query: 1058 EEMLVSSIRDQVID---VLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
            +  L ++ +  V +   VL +AL CT   P++RP MR+VV  + +A
Sbjct: 1030 DARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEA 1075

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  619 bits (1597), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 411/1142 (35%), Positives = 597/1142 (52%), Gaps = 95/1142 (8%)

Query: 2    KFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQW 61
            K +F   L L +  V  S     +LN DG  LL L           + +WN  D TPC W
Sbjct: 13   KSMFVGVLFLLTLLVWTS----ESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNW 68

Query: 62   VGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSAL 121
            +G+ C     +  S +L                  + ++DLSS N SG + P +G     
Sbjct: 69   IGVNCSSQGSSSSSNSLV-----------------VTSLDLSSMNLSGIVSPSIGG---- 107

Query: 122  EYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSG 181
                                L NL YLNL  N L G+IP  +     L+ +FLNNN   G
Sbjct: 108  --------------------LVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGG 147

Query: 182  SIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENL 241
            SIP  +  L ++ +  + +N+LSG +PE IG+ Y L+EL    N L G LP SL NL  L
Sbjct: 148  SIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKL 207

Query: 242  VYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG 301
                 G N+  G I     KC NL  L L+ N  SG +   +G    L  + +  +K +G
Sbjct: 208  TTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSG 267

Query: 302  SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNL 361
             IP   G L  L +L L  N L G IP E+G  K L  L+LY NQL G IP ELG+LS +
Sbjct: 268  FIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKV 327

Query: 362  QDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQL------------ 409
             +++  +N L+GE PV + +I+ L  L ++ N L G +P E+++L+ L            
Sbjct: 328  MEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTG 387

Query: 410  ------------KNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQL 457
                        + + L++N  SGVIPQ LG+ S L  +DF  N  +G+IPP +C    L
Sbjct: 388  PIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNL 447

Query: 458  RVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISG 516
             +LN+G N+  G IP  +  C +L ++ +  N+LTG  P E  K   LS +++ +N  SG
Sbjct: 448  ILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSG 507

Query: 517  AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
             +P  IG    L  +  ++N+FS  +P E+  L +LVT N+S N + G +PS+++ CK L
Sbjct: 508  PLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKML 567

Query: 577  EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG 636
            +  D+S N   GS+P  L S   L IL+LSEN F+G IP  I  L  L ELQ+GGN   G
Sbjct: 568  QRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSG 627

Query: 637  EIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHS 695
             IPP +G L  L  A+NLS N  +G IP ++  L  L  L +++N+L+G + +   N+ S
Sbjct: 628  SIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSS 687

Query: 696  LVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYH 755
            L+  N SYN  TG +P T +     + +SF GN  LC   L S D S     ++      
Sbjct: 688  LLGCNFSYNNLTGQLPHTQI-FQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKAG 746

Query: 756  SSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYL----- 810
            S+ +  +  +   VI   S LL  +V+  L +          D E   QE   Y      
Sbjct: 747  SARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKER 806

Query: 811  --LKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKL------AFRGHKRGSLS 862
              +K ++EAT+  +  +++GRGA G VYKA +      AVKKL                S
Sbjct: 807  FTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNS 866

Query: 863  MKREIQTIGKIRHRNLVRLEDFWLRK--DCGIIMYRYMENGSLRDVLHSITPPPTLEWNV 920
             + EI T+GKIRHRN+VRL  F   +  +  +++Y YM  GSL ++LH      +++W  
Sbjct: 867  FRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHG-GKSHSMDWPT 925

Query: 921  RYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
            R+ IALGAA  LAYLH+DC P I+HRDIK  NIL+D   E H+ DFG+AK++D  P S +
Sbjct: 926  RFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDM-PLSKS 984

Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
              +V G+ GYIAPE A+T   +++ D+YS+GVVLLEL+T K  + P  ++  D+  W R+
Sbjct: 985  VSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGDLATWTRN 1043

Query: 1041 VWSDTEEINDIVD--LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098
               D    ++I+D  L+ +E+     I + +I V  +A+ CT+  PS+RP MR+VV  L+
Sbjct: 1044 HIRDHSLTSEILDPYLTKVED---DVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLI 1100

Query: 1099 DA 1100
            ++
Sbjct: 1101 ES 1102

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  598 bits (1543), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 416/1217 (34%), Positives = 604/1217 (49%), Gaps = 173/1217 (14%)

Query: 48   ISSWNSSDSTPCQWVGIECDDDA-HNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNN 106
            +  WNS +   C W G+ CD+     V++ NL+  G++G + P  G    L  +DLSSNN
Sbjct: 47   LRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNN 106

Query: 107  FSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRI 166
              G IP  L N ++LE L L +N  TG+IP    +L N++ L +  N L G+IPE L  +
Sbjct: 107  LVGPIPTALSNLTSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNL 166

Query: 167  LGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENK 226
            + LQ + L +  L+G IP  +G L  V++L L  N L G IP  +GNC  L      EN 
Sbjct: 167  VNLQMLALASCRLTGPIPSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENM 226

Query: 227  LMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNC 286
            L G +P  L  LENL  L++ +N+L G I     +   L +L L  N+  G I  +L + 
Sbjct: 227  LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADL 286

Query: 287  SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN------------------------- 321
             +L  LD+  + LTG IP  F  +++L  L L+ N                         
Sbjct: 287  GNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGT 346

Query: 322  QLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWR 381
            QLSG+IP EL KC+ L  L L  N L G IP+ L +L  L DL L +N L G    SI  
Sbjct: 347  QLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISN 406

Query: 382  IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN 441
            + +L++L++Y+NNL GKLP E++ L++L+ + LY N+FSG IPQ +G  +SL  +D   N
Sbjct: 407  LTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGN 466

Query: 442  SFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE---- 497
             F GEIPP++   K+L +L++ QN+  G +P+ LG+C  L  + L  NQL+G++P     
Sbjct: 467  HFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF 526

Query: 498  --------FSKNPV------------------LSH------------------LDVSRNN 513
                       N +                  LSH                   DV+ N 
Sbjct: 527  LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNG 586

Query: 514  ISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKC 573
                IP  +GNS NL  +    N+ +G +P  LG +  L  L++S N + G++P QL  C
Sbjct: 587  FEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLC 646

Query: 574  KNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS--------------------------- 606
            K L   D++ N L+G IP  L     L  LKLS                           
Sbjct: 647  KKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNS 706

Query: 607  ---------------------ENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGAL 645
                                 +N F+G +P  + +L KL EL+L  N L GEIP  IG L
Sbjct: 707  LNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQL 766

Query: 646  QDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHSLVEVNVSYN 704
            QDL  AL+LS N  TG IPS +  LSKLE LD+S N LTG +   + ++ SL  +NVS+N
Sbjct: 767  QDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFN 826

Query: 705  LFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNK 764
               G + +           SF GN  LC   LS  +               ++ QQGL+ 
Sbjct: 827  NLGGKLKKQFSRW---PADSFLGNTGLCGSPLSRCNRV-----------RSNNKQQGLSA 872

Query: 765  VKIVVIALGSSLLTVLVMLGLVSCCLFRRR--------------SKQDLEIPAQEGPSY- 809
              +V+I+  S+L  + +M+ LV    F++R              +       A   P + 
Sbjct: 873  RSVVIISAISALTAIGLMI-LVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFR 931

Query: 810  --------LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL 861
                      + ++EAT NL+ + +IG G  G VYKA L      AVKK+ ++     + 
Sbjct: 932  NGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNK 991

Query: 862  SMKREIQTIGKIRHRNLVRLEDFWLRKDCG--IIMYRYMENGSLRDVLHSITP-----PP 914
            S  RE++T+G+IRHR+LV+L  +   K  G  +++Y YM+NGS+ D LH   P       
Sbjct: 992  SFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKK 1051

Query: 915  TLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK 974
             L+W  R +IA+G A  + YLH+DC PPIVHRDIK  N+LLDS ME H+ DFG+AK+L +
Sbjct: 1052 LLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTE 1111

Query: 975  SPASTTSISV--VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032
            +  + T  +     + GYIAPE A++   +++SDVYS G+VL+E++T K   D  +    
Sbjct: 1112 NCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEM 1171

Query: 1033 DIVGWVRSVWSDTEEIND-IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
            D+V WV +         D ++D  L  + L+    D    VL +AL+CT+  P  RP+ R
Sbjct: 1172 DMVRWVETHLEVAGSARDKLIDPKL--KPLLPFEEDAACQVLEIALQCTKTSPQERPSSR 1229

Query: 1092 DVVRQLVDASVPMTSKY 1108
                 L+      T+ Y
Sbjct: 1230 QACDSLLHVYNNRTAGY 1246

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  594 bits (1531), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 381/1014 (37%), Positives = 555/1014 (54%), Gaps = 53/1014 (5%)

Query: 118  CSALEYLDLSTNGFTGDI-----------PDNFENLQNLQYLNLYGNLLDGEIPEPLFRI 166
            C+   ++  S+ GF  DI           P N    ++LQ L + G  L G +PE L   
Sbjct: 69   CNNWTFITCSSQGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDC 128

Query: 167  LGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENK 226
            LGL+ + L++N L G IP ++  L+ +E L L SN+L+G IP  I  C +L+ L L +N 
Sbjct: 129  LGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNL 188

Query: 227  LMGFLPESLSNLENLVYLDVGDNN-LEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGN 285
            L G +P  L  L  L  + +G N  + G+I      C NLT L L+    SG +  +LG 
Sbjct: 189  LTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGK 248

Query: 286  CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
               L  L I  + ++G IPS  G  + L  L L EN LSG IP E+G+   L  L L+ N
Sbjct: 249  LKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQN 308

Query: 346  QLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTE 405
             L G IP+E+G  SNL+ ++L  N L+G  P SI R++ LE  ++ +N   G +P  ++ 
Sbjct: 309  SLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISN 368

Query: 406  LKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQN 465
               L  + L  NQ SG+IP  LG  + L      +N   G IPP L     L+ L++ +N
Sbjct: 369  CSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRN 428

Query: 466  QFHGPIPSLLGSCPTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGN 524
               G IPS L     L +++L  N L+G +P E      L  L +  N I+G IPS IG+
Sbjct: 429  SLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGS 488

Query: 525  SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN 584
               +  +DFSSN+  G +P E+G+   L  +++S N +EGSLP+ +S    L+V DVS N
Sbjct: 489  LKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSAN 548

Query: 585  LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGA 644
              +G IP+SL    SL+ L LS+N F+G IPT +     L  L LG N+L GEIP  +G 
Sbjct: 549  QFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGD 608

Query: 645  LQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYN 704
            +++L  ALNLS N LTG+IPS +  L+KL  LD+S N L G L+PL+NI +LV +N+SYN
Sbjct: 609  IENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYN 668

Query: 705  LFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQG--- 761
             F+G +P+  +     SP    GN  LC    SST  SCF T       Y   +  G   
Sbjct: 669  SFSGYLPDNKL-FRQLSPQDLEGNKKLC----SSTQDSCFLT-------YRKGNGLGDDG 716

Query: 762  -LNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLK-------- 812
              ++ + + + L   +   +V++ L +  + R R   D E  ++ G +Y  +        
Sbjct: 717  DASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLN 776

Query: 813  -QVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKL----AFRGHKRGSLSMK--- 864
              V +    L   +VIG+G  G+VY+A +    V AVKKL       GH   + +++   
Sbjct: 777  FSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSF 836

Query: 865  -REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
              E++T+G IRH+N+VR       ++  ++MY YM NGSL  +LH      +L+W++RY+
Sbjct: 837  SAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHE-RRGSSLDWDLRYR 895

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            I LGAA  LAYLH+DC PPIVHRDIK  NIL+  + EP+I+DFG+AKL+D+      S +
Sbjct: 896  ILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNT 955

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043
            V G+ GYIAPE  ++   +++SDVYSYGVV+LE++T K+ +DP+  E   +V WVR    
Sbjct: 956  VAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRG 1015

Query: 1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              E    ++D +L       +  D+++ VL  AL C    P  RP M+DV   L
Sbjct: 1016 SLE----VLDSTLRSRTEAEA--DEMMQVLGTALLCVNSSPDERPTMKDVAAML 1063

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  589 bits (1519), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 416/1210 (34%), Positives = 590/1210 (48%), Gaps = 179/1210 (14%)

Query: 47   IISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNN 106
            ++  WNS   + C W G+ C      ++  NLS  G++G + P IG  + L  IDLSSN 
Sbjct: 49   VLRDWNSGSPSYCNWTGVTCG--GREIIGLNLSGLGLTGSISPSIGRFNNLIHIDLSSNR 106

Query: 107  F-------------------------SGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFEN 141
                                      SG+IP +LG+   L+ L L  N   G IP+ F N
Sbjct: 107  LVGPIPTTLSNLSSSLESLHLFSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGN 166

Query: 142  LQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGD------------ 189
            L NLQ L L    L G IP    R++ LQ + L +N L G IP  +G+            
Sbjct: 167  LVNLQMLALASCRLTGLIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFN 226

Query: 190  ------------LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSN 237
                        LK ++ L L  N  SG IP  +G+   +Q L L  N+L G +P+ L+ 
Sbjct: 227  RLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTE 286

Query: 238  LENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGG------------------- 278
            L NL  LD+  NNL G I+    +   L FL L+ NR SG                    
Sbjct: 287  LANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSE 346

Query: 279  ------ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELG 332
                  I   + NC SL  LD+  + LTG IP S   L  L++L L+ N L G +   + 
Sbjct: 347  TQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSIS 406

Query: 333  KCKYLTVLHLYANQLEGEIPDELGQL------------------------SNLQDLELFD 368
                L    LY N LEG++P E+G L                        + LQ+++ + 
Sbjct: 407  NLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYG 466

Query: 369  NRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLG 428
            NRL+GE P SI R+  L  L +  N L+G +P  +    Q+  I L +NQ SG IP S G
Sbjct: 467  NRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFG 526

Query: 429  -----------------------IN-SSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQ 464
                                   IN  +L +++F +N F G I P LC        ++ +
Sbjct: 527  FLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISP-LCGSSSYLSFDVTE 585

Query: 465  NQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIG 523
            N F G IP  LG    L R+ L +NQ TG +P  F K   LS LD+SRN++SG IP  +G
Sbjct: 586  NGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELG 645

Query: 524  NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSF 583
                LT ID ++N  SG++P  LG L  L  L +S N   GSLP+++    N+    +  
Sbjct: 646  LCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDG 705

Query: 584  NLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIG 643
            N LNGSIP  + + ++L+ L L EN  +G +P+ I +L KL EL+L  N L GEIP  IG
Sbjct: 706  NSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIG 765

Query: 644  ALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHSLVEVNVS 702
             LQDL  AL+LS N  TGRIPS +  L KLE LD+S N L G +   + ++ SL  +N+S
Sbjct: 766  QLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLS 825

Query: 703  YNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGL 762
            YN   G + +           +F GN  LC   LS  + +             S +Q+ L
Sbjct: 826  YNNLEGKLKKQFSRW---QADAFVGNAGLCGSPLSHCNRA------------GSKNQRSL 870

Query: 763  NKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLL----------- 811
            +   +V+I+  SSL  + +M+ LV    F++    DL    + G S              
Sbjct: 871  SPKTVVIISAISSLAAIALMV-LVIILFFKQ--NHDLFKKVRGGNSAFSSNSSSSQAPLF 927

Query: 812  -----------KQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGS 860
                         ++EAT  LN + +IG G  G VYKA L      AVKK+ ++     +
Sbjct: 928  SNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSN 987

Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCG--IIMYRYMENGSLRDVLHS---ITPPPT 915
             S  RE++T+G IRHR+LV+L  +   K  G  +++Y YM NGS+ D LH+         
Sbjct: 988  KSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEV 1047

Query: 916  LEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W  R KIALG A  + YLHYDC PPIVHRDIK  N+LLDS +E H+ DFG+AK+L  +
Sbjct: 1048 LGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGN 1107

Query: 976  PASTTSISVV--GTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033
              + T  + +  G+ GYIAPE A++   +++SDVYS G+VL+E++T K   +  + E TD
Sbjct: 1108 YDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETD 1167

Query: 1034 IVGWVRSVWSD---TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM 1090
            +V WV +V      +E    ++D  L  + L+    +    VL +AL+CT+  P  RP+ 
Sbjct: 1168 MVRWVETVLDTPPGSEAREKLIDSEL--KSLLPCEEEAAYQVLEIALQCTKSYPQERPSS 1225

Query: 1091 RDVVRQLVDA 1100
            R     L++ 
Sbjct: 1226 RQASEYLLNV 1235

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  565 bits (1455), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 389/1114 (34%), Positives = 572/1114 (51%), Gaps = 90/1114 (8%)

Query: 7    HFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIEC 66
            HF +  S F+A  + S +A   +  AL+S +   NS PP + S WN SDS PCQW  I C
Sbjct: 17   HFSITLSLFLAFFISSTSASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYITC 76

Query: 67   DDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDL 126
                + +V+                        I++ S   +   PP + + ++L+ L +
Sbjct: 77   SSSDNKLVT-----------------------EINVVSVQLALPFPPNISSFTSLQKLVI 113

Query: 127  STNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRN 186
            S    TG I                     G+  E       L  + L++NSL G IP +
Sbjct: 114  SNTNLTGAISSEI-----------------GDCSE-------LIVIDLSSNSLVGEIPSS 149

Query: 187  VGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDV 246
            +G LK ++ L L SN L+G IP  +G+C  L+ L + +N L   LP  L  +  L  +  
Sbjct: 150  LGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKISTLESIRA 209

Query: 247  GDNN-LEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS 305
            G N+ L G+I      C+NL  L L+  + SG +  +LG  S L  L +  + L+G IP 
Sbjct: 210  GGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTMLSGEIPK 269

Query: 306  SFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLE 365
              G  + L +L L +N LSG +P ELGK + L  + L+ N L G IP+E+G + +L  ++
Sbjct: 270  ELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAID 329

Query: 366  LFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQ 425
            L  N  +G  P S   +++L+ L++ +NN+ G +P  ++   +L    +  NQ SG+IP 
Sbjct: 330  LSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPP 389

Query: 426  SLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVI 485
             +G+   L       N   G IP  L   + L+ L++ QN   G +P+ L     L +++
Sbjct: 390  EIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLL 449

Query: 486  LKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQ 544
            L  N ++G +P E      L  L +  N I+G IP  IG   NL+ +D S N  SG +P 
Sbjct: 450  LISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPL 509

Query: 545  ELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILK 604
            E+ N   L  LN+S N ++G LP  LS    L+V DVS N L G IP SL    SL+ L 
Sbjct: 510  EISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLI 569

Query: 605  LSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIP 664
            LS+N F G IP+ +     L  L L  N + G IP  +  +QDL  ALNLS N L G IP
Sbjct: 570  LSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIP 629

Query: 665  SDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPET--LMNLLGPSP 722
              +  L++L  LDIS N L+G LS LS + +LV +N+S+N F+G +P++     L+G   
Sbjct: 630  ERISALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIG--- 686

Query: 723  SSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVM 782
            +   GN  LC K   S    CF +++ +       H   L     + I L  S+  VL +
Sbjct: 687  AEMEGNNGLCSKGFRS----CFVSNSSQLTTQRGVHSHRLR----IAIGLLISVTAVLAV 738

Query: 783  LGLVSCCLFRRRSKQDLEIPAQEG-------PSYLLKQVIEAT-ENLNAKHVIGRGAHGI 834
            LG+++    ++  + D +    E        P   L   +E   + L   +VIG+G  GI
Sbjct: 739  LGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGI 798

Query: 835  VYKASLGPNAVFAVKKL-----------AFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            VYKA +    V AVKKL                 R S S   E++T+G IRH+N+VR   
Sbjct: 799  VYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSA--EVKTLGSIRHKNIVRFLG 856

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
                K+  ++MY YM NGSL  +LH  +   +L W VRYKI LGAA  LAYLH+DC PPI
Sbjct: 857  CCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPI 916

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            VHRDIK  NIL+  + EP+I DFG+AKL+D    + +S ++ G+ GYIAPE  ++   ++
Sbjct: 917  VHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITE 976

Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDVYSYGVV+LE++T K+ +DP+  +   IV WV+       +I DI  +    +    
Sbjct: 977  KSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVK-------KIRDIQVIDQGLQARPE 1029

Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            S  ++++  L VAL C    P +RP M+DV   L
Sbjct: 1030 SEVEEMMQTLGVALLCINPIPEDRPTMKDVAAML 1063

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1109
224100529	1081	predicted protein [Populus trichocarpa]	0.963	0.987	0.665	0.0
225443276	1105	PREDICTED: receptor-like protein kinase-	0.986	0.990	0.63	0.0
356555936	1084	PREDICTED: receptor-like protein kinase-	0.961	0.983	0.598	0.0
255568055	1054	Receptor protein kinase CLAVATA1 precurs	0.872	0.918	0.634	0.0
357442807	1088	Receptor-like protein kinase [Medicago t	0.976	0.995	0.567	0.0
449526646	1104	PREDICTED: receptor-like protein kinase-	0.990	0.995	0.580	0.0
449461709	1294	PREDICTED: receptor-like protein kinase-	0.966	0.828	0.587	0.0
356574697	1082	PREDICTED: receptor-like protein kinase-	0.960	0.984	0.581	0.0
449461711	1118	PREDICTED: receptor-like protein kinase-	0.988	0.980	0.563	0.0
46396756	1109	RecName: Full=Receptor-like protein kina	0.994	0.994	0.562	0.0

>gi|224100529|ref|XP_002311912.1| predicted protein [Populus trichocarpa] gi|222851732|gb|EEE89279.1| predicted protein [Populus trichocarpa]

 Score = 1423 bits (3684), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 717/1077 (66%), Positives = 854/1077 (79%), Gaps = 9/1077 (0%)

Query: 34   LSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGH 93
            +SL+R W+SVP  I SSWNSSDSTPC W+GI CD  +H VVS NLS  G+SG LGPE G 
Sbjct: 1    MSLLRKWDSVPTSITSSWNSSDSTPCSWLGIGCDHRSHCVVSLNLSGLGISGPLGPETGQ 60

Query: 94   LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
            L +L+T+DL++N FSG+IP +LGNCS LEYLDLS N FTG IPD+F+ LQNLQ L ++ N
Sbjct: 61   LKQLKTVDLNTNYFSGDIPSQLGNCSLLEYLDLSANSFTGGIPDSFKYLQNLQTLIIFSN 120

Query: 154  LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
             L GEIPE LF+ L LQ ++L+ N  +GSIPR+VG+L E+  L LF N+LSGTIPESIGN
Sbjct: 121  SLSGEIPESLFQDLALQVLYLDTNKFNGSIPRSVGNLTELLELSLFGNQLSGTIPESIGN 180

Query: 214  CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
            C +LQ L L+ NKL G LPE L+NLE+LV L V  N+LEGRI  G  KCKNL  LDLS+N
Sbjct: 181  CRKLQSLPLSYNKLSGSLPEILTNLESLVELFVSHNSLEGRIPLGFGKCKNLETLDLSFN 240

Query: 274  RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGK 333
             +SGG+ P+LGNCSSL  L I+ S L G+IPSSFG L +LS LDLSEN+LSG IPPEL  
Sbjct: 241  SYSGGLPPDLGNCSSLATLAIIHSNLRGAIPSSFGQLKKLSVLDLSENRLSGTIPPELSN 300

Query: 334  CKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNN 393
            CK L  L+LY N+LEG+IP ELG+L+ L+DLELF+N L+G  P+SIW+IASL+YLLVYNN
Sbjct: 301  CKSLMTLNLYTNELEGKIPSELGRLNKLEDLELFNNHLSGAIPISIWKIASLKYLLVYNN 360

Query: 394  NLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCF 453
            +L G+LPLE+T LK LKN+SLYNNQF GVIPQSLGINSSL+QLDF +N FTGEIPPNLC 
Sbjct: 361  SLSGELPLEITHLKNLKNLSLYNNQFFGVIPQSLGINSSLLQLDFTDNKFTGEIPPNLCH 420

Query: 454  GKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNN 513
            GKQLRVLNMG+NQ  G IPS +G C TLWR+ILK+N L+GALPEFS+NP+L H+DVS+NN
Sbjct: 421  GKQLRVLNMGRNQLQGSIPSDVGGCLTLWRLILKENNLSGALPEFSENPILYHMDVSKNN 480

Query: 514  ISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKC 573
            I+G IP SIGN   LTSI  S NK +G +P ELGNLV+L+ +++S N +EGSLPSQLSKC
Sbjct: 481  ITGPIPPSIGNCSGLTSIHLSMNKLTGFIPSELGNLVNLLVVDLSSNQLEGSLPSQLSKC 540

Query: 574  KNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQ 633
             NL  FDV FN LNGS+PSSLR+W SLS L L ENHF GGIP F+SELEKL E+QLGGN 
Sbjct: 541  HNLGKFDVGFNSLNGSVPSSLRNWTSLSTLILKENHFIGGIPPFLSELEKLTEIQLGGNF 600

Query: 634  LGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNI 693
            LGGEIP  IG+LQ L YALNLS NGL G +PS+L  L KLEQL +S+NNLTGTL+PL  I
Sbjct: 601  LGGEIPSWIGSLQSLQYALNLSSNGLFGELPSELGNLIKLEQLQLSNNNLTGTLAPLDKI 660

Query: 694  HSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCD 753
            HSLV+V++SYN F+GP+PETLMNLL  SPSSF GNP LCV CL S   +C    +++PCD
Sbjct: 661  HSLVQVDISYNHFSGPIPETLMNLLNSSPSSFWGNPDLCVSCLPSGGLTCTKNRSIKPCD 720

Query: 754  YHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDL------EIPAQEGP 807
              SS +   ++V + +IA+ +S++ V +++GLV   +  RR KQDL      EI AQEGP
Sbjct: 721  SQSSKRDSFSRVAVALIAI-ASVVAVFMLVGLVCMFILCRRCKQDLGIDHDVEIAAQEGP 779

Query: 808  SYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREI 867
            S LL +V++ATENLN +H++GRG HG VYKASLG + +FAVKK+ F GHK G+ SM  EI
Sbjct: 780  SSLLNKVMQATENLNDRHIVGRGTHGTVYKASLGGDKIFAVKKIVFTGHKGGNKSMVTEI 839

Query: 868  QTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            QTIGKIRHRNL++LE+FWLRKD G+I+Y YM+NGS+ DVLH  TPP TLEW++R+KIALG
Sbjct: 840  QTIGKIRHRNLLKLENFWLRKDYGLILYAYMQNGSVHDVLHGSTPPQTLEWSIRHKIALG 899

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
             AH L YLHYDC+PPIVHRDIKPENILLDS+MEPHISDFGIAKLLD+S AS  S  V GT
Sbjct: 900  TAHGLEYLHYDCNPPIVHRDIKPENILLDSDMEPHISDFGIAKLLDQSSASAQSFLVAGT 959

Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            IGYIAPENA +T KSKESDVYSYGVVLLELITRKKALDP +   TDIV WVRSVWS TE+
Sbjct: 960  IGYIAPENALSTIKSKESDVYSYGVVLLELITRKKALDPLFVGETDIVEWVRSVWSSTED 1019

Query: 1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV--DASV 1102
            IN I D SL EE L S+I +Q IDVLLVALRCTEK P  RP MRDVV++LV  DAS+
Sbjct: 1020 INKIADSSLREEFLDSNIMNQAIDVLLVALRCTEKAPRRRPTMRDVVKRLVKRDASI 1076

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225443276|ref|XP_002273607.1| PREDICTED: receptor-like protein kinase-like [Vitis vinifera]

 Score = 1343 bits (3476), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 693/1100 (63%), Positives = 842/1100 (76%), Gaps = 6/1100 (0%)

Query: 8    FLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECD 67
            FLLL++    + L  V  L+ DG +L++L   W +VP  +  SWN+S STPC WVG+ CD
Sbjct: 10   FLLLWN---CMCLFPVCGLSSDGKSLMALKSKW-AVPTFMEESWNASHSTPCSWVGVSCD 65

Query: 68   DDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLS 127
            +  H VVS N+S  G+SG LGPEI  L  L ++D S N+FSG IPP+ GNCS L  LDLS
Sbjct: 66   E-THIVVSLNVSGLGISGHLGPEIADLRHLTSVDFSYNSFSGPIPPEFGNCSLLMDLDLS 124

Query: 128  TNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV 187
             NGF G+IP N  +L  L+YL+   N L G +PE LFRI  L+ ++LN+N LSGSIP NV
Sbjct: 125  VNGFVGEIPQNLNSLGKLEYLSFCNNSLTGAVPESLFRIPNLEMLYLNSNKLSGSIPLNV 184

Query: 188  GDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVG 247
            G+  ++ ALWL+ N LSG IP SIGNC  L+ELYLN N+ +G LPES++NLENLVYLDV 
Sbjct: 185  GNATQIIALWLYDNALSGDIPSSIGNCSELEELYLNHNQFLGVLPESINNLENLVYLDVS 244

Query: 248  DNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSF 307
            +NNLEG+I  GS  CK L  L LS N F G I P LGNC+SL+    + ++L+GSIPSSF
Sbjct: 245  NNNLEGKIPLGSGYCKKLDTLVLSMNGFGGEIPPGLGNCTSLSQFAALNNRLSGSIPSSF 304

Query: 308  GLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELF 367
            GLL +L  L LSEN LSGKIPPE+G+CK L  LHLY NQLEGEIP ELG L+ LQDL LF
Sbjct: 305  GLLHKLLLLYLSENHLSGKIPPEIGQCKSLRSLHLYMNQLEGEIPSELGMLNELQDLRLF 364

Query: 368  DNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSL 427
            +NRLTGE P+SIW+I SLE +LVYNN L G+LP+E+TELK LKNISL+NN+FSGVIPQ L
Sbjct: 365  NNRLTGEIPISIWKIPSLENVLVYNNTLSGELPVEITELKHLKNISLFNNRFSGVIPQRL 424

Query: 428  GINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK 487
            GINSSL+QLD  NN FTGEIP ++CFGKQL VLNMG N   G IPS +GSC TL R+IL+
Sbjct: 425  GINSSLVQLDVTNNKFTGEIPKSICFGKQLSVLNMGLNLLQGSIPSAVGSCSTLRRLILR 484

Query: 488  QNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG 547
            +N LTG LP F+KNP L  LD+S N I+G IP S+GN  N+TSI+ S N+ SGL+PQELG
Sbjct: 485  KNNLTGVLPNFAKNPNLLLLDLSENGINGTIPLSLGNCTNVTSINLSMNRLSGLIPQELG 544

Query: 548  NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSE 607
            NL  L  LN+S N + G LPSQLS CKNL  FDV FN LNGS PSSLRS ++LS+L L E
Sbjct: 545  NLNVLQALNLSHNDLGGPLPSQLSNCKNLFKFDVGFNSLNGSFPSSLRSLENLSVLILRE 604

Query: 608  NHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDL 667
            N FTGGIP+F+SEL+ L E+QLGGN LGG IP SIG LQ+L Y+LN+S N LTG +P +L
Sbjct: 605  NRFTGGIPSFLSELQYLSEIQLGGNFLGGNIPSSIGMLQNLIYSLNISHNRLTGSLPLEL 664

Query: 668  EKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSG 727
             KL  LE+LDIS NNL+GTLS L  +HSLV V+VSYNLF GP+PETL+  L  SPSS  G
Sbjct: 665  GKLIMLERLDISHNNLSGTLSALDGLHSLVVVDVSYNLFNGPLPETLLLFLNSSPSSLQG 724

Query: 728  NPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVS 787
            NP LCVKC  +   +C    N RPC+++SS+++ L K++I  IA  +SLL+ LV++GLV 
Sbjct: 725  NPDLCVKCPQTGGLTCIQNRNFRPCEHYSSNRRALGKIEIAWIAF-ASLLSFLVLVGLVC 783

Query: 788  CCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFA 847
              L+ +R+KQ+ +I AQEG S LL +VIEATENL   +++G+GAHG VYKASLGPN  +A
Sbjct: 784  MFLWYKRTKQEDKITAQEGSSSLLNKVIEATENLKECYIVGKGAHGTVYKASLGPNNQYA 843

Query: 848  VKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL 907
            +KKL F G K GS++M  EIQT+GKIRHRNLV+LEDFW+RK+ G I+YRYMENGSL DVL
Sbjct: 844  LKKLVFAGLKGGSMAMVTEIQTVGKIRHRNLVKLEDFWIRKEYGFILYRYMENGSLHDVL 903

Query: 908  HSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
            H   PPP L+W+VRYKIA+G AH L YLHYDCDP IVHRD+KP+NILLDS+MEPHISDFG
Sbjct: 904  HERNPPPILKWDVRYKIAIGTAHGLTYLHYDCDPAIVHRDVKPDNILLDSDMEPHISDFG 963

Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027
            IAKLLD+S + + SISVVGTIGYIAPENAFTT KSKESDVYS+GVVLLELITRK+ALDPS
Sbjct: 964  IAKLLDQSSSLSPSISVVGTIGYIAPENAFTTTKSKESDVYSFGVVLLELITRKRALDPS 1023

Query: 1028 YKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNR 1087
            + E TDIVGWV+S+W + EE++ IVD SL+EE +  +I DQV+ VLLVALRCT+K+ S R
Sbjct: 1024 FMEETDIVGWVQSIWRNLEEVDKIVDPSLLEEFIDPNIMDQVVCVLLVALRCTQKEASKR 1083

Query: 1088 PNMRDVVRQLVDASVPMTSK 1107
            P MRDVV QL DA+ P   K
Sbjct: 1084 PTMRDVVNQLTDANAPARGK 1103

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356555936|ref|XP_003546285.1| PREDICTED: receptor-like protein kinase-like [Glycine max]

 Score = 1266 bits (3275), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 657/1097 (59%), Positives = 814/1097 (74%), Gaps = 31/1097 (2%)

Query: 10   LLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQ-WVGIECDD 68
            ++F S   +S   V++L  DGV LLSL+RHW SVPP I ++W +SD+TPC  WVG++CD 
Sbjct: 4    IVFFSLSCMSCAVVSSLTSDGVTLLSLLRHWTSVPPSINATWLASDTTPCSSWVGVQCDH 63

Query: 69   DAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLST 128
             +H+VV+  L  YG++GQLGPEIG+LS+                        LEYL+L++
Sbjct: 64   -SHHVVNLTLPDYGIAGQLGPEIGNLSR------------------------LEYLELAS 98

Query: 129  NGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVG 188
            N  TG IPD F+N+ NL  L+L  N L GEIP+ L     L  V L++N+LSGSIP ++G
Sbjct: 99   NNLTGQIPDAFKNMHNLNLLSLPYNQLSGEIPDSLTHAPQLNLVDLSHNTLSGSIPTSIG 158

Query: 189  DLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGD 248
            ++ ++  L+L SN+LSGTIP SIGNC +LQEL+L++N L G LP+SL+NL +L Y DV  
Sbjct: 159  NMTQLLQLYLQSNQLSGTIPSSIGNCSKLQELFLDKNHLEGILPQSLNNLNDLAYFDVAS 218

Query: 249  NNLEGRINFGSEK-CKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSF 307
            N L+G I FGS   CKNL  LDLS+N FSGG+  +LGNCS+L+    V   L G+IP SF
Sbjct: 219  NRLKGTIPFGSAASCKNLKNLDLSFNDFSGGLPSSLGNCSALSEFSAVNCNLDGNIPPSF 278

Query: 308  GLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELF 367
            GLL +LS L L EN LSGK+PPE+G C  LT LHLY+NQLEG IP ELG+L  L DLELF
Sbjct: 279  GLLTKLSILYLPENHLSGKVPPEIGNCMSLTELHLYSNQLEGNIPSELGKLRKLVDLELF 338

Query: 368  DNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSL 427
             N+LTGE P+SIW+I SL++LLVYNN+L G+LPLEMTELKQLKNISL++NQFSGVIPQSL
Sbjct: 339  SNQLTGEIPLSIWKIKSLKHLLVYNNSLSGELPLEMTELKQLKNISLFSNQFSGVIPQSL 398

Query: 428  GINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK 487
            GINSSL+ LDF NN FTG IPPNLCFGK+L +LN+G NQ  G IP  +G C TL R+IL+
Sbjct: 399  GINSSLVLLDFTNNKFTGNIPPNLCFGKKLNILNLGINQLQGSIPPDVGRCTTLRRLILQ 458

Query: 488  QNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG 547
            QN  TG LP+F  NP L H+D+S N I G IPSS+ N  ++T +  S NKF+G +P ELG
Sbjct: 459  QNNFTGPLPDFKSNPNLEHMDISSNKIHGEIPSSLRNCRHITHLILSMNKFNGPIPSELG 518

Query: 548  NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSE 607
            N+V+L TLN++ N++EG LPSQLSKC  ++ FDV FN LNGS+PS L+SW  L+ L LSE
Sbjct: 519  NIVNLQTLNLAHNNLEGPLPSQLSKCTKMDRFDVGFNFLNGSLPSGLQSWTRLTTLILSE 578

Query: 608  NHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDL 667
            NHF+GG+P F+SE + L ELQLGGN  GG IP S+GALQ L Y +NLS NGL G IP ++
Sbjct: 579  NHFSGGLPAFLSEYKMLSELQLGGNMFGGRIPRSVGALQSLRYGMNLSSNGLIGDIPVEI 638

Query: 668  EKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSG 727
              L+ LE+LD+S NNLTG++  L  + SLVEVN+SYN F G VP+ LM LL    SSF G
Sbjct: 639  GNLNFLERLDLSQNNLTGSIEVLGELLSLVEVNISYNSFHGRVPKKLMKLLKSPLSSFLG 698

Query: 728  NPSLC--VKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGL 785
            NP LC   +C +S   +C   S+++PCD  S+ Q+GL+KV+IV+IALGSS+L VL++LGL
Sbjct: 699  NPGLCTTTRCSASDGLACTARSSIKPCDDKSTKQKGLSKVEIVMIALGSSILVVLLLLGL 758

Query: 786  VSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV 845
            V    F R++ Q++ I A+ G S LL +V+EAT NLN +++IGRGA+G+VYKA +GP+  
Sbjct: 759  VYIFYFGRKAYQEVHIFAEGGSSSLLNEVMEATANLNDRYIIGRGAYGVVYKALVGPDKA 818

Query: 846  FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            FA KK+ F   K  +LSM REI+T+GKIRHRNLV+LEDFWLR+D GII+Y YM NGSL D
Sbjct: 819  FAAKKIGFAASKGKNLSMAREIETLGKIRHRNLVKLEDFWLREDYGIILYSYMANGSLHD 878

Query: 906  VLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISD 965
            VLH  TPP TLEWNVR KIA+G AH LAYLHYDCDPPIVHRDIKP NILLDS+MEPHI+D
Sbjct: 879  VLHEKTPPLTLEWNVRNKIAVGIAHGLAYLHYDCDPPIVHRDIKPSNILLDSDMEPHIAD 938

Query: 966  FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKAL- 1024
            FGIAKLLD+S AS  SISV GTIGYIAPENA+TT  S+ESDVYSYGVVLLELITRKKA  
Sbjct: 939  FGIAKLLDQSSASNPSISVPGTIGYIAPENAYTTTNSRESDVYSYGVVLLELITRKKAAE 998

Query: 1025 -DPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKK 1083
             DPS+ E T +V WVRSVW +T +IN IVD SL EE L   I + +  VL+VALRCTEK 
Sbjct: 999  SDPSFMEGTIVVDWVRSVWRETGDINQIVDSSLAEEFLDIHIMENITKVLMVALRCTEKD 1058

Query: 1084 PSNRPNMRDVVRQLVDA 1100
            P  RP MRDV +QL DA
Sbjct: 1059 PHKRPTMRDVTKQLADA 1075

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255568055|ref|XP_002525004.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223535712|gb|EEF37376.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis]

 Score = 1230 bits (3183), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 617/973 (63%), Positives = 754/973 (77%), Gaps = 5/973 (0%)

Query: 1   MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQ 60
           M   F +FLLL+   + LS   V+ALN DG  LLSL+RHW  VPP I SSWN+S +TPC 
Sbjct: 1   MNLSFTYFLLLYC--LILSTYPVSALNSDGSTLLSLLRHWTYVPPAIASSWNASHTTPCS 58

Query: 61  WVGIECDDDAHNVV-SFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCS 119
           WVGIECD+ + +VV +  LS   +SGQLGPEI HLS LQT+DLS+N+FSG+IP +LG+C 
Sbjct: 59  WVGIECDNLSRSVVVTLELSGNAISGQLGPEIAHLSHLQTLDLSNNSFSGHIPSQLGSCR 118

Query: 120 ALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSL 179
            LEYLDLS N F+G+IPD+F+ LQ L +LNLY N L GEIPE LFR+L L+YV+LN N+ 
Sbjct: 119 LLEYLDLSLNNFSGEIPDSFKYLQGLSFLNLYSNSLSGEIPESLFRVLSLEYVYLNTNNF 178

Query: 180 SGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLE 239
           SGSIP  VG+L +V  LWL+ N+LSG IPESIGNC RLQ LYLNEN L+G LPE+L+NLE
Sbjct: 179 SGSIPNTVGNLSQVLELWLYGNQLSGAIPESIGNCSRLQMLYLNENHLVGSLPETLTNLE 238

Query: 240 NLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKL 299
           +LV L +  N+ +G I  G   CKNL+ LDLS+N FSGG+ P+LGN SSLT L IV S L
Sbjct: 239 SLVNLFLYRNSFKGNIPLGFGNCKNLSVLDLSFNDFSGGLPPDLGNSSSLTTLVIVHSNL 298

Query: 300 TGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLS 359
            GSIPSSFG L +LS LDLSEN+LSG+IPPEL  CK L  L LY NQLEGEIP ELG L+
Sbjct: 299 VGSIPSSFGQLDKLSHLDLSENRLSGRIPPELSNCKSLKSLKLYKNQLEGEIPGELGMLT 358

Query: 360 NLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQF 419
            LQDLELF N L+GE P++IWRI SLEY+LVYNN+L G+LP +MTELKQLKNISL++NQF
Sbjct: 359 ELQDLELFSNHLSGEIPINIWRIPSLEYVLVYNNSLSGELPCDMTELKQLKNISLFDNQF 418

Query: 420 SGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCP 479
            GVIP++LG+NSSL+QLDF NN F GEIPPNLC GKQLRVLNMG+N   G IPS +G C 
Sbjct: 419 FGVIPENLGVNSSLLQLDFTNNKFKGEIPPNLCLGKQLRVLNMGRNHLQGSIPSDVGRCS 478

Query: 480 TLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS 539
           TLWR+IL QN L+GALP+F+ NP LSH+D+S+NNI+G IP S+GN   L+ IDFS NKF+
Sbjct: 479 TLWRLILSQNNLSGALPKFAVNPSLSHIDISKNNIAGPIPPSLGNCPGLSYIDFSMNKFT 538

Query: 540 GLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKS 599
           GL+  +LGNLV L  +++S N +EGSLPSQLS    L  FDV FN LNGSIP SLR+W +
Sbjct: 539 GLISPDLGNLVQLELVDLSYNQLEGSLPSQLSYWSRLYKFDVGFNSLNGSIPLSLRNWTN 598

Query: 600 LSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGL 659
           LS L L +N F GGIP F+ E ++L +LQ+GGN LGGEIP SIG+L+ L YALNLS NGL
Sbjct: 599 LSTLILRQNQFIGGIPLFLPEFKELTDLQIGGNLLGGEIPSSIGSLRALQYALNLSSNGL 658

Query: 660 TGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLG 719
           TG IPS L  L KLE+LDIS+NNLTGTL+ L  IH++V VN SYN FTGP+P T+M+ L 
Sbjct: 659 TGVIPSGLGNLIKLERLDISNNNLTGTLAALDRIHTMVLVNTSYNHFTGPIPYTMMDFLN 718

Query: 720 PSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTV 779
            SPSSF GNP LC+ C+ S + +C    N +PC   SS Q+G+ +++I +IAL  +LL  
Sbjct: 719 TSPSSFLGNPGLCISCIGSVNLTCTRVGNFKPCTSRSSKQKGITELEIAMIAL--ALLVA 776

Query: 780 LVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS 839
            V++GL      RRR KQD++I A+EGP+ LL +V+EATENLN +++IG+GAHG VYKAS
Sbjct: 777 FVLVGLACTFALRRRWKQDVDIAAEEGPASLLGKVMEATENLNDRYIIGKGAHGTVYKAS 836

Query: 840 LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME 899
           +G +  FA KK+AF     G+ SM REIQTIGKIRHRNL+RLE+FWLRKD GII+YRYM+
Sbjct: 837 MGEDKFFAAKKIAFADCTGGNRSMVREIQTIGKIRHRNLIRLEEFWLRKDYGIILYRYMK 896

Query: 900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM 959
           NGSL DVLH    P TLEWNVR++IA+G AHALAYLHYDCDPP+VHRDIKP+NILLDS+M
Sbjct: 897 NGSLHDVLHGTNAPWTLEWNVRHRIAIGTAHALAYLHYDCDPPVVHRDIKPKNILLDSDM 956

Query: 960 EPHISDFGIAKLL 972
           EPH+SDFG  ++L
Sbjct: 957 EPHVSDFGREQIL 969

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357442807|ref|XP_003591681.1| Receptor-like protein kinase [Medicago truncatula] gi|358346035|ref|XP_003637078.1| Receptor-like protein kinase [Medicago truncatula] gi|355480729|gb|AES61932.1| Receptor-like protein kinase [Medicago truncatula] gi|355503013|gb|AES84216.1| Receptor-like protein kinase [Medicago truncatula]

 Score = 1197 bits (3096), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 626/1103 (56%), Positives = 804/1103 (72%), Gaps = 20/1103 (1%)

Query: 1    MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQ 60
            M +L+  FLL FS  + ++    +ALN +G+ALLSL+ HW  VP  I S+WNSS STPC 
Sbjct: 1    MGYLYV-FLLCFSILLYVT----SALNFEGLALLSLLSHWTVVPANISSTWNSSHSTPCS 55

Query: 61   WVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSA 120
            W G+EC DD+ NV S +LS + +SGQLGPEIG L  LQ +DLS N+ SG IP +L NC+ 
Sbjct: 56   WKGVECSDDSLNVTSLSLSDHSISGQLGPEIGKLIHLQLLDLSINDLSGEIPIELSNCNM 115

Query: 121  LEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLS 180
            L+YLDLS N F+G+IP    N   LQYL L  N   GEIP+ LF+I  L+ + LNNNSL+
Sbjct: 116  LQYLDLSENNFSGEIPSELSNCSMLQYLYLSVNSFRGEIPQSLFQINPLEDLRLNNNSLN 175

Query: 181  GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
            GSIP  +G+L  +  + L SN+LSGTIP+SIGNC +L  L L+ N+L G LPESL+NL+ 
Sbjct: 176  GSIPVGIGNLANLSVISLESNQLSGTIPKSIGNCSQLSYLILDSNRLEGVLPESLNNLKE 235

Query: 241  LVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT 300
            L Y+ +  NNL G I  GS  CKNL +L LS+N F+GGI  +LGNCS LT      +KL 
Sbjct: 236  LYYVSLNHNNLGGAIQLGSRNCKNLNYLSLSFNNFTGGIPSSLGNCSGLTEFYAAMNKLD 295

Query: 301  GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSN 360
            G+IPS+FGLL  LS L++ EN LSG IPP++G CK L +LHLY N+LEGEIP ELG+LS 
Sbjct: 296  GNIPSTFGLLHNLSILEIPENLLSGNIPPQIGNCKSLEMLHLYTNELEGEIPSELGKLSK 355

Query: 361  LQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
            L+DL L++N L GE P+ IW+I SLE++LVYNN+L+G+LP+EMTELK LKNISL+NNQFS
Sbjct: 356  LRDLRLYENLLVGEIPLGIWKIRSLEHVLVYNNSLMGELPVEMTELKNLKNISLFNNQFS 415

Query: 421  GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT 480
            GVIPQ+LGINSSL+QLDF +N+F G +PPNLCFGK+L  LNMG+NQF G I S +GSC T
Sbjct: 416  GVIPQTLGINSSLVQLDFTSNNFNGTLPPNLCFGKKLAKLNMGENQFIGRITSDVGSCTT 475

Query: 481  LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
            L R+ L+ N  TG LP+F  NP +S+L +  NNI+G IPSS+ N  NL+ +D S N  +G
Sbjct: 476  LTRLKLEDNYFTGPLPDFETNPSISYLSIGNNNINGTIPSSLSNCTNLSLLDLSMNSLTG 535

Query: 541  LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL 600
             +P ELGNL++L +L +S N++EG LP QLSKC  + VFDV FN LNGS PSSLRSW +L
Sbjct: 536  FVPLELGNLLNLQSLKLSYNNLEGPLPHQLSKCTKMSVFDVGFNFLNGSFPSSLRSWTAL 595

Query: 601  SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT 660
            + L L EN F+GGIP F+S  E L EL+L GN  GG IP SIG LQ+L Y LNLS NGL 
Sbjct: 596  TSLTLRENRFSGGIPDFLSAFENLNELKLDGNNFGGNIPKSIGQLQNLLYDLNLSANGLV 655

Query: 661  GRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGP 720
            G +P ++  L  L ++D+S NNLTG++  L  + SL E+N+SYN F GPVPE L   L  
Sbjct: 656  GELPREIGNLKSLLKMDLSWNNLTGSIQVLDELESLSELNISYNSFEGPVPEQLTK-LSN 714

Query: 721  SPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVL 780
            S SSF GNP LCV       S    +SNL+ C++  +  +G  KV IV+IALGSS+L V+
Sbjct: 715  SSSSFLGNPGLCV-------SLSLPSSNLKLCNHDGTKSKGHGKVAIVMIALGSSIL-VV 766

Query: 781  VMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASL 840
            V+LGL+   L  R+SKQ+  I  ++G S LLK+V++AT NLN +++IGRGA G+VYKA++
Sbjct: 767  VLLGLIYIFLV-RKSKQEAVITEEDGSSDLLKKVMKATANLNDEYIIGRGAEGVVYKAAI 825

Query: 841  GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN 900
            GP+ + AVKKL F  ++R  +SM RE++T+ KIRHRNLVRLE  WLR++ G+I YR+M N
Sbjct: 826  GPDNILAVKKLVFGENERKRVSMLREVETLSKIRHRNLVRLEGVWLRENYGLISYRFMPN 885

Query: 901  GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME 960
            GSL +VLH   PP +L+WNVR KIA+G A  L YLHYDCDP IVHRDIK  NILLDSEME
Sbjct: 886  GSLYEVLHEKNPPQSLKWNVRNKIAVGIAQGLVYLHYDCDPVIVHRDIKTSNILLDSEME 945

Query: 961  PHISDFGIAKLLD--KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            PH++DFG++K+LD   S +ST S++V GT+GYIAPENA+TT   KESDVYSYGVVLLELI
Sbjct: 946  PHVADFGLSKILDQSSSSSSTQSVNVSGTLGYIAPENAYTTVMGKESDVYSYGVVLLELI 1005

Query: 1019 TRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEML---VSSIRDQVIDVLLV 1075
            +RKKA++PS+ E  DIV WVRS+W +T  +++IVD  L  E+     + +  +V +VLLV
Sbjct: 1006 SRKKAINPSFMEGMDIVTWVRSLWEETGVVDEIVDSELANEISNYDSNKVMKEVTNVLLV 1065

Query: 1076 ALRCTEKKPSNRPNMRDVVRQLV 1098
            ALRCTE+ P  RP MRDV++ L+
Sbjct: 1066 ALRCTERDPRRRPTMRDVIKHLL 1088

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449526646|ref|XP_004170324.1| PREDICTED: receptor-like protein kinase-like [Cucumis sativus]

 Score = 1194 bits (3088), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 641/1105 (58%), Positives = 804/1105 (72%), Gaps = 6/1105 (0%)

Query: 1    MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQ 60
            M+ L  HF LL        +  V  L  DG+ALLSL   W +    +   WN+S STPC 
Sbjct: 1    MQLLTRHFFLLVCF-SFHFVVVVFGLTSDGLALLSLQSRWTTHTSFV-PVWNASHSTPCS 58

Query: 61   WVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSA 120
            W GIECD +   VV+FNLS YGVSG LGPEI  L++L+TIDL++N+FSG IP  +GNCS 
Sbjct: 59   WAGIECDQNLR-VVTFNLSFYGVSGHLGPEISSLTQLRTIDLTTNDFSGEIPYGIGNCSH 117

Query: 121  LEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLS 180
            LEYLDLS N F+G IP +   L NL +LN + N+L G IP+ LF+ L  QYV+L+ N+L+
Sbjct: 118  LEYLDLSFNQFSGQIPQSLTLLTNLTFLNFHENVLTGPIPDSLFQNLNFQYVYLSENNLN 177

Query: 181  GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
            GSIP NVG+  ++  L+L+ N  SG+IP SIGNC +L++LYL+ N+L+G LP SL+NL+N
Sbjct: 178  GSIPSNVGNSNQLLHLYLYGNEFSGSIPSSIGNCSQLEDLYLDGNQLVGTLPHSLNNLDN 237

Query: 241  LVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT 300
            LV L V  NNL+G I  GS  C++L ++DLS+N ++GGI   LGNCS+L  L IV S LT
Sbjct: 238  LVNLGVSRNNLQGPIPLGSGVCQSLEYIDLSFNGYTGGIPAGLGNCSALKTLLIVNSSLT 297

Query: 301  GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSN 360
            G IPSSFG L +LS +DLS NQLSG IPPE G CK L  L LY NQLEG IP ELG LS 
Sbjct: 298  GHIPSSFGRLRKLSHIDLSRNQLSGNIPPEFGACKSLKELDLYDNQLEGRIPSELGLLSR 357

Query: 361  LQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
            L+ L+LF NRLTGE P+SIW+IASL+ +LVY+NNL G+LPL +TEL+ LK IS++NN FS
Sbjct: 358  LEVLQLFSNRLTGEIPISIWKIASLQQILVYDNNLFGELPLIITELRHLKIISVFNNHFS 417

Query: 421  GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT 480
            GVIPQSLG+NSSL+Q++F NN FTG+IPPNLC GK LRVLN+G NQF G +P  +G+C T
Sbjct: 418  GVIPQSLGLNSSLVQVEFTNNQFTGQIPPNLCSGKTLRVLNLGLNQFQGNVPLDIGTCLT 477

Query: 481  LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
            L R+IL++N L G LPEF+ N  L  +D S NN++G IPSS+GN INLTSI+  SN+ SG
Sbjct: 478  LQRLILRRNNLAGVLPEFTINHGLRFMDASENNLNGTIPSSLGNCINLTSINLQSNRLSG 537

Query: 541  LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL 600
            L+P  L NL +L +L +S N +EG LPS LS C  L+ FDV FNLLNGSIP SL SWK +
Sbjct: 538  LIPNGLRNLENLQSLILSHNFLEGPLPSSLSNCTKLDKFDVGFNLLNGSIPRSLASWKVI 597

Query: 601  SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT 660
            S   + EN F GGIP  +SELE L  L LGGN  GGEIP SIG L+ L Y+LNLS NGL+
Sbjct: 598  STFIIKENRFAGGIPNVLSELESLSLLDLGGNLFGGEIPSSIGNLKSLFYSLNLSNNGLS 657

Query: 661  GRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHS-LVEVNVSYNLFTGPVPETLMNLLG 719
            G +PS+L  L KL++LDIS NNLTG+L+ L  + S LVE+N+SYN FTGPVP+TLM LL 
Sbjct: 658  GTLPSELANLVKLQELDISHNNLTGSLTVLGELSSTLVELNISYNFFTGPVPQTLMKLLN 717

Query: 720  PSPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQG--LNKVKIVVIALGSSLL 777
              PSSF GNP LC+ C      SC    ++ PC  HSS +    L  V+I +IALGSSL 
Sbjct: 718  SDPSSFLGNPGLCISCDVPDGLSCNRNISISPCAVHSSARGSSRLGNVQIAMIALGSSLF 777

Query: 778  TVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYK 837
             +L++LGLV   ++ RR+KQ++E  AQ G + LL +V+EAT+NL+ + VIGRGAHG+VYK
Sbjct: 778  VILLLLGLVYKFVYNRRNKQNIETAAQVGTTSLLNKVMEATDNLDERFVIGRGAHGVVYK 837

Query: 838  ASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY 897
             SL  N VFAVKKL F GHKRGS  M +EI+T+  I+HRNL+ LE FWL KD G+++Y+Y
Sbjct: 838  VSLDSNKVFAVKKLTFLGHKRGSRDMVKEIRTVSNIKHRNLISLESFWLGKDYGLLLYKY 897

Query: 898  MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS 957
              NGSL DVLH +   P+L W  RY IA+G AHALAYLHYDCDPPI+HRDIKP+NILLDS
Sbjct: 898  YPNGSLYDVLHEMNTTPSLTWKARYNIAIGIAHALAYLHYDCDPPIIHRDIKPQNILLDS 957

Query: 958  EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLEL 1017
            EMEPHI+DFG+AKLLD++    TS S  GTIGYIAPENAF+ AK+K SDVYSYGVVLLEL
Sbjct: 958  EMEPHIADFGLAKLLDQTFEPATSSSFAGTIGYIAPENAFSAAKTKASDVYSYGVVLLEL 1017

Query: 1018 ITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVAL 1077
            +T KK  DPS+ E  ++  W+RSVW + +EI+ IVD  L EE+     R+Q+  V+LVAL
Sbjct: 1018 VTGKKPSDPSFIEVGNMTAWIRSVWKERDEIDRIVDPRLEEELANLDHREQMNQVVLVAL 1077

Query: 1078 RCTEKKPSNRPNMRDVVRQLVDASV 1102
            RCTE + + RP MR++V  L+D  +
Sbjct: 1078 RCTENEANKRPIMREIVDHLIDLKI 1102

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461709|ref|XP_004148584.1| PREDICTED: receptor-like protein kinase-like [Cucumis sativus]

 Score = 1189 bits (3076), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 633/1077 (58%), Positives = 794/1077 (73%), Gaps = 5/1077 (0%)

Query: 29   DGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLG 88
            DG+ALLSL   W +    +   WN+S STPC W GIECD +   VV+FNLS YGVSG LG
Sbjct: 218  DGLALLSLQSRWTTHTSFV-PVWNASHSTPCSWAGIECDQNLR-VVTFNLSFYGVSGHLG 275

Query: 89   PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
            PEI  L++L+TIDL++N+FSG IP  +GNCS LEYLDLS N F+G IP +   L NL +L
Sbjct: 276  PEISSLTQLRTIDLTTNDFSGEIPYGIGNCSHLEYLDLSFNQFSGQIPQSLTLLTNLTFL 335

Query: 149  NLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIP 208
            N + N+L G IP+ LF+ L  QYV+L+ N+L+GSIP NVG+  ++  L+L+ N  SG+IP
Sbjct: 336  NFHENVLTGPIPDSLFQNLNFQYVYLSENNLNGSIPSNVGNSNQLLHLYLYGNEFSGSIP 395

Query: 209  ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL 268
             SIGNC +L++LYL+ N+L+G LP SL+NL+NLV L V  NNL+G I  GS  C++L ++
Sbjct: 396  SSIGNCSQLEDLYLDGNQLVGTLPHSLNNLDNLVNLGVSRNNLQGPIPLGSGVCQSLEYI 455

Query: 269  DLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIP 328
            DLS+N ++GGI   LGNCS+L  L IV S LTG IPSSFG L +LS +DLS NQLSG IP
Sbjct: 456  DLSFNGYTGGIPAGLGNCSALKTLLIVNSSLTGHIPSSFGRLRKLSHIDLSRNQLSGNIP 515

Query: 329  PELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL 388
            PE G CK L  L LY NQLEG IP ELG LS L+ L+LF NRLTGE P+SIW+IASL+ +
Sbjct: 516  PEFGACKSLKELDLYDNQLEGRIPSELGLLSRLEVLQLFSNRLTGEIPISIWKIASLQQI 575

Query: 389  LVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIP 448
            LVY+NNL G+LPL +TEL+ LK IS++NN FSGVIPQSLG+NSSL+Q++F NN FTG+IP
Sbjct: 576  LVYDNNLFGELPLIITELRHLKIISVFNNHFSGVIPQSLGLNSSLVQVEFTNNQFTGQIP 635

Query: 449  PNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLD 508
            PNLC GK LRVLN+G NQF G +P  +G+C TL R+IL++N L G LPEF+ N  L  +D
Sbjct: 636  PNLCSGKTLRVLNLGLNQFQGNVPLDIGTCLTLQRLILRRNNLAGVLPEFTINHGLRFMD 695

Query: 509  VSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPS 568
             S NN++G IPSS+GN INLTSI+  SN+ SGL+P  L NL +L +L +S N +EG LPS
Sbjct: 696  ASENNLNGTIPSSLGNCINLTSINLQSNRLSGLIPNGLRNLENLQSLILSHNFLEGPLPS 755

Query: 569  QLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQ 628
             LS C  L+ FDV FNLLNGSIP SL SWK +S   + EN F GGIP  +SELE L  L 
Sbjct: 756  SLSNCTKLDKFDVGFNLLNGSIPRSLASWKVISTFIIKENRFAGGIPNVLSELESLSLLD 815

Query: 629  LGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLS 688
            LGGN  GGEIP SIG L+ L Y+LNLS NGL+G +PS+L  L KL++LDIS NNLTG+L+
Sbjct: 816  LGGNLFGGEIPSSIGNLKSLFYSLNLSNNGLSGTLPSELANLVKLQELDISHNNLTGSLT 875

Query: 689  PLSNIHS-LVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSCFGTS 747
             L  + S LVE+N+SYN FTGPVP+TLM LL   PSSF GNP LC+ C      SC    
Sbjct: 876  VLGELSSTLVELNISYNFFTGPVPQTLMKLLNSDPSSFLGNPGLCISCDVPDGLSCNRNI 935

Query: 748  NLRPCDYHSSHQQG--LNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQE 805
            ++ PC  HSS +    L  V+I +IALGSSL  +L++LGLV   ++ RR+KQ++E  AQ 
Sbjct: 936  SISPCAVHSSARGSSRLGNVQIAMIALGSSLFVILLLLGLVYKFVYNRRNKQNIETAAQV 995

Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKR 865
            G + LL +V+EAT+NL+ + VIGRGAHG+VYK SL  N VFAVKKL F GHKRGS  M +
Sbjct: 996  GTTSLLNKVMEATDNLDERFVIGRGAHGVVYKVSLDSNKVFAVKKLTFLGHKRGSRDMVK 1055

Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIA 925
            EI+T+  I+HRNL+ LE FWL KD G+++Y+Y  NGSL DVLH +   P+L W  RY IA
Sbjct: 1056 EIRTVSNIKHRNLISLESFWLGKDYGLLLYKYYPNGSLYDVLHEMNTTPSLTWKARYNIA 1115

Query: 926  LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
            +G AHALAYLHYDCDPPI+HRDIKP+NILLDSEMEPHI+DFG+AKLLD++    TS S  
Sbjct: 1116 IGIAHALAYLHYDCDPPIIHRDIKPQNILLDSEMEPHIADFGLAKLLDQTFEPATSSSFA 1175

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045
            GTIGYIAPENAF+ AK+K SDVYSYGVVLLEL+T KK  DPS+ E  ++  W+RSVW + 
Sbjct: 1176 GTIGYIAPENAFSAAKTKASDVYSYGVVLLELVTGKKPSDPSFIEVGNMTAWIRSVWKER 1235

Query: 1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102
            +EI+ IVD  L EE+     R+Q+  V+LVALRCTE + + RP MR++V  L+D  +
Sbjct: 1236 DEIDRIVDPRLEEELANLDHREQMNQVVLVALRCTENEANKRPIMREIVDHLIDLKI 1292

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574697|ref|XP_003555482.1| PREDICTED: receptor-like protein kinase-like [Glycine max]

 Score = 1178 bits (3048), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 628/1080 (58%), Positives = 779/1080 (72%), Gaps = 15/1080 (1%)

Query: 20   LRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQ-WVGIECDDDAHNVVSFNL 78
            L + +ALN DG+ALLSL+R W  VP  I S+W  SDSTPC  W G+ CD+ A+NVVS NL
Sbjct: 16   LYAASALNSDGLALLSLLRDWTIVPSDINSTWKLSDSTPCSSWAGVHCDN-ANNVVSLNL 74

Query: 79   SSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDN 138
            +SY + GQLGP++G +  LQTIDLS N+  G IPP+L NC+ LEYLDLS N F+G IP +
Sbjct: 75   TSYSIFGQLGPDLGRMVHLQTIDLSYNDLFGKIPPELDNCTMLEYLDLSVNNFSGGIPQS 134

Query: 139  FENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL 198
            F+NLQNL++++L  N L+GEIPEPLF I  L+ V+L+NNSL+GSI  +VG++ ++  L L
Sbjct: 135  FKNLQNLKHIDLSSNPLNGEIPEPLFDIYHLEEVYLSNNSLTGSISSSVGNITKLVTLDL 194

Query: 199  FSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFG 258
              N+LSGTIP SIGNC  L+ LYL  N+L G +PESL+NL+NL  L +  NNL G +  G
Sbjct: 195  SYNQLSGTIPMSIGNCSNLENLYLERNQLEGVIPESLNNLKNLQELFLNYNNLGGTVQLG 254

Query: 259  SEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDL 318
            +  CK L+ L LSYN FSGGI  +LGNCS L       S L GSIPS+ GL+  LS L +
Sbjct: 255  TGNCKKLSSLSLSYNNFSGGIPSSLGNCSGLMEFYAARSNLVGSIPSTLGLMPNLSLLII 314

Query: 319  SENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
             EN LSGKIPP++G CK L  L L +N+LEGEIP ELG LS L+DL L++N LTGE P+ 
Sbjct: 315  PENLLSGKIPPQIGNCKALEELRLNSNELEGEIPSELGNLSKLRDLRLYENLLTGEIPLG 374

Query: 379  IWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDF 438
            IW+I SLE + +Y NNL G+LP EMTELK LKNISL+NNQFSGVIPQSLGINSSL+ LDF
Sbjct: 375  IWKIQSLEQIYLYINNLSGELPFEMTELKHLKNISLFNNQFSGVIPQSLGINSSLVVLDF 434

Query: 439  INNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEF 498
            + N+FTG +PPNLCFGKQL  LNMG NQF+G IP  +G C TL RV L++N  TG+LP+F
Sbjct: 435  MYNNFTGTLPPNLCFGKQLVKLNMGVNQFYGNIPPDVGRCTTLTRVRLEENHFTGSLPDF 494

Query: 499  SKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNIS 558
              NP LS++ ++ NNISGAIPSS+G   NL+ ++ S N  +GL+P ELGNL +L TL++S
Sbjct: 495  YINPNLSYMSINNNNISGAIPSSLGKCTNLSLLNLSMNSLTGLVPSELGNLENLQTLDLS 554

Query: 559  LNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFI 618
             N++EG LP QLS C  +  FDV FN LNGS+PSS RSW +L+ L LSENHF GGIP F+
Sbjct: 555  HNNLEGPLPHQLSNCAKMIKFDVRFNSLNGSVPSSFRSWTTLTALILSENHFNGGIPAFL 614

Query: 619  SELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDI 678
            SE +KL ELQLGGN  GG IP SIG L +L Y LNLS  GL G +P ++  L  L  LD+
Sbjct: 615  SEFKKLNELQLGGNMFGGNIPRSIGELVNLIYELNLSATGLIGELPREIGNLKSLLSLDL 674

Query: 679  SSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPS-SFSGNPSLCVKCLS 737
            S NNLTG++  L  + SL E N+SYN F GPVP+ L  L  P+ S SF GNP LC     
Sbjct: 675  SWNNLTGSIQVLDGLSSLSEFNISYNSFEGPVPQQLTTL--PNSSLSFLGNPGLC----- 727

Query: 738  STDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQ 797
               S+   +S L+PCD +S   + L+KV  V+IALGS++  VL++   +    F R+ KQ
Sbjct: 728  --GSNFTESSYLKPCDTNSKKSKKLSKVATVMIALGSAIFVVLLL--WLVYIFFIRKIKQ 783

Query: 798  DLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHK 857
            +  I  ++    LL +V+EATENLN +++IGRGA G+VYKA++GP+   A+KK  F  H+
Sbjct: 784  EAIIIKEDDSPTLLNEVMEATENLNDEYIIGRGAQGVVYKAAIGPDKTLAIKKFVFS-HE 842

Query: 858  RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE 917
              S SM REIQT+GKIRHRNLV+LE  WLR++ G+I Y+YM NGSL D LH   PP +LE
Sbjct: 843  GKSSSMTREIQTLGKIRHRNLVKLEGCWLRENYGLIAYKYMPNGSLHDALHEKNPPYSLE 902

Query: 918  WNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA 977
            W VR  IALG AH L YLHYDCDP IVHRDIK  NILLDSEMEPHI+DFGIAKL+D+   
Sbjct: 903  WIVRNNIALGIAHGLTYLHYDCDPVIVHRDIKTSNILLDSEMEPHIADFGIAKLIDQPST 962

Query: 978  STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGW 1037
            ST   SV GT+GYIAPENA+TT K KESDVYSYGVVLLELI+RKK LD S+ E TDIV W
Sbjct: 963  STQLSSVAGTLGYIAPENAYTTTKGKESDVYSYGVVLLELISRKKPLDASFMEGTDIVNW 1022

Query: 1038 VRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             RSVW +T  +++IVD  L +E+  S +  QV  VLLVALRCTEK P  RP MRDV+R L
Sbjct: 1023 ARSVWEETGVVDEIVDPELADEISNSEVMKQVTKVLLVALRCTEKDPRKRPTMRDVIRHL 1082

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461711|ref|XP_004148585.1| PREDICTED: receptor-like protein kinase-like [Cucumis sativus] gi|449526644|ref|XP_004170323.1| PREDICTED: receptor-like protein kinase-like [Cucumis sativus]

 Score = 1176 bits (3042), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 630/1118 (56%), Positives = 791/1118 (70%), Gaps = 22/1118 (1%)

Query: 7    HFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIEC 66
            HF LL     +  L  V AL  DG+ALLSL   W S  P I   WN+SDSTPC W GIEC
Sbjct: 7    HFFLLVC--FSFHLYVVFALTSDGLALLSLQSRWTSHTPFI-PLWNASDSTPCSWAGIEC 63

Query: 67   DDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDL 126
            D +   V++FNLS Y VSG LGPEI  L+ L+TI L++N FSG IP  +GNCS LEYLDL
Sbjct: 64   DQNLR-VITFNLS-YNVSGPLGPEIARLTHLRTIALTANRFSGEIPYGIGNCSHLEYLDL 121

Query: 127  STNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRN 186
            S N F+G IP +   L NL +LN + N+L G IP  LF+ L L YV+L  N+L+GSIP N
Sbjct: 122  SFNQFSGQIPQSLTLLTNLTFLNFHDNVLTGAIPNSLFQNLNLLYVYLGENNLNGSIPSN 181

Query: 187  VGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDV 246
            VG+  ++  L+L+ N  SG+IP SIGNC +L++LYL+ N+L+G LP+SL+NL+NLV L V
Sbjct: 182  VGNSSQLFHLYLYGNEFSGSIPSSIGNCSQLEDLYLDGNQLVGTLPDSLNNLDNLVNLGV 241

Query: 247  GDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSS 306
              NNL+G I  GS  C++L ++DLS+N ++GGI   LGNCS+L  L I+ S LTG IPSS
Sbjct: 242  SRNNLQGPIPLGSGGCQSLEYIDLSFNGYTGGIPAGLGNCSALRTLLIINSSLTGHIPSS 301

Query: 307  FGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLEL 366
            FG L +LS +DL  NQLSG IPPE G CK L  L+LY NQ EG IP ELG LS L+ L+L
Sbjct: 302  FGRLRKLSHIDLCRNQLSGNIPPEFGACKSLKELNLYVNQFEGRIPSELGLLSKLEVLQL 361

Query: 367  FDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQS 426
            F N L G+ P+SIW+IASL+++L+YNNNL G+LPL +TELK LKNISL+NNQFSGVIPQS
Sbjct: 362  FSNHLIGQIPISIWKIASLQHILLYNNNLSGELPLIITELKHLKNISLFNNQFSGVIPQS 421

Query: 427  LGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVIL 486
            LG+N SL+Q++  NN F+G+IPPNLCFGK LRVLN+G NQF G IPS +G+C TL R+IL
Sbjct: 422  LGLNRSLVQVELTNNKFSGQIPPNLCFGKTLRVLNLGLNQFQGSIPSDIGTCLTLQRLIL 481

Query: 487  KQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQEL 546
            ++N LTG LPEF +N  L  +D S NN++  IP S+GN INLTS+D S NK +GL+P EL
Sbjct: 482  RRNNLTGVLPEFMRNHGLQFMDASENNLNEKIPLSLGNCINLTSVDLSRNKLTGLVPNEL 541

Query: 547  GNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS 606
            GNLV++ +L++S N +EG LP  LS    L  FDV FNLLNGSI  SL  WK +S L L+
Sbjct: 542  GNLVNIQSLSLSHNFLEGPLPPSLSNWTKLNNFDVGFNLLNGSISHSLAGWKVISTLILT 601

Query: 607  ENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSD 666
            EN FTGGIP  +SELE L  L LGGN  GGEIP SIG  +++ Y LN S NGLTG+IPS+
Sbjct: 602  ENQFTGGIPNVLSELESLSVLDLGGNLFGGEIPSSIGGWKNMFYFLNFSDNGLTGQIPSE 661

Query: 667  LEKLSKLEQLDISSNNLTGTLSPLSNIHS-LVEVNVSYNLFTGPVPETLMNLLGPSPSSF 725
            L+ L  +E LDIS NNLTG++  L  + S LVE+N+SYN FTG VP TLM  L   P+SF
Sbjct: 662  LKNLIMVENLDISHNNLTGSIRVLGELSSLLVELNISYNFFTGTVPPTLMKFLNSHPASF 721

Query: 726  SGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGL 785
             GN  LC+ C  +    C  +S+++ C  HSS +  LN  +I +IA GSSL  V ++LGL
Sbjct: 722  LGNSGLCISCDETDGLICNRSSSIKTCASHSSSR--LNNTQIAMIAFGSSLFIVFLLLGL 779

Query: 786  VSCCLFRRRSKQDLEIPAQEG-PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA 844
            V   ++ RR+K   +  A+ G  S L+ +VIEAT+NL+ + +IGRGAHG+VYKA L    
Sbjct: 780  VYKFVYIRRNKDTFDTFAEVGTTSLLVHKVIEATDNLDERFIIGRGAHGVVYKALLDSKT 839

Query: 845  VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLR 904
             FAVKKL F G K GS SM REI+T+G+I+HRNL+ LED W  KD G+++YRY  NGSL 
Sbjct: 840  TFAVKKLTFGGCKGGSQSMIREIETVGRIKHRNLIALEDCWFGKDHGLLIYRYQANGSLD 899

Query: 905  DVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHIS 964
            DVLH + P P L W VRY IA+G AH L YLHYDCDPPI+HRDIKP+N+LLDSEMEP I+
Sbjct: 900  DVLHQMNPAPFLPWEVRYNIAIGIAHGLIYLHYDCDPPIIHRDIKPQNVLLDSEMEPRIA 959

Query: 965  DFGIAKLLDKSPASTTSISVVGTIGYIAP-------------ENAFTTAKSKESDVYSYG 1011
            DFG+AKLLD++ A   S    GTIGYIAP             ENAF+ AK+K SDVYSYG
Sbjct: 960  DFGLAKLLDQTSAPAVSSLFAGTIGYIAPVSNYLLIHYGLVTENAFSAAKNKASDVYSYG 1019

Query: 1012 VVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVID 1071
            VVLLELITRKK  D S+ E   I  WVRS W++T EI+ IVD  L+EE+L S  R+Q+  
Sbjct: 1020 VVLLELITRKKPSDASFTEVGSITAWVRSGWNETGEIDSIVDPMLVEELLDSDRREQIKK 1079

Query: 1072 VLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKYV 1109
            V+L+ALRCTEK P+ RP M DV+  L+D  +  +  ++
Sbjct: 1080 VILLALRCTEKDPNKRPIMIDVLNHLIDLKINQSRVFL 1117

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|46396756|sp|P93194.2|RPK1_IPONI RecName: Full=Receptor-like protein kinase; Flags: Precursor gi|14495542|gb|AAB36558.2| receptor-like protein kinase INRPK1 [Ipomoea nil]

 Score = 1171 bits (3029), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 624/1110 (56%), Positives = 784/1110 (70%), Gaps = 7/1110 (0%)

Query: 1    MKFLFCHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQ 60
            MK     FLL   S    S+ +  ALN DG ALLSL RHW S+P  I  SWN+SDSTPC 
Sbjct: 1    MKVAVNTFLLFLCS--TSSIYAAFALNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCS 58

Query: 61   WVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSA 120
            W+G+ECD     V + NLSSYG+SG+ GPEI HL  L+ + LS N F G+IP +LGNCS 
Sbjct: 59   WLGVECDRRQF-VDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSL 117

Query: 121  LEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLS 180
            LE++DLS+N FTG+IPD    LQNL+ L+L+ N L G  PE L  I  L+ V+   N L+
Sbjct: 118  LEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLN 177

Query: 181  GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
            GSIP N+G++ E+  LWL  N+ SG +P S+GN   LQELYLN+N L+G LP +L+NLEN
Sbjct: 178  GSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLEN 237

Query: 241  LVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT 300
            LVYLDV +N+L G I      CK +  + LS N+F+GG+ P LGNC+SL         L+
Sbjct: 238  LVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALS 297

Query: 301  GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSN 360
            G IPS FG L +L +L L+ N  SG+IPPELGKCK +  L L  NQLEGEIP ELG LS 
Sbjct: 298  GPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQ 357

Query: 361  LQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
            LQ L L+ N L+GE P+SIW+I SL+ L +Y NNL G+LP++MTELKQL +++LY N F+
Sbjct: 358  LQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFT 417

Query: 421  GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT 480
            GVIPQ LG NSSL  LD   N FTG IPPNLC  K+L+ L +G N   G +PS LG C T
Sbjct: 418  GVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCST 477

Query: 481  LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
            L R+IL++N L G LP+F +   L   D+S NN +G IP S+GN  N+T+I  SSN+ SG
Sbjct: 478  LERLILEENNLRGGLPDFVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSG 537

Query: 541  LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL 600
             +P ELG+LV L  LN+S N ++G LPS+LS C  L   D S NLLNGSIPS+L S   L
Sbjct: 538  SIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTEL 597

Query: 601  SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT 660
            + L L EN F+GGIPT + +  KLL LQLGGN L G+IPP +GALQ L  +LNLS N L 
Sbjct: 598  TKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPP-VGALQALR-SLNLSSNKLN 655

Query: 661  GRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGP 720
            G++P DL KL  LE+LD+S NNL+GTL  LS I SL  +N+S+NLF+GPVP +L   L  
Sbjct: 656  GQLPIDLGKLKMLEELDVSHNNLSGTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNS 715

Query: 721  SPSSFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHS-SHQQGLNKVKIVVIALGSSLLTV 779
            SP+SFSGN  LC+ C  +   +C  +S LRPC+  S + + GL+ + I +I LG+ L  +
Sbjct: 716  SPTSFSGNSDLCINC-PADGLACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFII 774

Query: 780  LVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS 839
             + L      L  ++S Q++ I AQEG   LL +V+EATENLN K+VIG+GAHG +YKA+
Sbjct: 775  CLFLFSAFLFLHCKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKAT 834

Query: 840  LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME 899
            L P+ V+AVKKL F G K GS+SM REI+TIGK+RHRNL++LE+FWLRK+ G+I+Y YME
Sbjct: 835  LSPDKVYAVKKLVFTGIKNGSVSMVREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYME 894

Query: 900  NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM 959
            NGSL D+LH   PP  L+W+ R+ IA+G AH LAYLH+DCDP IVHRDIKP NILLDS++
Sbjct: 895  NGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDL 954

Query: 960  EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            EPHISDFGIAKLLD+S  S  S +V GTIGY+APENAFTT KS+ESDVYSYGVVLLELIT
Sbjct: 955  EPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELIT 1014

Query: 1020 RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRC 1079
            RKKALDPS+   TDIVGWVRSVW+ T EI  IVD SL++E++ SS+ +QV + L +ALRC
Sbjct: 1015 RKKALDPSFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRC 1074

Query: 1080 TEKKPSNRPNMRDVVRQLVDASVPMTSKYV 1109
             EK+   RP MRDVV+QL   S+   S  V
Sbjct: 1075 AEKEVDKRPTMRDVVKQLTRWSIRSYSSSV 1104

Source: Ipomoea nil

Species: Ipomoea nil

Genus: Ipomoea

Family: Convolvulaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1109
UNIPROTKB|P93194	1109	INRPK1 "Receptor-like protein	0.974	0.974	0.526	1.8e-293
TAIR|locus:2032697	1123	PEPR1 "PEP1 receptor 1" [Arabi	0.967	0.955	0.522	6.2e-291
TAIR|locus:2007918	1088	PEPR2 "PEP1 receptor 2" [Arabi	0.938	0.956	0.472	2.3e-245
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.920	0.926	0.349	1.1e-153
TAIR|locus:4515102753	598	AT1G73066 [Arabidopsis thalian	0.517	0.959	0.507	2e-150
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.922	0.910	0.338	4.8e-149
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.933	0.940	0.338	1.5e-145
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.866	0.842	0.356	9.6e-144
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.899	0.796	0.332	2.1e-139
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.804	0.714	0.335	7.7e-119

UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)]

 Score = 2818 (997.0 bits), Expect = 1.8e-293, P = 1.8e-293
 Identities = 572/1086 (52%), Positives = 719/1086 (66%)

Query:    25 ALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVS 84
             ALN DG ALLSL RHW S+P  I  SWN+SDSTPC W+G+ECD     V + NLSSYG+S
Sbjct:    23 ALNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVECDRRQF-VDTLNLSSYGIS 81

Query:    85 GQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFEXXXX 144
             G+ GPEI HL  L+ + LS N F G+IP +LGNCS LE++DLS+N FTG+IPD       
Sbjct:    82 GEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQN 141

Query:   145 XXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS 204
                         G  PE L  I  L+ V+   N L+GSIP N+G++ E+  LWL  N+ S
Sbjct:   142 LRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFS 201

Query:   205 GTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKN 264
             G +P S+GN   LQELYLN+N L+G LP +L+NLENLVYLDV +N+L G I      CK 
Sbjct:   202 GPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQ 261

Query:   265 LTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLS 324
             +  + LS N+F+GG+ P LGNC+SL         L+G IPS FG L +L +L L+ N  S
Sbjct:   262 IDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFS 321

Query:   325 GKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIAS 384
             G+IPPELGKCK +  L L  NQLEGEIP ELG LS LQ L L+ N L+GE P+SIW+I S
Sbjct:   322 GRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQS 381

Query:   385 XXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFT 444
                            P++MTELKQL +++LY N F+GVIPQ LG NSSL  LD   N FT
Sbjct:   382 LQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFT 441

Query:   445 GEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVL 504
             G IPPNLC  K+L+ L +G N   G +PS LG C TL R+IL++N L G LP+F +   L
Sbjct:   442 GHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPDFVEKQNL 501

Query:   505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEG 564
                D+S NN +G IP S+GN  N+T+I  SSN+ SG +P ELG+LV L  LN+S N ++G
Sbjct:   502 LFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKG 561

Query:   565 SLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISXXXXX 624
              LPS+LS C  L   D S NLLNGSIPS+L S   L+ L L EN F+GGIPT +      
Sbjct:   562 ILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKL 621

Query:   625 XXXXXXXXXXXXXIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT 684
                          IPP +GALQ L  +LNLS N L G++P DL KL  LE+LD+S NNL+
Sbjct:   622 LNLQLGGNLLAGDIPP-VGALQALR-SLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLS 679

Query:   685 GTLSPLSNIHSLVEVNVSYNLFTGPVPETLMXXXXXXXXXXXXXXXXCVKCLSSTDSSCF 744
             GTL  LS I SL  +N+S+NLF+GPVP +L                 C+ C  +   +C 
Sbjct:   680 GTLRVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSGNSDLCINC-PADGLACP 738

Query:   745 GTSNLRPCDYHSSHQQG-LNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPA 803
              +S LRPC+  S+  +G L+ + I +I LG+ L  + + L      L  ++S Q++ I A
Sbjct:   739 ESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAISA 798

Query:   804 QEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSM 863
             QEG   LL +V+EATENLN K+VIG+GAHG +YKA+L P+ V+AVKKL F G K GS+SM
Sbjct:   799 QEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSVSM 858

Query:   864 KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
              REI+TIGK+RHRNL++LE+FWLRK+ G+I+Y YMENGSL D+LH   PP  L+W+ R+ 
Sbjct:   859 VREIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHN 918

Query:   924 IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
             I             DCDP IVHRDIKP NILLDS++EPHISDFGIAKLLD+S  S  S +
Sbjct:   919 IAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNT 978

Query:   984 VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043
             V GTIGY+APENAFTT KS+ESDVYSYGVVLLELITRKKALDPS+   TDIVGWVRSVW+
Sbjct:   979 VQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWVRSVWT 1038

Query:  1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVP 1103
              T EI  IVD SL++E++ SS+ +QV + L +ALRC EK+   RP MRDVV+QL   S+ 
Sbjct:  1039 QTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQLTRWSIR 1098

Query:  1104 MTSKYV 1109
               S  V
Sbjct:  1099 SYSSSV 1104

GO:0005524 "ATP binding" evidence=NAS

GO:0005576 "extracellular region" evidence=NAS

GO:0005886 "plasma membrane" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=NAS

GO:0019199 "transmembrane receptor protein kinase activity" evidence=NAS

TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 2794 (988.6 bits), Expect = 6.2e-291, P = 6.2e-291
 Identities = 569/1090 (52%), Positives = 735/1090 (67%)

Query:    22 SVNALNGDGVALLSLMRHWNSVPPLIISSW--NSSDSTPCQWVGIECDDDAHNVVSFNLS 79
             SV+ LN DG+ LLSL++H + VPP + S+W  N+S++TPC W GI CDD + NV S N +
Sbjct:    25 SVSCLNSDGLTLLSLLKHLDRVPPQVTSTWKINASEATPCNWFGITCDD-SKNVASLNFT 83

Query:    80 SYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNF 139
                VSGQLGPEIG L  LQ +DLS+NNFSG IP  LGNC+ L  LDLS NGF+  IPD  
Sbjct:    84 RSRVSGQLGPEIGELKSLQILDLSTNNFSGTIPSTLGNCTKLATLDLSENGFSDKIPDTL 143

Query:   140 EXXXXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF 199
             +                GE+PE LFRI  LQ ++L+ N+L+G IP+++GD KE+  L ++
Sbjct:   144 DSLKRLEVLYLYINFLTGELPESLFRIPKLQVLYLDYNNLTGPIPQSIGDAKELVELSMY 203

Query:   200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS 259
             +N+ SG IPESIGN   LQ LYL+ NKL+G LPESL+ L NL  L VG+N+L+G + FGS
Sbjct:   204 ANQFSGNIPESIGNSSSLQILYLHRNKLVGSLPESLNLLGNLTTLFVGNNSLQGPVRFGS 263

Query:   260 EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLS 319
               CKNL  LDLSYN F GG+ P LGNCSSL  L IV   L+G+IPSS G+L  L+ L+LS
Sbjct:   264 PNCKNLLTLDLSYNEFEGGVPPALGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLS 323

Query:   320 ENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI 379
             EN+LSG IP ELG C  L +L L  NQL G IP  LG+L  L+ LELF+NR +GE P+ I
Sbjct:   324 ENRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPSALGKLRKLESLELFENRFSGEIPIEI 383

Query:   380 WRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFI 439
             W+  S               P+EMTE+K+LK  +L+NN F G IP  LG+NSSL ++DFI
Sbjct:   384 WKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFI 443

Query:   440 NNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFS 499
              N  TGEIPPNLC G++LR+LN+G N  HG IP+ +G C T+ R IL++N L+G LPEFS
Sbjct:   444 GNKLTGEIPPNLCHGRKLRILNLGSNLLHGTIPASIGHCKTIRRFILRENNLSGLLPEFS 503

Query:   500 KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISL 559
             ++  LS LD + NN  G IP S+G+  NL+SI+ S N+F+G +P +LGNL +L  +N+S 
Sbjct:   504 QDHSLSFLDFNSNNFEGPIPGSLGSCKNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSR 563

Query:   560 NHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFIS 619
             N +EGSLP+QLS C +LE FDV FN LNGS+PS+  +WK L+ L LSEN F+GGIP F+ 
Sbjct:   564 NLLEGSLPAQLSNCVSLERFDVGFNSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLP 623

Query:   620 XXXXXXXXXXXXXXXXXXIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDIS 679
                               IP SIG ++DL Y L+LS NGLTG IP+ L  L KL +L+IS
Sbjct:   624 ELKKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNIS 683

Query:   680 SNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMXXXXXXXXXXXXXXXXCVKCLSST 739
             +NNLTG+LS L  + SL+ V+VS N FTGP+P+ L                 C+    S 
Sbjct:   684 NNNLTGSLSVLKGLTSLLHVDVSNNQFTGPIPDNLEGQLLSEPSSFSGNPNLCIP--HSF 741

Query:   740 DSSCFGTSNLRPC-DYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRR--RSK 796
              +S    S L+ C D   S + GL+  +IV+IA+ SSLL ++V+L LV  CL RR  R +
Sbjct:   742 SASNNSRSALKYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPE 801

Query:   797 QDLEIPAQE-GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG 855
             +D  +  QE GPS LL +V+ AT+NLN K+ IGRGAHGIVY+ASLG   V+AVK+L F  
Sbjct:   802 KDAYVFTQEEGPSLLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFAS 861

Query:   856 HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPT 915
             H R + SM REI TIGK+RHRNL++LE FWLRKD G+++YRYM  GSL DVLH ++P   
Sbjct:   862 HIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKEN 921

Query:   916 -LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK 974
              L+W+ RY +             DC PPIVHRDIKPENIL+DS++EPHI DFG+A+LLD 
Sbjct:   922 VLDWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDD 981

Query:   975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
             S  ST +++  GT GYIAPENAF T + +ESDVYSYGVVLLEL+TRK+A+D S+ E TDI
Sbjct:   982 STVSTATVT--GTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDI 1039

Query:  1035 VGWVRSVWSDTEE-IND----IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN 1089
             V WVRS  S +   + D    IVD  L++E+L SS+R+QV+ V  +AL CT++ P+ RP 
Sbjct:  1040 VSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPT 1099

Query:  1090 MRDVVRQLVD 1099
             MRD V+ L D
Sbjct:  1100 MRDAVKLLED 1109

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045087 "innate immune response" evidence=TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006955 "immune response" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 2364 (837.2 bits), Expect = 2.3e-245, P = 2.3e-245
 Identities = 504/1066 (47%), Positives = 672/1066 (63%)

Query:    41 NSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTI 100
             NS    ++S     D  P + V     ++       N + +GV   L   +     ++T+
Sbjct:    28 NSDGLALLSLLKHFDKVPLE-VASTWKENTSETTPCNNNWFGVICDLSGNV-----VETL 81

Query:   101 DLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFEXXXXXXXXXXXXXXXDGEIP 160
             +LS++  SG +  ++G   +L  LDLS N F+G +P                    GE+P
Sbjct:    82 NLSASGLSGQLGSEIGELKSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVP 141

Query:   161 EPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQEL 220
             +    +  L +++L+ N+LSG IP +VG L E+  L +  N LSGTIPE +GNC +L+ L
Sbjct:   142 DIFGSLQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPELLGNCSKLEYL 201

Query:   221 YLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGIS 280
              LN NKL G LP SL  LENL  L V +N+L GR++FGS  CK L  LDLS+N F GG+ 
Sbjct:   202 ALNNNKLNGSLPASLYLLENLGELFVSNNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVP 261

Query:   281 PNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVL 340
             P +GNCSSL  L +V   LTG+IPSS G+L ++S +DLS+N+LSG IP ELG C  L  L
Sbjct:   262 PEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQELGNCSSLETL 321

Query:   341 HLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASXXXXXXXXXXXXXXXP 400
              L  NQL+GEIP  L +L  LQ LELF N+L+GE P+ IW+I S               P
Sbjct:   322 KLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELP 381

Query:   401 LEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVL 460
             +E+T+LK LK ++L+NN F G IP SLG+N SL ++D + N FTGEIPP+LC G++LR+ 
Sbjct:   382 VEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLF 441

Query:   461 NMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPS 520
              +G NQ HG IP+ +  C TL RV L+ N+L+G LPEF ++  LS++++  N+  G+IP 
Sbjct:   442 ILGSNQLHGKIPASIRQCKTLERVRLEDNKLSGVLPEFPESLSLSYVNLGSNSFEGSIPR 501

Query:   521 SIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFD 580
             S+G+  NL +ID S NK +GL+P ELGNL SL  LN+S N++EG LPSQLS C  L  FD
Sbjct:   502 SLGSCKNLLTIDLSQNKLTGLIPPELGNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFD 561

Query:   581 VSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISXXXXXXXXXXXXXXXXXXIPP 640
             V  N LNGSIPSS RSWKSLS L LS+N+F G IP F++                  IP 
Sbjct:   562 VGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPS 621

Query:   641 SIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVN 700
             S+G L+ L Y L+LS N  TG IP+ L  L  LE+L+IS+N LTG LS L ++ SL +V+
Sbjct:   622 SVGLLKSLRYGLDLSANVFTGEIPTTLGALINLERLNISNNKLTGPLSVLQSLKSLNQVD 681

Query:   701 VSYNLFTGPVPETLMXXXXXXXXXXXXXXXXCVKCLSSTDSSCFGTSNLRPCDYHSSHQQ 760
             VSYN FTGP+P  L+                C++  +S   S       + C      Q 
Sbjct:   682 VSYNQFTGPIPVNLLSNSSKFSGNPDL----CIQ--ASYSVSAIIRKEFKSC----KGQV 731

Query:   761 GLNKVKIVVIALGSSL--LTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLKQVIEAT 818
              L+  KI +IA GSSL  L +L  L LV C   R    +D  I A+EG S LL +V+ AT
Sbjct:   732 KLSTWKIALIAAGSSLSVLALLFALFLVLCRCKRGTKTEDANILAEEGLSLLLNKVLAAT 791

Query:   819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
             +NL+ K++IGRGAHG+VY+ASLG    +AVKKL F  H R + +MKREI+TIG +RHRNL
Sbjct:   792 DNLDDKYIIGRGAHGVVYRASLGSGEEYAVKKLIFAEHIRANQNMKREIETIGLVRHRNL 851

Query:   879 VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIXXXXXXXXXXXXX 937
             +RLE FW+RK+ G+++Y+YM NGSL DVLH        L+W+ R+ I             
Sbjct:   852 IRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHGLAYLHH 911

Query:   938 DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
             DC PPI+HRDIKPENIL+DS+MEPHI DFG+A++LD S  ST +++  GT GYIAPENA+
Sbjct:   912 DCHPPIIHRDIKPENILMDSDMEPHIGDFGLARILDDSTVSTATVT--GTTGYIAPENAY 969

Query:   998 TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND----IVD 1053
              T +SKESDVYSYGVVLLEL+T K+ALD S+ E  +IV WVRSV S  E+ +D    IVD
Sbjct:   970 KTVRSKESDVYSYGVVLLELVTGKRALDRSFPEDINIVSWVRSVLSSYEDEDDTAGPIVD 1029

Query:  1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
               L++E+L + +R+Q I V  +ALRCT+K+P NRP+MRDVV+ L D
Sbjct:  1030 PKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRDVVKDLTD 1075

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0042277 "peptide binding" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1499 (532.7 bits), Expect = 1.1e-153, P = 1.1e-153
 Identities = 367/1051 (34%), Positives = 540/1051 (51%)

Query:    68 DDAHNVVSFNLSSYGVSGQLGPEIGHLS---KLQTIDLSSNNFSGNIPPKLGNCSALEYL 124
             D   N+ ++N +     G  G    + S   ++ +++LSS   SG + P +G    L+ L
Sbjct:    43 DAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQL 102

Query:   125 DLSTNGFTGDIPDNFEXXXXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSIP 184
             DLS NG +G IP                   DGEIP  + +++ L+ + + NN +SGS+P
Sbjct:   103 DLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLP 162

Query:   185 RNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYL 244
               +G+L  +  L  +SN +SG +P SIGN  RL      +N + G LP  +   E+LV L
Sbjct:   163 VEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVML 222

Query:   245 DVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIP 304
              +  N L G +       K L+ + L  N FSG I   + NC+SL  L +  ++L G IP
Sbjct:   223 GLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIP 282

Query:   305 SSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDL 364
                G L  L  L L  N L+G IP E+G   Y   +    N L GEIP ELG +  L+ L
Sbjct:   283 KELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELL 342

Query:   365 ELFDNRLTGEFPVSIWRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIP 424
              LF+N+LTG  PV +  + +               PL    L+ L  + L+ N  SG IP
Sbjct:   343 YLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIP 402

Query:   425 QSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRV 484
               LG  S L  LD  +N  +G IP  LC    + +LN+G N   G IP+ + +C TL ++
Sbjct:   403 PKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQL 462

Query:   485 ILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMP 543
              L +N L G  P    K   ++ +++ +N   G+IP  +GN   L  +  + N F+G +P
Sbjct:   463 RLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELP 522

Query:   544 QELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSIL 603
             +E+G L  L TLNIS N + G +PS++  CK L+  D+  N  +G++PS + S   L +L
Sbjct:   523 REIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELL 582

Query:   604 KLSENHFTGGIPTFISXXXXXXXXXXXXXXXXXXIPPSIGALQDLSYALNLSKNGLTGRI 663
             KLS N+ +G IP  +                   IP  +G+L  L  ALNLS N LTG I
Sbjct:   583 KLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEI 642

Query:   664 PSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHSLVEVNVSYNLFTGPVP---ETLMXXXX 719
             P +L  L  LE L +++NNL+G + S  +N+ SL+  N SYN  TGP+P      M    
Sbjct:   643 PPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFI 702

Query:   720 XXXXXXXXXXXXCVKCLSSTDSSCFGT-SNLRPCDYHSSHQQGLNKVKIVVIALGSSLLT 778
                         C++      S   G    +R     +     +  V +++IAL   L+ 
Sbjct:   703 GNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMR 762

Query:   779 VLVMLGLVSCCLFRRRSKQDLEI--PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVY 836
               V   + S     + S+  L+I  P +EG  +  + ++ AT+N +   V+GRGA G VY
Sbjct:   763 RPVRT-VASSAQDGQPSEMSLDIYFPPKEG--FTFQDLVAATDNFDESFVVGRGACGTVY 819

Query:   837 KASLGPNAVFAVKKLAFRGHKRGSL-----SMKREIQTIGKIRHRNLVRLEDFWLRKDCG 891
             KA L      AVKKLA   H+ G+      S + EI T+G IRHRN+V+L  F   +   
Sbjct:   820 KAVLPAGYTLAVKKLA-SNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSN 878

Query:   892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPE 951
             +++Y YM  GSL ++LH   P   L+W+ R+KI             DC P I HRDIK  
Sbjct:   879 LLLYEYMPKGSLGEILHD--PSCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSN 936

Query:   952 NILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYG 1011
             NILLD + E H+ DFG+AK++D  P S +  ++ G+ GYIAPE A+T   +++SD+YSYG
Sbjct:   937 NILLDDKFEAHVGDFGLAKVIDM-PHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYG 995

Query:  1012 VVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD--LSLMEEMLVSSIRDQV 1069
             VVLLEL+T K  + P   +  D+V WVRS        + ++D  L+L +E +VS     +
Sbjct:   996 VVLLELLTGKAPVQP-IDQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVS----HM 1050

Query:  1070 IDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
             + VL +AL CT   P  RP+MR VV  L+++
Sbjct:  1051 LTVLKIALLCTSVSPVARPSMRQVVLMLIES 1081

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:4515102753 AT1G73066 [Arabidopsis thaliana (taxid:3702)]

 Score = 1468 (521.8 bits), Expect = 2.0e-150, P = 2.0e-150
 Identities = 293/577 (50%), Positives = 385/577 (66%)

Query:    22 SVNALNGDGVALLSLMRHWNSVPPLIISSW--NSSDSTPCQWVGIECDDDAHNVVSFNLS 79
             SV+ LN DG+ LLSL +H + VPP + S+W  N+S++TPC W GI CDD +  V S N +
Sbjct:    23 SVSCLNSDGLTLLSLRKHLDKVPPELTSTWKTNASEATPCNWFGIICDD-SKKVTSLNFT 81

Query:    80 SYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNF 139
               GVSGQLGPEIG L  L+ +D+SSNNFSG IP  LGNCS+L Y+DLS N F+G +PD  
Sbjct:    82 GSGVSGQLGPEIGQLKSLEILDMSSNNFSGIIPSSLGNCSSLVYIDLSENSFSGKVPDTL 141

Query:   140 EXXXXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF 199
                              GE+P+ LFRI  L Y+ + +N+L+G IP+NVG+ KE+  L LF
Sbjct:   142 GSLKSLADLYLYSNSLTGELPKSLFRIPVLNYLHVEHNNLTGLIPQNVGEAKELLHLRLF 201

Query:   200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS 259
              N+ +GTIPESIGNC +L+ LYL++NKL+G LP SL+ LE+L  L V +N+L G + FGS
Sbjct:   202 DNQFTGTIPESIGNCSKLEILYLHKNKLVGSLPASLNLLESLTDLFVANNSLRGTVQFGS 261

Query:   260 EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLS 319
              KC+NL  LDLSYN F GG+ P LGNCSSL  L IV   L+G+IPSS G+L  L+ L+LS
Sbjct:   262 TKCRNLVTLDLSYNEFEGGVPPELGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLS 321

Query:   320 ENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI 379
             EN+LSG IP ELG C  L +L L  NQL G IP  LG+L  L+ LELF+NR +GE P+ I
Sbjct:   322 ENRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPSALGKLRKLESLELFENRFSGEIPIEI 381

Query:   380 WRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFI 439
             W+I S               P E+T+LK LK ++L+NN F GVIP +LG+NS+L  +DFI
Sbjct:   382 WKIQSLTQLLVYRNNLTGKLPEEITKLKNLKIVTLFNNSFYGVIPPNLGLNSNLEIIDFI 441

Query:   440 NNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFS 499
              N+FTGEIP NLC GK L V N+G N+ HG IP+ +  C TL R IL++N L+G LP+FS
Sbjct:   442 GNNFTGEIPRNLCHGKMLTVFNLGSNRLHGKIPASVSQCKTLSRFILRENNLSGFLPKFS 501

Query:   500 KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISL 559
             KN  LS LD++ N+  G IP S+G+  NLT+I+ S NK +  +P+EL NL +L  LN+  
Sbjct:   502 KNQDLSFLDLNSNSFEGPIPRSLGSCRNLTTINLSRNKLTRNIPRELENLQNLSHLNLGS 561

Query:   560 NHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRS 596
             N + G++PS+ S  K L    +S N  +G +P    S
Sbjct:   562 NLLNGTVPSKFSNWKELTTLVLSGNRFSGFVPPDRHS 598

GO:0005886 "plasma membrane" evidence=ISM

GO:0008150 "biological_process" evidence=ND

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 1455 (517.2 bits), Expect = 4.8e-149, P = 4.8e-149
 Identities = 359/1062 (33%), Positives = 544/1062 (51%)

Query:    61 WVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSA 120
             W GI  D+   N +  N SS G S      +     + ++DLSS N SG + P +G    
Sbjct:    58 WNGI--DETPCNWIGVNCSSQGSSSSSNSLV-----VTSLDLSSMNLSGIVSPSIGGLVN 110

Query:   121 LEYLDLSTNGFTGDIPDNFEXXXXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLS 180
             L YL+L+ N  TGDIP                    G IP  + ++  L+   + NN LS
Sbjct:   111 LVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLS 170

Query:   181 GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
             G +P  +GDL  +E L  ++N L+G +P S+GN  +L      +N   G +P  +    N
Sbjct:   171 GPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLN 230

Query:   241 LVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT 300
             L  L +  N + G +         L  + L  N+FSG I  ++GN +SL  L + G+ L 
Sbjct:   231 LKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLV 290

Query:   301 GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSN 360
             G IPS  G +  L  L L +NQL+G IP ELGK   +  +    N L GEIP EL ++S 
Sbjct:   291 GPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISE 350

Query:   361 LQDLELFDNRLTGEFPVSIWRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFS 420
             L+ L LF N+LTG  P  + ++ +               P     L  ++ + L++N  S
Sbjct:   351 LRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLS 410

Query:   421 GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT 480
             GVIPQ LG+ S L  +DF  N  +G+IPP +C    L +LN+G N+  G IP  +  C +
Sbjct:   411 GVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKS 470

Query:   481 LWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS 539
             L ++ +  N+LTG  P E  K   LS +++ +N  SG +P  IG    L  +  ++N+FS
Sbjct:   471 LLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFS 530

Query:   540 GLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKS 599
               +P E+  L +LVT N+S N + G +PS+++ CK L+  D+S N   GS+P  L S   
Sbjct:   531 SNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQ 590

Query:   600 LSILKLSENHFTGGIPTFISXXXXXXXXXXXXXXXXXXIPPSIGALQDLSYALNLSKNGL 659
             L IL+LSEN F+G IP  I                   IPP +G L  L  A+NLS N  
Sbjct:   591 LEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDF 650

Query:   660 TGRIPSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHSLVEVNVSYNLFTGPVPETLMXXX 718
             +G IP ++  L  L  L +++N+L+G + +   N+ SL+  N SYN  TG +P T +   
Sbjct:   651 SGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQN 710

Query:   719 XXXXXXXXXXXXXCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIAL--GSSL 776
                          C   L S D S     ++      S+ +    ++ I+V ++  G SL
Sbjct:   711 MTLTSFLGNKGL-CGGHLRSCDPSHSSWPHISSLKAGSARR---GRIIIIVSSVIGGISL 766

Query:   777 LTVLVMLGLVSCCLFRRRSK-QDLEIPAQEGPSYLL-------KQVIEATENLNAKHVIG 828
             L + +++  +   +        D E   QE   Y +       K ++EAT+  +  +++G
Sbjct:   767 LLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVG 826

Query:   829 RGAHGIVYKASLGPNAVFAVKKLAFR--GHKRGSL----SMKREIQTIGKIRHRNLVRLE 882
             RGA G VYKA +      AVKKL     G+   S     S + EI T+GKIRHRN+VRL 
Sbjct:   827 RGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLY 886

Query:   883 DFWLRK--DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCD 940
              F   +  +  +++Y YM  GSL ++LH      +++W  R+ I             DC 
Sbjct:   887 SFCYHQGSNSNLLLYEYMSRGSLGELLHG-GKSHSMDWPTRFAIALGAAEGLAYLHHDCK 945

Query:   941 PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
             P I+HRDIK  NIL+D   E H+ DFG+AK++D  P S +  +V G+ GYIAPE A+T  
Sbjct:   946 PRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDM-PLSKSVSAVAGSYGYIAPEYAYTMK 1004

Query:  1001 KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD--LSLME 1058
              +++ D+YS+GVVLLEL+T K  + P  ++  D+  W R+   D    ++I+D  L+ +E
Sbjct:  1005 VTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGDLATWTRNHIRDHSLTSEILDPYLTKVE 1063

Query:  1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
             + +   I + +I V  +A+ CT+  PS+RP MR+VV  L+++
Sbjct:  1064 DDV---ILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIES 1102

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 1422 (505.6 bits), Expect = 1.5e-145, P = 1.5e-145
 Identities = 365/1077 (33%), Positives = 540/1077 (50%)

Query:    46 LIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSN 105
             +++ S N       ++     D + + + S+N          G    HL  + ++DL+  
Sbjct:    19 ILVRSLNEEGRVLLEFKAFLNDSNGY-LASWNQLDSNPCNWTGIACTHLRTVTSVDLNGM 77

Query:   106 NFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFEXXXXXXXXXXXXXXXDGEIPEPLFR 165
             N SG + P +     L  L++STN  +G IP +                  G IP  L  
Sbjct:    78 NLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTM 137

Query:   166 ILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNEN 225
             I+ L+ ++L  N L GSIPR +G+L  ++ L ++SN L+G IP S+    +L+ +    N
Sbjct:   138 IITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRN 197

Query:   226 KLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGN 285
                G +P  +S  E+L  L + +N LEG +    EK +NLT L L  NR SG I P++GN
Sbjct:   198 GFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGN 257

Query:   286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
              S L  L +  +  TGSIP   G L ++  L L  NQL+G+IP E+G       +    N
Sbjct:   258 ISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSEN 317

Query:   346 QLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASXXXXXXXXXXXXXXXPLEMTE 405
             QL G IP E G + NL+ L LF+N L G  P  +  +                 P E+  
Sbjct:   318 QLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQF 377

Query:   406 LKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQN 465
             L  L ++ L++NQ  G IP  +G  S+   LD   NS +G IP + C  + L +L++G N
Sbjct:   378 LPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSN 437

Query:   466 QFHGPIPSLLGSCPTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGN 524
             +  G IP  L +C +L +++L  NQLTG+LP E      L+ L++ +N +SG I + +G 
Sbjct:   438 KLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGK 497

Query:   525 SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN 584
               NL  +  ++N F+G +P E+GNL  +V  NIS N + G +P +L  C  ++  D+S N
Sbjct:   498 LKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGN 557

Query:   585 LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISXXXXXXXXXXXXXXXXXXIPPSIGA 644
               +G I   L     L IL+LS+N  TG IP                      IP  +G 
Sbjct:   558 KFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGK 617

Query:   645 LQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHSLVEVNVSY 703
             L  L  +LN+S N L+G IP  L  L  LE L ++ N L+G + + + N+ SL+  N+S 
Sbjct:   618 LTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISN 677

Query:   704 NLFTGPVPETLMXXXXXXXXXXXXXXXXCVKCLSSTDSSCFGTSNLRPCDYHSSHQ---- 759
             N   G VP+T +                   C +S  S C      +P   HS  +    
Sbjct:   678 NNLVGTVPDTAVFQRMDSSNFAGNHGL----C-NSQRSHC------QPLVPHSDSKLNWL 726

Query:   760 -QGLNKVKIVVIA---LGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPS-----YL 810
               G  + KI+ I    +GS  L  +  LGL  C   +RR    + +  Q  P      Y 
Sbjct:   727 INGSQRQKILTITCIVIGSVFL--ITFLGL--CWTIKRREPAFVALEDQTKPDVMDSYYF 782

Query:   811 LKQ------VIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGS-LSM 863
              K+      +++AT N +   V+GRGA G VYKA +    V AVKKL  RG    S  S 
Sbjct:   783 PKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSF 842

Query:   864 KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
             + EI T+GKIRHRN+V+L  F   ++  +++Y YM  GSL + L        L+WN RY+
Sbjct:   843 RAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYR 902

Query:   924 IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
             I             DC P IVHRDIK  NILLD   + H+ DFG+AKL+D S + + S +
Sbjct:   903 IALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMS-A 961

Query:   984 VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043
             V G+ GYIAPE A+T   +++ D+YS+GVVLLELIT K  + P  ++  D+V WVR    
Sbjct:   962 VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRSIR 1020

Query:  1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
             +     ++ D  L +     ++ +  + VL +AL CT   P++RP MR+VV  + +A
Sbjct:  1021 NMIPTIEMFDARL-DTNDKRTVHEMSL-VLKIALFCTSNSPASRPTMREVVAMITEA 1075

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 1405 (499.6 bits), Expect = 9.6e-144, P = 9.6e-144
 Identities = 353/991 (35%), Positives = 512/991 (51%)

Query:   124 LDLSTNGFTGDIPDNFEXXXXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
             +D+ +      +P N                  G +PE L   LGL+ + L++N L G I
Sbjct:    86 IDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDI 145

Query:   184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
             P ++  L+ +E L L SN+L+G IP  I  C +L+ L L +N L G +P  L  L  L  
Sbjct:   146 PWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEV 205

Query:   244 LDVGDNN-LEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGS 302
             + +G N  + G+I      C NLT L L+    SG +  +LG    L  L I  + ++G 
Sbjct:   206 IRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGE 265

Query:   303 IPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQ 362
             IPS  G  + L  L L EN LSG IP E+G+   L  L L+ N L G IP+E+G  SNL+
Sbjct:   266 IPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLK 325

Query:   363 DLELFDNRLTGEFPVSIWRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGV 422
              ++L  N L+G  P SI R++                P  ++    L  + L  NQ SG+
Sbjct:   326 MIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGL 385

Query:   423 IPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLW 482
             IP  LG  + L      +N   G IPP L     L+ L++ +N   G IPS L     L 
Sbjct:   386 IPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLT 445

Query:   483 RVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGL 541
             +++L  N L+G +P E      L  L +  N I+G IPS IG+   +  +DFSSN+  G 
Sbjct:   446 KLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGK 505

Query:   542 MPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLS 601
             +P E+G+   L  +++S N +EGSLP+ +S    L+V DVS N  +G IP+SL    SL+
Sbjct:   506 VPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLN 565

Query:   602 ILKLSENHFTGGIPTFISXXXXXXXXXXXXXXXXXXIPPSIGALQDLSYALNLSKNGLTG 661
              L LS+N F+G IPT +                   IP  +G +++L  ALNLS N LTG
Sbjct:   566 KLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTG 625

Query:   662 RIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMXXXXXX 721
             +IPS +  L+KL  LD+S N L G L+PL+NI +LV +N+SYN F+G +P+  +      
Sbjct:   626 KIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSP 685

Query:   722 XXXXXXXXXXCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLV 781
                         K  SST  SCF T                 K+++  +AL  +L  VL+
Sbjct:   686 QDLEGNK-----KLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLT-LALLITLTVVLM 739

Query:   782 MLGLVSCCLFRRR--SKQDLEIPA----QEGPSYLLK-QVIEATENLNAKHVIGRGAHGI 834
             +LG V+    RR   +++D E+      Q  P   L   V +    L   +VIG+G  G+
Sbjct:   740 ILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRCLVEPNVIGKGCSGV 799

Query:   835 VYKASLGPNAVFAVKKL--AF--RGH--KRGSL--SMKREIQTIGKIRHRNLVRLEDFWL 886
             VY+A +    V AVKKL  A    GH  K  ++  S   E++T+G IRH+N+VR      
Sbjct:   800 VYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCW 859

Query:   887 RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHR 946
              ++  ++MY YM NGSL  +LH      +L+W++RY+I             DC PPIVHR
Sbjct:   860 NRNTRLLMYDYMPNGSLGSLLHE-RRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHR 918

Query:   947 DIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESD 1006
             DIK  NIL+  + EP+I+DFG+AKL+D+      S +V G+ GYIAPE  ++   +++SD
Sbjct:   919 DIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSD 978

Query:  1007 VYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIR 1066
             VYSYGVV+LE++T K+ +DP+  E   +V WVR      E    ++D +L       +  
Sbjct:   979 VYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLE----VLDSTLRSRTEAEA-- 1032

Query:  1067 DQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             D+++ VL  AL C    P  RP M+DV   L
Sbjct:  1033 DEMMQVLGTALLCVNSSPDERPTMKDVAAML 1063

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1364 (485.2 bits), Expect = 2.1e-139, P = 2.1e-139
 Identities = 349/1051 (33%), Positives = 529/1051 (50%)

Query:    83 VSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFEXX 142
             + G +  EIG+ + L     + N  +G++P +L     L+ L+L  N F+G+IP      
Sbjct:   204 LEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDL 263

Query:   143 XXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNR 202
                           G IP+ L  +  LQ + L++N+L+G I      + ++E L L  NR
Sbjct:   264 VSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNR 323

Query:   203 LSGTIPESI-GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEK 261
             LSG++P++I  N   L++L+L+E +L G +P  +SN ++L  LD+ +N L G+I     +
Sbjct:   324 LSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQ 383

Query:   262 CKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN 321
                LT L L+ N   G +S ++ N ++L    +  + L G +P   G L +L  + L EN
Sbjct:   384 LVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYEN 443

Query:   322 QLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWR 381
             + SG++P E+G C  L  +  Y N+L GEIP  +G+L +L  L L +N L G  P S+  
Sbjct:   444 RFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGN 503

Query:   382 IASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIPQSLGIN-SSLMQLDFIN 440
                               P     L  L+   +YNN   G +P SL IN  +L +++F +
Sbjct:   504 CHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSL-INLKNLTRINFSS 562

Query:   441 NSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FS 499
             N F G I P LC        ++ +N F G IP  LG    L R+ L +NQ TG +P  F 
Sbjct:   563 NKFNGSISP-LCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFG 621

Query:   500 KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISL 559
             K   LS LD+SRN++SG IP  +G    LT ID ++N  SG++P  LG L  L  L +S 
Sbjct:   622 KISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSS 681

Query:   560 NHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFIS 619
             N   GSLP+++    N+    +  N LNGSIP  + + ++L+ L L EN  +G +P+ I 
Sbjct:   682 NKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIG 741

Query:   620 XXXXXXXXXXXXXXXXXXIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDIS 679
                               IP  IG LQDL  AL+LS N  TGRIPS +  L KLE LD+S
Sbjct:   742 KLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLS 801

Query:   680 SNNLTGTL-SPLSNIHSLVEVNVSYNLFTGPVPETLMXXXXXXXXXXXXXXXXCVKCLSS 738
              N L G +   + ++ SL  +N+SYN   G + +                   C   LS 
Sbjct:   802 HNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQF---SRWQADAFVGNAGLCGSPLSH 858

Query:   739 TDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRR---- 794
              + +  G+ N          Q+ L+   +V+I+  SSL  + +M+ LV    F++     
Sbjct:   859 CNRA--GSKN----------QRSLSPKTVVIISAISSLAAIALMV-LVIILFFKQNHDLF 905

Query:   795 ------------SKQDLEIP--AQEGPSYLLK--QVIEATENLNAKHVIGRGAHGIVYKA 838
                         +    + P  +  G    +K   ++EAT  LN + +IG G  G VYKA
Sbjct:   906 KKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKA 965

Query:   839 SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI--IMYR 896
              L      AVKK+ ++     + S  RE++T+G IRHR+LV+L  +   K  G+  ++Y 
Sbjct:   966 ELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYE 1025

Query:   897 YMENGSLRDVLHS---ITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENI 953
             YM NGS+ D LH+         L W  R KI             DC PPIVHRDIK  N+
Sbjct:  1026 YMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNV 1085

Query:   954 LLDSEMEPHISDFGIAKLLDKSPASTTSISVV--GTIGYIAPENAFTTAKSKESDVYSYG 1011
             LLDS +E H+ DFG+AK+L  +  + T  + +  G+ GYIAPE A++   +++SDVYS G
Sbjct:  1086 LLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMG 1145

Query:  1012 VVLLELITRKKALDPSYKERTDIVGWVRSVWSD---TEEINDIVDLSLMEEMLVSSIRDQ 1068
             +VL+E++T K   +  + E TD+V WV +V      +E    ++D  L  + L+    + 
Sbjct:  1146 IVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSEL--KSLLPCEEEA 1203

Query:  1069 VIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
                VL +AL+CT+  P  RP+ R     L++
Sbjct:  1204 AYQVLEIALQCTKSYPQERPSSRQASEYLLN 1234

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1170 (416.9 bits), Expect = 7.7e-119, P = 7.7e-119
 Identities = 316/941 (33%), Positives = 461/941 (48%)

Query:    73 VVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFT 132
             V S  L    + G +  E+G+ S L     + N  +G IP +LG    LE L+L+ N  T
Sbjct:   193 VQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILNLANNSLT 252

Query:   133 GDIPDNFEXXXXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKE 192
             G+IP                    G IP+ L  +  LQ + L+ N+L+G IP    ++ +
Sbjct:   253 GEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQ 312

Query:   193 VEALWLFSNRLSGTIPESI-GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
             +  L L +N LSG++P+SI  N   L++L L+  +L G +P  LS  ++L  LD+ +N+L
Sbjct:   313 LLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSL 372

Query:   252 EGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLA 311
              G I     +   LT L L  N   G +SP++ N ++L  L +  + L G +P     L 
Sbjct:   373 AGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALR 432

Query:   312 RLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRL 371
             +L  L L EN+ SG+IP E+G C  L ++ ++ N  EGEIP  +G+L  L  L L  N L
Sbjct:   433 KLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNEL 492

Query:   372 TGEFPVSIWRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIPQSLGINS 431
              G  P S+                    P     LK L+ + LYNN   G +P SL    
Sbjct:   493 VGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLR 552

Query:   432 SLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQL 491
             +L +++  +N   G I P LC        ++  N F   IP  LG+   L R+ L +NQL
Sbjct:   553 NLTRINLSHNRLNGTIHP-LCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQL 611

Query:   492 TGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLV 550
             TG +P    K   LS LD+S N ++G IP  +     LT ID ++N  SG +P  LG L 
Sbjct:   612 TGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLS 671

Query:   551 SLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHF 610
              L  L +S N    SLP++L  C  L V  +  N LNGSIP  + +  +L++L L +N F
Sbjct:   672 QLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQF 731

Query:   611 TGGIPTFISXXXXXXXXXXXXXXXXXXIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKL 670
             +G +P  +                   IP  IG LQDL  AL+LS N  TG IPS +  L
Sbjct:   732 SGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTL 791

Query:   671 SKLEQLDISSNNLTGTL-SPLSNIHSLVEVNVSYNLFTGPVPETLMXXXXXXXXXXXXXX 729
             SKLE LD+S N LTG +   + ++ SL  +NVS+N   G + +                 
Sbjct:   792 SKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQF---SRWPADSFLGNT 848

Query:   730 XXCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCC 789
               C     S  S C   + +R     ++ QQGL+   +V+I+  S+L  + +M+ LV   
Sbjct:   849 GLC----GSPLSRC---NRVRS----NNKQQGLSARSVVIISAISALTAIGLMI-LVIAL 896

Query:   790 LFRRR-------------------SKQDLEIPA-QEGPS---YLLKQVIEATENLNAKHV 826
              F++R                   S Q    P  + G S      + ++EAT NL+ + +
Sbjct:   897 FFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFM 956

Query:   827 IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
             IG G  G VYKA L      AVKK+ ++     + S  RE++T+G+IRHR+LV+L  +  
Sbjct:   957 IGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCS 1016

Query:   887 RKDCGI--IMYRYMENGSLRDVLHSITP-----PPTLEWNVRYKIXXXXXXXXXXXXXDC 939
              K  G+  ++Y YM+NGS+ D LH   P        L+W  R +I             DC
Sbjct:  1017 SKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDC 1076

Query:   940 DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
              PPIVHRDIK  N+LLDS ME H+ DFG+AK+L ++  + T
Sbjct:  1077 VPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNT 1117

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SSL9	PEPR1_ARATH	2, ., 7, ., 1, 1, ., 1	0.5627	0.9684	0.9563	yes	no
P93194	RPK1_IPONI	2, ., 7, ., 1, 1, ., 1	0.5621	0.9945	0.9945	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1109
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-150
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-41
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-35
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-33
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-31
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-21
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-18
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-18
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	9e-17
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-15
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-14
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-13
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	9e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-11
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-09
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	1e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-09
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	7e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	1e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	5e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	5e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-07
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	9e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	8e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	5e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	7e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	7e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	0.001
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.004
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  474 bits (1221), Expect = e-150
 Identities = 359/1118 (32%), Positives = 543/1118 (48%), Gaps = 186/1118 (16%)

Query: 6    CHFLLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIE 65
            C +L+    F+ L+   ++A   + + LL   +   + P   +S+WNSS +  C W GI 
Sbjct: 9    CPYLIFMLFFLFLNFSMLHA---EELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGIT 64

Query: 66   CDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKL-GNCSALEYL 124
            C++ +  VVS +LS   +SG++   I  L  +QTI+LS+N  SG IP  +    S+L YL
Sbjct: 65   CNNSSR-VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123

Query: 125  DLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIP 184
            +LS N FTG IP     + NL+ L+L  N+L GEIP  +     L+ + L  N L G IP
Sbjct: 124  NLSNNNFTGSIPRGS--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181

Query: 185  RNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYL 244
             ++ +L  +E L L SN+L G IP  +G                                
Sbjct: 182  NSLTNLTSLEFLTLASNQLVGQIPRELG-------------------------------- 209

Query: 245  DVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIP 304
                            + K+L ++ L YN  SG I   +G  +SL HLD+V + LTG IP
Sbjct: 210  ----------------QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Query: 305  SSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDL 364
            SS G L  L  L L +N+LSG IPP +   + L  L L  N L GEIP+ + QL NL+ L
Sbjct: 254  SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313

Query: 365  ELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIP 424
             LF N  T                        GK+P+ +T L +L+ + L++N+FSG IP
Sbjct: 314  HLFSNNFT------------------------GKIPVALTSLPRLQVLQLWSNKFSGEIP 349

Query: 425  QSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRV 484
            ++LG +++L  LD   N+ TGEIP  LC    L  L +  N   G IP  LG+C +L RV
Sbjct: 350  KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRV 409

Query: 485  ILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMP 543
             L+ N  +G LP EF+K P++  LD+S NN+ G I S   +  +L  +  + NKF G +P
Sbjct: 410  RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469

Query: 544  QELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSIL 603
               G+                         K LE  D+S N  +G++P  L S   L  L
Sbjct: 470  DSFGS-------------------------KRLENLDLSRNQFSGAVPRKLGSLSELMQL 504

Query: 604  KLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRI 663
            KLSEN  +G IP  +S  +KL+ L L  NQL G+IP S   +  LS  L+LS+N L+G I
Sbjct: 505  KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS-QLDLSQNQLSGEI 563

Query: 664  PSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPS 723
            P +                       L N+ SLV+VN+S+N   G +P T    L  + S
Sbjct: 564  PKN-----------------------LGNVESLVQVNISHNHLHGSLPST-GAFLAINAS 599

Query: 724  SFSGNPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVK----IVVIALGSSLLTV 779
            + +GN  LC       D+    TS L PC       + + K       +   LG+ L+  
Sbjct: 600  AVAGNIDLC-----GGDT----TSGLPPC-------KRVRKTPSWWFYITCTLGAFLVLA 643

Query: 780  LVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLK----------QVIEATENLNAKHVIGR 829
            LV  G V     R R+  +L+    E  ++ L+           + +   +L  ++VI R
Sbjct: 644  LVAFGFV---FIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISR 700

Query: 830  GAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK 888
            G  G  YK     N + F VK++    +   S+    EI  +GK++H N+V+L      +
Sbjct: 701  GKKGASYKGKSIKNGMQFVVKEI----NDVNSIP-SSEIADMGKLQHPNIVKLIGLCRSE 755

Query: 889  DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDI 948
                +++ Y+E  +L +VL +      L W  R KIA+G A AL +LH  C P +V  ++
Sbjct: 756  KGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809

Query: 949  KPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVY 1008
             PE I++D + EPH+    +  LL       T      +  Y+APE   T   +++SD+Y
Sbjct: 810  SPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVAPETRETKDITEKSDIY 862

Query: 1009 SYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQ 1068
             +G++L+EL+T K   D  +     IV W R  +SD   ++  +D S+  ++ V+  +++
Sbjct: 863  GFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVN--QNE 919

Query: 1069 VIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTS 1106
            +++V+ +AL CT   P+ RP   DV++ L  AS   +S
Sbjct: 920  IVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  158 bits (401), Expect = 8e-44
 Identities = 70/217 (32%), Positives = 106/217 (48%), Gaps = 18/217 (8%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G G  G VY A         A+K +           + REI+ + K+ H N+V+L   +
Sbjct: 1    LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
              ++   ++  Y E GSL+D+L        L  +   +I L     L YLH      I+H
Sbjct: 61   EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 946  RDIKPENILLDS-EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SK 1003
            RD+KPENILLDS   +  ++DFG++KLL    +   +I  VGT  Y+APE        S+
Sbjct: 116  RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSE 173

Query: 1004 ESDVYSYGVVLLE------LITRKKALDPSYKERTDI 1034
            +SD++S GV+L E      LI  +K L    ++R   
Sbjct: 174  KSDIWSLGVILYELPELKDLI--RKMLQKDPEKRPSA 208

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (392), Expect = 3e-42
 Identities = 79/271 (29%), Positives = 117/271 (43%), Gaps = 27/271 (9%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +G G+ G VY A       + A+K +  +  K+    + REI+ + K++H N+VRL D 
Sbjct: 6    KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +  +D   ++  Y E G L D+L         E   R+        AL YLH      IV
Sbjct: 66   FEDEDKLYLVMEYCEGGDLFDLLKKRGRLS--EDEARF-YLRQILSALEYLHSKG---IV 119

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KPENILLD +    ++DFG+A+ LD     TT    VGT  Y+APE        K 
Sbjct: 120  HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVLLGKGYGKA 176

Query: 1005 SDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSS 1064
             D++S GV+L EL+T K    P +                 E    I             
Sbjct: 177  VDIWSLGVILYELLTGK----PPFPGDDQ----------LLELFKKIGKPKPPFPPPEWD 222

Query: 1065 IRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
            I  +  D++    +   K P  R    + ++
Sbjct: 223  ISPEAKDLI---RKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  152 bits (386), Expect = 2e-41
 Identities = 91/281 (32%), Positives = 127/281 (45%), Gaps = 43/281 (15%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMK-----REIQTIGKIRHRNLV 879
             +G G+ G VYKA   G   + AVK L     KR   S K     REI+ + ++ H N+V
Sbjct: 6    KLGSGSFGTVYKAKHKGTGKIVAVKIL----KKRSEKSKKDQTARREIRILRRLSHPNIV 61

Query: 880  RLEDFWLRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            RL D +  KD   ++M  Y E G L D L    P   L  +   KIAL     L YLH  
Sbjct: 62   RLIDAFEDKDHLYLVM-EYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH-- 115

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-NAF 997
                I+HRD+KPENILLD      I+DFG+AK L KS +S T+   VGT  Y+APE    
Sbjct: 116  -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF--VGTPWYMAPEVLLG 172

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057
                  + DV+S GV+L EL+T                   +  +S    ++ +  +  +
Sbjct: 173  GNGYGPKVDVWSLGVILYELLTG------------------KPPFSGENILDQLQLIRRI 214

Query: 1058 EEMLVSSIRDQVIDVLLVAL----RCTEKKPSNRPNMRDVV 1094
                +     +       A     +C  K PS RP   +++
Sbjct: 215  LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  134 bits (340), Expect = 4e-35
 Identities = 80/274 (29%), Positives = 126/274 (45%), Gaps = 30/274 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN 877
             +L    V+G+G+ G+VYK    P   ++A+KK+   G +     + RE++T+       
Sbjct: 1    SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 878  LVRL-EDFWLRKDCGIIMYRYMENGSLRDVL--HSITPPPTLEWNVRYKIALGAAHALAY 934
            +V+    F+   +  I++  YM+ GSL D+L      P P L       IA      L Y
Sbjct: 61   VVKCYGAFYKEGEISIVL-EYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDY 114

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            LH      I+HRDIKP N+L++S+ E  I+DFGI+K+L+ +     +   VGT+ Y++PE
Sbjct: 115  LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPE 170

Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054
                 + S  +D++S G+ LLE    K    P          +    +   + I D    
Sbjct: 171  RIQGESYSYAADIWSLGLTLLECALGKFPFLPP-----GQPSF----FELMQAICDGPPP 221

Query: 1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP 1088
            SL  E      RD +         C +K P  RP
Sbjct: 222  SLPAEEFSPEFRDFIS-------ACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  127 bits (322), Expect = 9e-33
 Identities = 73/296 (24%), Positives = 114/296 (38%), Gaps = 58/296 (19%)

Query: 821  LNAKHVIGRGAHGIVYKASLGPNAVF-----AVKKL---AFRGHKRGSLSMKREIQTIGK 872
            L     +G GA G VYK  L           AVK L   A            RE + + K
Sbjct: 1    LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE---EFLREARIMRK 57

Query: 873  IRHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIA 925
            + H N+V+L       E  +      I+M  YME G L   L      P L  +     A
Sbjct: 58   LDHPNVVKLLGVCTEEEPLY------IVM-EYMEGGDLLSYLRK--NRPKLSLSDLLSFA 108

Query: 926  LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
            L  A  + YL        +HRD+   N L+   +   ISDFG+++ L             
Sbjct: 109  LQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYRKR 161

Query: 986  GT---IGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041
            G    I ++APE +    K + +SDV+S+GV+L E+ T  +     Y             
Sbjct: 162  GGKLPIRWMAPE-SLKEGKFTSKSDVWSFGVLLWEIFTLGE---QPYPG----------- 206

Query: 1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             S+ E +  + +   + +           ++  + L+C  + P +RP   ++V  L
Sbjct: 207  MSNEEVLEYLKNGYRLPQPPNCP-----PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  126 bits (320), Expect = 2e-32
 Identities = 72/296 (24%), Positives = 111/296 (37%), Gaps = 67/296 (22%)

Query: 826  VIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
             +G GA G VYK +L     G     AVK L     +        E   + K+ H N+VR
Sbjct: 6    KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            L     + +   I+  YM  G L D L       TL+     ++AL  A  + YL     
Sbjct: 66   LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE---S 120

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE- 994
               VHRD+   N L+   +   ISDFG+++ + +              G +     APE 
Sbjct: 121  KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE-----DDYYRKRGGGKLPIKWMAPES 175

Query: 995  ---NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT--DIVGWVRS--------V 1041
                 FT+     SDV+S+GV+L E+ T  +     Y   +  +++  +           
Sbjct: 176  LKDGKFTSK----SDVWSFGVLLWEIFTLGE---QPYPGMSNEEVLELLEDGYRLPRPEN 228

Query: 1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              D  E+ +     LM                   L+C    P +RP   ++V  L
Sbjct: 229  CPD--ELYE-----LM-------------------LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (313), Expect = 1e-31
 Identities = 73/293 (24%), Positives = 115/293 (39%), Gaps = 51/293 (17%)

Query: 821  LNAKHVIGRGAHGIVYKASLGPNAVF-----AVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
            L     +G GA G VYK +L           AVK L     ++      RE + + K+ H
Sbjct: 1    LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 876  RNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGA 928
             N+V+L       E         I+M  YM  G L D L     P  L  +     AL  
Sbjct: 61   PNIVKLLGVCTEEEPLM------IVM-EYMPGGDLLDYLRK-NRPKELSLSDLLSFALQI 112

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT- 987
            A  + YL        +HRD+   N L+   +   ISDFG+++ L           V G  
Sbjct: 113  ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYKVKGGK 165

Query: 988  --IGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044
              I ++APE +    K + +SDV+S+GV+L E+ T  +     Y              S+
Sbjct: 166  LPIRWMAPE-SLKEGKFTSKSDVWSFGVLLWEIFTLGE---EPYPG-----------MSN 210

Query: 1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             E +  +     + +           ++  + L+C  + P +RP   ++V  L
Sbjct: 211  AEVLEYLKKGYRLPKPPNCP-----PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  121 bits (307), Expect = 7e-31
 Identities = 66/208 (31%), Positives = 100/208 (48%), Gaps = 14/208 (6%)

Query: 824  KHVIGRGAHGIVYKASLGPN-AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
               IG+G  G VYKA         A+K +     ++    +  EIQ + K +H N+V+  
Sbjct: 5    LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE-KIINEIQILKKCKHPNIVKYY 63

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +L+KD   I+  +   GSL+D+L S T     E  + Y +       L YLH      
Sbjct: 64   GSYLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAY-VCKELLKGLEYLH---SNG 118

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRDIK  NILL S+ E  + DFG++  L  + A     ++VGT  ++APE        
Sbjct: 119  IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYD 175

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKE 1030
             ++D++S G+  +EL   K    P Y E
Sbjct: 176  YKADIWSLGITAIELAEGK----PPYSE 199

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  121 bits (305), Expect = 2e-30
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAF-RGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
             ++GRG+ G VY A       + AVK +      +    +++REI+ +  ++H N+VR  
Sbjct: 6    ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 883  DFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLH 936
                 ++     I +  Y+  GSL  +L      P  E  +R    +I  G    LAYLH
Sbjct: 66   GSERDEEKNTLNIFL-EYVSGGSLSSLLKKFGKLP--EPVIRKYTRQILEG----LAYLH 118

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
             +    IVHRDIK  NIL+DS+    ++DFG AK L        + SV GT  ++APE  
Sbjct: 119  SNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 997  FTTAKSKESDVYSYGVVLLELITRK 1021
                  + +D++S G  ++E+ T K
Sbjct: 176  RGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 4e-29
 Identities = 76/295 (25%), Positives = 119/295 (40%), Gaps = 58/295 (19%)

Query: 826  VIGRGAHGIVYKASL-----GPNAVFAVKKL---AFRGHKRGSLSMKREIQTIGKIRHRN 877
             +G GA G VYK  L         V AVK L   A    ++  L   +E + + K+ H N
Sbjct: 2    KLGEGAFGEVYKGKLKGKDGKTTEV-AVKTLKEDASEEERKDFL---KEARVMKKLGHPN 57

Query: 878  LVRL-----EDFWLRKDCGIIMYRYMENGSLRDVLHSITP------PPTLEWNVRYKIAL 926
            +VRL     E+  L      ++  YME G L D L    P        TL        A+
Sbjct: 58   VVRLLGVCTEEEPL-----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
              A  + YL        VHRD+   N L+  ++   ISDFG+++ +              
Sbjct: 113  QIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169

Query: 987  TIGYIAPE----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042
             I ++APE      FT+     SDV+S+GV+L E+ T      P Y              
Sbjct: 170  PIRWMAPESLKDGIFTSK----SDVWSFGVLLWEIFTL--GATP-YPG-----------L 211

Query: 1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            S+ E +  +     + +       D++ +++   L C +  P +RP   ++V +L
Sbjct: 212  SNEEVLEYLRKGYRLPKP--EYCPDELYELM---LSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (288), Expect = 2e-27
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 24/284 (8%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL--SMKREIQTIGKIRH-RNLVRLE 882
             +G G+ G VY A      + A+K LA +   +        REIQ +  + H  N+V+L 
Sbjct: 7    KLGEGSFGEVYLARD--RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
            DF+  +    ++  Y++ GSL D+L  I     L  +    I      AL YLH      
Sbjct: 65   DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 943  IVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTT----SISVVGTIGYIAPE--- 994
            I+HRDIKPENILLD +     + DFG+AKLL    ++++      + VGT GY+APE   
Sbjct: 122  IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054
                   S  SD++S G+ L EL+T         K  +     ++ +             
Sbjct: 182  GLSLAYASSSSDIWSLGITLYELLTGLPPF-EGEKNSSATSQTLKIILELPTPSLASPLS 240

Query: 1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098
                E++  +  D       +  +   K P NR +    +   +
Sbjct: 241  PSNPELISKAASD-------LLKKLLAKDPKNRLSSSSDLSHDL 277

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (271), Expect = 6e-26
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRG----HKRGSLSMKREIQTIGKIRHRNLVR 880
             IG+G+ G VY         ++ +K++         +  +L    E++ + K+ H N+++
Sbjct: 7    QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL---NEVKILKKLNHPNIIK 63

Query: 881  LEDFWLRKDC-GIIMYRYMENGSLRDVLHS-------ITPPPTLEWNVRYKIALGAAHAL 932
              + +  K    I+M  Y + G L   +               L+W V  ++ L    AL
Sbjct: 64   YYESFEEKGKLCIVM-EYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCL----AL 116

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
             YLH      I+HRDIKP+NI L S     + DFGI+K+L  +       +VVGT  Y++
Sbjct: 117  KYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK--TVVGTPYYLS 171

Query: 993  PE---NAFTTAKSKESDVYSYGVVLLELITRKKA 1023
            PE   N      + +SD++S G VL EL T K  
Sbjct: 172  PELCQNK---PYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-25
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 40/271 (14%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED 883
            +IGRGA G+VYK  +L      A+K+++    K  +L S+ +EI  +  ++H N+V+   
Sbjct: 7    LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
                 D   I+  Y ENGSLR ++    P P +L     Y++  G    LAYLH   +  
Sbjct: 67   SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQG----LAYLH---EQG 119

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE----NAFT 998
            ++HRDIK  NIL   +    ++DFG+A  L+    S    SVVGT  ++APE    +  +
Sbjct: 120  VIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 999  TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058
            TA    SD++S G  ++EL+T      P Y +   +    R V  D              
Sbjct: 178  TA----SDIWSLGCTVIELLTGN----PPYYDLNPMAALFRIVQDD-------------H 216

Query: 1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPN 1089
              L   I  ++ D L   ++C +K P+ RP 
Sbjct: 217  PPLPEGISPELKDFL---MQCFQKDPNLRPT 244

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (255), Expect = 1e-23
 Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 20/204 (9%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDF 884
            IG G +G VYKA +     + A+KK+     K G  ++  REI+ + K+RH N+VRL++ 
Sbjct: 7    IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 885  WLRKDCG-IIM-YRYME---NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
               K  G I M + YM+    G L       T        ++          L YLH + 
Sbjct: 67   VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES-----QIKC-YMKQLLEGLQYLHSN- 119

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK-SPASTTSISVVGTIGYIAPENAF- 997
               I+HRDIK  NIL++++    ++DFG+A+   K + A  T  + V T+ Y  PE    
Sbjct: 120  --GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT--NRVITLWYRPPELLLG 175

Query: 998  TTAKSKESDVYSYGVVLLELITRK 1021
             T    E D++S G +L EL   K
Sbjct: 176  ATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (250), Expect = 3e-23
 Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 14/201 (6%)

Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGH-KRGSL-SMKREIQTIGKIRHRNLVRL- 881
            VIG+GA G V          +FA+K +  +   ++GS+ ++  E + + ++ H  LV L 
Sbjct: 7    VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
              F   ++  +++   +  G LR   H        E  V++ I      AL YLH     
Sbjct: 67   YSFQDEENMYLVV-DLLLGGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SK 119

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             I+HRDIKP+NILLD +   HI+DF IA  +      T + S  GT GY+APE       
Sbjct: 120  GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEVLCRQGY 176

Query: 1002 SKESDVYSYGVVLLELITRKK 1022
            S   D +S GV   E +  K+
Sbjct: 177  SVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 2e-22
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 14/207 (6%)

Query: 824  KHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMK----REIQTIGKIRHRNL 878
             + IG+G+ G+V+K     +  V+A+K++      R     +     E + + K+    +
Sbjct: 5    LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR---REREEAIDEARVLAKLDSSYI 61

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            +R  + +L K    I+  Y ENG L  +L      P  E  V ++  +     LA+LH  
Sbjct: 62   IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-WRFFIQILLGLAHLH-- 118

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
                I+HRDIK  N+ LD+     I D G+AKLL  S  +  + ++VGT  Y++PE    
Sbjct: 119  -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSPELCED 175

Query: 999  TAKSKESDVYSYGVVLLELITRKKALD 1025
               +++SDV++ GVVL E  T K   D
Sbjct: 176  KPYNEKSDVWALGVVLYECCTGKHPFD 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAF-RGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            + IG G  G VY A +L    + AVK++       +    +  E++ +  ++H NLV+  
Sbjct: 6    NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLH--SITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
               + ++   I   Y   G+L ++L    I     +     Y + L     LAYLH    
Sbjct: 66   GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR---VYTLQL--LEGLAYLH---S 117

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI----SVVGTIGYIAPENA 996
              IVHRDIKP NI LD      + DFG A  L     +TT      S+ GT  Y+APE  
Sbjct: 118  HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL--KNNTTTMGEEVQSLAGTPAYMAPE-V 174

Query: 997  FTTAKSKE----SDVYSYGVVLLELITRKK 1022
             T  K K     +D++S G V+LE+ T K+
Sbjct: 175  ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 98.4 bits (246), Expect = 2e-22
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 13/212 (6%)

Query: 811  LKQVIEA---TENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKRE 866
            LK ++      E       IG GA G VYKA         A+KK+  R   +  +    E
Sbjct: 8    LKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI--INE 65

Query: 867  IQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIAL 926
            I  +   +H N+V   D +L  D   ++  YM+ GSL D++ +       E  + Y +  
Sbjct: 66   ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAY-VCR 123

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                 L YLH      ++HRDIK +NILL  +    ++DFG A  L  +   +   SVVG
Sbjct: 124  EVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVVG 178

Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T  ++APE         + D++S G++ +E+ 
Sbjct: 179  TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 97.1 bits (242), Expect = 5e-22
 Identities = 78/290 (26%), Positives = 123/290 (42%), Gaps = 40/290 (13%)

Query: 827  IGRGAHGIVYKASLGPN-----AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G G  G V      P         AVK L   G ++     +REI+ +  + H N+V+ 
Sbjct: 12   LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 882  EDFWLRKDCG----IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            +     K  G    +IM  Y+ +GSLRD L        L+  + +  +      + YL  
Sbjct: 72   K-GVCEKPGGRSLRLIM-EYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKGMDYLG- 126

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT-IGYIAPENA 996
                  +HRD+   NIL++SE    ISDFG+AK+L +            + I + APE  
Sbjct: 127  --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 997  FTTAKSKESDVYSYGVVLLELITR-KKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
             T+  S  SDV+S+GV L EL T    +  P   E   ++G  +     T          
Sbjct: 185  RTSKFSSASDVWSFGVTLYELFTYGDPSQSPP-AEFLRMIGIAQGQMIVTR--------- 234

Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             + E+L    R        D+V D++     C E +P +RP+  D++  +
Sbjct: 235  -LLELLKEGERLPRPPSCPDEVYDLM---KLCWEAEPQDRPSFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 14/211 (6%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFR-GHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            IG GAHGIV+KA         A+KK+A R           REI+ +   +H  +V+L D 
Sbjct: 8    IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +      +++  YM    L +VL     P        Y   L     +AY+H      I+
Sbjct: 68   FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKG--VAYMH---ANGIM 121

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP N+L+ ++    I+DFG+A+L  +      S   V T  Y APE  +   K   
Sbjct: 122  HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS-HQVATRWYRAPELLYGARKYDP 180

Query: 1005 S-DVYSYGVVLLELITRKKALDPSYKERTDI 1034
              D+++ G +  EL+     L P      DI
Sbjct: 181  GVDLWAVGCIFAELL-NGSPLFPG---ENDI 207

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 93.4 bits (233), Expect = 5e-21
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 45/213 (21%)

Query: 827  IGRGAHGIVY----KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIG------KIRHR 876
            +G+G+ G V     K +     ++A+K L     K+  +  K    T+       +I H 
Sbjct: 1    LGKGSFGKVLLVRKKDT---GKLYAMKVL----KKKKIIKRKEVEHTLTERNILSRINHP 53

Query: 877  NLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY---KIAL 926
             +V+L       E  +L      ++  Y   G L   L         E   R+   +I L
Sbjct: 54   FIVKLHYAFQTEEKLYL------VL-EYAPGGELFSHLSKEGRFS--EERARFYAAEIVL 104

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                AL YLH      I++RD+KPENILLD++    ++DFG+AK L    + T +    G
Sbjct: 105  ----ALEYLH-SLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF--CG 155

Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            T  Y+APE        K  D +S GV+L E++T
Sbjct: 156  TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 93.4 bits (232), Expect = 5e-21
 Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 24/210 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVR-LE 882
            V+GRGA GIV+         +  +K++      K   L+ + E Q +  + H N++   E
Sbjct: 7    VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPT-LEWNVRYKIALGAAHALAYLHY 937
            +F   K   I+M  Y   G+L + +     S+    T L + V+  +AL   H       
Sbjct: 67   NFLEDKALMIVM-EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT------ 119

Query: 938  DCDPPIVHRDIKPENILLDS-EMEPHISDFGIAKLL-DKSPASTTSISVVGTIGYIAPEN 995
                 I+HRD+K +NILLD  +M   I DFGI+K+L  KS A T    VVGT  YI+PE 
Sbjct: 120  ---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT----VVGTPCYISPEL 172

Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALD 1025
                  +++SD+++ G VL EL + K+A +
Sbjct: 173  CEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 97.2 bits (242), Expect = 1e-20
 Identities = 56/142 (39%), Positives = 76/142 (53%), Gaps = 9/142 (6%)

Query: 51  WNSSDSTPCQ--WVGIEC--DDDAHN--VVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSS 104
           WN     P Q  W G +C  D       +    L + G+ G +  +I  L  LQ+I+LS 
Sbjct: 392 WNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSG 451

Query: 105 NNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPL- 163
           N+  GNIPP LG+ ++LE LDLS N F G IP++   L +L+ LNL GN L G +P  L 
Sbjct: 452 NSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Query: 164 FRIL-GLQYVFLNNNSLSGSIP 184
            R+L    + F +N  L G IP
Sbjct: 512 GRLLHRASFNFTDNAGLCG-IP 532

Length = 623

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 17/199 (8%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL-ED 883
             +G G  G+V K    P   + AVK +    ++     + RE+  + K     +V     
Sbjct: 8    ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSI---TPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            F+   D  I M  YM+ GSL  +L  +    P   L      KIA+     L YLH    
Sbjct: 68   FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK 121

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              I+HRD+KP NIL++S  +  + DFG++  L  S A T     VGT  Y+APE      
Sbjct: 122  --IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQGND 175

Query: 1001 KSKESDVYSYGVVLLELIT 1019
             S +SD++S G+ L+EL T
Sbjct: 176  YSVKSDIWSLGLSLIELAT 194

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 15/202 (7%)

Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG GA  +VY A   PN    A+K++     +     +++E+Q + +  H N+V+    
Sbjct: 8    VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            ++  D   ++  Y+  GSL D++ S  P   L+  +   +       L YLH       +
Sbjct: 68   FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI--SVVGTIGYIAPE-----NAF 997
            HRDIK  NILL  +    I+DFG++  L      T  +  + VGT  ++APE     + +
Sbjct: 125  HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184

Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
                  ++D++S+G+  +EL T
Sbjct: 185  D----FKADIWSFGITAIELAT 202

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G +G+VYKA       + A+KK+  R    G      REI+ + ++ H N+++L D 
Sbjct: 7    IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
            +  K    +++ +M+    + +       P +L  +  Y++  G    LA+ H      I
Sbjct: 67   FRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQG----LAFCHSH---GI 119

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+KPEN+L+++E    ++DFG+A+         T    V T  Y APE         
Sbjct: 120  LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT--HYVVTRWYRAPELLLGDKGYS 177

Query: 1004 ES-DVYSYGVVLLELITRK 1021
               D++S G +  EL++R+
Sbjct: 178  TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.1 bits (222), Expect = 2e-19
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLED 883
            +G G +G+VYKA       + A+KK+     + G  S ++ REI  + +++H N+V+L D
Sbjct: 7    LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-REISLLKELKHPNIVKLLD 65

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
                +    +++ Y +   L+  L     P +    ++  I       LAY H      I
Sbjct: 66   VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IKS-IMYQLLRGLAYCHSHR---I 119

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-----NAFT 998
            +HRD+KP+NIL++ +    ++DFG+A+         T    V T+ Y APE       ++
Sbjct: 120  LHRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGSKHYS 177

Query: 999  TAKSKESDVYSYGVVLLELITRK 1021
            TA     D++S G +  E+IT K
Sbjct: 178  TA----VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 5e-19
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 24/208 (11%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVRL 881
            IG GA+G VYKA  L      A+KK+     + G  LS  REI  + ++    H N+VRL
Sbjct: 7    IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 882  EDFWL--RKDCGIIMYRYME------NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALA 933
             D     R D  + +    E         L        PP T++ ++  ++  G    + 
Sbjct: 67   LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIK-DLMRQLLRG----VD 121

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            +LH      IVHRD+KP+NIL+ S+ +  I+DFG+A++     A T   SVV T+ Y AP
Sbjct: 122  FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT---SVVVTLWYRAP 175

Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRK 1021
            E    ++ +   D++S G +  EL  R+
Sbjct: 176  EVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 16/201 (7%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVR 880
             V+G GA+G+V K  +     + A+KK  F+  +      K   RE++ + ++RH N+V 
Sbjct: 7    GVVGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPT-LEWNVRYKIALGAAHALAYLHYDC 939
            L++ + RK    +++ Y+E    R +L  +   P  L  +           A+AY H   
Sbjct: 65   LKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH- 119

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-T 998
               I+HRDIKPENIL+       + DFG A+ L   PAS  +   V T  Y APE     
Sbjct: 120  --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVATRWYRAPELLVGD 176

Query: 999  TAKSKESDVYSYGVVLLELIT 1019
            T   K  DV++ G ++ EL+ 
Sbjct: 177  TNYGKPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 36/220 (16%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVK----KLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +IG G+   V  A     N  +A+K    +   +  K   + +++E+ T     H  +++
Sbjct: 8    IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-GHPGIIK 66

Query: 881  LEDFWLRKD--CGIIMYRYMENGSLRDVLHSITPPPTL-EWNVRYKIALGAAHALAYLHY 937
            L  ++  +D      +  Y  NG   ++L  I    +L E   R+  A     AL YLH 
Sbjct: 67   L--YYTFQDEENLYFVLEYAPNG---ELLQYIRKYGSLDEKCTRFYAAE-ILLALEYLH- 119

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD--KSPASTTSI------------- 982
                 I+HRD+KPENILLD +M   I+DFG AK+LD   SP S                 
Sbjct: 120  --SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 983  ---SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               S VGT  Y++PE        K SD+++ G ++ +++T
Sbjct: 178  RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 83/286 (29%), Positives = 122/286 (42%), Gaps = 48/286 (16%)

Query: 826  VIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKR-----EIQTIGKIRHR 876
            VIG G  G V +  L          A+K L     K GS   +R     E   +G+  H 
Sbjct: 11   VIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-----KAGSSDKQRLDFLTEASIMGQFDHP 65

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
            N++RLE    +    +I+  YMENGSL   L                +  G A  + YL 
Sbjct: 66   NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL- 122

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-- 994
               +   VHRD+   NIL++S +   +SDFG+++ L+ S A+ T+      I + APE  
Sbjct: 123  --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180

Query: 995  --NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052
                FT+A    SDV+S+G+V+ E++        SY ER     W     S+ + I  + 
Sbjct: 181  AYRKFTSA----SDVWSFGIVMWEVM--------SYGERP---YW---DMSNQDVIKAVE 222

Query: 1053 D-LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            D   L   M   S   Q      + L C +K  + RP    +V  L
Sbjct: 223  DGYRLPPPMDCPSALYQ------LMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 4e-18
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 41/219 (18%)

Query: 827  IGRGAHGIVYKA---SLGPNAVFAVKKLAFRGHKRG----SLSMKREIQTIGKIRHRNLV 879
            IGRG +G VYKA   +      +A+KK  F+G K      S S  REI  + +++H N+V
Sbjct: 8    IGRGTYGRVYKAKRKNGKDGKEYAIKK--FKGDKEQYTGISQSACREIALLRELKHENVV 65

Query: 880  RLEDFWLRKDCGII--MYRYMENGSLRDVLHSIT----------PPPTLEWNVRYKIALG 927
             L + +L      +  ++ Y E+    D+   I           PP  ++ ++ ++I  G
Sbjct: 66   SLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVK-SLLWQILNG 120

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSIS 983
                + YLH +    ++HRD+KP NIL+  E        I D G+A+L +        + 
Sbjct: 121  ----VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 984  -VVGTIGYIAPENAFTTAK--SKESDVYSYGVVLLELIT 1019
             VV TI Y APE     A+  +K  D+++ G +  EL+T
Sbjct: 174  PVVVTIWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 84.2 bits (209), Expect = 6e-18
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 19/197 (9%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR-LED 883
             +G G++G VYKA       V A+K +           + +EI  + +     +V+    
Sbjct: 10   KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGS 66

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIAL---GAAHALAYLHYDCD 940
            ++   D  I+M  Y   GS+ D++       T E     +IA         L YLH    
Sbjct: 67   YFKNTDLWIVM-EYCGAGSVSDIMKITNKTLTEE-----EIAAILYQTLKGLEYLH---S 117

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
               +HRDIK  NILL+ E +  ++DFG++  L  + A     +V+GT  ++APE      
Sbjct: 118  NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN--TVIGTPFWMAPEVIQEIG 175

Query: 1001 KSKESDVYSYGVVLLEL 1017
             + ++D++S G+  +E+
Sbjct: 176  YNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 84.6 bits (209), Expect = 7e-18
 Identities = 82/285 (28%), Positives = 128/285 (44%), Gaps = 45/285 (15%)

Query: 826  VIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            VIG G  G V++  L          A+K L     ++       E   +G+  H N++RL
Sbjct: 12   VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIAL--GAAHALAYLHYDC 939
            E    +    +I+  YMENG+L   L         E++    + +  G A  + YL    
Sbjct: 72   EGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYL---S 124

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG---TIGYIAPE-- 994
            D   VHRD+   NIL++S +E  +SDFG++++L+  P  T + S  G    I + APE  
Sbjct: 125  DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS--GGKIPIRWTAPEAI 182

Query: 995  --NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052
                FT+A    SDV+S+G+V+ E++        S+ ER     W  S     + IND  
Sbjct: 183  AYRKFTSA----SDVWSFGIVMWEVM--------SFGERP---YWDMSNHEVMKAIND-- 225

Query: 1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
               L   M   S   Q++      L+C ++  + RP   D+V  L
Sbjct: 226  GFRLPAPMDCPSAVYQLM------LQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 85.5 bits (211), Expect = 7e-18
 Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 825  HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGS--LSMKREIQTIGKIRHRNLVRL 881
            H IG G+ G VY A+    N V AVKK+++ G +       + +E++ + +++H N +  
Sbjct: 27   HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
            +  +L++    ++  Y   GS  D+L  +   P  E  +   I  GA   LAYLH     
Sbjct: 87   KGCYLKEHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIA-AITHGALQGLAYLHSHN-- 141

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             ++HRDIK  NILL    +  ++DFG A     SPA+    S VGT  ++APE      +
Sbjct: 142  -MIHRDIKAGNILLTEPGQVKLADFGSASKS--SPAN----SFVGTPYWMAPEVILAMDE 194

Query: 1002 SK---ESDVYSYGVVLLELITRKKAL 1024
             +   + DV+S G+  +EL  RK  L
Sbjct: 195  GQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.1 bits (208), Expect = 9e-18
 Identities = 68/291 (23%), Positives = 121/291 (41%), Gaps = 55/291 (18%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-----SMKREIQTIGKIRHRNLV 879
             +G GA    Y+A  +    + AVK++ +  +          ++++EI+ + ++ H +++
Sbjct: 7    QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
            R+           +   +M  GS+  +L         +  V           L+YLH   
Sbjct: 67   RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLH--- 120

Query: 940  DPPIVHRDIKPENILLDSE-MEPHISDFGIAKLL--DKSPASTTSISVVGTIGYIAPENA 996
            +  I+HRD+K  N+L+DS      I+DFG A  L    + A      ++GTI ++APE  
Sbjct: 121  ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056
                  +  DV+S G V++E+ T K                    W+  +  N    L+L
Sbjct: 181  RGEQYGRSCDVWSVGCVIIEMATAKPP------------------WNAEKHSN---HLAL 219

Query: 1057 M------------EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
            +             E L   +RD       V LRC E +P +RP  R++++
Sbjct: 220  IFKIASATTAPSIPEHLSPGLRD-------VTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 18/204 (8%)

Query: 827  IGRGAHGIVY---KASLGPNAVFAVKKLAF----RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+GA G VY       G     AVK++ F       K+   +++ EIQ +  ++H  +V
Sbjct: 10   LGQGAFGRVYLCYDVDTGRE--LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 880  RLEDFWLRKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            +     LR D  + I   YM  GS++D L +      L   V  K        + YLH  
Sbjct: 68   QYYGC-LRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLH-- 121

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI-SVVGTIGYIAPENAF 997
                IVHRDIK  NIL DS     + DFG +K L    +S T + SV GT  +++PE   
Sbjct: 122  -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 998  TTAKSKESDVYSYGVVLLELITRK 1021
                 +++DV+S G  ++E++T K
Sbjct: 181  GEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 62/200 (31%), Positives = 87/200 (43%), Gaps = 21/200 (10%)

Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED-F 884
            +G GA G V K  L     +FA+K +    +      + RE++     +   +V+    F
Sbjct: 9    LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 885  WLRKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRY------KIALGAAHALAYLHY 937
                   I I   Y E GSL  +   +      +   R       KIA      L+YLH 
Sbjct: 69   LDESSSSIGIAMEYCEGGSLDSIYKKV-----KKRGGRIGEKVLGKIAESVLKGLSYLH- 122

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I+HRDIKP NILL  + +  + DFG++  L  S A T      GT  Y+APE   
Sbjct: 123  --SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT----FTGTSFYMAPERIQ 176

Query: 998  TTAKSKESDVYSYGVVLLEL 1017
                S  SDV+S G+ LLE+
Sbjct: 177  GKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 85.6 bits (212), Expect = 1e-17
 Identities = 63/198 (31%), Positives = 96/198 (48%), Gaps = 22/198 (11%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG GA G VYK    P       K+ +  H+      + REI+ +  + H N+V+  D +
Sbjct: 82   IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
                   ++  +M+ GSL      I     L  +V  +I  G    +AYLH      IVH
Sbjct: 142  DHNGEIQVLLEFMDGGSLEG--THIADEQFLA-DVARQILSG----IAYLHRR---HIVH 191

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKS--PASTTSISVVGTIGYIAPENAFTTAKSK 1003
            RDIKP N+L++S     I+DFG++++L ++  P +    S VGTI Y++PE   T     
Sbjct: 192  RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN----SSVGTIAYMSPERINTDLNHG 247

Query: 1004 E-----SDVYSYGVVLLE 1016
                   D++S GV +LE
Sbjct: 248  AYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 84/293 (28%), Positives = 129/293 (44%), Gaps = 40/293 (13%)

Query: 815  IEATENLNAKHVIGRGAHGIVYKASL---GPNAV-FAVKKLAFRGHKRGSLSMKREIQTI 870
            I+A+  +  + VIG G  G V    L   G   +  A+K L     ++       E   +
Sbjct: 1    IDAS-CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59

Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH 930
            G+  H N++ LE    +    +I+  YMENGSL   L       T+   V   +  G A 
Sbjct: 60   GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV--GMLRGIAS 117

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP--ASTTSISVVGTI 988
             + YL    D   VHRD+   NIL++S +   +SDFG++++L+  P  A TT    +  I
Sbjct: 118  GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PI 173

Query: 989  GYIAPE----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044
             + APE      FT+A    SDV+SYG+V+ E++        SY E        R  W  
Sbjct: 174  RWTAPEAIAYRKFTSA----SDVWSYGIVMWEVM--------SYGE--------RPYW-- 211

Query: 1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             E  N  V  ++ E   + +  D    +  + L C +K  + RP    +V  L
Sbjct: 212  -EMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 82.2 bits (203), Expect = 5e-17
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 51/291 (17%)

Query: 824  KHVIGRGAHGIVYKASL---GPNAVF-AVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            + VIG G  G V +  L   G   +F A+K L     ++       E   +G+  H N++
Sbjct: 9    EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSIT---PPPTLEWNVRYKIALGAAHALAYLH 936
             LE    +    +I+  +MENG+L   L           L   +R     G A  + YL 
Sbjct: 69   HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL- 122

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG---TIGYIAP 993
               +   VHRD+   NIL++S +   +SDFG+++ L+   +  T  S +G    I + AP
Sbjct: 123  --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 994  E----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW--SDTEE 1047
            E      FT+A    SDV+SYG+V+ E++        SY E        R  W  S+ + 
Sbjct: 181  EAIAYRKFTSA----SDVWSYGIVMWEVM--------SYGE--------RPYWDMSNQDV 220

Query: 1048 INDI-VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            IN I  D  L   M   +   Q++      L C +K  + RP    +V  L
Sbjct: 221  INAIEQDYRLPPPMDCPTALHQLM------LDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 19/199 (9%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLED 883
            +G G  G V+  +       AVK L     K G++S +   +E Q + K+RH  LV+L  
Sbjct: 14   LGAGQFGEVWMGTWNGTTKVAVKTL-----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL---HYDCD 940
                ++   I+  YM  GSL D L S      L       +A   A  +AYL   +Y   
Sbjct: 69   VCSEEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLESRNY--- 124

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
               +HRD+   NIL+   +   I+DFG+A+L+ +    T        I + APE A    
Sbjct: 125  ---IHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGR 180

Query: 1001 KSKESDVYSYGVVLLELIT 1019
             + +SDV+S+G++L E++T
Sbjct: 181  FTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 81.8 bits (202), Expect = 7e-17
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 827  IGRGAHGIVYKA--SLGPNAVFAVKK-----LAFRGHKRGSLS----MKREIQTIGK-IR 874
            +G GA G VYK         + A+K+      AF   KR        +  E+  I + +R
Sbjct: 8    LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSI-----TPPPTLEWNVRYKIALGAA 929
            H N+VR    +L  D   I+   +E   L +  +S+            WN+  ++ L   
Sbjct: 68   HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG 989
             AL YLH +    IVHRD+ P NI+L  + +  I+DFG+AK   K P S  + SVVGTI 
Sbjct: 125  -ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLT-SVVGTIL 178

Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            Y  PE        +++DV+++G +L ++ T
Sbjct: 179  YSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 65/207 (31%), Positives = 100/207 (48%), Gaps = 32/207 (15%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR------HRNLV 879
            +G+G++G VYK   L  N  +A+K++       GS+S K     + +IR      H N++
Sbjct: 8    LGKGSYGSVYKVKRLSDNQFYALKEV-----DLGSMSQKEREDAVNEIRILASVNHPNII 62

Query: 880  RLEDFWL--RKDCGIIMYRYMENGSLRDVL----HSITPPPTLE-WNVRYKIALGAAHAL 932
              ++ +L   K C I+M  Y   G L   +          P  E W +  ++  G    L
Sbjct: 63   SYKEAFLDGNKLC-IVM-EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----L 116

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
              LH   +  I+HRD+K  NILL +     I D GI+K+L K+ A T     +GT  Y+A
Sbjct: 117  QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT----QIGTPHYMA 169

Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE       S +SD++S G +L E+ T
Sbjct: 170  PEVWKGRPYSYKSDIWSLGCLLYEMAT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 80/307 (26%), Positives = 126/307 (41%), Gaps = 61/307 (19%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
            + +  K  +G GA G V+              + AVK L            +RE + +  
Sbjct: 5    DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64

Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR-- 921
             +H N+V+        D  I+++ YME+G L   L S  P          P  E  +   
Sbjct: 65   FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124

Query: 922  YKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             +IA+  A  + YL   H+      VHRD+   N L+  ++   I DFG+++ +     +
Sbjct: 125  LQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDV----YT 174

Query: 979  TTSISVVGT----IGYIAPEN----AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
            T    V G     I ++ PE+     FTT    ESDV+S+GVVL E+ T  K   P Y  
Sbjct: 175  TDYYRVGGHTMLPIRWMPPESIMYRKFTT----ESDVWSFGVVLWEIFTYGK--QPWYG- 227

Query: 1031 RTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM 1090
                        S+ E I  I    L++       R    +V  + L C ++ P  R N+
Sbjct: 228  -----------LSNEEVIECITQGRLLQRP-----RTCPSEVYDIMLGCWKRDPQQRINI 271

Query: 1091 RDVVRQL 1097
            +D+  +L
Sbjct: 272  KDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 81.5 bits (202), Expect = 8e-17
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 15/206 (7%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSM-KREIQTIGKIRHRNLVRLED 883
             IG+G+ G V K        +   K++ +             E+  + +++H N+VR  D
Sbjct: 7    TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 884  FWLRKDCGIIMYRYME---NGSLRDVL-HSITPPPTLEWNVRYKIALGAAHALAYLHY-- 937
              + +    + Y  ME    G L  ++         +E    ++I      AL   H   
Sbjct: 67   RIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL--DKSPASTTSISVVGTIGYIAPEN 995
            D    ++HRD+KP NI LD+     + DFG+AK+L  D S A T     VGT  Y++PE 
Sbjct: 126  DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT----YVGTPYYMSPEQ 181

Query: 996  AFTTAKSKESDVYSYGVVLLELITRK 1021
                +  ++SD++S G ++ EL    
Sbjct: 182  LNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 9e-17
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK----REIQTIGKIRHRNLVRLE 882
            +G G  G V K    P      KK+   G K    S++    RE+Q + + R   +V   
Sbjct: 13   LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS---SVRKQILRELQIMHECRSPYIVSFY 69

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +L ++   +   +M+ GSL  +     P   +   +  KIA+     L YL+      
Sbjct: 70   GAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLYNVHR-- 124

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRDIKP NIL++S  +  + DFG++  L  S A T     VGT  Y++PE       +
Sbjct: 125  IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT----FVGTSTYMSPERIQGGKYT 180

Query: 1003 KESDVYSYGVVLLELITRK 1021
             +SDV+S G+ ++EL   K
Sbjct: 181  VKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 81.5 bits (201), Expect = 1e-16
 Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 16/204 (7%)

Query: 827  IGRGAHGIVYKASLGPNAVF-AVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVRL 881
            IG GA+G VYKA    +  F A+K +  + ++ G  LS  RE+  + ++    H N+VRL
Sbjct: 8    IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 882  EDFW--LRKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
             D     R D    +    E  +  LR  L  + PPP L       +       L +LH 
Sbjct: 68   MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +C   IVHRD+KPENIL+ S  +  ++DFG+A++     A T    VV T+ Y APE   
Sbjct: 127  NC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT---PVVVTLWYRAPEVLL 180

Query: 998  TTAKSKESDVYSYGVVLLELITRK 1021
             +  +   D++S G +  E+  RK
Sbjct: 181  QSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 45/288 (15%)

Query: 826  VIGRGAHGIVYKASLGPNA----VFAVKKL-----AFRGHKRGSLSM----KREIQTIGK 872
            +IG+G +G VY   L  N     + AVK++         H      M    + EI+T+  
Sbjct: 8    LIGKGTYGRVY---LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHAL 932
            + H N+V+   F   ++   I   Y+  GS+   L   T     E  VR+         L
Sbjct: 65   LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRF-FTEQVLEGL 121

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
            AYLH      I+HRD+K +N+L+D++    ISDFGI+K  D    +  ++S+ G++ ++A
Sbjct: 122  AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178

Query: 993  PENAFTTAK--SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050
            PE   + ++  S + D++S G V+LE+   ++                   WSD E I  
Sbjct: 179  PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP------------------WSDEEAIAA 220

Query: 1051 IVDLSLMEEM--LVSSIRDQVIDVLLVALR-CTEKKPSNRPNMRDVVR 1095
            +  L        +   +   +  V L  L  C    P NRP  R++++
Sbjct: 221  MFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 80.1 bits (197), Expect = 5e-16
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGS--LSMKREIQTIGKIRHRNLVRLED 883
            IG G+ G VY A  +  + V A+KK+++ G +       + +E++ + K+RH N ++   
Sbjct: 23   IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
             +LR+    ++  Y   GS  D+L  +   P  E  +   +  GA   LAYLH      +
Sbjct: 83   CYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIA-AVTHGALQGLAYLH---SHNM 136

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+K  NILL       + DFG A ++  +PA+      VGT  ++APE      + +
Sbjct: 137  IHRDVKAGNILLSEPGLVKLGDFGSASIM--APAN----XFVGTPYWMAPEVILAMDEGQ 190

Query: 1004 ---ESDVYSYGVVLLELITRKKAL 1024
               + DV+S G+  +EL  RK  L
Sbjct: 191  YDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 20/202 (9%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH---RNLVRL 881
            +IGRGA+G VY+    P   V A+K +           ++RE+  + ++R     N+ + 
Sbjct: 8    LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK--IALGAAHALAYLHYDC 939
               +L+     I+  Y E GS+R ++      P  E   +Y   I      AL Y+H   
Sbjct: 68   YGSYLKGPRLWIIMEYAEGGSVRTLMK---AGPIAE---KYISVIIREVLVALKYIHKV- 120

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
               ++HRDIK  NIL+ +     + DFG+A LL+++  S+   + VGT  ++APE   T 
Sbjct: 121  --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFVGTPYWMAPE-VITE 175

Query: 1000 AKS--KESDVYSYGVVLLELIT 1019
             K    ++D++S G+ + E+ T
Sbjct: 176  GKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 13/202 (6%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLE 882
            + IG G +GIVY+A       + A+KK+     + G  +S  REI  +  +RH N+V L+
Sbjct: 13   NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 883  DFWLRK--DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            +  + K  D   ++  Y E   L  +L ++  P + E  V+  + L     L YLH +  
Sbjct: 73   EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFS-ESQVK-CLMLQLLRGLQYLHENF- 128

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              I+HRD+K  N+LL  +    I+DFG+A+         T    V T+ Y APE      
Sbjct: 129  --IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT--PKVVTLWYRAPELLLGCT 184

Query: 1001 KSKES-DVYSYGVVLLELITRK 1021
                + D+++ G +L EL+  K
Sbjct: 185  TYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.4 bits (195), Expect = 9e-16
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 18/204 (8%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGS--LSMKREIQTIGKIRHRNLVRLED 883
            IG G+ G VY A  +  N V A+KK+++ G +       + +E++ + +I+H N +  + 
Sbjct: 33   IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
             +LR+    ++  Y   GS  D+L  +   P  E  +   I  GA   LAYLH      +
Sbjct: 93   CYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIA-AITHGALQGLAYLH---SHNM 146

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRDIK  NILL    +  ++DFG A +   SPA+    S VGT  ++APE      + +
Sbjct: 147  IHRDIKAGNILLTEPGQVKLADFGSASIA--SPAN----SFVGTPYWMAPEVILAMDEGQ 200

Query: 1004 ---ESDVYSYGVVLLELITRKKAL 1024
               + DV+S G+  +EL  RK  L
Sbjct: 201  YDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 82.2 bits (203), Expect = 1e-15
 Identities = 52/173 (30%), Positives = 85/173 (49%), Gaps = 21/173 (12%)

Query: 864  KREIQTIGKIRHRNLVRLEDFWLRKDCG----IIMYRYMENGSLRDVLHSITPPPTLEWN 919
            +RE     ++ H N+V L D     +        ++ Y+   +LR+VL +    P  E  
Sbjct: 26   RRETALCARLYHPNIVALLD---SGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGE-T 81

Query: 920  VRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD-SEMEPH--ISDFGIAKLLDKSP 976
             R  + L    ALA  H   +  IVHRD+KP+NI++  + + PH  + DFGI  LL    
Sbjct: 82   GR--LMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136

Query: 977  AS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKAL 1024
             +     T +  V+GT  Y APE       +  SD+Y++G++ LE +T ++ +
Sbjct: 137  DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 70/213 (32%), Positives = 115/213 (53%), Gaps = 27/213 (12%)

Query: 826  VIGRGAHGIVYKASLGPNA----VFAVKKLAF-------RGHKRGSLS-MKREIQTIGKI 873
            +IG G+ G VY   LG NA    + AVK++         +  KR  L  + REI  + ++
Sbjct: 7    LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHAL 932
            +H N+V+     L  D   I   Y+  GS+  +L++      TL  N   +I  G    L
Sbjct: 64   QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKG----L 119

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS----ISVVGTI 988
             YLH   +  I+HRDIK  NIL+D++    ISDFGI+K L+ +  ST +     S+ G++
Sbjct: 120  NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176

Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
             ++APE    T+ ++++D++S G +++E++T K
Sbjct: 177  FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 79.1 bits (196), Expect = 1e-15
 Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 56/227 (24%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGH----KRGSLSMKREIQTIGKIRHR 876
               IG GA+G+V  A         A+KK+   F       KR    + REI+ +  +RH 
Sbjct: 5    LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKR----ILREIKLLRHLRHE 59

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDV----------LHSI--TPPPTLEWNVR--- 921
            N++ L D          + R        DV          LH +  +P P  + +++   
Sbjct: 60   NIIGLLD----------ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFL 109

Query: 922  YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
            Y+I  G    L YLH   +  ++HRD+KP NIL++S  +  I DFG+A+ +D        
Sbjct: 110  YQILRG----LKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 982  IS--VVGTIGYIAPE-----NAFTTAKSKESDVYSYGVVLLELITRK 1021
            ++  VV T  Y APE     + +T A     D++S G +  EL+TRK
Sbjct: 163  LTEYVV-TRWYRAPELLLSSSRYTKA----IDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 44/273 (16%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVK--KLAFRGHK-RGSLS-MKREIQTIGKIRHRNLVRL 881
            +G G+ G VY+  +L     FAVK   LA  G   + ++  +++EI  + K++H N+V+ 
Sbjct: 8    LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCD 940
                  +D   I    +  GSL  +L      P  +      +I LG    L YLH   D
Sbjct: 68   LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH---D 120

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-----N 995
               VHRDIK  NIL+D+     ++DFG+AK   +    + + S  G+  ++APE      
Sbjct: 121  RNTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
             +  A    +D++S G  +LE+ T K    P + +       V +V+    +I    +L 
Sbjct: 178  GYGLA----ADIWSLGCTVLEMATGK----PPWSQLEG----VAAVF----KIGRSKELP 221

Query: 1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP 1088
             + + L    +D +       L+C ++ PS RP
Sbjct: 222  PIPDHLSDEAKDFI-------LKCLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 78.9 bits (195), Expect = 2e-15
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 38/223 (17%)

Query: 816  EATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGH---KRGSLSMKREIQT 869
            +  EN      IG GA+G+V  A         A+KK+  AF      KR +L   RE++ 
Sbjct: 8    KPIEN------IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKR-TL---RELKI 57

Query: 870  IGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR--- 921
            +   +H N++ + D         KD  ++M   ME+  L  ++HS   P T E ++R   
Sbjct: 58   LRHFKHDNIIAIRDILRPPGADFKDVYVVM-DLMES-DLHHIIHS-DQPLTEE-HIRYFL 113

Query: 922  YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
            Y++  G    L Y+H      ++HRD+KP N+L++ + E  I DFG+A+ L  SP     
Sbjct: 114  YQLLRG----LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166

Query: 982  I--SVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
                 V T  Y APE   +  + +   D++S G +  E++ R+
Sbjct: 167  FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 10/196 (5%)

Query: 825  HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
              IG G +G VYKA           K+           +++EI  + + RH N+V     
Sbjct: 9    QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +LR+D   I+  Y   GSL+D+   +T  P  E  + Y +       LAYLH   +   +
Sbjct: 69   YLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLSELQIAY-VCRETLKGLAYLH---ETGKI 123

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK- 1003
            HRDIK  NILL  + +  ++DFG++  L  + A   S   +GT  ++APE A    K   
Sbjct: 124  HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF--IGTPYWMAPEVAAVERKGGY 181

Query: 1004 --ESDVYSYGVVLLEL 1017
              + D+++ G+  +EL
Sbjct: 182  DGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 50/219 (22%)

Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 12   LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNIV 68

Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVL----HSITPPPTLEWNVRYKIALGAAHAL 932
            + +       R++  ++M  Y+  GSLRD L      +     L +    +I  G  + L
Sbjct: 69   KYKGVCYSAGRRNLRLVM-EYLPYGSLRDYLQKHRERLDHRKLLLYA--SQICKGMEY-L 124

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL--DK----------SPASTT 980
                Y      VHRD+   NIL++SE    I DFG+ K+L  DK          SP    
Sbjct: 125  GSKRY------VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP---- 174

Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                   I + APE+   +  S  SDV+S+GVVL EL T
Sbjct: 175  -------IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 25/202 (12%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLED 883
            +G G  G V++         AVK L     K G++  K    E Q + K+RH  L++L  
Sbjct: 14   LGAGQFGEVWEGLWNNTTPVAVKTL-----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL---HYDCD 940
                ++   I+   M+ GSL + L        L+      +A   A  +AYL   +Y   
Sbjct: 69   VCTLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNY--- 124

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---IGYIAPENAF 997
               +HRD+   N+L+       ++DFG+A+++ +           G    I + APE A 
Sbjct: 125  ---IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR----EGAKFPIKWTAPEAAL 177

Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
                S +SDV+S+G++L E++T
Sbjct: 178  YNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 23/202 (11%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
            +G G  G V++         A+K L            ++E+Q + ++RH++L+ L     
Sbjct: 14   LGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 887  RKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
              +   I+   ME GSL   L S     +     ++      +A   A  +AYL    + 
Sbjct: 73   VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID------MACQVAEGMAYLE---EQ 123

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP---ASTTSISVVGTIGYIAPENAFT 998
              +HRD+   NIL+  ++   ++DFG+A+L+ K     +S   I    T    APE A  
Sbjct: 124  NSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWT----APEAASH 178

Query: 999  TAKSKESDVYSYGVVLLELITR 1020
               S +SDV+S+G++L E+ T 
Sbjct: 179  GTFSTKSDVWSFGILLYEMFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 76.5 bits (189), Expect = 3e-15
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 31/210 (14%)

Query: 827  IGRGAHGIVY---KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTI-------GKIRHR 876
            I +GA+G V+   K S G   ++A+K +     K+  +  K ++  +        + +  
Sbjct: 1    ISKGAYGRVFLAKKKSTG--DIYAIKVI-----KKADMIRKNQVDQVLTERDILSQAQSP 53

Query: 877  NLVRL-EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
             +V+L   F  +K+  ++M  Y+  G L  +L ++      E   R  IA     AL YL
Sbjct: 54   YVVKLYYSFQGKKNLYLVM-EYLPGGDLASLLENVGSLD--EDVARIYIAEIVL-ALEYL 109

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL------LDKSPASTTSISVVGTIG 989
            H      I+HRD+KP+NIL+DS     ++DFG++K+      ++ +        +VGT  
Sbjct: 110  H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            YIAPE       SK  D +S G +L E + 
Sbjct: 167  YIAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 59/203 (29%), Positives = 90/203 (44%), Gaps = 20/203 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + L     IG+G  G V         V AVK L  +     + +   E   +  +RH NL
Sbjct: 6    KELKLGATIGKGEFGDVMLGDYRGQKV-AVKCL--KDDSTAAQAFLAEASVMTTLRHPNL 62

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            V+L    L+ +   I+  YM  GSL D L S      +    +   AL     + YL   
Sbjct: 63   VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS-RGRAVITLAQQLGFALDVCEGMEYLE-- 119

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE---- 994
             +   VHRD+   N+L+  ++   +SDFG+AK      AS    S    + + APE    
Sbjct: 120  -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEALRE 173

Query: 995  NAFTTAKSKESDVYSYGVVLLEL 1017
              F+T    +SDV+S+G++L E+
Sbjct: 174  KKFST----KSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 77.2 bits (190), Expect = 5e-15
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 18/206 (8%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGS--LSMKREIQTIGKIRHRNLVRL 881
              IG G+ G VY A  +  N V A+KK+++ G +       + +E++ + ++RH N +  
Sbjct: 21   REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
            +  +LR+    ++  Y   GS  D+L     P  L+      I  GA   LAYLH     
Sbjct: 81   KGCYLREHTAWLVMEYCL-GSASDILEVHKKP--LQEVEIAAICHGALQGLAYLHSHE-- 135

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
              +HRDIK  NILL       ++DFG A L   SPA+    S VGT  ++APE      +
Sbjct: 136  -RIHRDIKAGNILLTEPGTVKLADFGSASL--VSPAN----SFVGTPYWMAPEVILAMDE 188

Query: 1002 SK---ESDVYSYGVVLLELITRKKAL 1024
             +   + DV+S G+  +EL  RK  L
Sbjct: 189  GQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 61/202 (30%), Positives = 91/202 (45%), Gaps = 24/202 (11%)

Query: 827  IGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLS-------MKREIQTIGKIRHRNL 878
            +G G  G V    +   N  FA+K +     K+  +        +  E + + +  H  +
Sbjct: 1    LGVGGFGRVELVKVKSKNRTFALKCV-----KKRHIVETGQQEHIFSEKEILEECNHPFI 55

Query: 879  VRL-EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            V+L   F  +K   ++M  Y   G L  +L         E+  R+ IA     A  YLH 
Sbjct: 56   VKLYRTFKDKKYIYMLM-EYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLAFEYLH- 110

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
              +  I++RD+KPEN+LLDS     + DFG AK L KS   T +    GT  Y+APE   
Sbjct: 111  --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-KSGQKTWTF--CGTPEYVAPEIIL 165

Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
                    D +S G++L EL+T
Sbjct: 166  NKGYDFSVDYWSLGILLYELLT 187

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 71/283 (25%), Positives = 132/283 (46%), Gaps = 47/283 (16%)

Query: 826  VIGRGAHG---IVYKASLGPNAVFAVKKLAFR-GHKRGSLSMKREIQTIGKIRHRNLVRL 881
            V+G+G++G   +V   + G    + +KKL  R   +R   + ++E Q + +++H N+V  
Sbjct: 7    VVGKGSYGEVSLVRHRTDGKQ--YVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 882  EDFWLRKDCGI-IMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIALGAAHALAYL 935
             + W  +D  + I+  + E G L   L       +     +EW V+       A AL YL
Sbjct: 65   RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYL 118

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK--SPASTTSISVVGTIGYIAP 993
            H   +  I+HRD+K +N+ L       + D GIA++L+     AST    ++GT  Y++P
Sbjct: 119  H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST----LIGTPYYMSP 171

Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053
            E       + +SDV++ G  + E+ T K A                    + +++N +V 
Sbjct: 172  ELFSNKPYNYKSDVWALGCCVYEMATLKHAF-------------------NAKDMNSLV- 211

Query: 1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
              ++E  L    +D   ++  +      K+P  RP+++ ++RQ
Sbjct: 212  YRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.2 bits (187), Expect = 7e-15
 Identities = 73/269 (27%), Positives = 127/269 (47%), Gaps = 29/269 (10%)

Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A+        AVKK+  R  +R  L +  E+  +    H N+V + + +
Sbjct: 30   IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL-LFNEVVIMRDYHHENVVDMYNSY 88

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L  D   ++  ++E G+L D+   +T     E  +   + L    AL+YLH   +  ++H
Sbjct: 89   LVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIA-TVCLSVLRALSYLH---NQGVIH 141

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL S+    +SDFG    + K      S+  VGT  ++APE         E 
Sbjct: 142  RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPEVISRLPYGTEV 199

Query: 1006 DVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSI 1065
            D++S G++++E+I      +P Y     +    R        I D +   + +   VSS+
Sbjct: 200  DIWSLGIMVIEMIDG----EPPYFNEPPLQAMRR--------IRDNLPPRVKDSHKVSSV 247

Query: 1066 RDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
                +D++LV      ++PS R   ++++
Sbjct: 248  LRGFLDLMLV------REPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.0 bits (187), Expect = 8e-15
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 19/211 (9%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G +G+VYKA +     V A+KK+       G  S   REI  + ++ H N+V+L D 
Sbjct: 8    IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
               ++   +++ ++ +  L+  +   +P   +   +           LA+ H      ++
Sbjct: 68   IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVL 122

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-----NAFTT 999
            HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE       ++T
Sbjct: 123  HRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEILLGCKYYST 180

Query: 1000 AKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
            A     D++S G +  E++TR +AL P   E
Sbjct: 181  A----VDIWSLGCIFAEMVTR-RALFPGDSE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 20/215 (9%)

Query: 811  LKQVIEAT---ENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLAFRGHKRGSLSMK 864
            L+ V++       L+    IG G+ GIV      S G     AVKK+  R  +R  L + 
Sbjct: 8    LQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTG--RQVAVKKMDLRKQQRREL-LF 64

Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
             E+  +   +H N+V +   +L  D   ++  ++E G+L D+   +T     E  +   +
Sbjct: 65   NEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAT-V 120

Query: 925  ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI-AKLLDKSPASTTSIS 983
             L    AL++LH      ++HRDIK ++ILL S+    +SDFG  A++  + P      S
Sbjct: 121  CLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK---S 174

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            +VGT  ++APE         E D++S G++++E++
Sbjct: 175  LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 22/215 (10%)

Query: 819  ENLNAKHVIGRGAHGIVY---KASLGPNAVFAVKKLAF----RGHKRGSLSMKREIQTIG 871
             N     ++GRGA G VY    A  G     AVK++ F    +   +   +++ EIQ + 
Sbjct: 2    VNWRLGKLLGRGAFGEVYLCYDADTGRE--LAVKQVPFDPDSQETSKEVNALECEIQLLK 59

Query: 872  KIRHRNLVR----LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
             +RH  +V+    L D   +K    I   YM  GS++D L +      L  NV  +    
Sbjct: 60   NLRHDRIVQYYGCLRDPEEKKLS--IFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQ 114

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI-SVVG 986
                ++YLH +    IVHRDIK  NIL DS     + DFG +K +     S T I SV G
Sbjct: 115  ILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171

Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
            T  +++PE        +++DV+S    ++E++T K
Sbjct: 172  TPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G +G+VYKA     N   A+KK+       G  S   REI  + +++H N+VRL+D 
Sbjct: 10   IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR------YKIALGAAHALAYLHYD 938
               +    +++ Y++     D+   +   P    N R      Y+I  G    +AY H  
Sbjct: 70   VHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRG----IAYCH-- 119

Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                ++HRD+KP+N+L+D       ++DFG+A+     P  T +  VV T+ Y APE   
Sbjct: 120  -SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG-IPVRTFTHEVV-TLWYRAPEILL 176

Query: 998  TTAK-SKESDVYSYGVVLLELITRK 1021
             +   S   D++S G +  E++ +K
Sbjct: 177  GSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 21/204 (10%)

Query: 826  VIGRGAHGIVYKASLGPN------AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            V+G GA G VYK    P        V A+K L      + +  +  E   +  + H ++V
Sbjct: 14   VLGSGAFGTVYKGVWIPEGEKVKIPV-AIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPTLEWNVRYKIALGAAHALAYL 935
            RL    L     +I  + M  G L D +     +I     L W V  +IA G    ++YL
Sbjct: 73   RLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIAKG----MSYL 125

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +  +VHRD+   N+L+ +     I+DFG+AKLLD       +      I ++A E+
Sbjct: 126  E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 996  AFTTAKSKESDVYSYGVVLLELIT 1019
                  + +SDV+SYGV + EL+T
Sbjct: 183  ILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.5 bits (185), Expect = 2e-14
 Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 13/213 (6%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V K    P+ +   +KL     K    + + RE+Q + +     +V     F
Sbjct: 13   LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+++     LAYL       I+
Sbjct: 73   YSDGEISICM-EHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYLREKHQ--IM 126

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S +
Sbjct: 127  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQ 182

Query: 1005 SDVYSYGVVLLEL-ITRKKALDPSYKERTDIVG 1036
            SD++S G+ L+EL I R     P  KE   I G
Sbjct: 183  SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 26/210 (12%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK--------REIQTI 870
            ++      +G G  G+V K    P+ +   +KL         L +K        RE++ +
Sbjct: 1    DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI-------HLEIKPAIRNQIIRELKVL 53

Query: 871  GKIRHRNLVRL-EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
             +     +V     F+   +  I M  +M+ GSL  VL      P    N+  KI++   
Sbjct: 54   HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE---NILGKISIAVL 109

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG 989
              L YL       I+HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  
Sbjct: 110  RGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRS 163

Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            Y++PE    T  + +SD++S G+ L+E+  
Sbjct: 164  YMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 64/220 (29%), Positives = 109/220 (49%), Gaps = 22/220 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 6    ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 60

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP----PTLEWNVRYKIALGAAHA 931
              LV+L    + ++   I+  YM  GSL D L          P L  ++  +IA G A+ 
Sbjct: 61   EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV-DMAAQIASGMAY- 117

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
            +  ++Y      VHRD++  NIL+   +   ++DFG+A+L++ +   T        I + 
Sbjct: 118  VERMNY------VHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWT 170

Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 171  APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 23/216 (10%)

Query: 816  EATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E  EN   + V+G+G +GIVY A      V  A+K++  R   R    +  EI     ++
Sbjct: 6    EYDEN-GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYLK 63

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP-----PTLEWNVRYKIALGAA 929
            HRN+V+            I    +  GSL  +L S   P      T+ +  + +I  G  
Sbjct: 64   HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILEG-- 120

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDS-EMEPHISDFGIAKLLDK-SPASTTSISVVGT 987
              L YLH   D  IVHRDIK +N+L+++      ISDFG +K L   +P + T     GT
Sbjct: 121  --LKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET---FTGT 172

Query: 988  IGYIAPE--NAFTTAKSKESDVYSYGVVLLELITRK 1021
            + Y+APE  +         +D++S G  ++E+ T K
Sbjct: 173  LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 24/216 (11%)

Query: 815  IEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG----SLSMKREIQT 869
            ++  E LN    I  G +G+VY+A       + A+KKL     K G    SL   REI  
Sbjct: 4    VDEYEKLNR---IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL---REINI 57

Query: 870  IGKIRHRNLVRLEDFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIAL 926
            + K++H N+V +++  +  +     ++M  Y+E+  L+ ++ ++   P L+  V+  + L
Sbjct: 58   LLKLQHPNIVTVKEVVVGSNLDKIYMVM-EYVEH-DLKSLMETM-KQPFLQSEVKC-LML 113

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                 +A+LH   D  I+HRD+K  N+LL++     I DFG+A+         T + V  
Sbjct: 114  QLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-- 168

Query: 987  TIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            T+ Y APE      + S   D++S G +  EL+T+K
Sbjct: 169  TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 24/223 (10%)

Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKI 873
              E+L     +G G  G V+  +   N   AVK L     K G++S +    E Q + K+
Sbjct: 4    PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-----KPGTMSPESFLEEAQIMKKL 58

Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL-----HSITPPPTLEWNVRYKIALGA 928
            RH  LV+L      +   I+   YM  GSL D L      ++  P  ++  +  ++A G 
Sbjct: 59   RHDKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKDGEGRALKLPNLVD--MAAQVAAGM 115

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTI 988
            A+ +  ++Y      +HRD++  NIL+   +   I+DFG+A+L++ +   T        I
Sbjct: 116  AY-IERMNY------IHRDLRSANILVGDGLVCKIADFGLARLIEDN-EYTARQGAKFPI 167

Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             + APE A     + +SDV+S+G++L EL+T+ +   P    R
Sbjct: 168  KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.0 bits (187), Expect = 5e-14
 Identities = 36/89 (40%), Positives = 52/89 (58%)

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
           L L   G  G IP++   L++LQ +NL GN + G IP  L  I  L+ + L+ NS +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIG 212
           P ++G L  +  L L  N LSG +P ++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 74/309 (23%), Positives = 122/309 (39%), Gaps = 73/309 (23%)

Query: 827  IGRGAHGIVYKA-SLG-----PNAVFAVKKLAFRGHKRGSLSMK----REIQTIGKIRHR 876
            IG+GA G V++A + G     P  + AVK L     +  S  M+    RE   + +  H 
Sbjct: 13   IGQGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQREAALMAEFDHP 68

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP-------------------PPTLE 917
            N+V+L           +++ YM  G L + L   +P                   P  L 
Sbjct: 69   NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 918  WNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA 977
               +  IA   A  +AYL    +   VHRD+   N L+   M   I+DFG+++ +  +  
Sbjct: 129  CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 978  STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGW 1037
               S +    I ++ PE+ F    + ESDV++YGVVL E+ +    + P Y         
Sbjct: 186  YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY--GMQPYY--------- 234

Query: 1038 VRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVI---------DVLLVALRCTEKKPSNRP 1088
                              +  E ++  +RD  +         ++  +   C  K PS+RP
Sbjct: 235  -----------------GMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277

Query: 1089 NMRDVVRQL 1097
            +   + R L
Sbjct: 278  SFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 73.8 bits (182), Expect = 5e-14
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 52/220 (23%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK---------REIQTIGKIRHR 876
            +G G + +VYKA       + A+KK+     K G              REI+ + +++H 
Sbjct: 8    LGEGTYAVVYKARDKETGRIVAIKKI-----KLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH------ 930
            N++ L D +  K    +++ +ME   L  V+                I L  A       
Sbjct: 63   NIIGLLDVFGHKSNINLVFEFME-TDLEKVIK------------DKSIVLTPADIKSYML 109

Query: 931  ----ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                 L YLH      I+HRD+KP N+L+ S+    ++DFG+A+    SP    +  VV 
Sbjct: 110  MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV- 164

Query: 987  TIGYIAPE-----NAFTTAKSKESDVYSYGVVLLELITRK 1021
            T  Y APE       +        D++S G +  EL+ R 
Sbjct: 165  TRWYRAPELLFGARHYGVG----VDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.3 bits (180), Expect = 7e-14
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 29/237 (12%)

Query: 826  VIGRGAHGIV----YKASLGPNAVFAVKKL-AFRGHKRGSLSMK-REIQTIGKIRHRNLV 879
            V+G+G  G V     +A+     ++A KKL   R  KR   +M   E Q + K+  R +V
Sbjct: 7    VLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 63

Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY---KIALGAAHALAYLH 936
             L   +  KD   ++   M  G L+  ++++  P   E    +   +I  G       LH
Sbjct: 64   SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED----LH 119

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
             +    IV+RD+KPENILLD      ISD G+A    + P   T    VGT+GY+APE  
Sbjct: 120  RE---RIVYRDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVV 173

Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWV---RSVWSDTEEIND 1050
                 +   D +  G ++ E+I  K      +++R + V      R V  D EE ++
Sbjct: 174  KNERYTFSPDWWGLGCLIYEMIEGKS----PFRQRKEKVKREEVERRVKEDQEEYSE 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 73.0 bits (180), Expect = 9e-14
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 32/181 (17%)

Query: 827 IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-----REIQTIGKI-RHRNLV 879
           +G G  G VY A +     + A+KK+     K+   S +     RE++++ K+  H N+V
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM-----KKKFYSWEECMNLREVKSLRKLNEHPNIV 61

Query: 880 RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLH 936
           +L++ +   D    ++ YME G+L  ++      P  E  +R   Y+I  G    LA++H
Sbjct: 62  KLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQG----LAHIH 116

Query: 937 ---YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
              +       HRD+KPEN+L+       I+DFG+A+ +   P  T  +S   T  Y AP
Sbjct: 117 KHGF------FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS---TRWYRAP 167

Query: 994 E 994
           E
Sbjct: 168 E 168

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.2 bits (185), Expect = 1e-13
 Identities = 35/81 (43%), Positives = 46/81 (56%)

Query: 299 LTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL 358
           L G IP+    L  L S++LS N + G IPP LG    L VL L  N   G IP+ LGQL
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 359 SNLQDLELFDNRLTGEFPVSI 379
           ++L+ L L  N L+G  P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 18/206 (8%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E L     +G G  G V+      +   A+K L     K+GS+S +    E   + +++H
Sbjct: 6    ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-----KQGSMSPEAFLAEANLMKQLQH 60

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGA--AHALA 933
              LVRL     ++   II   YMENGSL D L +   P  ++  +   I + A  A  +A
Sbjct: 61   PRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PEGIKLTINKLIDMAAQIAEGMA 116

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            ++        +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + AP
Sbjct: 117  FIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN-EYTAREGAKFPIKWTAP 172

Query: 994  ENAFTTAKSKESDVYSYGVVLLELIT 1019
            E       + +SDV+S+G++L E++T
Sbjct: 173  EAINYGTFTIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 70/277 (25%), Positives = 128/277 (46%), Gaps = 41/277 (14%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G G  G V+ A+   +   AVK +     K GS+S++    E   +  ++H
Sbjct: 6    ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-----KPGSMSVEAFLAEANVMKTLQH 60

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPTLEWNVRYKIALGAAHA 931
              LV+L     ++   II   +M  GSL D L S      P P L  +   +IA G A  
Sbjct: 61   DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAF- 117

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
            +   +Y      +HRD++  NIL+ + +   I+DFG+A++++ +   T        I + 
Sbjct: 118  IEQRNY------IHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWT 170

Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051
            APE     + + +SDV+S+G++L+E++T  +   P                S+ E I  +
Sbjct: 171  APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM--------------SNPEVIRAL 216

Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP 1088
                 M      +  +++ +++   +RC + +P  RP
Sbjct: 217  ERGYRMPR--PENCPEELYNIM---MRCWKNRPEERP 248

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.4 bits (177), Expect = 2e-13
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 11/193 (5%)

Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A++  +  + AVKK+  R  +R  L +  E+  +   +H N+V + + +
Sbjct: 28   IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL-LFNEVVIMRDYQHENVVEMYNSY 86

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L  D   ++  ++E G+L D+   +T     E  +   + L    AL+ LH      ++H
Sbjct: 87   LVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIA-AVCLAVLKALSVLHAQ---GVIH 139

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K      S+  VGT  ++APE         E 
Sbjct: 140  RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPELISRLPYGPEV 197

Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 198  DIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 24/171 (14%)

Query: 864  KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL-------RDVLHSITPPPTL 916
            ++E+  +  ++H N+V+ ++ +       I+  Y E G L       R VL        L
Sbjct: 47   RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFP--EDQIL 104

Query: 917  EWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
            +W V+  +AL   H         D  I+HRDIK +NI L  +    + DFGIA++L+   
Sbjct: 105  DWFVQICLALKHVH---------DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN--- 152

Query: 977  ASTTSI--SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
             ST  +  + +GT  Y++PE       + +SD+++ G VL E+ T K A +
Sbjct: 153  -STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.8 bits (178), Expect = 2e-13
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 13/213 (6%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K    + + RE+Q + +     +V     F
Sbjct: 13   LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+++     L YL       I+
Sbjct: 73   YSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREK--HKIM 126

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S +
Sbjct: 127  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQ 182

Query: 1005 SDVYSYGVVLLEL-ITRKKALDPSYKERTDIVG 1036
            SD++S G+ L+E+ I R     P  KE   + G
Sbjct: 183  SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG 215

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 67/220 (30%), Positives = 97/220 (44%), Gaps = 33/220 (15%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH-R 876
            E+L     IGRGA G V K    P   + AVK++     ++    +  ++  + +     
Sbjct: 4    EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 877  NLVRLED--FWLRKDCGIIM----------YRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
             +V+     F    DC I M          Y+Y     + +VL S+ P       +  KI
Sbjct: 64   YIVKFYGALFR-EGDCWICMELMDISLDKFYKY-----VYEVLKSVIPE-----EILGKI 112

Query: 925  ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
            A+    AL YL  +    I+HRD+KP NILLD      + DFGI+  L  S A T     
Sbjct: 113  AVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD--- 167

Query: 985  VGTIGYIAPENAFTTAKSK---ESDVYSYGVVLLELITRK 1021
             G   Y+APE    +A+      SDV+S G+ L E+ T K
Sbjct: 168  AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 35/275 (12%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRHRNLVRLED 883
            IG G  G+V+          A+K +     + G++S      E Q + K+ H  LV+L  
Sbjct: 12   IGSGQFGLVWLGYWLEKRKVAIKTI-----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
                +    +++ +ME+G L D L                + L     +AYL       +
Sbjct: 67   VCTERSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKL-LDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +HRD+   N L+       +SDFG+ +  LD    S+T       + + +PE    +  S
Sbjct: 122  IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYS 179

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
             +SDV+S+GV++ E+ +  K     Y+ R++    V       E IN      L +  L 
Sbjct: 180  SKSDVWSFGVLMWEVFSEGKT---PYENRSN--SEV------VETIN--AGFRLYKPRLA 226

Query: 1063 SSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            S    +++        C +++P +RP+   ++ QL
Sbjct: 227  SQSVYELMQ------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.7 bits (175), Expect = 2e-13
 Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 15/195 (7%)

Query: 827  IGRGAHGIVYKAS---LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            IG+GA G V+ A     G     A+K++  +   +  L +  EI  + ++++ N+V   D
Sbjct: 27   IGQGASGTVFTAIDVATGQEV--AIKQINLQKQPKKELIIN-EILVMKELKNPNIVNFLD 83

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
             +L  D   ++  Y+  GSL DV   +T     E  +   +      AL +LH +    +
Sbjct: 84   SFLVGDELFVVMEYLAGGSLTDV---VTETCMDEAQIA-AVCRECLQALEFLHAN---QV 136

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRDIK +N+LL  +    ++DFG    +  +P  +   ++VGT  ++APE     A   
Sbjct: 137  IHRDIKSDNVLLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 1004 ESDVYSYGVVLLELI 1018
            + D++S G++ +E++
Sbjct: 195  KVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 55/202 (27%), Positives = 103/202 (50%), Gaps = 17/202 (8%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G +G+VYK  +     + A+KK+     + G  S   REI  + +++H N+V L+D 
Sbjct: 8    IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIALGAAHALAYLHYDCD 940
             +++    +++ ++    L+  L S+         L  +  Y+I  G    + + H    
Sbjct: 68   LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG----ILFCH---S 119

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              ++HRD+KP+N+L+D++    ++DFG+A+     P    +  VV T+ Y APE    + 
Sbjct: 120  RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFG-IPVRVYTHEVV-TLWYRAPEVLLGSP 177

Query: 1001 K-SKESDVYSYGVVLLELITRK 1021
            + S   D++S G +  E+ T+K
Sbjct: 178  RYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + L     IG+G  G V       N V AVK +    +   + +   E   + ++RH NL
Sbjct: 6    KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIK---NDATAQAFLAEASVMTQLRHSNL 61

Query: 879  VRLEDFWLRKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            V+L    + +  G+ I+  YM  GSL D L S      L  +   K +L    A+ YL  
Sbjct: 62   VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEA 120

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +     VHRD+   N+L+  +    +SDFG+ K      AS+T  +    + + APE   
Sbjct: 121  N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 172

Query: 998  TTAKSKESDVYSYGVVLLEL 1017
                S +SDV+S+G++L E+
Sbjct: 173  EKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.9 bits (173), Expect = 3e-13
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 18/206 (8%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHK----RGSLSMKREIQTIGKIRHRNLVR 880
            ++G+GA G VY    +      A K++ F        +   +++ EIQ +  ++H  +V+
Sbjct: 9    LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 881  LEDFWLRKDCG----IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
               +   +D       I   YM  GS++D L +      L  +V  K        ++YLH
Sbjct: 69   Y--YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH 123

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI-SVVGTIGYIAPEN 995
             +    IVHRDIK  NIL DS     + DFG +K L     S T I SV GT  +++PE 
Sbjct: 124  SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 996  AFTTAKSKESDVYSYGVVLLELITRK 1021
                   +++DV+S G  ++E++T K
Sbjct: 181  ISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 16/201 (7%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G +G+VYKA       + A+KK+       G  S   REI  + ++ H N+VRL D 
Sbjct: 7    IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITP---PPTLEWNVRYKIALGAAHALAYLHYDCDP 941
               ++   +++ ++ +  L+  + S       P L  +  Y++       +AY H     
Sbjct: 67   VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYCHSH--- 118

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             ++HRD+KP+N+L+D E    ++DFG+A+     P  T +  VV T+ Y APE    + +
Sbjct: 119  RVLHRDLKPQNLLIDREGALKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEILLGSRQ 176

Query: 1002 -SKESDVYSYGVVLLELITRK 1021
             S   D++S G +  E++ R+
Sbjct: 177  YSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 41/216 (18%)

Query: 827  IGRGAHGIVYKASLGPN-AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +GRGA+G+V K    P   + AVK++      R +++ + +         R L+ L D  
Sbjct: 9    LGRGAYGVVDKMRHVPTGTIMAVKRI------RATVNSQEQ--------KRLLMDL-DIS 53

Query: 886  LRK-DCGIIMYRY------------ME--NGSLRDVL-HSITPPPTLEWNVRYKIALGAA 929
            +R  DC   +  Y            ME  + SL            T+  ++  KIA+   
Sbjct: 54   MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG 989
             AL YLH      ++HRD+KP N+L++   +  + DFGI+  L  S A T      G   
Sbjct: 114  KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA---GCKP 168

Query: 990  YIAPE--NAFTTAK--SKESDVYSYGVVLLELITRK 1021
            Y+APE  N     K    +SDV+S G+ ++EL T +
Sbjct: 169  YMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.7 bits (174), Expect = 5e-13
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 32/205 (15%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK------REIQTIGKIRHRNL 878
             +G G+ G V      G    +A+K L     K   + +K       E + +  IRH  L
Sbjct: 8    TLGTGSFGRVMLVRHKGSGKYYALKIL----SKAKIVKLKQVEHVLNEKRILQSIRHPFL 63

Query: 879  VRLEDFWLRKD---CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY--KIALGAAHALA 933
            V L   +  +D     ++M  Y+  G L   L      P       Y  ++ L    AL 
Sbjct: 64   VNLYGSF--QDDSNLYLVM-EYVPGGELFSHLRKSGRFP-EPVARFYAAQVVL----ALE 115

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            YLH   D  IV+RD+KPEN+LLDS+    I+DFG AK +      T ++   GT  Y+AP
Sbjct: 116  YLH-SLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG---RTYTLC--GTPEYLAP 167

Query: 994  ENAFTTAKSKESDVYSYGVVLLELI 1018
            E   +    K  D ++ G+++ E++
Sbjct: 168  EIILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.3 bits (172), Expect = 6e-13
 Identities = 53/193 (27%), Positives = 96/193 (49%), Gaps = 11/193 (5%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A+K++  +   +  L +  EI  + + +H N+V   D +
Sbjct: 27   IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKHPNIVNYLDSY 85

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L  D   ++  Y+  GSL DV+        ++      +      AL +LH +    ++H
Sbjct: 86   LVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSN---QVIH 138

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK +NILL  +    ++DFG    +  +P  +   ++VGT  ++APE     A   + 
Sbjct: 139  RDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 1006 DVYSYGVVLLELI 1018
            D++S G++ +E++
Sbjct: 197  DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.0 bits (171), Expect = 7e-13
 Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 29/222 (13%)

Query: 827  IGRGAHGIVYKASLGPNA--VFAVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVR 880
            IG GA+G V+KA    N     A+K++  +  + G  LS  RE+  +  +    H N+VR
Sbjct: 9    IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 881  LEDFWL-----RKDCGIIMYRYMENG---SLRDVLHSITPPPTLEWNVRYKIALGAAHAL 932
            L D        R+    +++ +++      L  V     P  T++ ++ +++  G    L
Sbjct: 69   LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-DMMFQLLRG----L 123

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
             +LH      +VHRD+KP+NIL+ S  +  ++DFG+A++     A T   SVV T+ Y A
Sbjct: 124  DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVTLWYRA 177

Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
            PE    ++ +   D++S G +  E+  RK    P ++  +D+
Sbjct: 178  PEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDV 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.6 bits (170), Expect = 8e-13
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-------IRHRNL 878
            V+G+GA+G VY        + AVK++         L+ ++E + + +       ++H N+
Sbjct: 7    VLGKGAYGTVYCGLTNQGQLIAVKQVEL--DTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            V+     L  +   I   ++  GS+  +L+   P P     V  K        +AYLH +
Sbjct: 65   VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP---VFCKYTKQILDGVAYLHNN 121

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI----SVVGTIGYIAPE 994
            C   +VHRDIK  N++L       + DFG A+ L       T      S+ GT  ++APE
Sbjct: 122  C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKAL 1024
                +   ++SD++S G  + E+ T K  L
Sbjct: 179  VINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 20/207 (9%)

Query: 826  VIGRGAHGIVY---KASLGPNAVFAVKKLAFRGHK----RGSLSMKREIQTIGKIRHRNL 878
            ++G+GA G VY    A  G     AVK++ F        +   +++ EIQ +  + H  +
Sbjct: 9    LLGQGAFGRVYLCYDADTGRE--LAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66

Query: 879  VRLEDFW---LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
            V+        + +   I M  +M  GS++D L S      L  NV  K        ++YL
Sbjct: 67   VQYYGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYL 122

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI-SVVGTIGYIAPE 994
            H +    IVHRDIK  NIL DS     + DFG +K L     S T + SV GT  +++PE
Sbjct: 123  HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 995  NAFTTAKSKESDVYSYGVVLLELITRK 1021
                    +++D++S G  ++E++T K
Sbjct: 180  VISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 826  VIGRGAHG--IVY-KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            V+G+GA G   +Y +       V+    L     K    ++  EI  +  ++H N++   
Sbjct: 7    VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN-EIVILSLLQHPNIIAYY 65

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVL----HSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            + ++  +  +I   Y   G+L D +      +     + W   ++I      A++Y+H  
Sbjct: 66   NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-YLFQIV----SAVSYIH-- 118

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL--DKSPASTTSISVVGTIGYIAPENA 996
                I+HRDIK  NI L       + DFGI+K+L  + S A T    VVGT  Y++PE  
Sbjct: 119  -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET----VVGTPYYMSPELC 173

Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPS 1027
                 + +SD+++ G VL EL+T K+  D +
Sbjct: 174  QGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 77/307 (25%), Positives = 123/307 (40%), Gaps = 52/307 (16%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN 877
            +++  + ++G G  G VYKA       + AVK +           +  E++ + K     
Sbjct: 1    QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            ++     +  ++   I   +M+ GSL DV   I P   L      +IA+     L YL  
Sbjct: 61   IIGFYGAFFVENRISICTEFMDGGSL-DVYRKI-PEHVLG-----RIAVAVVKGLTYL-- 111

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I+HRD+KP N+L+++  +  + DFG++  L  S A T     VGT  Y+APE   
Sbjct: 112  -WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERIS 166

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057
                   SDV+S G+  +EL   +       K +                       SLM
Sbjct: 167  GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG----------------------SLM 204

Query: 1058 EEMLVSSIRDQVIDVLLVAL----------RCTEKKPSNRP---NMRD--VVRQLVDASV 1102
               L+  I D+   VL V            +C  K+P  RP   N+ D   + Q  D + 
Sbjct: 205  PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Query: 1103 PMTSKYV 1109
             + S +V
Sbjct: 265  EVVSMWV 271

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 70.0 bits (172), Expect = 1e-12
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 38/232 (16%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDF 884
            +G G  G VYKA  +    V A+KK+     K G  ++  REI+ + K++H N+V L D 
Sbjct: 16   LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 885  WLRKDCGI-----IMYR---YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
             + +          +Y    YM++  L  +L +  P   L  +      L     + YLH
Sbjct: 76   AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLH 132

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS---------ISVVGT 987
               +  I+HRDIK  NIL+D++    I+DFG+A+  D  P +             ++V T
Sbjct: 133  ---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189

Query: 988  IGYIAPE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
              Y  PE       +TTA     D++  G V  E+ TR+    P  + ++DI
Sbjct: 190  RWYRPPELLLGERRYTTA----VDIWGIGCVFAEMFTRR----PILQGKSDI 233

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 70/292 (23%), Positives = 124/292 (42%), Gaps = 52/292 (17%)

Query: 815  IEATENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMK---REIQTI 870
            +E T+ +  KH +G G +G VY+      +   AVK L     K  ++ ++   +E   +
Sbjct: 3    MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVM 56

Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH 930
             +I+H NLV+L     R+    I+  +M  G+L D L        +   V   +A   + 
Sbjct: 57   KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISS 115

Query: 931  ALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
            A+ YL   ++      +HRD+   N L+       ++DFG+++L+      T        
Sbjct: 116  AMEYLEKKNF------IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFP 168

Query: 988  IGYIAPEN-AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046
            I + APE+ A+     K SDV+++GV+L E+ T   +  P                    
Sbjct: 169  IKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPG------------------- 208

Query: 1047 EINDIVDLSLMEEMLVSSIRDQ-----VIDVLLVALRCTEKKPSNRPNMRDV 1093
                 +DLS + E+L    R +        V  +   C +  PS+RP+  ++
Sbjct: 209  -----IDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 36/207 (17%)

Query: 827  IGRGAHGIVY---KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL----- 878
            I +GA G VY   K S G    FA+K L     K+  +  K ++  + K     +     
Sbjct: 4    ISKGAFGSVYLAKKRSTGD--YFAIKVL-----KKSDMIAKNQVTNV-KAERAIMMIQGE 55

Query: 879  ----VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY--KIALGAAHAL 932
                 +L   +  KD   ++  Y+  G    ++ ++   P  +W  +Y  ++ LG    +
Sbjct: 56   SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP-EDWAKQYIAEVVLG----V 110

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
              LH      I+HRDIKPEN+L+D      ++DFG+++   ++         VGT  Y+A
Sbjct: 111  EDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLA 161

Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE        K SD +S G V+ E + 
Sbjct: 162  PETILGVGDDKMSDWWSLGCVIFEFLF 188

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 19/213 (8%)

Query: 814  VIEATENLNAKHVIGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRGSLS--MKREIQT 869
            V E T        +G GA G+V  A   L    V A+KK+  +      L+    RE++ 
Sbjct: 5    VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNV-AIKKI-MKPFSTPVLAKRTYRELKL 62

Query: 870  IGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
            +  +RH N++ L D ++     I     +    L  +L S            Y+I  G  
Sbjct: 63   LKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRG-- 120

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG 989
              L Y+H      +VHRD+KP NIL++   +  I DFG+A++ D  P  T  +S   T  
Sbjct: 121  --LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD--PQMTGYVS---TRY 170

Query: 990  YIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            Y APE   T  K   E D++S G +  E++  K
Sbjct: 171  YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 59/200 (29%), Positives = 86/200 (43%), Gaps = 20/200 (10%)

Query: 827  IGRGAHGIVY---KASLGPNAVFAVKKL-AFRGHKRGSLSMK-REIQTIGKIRHRNLVRL 881
            +G+G  G V      + G   ++A KKL   R  KR    M   E + + K+  R +V L
Sbjct: 1    LGKGGFGEVCACQVKATG--KMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY---KIALGAAHALAYLHYD 938
               +  KD   ++   M  G L+  ++++  P   E    +   +I  G  H    LH  
Sbjct: 59   AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH----LH-- 112

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
                IV+RD+KPEN+LLD      ISD G+A  L             GT GY+APE    
Sbjct: 113  -QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL---KGGKKIKGRAGTPGYMAPEVLQG 168

Query: 999  TAKSKESDVYSYGVVLLELI 1018
                   D ++ G  L E+I
Sbjct: 169  EVYDFSVDWFALGCTLYEMI 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 24/202 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR---- 880
             IG+G+ G VYKA     N V A+K +     +     +++EIQ + + R   + +    
Sbjct: 8    CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 881  -LEDF--WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
             L+    W      IIM  Y   GS  D+L        L+      I       L YLH 
Sbjct: 68   FLKGSKLW------IIM-EYCGGGSCLDLLKPGK----LDETYIAFILREVLLGLEYLHE 116

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +     +HRDIK  NILL  E +  ++DFG++  L  +   +   + VGT  ++APE   
Sbjct: 117  E---GKIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNTFVGTPFWMAPEVIK 171

Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
             +   +++D++S G+  +EL  
Sbjct: 172  QSGYDEKADIWSLGITAIELAK 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.6 bits (173), Expect = 3e-12
 Identities = 40/102 (39%), Positives = 58/102 (56%), Gaps = 2/102 (1%)

Query: 564 GSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEK 623
           G +P+ +SK ++L+  ++S N + G+IP SL S  SL +L LS N F G IP  + +L  
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 624 LLELQLGGNQLGGEIPPSIGALQDLSYALNLSKN-GLTGRIP 664
           L  L L GN L G +P ++G       + N + N GL G IP
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IP 532

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.6 bits (173), Expect = 3e-12
 Identities = 57/187 (30%), Positives = 82/187 (43%), Gaps = 52/187 (27%)

Query: 651 ALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFTGP 709
            L L   GL G IP+D+ KL  L+ +++S N++ G + P L +I SL  +++SYN F G 
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 710 VPETL--------MNLLGPSPS-----------------SFSGNPSLCVKCLSSTDSSCF 744
           +PE+L        +NL G S S                 +F+ N  LC            
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLC------------ 529

Query: 745 GTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRR----RSKQDLE 800
           G   LR C  H S        KI  IA G S +  L ++    C   RR    R+++   
Sbjct: 530 GIPGLRACGPHLS-----VGAKI-GIAFGVS-VAFLFLVICAMCWWKRRQNILRAQR--- 579

Query: 801 IPAQEGP 807
           I A+E P
Sbjct: 580 IAAREAP 586

Length = 623

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 11/228 (4%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKL-AFRGHKRGSLSMK-REIQTIGKIRHRNLVRLE 882
            V+G+G  G V    +     ++A KKL   R  KR   +M   E + + K+  R +V L 
Sbjct: 7    VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +  KD   ++   M  G L+  ++++  P   E    +  A      L  L  +    
Sbjct: 67   YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF-YAAELCCGLEDLQRE---R 122

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IV+RD+KPENILLD      ISD G+A  +   P   T    VGT+GY+APE       +
Sbjct: 123  IVYRDLKPENILLDDRGHIRISDLGLAVQI---PEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050
               D +  G ++ E+I  +       KER       R V  D EE ++
Sbjct: 180  FSPDWWGLGCLIYEMIQGQSPFR-KRKERVKREEVDRRVKEDQEEYSE 226

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 3e-12
 Identities = 58/206 (28%), Positives = 110/206 (53%), Gaps = 27/206 (13%)

Query: 826  VIGRGAHGIVY--KASLGPNA--VFAVK---KLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            V+G+G+ G V+  +   GP+A  ++A+K   K   +   R    M+R+I  + ++ H  +
Sbjct: 3    VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI--LAEVNHPFI 60

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSL-----RDVLHSITPPPTLEWNVRYKIALGAAHALA 933
            V+L   +  +    ++  ++  G L     ++V+ +       E +V++ +A   A AL 
Sbjct: 61   VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-------EEDVKFYLA-ELALALD 112

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            +LH      I++RD+KPENILLD E    ++DFG++K  +       + S  GT+ Y+AP
Sbjct: 113  HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAP 167

Query: 994  ENAFTTAKSKESDVYSYGVVLLELIT 1019
            E       ++ +D +S+GV++ E++T
Sbjct: 168  EVVNRRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 58/214 (27%), Positives = 85/214 (39%), Gaps = 42/214 (19%)

Query: 827  IGRGAHGIV----YKASLGPNAVFAVKKLAFRGHKRGSLS-----MKREIQTIGKIRHRN 877
            +G G+ G+V    +  S G     AVK L     K   LS       +E   +  + H N
Sbjct: 3    LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-----KSDKLSDIMDDFLKEAAIMHSLDHEN 57

Query: 878  LVRLEDFWLRKDCGIIMYRYM-------ENGSLRDVLH----SITPPPTLEWNVRYKIAL 926
            L+RL         G+++   +         GSL D L           TL  +   +IA 
Sbjct: 58   LIRLY--------GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTL-CDYAVQIAN 108

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVV 985
            G    + YL        +HRD+   NILL S+ +  I DFG+ + L            + 
Sbjct: 109  G----MRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                + APE+  T   S  SDV+ +GV L E+ T
Sbjct: 162  VPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 54/204 (26%), Positives = 99/204 (48%), Gaps = 23/204 (11%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLED 883
            +G G  G V+      +   AVK L     K G++S++    E   +  ++H  LVRL  
Sbjct: 14   LGAGQFGEVWMGYYNNSTKVAVKTL-----KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIALGAAHALAYLHYD 938
               +++   I+  YM  GSL D L S     +  P  ++++ +       A  +AY+   
Sbjct: 69   VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIE-- 120

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
                 +HRD++  N+L+   +   I+DFG+A++++ +   T        I + APE    
Sbjct: 121  -RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINF 178

Query: 999  TAKSKESDVYSYGVVLLELITRKK 1022
             + + +SDV+S+G++L E++T  K
Sbjct: 179  GSFTIKSDVWSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)

Query: 816  EATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIG 871
            E  ENL    ++G G++G+V K        + A+KK  F   +   +  K   REI+ + 
Sbjct: 1    EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKK--FLESEDDKMVKKIAMREIRMLK 55

Query: 872  KIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHA 931
            ++RH NLV L + + RK    +++ ++++  L D+      P  L+ +   K        
Sbjct: 56   QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRG 112

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
            + + H      I+HRDIKPENIL+       + DFG A+ L       T    V T  Y 
Sbjct: 113  IEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT--DYVATRWYR 167

Query: 992  APENAFTTAK-SKESDVYSYGVVLLELIT 1019
            APE      K  +  D+++ G ++ E++T
Sbjct: 168  APELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 68.6 bits (167), Expect = 3e-12
 Identities = 54/193 (27%), Positives = 97/193 (50%), Gaps = 11/193 (5%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A+K++  +   +  L +  EI  + + ++ N+V   D +
Sbjct: 27   IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 85

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L  D   ++  Y+  GSL DV   +T     E  +   +      AL +LH +    ++H
Sbjct: 86   LVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIA-AVCRECLQALDFLHSN---QVIH 138

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK +NILL  +    ++DFG    +  +P  +   ++VGT  ++APE     A   + 
Sbjct: 139  RDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 1006 DVYSYGVVLLELI 1018
            D++S G++ +E++
Sbjct: 197  DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 24/223 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + L    +IG G  G V +       V AVK +      +  L    E   + K+ H+NL
Sbjct: 6    QKLTLGEIIGEGEFGAVLQGEYTGQKV-AVKNIKCDVTAQAFLE---ETAVMTKLHHKNL 61

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPTLEWNVRYKIALGAAHALAY 934
            VRL    L     I+M   M  G+L + L +    +     L      + +L  A  + Y
Sbjct: 62   VRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEY 115

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            L       +VHRD+   NIL+  +    +SDFG+A++        + + V  T    APE
Sbjct: 116  LE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWT----APE 167

Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDP--SYKERTDIV 1035
                   S +SDV+SYGV+L E+ +  +A  P  S KE  + V
Sbjct: 168  ALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
            +G GA G VYKA      +FA  K+     +        EI  + + +H N+V L + + 
Sbjct: 13   LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 887  RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHR 946
             ++   I+  + + G+L  ++  +    T E  +RY +      AL +LH      ++HR
Sbjct: 73   YENKLWILIEFCDGGALDSIMLELERGLT-EPQIRY-VCRQMLEALNFLH---SHKVIHR 127

Query: 947  DIKPENILLDSEMEPHISDFGI-AKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSK- 1003
            D+K  NILL  + +  ++DFG+ AK         T I   GT  ++APE     T K   
Sbjct: 128  DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFKDNP 184

Query: 1004 ---ESDVYSYGVVLLEL 1017
               ++D++S G+ L+EL
Sbjct: 185  YDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 55/196 (28%), Positives = 85/196 (43%), Gaps = 11/196 (5%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLA---FRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            IG+G  G VYK  L  N   AVK          KR  L   +E + + +  H N+V+L  
Sbjct: 3    IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFL---QEAEILKQYDHPNIVKLIG 59

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
              ++K    I+   +  GSL   L        L      +++L AA  + YL        
Sbjct: 60   VCVQKQPIYIVMELVPGGSLLTFLR--KKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   N L+       ISDFG+++  +    + +       I + APE       + 
Sbjct: 115  IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 1004 ESDVYSYGVVLLELIT 1019
            ESDV+SYG++L E  +
Sbjct: 175  ESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 13/195 (6%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G +G VYKA ++    + A+K +     +  ++ +++EI  +   +H N+V     +
Sbjct: 17   IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSNIVAYFGSY 75

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            LR+D   I   +   GSL+D+ H   P    +      IA  +   L  L+Y      +H
Sbjct: 76   LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQ------IAYVSRETLQGLYYLHSKGKMH 129

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---S 1002
            RDIK  NILL       ++DFG++  +  + A   S   +GT  ++APE A    K   +
Sbjct: 130  RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF--IGTPYWMAPEVAAVERKGGYN 187

Query: 1003 KESDVYSYGVVLLEL 1017
            +  D+++ G+  +EL
Sbjct: 188  QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 51/195 (26%), Positives = 99/195 (50%), Gaps = 8/195 (4%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G G +  VYK  +     + A+K++     +    +  REI  + +++H N+VRL D  
Sbjct: 8    LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
              ++  ++++ YM+   L+  + +      L+ N            +A+ H   +  ++H
Sbjct: 68   HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RD+KP+N+L++   E  ++DFG+A+     P +T S  VV T+ Y AP+    +     S
Sbjct: 124  RDLKPQNLLINKRGELKLADFGLARAFG-IPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181

Query: 1006 -DVYSYGVVLLELIT 1019
             D++S G ++ E+IT
Sbjct: 182  IDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.4 bits (164), Expect = 4e-12
 Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 13/195 (6%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G G +G VYKA +L    + AVK +        SL +++EI  + + +H N+V     +
Sbjct: 17   VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIVAYFGSY 75

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L ++   I   Y   GSL+D+ H     P  E  + Y +       LAYLH       +H
Sbjct: 76   LSREKLWICMEYCGGGSLQDIYH--VTGPLSELQIAY-VCRETLQGLAYLHSKGK---MH 129

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---S 1002
            RDIK  NILL    +  ++DFG+A  +  + A   S   +GT  ++APE A        +
Sbjct: 130  RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF--IGTPYWMAPEVAAVEKNGGYN 187

Query: 1003 KESDVYSYGVVLLEL 1017
            +  D+++ G+  +EL
Sbjct: 188  QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 59/196 (30%), Positives = 89/196 (45%), Gaps = 10/196 (5%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKL-AFRGHKRGSLSMK-REIQTIGKIRHRNLVRLE 882
            V+G+G  G V    +     ++A K+L   R  KR   SM   E Q + K+  + +V L 
Sbjct: 7    VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +  KD   ++   M  G L+  ++++  P   E    +     AA  L  L       
Sbjct: 67   YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFY----AAEILCGLEDLHREN 122

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
             V+RD+KPENILLD      ISD G+A    K P   +    VGT+GY+APE       +
Sbjct: 123  TVYRDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRYT 179

Query: 1003 KESDVYSYGVVLLELI 1018
               D +  G ++ E+I
Sbjct: 180  LSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 20/209 (9%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLE- 882
             IG G +G VYKA       + A+KK+     K G  ++  REI+ + ++ HRN+V L+ 
Sbjct: 14   QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 883  ---------DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALA 933
                     DF   K    +++ YM++  L  +L S     + +    +   L     L 
Sbjct: 74   IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQL--LEGLN 130

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            Y H       +HRDIK  NILL+++ +  ++DFG+A+L +   +   +  V+ T+ Y  P
Sbjct: 131  YCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWYRPP 186

Query: 994  ENAFTTAKSKES-DVYSYGVVLLELITRK 1021
            E      +   + DV+S G +L EL T+K
Sbjct: 187  ELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.8 bits (165), Expect = 5e-12
 Identities = 54/193 (27%), Positives = 97/193 (50%), Gaps = 11/193 (5%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A++++  +   +  L +  EI  + + ++ N+V   D +
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L  D   ++  Y+  GSL DV   +T     E  +   +      AL +LH +    ++H
Sbjct: 87   LVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIA-AVCRECLQALEFLHSN---QVIH 139

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK +NILL  +    ++DFG    +  +P  +   ++VGT  ++APE     A   + 
Sbjct: 140  RDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 1006 DVYSYGVVLLELI 1018
            D++S G++ +E+I
Sbjct: 198  DIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 69.5 bits (170), Expect = 6e-12
 Identities = 35/89 (39%), Positives = 50/89 (56%)

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI 303
           L + +  L G I     K ++L  ++LS N   G I P+LG+ +SL  LD+  +   GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 304 PSSFGLLARLSSLDLSENQLSGKIPPELG 332
           P S G L  L  L+L+ N LSG++P  LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 67.3 bits (164), Expect = 6e-12
 Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 49/289 (16%)

Query: 827  IGRGAHGIVYKA---SLGPNA---VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G GA G V+ A   +L P     + AVK L     +      +RE + +  ++H+++VR
Sbjct: 13   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP--------------PPTLE--WNVRYKI 924
                       ++++ YM +G L   L S  P                TL     +  +I
Sbjct: 72   FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 925  ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
            A G  + LA LH+      VHRD+   N L+   +   I DFG+++ +  +         
Sbjct: 132  ASGMVY-LASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184

Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044
            +  I ++ PE+      + ESD++S+GVVL E+ T  K   P Y+             S+
Sbjct: 185  MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK--QPWYQ------------LSN 230

Query: 1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
            TE I  I     +E       R    +V  +   C +++P  R  ++D+
Sbjct: 231  TEAIECITQGRELERP-----RTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 24/221 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L     +G+G  G V+  +       A+K L     K G++  +   +E Q + K+RH
Sbjct: 6    ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-----KPGTMMPEAFLQEAQIMKKLRH 60

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIALGAAH 930
              LV L    + ++   I+  +M  GSL D L       +  P  ++  +  +IA G A+
Sbjct: 61   DKLVPLYAV-VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVD--MAAQIADGMAY 117

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             +  ++Y      +HRD++  NIL+   +   I+DFG+A+L++ +   T        I +
Sbjct: 118  -IERMNY------IHRDLRAANILVGDNLVCKIADFGLARLIEDN-EYTARQGAKFPIKW 169

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL+T+ +   P    R
Sbjct: 170  TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR 210

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.0 bits (163), Expect = 9e-12
 Identities = 67/216 (31%), Positives = 96/216 (44%), Gaps = 17/216 (7%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKL-AFRGHKRGSLSMK-REIQTIGKIRHRNLVRLE 882
            V+G+G  G V    +     ++A KKL   R  KR   SM   E Q + K+  R +V L 
Sbjct: 7    VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +  KD   ++   M  G L+  ++ +      E    +  A      L  LH +    
Sbjct: 67   YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-YAAEICCGLEDLHQE---R 122

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IV+RD+KPENILLD      ISD G+A  +   P   T    VGT+GY+APE       +
Sbjct: 123  IVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQTIKGRVGTVGYMAPEVVKNERYT 179

Query: 1003 KESDVYSYGVVLLELIT-------RKKALDPSYKER 1031
               D ++ G +L E+I        RKK +     ER
Sbjct: 180  FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 66.6 bits (163), Expect = 9e-12
 Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 31/206 (15%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLE 882
            IG G++G+V+K  +     + A+KK  F   +   +  K   REI+ + +++H NLV L 
Sbjct: 9    IGEGSYGVVFKCRNRETGQIVAIKK--FVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-------YKIALGAAHALAYL 935
            + + RK    +++ Y ++     VL+       LE N R        KI      A+ + 
Sbjct: 67   EVFRRKRKLHLVFEYCDH----TVLN------ELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 936  H-YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            H ++C    +HRD+KPENIL+  + +  + DFG A++L       T    V T  Y APE
Sbjct: 117  HKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVATRWYRAPE 170

Query: 995  NAF-TTAKSKESDVYSYGVVLLELIT 1019
                 T      DV++ G V  EL+T
Sbjct: 171  LLVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 1e-11
 Identities = 40/113 (35%), Positives = 56/113 (49%), Gaps = 11/113 (9%)

Query: 392 NNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNL 451
           N  L G +P ++++L+ L++I+L  N   G IP SLG  +SL  LD   NSF G IP +L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 452 CFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVL 504
                LR+LN+  N   G +P+ LG              L  A   F+ N  L
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRL-----------LHRASFNFTDNAGL 528

Length = 623

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.0 bits (163), Expect = 1e-11
 Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 11/193 (5%)

Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A    +    AVK +  R  +R  L +  E+  +   +H+N+V +   +
Sbjct: 29   IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHQNVVEMYKSY 87

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L  +   ++  +++ G+L D++        L       +      AL YLH      ++H
Sbjct: 88   LVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLH---SQGVIH 140

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K      S+  VGT  ++APE    T    E 
Sbjct: 141  RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVISRTPYGTEV 198

Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 199  DIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 24/204 (11%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLED 883
            +G G  G+V+          A+K +     + G++S      E + + K+ H NLV+L  
Sbjct: 12   LGSGQFGVVHLGKWRGKIDVAIKMI-----REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
               ++    I+  YM NG L + L         EW +   +      A+ YL  +     
Sbjct: 67   VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAMEYLESNG---F 121

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT---IGYIAPENAFTT 999
            +HRD+   N L+  +    +SDFG+A+ +LD    S+      GT   + +  PE  F  
Sbjct: 122  IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-----GTKFPVKWAPPE-VFDY 175

Query: 1000 AK-SKESDVYSYGVVLLELITRKK 1022
            ++ S +SDV+S+GV++ E+ +  K
Sbjct: 176  SRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 71/293 (24%), Positives = 127/293 (43%), Gaps = 42/293 (14%)

Query: 824  KHVIGRGAHGIVYKA---SLGPN------AVFAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            K  +G GA G V+ A   +L P       AV A+K       K      +RE + +  ++
Sbjct: 10   KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK----DFQREAELLTNLQ 65

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            H ++V+        D  I+++ YM++G L   L +  P   +  + + + A G       
Sbjct: 66   HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 935  LH----------YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
            LH          Y      VHRD+   N L+ + +   I DFG+++ +  +         
Sbjct: 126  LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044
            +  I ++ PE+      + ESDV+S+GV+L E+ T  K   P ++             S+
Sbjct: 186  MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK--QPWFQ------------LSN 231

Query: 1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            TE I  I    ++E   V     +V D++   L C +++P  R N++++ + L
Sbjct: 232  TEVIECITQGRVLERPRVCP--KEVYDIM---LGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.8 bits (164), Expect = 1e-11
 Identities = 70/212 (33%), Positives = 109/212 (51%), Gaps = 33/212 (15%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGH---KRGSLSMKREI---QTIGKIRHRN 877
            +G+GA+GIV+KA       V A+KK+  AFR     +R      REI   Q +G   H N
Sbjct: 15   LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR----TFREIMFLQELGD--HPN 68

Query: 878  LVRLEDFWLRKDCGIIMY---RYMENGSLRDVLHSITPPPTLE-WNVRYKIALGAAHALA 933
            +V+L +  ++ +    +Y    YME     D LH++     LE  + RY I      AL 
Sbjct: 69   IVKLLNV-IKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRY-IMYQLLKALK 121

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV---VGTIGY 990
            Y+H      ++HRD+KP NILL+S+    ++DFG+A+ L +   +  +  +   V T  Y
Sbjct: 122  YIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178

Query: 991  IAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             APE    +T  +K  D++S G +L E++  K
Sbjct: 179  RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 2e-11
 Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 1/103 (0%)

Query: 220 LYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGI 279
           L L+   L GF+P  +S L +L  +++  N++ G I        +L  LDLSYN F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 280 SPNLGNCSSLTHLDIVGSKLTGSIPSSFG-LLARLSSLDLSEN 321
             +LG  +SL  L++ G+ L+G +P++ G  L   +S + ++N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.7 bits (163), Expect = 2e-11
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 41/218 (18%)

Query: 827  IGRGAHGIVYKA---SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR----HRNLV 879
            +G+GA+GIV  A           A+KK+     K   +  KR ++ +  +R    H+N+ 
Sbjct: 8    LGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFRGHKNIT 65

Query: 880  RLEDF---WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH------ 930
             L D    +      + +Y  +    L  ++ S  P             L  AH      
Sbjct: 66   CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP-------------LTDAHFQSFIY 112

Query: 931  ----ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS--ISV 984
                 L Y+H      ++HRD+KP N+L++++ E  I DFG+A+   ++P          
Sbjct: 113  QILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169

Query: 985  VGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            V T  Y APE   +    +K  DV+S G +L EL+ RK
Sbjct: 170  VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 23/206 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAF-RGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
             IG G+ G +Y A +   +    +K++   +   +   + K+E+  + K++H N+V    
Sbjct: 7    KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 884  FWLRKDCGIIMYRYMENGSL-------RDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
             +       I+  Y + G L       R VL S      L W V  +I+LG  H    +H
Sbjct: 67   SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQILSWFV--QISLGLKH----IH 118

Query: 937  YDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
               D  I+HRDIK +NI L    M   + DFGIA+ L+ S     + + VGT  Y++PE 
Sbjct: 119  ---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSPEI 173

Query: 996  AFTTAKSKESDVYSYGVVLLELITRK 1021
                  + ++D++S G VL EL T K
Sbjct: 174  CQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 67.3 bits (164), Expect = 2e-11
 Identities = 88/280 (31%), Positives = 133/280 (47%), Gaps = 12/280 (4%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
           +L  L ++DL+ N    NI   L   + L  LDL  N  T   P       NL+ L+L  
Sbjct: 91  NLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSD 149

Query: 153 NLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIG 212
           N +   +P PL  +  L+ + L+ N LS  +P+ + +L  +  L L  N++S  +P  I 
Sbjct: 150 NKI-ESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE 206

Query: 213 NCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSY 272
               L+EL L+ N ++  L  SLSNL+NL  L++ +N LE           NL  LDLS 
Sbjct: 207 LLSALEELDLSNNSIIE-LLSSLSNLKNLSGLELSNNKLEDLPESIG-NLSNLETLDLSN 264

Query: 273 NRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELG 332
           N+ S     +LG+ ++L  LD+ G+ L+ ++P    LL  L  L    N L      EL 
Sbjct: 265 NQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELL---LNLLLTLKALELK 319

Query: 333 KCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT 372
               L   ++ +N  E   P+ L  L +L +L   DN L 
Sbjct: 320 LNSILLNNNILSNG-ETSSPEALSILESLNNLWTLDNALD 358

Length = 394

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 47/218 (21%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            IGRGA+GIV  A +   N   A+KK+  AF        ++ REI+ +  + H N++ ++D
Sbjct: 13   IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAIKD 71

Query: 884  FWLRKDCGIIMYRYMENGSLRDV----------LHSI--TPPPTLEWNVRY---KIALGA 928
                    I+   + E  +  DV          LH I  +     + + +Y   ++  G 
Sbjct: 72   --------IMPPPHRE--AFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG- 120

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTI 988
               L Y+H      ++HRD+KP N+LL++  +  I DFG+A+   +     T   V  T 
Sbjct: 121  ---LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV--TR 172

Query: 989  GYIAPE-----NAFTTAKSKESDVYSYGVVLLELITRK 1021
             Y APE     + +TTA     DV+S G +  EL+ RK
Sbjct: 173  WYRAPELLLNCSEYTTA----IDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 39/294 (13%)

Query: 813  QVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGSLSMKREI 867
            ++++ TE L    V+G GA G VYK    P+        A+K L      + +  +  E 
Sbjct: 2    RILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEA 60

Query: 868  QTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPTLEWNVRYK 923
              +  +    + RL    L     ++  + M  G L D +      I     L W V  +
Sbjct: 61   YVMAGVGSPYVCRLLGICLTSTVQLVT-QLMPYGCLLDYVRENKDRIGSQDLLNWCV--Q 117

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            IA G    ++YL    +  +VHRD+   N+L+ S     I+DFG+A+LLD       +  
Sbjct: 118  IAKG----MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043
                I ++A E+      + +SDV+SYGV + EL+T           R            
Sbjct: 171  GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR------------ 218

Query: 1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                  +I DL    E L        IDV ++ ++C       RP  R++V + 
Sbjct: 219  ------EIPDLLEKGERL-PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 71/290 (24%), Positives = 121/290 (41%), Gaps = 39/290 (13%)

Query: 820  NLNAKHVIGRGAHGIVYKA---SLGPNA---VFAVKKLAFRGHKRGSLSMKREIQTIGKI 873
            N+  K  +G GA G V+ A   +L P     + AVK L             RE + +  +
Sbjct: 6    NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNL 64

Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPT-LEWNVRYK 923
            +H ++V+     +  D  I+++ YM++G L   L +  P          P  L  +    
Sbjct: 65   QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            IA   A  + YL        VHRD+   N L+   +   I DFG+++ +  +        
Sbjct: 125  IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043
             +  I ++ PE+      + ESDV+S GVVL E+ T  K   P Y+             S
Sbjct: 182  TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK--QPWYQ------------LS 227

Query: 1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
            + E I  I    +++       R    +V  + L C +++P  R N++++
Sbjct: 228  NNEVIECITQGRVLQRP-----RTCPKEVYDLMLGCWQREPHMRLNIKEI 272

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 67/211 (31%), Positives = 91/211 (43%), Gaps = 15/211 (7%)

Query: 826  VIGRGAHGIVYKASLGPNAVF-AVK---KLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            VIG+G+ G V  A    +  F AVK   K A    K     M      +  ++H  LV L
Sbjct: 2    VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
               +   D    +  Y+  G L    H        E   R+  A   A AL YLH     
Sbjct: 62   HYSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLH---SL 115

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             I++RD+KPENILLDS+    ++DFG+ K      + TTS +  GT  Y+APE       
Sbjct: 116  NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTS-TFCGTPEYLAPEVLRKQPY 173

Query: 1002 SKESDVYSYGVVLLELITRKKALDPSYKERT 1032
             +  D +  G VL E++     L P Y   T
Sbjct: 174  DRTVDWWCLGAVLYEMLY---GLPPFYSRDT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.3 bits (162), Expect = 2e-11
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 35/217 (16%)

Query: 819  ENLNAKHVIGRGAHGIV----YKASLGPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGKI 873
            E+ +   VIGRGA G V    +K+S     V+A+K L+ F   KR   +   E + I  +
Sbjct: 43   EDFDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDI--M 97

Query: 874  RHRN---LVRLE-DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK----IA 925
             H N   +V+L   F   K   ++M  YM  G L +++ +   P   +W   Y     +A
Sbjct: 98   AHANSEWIVQLHYAFQDDKYLYMVM-EYMPGGDLVNLMSNYDIPE--KWARFYTAEVVLA 154

Query: 926  LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
            L A H++ +         +HRD+KP+N+LLD      ++DFG    +D +       + V
Sbjct: 155  LDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAV 204

Query: 986  GTIGYIAPENAFTTAKS----KESDVYSYGVVLLELI 1018
            GT  YI+PE   +        +E D +S GV L E++
Sbjct: 205  GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 19/201 (9%)

Query: 827  IGRGAHGIVYKASLGP-NAVFAVK--KLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            +G+G +G VYK    P     A+K  +L     K   + M  E+  + K     +V    
Sbjct: 9    LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM--ELDILHKAVSPYIVDFYG 66

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
             +  +    +   YM+ GSL  +         +  +V  +I       L +L  + +  I
Sbjct: 67   AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-------NA 996
            +HRD+KP N+L++   +  + DFG++  L  S A T     +G   Y+APE       N 
Sbjct: 125  IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKSGGPNQ 180

Query: 997  FTTAKSKESDVYSYGVVLLEL 1017
              T  + +SDV+S G+ +LE+
Sbjct: 181  NPTY-TVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 34/216 (15%)

Query: 827  IGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSL-----SMKREIQTIGKIRHRNLVR 880
            +G GA G VYK  L GPN   +   +A +  K  +        ++E + +  ++H N+V 
Sbjct: 13   LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 881  LEDFWLRKDCGIIMYRYMENGSL-------------------RDVLHSITPPPTLEWNVR 921
            L     ++    +++ Y+ +G L                     V  S+     L  ++ 
Sbjct: 73   LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL--HIA 130

Query: 922  YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             +IA G  + L+  H+      VHRD+   N L+   +   ISDFG+++ +  +      
Sbjct: 131  IQIAAGMEY-LSSHHF------VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183

Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLEL 1017
               +  + ++ PE       + ESD++S+GVVL E+
Sbjct: 184  SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 30/220 (13%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
             NL     +GRG  G V+ A        G   +  VK L     +      +RE+    K
Sbjct: 5    SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL-------HSITPPPT---LEWNVRY 922
            + H+N+VRL       +   ++  Y + G L+  L         + PPP     +  +  
Sbjct: 65   LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 923  KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
            +IALG  H L+   +      VHRD+   N L+ S+ E  +S       L K   ++   
Sbjct: 125  QIALGMDH-LSNARF------VHRDLAARNCLVSSQREVKVSLLS----LSKDVYNSEYY 173

Query: 983  SVVGT---IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             +      + ++APE       S +SDV+S+GV++ E+ T
Sbjct: 174  KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.4 bits (162), Expect = 5e-11
 Identities = 34/84 (40%), Positives = 52/84 (61%), Gaps = 2/84 (2%)

Query: 489 NQ-LTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQEL 546
           NQ L G +P + SK   L  +++S N+I G IP S+G+  +L  +D S N F+G +P+ L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 547 GNLVSLVTLNISLNHVEGSLPSQL 570
           G L SL  LN++ N + G +P+ L
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 5e-11
 Identities = 70/247 (28%), Positives = 100/247 (40%), Gaps = 84/247 (34%)

Query: 826  VIGRGAHGIVY----KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            VIGRGA G V+    K +     V+A+K L      R S  +KR      +I H   VR 
Sbjct: 8    VIGRGAFGEVWLVRDKDT---GQVYAMKVL------RKSDMIKRN-----QIAH---VRA 50

Query: 882  E-DFWLRKDCG----------------IIMYRYMENGSLRDVL--HSITPPPTLEWNVRY 922
            E D     D                  ++M  YM  G L ++L    + P    E   R+
Sbjct: 51   ERDILADADSPWIVKLYYSFQDEEHLYLVM-EYMPGGDLMNLLIRKDVFPE---ET-ARF 105

Query: 923  KIA--LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAK-------- 970
             IA  + A  ++  L +      +HRDIKP+NIL+D+  + HI  +DFG+ K        
Sbjct: 106  YIAELVLALDSVHKLGF------IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDR 157

Query: 971  ----LLDKSPASTTSI---------------SVVGTIGYIAPENAFTTAKSKESDVYSYG 1011
                    +     ++               S VGT  YIAPE    T    E D +S G
Sbjct: 158  EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG 217

Query: 1012 VVLLELI 1018
            V+L E++
Sbjct: 218  VILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 5e-11
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 38/215 (17%)

Query: 826  VIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             IG GA+G+V  A+  P  V  A+KK++   H+       REI+ + + +H N++ + D 
Sbjct: 12   YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDI 71

Query: 885  WLR-------KDCGII-------MYRYMENGSLRD--VLHSITPPPTLEWNVRYKIALGA 928
             +R        D  I+       +Y+ ++   L +  + + +           Y+I  G 
Sbjct: 72   -IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-----------YQILRG- 118

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK-SPASTTSISVVGT 987
               L Y+H      ++HRD+KP N+LL++  +  I DFG+A++ D     +      V T
Sbjct: 119  ---LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 988  IGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
              Y APE    +   +K  D++S G +L E+++ +
Sbjct: 173  RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 5e-11
 Identities = 70/215 (32%), Positives = 94/215 (43%), Gaps = 23/215 (10%)

Query: 826  VIGRGAHGIVYKASLGPNAVF-AVKKLAFRGHKRGSLSMKREIQTIGK-------IRHRN 877
            VIG+G+ G V  A       F AVK L     K+  L  K E   + +       ++H  
Sbjct: 2    VIGKGSFGKVLLARHKAEEKFYAVKVL----QKKAILKKKEEKHIMSERNVLLKNVKHPF 57

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            LV L   +   D    +  Y+  G L    H       LE   R+  A   A AL YLH 
Sbjct: 58   LVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARF-YAAEIASALGYLH- 113

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 IV+RD+KPENILLDS+    ++DFG+ K  +     TTS +  GT  Y+APE   
Sbjct: 114  --SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTS-TFCGTPEYLAPEVLH 169

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032
                 +  D +  G VL E++     L P Y   T
Sbjct: 170  KQPYDRTVDWWCLGAVLYEMLY---GLPPFYSRNT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 6e-11
 Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 39/215 (18%)

Query: 826  VIGRGAHGIVYKA---SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRL 881
            VIG G +G VYKA     G     A+K +     +   +  K E   + K   H N+   
Sbjct: 13   VIGEGTYGKVYKARHKKTGQLV--AIKIMDIIEDEEEEI--KEEYNILRKYSNHPNIATF 68

Query: 882  EDFWLRKDCGI-------IMYRYMENGSLRDVLHSITPPPTLEWNVRYK------IALGA 928
               +++K+          +M      GS+ D++         +   R K      I    
Sbjct: 69   YGAFIKKNPPGNDDQLWLVM-ELCGGGSVTDLVKG-----LRKKGKRLKEEWIAYILRET 122

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTI 988
               LAYLH   +  ++HRDIK +NILL    E  + DFG++  LD +       + +GT 
Sbjct: 123  LRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN--TFIGTP 177

Query: 989  GYIAPE------NAFTTAKSKESDVYSYGVVLLEL 1017
             ++APE          +  ++ SDV+S G+  +EL
Sbjct: 178  YWMAPEVIACDEQPDASYDAR-SDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 20/200 (10%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
            +G GA G VYKA      V A  K+     +        EI  +    H N+V+L D + 
Sbjct: 13   LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 887  RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHR 946
             ++   I+  +   G++  V+  +  P T E  +R  +      AL YLH   +  I+HR
Sbjct: 73   YENNLWILIEFCAGGAVDAVMLELERPLT-EPQIRV-VCKQTLEALNYLH---ENKIIHR 127

Query: 947  DIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI----SVVGTIGYIAPENAF-TTAK 1001
            D+K  NIL   + +  ++DFG+      S  +T +I    S +GT  ++APE     T+K
Sbjct: 128  DLKAGNILFTLDGDIKLADFGV------SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181

Query: 1002 SK----ESDVYSYGVVLLEL 1017
             +    ++DV+S G+ L+E+
Sbjct: 182  DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 63.9 bits (156), Expect = 7e-11
 Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 28/212 (13%)

Query: 827  IGRGAHGIVYK---ASLGPNAVF---AVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+     +         A+K +      R  +    E   + +    ++VR
Sbjct: 14   LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIALGAAHA 931
            L          +++   M  G L+  L S  P         PPTL+     ++A   A  
Sbjct: 74   LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ--KFIQMAAEIADG 131

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
            +AYL        VHRD+   N ++  ++   I DFG+ + + ++         +  + ++
Sbjct: 132  MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 992  APEN----AFTTAKSKESDVYSYGVVLLELIT 1019
            APE+     FTT     SDV+S+GVVL E+ T
Sbjct: 189  APESLKDGVFTTK----SDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.7 bits (155), Expect = 7e-11
 Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 31/215 (14%)

Query: 827  IGRGAHGIVYKASL--------GPNAVFAVKKLAFRGHKRGSLSMK-----REIQTIGKI 873
            +G GA G VY+ +         GP  V AVK L     ++G+   +     +E   +   
Sbjct: 3    LGSGAFGEVYEGTATDILGPGSGPIRV-AVKTL-----RKGATDQEKKEFLKEAHLMSNF 56

Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSL----RDVLHSITPPPTLEWNVRYKIALGAA 929
             H N+V+L    L  +   I+   ME G L    RD       PP L       I L  A
Sbjct: 57   NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116

Query: 930  HALAYLHYDCDPPIVHRDIKPENILL-----DSEMEPHISDFGIAKLLDKSPASTTSISV 984
                YL        +HRD+   N L+     D++    I DFG+A+ + KS         
Sbjct: 117  KGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173

Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            +  + ++APE+      + +SDV+S+GV++ E++T
Sbjct: 174  LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.6 bits (157), Expect = 7e-11
 Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 20/201 (9%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-------IRHRN 877
            VIG+G+ G V  A      + +AVK L     K+  L  K +   + +       ++H  
Sbjct: 2    VIGKGSFGKVLLAKRKSDGSFYAVKVL----QKKTILKKKEQNHIMAERNVLLKNLKHPF 57

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            LV L   +   +    +  Y+  G L    H       LE   R+  A   A A+ YLH 
Sbjct: 58   LVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARF-YAAEVASAIGYLH- 113

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I++RD+KPENILLDS+    ++DFG+ K     P  TTS +  GT  Y+APE   
Sbjct: 114  --SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTS-TFCGTPEYLAPEVLR 169

Query: 998  TTAKSKESDVYSYGVVLLELI 1018
                 +  D +  G VL E++
Sbjct: 170  KEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.8 bits (155), Expect = 8e-11
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 33/221 (14%)

Query: 815  IEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGSLSMKREIQT 869
            I     L    ++G G  G V+K    P         A+K +  R  ++    +   +  
Sbjct: 3    ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62

Query: 870  IGKIRHRNLVRLEDFWLRKDCGI-------IMYRYMENGSLRDVLH----SITPPPTLEW 918
            +G + H  +VRL         GI       ++ +    GSL D +     S+ P   L W
Sbjct: 63   MGSLDHAYIVRL--------LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW 114

Query: 919  NVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             V+       A  + YL       +VHR++   NILL S+    I+DFG+A LL      
Sbjct: 115  CVQ------IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165

Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                     I ++A E+      + +SDV+SYGV + E+++
Sbjct: 166  YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.9 bits (155), Expect = 1e-10
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 20/216 (9%)

Query: 813  QVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGSLSMKREI 867
            ++++ TE L    V+G GA G VYK    P         A+K L      + ++    E 
Sbjct: 2    RILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA 60

Query: 868  QTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPTLEWNVRYK 923
              +  + H +LVRL    L     ++  + M +G L D +H    +I     L W V+  
Sbjct: 61   LIMASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ-- 117

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                 A  + YL    +  +VHRD+   N+L+ S     I+DFG+A+LL+       +  
Sbjct: 118  ----IAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG 170

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                I ++A E       + +SDV+SYGV + EL+T
Sbjct: 171  GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 19/200 (9%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            IG+G   +VYKA  L    V A+KK+        +      +EI  + ++ H N+++   
Sbjct: 10   IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 884  FWLRKDCGIIMYRYMENGSL-RDVLH-----SITPPPTLEWNVRYKIALGAAHALAYLHY 937
             ++  +   I+    + G L R + H      + P  T+ W    ++      AL ++H 
Sbjct: 70   SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLC----SALEHMH- 123

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I+HRDIKP N+ + +     + D G+ +    S  +T + S+VGT  Y++PE   
Sbjct: 124  --SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIH 179

Query: 998  TTAKSKESDVYSYGVVLLEL 1017
                + +SD++S G +L E+
Sbjct: 180  ENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 6/91 (6%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL +LH      I++RDIK ENILLDSE    ++DFG++K    +     + S  GTI Y
Sbjct: 117  ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEY 172

Query: 991  IAPE--NAFTTAKSKESDVYSYGVVLLELIT 1019
            +APE     +    K  D +S GV+  EL+T
Sbjct: 173  MAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 36/88 (40%), Positives = 51/88 (57%), Gaps = 8/88 (9%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            A  YLH   D  I++RD+KPEN+LLD++    ++DFG AK   K P  T   ++ GT  Y
Sbjct: 130  AFEYLH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK---KVPDRT--FTLCGTPEY 181

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELI 1018
            +APE   +    K  D ++ GV+L E I
Sbjct: 182  LAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 39/104 (37%), Positives = 52/104 (50%), Gaps = 15/104 (14%)

Query: 923  KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST 979
            K+ +    AL YL   H      ++HRD+KP NILLD+     + DFGI+  L  S A T
Sbjct: 118  KMTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT 172

Query: 980  TSISVVGTIGYIAPEN-AFTTAKSK---ESDVYSYGVVLLELIT 1019
             S    G   Y+APE         K    +DV+S G+ L+EL T
Sbjct: 173  RS---AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.4 bits (154), Expect = 3e-10
 Identities = 73/233 (31%), Positives = 106/233 (45%), Gaps = 10/233 (4%)

Query: 398 KLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLC-FGKQ 456
                +  L  L ++ L  N+    I   L   ++L  LD  NN+ T +IPP +      
Sbjct: 84  DGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSN 141

Query: 457 LRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISG 516
           L+ L++  N+    +PS L + P L  + L  N L+      S    L++LD+S N IS 
Sbjct: 142 LKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS- 199

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
            +P  I     L  +D S+N     +   L NL +L  L +S N +E  LP  +    NL
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNL 257

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQL 629
           E  D+S N +  S  SSL S  +L  L LS N  +      I+ L  LLEL L
Sbjct: 258 ETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLS-NALPLIALLLLLLELLL 307

Length = 394

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 35/89 (39%), Positives = 53/89 (59%), Gaps = 10/89 (11%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIG 989
            AL YLH      IV+RD+KPENILLD E    ++DFG AK L D+      + ++ GT  
Sbjct: 113  ALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------TWTLCGTPE 163

Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            Y+APE   +   +K  D ++ G+++ E++
Sbjct: 164  YLAPEVIQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 55/260 (21%), Positives = 100/260 (38%), Gaps = 30/260 (11%)

Query: 846  FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
             AVK L             +E++ + ++   N+ RL           ++  YMENG L  
Sbjct: 49   VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 906  VLH-SITPPPTLEWNVRY-----------KIALGAAHALAYLHYDCDPPIVHRDIKPENI 953
             L   +     L  N +            +IA G  + L  L++      VHRD+   N 
Sbjct: 109  FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY-LESLNF------VHRDLATRNC 161

Query: 954  LLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
            L+       I+DFG+++ L  S            I ++A E+      + +SDV+++GV 
Sbjct: 162  LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221

Query: 1014 LLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVL 1073
            L E++T  +     Y+  TD     + V  +              ++ +    +   D+ 
Sbjct: 222  LWEILTLCRE--QPYEHLTD-----QQVIENAGHFFRDDG----RQIYLPRPPNCPKDIY 270

Query: 1074 LVALRCTEKKPSNRPNMRDV 1093
             + L C  +   +RP  R++
Sbjct: 271  ELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 64/239 (26%), Positives = 112/239 (46%), Gaps = 21/239 (8%)

Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
            AT  LN +  +G G++  VYK     N  + A+K ++ +  +    +  RE   +  ++H
Sbjct: 4    ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE-WNVRYKIALGAAHALAY 934
             N+V L D    K+    ++ YM     +   + I  P  L  +NVR          LAY
Sbjct: 63   ANIVLLHDIIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRL-FMFQLLRGLAY 118

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            +H      I+HRD+KP+N+L+    E  ++DFG+A+   KS  S T  S V T+ Y  P+
Sbjct: 119  IHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPD 173

Query: 995  NAF-TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS----DTEEI 1048
                 T  S   D++  G + +E++  +    P++   +D+   +  +W+     TE+ 
Sbjct: 174  VLLGATDYSSALDIWGAGCIFIEMLQGQ----PAFPGVSDVFEQLEKIWTVLGVPTEDT 228

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 4e-10
 Identities = 29/88 (32%), Positives = 49/88 (55%)

Query: 313 LSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT 372
           +  L L    L G IP ++ K ++L  ++L  N + G IP  LG +++L+ L+L  N   
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 373 GEFPVSIWRIASLEYLLVYNNNLLGKLP 400
           G  P S+ ++ SL  L +  N+L G++P
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 4e-10
 Identities = 30/82 (36%), Positives = 49/82 (59%)

Query: 174 LNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPE 233
           L+N  L G IP ++  L+ ++++ L  N + G IP S+G+   L+ L L+ N   G +PE
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 234 SLSNLENLVYLDVGDNNLEGRI 255
           SL  L +L  L++  N+L GR+
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRV 506

Length = 623

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 9/194 (4%)

Query: 826  VIGRGAHGIVYKASLG-PNAVFAVKKLA-FRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            V+G GA+G+V K        + A+KK      ++    +  RE++ +  ++  N+V L++
Sbjct: 8    VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
             + R+    +++ Y+E   L   L    P       VR  I       +  +H+     I
Sbjct: 68   AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDI 121

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            VHRDIKPEN+L+       + DFG A+ L +   +  +   V T  Y +PE        K
Sbjct: 122  VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT-EYVATRWYRSPELLLGAPYGK 180

Query: 1004 ESDVYSYGVVLLEL 1017
              D++S G +L EL
Sbjct: 181  AVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.0 bits (156), Expect = 4e-10
 Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 22/111 (19%)

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAK--------LLDKSPASTTSIS--------VVG 986
            ++HRD+KP+NILL    E  I D+G A         LLD                  +VG
Sbjct: 134  VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193

Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT------RKKALDPSYKER 1031
            T  Y+APE       S+ +D+Y+ GV+L +++T      RKK    SY++ 
Sbjct: 194  TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDV 244

Length = 932

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 26/205 (12%)

Query: 827  IGRGAHGIV-YKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLE 882
            +G G  G+V Y    G   V A+K +     K GS+S      E + + K+ H  LV+L 
Sbjct: 12   LGTGQFGVVKYGKWRGQYDV-AIKMI-----KEGSMSEDEFIEEAKVMMKLSHEKLVQLY 65

Query: 883  DFWLRKDCGIIMYRYMENGSL----RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
                ++    I+  YM NG L    R+      P   LE      +       +AYL   
Sbjct: 66   GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE------MCKDVCEGMAYLE-- 117

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAF 997
                 +HRD+   N L+D +    +SDFG+++ +LD     T+S+     + +  PE   
Sbjct: 118  -SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLL 174

Query: 998  TTAKSKESDVYSYGVVLLELITRKK 1022
             +  S +SDV+++GV++ E+ +  K
Sbjct: 175  YSKFSSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 5e-10
 Identities = 31/85 (36%), Positives = 49/85 (57%), Gaps = 1/85 (1%)

Query: 345 NQ-LEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM 403
           NQ L G IP+++ +L +LQ + L  N + G  P S+  I SLE L +  N+  G +P  +
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 404 TELKQLKNISLYNNQFSGVIPQSLG 428
            +L  L+ ++L  N  SG +P +LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 62.4 bits (151), Expect = 5e-10
 Identities = 68/250 (27%), Positives = 108/250 (43%), Gaps = 70/250 (28%)

Query: 819  ENLNAKHVIGRGAHG---IVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
            E+  +  VIGRGA G   +V K   G   V+A+K L      R +  +++E   +G IR 
Sbjct: 1    EDFESLKVIGRGAFGEVRLVQKKDTG--HVYAMKIL------RKADMLEKE--QVGHIRA 50

Query: 876  RN--LVRLEDFWLRK---------DCGIIMYRYMENGSLRDVL---HSITPPPTLEWNVR 921
                LV  +  W+ K         +  +IM  ++  G +  +L    ++T   T  +   
Sbjct: 51   ERDILVEADSLWVVKMFYSFQDKLNLYLIM-EFLPGGDMMTLLMKKDTLTEEETQFYIAE 109

Query: 922  YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS------ 975
              +A+ + H L +         +HRDIKP+N+LLDS+    +SDFG+   L K+      
Sbjct: 110  TVLAIDSIHQLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160

Query: 976  -------PASTT--------------------SISVVGTIGYIAPENAFTTAKSKESDVY 1008
                   P+  T                    + S VGT  YIAPE    T  +K  D +
Sbjct: 161  RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220

Query: 1009 SYGVVLLELI 1018
            S GV++ E++
Sbjct: 221  SLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 18/205 (8%)

Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVR 880
            VIG+G  G VY  +L    G     AVK L  R      +    +E   +    H N++ 
Sbjct: 2    VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 881  LEDFWLRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
            L    L  +   +++  YM++G LR+ + S T  PT++  + +   L  A  + YL    
Sbjct: 61   LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF--GLQVAKGMEYL---A 115

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDK---SPASTTSISVVGTIGYIAPEN 995
                VHRD+   N +LD      ++DFG+A+ + DK   S  + T   +   + ++A E+
Sbjct: 116  SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMALES 173

Query: 996  AFTTAKSKESDVYSYGVVLLELITR 1020
              T   + +SDV+S+GV+L EL+TR
Sbjct: 174  LQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 62.5 bits (152), Expect = 7e-10
 Identities = 31/76 (40%), Positives = 46/76 (60%)

Query: 540 GLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKS 599
           G +P ++  L  L ++N+S N + G++P  L    +LEV D+S+N  NGSIP SL    S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 600 LSILKLSENHFTGGIP 615
           L IL L+ N  +G +P
Sbjct: 492 LRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 7e-10
 Identities = 47/163 (28%), Positives = 69/163 (42%), Gaps = 13/163 (7%)

Query: 865  REIQTIGKIRHRNLVRLEDFWLRKD--CGII-MYRYMENGSLRDVLHSITPPPTLEWNVR 921
            REI  +  I HR ++ L   +  K   C ++  Y+        D+   +     L     
Sbjct: 135  REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-------DLFTYVDRSGPLPLEQA 187

Query: 922  YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
              I      ALAYLH      I+HRD+K ENI LD      + DFG A  LD  P +   
Sbjct: 188  ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244

Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKAL 1024
                GT+   +PE         ++D++S G+VL E+  +   L
Sbjct: 245  YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 23/205 (11%)

Query: 826  VIGRGAHG----IVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            V+G G+ G    + +  S   +  +A+K++            ++E   + K++H N+V  
Sbjct: 7    VVGEGSFGRALLVQHVNS---DQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63

Query: 882  EDFWLRKDCGIIMYRYMENGSL----RDVLHSITPPPT-LEWNVRYKIALGAAHALAYLH 936
            ++ +       I+  Y + G L    +     + P  T L+W V  ++ LG  H    +H
Sbjct: 64   KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV--QMCLGVQH----IH 117

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
               +  ++HRDIK +NI L    +  + DFG A+LL  SP +  + + VGT  Y+ PE  
Sbjct: 118  ---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-TSPGA-YACTYVGTPYYVPPEIW 172

Query: 997  FTTAKSKESDVYSYGVVLLELITRK 1021
                 + +SD++S G +L EL T K
Sbjct: 173  ENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 66/273 (24%), Positives = 113/273 (41%), Gaps = 27/273 (9%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            ++G+G  G V+K +L      AVK       +   +    E + + +  H N+V+L    
Sbjct: 2    LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY-DCDPPIV 944
             ++    I+   +  G     L         +  V++  AL AA  +AYL   +C    +
Sbjct: 62   TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESKNC----I 115

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+   N L+       ISDFG+++  D    S++ +  +  I + APE       S E
Sbjct: 116  HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSE 174

Query: 1005 SDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSS 1064
            SDV+SYG++L E  +      P    +              E++     +S  ++     
Sbjct: 175  SDVWSYGILLWETFSLGVCPYPGMTNQ-----------QAREQVEKGYRMSCPQKC---- 219

Query: 1065 IRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                  DV  V  RC + KP NRP   ++ ++L
Sbjct: 220  ----PDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 14/197 (7%)

Query: 827  IGRGAHGIVYK--ASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            +G G +  V+K  + L  N V A+K++     +    +  RE+  +  ++H N+V L D 
Sbjct: 13   LGEGTYATVFKGRSKLTENLV-ALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
               + C  +++ Y+++  L+  L +     ++  NV+          L+Y H      I+
Sbjct: 72   IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMH-NVKI-FMFQLLRGLSYCHKR---KIL 125

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKS-PASTTSISVVGTIGYIAPENAF-TTAKS 1002
            HRD+KP+N+L++ + E  ++DFG+A+   KS P  T S  VV T+ Y  P+    +T  S
Sbjct: 126  HRDLKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVV-TLWYRPPDVLLGSTEYS 182

Query: 1003 KESDVYSYGVVLLELIT 1019
               D++  G +L E+ T
Sbjct: 183  TPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 9e-10
 Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 29/195 (14%)

Query: 842  PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG 901
            P  V AVK L     K       +EI+ + ++++ N++RL    +  D   ++  YMENG
Sbjct: 44   PVLV-AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENG 102

Query: 902  SLRDVL----------HSITPPPTLEWNVRY---KIALGAAHALAYLHYDCDPPIVHRDI 948
             L   L          H+   P     N+ Y   +IA G  + LA L++      VHRD+
Sbjct: 103  DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKY-LASLNF------VHRDL 155

Query: 949  KPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN----AFTTAKSKE 1004
               N L+ +     I+DFG+++ L            V  I ++A E+     FTTA    
Sbjct: 156  ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA---- 211

Query: 1005 SDVYSYGVVLLELIT 1019
            SDV+++GV L E+ T
Sbjct: 212  SDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 61.5 bits (149), Expect = 1e-09
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 8/224 (3%)

Query: 483 RVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLM 542
             +   +     LP      +   L       S     ++ N + L S+D + N+     
Sbjct: 50  LALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSN- 108

Query: 543 PQELGNLVSLVTLNISLNHVEGSLPSQLSK-CKNLEVFDVSFNLLNGSIPSSLRSWKSLS 601
             EL  L +L +L++  N++   +P  +     NL+  D+S N +  S+PS LR+  +L 
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLK 166

Query: 602 ILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTG 661
            L LS N  +  +P  +S L  L  L L GN++  ++PP I  L  L   L+LS N +  
Sbjct: 167 NLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE-LDLSNNSII- 222

Query: 662 RIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNL 705
            + S L  L  L  L++S+N L      + N+ +L  +++S N 
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ 266

Length = 394

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 54.6 bits (132), Expect = 1e-09
 Identities = 20/42 (47%), Positives = 23/42 (54%)

Query: 26 LNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECD 67
          LN D  ALL+     N  P   +SSWN S S PC W G+ CD
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 10/192 (5%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+G+ G VYK        V A+K +     +     +++EI  + +     + R    +
Sbjct: 12   IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L+     I+  Y+  GS  D+L     P  LE      I       L YLH +     +H
Sbjct: 72   LKGTKLWIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSERK---IH 124

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK  N+LL  + +  ++DFG+A  L  +     +   VGT  ++APE    +A   ++
Sbjct: 125  RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQSAYDFKA 182

Query: 1006 DVYSYGVVLLEL 1017
            D++S G+  +EL
Sbjct: 183  DIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.9 bits (148), Expect = 1e-09
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 32/211 (15%)

Query: 827  IGRGAHGIVYKASLGPNAV-FAVKKL--AFRGHKRGSLSMKR---EIQTIGKIRHRNLVR 880
            IG GA G+V+  +   +    A+KK+   F+      +S KR   E++ +   +H N++ 
Sbjct: 8    IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNL----VSCKRVFRELKMLCFFKHDNVLS 63

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSI--TPPPTLEWNVR---YKIALGAAHALAYL 935
              D             Y+    ++  LH I  +P P    +V+   Y+I  G    L YL
Sbjct: 64   ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKYL 119

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE- 994
            H      I+HRDIKP N+L++S     I DFG+A++ +   +   +  VV T  Y APE 
Sbjct: 120  H---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEI 175

Query: 995  ----NAFTTAKSKESDVYSYGVVLLELITRK 1021
                  +T+A     D++S G +  EL+ R+
Sbjct: 176  LMGSRHYTSA----VDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.4 bits (149), Expect = 2e-09
 Identities = 33/82 (40%), Positives = 45/82 (54%), Gaps = 5/82 (6%)

Query: 278 GISPNLGNCSSLTHL---DIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKC 334
           G  PN  + S L HL   ++ G+ + G+IP S G +  L  LDLS N  +G IP  LG+ 
Sbjct: 432 GFIPN--DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 335 KYLTVLHLYANQLEGEIPDELG 356
             L +L+L  N L G +P  LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.8 bits (147), Expect = 2e-09
 Identities = 81/286 (28%), Positives = 127/286 (44%), Gaps = 35/286 (12%)

Query: 431 SSLMQLDFINNSFTGEI-PPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
            ++ +L    +S T  + P +L     L +L+             L +   L  + L  N
Sbjct: 45  VAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLPLPSLDLNLN 103

Query: 490 QLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNS-INLTSIDFSSNKFSGLMPQELGN 548
           +L   + E  +   L+ LD+  NNI+  IP  IG    NL  +D S NK   L P  L N
Sbjct: 104 RLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESL-PSPLRN 161

Query: 549 LVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSEN 608
           L +L  L++S N +   LP  LS   NL   D+S N ++                     
Sbjct: 162 LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-------------------- 200

Query: 609 HFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLE 668
                +P  I  L  L EL L  N +  E+  S+  L++LS  L LS N L   +P  + 
Sbjct: 201 -----LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSG-LELSNNKLE-DLPESIG 252

Query: 669 KLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETL 714
            LS LE LD+S+N ++ ++S L ++ +L E+++S N  +  +P   
Sbjct: 253 NLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPLIA 297

Length = 394

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 44/220 (20%)

Query: 826  VIGRGAHGIVY----KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +I  GA+G VY    K +      FA+KK+      + +L ++ +IQ +     R+++  
Sbjct: 8    LISNGAYGAVYLVRHKETR---QRFAMKKI-----NKQNLILRNQIQQV--FVERDILTF 57

Query: 882  ED----------FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHA 931
             +          F  ++   ++M  Y+E G    +L +I   P      R   A     A
Sbjct: 58   AENPFVVSMFCSFETKRHLCMVM-EYVEGGDCATLLKNIGALPVDM--ARMYFA-ETVLA 113

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL-------------LDKSPAS 978
            L YLH   +  IVHRD+KP+N+L+ S     ++DFG++K+             ++K    
Sbjct: 114  LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
                 V GT  YIAPE        K  D ++ G++L E +
Sbjct: 171  FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 44/281 (15%)

Query: 826  VIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            V+G GA G VYK    P         A+K+L      + +  +  E   +  + + ++ R
Sbjct: 14   VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPTLEWNVRYKIALGAAHALAYLH 936
            L    L     +I  + M  G L D +     +I     L W V  +IA G       ++
Sbjct: 74   LLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKG-------MN 123

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
            Y  +  +VHRD+   N+L+ +     I+DFG+AKLL        +      I ++A E+ 
Sbjct: 124  YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 997  FTTAKSKESDVYSYGVVLLELIT-RKKALD--PSYKERTDIVGWVRSVWSDTEEINDIVD 1053
                 + +SDV+SYGV + EL+T   K  D  P+                   EI+ I++
Sbjct: 184  LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------------SEISSILE 225

Query: 1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
                E +    I    IDV ++ ++C      +RP  R+++
Sbjct: 226  KG--ERLPQPPI--CTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 820  NLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHR 876
            N   +  IGRG    VY+A+ L      A+KK+        +      +EI  + ++ H 
Sbjct: 3    NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVL------HSITPPPTLEWNVRYKIALGAAH 930
            N+++  D ++  +   I+    + G L  ++        + P  T+ W  +Y + L    
Sbjct: 63   NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W--KYFVQL--CS 117

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            A+ ++H      ++HRDIKP N+ + +     + D G+ +    S  +T + S+VGT  Y
Sbjct: 118  AVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 172

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLEL 1017
            ++PE       + +SD++S G +L E+
Sbjct: 173  MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 50/303 (16%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIG 871
            + L     +G GA G V KA           + V AVK L     ++    +  E++ + 
Sbjct: 12   DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTV-AVKMLKDDATEKDLSDLVSEMEMMK 70

Query: 872  KI-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE-----WNVRYKIA 925
             I +H+N++ L     ++    ++  Y  +G+LRD L +  PP               + 
Sbjct: 71   MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 926  LGAAHALAY-----LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK---LLDKSPA 977
                 + AY     + +      +HRD+   N+L+  +    I+DFG+A+    +D    
Sbjct: 131  QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 978  STTSISVVG--TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV 1035
            +T      G   + ++APE  F    + +SDV+S+GV+L E+ T   +  P         
Sbjct: 191  TTN-----GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------ 239

Query: 1036 GWVRSVWSDTEEINDIV-DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
                      EE+  ++ +   ME+    +      ++  +   C  + PS RP  + +V
Sbjct: 240  ---------VEELFKLLKEGYRMEKPQNCT-----QELYHLMRDCWHEVPSQRPTFKQLV 285

Query: 1095 RQL 1097
              L
Sbjct: 286  EDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 32/83 (38%), Positives = 48/83 (57%)

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRDIK  NILL S     + DFG +K+   + +     +  GT  Y+APE       S
Sbjct: 164  MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 1003 KESDVYSYGVVLLELITRKKALD 1025
            K++D++S GV+L EL+T K+  D
Sbjct: 224  KKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 76/300 (25%), Positives = 118/300 (39%), Gaps = 50/300 (16%)

Query: 821  LNAKHVIGRGAHGIVYKASLGPN-----AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
            L    V+G G  G V      P       + AVK L     ++ +   K+EI  +  + H
Sbjct: 6    LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 876  RNLVRLEDFWLRKDC---------GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIAL 926
             N+V+       K C          +IM  Y+  GSLRD L    P   L        A 
Sbjct: 66   ENIVKY------KGCCSEQGGKGLQLIM-EYVPLGSLRDYL----PKHKLNLAQLLLFAQ 114

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV- 985
                 +AYLH       +HRD+   N+LLD++    I DFG+AK +   P       V  
Sbjct: 115  QICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVRE 168

Query: 986  ---GTIGYIAP----ENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWV 1038
                 + + A     EN F+ A    SDV+S+GV L EL+T     D           + 
Sbjct: 169  DGDSPVFWYAVECLKENKFSYA----SDVWSFGVTLYELLTH---CDSKQSPPKK---FE 218

Query: 1039 RSVWSDTEEINDIVDLSLMEE-MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              +     ++  +  + L+E  M +   ++   +V ++   C E +   RP  R ++  L
Sbjct: 219  EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 62/271 (22%), Positives = 98/271 (36%), Gaps = 51/271 (18%)

Query: 817  ATENLNAKHVIGRGAHGIVYKASL-------GPNAVFAVKKLAFRGHKRGSLSMKREIQT 869
              +++     +G GA G VY+              V AVK L     ++       E   
Sbjct: 4    PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQV-AVKTLPESCSEQDESDFLMEALI 62

Query: 870  IGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIA 925
            + K  H+N+VRL      +    I+   M  G L+  L    P    P +L        A
Sbjct: 63   MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122

Query: 926  LGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPAST 979
               A    YL   H+      +HRDI   N LL  +       I+DFG+A+ + ++    
Sbjct: 123  RDVAKGCKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176

Query: 980  TSISVVGTIGYIAPE----NAFTTAKSKESDVYSYGVVL-------------------LE 1016
                 +  I ++ PE      FT+    ++DV+S+GV+L                   +E
Sbjct: 177  KGGRAMLPIKWMPPEAFLDGIFTS----KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME 232

Query: 1017 LITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
             +T    LDP       +   +   W  T E
Sbjct: 233  FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPE 263

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 2e-09
 Identities = 39/131 (29%), Positives = 56/131 (42%), Gaps = 45/131 (34%)

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS-------- 975
            +A+ + H L Y         +HRDIKP+N+LLD++    +SDFG+   L KS        
Sbjct: 112  LAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162

Query: 976  ------------PASTTS----------------ISVVGTIGYIAPENAFTTAKSKESDV 1007
                         +   S                 S VGT  YIAPE    T  +KE D 
Sbjct: 163  LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222

Query: 1008 YSYGVVLLELI 1018
            +S GV++ E++
Sbjct: 223  WSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 63/276 (22%), Positives = 110/276 (39%), Gaps = 37/276 (13%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLED 883
            +G G  G+V+          A+K +       G++S +    E + + K+ H  LV+L  
Sbjct: 12   LGSGQFGVVHLGKWRAQIKVAIKAI-----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
               ++    I+  +MENG L + L        L  ++   +       + YL  +     
Sbjct: 67   VCTQQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERN---SF 121

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +HRD+   N L+ S     +SDFG+ + +LD    S++       + +  PE    +  S
Sbjct: 122  IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVFNFSKYS 179

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD-LSLMEEML 1061
             +SDV+S+GV++ E+ T  K                    S+ E +  I     L    L
Sbjct: 180  SKSDVWSFGVLMWEVFTEGKMPFEKK--------------SNYEVVEMISRGFRLYRPKL 225

Query: 1062 VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             S        V  V   C  +KP  RP   +++R +
Sbjct: 226  ASMT------VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 57/255 (22%), Positives = 113/255 (44%), Gaps = 30/255 (11%)

Query: 820  NLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHR 876
            N   +  IGRG    VY+A+ L      A+KK+        +      +EI  + ++ H 
Sbjct: 3    NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP-----PPTLEWNVRYKIALGAAHA 931
            N+++    ++  +   I+    + G L  ++          P    W  +Y + L    A
Sbjct: 63   NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQL--CSA 118

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
            L ++H      ++HRDIKP N+ + +     + D G+ +    S  +T + S+VGT  Y+
Sbjct: 119  LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYM 173

Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW--------S 1043
            +PE       + +SD++S G +L E+   +    P Y ++ ++    + +         S
Sbjct: 174  SPERIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCDYPPLPS 230

Query: 1044 D--TEEINDIVDLSL 1056
            D  +EE+  +V++ +
Sbjct: 231  DHYSEELRQLVNMCI 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 58.9 bits (142), Expect = 5e-09
 Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 19/212 (8%)

Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G G  G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 26   LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP-------PTL--EWNVRYKIALGA 928
            ++ L     +     ++  Y   G+LR+ L +  PP       PT   E  + +K  +  
Sbjct: 86   IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 929  AHALAY-LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
            A+ +A  + Y      +HRD+   N+L+  +    I+DFG+A+ +        + +    
Sbjct: 146  AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205

Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 206  VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.1 bits (141), Expect = 5e-09
 Identities = 59/220 (26%), Positives = 88/220 (40%), Gaps = 33/220 (15%)

Query: 827  IGRGAHGIV----YKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            +G G  G V    Y    G     AVK L       G     RE   + ++ H  +VRL 
Sbjct: 3    LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 883  DFWLRKDCGIIMYRYM-ENGSLRDVL--HSITPPPTL-EWNVRYKIALGAAHALAYL--- 935
               + K   +++   +   G L   L      P   L E    +++A+G    +AYL   
Sbjct: 62   -IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMG----MAYLESK 114

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG---TIGYIA 992
            H+      VHRD+   N+LL +  +  ISDFG+++ L     S    +       + + A
Sbjct: 115  HF------VHRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYA 166

Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032
            PE       S +SDV+SYGV L E  +        Y E  
Sbjct: 167  PECINYGKFSSKSDVWSYGVTLWEAFSYG---AKPYGEMK 203

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.6 bits (142), Expect = 6e-09
 Identities = 57/241 (23%), Positives = 94/241 (39%), Gaps = 55/241 (22%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-------------REIQTIGK 872
            +G G +G V KA       + A+KK+            +             RE++ + +
Sbjct: 17   LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH-- 930
            I+H N++ L D ++  D   ++   M    L+ V+               KI L  +   
Sbjct: 77   IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-------------KIRLTESQVK 122

Query: 931  --------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-----------L 971
                     L  LH       +HRD+ P NI ++S+    I+DFG+A+            
Sbjct: 123  CILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 972  LDKSPASTTSI-SVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRKKALDPSYK 1029
             D++      + S V T+ Y APE      K   + D++S G +  EL+T  K L P   
Sbjct: 180  KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPLFPGEN 238

Query: 1030 E 1030
            E
Sbjct: 239  E 239

Length = 335

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.5 bits (141), Expect = 6e-09
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 827  IGRGAHGIVYKASLGP---NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            +GRG +G VYKA       +  +A+K++   G    S+S  REI  + +++H N++ L+ 
Sbjct: 9    VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQK 65

Query: 884  FWL-RKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVR-YKIALGAAHALAY-----L 935
             +L   D  + +++ Y E+    D+ H I      + N +  ++  G   +L Y     +
Sbjct: 66   VFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSIS-VVGTIGY 990
            HY     ++HRD+KP NIL+  E        I+D G A+L +        +  VV T  Y
Sbjct: 122  HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 991  IAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
             APE        +K  D+++ G +  EL+T +
Sbjct: 182  RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 26/204 (12%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREI---QTIGKI-----RHR 876
            V+G+G+ G V  A L G + ++AVK L     K+  +    ++    T  ++     +H 
Sbjct: 2    VLGKGSFGKVLLAELKGTDELYAVKVL-----KKDVILQDDDVECTMTEKRVLALAGKHP 56

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
             L +L   +  KD    +  Y+  G   D++  I      +       A      L +LH
Sbjct: 57   FLTQLHSCFQTKDRLFFVMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK--LLDKSPASTTSISVVGTIGYIAPE 994
               +  I++RD+K +N+LLDSE    I+DFG+ K  +L      TTS +  GT  YIAPE
Sbjct: 114  ---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---GGVTTS-TFCGTPDYIAPE 166

Query: 995  NAFTTAKSKESDVYSYGVVLLELI 1018
                       D ++ GV+L E++
Sbjct: 167  ILSYQPYGPAVDWWALGVLLYEML 190

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.8 bits (144), Expect = 7e-09
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 30/203 (14%)

Query: 846  FAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG--IIMYRYMENGS 902
            F  K +++RG K R    +  E+  + +++H+N+VR  D +L K      I+  + + G 
Sbjct: 41   FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGD 100

Query: 903  L-RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP----IVHRDIKPENILLDS 957
            L R++         +E +    I     HALAY H   D P    ++HRD+KP+NI L +
Sbjct: 101  LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160

Query: 958  EME-----------------PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
             +                    I DFG++K +      + + S VGT  Y +PE      
Sbjct: 161  GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHET 217

Query: 1001 KS--KESDVYSYGVVLLELITRK 1021
            KS   +SD+++ G ++ EL + K
Sbjct: 218  KSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.1 bits (140), Expect = 8e-09
 Identities = 54/200 (27%), Positives = 98/200 (49%), Gaps = 20/200 (10%)

Query: 827  IGRGAHGIVYK--ASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            +G G +  VYK  + L  N V A+K++     +    +  RE+  +  ++H N+V L D 
Sbjct: 14   LGEGTYATVYKGRSKLTDNLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLHYDCDP 941
               +    +++ Y++   L+  L        +  NV+   +++  G    L Y H     
Sbjct: 73   IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH-NVKLFLFQLLRG----LNYCHRR--- 123

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS-PASTTSISVVGTIGYIAPENAF-TT 999
             ++HRD+KP+N+L++   E  ++DFG+A+   KS P  T S  VV T+ Y  P+    +T
Sbjct: 124  KVLHRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVV-TLWYRPPDILLGST 180

Query: 1000 AKSKESDVYSYGVVLLELIT 1019
              S + D++  G +  E+ T
Sbjct: 181  DYSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.5 bits (142), Expect = 8e-09
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 46/216 (21%)

Query: 827  IGRGAHGIVYKASL-GPNAVFAVKKLA--FRG--HKRGSLSMKREIQTIGKIRHRNLV-- 879
            +G GA+G V  A         A+KKL+  F+   H + +    RE++ +  + H N++  
Sbjct: 23   VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY---RELRLLKHMDHENVIGL 79

Query: 880  --------RLEDFWLRKDCGIIMYRYMENGSLRDV-LHSITPPPTL-EWNVR---YKIAL 926
                     LEDF   +D    +Y       L    L++I     L + +++   Y+I  
Sbjct: 80   LDVFTPASSLEDF---QD----VYLVTH---LMGADLNNIVKCQKLSDDHIQFLVYQILR 129

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
            G    L Y+H      I+HRD+KP NI ++ + E  I DFG+A+  D     T     V 
Sbjct: 130  G----LKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTG---YVA 177

Query: 987  TIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            T  Y APE        ++  D++S G ++ EL+T K
Sbjct: 178  TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (140), Expect = 8e-09
 Identities = 38/103 (36%), Positives = 54/103 (52%), Gaps = 8/103 (7%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL  LH      +++RD+KPENILLD +    + DFG+ KL  K    T +    GT  Y
Sbjct: 105  ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEY 159

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033
            +APE       +K  D ++ GV+L E++T    L P Y E  +
Sbjct: 160  LAPELLLGHGYTKAVDWWTLGVLLYEMLT---GLPPFYDENVN 199

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 8e-09
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
            L YLH      I+HRD+K ENI ++   +  I D G A+    +PA    + + GT+   
Sbjct: 170  LRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETN 223

Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKAL 1024
            APE       + ++D++S G+VL E++     +
Sbjct: 224  APEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256

Length = 357

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.5 bits (141), Expect = 9e-09
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 31/215 (14%)

Query: 819  ENLNAKHVIGRGAHGIV----YKASLGPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGKI 873
            E+ +   VIGRGA G V    +K+S     V+A+K L+ F   KR   +   E + I   
Sbjct: 43   EDYDVVKVIGRGAFGEVQLVRHKSS---QKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 874  RHRNLV--RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK----IALG 927
             +   V      F   K   ++M  YM  G L +++ +   P   +W   Y     +AL 
Sbjct: 100  ANSPWVVQLFCAFQDDKYLYMVM-EYMPGGDLVNLMSNYDVPE--KWAKFYTAEVVLALD 156

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
            A H++          ++HRD+KP+N+LLD      ++DFG    +D++       + VGT
Sbjct: 157  AIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVRCDTAVGT 206

Query: 988  IGYIAPENAFTTAKS----KESDVYSYGVVLLELI 1018
              YI+PE   +        +E D +S GV L E++
Sbjct: 207  PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.8 bits (139), Expect = 9e-09
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 10/192 (5%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+G+ G V+K        V A+K +     +     +++EI  + +     + +    +
Sbjct: 12   IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L+     I+  Y+  GS  D+L    P P  E  +   I       L YLH +     +H
Sbjct: 72   LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIA-TILREILKGLDYLHSE---KKIH 124

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK  N+LL    E  ++DFG+A  L  +     +   VGT  ++APE    +A   ++
Sbjct: 125  RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQSAYDSKA 182

Query: 1006 DVYSYGVVLLEL 1017
            D++S G+  +EL
Sbjct: 183  DIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.1 bits (140), Expect = 9e-09
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 8/106 (7%)

Query: 916  LEWNVRYKIALG---AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
            L  N R+   +G   AA  +    Y     IV+RD+KPEN+LLD +    ++DFG AK++
Sbjct: 122  LRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181

Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            D     T + ++ GT  YIAPE        K +D ++ G+ + E++
Sbjct: 182  D-----TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.3 bits (141), Expect = 9e-09
 Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 29/212 (13%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            VIG+G++G+V  A         A+KK+   F  H   +  + REI+ +  +RH ++V ++
Sbjct: 7    VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIK 65

Query: 883  DFWLR------KDCGIIMYRYMENGSLRDVLHS---ITPPPTLEWNVRYKIAL-GAAHAL 932
               L       KD   +++  ME+  L  V+ +   +TP         ++  L     AL
Sbjct: 66   HIMLPPSRREFKDI-YVVFELMES-DLHQVIKANDDLTPE-------HHQFFLYQLLRAL 116

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL-LDKSPASTTSISVVGTIGYI 991
             Y+H      + HRD+KP+NIL +++ +  I DFG+A++  + +P +      V T  Y 
Sbjct: 117  KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173

Query: 992  APE--NAFTTAKSKESDVYSYGVVLLELITRK 1021
            APE   +F +  +   D++S G +  E++T K
Sbjct: 174  APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 1e-08
 Identities = 33/110 (30%), Positives = 58/110 (52%), Gaps = 3/110 (2%)

Query: 488 QNQLTGALPEFSKNP---VLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQ 544
           Q+  +GA  +F        +  L +    + G IP+ I    +L SI+ S N   G +P 
Sbjct: 401 QHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPP 460

Query: 545 ELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSL 594
            LG++ SL  L++S N   GS+P  L +  +L + +++ N L+G +P++L
Sbjct: 461 SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.6 bits (141), Expect = 1e-08
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 25/178 (14%)

Query: 854  RGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM---------YRYMENGSL- 903
            +   R ++ ++ EI  +G++ H N++++E+  LR +    M         Y +M + +  
Sbjct: 201  KAGSRAAIQLENEILALGRLNHENILKIEEI-LRSEANTYMITQKYDFDLYSFMYDEAFD 259

Query: 904  -RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH 962
             +D        P L    R  I      A+ Y+H   D  ++HRDIK ENI L+ + +  
Sbjct: 260  WKD-------RPLL-KQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIV 307

Query: 963  ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR 1020
            + DFG A   +K          VGT+   +PE        + +D++S G++LL++++ 
Sbjct: 308  LGDFGTAMPFEK-EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 31/271 (11%)

Query: 847  AVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            AVK L      +    +  E++ +  I +H+N++ L     +     ++  Y   G+LR+
Sbjct: 48   AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE 107

Query: 906  VLHSITPP---------PTLEWNVRYKIALGAAHALAY-LHYDCDPPIVHRDIKPENILL 955
             L +  PP            E  + +K  +  A+ +A  + Y      +HRD+   N+L+
Sbjct: 108  YLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167

Query: 956  DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLL 1015
              +    I+DFG+A+ +        + +    + ++APE  F    + +SDV+S+GV+L 
Sbjct: 168  TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227

Query: 1016 ELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLV 1075
            E+ T   +  P                   EE+  +    L E   +    +   ++ ++
Sbjct: 228  EIFTLGGSPYPGIP---------------VEELFKL----LKEGHRMDKPANCTHELYMI 268

Query: 1076 ALRCTEKKPSNRPNMRDVVRQLVDASVPMTS 1106
               C    PS RP  + +V  L D  + +TS
Sbjct: 269  MRECWHAVPSQRPTFKQLVEDL-DRVLTVTS 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 50/192 (26%), Positives = 89/192 (46%), Gaps = 10/192 (5%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+G+ G V+K        V A+K +     +     +++EI  + +     + +    +
Sbjct: 12   IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH 945
            L+     I+  Y+  GS  D+L +    P  E    ++IA      L  L Y      +H
Sbjct: 72   LKGTKLWIIMEYLGGGSALDLLRA---GPFDE----FQIATMLKEILKGLDYLHSEKKIH 124

Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK  N+LL  + +  ++DFG+A  L  +     +   VGT  ++APE    +A   ++
Sbjct: 125  RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIQQSAYDSKA 182

Query: 1006 DVYSYGVVLLEL 1017
            D++S G+  +EL
Sbjct: 183  DIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 58/255 (22%), Positives = 108/255 (42%), Gaps = 19/255 (7%)

Query: 847  AVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-DCGI-IMYRYMENGSLR 904
            AVK L           +K+EI+ +  + H N+V+ +         GI ++  ++ +GSL+
Sbjct: 37   AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 96

Query: 905  DVLHSITPPPTLEWNVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEP 961
            + L        L+  ++Y + +     + YL    Y      VHRD+   N+L++SE + 
Sbjct: 97   EYLPRNKNKINLKQQLKYAVQI--CKGMDYLGSRQY------VHRDLAARNVLVESEHQV 148

Query: 962  HISDFGIAKLL-DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR 1020
             I DFG+ K +       T    +   + + APE    +     SDV+S+GV L EL+T 
Sbjct: 149  KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTY 208

Query: 1021 KKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCT 1080
              +          ++G      + T  +       L E   +    +   +V  +  +C 
Sbjct: 209  CDSESSPMTLFLKMIGPTHGQMTVTRLVR-----VLEEGKRLPRPPNCPEEVYQLMRKCW 263

Query: 1081 EKKPSNRPNMRDVVR 1095
            E +PS R   ++++ 
Sbjct: 264  EFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.8 bits (140), Expect = 1e-08
 Identities = 61/206 (29%), Positives = 94/206 (45%), Gaps = 29/206 (14%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGS----------LSMKREIQTIGKIR 874
            V+GRG  G V  A       ++A+K L     K+G           +  KR  +T    R
Sbjct: 6    VLGRGHFGKVLLAEYKKTGELYAIKAL-----KKGDIIARDEVESLMCEKRIFETANSER 60

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK--IALGAAHAL 932
            H  LV L   +  +D    +  Y   G L  ++H  T   +    V Y   + LG    L
Sbjct: 61   HPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLG----L 114

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
             YLH   +  IV+RD+K +N+LLD+E    I+DFG+ K         TS +  GT  ++A
Sbjct: 115  QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTS-TFCGTPEFLA 169

Query: 993  PENAFTTAKSKESDVYSYGVVLLELI 1018
            PE    T+ ++  D +  GV++ E++
Sbjct: 170  PEVLTETSYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 62/248 (25%), Positives = 106/248 (42%), Gaps = 66/248 (26%)

Query: 819  ENLNAKHVIGRGAHG---IVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
            ++  +  VIGRGA G   +V K   G   ++A+K L     ++  +  K ++  I +   
Sbjct: 1    DDFESLKVIGRGAFGEVRLVQKKDTG--HIYAMKIL-----RKADMLEKEQVAHI-RAER 52

Query: 876  RNLVRLEDFWL---------RKDCGIIMYRYMENGSLRDVL---HSITPPPTLEWNVRYK 923
              LV  +  W+         +++  +IM  ++  G +  +L    +++   T  +     
Sbjct: 53   DILVEADGAWVVKMFYSFQDKRNLYLIM-EFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS-------- 975
            +A+ A H L +         +HRDIKP+N+LLD++    +SDFG+   L K+        
Sbjct: 112  LAIDAIHQLGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162

Query: 976  ----PASTTSI---------------------SVVGTIGYIAPENAFTTAKSKESDVYSY 1010
                P S  S                      S VGT  YIAPE    T  +K  D +S 
Sbjct: 163  LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222

Query: 1011 GVVLLELI 1018
            GV++ E++
Sbjct: 223  GVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 27/208 (12%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLED 883
            ++G G +G VYK   +    + A+K +   G +   +  K+EI  + K   HRN+     
Sbjct: 13   LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI--KQEINMLKKYSHHRNIATYYG 70

Query: 884  FWLRK------DCGIIMYRYMENGSLRDVLHSITPPPTL--EWNVRYKIALGAAHALAYL 935
             +++K      D   ++  +   GS+ D++ + T   TL  EW + Y I       L++L
Sbjct: 71   AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEW-IAY-ICREILRGLSHL 127

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP-- 993
            H      ++HRDIK +N+LL    E  + DFG++  LD++     +   +GT  ++AP  
Sbjct: 128  H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEV 182

Query: 994  ----ENAFTTAKSKESDVYSYGVVLLEL 1017
                EN   T   K SD++S G+  +E+
Sbjct: 183  IACDENPDATYDFK-SDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.5 bits (139), Expect = 2e-08
 Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 14/104 (13%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL +LH      I++RD+KPENILLD++    ++DFG+ K  +     T + +  GTI Y
Sbjct: 112  ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEY 166

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT---------RKKALD 1025
            +APE    +   K  D +S G ++ +++T         RKK +D
Sbjct: 167  MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 27/208 (12%)

Query: 827  IGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKR-----GSLSMKREIQTIGKIRHRNLVR 880
            +G+G  G V    +     ++A KKL  +  K+     G++  KR    + K+  R +V 
Sbjct: 1    LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR---ILAKVHSRFIVS 57

Query: 881  LE-DFWLRKDCGIIMYRYMENGSLRDVLHSITP--PPTLEWNVRY---KIALGAAHALAY 934
            L   F  + D  ++M   M  G LR  ++++    P   E    +   +I  G  H    
Sbjct: 58   LAYAFQTKTDLCLVM-TIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEH---- 112

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGYIAP 993
            LH      I++RD+KPEN+LLD++    ISD G+A +L D     + +    GT G++AP
Sbjct: 113  LHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---QSKTKGYAGTPGFMAP 166

Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRK 1021
            E           D ++ GV L E+I  +
Sbjct: 167  ELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.1 bits (140), Expect = 2e-08
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 14/214 (6%)

Query: 824  KHVIGRGAHGIVYKASLGPN-AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
              ++GR      + A+ G +     V K      +R +   + E+  +    H  +V+  
Sbjct: 72   TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHF 131

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPP--PTLEWNVR---YKIALGAAHALAYLHY 937
            D +   D  +++  Y   G L   +        P  E+ V    Y+I L    AL  +H 
Sbjct: 132  DDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL----ALDEVHS 187

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 ++HRD+K  NI L       + DFG +K    S +   + S  GT  Y+APE   
Sbjct: 188  RK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALD-PSYKE 1030
                SK++D++S GV+L EL+T  +    PS +E
Sbjct: 245  RKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278

Length = 478

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTI 988
            A AL YLH      IV+RD+KPENILLDS+    ++DFG+ K  +    S T+ +  GT 
Sbjct: 106  ASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTP 160

Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
             Y+APE           D +  G VL E++
Sbjct: 161  EYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 39/91 (42%), Positives = 52/91 (57%), Gaps = 7/91 (7%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIG 989
            AL +LH      IV+RDIK ENILLDSE    ++DFG++K  L +    T   S  GTI 
Sbjct: 117  ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT--YSFCGTIE 171

Query: 990  YIAPENAFT-TAKSKESDVYSYGVVLLELIT 1019
            Y+APE         K  D +S G+++ EL+T
Sbjct: 172  YMAPEIIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 64/299 (21%), Positives = 125/299 (41%), Gaps = 41/299 (13%)

Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 4    AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L+  + 
Sbjct: 64   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI- 122

Query: 922  YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             ++A   A  +AYL+ +     VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 123  -QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041
               +  + +++PE+      +  SDV+S+GVVL E+ T     +  Y+  +         
Sbjct: 179  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---EQPYQGMS--------- 226

Query: 1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALR-CTEKKPSNRPNMRDVVRQLVD 1099
                   N+ V   +ME  L+    D   D+L   +R C +  P  RP+  +++  + +
Sbjct: 227  -------NEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 29/214 (13%)

Query: 819  ENLNAKHVIGRGAHGIV----YKASLGPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGKI 873
            E+     VIGRGA G V    +K++     V+A+K L+ F   KR   +   E + I   
Sbjct: 43   EDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 874  RHRNLVRLEDFWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVRYK----IALGA 928
             +   V    +  + D  + M   YM  G L +++ +   P   +W   Y     +AL A
Sbjct: 100  ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWARFYTAEVVLALDA 157

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTI 988
             H++ +         +HRD+KP+N+LLD      ++DFG    ++K        + VGT 
Sbjct: 158  IHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTP 207

Query: 989  GYIAPENAFTTAKS----KESDVYSYGVVLLELI 1018
             YI+PE   +        +E D +S GV L E++
Sbjct: 208  DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G +G V+KA +   + + A+K++       G  S   REI  + +++H+N+VRL D 
Sbjct: 8    IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
                    +++ Y +   L+    S      ++  +           LA+ H      ++
Sbjct: 68   LHSDKKLTLVFEYCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCH---SHNVL 121

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAKSK 1003
            HRD+KP+N+L++   E  ++DFG+A+     P    S  VV T+ Y  P+  F     S 
Sbjct: 122  HRDLKPQNLLINKNGELKLADFGLARAFG-IPVRCYSAEVV-TLWYRPPDVLFGAKLYST 179

Query: 1004 ESDVYSYGVVLLELITRKKALDPSY 1028
              D++S G +  EL    + L P  
Sbjct: 180  SIDMWSAGCIFAELANAGRPLFPGN 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 2e-08
 Identities = 40/104 (38%), Positives = 57/104 (54%), Gaps = 11/104 (10%)

Query: 931  ALAYLH-YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG 989
            AL +LH YD    IV+RD+KPENILLD+     + DFG++K  + +   TT+ +  GT  
Sbjct: 108  ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTN-TFCGTTE 161

Query: 990  YIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERT 1032
            Y+APE        +K  D +S GV++ E+        P Y E T
Sbjct: 162  YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC---GWSPFYAEDT 202

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 13/210 (6%)

Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G G++  VYK     N  + A+K +  +  +    +  RE   +  ++H N+V L D  
Sbjct: 13   LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIAL-GAAHALAYLHYDCDPPIV 944
              K+   +++ Y+      D+   +   P        K+ L      L+Y+H      I+
Sbjct: 73   HTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYIL 125

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAKSK 1003
            HRD+KP+N+L+    E  ++DFG+A+   KS  S T  + V T+ Y  P+    +T  S 
Sbjct: 126  HRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTD 1033
              D++  G + +E+I    A  P  K+  D
Sbjct: 184  CLDMWGVGCIFVEMIQGVAAF-PGMKDIQD 212

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 31/206 (15%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDF 884
            IG G    V KA S      +A+K +         ++  REIQ + ++  H N++RL + 
Sbjct: 7    IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 885  WLRKDCG----------IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
               +  G          + +Y  ++            P   ++  + Y++      +L +
Sbjct: 67   LFDRKTGRLALVFELMDMNLYELIKG------RKRPLPEKRVKSYM-YQLL----KSLDH 115

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            +H +    I HRDIKPENIL+  +    ++DFG  + +   P  T  IS   T  Y APE
Sbjct: 116  MHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS---TRWYRAPE 168

Query: 995  NAFTTAK-SKESDVYSYGVVLLELIT 1019
               T      + D+++ G V  E+++
Sbjct: 169  CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 66/277 (23%), Positives = 110/277 (39%), Gaps = 54/277 (19%)

Query: 847  AVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDV 906
            AVK L    +K       +EI+ + +++  N++RL    +  D   ++  YMENG L   
Sbjct: 50   AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109

Query: 907  LHSITPP--------PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE 958
            L    P          T+ ++    +A   A  + YL        VHRD+   N L+   
Sbjct: 110  LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKN 166

Query: 959  MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN----AFTTAKSKESDVYSYGVVL 1014
                I+DFG+++ L            V  I +++ E+     FTTA    SDV+++GV L
Sbjct: 167  YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA----SDVWAFGVTL 222

Query: 1015 LELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLL 1074
             E++T  K  +  Y + +D       V  +T E                  RDQ   V L
Sbjct: 223  WEILTLCK--EQPYSQLSD-----EQVIENTGEF----------------FRDQGRQVYL 259

Query: 1075 ------------VALRCTEKKPSNRPNMRDVVRQLVD 1099
                        + L C  +    RP+ +++   L++
Sbjct: 260  PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 3e-08
 Identities = 51/197 (25%), Positives = 97/197 (49%), Gaps = 18/197 (9%)

Query: 827  IGRGAHGIVYK--ASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            +G G +  V+K  + L  N V A+K++     +    +  RE+  +  ++H N+V L D 
Sbjct: 14   LGEGTYATVFKGRSKLTENLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLHYDCDP 941
                    +++ Y++   L+  +       ++  NV+   Y+I  G    LAY H     
Sbjct: 73   VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH-NVKIFLYQILRG----LAYCHRR--- 123

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             ++HRD+KP+N+L++   E  ++DFG+A+     P  T S  VV T+ Y  P+    +++
Sbjct: 124  KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181

Query: 1002 -SKESDVYSYGVVLLEL 1017
             S + D++  G +  E+
Sbjct: 182  YSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 38/219 (17%)

Query: 827  IGRGAHGIVYKASLGP---NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            +GRG +G VYKA          +A+K++   G    S+S  REI  + +++H N++ L+ 
Sbjct: 9    VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQK 65

Query: 884  FWL-RKDCGI-IMYRYMENGSLRDVLHSIT----------P---PPTLEWNVRYKIALGA 928
             +L   D  + +++ Y E+    D+ H I           P   P ++  ++ Y+I  G 
Sbjct: 66   VFLSHSDRKVWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG- 120

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSIS- 983
               + YLH +    ++HRD+KP NIL+  E        I+D G A+L +        +  
Sbjct: 121  ---IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 984  VVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            VV T  Y APE        +K  D+++ G +  EL+T +
Sbjct: 175  VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 9/103 (8%)

Query: 923  KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
            +IA+G    L +LH      I++RD+K +N++LD+E    I+DFG+ K  +      T+ 
Sbjct: 109  EIAIG----LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTR 159

Query: 983  SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            +  GT  YIAPE        K  D +++GV+L E++  +   D
Sbjct: 160  TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 56.6 bits (136), Expect = 3e-08
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 38/209 (18%)

Query: 827  IGRGAHGIVYKA---SLGPNAVFAVKKLA--FRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            IG GA GIV  A    LG N   AVKKL+  F+       +  RE+  +  + H+N++ L
Sbjct: 29   IGSGAQGIVCAAFDTVLGINV--AVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85

Query: 882  ----------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHA 931
                      E+F   +D  ++M   + + +L  V+H       + + + Y++  G  H 
Sbjct: 86   LNVFTPQKSLEEF---QDVYLVME--LMDANLCQVIHMELDHERMSY-LLYQMLCGIKH- 138

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV--VGTIG 989
               LH      I+HRD+KP NI++ S+    I DFG+A+      A T  +    V T  
Sbjct: 139  ---LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TACTNFMMTPYVVTRY 187

Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            Y APE        +  D++S G ++ EL+
Sbjct: 188  YRAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 21/218 (9%)

Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRGH---KRGSLSMKR 865
            K V E  E   +   +G GA+G V  A         A+KKL+  F+     KR      R
Sbjct: 8    KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY----R 63

Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR-YMENGSLRDVLHSITPPPTLEWNVRYKI 924
            E+  +  ++H N++ L D +     G      Y+    ++  L  I   P  E  V+Y +
Sbjct: 64   ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123

Query: 925  ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
                   L Y+H      I+HRD+KP N+ ++ + E  I DFG+A+  D   A  T   V
Sbjct: 124  -YQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVV 176

Query: 985  VGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
              T  Y APE        ++  D++S G ++ E++T K
Sbjct: 177  --TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 57/194 (29%), Positives = 87/194 (44%), Gaps = 12/194 (6%)

Query: 827  IGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMK--REIQTIGKIRHRNLVRLED 883
            IGRG  G V+   L   N   AVK  + R      L  K  +E + + +  H N+VRL  
Sbjct: 3    IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
               +K    I+   ++ G     L   T  P L+     ++   AA  + YL        
Sbjct: 61   VCTQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKL-LDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +HRD+   N L+  +    ISDFG+++   D   AST  +  +  + + APE       S
Sbjct: 116  IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-PVKWTAPEALNYGRYS 174

Query: 1003 KESDVYSYGVVLLE 1016
             ESDV+S+G++L E
Sbjct: 175  SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.8 bits (134), Expect = 4e-08
 Identities = 35/91 (38%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL +LH      I++RDIK ENILLDS     ++DFG++K          + S  GTI Y
Sbjct: 117  ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEY 172

Query: 991  IAPE--NAFTTAKSKESDVYSYGVVLLELIT 1019
            +AP+          K  D +S GV++ EL+T
Sbjct: 173  MAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 56.7 bits (137), Expect = 5e-08
 Identities = 31/82 (37%), Positives = 42/82 (51%), Gaps = 1/82 (1%)

Query: 586 LNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGAL 645
           L G IP+ +   + L  + LS N   G IP  +  +  L  L L  N   G IP S+G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 646 QDLSYALNLSKNGLTGRIPSDL 667
             L   LNL+ N L+GR+P+ L
Sbjct: 490 TSLR-ILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 5e-08
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 25/177 (14%)

Query: 849  KKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH 908
            K L F+ ++   +  +R+I T  K     LV+L   +   +   +   Y+  G  R +L+
Sbjct: 36   KSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN 93

Query: 909  SITPPPTL-EWNVRYKI-----ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH 962
            ++     L E + R+ +     A+ A H L Y         +HRD+KPEN L+D+     
Sbjct: 94   NLG---VLSEDHARFYMAEMFEAVDALHELGY---------IHRDLKPENFLIDASGHIK 141

Query: 963  ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            ++DFG++K        T + SVVG+  Y+APE           D +S G +L E + 
Sbjct: 142  LTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 33/238 (13%)

Query: 794  RSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLA 852
            RS  D+++ A   P+ + + V           V+G G +G VYK   +    + A+K + 
Sbjct: 1    RSLDDIDLSALRDPAGIFELV----------EVVGNGTYGQVYKGRHVKTGQLAAIKVMD 50

Query: 853  FRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK------DCGIIMYRYMENGSLRD 905
                +   +  K EI  + K   HRN+      +++K      D   ++  +   GS+ D
Sbjct: 51   VTEDEEEEI--KLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD 108

Query: 906  VLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISD 965
            ++ + T    L+ +    I       LA+LH      ++HRDIK +N+LL    E  + D
Sbjct: 109  LVKN-TKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVD 164

Query: 966  FGIAKLLDKSPASTTSISVVGTIGYIAP------ENAFTTAKSKESDVYSYGVVLLEL 1017
            FG++  LD++     +   +GT  ++AP      EN   T   + SD++S G+  +E+
Sbjct: 165  FGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 42/185 (22%), Positives = 88/185 (47%), Gaps = 13/185 (7%)

Query: 847  AVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            AVK L     ++    +  E++ +  I +H+N++ L     +     ++  Y   G+LR+
Sbjct: 51   AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110

Query: 906  VLHSITPPPTLEWN----------VRYKIALGAAHALAY-LHYDCDPPIVHRDIKPENIL 954
             L +   PP +E++          + +K  +   + +A  + Y      +HRD+   N+L
Sbjct: 111  YLRA-RRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169

Query: 955  LDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
            +       I+DFG+A+ ++       + +    + ++APE  F    + +SDV+S+GV++
Sbjct: 170  VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229

Query: 1015 LELIT 1019
             E+ T
Sbjct: 230  WEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.6 bits (134), Expect = 7e-08
 Identities = 26/76 (34%), Positives = 42/76 (55%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ + K P           + ++APE+ F    + 
Sbjct: 195  IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+S+GV+L E+ +
Sbjct: 255  QSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 45/240 (18%)

Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH-------SITPPPTLEW 918
            E Q + K+ H  +V+    +L +D   I+  Y E   L   L        +++     EW
Sbjct: 52   EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 919  NVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             +  ++ LG       +HY     I+HRD+K +NI L + +   I DFG+++LL  S   
Sbjct: 112  FI--QLLLG-------VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL 161

Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWV 1038
             T+ +  GT  Y++PE         +SD++S G +L E+     A +        +V  +
Sbjct: 162  ATTFT--GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--NFLSVV--L 215

Query: 1039 RSVWSDTEEINDIVDLSL---MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
            R V   T  + +     L   M+ ML                    K PS RP+  +++R
Sbjct: 216  RIVEGPTPSLPETYSRQLNSIMQSML-------------------NKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.5 bits (131), Expect = 7e-08
 Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 17/190 (8%)

Query: 842  PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG 901
            P A+  ++       +RG L+   E  T+G+  H N+VRLE    R +  +I+  YM NG
Sbjct: 35   PVAIHTLRAGCSDKQRRGFLA---EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNG 91

Query: 902  SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP 961
            +L   L        L       +  G A  + YL    +   VH+ +    +L++S++  
Sbjct: 92   ALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVC 146

Query: 962  HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
             IS F   +  DKS A  T++S    + + APE       S  SDV+S+G+V+ E++   
Sbjct: 147  KISGFRRLQ-EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM--- 202

Query: 1022 KALDPSYKER 1031
                 SY ER
Sbjct: 203  -----SYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 8e-08
 Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 45/229 (19%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKL-AFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            VIGRGA G V    +     V+A+K L  +   KR   +  RE + +       LV  + 
Sbjct: 8    VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV-------LVNGDR 60

Query: 884  FWLR------KDCGIIMYRYMENGSLRDVLHSITP-----PPTLEWNVRYKIA--LGAAH 930
             W+       +D    +Y  M+     D+L  ++      P  +    R+ +A  + A  
Sbjct: 61   RWITNLHYAFQD-ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFYLAEMVLAID 116

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTI 988
            ++  L Y      VHRDIKP+N+LLD     HI  +DFG    L       ++++ VGT 
Sbjct: 117  SVHQLGY------VHRDIKPDNVLLD--KNGHIRLADFGSCLRLLADGTVQSNVA-VGTP 167

Query: 989  GYIAPE--NAFTTAKSK---ESDVYSYGVVLLELITRKKALDPSYKERT 1032
             YI+PE   A    K +   E D +S GV + E++  +    P Y E  
Sbjct: 168  DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET---PFYAESL 213

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.2 bits (133), Expect = 8e-08
 Identities = 33/88 (37%), Positives = 49/88 (55%), Gaps = 5/88 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH  CD  +V+RD+K EN++LD +    I+DFG+ K    S  +T   +  GT  Y
Sbjct: 107  ALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMK-TFCGTPEY 161

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELI 1018
            +APE        +  D +  GVV+ E++
Sbjct: 162  LAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 54.7 bits (131), Expect = 9e-08
 Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 20/200 (10%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
            +G GA G VYKA        A  K+     +        EI+ +    H  +V+L   + 
Sbjct: 20   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 887  RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHR 946
                  IM  +   G++  ++  +    T E  ++  I      AL YLH      I+HR
Sbjct: 80   WDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQV-ICRQMLEALQYLH---SMKIIHR 134

Query: 947  DIKPENILLDSEMEPHISDFGIA----KLLDKSPASTTSISVVGTIGYIAPENAFT---- 998
            D+K  N+LL  + +  ++DFG++    K L +        S +GT  ++APE        
Sbjct: 135  DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD------SFIGTPYWMAPEVVMCETMK 188

Query: 999  -TAKSKESDVYSYGVVLLEL 1017
             T    ++D++S G+ L+E+
Sbjct: 189  DTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.0 bits (132), Expect = 9e-08
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 12/96 (12%)

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
            A H++  LHY      VHRDIKP+N+LLD      ++DFG    +++     +S++ VGT
Sbjct: 114  AIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA-VGT 166

Query: 988  IGYIAPE--NAFTTAKSK---ESDVYSYGVVLLELI 1018
              YI+PE   A      K   E D +S GV + E++
Sbjct: 167  PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.1 bits (132), Expect = 9e-08
 Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 44/223 (19%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKL-AFRGHKRGSLSMKREIQTIGKIRHR 876
            E+     VIGRGA G V    L   + VFA+K L  +   KR   +  RE + +      
Sbjct: 1    EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV------ 54

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK------------- 923
             LV  ++ W+      + Y + +  +L  V+        L    +++             
Sbjct: 55   -LVNGDNQWITT----LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA 109

Query: 924  ---IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
               IA+ + H L Y         VHRDIKP+NIL+D      ++DFG    L +     +
Sbjct: 110  EMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160

Query: 981  SISVVGTIGYIAPE--NAFTTAKSK---ESDVYSYGVVLLELI 1018
            S++ VGT  YI+PE   A    K K   E D +S GV + E++
Sbjct: 161  SVA-VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.0 bits (132), Expect = 1e-07
 Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 9/103 (8%)

Query: 923  KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
            +I++G    L +LH      I++RD+K +N++LDSE    I+DFG+ K  +      T+ 
Sbjct: 109  EISVG----LFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTR 159

Query: 983  SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            +  GT  YIAPE        K  D ++YGV+L E++  +   D
Sbjct: 160  TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 54.8 bits (132), Expect = 1e-07
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 51/225 (22%)

Query: 827  IGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRL 881
            +G G++G+V+ A  S     V AVKK+     +    S+K   REI+ I ++ H N+V++
Sbjct: 13   LGCGSNGLVFSAVDSDCDKRV-AVKKIVLTDPQ----SVKHALREIKIIRRLDHDNIVKV 67

Query: 882  EDFW------LRKDCGI--------IMYRYMENGSLRDVLHSITPPPTLEWNVR---YKI 924
             +        L +D G         I+  YME   L +VL      P  E + R   Y++
Sbjct: 68   YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ---GPLSEEHARLFMYQL 123

Query: 925  ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDK--SPASTTS 981
              G    L Y+H      ++HRD+KP N+ +++E +   I DFG+A+++D   S     S
Sbjct: 124  LRG----LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 982  ISVVGTIGYIAPE-----NAFTTAKSKESDVYSYGVVLLELITRK 1021
              +V T  Y +P      N +T A     D+++ G +  E++T K
Sbjct: 177  EGLV-TKWYRSPRLLLSPNNYTKA----IDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 39/123 (31%), Positives = 54/123 (43%), Gaps = 13/123 (10%)

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IV+RD+KPEN+LLD +    +SD G+A  L       T     GT GY+APE       S
Sbjct: 116  IVYRDMKPENVLLDDQGNCRLSDLGLAVEL---KDGKTITQRAGTNGYMAPEILKEEPYS 172

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD---------TEEINDIVD 1053
               D ++ G  + E++  +      +KE+       R    D         TEE  DI  
Sbjct: 173  YPVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR 231

Query: 1054 LSL 1056
            L L
Sbjct: 232  LFL 234

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 71/299 (23%), Positives = 116/299 (38%), Gaps = 66/299 (22%)

Query: 827  IGRGAHGIVYKASLGP------------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            +GRG    +Y   L                +  + K+    H+  SL+       + ++ 
Sbjct: 3    LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            H+++V L    +R    I++  ++E G L   +H  +   T  W  ++K+A   A AL+Y
Sbjct: 63   HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 935  LHYDCDPPIVHRDIKPENILL-----DSEMEPHI--SDFGIAKLLDKSPASTTS-ISVVG 986
            L    D  +VH ++  +NILL     D E  P I  SD GI       P +  S    V 
Sbjct: 121  LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI-------PITVLSRQECVE 170

Query: 987  TIGYIAPENAFTTAK-SKESDVYSYGVVLLELI------TRKKALDPSYKERTDIVGWVR 1039
             I +IAPE    +   S  +D +S+G  L E+        + K L  + KER    G   
Sbjct: 171  RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--AEKERF-YEGQCM 227

Query: 1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098
             V    +E+ D++                          C    P+ RP  R ++R + 
Sbjct: 228  LVTPSCKELADLMT------------------------HCMNYDPNQRPFFRAIMRDIN 262

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 28/205 (13%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQ-TIGKIR-------HR 876
            ++G+G+ G V+ A L G N  FA+K L     K+  + M  +++ T+ + R       H 
Sbjct: 2    MLGKGSFGKVFLAELKGTNQFFAIKAL-----KKDVVLMDDDVECTMVEKRVLSLAWEHP 56

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLR---DVLHSITPPPTLEWNVRYKIALGAAHALA 933
             L  L   +  K+    +  Y+  G L       H    P    +    +I  G    L 
Sbjct: 57   FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAA--EIICG----LQ 110

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            +LH      IV+RD+K +NILLD++    I+DFG+ K      A T +    GT  YIAP
Sbjct: 111  FLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF--CGTPDYIAP 165

Query: 994  ENAFTTAKSKESDVYSYGVVLLELI 1018
            E       +   D +S+GV+L E++
Sbjct: 166  EILLGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 45/224 (20%)

Query: 825  HVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRG--H-KRGSLSMKREIQTIGKIRHR 876
              IG GA GIV   Y    G N   A+KKL+  F+   H KR      RE+  +  + H+
Sbjct: 22   KPIGSGAQGIVCAAYDTVTGQNV--AIKKLSRPFQNVTHAKRAY----RELVLMKLVNHK 75

Query: 877  NLVRL----------EDFWLRKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKI 924
            N++ L          E+F   +D    +Y  ME  + +L  V+        + + + Y++
Sbjct: 76   NIIGLLNVFTPQKSLEEF---QD----VYLVMELMDANLCQVIQMDLDHERMSYLL-YQM 127

Query: 925  ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
              G  H    LH      I+HRD+KP NI++ S+    I DFG+A+    +  S      
Sbjct: 128  LCGIKH----LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPY 177

Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSY 1028
            V T  Y APE        +  D++S G ++ E+I R   L P  
Sbjct: 178  VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-RGTVLFPGT 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 54.3 bits (130), Expect = 2e-07
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 28/223 (12%)

Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 15   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 68

Query: 869  TIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
             +  + H+N++ L + +     L +   + +   + + +L  V+        + + + Y+
Sbjct: 69   LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQ 127

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +  G  H    LH      I+HRD+KP NI++ S+    I DFG+A+    S   T    
Sbjct: 128  MLCGIKH----LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---P 177

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
             V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 178  YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 53/187 (28%), Positives = 81/187 (43%), Gaps = 25/187 (13%)

Query: 858  RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE 917
            R SL+       + ++ H++LV+L    +R D  I++  Y++ G L   LH      +L 
Sbjct: 43   RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLH 101

Query: 918  WNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL-----DSEMEPHI--SDFGIAK 970
            W  +  +A   A AL YL    D  +VH ++  +NIL+     +    P I  SD GI  
Sbjct: 102  W--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156

Query: 971  LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES--DVYSYGVVLLELITRKK----AL 1024
                    +    V   I +IAPE       S     D +S+G  LLE+ +  +     L
Sbjct: 157  -----TVLSREERVE-RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210

Query: 1025 DPSYKER 1031
              S KER
Sbjct: 211  SSSEKER 217

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 49/220 (22%), Positives = 100/220 (45%), Gaps = 19/220 (8%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTI 870
            + L     +G G  G V +A + G +          AVK L      +    +  E++ +
Sbjct: 12   DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71

Query: 871  GKI-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP-PTLEWNV-------- 920
              I +H+N++ L     ++    ++  Y   G+LR+ L +  PP P   +++        
Sbjct: 72   KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 921  RYKIALGAAHALAY-LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST 979
             +K  +  A+ +A  + Y      +HRD+   N+L+  +    I+DFG+A+ +       
Sbjct: 132  SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191

Query: 980  TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + +    + ++APE  F    + +SDV+S+G+++ E+ T
Sbjct: 192  KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 36/101 (35%), Positives = 48/101 (47%), Gaps = 16/101 (15%)

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +A+ + H + Y         VHRDIKPEN+L+D      ++DFG A  L  +     S  
Sbjct: 113  LAIHSVHQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKL 162

Query: 984  VVGTIGYIAPENAFTTAKSK------ESDVYSYGVVLLELI 1018
             VGT  YIAPE   T           E D +S GV+  E+I
Sbjct: 163  PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 13/98 (13%)

Query: 923  KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK--LLDKSPASTT 980
            +IA+G    L +LH      I++RD+K +N++LDSE    I+DFG+ K  + D      T
Sbjct: 109  EIAIG----LFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD----GVT 157

Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            + +  GT  YIAPE        K  D +++GV+L E++
Sbjct: 158  TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.5 bits (128), Expect = 3e-07
 Identities = 27/76 (35%), Positives = 43/76 (56%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ + K P      S    + ++APE+ F    + 
Sbjct: 196  IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+S+GV+L E+ +
Sbjct: 256  QSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 60/238 (25%), Positives = 103/238 (43%), Gaps = 27/238 (11%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRN-LVRLED 883
            IG G +G VYKA       + A+KK      + G      REI  +  +     +VRL D
Sbjct: 9    IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 884  FW-----LRKDCGIIMYRYMENG------SLRDVLHSITPPPTLEWNVRYKIALGAAHAL 932
                     K    +++ Y+++       S         P  T++ +  Y++  G AH  
Sbjct: 69   VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK-SFMYQLLKGVAHCH 127

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYI 991
             +        ++HRD+KP+N+L+D +     I+D G+ +       S T   V  T+ Y 
Sbjct: 128  KH-------GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR 178

Query: 992  APENAF-TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
            APE    +T  S   D++S G +  E+  RK+ L P   E   ++   + + + TE++
Sbjct: 179  APEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGTPTEQV 235

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 45/288 (15%)

Query: 827  IGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G  A G +YK  L         + A+K L    + +     ++E   + ++ H N+V L
Sbjct: 13   LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVL-----HSI---------TPPPTLEWNVRYKIALG 927
                 ++    +++ Y+  G L + L     HS          T   +L+      IA+ 
Sbjct: 73   LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 928  AAHALAYL--HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
             A  + YL  H+      VH+D+   NIL+  ++   ISD G+++ +  +         +
Sbjct: 133  IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045
              I ++ PE       S +SD++S+GVVL E+ +    L P Y       G+        
Sbjct: 188  LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF--GLQPYY-------GF------SN 232

Query: 1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
            +E+ ++V     +  L+    D    +  +   C ++ PS RP  +D+
Sbjct: 233  QEVIEMV----RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 31/78 (39%), Positives = 43/78 (55%), Gaps = 7/78 (8%)

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGYIAPEN-AFTTA 1000
            +V+RD+KP NILLD      ISD G+A     K P ++     VGT GY+APE      A
Sbjct: 118  VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172

Query: 1001 KSKESDVYSYGVVLLELI 1018
                +D +S G +L +L+
Sbjct: 173  YDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 4e-07
 Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
              +G G++  VYK  S     + A+K++     +    +  RE   +  ++H N+V L D
Sbjct: 11   DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL--EWNVR---YKIALGAAHALAYLHYD 938
                K    +++ Y++     D+   +          NVR   +++  G    LAY H  
Sbjct: 71   IIHTKKTLTLVFEYLD----TDLKQYMDDCGGGLSMHNVRLFLFQLLRG----LAYCH-- 120

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS-PASTTSISVVGTIGYIAPENAF 997
                ++HRD+KP+N+L+    E  ++DFG+A+   KS P+ T S  VV T+ Y  P+   
Sbjct: 121  -QRRVLHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVV-TLWYRPPDVLL 176

Query: 998  -TTAKSKESDVYSYGVVLLELIT 1019
             +T  S   D++  G +  E+ T
Sbjct: 177  GSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.0 bits (127), Expect = 5e-07
 Identities = 54/165 (32%), Positives = 85/165 (51%), Gaps = 7/165 (4%)

Query: 72  NVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGF 131
           N+   +LS   +   L   + +L  L+ +DLS N+ S ++P  L N S L  LDLS N  
Sbjct: 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198

Query: 132 TGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLK 191
           + D+P   E L  L+ L+L  N +  E+   L  +  L  + L+NN L   +P ++G+L 
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS 255

Query: 192 EVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLS 236
            +E L L +N++S     S+G+   L+EL L+ N L   LP    
Sbjct: 256 NLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIAL 298

Length = 394

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.1 bits (127), Expect = 5e-07
 Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 40/244 (16%)

Query: 794  RSKQDLEIPAQE-GPSYLLKQVIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVK 849
            RSK+D    + E G S     V++  +NL     IG GA GIV   Y A L  N   A+K
Sbjct: 3    RSKRDNNFYSVEIGDSTF--TVLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIK 55

Query: 850  KLA--FRGHKRGSLSMKREIQTIGKIRHRNLV----------RLEDFWLRKDCGIIMYRY 897
            KL+  F+       +  RE+  +  + H+N++           LE+F   +D  I+M   
Sbjct: 56   KLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME-- 109

Query: 898  MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS 957
            + + +L  V+        + + + Y++  G  H    LH      I+HRD+KP NI++ S
Sbjct: 110  LMDANLCQVIQMELDHERMSY-LLYQMLCGIKH----LH---SAGIIHRDLKPSNIVVKS 161

Query: 958  EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLEL 1017
            +    I DFG+A+    S   T  +    T  Y APE        +  D++S G ++ E+
Sbjct: 162  DCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

Query: 1018 ITRK 1021
            I   
Sbjct: 219  IKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 52.3 bits (125), Expect = 5e-07
 Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 20/218 (9%)

Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            + E +     +G+G+ G+VY+ +             AVK +      R  +    E   +
Sbjct: 4    SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63

Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSI---------TPPPTLEWNVR 921
                  ++VRL     +    +++   M +G L+  L S+          PPPTL+  + 
Sbjct: 64   KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI- 122

Query: 922  YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             ++A   A  +AYL+       VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 123  -QMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + ++APE+      +  SD++S+GVVL E+ +
Sbjct: 179  GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 52.2 bits (125), Expect = 6e-07
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 847  AVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDV 906
            AVK L    +K       +E++ + +++  N++RL    + +D   ++  YMENG L   
Sbjct: 50   AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109

Query: 907  LHS----------------ITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKP 950
            L S                    P + ++    +AL  A  + YL        VHRD+  
Sbjct: 110  LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLAT 166

Query: 951  ENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE----NAFTTAKSKESD 1006
             N L+   +   I+DFG+++ L            V  I ++A E      FTTA    SD
Sbjct: 167  RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA----SD 222

Query: 1007 VYSYGVVLLELITRKKALDPSYKERTD 1033
            V+++GV L E++   K     Y E TD
Sbjct: 223  VWAFGVTLWEILMLCKE--QPYGELTD 247

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 32/78 (41%), Positives = 44/78 (56%), Gaps = 7/78 (8%)

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGYIAPENAFT-TA 1000
            +V+RD+KP NILLD      ISD G+A     K P ++     VGT GY+APE     TA
Sbjct: 118  VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172

Query: 1001 KSKESDVYSYGVVLLELI 1018
                +D +S G +L +L+
Sbjct: 173  YDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 51.9 bits (124), Expect = 7e-07
 Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 24/224 (10%)

Query: 820  NLNAKHVIGRGAHGIVYKAS------LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI 873
            NL     +G G  G V KA+             AVK L           +  E   + ++
Sbjct: 1    NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH---SITPPPTLEWNVRYK------- 923
             H ++++L     +    +++  Y + GSLR  L     + P        R         
Sbjct: 61   NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 924  ---IALGAAHALAY-----LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
               + +G   + A+     + Y  +  +VHRD+   N+L+    +  ISDFG+++ + + 
Sbjct: 121  ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             +          + ++A E+ F    + +SDV+S+GV+L E++T
Sbjct: 181  DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.1 bits (125), Expect = 7e-07
 Identities = 29/88 (32%), Positives = 47/88 (53%), Gaps = 5/88 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             L +LH      I++RD+K +N+LLD +    I+DFG+ K          + +  GT  Y
Sbjct: 108  GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDY 162

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELI 1018
            IAPE       ++  D +S+GV+L E++
Sbjct: 163  IAPEILKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 52.0 bits (124), Expect = 9e-07
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 5/95 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH   +  I++RD+K +N+LLDSE    ++D+G+ K     P  TTS +  GT  Y
Sbjct: 108  ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNY 162

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            IAPE           D ++ GV++ E++  +   D
Sbjct: 163  IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.9 bits (124), Expect = 1e-06
 Identities = 60/232 (25%), Positives = 100/232 (43%), Gaps = 48/232 (20%)

Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK--REIQ 868
            K + E  +       +G GA+G V  A      A  A+KKL +R  +    + +  RE++
Sbjct: 8    KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELR 66

Query: 869  TIGKIRHRNLV-------------RLEDFWL-----RKDCGIIMYRYMENGSLRDVLHSI 910
             +  ++H N++             R  DF+L       D G +M    E  S   +   +
Sbjct: 67   LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLV 124

Query: 911  TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK 970
                       Y++  G    L Y+H      I+HRD+KP N+ ++ + E  I DFG+A+
Sbjct: 125  -----------YQMLKG----LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Query: 971  LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRK 1021
              D    S  +  VV T  Y APE         ++ D++S G ++ E++T K
Sbjct: 167  QTD----SEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 1e-06
 Identities = 57/213 (26%), Positives = 104/213 (48%), Gaps = 38/213 (17%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            ++IG G+ G+VY+A  +  +   A+KK+      +      RE+  +  + H N++ L+D
Sbjct: 72   NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK-----NRELLIMKNLNHINIIFLKD 126

Query: 884  FW----LRKD-----CGIIM-------YRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            ++     +K+       ++M       ++YM++ +  +  H++  P  L     Y++   
Sbjct: 127  YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNN--HAL--PLFLVKLYSYQLC-- 180

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVG 986
               ALAY+H      I HRD+KP+N+L+D       + DFG AK L    A   S+S + 
Sbjct: 181  --RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL---LAGQRSVSYIC 232

Query: 987  TIGYIAPENAF-TTAKSKESDVYSYGVVLLELI 1018
            +  Y APE     T  +   D++S G ++ E+I
Sbjct: 233  SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 12/130 (9%)

Query: 897  YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY-------LHYDCDPPIVHRDIK 949
            ++E  SL DV         L     YK  L     + Y       + +      +HRD+ 
Sbjct: 152  FVEEKSLSDVEEEEAEQEDL-----YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLA 206

Query: 950  PENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYS 1009
              NILL       I DFG+A+ + K P           + ++APE  F    + +SDV+S
Sbjct: 207  ARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 266

Query: 1010 YGVVLLELIT 1019
            +GV+L E+ +
Sbjct: 267  FGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.3 bits (123), Expect = 2e-06
 Identities = 60/261 (22%), Positives = 103/261 (39%), Gaps = 60/261 (22%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKL----AFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            IG GA G V     +  NA++A+K L        ++   +  +R+I  + +  +  +V+L
Sbjct: 9    IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDI--LAEADNEWVVKL 66

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVL--HSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
               +  KD    +  Y+  G +  +L    I      E   R+ IA     A+  +H   
Sbjct: 67   YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFE----EDLARFYIA-ELTCAIESVH--- 118

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIA---------------------------KLL 972
                +HRDIKP+NIL+D +    ++DFG+                            +  
Sbjct: 119  KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 973  DKSPASTTSI--------------SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLE-L 1017
            +        +              S+VGT  YIAPE    T  ++  D +S GV+L E L
Sbjct: 179  EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 1018 ITRKKALDPSYKE-RTDIVGW 1037
            + +   L  +  E +  ++ W
Sbjct: 239  VGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQ-TIGKIR-------HR 876
            V+G+G+ G V  A L G    FAVK L     K+  + +  +++ T+ + R       + 
Sbjct: 2    VLGKGSFGKVLLAELKGKGEYFAVKAL-----KKDVVLIDDDVECTMVEKRVLALAWENP 56

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
             L  L   +  K+    +  ++  G   D++  I      +    Y+    AA  +  L 
Sbjct: 57   FLTHLYCTFQTKEHLFFVMEFLNGG---DLMFHIQDKGRFDL---YRATFYAAEIVCGLQ 110

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK--LLDKSPASTTSISVVGTIGYIAPE 994
            +     I++RD+K +N++LD +    I+DFG+ K  +   + AST      GT  YIAPE
Sbjct: 111  FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTPDYIAPE 166

Query: 995  NAFTTAKSKESDVYSYGVVLLELI 1018
                   +   D +S+GV+L E++
Sbjct: 167  ILQGLKYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 13/209 (6%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
             NL+    +G GA G V +A+             AVK L    H     ++  E++ +  
Sbjct: 35   NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 873  I-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHA 931
            +  H N+V L          +++  Y   G L + L        L        +   A  
Sbjct: 95   LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR-KRESFLTLEDLLSFSYQVAKG 153

Query: 932  LAYLHY-DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            +A+L   +C    +HRD+   N+LL       I DFG+A+ +          +    + +
Sbjct: 154  MAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            +APE+ F    + ESDV+SYG++L E+ +
Sbjct: 210  MAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 25/208 (12%)

Query: 827  IGRGAHGIVY----KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            IG G  G V      +   P  V  VK+L      +  +    E Q    ++H NL++  
Sbjct: 3    IGNGWFGKVILGEVNSGYTPAQV-VVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHS------ITPPPTLEWNVRYKIALGAAHALAYLH 936
                     +++  +   G L+  L S      +TP PT    +  +IALG  H    LH
Sbjct: 62   GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH----LH 117

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-- 994
             +     +H D+   N LL +++   I D+G++    K     T   +   + +IAPE  
Sbjct: 118  KN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 995  -----NAFTTAKSKESDVYSYGVVLLEL 1017
                 N     ++KES+V+S GV + EL
Sbjct: 175  DEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 27/214 (12%)

Query: 826  VIGRGAHGIVYKASLG-PNAVF---AVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVR 880
            ++G G  G V +  L   +      AVK +    H    +     E   +    H N+++
Sbjct: 6    ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 881  LEDFWLRKDCG------IIMYRYMENGSLRDVLHSI---TPPPTLEWNVRYKIALGAAHA 931
            L                +++  +M++G L   L        P  L      K  +  A  
Sbjct: 66   LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGY 990
            + YL    +   +HRD+   N +L  +M   ++DFG++ K+          I+ +  + +
Sbjct: 126  MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-PVKW 181

Query: 991  IAPE----NAFTTAKSKESDVYSYGVVLLELITR 1020
            IA E      +T+    +SDV+++GV + E+ TR
Sbjct: 182  IAIESLADRVYTS----KSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 3e-06
 Identities = 39/117 (33%), Positives = 49/117 (41%), Gaps = 34/117 (29%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSP------------ 976
            AL YLH      IV+RD+KPENILL      HI  SDF ++K  D  P            
Sbjct: 115  ALEYLHLL---GIVYRDLKPENILLHE--SGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 977  ---------------ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
                            S  S S VGT  YIAPE           D ++ G++L E++
Sbjct: 170  RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 43/224 (19%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMK--REIQTIGK 872
            E++     IG G  G VY+             AVK    +     S+  K  +E   + +
Sbjct: 6    EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK--TCKNCTSPSVREKFLQEAYIMRQ 63

Query: 873  IRHRNLVRLEDFWLRKDCGII----MYRYME---NGSLRDVLHSITPPPTLEWNVRYKIA 925
              H ++V+L         G+I    ++  ME    G LR  L        L   + Y  +
Sbjct: 64   FDHPHIVKL--------IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY--S 113

Query: 926  LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP---ASTTSI 982
               + ALAYL        VHRDI   N+L+ S     + DFG+++ L+      AS   +
Sbjct: 114  YQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL 170

Query: 983  SVVGTIGYIAPENA----FTTAKSKESDVYSYGVVLLELITRKK 1022
                 I ++APE+     FT+A    SDV+ +GV + E++    
Sbjct: 171  P----IKWMAPESINFRRFTSA----SDVWMFGVCMWEILMLGV 206

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 3e-06
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 29/218 (13%)

Query: 813  QVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG--HKRGSLSMKREI 867
            +V E  +NL+    +G GA+G V  A      +  AVKKL+  F+   H + +    RE+
Sbjct: 14   EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY---REL 67

Query: 868  QTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY 922
            + +  ++H N++ L D +     L +   + +  ++    L +++            + Y
Sbjct: 68   RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 127

Query: 923  KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
            +I  G    L Y+H      I+HRD+KP N+ ++ + E  I DFG+A+  D         
Sbjct: 128  QILRG----LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 175

Query: 983  SVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
              V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 176  GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 33/223 (14%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL---GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-R 874
            E++  + VIG G  G V +A +   G     A+K L     +        E++ + K+  
Sbjct: 2    EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            H N++ L      +    I   Y   G+L D L        LE +  +    G A  L  
Sbjct: 62   HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRK---SRVLETDPAFAKEHGTASTLTS 118

Query: 935  -------------LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
                         + Y  +   +HRD+   N+L+   +   I+DFG+++           
Sbjct: 119  QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--------GEE 170

Query: 982  ISVVGTIG-----YIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            + V  T+G     ++A E+   +  + +SDV+S+GV+L E+++
Sbjct: 171  VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 31/88 (35%), Positives = 49/88 (55%), Gaps = 4/88 (4%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH + +  +V+RD+K EN++LD +    I+DFG+ K   K  A+  +    GT  Y
Sbjct: 107  ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEY 162

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELI 1018
            +APE        +  D +  GVV+ E++
Sbjct: 163  LAPEVLEDNDYGRAVDWWGLGVVMYEMM 190

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.0 bits (119), Expect = 3e-06
 Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 33/222 (14%)

Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV---FAVKKLAFRGHKRGSLSMKREIQTIGKI-RH 875
            ++  + VIG G  G V KA +  + +    A+K++     K        E++ + K+  H
Sbjct: 8    DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALA-- 933
             N++ L      +    +   Y  +G+L D L        LE +  + IA   A  L+  
Sbjct: 68   PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK---SRVLETDPAFAIANSTASTLSSQ 124

Query: 934  -YLHYDCD----------PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
              LH+  D             +HRD+   NIL+       I+DFG+++           +
Sbjct: 125  QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEV 176

Query: 983  SVVGTIG-----YIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             V  T+G     ++A E+   +  +  SDV+SYGV+L E+++
Sbjct: 177  YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.6 bits (121), Expect = 4e-06
 Identities = 29/85 (34%), Positives = 41/85 (48%)

Query: 412 ISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPI 471
           + L N    G IP  +     L  ++   NS  G IPP+L     L VL++  N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 472 PSLLGSCPTLWRVILKQNQLTGALP 496
           P  LG   +L  + L  N L+G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 49.7 bits (119), Expect = 4e-06
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 26/184 (14%)

Query: 827 IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDF 884
           IG+G  G V+KA       + A+KK+     K G  ++  REI+ +  ++H N+V L + 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 885 WLRKDCGIIMYRYMENGSLRDVL----HSITPPPTLEWNVRYKIALGAA--------HAL 932
              K      Y+    GS   V     H +     L  N   K  L           + L
Sbjct: 80  CRTKATPYNRYK----GSFYLVFEFCEHDLA---GLLSNKNVKFTLSEIKKVMKMLLNGL 132

Query: 933 AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK--LLDKSPASTTSISVVGTIGY 990
            Y+H +    I+HRD+K  NIL+  +    ++DFG+A+   L K+       + V T+ Y
Sbjct: 133 YYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189

Query: 991 IAPE 994
             PE
Sbjct: 190 RPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.4 bits (118), Expect = 5e-06
 Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 5/95 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL +LH   +  I++RD+K +N+LLD+E    ++D+G+ K     P  TTS +  GT  Y
Sbjct: 108  ALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTS-TFCGTPNY 162

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            IAPE           D ++ GV++ E++  +   D
Sbjct: 163  IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 6e-06
 Identities = 63/225 (28%), Positives = 101/225 (44%), Gaps = 21/225 (9%)

Query: 810  LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG--HKRGSLSMK 864
            L K V E  E       +G GA+G V  A         AVKKL+  F+   H R +    
Sbjct: 6    LNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY--- 62

Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR-YMENGSLRDVLHSITPPPTL-EWNVRY 922
            RE++ +  ++H N++ L D +            Y+    +   L++I     L + +V++
Sbjct: 63   RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122

Query: 923  KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
             I       L Y+H      I+HRD+KP N+ ++ + E  I DFG+A+  D         
Sbjct: 123  LI-YQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MT 173

Query: 983  SVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRKKALDP 1026
              V T  Y APE         ++ D++S G ++ EL+ + KAL P
Sbjct: 174  GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFP 217

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.1 bits (117), Expect = 6e-06
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 5/88 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL +LH   D  I++RD+K +N+LLD E    ++DFG+ K  +      T+ +  GT  Y
Sbjct: 108  ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDY 162

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELI 1018
            IAPE           D ++ GV+L E++
Sbjct: 163  IAPEILQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 49.2 bits (117), Expect = 6e-06
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 5/88 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH      +V+RDIK EN++LD +    I+DFG+ K  +      T  +  GT  Y
Sbjct: 107  ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 161

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELI 1018
            +APE        +  D +  GVV+ E++
Sbjct: 162  LAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 49.3 bits (117), Expect = 7e-06
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL +LH   +  I++RD+K +N+LLD++    ++D+G+ K     P  TTS +  GT  Y
Sbjct: 108  ALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTS-TFCGTPNY 162

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            IAPE           D ++ GV++ E++  +   D
Sbjct: 163  IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 8e-06
 Identities = 30/103 (29%), Positives = 54/103 (52%), Gaps = 2/103 (1%)

Query: 436 LDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGAL 495
           L   N    G IP ++   + L+ +N+  N   G IP  LGS  +L  + L  N   G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 496 PE-FSKNPVLSHLDVSRNNISGAIPSSIGNS-INLTSIDFSSN 536
           PE   +   L  L+++ N++SG +P+++G   ++  S +F+ N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 8e-06
 Identities = 20/56 (35%), Positives = 28/56 (50%)

Query: 196 LWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
           L L +NRL+     +      L+ L L+ N L    PE+ S L +L  LD+  NNL
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.9 bits (116), Expect = 9e-06
 Identities = 31/88 (35%), Positives = 47/88 (53%), Gaps = 5/88 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH      IV+RD+K EN++LD +    I+DFG+ K  +    + T  +  GT  Y
Sbjct: 107  ALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEY 161

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELI 1018
            +APE        +  D +  GVV+ E++
Sbjct: 162  LAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 48.8 bits (116), Expect = 1e-05
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 7/230 (3%)

Query: 499 SKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNIS 558
               V        +N    +PSS+   ++L  +  S           L NL+ L +L+++
Sbjct: 43  ESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLN 101

Query: 559 LNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFI 618
           LN +  ++   L +  NL   D+  N +    P       +L  L LS+N     +P+ +
Sbjct: 102 LNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIES-LPSPL 159

Query: 619 SELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDI 678
             L  L  L L  N L  ++P  +  L +L+  L+LS N ++  +P ++E LS LE+LD+
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLN-NLDLSGNKIS-DLPPEIELLSALEELDL 216

Query: 679 SSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGN 728
           S+N++   LS LSN+ +L  + +S N      PE++ NL        S N
Sbjct: 217 SNNSIIELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNN 265

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 1e-05
 Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 96  KLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
            L+++DLS+N  +  IP         L+ LDLS N  T   P+ F  L +L+ L+L GN 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 155 L 155
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.7 bits (116), Expect = 1e-05
 Identities = 25/76 (32%), Positives = 41/76 (53%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 236  IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295

Query: 1004 ESDVYSYGVVLLELIT 1019
            ESDV+SYG++L E+ +
Sbjct: 296  ESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 30/88 (34%), Positives = 49/88 (55%), Gaps = 5/88 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL +LH      +++RD+K +NILLD+E    ++DFG+ K    +  +TT+    GT  Y
Sbjct: 108  ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF--CGTPDY 162

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELI 1018
            IAPE           D ++ GV++ E++
Sbjct: 163  IAPEILQELEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 2e-05
 Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 3/86 (3%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            A+ Y+H +    I+HRDIK EN+L++   +  + DFG A     S ++     + GT+  
Sbjct: 272  AIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDT 328

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLE 1016
             APE       +   D++S G+V+ E
Sbjct: 329  NAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 28/224 (12%)

Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            L+ + + T+       IG+G +G VYK +   +   A  K+           +  EI+  
Sbjct: 14   LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-----DPISDVDEEIEAE 68

Query: 871  GKI-----RHRNLVRLEDFWLRKD--CGIIMYRYME---NGSLRDVLHSITP-PPTLEWN 919
              I      H N+V+    + + D   G  ++  +E    GS+ +++  +      L+  
Sbjct: 69   YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEA 128

Query: 920  VRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI-AKLLDKSPAS 978
            +   I  GA   L +LH   +  I+HRD+K  NILL +E    + DFG+ A+L       
Sbjct: 129  MISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 979  TTSISVVGTIGYIAP-----ENAFTTAKSKESDVYSYGVVLLEL 1017
             TS   VGT  ++AP     E  +  +     DV+S G+  +EL
Sbjct: 186  NTS---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.9 bits (111), Expect = 4e-05
 Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 5/156 (3%)

Query: 87  LGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQ 146
           L   + +LS L  +DLS N  S ++PP++   SALE LDLS N    ++  +  NL+NL 
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS-NNSIIELLSSLSNLKNLS 235

Query: 147 YLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGT 206
            L L  N L  ++PE +  +  L+ + L+NN +  S   ++G L  +  L L  N LS  
Sbjct: 236 GLELSNNKL-EDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNA 292

Query: 207 IPESIGNCYRLQELYLNENKLMGFLPESLSNLENLV 242
           +P        L+ L      L     +  S L N  
Sbjct: 293 LPLIALLLLLLELLLNLLLTLKALELKLNSILLNNN 328

Length = 394

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 4e-05
 Identities = 36/138 (26%), Positives = 51/138 (36%), Gaps = 54/138 (39%)

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA-------------K 970
            +A+ A H L +         +HRDIKP+NIL+D      +SDFG++             K
Sbjct: 112  LAIEAVHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162

Query: 971  LLD----KSPASTT----------------------------SISVVGTIGYIAPENAFT 998
            LL     K+                                 + S VGT  YIAPE    
Sbjct: 163  LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222

Query: 999  TAKSKESDVYSYGVVLLE 1016
                +E D +S G ++ E
Sbjct: 223  QGYGQECDWWSLGAIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 33/216 (15%)

Query: 826  VIGRGAHGIVYKASLGPNAV---FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRL 881
            VIG G  G V KA +  + +    A+K++     K        E++ + K+  H N++ L
Sbjct: 2    VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSI----TPPP---------TLEWNVRYKIALGA 928
                  +    +   Y  +G+L D L       T P          TL        A   
Sbjct: 62   LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTI 988
            A  + YL        +HRD+   NIL+       I+DFG+++           + V  T+
Sbjct: 122  ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTM 170

Query: 989  G-----YIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            G     ++A E+   +  +  SDV+SYGV+L E+++
Sbjct: 171  GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 53/255 (20%), Positives = 102/255 (40%), Gaps = 45/255 (17%)

Query: 854  RGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD----CGIIMYRYMENGSLRDVLHS 909
            +GHK      + EI+ + +I   N++++  F +          ++  Y   G LR+VL  
Sbjct: 56   KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK 115

Query: 910  ITPPPTLEWNVRYKIALGAAHALAYLH-YDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
                  L +  +  +A+     L  L+ Y   P   ++++   + L+    +  I   G+
Sbjct: 116  ---EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGL 169

Query: 969  AKLLDKSPASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
             K+L   P        V  + Y + +   + F+   + + D+YS GVVL E+ T K   +
Sbjct: 170  EKILSSPPFKN-----VNFMVYFSYKMLNDIFSE-YTIKDDIYSLGVVLWEIFTGKIPFE 223

Query: 1026 P-SYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE--MLVSSIRDQVIDVLLVALRCTEK 1082
              + KE  D++            IN    L L  +  + +  I +           CT  
Sbjct: 224  NLTTKEIYDLI------------INKNNSLKLPLDCPLEIKCIVE----------ACTSH 261

Query: 1083 KPSNRPNMRDVVRQL 1097
                RPN+++++  L
Sbjct: 262  DSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.6 bits (110), Expect = 6e-05
 Identities = 25/76 (32%), Positives = 41/76 (53%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            VHRD+   N+LL       I DFG+A+ +       +  S    + ++APE+ F    + 
Sbjct: 259  VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 1004 ESDVYSYGVVLLELIT 1019
             SDV+SYG++L E+ +
Sbjct: 319  LSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 46.5 bits (110), Expect = 6e-05
 Identities = 24/76 (31%), Positives = 42/76 (55%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            VHRD+   N+L+       I DFG+A+ + +     +  S    + ++APE+ F    + 
Sbjct: 261  VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 1004 ESDVYSYGVVLLELIT 1019
             SDV+S+G++L E+ T
Sbjct: 321  LSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.0 bits (109), Expect = 8e-05
 Identities = 25/84 (29%), Positives = 44/84 (52%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   N+LL       I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 234  IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293

Query: 1004 ESDVYSYGVVLLELITRKKALDPS 1027
            +SDV+SYG++L E+ +  K+  P 
Sbjct: 294  QSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.1 bits (109), Expect = 8e-05
 Identities = 32/97 (32%), Positives = 45/97 (46%), Gaps = 10/97 (10%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS---ISVVGT 987
            A+ YLH   +  I+HRDIK ENI ++   +  + DFG A      P    +       GT
Sbjct: 194  AIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF----PVDINANKYYGWAGT 246

Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKAL 1024
            I   APE           D++S G+VL E+ T   +L
Sbjct: 247  IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 7/151 (4%)

Query: 892  IIMYRYMENGSLRD-VLHSI--TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDI 948
            +++  +M++G L   +L+S     P  L   +  K     A  + YL        +HRD+
Sbjct: 82   VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDL 138

Query: 949  KPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVY 1008
               N +L+  M   ++DFG++K +               + +IA E+      + +SDV+
Sbjct: 139  AARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVW 198

Query: 1009 SYGVVLLELITRKKALDPSYKERTDIVGWVR 1039
            S+GV + E+ TR +   P   E ++I  ++R
Sbjct: 199  SFGVTMWEIATRGQTPYPGV-ENSEIYDYLR 228

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 41.0 bits (97), Expect = 1e-04
 Identities = 19/60 (31%), Positives = 25/60 (41%)

Query: 216 RLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRF 275
            L+ L L+ N+L      +   L NL  LD+  NNL            +L  LDLS N  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 44.9 bits (106), Expect = 1e-04
 Identities = 27/78 (34%), Positives = 39/78 (50%), Gaps = 9/78 (11%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG-----YIAPENAFT 998
            VHRD+   N+LL ++    ISDFG++K L     +  S     + G     + APE    
Sbjct: 117  VHRDLAARNVLLVNQHYAKISDFGLSKAL----GADDSYYKARSAGKWPLKWYAPECINF 172

Query: 999  TAKSKESDVYSYGVVLLE 1016
               S  SDV+SYG+ + E
Sbjct: 173  RKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 46.0 bits (109), Expect = 1e-04
 Identities = 65/274 (23%), Positives = 107/274 (39%), Gaps = 61/274 (22%)

Query: 70  AHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPP----------KLGNCS 119
           A N+ +  LS      +L   I +L+KL+ +D+S       +P            L  CS
Sbjct: 656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCS 715

Query: 120 ALE-YLDLSTN------GFTG--DIPDNFENLQNLQYLNLY----GNLLDGEIP-EPLFR 165
            L+ + D+STN        T   + P N   L+NL  L L       L +   P  PL  
Sbjct: 716 RLKSFPDISTNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMT 774

Query: 166 IL--GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIG----------N 213
           +L   L  +FL++      +P ++ +L ++E L + +     T+P  I            
Sbjct: 775 MLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSG 834

Query: 214 CYRLQ----------ELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCK 263
           C RL+          +L L+   +   +P  +    NL +LD+   N   R++    K K
Sbjct: 835 CSRLRTFPDISTNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLK 893

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGS 297
           +L  +D S             +C +LT     GS
Sbjct: 894 HLETVDFS-------------DCGALTEASWNGS 914

syringae 6; Provisional. Length = 1153

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 27/162 (16%)

Query: 873  IRHRNL-----VRLEDFWLRKDCGIIMYRYMENGSLRDVLH-----SITPPPTLEWNVRY 922
            + H+N+     V +ED     +   ++Y YM  G+L+  L          P  L      
Sbjct: 65   LSHQNILPILHVCIEDG----EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 923  KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
             +A+  A  ++YLH      ++H+DI   N ++D E++  I+D  +++  D  P     +
Sbjct: 121  HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSR--DLFPMDYHCL 175

Query: 983  SVVGT-----IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               G      + ++A E+      S  SDV+S+GV+L EL+T
Sbjct: 176  ---GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 43.8 bits (103), Expect = 3e-04
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 28/208 (13%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-----RHRNLVRL 881
            IG+G +G V+K     N   A  K+    H      +  EI+    I      H N+V+ 
Sbjct: 26   IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-----DIDEEIEAEYNILKALSDHPNVVKF 80

Query: 882  EDFWLRKDC--GIIMYRYME---NGSLRDVLHS-ITPPPTLEWNVRYKIALGAAHALAYL 935
               + +KD   G  ++  +E    GS+ D++   +     +E  +   I   A   L +L
Sbjct: 81   YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGI-AKLLDKSPASTTSISVVGTIGYIAP- 993
            H +     +HRD+K  NILL +E    + DFG+ A+L        TS   VGT  ++AP 
Sbjct: 141  HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPE 194

Query: 994  ----ENAFTTAKSKESDVYSYGVVLLEL 1017
                E    +      DV+S G+  +EL
Sbjct: 195  VIACEQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.9 bits (103), Expect = 3e-04
 Identities = 65/294 (22%), Positives = 115/294 (39%), Gaps = 49/294 (16%)

Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G    G VYK  L            A+K L  +         K E     +++H N+V 
Sbjct: 13   LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVL-----HS--------ITPPPTLEWNVRYKIALG 927
            L     ++    +++ Y  +  L + L     HS         T   TLE      I   
Sbjct: 73   LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 928  AAHALAYL--HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
             A  + +L  H+     +VH+D+   N+L+  ++   ISD G+ + +  +       + +
Sbjct: 133  IAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP--SYKERTDIVGWVRSVWS 1043
              I +++PE       S +SD++SYGVVL E+ +    L P   Y  + D++  +R+   
Sbjct: 188  LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY--GLQPYCGYSNQ-DVIEMIRN--- 241

Query: 1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                             ++    D    V  + L C  + PS RP  +D+  +L
Sbjct: 242  ---------------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 43.9 bits (104), Expect = 3e-04
 Identities = 64/263 (24%), Positives = 90/263 (34%), Gaps = 67/263 (25%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGNIPPK-------LGNCSALEYLDLSTNGFTGDIPDN 138
            L   +     L+ + LS N  +G IP         L     L+ LDLS N    D    
Sbjct: 42  ALASALRPQPSLKELCLSLN-ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGV 100

Query: 139 FENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGD-LKEV---- 193
            E+L                      R   LQ + LNNN L     R +   LK++    
Sbjct: 101 LESLL---------------------RSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL 139

Query: 194 EALWLFSNRLSGTIPESIGNCYR----LQELYLNENKLMGF----LPESLSNLENLVYLD 245
           E L L  NRL G   E++    R    L+EL L  N +       L E L    NL  LD
Sbjct: 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199

Query: 246 VGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI-- 303
           + +N L        E    L          +  ++       SL  L++  + LT +   
Sbjct: 200 LNNNGLT------DEGASAL----------AETLASL----KSLEVLNLGDNNLTDAGAA 239

Query: 304 ---PSSFGLLARLSSLDLSENQL 323
               +       L +L LS N +
Sbjct: 240 ALASALLSPNISLLTLSLSCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 3e-04
 Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 27/164 (16%)

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            + N ++L          +++  Y+++G L D+L         E  V+ KI      AL  
Sbjct: 68   NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAE--VK-KIIRQLVEALND 124

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVV-GTIGYIA 992
            LH      I+H DIK EN+L D   +  ++ D+G+ K++  +P      S   GT+ Y +
Sbjct: 125  LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG-TP------SCYDGTLDYFS 174

Query: 993  PENAFTTAKSKES------DVYSYGVVLLELITRKKALDPSYKE 1030
            PE      K K        D ++ GV+  EL+T K        E
Sbjct: 175  PE------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212

Length = 267

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 17/58 (29%), Positives = 29/58 (50%)

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
           L  LD+S N ++     +     NL  +D S N  + + P+    L SL +L++S N+
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Length = 60

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.8 bits (103), Expect = 4e-04
 Identities = 32/120 (26%), Positives = 49/120 (40%), Gaps = 45/120 (37%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIA---------------------------------- 969
            +HRDIKP+NIL+D +    ++DFG+                                   
Sbjct: 123  IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 970  -------KLLDKSPAST----TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
                   K L++  A       + S+VGT  YIAPE    T  ++  D +S GV+L E++
Sbjct: 183  CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 41/209 (19%), Positives = 79/209 (37%), Gaps = 23/209 (11%)

Query: 827  IGRGAHGIVYKA---SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            IG G  G V           A   VK+L         L   +E+Q   ++ H N+++   
Sbjct: 3    IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHS------ITPPPTLEWNVRYKIALGAAHALAYLHY 937
              +     +++  +   G L++ L S            +   +  ++A G    L    +
Sbjct: 63   QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW-LHQADF 121

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--- 994
                  +H D+   N  L +++   I D+G+A          T       + ++APE   
Sbjct: 122  ------IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 995  ----NAFTTAKSKESDVYSYGVVLLELIT 1019
                +     ++K+S+++S GV + EL T
Sbjct: 176  IRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 26/108 (24%), Positives = 50/108 (46%), Gaps = 3/108 (2%)

Query: 913  PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
            P TL      +  +  A  + YL        +HRD+   N +L+  M   ++DFG++K +
Sbjct: 107  PFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163

Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR 1020
                      +    + ++A E+      +  SDV+++GV + E++TR
Sbjct: 164  YSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.3 bits (102), Expect = 6e-04
 Identities = 19/44 (43%), Positives = 30/44 (68%), Gaps = 3/44 (6%)

Query: 928 AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
            A AL YLH      I+HRD+KP+N+L+ +E    ++DFG++K+
Sbjct: 113 VALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 43.7 bits (103), Expect = 7e-04
 Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 21/174 (12%)

Query: 546 LGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNL-----LNGSIPSSLRSW--- 597
           L +  SLV L  S+ ++       +S+C+NLE+     NL     LN S  S L+S+   
Sbjct: 664 LSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI 723

Query: 598 -KSLSILKLSENHFTGGIPTFISEL--EKLLELQL---GGNQLGGEIPPSIGALQDLSYA 651
             ++S L L E      I  F S L  E L EL L      +L   + P    +  LS +
Sbjct: 724 STNISWLDLDET----AIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779

Query: 652 LN---LSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVS 702
           L    LS       +PS ++ L KLE L+I +     TL    N+ SL  +++S
Sbjct: 780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLS 833

syringae 6; Provisional. Length = 1153

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 42.7 bits (101), Expect = 7e-04
 Identities = 66/310 (21%), Positives = 109/310 (35%), Gaps = 70/310 (22%)

Query: 309 LLARLSSLDLSENQLSGK----IPPELGKCKYLTVLHLYANQLEGE------IPDELGQL 358
            L  L  L L  N L  +    +   L     L  L L  N+          +   L + 
Sbjct: 21  KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80

Query: 359 SNLQDLELFDNRLTGEFP---VSIWRIASLEYLLVYNNNLLGKLPLEM-----TELK-QL 409
             LQ+L+L DN L  +      S+ R +SL+  L  NNN LG   L +      +L   L
Sbjct: 81  CGLQELDLSDNALGPDGCGVLESLLRSSSLQ-ELKLNNNGLGDRGLRLLAKGLKDLPPAL 139

Query: 410 KNISLYNNQFSGVIPQSLG----INSSLMQLDFINNSFTGEIPPNLCFG----KQLRVLN 461
           + + L  N+  G   ++L      N  L +L+  NN         L  G      L VL+
Sbjct: 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199

Query: 462 MGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSS 521
           +  N       S L                       +    L  L++  NN++ A  ++
Sbjct: 200 LNNNGLTDEGASALAET-------------------LASLKSLEVLNLGDNNLTDAGAAA 240

Query: 522 IGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE----GSLPSQLSKCKNLE 577
           + +++   +I                   SL+TL++S N +       L   L++ ++L 
Sbjct: 241 LASALLSPNI-------------------SLLTLSLSCNDITDDGAKDLAEVLAEKESLL 281

Query: 578 VFDVSFNLLN 587
             D+  N   
Sbjct: 282 ELDLRGNKFG 291

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 0.001
 Identities = 26/61 (42%), Positives = 31/61 (50%), Gaps = 2/61 (3%)

Query: 264 NLTFLDLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQ 322
           NL  LDLS NR +  I         +L  LD+ G+ LT   P +F  L  L SLDLS N 
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 323 L 323
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 27/77 (35%), Positives = 40/77 (51%), Gaps = 7/77 (9%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKS----PASTTSISVVGTIGYIAPENAFTT 999
            VHRD+   N+LL ++    ISDFG++K L        A T        + + APE     
Sbjct: 117  VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG---KWPVKWYAPECMNYY 173

Query: 1000 AKSKESDVYSYGVVLLE 1016
              S +SDV+S+GV++ E
Sbjct: 174  KFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 40.4 bits (95), Expect = 0.003
 Identities = 53/233 (22%), Positives = 84/233 (36%), Gaps = 51/233 (21%)

Query: 501 NPVLSHLDVSRNN------ISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVT 554
            P L  L +S N          ++   +     L  +D S N         L +L+   +
Sbjct: 50  QPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSS 109

Query: 555 L-NISLNHV-EGSLPSQLSKCK------NLEVFDVSFNLLNG----SIPSSLRSWKSLSI 602
           L  + LN+   G    +L           LE   +  N L G    ++  +LR+ + L  
Sbjct: 110 LQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKE 169

Query: 603 LKLSENHFTG-GIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT- 660
           L L+ N     GI      L+    L++                      L+L+ NGLT 
Sbjct: 170 LNLANNGIGDAGIRALAEGLKANCNLEV----------------------LDLNNNGLTD 207

Query: 661 ---GRIPSDLEKLSKLEQLDISSNNLTG----TLSP--LSNIHSLVEVNVSYN 704
                +   L  L  LE L++  NNLT      L+   LS   SL+ +++S N
Sbjct: 208 EGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.4 bits (94), Expect = 0.004
 Identities = 36/141 (25%), Positives = 56/141 (39%), Gaps = 47/141 (33%)

Query: 944  VHRDIKPENILLDSEMEPHISDFGI--------------------------AKLLD---- 973
            +HRDIKP+NIL+D +    ++DFG+                          + L D    
Sbjct: 123  IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 974  ---------------KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLE-L 1017
                           K      + S+VGT  YIAPE       ++  D +S GV+L E L
Sbjct: 183  CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 1018 ITRKKALDPSYKE-RTDIVGW 1037
            + +   L P+  E +  ++ W
Sbjct: 243  VGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.6 bits (93), Expect = 0.004
 Identities = 40/165 (24%), Positives = 59/165 (35%), Gaps = 46/165 (27%)

Query: 825 HVIGRGAHGIVYKAS-LGPNAVFA--VKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +I +GA  I+Y    LG  AV    + K  +R H      ++RE       R R   R+
Sbjct: 2   DLIKQGAEAIIYLTDFLGLPAVVKERIPK-RYR-HPELDEKLRRE-------RTRREARI 52

Query: 882 EDFWLRK----------------DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIA 925
               L K                D G+I+  Y+E   L+D L             R  + 
Sbjct: 53  ----LAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----------EEARPDLL 98

Query: 926 LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK 970
                 +  LH      IVH D+   NI+L      +  DFG+ +
Sbjct: 99  REVGRLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGE 139

Length = 204

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1109
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.98
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.98
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.98
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.98
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.98
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.98
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.98
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.98
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.98
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.98
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.98
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.98
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PLN00181	793	protein SPA1-RELATED; Provisional	99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
PRK12274	218	serine/threonine protein kinase; Provisional	99.75
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.72
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.7
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.7
PRK10345	210	hypothetical protein; Provisional	99.67
smart00090	237	RIO RIO-like kinase.	99.63
PRK14879	211	serine/threonine protein kinase; Provisional	99.62
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.62
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.6
PLN03150	623	hypothetical protein; Provisional	99.6
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.59
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.58
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.56
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.56
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.55
PLN03150	623	hypothetical protein; Provisional	99.52
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.5
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.48
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.45
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.12
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.11
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.11
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.1
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.07
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.06
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.06
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.05
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.04
KOG1243	690	consensus Protein kinase [General function predict	99.03
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.01
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.01
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.95
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.94
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.92
KOG3087	229	consensus Serine/threonine protein kinase [General	98.92
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.89
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.85
COG4248	637	Uncharacterized protein with protein kinase and he	98.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.72
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.69
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.65
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.64
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.64
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.57
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.56
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.5
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.43
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.43
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.41
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.4
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.35
PRK09902	216	hypothetical protein; Provisional	98.26

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.7e-115  Score=1130.86  Aligned_cols=915  Identities=34%  Similarity=0.549  Sum_probs=644.7

Q ss_pred             ChhhHHHHHHHHHhccCCCCcccCCCCCCCCCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCC
Q 001275           26 LNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSN  105 (1109)
Q Consensus        26 ~~~~~~all~~~~~~~~~~~~~l~sW~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n  105 (1109)
                      .++|++||++||+++. +|...+.+|+.. .+||.|.||+|+. .++|+.++|+++.++|.+++.+..+++|++|+|++|
T Consensus        27 ~~~~~~~l~~~~~~~~-~~~~~~~~w~~~-~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n  103 (968)
T PLN00113         27 HAEELELLLSFKSSIN-DPLKYLSNWNSS-ADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN  103 (968)
T ss_pred             CHHHHHHHHHHHHhCC-CCcccCCCCCCC-CCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence            5689999999999995 577788999754 4689999999985 468999999999999999999999999999999999


Q ss_pred             cccccCCCCCC-CCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccc
Q 001275          106 NFSGNIPPKLG-NCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIP  184 (1109)
Q Consensus       106 ~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p  184 (1109)
                      +++|.+|..+. .+++|++|+|++|.+++.+|.  +.+++|++|+|++|.+++.+|..++.+++|++|++++|.+.+.+|
T Consensus       104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  181 (968)
T PLN00113        104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP  181 (968)
T ss_pred             ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence            99988887755 889999999999999887775  457888888888888877777777777777777777777777777


Q ss_pred             cccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCC
Q 001275          185 RNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKN  264 (1109)
Q Consensus       185 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  264 (1109)
                      ..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|++|++++|++++           
T Consensus       182 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-----------  250 (968)
T PLN00113        182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG-----------  250 (968)
T ss_pred             hhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecc-----------
Confidence            777777777777777777777777777777777777777776666666666666655555555555554           


Q ss_pred             cchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccC
Q 001275          265 LTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYA  344 (1109)
Q Consensus       265 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  344 (1109)
                                   .+|..++++++|+.|++++|++++.+|..+..+++|++|++++|.+++.+|..+.++++|+.|++++
T Consensus       251 -------------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~  317 (968)
T PLN00113        251 -------------PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS  317 (968)
T ss_pred             -------------ccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCC
Confidence                         4455555556666666666666666666666677777777777777777777777777777777777


Q ss_pred             cccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCC
Q 001275          345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIP  424 (1109)
Q Consensus       345 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  424 (1109)
                      |.+.+.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+..+++|+.|++++|++.+.+|
T Consensus       318 n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p  397 (968)
T PLN00113        318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP  397 (968)
T ss_pred             CccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCC
Confidence            77777777777778888888888888887788777777777777777766665555555544444444444444433322


Q ss_pred             ccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCC
Q 001275          425 QSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVL  504 (1109)
Q Consensus       425 ~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L  504 (1109)
                      ..+                                                                       ..+++|
T Consensus       398 ~~~-----------------------------------------------------------------------~~~~~L  406 (968)
T PLN00113        398 KSL-----------------------------------------------------------------------GACRSL  406 (968)
T ss_pred             HHH-----------------------------------------------------------------------hCCCCC
Confidence            222                                                                       222334


Q ss_pred             ceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCc
Q 001275          505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN  584 (1109)
Q Consensus       505 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N  584 (1109)
                      +.|++++|++++.+|..+.++++|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+. .++|+.||+++|
T Consensus       407 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~-~~~L~~L~ls~n  485 (968)
T PLN00113        407 RRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRN  485 (968)
T ss_pred             CEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccc-cccceEEECcCC
Confidence            4555555555555666666677777777777777777776666666666666666666665555432 344555555555


Q ss_pred             cccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccC
Q 001275          585 LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIP  664 (1109)
Q Consensus       585 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip  664 (1109)
                      +++                        +.+|..+..+++|+.|+|++|+++|.+|..++.+++| ..|+|++|.++|.+|
T Consensus       486 ~l~------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p  540 (968)
T PLN00113        486 QFS------------------------GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL-VSLDLSHNQLSGQIP  540 (968)
T ss_pred             ccC------------------------CccChhhhhhhccCEEECcCCcceeeCChHHcCccCC-CEEECCCCcccccCC
Confidence            554                        4455555555555556666666666666666666666 357777777777777


Q ss_pred             cchhhcccCCeEEccCCcccccCCC-CCccccceEEeeeccccccccchhhhhccCCCCCCCCCCCcccccccCCCCCCC
Q 001275          665 SDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSC  743 (1109)
Q Consensus       665 ~~l~~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~~n~l~g~~p~~~~~~~~~~~~~~~gn~~~c~~~~~~~~~~c  743 (1109)
                      ..++++++|+.|||++|+++|.+|. +..+++|+.+++++|+++|.+|.. ..|......++.||+++||.......+.|
T Consensus       541 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~~~~~~~~~~c  619 (968)
T PLN00113        541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCGGDTTSGLPPC  619 (968)
T ss_pred             hhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccCCccccCCCCC
Confidence            7777888888888888888887777 777788888888888888888842 22333367789999999986543322333


Q ss_pred             CCCCCCCCCCCCCccccCCcceEEEeeehhHHHHHHHHHHhheeeEEEeecccc--ccccCC--cCCCcc-----cHHHH
Q 001275          744 FGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQ--DLEIPA--QEGPSY-----LLKQV  814 (1109)
Q Consensus       744 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~r~~~~~--~~~~~~--~~~~~~-----~~~~~  814 (1109)
                      ..         .   .+  ....+++++++++++++++++++++++++||++.+  ..+...  .+...+     .....
T Consensus       620 ~~---------~---~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  685 (968)
T PLN00113        620 KR---------V---RK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI  685 (968)
T ss_pred             cc---------c---cc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhH
Confidence            21         1   11  11122222222222222222222222222222111  111100  000000     00112


Q ss_pred             HHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          815 IEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       815 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ......|...++||+|+||.||+|.. .+++.||||++.....     ...+|++.+++++|||||+++++|.+.+..++
T Consensus       686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            23345678889999999999999976 5789999998843211     12356889999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.++++.      ++|..+.+++.|+|+|++|||+.++++|+|||+||+||+++.++.+++. ||.+....
T Consensus       761 v~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        761 IHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            9999999999999963      7899999999999999999997778899999999999999999988875 66554332


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ..      ....+|++|+|||++.+..++.++|||||||++|||+||+.||+...........|++...... ....++|
T Consensus       834 ~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  906 (968)
T PLN00113        834 TD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWID  906 (968)
T ss_pred             cC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-chhheeC
Confidence            11      1236789999999999999999999999999999999999999776666666777776544332 2334445


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      +......  ....++..++.+++.+||+.||++||+|+||+++|+++..
T Consensus       907 ~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        907 PSIRGDV--SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccccCCC--CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            4432211  1234556778899999999999999999999999998733

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-62  Score=638.80  Aligned_cols=514  Identities=36%  Similarity=0.536  Sum_probs=374.5

Q ss_pred             cccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcc-cccccccccccCcccCCcccccccCCCCcchhc
Q 001275          191 KEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLS-NLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD  269 (1109)
Q Consensus       191 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  269 (1109)
                      .+++.|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+. ++++|++|+|++|++++.+|.  ..+++|    
T Consensus        69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L----  142 (968)
T PLN00113         69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNL----  142 (968)
T ss_pred             CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCC----
Confidence            3566666666666666666666666666666666666655555433 566666666666666554443  234444    


Q ss_pred             cccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCC
Q 001275          270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       270 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                                          ++|++++|.+++.+|..++.+++|++|+|++|.+.+.+|..++++++|++|+|++|++.+
T Consensus       143 --------------------~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~  202 (968)
T PLN00113        143 --------------------ETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG  202 (968)
T ss_pred             --------------------CEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcC
Confidence                                445555554444444445555555555555555554555555555555555555555555


Q ss_pred             CCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccC
Q 001275          350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI  429 (1109)
Q Consensus       350 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  429 (1109)
                      .+|..++.+++|++|+|++|++++.+|..+.++++|++|++++|++++.+|..+.++++|+.|++++|++++.+|..++.
T Consensus       203 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~  282 (968)
T PLN00113        203 QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS  282 (968)
T ss_pred             cCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhh
Confidence            55555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCC-CCCCCCCceEE
Q 001275          430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLD  508 (1109)
Q Consensus       430 ~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~L~~L~  508 (1109)
                      +++|++|++++|.+++.+|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++++.+|. ++.+++|+.|+
T Consensus       283 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~  362 (968)
T PLN00113        283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD  362 (968)
T ss_pred             ccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEE
Confidence            55555566666655555555555566666666666666666666666666666666666666666665 77778899999


Q ss_pred             eecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccC
Q 001275          509 VSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNG  588 (1109)
Q Consensus       509 Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~  588 (1109)
                      +++|++++.+|..+..+.+|+.|++++|++.+.+|..++.+++|+.|++++|++++.+|..+..+++|+.||+++|+++|
T Consensus       363 Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  442 (968)
T PLN00113        363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG  442 (968)
T ss_pred             CCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchh
Q 001275          589 SIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLE  668 (1109)
Q Consensus       589 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~  668 (1109)
                      .+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|+++|.+|..++++..| ..|+|++|+++|.+|..++
T Consensus       443 ~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~  520 (968)
T PLN00113        443 RINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSEL-MQLKLSENKLSGEIPDELS  520 (968)
T ss_pred             ccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhcc-CEEECcCCcceeeCChHHc
Confidence            999999999999999999999999998876 45899999999999999999999999999 4799999999999999999


Q ss_pred             hcccCCeEEccCCcccccCCC-CCccccceEEeeeccccccccchhhhhccCCCCCCCCCCCccc
Q 001275          669 KLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLC  732 (1109)
Q Consensus       669 ~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~~n~l~g~~p~~~~~~~~~~~~~~~gn~~~c  732 (1109)
                      ++++|++|||++|+++|.+|. +..+++|+.|++++|.++|.+|..+..+.........+|+..+
T Consensus       521 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        521 SCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence            999999999999999999998 9999999999999999999999887765333444566776554

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-49  Score=447.54  Aligned_cols=290  Identities=41%  Similarity=0.680  Sum_probs=249.6

Q ss_pred             CCCcccHHHHHHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeE
Q 001275          805 EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF  884 (1109)
Q Consensus       805 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  884 (1109)
                      ....|+++++..||++|...++||+|+||.||+|...+++.||||++....... .++|.+|++++.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            456799999999999999999999999999999999999999999875544333 5679999999999999999999999


Q ss_pred             EecCCc-eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          885 WLRKDC-GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       885 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                      |.+.+. .++|||||++|+|.++++..... .++|..|++||.++|+||+|||+.+.++|+||||||+|||+|+++.+||
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            999984 99999999999999999986543 7899999999999999999999988889999999999999999999999


Q ss_pred             ecccCCcccCCCCCCceeeec-ccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCc-cccccHHHHHHHh
Q 001275          964 SDFGIAKLLDKSPASTTSISV-VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSY-KERTDIVGWVRSV 1041 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~ 1041 (1109)
                      +|||+|+.....  ....... .||.+|+|||++..+..+.|+|||||||+++|++||+.+.+... .....+..|+...
T Consensus       219 sDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  219 SDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             cCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            999999755331  1111112 79999999999999999999999999999999999999887654 3444588888777


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      +... .+.+++|+.+.....  ...+++.++..++.+|++.+|++||+|.||+++|+.+.
T Consensus       297 ~~~~-~~~eiiD~~l~~~~~--~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  297 LEEG-KLREIVDPRLKEGEY--PDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHCc-chhheeCCCccCCCC--ChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            7655 788999998763111  01167888999999999999999999999999997653

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=1.5e-48  Score=408.82  Aligned_cols=488  Identities=31%  Similarity=0.453  Sum_probs=350.4

Q ss_pred             CCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeec
Q 001275          119 SALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL  198 (1109)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  198 (1109)
                      ..|+.|++++|.++ .+.+.+.+|..|.+|++.+|+++ ..|++++++.+++.|+.++|+++ .+|+.++.+.+|.+|+.
T Consensus        45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~  121 (565)
T KOG0472|consen   45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC  121 (565)
T ss_pred             cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence            44555555555554 23334555555555555555555 55555555555555555555555 55555666666666666


Q ss_pred             ccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCC
Q 001275          199 FSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGG  278 (1109)
Q Consensus       199 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  278 (1109)
                      ++|.+. .+|++++.+..|+.|+..+|+++. .|+++.++.+|..|++.+|++....                       
T Consensus       122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~s-lp~~~~~~~~l~~l~~~~n~l~~l~-----------------------  176 (565)
T KOG0472|consen  122 SSNELK-ELPDSIGRLLDLEDLDATNNQISS-LPEDMVNLSKLSKLDLEGNKLKALP-----------------------  176 (565)
T ss_pred             ccccee-ecCchHHHHhhhhhhhcccccccc-CchHHHHHHHHHHhhccccchhhCC-----------------------
Confidence            666665 556666666666666666666663 4555555555555555555554322                       


Q ss_pred             CCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCcccc-C
Q 001275          279 ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELG-Q  357 (1109)
Q Consensus       279 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~  357 (1109)
                        +..-+++.|++||..+|.++ .+|..++.+.+|..|||.+|++. .+| +|.+|..|++|+++.|+|+ .+|.+.+ +
T Consensus       177 --~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~  250 (565)
T KOG0472|consen  177 --ENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKH  250 (565)
T ss_pred             --HHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcc
Confidence              22223666666666666666 67778888888999999999988 566 8999999999999999998 6777666 8


Q ss_pred             CCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCC---CCc
Q 001275          358 LSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINS---SLM  434 (1109)
Q Consensus       358 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~---~L~  434 (1109)
                      ++++..|||.+|+++ +.|+.++.+.+|++||+|+|.|+ .+|.+++++ .|+.|-+.+|++... ...+-...   -|+
T Consensus       251 L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~vLK  326 (565)
T KOG0472|consen  251 LNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTI-RREIISKGTQEVLK  326 (565)
T ss_pred             cccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHH-HHHHHcccHHHHHH
Confidence            999999999999999 79999999999999999999998 588889999 999999999998732 22221111   111


Q ss_pred             eEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCcc
Q 001275          435 QLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNI  514 (1109)
Q Consensus       435 ~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i  514 (1109)
                      +|.   -.++...+..-                .|.-.+.             .-.-.+..|+.....+.+.|+++.-++
T Consensus       327 yLr---s~~~~dglS~s----------------e~~~e~~-------------~t~~~~~~~~~~~~i~tkiL~~s~~ql  374 (565)
T KOG0472|consen  327 YLR---SKIKDDGLSQS----------------EGGTETA-------------MTLPSESFPDIYAIITTKILDVSDKQL  374 (565)
T ss_pred             HHH---HhhccCCCCCC----------------ccccccc-------------CCCCCCcccchhhhhhhhhhccccccc
Confidence            110   01111111000                0000000             001123445566777889999999999


Q ss_pred             CCCCCCccccccc---ccEEeccCCcccCCcchhhhccccccee-ecccccccccCCccccCCCCccEEEecCccccCCC
Q 001275          515 SGAIPSSIGNSIN---LTSIDFSSNKFSGLMPQELGNLVSLVTL-NISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSI  590 (1109)
Q Consensus       515 ~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~  590 (1109)
                      + .+|+++.....   .+..+++.|++. ++|..+..++.+.+. .+++|.+. .+|..++.+++|..|+|++|-+. .+
T Consensus       375 t-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~L  450 (565)
T KOG0472|consen  375 T-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DL  450 (565)
T ss_pred             c-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hc
Confidence            9 67877766555   889999999999 789999998876655 55555555 99999999999999999999998 89


Q ss_pred             CcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCC-chhhhhhhhhhcccccccccccCcchhh
Q 001275          591 PSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPS-IGALQDLSYALNLSKNGLTGRIPSDLEK  669 (1109)
Q Consensus       591 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~-~~~l~~l~~~L~L~~N~l~g~ip~~l~~  669 (1109)
                      |..++.+..|+.|++|.|+|. .+|.++..+..++.+-.++|++. ++|++ +++|.+| .+|||.+|.+. .||+.+|+
T Consensus       451 P~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL-~tLDL~nNdlq-~IPp~Lgn  526 (565)
T KOG0472|consen  451 PEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNL-TTLDLQNNDLQ-QIPPILGN  526 (565)
T ss_pred             chhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhc-ceeccCCCchh-hCChhhcc
Confidence            999999999999999999999 89999999999988888889997 55544 8888888 47888888888 78888888


Q ss_pred             cccCCeEEccCCccc
Q 001275          670 LSKLEQLDISSNNLT  684 (1109)
Q Consensus       670 l~~L~~L~Ls~N~l~  684 (1109)
                      |.+|++|+|++|++.
T Consensus       527 mtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  527 MTNLRHLELDGNPFR  541 (565)
T ss_pred             ccceeEEEecCCccC
Confidence            888888888888888

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-44  Score=376.33  Aligned_cols=256  Identities=28%  Similarity=0.425  Sum_probs=212.5

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-ceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-CGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  897 (1109)
                      +++..+.||+|..|+|||+.++ +++.+|+|.+.....+...+++.+|++++++.+||+||+++|.|.... ...++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445678999999999999775 578899999966666667788999999999999999999999999988 49999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |++|||+++++..+   .+++...-+|+.+|++||.|||+  +++||||||||+|||++..|.|||+|||.++.+.+.  
T Consensus       160 MDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999998754   48999999999999999999994  389999999999999999999999999999987654  


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ....++||..|||||-+.+..|+.++||||||+.++|+.+|+.|+.+......+....+.....+.       .+.+.
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-------pP~lP  303 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-------PPRLP  303 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-------CCCCC
Confidence              334579999999999999999999999999999999999999999776333344444433332211       01110


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .       ..+..++..++..|+++||.+||+++|+++|=.
T Consensus       304 ~-------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf  337 (364)
T KOG0581|consen  304 E-------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF  337 (364)
T ss_pred             c-------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence            0       023455666777999999999999999998754

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-43  Score=390.88  Aligned_cols=254  Identities=30%  Similarity=0.445  Sum_probs=205.2

Q ss_pred             CCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-ceeEEEEecc
Q 001275          822 NAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-CGIIMYRYME  899 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~  899 (1109)
                      ...+.+|+|+||+||+|.+.....||||++..... .....+|.+|+.++.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            33455999999999999999666699999854322 122568999999999999999999999999887 7899999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEEeccCCCCeeeCCCC-cEEEecccCCcccCCCCC
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP-IVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~~  977 (1109)
                      +|+|.++++.. ....+++..++++|.+||+|++|||   +.+ ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999874 3456999999999999999999999   777 99999999999999997 99999999998765432 


Q ss_pred             CceeeecccCcccccccccc--cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          978 STTSISVVGTIGYIAPENAF--TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                       .......||++|||||++.  ...|+.|+|||||||++|||+||+.||.....  .....   .+.....         
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~---~v~~~~~---------  263 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVAS---AVVVGGL---------  263 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHH---HHHhcCC---------
Confidence             2333478999999999999  66999999999999999999999999975432  11111   1111100         


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       ...    ....+...+..++.+||+.||++||++.|++..|+.+
T Consensus       264 -Rp~----~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  264 -RPP----IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             -CCC----CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence             000    0111445567788899999999999999999999865

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-43  Score=370.14  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=203.4

Q ss_pred             hCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeeccccc------ChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKR------GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      +.|...+.+|+|+||.|-+| ..++|+.||||.+.......      ...++++|+++|++++|||||++.+++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            45777899999999999999 45679999999996543222      234568999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC---CcEEEecccC
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE---MEPHISDFGI  968 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGl  968 (1109)
                      |+|+||++||+|.+++-..+.   +.+....-+++|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999976543   777778899999999999999   9999999999999999765   6799999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCC---CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      |+..+..   ..+...+||+.|.|||++.++.+   ..++|+||+||++|-+++|..||.....+.. +.+.+.      
T Consensus       326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-l~eQI~------  395 (475)
T KOG0615|consen  326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-LKEQIL------  395 (475)
T ss_pred             hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-HHHHHh------
Confidence            9987633   33445799999999999987654   3488999999999999999999976654321 111111      


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             ..+...  .+..+.+-..+..+++.+|+..||++||+++|+++|-|--
T Consensus       396 -------~G~y~f--~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  396 -------KGRYAF--GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             -------cCcccc--cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence                   111000  0011122233445566699999999999999999986643

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.6e-46  Score=390.96  Aligned_cols=492  Identities=27%  Similarity=0.379  Sum_probs=369.1

Q ss_pred             CcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccc
Q 001275           89 PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILG  168 (1109)
Q Consensus        89 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~  168 (1109)
                      ..+..-..|+.|++++|.+. .+.+.+.++..|++|++++|+++ ..|.+++.+..++.|+.++|+++ .+|+.++.+.+
T Consensus        39 e~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~  115 (565)
T KOG0472|consen   39 ENWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLIS  115 (565)
T ss_pred             hhhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhh
Confidence            34666677888999999988 55567888999999999999998 68888999999999999999998 89999999999


Q ss_pred             cceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccC
Q 001275          169 LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGD  248 (1109)
Q Consensus       169 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  248 (1109)
                      |+.|+.++|.+. .+|+.++.+..|+.++..+|+++ ..|++++++.+|..|++.+|++....|+.+. ++.|++||..+
T Consensus       116 l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~  192 (565)
T KOG0472|consen  116 LVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNS  192 (565)
T ss_pred             hhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccch
Confidence            999999999998 78888999999999999999998 7888999999999999999999976666555 99999999999


Q ss_pred             cccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCcc-ccccccccEEEcCCCCCCCCC
Q 001275          249 NNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQLSGKI  327 (1109)
Q Consensus       249 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~~  327 (1109)
                      |-++ .+|..++.+.+|+.|+|.+|++. ..| +|.++..|++|+++.|+|. .+|.. ...+.++..|||.+|+++ ..
T Consensus       193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~  267 (565)
T KOG0472|consen  193 NLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV  267 (565)
T ss_pred             hhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence            9887 56777899999999999999998 455 8999999999999999998 45554 458999999999999998 78


Q ss_pred             CCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhh---cccceeec--cCCccCCCCchh
Q 001275          328 PPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRI---ASLEYLLV--YNNNLLGKLPLE  402 (1109)
Q Consensus       328 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~l--~~N~l~~~~~~~  402 (1109)
                      |+.+.-+++|++||+|+|.|+ ..|.+++++ .|+.|-+.+|.+.. +-..+-..   .-|+||.=  -.-.++..-...
T Consensus       268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~  344 (565)
T KOG0472|consen  268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRSKIKDDGLSQSEGGT  344 (565)
T ss_pred             chHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHHhhccCCCCCCcccc
Confidence            999999999999999999999 678889999 99999999999873 33333221   11222211  000111000000


Q ss_pred             hhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCcc---ceEEECCCcccccCCCcccCCCC
Q 001275          403 MTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQ---LRVLNMGQNQFHGPIPSLLGSCP  479 (1109)
Q Consensus       403 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~---L~~L~L~~N~l~~~~p~~~~~l~  479 (1109)
                      .+..+          ...+.. .......+.+.|+++.-+++ .+|...+...+   ....+++.|++. .+|..+..+.
T Consensus       345 e~~~t----------~~~~~~-~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lk  411 (565)
T KOG0472|consen  345 ETAMT----------LPSESF-PDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELK  411 (565)
T ss_pred             cccCC----------CCCCcc-cchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHH
Confidence            00000          000011 11223456677777777777 55655554433   678888888887 6776666665


Q ss_pred             ccchh-hccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeec
Q 001275          480 TLWRV-ILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNI  557 (1109)
Q Consensus       480 ~L~~l-~l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  557 (1109)
                      .+... .+++|.++ .+|. ++.+++|..|+|++|-+. .+|.+++.+..|+.||+|.|+|. .+|.++..+..|+.+-.
T Consensus       412 elvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtlla  488 (565)
T KOG0472|consen  412 ELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLA  488 (565)
T ss_pred             HHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHh
Confidence            55443 44444444 4444 777777888888777776 67777777777888888888777 56777777777777777


Q ss_pred             ccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceecccccccc
Q 001275          558 SLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       558 ~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      ++|++....|+.+.++.+|..|||.+|.+. .+|..+++|++|++|+|++|.|+
T Consensus       489 s~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  489 SNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            777777555555777777777777777777 66777777777777777777776

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=384.02  Aligned_cols=258  Identities=27%  Similarity=0.364  Sum_probs=211.5

Q ss_pred             CCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          821 LNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +...+.||+|.||+||.|.++....||+|.++..  .....+|.+|+++|++++|++||+++|+|..++..|||||||+.
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            4456779999999999999998889999998543  44456788999999999999999999999998899999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+|++. .....+.....+.++.|||+|++||+   ++++|||||.++||||+++..+||+|||+|+...++ ....
T Consensus       286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~  360 (468)
T KOG0197|consen  286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTA  360 (468)
T ss_pred             CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC-ceee
Confidence            999999987 33456889999999999999999999   999999999999999999999999999999955433 3334


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHH
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1059 (1109)
                      .....-+..|+|||.+....++.|||||||||++|||+| |+.|+... . ..++...+..   ..    +         
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-s-n~ev~~~le~---Gy----R---------  422 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-S-NEEVLELLER---GY----R---------  422 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-C-HHHHHHHHhc---cC----c---------
Confidence            445566789999999999999999999999999999999 55554322 1 1122222211   10    1         


Q ss_pred             hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCC
Q 001275         1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMT 1105 (1109)
Q Consensus      1060 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1105 (1109)
                        .+....++.++++++..||+.+|++|||++.+...++++.....
T Consensus       423 --lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  423 --LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence              11123456678889999999999999999999999998855443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.1e-42  Score=402.64  Aligned_cols=261  Identities=26%  Similarity=0.442  Sum_probs=219.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      .+....+.||+|+||+||+|+.      ++.+.||||.++.....+..++|++|++++..++|||||+++|+|.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            4556678899999999999965      3457799999988777778899999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          893 IMYRYMENGSLRDVLHSITP-----------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                      +|+|||..|||.+||+...+           +++++..+.+.||.|||.|++||-   +..+|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence            99999999999999976432           234889999999999999999999   8999999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||+++.....++........-+++|||||.+..++||.+||||||||++||+++ |+.|+.....+  ++.+.++ 
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--EVIe~i~-  719 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--EVIECIR-  719 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--HHHHHHH-
Confidence            9999999998876665554434567889999999999999999999999999999998 77787654222  1222111 


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                                  +..     ..+..+.++.+++.|+..||+..|++||+++|+-..|.....
T Consensus       720 ------------~g~-----lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  720 ------------AGQ-----LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             ------------cCC-----cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                        111     123345677889999999999999999999999999988743

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-42  Score=363.52  Aligned_cols=200  Identities=29%  Similarity=0.456  Sum_probs=179.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .+|...+.||+|+||+||+|+++ ++.+||||.+.... .++.......|+.+++.++|||||++++++..++..|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            56788888999999999999764 57999999996554 45556678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC------CcEEEecccCCc
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE------MEPHISDFGIAK  970 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~DfGla~  970 (1109)
                      ||.||+|.+|++..+   .+++..+..++.|+|.|+++||   +++||||||||.|||++..      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999999865   4899999999999999999999   9999999999999999764      458999999999


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      .+......   ...+|++-|||||++...+|+.|+|+||+|+|+|||++|+.||+..
T Consensus       164 ~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  164 FLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98754332   3479999999999999999999999999999999999999999754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-41  Score=376.05  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=209.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+|...+.||+|||+.||+++. ..|+.||+|++.++.-  ......+.+|+++.++++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999977 8899999999966443  233557889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      |+|+.|+|..+++..+   ++++.++..+..||+.|+.|||   +.+|+|||||..|++++++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999998533   5999999999999999999999   999999999999999999999999999999988654


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      +.  .....+|||.|.|||++.....+..+||||+||++|-++.|++||+..     .+.+...........        
T Consensus       172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~Ik~~~Y~--------  236 (592)
T KOG0575|consen  172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKIKLNEYS--------  236 (592)
T ss_pred             cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHHHhcCcc--------
Confidence            32  223479999999999999999999999999999999999999999642     222222222111111        


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                           .+.....+   ..+++..+++.+|.+|||+++|+.|=.-
T Consensus       237 -----~P~~ls~~---A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  237 -----MPSHLSAE---AKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             -----cccccCHH---HHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence                 11112233   3446669999999999999999987543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-42  Score=343.55  Aligned_cols=260  Identities=22%  Similarity=0.373  Sum_probs=204.1

Q ss_pred             hCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeE-EecCCc-eeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDF-WLRKDC-GIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~-~~lv  894 (1109)
                      .+|.+.++||+|.||+|||+ ...+|..+|.|.+.... +.+..++...|+.++++++|||||+++++ +.+... .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            45777889999999999999 45689999999986443 33445678899999999999999999983 444444 8999


Q ss_pred             EEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          895 YRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      |||+..|+|...++..+ ....+++..+++++.|++.||.++|+...++ |+||||||.||+++++|.+|++|||+++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999987643 3456899999999999999999999533332 889999999999999999999999999988


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ...  .......+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+.     .+....+..-+.  +...+ 
T Consensus       179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qg--d~~~~-  248 (375)
T KOG0591|consen  179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQG--DYPPL-  248 (375)
T ss_pred             cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcC--CCCCC-
Confidence            653  33445689999999999999999999999999999999999999999753     222222221111  00000 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                                 .......++..++..|+..||+.||+.-..++.+..
T Consensus       249 -----------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  249 -----------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -----------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                       012234556678889999999999996555555443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-40  Score=338.67  Aligned_cols=269  Identities=22%  Similarity=0.302  Sum_probs=203.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccC-hHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +.|+...++|+|+||.|||++.+ +|+.||||++....+... .+-..||++++++++|+|+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35677788999999999999765 599999999966555333 4557899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |++.. +.+-+....  ..++.+.+.+++.|+++|+.|+|   +.+++||||||+|||++.++.+|+||||+|+.+..+.
T Consensus        82 ~~dhT-vL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHT-VLHELERYP--NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchH-HHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99884 444444432  34889999999999999999999   9999999999999999999999999999999886432


Q ss_pred             CCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHH----------hhcCc
Q 001275          977 ASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS----------VWSDT 1045 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~ 1045 (1109)
                      .  ..+.++.|..|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+. .+-.++..+...          .+...
T Consensus       156 d--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~-SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  156 D--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR-SDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             c--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc-chHHHHHHHHHHHcccCHHHHHHhccC
Confidence            2  2334789999999998887 78999999999999999999999776432 222222211111          11111


Q ss_pred             cccccccchhhh-HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1046 EEINDIVDLSLM-EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1046 ~~~~~~~d~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..+..+.-|... .+.....++....-+++++..|++.||.+|++-+|++.|
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111111111100 111112233344467888999999999999999999865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-40  Score=345.66  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=202.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .+.|++.++||+|+||+||.++. ++++.||+|++.++...  ...+...+|..++.+++||.||+++..|++.+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            46799999999999999999955 56899999999665433  3466788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      +||+.||.|..++.+.+   .+++..+.-++.+|+.||.|||   +.+||||||||+|||+|++|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999998644   4889999999999999999999   99999999999999999999999999999985433


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-cccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-EEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d 1053 (1109)
                      ...  .....+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...     +...+.+...... ......  
T Consensus       178 ~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~I~~~k~~~~p~~--  248 (357)
T KOG0598|consen  178 DGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDKILKGKLPLPPGY--  248 (357)
T ss_pred             CCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHHHhcCcCCCCCcc--
Confidence            322  223479999999999999999999999999999999999999999653     2223333322221 000010  


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHH
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP----NMRDVVRQ 1096 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~~ 1096 (1109)
                                 ..   .+..+++.+.++.||++|.    ++.++-+|
T Consensus       249 -----------ls---~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  249 -----------LS---EEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             -----------CC---HHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                       12   2344466689999999995    55665544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-41  Score=359.42  Aligned_cols=271  Identities=20%  Similarity=0.296  Sum_probs=209.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCC-ceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKD-CGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  894 (1109)
                      .++|...++||.|.||.||+|+. .++..||||+++.+-.......-.||+..+++++ |||||++.+++.+.+ ..|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            46788889999999999999954 5789999999965544433444579999999998 999999999999888 89999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||||+. +|++.++..  ...+++..+..|+.||++||+|+|   ++|+.|||+||+|||+.....+||+|||+||.+..
T Consensus        89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence            999975 999999875  456999999999999999999999   99999999999999999999999999999998765


Q ss_pred             CCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc-c--
Q 001275          975 SPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN-D-- 1050 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 1050 (1109)
                      ...   .+.++.|..|+|||++.. +.|+.+.|+||+|||++|+.+-++.|.+ ..+..++..+........+... +  
T Consensus       163 kpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG-~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  163 KPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG-ASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             CCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC-CcHHHHHHHHHHHhCCCccccchhHH
Confidence            433   345789999999997764 5679999999999999999999987743 2333333333222221111100 0  


Q ss_pred             ----ccc---hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1051 ----IVD---LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1051 ----~~d---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                          .+.   +...+.....-......+.++++.+|+++||.+||||+|+++|--
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf  293 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF  293 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence                000   000000011112345567888999999999999999999998853

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=378.25  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=216.0

Q ss_pred             CCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          822 NAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+.++||.|.||.||+|+++    ....||||.++....++...+|..|+.+|.++.||||+++.|+.......++|+||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            55789999999999999774    24579999998888888889999999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC-
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-  976 (1109)
                      |++|+|+.||+.+..  .+++.+...+.++||.|+.||.   +.++|||||.++|||++.+-.+|++|||+++.+.++. 
T Consensus       712 MENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999999998663  4999999999999999999999   9999999999999999999999999999999885544 


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ...+..+..-+.+|.|||.+..+++|.++|||||||++||.++ |.+||.....  +++...+..               
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--QdVIkaIe~---------------  849 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVIKAIEQ---------------  849 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--HHHHHHHHh---------------
Confidence            2223333445679999999999999999999999999999887 8888764322  222221111               


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                         ..-.+...+++..+++|+++||++|-.+||++.|++.+|.+...
T Consensus       850 ---gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  850 ---GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ---ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence               11122234677789999999999999999999999999987643

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-39  Score=322.35  Aligned_cols=273  Identities=24%  Similarity=0.373  Sum_probs=213.8

Q ss_pred             hCCCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecccccC-hHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .+|...+++|+|.||.||+|+ ..+|+.||||+++....+.+ .....||++.++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            467778899999999999995 46799999999976654443 3467899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      ||+. +|+..++...  -.++...+..++.++.+|++|+|   .+.|+|||+||.|+|++++|.+||+|||+|+.+....
T Consensus        82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9986 9999887643  45888999999999999999999   9999999999999999999999999999999887654


Q ss_pred             CCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh-------hcCcccc
Q 001275          977 ASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV-------WSDTEEI 1048 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~ 1048 (1109)
                      .....  .+.|..|+|||.+.+ +.|+..+|+||.|||+.||+-|.+-| ++..+-.++...++..       |.+-..+
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f-pG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF-PGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC-CCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            44332  378999999998886 46899999999999999999887544 4444444444444433       2222223


Q ss_pred             ccccchhhhHHhhh-chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1049 NDIVDLSLMEEMLV-SSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .+.++-...+.... .-...+..+.++++..|+..||.+|+++.|+++|=--.
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~  285 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK  285 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence            33222221111111 11234445678888899999999999999999886444

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-40  Score=361.45  Aligned_cols=368  Identities=22%  Similarity=0.203  Sum_probs=298.4

Q ss_pred             CCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecc
Q 001275          120 ALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF  199 (1109)
Q Consensus       120 ~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~  199 (1109)
                      .-+.||+|+|+++...+..|.++++|++++|..|.++ .||.......+|+.|+|.+|.|+..-.+.+..++.|+.|||+
T Consensus        79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS  157 (873)
T KOG4194|consen   79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS  157 (873)
T ss_pred             ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence            3456777777777777777777788888888888777 777766666678888888888877777777778888888888


Q ss_pred             cccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCC
Q 001275          200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGI  279 (1109)
Q Consensus       200 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  279 (1109)
                      .|.|+.+.-.+|..-.++++|+|++|+|+......|.++.+|..|.|+.|+++...+..|..+++|+.|+|.+|+|.-.-
T Consensus       158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive  237 (873)
T KOG4194|consen  158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE  237 (873)
T ss_pred             hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence            88888666667777778888888888888877888888888888888888888888888888888888888888887444


Q ss_pred             CcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCC
Q 001275          280 SPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLS  359 (1109)
Q Consensus       280 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  359 (1109)
                      --.|.++++|+.|.|..|++...-..+|-.+.++++|+|+.|+++..-..++.++++|+.|+||+|.|+..-++.+...+
T Consensus       238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq  317 (873)
T KOG4194|consen  238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ  317 (873)
T ss_pred             hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence            56788888888888888888877778888888888888888888877777888888999999999998888888888888


Q ss_pred             CccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCcc---ccCCCCCceE
Q 001275          360 NLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQS---LGINSSLMQL  436 (1109)
Q Consensus       360 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~---~~~~~~L~~L  436 (1109)
                      +|++|+|++|+|+...+.+|..+..|+.|.|++|++...-...|..+++|+.|||++|.++..+.+.   |..+++|+.|
T Consensus       318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL  397 (873)
T KOG4194|consen  318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL  397 (873)
T ss_pred             cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence            8999999999998777788888889999999999988766777888899999999999988777653   5578888889


Q ss_pred             EecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCc
Q 001275          437 DFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN  489 (1109)
Q Consensus       437 ~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N  489 (1109)
                      +|.+|++....-..|..+..|+.|||.+|-|...-|++|..+ .|++|.+..-
T Consensus       398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs  449 (873)
T KOG4194|consen  398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS  449 (873)
T ss_pred             eecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence            999998886555677788888999999998888888888877 7777766543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-39  Score=347.67  Aligned_cols=271  Identities=26%  Similarity=0.348  Sum_probs=208.4

Q ss_pred             hCCCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  894 (1109)
                      +.|+..++||+|.||.||+|+ ..+|+.||+|++.....+ .....+.+||.++++++||||+++.+...+.  ...|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            456667889999999999995 567999999999776543 4456778999999999999999999998876  688999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      +|||+. +|.-++..-  .-.++..++..++.|+++||+|+|   +++|+|||||.+|||+|.+|.+||+|||+|+++..
T Consensus       197 FeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999987 888877652  235899999999999999999999   99999999999999999999999999999998865


Q ss_pred             CCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      .. ....+..+.|..|+|||.+.+. .|+.++|+||.|||+.||++|++.|.+. .+..++..+++......+......+
T Consensus       271 ~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~-tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  271 SG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGR-TEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCc-cHHHHHHHHHHHhCCCChhcccccc
Confidence            43 3335667899999999988874 6899999999999999999999887543 3444444444333222222111111


Q ss_pred             hh--------hh-HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1054 LS--------LM-EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1054 ~~--------~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ..        .. .....+.........++++..++..||.+|.||.++++.=
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~se  401 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSE  401 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCc
Confidence            00        00 0001111222234556677799999999999999998754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=337.68  Aligned_cols=264  Identities=25%  Similarity=0.364  Sum_probs=211.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.|+..++||.|.-++||+|+. ..+++||||++..+......+.+.+|++.|+.++||||++++..|..+...++||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            5688899999999999999955 568999999998877777788999999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |.+|++.++++..-+ ..+++..+..|.+++++||.|||   .+|.+|||||+.|||++.+|.|||+|||.+..+.....
T Consensus       106 Ma~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            999999999987654 34899999999999999999999   99999999999999999999999999999876644332


Q ss_pred             C-cee-eecccCcccccccccc--cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc-ccc
Q 001275          978 S-TTS-ISVVGTIGYIAPENAF--TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN-DIV 1052 (1109)
Q Consensus       978 ~-~~~-~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1052 (1109)
                      . ... ...+||+.|||||++.  ...|+.|+||||||++..|+.+|..||.......    -............. ...
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk----vLl~tLqn~pp~~~t~~~  257 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK----VLLLTLQNDPPTLLTSGL  257 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH----HHHHHhcCCCCCcccccC
Confidence            1 111 4468999999999854  3568999999999999999999999996543221    11111111111010 011


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      +.+        ........+.+++..|++.||++|||+++++++=.
T Consensus       258 ~~d--------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F  295 (516)
T KOG0582|consen  258 DKD--------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF  295 (516)
T ss_pred             ChH--------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence            111        11222335666777999999999999999998753

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=344.97  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=201.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC--ceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD--CGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  895 (1109)
                      .+|...+.||+|+||+||++...+ |+..|||.+....... .+.+++|+.++.+++|||||+++|......  ..+++|
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            456778899999999999997654 8999999885543222 567899999999999999999999855444  589999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~  974 (1109)
                      ||+++|+|.+++...+.  .+++..+.+++.||++||+|||   +++||||||||+|||++. ++.+||+|||.++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999998664  5999999999999999999999   999999999999999999 79999999999987653


Q ss_pred             -CCCCceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          975 -SPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       975 -~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                       ...........||+.|||||++.++. ...++||||+||++.||+||+.||...    .+...+........ ....+ 
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~-~~P~i-  244 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGRED-SLPEI-  244 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccC-CCCCC-
Confidence             11222234578999999999999643 346999999999999999999998643    11122221111111 01111 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                               +....   .+..+++.+|++.||++||||+|+++|....
T Consensus       245 ---------p~~ls---~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~  280 (313)
T KOG0198|consen  245 ---------PDSLS---DEAKDFLRKCFKRDPEKRPTAEELLEHPFLK  280 (313)
T ss_pred             ---------CcccC---HHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence                     11112   2344566799999999999999999998664

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-39  Score=349.88  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=208.5

Q ss_pred             HHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCc
Q 001275          815 IEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       815 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  890 (1109)
                      .+...+|...+.||+|+|++||+|+. .++++||||++.++.  .+...+-+.+|-++|.++ .||.|++++..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34457899999999999999999954 578999999985443  233455678899999999 89999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .|+|+||+++|+|.+++++.+.   +++.-...++.+|+.|++|||   +.|||||||||+|||+|+|+++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999998764   888888999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCC---------cee--eecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHH
Q 001275          971 LLDKSPAS---------TTS--ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       971 ~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      .+......         ...  ..++||..|.+||++.....++.+|+|+||||+|+|+.|++||....+ .. +   ++
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yl-i---Fq  297 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YL-I---FQ  297 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HH-H---HH
Confidence            87543211         111  458999999999999999999999999999999999999999975421 11 1   11


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                                .+++..   ...++..++.   ..+|+.+.+..||.+|+++.|+.+|-.-
T Consensus       298 ----------kI~~l~---y~fp~~fp~~---a~dLv~KLLv~dp~~Rlt~~qIk~HpFF  341 (604)
T KOG0592|consen  298 ----------KIQALD---YEFPEGFPED---ARDLIKKLLVRDPSDRLTSQQIKAHPFF  341 (604)
T ss_pred             ----------HHHHhc---ccCCCCCCHH---HHHHHHHHHccCccccccHHHHhhCccc
Confidence                      111100   1112223333   4445668999999999999999988643

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-39  Score=350.18  Aligned_cols=265  Identities=25%  Similarity=0.349  Sum_probs=218.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ....++++||+|.||.|..+....+..||||+++.........+|.+|+++|.+++|||||+++|+|..++..++|+|||
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            44567889999999999999999899999999987777777789999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+|+..+..+. ...+...+|+.||+.|++||.   +.++||||+.++|+|+++++++||+|||+++-+...++.
T Consensus       618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999999998865433 566677889999999999999   999999999999999999999999999999977666665


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh--CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT--RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      ......+-+.+|||||.+..+++|.++|||+|||++||+++  ...||....  +++.++-...+.......        
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~~~~~~~--------  763 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFFRDQGRQ--------  763 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhcCCCCcc--------
Confidence            55455677899999999999999999999999999999886  556765332  122222222222111111        


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                         ......+.+..++++++.+||..|-++||+++++..+|.+.
T Consensus       764 ---~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 ---VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               01112345566788999999999999999999999999875

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-39  Score=354.04  Aligned_cols=251  Identities=23%  Similarity=0.345  Sum_probs=204.3

Q ss_pred             hCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ..|...++||+|+.|.||.| +..+++.||||++.... +....-+.+|+.+|+..+|+|||++++.|..+++.++||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            45777788999999999999 45678999999995543 33344578999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |+||+|.|.+....    +++.++..|..++++||+|||   ..+|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       352 m~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            99999999987654    899999999999999999999   99999999999999999999999999999988765433


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        .....+||+.|||||++....|++|+||||+|++++||+-|.+||-....    +........ ..       .+++.
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrAlyLIa~-ng-------~P~lk  490 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIAT-NG-------TPKLK  490 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HHHHHHHhh-cC-------CCCcC
Confidence              33457999999999999999999999999999999999999999853211    111111100 00       01111


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                            ........+.+++.+|++.||++||+|+|+++|=
T Consensus       491 ------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp  524 (550)
T KOG0578|consen  491 ------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP  524 (550)
T ss_pred             ------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence                  0112223455677799999999999999999874

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=357.94  Aligned_cols=390  Identities=22%  Similarity=0.195  Sum_probs=262.5

Q ss_pred             ceeccccccccccCCcccccc--cccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEec
Q 001275          146 QYLNLYGNLLDGEIPEPLFRI--LGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLN  223 (1109)
Q Consensus       146 ~~L~L~~n~l~~~~p~~l~~l--~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  223 (1109)
                      +.||.+++.+....-..+...  ..-+.|++++|+++..-+..|.++++|+.+++..|.++ .+|...+...+|+.|+|.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence            457777777653211111111  13456888888888888888888888888888888888 677777777778888888


Q ss_pred             cccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcC
Q 001275          224 ENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI  303 (1109)
Q Consensus       224 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  303 (1109)
                      +|.|+.+-.+++..++.|+.|||+.|.|+...-..|..-.++++|+|++|+|+......|.++.+|..|.|+.|+++...
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp  213 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP  213 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence            88888888888888888888888888888776666777777888888888888777777777778888888888888777


Q ss_pred             CccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhc
Q 001275          304 PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIA  383 (1109)
Q Consensus       304 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  383 (1109)
                      +..|..+++|+.|+|..|+|.-.---.|.++++|+.|.|..|.+...-...|..+.++++|+|+.|+++..-..++.+++
T Consensus       214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt  293 (873)
T KOG4194|consen  214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT  293 (873)
T ss_pred             HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence            77777788888888888877633234677777777777777777765556666777777777777777755555666666


Q ss_pred             ccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECC
Q 001275          384 SLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMG  463 (1109)
Q Consensus       384 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~  463 (1109)
                      .|+.|+||+|.|...-+..+.-.++|++|+|++|+|+...+.+|..+..|++|+|++|.++..-...|..+++|++|||+
T Consensus       294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr  373 (873)
T KOG4194|consen  294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR  373 (873)
T ss_pred             hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence            66666666666666556666556666666666666665555556555666666666665554433444444555555555


Q ss_pred             CcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcc
Q 001275          464 QNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMP  543 (1109)
Q Consensus       464 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  543 (1109)
                      +|.|+..+.+.                    -..|..++.|+.|++.+|+|..+.-.+|.++.+|+.|||.+|.|...-|
T Consensus       374 ~N~ls~~IEDa--------------------a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~  433 (873)
T KOG4194|consen  374 SNELSWCIEDA--------------------AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQP  433 (873)
T ss_pred             CCeEEEEEecc--------------------hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecc
Confidence            55554433321                    0015556666666666666664444556666666666666666665556


Q ss_pred             hhhhcccccceeec
Q 001275          544 QELGNLVSLVTLNI  557 (1109)
Q Consensus       544 ~~~~~l~~L~~L~L  557 (1109)
                      ..|..+ .|++|.+
T Consensus       434 nAFe~m-~Lk~Lv~  446 (873)
T KOG4194|consen  434 NAFEPM-ELKELVM  446 (873)
T ss_pred             cccccc-hhhhhhh
Confidence            666555 5555554

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4e-38  Score=360.65  Aligned_cols=262  Identities=23%  Similarity=0.353  Sum_probs=203.1

Q ss_pred             hhCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC-
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD-  889 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  889 (1109)
                      .++|++.++||+|+||.||+|..      .+++.||||++...........+.+|+.++.++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            36789999999999999999964      235689999986443344456789999999999 8999999999887644 


Q ss_pred             ceeEEEEeccCCCHHHHHhccCC---------------------------------------------------------
Q 001275          890 CGIIMYRYMENGSLRDVLHSITP---------------------------------------------------------  912 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  912 (1109)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999999975321                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCccc
Q 001275          913 --PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY  990 (1109)
Q Consensus       913 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  990 (1109)
                        ...+++..+.+++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              124788899999999999999999   899999999999999999999999999999865433222222234567889


Q ss_pred             ccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHH
Q 001275          991 IAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQV 1069 (1109)
Q Consensus       991 ~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 1069 (1109)
                      +|||++.+..++.++|||||||++|||++ |+.||...... .....   ... ..... ..             .....
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~---~~~-~~~~~-~~-------------~~~~~  303 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQ---RLK-DGTRM-RA-------------PENAT  303 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHH---HHh-cCCCC-CC-------------CCCCC
Confidence            99999999999999999999999999997 99888643211 11111   110 00000 00             01122


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1070 IDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1070 ~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .++.+++.+||+.||++||++.|+++.|+++.
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            35677888999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=339.99  Aligned_cols=273  Identities=26%  Similarity=0.367  Sum_probs=204.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhc--CCCCceeeEeeEEecCC----cee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK--IRHRNLVRLEDFWLRKD----CGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~  892 (1109)
                      ......+++|+|+||.||||.+. ++.||||++.    .+..+.|+.|-++.+.  ++|+||++|+++-...+    +++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            44556788999999999999998 5899999984    3345567777666655  48999999999876665    789


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------CCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD------CDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                      +|+||.+.|+|.+|++.+.    ++|....+|+..+++||+|||++      .+++|+|||||++||||.+|+++.|+||
T Consensus       285 LVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999998754    89999999999999999999964      3788999999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccCCC------CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHH
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK------SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      |+|..+..........+.+||.+|||||++.+.--      -.+.||||+|.|+|||+++...+++.....  ..-.+..
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~--Yqlpfe~  438 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE--YQLPFEA  438 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc--ccCchhH
Confidence            99999887666666667899999999998875422      247899999999999999887765421111  1111111


Q ss_pred             hhcCcccc---ccccchhhhHHhhhchh--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1041 VWSDTEEI---NDIVDLSLMEEMLVSSI--RDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1041 ~~~~~~~~---~~~~d~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      .......+   .+.+-.+..+...++..  ...+.-+.+.+..||..||+.|.|+.=|-+.+++...
T Consensus       439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            11111111   11111111111111111  1334557778889999999999999988888877643

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=350.60  Aligned_cols=267  Identities=24%  Similarity=0.337  Sum_probs=207.0

Q ss_pred             HHHHHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          812 KQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       812 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      ++.....+.+...+.||+|.||+||+|.+.+  .||||++..... .+..+.|+.|+..+++-+|.||+=|.|||.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            3444445566778899999999999999873  479999965543 3345689999999999999999999999987766


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                       .+|+.+|+|-+|+.++|..+  ..++....+.||.|||+|+.|||   .++|||||||..||++.++++|||+|||++.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999999754  45889999999999999999999   9999999999999999999999999999987


Q ss_pred             ccCCCCCCceeeecccCcccccccccccC---CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTT---AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      .-..-..........|...|||||++...   +|++.+||||||+++|||+||..||.....+.  +      .|...+-
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq--I------ifmVGrG  608 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ--I------IFMVGRG  608 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh--e------EEEeccc
Confidence            54322111122224678899999998743   57999999999999999999999997321111  0      1111100


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                         ..-++.     ......+..++.+|+..||..++++||.+.+++..|+....
T Consensus       609 ---~l~pd~-----s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 ---YLMPDL-----SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ---ccCccc-----hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence               000010     11123455577778889999999999999999998887643

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-38  Score=376.83  Aligned_cols=261  Identities=26%  Similarity=0.384  Sum_probs=213.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC--Cc----EEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP--NA----VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      .+....+.||+|+||.||+|...+  +.    .||||.+....+.+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            345566789999999999996642  33    489999977777788889999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          893 IMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      +++|||++|+|..|++..+.    ...++....+.++.+||+|+.||+   ++++|||||.++|+|+++...|||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            99999999999999988643    346899999999999999999999   99999999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      |+.+.+.++........-+.+|||||.+..+.++.|+|||||||++||++|...+.++..... ++...+..    ..  
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~~----gg--  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVLE----GG--  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHHh----CC--
Confidence            996655555444333456679999999999999999999999999999999554433432221 11111110    00  


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                                  -.+....+...+++++..||+.+|++||++.++++.+..+.
T Consensus       922 ------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~  962 (1025)
T KOG1095|consen  922 ------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS  962 (1025)
T ss_pred             ------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence                        11123455667889999999999999999999999887763

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-40  Score=376.60  Aligned_cols=487  Identities=27%  Similarity=0.306  Sum_probs=290.7

Q ss_pred             CCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecc
Q 001275           95 SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFL  174 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  174 (1109)
                      ..++.|+++.|-+-...-+.+.+.-.|+.||+++|++. ..|..+..+.+|+.|+++.|.+. ..|.+..++.+|++|.|
T Consensus        21 ~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL   98 (1081)
T KOG0618|consen   21 EALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNL   98 (1081)
T ss_pred             HHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhhee
Confidence            34555555555544221222333333555555555554 45555555555555555555555 44555555555555555


Q ss_pred             cccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCc
Q 001275          175 NNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGR  254 (1109)
Q Consensus       175 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  254 (1109)
                      .+|++. ..|..+..+++|+.|+++.|++. .+|.-+..++.++.+..++|.....    ++...               
T Consensus        99 ~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~---------------  157 (1081)
T KOG0618|consen   99 KNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS---------------  157 (1081)
T ss_pred             ccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc---------------
Confidence            555554 44444555555555555555544 4444444444444444444411111    11111               


Q ss_pred             ccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccc
Q 001275          255 INFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKC  334 (1109)
Q Consensus       255 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l  334 (1109)
                                ++.++|..|.+.+.++..+..+..  .|+|.+|.+.   -..+..+.+|+.|....|++...    --.-
T Consensus       158 ----------ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l----~~~g  218 (1081)
T KOG0618|consen  158 ----------IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSEL----EISG  218 (1081)
T ss_pred             ----------chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceE----EecC
Confidence                      444555555555444444444433  4555555544   11233445555555555555421    1122


Q ss_pred             cccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEc
Q 001275          335 KYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISL  414 (1109)
Q Consensus       335 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  414 (1109)
                      ++|+.|+.++|.+....+.  ..-.+|+++++++|+++ .+|.++..+.+|+.+...+|+++ .+|..+..+++|+.|++
T Consensus       219 ~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~  294 (1081)
T KOG0618|consen  219 PSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA  294 (1081)
T ss_pred             cchheeeeccCcceeeccc--cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence            4555555555555522111  12235566666666665 34556666666666666666663 55555555666666666


Q ss_pred             cCCcCcccCCccccCCCCCceEEecCCcccccCCCCc-ccCc-cceEEECCCcccccCCCcccCCCCccchhhccCcccC
Q 001275          415 YNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNL-CFGK-QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLT  492 (1109)
Q Consensus       415 ~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~-~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  492 (1109)
                      ..|.+. .+|+.....++|++|||..|+|. ..|+.+ .-.. .|+.|+.+.|++....--.=...+.|+.|++.+|.|+
T Consensus       295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt  372 (1081)
T KOG0618|consen  295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT  372 (1081)
T ss_pred             hhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence            666665 45555555666666666666665 333322 2222 2566666666665322222234678999999999999


Q ss_pred             CC-CCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCcccc
Q 001275          493 GA-LPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLS  571 (1109)
Q Consensus       493 ~~-~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~  571 (1109)
                      .. +|.+.....|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|..+.+++.|++|...+|+|. ..| ++.
T Consensus       373 d~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~  449 (1081)
T KOG0618|consen  373 DSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELA  449 (1081)
T ss_pred             ccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhh
Confidence            75 577999999999999999998555567889999999999999999 67899999999999999999999 788 899


Q ss_pred             CCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccC
Q 001275          572 KCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGN  632 (1109)
Q Consensus       572 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N  632 (1109)
                      .++.|+++|+|.|+|+...-..-.-+++|++|||++|.-.-..-..+..++.+...++.-|
T Consensus       450 ~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  450 QLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             hcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            9999999999999998433333333489999999999854344555666666666666555

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=345.84  Aligned_cols=256  Identities=25%  Similarity=0.328  Sum_probs=206.2

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc---c-cChHHHHHHHHHHhcCC-CCceeeEeeEEecCCc
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH---K-RGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  890 (1109)
                      ...+|...+.||+|+||+||.|.. .+++.||+|.+.....   . .....+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            346788999999999999999954 5689999996644311   1 23456779999999998 9999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccCC
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIA  969 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla  969 (1109)
                      .++||||+.+|+|.+++...+   .+.+.++.+++.|++.|++|+|   +.+|+||||||+||+++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999998733   3888999999999999999999   9999999999999999999 99999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCC-C-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTA-K-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      ....  .........+||+.|+|||++.+.. | +.++||||+||++|.|++|+.||+..     ......+......-.
T Consensus       169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~~l~~ki~~~~~~  241 (370)
T KOG0583|consen  169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVPNLYRKIRKGEFK  241 (370)
T ss_pred             cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHHHHHHHHhcCCcc
Confidence            9774  1222334479999999999999987 8 58999999999999999999999752     222222222222111


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      +...++               ..++..++.+|++.||.+|+++.|++++=+--
T Consensus       242 ~p~~~~---------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~  279 (370)
T KOG0583|consen  242 IPSYLL---------------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQ  279 (370)
T ss_pred             CCCCcC---------------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhc
Confidence            212110               23456678899999999999999999765543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-37  Score=344.45  Aligned_cols=250  Identities=27%  Similarity=0.367  Sum_probs=208.2

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      -|+..+.||+|+-|.|..|++ .+|+.+|||.+....  .......+++|+-+|+-+.||||++++++|+...+.|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            467788999999999999965 679999999996542  23335678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|-|++++...++   +.+.++.+++.||+.|+.|+|   ..+|+|||+||+|+|+|..+.+||+|||+|..-..+.
T Consensus        93 yv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             ecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            9999999999987654   889999999999999999999   8999999999999999999999999999998655443


Q ss_pred             CCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .-   ...+|++.|.|||++.+.+| +.++||||+|||+|.++||+.||+..     .+..++..+....-.+..     
T Consensus       167 lL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlKV~~G~f~MPs-----  233 (786)
T KOG0588|consen  167 LL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLKVQRGVFEMPS-----  233 (786)
T ss_pred             cc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHHHHcCcccCCC-----
Confidence            32   23589999999999999999 78999999999999999999999732     233333333322222211     


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                                 ....+..+++.+|+..||++|.|++||++|-+-
T Consensus       234 -----------~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  234 -----------NISSEAQDLLRRMLDVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             -----------cCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence                       112334557779999999999999999999764

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-40  Score=376.27  Aligned_cols=481  Identities=28%  Similarity=0.356  Sum_probs=228.4

Q ss_pred             ecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCccc
Q 001275          172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL  251 (1109)
Q Consensus       172 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  251 (1109)
                      +|++..++. .+|..+-.-..+..|++..|-+-...-+.+.+.-+|+.|++++|++. ..|..+..+.+|+.|+++.|-|
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i   80 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI   80 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence            455555555 44444433333555666665554222222233333555555555554 2344455555555555555554


Q ss_pred             CCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcc
Q 001275          252 EGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPEL  331 (1109)
Q Consensus       252 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  331 (1109)
                      .                         ..|.+..++.+|++|.|.+|.+. ..|..+..+++|+.|++|+|++. .+|..+
T Consensus        81 ~-------------------------~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i  133 (1081)
T KOG0618|consen   81 R-------------------------SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVI  133 (1081)
T ss_pred             h-------------------------hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhH
Confidence            4                         23344444444444444444444 34444555555555555555544 444444


Q ss_pred             ccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCe
Q 001275          332 GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKN  411 (1109)
Q Consensus       332 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  411 (1109)
                      ..++.++.+..++|....    .++... ++.++|..|.+.+.++..+..++.  .|+|++|.+.   ...+..+.+|+.
T Consensus       134 ~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~  203 (1081)
T KOG0618|consen  134 EVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEV  203 (1081)
T ss_pred             HhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhh
Confidence            455555555555551111    112211 444555555554444444444443  4555555443   122344444555


Q ss_pred             EEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCccc
Q 001275          412 ISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQL  491 (1109)
Q Consensus       412 L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  491 (1109)
                      |....|+++...    -..++|+.|+.++|.++...+  -....+|+.+++++|+++ .+|+|++.|.+|+.+...+|+|
T Consensus       204 l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l  276 (1081)
T KOG0618|consen  204 LHCERNQLSELE----ISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRL  276 (1081)
T ss_pred             hhhhhcccceEE----ecCcchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhH
Confidence            555555444211    123445555555555541111  112234555555555554 2335555555555555555555


Q ss_pred             CCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccc-cceeecccccccccCCc-c
Q 001275          492 TGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVS-LVTLNISLNHVEGSLPS-Q  569 (1109)
Q Consensus       492 ~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~-~  569 (1109)
                      +..+..+....+|+.|++.+|.+. -+|.....++.|+.|||..|+|....+..+.-+.. |..|+.+.|.++ ..|. .
T Consensus       277 ~~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~  354 (1081)
T KOG0618|consen  277 VALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYE  354 (1081)
T ss_pred             HhhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-cccccc
Confidence            433333445555555555555554 44555555555555555555555332222222222 555555555555 2221 1


Q ss_pred             ccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcc-hhhhhhhhhhhhcccCcCCCCCCCCchhhhhh
Q 001275          570 LSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPT-FISELEKLLELQLGGNQLGGEIPPSIGALQDL  648 (1109)
Q Consensus       570 l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l  648 (1109)
                      =...+.|+.|++.+|.++...-..+.++++|++|+|++|++. ++|+ .+.++..|++|+||+|+|+ .+|..+..+..|
T Consensus       355 e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L  432 (1081)
T KOG0618|consen  355 ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRL  432 (1081)
T ss_pred             chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhh
Confidence            112345555555555555544444555555555555555555 3333 3455555555555555555 555555555555


Q ss_pred             hhhhcccccccccccCcchhhcccCCeEEccCCcccc-cCCCCCccccceEEeeeccc
Q 001275          649 SYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTG-TLSPLSNIHSLVEVNVSYNL  705 (1109)
Q Consensus       649 ~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g-~~~~l~~~~~l~~l~~~~n~  705 (1109)
                       .+|...+|+|. ..| ++.++++|+.+|||.|+|+- ++|....-+.|+.||+++|.
T Consensus       433 -~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  433 -HTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             -HHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence             34555555555 455 55555555555555555542 23332222455555555554

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.3e-37  Score=344.33  Aligned_cols=265  Identities=22%  Similarity=0.327  Sum_probs=201.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-----------------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-----------------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL  881 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  881 (1109)
                      ++|...++||+|+||.||+|.+.+                 +..||+|.+..........++.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568889999999999999997532                 346999988654444445679999999999999999999


Q ss_pred             eeEEecCCceeEEEEeccCCCHHHHHhccC----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEE
Q 001275          882 EDFWLRKDCGIIMYRYMENGSLRDVLHSIT----------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH  945 (1109)
Q Consensus       882 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  945 (1109)
                      ++++...+..++||||+++|+|.+++....                ....+++..+.+++.|++.|++|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999986532                1134788899999999999999999   889999


Q ss_pred             eccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhC--CCC
Q 001275          946 RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR--KKA 1023 (1109)
Q Consensus       946 ~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg--~~p 1023 (1109)
                      |||||+||++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||+++  ..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999866443322222234567899999999988999999999999999999974  455


Q ss_pred             CCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1024 LDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      |....  ..+....+..............           ........+.+++.+||+.||++||++.|+.+.|++
T Consensus       242 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELT--DEQVIENAGEFFRDQGRQVYLF-----------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCC--HHHHHHHHHHHhhhcccccccc-----------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            54321  1112222211111100000000           001123456778889999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=330.79  Aligned_cols=265  Identities=25%  Similarity=0.306  Sum_probs=198.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHH--HHHHhcCCCCceeeEeeEEecCC----ce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKRE--IQTIGKIRHRNLVRLEDFWLRKD----CG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~~~----~~  891 (1109)
                      .++....+.||+|.||.||+|++. |+.||||++..  .+  ++.+.+|  +..-..++|+||..|++.-..+.    ..
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s--rd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS--RD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecc--cc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            366778899999999999999998 88999999832  22  3334444  44445569999999999855443    46


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhc-----CCCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY-----DCDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                      ++|++|.+.|||+||+...    +++.+..++++..+|.||+|||.     ..++.|+|||||++||||..++.+.|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            8999999999999999874    49999999999999999999995     35888999999999999999999999999


Q ss_pred             cCCcccCCCCC--CceeeecccCcccccccccccCCC------CccCcchhhHHHHHHHHhCC----------CCCCCCc
Q 001275          967 GIAKLLDKSPA--STTSISVVGTIGYIAPENAFTTAK------SKESDVYSYGVVLLELITRK----------KALDPSY 1028 (1109)
Q Consensus       967 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~------~~~sDvwSlGvil~elltg~----------~p~~~~~ 1028 (1109)
                      |+|........  .......+||.+|||||++...--      -..+||||||.|+||+..+.          .||++.-
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            99987755422  223345799999999998864321      34799999999999998643          3443322


Q ss_pred             cccccHHHHHHHhhcCccccccccchhhhHHhhhc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1029 KERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS-SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      +.++...+.          .+.+-..++.+..... ...+.+..+.+++..||..+|..|-|+-.+-+.|.+..
T Consensus       441 p~DPs~eeM----------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  441 PSDPSFEEM----------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCCHHHH----------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            222211111          1111112222211111 12356788999999999999999999999999998875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.4e-37  Score=339.04  Aligned_cols=249  Identities=25%  Similarity=0.369  Sum_probs=208.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.. .++..+.+.+|++++++++|||||.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778889999999999999654 67899999985443 33456678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+.| +|..++...+   .++++.+..++.+++.||.|||   +.+|.|||+||.||+++..+.+|++|||+|+.+... 
T Consensus        82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9987 9999998654   4899999999999999999999   999999999999999999999999999999977543 


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                       ........|||-|||||...+++|+..+|.||+||++||+++|++||...     .+...++....+....        
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~v~~--------  219 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDPVKP--------  219 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCCCCC--------
Confidence             33445678999999999999999999999999999999999999999632     3344444433221111        


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                              .......+..++...+.+||..|.+-.+++.|-
T Consensus       220 --------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  220 --------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             --------cccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence                    113334566677789999999999999988774

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=350.74  Aligned_cols=258  Identities=23%  Similarity=0.323  Sum_probs=203.7

Q ss_pred             CCCCCceeecccCeEEEEEEeCC--C---cEEEEEEeee--cccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGP--N---AVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      +....++||+|+||.||+|++..  +   ..||||....  ........+|.+|+++|++++|||||+++|++....+.+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            34455889999999999996643  2   2389998753  234556778999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +|||+|.||+|.+|++....  .++..++.+++.++|+||+|||   +++++||||.++|+|++.++.+||+|||+++.-
T Consensus       238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999998653  5899999999999999999999   999999999999999999999999999998854


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHH-HHhhcCcccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWV-RSVWSDTEEIND 1050 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 1050 (1109)
                      ..  .........-+.+|+|||.+..+.|++++|||||||++||+++ |..||.+...  .++..++ ...+..      
T Consensus       313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--~~v~~kI~~~~~r~------  382 (474)
T KOG0194|consen  313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--YEVKAKIVKNGYRM------  382 (474)
T ss_pred             cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--HHHHHHHHhcCccC------
Confidence            31  1111112246789999999999999999999999999999999 7777754321  1222222 111100      


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPM 1104 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1104 (1109)
                                  ........++..++..||..+|++||+|.++.+.++.+....
T Consensus       383 ------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  383 ------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             ------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                        001122344555667999999999999999999998875543

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-38  Score=340.83  Aligned_cols=242  Identities=29%  Similarity=0.449  Sum_probs=200.4

Q ss_pred             CCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCC
Q 001275          823 AKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       823 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      ..+-+|+|+.|.||.|+.. ++.||||++..        --+.+|+-+++++|+||+.|.|+|.....+|+|||||..|-
T Consensus       128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhccCcccceeeeecc-CceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            3566999999999999998 77889998732        12357888999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceee
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI  982 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  982 (1109)
                      |++.++..+   +++......+..+||.|+.|||   ...|||||||+-||||+.+..|||+|||.++...+.   .+..
T Consensus       199 L~~VLka~~---~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM  269 (904)
T KOG4721|consen  199 LYEVLKAGR---PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM  269 (904)
T ss_pred             HHHHHhccC---ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence            999998744   4888899999999999999999   899999999999999999999999999999977543   3444


Q ss_pred             ecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhh
Q 001275          983 SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062 (1109)
Q Consensus       983 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1062 (1109)
                      .+.||..|||||++...+.++|+||||||||+|||+||..||..-...        ...|.-....-.           .
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--------AIIwGVGsNsL~-----------L  330 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--------AIIWGVGSNSLH-----------L  330 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--------eeEEeccCCccc-----------c
Confidence            679999999999999999999999999999999999999998542111        111221111111           1


Q ss_pred             chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1063 SSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1063 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .....+...+.-++..||+..|..||++++++.||.-+.
T Consensus       331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            112344556677888999999999999999999998664

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=335.99  Aligned_cols=251  Identities=25%  Similarity=0.334  Sum_probs=207.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ..|+..+.||+|.||.||+|.. ..++.||+|++.....+....++++|+.++.+++++||.++++.+..+...+++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4567778899999999999955 568999999998888888888999999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |.||++.+.++...   .+.+..+.-|+.++..|+.|+|   ..+.+|||||+.||++.++|.+|++|||++..+.....
T Consensus        93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999997643   3477778889999999999999   89999999999999999999999999999988765433


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      ..  ..++||+.|||||++....|+.|+||||+|++.+||.+|.+|+........ +.           .+..-..|.+.
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-lf-----------lIpk~~PP~L~  232 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-LF-----------LIPKSAPPRLD  232 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-EE-----------eccCCCCCccc
Confidence            32  457999999999999999999999999999999999999999865432110 00           00011111111


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .        .....+.+++..|++.+|+.||+|+++++|=
T Consensus       233 ~--------~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  233 G--------DFSPPFKEFVEACLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             c--------ccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence            1        2223355567799999999999999999874

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-37  Score=323.13  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=209.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+|++.+.||+|.||.|-+|.. ..|+.||||.+.+...+  .+.-.+.+|+++|..++||||+.++++|...+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            5677778899999999999954 78999999999665433  33446889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||..+|.|+||+...+.   +++.++..++.||..|+.|+|   +.++||||||.+|||+|.++.+||+|||++-.+...
T Consensus       133 EYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999999987654   999999999999999999999   999999999999999999999999999999877654


Q ss_pred             CCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..   .+.++|++-|.+||++.+.+| ++.+|-||+||++|-++.|..||++.     +....+++.-...         
T Consensus       207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQIs~Ga---------  269 (668)
T KOG0611|consen  207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQISRGA---------  269 (668)
T ss_pred             cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHhhccc---------
Confidence            33   345799999999999999999 78999999999999999999999753     3333443332111         


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                       ..       .++...+..-+++||+..+|++|.|+.|+..|-+-
T Consensus       270 -Yr-------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  270 -YR-------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             -cc-------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence             01       11222334457889999999999999999998763

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=349.78  Aligned_cols=254  Identities=26%  Similarity=0.363  Sum_probs=212.8

Q ss_pred             CCCCceeecccCeEEEEEEeC-CC----cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PN----AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+..++||+|+||+||+|.+- .|    -+||+|++......+...++.+|+.+|.+++|||+++++|+|.... ..+|+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            455788999999999999662 23    4689999977777778889999999999999999999999998765 88999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      +||+.|+|.||++..+.  .+..+..+.+..|||+|+.|||   +++.|||||.++||||.+...+||+|||+|+.....
T Consensus       777 q~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999998553  5888899999999999999999   999999999999999999999999999999988766


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      +.........-.+.|||-|.+..+.|+.++|||||||++||++| |..|++....+  ++.+.    ....+        
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--eI~dl----le~ge--------  917 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--EIPDL----LEKGE--------  917 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--HhhHH----Hhccc--------
Confidence            65555555566789999999999999999999999999999998 88887653211  11111    11111        


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                           . .+..+.+..+++.++.+||..|++.||+++++...+.+.
T Consensus       918 -----R-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  918 -----R-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             -----c-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence                 0 122345677899999999999999999999999999886

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-36  Score=351.35  Aligned_cols=260  Identities=21%  Similarity=0.333  Sum_probs=203.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      ++|+..++||+|+||+||+|+.      +++..||||++...........+.+|++++..+ +||||++++++|...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4688899999999999999963      345689999986444444456788999999999 899999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC-----------------------------------------------------------
Q 001275          892 IIMYRYMENGSLRDVLHSITP-----------------------------------------------------------  912 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  912 (1109)
                      ++||||+++|+|.++++....                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999865321                                                           


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          913 -------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       913 -------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                                   ...+++..+.+++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                         124788999999999999999999   8999999999999999999999999999998664432222


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ......+.....       ...+    
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~~-------~~~~----  339 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGYR-------MLSP----  339 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCcc-------CCCC----
Confidence            2222345678999999999999999999999999999998 77787543211 111111111000       0000    


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .....++.+++.+||+.||++||+++|+++.|++.
T Consensus       340 -------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 -------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                   01123567788899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=308.36  Aligned_cols=198  Identities=25%  Similarity=0.342  Sum_probs=177.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||.|+||.|..++.+ +|..+|+|++.+...  .+..+...+|..+++.+.||.++++++.|.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46788899999999999999765 588999999854331  223456778999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||++||.|..++++.+.   +++..+..+|.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+.+...
T Consensus       124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            99999999999998764   899999999999999999999   999999999999999999999999999999977432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                           ....+|||.|+|||++..+.|..++|.|||||++|||+.|..||...
T Consensus       198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence                 33479999999999999999999999999999999999999999754

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=313.69  Aligned_cols=274  Identities=24%  Similarity=0.313  Sum_probs=207.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccC-hHHHHHHHHHHhcCCCCceeeEeeEEec--CCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  894 (1109)
                      ++|...+.|++|.||.||+|+. ++++.||+|+++....+.+ ...-.+|+.++.+++|||||.+-++...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            5677889999999999999965 5689999999976554433 3356799999999999999999887654  4578999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||||+. +|...++...  ..+...++..+..|+++|++|||   +..|+|||||++|+|++..|.+||+|||+|+.+..
T Consensus       156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999987 9999998755  45888999999999999999999   89999999999999999999999999999998876


Q ss_pred             CCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc-ccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN-DIV 1052 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1052 (1109)
                      +.  ...+..+.|..|+|||.+.+. .|+.+.|+||+|||+.||+++++.|.+ ..+..++..+++......+.+. .+.
T Consensus       230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G-~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG-KSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC-CchHHHHHHHHHHhCCCccccCCCcc
Confidence            53  334567899999999988865 589999999999999999999987743 3333344444433322211111 111


Q ss_pred             chhhh---------HHhhhchhHHH--HHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1053 DLSLM---------EEMLVSSIRDQ--VIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1053 d~~~~---------~~~~~~~~~~~--~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .....         ...........  ...-.+++...+..||++|.||+|.++|=.-..
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence            10000         00001111111  133455667899999999999999999865544

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.7e-38  Score=347.99  Aligned_cols=363  Identities=27%  Similarity=0.396  Sum_probs=187.1

Q ss_pred             ccccEEEcCCCCCC-CCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceee
Q 001275          311 ARLSSLDLSENQLS-GKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLL  389 (1109)
Q Consensus       311 ~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  389 (1109)
                      +-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|++|.+++|++. .+-..+..++.|+.++
T Consensus         7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI   84 (1255)
T ss_pred             ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence            34445555555555 344555555555555555555554 45555555555555555555544 2333344444444444


Q ss_pred             ccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCccccc
Q 001275          390 VYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHG  469 (1109)
Q Consensus       390 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~  469 (1109)
                      +..|++...                       -+|..+..+..|+.||||+|+++ +.|..+...+++.+|+||+|+|..
T Consensus        85 ~R~N~LKns-----------------------GiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Iet  140 (1255)
T KOG0444|consen   85 VRDNNLKNS-----------------------GIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIET  140 (1255)
T ss_pred             hhccccccC-----------------------CCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcccc
Confidence            444444321                       23444444555555555555554 455555555555555555555553


Q ss_pred             CCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCccc-CCcchhhhc
Q 001275          470 PIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS-GLMPQELGN  548 (1109)
Q Consensus       470 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~  548 (1109)
                      +.-..+.+++.|..|+||+|++...+|.+..+..|++|+||+|.+...--..+-.+++|++|++|+-+=+ .-+|..+..
T Consensus       141 IPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~  220 (1255)
T KOG0444|consen  141 IPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD  220 (1255)
T ss_pred             CCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh
Confidence            3333444555555555555555555555555555555555555554222223333445555555543322 234555555


Q ss_pred             ccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhh
Q 001275          549 LVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQ  628 (1109)
Q Consensus       549 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  628 (1109)
                      |.+|..+|+|.|.+. .+|+.+-++++|+.|+||+|+|+ .+.-..+.+.+|+.|+||.|+++ .+|+.+..|++|+.|+
T Consensus       221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy  297 (1255)
T KOG0444|consen  221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLY  297 (1255)
T ss_pred             hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHH
Confidence            555555555555555 55555555555555555555555 44444555555555555555555 5555555555555555


Q ss_pred             cccCcCC-CCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCC-CCccccceEEeeeccc
Q 001275          629 LGGNQLG-GEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNL  705 (1109)
Q Consensus       629 l~~N~l~-g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~~n~  705 (1109)
                      +.+|+++ .-||..||++..| ..+..++|.|. -+|+.+..+..|+.|.|++|+|- ++|. +--++.|+.||+..|+
T Consensus       298 ~n~NkL~FeGiPSGIGKL~~L-evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  298 ANNNKLTFEGIPSGIGKLIQL-EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             hccCcccccCCccchhhhhhh-HHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence            5555554 2355555555555 34555555555 55555555555555555555555 3333 4445555555555553

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.3e-36  Score=349.42  Aligned_cols=260  Identities=21%  Similarity=0.340  Sum_probs=202.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      ++|+..+.||+|+||.||+|..      .++..||+|++...........+.+|+++++.+ +|+|||+++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4788899999999999999864      234579999986544444456788999999999 899999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC-----------------------------------------------------------
Q 001275          892 IIMYRYMENGSLRDVLHSITP-----------------------------------------------------------  912 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  912 (1109)
                      ++||||+++|+|.++++....                                                           
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999999999999864211                                                           


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeec
Q 001275          913 --------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV  984 (1109)
Q Consensus       913 --------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  984 (1109)
                              ...+++..+++++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                    124788899999999999999999   899999999999999999999999999999866443222222223


Q ss_pred             ccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          985 VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       985 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      .++..|+|||++.+..++.++|||||||++|||++ |+.||...... ...........       ....+         
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~~~~~-------~~~~~---------  337 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKRGY-------QMSRP---------  337 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHHHccc-------CccCC---------
Confidence            45678999999999999999999999999999997 99998643211 11111111000       00000         


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                        .....++.+++.+||+.||++||++.|+++.|+++
T Consensus       338 --~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         338 --DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              00124567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=326.89  Aligned_cols=258  Identities=24%  Similarity=0.301  Sum_probs=199.7

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc--------c-----ChHHHHHHHHHHhcCCCCceeeEe
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--------R-----GSLSMKREIQTIGKIRHRNLVRLE  882 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~-----~~~~~~~E~~~l~~l~h~niv~l~  882 (1109)
                      .-++|...+.||+|.||.|-+|+. .+++.||||++.+....        .     ..+.+.+|+.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            347899999999999999999965 56899999998554211        1     124788999999999999999999


Q ss_pred             eEEecC--CceeEEEEeccCCCHHHHHhccCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC
Q 001275          883 DFWLRK--DCGIIMYRYMENGSLRDVLHSITPPPT-LEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM  959 (1109)
Q Consensus       883 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  959 (1109)
                      ++..+.  +..|+|+|||..|.+..    ...... ++..++++++.++..||+|||   .++|+||||||+|+|++++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            998764  57899999999887743    222233 899999999999999999999   88999999999999999999


Q ss_pred             cEEEecccCCcccCCCC---CCceeeecccCcccccccccccCC---C-CccCcchhhHHHHHHHHhCCCCCCCCccccc
Q 001275          960 EPHISDFGIAKLLDKSP---ASTTSISVVGTIGYIAPENAFTTA---K-SKESDVYSYGVVLLELITRKKALDPSYKERT 1032 (1109)
Q Consensus       960 ~~kl~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~---~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~ 1032 (1109)
                      ++||+|||.+.......   ........+|||.|+|||...++.   + +.+.||||+||++|.++.|+.||.....   
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---  324 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---  324 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence            99999999998663221   111223468999999999887633   2 6789999999999999999999965422   


Q ss_pred             cHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1033 DIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                        ........          ...+.    .+..++..+++.+++.+++++||++|.+..||..|.+..
T Consensus       325 --~~l~~KIv----------n~pL~----fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  325 --LELFDKIV----------NDPLE----FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             --HHHHHHHh----------cCccc----CCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence              11111111          11111    111223445667788899999999999999999998754

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.9e-36  Score=332.40  Aligned_cols=246  Identities=18%  Similarity=0.300  Sum_probs=194.8

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeeccccc--ChHHHHHHHHHHhcCCCCceeeEeeEEec----CCceeEEEEe
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR--GSLSMKREIQTIGKIRHRNLVRLEDFWLR----KDCGIIMYRY  897 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  897 (1109)
                      ...||+|++|.||+|.. +|+.||||++.......  ..+.+.+|++++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999988 48899999985432211  13567899999999999999999999876    3467899999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      +++|+|.++++...   .+++....+++.+++.|++|||   + .+++||||||+||++++++.+||+|||+++.+....
T Consensus       104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            99999999997643   4889999999999999999999   5 478899999999999999999999999998654322


Q ss_pred             CCceeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          977 ASTTSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                           ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....  .+   ............ . .+ 
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~---~~~~i~~~~~~~-~-~~-  244 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KE---IYDLIINKNNSL-K-LP-  244 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HH---HHHHHHhcCCCC-C-CC-
Confidence                 12468899999999876  6789999999999999999999999964321  11   111111111000 0 00 


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                 ......+.+++.+||+.||++||+++|+++.|+..
T Consensus       245 -----------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        245 -----------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             -----------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                       01233566788899999999999999999999864

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.9e-36  Score=329.63  Aligned_cols=257  Identities=24%  Similarity=0.318  Sum_probs=201.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .++|+..++||+|+||.||.|+. .+|..+|+|++++..  .......+..|-.+|....+|.||+++..|.+.+..|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            36899999999999999999954 569999999996544  234456788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||++||++...|...+   .+++..+..++.+.+-|++.+|   +.|+|||||||+|+|||..|++||+|||++.-+..
T Consensus       220 MEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99999999999997644   5999999999999999999999   99999999999999999999999999999853321


Q ss_pred             C----------------------CCCc----e-------------------eeecccCcccccccccccCCCCccCcchh
Q 001275          975 S----------------------PAST----T-------------------SISVVGTIGYIAPENAFTTAKSKESDVYS 1009 (1109)
Q Consensus       975 ~----------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 1009 (1109)
                      .                      +...    .                   ....+|||-|+|||++.+..|+..+|.||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence            0                      0000    0                   01247999999999999999999999999


Q ss_pred             hHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-
Q 001275         1010 YGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP- 1088 (1109)
Q Consensus      1010 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP- 1088 (1109)
                      +|||+|||+.|.+||....... ....++.+.  ..-...+              ......+..++|.+|+. ||++|. 
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~-T~rkI~nwr--~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQE-TYRKIVNWR--ETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh--hhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999997643221 111111111  0000000              11111445567779998 999996 


Q ss_pred             --CHHHHHHHhh
Q 001275         1089 --NMRDVVRQLV 1098 (1109)
Q Consensus      1089 --s~~evl~~L~ 1098 (1109)
                        .++||-+|-.
T Consensus       436 ~~G~~EIK~HPf  447 (550)
T KOG0605|consen  436 SKGAEEIKKHPF  447 (550)
T ss_pred             cccHHHHhcCCc
Confidence              4777777643

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=319.71  Aligned_cols=273  Identities=22%  Similarity=0.299  Sum_probs=204.7

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEee-ecccccChHHHHHHHHHHhcCCCCceeeEeeEEec-----CC
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR-----KD  889 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~  889 (1109)
                      ..+.|...+.||+|+||.|++|.. .+|+.||||++. ........++..+|+.+++.++|+||+.+.+.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            345566678899999999999955 568999999985 23445556788899999999999999999998765     34


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..|+|+|+|+ .+|...++...   .++.+.+..+++|+++||.|+|   +.+|+|||+||+|++++.+...||+|||+|
T Consensus       100 DvYiV~elMe-tDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccce
Confidence            6799999995 49999988643   3888999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccc-cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-ccc
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-TEE 1047 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 1047 (1109)
                      +...........+.++.|..|+|||.+. ...||.+.||||.|||+.||++|+..|.+. +.-.++.......... .+.
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~-d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK-DYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC-chHHHHHHHHHhcCCCCHHH
Confidence            9886543344556789999999999775 467899999999999999999999888432 1111111111111111 111


Q ss_pred             cccccchhhhHHh----------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1048 INDIVDLSLMEEM----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      +..+-........          .....+..-...++++.+|+..||.+|+|++|+++|-
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            1111111111000          0111122234567788899999999999999999874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2e-35  Score=329.53  Aligned_cols=254  Identities=25%  Similarity=0.320  Sum_probs=199.6

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .|+..+.||+|+||+||+|.. .+++.||+|.+.....  ......+.+|++++++++|++|+++++++...+..++|+|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367788999999999999965 5789999998854332  2233467889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++.... ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999998886432 235889999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                         ......||..|+|||++.+..++.++||||+||++|||++|+.||....... ..............   .      
T Consensus       157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~---~------  223 (285)
T cd05631         157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVKEDQE---E------  223 (285)
T ss_pred             ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHHHhhcccc---c------
Confidence               1223578999999999999999999999999999999999999996532211 00011100000000   0      


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQL 1097 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 1097 (1109)
                             .......++.+++.+||+.||++||+     ++|+++|-
T Consensus       224 -------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~  262 (285)
T cd05631         224 -------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP  262 (285)
T ss_pred             -------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence                   00112234667888999999999997     89999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8.9e-36  Score=332.96  Aligned_cols=269  Identities=20%  Similarity=0.315  Sum_probs=200.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...++||+|+||+||+|... +++.||+|.+...........+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999664 68899999986554444455788999999999999999999999998899999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            985 9999887543  34788999999999999999999   89999999999999999999999999999976533221


Q ss_pred             CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-c---------
Q 001275          978 STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-E--------- 1046 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~--------- 1046 (1109)
                        ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+........... .         
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-EELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHHhhccccch
Confidence              2223568999999998865 56799999999999999999999998653211 11111111111000 0         


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .......+................+..+++.+|++.||.+|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000000000000001112346678889999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=9.1e-36  Score=332.33  Aligned_cols=258  Identities=23%  Similarity=0.404  Sum_probs=205.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|++.+.||+|+||.||+|....      ...||+|.+..........++.+|++.+.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467888999999999999997543      25789998854444444567899999999999999999999999988999


Q ss_pred             EEEEeccCCCHHHHHhccCCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC
Q 001275          893 IMYRYMENGSLRDVLHSITPP-------------PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM  959 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~-------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  959 (1109)
                      ++|||+++|+|.+++......             ..+++..++.++.|+++|++|||   +.+|+||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            999999999999999764221             35788999999999999999999   89999999999999999999


Q ss_pred             cEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHH
Q 001275          960 EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWV 1038 (1109)
Q Consensus       960 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1038 (1109)
                      .++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....  .+....+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~~~~i  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEVIEMI  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence            999999999986543332222233456889999999998899999999999999999998 9989864322  1122111


Q ss_pred             HHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1039 RSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1039 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ..   ..  ..             ........++.+++.+||+.||.+||+++|++++|+.
T Consensus       240 ~~---~~--~~-------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         240 RS---RQ--LL-------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             Hc---CC--cC-------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11   00  00             0011233567778889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=9.1e-36  Score=345.36  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=204.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCc
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  890 (1109)
                      .++|.+.++||+|+||.||+|+..      .+..||||++...........+.+|+++++++. ||||++++++|...+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            457888999999999999999752      234699999865444444567899999999995 9999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCC----------------------------------------------------------
Q 001275          891 GIIMYRYMENGSLRDVLHSITP----------------------------------------------------------  912 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  912 (1109)
                      .++||||+++|+|.++++....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999999865321                                                          


Q ss_pred             -----------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC
Q 001275          913 -----------------------------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS  957 (1109)
Q Consensus       913 -----------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~  957 (1109)
                                                         ...+++..+.+++.|+++|++|||   +.+|+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                               124788889999999999999999   899999999999999999


Q ss_pred             CCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHH
Q 001275          958 EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVG 1036 (1109)
Q Consensus       958 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 1036 (1109)
                      ++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-~~~~~  351 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-STFYN  351 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-HHHHH
Confidence            99999999999986643322222233457788999999999999999999999999999997 88887543211 11111


Q ss_pred             HHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1037 WVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1037 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .+..   .. ..              ........++.+++.+||+.||++||++.++.++|+++
T Consensus       352 ~~~~---~~-~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         352 KIKS---GY-RM--------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HHhc---CC-CC--------------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence            1100   00 00              00112234577788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-35  Score=338.65  Aligned_cols=269  Identities=24%  Similarity=0.339  Sum_probs=204.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|+..+.||+|+||.||++... ++..||+|.+...........+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            57889999999999999999765 67889999886543334456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP-PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      +++|+|.+++....   .+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          85 MDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            99999999997643   4889999999999999999999   54 69999999999999999999999999997653321


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh-cCcccccc-c---
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW-SDTEEIND-I--- 1051 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~--- 1051 (1109)
                          .....||..|+|||++.+..++.++|||||||++|||++|+.||......  .+...+.... ........ .   
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--ELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHhcccccccccCCccccCcc
Confidence                22357899999999999999999999999999999999999999643211  1111111000 00000000 0   


Q ss_pred             ------------cch-------hhhHHh----hhc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1052 ------------VDL-------SLMEEM----LVS-SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1052 ------------~d~-------~~~~~~----~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                                  .+.       ......    ... .......++.+++.+||+.||++||+++|+++|-+-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence                        000       000000    000 001123567889999999999999999999998753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-36  Score=319.39  Aligned_cols=264  Identities=27%  Similarity=0.363  Sum_probs=199.8

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-----ceeE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-----CGII  893 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  893 (1109)
                      .|...+++|+|+||.||+|... +++.||||+.-.+..     .-.+|+++|++++|||||++..+|....     ...+
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            4667889999999999999764 469999998743322     2247999999999999999999886533     3368


Q ss_pred             EEEeccCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccCCcc
Q 001275          894 MYRYMENGSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKL  971 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~~  971 (1109)
                      |||||+. +|+++++.. .....++...+.-+..|+.+|++|||   +.+|+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999987 999998753 12234777778889999999999999   8999999999999999977 8999999999998


Q ss_pred             cCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc-cc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE-IN 1049 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1049 (1109)
                      +......   ..+..|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+ .....++..+++......++ +.
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHHHHHHHhCCCCHHHHh
Confidence            8765443   446789999999988875 689999999999999999999988754 33444455555444322211 11


Q ss_pred             -------cccchhhhHHhhhc-hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1050 -------DIVDLSLMEEMLVS-SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1050 -------~~~d~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                             +.-.+.+....... .......+.++++.++++.+|.+|.++.|++.|
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                   11111222111111 122334677888889999999999999999876

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-35  Score=327.69  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=201.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.+...........+.+|++.+++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46888899999999999999653    35689999886544444456789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++....  ..+++..++.++.|++.|++|||   +.+++||||||+||+++.++.++++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            99999999999997643  35899999999999999999999   89999999999999999999999999998765422


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......  +....+   .... .   .  
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~---~~~~-~---~--  227 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAV---EDGF-R---L--  227 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH---HCCC-C---C--
Confidence            211 11112345678999999999999999999999999999775 99998643211  111111   1000 0   0  


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                               .........+.+++.+||+.+|++||+++|+.+.|.+.
T Consensus       228 ---------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ---------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                     00112234566788899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=332.43  Aligned_cols=249  Identities=23%  Similarity=0.293  Sum_probs=200.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|+||+||+|... +++.||+|++....  .......+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999765 68999999985432  1223456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999997643   4889999999999999999999   899999999999999999999999999999866432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .     ....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ...............      
T Consensus       155 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~------  218 (291)
T cd05612         155 T-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAGKLEFP------  218 (291)
T ss_pred             c-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCcCCC------
Confidence            1     234689999999999999999999999999999999999999864321     111111111100000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLVD 1099 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~~ 1099 (1109)
                                ......+.+++.+|++.||.+||+     ++|+++|-+-
T Consensus       219 ----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         219 ----------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             ----------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence                      011224556788999999999995     9999988643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-35  Score=337.03  Aligned_cols=258  Identities=23%  Similarity=0.359  Sum_probs=202.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCc----EEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNA----VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .+|+..+.||+|+||+||+|.+. +++    .||+|++..........++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46888999999999999999753 333    38999885444444566788999999999999999999998764 5789


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      |+||+++|+|.++++...  ..+++..++.++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999998643  34789999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............++..|+|||++.+..++.++|||||||++||+++ |+.||+.....  .+.....    .....   .
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~----~~~~~---~  231 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE----KGERL---P  231 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHh----CCCCC---C
Confidence            4333222223345678999999999999999999999999999998 99888643211  1111111    10000   0


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      .           ......++.+++.+||+.+|.+||++.|++.++.+...
T Consensus       232 ~-----------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         232 Q-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             C-----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence            0           01122356778889999999999999999999987743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=8.9e-38  Score=342.35  Aligned_cols=383  Identities=26%  Similarity=0.378  Sum_probs=294.5

Q ss_pred             cCCcEEEeecCCCC-CcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEE
Q 001275          287 SSLTHLDIVGSKLT-GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLE  365 (1109)
Q Consensus       287 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  365 (1109)
                      +-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|+.|.+++|++. .+-..+..++.|+.+.
T Consensus         7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI   84 (1255)
T ss_pred             ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence            44455666666666 345666667777777777777776 67777777777777777777776 4555667777777777


Q ss_pred             ccCccccc-cCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCcc-ccCCCCCceEEecCCcc
Q 001275          366 LFDNRLTG-EFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQS-LGINSSLMQLDFINNSF  443 (1109)
Q Consensus       366 L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~~~~L~~L~ls~N~l  443 (1109)
                      +.+|++.. -+|..+..+..|+.||||+|++. +.|..+..-+++-.|+||+|+|. .||.. +-+++.|-.||||+|.+
T Consensus        85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchh
Confidence            77777643 36777777777777777777776 56777777777777777777776 44544 34667777777777777


Q ss_pred             cccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccC-CCCCCcc
Q 001275          444 TGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNIS-GAIPSSI  522 (1109)
Q Consensus       444 ~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~-~~~p~~~  522 (1109)
                      . .+|+.+..+.+|++|+|++|.+.-.--.                       .+..+++|+.|.+|+-+-+ ..+|.++
T Consensus       163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLr-----------------------QLPsmtsL~vLhms~TqRTl~N~Ptsl  218 (1255)
T KOG0444|consen  163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLR-----------------------QLPSMTSLSVLHMSNTQRTLDNIPTSL  218 (1255)
T ss_pred             h-hcCHHHHHHhhhhhhhcCCChhhHHHHh-----------------------cCccchhhhhhhcccccchhhcCCCch
Confidence            6 5666666777777777777765411111                       1223445566666654332 3689999


Q ss_pred             cccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccce
Q 001275          523 GNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI  602 (1109)
Q Consensus       523 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  602 (1109)
                      .++.||..+|||.|.+. ..|+++.++++|+.|+||+|+|+ .+....+...+|+.|+||.|+++ .+|++++.+++|+.
T Consensus       219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k  295 (1255)
T KOG0444|consen  219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK  295 (1255)
T ss_pred             hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence            99999999999999998 78999999999999999999999 67777888899999999999999 89999999999999


Q ss_pred             eccccccccC-CCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCC
Q 001275          603 LKLSENHFTG-GIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSN  681 (1109)
Q Consensus       603 L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N  681 (1109)
                      |.+.+|+++- .||..|+.|.+|+.+..++|++. .+|+.++.+.+|. .|+|++|+|. .+|+.+.-|+.|+.|||..|
T Consensus       296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~-kL~L~~NrLi-TLPeaIHlL~~l~vLDlreN  372 (1255)
T KOG0444|consen  296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQ-KLKLDHNRLI-TLPEAIHLLPDLKVLDLREN  372 (1255)
T ss_pred             HHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHH-Hhccccccee-echhhhhhcCCcceeeccCC
Confidence            9999999874 49999999999999999999998 8999999999995 7999999999 79999999999999999999


Q ss_pred             cccccCCC-CCccccceEEeeec
Q 001275          682 NLTGTLSP-LSNIHSLVEVNVSY  703 (1109)
Q Consensus       682 ~l~g~~~~-l~~~~~l~~l~~~~  703 (1109)
                      .=--.+|. -..-+.|++-|+..
T Consensus       373 pnLVMPPKP~da~~~lefYNIDF  395 (1255)
T KOG0444|consen  373 PNLVMPPKPNDARKKLEFYNIDF  395 (1255)
T ss_pred             cCccCCCCcchhhhcceeeecce
Confidence            63324443 33346677766553

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-35  Score=312.98  Aligned_cols=275  Identities=23%  Similarity=0.340  Sum_probs=208.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCc-eeeEeeEEecCC------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRN-LVRLEDFWLRKD------  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  889 (1109)
                      ..|...++||+|+||+||+|+. .+|+.||+|++..... +.......+|+.++++++|+| ||++++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4466677899999999999955 5689999999976655 344556789999999999999 999999998877      


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPP-PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      ..++|+||++. +|.+++...... ..++...+..++.|+++|++|||   +.+|+||||||.||+++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            78899999976 999999876532 34677889999999999999999   99999999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      |+...-+.  ......++|..|+|||++.+. .|+...||||+|||++||++++..|.... +..++....+......+.
T Consensus       167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s-e~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS-EIDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc-HHHHHHHHHHHcCCCCcc
Confidence            99664332  224456899999999999887 68999999999999999999988775443 333333333322211111


Q ss_pred             c-cc---ccchhh-hHHh-----hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhhC
Q 001275         1048 I-ND---IVDLSL-MEEM-----LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ--LVDA 1100 (1109)
Q Consensus      1048 ~-~~---~~d~~~-~~~~-----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 1100 (1109)
                      . ..   ..+.+. ....     .....+....+..+++.+|++.+|.+|.+++++++|  +...
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            0 00   111110 0000     000011111467788899999999999999999998  5444

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.4e-35  Score=330.91  Aligned_cols=274  Identities=19%  Similarity=0.264  Sum_probs=202.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|...+.||+|+||+||+|+.. +++.||+|++...........+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999775 6889999998654444445567899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |++ +++.+++....  ..++++.+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 68888876532  34788999999999999999999   8999999999999999999999999999987543221


Q ss_pred             CCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-------ccc
Q 001275          977 ASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-------EEI 1048 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~ 1048 (1109)
                        .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.........+...........       ...
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence              12233568999999998765 45788999999999999999999999754322111111111110000       000


Q ss_pred             ccccchhhhHHhhhchhH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1049 NDIVDLSLMEEMLVSSIR------DQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~------~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ... ++............      ....++.+++.+|++.||++|||++|+++|-.-.
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         236 PHF-KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             ccc-ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence            000 00000000000000      0113456788899999999999999999876543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-35  Score=325.42  Aligned_cols=257  Identities=26%  Similarity=0.400  Sum_probs=205.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|+..+.||+|+||+||+|.+.    +...||||.+..........++.+|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            56888999999999999999774    24578999886554444556789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++++|.+++....  ..+++..+.+++.|++.|++|||   +.+|+||||||+||++++++.++++|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999997643  25899999999999999999999   89999999999999999999999999999987752


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...........++..|+|||.+.+..++.++||||||+++|||++ |..||.....  ......+...+.    ..    
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~~~~~~----~~----  228 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAVEDGYR----LP----  228 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCCC----CC----
Confidence            222222223345678999999998999999999999999999998 9888854321  111111111100    00    


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                ........+.+++.+|++.+|++||+++|++++|.++
T Consensus       229 ----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 ----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      0011234567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.4e-36  Score=331.85  Aligned_cols=251  Identities=29%  Similarity=0.470  Sum_probs=192.5

Q ss_pred             CCceeecccCeEEEEEEeC-----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          823 AKHVIGRGAHGIVYKASLG-----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       823 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ..+.||.|.||.||+|.+.     .+..|+||.+...........+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3567999999999999776     35789999985544444567899999999999999999999999988889999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.++++.. ....+++..+.+++.|+++||+|||   +.+|+|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            9999999999886 2345899999999999999999999   88999999999999999999999999999987633322


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      ............|+|||.+.+..++.++||||||+++||+++ |+.|+...  ...+   +........ ...       
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~~~~---~~~~~~~~~-~~~-------  225 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--DNEE---IIEKLKQGQ-RLP-------  225 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--CHHH---HHHHHHTTE-ETT-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc--cccc---ccccccccc-cce-------
Confidence            222233467789999999999889999999999999999999 67776433  1111   111111111 000       


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                             ........+.+++.+||+.||++||++.|+++.|
T Consensus       226 -------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 -------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                   0011233466788899999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-36  Score=295.97  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=205.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|.||.||.|+. +++-.||+|++.+..-.  .....+.+|+++...++||||.++++++.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            6789999999999999999965 46788999998555422  33567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||.+.|+++..+.... ...+++.....++.|+|.|+.|+|   .++|+||||||+|+|++.++..|++|||.+..-.. 
T Consensus       102 Eya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-  176 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-  176 (281)
T ss_pred             EecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence            9999999999998533 345788888999999999999999   99999999999999999999999999999975432 


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                         ......+||.-|.|||...+..++.++|+|++|++.||++.|.+||+....  .+....++..        ++.+| 
T Consensus       177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--~etYkrI~k~--------~~~~p-  242 (281)
T KOG0580|consen  177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--SETYKRIRKV--------DLKFP-  242 (281)
T ss_pred             ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--HHHHHHHHHc--------cccCC-
Confidence               223346899999999999999999999999999999999999999975431  1111111110        11111 


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                             .....   +..+++.+|+..+|.+|.+..|+++|-+
T Consensus       243 -------~~is~---~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  243 -------STISG---GAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             -------cccCh---hHHHHHHHHhccCccccccHHHHhhhHH
Confidence                   11222   3445777999999999999999998865

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-35  Score=335.88  Aligned_cols=247  Identities=21%  Similarity=0.281  Sum_probs=199.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+|.+.+.||+|+||.||+|+.. +++.||+|.+....  .......+.+|++++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999775 58899999985432  2233457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999997643   4788899999999999999999   899999999999999999999999999999866432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .................    
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~~~p~~----  237 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKILAGRLKFPNW----  237 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHhcCCcCCCCC----
Confidence            2     134799999999999999999999999999999999999999864321     11111111111011010    


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQL 1097 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 1097 (1109)
                               .   ..++.+++.+||+.||++||+     ++|+++|-
T Consensus       238 ---------~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp  272 (329)
T PTZ00263        238 ---------F---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP  272 (329)
T ss_pred             ---------C---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence                     1   123556788999999999996     78888774

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-35  Score=334.48  Aligned_cols=244  Identities=21%  Similarity=0.257  Sum_probs=195.0

Q ss_pred             ceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          825 HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      +.||+|+||.||+|.. .+|+.||+|++....  .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999966 468999999986432  2223456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCcee
Q 001275          902 SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS  981 (1109)
Q Consensus       902 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  981 (1109)
                      +|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            9999987643   4889999999999999999999   8999999999999999999999999999987542221  122


Q ss_pred             eecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhh
Q 001275          982 ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEML 1061 (1109)
Q Consensus       982 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1061 (1109)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............             
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~~~~-------------  214 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEIRF-------------  214 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCCCCC-------------
Confidence            345799999999999999999999999999999999999999964321     11111111111000             


Q ss_pred             hchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 001275         1062 VSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQL 1097 (1109)
Q Consensus      1062 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 1097 (1109)
                      .   .....++.+++.+|++.||++||     +++|+++|-
T Consensus       215 p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~  252 (323)
T cd05571         215 P---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR  252 (323)
T ss_pred             C---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence            0   01123456677899999999999     899998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-35  Score=329.15  Aligned_cols=260  Identities=20%  Similarity=0.351  Sum_probs=202.1

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      ++++|+..+.||+|+||.||+|...      .+..||+|++..........++.+|+.+++.++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4577999999999999999998653      3567999987543333345578899999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          891 GIIMYRYMENGSLRDVLHSITP-------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                      .++||||+++|+|.++++....       ....++..+..++.|+++|++|||   +.+++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999975332       124678899999999999999999   889999999999999999999999


Q ss_pred             ecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhh
Q 001275          964 SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....  ......+   .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--~~~~~~~---~  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVLRFV---M  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---H
Confidence            99999986543322221122345788999999998899999999999999999999 6777753311  1111111   1


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ...  ....             .......+.+++.+|++.+|++||++.|+++++++
T Consensus       236 ~~~--~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGG--LLDK-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCC--cCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            000  0000             01122346778889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.5e-35  Score=338.03  Aligned_cols=260  Identities=23%  Similarity=0.350  Sum_probs=201.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecC-Cc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK-DC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  890 (1109)
                      ++|++.++||+|+||.||+|...      +++.||+|++...........+.+|++++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            57889999999999999999532      34789999885443333445678899999999 899999999988654 56


Q ss_pred             eeEEEEeccCCCHHHHHhccCC----------------------------------------------------------
Q 001275          891 GIIMYRYMENGSLRDVLHSITP----------------------------------------------------------  912 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  912 (1109)
                      .++++||+++|+|.+++.....                                                          
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            7899999999999999864321                                                          


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCccccc
Q 001275          913 PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA  992 (1109)
Q Consensus       913 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~a  992 (1109)
                      ...++|..+.+++.|+++|++|||   +.+|+||||||+||++++++.++|+|||+++.+.............++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            125789999999999999999999   89999999999999999999999999999987644332222223456778999


Q ss_pred             ccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHH
Q 001275          993 PENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVID 1071 (1109)
Q Consensus       993 PE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 1071 (1109)
                      ||++.+..++.++||||+||++|||++ |+.||...... .......    ......  . .           ......+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~----~~~~~~--~-~-----------~~~~~~~  304 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRL----KEGTRM--R-A-----------PEYATPE  304 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHH----hccCCC--C-C-----------CccCCHH
Confidence            999999999999999999999999998 98888542111 1111111    000000  0 0           0112345


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1072 VLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1072 l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      +.+++.+||+.+|++||++.|++++|+++
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            77888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=299.13  Aligned_cols=263  Identities=23%  Similarity=0.340  Sum_probs=205.0

Q ss_pred             hCCCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-----cee
Q 001275          819 ENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-----CGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  892 (1109)
                      ++|++.+.+|+|||..||.++ ..+++.||+|++.... .++....++|++..++++||||++++++...+.     +.|
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            578889999999999999996 5678999999996544 566778899999999999999999999876543     489


Q ss_pred             EEEEeccCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          893 IMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++++|...|+|.+.+..... ...+++.+++.|+.++++||++||.. .++++||||||.||++.+++.+++.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999999976543 44799999999999999999999932 33499999999999999999999999999875


Q ss_pred             cCCCCCC-------ceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh
Q 001275          972 LDKSPAS-------TTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       972 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      ..-.-..       ........|..|+|||.+.   +...++++||||+||++|+|+.|..||+..++....+.-     
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL-----  253 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL-----  253 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-----
Confidence            5321110       1122346899999999775   445589999999999999999999999865442221111     


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              .+..+.+.    .+......+.+.+++.+|++.||.+||++.|++.++.+.
T Consensus       254 --------Av~n~q~s----~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 --------AVQNAQIS----IPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             --------eeeccccc----cCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                    11111111    011112445677788899999999999999999998765

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-35  Score=328.30  Aligned_cols=258  Identities=26%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|.+.+.||+|+||.||+|...      +++.||+|.+......+....+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            46788899999999999999763      347899999865444445678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          893 IMYRYMENGSLRDVLHSITP-----------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                      +||||+++|+|.++++..+.           ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence            99999999999999976432           235789999999999999999999   8999999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |+.||......  .....+  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--~~~~~~--  237 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--EVIECI--  237 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH--
Confidence            9999999986543322222223456788999999999999999999999999999998 99998543221  111111  


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                       ....  ....             .......+.+++.+||+.||++||+++|+++.|.+
T Consensus       238 -~~~~--~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 -TQGR--LLQR-------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -HcCC--cCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence             1000  0000             01122446678889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.1e-35  Score=326.98  Aligned_cols=268  Identities=20%  Similarity=0.276  Sum_probs=200.2

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|++.+.||+|+||+||+|+.. +++.||+|++..... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            6888999999999999999775 578999999865432 23345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++++.+..+...   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          82 VEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            998877655432   234889999999999999999999   89999999999999999999999999999987643221


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-----------cc
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-----------TE 1046 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~~ 1046 (1109)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... ......           ..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLFTI-QKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHH-HHhhCCCCHHHHHhhhccc
Confidence             1222357899999999999989999999999999999999999998643211 111111 110000           00


Q ss_pred             ccccccchhhh--HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1047 EINDIVDLSLM--EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1047 ~~~~~~d~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .......+...  .............++.+++.+|++.||++||+++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00000000000  000000001123457788899999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.8e-35  Score=326.35  Aligned_cols=264  Identities=22%  Similarity=0.331  Sum_probs=202.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCc----EEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNA----VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .+|+..+.||+|+||+||+|.+. +++    .+++|.+..........++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46788899999999999999764 344    467777643333333456788888999999999999999875 456789


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ++||+++|+|.++++...  ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999997643  35899999999999999999999   8899999999999999999999999999998664


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............++..|+|||...+..++.++|||||||++||+++ |+.||......  ....++    ......   .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~----~~~~~~---~  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLL----EKGERL---A  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH----HCCCcC---C
Confidence            3322222233457789999999998999999999999999999998 98888543211  111111    111100   0


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCCCCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKYV 1109 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~ 1109 (1109)
                      .+.           ....++..++.+||..+|++||++.|+++.|.....+ +++|+
T Consensus       232 ~~~-----------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~-~~~~~  276 (279)
T cd05111         232 QPQ-----------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD-PPRYL  276 (279)
T ss_pred             CCC-----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC-Cccee
Confidence            000           1123456688899999999999999999999887443 36653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.4e-35  Score=321.57  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=201.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .+|+..+.||+|+||.||+|+.+++..+|+|.+..  ......++.+|++++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEeccc--CCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            45778889999999999999998888999998742  2334567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.++++...  ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+|++|||.++....... 
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05114          82 ENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-  155 (256)
T ss_pred             CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence            9999999997533  24889999999999999999999   89999999999999999999999999999986543222 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||++.+..++.++||||||+++|||++ |+.||.....  .+....+   .....    ...+.  
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--~~~~~~i---~~~~~----~~~~~--  224 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--YEVVEMI---SRGFR----LYRPK--  224 (256)
T ss_pred             eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH---HCCCC----CCCCC--
Confidence            11122345678999999988889999999999999999999 8888854321  1111111   11100    00000  


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               ....++.+++.+||+.+|++||+++|+++.|.
T Consensus       225 ---------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ---------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                     11235678889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.6e-35  Score=334.67  Aligned_cols=199  Identities=28%  Similarity=0.417  Sum_probs=173.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|+..++||+|+||.||+|... ++..+|+|.+...........+.+|++++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            67899999999999999999775 57888999875543334456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      +++|+|.+++....   .+++..+..++.++++|++|||   + .+|+||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          85 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            99999999997643   4788999999999999999999   5 479999999999999999999999999987653321


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                          .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                12346899999999999888999999999999999999999998653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=335.25  Aligned_cols=255  Identities=20%  Similarity=0.256  Sum_probs=201.9

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +|.+.+.||+|+||.||+|... +++.||+|++.....  ......+.+|++++.+++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            6888999999999999999775 588999999864422  2234568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....  
T Consensus        82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999997643   4889999999999999999999   89999999999999999999999999999986543  


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                         ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  +....+.. +..........++. 
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~i~~-~~~~~~~~~~~~~~-  226 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--ETWENLKY-WKETLQRPVYDDPR-  226 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--HHHHHHHh-ccccccCCCCCccc-
Confidence               122357999999999999999999999999999999999999999643211  11111110 00000000000000 


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               .....++.+++.+|++.+|++||+++|+++|-.
T Consensus       227 ---------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         227 ---------FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             ---------cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence                     112344667788999999999999999998843

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.2e-35  Score=333.48  Aligned_cols=248  Identities=20%  Similarity=0.261  Sum_probs=199.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC--CcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP--NAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|...+.||+|+||.||+|....  +..||+|++....  .......+.+|+++++.++||||+++++++...+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            568889999999999999997543  3689999885432  223345688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999997643   4889999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..     ....||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..............     
T Consensus       184 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~i~~~~~~~p-----  248 (340)
T PTZ00426        184 RT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIYQKILEGIIYFP-----  248 (340)
T ss_pred             Cc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHHHHHhcCCCCCC-----
Confidence            21     2357999999999999988999999999999999999999999643211     11111111110000     


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                              ....   .++.+++.+|++.||++|+     +++|+++|-+
T Consensus       249 --------~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        249 --------KFLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             --------CCCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence                    0111   2345677799999999995     8999998843

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.9e-35  Score=321.61  Aligned_cols=255  Identities=23%  Similarity=0.341  Sum_probs=204.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|++.++||+|+||.||+|...+++.||+|.+...  ......+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            568889999999999999999888889999987432  234567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.++++... ...+++..++.++.|+++|++|||   +.+++||||||+||+++.++.++|+|||+++....... 
T Consensus        84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  158 (261)
T cd05072          84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-  158 (261)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence            9999999997643 345889999999999999999999   89999999999999999999999999999987643321 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |+.||.....  .+....+...+    ...        
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~----~~~--------  224 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQRGY----RMP--------  224 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--HHHHHHHHcCC----CCC--------
Confidence            11122346778999999988889999999999999999998 8888854221  11111111100    000        


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                            .......++.+++.+|++.+|++||+++++.+.|+++
T Consensus       225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 ------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                  0011223466788899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-35  Score=320.22  Aligned_cols=256  Identities=23%  Similarity=0.330  Sum_probs=204.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .++|++.+.||+|+||.||+|...+++.||+|.+...  .....++.+|++++++++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG--TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC--cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            3568889999999999999998888889999987432  23456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++.... ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999997643 345899999999999999999999   89999999999999999999999999999987653221


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                       ........+..|+|||+..+..++.++||||||+++|||++ |+.||......  .....+..   . ...    .   
T Consensus       159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~---~-~~~----~---  224 (261)
T cd05068         159 -EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQVDQ---G-YRM----P---  224 (261)
T ss_pred             -cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc---C-CCC----C---
Confidence             11122234568999999999899999999999999999999 88888543211  11111110   0 000    0   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             ........+.+++.+|++.+|++||+++++++.|++.
T Consensus       225 -------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         225 -------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                   0011234567788899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.5e-35  Score=328.48  Aligned_cols=260  Identities=23%  Similarity=0.362  Sum_probs=205.0

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCc
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  890 (1109)
                      .++|+..+.||+|+||.||+|...      ....+|+|.+..........++.+|++++.++ +|+||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            356888899999999999999763      23678999886544444456788999999999 89999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC
Q 001275          891 GIIMYRYMENGSLRDVLHSIT-------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS  957 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~  957 (1109)
                      .++||||+++|+|.++++...             ....+++..+++++.|++.|++|||   +.+|+||||||+||+++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcC
Confidence            999999999999999997532             2346899999999999999999999   899999999999999999


Q ss_pred             CCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHH
Q 001275          958 EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVG 1036 (1109)
Q Consensus       958 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~ 1036 (1109)
                      ++.+|++|||+++.+.............++..|+|||+..+..++.++|||||||++||+++ |..||.....  .+...
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~  245 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--EELFK  245 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--HHHHH
Confidence            99999999999987654332222222345678999999988899999999999999999998 8888753211  11111


Q ss_pred             HHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1037 WVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1037 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..   .... ..              ........++.+++.+|++.+|++|||++|+++.|+++
T Consensus       246 ~~---~~~~-~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         246 LL---KEGY-RM--------------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HH---HcCC-cC--------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            11   1000 00              00112234577788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=344.20  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=205.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCC-cEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEee-EEec------CC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPN-AVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLED-FWLR------KD  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~------~~  889 (1109)
                      .++++.++|.+|||+.||.|....+ ..||+|++... ++.....+.+|+++|++++ |+|||.+++ ....      ..
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            3456778999999999999987666 99999999554 7777888999999999996 999999999 3221      13


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      +.++.||||+||.|-|++..+.... +++.++++|+.++++|+++||+. +++|+|||||.+|||++.++..||||||.|
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            5789999999999999998654333 99999999999999999999954 788999999999999999999999999998


Q ss_pred             cccCCCCCCc-------eeeecccCccccccccc---ccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHH
Q 001275          970 KLLDKSPAST-------TSISVVGTIGYIAPENA---FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       970 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      .-........       .......|+.|+|||++   .+...++|+|||++||++|-++....||+....-         
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------  264 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------  264 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence            7433222111       11234689999999966   4677899999999999999999999999753111         


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                                .+++...    ..+..+.....+..||..|+++||.+||++-+|+..+.++.
T Consensus       265 ----------aIlng~Y----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  265 ----------AILNGNY----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ----------eEEeccc----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                      1212111    11122345566777888999999999999999999998763

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.3e-35  Score=325.50  Aligned_cols=258  Identities=22%  Similarity=0.365  Sum_probs=202.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .+|++.+.||+|+||+||+|..     ..+..||+|.+...........+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            3577788999999999999974     35678999988644444445678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC
Q 001275          894 MYRYMENGSLRDVLHSITP--------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM  959 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  959 (1109)
                      ||||+++|+|.+++.....              ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            9999999999999864321              234788999999999999999999   88999999999999999999


Q ss_pred             cEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHH
Q 001275          960 EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWV 1038 (1109)
Q Consensus       960 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1038 (1109)
                      .+|++|||+++...............++..|+|||+..+..++.++|||||||++|||++ |..||.....  ..+...+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence            999999999986644332222233456778999999988889999999999999999998 8888754311  1111111


Q ss_pred             HHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1039 RSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1039 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ...   . .. .             .......++.+++.+|++.||++||++.++.++|..
T Consensus       240 ~~~---~-~~-~-------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKR---Q-LL-P-------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcC---C-cC-C-------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            110   0 00 0             001112346668889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-35  Score=328.64  Aligned_cols=241  Identities=21%  Similarity=0.293  Sum_probs=192.1

Q ss_pred             eecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          827 IGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      ||+|+||.||+|... +++.||+|++....  .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999765 57899999985432  233345678899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeee
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS  983 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  983 (1109)
                      .+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            99997643   4889999999999999999999   8999999999999999999999999999998543221  12233


Q ss_pred             cccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          984 VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       984 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||....     ................             .
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~~~~~~~~~-------------~  214 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKILQEPLRFP-------------D  214 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHHHcCCCCCC-------------C
Confidence            579999999999999999999999999999999999999996432     1122222111110000             0


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCC---CHHHHHHH
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRP---NMRDVVRQ 1096 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RP---s~~evl~~ 1096 (1109)
                         ....++.+++.+|++.||++||   ++.|+++|
T Consensus       215 ---~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         215 ---GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             ---cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence               1123455677899999999997   46777766

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-34  Score=336.33  Aligned_cols=266  Identities=19%  Similarity=0.221  Sum_probs=199.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|.+.+.||+|+||.||+|.. .+++.||+|...       ...+.+|++++++++||||+++++++......++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            5799999999999999999965 568899999642       23467899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +. ++|.+++....   .+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+...... 
T Consensus       165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            95 68988886543   4789999999999999999999   8899999999999999999999999999997543221 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc------cccHHHHHHHhhcCccccc--
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE------RTDIVGWVRSVWSDTEEIN-- 1049 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~-- 1049 (1109)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.|+......      ...+...+...........  
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            11223457999999999999999999999999999999999999887542211      1111111111111000000  


Q ss_pred             --cccchhh---hH--------HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1050 --DIVDLSL---ME--------EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1050 --~~~d~~~---~~--------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                        ...+...   ..        ............++.+++.+|++.||++|||++|+++|=+-
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f  379 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF  379 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence              0000000   00        00000111234567788999999999999999999987554

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-36  Score=299.54  Aligned_cols=256  Identities=26%  Similarity=0.387  Sum_probs=202.1

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccC---h----HHHHHHHHHHhcC-CCCceeeEeeEEecC
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRG---S----LSMKREIQTIGKI-RHRNLVRLEDFWLRK  888 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~----~~~~~E~~~l~~l-~h~niv~l~~~~~~~  888 (1109)
                      -+.|...+++|+|..++|.++.. .+|..+|+|++...+....   .    ..-.+|+.+++++ .||+|+++.++|..+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            46788889999999999999844 5688999999865443221   2    2345799999999 799999999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      ...++|+|.|+.|.|.|++.+.-   ++++++..+|+.|+.+|++|||   ...||||||||+|||++++.++||+|||+
T Consensus        96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccce
Confidence            99999999999999999998643   5899999999999999999999   99999999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccc------cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAF------TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      |+.+..+..   ....+|||+|.|||.+.      ...|+..+|+|++|||+|.++.|.+||..-.    ++. .++...
T Consensus       170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----Qml-MLR~Im  241 (411)
T KOG0599|consen  170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----QML-MLRMIM  241 (411)
T ss_pred             eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH----HHH-HHHHHH
Confidence            998865543   33479999999999775      3457889999999999999999999996321    111 111111


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      +..-            .+..+...+......+++.+|++.||++|.|++|+++|-.-
T Consensus       242 eGky------------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  242 EGKY------------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             hccc------------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            1100            01111222333445567779999999999999999988643

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.9e-35  Score=325.54  Aligned_cols=268  Identities=23%  Similarity=0.321  Sum_probs=195.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe--CCCcEEEEEEeeeccccc-ChHHHHHHHHHHhcC---CCCceeeEeeEEec-----
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL--GPNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKI---RHRNLVRLEDFWLR-----  887 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----  887 (1109)
                      ++|++.+.||+|+||+||+|+.  .+++.||+|++....... ....+.+|+.+++++   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3688899999999999999976  346889999886543322 234566787777766   69999999999853     


Q ss_pred             CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          888 KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       888 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                      ....++||||++ ++|.+++.... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345799999997 59999987643 234889999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-cc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-TE 1046 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~ 1046 (1109)
                      +++.....   .......||+.|+|||.+.+..++.++||||+||++|||++|+.||...... ..+...+...... ..
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~  231 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE  231 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChh
Confidence            99866433   1223357899999999999889999999999999999999999998654221 1111111111000 00


Q ss_pred             ccc-------cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1047 EIN-------DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1047 ~~~-------~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...       ....... ........+.....+.+++.+|++.||++||++.|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         232 DWPRDVALPRQAFHSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hchhhhcccchhccCCC-CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            000       0000000 000000001122445678889999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=7.3e-35  Score=335.31  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=194.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|+..++||+|+||+||+|+.. +++.||||++...........+.+|++++++++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34556788999999999999764 68999999985444444456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+..       ...+..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.......
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986532       2456778899999999999999   89999999999999999999999999999986643221


Q ss_pred             CceeeecccCccccccccccc-----CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          978 STTSISVVGTIGYIAPENAFT-----TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                        ......||..|+|||++..     ...+.++|||||||++|||++|+.||.....  .+.............      
T Consensus       224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~------  293 (353)
T PLN00034        224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDWASLMCAICMSQP------  293 (353)
T ss_pred             --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccHHHHHHHHhccCC------
Confidence              1223579999999998743     2335689999999999999999999963211  111111111100000      


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                               .........++.+++.+||+.||++||+++|+++|-+-
T Consensus       294 ---------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~  331 (353)
T PLN00034        294 ---------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI  331 (353)
T ss_pred             ---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence                     00001122356778889999999999999999998543

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-34  Score=329.37  Aligned_cols=244  Identities=22%  Similarity=0.261  Sum_probs=194.1

Q ss_pred             ceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          825 HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      +.||+|+||.||++.. .+|+.||+|++....  .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999976 468999999985432  2233456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCcee
Q 001275          902 SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS  981 (1109)
Q Consensus       902 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  981 (1109)
                      +|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            9999887543   4889999999999999999999   8999999999999999999999999999987532221  122


Q ss_pred             eecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhh
Q 001275          982 ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEML 1061 (1109)
Q Consensus       982 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1061 (1109)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......     .............             
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~~~~-------------  214 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEIRF-------------  214 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCCCC-------------
Confidence            3357999999999999999999999999999999999999998643211     1111111111000             


Q ss_pred             hchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 001275         1062 VSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQL 1097 (1109)
Q Consensus      1062 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 1097 (1109)
                      +.   ....++.+++.+|++.||++||     ++.|+++|-
T Consensus       215 p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         215 PR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             CC---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence            00   1123455677799999999998     899998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=324.28  Aligned_cols=265  Identities=22%  Similarity=0.316  Sum_probs=200.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC---------------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP---------------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED  883 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  883 (1109)
                      ++|++.++||+|+||.||++....               ...||+|.+...........+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999986532               23589998854433444557899999999999999999999


Q ss_pred             EEecCCceeEEEEeccCCCHHHHHhccCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCee
Q 001275          884 FWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENIL  954 (1109)
Q Consensus       884 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  954 (1109)
                      ++...+..++||||+++++|.+++.....         ...+++..++.++.|+++|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            99999999999999999999999865321         124688999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh--CCCCCCCCccccc
Q 001275          955 LDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT--RKKALDPSYKERT 1032 (1109)
Q Consensus       955 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~~ 1032 (1109)
                      +++++.+||+|||++................++..|+|||+..++.++.++|||||||++|+|++  |..||.....  .
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--~  239 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--E  239 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--H
Confidence            99999999999999986543322222222345778999999998899999999999999999998  4556643211  1


Q ss_pred             cHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1033 DIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .........+...........           .......+.+++.+||+.||++||+++++++.|.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYLSQ-----------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHhhhhccccccCCC-----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            111111111111000000000           01122457788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=301.75  Aligned_cols=257  Identities=23%  Similarity=0.319  Sum_probs=201.9

Q ss_pred             hhCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +++|++.++||+|.|+.||++ ...+|+.+|+|.+.... ...+.+++.+|+++-+.++|||||++.+.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            467788889999999999998 44578999999874332 3336678999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC---CcEEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla~~~  972 (1109)
                      |+|+|++|..-+-..   ..+++..+-..+.||+++++|+|   .++|||||+||.|+++...   --+|++|||+|..+
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999997655332   24677778889999999999999   9999999999999999543   35899999999988


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ..   .....+.+|||+|||||++...+|+..+|||+.|||+|-++.|+.||.....  .++.+   ......-.+    
T Consensus       164 ~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--~rlye---~I~~g~yd~----  231 (355)
T KOG0033|consen  164 ND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYE---QIKAGAYDY----  231 (355)
T ss_pred             CC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--HHHHH---HHhccccCC----
Confidence            63   3344568999999999999999999999999999999999999999975322  22222   111111111    


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ++     ...+...+++.   +++.+|+..||.+|.|+.|+++|-+-.
T Consensus       232 ~~-----~~w~~is~~Ak---~LvrrML~~dP~kRIta~EAL~HpWi~  271 (355)
T KOG0033|consen  232 PS-----PEWDTVTPEAK---SLIRRMLTVNPKKRITADEALKHPWIC  271 (355)
T ss_pred             CC-----cccCcCCHHHH---HHHHHHhccChhhhccHHHHhCCchhc
Confidence            11     01112334444   466699999999999999999887643

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=331.60  Aligned_cols=242  Identities=25%  Similarity=0.349  Sum_probs=194.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|...++||+|.||+|+.+..+ +++.+|||.+++..  ...+....+.|.+++... +||.+++++.+|...++.|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            67899999999999999999765 57899999996654  234456778888888877 599999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+.||++..+.+    ...+++..+..+|..|+.||+|||   +++|||||||.+|||+|.+|.+||+|||+++.-..
T Consensus       448 mey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  448 MEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999444333    235899999999999999999999   99999999999999999999999999999985432


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..  .....++||+.|||||++.+..|+..+|.|||||++|||+.|..||.+..++  ++.   .....+     +..- 
T Consensus       521 ~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--e~F---dsI~~d-----~~~y-  587 (694)
T KOG0694|consen  521 QG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--EVF---DSIVND-----EVRY-  587 (694)
T ss_pred             CC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--HHH---HHHhcC-----CCCC-
Confidence            22  2334579999999999999999999999999999999999999999654222  111   111111     1111 


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM 1090 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 1090 (1109)
                                ..-...+.+.++.+++..+|++|..+
T Consensus       588 ----------P~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  588 ----------PRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ----------CCcccHHHHHHHHHHhccCcccccCC
Confidence                      11223456667889999999999865

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-34  Score=328.64  Aligned_cols=245  Identities=22%  Similarity=0.270  Sum_probs=195.4

Q ss_pred             ceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          825 HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      +.||+|+||.||++.. .+++.||+|++....  .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999976 468999999985432  2233457788999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCcee
Q 001275          902 SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS  981 (1109)
Q Consensus       902 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  981 (1109)
                      +|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            9999887543   4889999999999999999999   8999999999999999999999999999987542221  122


Q ss_pred             eecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhh
Q 001275          982 ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEML 1061 (1109)
Q Consensus       982 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 1061 (1109)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .............+             
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~-------------  214 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEDIKF-------------  214 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccCCccC-------------
Confidence            335799999999999999999999999999999999999999964321     11111111111000             


Q ss_pred             hchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1062 VSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1062 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                      +.   ....++.+++.+|++.||++||     +++|+++|-+
T Consensus       215 p~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         215 PR---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             CC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence            00   1123456677899999999997     8999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.8e-35  Score=325.62  Aligned_cols=261  Identities=23%  Similarity=0.365  Sum_probs=204.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|...+.||+|+||.||+|...      ++..+++|.+.. ......+.+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC-ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            45777889999999999999642      345688888732 22333457899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC
Q 001275          893 IMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM  959 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  959 (1109)
                      +||||+++++|.+++.....             ...+++..++.++.|++.|++|||   +.+|+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            99999999999999975431             234889999999999999999999   89999999999999999999


Q ss_pred             cEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHH
Q 001275          960 EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWV 1038 (1109)
Q Consensus       960 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1038 (1109)
                      .++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||......  ...   
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~---  235 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVI---  235 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHH---
Confidence            999999999986644322222233456789999999999999999999999999999999 99887543221  111   


Q ss_pred             HHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCC
Q 001275         1039 RSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVP 1103 (1109)
Q Consensus      1039 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1103 (1109)
                      .......  ....             ......++.+++.+||+.+|++||+++++++.|.++..+
T Consensus       236 ~~~~~~~--~~~~-------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 ECITQGR--VLER-------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHhCCC--CCCC-------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            1111100  0000             011234567788899999999999999999999998443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=325.66  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=209.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC---CC--cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG---PN--AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      +.....++||.|.||.||+|.+.   .|  -.||||..+..........|..|..+|++++|||||+++|+|.+ ...++
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            34455678999999999999553   23  35788887666666677889999999999999999999999975 56899


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      |||.++.|.|..|++...  ..++......++.|++.||+|||   +..+|||||..+|||+.....+|++|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            999999999999998754  35888889999999999999999   9999999999999999999999999999999987


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      +....... ...-+..|||||.+.-++++.++|||.|||.+||+++ |..||..-...               +.+..+-
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs---------------DVI~~iE  606 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS---------------DVIGHIE  606 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc---------------ceEEEec
Confidence            66554433 3456779999999999999999999999999999987 88898653221               1111111


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..     .-.+..+.+++.++.++.+||.+||.+||.+.|+...|.++
T Consensus       607 nG-----eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  607 NG-----ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             CC-----CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence            11     11122456778899999999999999999999999888764

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1e-34  Score=317.88  Aligned_cols=249  Identities=24%  Similarity=0.291  Sum_probs=194.8

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      +.||+|+||.||+|+.. +++.||+|.+...........+.+|++++++++||||+++++++...+..++|+||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999764 68899999875443344456789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeee
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS  983 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  983 (1109)
                      .+++....  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+|++|||++..............
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99997533  34889999999999999999999   89999999999999999999999999999886543221111111


Q ss_pred             cccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhh
Q 001275          984 VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062 (1109)
Q Consensus       984 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1062 (1109)
                      ...+..|+|||.+.++.++.++||||+|+++|||++ |..||......  .....+..   . ... ..           
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~---~-~~~-~~-----------  217 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQ---G-VRL-PC-----------  217 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHc---C-CCC-CC-----------
Confidence            233567999999998899999999999999999998 87777532211  11111100   0 000 00           


Q ss_pred             chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1063 SSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1063 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                        .......+.+++.+|++.+|++||++.|+.+.|.
T Consensus       218 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 --PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             --cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence              0111235677888999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.1e-35  Score=325.38  Aligned_cols=259  Identities=25%  Similarity=0.392  Sum_probs=203.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|.+.+.||+|+||+||++..      .++..+|+|.+... .......+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            5688889999999999999964      23456889987432 2334567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEE
Q 001275          893 IMYRYMENGSLRDVLHSITP----------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH  962 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  962 (1109)
                      +||||+++++|.++++....          ...+++..++.++.|++.|++|||   +.+++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            99999999999999975431          234899999999999999999999   89999999999999999999999


Q ss_pred             EecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHh
Q 001275          963 ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       963 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||......  ..   ....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~---~~~i  235 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EV---IECI  235 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HH---HHHH
Confidence            999999986643322222222345778999999998899999999999999999998 88887543211  11   1111


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ....  ....             ......++.+++.+||+.+|.+||++.|+.+.|+++.
T Consensus       236 ~~~~--~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         236 TQGR--VLQR-------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HcCC--cCCC-------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1100  0000             0112234777888999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-34  Score=322.99  Aligned_cols=263  Identities=24%  Similarity=0.351  Sum_probs=204.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCc----EEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNA----VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|+..++||+|+||+||+|++. +++    .||+|.+...........+.+|+.+++.++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            56888899999999999999753 444    4799988654444456678899999999999999999999875 45789


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ++||+++|+|.++++...  ..+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        86 ~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            999999999999997643  35889999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............++..|+|||...+..++.++|||||||++|||++ |..||.....  .....++...    ....   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~----~~~~---  231 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKG----ERLP---  231 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCC----CcCC---
Confidence            4322222222345678999999999999999999999999999998 8888754321  1122222110    0000   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCCCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKY 1108 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1108 (1109)
                                 .......++.+++.+||+.||++||++.|+++.+.+.... +.+|
T Consensus       232 -----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~-~~~~  275 (279)
T cd05109         232 -----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD-PSRF  275 (279)
T ss_pred             -----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC-CcCe
Confidence                       0011223566788899999999999999999999888443 3444

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.4e-35  Score=323.37  Aligned_cols=259  Identities=23%  Similarity=0.361  Sum_probs=201.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      +++|...+.||+|+||.||+|...      .+..||+|.+...........+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            467888999999999999999765      35778899875444444456789999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC---cEEEe
Q 001275          892 IIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM---EPHIS  964 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~  964 (1109)
                      ++||||+++|+|.++++....    ...+++..+.+++.|++.|++|||   +.+++||||||+||+++.++   .+|++
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEec
Confidence            999999999999999976532    235899999999999999999999   88999999999999998654   59999


Q ss_pred             cccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhc
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......  .....+   ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--~~~~~~---~~  236 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--EVMEFV---TG  236 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH---Hc
Confidence            9999987643322211112234568999999999999999999999999999997 88888643211  111111   11


Q ss_pred             CccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1044 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .. ..    .      .    .......+.+++.+|++.+|++||++.||+++|..
T Consensus       237 ~~-~~----~------~----~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         237 GG-RL----D------P----PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CC-cC----C------C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            00 00    0      0    01112356778889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-34  Score=317.87  Aligned_cols=252  Identities=21%  Similarity=0.303  Sum_probs=201.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|...+.||+|+||+||+|+..++..+|+|.+...  ......+.+|++++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC--cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            457788899999999999998887778999987432  234567899999999999999999999999888999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++.....  .+++..++.++.|++.|++|||   +.+|+|+||||+||+++.++.+||+|||.++....... 
T Consensus        82 ~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-  155 (256)
T cd05113          82 SNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-  155 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence            99999999976432  5899999999999999999999   89999999999999999999999999999886543321 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||...+..++.++|||||||++|||++ |+.||.....  ......+   .......    .    
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~---~~~~~~~----~----  222 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKV---SQGLRLY----R----  222 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HHHHHHH---hcCCCCC----C----
Confidence            11222346678999999988889999999999999999999 8888854321  1111111   1110000    0    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                             .......+.+++.+||+.+|++||++.++++.++
T Consensus       223 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 -------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                   0011245677888999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=9.3e-35  Score=323.60  Aligned_cols=262  Identities=19%  Similarity=0.297  Sum_probs=206.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC-----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec-CCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR-KDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  891 (1109)
                      .++|...+.||+|+||.||+|....     +..||+|++...........+.+|+.++++++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999998765     788999988544444446678899999999999999999998776 4678


Q ss_pred             eEEEEeccCCCHHHHHhccCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          892 IIMYRYMENGSLRDVLHSITPP-----PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                      ++++||+++|+|.+++......     ..+++..++.++.|++.|++|||   +.+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999999764322     45899999999999999999999   899999999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCc
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      |+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||.....  .++..++..    .
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~----~  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKD----G  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHc----C
Confidence            99986643322211222356778999999998889999999999999999999 9998864311  112221111    0


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      .....              ......++.+++.+||+.||++||++.|+++.|.++..
T Consensus       236 ~~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         236 YRLAQ--------------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCCCC--------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            00000              01112346778889999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-34  Score=326.41  Aligned_cols=244  Identities=22%  Similarity=0.320  Sum_probs=193.9

Q ss_pred             ceeecccCeEEEEEEe----CCCcEEEEEEeeecc---cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          825 HVIGRGAHGIVYKASL----GPNAVFAVKKLAFRG---HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++||+|+||.||+++.    ..++.||+|.+....   .......+.+|++++++++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999965    357899999985432   223345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++....   .+.+..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999997643   3778888999999999999999   89999999999999999999999999999875432211


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .............+.        
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~~~~~~~~~~~--------  220 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTIDKILKGKLNLP--------  220 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCCC--------
Confidence              12235799999999999998899999999999999999999999964321     111111111110000        


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQL 1097 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 1097 (1109)
                           .   ....++.+++.+|++.||++||     ++.++++|-
T Consensus       221 -----~---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         221 -----P---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             -----C---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence                 0   1123456678899999999999     899988864

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.3e-34  Score=335.52  Aligned_cols=260  Identities=23%  Similarity=0.323  Sum_probs=202.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  891 (1109)
                      ++|.+.++||+|+||.||+|++.      .++.||+|++...........+.+|++++.++. |||||+++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46778899999999999999753      346899999965443444457889999999997 99999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC-----------------------------------------------------------
Q 001275          892 IIMYRYMENGSLRDVLHSITP-----------------------------------------------------------  912 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  912 (1109)
                      ++|+||+++|+|.++++....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999975321                                                           


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          913 ------------------------------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       913 ------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                                                          ...+++..+.+++.|+++|++|||   +.+|+||||||+||+++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEe
Confidence                                                124678888999999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1109)
                      +++.+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ....
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~-~~~~  352 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN-EQFY  352 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch-HHHH
Confidence            999999999999986533222112223457889999999998889999999999999999998 88887532111 1111


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..   ..... ..   ..           ......++.+++.+||+.+|++||+++|+++.|+++
T Consensus       353 ~~---~~~~~-~~---~~-----------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         353 NA---IKRGY-RM---AK-----------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HH---HHcCC-CC---CC-----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11   01000 00   00           011124567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-34  Score=324.27  Aligned_cols=259  Identities=21%  Similarity=0.334  Sum_probs=202.3

Q ss_pred             CCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      +|++.+.||+|+||.||+|...      ....+|+|.+..........++.+|+++++.++||||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677889999999999999653      2356888877544333445678899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCC
Q 001275          894 MYRYMENGSLRDVLHSITP---------------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPEN  952 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  952 (1109)
                      |+||+++|+|.+++.....                     ...+++..++.++.|++.|++|||   +.+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            9999999999999865321                     134789999999999999999999   8999999999999


Q ss_pred             eeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCcccc
Q 001275          953 ILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKER 1031 (1109)
Q Consensus       953 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~ 1031 (1109)
                      |++++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.....  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--  235 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--  235 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            9999999999999999986543322222223356778999999988889999999999999999999 8888854321  


Q ss_pred             ccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ..+..+....+.    .      .        .......++.+++.+|++.+|++||+++|+++.|+++.
T Consensus       236 ~~~~~~~~~~~~----~------~--------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         236 ERLFNLLKTGYR----M------E--------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHHHHhCCCC----C------C--------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            112221111100    0      0        00112235677888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.8e-34  Score=321.45  Aligned_cols=266  Identities=22%  Similarity=0.319  Sum_probs=204.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC-----------------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceee
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP-----------------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR  880 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  880 (1109)
                      ..+|++.+.||+|+||.||+|....                 +..||+|++...........+.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999986542                 24589998865544455668899999999999999999


Q ss_pred             EeeEEecCCceeEEEEeccCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCC
Q 001275          881 LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP--------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPEN  952 (1109)
Q Consensus       881 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  952 (1109)
                      +++++..++..++|+||+++++|.+++.....        ...+++..++.++.|++.|++|||   +.+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            99999999999999999999999999976431        125899999999999999999999   8999999999999


Q ss_pred             eeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh--CCCCCCCCccc
Q 001275          953 ILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT--RKKALDPSYKE 1030 (1109)
Q Consensus       953 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~ 1030 (1109)
                      |+++.++.++++|||+++...............+++.|+|||+..+..++.++|||||||++|||++  +..||....  
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~--  238 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT--  238 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence            9999999999999999986544332222233456789999999988889999999999999999998  566664321  


Q ss_pred             cccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1031 RTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ..+........+......... .          .......++.+++.+|++.||++||++.|+++.|.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~----------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYL-P----------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             hHHHHHHHHhccccccccccC-C----------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            111111111111110000000 0          011122457788999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-34  Score=332.31  Aligned_cols=270  Identities=22%  Similarity=0.325  Sum_probs=196.2

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-----cee
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-----CGI  892 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  892 (1109)
                      +|++.++||+|+||.||+|.. .+++.||||++.... .......+.+|++++++++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999975 468999999885432 2233456889999999999999999999886432     479


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +||||++ ++|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 68999887543   4899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCC-ceeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc--cc
Q 001275          973 DKSPAS-TTSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT--EE 1047 (1109)
Q Consensus       973 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 1047 (1109)
                      ...... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||......  .....+.......  ..
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHH
Confidence            322211 12234579999999998865  67899999999999999999999998643211  1111111100000  00


Q ss_pred             cccccchh---hhHHh-------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 INDIVDLS---LMEEM-------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ~~~~~d~~---~~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ...+....   .....       .....+....++.+++.+|++.||++||+++|+++|-+
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence            00000000   00000       00001112245677888999999999999999998743

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-35  Score=324.74  Aligned_cols=252  Identities=24%  Similarity=0.366  Sum_probs=208.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc-eeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC-GIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  895 (1109)
                      ++|...+++|+|+||.++.++.+ ++..||+|.+..... ........+|+.++++++|||||.+.+.|..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46888899999999999999654 577899999865543 3344478899999999999999999999999988 89999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      +|++||++.+.+...+ ...++++.+..++.|++.|+.|||   +..|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999998755 456899999999999999999999   899999999999999999999999999999988765


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..  .....+||+.||.||.+.+.+|..|+||||+||++|||++-+++|...     +....+.+.....      +.  
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-----~m~~Li~ki~~~~------~~--  224 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-----NMSELILKINRGL------YS--  224 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-----chHHHHHHHhhcc------CC--
Confidence            42  233478999999999999999999999999999999999999999654     2222222221111      01  


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                             +.......++..++..|++.+|+.||++.+++.+
T Consensus       225 -------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 -------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                   1112233445567779999999999999999987

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.4e-34  Score=328.42  Aligned_cols=255  Identities=23%  Similarity=0.260  Sum_probs=197.1

Q ss_pred             CCCCCceeecccCeEEEEEEe----CCCcEEEEEEeeecc---cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          820 NLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRG---HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      +|++.+.||+|+||+||+++.    .+++.||+|++....   .......+.+|++++.++ +|++|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999865    367899999985432   122345678899999999 599999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999987643   4889999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .................  
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~--  230 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQSEVSRRILKCDPPF--  230 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC-CCHHHHHHHHhcCCCCC--
Confidence            5332221 22245799999999998765 4789999999999999999999999643211 11111111111100000  


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                                 ..   .....+.+++.+|++.||++||     +++|+++|-+
T Consensus       231 -----------~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         231 -----------PS---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             -----------CC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence                       00   1123355677799999999999     7889988743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=316.48  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=199.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .+|+..+.||+|+||.||+|...++..+|+|.+...  ......+.+|++++++++|+||+++++++...+..++|+||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG--AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            347788899999999999998887888999987422  233457889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.++++...  ..+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+||+|||+++....... 
T Consensus        82 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-  155 (256)
T cd05059          82 ANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-  155 (256)
T ss_pred             CCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence            9999999997643  25899999999999999999999   89999999999999999999999999999986543221 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||.+.+..++.++||||||+++||+++ |+.||.....  .+..   .......    ..      
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~---~~~~~~~----~~------  220 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVV---ESVSAGY----RL------  220 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHH---HHHHcCC----cC------
Confidence            11112234568999999998999999999999999999999 7888854321  1111   1111000    00      


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                           ........++.+++.+||+.+|++||++.|+++.|.
T Consensus       221 -----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         221 -----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                 000112345777888999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-34  Score=319.07  Aligned_cols=257  Identities=23%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +..+|...++||+|+||+||+|...+++.+|+|.+... .......+.+|+++++.++|+||+++++++...+..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD-DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc-chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34568889999999999999999888999999988433 23345678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.++++... ...+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+||+|||.+.......
T Consensus        83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999997643 345899999999999999999999   8999999999999999999999999999998664322


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..  .....++..|+|||...+..++.++||||||+++|+|++ |+.||.....  ........   .... .       
T Consensus       159 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--~~~~~~~~---~~~~-~-------  223 (261)
T cd05148         159 YL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--HEVYDQIT---AGYR-M-------  223 (261)
T ss_pred             cc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--HHHHHHHH---hCCc-C-------
Confidence            11  113456778999999988899999999999999999998 7888854321  11111111   1000 0       


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .........+.+++.+|++.||++||+++|+++.|+.+
T Consensus       224 -------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 -------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                   00112234567788899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.8e-34  Score=322.57  Aligned_cols=262  Identities=21%  Similarity=0.343  Sum_probs=203.6

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      .+++|++.++||+|+||.||+|...      .+..||+|.+...........+.+|+.++++++|+||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999999643      2457999987544333344568899999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          891 GIIMYRYMENGSLRDVLHSITP-------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                      .++||||+++|+|.++++....       ....++..+.+++.|++.|++|||   +++|+||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999975321       234577888999999999999999   899999999999999999999999


Q ss_pred             ecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhh
Q 001275          964 SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      +|||+++...............++..|+|||...+..++.++|||||||++|||++ |+.||.....  .+...   ...
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--~~~~~---~~~  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK---FVM  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---HHH
Confidence            99999986543322222222345778999999998899999999999999999999 6777754221  11111   111


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ... .. .             ........+.+++.+|++.||++||++.|+++.+.+..
T Consensus       236 ~~~-~~-~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 DGG-YL-D-------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             cCC-CC-C-------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            000 00 0             00111245777888999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-34  Score=325.60  Aligned_cols=261  Identities=21%  Similarity=0.349  Sum_probs=204.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEe--------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecC
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL--------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK  888 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  888 (1109)
                      .++|.+.+.||+|+||.||+|+.        .++..||+|.+..........++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            36788889999999999999964        134578999875443344556789999999999 899999999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL  955 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  955 (1109)
                      +..++||||+++|+|.+++.....             ...+++..+..++.|+++|++|||   +.+|+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            999999999999999999976432             235788999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccH
Q 001275          956 DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDI 1034 (1109)
Q Consensus       956 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1109)
                      ++++.+||+|||.++...............+++.|+|||++.+..++.++||||||+++||+++ |..||....     .
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H
Confidence            9999999999999987654332222223456778999999998889999999999999999998 677764321     1


Q ss_pred             HHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1035 VGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ..+......... . .  .           ......++.+++.+||+.+|++||++.|+++.|.++.
T Consensus       246 ~~~~~~~~~~~~-~-~--~-----------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 EELFKLLKEGHR-M-D--K-----------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHHHHHHcCCc-C-C--C-----------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            122221111100 0 0  0           0122345667888999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=344.70  Aligned_cols=253  Identities=21%  Similarity=0.257  Sum_probs=199.5

Q ss_pred             CCCCCceeecccCeEEEEEEeC-C-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-P-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .|...+.||+|+||.||+|... + ++.||+|.+... .......+.+|+++++.++|||||++++++...+..++||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3788899999999999999654 3 577888876332 333345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      +++|+|.++++.. .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999988643 22345889999999999999999999   8999999999999999999999999999998765432


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      .........||++|+|||++.+..++.++||||+||++|||++|+.||.....     ...........  .    ++  
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~--~----~~--  290 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGK--Y----DP--  290 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC--C----CC--
Confidence            22223345799999999999999999999999999999999999999864321     11111111100  0    00  


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                          .   ......++.+++.+|++.||++||+++|++++
T Consensus       291 ----~---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        291 ----F---PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             ----C---CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                0   00112346678889999999999999998764

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-34  Score=323.68  Aligned_cols=257  Identities=22%  Similarity=0.279  Sum_probs=199.8

Q ss_pred             CCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      +|+..+.||+|+||+||+|...      .+..||+|++...........+.+|+.++.+++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4566788999999999999753      3578999998644333334568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc
Q 001275          894 MYRYMENGSLRDVLHSIT-------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME  960 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  960 (1109)
                      ++||+++++|.+++....             ....+++..+.+++.|+++|++|+|   +.+|+||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            999999999999985321             1234788899999999999999999   899999999999999999999


Q ss_pred             EEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHH
Q 001275          961 PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      +||+|||+++...............+++.|+|||.+.+..++.++||||+||++|||++ |..||.....     ..+..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDVIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Confidence            99999999886643332222223456789999999988899999999999999999998 7777754311     11111


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .......  ...             .......+.+++.+||+.+|++||+++|+++.|+.
T Consensus       238 ~i~~~~~--~~~-------------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 MIRNRQV--LPC-------------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHcCCc--CCC-------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111100  000             01223446678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.5e-34  Score=315.70  Aligned_cols=260  Identities=19%  Similarity=0.313  Sum_probs=205.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.++||+|+||.||+|+. .+++.||||.+....  .......+.+|++++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4788899999999999999976 468999999875422  2233456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||+++|+|.+++..... ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998864322 335788999999999999999999   89999999999999999999999999999886643


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ...  ......+++.|+|||...+..++.++||||+|+++|||++|+.||.......   ..+........       .+
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~-------~~  226 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKIEQCD-------YP  226 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHHHhcCC-------CC
Confidence            221  1123468889999999988889999999999999999999999986432221   11211111000       00


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ...       ......++.+++.+||+.+|++||++.|+++.+...
T Consensus       227 ~~~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PLP-------TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCC-------hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            000       112234567788899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=320.89  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=207.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ..+.....+||-|.||.||.|.|+. .-.||||.++  .+.....+|.+|+.+|+.++|||+|+++|+|..+..+|+|+|
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK--EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhh--hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            3455667899999999999998864 5678999874  345567899999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      ||.+|+|.+|+++... ..++.-..+.+|.||+.|++||.   ++++|||||.++|+|+.++..+||+|||+++.+..+.
T Consensus       344 fM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             cccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999998653 34677788899999999999999   9999999999999999999999999999999886543


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCC-CCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK-KALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                       .+...+..-++.|.|||.+....++.|+|||+|||++||+.|.. .|| +.. +..++.+.+..              .
T Consensus       420 -YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY-PGi-dlSqVY~LLEk--------------g  482 (1157)
T KOG4278|consen  420 -YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-PGI-DLSQVYGLLEK--------------G  482 (1157)
T ss_pred             -eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC-CCc-cHHHHHHHHhc--------------c
Confidence             33334455678999999999999999999999999999999954 444 321 11111111111              1


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..    .+...-+.+.++++++.||++.|.+||+++|+-+.++..
T Consensus       483 yR----M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  483 YR----MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             cc----ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            00    111234567788999999999999999999999888754

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.6e-34  Score=334.04  Aligned_cols=256  Identities=22%  Similarity=0.331  Sum_probs=194.5

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .|...+.||+|+||+||+|.. .+++.||+|++....  .......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            577889999999999999965 467899999985432  22334578899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999997643   4788899999999999999999   8999999999999999999999999999986432110


Q ss_pred             CC---------------------------------------------ceeeecccCcccccccccccCCCCccCcchhhH
Q 001275          977 AS---------------------------------------------TTSISVVGTIGYIAPENAFTTAKSKESDVYSYG 1011 (1109)
Q Consensus       977 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 1011 (1109)
                      ..                                             .......||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001234799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHh--ccCCCCCCCCC
Q 001275         1012 VVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALR--CTEKKPSNRPN 1089 (1109)
Q Consensus      1012 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~RPs 1089 (1109)
                      |++|||++|+.||........ .....  .+........           ......   ++.+++.+  |+..+|..||+
T Consensus       236 ~il~elltG~~Pf~~~~~~~~-~~~i~--~~~~~~~~~~-----------~~~~s~---~~~dli~~ll~~~~~~~~R~~  298 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET-QLKVI--NWENTLHIPP-----------QVKLSP---EAVDLITKLCCSAEERLGRNG  298 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH-HHHHH--ccccccCCCC-----------CCCCCH---HHHHHHHHHccCcccccCCCC
Confidence            999999999999965422111 11000  0000000000           000112   23344445  55667777999


Q ss_pred             HHHHHHHhh
Q 001275         1090 MRDVVRQLV 1098 (1109)
Q Consensus      1090 ~~evl~~L~ 1098 (1109)
                      ++|+++|-.
T Consensus       299 ~~~~l~hp~  307 (381)
T cd05626         299 ADDIKAHPF  307 (381)
T ss_pred             HHHHhcCcc
Confidence            999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-34  Score=345.90  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=202.8

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC----
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD----  889 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  889 (1109)
                      ...++|.+.++||+|+||+||+|.. .+++.||||++.... .......+.+|+.++..++|+|++++.+.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3446899999999999999999965 568999999985443 2333456889999999999999999988765433    


Q ss_pred             ----ceeEEEEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEe
Q 001275          890 ----CGIIMYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHIS  964 (1109)
Q Consensus       890 ----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  964 (1109)
                          ..++||||+++|+|.++++... ....+++..+..++.|++.||+|+|   +.+|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                2579999999999999997532 2346889999999999999999999   8999999999999999999999999


Q ss_pred             cccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      |||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||....     ....+......
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~~~~~  260 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHKTLAG  260 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHhcC
Confidence            9999987644322222334679999999999999999999999999999999999999996431     11122111111


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .  .    ++      ..   .....++.+++.+||+.||++||++.|++++
T Consensus       261 ~--~----~~------~~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        261 R--Y----DP------LP---PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             C--C----CC------CC---CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            0  0    00      00   1122346678889999999999999999876

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.1e-34  Score=319.64  Aligned_cols=265  Identities=22%  Similarity=0.333  Sum_probs=201.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-----------------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-----------------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL  881 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  881 (1109)
                      ++|++.++||+|+||.||++...                 ++..||+|++..........++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888999999999999998532                 2346899988544444445678999999999999999999


Q ss_pred             eeEEecCCceeEEEEeccCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCe
Q 001275          882 EDFWLRKDCGIIMYRYMENGSLRDVLHSITP--------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENI  953 (1109)
Q Consensus       882 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI  953 (1109)
                      ++++...+..++||||+++|+|.+++.....        ...+++..+..++.|++.|++|||   +.+|+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            9999999999999999999999999976432        124778899999999999999999   88999999999999


Q ss_pred             eeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh--CCCCCCCCcccc
Q 001275          954 LLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT--RKKALDPSYKER 1031 (1109)
Q Consensus       954 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt--g~~p~~~~~~~~ 1031 (1109)
                      +++.++.++++|||+++.+.............++..|+|||...++.++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD--  239 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence            999999999999999986643322221222345678999999888899999999999999999998  6677643211  


Q ss_pred             ccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ................. .. .         .........+.+++.+||+.||++||++.|+++.|.+
T Consensus       240 ~~~~~~~~~~~~~~~~~-~~-~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 EQVIENTGEFFRDQGRQ-VY-L---------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHHHhhcccc-cc-C---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11111111111000000 00 0         0011122456778889999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.1e-34  Score=316.21  Aligned_cols=255  Identities=23%  Similarity=0.307  Sum_probs=201.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|...++||+|+||.||+|... .++.||+|.+..  ......++.+|++++++++|+||+++++++...+..++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecC--CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            35777889999999999999664 588899998743  233456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++.... ...+++..++.++.|+++|++|||   +.+++||||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999997643 345899999999999999999999   89999999999999999999999999999987643321


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                       .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....  .   ..........       ... 
T Consensus       160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~---~~~~~~~~~~-------~~~-  225 (263)
T cd05052         160 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--S---QVYELLEKGY-------RME-  225 (263)
T ss_pred             -eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--H---HHHHHHHCCC-------CCC-
Confidence             11112334678999999999999999999999999999998 8888754311  1   1111111000       000 


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .......++.+++.+|++.+|++||++.|+++.|+.+
T Consensus       226 -------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 -------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                   0011124466788899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.1e-34  Score=322.22  Aligned_cols=259  Identities=26%  Similarity=0.383  Sum_probs=202.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      ..+|+..+.||+|+||.||+|...      +++.||+|.+..........++.+|++++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            357888999999999999999753      46889999885444444456789999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCC
Q 001275          892 IIMYRYMENGSLRDVLHSIT-------------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPEN  952 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~N  952 (1109)
                      ++|+||+++|+|.+++....                   ....+++..++.++.|++.||+|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999997432                   1234788899999999999999999   8999999999999


Q ss_pred             eeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCcccc
Q 001275          953 ILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKER 1031 (1109)
Q Consensus       953 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~ 1031 (1109)
                      |++++++.++++|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876543322222222345678999999998899999999999999999998 77787543211 


Q ss_pred             ccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                          ........ .. ...             .......++.+++.+|++.+|++||++.|+++.|++
T Consensus       240 ----~~~~~~~~-~~-~~~-------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVIYYVRD-GN-VLS-------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHHHHhc-CC-CCC-------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                11111110 00 000             001123457778889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.3e-34  Score=327.28  Aligned_cols=245  Identities=22%  Similarity=0.262  Sum_probs=194.2

Q ss_pred             ceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          825 HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      +.||+|+||.||++.. .+++.||+|.+....  .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999965 468999999985432  2223456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          902 SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       902 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      +|.+++....   .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            9999887543   4889999999999999999999   6 799999999999999999999999999987543221  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..............           
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~~~~p-----------  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEIRFP-----------  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCCCCCC-----------
Confidence            22357999999999999999999999999999999999999999643211     11111111110000           


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                        .   ....++.+++.+|++.||++|+     +++|+++|-+
T Consensus       217 --~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         217 --R---TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             --C---CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence              0   1123455677899999999996     8999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-34  Score=320.24  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=203.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|.+.+.||+|+||.||+|...      .+..||+|.+...........+.+|+++++.++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            57888899999999999999664      246899998754433344567889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEec
Q 001275          893 IMYRYMENGSLRDVLHSITP-------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISD  965 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  965 (1109)
                      +||||+++|+|.+++.....       ...+++..++.++.|++.|++|||   +.+|+||||||+||++++++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECC
Confidence            99999999999999975432       224789999999999999999999   89999999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcC
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      ||+++...............++..|+|||.+.+..++.++|||||||++||+++ |+.||.....  ........    .
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~----~  236 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVI----D  236 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--HHHHHHHh----c
Confidence            999986544322222223456789999999988889999999999999999998 8888753211  11111111    0


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .. ....             ......++.+++.+||+.+|++|||+.|+++.|++
T Consensus       237 ~~-~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         237 GG-HLDL-------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CC-CCCC-------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            00 0000             01113456778889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=332.50  Aligned_cols=256  Identities=23%  Similarity=0.297  Sum_probs=202.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.+.||+|+||+||+|+.. +++.||+|++.....  ......+.+|++++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999765 689999999864322  234457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++...   ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999765   34889999999999999999999   899999999999999999999999999999866443


Q ss_pred             C---------------------------CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCc
Q 001275          976 P---------------------------ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSY 1028 (1109)
Q Consensus       976 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~ 1028 (1109)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011223579999999999999999999999999999999999999996542


Q ss_pred             cccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhh
Q 001275         1029 KERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-MRDVVRQLV 1098 (1109)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~ 1098 (1109)
                      ..     ..............   -+         .......++.+++.+|++ ||++||+ ++|+++|-.
T Consensus       235 ~~-----~~~~~i~~~~~~~~---~p---------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         235 LQ-----ETYNKIINWKESLR---FP---------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             HH-----HHHHHHhccCCccc---CC---------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            11     11111111000000   00         000022345667779997 9999999 999999854

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.1e-34  Score=325.22  Aligned_cols=260  Identities=22%  Similarity=0.356  Sum_probs=202.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC--------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG--------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  889 (1109)
                      ++|.+.+.||+|+||.||+|...        ....+|+|.+..........++.+|+++++++ +|+||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            57889999999999999999652        23569999885443344456788899999999 7999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ..++||||+++|+|.+++.....             ...+++..+++++.|++.|++|||   +.+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEc
Confidence            99999999999999999976432             135889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1109)
                      .++.+||+|||.++...............++..|+|||++.+..++.++||||+||++|||++ |+.||....  ..+..
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--~~~~~  252 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELF  252 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC--HHHHH
Confidence            999999999999986543221111122234578999999998889999999999999999998 777774321  11111


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ..+..   . ... +             .......++.+++.+|++.+|++||++.|+++.|.++.
T Consensus       253 ~~~~~---~-~~~-~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         253 KLLKE---G-HRM-D-------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             HHHHc---C-CCC-C-------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            11111   0 000 0             01112345667888999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.4e-34  Score=320.74  Aligned_cols=268  Identities=24%  Similarity=0.350  Sum_probs=199.8

Q ss_pred             CCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeE
Q 001275          821 LNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGII  893 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  893 (1109)
                      |...+.||+|+||+||++..     .+++.||+|.+...........+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            47889999999999988642     467889999885443334456788999999999999999999988654  35789


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++...    .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999999753    3899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCCce-eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTT-SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ....... .....++..|+|||...+..++.++||||||+++|||++|+.|+........+......... ......+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM-TVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc-chhhhhhhh
Confidence            4322111 11234566799999998888999999999999999999999997543221111110000000 000000000


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      +...    ..+.......++.+++.+||+.+|++||+++++++.|+++
T Consensus       238 ~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         238 ERGM----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hcCC----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            0000    0000112234677788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.5e-34  Score=325.55  Aligned_cols=261  Identities=21%  Similarity=0.366  Sum_probs=202.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC--------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG--------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  889 (1109)
                      ++|.+.++||+|+||.||+|+..        ....||+|.+..........++.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57888999999999999999642        34578999875443444456788999999999 6999999999999988


Q ss_pred             ceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ..++|+||+++|+|.+++.....             ...+++..+.+++.|++.|++|||   +.+|+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEc
Confidence            99999999999999999976321             235889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1109)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.....  .+..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~  246 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--EELF  246 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence            999999999999986643222111112234567999999998899999999999999999999 7888753211  1111


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      .....   . ... ..             ......++.+++.+|++.+|++||++.|+++.|.++..
T Consensus       247 ~~~~~---~-~~~-~~-------------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         247 KLLRE---G-HRM-DK-------------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHc---C-CCC-CC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11111   0 000 00             01122356678889999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-34  Score=316.50  Aligned_cols=257  Identities=20%  Similarity=0.337  Sum_probs=198.9

Q ss_pred             CCCCceeecccCeEEEEEEeCC----CcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc-----
Q 001275          821 LNAKHVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC-----  890 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  890 (1109)
                      |.+.+.||+|+||.||+|....    +..||+|++..... ......+.+|++.++.++|+||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567889999999999997642    36799998854322 2234578899999999999999999998876554     


Q ss_pred             -eeEEEEeccCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          891 -GIIMYRYMENGSLRDVLHSIT---PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       891 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                       .++|+||+++|+|.+++....   ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             699999999999999985532   2346899999999999999999999   899999999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCc
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      |+++...............++..|+|||+..+..++.++|||||||++|||++ |..||.....  .....   ......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~---~~~~~~  232 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYD---YLRHGN  232 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHH---HHHcCC
Confidence            99987654332222222345678999999988889999999999999999999 7787753221  11111   111110


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       .. .             .......++.+++.+|++.||++||++.|++++|+++
T Consensus       233 -~~-~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 -RL-K-------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -CC-C-------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             00 0             0011234577788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-34  Score=318.03  Aligned_cols=255  Identities=25%  Similarity=0.316  Sum_probs=200.1

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +|+..++||+|+||+||++... +++.||+|++.....  ......+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999764 689999999854322  2223457789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++.... ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999999886532 245899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      .   .....|+..|+|||++.+..++.++||||+||++|||++|+.||...... ...............          
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~----------  222 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKEDQE----------  222 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhhccc----------
Confidence            1   12347899999999999889999999999999999999999999643211 111111000000000          


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                            .........+.+++.+||+.||++||     +++++++|-+
T Consensus       223 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05605         223 ------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF  263 (285)
T ss_pred             ------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence                  00011233466788899999999999     8999988743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.7e-34  Score=317.31  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=195.5

Q ss_pred             CCCCceeecccCeEEEEEEeCCC-c--EEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC------Cc
Q 001275          821 LNAKHVIGRGAHGIVYKASLGPN-A--VFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------DC  890 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  890 (1109)
                      |.+.++||+|+||.||+|..... .  .||+|.+.... .......+.+|++++++++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            34678899999999999977543 2  58999875432 233356788999999999999999999987532      24


Q ss_pred             eeEEEEeccCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          891 GIIMYRYMENGSLRDVLHSIT---PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                      .++|+||+++|+|.+++....   ....+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999874321   2345899999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      +++...............+++.|+|||+..+..++.++||||||+++|||++ |+.||....  .......+   .. ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~---~~-~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDYL---RQ-GN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHH---Hc-CC
Confidence            9987644332212222356778999999999999999999999999999999 778875321  11111111   11 00


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ...   .           .......+.+++.+||+.+|++||++.|+++.|+++
T Consensus       232 ~~~---~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK---Q-----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC---C-----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            000   0           011223466788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.4e-34  Score=322.58  Aligned_cols=243  Identities=24%  Similarity=0.308  Sum_probs=188.4

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||+||+|+.. +++.||+|.+....  .......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 57889999986432  222334556677776654 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99999987643   4888999999999999999999   8999999999999999999999999999997543222  22


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ...............           
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~~~~-----------  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILNDRPHFP-----------  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCC-----------
Confidence            2345799999999999999999999999999999999999999964321     111111111110000           


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMR-DVVRQ 1096 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~ 1096 (1109)
                        ...   ..++.+++.+||+.||++||++. ++++|
T Consensus       217 --~~~---~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         217 --RWI---SKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             --CCC---CHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence              011   22345677799999999999875 56554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-34  Score=329.65  Aligned_cols=260  Identities=23%  Similarity=0.339  Sum_probs=199.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecC-Cc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK-DC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~  890 (1109)
                      ++|++.+.||+|+||+||+|..      .+++.||||++...........+.+|+.++.++ +|+||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5789999999999999999963      356889999986544344456788999999999 689999999988654 45


Q ss_pred             eeEEEEeccCCCHHHHHhccCC----------------------------------------------------------
Q 001275          891 GIIMYRYMENGSLRDVLHSITP----------------------------------------------------------  912 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  912 (1109)
                      .++||||+++|+|.++++....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999865321                                                          


Q ss_pred             ------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeeccc
Q 001275          913 ------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG  986 (1109)
Q Consensus       913 ------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  986 (1109)
                            ...+++..+.+++.|+++|++|||   +.+|+||||||+||++++++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                  123688889999999999999999   89999999999999999999999999999986533222122222345


Q ss_pred             CcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchh
Q 001275          987 TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSI 1065 (1109)
Q Consensus       987 t~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 1065 (1109)
                      +..|+|||...+..++.++||||||+++|||++ |..||...... .....   ... ..... .  .+           
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~---~~~-~~~~~-~--~~-----------  304 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCR---RLK-EGTRM-R--AP-----------  304 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-HHHHH---HHh-ccCCC-C--CC-----------
Confidence            678999999988899999999999999999997 88887542211 11111   110 00000 0  00           


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1066 RDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1066 ~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .....++.+++.+||+.+|++||++.|++++|+.+
T Consensus       305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            00123467788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.9e-34  Score=314.59  Aligned_cols=255  Identities=22%  Similarity=0.268  Sum_probs=190.1

Q ss_pred             ceeecccCeEEEEEEeCC---CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          825 HVIGRGAHGIVYKASLGP---NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      +.||+|+||.||+|...+   +..+|+|++...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999997643   45789998755444444557889999999999999999999999989999999999999


Q ss_pred             CHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          902 SLRDVLHSITP--PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       902 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +|.++++....  ....++..+..++.|+++|++|||   +.+++||||||+||+++.++.+|++|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999976432  234677888899999999999999   8999999999999999999999999999997554332222


Q ss_pred             eeeecccCcccccccccccC-------CCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          980 TSISVVGTIGYIAPENAFTT-------AKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||......+  .....   ...  .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~---~~~--~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYT---VRE--QQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH--HHHHH---hhc--ccCCC
Confidence            22334678899999987642       35789999999999999996 999985432211  11110   000  00011


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .++...     ...   ...+.+++..|+ .+|++||+++|+++.|+
T Consensus       231 ~~~~~~-----~~~---~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK-----LPL---SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC-----CCC---ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111110     001   123455777898 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.1e-34  Score=319.28  Aligned_cols=257  Identities=24%  Similarity=0.389  Sum_probs=200.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|...++||+|+||.||+|..      .++..+|+|.+.. ........+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc-CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            4677889999999999999953      2456788888743 33344567999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc
Q 001275          893 IMYRYMENGSLRDVLHSITP------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME  960 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  960 (1109)
                      +|+||+++|+|.++++....            ...+++..++.++.|++.|++|||   +.+|+||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence            99999999999999976432            134789999999999999999999   899999999999999999999


Q ss_pred             EEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHH
Q 001275          961 PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      +||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |+.||......  +...   
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~---  235 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT--EAIE---  235 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--HHHH---
Confidence            99999999976543222111222345788999999999999999999999999999998 88887532211  1111   


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ..... ... .  .           .......+.+++.+||+.||.+||+++|+.+.|+.
T Consensus       236 ~~~~~-~~~-~--~-----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 CITQG-REL-E--R-----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             HHHcC-ccC-C--C-----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            11000 000 0  0           01122346678889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=322.19  Aligned_cols=256  Identities=25%  Similarity=0.336  Sum_probs=207.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeeccccc--ChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKR--GSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  893 (1109)
                      ...|...+.||+|.||.||++.... |+.+|+|.+.......  ....+.+|+++|+++. |||||.+.+++...+..++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            3567888999999999999997654 9999999996654432  3468999999999998 9999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC----CcEEEecccCC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE----MEPHISDFGIA  969 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfGla  969 (1109)
                      |||++.||.|.+.+...    .+++..+..++.|++.|++|||   +.+|||||+||+|+|+...    +.+|++|||++
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999999775    2899999999999999999999   8999999999999999543    47999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      .....   .......+||+.|+|||++....|+.++||||+||++|.|++|..||........ ........+       
T Consensus       187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~-~~~i~~~~~-------  255 (382)
T KOG0032|consen  187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI-FLAILRGDF-------  255 (382)
T ss_pred             eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH-HHHHHcCCC-------
Confidence            98765   3344567999999999999999999999999999999999999999976532211 111111111       


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ++-+      .......+.   ..+++..|+..||.+|+++.++++|-|-.
T Consensus       256 ~f~~------~~w~~is~~---akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  256 DFTS------EPWDDISES---AKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             CCCC------CCccccCHH---HHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence            0100      011112233   44466699999999999999999997644

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.6e-34  Score=323.33  Aligned_cols=248  Identities=22%  Similarity=0.290  Sum_probs=193.1

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||.||+|+.. +++.||+|.+....  .......+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999764 68899999986432  223345678899999998 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            99999886543   4899999999999999999999   8999999999999999999999999999987432211  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc---cccHHHHHHHhh-cCccccccccchhh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE---RTDIVGWVRSVW-SDTEEINDIVDLSL 1056 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~d~~~ 1056 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||+.....   ......+..... ......        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  224 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI--------  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC--------
Confidence            23457999999999999999999999999999999999999999632111   111111111111 000000        


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN------MRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~ 1096 (1109)
                           +   .....++.+++.+|++.||.+||+      ++|+++|
T Consensus       225 -----p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         225 -----P---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -----C---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                 0   011234566788999999999997      7888876

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.2e-34  Score=323.33  Aligned_cols=244  Identities=23%  Similarity=0.280  Sum_probs=192.4

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||+||+|... +++.||+|++....  .......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 57899999985432  223345677888888876 699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            99999987643   4889999999999999999999   8999999999999999999999999999987543221  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............     +      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~~~-----~------  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEVVY-----P------  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCCCCC-----C------
Confidence            2335799999999999999999999999999999999999999964321     11111111111000     0      


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHh
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNM------RDVVRQL 1097 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~L 1097 (1109)
                        .   ....++.+++.+|++.||++||++      +++++|-
T Consensus       217 --~---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~  254 (320)
T cd05590         217 --T---WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHP  254 (320)
T ss_pred             --C---CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence              0   012345667789999999999998      7777663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.8e-34  Score=323.06  Aligned_cols=248  Identities=23%  Similarity=0.296  Sum_probs=192.0

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.||+|+||+||+|... +++.||+|.+....  .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 57899999986432  223345677898888877 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~  152 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T  152 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence            99999886543   4889999999999999999999   89999999999999999999999999999875422211  1


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc---cccHHHHHHHhh-cCccccccccchhh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE---RTDIVGWVRSVW-SDTEEINDIVDLSL 1056 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~d~~~ 1056 (1109)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......   ......++.... .....+        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--------  224 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--------  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC--------
Confidence            22357899999999999999999999999999999999999999532111   111111111111 100000        


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN------MRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~ 1096 (1109)
                           +   .....++.+++.+|++.||++||+      +.|+++|
T Consensus       225 -----p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         225 -----P---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -----C---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence                 0   111234566788999999999998      5787776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.2e-34  Score=321.53  Aligned_cols=259  Identities=21%  Similarity=0.335  Sum_probs=203.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      ++|...+.||+|+||.||+|..      ..+..||+|++...........+.+|+++++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            5688899999999999999964      234579999885443344456789999999999 799999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.++++... ...+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.++++|||+++.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            99999999999999997533 234899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ..............++..|+|||.+.+..++.++||||+||++|||++ |+.||...... ..........+    ..  
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-~~~~~~~~~~~----~~--  263 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-SKFYKLIKEGY----RM--  263 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-HHHHHHHHcCC----cC--
Confidence            643322111222356788999999999999999999999999999998 88887543211 11111111000    00  


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                        .       .   ......++.+++.+|++.+|++||++.|+++.|.+.
T Consensus       264 --~-------~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 --A-------Q---PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --C-------C---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              0       0   001123567788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.7e-34  Score=315.06  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=202.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CC---cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PN---AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .+|+..+.||+|+||.||+|... ++   ..+|+|++...........+..|++++++++|+|++++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46788899999999999999764 23   378999885443444456789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++++|.++++...  ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+|++|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999999997533  35899999999999999999999   88999999999999999999999999999986643


Q ss_pred             CCCCce-eeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          975 SPASTT-SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       975 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ...... ......+..|+|||++.+..++.++|||||||++||+++ |+.||.....  ...   ...... .....   
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--~~~---~~~i~~-~~~~~---  230 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEV---MKAIND-GFRLP---  230 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--HHH---HHHHhc-CCCCC---
Confidence            322111 112234567999999998889999999999999999998 9999854321  111   111110 00000   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                 .......++.+++.+||+.+|++||++.++++.|.++
T Consensus       231 -----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         231 -----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                       0011234567888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.7e-34  Score=327.98  Aligned_cols=203  Identities=28%  Similarity=0.357  Sum_probs=174.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|+||+||+|... +++.||+|++.....  ......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999664 588999999854321  223456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999997643   4889999999999999999999   899999999999999999999999999999765321


Q ss_pred             CCC---------------------------------ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCC
Q 001275          976 PAS---------------------------------TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKK 1022 (1109)
Q Consensus       976 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~ 1022 (1109)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 001275         1023 ALDPS 1027 (1109)
Q Consensus      1023 p~~~~ 1027 (1109)
                      ||...
T Consensus       235 Pf~~~  239 (363)
T cd05628         235 PFCSE  239 (363)
T ss_pred             CCCCC
Confidence            99643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.2e-34  Score=322.26  Aligned_cols=272  Identities=18%  Similarity=0.305  Sum_probs=201.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...++||+|+||+||+|+.. +++.||+|++...........+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999764 67889999986554444555788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++ ++.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            985 8888886543  34788999999999999999999   89999999999999999999999999999975433221


Q ss_pred             CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc-------ccc
Q 001275          978 STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE-------EIN 1049 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 1049 (1109)
                        ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .......+.......       ...
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-DELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhhcchh
Confidence              1223467899999998865 45789999999999999999999998653221 111111111100000       000


Q ss_pred             cccchhhhH---HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1050 DIVDLSLME---EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1050 ~~~d~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ...+.....   ............++.+++.+|++.||++|||++|+++|-+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  289 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF  289 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence            000000000   00000001122346678889999999999999999986544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-34  Score=333.35  Aligned_cols=267  Identities=20%  Similarity=0.245  Sum_probs=198.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ..+|.+.+.||+|+||.||+|... .++.||||...       ...+.+|++++++++|+|||++++++...+..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            346888999999999999999765 47889999532       2245789999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      ++. ++|.+++....  ..++|..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       241 ~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        241 KYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             ccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            995 68999886532  25899999999999999999999   8999999999999999999999999999998664332


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc------cccHHHHHHHhhcCcccccc
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE------RTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .........||..|+|||++.+..++.++|||||||++|||++|..++......      ...+...+............
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            222223457999999999999999999999999999999999998765432111      11122222221111111111


Q ss_pred             ccchhhhHHhh---------------hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1051 IVDLSLMEEML---------------VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~---------------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .....+.....               .........++.+++.+|++.||++|||+.|+++|-
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp  456 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP  456 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence            10101100000               000011123567788899999999999999999874

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.7e-34  Score=322.82  Aligned_cols=247  Identities=25%  Similarity=0.317  Sum_probs=192.6

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHH---hcCCCCceeeEeeEEecCCceeEE
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTI---GKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      |++.+.||+|+||.||+|... +++.||||++....  .......+.+|++++   ++++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567789999999999999764 68999999985432  122334566666554   567899999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|..+++.    ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999988864    24899999999999999999999   89999999999999999999999999999875322


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......     .............      
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~~~~~~------  220 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVNDEVRY------  220 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCCC------
Confidence            21  1223457999999999999999999999999999999999999998643211     1111111110000      


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQL 1097 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 1097 (1109)
                             .   .....++.+++.+|++.||++||     ++.|++++-
T Consensus       221 -------p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         221 -------P---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             -------C---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence                   0   01123456688899999999999     678887764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.6e-34  Score=315.56  Aligned_cols=249  Identities=23%  Similarity=0.296  Sum_probs=194.1

Q ss_pred             eecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          827 IGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      ||+|+||+||++... +++.||+|++......  .....+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999664 6889999998543222  2234677899999999999999999999999999999999999999


Q ss_pred             HHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceee
Q 001275          904 RDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI  982 (1109)
Q Consensus       904 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  982 (1109)
                      .+++.... ....+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            98875432 2346899999999999999999999   89999999999999999999999999999986643322  122


Q ss_pred             ecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhh
Q 001275          983 SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062 (1109)
Q Consensus       983 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1062 (1109)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............                
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~----------------  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRILNDSV----------------  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHHhhcccCC----------------
Confidence            3578999999999999999999999999999999999999996432111 11111111100000                


Q ss_pred             chhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 001275         1063 SSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQL 1097 (1109)
Q Consensus      1063 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 1097 (1109)
                      ........++.+++.+|++.||++||     +++|+++|-
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~  258 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHP  258 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcCh
Confidence            00011223456677899999999999     788898763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8e-34  Score=312.65  Aligned_cols=254  Identities=26%  Similarity=0.359  Sum_probs=201.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|.+.++||+|+||+||+|...++..||+|++...  ......+.+|++++++++|+||+++++++. .+..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC--ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            568889999999999999998877778999988532  233457899999999999999999999874 45689999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++.... ...+++..+..++.|+++||+|+|   +.+|+||||||+||++++++.++|+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-  157 (262)
T cd05071          83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  157 (262)
T ss_pred             CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence            9999999997632 235789999999999999999999   89999999999999999999999999999986643322 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||+..+..++.++||||||+++|||++ |+.||......  ..   ........ ..         
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~~---~~~~~~~~-~~---------  222 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV---LDQVERGY-RM---------  222 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--HH---HHHHhcCC-CC---------
Confidence            11223456778999999988899999999999999999999 77777543211  11   11110000 00         


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                           .........+.+++.+|++.+|++||+++++++.|++.
T Consensus       223 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                 00112234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.9e-34  Score=322.31  Aligned_cols=248  Identities=23%  Similarity=0.303  Sum_probs=194.8

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCC-CceeeEeeEEecCCceeEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRH-RNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +|++.+.||+|+||.||+|... +++.||+|++....  .......+..|.+++..++| ++|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999765 57889999986432  23344567889999999966 56888999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999987643   4789999999999999999999   899999999999999999999999999998753221


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..............      
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~~~~~~~~------  221 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQSIMEHNVSYP------  221 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCCCCCC------
Confidence            1  1223457999999999999999999999999999999999999999643211     11111111110000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM-----RDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 1096 (1109)
                             .   ....++.+++.+|++.||++|++.     +|+.+|
T Consensus       222 -------~---~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         222 -------K---SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -------C---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                   0   112345667789999999999976     677665

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-34  Score=319.46  Aligned_cols=272  Identities=21%  Similarity=0.319  Sum_probs=202.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC--Cce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  891 (1109)
                      +.|.+.+.||+|+||.||+|..     .++..||+|.+...........+.+|++++++++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3567889999999999999964     357889999985444444556799999999999999999999998775  567


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++++|.+++....  ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccc
Confidence            89999999999999986532  24899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ........ ......++..|+|||+..+..++.++|||||||++||+++++.|........   ...... .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~~~-~~~~~~~~~  234 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMIGP-THGQMTVTR  234 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhccc-ccccccHHH
Confidence            64432211 1123456778999999988889999999999999999999887643221100   000000 000000000


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .+. ........+.......++.+++.+|++.+|++||+++|+++.++++
T Consensus       235 ~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVR-VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHH-HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000 0000000000112235677888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.2e-34  Score=347.18  Aligned_cols=261  Identities=23%  Similarity=0.296  Sum_probs=199.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.++||+|+||.||+|... +++.||+|++.....  +....++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47888999999999999999764 589999999854322  223457899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          896 RYMENGSLRDVLHSITP--------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                      ||+++|+|.+++.....        ....++..+++++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211        123567788999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCC----------------CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc
Q 001275          968 IAKLLDKSPA----------------STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031 (1109)
Q Consensus       968 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~ 1031 (1109)
                      +++.......                ........||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                001112469999999999999999999999999999999999999986422110


Q ss_pred             ccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhhC
Q 001275         1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-NMRDVVRQLVDA 1100 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 1100 (1109)
                        ..  ...         ...++...     .........+.+++.+|++.||++|| +++++.+.|+..
T Consensus       239 --i~--~~~---------~i~~P~~~-----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 --IS--YRD---------VILSPIEV-----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             --hh--hhh---------hccChhhc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              00  000         00010000     00112234466788899999999996 556677766654

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.5e-34  Score=320.85  Aligned_cols=257  Identities=21%  Similarity=0.304  Sum_probs=198.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-Cc--EEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NA--VFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|++.++||+|+||.||+|...+ +.  .+++|.+.........+.+.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468889999999999999997643 32  46888775433344456789999999999 799999999999998999999


Q ss_pred             EEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          895 YRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                      +||+++|+|.++++....             ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            999999999999975321             134889999999999999999999   8999999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||++......   ........+..|+|||+..+..++.++|||||||++|||++ |+.||......     .....
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-----~~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-----ELYEK  230 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHH
Confidence            99999998643211   11111233567999999998889999999999999999998 99998543211     11111


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .....       ...        .......++.+++.+|++.+|.+||+++++++.|..+.
T Consensus       231 ~~~~~-------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         231 LPQGY-------RME--------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             HhcCC-------CCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11000       000        00112234667888999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.2e-34  Score=310.78  Aligned_cols=248  Identities=26%  Similarity=0.334  Sum_probs=196.6

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCHH
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLR  904 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  904 (1109)
                      ++||+|+||.||+|...+++.||+|.+...........+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999998754443444457889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeec
Q 001275          905 DVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV  984 (1109)
Q Consensus       905 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  984 (1109)
                      +++....  ..+++..+..++.|+++|+.|+|   +.+++||||||+||+++.++.+|++|||++......... .....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            9987543  34789999999999999999999   899999999999999999999999999998754332211 11122


Q ss_pred             ccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          985 VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       985 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      .++..|+|||+..+..++.++||||||+++||+++ |..||......  .....+..    .... ..            
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--~~~~~~~~----~~~~-~~------------  215 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--QAREQVEK----GYRM-SC------------  215 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHHc----CCCC-CC------------
Confidence            44678999999998889999999999999999998 88888543111  11111110    0000 00            


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       ......++.+++.+|++.+|++||++.|+++.|.
T Consensus       216 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         216 -PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence             0112345677888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-33  Score=311.48  Aligned_cols=260  Identities=20%  Similarity=0.355  Sum_probs=207.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....  .......+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999776 78999999885322  2233567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||+++|+|.+++.... ....+++..+..++.++++|++|||   +.+|+||||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999986532 2345889999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ...  ......++..|+|||...+..++.++|||||||++|+|++|+.||.....   ............  .....   
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~--~~~~~---  228 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEKC--DYPPL---  228 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhcC--CCCCC---
Confidence            221  12234688899999999988899999999999999999999999854321   111111111100  00000   


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                               ........+.+++.+||+.+|++||++.++++.++++
T Consensus       229 ---------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         229 ---------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             ---------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                     0012233566788899999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=330.10  Aligned_cols=256  Identities=23%  Similarity=0.322  Sum_probs=197.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..++||+|+||+||+|+.. +++.||||++....  .......+.+|++++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            36888999999999999999764 68999999985432  1233456789999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999997643   4899999999999999999999   899999999999999999999999999998754321


Q ss_pred             CCCc------------------------------------eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh
Q 001275          976 PAST------------------------------------TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019 (1109)
Q Consensus       976 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt 1019 (1109)
                      ....                                    .....+||+.|+|||++.+..++.++||||+||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0112469999999999999999999999999999999999


Q ss_pred             CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHH
Q 001275         1020 RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN---MRDVVRQ 1096 (1109)
Q Consensus      1020 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~ 1096 (1109)
                      |+.||......     ............. .. ...       ....   .++.+++.+|+. +|.+|++   ++|+++|
T Consensus       235 G~~Pf~~~~~~-----~~~~~i~~~~~~~-~~-~~~-------~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQ-----ETYRKIINWKETL-QF-PDE-------VPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHH-----HHHHHHHcCCCcc-CC-CCC-------CCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99999643211     1111111100000 00 000       0112   234456668886 9999997   9999887


Q ss_pred             hh
Q 001275         1097 LV 1098 (1109)
Q Consensus      1097 L~ 1098 (1109)
                      -+
T Consensus       297 ~~  298 (364)
T cd05599         297 PF  298 (364)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.3e-34  Score=327.03  Aligned_cols=255  Identities=21%  Similarity=0.239  Sum_probs=199.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.+.||+|+||+||+|... +++.||+|++.....  ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            36888999999999999999664 688999999865432  234456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999997642  34889999999999999999999   899999999999999999999999999999876443


Q ss_pred             CCCceeeecccCcccccccccc------cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAF------TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||......     ............. 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~~-  228 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----KTYNNIMNFQRFL-  228 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----HHHHHHHcCCCcc-
Confidence            221 223357899999999886      456789999999999999999999999643211     1111111110000 


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ...+           ......++.+++..|++ +|++||+++++++|-
T Consensus       229 ~~~~-----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~  264 (330)
T cd05601         229 KFPE-----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHP  264 (330)
T ss_pred             CCCC-----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence            0000           00112335567778997 999999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=323.95  Aligned_cols=255  Identities=24%  Similarity=0.334  Sum_probs=206.1

Q ss_pred             CCCCceeecccCeEEEEEEeC--CC--cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          821 LNAKHVIGRGAHGIVYKASLG--PN--AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ....++||+|.||.|++|.|+  +|  ..||||.+....-.....+|.+|+.+|.+++|+|++++||+..+ ....+|+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            344678999999999999775  23  45899999766555577899999999999999999999999876 77899999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      .++.|+|.+.++. .....+-......++.|||.|+.||.   .++.|||||..+|+++.....|||+|||+.+-+...+
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999998 55567888889999999999999999   9999999999999999999999999999999887655


Q ss_pred             CCceee-ecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          977 ASTTSI-SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       977 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ....+. ...-+..|+|||.+..+.++.++|||+|||++|||+| |..||-+-..  .++..              .+| 
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL~--------------~iD-  329 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQILK--------------NID-  329 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHHH--------------hcc-
Confidence            444332 2345678999999999999999999999999999999 4556643211  11111              111 


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                         ..........+.+++++++.+||...|++||++..+.+.+...
T Consensus       330 ---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  330 ---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence               0011122346678899999999999999999999998655443

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.4e-34  Score=321.72  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCc--EEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNA--VFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|++.+.||+|+||.||+|... ++.  .+|+|++...........+.+|++++.++ +|+||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            56888899999999999999764 344  45777664333334456788999999999 899999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          895 YRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                      +||+++|+|.++++....             ...+++..++.++.|+++|++|||   +.+|+||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcE
Confidence            999999999999975431             235789999999999999999999   8999999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||++......   .......++..|+|||++.+..++.++|||||||++|||+| |..||.....  .+.......
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~  238 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--AELYEKLPQ  238 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--HHHHHHHhc
Confidence            99999998643211   11111234678999999988889999999999999999998 9988854321  111111100


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                         . ... .             .......++.+++.+|++.+|++||+++++++++.++
T Consensus       239 ---~-~~~-~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         239 ---G-YRL-E-------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             ---C-CcC-C-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0 000 0             0001123467788899999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=334.15  Aligned_cols=256  Identities=23%  Similarity=0.289  Sum_probs=195.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.++||+|+||+||+|.. .+++.||||++....  .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688899999999999999965 468999999985432  1223456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999997643   4788999999999999999999   899999999999999999999999999999643211


Q ss_pred             CCC------------c---------------------------------eeeecccCcccccccccccCCCCccCcchhh
Q 001275          976 PAS------------T---------------------------------TSISVVGTIGYIAPENAFTTAKSKESDVYSY 1010 (1109)
Q Consensus       976 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 1010 (1109)
                      ...            .                                 ......||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCC---C
Q 001275         1011 GVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSN---R 1087 (1109)
Q Consensus      1011 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~---R 1087 (1109)
                      ||++|||++|+.||......     ............. .+  +.         ......++.+++.+|++ +|.+   |
T Consensus       235 Gvil~elltG~~Pf~~~~~~-----~~~~~i~~~~~~~-~~--p~---------~~~~s~~~~dli~~lL~-~~~~r~~r  296 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH-----ETYRKIINWRETL-YF--PD---------DIHLSVEAEDLIRRLIT-NAENRLGR  296 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH-----HHHHHHHccCCcc-CC--CC---------CCCCCHHHHHHHHHHhc-CHhhcCCC
Confidence            99999999999999643221     1111111100000 00  00         00111234556678887 6665   4


Q ss_pred             CCHHHHHHHhh
Q 001275         1088 PNMRDVVRQLV 1098 (1109)
Q Consensus      1088 Ps~~evl~~L~ 1098 (1109)
                      +++.|+++|-+
T Consensus       297 ~~~~~~l~hp~  307 (377)
T cd05629         297 GGAHEIKSHPF  307 (377)
T ss_pred             CCHHHHhcCCC
Confidence            69999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-33  Score=314.66  Aligned_cols=253  Identities=23%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|+..++||+|+||.||+|.. .+++.||+|.+..........++.+|++++++++||||+++++++...+..++|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999965 568899999886543444456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|..+.       .+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999997652       2678888999999999999999   8999999999999999999999999999998654321 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccH--HHHHHHhhcCccccccccchh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI--VGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                         .....||..|+|||++.+..++.++||||+|+++|+|++|+.||..........  ...........       .+.
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~  219 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------PPV  219 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------CCC
Confidence               223578999999999999999999999999999999999999986532221111  01111100000       000


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .    .   ......++.+++.+|++.+|++||+++|++++-+-
T Consensus       220 ~----~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~  256 (279)
T cd06619         220 L----P---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI  256 (279)
T ss_pred             C----C---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence            0    0   01122346678889999999999999999988543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.2e-34  Score=322.19  Aligned_cols=244  Identities=23%  Similarity=0.291  Sum_probs=192.9

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||.||+|+.. +++.||+|++....  .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999765 57899999985432  223345577888888866 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  152 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T  152 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence            99999987543   4889999999999999999999   89999999999999999999999999999875432211  1


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||......     .............     +.     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~~~~-----p~-----  217 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDVLY-----PV-----  217 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCCCC-----CC-----
Confidence            23357899999999999999999999999999999999999999643211     1111111111000     00     


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCC-------CHHHHHHHh
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRP-------NMRDVVRQL 1097 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------s~~evl~~L 1097 (1109)
                            ....++.+++.+|++.||++||       +++++++|-
T Consensus       218 ------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp  255 (321)
T cd05591         218 ------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP  255 (321)
T ss_pred             ------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence                  0123456677899999999999       888998774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-33  Score=311.18  Aligned_cols=253  Identities=28%  Similarity=0.389  Sum_probs=200.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|++.++||+|+||.||+|...++..+|+|.+...  ......+.+|++++++++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~--~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPG--TMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCC--CCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            468888999999999999999888889999988532  223567899999999999999999999875 45689999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.++++... ...+++..+..++.+++.|++|||   +.+|+||||||+||++++++.++|+|||.+........ 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05070          83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence            9999999997643 335899999999999999999999   88999999999999999999999999999986643321 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||...+..++.++||||||+++|||++ |+.||.....  .+.....   .... ..      .  
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~~~~~~---~~~~-~~------~--  223 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQV---ERGY-RM------P--  223 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHH---HcCC-CC------C--
Confidence            11122345678999999988889999999999999999999 8888754211  1111111   1000 00      0  


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                            ........+.+++.+|++.+|++||+++++.+.|++
T Consensus       224 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 ------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  001122456778889999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-33  Score=310.99  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=201.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|++.++||+|+||.||+|...+++.||+|.+...  .....++.+|++++++++|+||+++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG--SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCC--CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            568889999999999999999888999999988432  334567899999999999999999999874 56789999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++.... ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++........ 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            9999999987643 345899999999999999999999   89999999999999999999999999999986643221 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||++.+..++.++||||||+++||+++ |+.||.....  .........   .. .. ..      
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~---~~-~~-~~------  224 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--PEVIQNLER---GY-RM-PR------  224 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHHc---CC-CC-CC------
Confidence            11223356778999999998889999999999999999999 9998854321  111111100   00 00 00      


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                             ......++.+++.+|++.+|++||+++++++.|+.
T Consensus       225 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 -------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                   01112357778889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-33  Score=313.21  Aligned_cols=246  Identities=24%  Similarity=0.301  Sum_probs=190.5

Q ss_pred             eecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          827 IGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      ||+|+||+||++... +|+.||+|++......  .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999764 5899999998543221  2234556799999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeee
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS  983 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  983 (1109)
                      .+++.... ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            99886533 234889999999999999999999   8999999999999999999999999999998664322   2233


Q ss_pred             cccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          984 VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       984 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      ..|+..|+|||++.+..++.++||||+||++|||++|+.||...... .......+......      ...      .  
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~------~~~------~--  218 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRRTLEDE------VKF------E--  218 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHHhhccc------ccc------c--
Confidence            57899999999999989999999999999999999999998643211 11111111111100      000      0  


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 1095 (1109)
                       ......++.+++.+|++.||++||+++|+++
T Consensus       219 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         219 -HQNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             -cccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence             0111234567888999999999999966553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.1e-34  Score=315.68  Aligned_cols=255  Identities=21%  Similarity=0.265  Sum_probs=186.8

Q ss_pred             ceeecccCeEEEEEEeCC---CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          825 HVIGRGAHGIVYKASLGP---NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      +.||+|+||+||+|....   ...+|+|.+...........+.+|++.++.++|+||+++++++...+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            359999999999996543   35678887654434444567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          902 SLRDVLHSITP--PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       902 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +|.+++.....  ....++.....++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999976542  223567888999999999999999   8999999999999999999999999999987543332222


Q ss_pred             eeeecccCccccccccccc-------CCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          980 TSISVVGTIGYIAPENAFT-------TAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ......++..|+|||+...       ..++.++||||+||++|||++ |..||......  +.   ........  ....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~---~~~~~~~~--~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QV---LKQVVREQ--DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HH---HHHHhhcc--CccC
Confidence            2233456778999998643       356889999999999999999 66776432111  11   11111110  0001


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .++..     .   ......+.+++..|| .||++||+++||++.|.
T Consensus       231 ~~~~~-----~---~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQL-----D---LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcc-----c---ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            01110     0   111223444666788 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.5e-34  Score=304.29  Aligned_cols=256  Identities=23%  Similarity=0.289  Sum_probs=202.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.|+..+.||+|.-|+||.++..+ +..+|+|++.+..-  .....+.+.|-+|++.++||.++.+++.++.++..|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            346667889999999999998765 58999999955432  233457888999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      |||+||+|....++. +...+++..+..+|.+|+-||+|||   ..|||+|||||+||||.++|++.++||.++......
T Consensus       157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999988764 4567999999999999999999999   999999999999999999999999999987543210


Q ss_pred             --------------------------------C-C---------------------CceeeecccCcccccccccccCCC
Q 001275          976 --------------------------------P-A---------------------STTSISVVGTIGYIAPENAFTTAK 1001 (1109)
Q Consensus       976 --------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 1001 (1109)
                                                      . .                     .......+||-.|.|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                     001123589999999999999999


Q ss_pred             CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccC
Q 001275         1002 SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTE 1081 (1109)
Q Consensus      1002 ~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 1081 (1109)
                      +.++|.|+|||++|||+.|+.||.+.... ..+...+.+              .+.-    +..........++|++.+.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~--------------~l~F----p~~~~vs~~akDLIr~LLv  373 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQ--------------PLKF----PEEPEVSSAAKDLIRKLLV  373 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcC--------------CCcC----CCCCcchhHHHHHHHHHhc
Confidence            99999999999999999999999765322 222222111              1100    0011222345557779999


Q ss_pred             CCCCCCCC----HHHHHHHh
Q 001275         1082 KKPSNRPN----MRDVVRQL 1097 (1109)
Q Consensus      1082 ~dP~~RPs----~~evl~~L 1097 (1109)
                      +||++|..    |.||-+|-
T Consensus       374 KdP~kRlg~~rGA~eIK~Hp  393 (459)
T KOG0610|consen  374 KDPSKRLGSKRGAAEIKRHP  393 (459)
T ss_pred             cChhhhhccccchHHhhcCc
Confidence            99999987    88888774

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-34  Score=325.40  Aligned_cols=260  Identities=22%  Similarity=0.347  Sum_probs=203.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC--------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG--------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  889 (1109)
                      .+|.+.+.||+|+||.||+|...        .+..||+|.+..........++.+|+++++++ +|+||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46888999999999999999642        12368999875444444456789999999999 8999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          890 CGIIMYRYMENGSLRDVLHSIT-------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ..++++||+++|+|.+++....             ....+++..++.++.|+++|++|||   +.+|+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999997642             1235889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1109)
                      +++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||....     ..
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~  243 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-----VE  243 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence            999999999999986644322222222345578999999999999999999999999999998 777775321     11


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .+......... . ..             ......++.+++.+||+.+|++||++.|++++|.++.
T Consensus       244 ~~~~~~~~~~~-~-~~-------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         244 ELFKLLKEGHR-M-DK-------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             HHHHHHHcCCC-C-CC-------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            11111111100 0 00             0112345677888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-33  Score=319.15  Aligned_cols=243  Identities=23%  Similarity=0.324  Sum_probs=189.7

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.||+|+||+||+|+.. +++.||+|.+.....  ......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999765 578999999864321  23344566778888764 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            99999997633   4789999999999999999999   8999999999999999999999999999987532221  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ......+.   ......    .       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--~~~~~~i~---~~~~~~----~-------  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--EELFQSIR---MDNPCY----P-------  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--HHHHHHHH---hCCCCC----C-------
Confidence            2345799999999999999999999999999999999999999964321  11111111   000000    0       


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMR-DVVRQ 1096 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~ 1096 (1109)
                        .   ....++.+++.+|++.||++||++. ++.+|
T Consensus       217 --~---~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         217 --R---WLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             --c---cCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence              0   0112355677899999999999997 66654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.6e-34  Score=320.10  Aligned_cols=267  Identities=23%  Similarity=0.335  Sum_probs=201.8

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      +|+..++||+|+||.||+|... ++..+|+|.+..........++.+|++++++++||||+++++++..++..++|+||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            6888999999999999999764 578888888754433333456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++++|.++++...   .+++..+..++.|+++|++|||   + .+++||||||+||+++.++.+||+|||++....... 
T Consensus        82 ~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          82 DGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999997643   4789999999999999999999   5 589999999999999999999999999987553321 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc-------
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND------- 1050 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1050 (1109)
                         .....++..|+|||...+..++.++||||||+++|||++|+.||....  ......+.............       
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGH  229 (308)
T ss_pred             ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCC
Confidence               123578899999999988889999999999999999999999986432  11111111111000000000       


Q ss_pred             -ccch------hhhHHhhh---ch--hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1051 -IVDL------SLMEEMLV---SS--IRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1051 -~~d~------~~~~~~~~---~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       .-++      ........   ..  ......++.+++.+|++.+|++||+++|++++-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence             0000      00000000   00  0012345778899999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-34  Score=323.78  Aligned_cols=243  Identities=23%  Similarity=0.333  Sum_probs=192.2

Q ss_pred             ceeecccCeEEEEEEe----CCCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEecc
Q 001275          825 HVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      +.||+|+||.||+++.    .+|+.||+|++...... .....+.+|++++++++||||+++++++...+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    46789999998643322 234467789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            999999986533   4899999999999999999999   8999999999999999999999999999998654321  1


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHH
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1059 (1109)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     ...............          
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~i~~~~~~~p----------  218 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMTMILKAKLGMP----------  218 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHHHHHcCCCCCC----------
Confidence            22345799999999999988899999999999999999999999864321     111111111110000          


Q ss_pred             hhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 001275         1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQ 1096 (1109)
Q Consensus      1060 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 1096 (1109)
                            .....++.+++.+|++.||++||+     +++++++
T Consensus       219 ------~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         219 ------QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             ------CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence                  011234556778999999999999     4556654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.2e-33  Score=310.18  Aligned_cols=249  Identities=21%  Similarity=0.297  Sum_probs=193.4

Q ss_pred             eeecccCeEEEEEEeC---CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCC
Q 001275          826 VIGRGAHGIVYKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       826 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      .||+|+||.||+|.+.   .+..||+|.+...........+.+|++++++++|+||+++++++. .+..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999653   355799998855444444567899999999999999999999885 457899999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc-ee
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST-TS  981 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~  981 (1109)
                      |.+++....  ..+++..+++++.|+++|++|||   +.+++||||||+||+++.++.+|++|||++.......... ..
T Consensus        81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999987532  35899999999999999999999   8899999999999999999999999999998654332211 11


Q ss_pred             eecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          982 ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       982 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      ....++..|+|||.+.+..++.++|||||||++||+++ |+.||......  +....+.   ... ..    +       
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~---~~~-~~----~-------  218 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIE---QGK-RL----D-------  218 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHH---CCC-CC----C-------
Confidence            12234678999999988889999999999999999996 99988643211  1111111   100 00    0       


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                         .......++.+++.+||+.+|++||++.++.+.|+..
T Consensus       219 ---~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 ---CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence               0011234566788899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1e-33  Score=326.99  Aligned_cols=256  Identities=21%  Similarity=0.286  Sum_probs=198.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .++|+..++||+|+||+||+|+.. +++.||+|++....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467889999999999999999764 68899999985432  222344578899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++...    .++...+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999998753    2778888899999999999999   89999999999999999999999999999986643


Q ss_pred             CCCCceeeecccCcccccccccccC----CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTT----AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ... .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||.....     .............. .
T Consensus       195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~-~  267 (370)
T cd05596         195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMDHKNSL-T  267 (370)
T ss_pred             CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCCcC-C
Confidence            221 112235799999999988653    478999999999999999999999965321     11111111110000 0


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSN--RPNMRDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L~ 1098 (1109)
                      +  +         .......++.+++.+|++.+|++  ||+++|+++|-+
T Consensus       268 ~--~---------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         268 F--P---------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             C--C---------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence            0  0         00011234556777999999998  999999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-33  Score=326.55  Aligned_cols=256  Identities=21%  Similarity=0.286  Sum_probs=196.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .++|+..++||+|+||.||+|+.. +++.||+|.+....  .......+.+|+.+++.++||||+++++++..++..++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            468999999999999999999765 57899999985422  222345678999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.....
T Consensus       122 ~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         122 MEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            9999999999999753    3788889999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCCceeeecccCcccccccccccCC----CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTA----KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ... .......||+.|+|||++.+..    ++.++||||+||++|||++|+.||.....     .............. .
T Consensus       195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~-~  267 (370)
T cd05621         195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMDHKNSL-N  267 (370)
T ss_pred             CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCccc-C
Confidence            221 1223457999999999887543    68899999999999999999999964321     11111111110000 0


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSN--RPNMRDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L~ 1098 (1109)
                      +  +         ........+.+++.+|++.+|.+  ||+++|+++|-+
T Consensus       268 ~--p---------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~  306 (370)
T cd05621         268 F--P---------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF  306 (370)
T ss_pred             C--C---------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence            0  0         00011223444566788765544  899999999854

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1e-33  Score=312.87  Aligned_cols=254  Identities=24%  Similarity=0.308  Sum_probs=198.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|++.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++||||+++++++...+..++|+||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC-ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            5688999999999999999976 56889999988533 233445688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.++++...   .+++..+..++.|+++|++|||   +.+|+|||+||+||+++.++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06646          88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-  160 (267)
T ss_pred             CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence            99999999987533   4789999999999999999999   8999999999999999999999999999998664321 


Q ss_pred             CceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                       .......++..|+|||.+.   ...++.++||||+||++|||++|+.||........ ...+     ...    ....+
T Consensus       161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~-----~~~----~~~~~  229 (267)
T cd06646         161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLM-----SKS----NFQPP  229 (267)
T ss_pred             -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heee-----ecC----CCCCC
Confidence             1122356889999999874   34578899999999999999999999853321100 0000     000    00000


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ...      ........+.+++.+||+.+|++||+++++++++
T Consensus       230 ~~~------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLK------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCc------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000      0011224566788899999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.8e-34  Score=335.03  Aligned_cols=264  Identities=22%  Similarity=0.334  Sum_probs=192.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC--------
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--------  888 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  888 (1109)
                      .++|...++||+|+||.||+|.. .+++.||||++...     .....+|+.++++++|||||++++++...        
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            35789999999999999999976 46889999987432     22346799999999999999998876432        


Q ss_pred             CceeEEEEeccCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecc
Q 001275          889 DCGIIMYRYMENGSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDF  966 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Df  966 (1109)
                      ...++||||+++ ++.+++... .....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            235689999985 787776542 22345889999999999999999999   89999999999999998665 7999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      |+|+.+.....   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+...+.......
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS-VDQLVRIIQVLGTPT  291 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCC
Confidence            99986643322   2235789999999988764 689999999999999999999999865321 111222211111000


Q ss_pred             cc-c------------ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1046 EE-I------------NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1046 ~~-~------------~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .. .            ..+....+. ...+.   ....++.+++.+||+.||++||++.|+++|-+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~-~~~p~---~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLK-KVFPK---GTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHH-HHhcc---CCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            00 0            000000000 00000   12245777888999999999999999998754

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-33  Score=319.49  Aligned_cols=243  Identities=22%  Similarity=0.265  Sum_probs=189.6

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||.||+|+.. +++.||+|.+.....  ......+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999765 588999999864321  23344567788887754 899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            99999987643   4789999999999999999999   8999999999999999999999999999987432211  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....  .   ...............          
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--~---~~~~~~~~~~~~~~~----------  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--D---ELFESIRVDTPHYPR----------  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--H---HHHHHHHhCCCCCCC----------
Confidence            2345799999999999999999999999999999999999999964321  1   111111111000000          


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMR-DVVRQ 1096 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~ 1096 (1109)
                            ....++.+++.+|++.||++||++. ++.+|
T Consensus       218 ------~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         218 ------WITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             ------CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                  0122355677899999999999984 66644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.8e-34  Score=312.97  Aligned_cols=257  Identities=26%  Similarity=0.393  Sum_probs=202.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|+..+.||+|+||.||+|...    .+..+|+|.+...........+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999753    23478999875443334456789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++++|.+++....  ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999997643  35899999999999999999999   89999999999999999999999999999987644


Q ss_pred             CCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          975 SPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       975 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ..... ......++..|+|||++.+..++.++||||||+++||+++ |+.||.....  .+....+...+    ...   
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--~~~~~~~~~~~----~~~---  229 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIEEGY----RLP---  229 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--HHHHHHHhCCC----cCC---
Confidence            32111 1112234568999999998899999999999999999887 9998854321  11111111100    000   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                 ........+.+++.+|++.+|++||++.++++.|.++
T Consensus       230 -----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         230 -----------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                       0011234567788899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.3e-34  Score=313.98  Aligned_cols=256  Identities=25%  Similarity=0.380  Sum_probs=201.1

Q ss_pred             CCCCCceeecccCeEEEEEEeCC-C---cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGP-N---AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .|++.+.||+|+||.||+|.... +   ..||+|.+..........++..|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            47788999999999999997643 3   3699998855434445568999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.++++...  ..+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+|++|||++......
T Consensus        85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999997643  35899999999999999999999   899999999999999999999999999998866433


Q ss_pred             CCCceeee---cccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          976 PASTTSIS---VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       976 ~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ........   ...+..|+|||++.+..++.++||||+||++||+++ |..||.....  .+...++...+    ...  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--~~~~~~i~~~~----~~~--  231 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQDY----RLP--  231 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--HHHHHHHHcCC----cCC--
Confidence            22111111   122457999999999999999999999999999886 9988864321  11222221100    000  


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                  ...+....+.+++.+||+.+|.+||+++++++.|+.+
T Consensus       232 ------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         232 ------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                        0012234466788899999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=307.89  Aligned_cols=253  Identities=21%  Similarity=0.309  Sum_probs=205.1

Q ss_pred             hCCCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .=|+..+.||+|.|+.|-.|+ .-+|++||||++.+.. +......+.+|++.|+.++|||||++|++.......|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            347778889999999999995 4689999999995443 33445678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee-CCCCcEEEecccCCcccCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL-DSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DfGla~~~~~~  975 (1109)
                      .-++|+|+||+-++..  .+.++...+++.||+.|+.|+|   +..+|||||||+||.+ ..-|-+|++|||++-.+..+
T Consensus        98 LGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999977553  4889999999999999999999   8999999999999966 56789999999999877654


Q ss_pred             CCCceeeecccCcccccccccccCCCC-ccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKS-KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..-   ...+|+..|.|||++.+..|+ +++||||+|||+|.+++|+.||....+.               +.+--++|.
T Consensus       173 ~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImDC  234 (864)
T KOG4717|consen  173 KKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMDC  234 (864)
T ss_pred             chh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhcc
Confidence            433   346899999999999999995 6899999999999999999999754221               112223333


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      +..-   +....   .+..+++..|+..||++|.+.+|++.+-|--
T Consensus       235 KYtv---PshvS---~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq  274 (864)
T KOG4717|consen  235 KYTV---PSHVS---KECRDLIQSMLVRDPKKRASLEEIVSTSWLQ  274 (864)
T ss_pred             cccC---chhhh---HHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence            2211   11122   3445567799999999999999999876543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.4e-34  Score=322.96  Aligned_cols=267  Identities=23%  Similarity=0.309  Sum_probs=202.2

Q ss_pred             hCCCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-C-----CceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-H-----RNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~  891 (1109)
                      -+|.+.+.||+|+||.|-+|. .++++.||||+++..  ..-..+...|+.++..++ |     -|+|++++++...++.
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            378889999999999999994 567999999998543  333445677999999996 4     4899999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC--cEEEecccCC
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM--EPHISDFGIA  969 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DfGla  969 (1109)
                      |+|+|.++. +|+++++.... ..++...+..++.||++||.+||   +.+|||+||||+|||+.+.+  .+||+|||.|
T Consensus       264 ciVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  264 CIVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            999999965 99999998664 34899999999999999999999   99999999999999996543  6999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-----
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD----- 1044 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 1044 (1109)
                      +.....-.     .+..+..|+|||++.+.+|+.+.||||||||++||++|.+.| ++..+..++..++......     
T Consensus       339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf-pG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF-PGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc-CCCCHHHHHHHHHHHhCCCCHHHH
Confidence            97654322     467888999999999999999999999999999999996555 4433333332222111100     


Q ss_pred             --ccccccccch-----------h-----------------hhHHhhh-------ch-hHHHHHHHHHHHHhccCCCCCC
Q 001275         1045 --TEEINDIVDL-----------S-----------------LMEEMLV-------SS-IRDQVIDVLLVALRCTEKKPSN 1086 (1109)
Q Consensus      1045 --~~~~~~~~d~-----------~-----------------~~~~~~~-------~~-~~~~~~~l~~l~~~cl~~dP~~ 1086 (1109)
                        ......+++.           .                 ......+       .. .......+++++.+|++.||.+
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence              0000011111           0                 0000000       00 1133456788999999999999


Q ss_pred             CCCHHHHHHHhh
Q 001275         1087 RPNMRDVVRQLV 1098 (1109)
Q Consensus      1087 RPs~~evl~~L~ 1098 (1109)
                      |+|+.|+++|-+
T Consensus       493 R~tp~qal~Hpf  504 (586)
T KOG0667|consen  493 RITPAQALNHPF  504 (586)
T ss_pred             cCCHHHHhcCcc
Confidence            999999999864

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-33  Score=311.44  Aligned_cols=260  Identities=19%  Similarity=0.323  Sum_probs=205.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||.||+|.. .+++.+|||.+....  ......++.+|+++++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677888999999999999975 578999999875432  2223457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||+++++|.+++.... ....+++..++.++.|+++|++|||   +.+++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999987432 2345899999999999999999999   89999999999999999999999999999886643


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ...  ......++..|+|||...+..++.++||||||+++|+|++|+.||.....+   .........       ....+
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~-------~~~~~  226 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIE-------QCDYP  226 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhh-------cCCCC
Confidence            321  122356889999999998888999999999999999999999998643221   111111110       00000


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ...       ......++.+++.+||+.+|++||||.+|++.+++.
T Consensus       227 ~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PLP-------SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCC-------cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            000       011234566788899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=310.80  Aligned_cols=254  Identities=26%  Similarity=0.351  Sum_probs=200.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc----cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK----RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|...+.||+|++|.||+|.. .+++.||+|.+......    .....+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999965 46899999988543221    123568899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      |+||+++++|.+++....   .+++..+.+++.|++.|++|||   +.+|+||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999987643   4788999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCCCce-eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTT-SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ....... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||.....    .... ........ ...+ 
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~-~~~~~~~~-~~~~-  228 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAI-FKIATQPT-NPQL-  228 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHH-HHHhccCC-CCCC-
Confidence            3221111 1234678899999999998899999999999999999999999854311    1111 11110000 0000 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                  .......+.+++.+||+.+|++||++.|++++.
T Consensus       229 ------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         229 ------------PSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             ------------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                        011223456678899999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-34  Score=315.28  Aligned_cols=263  Identities=24%  Similarity=0.377  Sum_probs=204.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCc----EEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNA----VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .+|+..+.||+|+||+||+|... +++    .+|+|.+..........++.+|++++++++|+||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56788899999999999999754 233    5888887554444445678899999999999999999999987 78899


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      |+||+++|+|.++++...  ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||.++...
T Consensus        86 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999999997643  24899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............++..|+|||......++.++||||||+++||+++ |+.||.....  .++...+..   . ...   .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~---~-~~~---~  231 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VEIPDLLEK---G-ERL---P  231 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhC---C-CCC---C
Confidence            3322222222334678999999988889999999999999999998 9999864321  112211111   0 000   0


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCCCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKY 1108 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1108 (1109)
                      .           ......++.+++.+||..+|++||++.++++.+.++ ...+.+|
T Consensus       232 ~-----------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~-~~~~~~~  275 (279)
T cd05057         232 Q-----------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM-ARDPQRY  275 (279)
T ss_pred             C-----------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH-HhCCcce
Confidence            0           011123466788899999999999999999999987 3344443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-33  Score=310.00  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=201.5

Q ss_pred             ceeecccCeEEEEEEeCC----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.||+|+||.||+|....    +..||+|.+...........+.+|++.+.+++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999997654    7889999986544444467889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          901 GSLRDVLHSITP------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       901 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ++|.+++.....      ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+|++|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999987521      246899999999999999999999   89999999999999999999999999999987754


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...........++..|+|||.+....++.++||||+|+++|||++ |+.||....  ..+...   ..... .   ..  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~---~~~~~-~---~~--  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLE---YLRKG-Y---RL--  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHH---HHHcC-C---CC--
Confidence            432222334567889999999988889999999999999999999 588886431  111111   11110 0   00  


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               ........++.+++.+|++.+|++||++.|++++|+
T Consensus       227 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 ---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                     000111345777888999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-33  Score=319.50  Aligned_cols=243  Identities=24%  Similarity=0.309  Sum_probs=193.0

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.||+|+||+||+|... +++.||+|.+....  .......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 57899999986432  223345677888898888 799999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  152 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T  152 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence            99999987643   4899999999999999999999   89999999999999999999999999999875322211  1


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ...............           
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~~~~~~-----------  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILEDEVRYP-----------  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCCCC-----------
Confidence            2234689999999999999999999999999999999999999964321     111111111110000           


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNM-----RDVVRQ 1096 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 1096 (1109)
                           .....++.+++.+||+.||++||++     .+++++
T Consensus       217 -----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         217 -----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                 0112345667889999999999999     888876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.3e-33  Score=308.75  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=199.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|.+.+.||+|+||.||+|....+..+|+|.+...  ......+.+|++++++++|+|++++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG--TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC--CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            468888999999999999998887778999987432  234467889999999999999999999875 45689999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.++++... ...+++..+..++.|+++|++|||   +.+|+||||||+||++++++.++|+|||.+........ 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05069          83 GKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence            9999999997643 345789999999999999999999   89999999999999999999999999999986643321 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||...+..++.++|||||||++|||++ |+.||......  ........   ... .      .  
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~---~~~-~------~--  223 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVER---GYR-M------P--  223 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc---CCC-C------C--
Confidence            11122346778999999988899999999999999999999 88887543211  11111110   000 0      0  


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                            ........+.+++.+||+.+|++||+++++++.|++
T Consensus       224 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 ------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                  001123456678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.9e-34  Score=330.93  Aligned_cols=202  Identities=25%  Similarity=0.354  Sum_probs=171.6

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .|...++||+|+||+||+|.. .+++.||+|++.....  ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            578889999999999999966 4688999999854321  2334578899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999987643   4788889999999999999999   8999999999999999999999999999975331100


Q ss_pred             C---------------------------------------------CceeeecccCcccccccccccCCCCccCcchhhH
Q 001275          977 A---------------------------------------------STTSISVVGTIGYIAPENAFTTAKSKESDVYSYG 1011 (1109)
Q Consensus       977 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 1011 (1109)
                      .                                             ........||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 001275         1012 VVLLELITRKKALDPS 1027 (1109)
Q Consensus      1012 vil~elltg~~p~~~~ 1027 (1109)
                      |++|||++|+.||...
T Consensus       236 vil~elltG~~Pf~~~  251 (382)
T cd05625         236 VILYEMLVGQPPFLAQ  251 (382)
T ss_pred             HHHHHHHhCCCCCCCC
Confidence            9999999999999653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.9e-34  Score=315.99  Aligned_cols=259  Identities=25%  Similarity=0.328  Sum_probs=204.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.++||+|+||+||+|... +++.||+|++...........+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46777889999999999999764 58899999886554444567889999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++...+   .+++..+..++.+++.|+.|||+  ..+|+||||||+||++++++.++|+|||++....... 
T Consensus        85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            99999999987643   48999999999999999999993  2589999999999999999999999999987543221 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc------ccHHHHHHHhhcCccccccc
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER------TDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                         .....|+..|+|||++.+..++.++|||||||++|++++|+.||.......      ..+..++.......      
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  229 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------  229 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence               123478999999999988889999999999999999999999997543211      01111111111100      


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       .+..       .......++.+++.+|++.||++||+++|++++..-.
T Consensus       230 -~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         230 -PPRL-------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             -CCCC-------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence             0000       0011234567788899999999999999999986444

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.7e-34  Score=333.75  Aligned_cols=255  Identities=23%  Similarity=0.291  Sum_probs=194.5

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +|++.+.||+|+||.||+|+. .+++.||+|.+....  .......+.+|++++++++|+||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            688899999999999999965 458999999985432  12234568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|..+....
T Consensus        82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999997643   4788888999999999999999   8999999999999999999999999999985331100


Q ss_pred             C-----------------------------------------CceeeecccCcccccccccccCCCCccCcchhhHHHHH
Q 001275          977 A-----------------------------------------STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLL 1015 (1109)
Q Consensus       977 ~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ 1015 (1109)
                      .                                         ........||+.|+|||++.+..++.++||||+||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                         00011347999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC---CHHH
Q 001275         1016 ELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP---NMRD 1092 (1109)
Q Consensus      1016 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP---s~~e 1092 (1109)
                      ||++|+.||.......     ............ ..  +.      .....   .++.+++.+|+ .+|++|+   ++.|
T Consensus       236 ell~G~~Pf~~~~~~~-----~~~~i~~~~~~~-~~--~~------~~~~s---~~~~~li~~l~-~~p~~R~~~~t~~e  297 (376)
T cd05598         236 EMLVGQPPFLADTPAE-----TQLKVINWETTL-HI--PS------QAKLS---REASDLILRLC-CGAEDRLGKNGADE  297 (376)
T ss_pred             ehhhCCCCCCCCCHHH-----HHHHHhccCccc-cC--CC------CCCCC---HHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence            9999999996542211     111111000000 00  00      00111   22344555655 5999999   8999


Q ss_pred             HHHHhh
Q 001275         1093 VVRQLV 1098 (1109)
Q Consensus      1093 vl~~L~ 1098 (1109)
                      +++|-+
T Consensus       298 ll~h~~  303 (376)
T cd05598         298 IKAHPF  303 (376)
T ss_pred             HhCCCC
Confidence            998844

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-33  Score=309.93  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=197.4

Q ss_pred             ceeecccCeEEEEEEeCC--C--cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLGP--N--AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|++|.||+|.+..  +  ..||+|.+.........+++.+|++.+++++|+||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  3  36899988554433456689999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc-
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST-  979 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-  979 (1109)
                      |+|.+++..... ..+++..++.++.|+++||+|||   +.+++||||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999987542 45899999999999999999999   8999999999999999999999999999998765432211 


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      ......++..|+|||++.+..++.++|||||||++|||++ |+.||......  +.......   ...   ....     
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~---~~~---~~~~-----  222 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--QILKKIDK---EGE---RLER-----  222 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHh---cCC---cCCC-----
Confidence            1112457789999999998899999999999999999999 99998543211  11111111   000   0000     


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                            .......+.+++.+|++.+|++||++.|+++.|.+
T Consensus       223 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         223 ------PEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ------CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence                  01123456778889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-33  Score=319.33  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=193.8

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +|+..+.||+|+||+||+|... +++.||+|.+.....  ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999765 578999999864322  22334567788888777 5899999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999987643   4889999999999999999999   899999999999999999999999999999754322


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ..   ...........       
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~---~~~i~~~~~~~-------  220 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL---FQSIMEHNVAY-------  220 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HH---HHHHHhCCCCC-------
Confidence            1  1223457999999999999999999999999999999999999999653211  11   11111110000       


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM-----RDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 1096 (1109)
                            +   .....++.+++.+|++.||++|++.     +++.+|
T Consensus       221 ------p---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         221 ------P---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ------C---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                  0   0112345667789999999999974     666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-33  Score=315.67  Aligned_cols=268  Identities=26%  Similarity=0.371  Sum_probs=198.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC--Cce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  891 (1109)
                      ++|+..+.||+|+||+||+|..     .+++.||+|++... .......+.+|++++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            4678889999999999999964     35789999987432 333456789999999999999999999987543  467


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++|+||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence            89999999999999997543  34899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCCce-eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPASTT-SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ......... .....++..|+|||+..+..++.++|||||||++|||++|..++......      +....... ... .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~~~~-~~~-~  229 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMMGND-KQG-Q  229 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhcccc-ccc-c
Confidence            643322111 11123445699999999888999999999999999999998765322110      11100000 000 0


Q ss_pred             ccchhhhH----HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1051 IVDLSLME----EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1051 ~~d~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .....+..    ............++.+++.+||+.+|++||||+|+++.|+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000000    000000112234577888899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.8e-33  Score=308.69  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=202.1

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|...+.||+|++|.||+|... +++.|++|.+.... .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677889999999999999764 68899999885432 334456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.++++... ...+++..++.++.|++.|+.|||   +.+|+||||||+||++++++.++++|||+++.......
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999998642 345889999999999999999999   89999999999999999999999999999886644322


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......|++.|+|||+..+..++.++|||||||++|||++|+.||.....  ..   ........  ....+      
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~---~~~~~~~~--~~~~~------  221 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--GA---LILKIIRG--VFPPV------  221 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--HH---HHHHHHcC--CCCCC------
Confidence              12234688999999999999999999999999999999999999864421  11   11111100  00000      


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                             ......++.+++.+||+.+|++||++.|++++
T Consensus       222 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 -------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                   01123456778889999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2e-33  Score=314.28  Aligned_cols=267  Identities=24%  Similarity=0.338  Sum_probs=194.2

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-ChHHHHHHHHHHhcC---CCCceeeEeeEEecC-----C
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKI---RHRNLVRLEDFWLRK-----D  889 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~  889 (1109)
                      +|++.+.||+|+||+||+|... +++.||+|.+....... ....+.+|+++++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999665 68899999885433222 234566787777766   699999999987642     3


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..++|+||+++ +|.+++.... ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            47899999985 8999887643 245899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh-------h
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV-------W 1042 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~ 1042 (1109)
                      +.......   .....+|..|+|||++.+..++.++||||+||++|||++|+.||...... ..........       |
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhC
Confidence            86643221   12346889999999999989999999999999999999999998643221 1111111111       0


Q ss_pred             cCcccc-ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1043 SDTEEI-NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1043 ~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...... .....+... .......+....++.+++.+|++.||++||++.|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         232 PRDVTLPRGAFSPRGP-RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccccCCCCC-CchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000 000000000 00000011123446678889999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.7e-33  Score=319.98  Aligned_cols=243  Identities=24%  Similarity=0.302  Sum_probs=188.3

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHH-HHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQ-TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.||+|+||+||+|... +++.||+|++.....  ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999764 689999999854321  222334555544 56788999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            99999987533   4889999999999999999999   8999999999999999999999999999987542221  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....     ...............    .       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~~~~----~-------  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDNILNKPLRL----K-------  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHHHHcCCCCC----C-------
Confidence            234579999999999999999999999999999999999999986432     111111111111000    0       


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMR----DVVRQ 1096 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~----evl~~ 1096 (1109)
                           ......+.+++.+|++.||++||+++    |++++
T Consensus       217 -----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         217 -----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             -----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence                 01123456677899999999999884    66654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=309.24  Aligned_cols=255  Identities=27%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .++|.+.++||+|+||+||+|..++++.||||.+..  ......++.+|+.++++++|+||+++++++......++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP--GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecC--CccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            367888999999999999999988888999998753  233456799999999999999999999999988899999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++.... ...+++..+..++.+++.|++|||   +.+|+||||||+||++++++.+|++|||.+........
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999997643 245899999999999999999999   88999999999999999999999999999986643211


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                       .......++..|+|||...+..++.++||||+|+++||+++ |+.||.....  ....   ........   .. .   
T Consensus       159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~---~~~~~~~~---~~-~---  225 (261)
T cd05034         159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--REVL---EQVERGYR---MP-R---  225 (261)
T ss_pred             -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH---HHHHcCCC---CC-C---
Confidence             11122345678999999998889999999999999999999 8888854311  1111   11111000   00 0   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                              ......++.+++.+|++.+|++||+++|+.+.|+.
T Consensus       226 --------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 --------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                    00112356778889999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-33  Score=311.46  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=193.0

Q ss_pred             ceeecccCeEEEEEEeCC-Cc--EEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLGP-NA--VFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||.||+|...+ +.  .+|+|.+...........+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999997753 33  46888775433344456788999999999 899999999999999999999999999


Q ss_pred             CCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          901 GSLRDVLHSIT-------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       901 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                      |+|.++++...             ....+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999997543             1234789999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      ++......   ........+..|+|||++....++.++|||||||++|||++ |+.||.....  .   ......... .
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--~---~~~~~~~~~-~  228 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--A---ELYEKLPQG-Y  228 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--H---HHHHHHhCC-C
Confidence            98632211   11111234567999999988889999999999999999997 9988854211  1   111111000 0


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..    +          .......++.+++.+||+.+|.+||++.|+++.|.++
T Consensus       229 ~~----~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         229 RL----E----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             CC----C----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            00    0          0011223567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-33  Score=307.78  Aligned_cols=250  Identities=27%  Similarity=0.380  Sum_probs=202.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|...+.||+|+||.||+|... ++.||+|.+.....  ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            56888999999999999999876 78899998854332  4567899999999999999999999999889999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.++++... ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999997643 235899999999999999999999   89999999999999999999999999999986632211 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                          ....+..|+|||++.+..++.++||||||+++||+++ |+.||.....  .++...+...+.    . ..      
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~~----~-~~------  220 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPHVEKGYR----M-EA------  220 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhcCCC----C-CC------
Confidence                2345678999999988889999999999999999997 8888854321  111111111000    0 00      


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             ......++.+++.+|++.+|++||+++|+++.|..+
T Consensus       221 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 -------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                   011234567788899999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.9e-33  Score=308.75  Aligned_cols=248  Identities=21%  Similarity=0.275  Sum_probs=193.8

Q ss_pred             eeecccCeEEEEEEe---CCCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          826 VIGRGAHGIVYKASL---GPNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       826 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      .||+|+||+||+|.+   .++..+|+|++...... ....++.+|+.++++++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999964   35788999987543322 23457889999999999999999999875 45678999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc-e
Q 001275          902 SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST-T  980 (1109)
Q Consensus       902 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-~  980 (1109)
                      +|.+++....   .+++..+..++.|++.|++|+|   +.+|+||||||+||++++++.+||+|||+++......... .
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999997533   4889999999999999999999   8999999999999999999999999999998764432211 1


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHH
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1059 (1109)
                      .....++..|+|||.+....++.++|||||||++|||++ |+.||.....  ......+..    .... ..        
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~i~~----~~~~-~~--------  219 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIES----GERM-EC--------  219 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC----CCCC-CC--------
Confidence            112344678999999988888999999999999999998 8989864321  122222211    0000 00        


Q ss_pred             hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1060 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                        +   .....++.+++.+||+.||++||++++|++.|+..
T Consensus       220 --~---~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 --P---QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --C---CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              0   11224566788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-33  Score=328.13  Aligned_cols=267  Identities=20%  Similarity=0.277  Sum_probs=197.3

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-----cee
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-----CGI  892 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  892 (1109)
                      +|+..++||+|+||+||+|.. .+++.||+|++.... .....+++.+|+++++.++|+||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999976 578999999885332 2233457889999999999999999999998776     789


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +|+||+. ++|.+++...   ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 5888877643   34899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ..... .......+++.|+|||++.+. .++.++||||+||++|||++|+.||......  +....+........ ..++
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~g~~~-~~~~  229 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI--QQLDLITDLLGTPS-LEAM  229 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHcCCCC-HHHH
Confidence            43221 122234688999999988774 4789999999999999999999999654211  11111111110000 0000


Q ss_pred             ---------------cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 ---------------VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ---------------~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                     ..+...... .........++.+++.+|++.||++|||++|+++|-+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  290 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY  290 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence                           000000000 0000111345677888999999999999999998743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=319.18  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=194.6

Q ss_pred             CceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCC
Q 001275          824 KHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      .-++|+|.||+||-|+.. +...+|||.+..+ ..+..+-+..|+..-++++|+|||+++|.+.+++..-+.||-++||+
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            347999999999999765 4567899988543 33445567899999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC-CCCcEEEecccCCcccCCCCCCcee
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD-SEMEPHISDFGIAKLLDKSPASTTS  981 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~  981 (1109)
                      |.+.++..=.+-.-.+...-.+.+||++||.|||   ...|||||||-+|||++ -.|.+||+|||.++.+..-  ....
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~T  733 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCT  733 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccC--Cccc
Confidence            9999987533333377778889999999999999   99999999999999995 5789999999999876432  2333


Q ss_pred             eecccCcccccccccccC--CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHH
Q 001275          982 ISVVGTIGYIAPENAFTT--AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059 (1109)
Q Consensus       982 ~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1059 (1109)
                      ..+.||..|||||++..+  .|+.++|||||||++.||.||++||.......   ...++.     ...          +
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkV-----Gmy----------K  795 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKV-----GMY----------K  795 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhhh-----cce----------e
Confidence            457899999999999865  47899999999999999999999995432111   000000     001          0


Q ss_pred             hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1060 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..++...+...+...++++|+.+||.+||+|+++++.
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            1111122333455668889999999999999999864

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.9e-33  Score=324.53  Aligned_cols=269  Identities=21%  Similarity=0.265  Sum_probs=196.8

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-----
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-----  889 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  889 (1109)
                      ..++|...+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            347899999999999999999966 468999999985432 2334557889999999999999999999986543     


Q ss_pred             -ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          890 -CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       890 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                       ..++||||+++ ++.+.++.     .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence             46999999975 56666643     2788889999999999999999   89999999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      ++......   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .................
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCcHHH
Confidence            97543221   122357899999999999999999999999999999999999999643211 11111111000000000


Q ss_pred             --------ccccc--h-----h---hhHHhh----hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1049 --------NDIVD--L-----S---LMEEML----VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1049 --------~~~~d--~-----~---~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                              .....  +     .   ......    .........++.+++.+|++.||++|||++|+++|-+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  317 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY  317 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence                    00000  0     0   000000    0000011245677888999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.9e-33  Score=315.34  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=200.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            5788889999999999999975 568899999885433 33356788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++...    .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~  171 (296)
T cd06654          99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (296)
T ss_pred             cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence            9999999998642    3789999999999999999999   89999999999999999999999999999876533221


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......+++.|+|||...+..++.++|||||||++|+|++|+.||.......    .+. ..+....  .....    
T Consensus       172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~-~~~~~~~--~~~~~----  238 (296)
T cd06654         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALY-LIATNGT--PELQN----  238 (296)
T ss_pred             --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHH-HHhcCCC--CCCCC----
Confidence              1223468899999999988889999999999999999999999996432211    111 1110000  00000    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                             .......+.+++.+||+.+|++||++.|++++-
T Consensus       239 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~  271 (296)
T cd06654         239 -------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (296)
T ss_pred             -------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence                   011223466788899999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-33  Score=311.93  Aligned_cols=269  Identities=21%  Similarity=0.358  Sum_probs=199.2

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|+..+.||+|++|.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777889999999999999764 689999998854332 22345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++ ++|.+++........+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 689999876554456899999999999999999999   8999999999999999999999999999987553321 


Q ss_pred             CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh-------hcCccccc
Q 001275          978 STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV-------WSDTEEIN 1049 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 1049 (1109)
                       .......+++.|+|||++.+. .++.++||||+||++|||++|+.||....... .........       |.......
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhcchhhH
Confidence             112234578899999987654 46899999999999999999999986432211 111111111       00000000


Q ss_pred             c---ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1050 D---IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1050 ~---~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .   .++ ................++.+++.+|++.||++||+++|++++
T Consensus       234 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         234 DYKNTFP-KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHhhcc-ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0   000 000000000001123456678889999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-33  Score=307.69  Aligned_cols=249  Identities=23%  Similarity=0.316  Sum_probs=195.8

Q ss_pred             ceeecccCeEEEEEEeCC----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||.||+|....    +..+|+|.+..........++.+|+++++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999996532    26899998865444445567899999999999999999999876 4568999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc-
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST-  979 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-  979 (1109)
                      |+|.+++....   .+++..+..++.|+++|++|||   ..+++||||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999997643   5899999999999999999999   8899999999999999999999999999998664332211 


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      ......++..|+|||...+..++.++|||||||++|||++ |+.||.....  .+...++....    .. .  .     
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~----~~-~--~-----  219 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGE----RL-P--R-----  219 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCC----cC-C--C-----
Confidence            1112234568999999998899999999999999999998 8998864321  22222221110    00 0  0     


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                            .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus       220 ------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         220 ------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                  011223566788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.3e-33  Score=317.78  Aligned_cols=249  Identities=22%  Similarity=0.268  Sum_probs=192.5

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||+||+|... +++.||+|++.....  ......+.+|+.++.++ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999764 578999999864322  23345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++...+   .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            99999886543   4899999999999999999999   8999999999999999999999999999987532221  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc-cccHHHHHHHhhc-CccccccccchhhhH
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE-RTDIVGWVRSVWS-DTEEINDIVDLSLME 1058 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~d~~~~~ 1058 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+...... ......         
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p---------  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP---------  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC---------
Confidence            23457999999999999999999999999999999999999999642211 1111111111110 000000         


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCC------HHHHHHHh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPN------MRDVVRQL 1097 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs------~~evl~~L 1097 (1109)
                             .....++.+++.+|++.||++|++      +.++++|-
T Consensus       224 -------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         224 -------RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             -------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence                   011233556778999999999998      46777663

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.6e-33  Score=311.74  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=196.3

Q ss_pred             ceeecccCeEEEEEEeCC-------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          825 HVIGRGAHGIVYKASLGP-------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.||+|+||.||+|+..+       ++.+|+|.+...........+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999997642       2578999875443334566788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-----cEEEecccC
Q 001275          898 MENGSLRDVLHSIT----PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-----EPHISDFGI  968 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DfGl  968 (1109)
                      +++|+|.+++....    ....+++..++.++.|+++|++|||   +.+++|+||||+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997532    2234789999999999999999999   88999999999999999877     899999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |+.||.....  .+....+.    ... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--~~~~~~~~----~~~-  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--QEVLQHVT----AGG-  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--HHHHHHHh----cCC-
Confidence            986543322222223356788999999999999999999999999999998 8888853211  11111110    000 


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                        ..           .........+.+++.+||+.+|++||+++++++.|.+
T Consensus       231 --~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         231 --RL-----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             --cc-----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              00           0011123456778889999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-33  Score=307.42  Aligned_cols=240  Identities=24%  Similarity=0.346  Sum_probs=184.7

Q ss_pred             ceeecccCeEEEEEEeCC-------------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          825 HVIGRGAHGIVYKASLGP-------------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      +.||+|+||.||+|+...             ...||+|.+... .......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            358999999999997532             235788876432 233445788899999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc-------EEEe
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME-------PHIS  964 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~kl~  964 (1109)
                      ++||||+++|+|..+++...  ..+++..+++++.|+++|++|||   +.+|+||||||+||+++.++.       ++++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            99999999999999887533  34899999999999999999999   899999999999999987654       8999


Q ss_pred             cccCCcccCCCCCCceeeecccCcccccccccc-cCCCCccCcchhhHHHHHHHH-hCCCCCCCCccccccHHHHHHHhh
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELI-TRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      |||++......      ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......     .. ....
T Consensus       155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~-~~~~  222 (262)
T cd05077         155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-----EK-ERFY  222 (262)
T ss_pred             CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----HH-HHHH
Confidence            99998755322      1245788999999886 466899999999999999998 577776432111     00 0000


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ....   ..             ......++.+++.+||+.||++||+++|+++++.
T Consensus       223 ~~~~---~~-------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQC---ML-------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcCc---cC-------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0000   00             0011235677888999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3e-33  Score=309.01  Aligned_cols=260  Identities=24%  Similarity=0.379  Sum_probs=205.5

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.+.||.|+||+||+|.. .++..+|+|++...........+.+|+++++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            3688899999999999999975 467889999886544444567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.++++.......+++..+..++.|++.|++|||   +.+|+||||+|+||++++++.++++|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999986544356899999999999999999999   89999999999999999999999999999886654332


Q ss_pred             Cc--eeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 ST--TSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..  ......|+..|+|||++... .++.++|+|||||++|||++|+.||...... ........   .........   
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~---~~~~~~~~~---  230 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQ---NDPPSLETG---  230 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhc---CCCCCcCCc---
Confidence            21  22334688999999988777 7899999999999999999999998643221 11111111   100000000   


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                           .   ........+.+++.+|++.||++||+++|+++|
T Consensus       231 -----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         231 -----A---DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -----c---ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                 0   011223456678889999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.7e-33  Score=312.32  Aligned_cols=254  Identities=26%  Similarity=0.330  Sum_probs=198.3

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      |+..++||+|+||+||+|... +++.||+|.+......  .....+.+|+.++++++|++++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667788999999999999664 6889999988543322  2234577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++.... ...+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            99999999986533 234889999999999999999999   8999999999999999999999999999987653222 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......|+..|+|||++.+..++.++||||+||++|||++|+.||........  ..........   .        .
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~~---~--------~  221 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKE---V--------Q  221 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhhh---h--------h
Confidence              11234789999999999999999999999999999999999999965322110  0000000000   0        0


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~ 1098 (1109)
                      . ...   .....++.+++.+|++.||++||+     ++|+++|-+
T Consensus       222 ~-~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         222 E-EYS---EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             h-hcC---ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence            0 000   111234567788999999999999     899998644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-33  Score=327.08  Aligned_cols=269  Identities=22%  Similarity=0.271  Sum_probs=200.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC---CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+|.+.+.||+|+||.||+|...   .++.||+|.+...      ....+|++++++++||||+++++++......++||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            57899999999999999999653   3577899977321      24568999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+. ++|.+++...   ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus       166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9996 6898888543   35899999999999999999999   899999999999999999999999999999866544


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc--ccHHHHHHHhhcCccccccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER--TDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ..+...++...........-..
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            33333334679999999999999999999999999999999999999996532211  1111111111110000000000


Q ss_pred             hhh-----------hHHhhhch-h--HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1054 LSL-----------MEEMLVSS-I--RDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1054 ~~~-----------~~~~~~~~-~--~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..+           ......+. .  .....++.+++.+|++.||++||++.|++.|=.-.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence            000           00000000 0  01123566788899999999999999999985443

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-33  Score=305.65  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCHH
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLR  904 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  904 (1109)
                      ++||+|+||.||+|...+++.||+|.+...........+.+|++++++++|+||+++++++......++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999887799999998855443334567899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeec
Q 001275          905 DVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV  984 (1109)
Q Consensus       905 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  984 (1109)
                      +++....  ..+++..+..++.+++.|++|||   +.+++||||||+||+++.++.++|+|||++...............
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9997643  24789999999999999999999   899999999999999999999999999999865432211111122


Q ss_pred             ccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          985 VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       985 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      .++..|+|||.+.+..++.++||||+||++|||++ |..||.....  ......+..    ..   ....          
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~~~~~~~----~~---~~~~----------  216 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIES----GY---RMPA----------  216 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHHHHHHhc----CC---CCCC----------
Confidence            34667999999988899999999999999999999 7777743321  111111110    00   0000          


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       ......++.+++.+|++.+|++||++.|+++.|.
T Consensus       217 -~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         217 -PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence             0112335777888999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-33  Score=307.55  Aligned_cols=251  Identities=20%  Similarity=0.333  Sum_probs=201.0

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      +|++.++||+|+||.||++... +++.||+|.+.........+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4777899999999999999764 688999998865444455667889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++.... ...+++..+..++.|++.|++|||   +.+|+|+||||+||++++++.++++|||.+........ 
T Consensus        81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            9999999887533 234788999999999999999999   89999999999999999999999999999976643221 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                       ......|++.|+|||+..+..++.++|+||||+++|+|++|+.||....     ............  .... .     
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~--~~~~-~-----  221 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGS--YKPL-P-----  221 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCC--CCCC-C-----
Confidence             1223568899999999998889999999999999999999999986431     111111111110  0000 0     


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                             .....++.+++.+||+.||++||+++|++..
T Consensus       222 -------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 -------SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   0112345678889999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-33  Score=317.80  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=199.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCc----EEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNA----VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|+..+.||+|+||.||+|... ++.    .||+|.+..........++.+|+.++++++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            46778889999999999999753 343    46888775443333345788999999999999999999998754 5679


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ++||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccccc
Confidence            999999999999987643  34789999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............++..|+|||++.+..++.++|||||||++||+++ |+.||.....  .....++..    .....   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--~~~~~~~~~----~~~~~---  231 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--REIPDLLEK----GERLP---  231 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHC----CCCCC---
Confidence            3322222223456778999999998999999999999999999997 8888854321  112222111    10000   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .           ......++.+++.+||..+|++||+++|+++.+.++.
T Consensus       232 ~-----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         232 Q-----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             C-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0           0112235677888999999999999999999998863

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.5e-34  Score=311.68  Aligned_cols=254  Identities=31%  Similarity=0.442  Sum_probs=197.9

Q ss_pred             CCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccCh-HHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          821 LNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGS-LSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      |+..+.||+|+||+||++.... ++.||+|.+......... ....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            4567899999999999997754 568999998654433322 23456999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.+++....   .+++..+..++.|+++||+|||   +.+|+|+||||+||++++++.++|+|||.+.....  ..
T Consensus        81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN  152 (260)
T ss_dssp             TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred             ccccccccccccc---cccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--cc
Confidence            9999999998333   4899999999999999999999   88999999999999999999999999999986421  22


Q ss_pred             ceeeecccCcccccccccc-cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||++. +..++.++||||+|+++|+|++|+.||.....  .+.........          .....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~----------~~~~~  220 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKIL----------KRPLP  220 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHH----------HTHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcc----------ccccc
Confidence            2333467899999999988 78889999999999999999999999875410  11111111100          00000


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...  ........++.+++.+|++.||++||++.|++++
T Consensus       221 ~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  221 SSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000  0001112567788889999999999999999976

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.2e-33  Score=322.77  Aligned_cols=261  Identities=22%  Similarity=0.292  Sum_probs=198.6

Q ss_pred             HHHHHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC
Q 001275          813 QVIEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       813 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  889 (1109)
                      +.....++|.+.+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.+++.++||||+++++++...+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            33445588999999999999999999765 57889999885422  2223445788999999999999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..++||||+++|+|.+++...    .++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999998753    2788888999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCC----CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTA----KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      +....... .......||+.|+|||++.+..    ++.++||||+||++|||++|+.||.....     ...........
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~  263 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHK  263 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC
Confidence            86643221 1223457999999999887543    78999999999999999999999964321     11111111111


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhh
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSN--RPNMRDVVRQLV 1098 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L~ 1098 (1109)
                      ... .+.+           .......+.+++.+|++.++.+  ||+++|+++|.+
T Consensus       264 ~~~-~~~~-----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         264 NSL-TFPD-----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             Ccc-cCCC-----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence            000 0000           0011223445667888744443  789999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.2e-33  Score=315.97  Aligned_cols=270  Identities=19%  Similarity=0.302  Sum_probs=200.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...++||+|+||.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++...+..++|+||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999764 57899999986554444456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++ ++|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 59999887543  34789999999999999999999   89999999999999999999999999999975433221


Q ss_pred             CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC--ccccccccc-
Q 001275          978 STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD--TEEINDIVD- 1053 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d- 1053 (1109)
                        ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||......  .....+......  ......+.. 
T Consensus       160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCChhhchhhhcc
Confidence              12234678899999987654 4788999999999999999999998654221  111111111100  000000000 


Q ss_pred             --------hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1054 --------LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1054 --------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                              +................++.+++.+|++.||.+|||++|+++|-+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~  288 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY  288 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence                    000000000000111234667888999999999999999998654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-33  Score=313.40  Aligned_cols=272  Identities=25%  Similarity=0.331  Sum_probs=203.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec--CCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  891 (1109)
                      +.|...+.||+|+||.||+|...     +++.||||.+...........+.+|++++++++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677789999999999999753     4688999998544333345689999999999999999999999877  5578


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999999997643  24899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ........ ......++..|+|||...+..++.++||||||+++|||++|+.|+............   .. ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~---~~-~~~~~~~~  234 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG---IA-QGQMIVTR  234 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc---cc-cccccHHH
Confidence            65332211 111234566799999998889999999999999999999999987543221111000   00 00000000


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      + ...+..............++.+++.+|++.+|++||+|.|++++|..+
T Consensus       235 ~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         235 L-LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             H-HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0 000000000000112235677889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=299.17  Aligned_cols=250  Identities=22%  Similarity=0.320  Sum_probs=204.1

Q ss_pred             CCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEecc
Q 001275          821 LNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      |++..+||+|+||.||+|.+ ..|+++|||++..   +.+.+++.+|+.+|.+++.|+||++||.|......++|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV---~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV---DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc---cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            55677899999999999955 5699999998854   3456788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      -|+..|+++..+  .++++.++..++..-++||+|||   ...-+|||||+.|||++.+|.+|++|||+|..+.+...  
T Consensus       112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--  184 (502)
T KOG0574|consen  112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--  184 (502)
T ss_pred             CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--
Confidence            999999998654  46999999999999999999999   78889999999999999999999999999987654322  


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHH
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1059 (1109)
                      ......||+-|||||++..-.|+.++||||+|++..||.-|++||..-..-.                  .++--.-.+.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------------------AIFMIPT~PP  246 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------------------AIFMIPTKPP  246 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------------------eeEeccCCCC
Confidence            2234689999999999999999999999999999999999999986432111                  1000000000


Q ss_pred             hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1060 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ...........++-+++..|+-..|++|.|+.++++|-.
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence            111112334456677888999999999999999998854

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.6e-33  Score=305.55  Aligned_cols=249  Identities=26%  Similarity=0.332  Sum_probs=197.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEe-cCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL-RKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~  897 (1109)
                      ++|...+.||+|+||.||+|... ++.||+|.+..   ....+.+.+|+.++++++|+|++++++++. .++..++|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCC---CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46888899999999999999776 77889998742   233557889999999999999999999765 44568999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.++++... ...+++..+.+++.|++.|++|||   +.+|+||||||+||++++++.+|++|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  157 (256)
T cd05082          82 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  157 (256)
T ss_pred             CCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence            99999999997643 335889999999999999999999   89999999999999999999999999999885533221


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                           ...++..|+|||++.+..++.++|||||||++|||++ |+.||...     ..............  ...     
T Consensus       158 -----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~~~~~~--~~~-----  220 (256)
T cd05082         158 -----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVEKGYK--MDA-----  220 (256)
T ss_pred             -----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhcCCC--CCC-----
Confidence                 2345678999999998889999999999999999998 88887532     11112111111000  000     


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              .......+.+++.+|++.+|++||++.++++.|.++
T Consensus       221 --------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 --------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                    011234566788899999999999999999998763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.5e-33  Score=316.00  Aligned_cols=197  Identities=27%  Similarity=0.420  Sum_probs=160.4

Q ss_pred             CceeecccCeEEEEEEeC---CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec--CCceeEEEEec
Q 001275          824 KHVIGRGAHGIVYKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCGIIMYRYM  898 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  898 (1109)
                      .++||+|+||+||+|...   +++.||+|.+...   .....+.+|++++++++||||+++++++..  ....++|+||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC---CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            467999999999999764   4678999987432   223467899999999999999999998864  34578999998


Q ss_pred             cCCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee----CCCCcEEEecccC
Q 001275          899 ENGSLRDVLHSIT------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL----DSEMEPHISDFGI  968 (1109)
Q Consensus       899 ~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfGl  968 (1109)
                      ++ +|.+++....      ....+++..+..++.|+++||+|||   +.+|+||||||+||++    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            64 8888875422      1235889999999999999999999   8999999999999999    4567899999999


Q ss_pred             CcccCCCCCC-ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          969 AKLLDKSPAS-TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       969 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      ++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9876443221 122345789999999988774 5799999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.1e-33  Score=318.02  Aligned_cols=239  Identities=26%  Similarity=0.310  Sum_probs=184.0

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHH-HHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQ-TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.||+|+||+||+|... +++.||+|++.....  ......+.+|.. +++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999765 578899999854322  122334444444 56788999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+.+..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            99999997633   3778888899999999999999   8999999999999999999999999999997543221  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............    .       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~----~-------  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKPLQL----K-------  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCCcCC----C-------
Confidence            2345799999999999999999999999999999999999999964321     11111111110000    0       


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRD 1092 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 1092 (1109)
                        ...   ...+.+++.+|++.||++||++.+
T Consensus       217 --~~~---~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         217 --PNI---TNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             --CCC---CHHHHHHHHHHcccCHHHCCCCCC
Confidence              011   223456777999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-33  Score=309.53  Aligned_cols=256  Identities=21%  Similarity=0.298  Sum_probs=204.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ..|+..++||+|+||.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35667788999999999999764 58899999886544445566789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++...    .+++..+..++.|+++|++|+|   +.+++|+||+|+||+++.++.++++|||++........
T Consensus        84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            9999999998652    3788899999999999999999   89999999999999999999999999999976643221


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......++..|+|||++.+..++.++|||||||++|||++|+.||.......     ...... .. .     .+   
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~~~~-~~-~-----~~---  219 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----VLFLIP-KN-N-----PP---  219 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----Hhhhhh-cC-C-----CC---
Confidence              1223467889999999988889999999999999999999999986432110     000000 00 0     00   


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVP 1103 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1103 (1109)
                           .........+.+++.+||+.+|++||+++|++++-.-....
T Consensus       220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         220 -----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             -----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence                 01122345567788899999999999999999886544333

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8.3e-33  Score=304.66  Aligned_cols=252  Identities=25%  Similarity=0.346  Sum_probs=191.1

Q ss_pred             ceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEe-cCCceeEEEEecc
Q 001275          825 HVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL-RKDCGIIMYRYME  899 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  899 (1109)
                      +.||+|+||.||+|...    ....||+|++...........+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999753    245789998743333344567889999999999999999999876 4556799999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC-
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS-  978 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-  978 (1109)
                      +|+|.+++....  ...++..+..++.|+++|++|||   +.+|+||||||+||++++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            999999997543  23678888999999999999999   889999999999999999999999999999765332111 


Q ss_pred             -ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 -TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                       .......++..|+|||...+..++.++|||||||++|||++|+.|+.....    ...............    .    
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~~~~~~~~~~~~~----~----  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFDITVYLLQGRRLL----Q----  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHhcCCCCC----C----
Confidence             111223567789999999888999999999999999999996554332211    111222211111000    0    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .......+.+++.+||+.+|++||++.|+++.|+++
T Consensus       224 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         224 -------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             -------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                   001123467788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.1e-33  Score=306.22  Aligned_cols=255  Identities=20%  Similarity=0.234  Sum_probs=185.9

Q ss_pred             ceeecccCeEEEEEEeCCC---cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          825 HVIGRGAHGIVYKASLGPN---AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      +.||+|+||+||+|...++   ..+++|.+...........+.+|+..++.++||||++++++|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3599999999999965433   3456666544333344568999999999999999999999999999999999999999


Q ss_pred             CHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          902 SLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       902 sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      +|.++++.... ....++..+..++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999976432 234667778899999999999999   88999999999999999999999999999864322222222


Q ss_pred             eeecccCccccccccccc-------CCCCccCcchhhHHHHHHHHhC-CCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          981 SISVVGTIGYIAPENAFT-------TAKSKESDVYSYGVVLLELITR-KKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .....++..|+|||+...       ..++.++|||||||++|||+++ ..||.... .    ...........  .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~----~~~~~~~~~~~--~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-D----REVLNHVIKDQ--QVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-H----HHHHHHHHhhc--ccccC
Confidence            234568899999998753       2457899999999999999975 55664321 1    11111111110  01111


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ++....     ..   ..++.+++..|| .+|++||+++|+++.|.
T Consensus       231 ~~~~~~-----~~---~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLEL-----PY---SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCC-----CC---cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            111110     11   233555677899 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.5e-33  Score=317.08  Aligned_cols=243  Identities=23%  Similarity=0.293  Sum_probs=187.2

Q ss_pred             ceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHH-HHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQ-TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||.||+|+.. +++.||+|++.....  ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999764 688999999854321  222334555554 57889999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++...   ..+.+..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            9999888653   24788889999999999999999   8999999999999999999999999999987532221  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||....     ...............            
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~~------------  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDNILHKPLQL------------  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHHHhcCCCCC------------
Confidence            234578999999999999899999999999999999999999996532     111111111111000            


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMR----DVVRQ 1096 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~----evl~~ 1096 (1109)
                       .   .....++.+++.+|++.||++||++.    |++++
T Consensus       216 -~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         216 -P---GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             -C---CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence             0   01123456678899999999999763    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3e-33  Score=308.76  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=198.6

Q ss_pred             CCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccc-----cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHK-----RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      +|...+.||+|+||+||+|...+++.+|+|.+......     .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47788999999999999998888999999988543221     2234688999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      +||+++++|.+++....   .+++..+..++.|++.|++|||   +.+|+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999997643   3789999999999999999999   88999999999999999999999999999876532


Q ss_pred             CCC----CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          975 SPA----STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       975 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ...    ........++..|+|||+..+..++.++||||+||++|+|++|+.||...... ......    .........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~~~~  229 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-AAMFYI----GAHRGLMPR  229 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-HHHHHh----hhccCCCCC
Confidence            111    11112346889999999999888999999999999999999999998643111 111000    000000000


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .          ..   ....++.+++.+|++.+|++||++.|++++
T Consensus       230 ~----------~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         230 L----------PD---SFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             C----------CC---CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0          01   122345667889999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.8e-33  Score=306.22  Aligned_cols=250  Identities=23%  Similarity=0.343  Sum_probs=200.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|+..++||+|+||.||+|.... ++.||+|.+.....   ..++.+|++++++++|+||+++++++......++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            578889999999999999998764 78999998854322   66899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++....  ..+++..+..++.|+++|++|||   +.+|+|||++|+||++++++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999999987533  35899999999999999999999   88999999999999999999999999999986643321


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......++..|+|||++.+..++.++|||||||++|+|++|+.||........    .. .....  ..... .    
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~----~~-~~~~~--~~~~~-~----  220 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA----IF-MIPNK--PPPTL-S----  220 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh----hh-hhccC--CCCCC-C----
Confidence              22234588899999999988999999999999999999999999864321110    00 00000  00000 0    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                            .......++.+++.+|++.+|++||++.|++++
T Consensus       221 ------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         221 ------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             ------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence                  001122346678889999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-33  Score=306.41  Aligned_cols=252  Identities=22%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .+|+..+.||+|+||.||+|...+++.+|+|.+..  .......+.+|++++++++|||++++++++......++|+||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCC--CCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            45777899999999999999887788999998742  2334567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.+++....  ..++++.+..++.+++.|++|||   +.+++||||||+||+++.++.++|+|||+++....... 
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          82 EHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence            9999999987543  34789999999999999999999   88999999999999999999999999999876543211 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++.+|+|||...+..++.++||||+|+++|||++ |+.||.....     ...........    ....+.  
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~----~~~~~~--  224 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETINAGF----RLYKPR--  224 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHHhCCC----CCCCCC--
Confidence            11122345678999999998899999999999999999998 8888854321     11111111000    000111  


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               ....++.+++.+||+.+|++||+++|++++|.
T Consensus       225 ---------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 ---------LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---------CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                     11245777889999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.1e-33  Score=315.67  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=193.2

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +|+..+.||+|+||+||+|... +++.||+|++....  .......+..|.+++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677889999999999999764 68899999986432  2233456778888888885 577888999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999987643   4889999999999999999999   899999999999999999999999999998754322


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..............      
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~~i~~~~~~~p------  221 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQSIMEHNVSYP------  221 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCCCC------
Confidence            1  1222356899999999999999999999999999999999999999653211     11111111100000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM-----RDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~ 1096 (1109)
                                .....++.+++.+|++.+|++|++.     +|+.+|
T Consensus       222 ----------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         222 ----------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ----------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                      0112345667789999999999974     555554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-33  Score=305.56  Aligned_cols=253  Identities=22%  Similarity=0.372  Sum_probs=200.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|++.++||+|+||.||+|...++..+|+|.+...  ......+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cceeEEeEecCccceEEEEEEecCCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            578889999999999999999888888999987432  3345678899999999999999999999877 7789999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++.... ....++..++.++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.+........ 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  157 (260)
T cd05073          83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-  157 (260)
T ss_pred             CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence            9999999997643 345789999999999999999999   88999999999999999999999999999976543221 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||++....++.++|+|||||++|++++ |+.||.....  .+........+    .. .       
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--~~~~~~~~~~~----~~-~-------  223 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGY----RM-P-------  223 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCC----CC-C-------
Confidence            11222346678999999998889999999999999999999 8888754211  11111111100    00 0       


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                            .......++.+++.+|++.+|++||++.++.+.|..
T Consensus       224 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  001122356778889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-33  Score=320.50  Aligned_cols=193  Identities=21%  Similarity=0.296  Sum_probs=164.7

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ....+|.+.+.||+|+||.||+|... +++.||+|....       .....|+.++++++|+||+++++++...+..++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc-------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            33467999999999999999999765 467888886421       1235699999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      +||+. |+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       136 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            99995 58998886533  35899999999999999999999   89999999999999999999999999999975432


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCC
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKAL 1024 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~ 1024 (1109)
                      .   .......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       210 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 A---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             C---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            2   1223357899999999999999999999999999999999976665

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.8e-33  Score=308.27  Aligned_cols=252  Identities=25%  Similarity=0.321  Sum_probs=197.2

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      |+..+.||+|+||+||+|... +++.||+|.+......  .....+.+|++++++++|++|+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            566788999999999999664 6889999988543222  2234577899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++.... ...+++..+..++.|++.|+.|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            99999999886533 235899999999999999999999   8999999999999999999999999999997653221 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......|+..|+|||++.+..++.++|+||+||++|||++|+.||...... .....+.........    ..     
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~~~~~~~~~~~~~~~----~~-----  224 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-VKREEVDRRVLETEE----VY-----  224 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhhhcccc----cc-----
Confidence              122357899999999999999999999999999999999999999643211 111111111100000    00     


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQ 1096 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~ 1096 (1109)
                             ......++.+++.+|++.||++||+     ++|++++
T Consensus       225 -------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         225 -------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             -------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                   0111234566788999999999999     7788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.7e-33  Score=307.06  Aligned_cols=258  Identities=25%  Similarity=0.317  Sum_probs=197.1

Q ss_pred             HHHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          815 IEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       815 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ..+++++.....||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++..++..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER-DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC-CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            345566777788999999999999754 5788999987433 23345678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcEEEecccCCccc
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEPHISDFGIAKLL  972 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~  972 (1109)
                      |+||+++++|.++++........++..+..++.|+++|++|||   +.+|+||||||+||+++. ++.++|+|||.+...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999999976432222378888899999999999999   899999999999999976 678999999998765


Q ss_pred             CCCCCCceeeecccCcccccccccccCC--CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTA--KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .....  ......++..|+|||++.+..  ++.++||||+|+++|+|++|+.||........  ..+........     
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~-----  230 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKIH-----  230 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhccC-----
Confidence            33221  122346889999999886543  78899999999999999999999854211110  00000000000     


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                         +.        .......++.+++.+||+.+|++||++.|+++|
T Consensus       231 ---~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         231 ---PE--------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ---CC--------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence               00        001122346678889999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=312.27  Aligned_cols=249  Identities=27%  Similarity=0.380  Sum_probs=197.7

Q ss_pred             CCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          821 LNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      |...+.||.|+||.||-|+. .+.++||||++......  +...++.+|+.++.+++|||+|.+-|||..+...++||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            44456699999999999955 56889999999665433  3346899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |-| +-.|++.-.+.  ++.+.++..|..|.+.||+|||   +.+.||||||+.|||+++.|.||++|||.|.++...  
T Consensus       108 ClG-SAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--  179 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--  179 (948)
T ss_pred             Hhc-cHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence            964 88888766443  4888899999999999999999   999999999999999999999999999999876432  


Q ss_pred             CceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                          ..++|||.|||||++.   .+.|+-|+||||+|++..|+.-.++|+.... .    ...+....+...+.      
T Consensus       180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-A----MSALYHIAQNesPt------  244 (948)
T KOG0577|consen  180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-A----MSALYHIAQNESPT------  244 (948)
T ss_pred             ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-H----HHHHHHHHhcCCCC------
Confidence                3478999999999886   5788999999999999999999999975431 1    11111111111110      


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       +.       ..+....+..++..|++.-|.+|||.+++++|-.-.
T Consensus       245 -Lq-------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~  282 (948)
T KOG0577|consen  245 -LQ-------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL  282 (948)
T ss_pred             -CC-------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence             00       112233455566699999999999999999986544

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-33  Score=311.24  Aligned_cols=256  Identities=21%  Similarity=0.336  Sum_probs=200.2

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      +|++.+.||+|+||.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            5778899999999999999775 789999998865434444567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.++++.......+++..+..++.+++.|+.|||+  +.+|+||||||+||+++.++.++|+|||.+........ 
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  158 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-  158 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence            999999998764334468999999999999999999993  25899999999999999999999999999876533211 


Q ss_pred             ceeeecccCcccccccccccCC------CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          979 TTSISVVGTIGYIAPENAFTTA------KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                         ....++..|+|||.+.+..      ++.++||||+||++|+|++|+.||.....  ..............  .    
T Consensus       159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~--~----  227 (286)
T cd06622         159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY--ANIFAQLSAIVDGD--P----  227 (286)
T ss_pred             ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch--hhHHHHHHHHhhcC--C----
Confidence               2245788999999885543      48899999999999999999999864321  11111111100000  0    


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       +        ........++.+++.+|++.+|++||+++|++++-+
T Consensus       228 -~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         228 -P--------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             -C--------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence             0        001122344667888999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.5e-33  Score=303.90  Aligned_cols=252  Identities=23%  Similarity=0.357  Sum_probs=202.3

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|+..++||.|+||.||.++. .+++.+++|++.... ......++.+|++++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999965 458899999885443 334456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++.... ...+++..+..++.|+++|++|||   +.+++||||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999997643 345899999999999999999999   88999999999999999999999999999986643321


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......+++.|+|||...+..++.++||||+|+++|||++|+.||.....     ...........  ....      
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~--~~~~------  221 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKIVQGN--YTPV------  221 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCC--CCCC------
Confidence              22335689999999999888899999999999999999999999864321     11111111100  0000      


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                             ......++.+++.+||+.+|++||+++|+++++
T Consensus       222 -------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 -------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                   011223466678899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.4e-33  Score=323.21  Aligned_cols=269  Identities=20%  Similarity=0.241  Sum_probs=197.3

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC----
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD----  889 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  889 (1109)
                      ...++|...+.||+|+||.||+|.. ..++.||||++.... .......+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999965 468899999885432 2233456788999999999999999999886433    


Q ss_pred             --ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          890 --CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       890 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                        ..++||||+++ ++.+++..     .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCc
Confidence              46999999975 67666643     3788899999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC---
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD--- 1044 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 1044 (1109)
                      +++......   ......||..|+|||++.+..++.++||||+||++|||++|+.||...... ......+......   
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  240 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPE  240 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence            998654321   122357899999999999999999999999999999999999999643211 1111111110000   


Q ss_pred             ---------------ccccccccchhhhHHhh----hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1045 ---------------TEEINDIVDLSLMEEML----VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1045 ---------------~~~~~~~~d~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                     .........+.......    .........++.+++.+|++.||++|||+.|+++|-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp  312 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP  312 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence                           00000000000000000    000111234567888899999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-34  Score=317.16  Aligned_cols=246  Identities=28%  Similarity=0.415  Sum_probs=197.0

Q ss_pred             CCCceeecccCeEEEEEEe-CCCcEEE---EEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc--eeEEE
Q 001275          822 NAKHVIGRGAHGIVYKASL-GPNAVFA---VKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC--GIIMY  895 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~-~~~~~va---vK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~  895 (1109)
                      +...+||+|+|-+||||.+ .+|..||   ||.-......+...+|..|+.+++.++|+|||+++++|.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3456799999999999955 3466665   2322223344455789999999999999999999999988665  78999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~  974 (1109)
                      |.+..|+|..|.++++.   .+.+.+..|+.||++||.|||.. .++|+|||||-+||+|+.+ |.|||+|.|+|.....
T Consensus       123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999998764   88899999999999999999954 7899999999999999754 8999999999998754


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc--ccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE--INDIV 1052 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 1052 (1109)
                      ...    ....|||.|||||... ..|+..+||||||+.++||+|+.+||.    +....+++.+.+.....+  +..+-
T Consensus       199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs----EC~n~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS----ECTNPAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh----hhCCHHHHHHHHHcCCCHHHhhccC
Confidence            432    2368999999999665 889999999999999999999999975    455555666655543211  11221


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                      -+++.++|.+|+.. .++||++.|++++=
T Consensus       270 ----------------dPevr~fIekCl~~-~~~R~sa~eLL~d~  297 (632)
T KOG0584|consen  270 ----------------DPEVREFIEKCLAT-KSERLSAKELLKDP  297 (632)
T ss_pred             ----------------CHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence                            23455677899999 99999999999864

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.8e-33  Score=307.12  Aligned_cols=255  Identities=27%  Similarity=0.397  Sum_probs=204.3

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      +|+..+.||+|+||.||+|... +++.||+|++..........++.+|++++++++||||+++++++...+..++|+||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5677888999999999999775 688999999866544555667899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++++|.+++....  ..+++..+..++.|+++|++|+|   + .+++||||||+||++++++.++|+|||.+........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            9999999997643  45889999999999999999999   7 8999999999999999999999999999875532211


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .    ...++..|+|||...+..++.++||||+|+++|+|++|+.||......................       +...
T Consensus       157 ~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~  225 (265)
T cd06605         157 K----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------PRLP  225 (265)
T ss_pred             h----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------CCCC
Confidence            1    1578889999999999999999999999999999999999986543222222222222211100       0000


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                             ......++.+++.+||..+|++||++.|++++-
T Consensus       226 -------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  258 (265)
T cd06605         226 -------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEHP  258 (265)
T ss_pred             -------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCc
Confidence                   001233466788899999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.9e-33  Score=307.97  Aligned_cols=256  Identities=23%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .+|...++||+|+||.||+|...+    ...||+|...........+.+.+|++++++++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999997643    346899987544434455678999999999999999999998875 567899


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++....  ..+++..+..++.+++.|++|||   +.+++||||||+||+++.++.++++|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            99999999999997643  34899999999999999999999   89999999999999999999999999999986644


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      .... ......++..|+|||.+....++.++||||||+++||+++ |+.||......  ........    .....   .
T Consensus       160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~----~~~~~---~  229 (270)
T cd05056         160 ESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--DVIGRIEN----GERLP---M  229 (270)
T ss_pred             ccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHc----CCcCC---C
Confidence            3211 1112345568999999988889999999999999999996 99998644221  11111110    00000   0


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                                 .......+.+++.+|+..+|++||++.|+++.|..+.
T Consensus       230 -----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         230 -----------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                       0112235667888999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.6e-33  Score=311.73  Aligned_cols=252  Identities=22%  Similarity=0.333  Sum_probs=200.5

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++...+..++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            6788999999999999999975 578999999885432 33446688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++...    .+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999999998652    3788999999999999999999   89999999999999999999999999999876543221


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......+++.|+|||...+..++.++||||+||++|++++|+.||..........     ..+....  .....    
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~~~--~~~~~----  237 (297)
T cd06656         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT--PELQN----  237 (297)
T ss_pred             --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccCCC--CCCCC----
Confidence              1123468889999999999889999999999999999999999996432211100     0000000  00000    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                             .......+.+++.+||+.+|++||+++|++++=+
T Consensus       238 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (297)
T cd06656         238 -------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF  271 (297)
T ss_pred             -------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence                   0111233566778999999999999999999644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-33  Score=308.64  Aligned_cols=252  Identities=24%  Similarity=0.324  Sum_probs=203.1

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      +|+..+.||.|+||.||+|... +++.||+|.+...........+.+|+++++.++|+||+++++++..+...++|+||+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            5778889999999999999764 688999999865544455567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.++++..    .+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++++|||+++......  
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  152 (274)
T cd06609          82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--  152 (274)
T ss_pred             CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence            999999998764    4899999999999999999999   8999999999999999999999999999998775432  


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      .......++..|+|||+..+..++.++|||||||++|||++|+.||......     .........  ......+     
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~--~~~~~~~-----  220 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFLIPKN--NPPSLEG-----  220 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHHhhhc--CCCCCcc-----
Confidence            1122346888999999999888999999999999999999999998643211     111111000  0000000     


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                             .....++.+++.+|++.+|++||++++++++-.-
T Consensus       221 -------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~  254 (274)
T cd06609         221 -------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFI  254 (274)
T ss_pred             -------cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhh
Confidence                   0022346668889999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-33  Score=318.83  Aligned_cols=270  Identities=21%  Similarity=0.264  Sum_probs=197.2

Q ss_pred             HHHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC---
Q 001275          814 VIEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK---  888 (1109)
Q Consensus       814 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  888 (1109)
                      ..+..++|...+.||+|+||+||+|.. .+++.||||++.... .......+.+|++++++++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            344567899999999999999999965 567899999885432 222345677899999999999999999987543   


Q ss_pred             ---CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEec
Q 001275          889 ---DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISD  965 (1109)
Q Consensus       889 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  965 (1109)
                         ...++++|++ +++|.++++..    .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence               3468999987 77998887642    3899999999999999999999   89999999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      ||+++.....     .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ...+..+.......
T Consensus       162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~  235 (343)
T cd07878         162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-IDQLKRIMEVVGTP  235 (343)
T ss_pred             CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCC
Confidence            9999865432     123578999999999877 5679999999999999999999999854321 11111111111000


Q ss_pred             ccc-cccccchhhhHHh-----------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1045 TEE-INDIVDLSLMEEM-----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1045 ~~~-~~~~~d~~~~~~~-----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ... ...+ ........           ...........+.+++.+|++.||++|||++|+++|-+
T Consensus       236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~  300 (343)
T cd07878         236 SPEVLKKI-SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY  300 (343)
T ss_pred             CHHHHHhc-chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            000 0000 00000000           00000011234677888999999999999999998743

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.2e-33  Score=308.65  Aligned_cols=258  Identities=22%  Similarity=0.348  Sum_probs=200.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|...+.||+|+||+||+|+.+      +.+.||+|.+...........+.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888899999999999999753      346789998744333324567899999999999999999999999989999


Q ss_pred             EEEEeccCCCHHHHHhccCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          893 IMYRYMENGSLRDVLHSITPP------PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                      +||||+++|+|.++++.....      ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999765422      25899999999999999999999   889999999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCc
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||.....  .....   ......
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--~~~~~---~~~~~~  235 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLN---RLQAGK  235 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--HHHHH---HHHcCC
Confidence            9987543221 112223456778999999988888999999999999999999 6777743211  11111   111000


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                        .. ...           .......+.+++.+|++.+|++||++.|++++|.+
T Consensus       236 --~~-~~~-----------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         236 --LE-LPV-----------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             --cC-CCC-----------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence              00 000           01122356778889999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.4e-33  Score=316.79  Aligned_cols=238  Identities=24%  Similarity=0.277  Sum_probs=185.2

Q ss_pred             ceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHH-HHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQ-TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.||+|+||+||+|.. .+|+.||+|++.....  ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999966 4689999999854321  222344555554 46778999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            99999887533   4889999999999999999999   8999999999999999999999999999987532221  12


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ............    ...       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~~~----~~~-------  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHKPL----VLR-------  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcCCc----cCC-------
Confidence            2345799999999999999999999999999999999999999864321     111111111100    000       


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ 1091 (1109)
                           ......+.+++.+|++.+|++||+++
T Consensus       217 -----~~~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         217 -----PGASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             -----CCCCHHHHHHHHHHhccCHHhcCCCC
Confidence                 01123455678899999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5e-33  Score=311.88  Aligned_cols=254  Identities=21%  Similarity=0.340  Sum_probs=201.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|+..+.||.|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++|+|++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc-cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4588889999999999999965 57899999988543 233456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++...    .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          98 LAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             cCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            9999999988653    3889999999999999999999   89999999999999999999999999999886543221


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......++..|+|||.+.+..++.++|||||||++|++++|+.||........ .    ........  .....    
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~----~~~~~~~~--~~~~~----  237 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L----YLIATNGT--PELQN----  237 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H----HHHHhcCC--cccCC----
Confidence              11234688899999999988899999999999999999999999865422111 1    01110000  00000    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .......+.+++.+||+.||++||++.+++++=+-.
T Consensus       238 -------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~  273 (296)
T cd06655         238 -------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (296)
T ss_pred             -------cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence                   011123455678899999999999999999875543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-32  Score=307.90  Aligned_cols=269  Identities=22%  Similarity=0.305  Sum_probs=200.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|+..+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            36888899999999999999775 589999999865432 2234567899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |++++++..+....   ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99999888876543   24899999999999999999999   8999999999999999999999999999998765432


Q ss_pred             CCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc----------Cc
Q 001275          977 ASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS----------DT 1045 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~ 1045 (1109)
                      .  ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+ ...........          ..
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD-QLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChHHhhhcccc
Confidence            1  1223457889999998876 457899999999999999999999986432211 11111110000          00


Q ss_pred             cccccccchhhhHH-hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1046 EEINDIVDLSLMEE-MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ........+..... ............+.+++.+||+.+|++||++.|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000000000000 0000011123567788899999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.9e-33  Score=321.06  Aligned_cols=202  Identities=26%  Similarity=0.366  Sum_probs=173.4

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +|+..+.||+|+||+||+|... +++.||+|++....  .......+.+|++++.+++|++|+++++++...+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            6788899999999999999764 68999999985432  22334578889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          82 FLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             CCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999997643   4889999999999999999999   9999999999999999999999999999987543211


Q ss_pred             CC---------------------------------ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCC
Q 001275          977 AS---------------------------------TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKA 1023 (1109)
Q Consensus       977 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p 1023 (1109)
                      ..                                 ......+||+.|+|||++.+..++.++||||+||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            00                                 001134799999999999999999999999999999999999999


Q ss_pred             CCCC
Q 001275         1024 LDPS 1027 (1109)
Q Consensus      1024 ~~~~ 1027 (1109)
                      |...
T Consensus       236 f~~~  239 (360)
T cd05627         236 FCSE  239 (360)
T ss_pred             CCCC
Confidence            9643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=7.2e-33  Score=307.02  Aligned_cols=254  Identities=22%  Similarity=0.329  Sum_probs=197.0

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecC-----
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK-----  888 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----  888 (1109)
                      .++..|+..+.||+|+||.||+|... +++.||+|++...  ......+.+|+.++.++ +|+||+++++++...     
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC--CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            45677888899999999999999764 5788999988533  33456788999999998 799999999998753     


Q ss_pred             -CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          889 -DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       889 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                       ...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||   +.+|+|||+||+||++++++.++|+|||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCC
Confidence             35789999999999999987633 235889999999999999999999   8899999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      ++.......  .......|+..|+|||++.     +..++.++||||+||++|||++|+.||......    .... ...
T Consensus       157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~-~~~  229 (272)
T cd06637         157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALF-LIP  229 (272)
T ss_pred             Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHH-HHh
Confidence            998653321  1223357899999999886     345788999999999999999999998643211    1111 000


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..  ......+            .....++.+++.+||+.+|.+||+++|+++|
T Consensus       230 ~~--~~~~~~~------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         230 RN--PAPRLKS------------KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             cC--CCCCCCC------------CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            00  0000000            0112346678889999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-33  Score=309.46  Aligned_cols=268  Identities=21%  Similarity=0.329  Sum_probs=198.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|+..+.||+|++|.||+|... +++.||+|.+...........+.+|++++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999765 68999999986544333445677899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++ +|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            985 9999887643  25789999999999999999999   89999999999999999999999999999875432211


Q ss_pred             CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc-------ccc
Q 001275          978 STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE-------EIN 1049 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 1049 (1109)
                        ......++..|+|||+..+ ..++.++||||+|+++|||++|+.||......................       ...
T Consensus       159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence              1122356889999998875 457899999999999999999999986433211111111111000000       000


Q ss_pred             c-------ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1050 D-------IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1050 ~-------~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .       ............ .. ....++.+++.+|++.+|++||+++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAP-RL-DRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccccccccCChhHHHhCc-CC-CCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0       000000000000 00 112456778899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=7.4e-33  Score=314.29  Aligned_cols=196  Identities=27%  Similarity=0.421  Sum_probs=159.4

Q ss_pred             CceeecccCeEEEEEEeC---CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec--CCceeEEEEec
Q 001275          824 KHVIGRGAHGIVYKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCGIIMYRYM  898 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~  898 (1109)
                      ..+||+|+||+||+|+..   ++..||+|.+...   .....+.+|++++++++||||+++++++..  ....++|+||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT---GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCC---CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999764   4578999987432   223467899999999999999999998854  45678999998


Q ss_pred             cCCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee----CCCCcEEEecccC
Q 001275          899 ENGSLRDVLHSIT------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL----DSEMEPHISDFGI  968 (1109)
Q Consensus       899 ~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfGl  968 (1109)
                      ++ +|.+++....      ....+++..+..++.|+++||+|||   +.+|+||||||+||++    ++++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            75 7888775321      1235889999999999999999999   8999999999999999    5667899999999


Q ss_pred             CcccCCCCCC-ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          969 AKLLDKSPAS-TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       969 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                      ++........ .......+|+.|+|||++.+. .++.++||||+||++|||+||+.||..
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            9876443221 122345789999999988764 579999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3e-33  Score=310.92  Aligned_cols=249  Identities=24%  Similarity=0.343  Sum_probs=198.5

Q ss_pred             CCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEecc
Q 001275          821 LNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      |+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|++++++++||||+++++++...+..++|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            45567799999999999965 45788999988644444455678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +++|.+++..    ..+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++.++++|||++........  
T Consensus        86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06642          86 GGSALDLLKP----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence            9999998864    24789999999999999999999   89999999999999999999999999999986643221  


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHH
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1059 (1109)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.|+.......  .....    ....      .+..   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~----~~~~------~~~~---  221 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--VLFLI----PKNS------PPTL---  221 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--HHhhh----hcCC------CCCC---
Confidence            1122467889999999999889999999999999999999999985332110  00000    0000      0000   


Q ss_pred             hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1060 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                           ......++.+++.+|++.+|++||++.|++++-.
T Consensus       222 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         222 -----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             -----CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence                 0112344667888999999999999999998753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-33  Score=311.65  Aligned_cols=265  Identities=21%  Similarity=0.267  Sum_probs=201.3

Q ss_pred             ccHHHHHHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 001275          809 YLLKQVIEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWL  886 (1109)
Q Consensus       809 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  886 (1109)
                      +.++.+..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+..  .......+.+|+.+++++ +|+||+++++++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP--IHDIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecc--ccchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            44455566788999999999999999999966 4578999998643  222345688899999999 6999999999874


Q ss_pred             -----cCCceeEEEEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc
Q 001275          887 -----RKDCGIIMYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME  960 (1109)
Q Consensus       887 -----~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  960 (1109)
                           .++..++||||+++++|.++++... ....+++..+..++.|+++|+.|||   +.+|+||||||+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCC
Confidence                 3456899999999999999886432 2345889999999999999999999   899999999999999999999


Q ss_pred             EEEecccCCcccCCCCCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHH
Q 001275          961 PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV 1035 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 1035 (1109)
                      ++++|||+++.......  ......|++.|+|||++.     +..++.++||||+||++|||++|+.||...... .   
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~---  236 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-R---  236 (286)
T ss_pred             EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-H---
Confidence            99999999986543221  122346899999999875     345788999999999999999999998643211 1   


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .+. ......  .....++.           ....++.+++.+||+.||++||++.|++++..
T Consensus       237 ~~~-~~~~~~--~~~~~~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         237 ALF-KIPRNP--PPTLHQPE-----------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             HHh-hccccC--CCcccCCC-----------CcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            110 000000  00000100           11234667888999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-32  Score=304.60  Aligned_cols=251  Identities=24%  Similarity=0.366  Sum_probs=197.5

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccccc--------ChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKR--------GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      +|...+.||+|+||.||+|.. .+++.||+|.+.......        ....+.+|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467788999999999999965 467899999885432211        12467899999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++|+||+++++|.+++....   .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999997643   4788899999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCC----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          971 LLDKSPAS----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       971 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      ........    .......|+..|+|||...+..++.++||||+||++|+|++|+.||......     ..+......  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~--  227 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QAIFKIGEN--  227 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HHHHHHhcc--
Confidence            66432111    1112345888999999999888999999999999999999999998643211     111110000  


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                           ..+..        ......++.+++.+||+.||++||++.|++++
T Consensus       228 -----~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 -----ASPEI--------PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -----CCCcC--------CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                 00000        01122446667789999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.5e-33  Score=306.85  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=196.5

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccccc---------ChHHHHHHHHHHhcCCCCceeeEeeEEecCC
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKR---------GSLSMKREIQTIGKIRHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  889 (1109)
                      +|...+.||+|+||.||+|.. .+++.||+|.+.......         ..+.+.+|++++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467788999999999999965 468899999875321111         1245788999999999999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..++|+||+++|+|.++++...   .+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999997653   4889999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCC--CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTA--KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      +...............++..|+|||......  ++.++||||+|+++||+++|+.||.....    ..... ......  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~-~~~~~~--  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMF-KLGNKR--  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHH-Hhhccc--
Confidence            7654322222223356889999999887654  78999999999999999999999853211    11111 110000  


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ....++..        ........+.+++.+|++.+|++||+++|+++|
T Consensus       229 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPIPPD--------VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcCCcc--------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00000000        001123456667789999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=313.74  Aligned_cols=202  Identities=25%  Similarity=0.335  Sum_probs=171.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||+||+++.. +++.||+|++....  .......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36888999999999999999764 58999999985422  2223456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999997532  34888999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCCceeeecccCccccccccccc-----CCCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          976 PASTTSISVVGTIGYIAPENAFT-----TAKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                      .. .......||+.|+|||++..     ..++.++||||+||++|||++|+.||..
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            22 11223469999999998863     4568899999999999999999999864

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.5e-33  Score=321.29  Aligned_cols=268  Identities=20%  Similarity=0.234  Sum_probs=196.6

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC------
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------  888 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  888 (1109)
                      ..++|...+.||+|+||.||+|.. ..++.||||++.... .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            346899999999999999999965 468899999985432 233345788999999999999999999987543      


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      ...|+||||+++ ++.+++..     .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            346999999975 77777643     2788899999999999999999   89999999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      ++......   ......+|..|+|||++.+..++.++||||+||++|||++|+.||...... ......+..........
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHH
Confidence            98654321   122357899999999999999999999999999999999999999643211 11111111000000000


Q ss_pred             ccccchh------------------hhHHh----hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1049 NDIVDLS------------------LMEEM----LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1049 ~~~~d~~------------------~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .....+.                  .....    ..........++.+++.+|++.||++|||+.|+++|-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp  319 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  319 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            0000000                  00000    0000011123567788899999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.1e-33  Score=310.35  Aligned_cols=270  Identities=21%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|...+.||+|+||.||+|... +|+.||+|++..... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999764 688999999864432 22345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++ ++|.+++....  ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-  153 (284)
T cd07839          81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-  153 (284)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence            97 58888876533  34899999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             CceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc----ccccc
Q 001275          978 STTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE----INDIV 1052 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 1052 (1109)
                       .......++..|+|||++.+.. ++.++||||+||++|||++|+.|+.+............+........    .....
T Consensus       154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence             1122346788999999887654 68999999999999999999999755433222111111111000000    00000


Q ss_pred             chhhhHHhh-----hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1053 DLSLMEEML-----VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1053 d~~~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      +........     .........++.+++.+|++.||.+|||++|+++|-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            000000000     000111234566788899999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8e-33  Score=306.62  Aligned_cols=239  Identities=22%  Similarity=0.325  Sum_probs=183.0

Q ss_pred             eeecccCeEEEEEEeCC-------------------------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceee
Q 001275          826 VIGRGAHGIVYKASLGP-------------------------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR  880 (1109)
Q Consensus       826 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~  880 (1109)
                      .||+|+||.||+|....                         ...||+|.+... .......+.+|++++++++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-HRDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-HHHHHHHHHHHHHHHhcCCCCCeee
Confidence            59999999999996421                         134788877432 2223456888999999999999999


Q ss_pred             EeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-
Q 001275          881 LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-  959 (1109)
Q Consensus       881 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-  959 (1109)
                      ++++|......++||||+++|+|.+++....  ..+++..+..++.|+++|++|||   +.+|+||||||+||+++..+ 
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCc
Confidence            9999999999999999999999999986532  35789999999999999999999   89999999999999997643 


Q ss_pred             ------cEEEecccCCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHH-hCCCCCCCCcccc
Q 001275          960 ------EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELI-TRKKALDPSYKER 1031 (1109)
Q Consensus       960 ------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~ell-tg~~p~~~~~~~~ 1031 (1109)
                            .+|++|||.+......      ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||...... 
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-  228 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-  228 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence                  3799999988644221      11357788999998865 56799999999999999995 688887543211 


Q ss_pred             ccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       ..........    ..             .   .....++.+++.+||+.+|++||+++|++++|.
T Consensus       229 -~~~~~~~~~~----~~-------------~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 -EKERFYEKKH----RL-------------P---EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HHHHHHHhcc----CC-------------C---CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             1111111000    00             0   001134677888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7.6e-33  Score=315.24  Aligned_cols=200  Identities=20%  Similarity=0.242  Sum_probs=164.8

Q ss_pred             CCceeecc--cCeEEEEEEe-CCCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          823 AKHVIGRG--AHGIVYKASL-GPNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       823 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ..++||+|  +||+||++.. .+|+.||+|++...... .....+++|+++++.++||||+++++++..++..++|+||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35679999  7899999965 56899999998544322 23456788999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999996533 234889999999999999999999   899999999999999999999999999875543221110


Q ss_pred             c-----eeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          979 T-----TSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       979 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                      .     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            0     1112356778999999876  4588999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.3e-33  Score=305.23  Aligned_cols=253  Identities=23%  Similarity=0.319  Sum_probs=196.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...++||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            4677788899999999999965 46889999988543 223345678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.++++..+   .+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            99999999987543   4889999999999999999999   8899999999999999999999999999987654321 


Q ss_pred             CceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                       .......|+..|+|||++.   ...++.++||||+||++|||++|+.||...... ........   ..      ...+
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~~~~~~---~~------~~~~  229 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMTK---SN------FQPP  229 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhHHhhhc---cC------CCCC
Confidence             1223457899999999874   456789999999999999999999998543211 11110000   00      0000


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ....      .......+.+++.+|++.+|++||+++|+++|
T Consensus       230 ~~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         230 KLKD------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cccc------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0000      00112235668889999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2e-32  Score=306.71  Aligned_cols=270  Identities=20%  Similarity=0.251  Sum_probs=199.2

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++.+|...+.||+|+||.||+|.. .+++.||+|++...........+.+|++++++++|+||+++.+++..++..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            457899999999999999999965 4688999999865544444557789999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||++ +++.+++....  ..+.+..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 68877765432  34778889999999999999999   889999999999999999999999999998754332


Q ss_pred             CCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc-------c
Q 001275          976 PASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE-------E 1047 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~ 1047 (1109)
                      ..  ......++..|+|||.+.+. .++.++||||+||++|||++|+.||+........+...+........       .
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            11  12234578899999988764 47889999999999999999999997543221111111110000000       0


Q ss_pred             c----ccccc---hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1048 I----NDIVD---LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1048 ~----~~~~d---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .    .....   +...... ... .....++.+++.+|++.||++|||++|++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVV-WKR-LSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccccchhccccCCcchhhh-ccc-cCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0    00000   0000000 000 0113456678889999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=316.07  Aligned_cols=255  Identities=21%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             CCCCCceeecccCeEEEEEEeCCCcE-EEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      -|.+...||.|+||.||+|..++... .|.|++ .....+...++.-|++++..+.||+||++++.|...+..+++.|||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvI-etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVI-ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhh-cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            35556679999999999997665444 455666 4445566778999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      .||-.+.++-..+.  .+++..+..+.+|++.||.|||   +.+|+|||||+.|||++-+|.++++|||++......  .
T Consensus       112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R  184 (1187)
T ss_pred             CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence            99999998876543  4899999999999999999999   999999999999999999999999999998754322  2


Q ss_pred             ceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          979 TTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      .....+.|||+|||||++.     ..+|++++||||||+++.||..+.+|...-     .....+-.+....       .
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-----npMRVllKiaKSe-------P  252 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSE-------P  252 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-----chHHHHHHHhhcC-------C
Confidence            2334579999999999764     578999999999999999999999885321     1111111111110       0


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      |.+..      .......+.+++.+|+..+|..||+++++++|-+--
T Consensus       253 PTLlq------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  253 PTLLQ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             CcccC------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            11111      122334455677799999999999999999986544

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-32  Score=304.90  Aligned_cols=262  Identities=27%  Similarity=0.345  Sum_probs=201.7

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  896 (1109)
                      +|...++||.|++|.||+|.. .+++.+|+|.+..........++.+|++++++++||||+++++++...  +..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            577889999999999999977 468899999886544444556789999999999999999999998654  36799999


Q ss_pred             eccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          897 YMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      |+++++|.+++.... ....+++..+..++.|+++|++|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            999999999876432 2345789999999999999999999   899999999999999999999999999998755322


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-cccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-EEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~d~ 1054 (1109)
                      ..    ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..................... ........ 
T Consensus       159 ~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  233 (287)
T cd06621         159 LA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG-  233 (287)
T ss_pred             cc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC-
Confidence            11    1245788999999999999999999999999999999999999755321111112111111100 00000000 


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               ........+.+++.+|++.+|++||++.|++++-+
T Consensus       234 ---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         234 ---------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             ---------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence                     00112345678888999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.7e-32  Score=302.96  Aligned_cols=252  Identities=26%  Similarity=0.349  Sum_probs=192.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc----ccChHHHHHHHHHHhcCCCCceeeEeeEEecC--Cce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH----KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  891 (1109)
                      .+|...+.||+|+||.||+|.. .+++.||+|++.....    .+....+.+|++++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688899999999999999966 4688999998754321    12234688899999999999999999988653  567


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++++||+++++|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999997643   3788999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ....... .......++..|+|||.+.+..++.++||||+||++||+++|+.||......     ..+........    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~~~~~~----  226 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKIATQPT----  226 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHHhcCCC----
Confidence            5432111 1112346889999999999888999999999999999999999998643111     11111100000    


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                        .+...        ......+..++ +||..+|++||+++|+++|
T Consensus       227 --~~~~~--------~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         227 --NPQLP--------SHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --CCCCc--------hhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence              00000        01112233344 6888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-32  Score=301.49  Aligned_cols=238  Identities=24%  Similarity=0.368  Sum_probs=186.0

Q ss_pred             ceeecccCeEEEEEEeCCCc-----------EEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          825 HVIGRGAHGIVYKASLGPNA-----------VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++||+|+||.||+|...+..           .+++|.+.....  ....+.+|+.++++++||||+++++++.. +..++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46999999999999775433           467776643322  26788999999999999999999999988 77899


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-------cEEEecc
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-------EPHISDF  966 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~Df  966 (1109)
                      |+||+++|+|.+++.....  .+++..++.++.|++.|++|||   +.+|+||||||+||+++.++       .+|++||
T Consensus        78 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999999986432  5889999999999999999999   89999999999999999887       7999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccC--CCCccCcchhhHHHHHHHHhC-CCCCCCCccccccHHHHHHHhhc
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTT--AKSKESDVYSYGVVLLELITR-KKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      |++......      ....++..|+|||++.+.  .++.++|||||||++||+++| ..|+.....  .....+..    
T Consensus       153 g~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~----  220 (259)
T cd05037         153 GIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ----  220 (259)
T ss_pred             Ccccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh----
Confidence            999865431      123567789999998876  789999999999999999995 666543211  11111111    


Q ss_pred             CccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1044 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ....   ...             .....+.+++.+||+.+|++||++.|+++.|+
T Consensus       221 ~~~~---~~~-------------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQHR---LPM-------------PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCC---CCC-------------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0000   000             00145677888999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=316.50  Aligned_cols=205  Identities=31%  Similarity=0.406  Sum_probs=179.2

Q ss_pred             CCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC------CceeE
Q 001275          821 LNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------DCGII  893 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  893 (1109)
                      |...+.||+|+||.||+|+ ..+|+.||||.+.........+...+|++++++++|+|||+++++-...      +...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3445679999999999998 5679999999998777777788899999999999999999999875443      35689


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee--CCCCc--EEEecccCC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL--DSEME--PHISDFGIA  969 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~~--~kl~DfGla  969 (1109)
                      |||||.+|||+..+.+-.....+++.+.+.+...++.||.|||   ..+||||||||.||++  .++|+  .||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999987666667999999999999999999999   8999999999999998  44454  699999999


Q ss_pred             cccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCcccc
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~ 1031 (1109)
                      +.+++..   .....+||..|.+||.... +.|+..+|.|||||++|+++||..||.|..+..
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk  231 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK  231 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc
Confidence            9886554   4566899999999998884 889999999999999999999999998865553

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.6e-32  Score=307.53  Aligned_cols=255  Identities=22%  Similarity=0.287  Sum_probs=198.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.|++.++||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++..+...++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            56888999999999999999775 4789999988433 333456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|..++....  ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++|+|||++......  
T Consensus        91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--  163 (292)
T cd06644          91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--  163 (292)
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence            99999998876533  34899999999999999999999   899999999999999999999999999998754322  


Q ss_pred             CceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          978 STTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ........++..|+|||++.     ...++.++|||||||++|||++|+.||.....     ............  ....
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~--~~~~  236 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSEP--PTLS  236 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-----HHHHHHHhcCCC--ccCC
Confidence            11222356888999999884     34568899999999999999999999854321     111111111000  0000


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .           ......++.+++.+||+.+|++||+++|++++-.-
T Consensus       237 ~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         237 Q-----------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             C-----------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            0           01112346678889999999999999999987543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-32  Score=300.66  Aligned_cols=254  Identities=25%  Similarity=0.342  Sum_probs=201.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...+.+|+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++...+..+++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            57888999999999999999764 57889999885433 23557789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   +.+|+||||+|+||++++++.+||+|||.+....... 
T Consensus        82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            99999999987642  34889999999999999999999   8999999999999999999999999999987654321 


Q ss_pred             CceeeecccCcccccccccccC---CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAFTT---AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                       .......++..|+|||.+.+.   .++.++||||+||++|||++|+.||........ ...    .....  ..   ..
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~----~~~~~--~~---~~  224 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFL----ISKSN--FP---PP  224 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHH----HHhcc--CC---Cc
Confidence             122235688899999998777   789999999999999999999999864321111 110    00000  00   00


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..      ........++.+++.+||+.+|.+||++.|++.+
T Consensus       225 ~~------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         225 KL------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cc------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00      0011223457788889999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-32  Score=335.08  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=194.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  893 (1109)
                      ..+|.+.+.||+|+||+||+|... .+..||+|.+.... .......+..|+.++++++|||||+++++|...  ...|+
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            467999999999999999999764 56788899885433 223345788999999999999999999988643  46899


Q ss_pred             EEEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCeEEeccCCCCeeeCC-----------
Q 001275          894 MYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDC----DPPIVHRDIKPENILLDS-----------  957 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~Dlk~~NIll~~-----------  957 (1109)
                      ||||+++|+|.+++.... ....+++..++.|+.||+.||+|||...    ..+||||||||+|||++.           
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            999999999999997632 2245899999999999999999999421    145999999999999964           


Q ss_pred             ------CCcEEEecccCCcccCCCCCCceeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCCCCCcc
Q 001275          958 ------EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKALDPSYK 1029 (1109)
Q Consensus       958 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~ 1029 (1109)
                            .+.+||+|||++........   .....||+.|+|||++.+  ..++.++|||||||++|||++|+.||.....
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             ccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                  23489999999986643322   223579999999998864  4578999999999999999999999964321


Q ss_pred             ccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1030 ERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                          ....+.......    ..   .         ......++.+++..||+.+|++||++.|++++
T Consensus       249 ----~~qli~~lk~~p----~l---p---------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        249 ----FSQLISELKRGP----DL---P---------IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             ----HHHHHHHHhcCC----CC---C---------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence                111221111100    00   0         00112346678889999999999999999954

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.8e-32  Score=312.64  Aligned_cols=257  Identities=23%  Similarity=0.293  Sum_probs=193.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.++||+|+||+||++... +++.||+|.+....  .......+.+|+.++..++|++|+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36888999999999999999765 47889999885322  1223345788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.++++...  ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999997632  24889999999999999999999   899999999999999999999999999998755332


Q ss_pred             CCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .. .......||+.|+|||++.     ...++.++|||||||++|||++|+.||....     ................ 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-----~~~~~~~i~~~~~~~~-  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-----LVETYGKIMNHKERFQ-  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-----HHHHHHHHhCCCcccc-
Confidence            21 2222357999999999886     3467899999999999999999999996432     1111111111110000 


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSN--RPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 1097 (1109)
                      + .         ........++.+++.+|+..+|++  |++++|+++|-
T Consensus       229 ~-p---------~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         229 F-P---------AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             C-C---------CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence            0 0         000111233445666777554444  78999999884

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-32  Score=306.43  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=195.1

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEecc
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      |++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+++++.++||||+++++++...+..++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            566788999999999999775 4677888887432 23345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +|+|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+|++|||++.......  .
T Consensus        86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~  158 (282)
T cd06643          86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q  158 (282)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence            999999886532  34899999999999999999999   8999999999999999999999999999987553221  1


Q ss_pred             eeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          980 TSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ......++..|+|||++.     +..++.++||||+||++|||++|+.||..... ........    ....  .....+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~----~~~~--~~~~~~  231 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIA----KSEP--PTLAQP  231 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHHHHHh----hcCC--CCCCCc
Confidence            222356889999999873     45578899999999999999999999854321 11111110    0000  000000


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                 .....++.+++.+||+.+|.+||++.+++++-.
T Consensus       232 -----------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         232 -----------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             -----------cccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence                       011234566788999999999999999998764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.9e-32  Score=303.17  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=198.4

Q ss_pred             CCCCCceeecccCeEEEEEEeCC--CcEEEEEEeeecc---------cccChHHHHHHHHHHhc-CCCCceeeEeeEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGP--NAVFAVKKLAFRG---------HKRGSLSMKREIQTIGK-IRHRNLVRLEDFWLR  887 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  887 (1109)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+....         ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999997754  7889999875322         12223456778888765 799999999999999


Q ss_pred             CCceeEEEEeccCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEec
Q 001275          888 KDCGIIMYRYMENGSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISD  965 (1109)
Q Consensus       888 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~D  965 (1109)
                      .+..++||||+++++|.+++... .....+++..+++++.|++.|+.|||   + .+++||||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999999988543 22345889999999999999999999   5 6799999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      ||.+.......   ......++..|+|||...+..++.++||||||+++|||++|+.||.....     ...........
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~~~~~~  229 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATKIVEAV  229 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHHHhhcc
Confidence            99998654432   22345788999999999988899999999999999999999999854311     11111111000


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                        ....         .   ......++.+++.+||+.||++||++.|+..++.+
T Consensus       230 --~~~~---------~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         230 --YEPL---------P---EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             --CCcC---------C---cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence              0000         0   00112446678889999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-32  Score=300.68  Aligned_cols=252  Identities=26%  Similarity=0.414  Sum_probs=198.6

Q ss_pred             CCCCceeecccCeEEEEEEeCC-----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          821 LNAKHVIGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.+.+.||.|+||.||+|....     +..||+|++...........+..|++++.+++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3467889999999999997754     48899999855444435678999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++..... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999976432 22899999999999999999999   899999999999999999999999999999876544


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ...... ...+++.|+|||...+..++.++||||+|+++|+|++ |+.||...  ...+....+   ..... . .  . 
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--~~~~~~~~~---~~~~~-~-~--~-  225 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--SNEEVLEYL---KKGYR-L-P--K-  225 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHHHHH---hcCCC-C-C--C-
Confidence            222211 2337789999999988889999999999999999998 67776532  111111111   11000 0 0  0 


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                ......++.+++.+|++.+|++||++.|+++.|
T Consensus       226 ----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ----------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                      011234567788899999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-32  Score=300.63  Aligned_cols=251  Identities=25%  Similarity=0.386  Sum_probs=198.1

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecC-CceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-DCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e  896 (1109)
                      +|++.+.||+|++|.||++... +++.||+|++..... ....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999754 578899999854332 33455788999999999999999999887644 45789999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.+++.... ...+++..+..++.+++.|++|||   +.+|+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999997633 235899999999999999999999   8999999999999999999999999999998664322


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      .  ......+++.|+|||+..+..++.++||||+|+++|++++|+.||+....     ...........  ....     
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~--~~~~-----  222 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGK--LPPM-----  222 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcC--CCCC-----
Confidence            1  22235688999999999999999999999999999999999999864321     11111111100  0000     


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                              .......+.+++.+|++.+|++||++.|++++
T Consensus       223 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 --------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                    01122346678889999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.3e-33  Score=315.57  Aligned_cols=257  Identities=21%  Similarity=0.289  Sum_probs=195.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.+.||+|+||+||+++.. +++.||+|.+....  .......+.+|..++..++|++|+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999765 57889999885422  2223445788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999997632  24788999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCCceeeecccCccccccccccc-----CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAFT-----TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .. .......||+.|+|||++.+     ..++.++||||+||++|||++|+.||.....     .............. .
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~-~  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHEERF-Q  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCCCcc-c
Confidence            22 12223579999999998875     4678899999999999999999999964321     11111111111000 0


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSN--RPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L 1097 (1109)
                      + .         ........++.+++.+|++.++++  |++++++++|-
T Consensus       229 ~-p---------~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         229 F-P---------SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             C-C---------CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence            0 0         000111234555666888766554  57899998874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=8e-33  Score=309.10  Aligned_cols=269  Identities=23%  Similarity=0.341  Sum_probs=199.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|+..++||+|+||.||+|... +++.||+|++....... ....+.+|++++++++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999875 58999999875433222 34568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |++++++.++....   ..+++..+..++.|+++|++|||   +.+|+|||++|+||++++++.++++|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999998877543   23899999999999999999999   8899999999999999999999999999988654332


Q ss_pred             CCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          977 ASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .  ......++..|+|||+..+ ..++.++||||||+++|||++|+.||...... .....................+..
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccc
Confidence            1  1223467889999998875 44688999999999999999999888543211 111111110000000000000000


Q ss_pred             h------hHH-----hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1056 L------MEE-----MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1056 ~------~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .      ...     ............+.+++.+||+.+|++||+++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0      000     0000011224567788899999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=4e-32  Score=298.36  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=198.6

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc----ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH----KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      +|+..+.||+|+||.||+|... +++.|++|.+.....    ++..+.+.+|++++++++|+||+++++++...+..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999776 789999998855432    22345788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      +||+++++|.+++....   .+++..+..++.|+++|++|||   +.+|+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999997643   4789999999999999999999   89999999999999999999999999999886543


Q ss_pred             CCCCceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ..   ......++..|+|||...... ++.++|+||||+++|++++|+.||.....    ........  .......+  
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~--~~~~~~~~--  223 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIG--RSKELPPI--  223 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHH--hcccCCCc--
Confidence            32   123356889999999887766 89999999999999999999999865321    11111100  00000000  


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                                 ......++.+++.+||+.+|++||+++|++++
T Consensus       224 -----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         224 -----------PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -----------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                       00112345667889999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.3e-32  Score=305.42  Aligned_cols=270  Identities=24%  Similarity=0.323  Sum_probs=201.2

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|+.++++++||||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999764 689999999865432 33356789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      + +++|.+++....  ..+++..+..++.|+++|++|||   +.+|+|+||||+||+++.++.++++|||.+........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999987543  35899999999999999999999   89999999999999999999999999999987654321


Q ss_pred             CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh-------hcCcccc-
Q 001275          978 STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV-------WSDTEEI- 1048 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~- 1048 (1109)
                       .......++..|+|||.+.+. .++.++||||+|+++|||++|+.+|.... +...........       |...... 
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHHHHHHHHcCCCChHHHhhccCcc
Confidence             112234688999999988654 45899999999999999999977764332 111111111110       0000000 


Q ss_pred             --ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1049 --NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1049 --~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                        ..+..+............+...++.+++.+|++.+|++||+++++++|-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence              0000000000000000112236678888999999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-32  Score=300.67  Aligned_cols=251  Identities=21%  Similarity=0.344  Sum_probs=200.5

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|+..++||+|+||.||++.. .+++.||+|++.... ......++.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999965 468899999985432 233445789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++.... ...+++..+.+++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999987533 234789999999999999999999   89999999999999999999999999999986643221


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......|++.|+|||+..+..++.++|||||||++|+|++|+.||.....     ...+........  ..       
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~--~~-------  220 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSY--PP-------  220 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCC--CC-------
Confidence              11224588899999999988899999999999999999999999864311     111111111100  00       


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                            .......++.+++.+|++.+|++||+++||+++
T Consensus       221 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         221 ------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                  011223456778889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-32  Score=325.59  Aligned_cols=268  Identities=19%  Similarity=0.216  Sum_probs=192.1

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCC------CceeeEeeEEecC
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH------RNLVRLEDFWLRK  888 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~  888 (1109)
                      ..+++|.+.++||+|+||+||+|.. ..++.||||++...  .....++..|++++..++|      .+++++++++...
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            3457899999999999999999966 45788999998432  2223455667777777654      4588999988764


Q ss_pred             -CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCC-------
Q 001275          889 -DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEM-------  959 (1109)
Q Consensus       889 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~-------  959 (1109)
                       ...++|||++ +++|.+++...+   .+++..+..++.|++.||+|||   + .+||||||||+|||++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccccccc
Confidence             4678888887 678999887643   4899999999999999999999   6 5999999999999998765       


Q ss_pred             ---------cEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc
Q 001275          960 ---------EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030 (1109)
Q Consensus       960 ---------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~ 1030 (1109)
                               .+||+|||.+.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||+.... 
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~-  350 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN-  350 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence                     499999998864322     12245799999999999999999999999999999999999999965322 


Q ss_pred             cccHHHHHHHhhcC--------------------ccccccccchhhhHHhhhch---hHHHHHHHHHHHHhccCCCCCCC
Q 001275         1031 RTDIVGWVRSVWSD--------------------TEEINDIVDLSLMEEMLVSS---IRDQVIDVLLVALRCTEKKPSNR 1087 (1109)
Q Consensus      1031 ~~~~~~~~~~~~~~--------------------~~~~~~~~d~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~R 1087 (1109)
                       .+....+......                    ........++..........   .......+.+++.+|++.||++|
T Consensus       351 -~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        351 -LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             -HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence             1111111111000                    00000001111000000000   00112456789999999999999


Q ss_pred             CCHHHHHHHhhh
Q 001275         1088 PNMRDVVRQLVD 1099 (1109)
Q Consensus      1088 Ps~~evl~~L~~ 1099 (1109)
                      ||++|+++|=+-
T Consensus       430 ~ta~e~L~Hp~~  441 (467)
T PTZ00284        430 LNARQMTTHPYV  441 (467)
T ss_pred             CCHHHHhcCccc
Confidence            999999987543

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4e-32  Score=303.11  Aligned_cols=270  Identities=21%  Similarity=0.333  Sum_probs=201.5

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      +|+..++||.|++|.||+|+.. +++.||||++...........+.+|++++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788899999999999999775 688999999866554445567788999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++ +|.+++........+++..+..++.|+++|++|||   +.+++||||||+||++++++.++++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 89998876554456899999999999999999999   88999999999999999999999999999975533211 


Q ss_pred             ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-ccccccccc---
Q 001275          979 TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-TEEINDIVD--- 1053 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d--- 1053 (1109)
                       ......++..|+|||++.+. .++.++||||+||++|+|++|+.||...... ............. ......+.+   
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCch
Confidence             11234578899999987654 4688999999999999999999998654221 1111111110000 000000000   


Q ss_pred             -----hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1054 -----LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1054 -----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                           +................++.+++.+|++.||.+||+++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 0000000000011223456778889999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-33  Score=304.97  Aligned_cols=257  Identities=22%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +.|++.+.||+||.+.||++...+.+.||+|++.... +......|..|+..+.++ .|.+||++++|-..++..|+|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            5688889999999999999999988999999875443 445567799999999999 59999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |-+ .+|..+++.... ....| .++.+..|++.|+.+.|   ..+|||.||||.|+++- +|.+||+|||.|..+..+.
T Consensus       441 ~Gd-~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  441 CGD-IDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             ccc-ccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            975 499999987543 22345 78889999999999999   99999999999999884 5789999999999887665


Q ss_pred             CCceeeecccCcccccccccccCC-----------CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTA-----------KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      ........+||+.||+||.+....           .+.++||||+|||+|+|+.|+.||.....      .|.       
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~a-------  580 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QIA-------  580 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HHH-------
Confidence            555566789999999999876432           46799999999999999999999853211      111       


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                       .+..+.++.-..++..  .. ...++++++..|++.||++||+..|+++|-.-
T Consensus       581 -Kl~aI~~P~~~Iefp~--~~-~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl  630 (677)
T KOG0596|consen  581 -KLHAITDPNHEIEFPD--IP-ENDELIDVMKCCLARDPKKRWSIPELLQHPFL  630 (677)
T ss_pred             -HHHhhcCCCccccccC--CC-CchHHHHHHHHHHhcCcccCCCcHHHhcCccc
Confidence             1122333322111110  00 01127788889999999999999999987543

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.2e-32  Score=303.66  Aligned_cols=255  Identities=23%  Similarity=0.336  Sum_probs=193.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHH-HhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQT-IGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|++.+.||+|+||.||+|... +|+.||+|++...........+..|+.. ++..+||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36788899999999999999765 6899999998654333344556666665 566689999999999999999999999


Q ss_pred             eccCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          897 YMENGSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYLHYDCDP-PIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |++ |+|.+++... .....+++..++.++.|++.|++|||   +. +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 6898887653 23346899999999999999999999   76 899999999999999999999999999986533


Q ss_pred             CCCCceeeecccCccccccccccc----CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFT----TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ..   ......++..|+|||.+.+    ..++.++|+||+||++|||++|+.||.............    ....     
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~-----  224 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV----VEEP-----  224 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH----HhcC-----
Confidence            21   1122468889999998764    456889999999999999999999985422111111111    0000     


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                        .+...       ......++.+++.+|++.+|++||+++|++++-.
T Consensus       225 --~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  263 (283)
T cd06617         225 --SPQLP-------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF  263 (283)
T ss_pred             --CCCCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence              00000       0011234667888999999999999999998543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.3e-32  Score=303.20  Aligned_cols=257  Identities=22%  Similarity=0.354  Sum_probs=196.6

Q ss_pred             CCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC------
Q 001275          821 LNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD------  889 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  889 (1109)
                      |.+.++||+|+||+||+|...    .++.||||++.... ......++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            556788999999999999653    46889999885432 2233557889999999999999999999886542      


Q ss_pred             ceeEEEEeccCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          890 CGIIMYRYMENGSLRDVLHSIT---PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                      ..++++||+++|+|.+++....   ....+++..+.+++.|++.|++|||   +.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            2378899999999998875321   2235789999999999999999999   889999999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCc
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      |+++...............+++.|++||......++.++||||||+++|||++ |+.||.....  .....+.   ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~~~~~---~~~~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEIYNYL---IKGN  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHHHHHH---HcCC
Confidence            99986643322222223346678999999998889999999999999999999 7777753311  1111111   1110


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       ...   .           ......++.+++.+|++.+|++||++.|+++.|+++
T Consensus       233 -~~~---~-----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 -RLK---Q-----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -cCC---C-----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             000   0           011234577788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=306.40  Aligned_cols=255  Identities=20%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|.+.+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++|+||+++++++...+..++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            356888899999999999999764 6889999988533 33344578899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.+++....  ..+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          83 FCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             ccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            999999999987643  34899999999999999999999   8999999999999999999999999999987553321


Q ss_pred             CCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          977 ASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                        .......+++.|+|||.+.     +..++.++||||+|+++|||++|+.||......     ...........  ...
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--~~~  228 (280)
T cd06611         158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLKILKSEP--PTL  228 (280)
T ss_pred             --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHHHhcCCC--CCc
Confidence              1222356899999999874     345678999999999999999999998643211     11111111000  000


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       +.          ......++.+++.+||+.+|.+||++.+++++-+
T Consensus       229 -~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (280)
T cd06611         229 -DQ----------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF  264 (280)
T ss_pred             -CC----------cccCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence             00          0111234566788999999999999999998854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-32  Score=307.39  Aligned_cols=260  Identities=22%  Similarity=0.291  Sum_probs=198.9

Q ss_pred             HHHHHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecC-
Q 001275          812 KQVIEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK-  888 (1109)
Q Consensus       812 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  888 (1109)
                      .++..++++|.+.+.||+|+||.||+|.. .+++.+|+|.+...  ......+.+|+.++.++ +|||++++++++... 
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI--SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc--ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            44445678899999999999999999976 46889999987432  22345678899999999 899999999998754 


Q ss_pred             ----CceeEEEEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          889 ----DCGIIMYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       889 ----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                          +..++|+||+++|+|.++++... ....+++..++.++.|++.|++|||   +.+|+||||||+||++++++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEE
Confidence                35799999999999999886432 2345899999999999999999999   889999999999999999999999


Q ss_pred             ecccCCcccCCCCCCceeeecccCcccccccccccC-----CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHH
Q 001275          964 SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT-----AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWV 1038 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1109)
                      +|||++.........  .....|+..|+|||.+...     .++.++||||+||++|||++|+.||...... ...   .
T Consensus       170 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~---~  243 (291)
T cd06639         170 VDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTL---F  243 (291)
T ss_pred             eecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHH---H
Confidence            999998865432211  1224688899999987543     3688999999999999999999998643211 111   1


Q ss_pred             HHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1039 RSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1039 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .. ...  ....+.+           ..+....+.+++.+|++.+|++||++.|+++|
T Consensus       244 ~~-~~~--~~~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 KI-PRN--PPPTLLH-----------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HH-hcC--CCCCCCc-----------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11 000  0000101           01122346778889999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.1e-32  Score=298.91  Aligned_cols=250  Identities=28%  Similarity=0.430  Sum_probs=198.7

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|+..+.||+|+||.||+|.. .+++.+|+|++.... .......+.+|++++++++|||++++++.+..++..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999965 468899999985443 223456788999999999999999999999988999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~~~~~~~  976 (1109)
                      +++++|.+++.... ...+++..+.+++.++++|++|||   +.+|+||||+|+||+++++ +.+|++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999997643 335889999999999999999999   8999999999999999865 458999999998664332


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      .   .....++..|+|||...+..++.++||||||+++|+|++|+.||.....     ...........  ...+     
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~--~~~~-----  221 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMSGT--FAPI-----  221 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHhcC--CCCC-----
Confidence            2   1234688999999999988899999999999999999999999854321     11111111000  0000     


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                              ......++.+++.+||+.+|++||+++|++++
T Consensus       222 --------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 --------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             --------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    01123346678889999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.3e-33  Score=303.86  Aligned_cols=241  Identities=21%  Similarity=0.313  Sum_probs=184.4

Q ss_pred             ceeecccCeEEEEEEeCC--------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          825 HVIGRGAHGIVYKASLGP--------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +.||+|+||.||+|....        ...||+|.+.. ........+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK-SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcc-hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            369999999999996532        23477777632 223334578889999999999999999999999899999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc--------EEEecccC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME--------PHISDFGI  968 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~DfGl  968 (1109)
                      |+++|+|.++++....  .+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.        ++++|||+
T Consensus        80 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          80 YVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             cCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999999976432  5889999999999999999999   899999999999999987765        69999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      +......      ....++..|+|||++.+. .++.++|||||||++|||++|..++.......    ..... ......
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----~~~~~-~~~~~~  223 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----KKLQF-YEDRHQ  223 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----HHHHH-HHcccc
Confidence            8755322      124678899999998864 57999999999999999999964432211110    00000 000000


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                         +             ......++.+++.+||+.||++||+++|+++.|+
T Consensus       224 ---~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         224 ---L-------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---C-------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               0             0011234677888999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.8e-32  Score=302.00  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=199.3

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      -|+..+.||+|+||.||+|.. .+++.||+|.+...........+.+|++++++++||||+++++++..++..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            466788899999999999976 4688999998754444444567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.+++...    .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++........ 
T Consensus        85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            999999998642    3789999999999999999999   89999999999999999999999999999876543221 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                       ......++..|+|||...+..++.++||||+||++|+|++|..||.....     ...........  ... +      
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~--~~~-~------  221 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLFLIPKNN--PPT-L------  221 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----HHHHHHHhcCC--CCC-C------
Confidence             12234678899999999888889999999999999999999999854221     11111110000  000 0      


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                            ......++.+++.+|++.+|++||+++|++++-
T Consensus       222 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  254 (277)
T cd06641         222 ------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  254 (277)
T ss_pred             ------CcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence                  011223456678899999999999999999973

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=314.30  Aligned_cols=243  Identities=22%  Similarity=0.250  Sum_probs=185.1

Q ss_pred             eecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcC---CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          827 IGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKI---RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ||+|+||+||+|+.. +++.||+|++.....  ......+..|..++.+.   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999764 589999999854321  12233455666666655   699999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.+++....   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99999987533   4889999999999999999999   8999999999999999999999999999987543221  11


Q ss_pred             eeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHH
Q 001275          981 SISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 1059 (1109)
                      .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.....     ...............   .      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~~---~------  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGKVRFP---K------  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCCCCCC---C------
Confidence            2235799999999988765 479999999999999999999999864321     111111111100000   0      


Q ss_pred             hhhchhHHHHHHHHHHHHhccCCCCCCCC----CHHHHHHHh
Q 001275         1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRP----NMRDVVRQL 1097 (1109)
Q Consensus      1060 ~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----s~~evl~~L 1097 (1109)
                         .   ....++.+++.+|++.||++||    ++.|+++|-
T Consensus       219 ---~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~  254 (330)
T cd05586         219 ---N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP  254 (330)
T ss_pred             ---c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence               0   0122345677799999999998    677777764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.1e-32  Score=298.63  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=194.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|.+.+.||+|+||.||+|.. .++.||+|.+...   .....+.+|+.++++++|||++++++++... ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4588899999999999999975 5778999987432   2345788999999999999999999998654 579999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++.... ...+++..+..++.|+++|++|||   +.+++||||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          81 SKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            9999999997643 335789999999999999999999   8999999999999999999999999999987543221  


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                         .....+..|+|||.+.+..++.++||||+||++|||++ |+.||......     ......... ...    ++   
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~-~~~----~~---  218 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKECVEKG-YRM----EP---  218 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHHhCC-CCC----CC---
Confidence               11234568999999988899999999999999999998 88887543211     111111100 000    00   


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                             .......+.+++.+||+.+|++||+++++++.|++
T Consensus       219 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 -------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                   01122446678889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.8e-32  Score=304.38  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=199.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|...+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++||||+++++++...+..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            5788899999999999999965 46788999987432 333456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++...    .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999998753    3789999999999999999999   89999999999999999999999999999876543222


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......+++.|+|||...+..++.++|||||||++|++++|+.||........ ..    .......  ...      
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~----~~~~~~~--~~~------  235 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----LIATNGT--PEL------  235 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-ee----ehhcCCC--CCC------
Confidence              22234688899999999888899999999999999999999999964322110 00    0000000  000      


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                           .........+.+++.+||+.+|++||+++|++.|-
T Consensus       236 -----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~  270 (293)
T cd06647         236 -----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (293)
T ss_pred             -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                 00011223456688899999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-33  Score=284.90  Aligned_cols=267  Identities=22%  Similarity=0.346  Sum_probs=200.9

Q ss_pred             cccHHHHHHHhhCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEE
Q 001275          808 SYLLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFW  885 (1109)
Q Consensus       808 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  885 (1109)
                      .-.+++..+.|.     +.||+|+|+.|-.+ ...+|..||||++. +.......++.+|++++.+. .|+||+++++||
T Consensus        72 ~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiid-Kq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   72 SGKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIID-KQPGHSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             cchHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhh-cCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            334667777764     56999999999988 56789999999984 33555667899999999999 599999999999


Q ss_pred             ecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc---EE
Q 001275          886 LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME---PH  962 (1109)
Q Consensus       886 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~k  962 (1109)
                      ++++..|+|||-|.||+|..++++..   .+++.++.++..+|+.||++||   .++|.|||+||+|||......   +|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence            99999999999999999999998755   4899999999999999999999   999999999999999976544   79


Q ss_pred             EecccCCcccCCC-----CCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccc
Q 001275          963 ISDFGIAKLLDKS-----PASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032 (1109)
Q Consensus       963 l~DfGla~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~ 1032 (1109)
                      |+||.++.-....     .........+|+..|||||+..     ...|+.++|.||+|||+|-|++|..||.+.-+.+-
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            9999887543211     1112223468899999999663     34578999999999999999999999976433211


Q ss_pred             cHHHHHHHhhcCccccccccchhhhH----------HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1033 DIVGWVRSVWSDTEEINDIVDLSLME----------EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~d~~~~~----------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                         +     |...+.- +.-...+.+          +..+..+..+..+++   ...+..||..|.++.++++|-+
T Consensus       300 ---G-----WdrGe~C-r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdli---snLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  300 ---G-----WDRGEVC-RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLI---SNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             ---C-----ccCCCcc-HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHH---HHHHhccHHhhhhhhhccCCcc
Confidence               1     1111110 000111111          111223445555544   4666799999999999998644

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.98  E-value=1.1e-31  Score=296.08  Aligned_cols=252  Identities=27%  Similarity=0.460  Sum_probs=204.4

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      +|+..+.||+|++|.||+|... +++.||+|++...........+.+|++.+.+++|+|++++++++...+..++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            5788899999999999999776 489999999865444345678999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++++|.+++...   ..+++..+..++.|+++|++|+|   + .+++||||+|+||+++.++.++++|||.+........
T Consensus        82 ~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          82 DGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            999999999764   34899999999999999999999   8 9999999999999999999999999999986643322


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      ..  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  ...............  ...      
T Consensus       156 ~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~--~~~------  223 (264)
T cd06623         156 QC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSFFELMQAICDGPP--PSL------  223 (264)
T ss_pred             cc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCHHHHHHHHhcCCC--CCC------
Confidence            21  234678899999999999899999999999999999999999865421  112222222211100  000      


Q ss_pred             HHhhhchhHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1058 EEMLVSSIRD-QVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1058 ~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                             ... ....+.+++.+|++.+|++||++.|++++
T Consensus       224 -------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 -------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   011 23456778889999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.98  E-value=5.8e-32  Score=298.48  Aligned_cols=253  Identities=26%  Similarity=0.313  Sum_probs=193.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc----ccChHHHHHHHHHHhcCCCCceeeEeeEEecC--Cce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH----KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  891 (1109)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+.....    ......+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4788899999999999999976 4589999998753321    12235688899999999999999999988764  457


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++++|.+++....   .+++..+.+++.|++.||+|||   +.+|+|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999987543   3788889999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||.....    ............     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~-----  226 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPT-----  226 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch----HHHHHHHhcCCC-----
Confidence            5432111 112234688999999999888899999999999999999999999853211    111111110000     


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                        .+..        .......+..++.+|+. +|++||+++|++++-
T Consensus       227 --~~~~--------~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         227 --NPVL--------PPHVSDHCRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             --CCCC--------chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence              0000        11122334556668884 999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.98  E-value=4.2e-32  Score=303.73  Aligned_cols=251  Identities=24%  Similarity=0.352  Sum_probs=195.9

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .|.....||+|+||.||++.. .++..||||++... .......+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            344456799999999999976 46889999987433 2334456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.+++...    .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++........ 
T Consensus       102 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         102 EGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            999999988542    3789999999999999999999   88999999999999999999999999999876533221 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                       ......|+..|+|||...+..++.++|||||||++|||++|+.||......  .....+...          ..+....
T Consensus       174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~~----------~~~~~~~  240 (292)
T cd06658         174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRIRDN----------LPPRVKD  240 (292)
T ss_pred             -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhc----------CCCcccc
Confidence             122356889999999998888999999999999999999999998643211  111111000          0000000


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                            .......+..++.+|++.||++||+++|++++-.
T Consensus       241 ------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  274 (292)
T cd06658         241 ------SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPF  274 (292)
T ss_pred             ------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence                  0011223556777999999999999999998843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.98  E-value=3.3e-32  Score=303.38  Aligned_cols=260  Identities=22%  Similarity=0.318  Sum_probs=199.2

Q ss_pred             cHHHHHHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEec
Q 001275          810 LLKQVIEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLR  887 (1109)
Q Consensus       810 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  887 (1109)
                      ++.+...+...|+..+.||+|+||.||+|.. .+++.+|+|.+...  .....++..|+.++.++ +|+||+++++++..
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            4445556678899999999999999999976 46789999987432  23345688899999998 79999999999853


Q ss_pred             ------CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          888 ------KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       888 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                            .+..+++|||+++|+|.+++.... ...+++..+..++.|+++|++|||   +.+|+|||++|+||++++++.+
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCE
Confidence                  456799999999999999987543 234788889999999999999999   8999999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVG 1036 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 1036 (1109)
                      +|+|||++........  ......|+..|+|||.+.     +..++.++||||+||++|||++|+.||........    
T Consensus       161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----  234 (282)
T cd06636         161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----  234 (282)
T ss_pred             EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----
Confidence            9999999875532211  122356889999999875     34678899999999999999999999864321110    


Q ss_pred             HHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1037 WVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1037 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ........        .+...       ......++.+++.+||+.||++||++.|++++
T Consensus       235 ~~~~~~~~--------~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 LFLIPRNP--------PPKLK-------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhhHhhCC--------CCCCc-------ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            00000000        00000       01123457778889999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.98  E-value=9.5e-32  Score=296.56  Aligned_cols=254  Identities=27%  Similarity=0.385  Sum_probs=199.4

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|...+.||+|+||.||+|... +++.||+|.+...... .....+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5778899999999999999764 6889999998544332 3566789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++....   .+++..+..++.++++|++|||   +.+|+|+||+|+||++++++.+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999987632   3788999999999999999999   89999999999999999999999999999987654322


Q ss_pred             Cce--eeecccCcccccccccccCC---CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          978 STT--SISVVGTIGYIAPENAFTTA---KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       978 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ...  .....++..|+|||++.+..   ++.++||||||+++||+++|+.||.......    .........  ....+ 
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~~--~~~~~-  227 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGAG--HKPPI-  227 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhcC--CCCCC-
Confidence            111  12346788999999988766   7899999999999999999999996432111    111111000  00000 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .          ........+.+++.+|++.+|++||++.|++.+
T Consensus       228 ~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         228 P----------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             C----------cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0          001112345567889999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=4.9e-32  Score=301.17  Aligned_cols=252  Identities=22%  Similarity=0.335  Sum_probs=200.1

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC---CCceeeEeeEEecCCceeEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR---HRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+..........++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788899999999999976 5689999998865544555667889999999996   999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.++++..    .+++..+..++.|+++|++|||   +.+|+||||+|+||+++.++.++++|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999998653    4889999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      .  .......|+..|+|||...++ .++.++|||||||++|+|++|+.||......     ....... .. .     .+
T Consensus       155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~~~-~~-~-----~~  220 (277)
T cd06917         155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMMLIP-KS-K-----PP  220 (277)
T ss_pred             c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhccc-cC-C-----CC
Confidence            2  122334688999999987654 4689999999999999999999998643211     1111000 00 0     00


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .+..       .....++.+++.+|++.||++||++.|++++-+-
T Consensus       221 ~~~~-------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         221 RLED-------NGYSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             CCCc-------ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence            0000       0123456778889999999999999999987543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.98  E-value=6.3e-32  Score=301.52  Aligned_cols=269  Identities=21%  Similarity=0.319  Sum_probs=198.0

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|+..+.||+|++|.||+|+.. +++.||||++..... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999764 689999998854332 22345788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +. ++|.+++.... ...+++..+..++.|+++|++|||   +.+++||||+|+||++++++.+|++|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 68999887643 345899999999999999999999   88999999999999999999999999999876543211


Q ss_pred             CceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc--h
Q 001275          978 STTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD--L 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~ 1054 (1109)
                        ......++..|+|||...+.. ++.++|||||||++|||+||+.||..... .....................+.  +
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHhCCCChhhhhhhhHHH
Confidence              112235688999999887654 58899999999999999999999864321 11222222111111000000000  0


Q ss_pred             h-------hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1055 S-------LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1055 ~-------~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .       ...............++.+++.+|++.||++||+++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0       00000000001112446678889999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.98  E-value=9.9e-32  Score=297.16  Aligned_cols=255  Identities=24%  Similarity=0.384  Sum_probs=198.6

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc-----cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK-----RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+......     .....+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999965 56899999988543321     124578899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecccCCccc
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLL  972 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~  972 (1109)
                      |+||+++++|.+++....   .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999997643   4789999999999999999999   89999999999999998776 5999999999866


Q ss_pred             CCCCCC--ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          973 DKSPAS--TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       973 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ......  .......++..|+|||.+.+..++.++||||+|+++|++++|+.||......  ............. .   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~-~---  228 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIFKIASAT-T---  228 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHHHHhccC-C---
Confidence            433111  1112346889999999998888999999999999999999999998533211  1111111100000 0   


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                        .+        ........++.+++.+|++.+|++||++.|++++
T Consensus       229 --~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         229 --AP--------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --CC--------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence              00        0011223456678889999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.98  E-value=6.1e-32  Score=298.08  Aligned_cols=255  Identities=22%  Similarity=0.380  Sum_probs=200.6

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEec--CCceeEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCGIIMY  895 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  895 (1109)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+..|++++++++|+||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999965 467899999885433 23334568899999999999999999998764  34578999


Q ss_pred             EeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDC--DPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      ||+++++|.+++.... ....+++..++.++.|+++|++|||..+  +.+|+||||+|+||++++++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            9999999999997642 2346899999999999999999999554  678999999999999999999999999999876


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .....  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....  .......+..   .  ....+ 
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~---~--~~~~~-  230 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKE---G--KFRRI-  230 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhc---C--CCCCC-
Confidence            54322  1223468999999999999889999999999999999999999986532  1111111110   0  00000 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                                  ......++.+++.+|++.+|++||+++|++++
T Consensus       231 ------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         231 ------------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                        11223456778889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=9.6e-32  Score=299.67  Aligned_cols=264  Identities=20%  Similarity=0.265  Sum_probs=193.9

Q ss_pred             CCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecC--CceeEEEE
Q 001275          821 LNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRK--DCGIIMYR  896 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  896 (1109)
                      |++.++||+|+||.||+|.. .+++.||+|++.............+|+.++.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56678899999999999975 4688999998854433333344567999999985 99999999999887  88999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |++ |++.+++....  ..+++..+..++.|++.||+|||   +.+|+||||+|+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 58888886533  35899999999999999999999   889999999999999999 999999999998664332


Q ss_pred             CCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc--------
Q 001275          977 ASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE-------- 1047 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------- 1047 (1109)
                      ..   ....++..|+|||.... ..++.++||||+||++|||++|+.||.....  .+..............        
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEVLKKFRK  228 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHHHHhhcc
Confidence            21   22467889999997654 5568999999999999999999999854321  1111111111110000        


Q ss_pred             --cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1048 --INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1048 --~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                        ......+................++.+++.+|++.+|++||+++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence              0000000000000000011234667888899999999999999999976

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=1.1e-31  Score=300.49  Aligned_cols=248  Identities=23%  Similarity=0.273  Sum_probs=199.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|...+.||+|+||.||+|... +++.||+|.+.....  ......+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788899999999999999764 589999998854321  233456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++....   .+++..+..++.|+++||+|||   +.+|+||||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999997643   4889999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                           .....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.....  .   .............       
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~---~~~~~~~~~~~~~-------  217 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--I---QIYEKILEGKVRF-------  217 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--H---HHHHHHhcCCccC-------
Confidence                 2234688999999999888889999999999999999999999864321  1   1111111100000       


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                            .   ......+.+++.+||+.+|++|+     +++|+++|-.
T Consensus       218 ------~---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         218 ------P---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             ------C---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence                  0   01123456678899999999999     8888887653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.98  E-value=7.8e-32  Score=303.02  Aligned_cols=269  Identities=23%  Similarity=0.322  Sum_probs=198.5

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc----cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK----RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      +|+..+.||+|+||.||+|... +++.||+|++......    .....+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4777889999999999999764 6899999998654322    1234567899999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+ +|+|.++++...  ..+++..+..++.|+++||+|||   +.+|+||||+|+||+++.++.++|+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999997643  35899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh-------cCcc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW-------SDTE 1046 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~ 1046 (1109)
                      ...  ......+++.|+|||.+.+ ..++.++|||||||++|||++|..+|.... .............       ....
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHHHHHHHHcCCCchhhhhhcc
Confidence            321  1122356788999998755 457899999999999999999977665322 1111111111100       0000


Q ss_pred             ccccccchhhhHHh-hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1047 EINDIVDLSLMEEM-LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .............. ..........++.+++.+||+.||++||+++|++++=
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~  283 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP  283 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence            00000000000000 0000112235677889999999999999999999983

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.98  E-value=5.9e-32  Score=302.36  Aligned_cols=265  Identities=24%  Similarity=0.332  Sum_probs=200.4

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++|+||+++++++..++..++|+||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            6888899999999999999765 578999998854332 33356789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++++.+..+....   ..+++..+..++.|+++|++|||   +.+++|||++|+||++++++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            9987777665432   34889999999999999999999   88999999999999999999999999999987654332


Q ss_pred             CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-----------c
Q 001275          978 STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-----------T 1045 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------~ 1045 (1109)
                       .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......  +........+..           .
T Consensus       156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccC
Confidence             122335678899999999888 7899999999999999999999988643211  111111111100           0


Q ss_pred             cc-----cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1046 EE-----INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1046 ~~-----~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..     .....++.......   ......++.+++.+||+.+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRY---PGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccccCCCCCcHHHHHhc---CCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00     00000000000000   01124567888899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=4.8e-32  Score=307.41  Aligned_cols=255  Identities=24%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|+||+||+|... +++.||+|.+......  .....+.+|++++++++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999765 4899999998654332  24457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++.... ...+++..+..++.|+++|++|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987532 345899999999999999999999   899999999999999999999999999998755322


Q ss_pred             CCCc---------------------------eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCc
Q 001275          976 PAST---------------------------TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSY 1028 (1109)
Q Consensus       976 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~ 1028 (1109)
                      ....                           ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1110                           1112468889999999999889999999999999999999999986432


Q ss_pred             cccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC----HHHHHHH
Q 001275         1029 KERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN----MRDVVRQ 1096 (1109)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs----~~evl~~ 1096 (1109)
                      .. ..    ...........              ........++.+++.+|++.||++||+    ++|++++
T Consensus       237 ~~-~~----~~~~~~~~~~~--------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         237 RD-ET----FSNILKKEVTF--------------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             hH-HH----HHHHhcCCccC--------------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            21 11    11111100000              000112345677888999999999999    8888886

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.9e-32  Score=300.03  Aligned_cols=255  Identities=25%  Similarity=0.334  Sum_probs=197.8

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC-----
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD-----  889 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  889 (1109)
                      ++++|+..+.||+|+||.||+|... +++.+++|.+....  .....+.+|+++++++ +|+||+++++++....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            5678999999999999999999774 57889999875432  2346789999999999 7999999999987644     


Q ss_pred             -ceeEEEEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          890 -CGIIMYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       890 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                       ..++||||+++++|.+++.... ....+++..+..++.|+++|++|||   +.+++||||+|+||++++++.++++|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4799999999999999987533 2345899999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCccccccccccc-----CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFT-----TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      ++.......  .......++..|+|||++..     ..++.++||||+||++|+|++|+.||...... .....    ..
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~----~~  231 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFK----IP  231 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHH----hh
Confidence            987654322  11223568899999998753     34678999999999999999999998643111 11111    00


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..  ......           .......++.+++.+|++.||++||++.|++++
T Consensus       232 ~~--~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         232 RN--PPPTLK-----------SPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             cc--CCCCCC-----------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            00  000000           011123456678889999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=4.1e-32  Score=310.50  Aligned_cols=270  Identities=21%  Similarity=0.301  Sum_probs=197.5

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-----ce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-----CG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  891 (1109)
                      +++|.+.++||+|+||.||+|.. .+++.||+|++...........+.+|+.++++++|+||+++++++...+     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999965 4689999999854333444567889999999999999999999876543     47


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++|+||+++ ++.+++...    .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 888877642    4899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCC-ceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc-Ccccc
Q 001275          972 LDKSPAS-TTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS-DTEEI 1048 (1109)
Q Consensus       972 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 1048 (1109)
                      ....... .......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||..... ......+...... ..+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-~~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-LHQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCCHHHH
Confidence            5432221 11223568899999998754 5679999999999999999999999854311 1111111111000 00111


Q ss_pred             ccccchhhhHHh----------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1049 NDIVDLSLMEEM----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1049 ~~~~d~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..+.+.......          .....+....++.+++.+||+.+|++||++.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111111000000          000011123457788999999999999999999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=9.6e-33  Score=327.01  Aligned_cols=253  Identities=26%  Similarity=0.417  Sum_probs=189.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC---------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK---------  888 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  888 (1109)
                      .+|++.+.||+||||.||+++.+ ||+.||||++...........+.+|+..+.+++|||||+++..|.+.         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            45777889999999999999765 79999999998777666677899999999999999999985421100         


Q ss_pred             --------------------------------------------------------------------------------
Q 001275          889 --------------------------------------------------------------------------------  888 (1109)
Q Consensus       889 --------------------------------------------------------------------------------  888 (1109)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ------------------------------CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 001275          889 ------------------------------DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD  938 (1109)
Q Consensus       889 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  938 (1109)
                                                    ...|+-||||+..++.++++.....  -.....++++.+|++|++|+|  
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH--  714 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH--  714 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH--
Confidence                                          1136788999988888888764421  146778999999999999999  


Q ss_pred             CCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC----------------CCCCCceeeecccCcccccccccccCC--
Q 001275          939 CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD----------------KSPASTTSISVVGTIGYIAPENAFTTA-- 1000 (1109)
Q Consensus       939 ~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~~-- 1000 (1109)
                       +.+||||||||.||+++++..|||+|||+|....                ........+..+||.-|+|||+..+..  
T Consensus       715 -~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  715 -DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             -hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence             8999999999999999999999999999998721                011122345678999999999887655  


Q ss_pred             -CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc-ccccchhhhHHhhhchhHHHHHHHHHHHHh
Q 001275         1001 -KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI-NDIVDLSLMEEMLVSSIRDQVIDVLLVALR 1078 (1109)
Q Consensus      1001 -~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~ 1078 (1109)
                       |+.|+|+||+|||++||+.   ||....+    .+..+.......-+. .++             .......-.+++.+
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsME----Ra~iL~~LR~g~iP~~~~f-------------~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSME----RASILTNLRKGSIPEPADF-------------FDPEHPEEASLIRW  853 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHH----HHHHHHhcccCCCCCCccc-------------ccccchHHHHHHHH
Confidence             8999999999999999984   4543321    111111111000000 111             12233344568889


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 001275         1079 CTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1079 cl~~dP~~RPs~~evl~~ 1096 (1109)
                      |++.||.+||||.|+++.
T Consensus       854 Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HhcCCCccCCCHHHHhhc
Confidence            999999999999999864

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.98  E-value=6.2e-32  Score=296.97  Aligned_cols=250  Identities=25%  Similarity=0.277  Sum_probs=200.3

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +|+..+.||.|+||.||+|... +++.||+|.+.....  ....+.+.+|++++++++||||+++++++...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999775 589999999864332  2345688999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.+++...   ..+++..+..++.|+++|++|||   +.+++|+||+|+||++++++.++++|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999999764   34889999999999999999999   8899999999999999999999999999988654332


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                         ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||......  ..............   ..     
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~---~~-----  221 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETADV---LY-----  221 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccccc---cC-----
Confidence               223356888999999999888999999999999999999999998754321  11111111100000   00     


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH--HHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM--RDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~--~evl~~ 1096 (1109)
                              ......++.+++.+||+.||.+||++  +|++++
T Consensus       222 --------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         222 --------PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             --------cccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence                    01122456678889999999999999  776643

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=7.9e-32  Score=302.31  Aligned_cols=247  Identities=22%  Similarity=0.333  Sum_probs=195.0

Q ss_pred             CceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCC
Q 001275          824 KHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      ...||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            446999999999999764 68999999985433 3345668899999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceee
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI  982 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  982 (1109)
                      |.+++..    ..+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus       105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  175 (297)
T cd06659         105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK  175 (297)
T ss_pred             HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence            9998754    23789999999999999999999   8999999999999999999999999999987553322  1222


Q ss_pred             ecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhh
Q 001275          983 SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062 (1109)
Q Consensus       983 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1062 (1109)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||......  .....+..   ........           
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~---~~~~~~~~-----------  239 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRD---SPPPKLKN-----------  239 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---cCCCCccc-----------
Confidence            356899999999999889999999999999999999999998643211  11111110   00000000           


Q ss_pred             chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1063 SSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1063 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                        ......++.+++.+|++.+|++||+++|++++-.
T Consensus       240 --~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~  273 (297)
T cd06659         240 --AHKISPVLRDFLERMLTREPQERATAQELLDHPF  273 (297)
T ss_pred             --cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence              0011234566788999999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.98  E-value=9.4e-32  Score=300.38  Aligned_cols=255  Identities=25%  Similarity=0.351  Sum_probs=202.6

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .++.|...+.+|+|+||.||+|... +++.||+|++.....  ....+.+|++.+++++|+|++++++++...+..++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            3466888889999999999999776 688999999854322  4567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||   +.+|+|+|++|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999998753  35899999999999999999999   899999999999999999999999999998755432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||......     .........  ......+  
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~~~~~--~~~~~~~--  238 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFLITTK--GIPPLKN--  238 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhc--CCCCCcc--
Confidence            21  112345788999999998888999999999999999999999998543211     011110000  0000000  


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               ......++.+++.+|++.+|.+||++.|++++-.
T Consensus       239 ---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  272 (286)
T cd06614         239 ---------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF  272 (286)
T ss_pred             ---------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence                     0112234667888999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.98  E-value=1.1e-31  Score=300.94  Aligned_cols=269  Identities=22%  Similarity=0.297  Sum_probs=197.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  894 (1109)
                      ++|+..+.||+|+||.||+|... +++.+|+|.+...... .....+.+|++++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888899999999999999775 5889999998644322 2234577899999999999999999998877  789999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      +||+++ +|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++.++|+|||+++....
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 9999887643  25899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCCceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-------cc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-------TE 1046 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 1046 (1109)
                      ...  ......+++.|+|||.+.+.. ++.++|+||+|+++|||++|+.||...... .............       ..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhh
Confidence            321  122345788999999887644 689999999999999999999998643211 1111111110000       00


Q ss_pred             ccccccch---hhhHHhhhchhHH--HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1047 EINDIVDL---SLMEEMLVSSIRD--QVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1047 ~~~~~~d~---~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ........   ...........+.  ....+.+++.+|++.+|++||+++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000000   0000000000111  13446678889999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=1.7e-31  Score=301.37  Aligned_cols=251  Identities=27%  Similarity=0.387  Sum_probs=196.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.|...+.||+|+||+||+|... +++.||+|++.....  .....++.+|+++++.++||||+++.+++...+..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55888899999999999999764 689999998854322  223456889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||++ |++.+++....  ..+++..+..++.|++.|+.|||   +.+|+||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 57877775433  24899999999999999999999   899999999999999999999999999998755322


Q ss_pred             CCCceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                            ....++..|+|||++.   ...++.++||||||+++|||++|+.||......     ..........  .... 
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~~~~~--~~~~-  234 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQND--SPTL-  234 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHHhcCC--CCCC-
Confidence                  1246788999999874   456789999999999999999999998543211     1111100000  0000 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .           ......++.+++.+||+.+|++||++.+++++.+-.
T Consensus       235 ~-----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         235 S-----------SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             C-----------chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence            0           011234567788899999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=9.8e-32  Score=325.80  Aligned_cols=260  Identities=23%  Similarity=0.339  Sum_probs=206.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC--------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG--------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  889 (1109)
                      ++....+.+|+|.||.||+|...        ....||||.++........+.+..|+++|+.+ +|+||+.++|+|..++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            44455668999999999999542        24679999998777777788999999999999 6999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccC---------C--C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          890 CGIIMYRYMENGSLRDVLHSIT---------P--P--PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~---------~--~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ..++|+||++.|+|.++++..+         .  .  ..++....+.++.|||.|++||+   +.++||||+.++|||++
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEec
Confidence            9999999999999999998766         0  0  23889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCcee-eecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTS-ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 1035 (1109)
                      ++..+||+|||+|+.....+..... ....-+..|||||.+....|+.|+|||||||++||++|...+.++......++.
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~  532 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL  532 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence            9999999999999976554433321 111135679999999999999999999999999999995544333322122222


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .+++.-.                  ..+....+..++++++..||+.+|++||++.|+++.+..
T Consensus       533 ~~l~~G~------------------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  533 EFLKEGN------------------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             HHHhcCC------------------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            2222111                  001112335567889999999999999999999999887

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.2e-33  Score=295.21  Aligned_cols=201  Identities=28%  Similarity=0.385  Sum_probs=178.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.|+.-++||+||||.||-++. .+|+.||.|++.++..+  ........|-+++.+++.+.||.+-.+|..++..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5678889999999999999955 56899999988544332  33445678999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ..|.||+|.-++...+. +.+++..+..+|.+|+.||++||   ..+||+||+||+|||+|+.|+++|+|.|+|..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999988877664 56999999999999999999999   899999999999999999999999999999987654


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                      ..   ....+||.+|||||++.+..|+...|.||+||++|||+.|+.||..
T Consensus       341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            33   2345899999999999999999999999999999999999999964

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=1.8e-31  Score=301.02  Aligned_cols=256  Identities=23%  Similarity=0.255  Sum_probs=195.2

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      +|...+.||+|+||.||++... .++.||+|.+.....  ......+.+|+++++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            6888899999999999999765 578899998854321  2234567899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.+++....   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||+++......
T Consensus        82 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          82 YVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999997643   4889999999999999999999   8999999999999999999999999999987421110


Q ss_pred             C-------------CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc
Q 001275          977 A-------------STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       977 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      .             ........++..|+|||.+.+..++.++|||||||++||+++|+.||.....     ..+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~~~  230 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVIS  230 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHh
Confidence            0             0011123578899999999888899999999999999999999999864321     111111110


Q ss_pred             CccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1044 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ..     ...+..        ......++.+++.+||+.+|++||++.++.+.++.
T Consensus       231 ~~-----~~~~~~--------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         231 DD-----IEWPEG--------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             cc-----cCCCCc--------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            00     000000        00122345678889999999999985444444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=1.6e-31  Score=300.07  Aligned_cols=271  Identities=19%  Similarity=0.254  Sum_probs=195.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCC-CCceeeEeeEEecCCc-----
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDC-----  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  890 (1109)
                      ++|+..+.||+|+||.||+|... +++.||+|++...... .....+.+|+.++++++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999764 6899999987544322 23457888999999995 6999999999887665     


Q ss_pred             eeEEEEeccCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcEEEeccc
Q 001275          891 GIIMYRYMENGSLRDVLHSITP--PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEPHISDFG  967 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfG  967 (1109)
                      .++||||+++ ++.+++.....  ...+++..+..++.|+++||+|||   +.+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 89988865432  245899999999999999999999   899999999999999998 8899999999


Q ss_pred             CCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT- 1045 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 1045 (1109)
                      +++.......  ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .............. 
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQLLHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHhCCCCh
Confidence            9886533211  1122356889999998765 45789999999999999999999998643211 11111111100000 


Q ss_pred             cccccccc-------hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1046 EEINDIVD-------LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1046 ~~~~~~~d-------~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ........       +...........+....++.+++.+|++.||++||+++|++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000000       0000000000011233557778889999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-31  Score=302.81  Aligned_cols=273  Identities=22%  Similarity=0.309  Sum_probs=197.2

Q ss_pred             CCCCCceeecccCeEEEEEEeC---CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecC--Ccee
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG---PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGI  892 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  892 (1109)
                      +|+..++||+|+||.||+|...   +++.||+|.+....  .......+.+|++++++++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4777889999999999999764   47899999985432  123345678899999999999999999999988  7899


Q ss_pred             EEEEeccCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC----CCcEEEecc
Q 001275          893 IMYRYMENGSLRDVLHSITP--PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS----EMEPHISDF  966 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~Df  966 (1109)
                      +||||+++ ++.+++.....  ...+++..+..++.|++.|++|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 77777654322  235889999999999999999999   899999999999999999    899999999


Q ss_pred             cCCcccCCCCC-CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCcccc--------ccHHH
Q 001275          967 GIAKLLDKSPA-STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKER--------TDIVG 1036 (1109)
Q Consensus       967 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~--------~~~~~ 1036 (1109)
                      |++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||.......        ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986643322 1122335678899999987764 57899999999999999999999986543221        01111


Q ss_pred             HHHHhhcCcc-------ccccccc-------hhhhHHhhhchh---HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1037 WVRSVWSDTE-------EINDIVD-------LSLMEEMLVSSI---RDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1037 ~~~~~~~~~~-------~~~~~~d-------~~~~~~~~~~~~---~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .+........       ...+...       ............   .....++.+++.+|++.||++||++.|+++|
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111100000       0000000       000000000000   0223467889999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=1.6e-31  Score=298.03  Aligned_cols=252  Identities=23%  Similarity=0.352  Sum_probs=198.7

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .|...++||+|++|.||+|.. .+++.+|+|++... .......+.+|+.++++++|+||+++++++...+..++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            455567899999999999975 46889999987432 2333456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.+++..    ..+++..+..++.|++.|++|||   +.+|+||||+|+||+++.++.++++|||.+........ 
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648          99 EGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            99999999876    23889999999999999999999   89999999999999999999999999998875533211 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                       ......|+..|+|||...+..++.++||||+||++|||++|+.||.....     ...........       .+... 
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~-------~~~~~-  236 (285)
T cd06648         171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNL-------PPKLK-  236 (285)
T ss_pred             -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcC-------CCCCc-
Confidence             12235688999999999888899999999999999999999999864211     11111111110       00000 


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                           ........+.+++.+||+.+|++||++.|++++-.-
T Consensus       237 -----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (285)
T cd06648         237 -----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL  272 (285)
T ss_pred             -----ccccCCHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence                 001122456778889999999999999999986443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=5.6e-31  Score=290.65  Aligned_cols=251  Identities=20%  Similarity=0.277  Sum_probs=192.1

Q ss_pred             HHHHHHHhhCCCCCcee--ecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEe
Q 001275          811 LKQVIEATENLNAKHVI--GRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWL  886 (1109)
Q Consensus       811 ~~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  886 (1109)
                      ..+.....++|.+.+.+  |+|+||.||++.. .++..+|+|.+.......    .  |+.....+ +|+||+++++++.
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEe
Confidence            34445555677777776  9999999999965 467889999874332111    1  22222222 7999999999999


Q ss_pred             cCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEec
Q 001275          887 RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISD  965 (1109)
Q Consensus       887 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~D  965 (1109)
                      ..+..++||||+++|+|.+++....   .+++..+..++.|+++|++|||   +.+++||||||+||+++.++ .++|+|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence            9999999999999999999997643   5899999999999999999999   88999999999999999988 999999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      ||+++......      ...++..|+|||++.+..++.++||||+||++|||++|+.||.....+..+...+.... ...
T Consensus       154 fg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~  226 (267)
T PHA03390        154 YGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK  226 (267)
T ss_pred             CccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc
Confidence            99987654321      23688999999999998999999999999999999999999974433322222222211 000


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-MRDVVRQ 1096 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~ 1096 (1109)
                        . .             ........+.+++.+|++.+|.+||+ ++|+++|
T Consensus       227 --~-~-------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        227 --L-P-------------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             --C-C-------------cccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence              0 0             01122344667778999999999996 6999875

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=1.8e-31  Score=307.21  Aligned_cols=269  Identities=20%  Similarity=0.244  Sum_probs=197.3

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC-----
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-----  888 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  888 (1109)
                      ...++|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.++++++|+||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            3457899999999999999999966 468999999885322 223345677899999999999999999988643     


Q ss_pred             -CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          889 -DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       889 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                       ...++||||++ ++|.+.+...     +++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence             24699999996 4888887542     788899999999999999999   8899999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      +++.......   .....++..|+|||.+.+..++.++||||+||++|+|++|+.||...... ................
T Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  239 (353)
T cd07850         164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLGTPSDE  239 (353)
T ss_pred             cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCHH
Confidence            9986643221   22346788999999999999999999999999999999999998643211 1111111100000000


Q ss_pred             -----------------------cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1048 -----------------------INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1048 -----------------------~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                             .......................++.+++.+|++.||++||++.|++++=
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~  312 (353)
T cd07850         240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP  312 (353)
T ss_pred             HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence                                   00000000000000000112234567788899999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=2.2e-31  Score=291.06  Aligned_cols=250  Identities=27%  Similarity=0.379  Sum_probs=200.6

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .|...+.||+|++|.||+|... +++.+++|++..... .....+.+|++++++++|++++++++++......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            3677889999999999999775 688999999854332 35568899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++++|.+++....  ..+++..+..++.|+++|++|||   ..+++||||+|+||++++++.++|+|||.+........ 
T Consensus        80 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          80 SGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            9999999987642  35899999999999999999999   89999999999999999999999999999987654321 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......     ........  ........     
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~--~~~~~~~~-----  219 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIAT--NGPPGLRN-----  219 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHh--cCCCCcCc-----
Confidence              23356889999999998888999999999999999999999998643211     11100000  00000000     


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                            ......++.+++.+|++.||++||++.|++++
T Consensus       220 ------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 ------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  00012346678889999999999999999876

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-31  Score=298.45  Aligned_cols=268  Identities=22%  Similarity=0.328  Sum_probs=197.0

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      |+..+.||+|++|.||+|... +|+.||+|++...... .....+.+|++++++++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999764 7899999998654322 23456889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      + ++|.+++..... ..+++..+..++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||.++....... 
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-  154 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-  154 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence            5 699999876442 35899999999999999999999   88999999999999999999999999999976533211 


Q ss_pred             ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc-cc-cchh
Q 001275          979 TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN-DI-VDLS 1055 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~d~~ 1055 (1109)
                       ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..... ........+.......... .. ..+.
T Consensus       155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-IDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChHHhhhhhhchh
Confidence             11223568899999987664 568899999999999999999999864321 1111111111110000000 00 0000


Q ss_pred             hhHH-------hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1056 LMEE-------MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~-------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ....       ...........++.+++.+|++.||++||+++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0000       0000011122456778889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=1.9e-31  Score=301.39  Aligned_cols=272  Identities=24%  Similarity=0.332  Sum_probs=198.0

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-ChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  893 (1109)
                      .++|+..+.||+|+||.||+|... +|+.||+|++....... ....+.+|++++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            367889999999999999999764 58999999986443222 234567899999999999999999998754  45799


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++ +|.+++....  ..+++..+..++.|+++|++|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 8988887543  35899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-cccc-cc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-TEEI-ND 1050 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~-~~ 1050 (1109)
                      ....  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.....  ......+...... .... ..
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IEQLDLIIQLLGTPNESIWPG  235 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCCCChhhchh
Confidence            4321  1222346788999998865 4578999999999999999999999864321  1111111111110 0000 00


Q ss_pred             ccc------hhhhHH---hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1051 IVD------LSLMEE---MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1051 ~~d------~~~~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ..+      ......   ...........++.+++.+|++.||++||+++|+++|-+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence            000      000000   0000001123456678889999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=5.7e-31  Score=290.02  Aligned_cols=246  Identities=22%  Similarity=0.312  Sum_probs=195.9

Q ss_pred             eecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          827 IGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      ||+|+||.||+|... +++.||+|.+.....  ......+.+|++++++++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999775 488999999854332  23456789999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeee
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS  983 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  983 (1109)
                      .+++....   .+++..+..++.|+++|++|+|   +.+++|+||+|+||+++.++.++|+|||.+.......   ....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            99997643   3789999999999999999999   8999999999999999999999999999998764432   1223


Q ss_pred             cccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          984 VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       984 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.....+.   .............. .         .   
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~-~---------~---  215 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKL-E---------F---  215 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHHhccCCCC-C---------C---
Confidence            468889999999988889999999999999999999999986543211   11111111000000 0         0   


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLV 1098 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~ 1098 (1109)
                       ......++.+++.+||+.+|++||+     ++|+++|-+
T Consensus       216 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~  254 (262)
T cd05572         216 -PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW  254 (262)
T ss_pred             -CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence             0011345777888999999999999     888887544

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=4.7e-31  Score=299.11  Aligned_cols=252  Identities=27%  Similarity=0.394  Sum_probs=195.7

Q ss_pred             CCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          821 LNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      |...+.||+|+||.||+|.. .++..||+|++.....  ......+.+|++++++++|+|++++++++..++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            66778899999999999976 4688999998854322  22345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++ |++.+++....  ..+++..+..++.++++|+.|||   +.+|+||||+|+||+++.++.++|+|||++......  
T Consensus       107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            97 48888775432  34899999999999999999999   899999999999999999999999999998754322  


Q ss_pred             CceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                          ....++..|+|||++.   .+.++.++|||||||++|||++|+.||...... .....+..    ....  .    
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~----~~~~--~----  243 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ----NESP--T----  243 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh----ccCC--C----
Confidence                1246888999999874   456789999999999999999999998643111 11111110    0000  0    


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVP 1103 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1103 (1109)
                              .........+.+++.+|++.+|++||++.|++++.......
T Consensus       244 --------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         244 --------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             --------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                    00011223466788899999999999999999988765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=1e-31  Score=300.55  Aligned_cols=257  Identities=26%  Similarity=0.328  Sum_probs=192.9

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|...++||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555678999999999999664 589999999865444445567889999999996 99999999999988899999999


Q ss_pred             ccCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          898 MENGSLRDVLHSI--TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       898 ~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ++. ++.++....  .....+++..+..++.++++|++|||+  +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 655543211  112458999999999999999999992  258999999999999999999999999999765432


Q ss_pred             CCCceeeecccCcccccccccccC---CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAFTT---AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ..   .....|+..|+|||++.+.   .++.++||||+||++|||++|+.||....    .............       
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~~~~~~-------  227 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQVVKGD-------  227 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhhhcCCC-------
Confidence            21   1223688899999988776   68999999999999999999999986432    1111111111100       


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .+.+..    ........++.+++.+|++.+|++||+++|++++-
T Consensus       228 ~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~  268 (288)
T cd06616         228 PPILSN----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP  268 (288)
T ss_pred             CCcCCC----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            000000    00012234567788899999999999999999873

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-31  Score=295.02  Aligned_cols=267  Identities=24%  Similarity=0.318  Sum_probs=198.3

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeEEEE
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGIIMYR  896 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  896 (1109)
                      |+..+.||+|+||.||+|... +++.+|+|++.... .......+.+|++++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566788999999999999775 58899999996553 233345788999999999999999999999887  78999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++ +|.+++....  ..+++..++.++.|+++|++|||   +.+++|+||+|+||++++++.+||+|||.+.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 8988886542  35899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             CCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc--cccccccc
Q 001275          977 ASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT--EEINDIVD 1053 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d 1053 (1109)
                      . .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......  .....+.......  .......+
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL--EQLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCchhhcccccc
Confidence            1 12223457889999997765 45789999999999999999999998653321  1111111111000  00000000


Q ss_pred             --------h-hhhHHhhhchhHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1054 --------L-SLMEEMLVSSIRD-QVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1054 --------~-~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                              + ............. ...++.+++.+|++.+|++||+++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                    0 0000000001111 24567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=285.62  Aligned_cols=269  Identities=17%  Similarity=0.227  Sum_probs=214.6

Q ss_pred             HHHHHhhCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEe
Q 001275          813 QVIEATENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL  886 (1109)
Q Consensus       813 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  886 (1109)
                      ++.....+++....+-+|.||.||+|.+      .+.+.|.||.++....+.....+..|.-.+..+.|||+..+.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            3334446677788899999999999954      3445677887766666666778889999999999999999999986


Q ss_pred             cC-CceeEEEEeccCCCHHHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc
Q 001275          887 RK-DCGIIMYRYMENGSLRDVLHSI-----TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME  960 (1109)
Q Consensus       887 ~~-~~~~lv~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  960 (1109)
                      +. +..+++|.++.-|+|..|+...     ..+..++..+...++.|++.|++|||   +.+|||.||.++|.++|+.-+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence            54 5678999999999999999832     23446788889999999999999999   999999999999999999999


Q ss_pred             EEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHH
Q 001275          961 PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      +|++|=.+++.+-..++..-..+...+..||+||.+.+..|+.++|||||||++|||+| |+.|+..-..  .+...++.
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--fEm~~ylk  512 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--FEMEHYLK  512 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--HHHHHHHh
Confidence            99999999998877766655556677889999999999999999999999999999998 7777643211  11111111


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCC
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPM 1104 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1104 (1109)
                      .    ...              ....-+++.+++.++.-||..+|++||+++|++.-|.++..+.
T Consensus       513 d----GyR--------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  513 D----GYR--------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             c----cce--------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            1    100              0112245667888999999999999999999999999985543

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=3.7e-31  Score=299.35  Aligned_cols=271  Identities=20%  Similarity=0.279  Sum_probs=194.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCc-----
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC-----  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  890 (1109)
                      .++|+..++||+|+||.||+|... +++.||||++...... .....+.+|++++++++||||+++++++...+.     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357889999999999999999764 6899999988544322 223456789999999999999999999876543     


Q ss_pred             ---eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          891 ---GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       891 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                         .++||||+++ ++.+++....  ..+++.++..++.|+++|++|||   +.+++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence               4999999975 8888876532  34899999999999999999999   8899999999999999999999999999


Q ss_pred             CCcccCCCCCC--ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          968 IAKLLDKSPAS--TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       968 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      ++.........  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||......  .....+......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~--~~~~~~~~~~~~  242 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ--HQLTLISQLCGS  242 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCC
Confidence            99866433221  112234678899999987664 4688999999999999999999988643221  111111111110


Q ss_pred             c--cccccc-----cc----hhhhHHhhhch--hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1045 T--EEINDI-----VD----LSLMEEMLVSS--IRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1045 ~--~~~~~~-----~d----~~~~~~~~~~~--~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .  ......     .+    +..........  .......+.+++.+|++.||++||+++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0  000000     00    00000000000  00012345678899999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=5.3e-31  Score=292.85  Aligned_cols=246  Identities=24%  Similarity=0.264  Sum_probs=186.0

Q ss_pred             eeecccCeEEEEEEe-CCCcEEEEEEeeecccc--cChHHHHHHHHHHh---cCCCCceeeEeeEEecCCceeEEEEecc
Q 001275          826 VIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--RGSLSMKREIQTIG---KIRHRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       826 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      .||+|+||.||++.. .+++.+|+|.+......  .....+.+|..+++   ..+|++|+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999976 46889999988544322  12233444544333   3479999999999999899999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +|+|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++++|||++........  
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            999999987543   4899999999999999999999   89999999999999999999999999999875533211  


Q ss_pred             eeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          980 TSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                        ....|+..|+|||...+ ..++.++||||+||++|||++|+.||........  ..........        ...+  
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~--------~~~~--  218 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTV--------NVEL--  218 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhcC--------CcCC--
Confidence              22468999999998864 5679999999999999999999999964322111  1110000000        0000  


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLVD 1099 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~~ 1099 (1109)
                            ......++.+++.+|++.||++||     +++|+++|-..
T Consensus       219 ------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~  258 (279)
T cd05633         219 ------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF  258 (279)
T ss_pred             ------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence                  011223566677899999999999     69999998543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=3.4e-31  Score=297.40  Aligned_cols=254  Identities=25%  Similarity=0.371  Sum_probs=194.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|+..+.||+|+||.||+|.... ++.||||.+...........+.+|+.++.+.. |+||+++++++......++|||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            567888999999999999998765 89999999865443444556777887777774 9999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      |++ +++.++.....  ..+++..+.+++.|+++|++|||   + .+|+||||+|+||++++++.+||+|||++......
T Consensus        95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            986 47777765533  25899999999999999999999   5 58999999999999999999999999998765432


Q ss_pred             CCCceeeecccCcccccccccccCC----CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTA----KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ..   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.....+.    ...........  ...
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~--~~~  239 (296)
T cd06618         169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----EVLTKILQEEP--PSL  239 (296)
T ss_pred             Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----HHHHHHhcCCC--CCC
Confidence            21   12235788999999887554    7899999999999999999999986432111    11111111100  000


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..           ......++.+++.+|++.||++||++++++++-+
T Consensus       240 ~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         240 PP-----------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             CC-----------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence            00           0012234677888999999999999999998865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=7.7e-31  Score=288.10  Aligned_cols=253  Identities=28%  Similarity=0.384  Sum_probs=202.9

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGIIMY  895 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  895 (1109)
                      +|...+.||+|++|.||+|... +++.|++|++..... ......+.+|++++++++|+||+++++++...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677889999999999999776 688999998854332 23456789999999999999999999999988  8899999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++....   .+++..+..++.|+++|++|||   +.+++|+|++|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999997644   5899999999999999999999   899999999999999999999999999999876544


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..........++..|+|||...+..++.++||||+|+++|+|++|+.||.....    .......... ......+    
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-~~~~~~~----  225 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGS-SGEPPEI----  225 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccc-cCCCcCC----
Confidence            321122345788999999999888899999999999999999999999865431    1111111110 0000000    


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                               ......++.+++.+|++.+|++||++.|++++
T Consensus       226 ---------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         226 ---------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ---------CcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                     01113456778889999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=4.3e-31  Score=299.35  Aligned_cols=269  Identities=19%  Similarity=0.209  Sum_probs=193.2

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEeeec-ccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKLAFR-GHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      +.+|.|+++.||++.. +++.||+|++... ........+.+|++++++++|+||+++++++...+..+++|||+++|+|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3345555555555544 6899999998654 2344566899999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC-----
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS-----  978 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-----  978 (1109)
                      .+++.... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+|++|||.+.........     
T Consensus        87 ~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          87 EDLLKTHF-PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence            99997643 234788999999999999999999   899999999999999999999999999988755322111     


Q ss_pred             ceeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC----c------c
Q 001275          979 TTSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD----T------E 1046 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~------~ 1046 (1109)
                      .......++..|+|||++..  ..++.++|||||||++|||++|+.||....... ............    .      .
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-MLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCccccccCchhhhcC
Confidence            11123457788999998866  357899999999999999999999996432111 111111100000    0      0


Q ss_pred             ccc----cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1047 EIN----DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1047 ~~~----~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ...    ...++................++.+++.+||+.||++||+++|++++-.-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence            000    00011111111111112233567788899999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=5.8e-31  Score=292.50  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=191.7

Q ss_pred             eecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          827 IGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      ||+|+||+||+|.. .+++.||+|.+.....  ......+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999965 4688999998854321  22344567899999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeee
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS  983 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  983 (1109)
                      .+++..... ..+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++++|||.+......   .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence            999976442 35899999999999999999999   899999999999999999999999999998765432   11223


Q ss_pred             cccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          984 VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       984 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      ..++..|+|||+..+..++.++||||+||++|+|++|+.||....... ...............             .  
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-------------~--  217 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLEMAVE-------------Y--  217 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcccccccc-------------C--
Confidence            467889999999988889999999999999999999999986542211 111111100000000             0  


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQ 1096 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1096 (1109)
                       ......++.+++.+||+.+|++||     ++.++++|
T Consensus       218 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         218 -PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             -CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence             011133456778899999999999     77778765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=4.3e-32  Score=276.51  Aligned_cols=206  Identities=28%  Similarity=0.391  Sum_probs=171.5

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC---C--CcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEec-CC
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG---P--NAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLR-KD  889 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  889 (1109)
                      --..|+....||+|.||.||+|...   +  ...+|+|+++-..+. .-....-+|+..++.++||||+.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3457889999999999999999332   2  237899988544332 224567899999999999999999999887 67


Q ss_pred             ceeEEEEeccCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC----CcEEE
Q 001275          890 CGIIMYRYMENGSLRDVLHSITP--PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE----MEPHI  963 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl  963 (1109)
                      ..++++||.+. +|..+++.++.  ...++...+..|+.||+.|+.|||   ++=|+||||||.|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            88999999997 89998865432  346888999999999999999999   8889999999999999877    89999


Q ss_pred             ecccCCcccCCCCCCc-eeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          964 SDFGIAKLLDKSPAST-TSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                      +|||+++.+...-... .....+.|..|+|||.+.+. .||.+.|||+.|||+.||+|-++.|..
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            9999999886543322 34557889999999988875 579999999999999999999888754

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=4.1e-31  Score=296.05  Aligned_cols=259  Identities=17%  Similarity=0.188  Sum_probs=181.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCC----cEEEEEEeeecccccCh----------HHHHHHHHHHhcCCCCceeeEeeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPN----AVFAVKKLAFRGHKRGS----------LSMKREIQTIGKIRHRNLVRLEDF  884 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~l~~~  884 (1109)
                      .+|.+.++||+|+||+||+|...++    ..+|+|...........          .....+...+..++|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5788999999999999999977543    45566643222111100          112233445667789999999997


Q ss_pred             EecCC----ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc
Q 001275          885 WLRKD----CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME  960 (1109)
Q Consensus       885 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  960 (1109)
                      +....    ..++++|++.. ++.+.+....   ..++..+..++.|+++|++|||   +.+|+||||||+||+++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence            66543    33677777643 6666665432   2567888999999999999999   899999999999999999999


Q ss_pred             EEEecccCCcccCCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHH
Q 001275          961 PHISDFGIAKLLDKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV 1035 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 1035 (1109)
                      ++|+|||+|+.+......     .......||+.|+|||+..+..++.++||||+||++|||++|+.||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            999999999866422111     111234699999999999999999999999999999999999999965422211111


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ......+      ..+...    ...   .......+.+++..|++.+|++||+++++++.+
T Consensus       245 ~~~~~~~------~~~~~~----~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 AAKCDFI------KRLHEG----KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HhHHHHH------HHhhhh----hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0000000      000000    000   112234566788899999999999999999876

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=4.4e-31  Score=296.24  Aligned_cols=271  Identities=23%  Similarity=0.322  Sum_probs=195.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|+..+.||+|++|+||+|... +++.||+|++..... ......+.+|++++++++|+||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999765 688999998854332 2334568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcEEEecccCCcccCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~  975 (1109)
                      |++ +++.+++.... ....++..+..++.|++.||+|||   +.+|+||||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 58888876533 234678888899999999999999   889999999999999985 567999999999755332


Q ss_pred             CCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc-------
Q 001275          976 PASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE------- 1047 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 1047 (1109)
                      .  .......+++.|+|||++.+. .++.++||||+||++|+|+||+.||...... ................       
T Consensus       157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhcccccc
Confidence            1  111224578899999988664 5789999999999999999999998643211 1111111111110000       


Q ss_pred             cccccc--hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1048 INDIVD--LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1048 ~~~~~d--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ..+...  +................++.+++.+|++.+|++||++.|++++=
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~  285 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE  285 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            000000  00000000000111234467788899999999999999999863

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.9e-31  Score=292.85  Aligned_cols=251  Identities=23%  Similarity=0.357  Sum_probs=198.4

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|...+.||+|+||.||+|... ++..+|+|.+..... ......+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4777889999999999999765 578899998854322 23445788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~  976 (1109)
                      +++++|.+++.... ...+++..+..++.|+++|++|||   +.+++|+||||+||++++++ .+|++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999997633 235799999999999999999999   88999999999999998885 46999999998664322


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      .  ......|++.|+|||+..+..++.++||||||+++|||++|+.||....     ...++.......  .... .   
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~--~~~~-~---  223 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQGY--FAPI-S---  223 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhccc--CCCC-C---
Confidence            1  1122468899999999988889999999999999999999999985431     112222111110  0000 0   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                               .....++.+++.+|++.+|++||++.|++++
T Consensus       224 ---------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         224 ---------PNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---------CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                     1112346677889999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.7e-31  Score=298.34  Aligned_cols=253  Identities=23%  Similarity=0.259  Sum_probs=204.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccccc-ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ...|...+.||+|.|++|..|+. .+++.||+|.+.+..... ..+.+.+|+++|+.++|||||+++.+.......|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            35688899999999999999965 569999999886554333 2345889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+.+|.+++|+..++.   .....+..++.|+..|++|+|   ++.|||||||++||+++.+..+||+|||++.++...
T Consensus       135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999988664   555788899999999999999   999999999999999999999999999999988644


Q ss_pred             CCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..   ....+|++.|.|||++.+.+| ++++|+||+|+++|.++.|..||+...-..     .          -+.++-.
T Consensus       209 ~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----L----------r~rvl~g  270 (596)
T KOG0586|consen  209 LM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----L----------RPRVLRG  270 (596)
T ss_pred             cc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----c----------cchheee
Confidence            33   344799999999999999888 789999999999999999999998542110     0          0000011


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      +..-..   ...   .+.-+++.+++-.+|.+|++++++.++-+..
T Consensus       271 k~rIp~---~ms---~dce~lLrk~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  271 KYRIPF---YMS---CDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             eecccc---eee---chhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence            110000   011   2233466789999999999999999987654

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=5.1e-31  Score=297.00  Aligned_cols=272  Identities=23%  Similarity=0.314  Sum_probs=198.1

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCC----
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD----  889 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  889 (1109)
                      .+.++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34578999999999999999999775 588999999865432 233456788999999999999999999987654    


Q ss_pred             ------ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          890 ------CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       890 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                            ..++|+||+++ ++.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence                  78999999986 777777653  235899999999999999999999   899999999999999999999999


Q ss_pred             ecccCCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          964 SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      +|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... . .....+....
T Consensus       158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~-~~~~~~~~~~  234 (302)
T cd07864         158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-L-AQLELISRLC  234 (302)
T ss_pred             CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-H-HHHHHHHHHh
Confidence            99999986644322 11122356788999998765 3568999999999999999999999864321 1 1111111111


Q ss_pred             cCc--ccccccc--------chhhh-HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1043 SDT--EEINDIV--------DLSLM-EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1043 ~~~--~~~~~~~--------d~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...  .....+.        ++... ..............+.+++.+|++.+|.+||+++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            100  0000000        00000 000000001123457788889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=2.6e-31  Score=303.62  Aligned_cols=274  Identities=21%  Similarity=0.289  Sum_probs=199.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEec----CCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLR----KDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  891 (1109)
                      .++|...+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            46888999999999999999965 4689999999864332 2345567889999999999999999988753    3457


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++|+||+. |+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 58999886533   3899999999999999999999   89999999999999999999999999999976


Q ss_pred             cCCCCCC--ceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc-c
Q 001275          972 LDKSPAS--TTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE-E 1047 (1109)
Q Consensus       972 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 1047 (1109)
                      .......  .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+............ .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-HQLKLILSVLGSPSEEV  235 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-HHHHHHHHHhCCChhHh
Confidence            5433221  11123478899999998765 45799999999999999999999999643211 111111110000000 0


Q ss_pred             cccccchhhhH---Hh-------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1048 INDIVDLSLME---EM-------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1048 ~~~~~d~~~~~---~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .....+.....   ..       .....+....++.+++.+|++.+|++||+++|++++-+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~  297 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL  297 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence            00000000000   00       000011234567888899999999999999999997654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=5.9e-31  Score=293.49  Aligned_cols=266  Identities=23%  Similarity=0.346  Sum_probs=196.6

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEEEec
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      |.+.+.||+|+||+||+|... +++.||+|++.............+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            566788999999999999875 578899998854433333445567999999998 999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                       +|+|.+++.... ...+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             789999887643 235899999999999999999999   89999999999999999999999999999986643222 


Q ss_pred             ceeeecccCcccccccccc-cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc--------Cccccc
Q 001275          979 TTSISVVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS--------DTEEIN 1049 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 1049 (1109)
                        .....++..|+|||++. ...++.++|+||||+++|||++|+.||....... .. ........        ......
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QL-YKICSVLGTPTKQDWPEGYKLA  230 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HH-HHHHHhcCCCChhhhhhHhhhh
Confidence              12346788999999775 4457899999999999999999998885432111 11 10000000        000000


Q ss_pred             cccchhhhH---HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1050 DIVDLSLME---EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1050 ~~~d~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...+.....   ............++.+++.+||+.+|++||+++|++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000   00000011113567889999999999999999999876

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=2.4e-31  Score=304.11  Aligned_cols=268  Identities=23%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-----c
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-----C  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~  890 (1109)
                      .++|...+.||+|+||+||+|.. .+++.||||.+.... .......+.+|+.+++.++|+||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45788899999999999999965 468999999885432 2333456778999999999999999999876542     4


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++|+||+. ++|.+++...   ..+++..+..++.|+++|++|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 6899888753   34899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC--ccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD--TEE 1047 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~ 1047 (1109)
                      ......  .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... .. ...........  ...
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~-~~~~~~~~~~~~~~~~  232 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VH-QLKLITELLGSPSEED  232 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HH-HHHHHHHHhCCCChHH
Confidence            664332  12223467889999998765 4688999999999999999999999854321 11 11111111110  000


Q ss_pred             cccccchhhhHHh----------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1048 INDIVDLSLMEEM----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...+.+.......          ..........++.+++.+|++.+|++||+++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            0000010000000          000011233557788999999999999999999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.6e-31  Score=319.51  Aligned_cols=276  Identities=19%  Similarity=0.277  Sum_probs=188.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC--CcEEEEEE--------------eee--cccccChHHHHHHHHHHhcCCCCcee
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP--NAVFAVKK--------------LAF--RGHKRGSLSMKREIQTIGKIRHRNLV  879 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~E~~~l~~l~h~niv  879 (1109)
                      .++|++.++||+|+||+||+|..+.  +..+++|.              +..  .........+.+|++++++++|+|||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            4689999999999999999986532  22222221              100  11112234678999999999999999


Q ss_pred             eEeeEEecCCceeEEEEeccCCCHHHHHhccCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC
Q 001275          880 RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP--PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS  957 (1109)
Q Consensus       880 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~  957 (1109)
                      ++++++...+..|+|+|++. +++.+++.....  ........+..++.|++.||+|||   +.+||||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            99999999999999999985 578777754221  122345667789999999999999   899999999999999999


Q ss_pred             CCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcc--ccccHH
Q 001275          958 EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYK--ERTDIV 1035 (1109)
Q Consensus       958 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~--~~~~~~ 1035 (1109)
                      ++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++.....  ....+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999987643322 122235799999999999999999999999999999999999865432211  111122


Q ss_pred             HHHHHhhcCcccccc-------ccchhhhH---HhhhchhH--HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1036 GWVRSVWSDTEEIND-------IVDLSLME---EMLVSSIR--DQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~-------~~d~~~~~---~~~~~~~~--~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..+.........+.+       .++.....   ........  ....++.+++.+|++.||++||++.|+++|-.
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~  456 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL  456 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence            221111100000000       00000000   00000000  01134566778999999999999999998754

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=290.87  Aligned_cols=267  Identities=25%  Similarity=0.311  Sum_probs=195.7

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-ChHHHHHHHHHHhcC---CCCceeeEeeEEecCCc-----
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKI---RHRNLVRLEDFWLRKDC-----  890 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  890 (1109)
                      |++.+.||+|+||.||+|+.. +++.||+|++....... ....+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999876 48999999986443322 234566788777666   59999999999988776     


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .+++|||+.+ +|.+++..... ..+++..+..++.|+++||+|||   +.+++|+|++|+||+++.++.+||+|||.+.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999974 89998876432 35899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc---c
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE---E 1047 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 1047 (1109)
                      ........   ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ......+.........   .
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcC
Confidence            76433221   223578899999999999999999999999999999999988864321 1112222111110000   0


Q ss_pred             cccccchhhh----HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1048 INDIVDLSLM----EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1048 ~~~~~d~~~~----~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..........    ..............+.+++.+||+.||++||+++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            0000000000    000001112233566778899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=4.8e-31  Score=294.15  Aligned_cols=267  Identities=22%  Similarity=0.327  Sum_probs=198.8

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      |...+.||+|++|.||+|... +++.+|+|++...... .....+.+|++++++++|+||+++++++..++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566788999999999999764 6889999988544322 33567889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++ ++.+++....  ..+++..+..++.|+++|++|||   +.+|+|+||||+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            75 8888887633  35899999999999999999999   8999999999999999999999999999998665432  


Q ss_pred             ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-ccccccccc---
Q 001275          979 TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-TEEINDIVD--- 1053 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d--- 1053 (1109)
                      .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ............. ........+   
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhh
Confidence            112234678899999988776 7899999999999999999999988543211 1111111110000 000000000   


Q ss_pred             ---hhhhH---HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1054 ---LSLME---EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1054 ---~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                         .....   ............++.+++.+||+.||.+||++.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence               00000   00000112234567889999999999999999999876

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=5.8e-31  Score=299.88  Aligned_cols=270  Identities=18%  Similarity=0.250  Sum_probs=193.2

Q ss_pred             ceeecc--cCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRG--AHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ..||+|  +||+||+|.. .+++.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  9999999976 478999999885433 223346788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |++.+++..... ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.++++||+.+...........
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999999876432 34889999999999999999999   89999999999999999999999999986543322111110


Q ss_pred             -----eeecccCcccccccccccC--CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc-------
Q 001275          981 -----SISVVGTIGYIAPENAFTT--AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE------- 1046 (1109)
Q Consensus       981 -----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 1046 (1109)
                           .....++..|+|||++.+.  .++.++||||+||++|||++|+.||....... ..............       
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ-MLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH-HHHHHhcCCCCCCccccccch
Confidence                 1112356679999998764  46899999999999999999999986542211 11111000000000       


Q ss_pred             ----------ccc-cccchh--------hh-HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1047 ----------EIN-DIVDLS--------LM-EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1047 ----------~~~-~~~d~~--------~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                                ... .+.+..        .. ..............+.+++.+|++.||++|||++|++++-+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                      000 000000        00 000001112344567889999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=2.7e-31  Score=291.48  Aligned_cols=250  Identities=24%  Similarity=0.346  Sum_probs=200.6

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|+..++||+|+||.||++.. .+++.+|+|++.... .......+.+|++++++++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999965 467899999885433 233455678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      +++++|.+++.... ....+++..++.++.|+++|++|||   +.+++||||+|+||++++++.+|++|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            99999999986632 2345899999999999999999999   8999999999999999999999999999998765431


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                          .....++..|+|||...+..++.++|+||+|+++||+++|+.||......     ........  ......     
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~--~~~~~~-----  221 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYKVQR--GKYPPI-----  221 (256)
T ss_pred             ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhc--CCCCCC-----
Confidence                12246888999999999999999999999999999999999998643211     11111100  000000     


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                              ......++.+++.+|++.+|++||++.|++++
T Consensus       222 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 --------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --------chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                    11223457778889999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=3.1e-31  Score=303.45  Aligned_cols=270  Identities=26%  Similarity=0.338  Sum_probs=196.7

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeec-ccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC--ce
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFR-GHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD--CG  891 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~--~~  891 (1109)
                      ..++|...+.||+|+||.||+|... +++.+|+|++... ........+.+|+.+++++ +|+||+++++++...+  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3467888899999999999999765 5889999988432 2223345677899999999 9999999999986543  57


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||++ ++|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5999988753    4789999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCC---ceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc--
Q 001275          972 LDKSPAS---TTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-- 1045 (1109)
Q Consensus       972 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 1045 (1109)
                      .......   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ...... ......  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~-~~~~~~~~  234 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKII-EVIGPPSA  234 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-HHhCCCCH
Confidence            6433221   12233568999999998765 457899999999999999999999985432211 111110 000000  


Q ss_pred             ccc--------ccccchh--hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1046 EEI--------NDIVDLS--LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1046 ~~~--------~~~~d~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...        ..+.+..  ...............++.+++.+||+.||++||++.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000        0000000  00000000011123567788899999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-33  Score=328.84  Aligned_cols=257  Identities=28%  Similarity=0.374  Sum_probs=199.7

Q ss_pred             hhCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +-++.....||.|.||.||.| ..++|+..|+|-+.... .......+.+|..++..++|||+|+++|+-.+.+..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            356777889999999999999 45678999999875432 2344567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      |||++|+|.+.+...+   ..++.....+..|++.|++|||   +.+||||||||.||+++.+|.+|++|||.|..+...
T Consensus      1314 EyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999987643   2556666778899999999999   899999999999999999999999999999987654


Q ss_pred             C--CCceeeecccCcccccccccccCC---CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          976 P--ASTTSISVVGTIGYIAPENAFTTA---KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       976 ~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .  .........||+.|||||++.+..   ...++||||+|||+.||+||+.||.....+ ..++.-|..   ..     
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-~aIMy~V~~---gh----- 1458 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-WAIMYHVAA---GH----- 1458 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-hHHHhHHhc---cC-----
Confidence            2  122334578999999999998654   467899999999999999999999643222 112111110   00     


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                        .|.+.+     ....+-.+   ++..|++.||++|.++.|++++=..
T Consensus      1459 --~Pq~P~-----~ls~~g~d---Fle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1459 --KPQIPE-----RLSSEGRD---FLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             --CCCCch-----hhhHhHHH---HHHHHHhcCchhhhHHHHHHHhhcc
Confidence              011111     12223333   5559999999999999999887543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=7.3e-31  Score=288.12  Aligned_cols=252  Identities=24%  Similarity=0.385  Sum_probs=202.4

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|...+.||+|+||.||++... +++.||+|++..... ......+.+|++++++++|+|++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999765 688999999855432 24556788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      +++++|.+++.... ....+++..+..++.+++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997642 1346899999999999999999999   8899999999999999999999999999998664432


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                        .......|++.|+|||...+..++.++||||+|+++|+|++|+.||....     ............  ...+     
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~~~~~--~~~~-----  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKILKGQ--YPPI-----  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHHhcCC--CCCC-----
Confidence              12223468889999999988889999999999999999999999986432     111111111100  0000     


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                           .   .....++.+++.+|++.+|++||++.|++++
T Consensus       224 -----~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 -----P---SQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -----C---CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 0   0112346678889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1e-30  Score=292.46  Aligned_cols=247  Identities=23%  Similarity=0.364  Sum_probs=194.1

Q ss_pred             CceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCC
Q 001275          824 KHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      ..+||+|+||.||+|.. .+++.||+|++... .......+.+|+.++++++|+|++++++++...+..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            35699999999999976 46899999987432 23345568899999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceee
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI  982 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  982 (1109)
                      |.+++...    .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||++.......  ....
T Consensus       104 L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~  174 (292)
T cd06657         104 LTDIVTHT----RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK  174 (292)
T ss_pred             HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence            99987542    3789999999999999999999   8899999999999999999999999999987554321  1223


Q ss_pred             ecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhh
Q 001275          983 SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062 (1109)
Q Consensus       983 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 1062 (1109)
                      ...++..|+|||...+..++.++||||+||++|+|++|+.||......  ...........  .....            
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~--~~~~~------------  238 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP--PKLKN------------  238 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCC--cccCC------------
Confidence            356889999999998888899999999999999999999998643211  11111111000  00000            


Q ss_pred             chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1063 SSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1063 ~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                        ......++.+++.+|++.+|.+||++.|++++=.
T Consensus       239 --~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~  272 (292)
T cd06657         239 --LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  272 (292)
T ss_pred             --cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence              0111234556778999999999999999998633

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-30  Score=283.91  Aligned_cols=249  Identities=28%  Similarity=0.440  Sum_probs=199.1

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|...+.||+|++|.||+|... +++.||+|.+...... .....+.+|++++++++|+|++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999665 6789999998544321 3446789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++...   ..+++..+..++.|++.|+.|||   +.+|+||||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999998764   34899999999999999999999   89999999999999999999999999999987654322


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .  .....++..|+|||...+..++.++||||+|+++|+|++|+.||.....    ............   ... .    
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~---~~~-~----  220 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQDDH---PPL-P----  220 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhccCC---CCC-C----
Confidence            1  2234688899999998888889999999999999999999999864321    111111100000   000 0    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                              ......+.+++.+|++.+|++||++.|++.+
T Consensus       221 --------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         221 --------EGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --------CCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                    0112345667889999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=267.45  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=195.5

Q ss_pred             CCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEEEecc
Q 001275          822 NAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      .....||.|.-|.||+++.. .|...|||.+......+..+++...++++..-+ .|.||+.+|||..+....+.||.|.
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs  174 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS  174 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence            34456999999999999765 589999999988777778888888888887775 8999999999999999999999985


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      . ..+..++....  ++++...-++...+..||.||.+  +.+|+|||+||+|||+|+.|.+|++|||.+-.+.+.... 
T Consensus       175 ~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-  248 (391)
T KOG0983|consen  175 T-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-  248 (391)
T ss_pred             H-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence            3 45566655443  37888888999999999999985  678999999999999999999999999999877544332 


Q ss_pred             eeeecccCccccccccccc---CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          980 TSISVVGTIGYIAPENAFT---TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                        ....|-+.|||||-+.-   ..|+.++||||||+.++|+.||+.||.....+-..+...    ..++       .+.+
T Consensus       249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv----ln~e-------PP~L  315 (391)
T KOG0983|consen  249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV----LNEE-------PPLL  315 (391)
T ss_pred             --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH----HhcC-------CCCC
Confidence              23468889999997753   467899999999999999999999996543221111111    1111       1111


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ....      ....++.+++..|++.|+.+||...++++|=
T Consensus       316 ~~~~------gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  316 PGHM------GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             Cccc------CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            1111      1345577788899999999999999998874

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2e-30  Score=290.32  Aligned_cols=253  Identities=24%  Similarity=0.294  Sum_probs=194.6

Q ss_pred             CCCCCceeecccCeEEEEEEe----CCCcEEEEEEeeeccc---ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          820 NLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGH---KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      +|++.+.||+|+||.||+|..    .+|+.||+|++.....   ......+.+|++++.++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477788999999999999975    3688999999854321   22345678899999999 699999999999988899


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++|+||+++++|.+++....   .+++..+..++.|+++|++|||   +.+++||||+|+||++++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999997643   4788899999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCCceeeecccCcccccccccccC--CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTT--AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      ...... .......|+..|+|||...+.  .++.++||||||+++|+|++|+.||..... ......+........... 
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~-  231 (290)
T cd05613         155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSEPPY-  231 (290)
T ss_pred             cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccCCCC-
Confidence            543221 112234688999999988753  467899999999999999999999853211 111122221111111000 


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQ 1096 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1096 (1109)
                                     .......+.+++.+|++.||++||     ++++++++
T Consensus       232 ---------------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         232 ---------------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---------------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                           011223456678899999999997     77888776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=3.7e-31  Score=291.79  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=192.9

Q ss_pred             eecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          827 IGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      ||+|+||.||+|... +++.+|+|.+.....  ......+.+|++++++++|+||+++++.+..++..++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 489999998854322  23456788999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC------
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA------  977 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~------  977 (1109)
                      .++++...   .+++..+..++.|+++||+|||   +.+++||||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997643   4899999999999999999999   89999999999999999999999999999875533211      


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      ........++..|+|||...+..++.++||||||+++|++++|+.||......     .............         
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~---------  220 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGKIEW---------  220 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCcCC---------
Confidence            11223356788999999998888999999999999999999999998643211     1111111100000         


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                           .........+.+++.+|++.+|++||++.++.+.+.
T Consensus       221 -----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 -----PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -----CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                 000001345667888999999999999955554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-30  Score=299.45  Aligned_cols=274  Identities=21%  Similarity=0.261  Sum_probs=199.8

Q ss_pred             cHHHHHHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEec
Q 001275          810 LLKQVIEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR  887 (1109)
Q Consensus       810 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  887 (1109)
                      ...++..++++|...+.||+|+||.||+|.. .+++.||+|++.... .......+.+|++++++++|+||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456677889999999999999999999965 568999999885422 22234567889999999999999999998764


Q ss_pred             C------CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          888 K------DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       888 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                      .      ...+++++++ +++|.+++...    .+++..+..++.|+++|++|||   +.+|+||||||+||++++++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence            3      2357777776 78998887642    3889999999999999999999   8999999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||+++.....     .....++..|+|||...+ ..++.++||||+||++|||++|+.||..... ..........
T Consensus       160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~  233 (345)
T cd07877         160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRL  233 (345)
T ss_pred             EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHH
Confidence            99999998854322     123467889999998766 4678999999999999999999999854321 1111111111


Q ss_pred             hhcCccc-cccccchhhhHHhh-------h----chhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1041 VWSDTEE-INDIVDLSLMEEML-------V----SSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1041 ~~~~~~~-~~~~~d~~~~~~~~-------~----~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ....... ...+.+ .......       .    ........++.+++.+|++.||++||++.|+++|=.
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         234 VGTPGAELLKKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             hCCCCHHHHhhccc-HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence            1100000 000000 0000000       0    000012345678888999999999999999998754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=287.32  Aligned_cols=253  Identities=26%  Similarity=0.318  Sum_probs=194.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc----cccChHHHHHHHHHHhcCCCCceeeEeeEEecC--Cce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG----HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  891 (1109)
                      .+|++.+.||+|+||.||+|.. .++..||+|.+....    .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999976 458999999874322    123345788999999999999999999998764  457


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++|+||+++++|.+++....   .+++..+.+++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999987543   3788899999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCC-CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPA-STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ...... ........++..|+|||...+..++.++|||||||++|++++|+.||.....    .............   .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~---~  228 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKIATQPTK---P  228 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHHHcCCCC---C
Confidence            543211 1111235688999999999988899999999999999999999999864311    1111111110000   0


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .         .+   ......+.+++.+|++ +|.+||++.+++.|.
T Consensus       229 ~---------~p---~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         229 M---------LP---DGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             C---------CC---cccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence            0         01   1112335557779998 579999999988763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=273.53  Aligned_cols=201  Identities=26%  Similarity=0.324  Sum_probs=175.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..++||+|.||+|-.++. .+++.||+|++++..  .+...+.-..|-++++..+||.+..+-..+...++.|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            6788899999999999999965 468999999985543  2233445667899999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+.||.|+-++...   ..+++.....+-..|+.||.|||   +.+||.||+|.+|.|+|.||++||+|||+++.--. 
T Consensus       248 eyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-  320 (516)
T KOG0690|consen  248 EYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-  320 (516)
T ss_pred             EEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc-
Confidence            999999999888653   35888888889999999999999   99999999999999999999999999999985332 


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                       ...+...++|||.|.|||++....|+.++|.|.+||++|||++|+.||...
T Consensus       321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence             233445689999999999999999999999999999999999999999753

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=4.7e-30  Score=285.16  Aligned_cols=246  Identities=22%  Similarity=0.234  Sum_probs=185.6

Q ss_pred             eeecccCeEEEEEEe-CCCcEEEEEEeeecccccC--hHHHHHHH---HHHhcCCCCceeeEeeEEecCCceeEEEEecc
Q 001275          826 VIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRG--SLSMKREI---QTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       826 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      +||+|+||.||+|.. .+++.||+|.+........  ...+..|.   +.++...||+|+++.+++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999966 4588999998854332211  12233343   34445589999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +|+|.+++...   ..+++..+..++.|+++|++|||   +.+|+||||||+||++++++.++|+|||++........  
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            99999988653   34899999999999999999999   89999999999999999999999999999876533211  


Q ss_pred             eeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          980 TSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                        ....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........  ..........        ....  
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~--------~~~~--  218 (278)
T cd05606         153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTM--------AVEL--  218 (278)
T ss_pred             --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhhcc--------CCCC--
Confidence              234689999999998754 689999999999999999999999965422111  0000000000        0000  


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLVD 1099 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~~ 1099 (1109)
                         .   .....++.+++.+|++.+|.+||     ++.|++++-+-
T Consensus       219 ---~---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~  258 (278)
T cd05606         219 ---P---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF  258 (278)
T ss_pred             ---C---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence               0   01123466677899999999999     99999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.1e-30  Score=290.89  Aligned_cols=251  Identities=25%  Similarity=0.363  Sum_probs=200.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|...+.||+|+||.||+|... +++.||+|++....  .......+.+|++++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            36888899999999999999764 68999999885422  2233467889999999998 99999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++++|.+++....   .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999997643   4899999999999999999999   89999999999999999999999999999986643


Q ss_pred             CCCC------------------ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHH
Q 001275          975 SPAS------------------TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVG 1036 (1109)
Q Consensus       975 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 1036 (1109)
                      ....                  .......++..|+|||...+..++.++||||+|+++|++++|+.||.....     ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~  229 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-----YL  229 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-----HH
Confidence            3211                  122234678899999999888899999999999999999999999864321     11


Q ss_pred             HHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH----HHHHHH
Q 001275         1037 WVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM----RDVVRQ 1096 (1109)
Q Consensus      1037 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~----~evl~~ 1096 (1109)
                      ............                .......+.+++.+|++.+|++||++    +|+++|
T Consensus       230 ~~~~~~~~~~~~----------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 TFQKILKLEYSF----------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHHHhcCCCC----------------CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            111111000000                01113446678889999999999999    888775

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-30  Score=299.28  Aligned_cols=268  Identities=20%  Similarity=0.259  Sum_probs=193.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC------
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD------  889 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  889 (1109)
                      ..+|...+.||+|+||.||+|.. .+++.||+|++.... .......+.+|++++++++|+||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            37898999999999999999975 468999999885432 2223456889999999999999999999986543      


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..++|+||+.. ++.++..     ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999974 7776653     23789999999999999999999   889999999999999999999999999998


Q ss_pred             cccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      +.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..+..............
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGPEF  238 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHH
Confidence            755322     123467889999998876 46789999999999999999999999643211 11111111000000000


Q ss_pred             ccccch----hhh-------HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhhC
Q 001275         1049 NDIVDL----SLM-------EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ--LVDA 1100 (1109)
Q Consensus      1049 ~~~~d~----~~~-------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~ 1100 (1109)
                      ....+.    ...       .............++.+++.+|++.||++||+++|++.|  +++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            000000    000       000000001123456788889999999999999999977  4443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.7e-30  Score=295.52  Aligned_cols=270  Identities=22%  Similarity=0.311  Sum_probs=197.8

Q ss_pred             HHHHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEec-CCc
Q 001275          814 VIEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR-KDC  890 (1109)
Q Consensus       814 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  890 (1109)
                      +..++++|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++.+++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            3456788999999999999999999654 78999999875432 22345678899999999999999999999865 457


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++|+||+ +++|.++++..    .+++..+..++.|+++|++|||   +.+|+||||+|+||++++++.++++|||.+.
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            88999998 56898888642    3778888899999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc-c
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE-I 1048 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 1048 (1109)
                      .....     .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||..... ......+.......... .
T Consensus       157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence            54321     122467889999998766 5689999999999999999999999854321 11111111110000000 0


Q ss_pred             ccccchhh---hHHh-------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1049 NDIVDLSL---MEEM-------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1049 ~~~~d~~~---~~~~-------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ....+...   ....       ..........++.+++.+|++.+|++||+++|++.+=
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            00000000   0000       0000011235677788899999999999999999883

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=2.3e-30  Score=289.49  Aligned_cols=257  Identities=25%  Similarity=0.269  Sum_probs=196.3

Q ss_pred             CCCCCceeecccCeEEEEEEe----CCCcEEEEEEeeeccc---ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          820 NLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGH---KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      +|+..+.||+|+||.||+++.    .+++.||||.+.....   ......+.+|++++.++ +|+||+++++++...+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367788999999999999964    3578899998854321   22345688999999999 599999999999988999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.+++....   .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++++|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999987532   4889999999999999999999   89999999999999999999999999999886


Q ss_pred             cCCCCCCceeeecccCcccccccccccCC--CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTA--KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      ...... .......|+..|+|||...+..  .+.++||||+|+++|||++|+.||.... .......+........... 
T Consensus       155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~-  231 (288)
T cd05583         155 FLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG-EQNSQSEISRRILKSKPPF-  231 (288)
T ss_pred             cccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc-ccchHHHHHHHHHccCCCC-
Confidence            543321 1122346889999999887665  6889999999999999999999985321 1111111111111110000 


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                     .......+.+++.+|++.||++|||++++.+.|...
T Consensus       232 ---------------~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         232 ---------------PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ---------------CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                           011123456678899999999999988776666543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=1.8e-30  Score=293.00  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=194.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.|...+.||+|+||.||+|... +++.+|+|.+....  ......++.+|+++++.++|+|++++.+++...+..++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34666788999999999999764 57889999885322  2223456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+. |++.+++....  ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||++......
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 58888775433  34789999999999999999999   889999999999999999999999999998765322


Q ss_pred             CCCceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                            ....++..|+|||.+.   ...++.++|||||||++|+|++|+.||...... .....+..    ..  .... 
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~----~~--~~~~-  234 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ----NE--SPAL-  234 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhh----cC--CCCc-
Confidence                  1246788999999874   356788999999999999999999998543111 00111100    00  0000 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                              .   .......+.+++.+||+.+|++||++.+++++.+....
T Consensus       235 --------~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         235 --------Q---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             --------C---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                    0   01122345667889999999999999999998776543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.3e-30  Score=297.49  Aligned_cols=269  Identities=24%  Similarity=0.290  Sum_probs=200.7

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-----cee
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-----CGI  892 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  892 (1109)
                      +|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++|+||+++.+++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999765 489999998854332 344567899999999999999999999988765     789


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +||||++ ++|.++++...   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++|+|||.+...
T Consensus        81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999998 48998887543   5899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCC-ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc----
Q 001275          973 DKSPAS-TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE---- 1046 (1109)
Q Consensus       973 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 1046 (1109)
                      ...... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......  .....+........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI--DQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHhcCCCChhHh
Confidence            543210 112334678899999999887 7899999999999999999999998643211  11111111110000    


Q ss_pred             ------ccccccch-hh-hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1047 ------EINDIVDL-SL-MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1047 ------~~~~~~d~-~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                            .....+.. .. .........+....++.+++.+||+.+|++||++++++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  290 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP  290 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence                  00000000 00 00000000112245677888999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=1.5e-30  Score=294.46  Aligned_cols=270  Identities=24%  Similarity=0.316  Sum_probs=195.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-ChHHHHHHHHHHhcCCCCceeeEeeEEecCC------
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKIRHRNLVRLEDFWLRKD------  889 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  889 (1109)
                      .++|...++||+|+||.||+|... +++.||+|++....... ....+.+|++++++++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999764 68899999986543322 2346788999999999999999999875433      


Q ss_pred             --ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          890 --CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       890 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                        ..++|+||+++ ++.+.+...  ...+++..+..++.|+++||+|||   +.+|+||||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence              35999999975 677776543  235899999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCCCc---------eeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHH
Q 001275          968 IAKLLDKSPAST---------TSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGW 1037 (1109)
Q Consensus       968 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~ 1037 (1109)
                      +++.........         ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~  239 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLI  239 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            998654322111         11234678889999987654 5789999999999999999999998643221 111111


Q ss_pred             HHHhhcCc--------ccccccc----chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1038 VRSVWSDT--------EEINDIV----DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1038 ~~~~~~~~--------~~~~~~~----d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .. .+...        .......    ...... ...........++.+++.+|++.||++||++.|++.+
T Consensus       240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         240 FK-LCGTPTEETWPGWRSLPGCEGVHSFTNYPR-TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HH-HhCCCChhhchhhhhcccccccccCCCCCc-cHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            11 11000        0000000    000000 0000111223567788999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-30  Score=283.43  Aligned_cols=242  Identities=22%  Similarity=0.283  Sum_probs=183.1

Q ss_pred             ceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHH-hcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTI-GKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.||+|+||.||+|.. .+++.||+|.+.....  ......+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4699999999999976 4588999998854321  11223344554444 455899999999999999999999999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      ++|.+++....   .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++....      
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999997643   4788999999999999999999   88999999999999999999999999999875432      


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....++..|+|||...+..++.++||||+|+++|||++|..||......     .............    ...     
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~----~~~-----  215 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVFDNILSRRINW----PEE-----  215 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcccCC----CCc-----
Confidence            12246888999999998888899999999999999999999998643211     1111110000000    000     


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 1095 (1109)
                         .......++.+++.+|++.+|++||++.++.+
T Consensus       216 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         216 ---VKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             ---ccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence               00112345677888999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2e-30  Score=289.00  Aligned_cols=266  Identities=23%  Similarity=0.329  Sum_probs=198.1

Q ss_pred             CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          821 LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      |+..+.||+|+||.||+|... +++.||+|.+.... .......+..|++++++++|+|++++++++...+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456778999999999999775 48999999986543 2333467788999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      + ++|.+++....  ..+++..+..++.++++|++|||   +.+|+||||+|+||++++++.++|+|||.++....... 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            8 59999998642  34899999999999999999999   88999999999999999999999999999986643321 


Q ss_pred             ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-------ccc--
Q 001275          979 TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-------EEI-- 1048 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~-- 1048 (1109)
                       ......++..|+|||.+.+. .++.++||||+||++||+++|+.||...... ..............       ...  
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhccccc
Confidence             12224567789999988776 7899999999999999999999888543211 11111111000000       000  


Q ss_pred             -ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1049 -NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1049 -~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                       ..... ................++.+++.+|++.+|++||++.|++.+
T Consensus       232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         232 YKPTFP-KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccc-ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence             00000 000000000011123567888999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=3.5e-30  Score=294.57  Aligned_cols=272  Identities=22%  Similarity=0.267  Sum_probs=196.8

Q ss_pred             hCCCC-CceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-------------ChHHHHHHHHHHhcCCCCceeeEee
Q 001275          819 ENLNA-KHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-------------GSLSMKREIQTIGKIRHRNLVRLED  883 (1109)
Q Consensus       819 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~l~~  883 (1109)
                      ++|.. .+.||+|+||+||+|... +++.||+|++.......             ....+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45553 567999999999999754 68999999885432221             1125778999999999999999999


Q ss_pred             EEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          884 FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       884 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                      ++...+..++||||++ |+|.+++....   .+++.....++.|+++|++|||   +.+|+||||+|+||+++.++.+++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEE
Confidence            9999999999999997 59999886532   4889999999999999999999   899999999999999999999999


Q ss_pred             ecccCCcccCCCCC------------CceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccc
Q 001275          964 SDFGIAKLLDKSPA------------STTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKE 1030 (1109)
Q Consensus       964 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~ 1030 (1109)
                      +|||.+........            ........++..|+|||.+.+.. ++.++||||+||++|||++|+.||......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999986641110            11112235688899999887644 689999999999999999999998643221


Q ss_pred             cccHHHHHHHhhcCccc--ccccc--------chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1031 RTDIVGWVRSVWSDTEE--INDIV--------DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~--~~~~~--------d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                        +....+.........  .....        .... .............++.+++.+|++.+|++||+++|++.+-+--
T Consensus       241 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~  317 (335)
T PTZ00024        241 --DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRK-PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK  317 (335)
T ss_pred             --HHHHHHHHHhCCCchhhCcchhhcccccccCcCC-cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence              111111111110000  00000        0000 0000000111234567788899999999999999999876544

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-30  Score=297.16  Aligned_cols=268  Identities=20%  Similarity=0.257  Sum_probs=195.3

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCC----
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD----  889 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  889 (1109)
                      ...++|...+.||+|+||.||+|.. .+++.||||++..... ......+.+|++++++++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3457899999999999999999964 5789999998843222 223456789999999999999999999887543    


Q ss_pred             --ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          890 --CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       890 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                        ..++||||+ +++|.+++...    .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++++|||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence              358999999 67999887642    3889999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      ++.......     ....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||...... ...............
T Consensus       164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~  237 (343)
T cd07880         164 LARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCH
Confidence            998653321     23467889999998876 45789999999999999999999998643211 111111110000000


Q ss_pred             ccc-cccch---hhhH-------HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1047 EIN-DIVDL---SLME-------EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1047 ~~~-~~~d~---~~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ... .+...   ....       .............+.+++.+|++.||++||++.+++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~  299 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP  299 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            000 00000   0000       000000011233567888899999999999999999653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-31  Score=266.02  Aligned_cols=256  Identities=22%  Similarity=0.291  Sum_probs=194.7

Q ss_pred             HhhCCCC-CceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEec----CC
Q 001275          817 ATENLNA-KHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLR----KD  889 (1109)
Q Consensus       817 ~~~~~~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~  889 (1109)
                      .+++|.+ .++||-|-.|.|..+.. .+++.+|+|++..      .....+|++.--+. .|||||.++++|..    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD------SPKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            3445544 36799999999999954 5689999998732      23456788876555 69999999999764    34


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCcEEEecc
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EMEPHISDF  966 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Df  966 (1109)
                      ...+|||.|+||.|+..+...+ ...+++.++..|+.||+.|+.|||   +.+|.||||||+|+|...   +-.+|++||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccc
Confidence            5689999999999999998755 345999999999999999999999   999999999999999964   446899999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccc--cHHHHHHHhhcC
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT--DIVGWVRSVWSD 1044 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~ 1044 (1109)
                      |+|+.-..   .......+.|+.|.|||++...+|+..+|+||+||++|-|++|.+||+...+...  .....++.   .
T Consensus       209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~---g  282 (400)
T KOG0604|consen  209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT---G  282 (400)
T ss_pred             ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc---c
Confidence            99986543   2333446889999999999999999999999999999999999999976533211  11111100   0


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .   -++.+         +.+..-.++..++++.++..+|++|.|+.|++.|-+-.
T Consensus       283 q---y~FP~---------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~  326 (400)
T KOG0604|consen  283 Q---YEFPE---------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN  326 (400)
T ss_pred             C---ccCCC---------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence            0   01111         11223334455567789999999999999999887644

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=244.05  Aligned_cols=270  Identities=22%  Similarity=0.346  Sum_probs=203.6

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccC-hHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +|...++||+|.||+||+|+. ++++.||+|++....+.++ .....+|+-+++.++|+|||+++++...+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678899999999999965 5688999999976655544 45788999999999999999999999888999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |.. +|..|......  .++.+.+..++.|+.+|+.++|   +.++.|||+||.|.+++.+|+.|++|||+++-++-+  
T Consensus        83 cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--  154 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--  154 (292)
T ss_pred             hhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence            965 88888877543  4889999999999999999999   999999999999999999999999999999976532  


Q ss_pred             CceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc----cccc
Q 001275          978 STTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI----NDIV 1052 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 1052 (1109)
                      .......+.|..|++|+++.+.+ |+...|+||.|||+.|+.....|..|+.+-..++..+++......+.-    ..+.
T Consensus       155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            22334567899999999998865 689999999999999999877777666544444554444332221110    1111


Q ss_pred             chhhhHHhh-hchhHHHHHH----HHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1053 DLSLMEEML-VSSIRDQVID----VLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1053 d~~~~~~~~-~~~~~~~~~~----l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      |....+... .....+.+++    =.++..+.+.-+|..|.++++++++-
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence            111111000 0011122221    13355567778999999999998863

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=1.4e-30  Score=298.25  Aligned_cols=269  Identities=21%  Similarity=0.292  Sum_probs=191.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC---------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK---------  888 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  888 (1109)
                      .+|...+.||.|+||.||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++++...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            5788899999999999999966 468899999885433 34456788999999999999999999776543         


Q ss_pred             -----CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcEE
Q 001275          889 -----DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEPH  962 (1109)
Q Consensus       889 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~k  962 (1109)
                           ...++|+||++ ++|.+++...    .+++..+..++.|+++|++|||   +.+|+||||||+||+++. ++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 5898888642    3889999999999999999999   889999999999999974 56789


Q ss_pred             EecccCCcccCCCCCC-ceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHH
Q 001275          963 ISDFGIAKLLDKSPAS-TTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       963 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ++|||.++........ .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...... .........
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~~~~~  234 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-EQMQLILES  234 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence            9999999765332111 11122457889999997654 55788999999999999999999999644221 111111111


Q ss_pred             hhcC-cccccccc---chhhh------HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1041 VWSD-TEEINDIV---DLSLM------EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1041 ~~~~-~~~~~~~~---d~~~~------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .... ........   .....      .............++.+++.+|++.||++||++.|+++|=
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~  301 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP  301 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCC
Confidence            0000 00000000   00000      0000000011224567788899999999999999999763

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=5.5e-30  Score=289.71  Aligned_cols=246  Identities=28%  Similarity=0.402  Sum_probs=190.1

Q ss_pred             CCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          821 LNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      |...++||+|+||+||+|+. .+++.||+|++.....  ......+.+|++++++++|+|++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55567899999999999976 4688999998854322  22235688899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +. |++.+++....  ..+++..+..++.|++.|++|||   +.+|+||||+|+||+++.++.+||+|||++......  
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            96 58888776432  34889999999999999999999   889999999999999999999999999998643211  


Q ss_pred             CceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                          ....|+..|+|||++.   ...++.++|||||||++|||++|+.||.....     ...........  ...... 
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~~~--~~~~~~-  242 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQND--SPTLQS-  242 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcC--CCCCCc-
Confidence                1346888999999874   45678899999999999999999999854321     11111111000  000000 


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                 ......+.+++.+|++.+|++||++.|++++-
T Consensus       243 -----------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~  274 (313)
T cd06633         243 -----------NEWTDSFRGFVDYCLQKIPQERPASAELLRHD  274 (313)
T ss_pred             -----------cccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                       01112356677899999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=2.4e-30  Score=284.74  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=192.2

Q ss_pred             CCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeec---c-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFR---G-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      +|.+.++||+|+||.||++.... +..+++|.++..   . .......+.+|+.++++++||||+++++++...+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999996643 444555554321   1 223344677899999999999999999999988899999


Q ss_pred             EEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          895 YRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      +||+++++|.+++.... ....+++..++.++.|+++|++|||   +.+++|+|++|+||+++. +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999887532 2346899999999999999999999   899999999999999975 569999999987664


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ....  ......++..|+|||...+..++.++|+||+|+++|+|++|+.||....     ............       .
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~~~~~-------~  222 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRIVEGP-------T  222 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHHcCC-------C
Confidence            3221  1223467889999999888888999999999999999999999985321     111111111100       0


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      +..        ......++.+++.+|++.+|++||++.|++++
T Consensus       223 ~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         223 PSL--------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCC--------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            000        01222356678889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=286.43  Aligned_cols=248  Identities=22%  Similarity=0.311  Sum_probs=194.4

Q ss_pred             CceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCC
Q 001275          824 KHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      .++||+|.||+||-|+. ++|+.||||++.+.. ..+....+.+|+.++.+++||.||.+...|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            57899999999999955 679999999995543 3344567899999999999999999999999999999999999764


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC---CcEEEecccCCcccCCCCCC
Q 001275          902 SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       902 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla~~~~~~~~~  978 (1109)
                      -|.-++..  +...+++.....++.||+.||.|||   .++|||+||||+|||+...   ..+||+|||+|+....... 
T Consensus       649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            44444443  2345888889999999999999999   8999999999999999653   4699999999998865432 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                        ....+||+.|.|||++..+.|...-|+||.|||+|.-++|..||...    +++.+.+...       .-++.     
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQNA-------aFMyP-----  784 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQNA-------AFMYP-----  784 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhcc-------ccccC-----
Confidence              33579999999999999999999999999999999999999999633    3333222110       00101     


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                         ...+.+...+.++++...++..-.+|-+.++.+.|-+
T Consensus       785 ---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W  821 (888)
T KOG4236|consen  785 ---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW  821 (888)
T ss_pred             ---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence               1112333344555666888888889999888776543

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4.9e-30  Score=292.83  Aligned_cols=270  Identities=23%  Similarity=0.287  Sum_probs=191.1

Q ss_pred             CCCCCceeecccCeEEEEEEeC-C--CcEEEEEEeeeccc-ccChHHHHHHHHHHhcC-CCCceeeEeeEEecC----Cc
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-P--NAVFAVKKLAFRGH-KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK----DC  890 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  890 (1109)
                      +|+..+.||+|+||.||+|... .  +..||+|++..... ......+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677889999999999999764 3  67899998854322 22345678899999999 599999999875432    34


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++++||++ ++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888886 68999886533   4889999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCC--ceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-cc
Q 001275          971 LLDKSPAS--TTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-TE 1046 (1109)
Q Consensus       971 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~ 1046 (1109)
                      ........  .......|+..|+|||+..+ ..++.++||||+||++|++++|+.||...... ......+...... ..
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence            65432211  11223578999999998765 46799999999999999999999998643211 0111111100000 00


Q ss_pred             ccccccchhhh---H---Hh----hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1047 EINDIVDLSLM---E---EM----LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1047 ~~~~~~d~~~~---~---~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ....+..+...   .   ..    ...........+.+++.+|++.||++||+++|++++=
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~  293 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP  293 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence            00000000000   0   00    0000011134577788899999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.6e-30  Score=297.89  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=196.2

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc---
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC---  890 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  890 (1109)
                      ...++|...+.||+|+||.||+|... +++.||+|++.... .......+.+|+.++++++|+|++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34578899999999999999999775 57899999875322 22334567789999999999999999988766554   


Q ss_pred             ---eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          891 ---GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       891 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                         .++|+||+ +++|.+++..    ..+++..+..++.|+++|++|||   +.+|+||||||+||++++++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 5699998875    24899999999999999999999   8999999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-c
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-T 1045 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~ 1045 (1109)
                      ++......     .....++..|+|||...+ ..++.++||||+||++||+++|+.||......  .....+...... .
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~  236 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPD  236 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCC
Confidence            99865432     123467889999998765 36789999999999999999999998543211  111111111100 0


Q ss_pred             cc-cccccchh---hhHH-------hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1046 EE-INDIVDLS---LMEE-------MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1046 ~~-~~~~~d~~---~~~~-------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .. ...+....   ....       ...........++.+++.+|++.+|++|||+.|+++|-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~  299 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP  299 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence            00 00000000   0000       00000011235677888999999999999999998864

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-29  Score=277.61  Aligned_cols=241  Identities=24%  Similarity=0.319  Sum_probs=192.4

Q ss_pred             eecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          827 IGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      ||+|+||.||++... +++.+|+|.+......  .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 5889999988544322  2355788999999999999999999999999999999999999999


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeee
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS  983 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  983 (1109)
                      .+++....   .+++..+..++.|+++|+.|+|   +.+++|+||+|+||+++.++.++++|||++.......  .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            99997643   4889999999999999999999   8999999999999999999999999999998664332  12233


Q ss_pred             cccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          984 VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       984 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      ..++..|+|||...+...+.++|+||||+++|++++|+.||.....     ................             
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~-------------  214 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDPLRFPE-------------  214 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCCCCCCC-------------
Confidence            5688899999999888889999999999999999999999854321     1111111111100100             


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCCCH---HHHHHH
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRPNM---RDVVRQ 1096 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RPs~---~evl~~ 1096 (1109)
                         ....++.+++.+|+..||++||++   +++++|
T Consensus       215 ---~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         215 ---FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             ---CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence               112345668889999999999999   666554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.3e-31  Score=309.68  Aligned_cols=263  Identities=23%  Similarity=0.289  Sum_probs=204.5

Q ss_pred             HHHHHHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecC
Q 001275          812 KQVIEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK  888 (1109)
Q Consensus       812 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  888 (1109)
                      +++....++|.+.++||+|+||.|..++.+ ++++||.|++.+...  ......|..|-.+|..-+.+.|++++..|.+.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344445688999999999999999999774 588999999854321  23456788999999999999999999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      .+.|+|||||+||+|-..+....   .++++.+..++..|.-||+-+|   +.|+|||||||+|||+|..|++|++|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999998765   4888999999999999999999   99999999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccc----c-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAF----T-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      +..+...+ .......+|||-|.+||++.    + +.|+..+|.||+||++|||+.|..||+..     .+++.......
T Consensus       222 Clkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm~  295 (1317)
T KOG0612|consen  222 CLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIMN  295 (1317)
T ss_pred             HHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHhc
Confidence            98876443 33344579999999999875    3 67899999999999999999999999743     12222222111


Q ss_pred             CccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHhhh
Q 001275         1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN---MRDVVRQLVD 1099 (1109)
Q Consensus      1044 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs---~~evl~~L~~ 1099 (1109)
                      -...+ .+.        .....++++.+++.   +.+ -+|+.|..   ++|+..|-.-
T Consensus       296 hk~~l-~FP--------~~~~VSeeakdLI~---~ll-~~~e~RLgrngiedik~HpFF  341 (1317)
T KOG0612|consen  296 HKESL-SFP--------DETDVSEEAKDLIE---ALL-CDREVRLGRNGIEDIKNHPFF  341 (1317)
T ss_pred             hhhhc-CCC--------cccccCHHHHHHHH---HHh-cChhhhcccccHHHHHhCccc
Confidence            10000 000        00113445555443   322 57888877   9999888643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=1.6e-29  Score=311.52  Aligned_cols=146  Identities=27%  Similarity=0.390  Sum_probs=129.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.++||+|+||+||+|... +++.||+|++.....  ......+.+|+.++..++|+||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999775 689999999854322  222357889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      ||+++++|.++++...   .+++..++.++.||+.||+|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997643   3788999999999999999999   8899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.8e-31  Score=262.83  Aligned_cols=273  Identities=21%  Similarity=0.352  Sum_probs=196.6

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccC-hHHHHHHHHHHhcCCCCceeeEeeEEecC--------C
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDFWLRK--------D  889 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~  889 (1109)
                      .|....+||+|.||.||+|+.+ +|+.||+|++-....+++ .....+|++++..++|+|++.+++.|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            4555678999999999999654 577889887644333332 44678999999999999999999988542        2


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..|+||++|+. +|...+...  ...++..++.+++.++..||.|+|   ...|+|||+||.|||++.++.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            47999999987 888877543  234888999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCC--CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHH-------
Q 001275          970 KLLDKSPA--STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVR------- 1039 (1109)
Q Consensus       970 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~------- 1039 (1109)
                      +.+...+.  ....+..+.|..|++||.+.+ +.|+++.|||..|||+.||+||.+-+...... .. ...+.       
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qq-l~~Is~LcGs~t  249 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQ-LHLISQLCGSIT  249 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HH-HHHHHHHhccCC
Confidence            86643322  222445678999999998876 56899999999999999999999887654322 11 11222       


Q ss_pred             -HhhcCcccccc--ccchhhhHHhhhchhHHHHH------HHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1040 -SVWSDTEEIND--IVDLSLMEEMLVSSIRDQVI------DVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1040 -~~~~~~~~~~~--~~d~~~~~~~~~~~~~~~~~------~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       .+|..-+.+.-  -+......+.......+...      +..+++..++..||.+|+++++++.|-.-.
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence             22322211110  00000000000001111111      455677789999999999999999987544

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.6e-30  Score=272.49  Aligned_cols=268  Identities=21%  Similarity=0.247  Sum_probs=200.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-C-C----ceeeEeeEEecCCc
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-H-R----NLVRLEDFWLRKDC  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~  890 (1109)
                      +++|.+...+|+|.||.|-++.. ..+..||+|+++  .........+-|++++.++. + |    -+|.+.+|+...++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik--~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK--NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHH--HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            67899999999999999999944 447899999873  33444455677999999993 2 2    37889999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-------------
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-------------  957 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------------  957 (1109)
                      .|+|+|.+ |-|+++++..+.. .+++...+..++.|+++++++||   +.+++|.||||+||++.+             
T Consensus       166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcc
Confidence            99999998 4499999987543 45888999999999999999999   999999999999999831             


Q ss_pred             -------CCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc
Q 001275          958 -------EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030 (1109)
Q Consensus       958 -------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~ 1030 (1109)
                             +..+|++|||.|+.-....     ...+.|..|+|||++.+-.++.++||||+|||++|+.||...|.... +
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe-n  314 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE-N  314 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC-c
Confidence                   2358999999998654433     34688999999999999999999999999999999999999886433 2


Q ss_pred             cccHHHHHHHhhcCcc---------------c-----------cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCC
Q 001275         1031 RTDIVGWVRSVWSDTE---------------E-----------INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKP 1084 (1109)
Q Consensus      1031 ~~~~~~~~~~~~~~~~---------------~-----------~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 1084 (1109)
                      .+.+...-+...+-..               .           ...+.++...-.........+..++++++.+|+..||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            2211111110000000               0           0001111111111112233556779999999999999


Q ss_pred             CCCCCHHHHHHHhh
Q 001275         1085 SNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1085 ~~RPs~~evl~~L~ 1098 (1109)
                      .+|+|++|+++|-.
T Consensus       395 ~~RiTl~EAL~HpF  408 (415)
T KOG0671|consen  395 ARRITLREALSHPF  408 (415)
T ss_pred             cccccHHHHhcCHH
Confidence            99999999998754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=274.46  Aligned_cols=259  Identities=25%  Similarity=0.371  Sum_probs=192.7

Q ss_pred             hCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeeccccc------ChHHHHHHHHHHhcCCCCceeeEeeEEec-CCc
Q 001275          819 ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKR------GSLSMKREIQTIGKIRHRNLVRLEDFWLR-KDC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  890 (1109)
                      ++|-....||+|||+.||+| +....+.||||+-.......      ..+...+|.++-+.+.||.||++++|+.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            45666788999999999999 55678899999764332221      13456789999999999999999999875 467


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC---CCCcEEEeccc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD---SEMEPHISDFG  967 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfG  967 (1109)
                      +|-|.|||+|-+|+-|++..+   .++++++..|+.||+.||.||. +.+++|+|-||||.|||+-   ..|.+||+|||
T Consensus       543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLN-EikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLN-EIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHh-ccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            899999999999999998765   4899999999999999999998 4488999999999999994   45789999999


Q ss_pred             CCcccCCCCCCce-----eeecccCcccccccccccC----CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHH
Q 001275          968 IAKLLDKSPASTT-----SISVVGTIGYIAPENAFTT----AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWV 1038 (1109)
Q Consensus       968 la~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1109)
                      +++.++.+.+...     ..-..||..|++||.+.-+    ..+.|+||||.|||+|+.+.|+.||..... ..++...-
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQdILqeN  697 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQDILQEN  697 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HHHHHhhh
Confidence            9999976654321     2235799999999976533    358899999999999999999999965422 22222111


Q ss_pred             HHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1039 RSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1039 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...  ...++.--..         +....   +...++++|+++--++|.+..++..+
T Consensus       698 TIl--kAtEVqFP~K---------PvVss---eAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  698 TIL--KATEVQFPPK---------PVVSS---EAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             chh--cceeccCCCC---------CccCH---HHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            000  0000100000         01122   23346669999988888888776543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-31  Score=267.32  Aligned_cols=254  Identities=26%  Similarity=0.305  Sum_probs=192.2

Q ss_pred             CCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          823 AKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       823 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ....||.|+||+|+|-.+ ..|+..|||++.......+.+++..|.+...+- +.||||+++|.+..++.-++.||.|.-
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~  147 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI  147 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence            345699999999999965 468999999998777777788898998876665 799999999999999999999999964


Q ss_pred             CCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          901 GSLRDVLHSI--TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       901 gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                       |++.+.+..  .....+++...-.|......||+||..  ...|+|||+||+|||++..|.+|++|||.+-.+...-. 
T Consensus       148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA-  223 (361)
T KOG1006|consen  148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA-  223 (361)
T ss_pred             -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH-
Confidence             666544321  123457888888888889999999985  56899999999999999999999999999876643322 


Q ss_pred             ceeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          979 TTSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                        .+.-.|-..|||||-+..  ..|+.++||||+|+++||+.||+.|+.....    +.+.+..+.....+.-. .+   
T Consensus       224 --kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~l~-~~---  293 (361)
T KOG1006|consen  224 --KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPILL-FD---  293 (361)
T ss_pred             --hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCeec-Cc---
Confidence              223467889999997763  3589999999999999999999999864322    23333333222111100 00   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                            ....+....+..++--|+.+|-..||+.+++.++
T Consensus       294 ------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  294 ------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ------ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                  0111233456677779999999999999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=285.65  Aligned_cols=243  Identities=23%  Similarity=0.289  Sum_probs=192.0

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++.|.....+|.|+|+.|-.+.. .+++..+||++...     ..+-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            45677777899999999999854 56788999998544     23345677776666 7999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee-CCCCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL-DSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~DfGla~~~~~  974 (1109)
                      |++.+|-+.+.+.....   .. ..+..|+.+++.|+.|||   .++|||||+||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            99999988887766442   23 677789999999999999   8999999999999999 6899999999999987754


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      .     ....+-|..|.|||+.....|++++|+||+|+++|+|++|+.||.....+ .++..   .... .         
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~---~i~~-~---------  529 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHT---RIQM-P---------  529 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHH---hhcC-C---------
Confidence            4     22246788999999999999999999999999999999999999755433 11111   1110 0         


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ..     .....+.+++   ++.+|++.||.+||+|+|+..|-+.
T Consensus       530 ~~-----s~~vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  530 KF-----SECVSDEAKD---LLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cc-----ccccCHHHHH---HHHHhccCChhhCcChhhhccCcch
Confidence            00     0123344444   5569999999999999999988776

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=2.6e-29  Score=272.19  Aligned_cols=219  Identities=21%  Similarity=0.213  Sum_probs=172.6

Q ss_pred             ccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCHHHHHh
Q 001275          830 GAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH  908 (1109)
Q Consensus       830 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~  908 (1109)
                      |.||.||++.. .+++.||+|++....      .+.+|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            88999999965 468899999985432      23445555566679999999999999999999999999999999987


Q ss_pred             ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCc
Q 001275          909 SITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTI  988 (1109)
Q Consensus       909 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~  988 (1109)
                      ...   .+++..+..++.|+++|++|+|   +.+|+||||||+||++++++.++++|||.+.......     ....++.
T Consensus        78 ~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~  146 (237)
T cd05576          78 KFL---NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVEN  146 (237)
T ss_pred             Hhc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCc
Confidence            643   3899999999999999999999   8999999999999999999999999999887554321     1235677


Q ss_pred             ccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHH
Q 001275          989 GYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQ 1068 (1109)
Q Consensus       989 ~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 1068 (1109)
                      .|+|||...+..++.++||||+|+++|||++|+.|+.......           ....   ..   ..     +   ...
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------~~~~---~~---~~-----~---~~~  201 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------NTHT---TL---NI-----P---EWV  201 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------cccc---cc---CC-----c---ccC
Confidence            8999999988889999999999999999999998764321100           0000   00   00     0   011


Q ss_pred             HHHHHHHHHhccCCCCCCCCCH
Q 001275         1069 VIDVLLVALRCTEKKPSNRPNM 1090 (1109)
Q Consensus      1069 ~~~l~~l~~~cl~~dP~~RPs~ 1090 (1109)
                      ..++.+++.+|++.||++||++
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCC
Confidence            2345667889999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-30  Score=269.92  Aligned_cols=201  Identities=26%  Similarity=0.341  Sum_probs=171.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .+|+...+||+|+||.|-.|..+ +.+.||||++++....  .+..--+.|-+++..- +-|.++++..++..-+..|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46888999999999999999554 5688999998654322  2223345566777666 578999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+.||+|.-+++..+.   +.+..+..+|.+||-||-+||   +++|+.||||.+|||++.+|++||+|||+++.---
T Consensus       429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999998887664   777888899999999999999   99999999999999999999999999999985432


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      +  ..+....+||+.|+|||++...+|+..+|.|||||++|||+.|+.||++.
T Consensus       503 ~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  503 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             C--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence            2  23445689999999999999999999999999999999999999999865

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-29  Score=286.84  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=203.0

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEec-----C
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLR-----K  888 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----~  888 (1109)
                      ..+..|.+.++||.|.+|.||+++. ++++.+|+|+....  .....+++.|.++++.. .|||++.++|++..     +
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~--~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT--EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC--ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            3456788899999999999999954 56888899877433  33345678899999888 69999999999864     4


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      +..++|||||.+||.-|.++... ...+.|+.+.-|+.+++.|+.+||   ...++|||+|-.|||+++++.+|++|||+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGv  169 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGV  169 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeee
Confidence            67899999999999999998765 567999999999999999999999   89999999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCccccccccccc-----CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFT-----TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      +..++....  ......||+.|||||++..     ..|+..+|+||+|++..||.-|.+|+......        +..+.
T Consensus       170 SaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--------raLF~  239 (953)
T KOG0587|consen  170 SAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--------RALFL  239 (953)
T ss_pred             eeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--------hhhcc
Confidence            988765432  2234689999999998863     34678999999999999999999998543221        11111


Q ss_pred             CccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1044 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                          +..-..+.++      .......++.+++..|+..|-++||++.++++|-
T Consensus       240 ----IpRNPPPkLk------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  240 ----IPRNPPPKLK------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             ----CCCCCCcccc------chhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence                0111112221      1234556677788899999999999999998874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.8e-28  Score=294.28  Aligned_cols=267  Identities=21%  Similarity=0.233  Sum_probs=168.4

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-C----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeE------E
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-P----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF------W  885 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~  885 (1109)
                      ..++|...++||+|+||.||+|... +    +..||+|++.....   ......|  .+....+.+++.+...      +
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4578999999999999999999775 4    68999998743211   1111111  1111122222222111      2


Q ss_pred             ecCCceeEEEEeccCCCHHHHHhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEecc
Q 001275          886 LRKDCGIIMYRYMENGSLRDVLHSITPP-----------------PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDI  948 (1109)
Q Consensus       886 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  948 (1109)
                      ......++|+||+++++|.++++.....                 .......+..++.|+++||+|||   +.+|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence            3456789999999999999998753211                 01123446679999999999999   899999999


Q ss_pred             CCCCeeeCC-CCcEEEecccCCcccCCCCCCceeeecccCcccccccccccC----------------------CCCccC
Q 001275          949 KPENILLDS-EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT----------------------AKSKES 1005 (1109)
Q Consensus       949 k~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~s 1005 (1109)
                      ||+|||+++ ++.+||+|||+|+.+..... .......+++.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 57899999999986643321 122335789999999955322                      234567


Q ss_pred             cchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc---cccccchhhhHHh--hhchhHHHHHHHHHHHHhcc
Q 001275         1006 DVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE---INDIVDLSLMEEM--LVSSIRDQVIDVLLVALRCT 1080 (1109)
Q Consensus      1006 DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~~~~~~--~~~~~~~~~~~l~~l~~~cl 1080 (1109)
                      ||||+||++|||+++..+++..      ...+.+........   ......+......  ..+.........++++.+|+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            9999999999999977654321      11111111000000   0000010000000  00000011223457888999


Q ss_pred             CCCCCCCCCHHHHHHHhh
Q 001275         1081 EKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1081 ~~dP~~RPs~~evl~~L~ 1098 (1109)
                      +.||++|||++|+++|=.
T Consensus       435 ~~dP~kR~ta~e~L~Hpf  452 (566)
T PLN03225        435 RFKGRQRISAKAALAHPY  452 (566)
T ss_pred             cCCcccCCCHHHHhCCcC
Confidence            999999999999999844

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=289.95  Aligned_cols=248  Identities=26%  Similarity=0.351  Sum_probs=188.4

Q ss_pred             CCCCceeecccCeE-EEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEec
Q 001275          821 LNAKHVIGRGAHGI-VYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      |...+++|.|+.|+ ||+|... |+.||||++.    .+.....++|++.++.- .|||||++++.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll----~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLL----EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHh----hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            34456789998876 6899887 7899999883    23344678999999988 6999999999888888999999999


Q ss_pred             cCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---C--CcEEEecccCCccc
Q 001275          899 ENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---E--MEPHISDFGIAKLL  972 (1109)
Q Consensus       899 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~DfGla~~~  972 (1109)
                      .. +|.+++.... ..........+.+..|++.|+++||   +.+||||||||.||||+.   +  .+++|+|||+++.+
T Consensus       586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            75 9999998741 1111122445788999999999999   899999999999999975   3  46999999999988


Q ss_pred             CCCCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhC-CCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          973 DKSPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR-KKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       973 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ..+.... ...+..||-+|+|||.+....-+.++||||+||++|+.++| .+||......+..+..       ....+..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~~  734 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLVH  734 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cccceee
Confidence            6554332 23457899999999999998889999999999999999997 8898755433222211       1111111


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      +..           ..++  +..+++.+|++.||..||+|.+|+.|-
T Consensus       735 L~~-----------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP  768 (903)
T KOG1027|consen  735 LEP-----------LPDC--EAKDLISRMLNPDPQLRPSATDVLNHP  768 (903)
T ss_pred             ecc-----------CchH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence            100           0111  445577799999999999999998763

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.9e-28  Score=284.46  Aligned_cols=268  Identities=18%  Similarity=0.229  Sum_probs=179.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-----------------CCCcEEEEEEeeeccccc-------------ChHHHHHHH
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-----------------GPNAVFAVKKLAFRGHKR-------------GSLSMKREI  867 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~E~  867 (1109)
                      .++|.+.++||+|+||+||+|..                 ..++.||||++.......             .......|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999953                 245679999985432111             112234577


Q ss_pred             HHHhcCCCCce-----eeEeeEEec--------CCceeEEEEeccCCCHHHHHhccCC---------------------C
Q 001275          868 QTIGKIRHRNL-----VRLEDFWLR--------KDCGIIMYRYMENGSLRDVLHSITP---------------------P  913 (1109)
Q Consensus       868 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~  913 (1109)
                      .++.+++|.++     ++++++|..        ++..++||||+++|+|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77788876654     677777653        3467999999999999999875321                     1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccc
Q 001275          914 PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP  993 (1109)
Q Consensus       914 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aP  993 (1109)
                      ...+|..+..++.|+++|++|+|   +.+|+||||||+||+++.++.+||+|||+++........ ......+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            23567889999999999999999   889999999999999999999999999999765432211 11223457899999


Q ss_pred             cccccCCC----------------------CccCcchhhHHHHHHHHhCCC-CCCCCccccccHHH--HHHHhhcCcccc
Q 001275          994 ENAFTTAK----------------------SKESDVYSYGVVLLELITRKK-ALDPSYKERTDIVG--WVRSVWSDTEEI 1048 (1109)
Q Consensus       994 E~~~~~~~----------------------~~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~~--~~~~~~~~~~~~ 1048 (1109)
                      |.+.....                      ..+.||||+||++|||++|.. |+............  .....|..... 
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~-  458 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG-  458 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc-
Confidence            98754321                      235799999999999999875 55321100000000  00000100000 


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHHhhh
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKP---SNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPs~~evl~~L~~ 1099 (1109)
                       ...+..        ..........+++.+|+..+|   .+|+|++|+++|-+-
T Consensus       459 -~~~~~~--------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f  503 (507)
T PLN03224        459 -QKYDFS--------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF  503 (507)
T ss_pred             -cCCCcc--------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence             000000        011112345567778888765   689999999998653

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=4.5e-28  Score=263.09  Aligned_cols=240  Identities=29%  Similarity=0.393  Sum_probs=191.2

Q ss_pred             cCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCHHHHHhc
Q 001275          831 AHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS  909 (1109)
Q Consensus       831 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  909 (1109)
                      +||.||+|... +++.+|+|++...........+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 48999999985443333267899999999999999999999999998999999999999999999876


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcc
Q 001275          910 ITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG  989 (1109)
Q Consensus       910 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  989 (1109)
                      ...   +++..+..++.+++++++|||   +.+|+|+||+|+||++++++.++++|||.+.......   ......++..
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            432   789999999999999999999   8899999999999999999999999999998765432   2233568889


Q ss_pred             cccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHH
Q 001275          990 YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQV 1069 (1109)
Q Consensus       990 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 1069 (1109)
                      |+|||...+..++.++||||+|+++|++++|..||.... .....   ..............             .....
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~---~~~~~~~~~~~~~~-------------~~~~~  214 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLEL---FKKIGKPKPPFPPP-------------EWKIS  214 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHH---HHHHhccCCCCccc-------------cccCC
Confidence            999999988888999999999999999999999986421 11111   11111100000000             00023


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1070 IDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1070 ~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .++.+++.+|+..+|++||++.|++++
T Consensus       215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      215 PEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHHHHHccCCchhccCHHHHhhC
Confidence            457778889999999999999999974

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-29  Score=240.17  Aligned_cols=202  Identities=28%  Similarity=0.376  Sum_probs=168.4

Q ss_pred             CCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEeccC
Q 001275          823 AKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       823 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ....||+|++|.|-+.++ .+|+..|+|++...-..+..++..+|+.+..+. .+|.+|.++|.+.+....++.||.|.-
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t  129 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT  129 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence            345699999999998865 579999999997776677777888999987776 799999999999999999999999965


Q ss_pred             CCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          901 GSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       901 gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                       ||+.+.+.. .....+++...-+||..+.+||.|||+  +..++|||+||+|||++.+|++|++|||.+-.+.+.-..+
T Consensus       130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt  206 (282)
T KOG0984|consen  130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT  206 (282)
T ss_pred             -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence             888776542 334568888999999999999999996  6789999999999999999999999999998775432211


Q ss_pred             eeeecccCcccccccccc----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccc
Q 001275          980 TSISVVGTIGYIAPENAF----TTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~ 1030 (1109)
                         -..|-..|||||.+.    ...|+.|+||||+|+++.||.+++.|++....+
T Consensus       207 ---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  207 ---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             ---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence               135777899999775    347899999999999999999999999755433

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-29  Score=270.88  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=199.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCc-EEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+++....||-|+||.|-.+..+... .+|+|.+++..  .......+..|-++|...+.|.||++|-.|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45556677999999999999776544 37888775443  2333456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      |-|-||.++..++..+.   ++......++..+.+|++|||   .++||+|||||+|.+++.+|-+|+.|||+|+.+..+
T Consensus       500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999987554   788888889999999999999   999999999999999999999999999999988655


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..   .-.++||+.|.|||++.++..+.++|.||+|+++||+++|.+||....+-.     ........   ++.+--  
T Consensus       574 ~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk-----tYn~ILkG---id~i~~--  640 (732)
T KOG0614|consen  574 RK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK-----TYNLILKG---IDKIEF--  640 (732)
T ss_pred             Cc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH-----HHHHHHhh---hhhhhc--
Confidence            33   334799999999999999999999999999999999999999997542211     11111111   000000  


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLVD 1099 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~~ 1099 (1109)
                            +..+..   ...+++.+.+..+|.+|..     +.|+-+|-+-
T Consensus       641 ------Pr~I~k---~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf  680 (732)
T KOG0614|consen  641 ------PRRITK---TATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF  680 (732)
T ss_pred             ------ccccch---hHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence                  011122   2344666888899999974     7888888764

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.2e-28  Score=268.41  Aligned_cols=204  Identities=25%  Similarity=0.355  Sum_probs=171.7

Q ss_pred             hCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .-|...+.||-|+||+|..+ +.++...||.|.+.+...  ......++.|-.|+..-..+.||+++..|.+++..|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            44777889999999999999 455678899998854432  223456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC--
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD--  973 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~--  973 (1109)
                      ||++||++...|.+.+   .+.++.+..++.++..|+++.|   +.|+|||||||+|||||.+|++||+|||++.-+.  
T Consensus       709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999987644   4788888889999999999999   9999999999999999999999999999985321  


Q ss_pred             -------CCCCC-------------------------------ceeeecccCcccccccccccCCCCccCcchhhHHHHH
Q 001275          974 -------KSPAS-------------------------------TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLL 1015 (1109)
Q Consensus       974 -------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ 1015 (1109)
                             .++..                               ......+||+.|+|||++....|+..+|.||.|||+|
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                   11000                               0011247999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCc
Q 001275         1016 ELITRKKALDPSY 1028 (1109)
Q Consensus      1016 elltg~~p~~~~~ 1028 (1109)
                      ||+.|+.||-...
T Consensus       863 em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  863 EMLVGQPPFLADT  875 (1034)
T ss_pred             HHhhCCCCccCCC
Confidence            9999999996543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=245.69  Aligned_cols=200  Identities=23%  Similarity=0.317  Sum_probs=173.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|+..++||+|+|++|..+++. +.+.||+|++++.-  ..+....++.|-.+..+- +||.+|.+..++..+...++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57889999999999999999764 57889999886543  344455677787777776 799999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      .||++||+|.-+++..+   .++++.+..+..+|+-||.|||   +++|+.||+|.+|||+|..|.+|++|||+++.--.
T Consensus       330 ieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            99999999987776544   4888888899999999999999   99999999999999999999999999999985433


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                      +.  .....++||+.|.|||++.+..|...+|.|++||+++||+.|+.||+-
T Consensus       404 ~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  404 PG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             CC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            32  233457999999999999999999999999999999999999999974

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=3.1e-28  Score=238.19  Aligned_cols=264  Identities=19%  Similarity=0.280  Sum_probs=200.5

Q ss_pred             hhCCCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCC--ceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKD--CGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~l  893 (1109)
                      .++|++.+++|+|.|++||.|. ..+.++++||.++    +...+.+.+|+.++..++ ||||+++++...+..  ...+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            4678888999999999999995 5678889999883    334567899999999996 999999999987654  5689


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccCCccc
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLL  972 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~~~  972 (1109)
                      |+||+.+.+......      +++...+...+.++++||.|+|   +.||+|||+||.||++|.. ...+++|+|+|.++
T Consensus       113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence            999999987766553      3667778889999999999999   9999999999999999865 56999999999988


Q ss_pred             CCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-----c
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-----E 1046 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~ 1046 (1109)
                      ......   ...+.+..|.-||.+..- .|+..-|+|||||++..|+..+.||..+.....+++.+++....++     .
T Consensus       184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            655432   235677788999987654 5688999999999999999999999887766666666554332110     0


Q ss_pred             ccccccchhhhH-----------HhhhchhHHH-HHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1047 EINDIVDLSLME-----------EMLVSSIRDQ-VIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1047 ~~~~~~d~~~~~-----------~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ...-..|+....           .+........ ..+.++++.+.+..|-.+|||++|++.|-
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence            001112222211           1111111111 25567777799999999999999998774

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-26  Score=250.64  Aligned_cols=273  Identities=21%  Similarity=0.263  Sum_probs=195.1

Q ss_pred             hCCCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-----C---CceeeEeeEEec--
Q 001275          819 ENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-----H---RNLVRLEDFWLR--  887 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--  887 (1109)
                      .+|.+.++||-|.|++||.|. ....+.||+|+.+  +.+........||+++++++     |   .+||++++.|..  
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK--SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK--SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe--hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            578889999999999999994 4567899999874  33444556788999999983     2   479999999875  


Q ss_pred             --CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-------
Q 001275          888 --KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-------  958 (1109)
Q Consensus       888 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-------  958 (1109)
                        +.+.|+|+|++ |.+|..++..... ..++...+.+|++||+.||.|||.+  .+|+|.||||+|||+...       
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhhh
Confidence              45789999999 5589998877543 3488999999999999999999974  599999999999998410       


Q ss_pred             --------------------------------------------------------------------------------
Q 001275          959 --------------------------------------------------------------------------------  958 (1109)
Q Consensus       959 --------------------------------------------------------------------------------  958 (1109)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             -------------------------------------------------------------------------------C
Q 001275          959 -------------------------------------------------------------------------------M  959 (1109)
Q Consensus       959 -------------------------------------------------------------------------------~  959 (1109)
                                                                                                     -
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                           0


Q ss_pred             cEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc----cccHH
Q 001275          960 EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE----RTDIV 1035 (1109)
Q Consensus       960 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~----~~~~~ 1035 (1109)
                      ++||+|||-|+.....     .+.-..|..|+|||++.+..|++.+||||++|++||++||...|+|..++    +++..
T Consensus       392 ~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi  466 (590)
T KOG1290|consen  392 RVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI  466 (590)
T ss_pred             eEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence            1233333333322111     01124678899999999999999999999999999999999999875332    22222


Q ss_pred             HHHHHh--------hcCccccccccch-----------------hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH
Q 001275         1036 GWVRSV--------WSDTEEINDIVDL-----------------SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM 1090 (1109)
Q Consensus      1036 ~~~~~~--------~~~~~~~~~~~d~-----------------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~ 1090 (1109)
                      ..+...        .......+++++.                 -+.+++  ....+++.++.+++.-|++.+|++||||
T Consensus       467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY--~~s~e~A~~fsdFL~PmLef~PeKR~tA  544 (590)
T KOG1290|consen  467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKY--EWSEEDAQQFSDFLSPMLEFDPEKRPTA  544 (590)
T ss_pred             HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHh--CCCHHHHHHHHHHHHHHHhcCccccccH
Confidence            111111        1111111111111                 111111  1234667888889999999999999999


Q ss_pred             HHHHHHhhhCCCCC
Q 001275         1091 RDVVRQLVDASVPM 1104 (1109)
Q Consensus      1091 ~evl~~L~~~~~~~ 1104 (1109)
                      .+.++|-+-..++.
T Consensus       545 ~~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  545 AQCLKHPWLNPVAG  558 (590)
T ss_pred             HHHhcCccccCCCC
Confidence            99999877654443

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=2.8e-27  Score=259.72  Aligned_cols=198  Identities=26%  Similarity=0.328  Sum_probs=170.0

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeeccc-------ccChHHHHHHHHHHhcCC---CCceeeEeeEEe
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGH-------KRGSLSMKREIQTIGKIR---HRNLVRLEDFWL  886 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  886 (1109)
                      ...|...+.+|+|+||.|+.|.++. ...|+||.+.+...       ......+-.|+++|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3568889999999999999997754 56788888754431       111224567999999997   999999999999


Q ss_pred             cCCceeEEEEec-cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEec
Q 001275          887 RKDCGIIMYRYM-ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISD  965 (1109)
Q Consensus       887 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  965 (1109)
                      +++.+|++||-. ++-+|++++....   .+++.++.-|+.||+.|+++||   +.+|||||||-+||.++.+|.+|++|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence            999999999986 4559999997643   4999999999999999999999   99999999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCC
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALD 1025 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~ 1025 (1109)
                      ||.|....++..    ..++||..|.|||++.+.+| +..-|||++|+++|.++....||+
T Consensus       714 fgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999987755433    34689999999999999988 788999999999999999988875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-28  Score=243.47  Aligned_cols=269  Identities=22%  Similarity=0.296  Sum_probs=190.5

Q ss_pred             CCCCceeecccCeEEEEEEe-CCCcEEEEEEeeec-ccccChHHHHHHHHHHhcCCCCceeeEeeEEecC-----CceeE
Q 001275          821 LNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFR-GHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-----DCGII  893 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l  893 (1109)
                      .+..+.||-|+||.||.+++ ++|+.||.|++..- ..-...+++.+|+.++...+|.|+...++...-.     .+.|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            34567799999999999965 57999999988432 2334567888999999999999999988765432     25688


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ++|.|.. +|..++-.   +..++.+.+.-+.+||++||+|||   +.+|.||||||.|.+++.+...||+|||+|+...
T Consensus       135 ~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence            8888864 77776644   445888888899999999999999   9999999999999999999999999999999764


Q ss_pred             CCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-------
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT------- 1045 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 1045 (1109)
                      .. ....++..+.|..|+|||.+.+. .|+.+.||||.|||+.|++.++..|.....-  +..+.+-......       
T Consensus       208 ~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi--qQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  208 QR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI--EQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             hh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH--HHHHHHHHHhCCCcHHHHHH
Confidence            33 23334456788999999998875 5799999999999999999998877543111  1111111111100       


Q ss_pred             -------cccccc-cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1046 -------EEINDI-VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1046 -------~~~~~~-~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                             ..++.- -.+....-.........-.+.+.+...++..||.+|.+..+++.++-.
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence                   000000 000000000000011122334556678999999999999999988644

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.4e-25  Score=237.52  Aligned_cols=212  Identities=33%  Similarity=0.525  Sum_probs=182.4

Q ss_pred             eecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCHHH
Q 001275          827 IGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD  905 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  905 (1109)
                      ||+|++|.||++.... ++.+++|++...........+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998764 899999998544333235679999999999999999999999999899999999999999999


Q ss_pred             HHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcEEEecccCCcccCCCCCCceeeec
Q 001275          906 VLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEPHISDFGIAKLLDKSPASTTSISV  984 (1109)
Q Consensus       906 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~  984 (1109)
                      ++....  ..+++..+..++.+++++++|||   +.+++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            987642  34889999999999999999999   889999999999999999 89999999999986644321  12234


Q ss_pred             ccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhc
Q 001275          985 VGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063 (1109)
Q Consensus       985 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 1063 (1109)
                      .+...|++||..... .++.++|+|++|++++++                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            678899999988877 788999999999999999                                              


Q ss_pred             hhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1064 ~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                            ..+.+++.+|++.+|++||+++++++++
T Consensus       188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                  3356678899999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=238.65  Aligned_cols=262  Identities=22%  Similarity=0.278  Sum_probs=191.6

Q ss_pred             hCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeec-ccccChHHHHHHHHHHhcCCCCceeeEeeEEecC------Cc
Q 001275          819 ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFR-GHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------DC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  890 (1109)
                      .+|...+.+|.|.- .|..| +.-.++.||+|+.... ......++..+|...+..+.|+||++++.++.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46667788999988 56666 3346889999987433 2344566788999999999999999999998643      35


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .|+|||||.. +|...++.     .++=+....+..|++.|+.|||   +.+|+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhc
Confidence            6999999964 88888773     2566778899999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .-+.   ....+.++.|..|+|||++.+..+.+.+||||.||++.||++|+.-|.+.    ..+.+|.+..-.-+..-..
T Consensus       167 ~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~----d~idQ~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  167 TEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK----DHIDQWNKIIEQLGTPDPS  239 (369)
T ss_pred             ccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc----hHHHHHHHHHHHhcCCCHH
Confidence            5432   23455678999999999999999999999999999999999999877521    2222232221111100000


Q ss_pred             ccc---------------------hhhhHHh----hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1051 IVD---------------------LSLMEEM----LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d---------------------~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      +.+                     .+..+..    ..+..+......-+++.+|+-.+|++|-+++++++|-
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence            000                     0000000    0001111222345577799999999999999999874

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=3.9e-26  Score=244.78  Aligned_cols=270  Identities=24%  Similarity=0.313  Sum_probs=200.2

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCc
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  890 (1109)
                      ...+.|...++||+|.|++||+|...    ..+.||+|.+....   ...++..|++++..+ .+.||+++.+++...+.
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            34467889999999999999999543    47889999885433   345689999999999 59999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcEEEecccCC
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEPHISDFGIA  969 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla  969 (1109)
                      ..+|+||++.....++...      ++..++..++..+..||+++|   +.|||||||||+|++.+. -+.-.|.|||+|
T Consensus       110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhH
Confidence            9999999999999998876      667888999999999999999   999999999999999975 467899999998


Q ss_pred             cccCCCC------------------------------------------CCceeeecccCcccccccccccCC-CCccCc
Q 001275          970 KLLDKSP------------------------------------------ASTTSISVVGTIGYIAPENAFTTA-KSKESD 1006 (1109)
Q Consensus       970 ~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sD 1006 (1109)
                      ...+...                                          .........||+||+|||++...+ .+.++|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7321100                                          000112347999999999887654 589999


Q ss_pred             chhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC--------ccc--ccc----ccchhhhHHh-------h----
Q 001275         1007 VYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD--------TEE--IND----IVDLSLMEEM-------L---- 1061 (1109)
Q Consensus      1007 vwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~----~~d~~~~~~~-------~---- 1061 (1109)
                      |||.|||++-++++++||.....+...+.+.+-.....        .+.  +.+    ...++....+       .    
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            99999999999999999977665555444443221110        000  000    0000000000       0    


Q ss_pred             -----hchhHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1062 -----VSSIRD-QVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1062 -----~~~~~~-~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                           .....+ .....+++..+|++.||.+|.+++|+++|-
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence                 000011 122567788899999999999999999875

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=1.8e-27  Score=250.80  Aligned_cols=314  Identities=24%  Similarity=0.259  Sum_probs=214.1

Q ss_pred             eEEecCCCCcEEEEEecccC---CccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccc
Q 001275           63 GIECDDDAHNVVSFNLSSYG---VSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNF  139 (1109)
Q Consensus        63 gv~C~~~~~~v~~l~l~~~~---l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l  139 (1109)
                      +++|++..+.  .++.++.+   +...+|++      -+.++|..|+|+...|.+|+.+++|++||||+|+|+.+-|++|
T Consensus        40 pC~Cs~~~g~--~VdCr~~GL~eVP~~LP~~------tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF  111 (498)
T KOG4237|consen   40 PCTCSDVEGG--IVDCRGKGLTEVPANLPPE------TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAF  111 (498)
T ss_pred             CcccCCCCCc--eEEccCCCcccCcccCCCc------ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhh
Confidence            4567654432  22334433   34445543      4678888999998778889999999999999999999899999


Q ss_pred             cccCccceecccc-ccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCcc
Q 001275          140 ENLQNLQYLNLYG-NLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQ  218 (1109)
Q Consensus       140 ~~L~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  218 (1109)
                      .+|++|.+|-+.+ |+|+..--..|.+|..|+.|.+.-|++.-...+.|.++++|..|.+.+|.+..+--.+|..+.+++
T Consensus       112 ~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~  191 (498)
T KOG4237|consen  112 KGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIK  191 (498)
T ss_pred             hhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccc
Confidence            9999998888877 888843335667788888888888888877778888888888888888888744444788888888


Q ss_pred             EEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccc-cCCcEEEeecC
Q 001275          219 ELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNC-SSLTHLDIVGS  297 (1109)
Q Consensus       219 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~n  297 (1109)
                      .+.+..|.+.     ...+++.+..- +..      .+..+++.+-..-..+.++++..+-+..|... .++..=..+.+
T Consensus       192 tlhlA~np~i-----cdCnL~wla~~-~a~------~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d  259 (498)
T KOG4237|consen  192 TLHLAQNPFI-----CDCNLPWLADD-LAM------NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSED  259 (498)
T ss_pred             hHhhhcCccc-----cccccchhhhH-Hhh------chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhcccc
Confidence            8888887742     12233322221 111      12234444444455555566554444444321 12211111222


Q ss_pred             CCCCcCC-ccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCc
Q 001275          298 KLTGSIP-SSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFP  376 (1109)
Q Consensus       298 ~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  376 (1109)
                      ...+.-| ..|..+++|+.|+|++|+++++-+.+|.++..+++|+|..|+|...-...|.++..|+.|+|.+|+|+..-|
T Consensus       260 ~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~  339 (498)
T KOG4237|consen  260 FPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAP  339 (498)
T ss_pred             CcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEec
Confidence            2222333 467888888888888888887777888888888888888888876556677778888888888888887777


Q ss_pred             hHHHhhcccceeeccCCccC
Q 001275          377 VSIWRIASLEYLLVYNNNLL  396 (1109)
Q Consensus       377 ~~~~~l~~L~~L~l~~N~l~  396 (1109)
                      .+|..+.+|.+|.|-.|.+.
T Consensus       340 ~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  340 GAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             ccccccceeeeeehccCccc
Confidence            77777777777777777664

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.6e-26  Score=227.53  Aligned_cols=251  Identities=16%  Similarity=0.250  Sum_probs=184.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeE-EecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDF-WLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv  894 (1109)
                      .+.|.+.+.+|+|.||.+-.++++ ..+.+|+|-+..  .....++|.+|+..--.+ .|.||+.-+++ |...+.++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~--p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR--PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc--chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            356888899999999999999775 467788887633  345578899999887777 58999987765 6667788899


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee-CC-CCcEEEecccCCccc
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL-DS-EMEPHISDFGIAKLL  972 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-~~-~~~~kl~DfGla~~~  972 (1109)
                      +||++.|+|.+-+...+    +.+....+++.|++.|++|||   ++++||||||.+|||+ +. ..++|++|||..+..
T Consensus       101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999998776533    778888999999999999999   9999999999999999 33 357999999998755


Q ss_pred             CCCCCCceeeecccCccccccccccc---CC--CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFT---TA--KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      +..     ......+..|.|||....   +.  ..+.+|||.||+++|.++||+.||......+.....|..........
T Consensus       174 g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~  248 (378)
T KOG1345|consen  174 GTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA  248 (378)
T ss_pred             Cce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc
Confidence            322     122345667999995543   22  36789999999999999999999986555555555555443322211


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 1095 (1109)
                      ..+     .        .....++..++-.+-+..+|++|=...++.+
T Consensus       249 ~P~-----~--------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  249 LPK-----K--------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             Cch-----h--------hcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence            111     1        1111223444555778889999844444333

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=4.3e-26  Score=247.10  Aligned_cols=270  Identities=19%  Similarity=0.194  Sum_probs=204.3

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC------CCceeeEeeEEecC
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR------HRNLVRLEDFWLRK  888 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~  888 (1109)
                      ....+|.+....|+|-|++|.+|.. ..|..||||+|...  +.-.+.=.+|++++++++      --|+++++..|...
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            3456888889999999999999965 45789999998533  222334468999999995      35899999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEeccc
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFG  967 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfG  967 (1109)
                      .+.|+|+|-+. -+|.+.++.++..-.+....+..++.|+.-||..|.   ..+|+|.||||+||||++.. ..||||||
T Consensus       507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence            99999999885 499999999888777899999999999999999999   88999999999999999875 47999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh-----
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW----- 1042 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----- 1042 (1109)
                      .|........    +.+..+.-|.|||++.+.+|+...|+||.||++||+.||+..|.+....  ++..+....-     
T Consensus       583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN--~MLrl~me~KGk~p~  656 (752)
T KOG0670|consen  583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN--QMLRLFMELKGKFPN  656 (752)
T ss_pred             cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH--HHHHHHHHhcCCCcH
Confidence            9987654432    2345566799999999999999999999999999999999988543221  1111111110     


Q ss_pred             ---cCccccccccchhh---------------------------hHHh------hhchhHHHHHHHHHHHHhccCCCCCC
Q 001275         1043 ---SDTEEINDIVDLSL---------------------------MEEM------LVSSIRDQVIDVLLVALRCTEKKPSN 1086 (1109)
Q Consensus      1043 ---~~~~~~~~~~d~~~---------------------------~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~ 1086 (1109)
                         ......++.+|..+                           ....      .+......+..+..++..|+..||++
T Consensus       657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K  736 (752)
T KOG0670|consen  657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK  736 (752)
T ss_pred             HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence               00111111111111                           0000      11223344567788888999999999


Q ss_pred             CCCHHHHHHHh
Q 001275         1087 RPNMRDVVRQL 1097 (1109)
Q Consensus      1087 RPs~~evl~~L 1097 (1109)
                      |.+..++++|-
T Consensus       737 Rit~nqAL~Hp  747 (752)
T KOG0670|consen  737 RITVNQALKHP  747 (752)
T ss_pred             cCCHHHHhcCC
Confidence            99999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-26  Score=257.89  Aligned_cols=252  Identities=24%  Similarity=0.310  Sum_probs=195.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...+.+|+|.||.||||+. ..++..|+|+++... .....-+++|+-+++..+|+|||.++|.|...+..++.|||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            5688889999999999999965 568889999885443 33455678899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +.+|+|.+..+..+   .+++.++..+.++..+|++|||   +.+-+|||||-.||++++.|.+|++|||.+..+...  
T Consensus        94 cgggslQdiy~~Tg---plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--  165 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--  165 (829)
T ss_pred             cCCCcccceeeecc---cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhh--
Confidence            99999999887755   4888888999999999999999   999999999999999999999999999998766432  


Q ss_pred             CceeeecccCccccccccc---ccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENA---FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..+...+.||+.|||||+.   ..+.|..++|||+.|+...|+---+.|...-... .  .-...  -.      .-+++
T Consensus       166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-r--~l~Lm--Tk------S~~qp  234 (829)
T KOG0576|consen  166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-R--ALFLM--TK------SGFQP  234 (829)
T ss_pred             hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-H--HHHHh--hc------cCCCC
Confidence            2333457899999999965   4677899999999999999998777765322111 0  00000  00      00111


Q ss_pred             -hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1055 -SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1055 -~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                       .+..+      ......+.+++..|+..+|++||+++.+++|
T Consensus       235 p~lkDk------~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  235 PTLKDK------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             CcccCC------ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence             11111      1122334456668999999999999887764

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-26  Score=244.26  Aligned_cols=397  Identities=22%  Similarity=0.258  Sum_probs=287.5

Q ss_pred             cCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccC-cccCCCCCccccCCCCccEEE
Q 001275          287 SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYA-NQLEGEIPDELGQLSNLQDLE  365 (1109)
Q Consensus       287 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~  365 (1109)
                      +.-+.++|..|+|+...|.+|+.+++|+.||||+|+|+.+-|++|.++++|..|-+.+ |+|+......|+.|..|+.|.
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            3567888999999988888999999999999999999988899999998888887766 889866667888899999999


Q ss_pred             ccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccc
Q 001275          366 LFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTG  445 (1109)
Q Consensus       366 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~  445 (1109)
                      +.-|++.....+.+..+++|..|.+.+|.+...--..|..+..++.+.+..|.+-.     .++++-+.. |+..|    
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~-~~a~~----  216 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLAD-DLAMN----  216 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhhh-HHhhc----
Confidence            99999988888888899999999999998875444478888888888888888532     112222211 11222    


Q ss_pred             cCCCCcccCccceEEECCCcccccCCCcccCCC-CccchhhccCcccCCCCCC--CCCCCCCceEEeecCccCCCCCCcc
Q 001275          446 EIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSC-PTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSI  522 (1109)
Q Consensus       446 ~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~~~--~~~~~~L~~L~Ls~N~i~~~~p~~~  522 (1109)
                        |..+.......-..+.++++...-+..|... ..+..-..+.+...+.-|.  |+++++|+.|+|++|+|+++-+.+|
T Consensus       217 --~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aF  294 (498)
T KOG4237|consen  217 --PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAF  294 (498)
T ss_pred             --hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhh
Confidence              2223333334444455555553333333322 2333333444445555665  9999999999999999999999999


Q ss_pred             cccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccC--------------
Q 001275          523 GNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNG--------------  588 (1109)
Q Consensus       523 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~--------------  588 (1109)
                      .++..+++|.|..|+|...--..|.++..|++|+|.+|+|+-.-|..|..+..|..|.|-.|.+.=              
T Consensus       295 e~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~  374 (498)
T KOG4237|consen  295 EGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKK  374 (498)
T ss_pred             cchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhC
Confidence            999999999999999987667789999999999999999998899999999999999999887750              


Q ss_pred             ---CCCcccccccccceeccccccccC---CCcchhh---------hhhhhhhh-hcccCcCCCCCCCCchhhhhhhhhh
Q 001275          589 ---SIPSSLRSWKSLSILKLSENHFTG---GIPTFIS---------ELEKLLEL-QLGGNQLGGEIPPSIGALQDLSYAL  652 (1109)
Q Consensus       589 ---~~p~~~~~l~~L~~L~L~~N~l~~---~~p~~~~---------~l~~L~~L-~l~~N~l~g~ip~~~~~l~~l~~~L  652 (1109)
                         ..|.. ++-..++.+.++.+.+..   ..|+..+         ..+-+... .-|++.+. .+|..|..=.   .+|
T Consensus       375 ~~~~~~~C-q~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP~d~---tel  449 (498)
T KOG4237|consen  375 SVVGNPRC-QSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIPVDV---TEL  449 (498)
T ss_pred             CCCCCCCC-CCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCCchh---HHH
Confidence               11110 112345566666655432   2222221         12333333 34444444 7777664322   468


Q ss_pred             cccccccccccCcchhhcccCCeEEccCCcccccCCC-CCccccceEEeeecc
Q 001275          653 NLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYN  704 (1109)
Q Consensus       653 ~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~~n  704 (1109)
                      +|.+|.++ .+|.+  .+..| .+|||+|+++..-.. +++++.|.+|.+|+|
T Consensus       450 yl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  450 YLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             hcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            99999999 89988  77888 999999999843223 899999999999987

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=2.6e-24  Score=230.70  Aligned_cols=200  Identities=31%  Similarity=0.410  Sum_probs=171.3

Q ss_pred             CCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEecc
Q 001275          821 LNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      |...+.||+|++|+||+|...+ ++.+|+|.+...........+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567889999999999998765 889999998544332246688999999999999999999999999899999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +++|.+++......  +++..+..++.++++++.+||   +.+++|+|++|+||+++.++.++|+|||.+........ .
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~  154 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A  154 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence            99999999864321  789999999999999999999   88999999999999999999999999999987654321 1


Q ss_pred             eeeecccCccccccccc-ccCCCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          980 TSISVVGTIGYIAPENA-FTTAKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                      ......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22234678899999988 667778899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03210 Resistant to P

Probab=99.91  E-value=7e-24  Score=276.29  Aligned_cols=339  Identities=21%  Similarity=0.274  Sum_probs=221.1

Q ss_pred             CcccccccCCcEEEeecCCC------CCcCCcccccc-ccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCC
Q 001275          280 SPNLGNCSSLTHLDIVGSKL------TGSIPSSFGLL-ARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIP  352 (1109)
Q Consensus       280 ~~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  352 (1109)
                      +.+|.++.+|+.|.+..+..      ...+|..|..+ .+|+.|++.+|.++ .+|..| ...+|+.|++++|++. .++
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence            34566777777777765532      23355555554 35777777777776 566666 4577777777777776 566


Q ss_pred             ccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCC
Q 001275          353 DELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSS  432 (1109)
Q Consensus       353 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~  432 (1109)
                      ..+..+++|+.|+|++|...+.+|. +..+++|+.|++++|.....+|..+..+++|+.|++++|...+.+|..+ .+++
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s  705 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS  705 (1153)
T ss_pred             cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence            6677777778888777654445553 6667777777777777666777777777778888877765555666655 5677


Q ss_pred             CceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccC-------CCCCC-CCCCCCC
Q 001275          433 LMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLT-------GALPE-FSKNPVL  504 (1109)
Q Consensus       433 L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~-------~~~~~-~~~~~~L  504 (1109)
                      |++|++++|.....+|..   ..+|+.|++++|.+. .+|..+ .+++|..|.+.++...       ...+. +...++|
T Consensus       706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL  780 (1153)
T PLN03210        706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL  780 (1153)
T ss_pred             CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence            777777777665555542   356777777777775 455443 4566666666553221       11111 2234567


Q ss_pred             ceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCc
Q 001275          505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN  584 (1109)
Q Consensus       505 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N  584 (1109)
                      +.|++++|...+.+|.+++++++|+.|++++|...+.+|..+ ++++|+.|++++|..-..+|..   ..+|+.|+|++|
T Consensus       781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n  856 (1153)
T PLN03210        781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT  856 (1153)
T ss_pred             hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence            777777777666777777777777777777765444566555 5777777777776544445543   256777777777


Q ss_pred             cccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCc
Q 001275          585 LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQ  633 (1109)
Q Consensus       585 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~  633 (1109)
                      .|+ .+|.++..+++|+.|++++|.--..+|..+..+++|+.|++++|.
T Consensus       857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence            776 567777777777777777633222566666666777777776664

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=2.4e-23  Score=271.33  Aligned_cols=338  Identities=24%  Similarity=0.280  Sum_probs=267.2

Q ss_pred             cccccCCCCcchhccccccc------cCCCCccccccc-CCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCC
Q 001275          256 NFGSEKCKNLTFLDLSYNRF------SGGISPNLGNCS-SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIP  328 (1109)
Q Consensus       256 ~~~~~~l~~L~~L~Ls~N~l------~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  328 (1109)
                      +..|.++++|+.|.+..+..      ...+|..|..++ +|+.|++.++.++ .+|..| .+.+|+.|++++|++. .++
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~  627 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLW  627 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccc
Confidence            34567778888887765532      234566666654 6999999998887 567766 4688999999999987 677


Q ss_pred             CccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCC
Q 001275          329 PELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQ  408 (1109)
Q Consensus       329 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  408 (1109)
                      ..+..+++|+.|+|+++...+.+|. ++.+++|++|+|++|.....+|..+..+++|+.|++++|...+.+|..+ ++++
T Consensus       628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s  705 (1153)
T PLN03210        628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS  705 (1153)
T ss_pred             cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence            8888899999999998765556774 7888999999999987666889999999999999999987666777765 7889


Q ss_pred             CCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCccc-------ccCCCcccCCCCcc
Q 001275          409 LKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQF-------HGPIPSLLGSCPTL  481 (1109)
Q Consensus       409 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l-------~~~~p~~~~~l~~L  481 (1109)
                      |+.|++++|...+.+|..   ..+|++|++++|.++ .+|..+ .+.+|+.|++.++..       ....|......++|
T Consensus       706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL  780 (1153)
T PLN03210        706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL  780 (1153)
T ss_pred             CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence            999999998766666653   467899999999987 566654 567888888877432       22223333445789


Q ss_pred             chhhccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccc
Q 001275          482 WRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLN  560 (1109)
Q Consensus       482 ~~l~l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  560 (1109)
                      +.|++++|...+.+|. ++.+++|+.|++++|...+.+|..+ ++++|+.|++++|.....+|..   ..+|+.|+|++|
T Consensus       781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n  856 (1153)
T PLN03210        781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT  856 (1153)
T ss_pred             hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence            9999999987777776 8999999999999986656888877 7899999999998665555543   367999999999


Q ss_pred             cccccCCccccCCCCccEEEecC-ccccCCCCcccccccccceecccccc
Q 001275          561 HVEGSLPSQLSKCKNLEVFDVSF-NLLNGSIPSSLRSWKSLSILKLSENH  609 (1109)
Q Consensus       561 ~l~~~~p~~l~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~  609 (1109)
                      .|+ .+|..+..+++|+.|++++ |++. .+|..+..+++|+.+++++|.
T Consensus       857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            998 7899999999999999998 6676 688889999999999998874

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.6e-23  Score=252.31  Aligned_cols=58  Identities=33%  Similarity=0.329  Sum_probs=27.7

Q ss_pred             hcccccccccccCcchhhcccCCeEEccCCcccccCCC-CCccccceEEeeeccccccccchhh
Q 001275          652 LNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFTGPVPETL  714 (1109)
Q Consensus       652 L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~~n~l~g~~p~~~  714 (1109)
                      |++++|+|+ .+|...   .+|+.|+|++|+|+ .+|. +.+++.|+.+++++|+|+|.+|..+
T Consensus       407 LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        407 LMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             EEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            445555544 244322   23444555555554 3343 4445555555555555555555444

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=3.4e-23  Score=249.60  Aligned_cols=126  Identities=26%  Similarity=0.317  Sum_probs=77.2

Q ss_pred             CCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEec
Q 001275          503 VLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVS  582 (1109)
Q Consensus       503 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls  582 (1109)
                      +|++|+|++|+|+ .+|...   .+|+.|++++|+|++ +|..   ..+|+.|++++|+|+ .+|...   ++|+.|+++
T Consensus       343 ~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS  410 (788)
T PRK15387        343 GLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVLP---SELKELMVS  410 (788)
T ss_pred             ccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCcc---cCCCEEEcc
Confidence            4555666666665 234322   345556666666663 4432   235666666666666 344332   467777777


Q ss_pred             CccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhh
Q 001275          583 FNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGAL  645 (1109)
Q Consensus       583 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l  645 (1109)
                      +|+|+ .+|...   .+|+.|++++|+++ .+|..+..+++|+.|+|++|+|+|.+|..+..+
T Consensus       411 ~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        411 GNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             CCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            77776 456432   35667777777777 677777777777777888888777666655443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.89  E-value=9.1e-24  Score=267.58  Aligned_cols=199  Identities=17%  Similarity=0.214  Sum_probs=139.3

Q ss_pred             cCCC-CceeeEeeEE-------ecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 001275          872 KIRH-RNLVRLEDFW-------LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI  943 (1109)
Q Consensus       872 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  943 (1109)
                      ..+| +||+++++++       ...+..+.++||+ +++|.++++..  ...+++.+++.++.||++||+|||   +++|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            3445 5777788876       2234567888887 55999999753  234899999999999999999999   8999


Q ss_pred             EEeccCCCCeeeCC-------------------CCcEEEecccCCcccCCCCC--------------CceeeecccCccc
Q 001275          944 VHRDIKPENILLDS-------------------EMEPHISDFGIAKLLDKSPA--------------STTSISVVGTIGY  990 (1109)
Q Consensus       944 vH~Dlk~~NIll~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y  990 (1109)
                      +||||||+|||++.                   ++.+|++|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999964                   34566666666653211000              0001124688899


Q ss_pred             ccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHH
Q 001275          991 IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVI 1070 (1109)
Q Consensus       991 ~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 1070 (1109)
                      ||||++.+..++.++|||||||++|||++|..|+....   .....+..          ....+.         ......
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~----------~~~~~~---------~~~~~~  239 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRH----------RVLPPQ---------ILLNWP  239 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHH----------hhcChh---------hhhcCH
Confidence            99999999999999999999999999999887753211   00000000          000110         011123


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1071 DVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1071 ~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      +...++.+|++.+|.+||+|.|+++|-.
T Consensus       240 ~~~~~~~~~L~~~P~~Rps~~eil~h~~  267 (793)
T PLN00181        240 KEASFCLWLLHPEPSCRPSMSELLQSEF  267 (793)
T ss_pred             HHHHHHHHhCCCChhhCcChHHHhhchh
Confidence            3456777999999999999999998754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.88  E-value=1.8e-22  Score=207.68  Aligned_cols=169  Identities=19%  Similarity=0.182  Sum_probs=125.4

Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCce
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |+|.++++..+  ..+++..++.++.|+++||+|||   +.+      ||+||+++.++.+|+  ||.++......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc----
Confidence            78999997643  34899999999999999999999   555      999999999999999  99998664321    


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                         ..||+.|+|||++.+..++.++|||||||++|||++|+.||............+....... ...    +.....  
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~--  133 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD-DPR----DRSNLE--  133 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC-Ccc----ccccHH--
Confidence               2588999999999999999999999999999999999999864322222222221111100 000    000000  


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                          ......++.+++.+|++.+|++||++.|+++++...
T Consensus       134 ----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      134 ----SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ----HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                001112578888999999999999999999998765

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=1.8e-21  Score=236.67  Aligned_cols=289  Identities=27%  Similarity=0.384  Sum_probs=177.3

Q ss_pred             CCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeec
Q 001275          119 SALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL  198 (1109)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  198 (1109)
                      .+.+.|++++++++ .+|..+.  ++|+.|+|++|+++ .+|..+.  .+|++|++++|+++ .+|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence            34566666666666 3555442  45666777777666 4555543  36677777777666 3454443  35677777


Q ss_pred             ccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCC
Q 001275          199 FSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGG  278 (1109)
Q Consensus       199 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  278 (1109)
                      ++|+++ .+|..+.  ++|+.|++++|+++. +|+.+.  ++|+.|++++|+|++. |..+  .++|+.|++++|.++. 
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l--p~sL~~L~Ls~N~Lt~-  318 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTL-PAHL--PSGITHLNVQSNSLTA-  318 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccC-cccc--hhhHHHHHhcCCcccc-
Confidence            777776 4555553  467777777777764 455443  3677777777777753 2222  2467777788877774 


Q ss_pred             CCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCC
Q 001275          279 ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL  358 (1109)
Q Consensus       279 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  358 (1109)
                      +|..+  .++|+.|++++|.+++ +|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|+|++|+++ .+|..+.  
T Consensus       319 LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--  387 (754)
T PRK15370        319 LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--  387 (754)
T ss_pred             CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--
Confidence            34333  2577888888888774 555443  67888888888887 4665553  57888888888887 4565543  


Q ss_pred             CCccEEEccCccccccCchHHHh----hcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcc-cCCccccCCCCC
Q 001275          359 SNLQDLELFDNRLTGEFPVSIWR----IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSG-VIPQSLGINSSL  433 (1109)
Q Consensus       359 ~~L~~L~L~~N~l~~~~~~~~~~----l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~~~L  433 (1109)
                      ..|+.|++++|+|+ .+|..+..    ++++..|++.+|.++.      ..+.+|+.| ++.+.+.| .++...+..+.+
T Consensus       388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l  459 (754)
T PRK15370        388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIV  459 (754)
T ss_pred             HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCcccccccccccc
Confidence            36888888888887 45655443    4677888888888762      233344444 34455444 334444444455


Q ss_pred             ceEEecCCcccc
Q 001275          434 MQLDFINNSFTG  445 (1109)
Q Consensus       434 ~~L~ls~N~l~~  445 (1109)
                      +....-.+.+.+
T Consensus       460 ~~~~~l~~a~~~  471 (754)
T PRK15370        460 RVTRPLHQAVQG  471 (754)
T ss_pred             cccchHHHHHhc
Confidence            444434444443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=1.3e-21  Score=219.19  Aligned_cols=166  Identities=20%  Similarity=0.210  Sum_probs=129.0

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC--CCcEEEEEEeeecc----cccChHHHHHHHHHHhcCCCCceee-EeeEEecCC
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG--PNAVFAVKKLAFRG----HKRGSLSMKREIQTIGKIRHRNLVR-LEDFWLRKD  889 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  889 (1109)
                      ...+|...+.||+|+||+||+|...  +++.||||++....    .......+.+|++++++++|+|+++ ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            3467999999999999999999764  57888999874221    1223456899999999999999985 4432    4


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEecc-CCCCeeeCCCCcEEEecccC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDI-KPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DfGl  968 (1109)
                      ..++||||+++++|... ..      ..   ...++.++++||+|||   +.+|+|||| ||+||+++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            57999999999999732 11      01   1467889999999999   899999999 99999999999999999999


Q ss_pred             CcccCCCCCCce------eeecccCcccccccccccC
Q 001275          969 AKLLDKSPASTT------SISVVGTIGYIAPENAFTT  999 (1109)
Q Consensus       969 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  999 (1109)
                      |+.+........      .....+++.|+|||++...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            997754432111      1345788899999988644

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=1.5e-21  Score=237.47  Aligned_cols=224  Identities=26%  Similarity=0.454  Sum_probs=125.9

Q ss_pred             ccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeec
Q 001275          311 ARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLV  390 (1109)
Q Consensus       311 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  390 (1109)
                      .+.+.|+++++.++ .+|..+.  +.|+.|+|++|+++ .+|..+.  ++|++|++++|+|+ .+|..+.  .+|+.|++
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence            45678999999988 5676553  57888999999888 5665543  57888888888887 4565443  35677777


Q ss_pred             cCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccC
Q 001275          391 YNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGP  470 (1109)
Q Consensus       391 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~  470 (1109)
                      ++|++. .+|..+.  ++|+.|++++|+++ .+|..+.  .                        +|+.|++++|+|++ 
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~------------------------sL~~L~Ls~N~Lt~-  297 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--E------------------------ELRYLSVYDNSIRT-  297 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--C------------------------CCcEEECCCCcccc-
Confidence            777766 4454443  35556666666555 2343332  2                        44555555555542 


Q ss_pred             CCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhccc
Q 001275          471 IPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLV  550 (1109)
Q Consensus       471 ~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  550 (1109)
                      +|..+.  ++|+.|++++|+++..++.+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+ .+|..+.  +
T Consensus       298 LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~  367 (754)
T PRK15370        298 LPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--P  367 (754)
T ss_pred             Ccccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--C
Confidence            232221  245555666666554322221  456666666666653 454442  45666666666655 2444332  3


Q ss_pred             ccceeecccccccccCCccccCCCCccEEEecCcccc
Q 001275          551 SLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLN  587 (1109)
Q Consensus       551 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~  587 (1109)
                      +|+.|+|++|+|+ .+|..+.  ..|+.||+++|+|+
T Consensus       368 ~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~  401 (754)
T PRK15370        368 TITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV  401 (754)
T ss_pred             CcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc
Confidence            4555555555554 3343332  23444455555444

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=5.8e-22  Score=198.78  Aligned_cols=251  Identities=20%  Similarity=0.282  Sum_probs=183.5

Q ss_pred             CCCCceeecccCeEEEEEEeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEecc
Q 001275          821 LNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      .+...+|.+...|+.|+|+++.+ .+++|++.... .....++|..|+-.++-+.||||+.++|.|.......++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            34455688899999999999844 44667664433 33445789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      .|+|+..+++.. .-..+-.++.+++.++|+|++|||+. .+-|..--+.+..|++|++.+++|.- +-++      ...
T Consensus       271 ~gslynvlhe~t-~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~k------fsf  341 (448)
T KOG0195|consen  271 FGSLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTK------FSF  341 (448)
T ss_pred             chHHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccce------eee
Confidence            999999999744 33466778899999999999999943 33344456899999999999887751 1111      111


Q ss_pred             eeeecccCcccccccccccCCCC---ccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          980 TSISVVGTIGYIAPENAFTTAKS---KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      ...+..-.+.||+||.+..++.+   .++|+|||++++||+.|...||..-..-+....-    .   .+.++..+.   
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----a---leglrv~ip---  411 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----A---LEGLRVHIP---  411 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----h---hccccccCC---
Confidence            22234567899999998877653   5899999999999999999999653221111000    0   011111111   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                               +-....+.+++.-|+.+||.+||.++.++-.|++-
T Consensus       412 ---------pgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  412 ---------PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ---------CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                     11233466677789999999999999999888764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=4.6e-20  Score=208.41  Aligned_cols=259  Identities=21%  Similarity=0.260  Sum_probs=188.4

Q ss_pred             CCCCCceeecccCeEEEEEEeCCC--cEEEEEEeeecccccChHHHHHHHHHHhcCCC----CceeeEeeEE-ecCCcee
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGPN--AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH----RNLVRLEDFW-LRKDCGI  892 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~  892 (1109)
                      +|.+.++||+|+||.||.|.....  ..+|+|........... .+..|..++..+..    +++.++++.+ ......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            799999999999999999976653  47888876544333333 67888888888863    6889999988 4777889


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-----CcEEEeccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-----MEPHISDFG  967 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~DfG  967 (1109)
                      +||+.+ |.+|.++..... ...++..++.+|+.|++.+|+++|   +.+++||||||.|+.+...     ..+.+.|||
T Consensus        98 iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            999887 669999876654 567999999999999999999999   9999999999999999765     469999999


Q ss_pred             CCcccC--CCCC-----Cce-eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHH
Q 001275          968 IAKLLD--KSPA-----STT-SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       968 la~~~~--~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      +++...  ....     ... .....||.+|+++....+.+.+.+.|+||++.++.|+..|..||........ ......
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~  251 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEK  251 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHH
Confidence            998332  1111     111 2345699999999999999999999999999999999999999854321111 111100


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ....      .....      .....+.+   +.++...+-..+..++|....+...+.+.
T Consensus       252 ~~~~------~~~~~------~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  252 DPRK------LLTDR------FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             Hhhh------hcccc------ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            0000      00000      00111222   33333344457888999999998887655

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.84  E-value=1.9e-22  Score=189.16  Aligned_cols=186  Identities=30%  Similarity=0.527  Sum_probs=163.6

Q ss_pred             cccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccce
Q 001275          523 GNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI  602 (1109)
Q Consensus       523 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  602 (1109)
                      .++.+.+.|.||+|+++ .+|..++.|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. .+|..|++++.|+.
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            35677888889999998 67888999999999999999998 78999999999999999999998 88999999999999


Q ss_pred             eccccccccC-CCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCC
Q 001275          603 LKLSENHFTG-GIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSN  681 (1109)
Q Consensus       603 L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N  681 (1109)
                      |||.+|++.. .+|..|-.++.|+.|+|++|.|. .+|+.+|++++| +.|.+..|.+- ++|.+++.++.|++|++.+|
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~l-qil~lrdndll-~lpkeig~lt~lrelhiqgn  183 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNL-QILSLRDNDLL-SLPKEIGDLTRLRELHIQGN  183 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcce-eEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence            9999999874 58999999999999999999998 899999999999 47999999999 89999999999999999999


Q ss_pred             cccccCCCCCccccc---eEEeeeccccccccchhh
Q 001275          682 NLTGTLSPLSNIHSL---VEVNVSYNLFTGPVPETL  714 (1109)
Q Consensus       682 ~l~g~~~~l~~~~~l---~~l~~~~n~l~g~~p~~~  714 (1109)
                      +|+-.+|.++++.-+   +.+.+.+|++-.+|-+++
T Consensus       184 rl~vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQf  219 (264)
T KOG0617|consen  184 RLTVLPPELANLDLVGNKQVMRMEENPWVNPIAEQF  219 (264)
T ss_pred             eeeecChhhhhhhhhhhHHHHhhhhCCCCChHHHHH
Confidence            999766668776433   457788899888877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2e-21  Score=232.33  Aligned_cols=259  Identities=20%  Similarity=0.212  Sum_probs=190.3

Q ss_pred             CCCceeecccCeEEEEEEe-CCCcEEEEEEeeec--c---cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          822 NAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFR--G---HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ...+++|.|++|.|+.+.. ......+.|.....  .   .......+..|+-+-..+.|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3467799999998887743 33444444443211  1   1111223667888888999999988887777766666669


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++ +|+.++....   .++..++..++.|+..|++|+|   +.+|.|||+|++|++++.++.+||+|||.+.....+
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999987642   3778889999999999999999   999999999999999999999999999999877555


Q ss_pred             CCC--ceeeecccCcccccccccccCCCC-ccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          976 PAS--TTSISVVGTIGYIAPENAFTTAKS-KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       976 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ...  ....+.+|+..|+|||+..+..|+ ...||||.|+++..|++|+.||............-.     .........
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-----~~~~~~~~~  548 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-----YSDQRNIFE  548 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-----ccccccccc
Confidence            443  445678999999999999999995 578999999999999999999976544433220000     000000000


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .       ...-......+...++.+|++.||++|.+++++++.=|-
T Consensus       549 ~-------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~  588 (601)
T KOG0590|consen  549 G-------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI  588 (601)
T ss_pred             C-------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence            0       011123444556678889999999999999999876443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=2.4e-19  Score=185.74  Aligned_cols=199  Identities=21%  Similarity=0.317  Sum_probs=169.7

Q ss_pred             CCCCCceeecccCeEEEEEE-eCCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .|++.++||+|.||..+.|+ +-+++.||||.-.   .+.....+..|.+..+.+ ..++|...+.|..++-+-.+|+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP---rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP---RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecc---ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            67889999999999999994 4579999999653   333445678899988888 578999998888888888999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-----cEEEecccCCccc
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-----EPHISDFGIAKLL  972 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~DfGla~~~  972 (1109)
                      + |-||.|.+.-++.  .++.+++..||.|++.-++|+|   ++..|.|||||+|+||...+     .+.++|||+|+.+
T Consensus       106 L-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 5699998877654  4899999999999999999999   89999999999999997543     4899999999988


Q ss_pred             CCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          973 DKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       973 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      .+....     .......||.+||+-.-..+++.+.+.|.=|+|-++.+.+.|..||.+-
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            655432     2334568999999999999999999999999999999999999999764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.81  E-value=7.7e-19  Score=200.35  Aligned_cols=261  Identities=29%  Similarity=0.395  Sum_probs=196.3

Q ss_pred             CCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccccc--ChHHHHHHHHHHhcCCCC-ceeeEeeEEecCCceeEEEEe
Q 001275          821 LNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR--GSLSMKREIQTIGKIRHR-NLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      |...+.+|.|+||.||++...  ..+++|.+.......  ....+.+|+..+..+.|+ +++++.+++......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            566788999999999999877  788999886655544  367899999999999988 799999999777778999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~  976 (1109)
                      +.++++.+++........+.......++.|++.+++|+|   ..+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977765331125888999999999999999999   88899999999999999988 79999999998654433


Q ss_pred             CCc----eeeecccCccccccccccc---CCCCccCcchhhHHHHHHHHhCCCCCCCCccc--cccHHHHHHHhhcCccc
Q 001275          977 AST----TSISVVGTIGYIAPENAFT---TAKSKESDVYSYGVVLLELITRKKALDPSYKE--RTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       977 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 1047 (1109)
                      ...    ......|+..|+|||.+.+   ..+....|+||+|++++++++|..|+......  .......+......  .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~  234 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--S  234 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--c
Confidence            221    2345789999999999987   57899999999999999999999996543321  11111111111110  0


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..........        ......+.+++..|+..+|..|.++.+...+
T Consensus       235 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNP--------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCcccc--------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0000000000        1112345567778999999999999887765

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=5.3e-19  Score=175.24  Aligned_cols=201  Identities=20%  Similarity=0.281  Sum_probs=166.8

Q ss_pred             hhCCCCCceeecccCeEEEEE-EeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCC-CceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH-RNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ..+|.+.++||+|+||.+|.| ...+|+.||||.-.   .......+..|..+.+.++| ..|..+..|..+++.-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es---~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES---SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeec---ccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            367999999999999999999 55789999999753   33334467788899988864 56777777888888899999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC---CcEEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla~~~  972 (1109)
                      |.. |.||.+.+.....  .++.++++..|-|++.-++|+|   .++++||||||+|+|..-+   ..+.++|||+|+.+
T Consensus        91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            998 5699998876543  3888999999999999999999   8999999999999999643   46899999999877


Q ss_pred             CCCCC-----CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          973 DKSPA-----STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       973 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      .+...     ........||.+|.+-....+...+.+.|+=|+|.++.++-.|..||.+.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            54322     12234568999999988888888899999999999999999999999764

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=9.6e-21  Score=177.80  Aligned_cols=177  Identities=29%  Similarity=0.492  Sum_probs=88.4

Q ss_pred             CCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEE
Q 001275          501 NPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFD  580 (1109)
Q Consensus       501 ~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  580 (1109)
                      +...+.|.||+|+++ .+|..|.++.+|+.|++++|+++ ..|..+..+++|+.|+++-|++. .+|..|+.++.|++||
T Consensus        32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld  108 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD  108 (264)
T ss_pred             hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence            333444444444444 44444555555555555555554 34445555555555555555554 4555555555555555


Q ss_pred             ecCccccC-CCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhccccccc
Q 001275          581 VSFNLLNG-SIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGL  659 (1109)
Q Consensus       581 ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l  659 (1109)
                      |++|+++. .+|..|..+..|+-|+|++|.|. .+|..++.+++|+.|.+.+|.+. ++|.++|.++.|. .|++.+|++
T Consensus       109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lr-elhiqgnrl  185 (264)
T KOG0617|consen  109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLR-ELHIQGNRL  185 (264)
T ss_pred             ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHH-HHhccccee
Confidence            55555442 34444555555555555555555 45555555555555555555554 4555555555552 455555555


Q ss_pred             ccccCcchhhccc---CCeEEccCCccc
Q 001275          660 TGRIPSDLEKLSK---LEQLDISSNNLT  684 (1109)
Q Consensus       660 ~g~ip~~l~~l~~---L~~L~Ls~N~l~  684 (1109)
                      + .+|++++++.-   =+.+.+.+|..-
T Consensus       186 ~-vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  186 T-VLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             e-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            5 45555544332   123444555544

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=2.6e-19  Score=186.15  Aligned_cols=171  Identities=16%  Similarity=0.190  Sum_probs=132.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccC--hH------HHHHHHHHHhcCCCCceeeEeeEEecC-
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRG--SL------SMKREIQTIGKIRHRNLVRLEDFWLRK-  888 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~------~~~~E~~~l~~l~h~niv~l~~~~~~~-  888 (1109)
                      ..+|+..+++|.|+||.||.+.. ++..+|+|.+........  ..      .+++|++.+.+++|++|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            57899999999999999999866 477899999854322211  11      268999999999999999998886533 


Q ss_pred             -------CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          889 -------DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       889 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                             ...++||||++|.+|.++..       .+.    ....+++.++..+|   ..+++|||+||+||+++.++ +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence                   35789999999999988732       222    34568999999999   99999999999999999988 9


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ell 1018 (1109)
                      +++|||...........              ..+...+.+..++|+|++|+++....
T Consensus       174 ~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988755321110              11445566778999999999876654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=9.8e-19  Score=180.60  Aligned_cols=141  Identities=16%  Similarity=0.161  Sum_probs=108.7

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeeccccc-C-------h-----------------HHHHHHHHHHhcCCCCce
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR-G-------S-----------------LSMKREIQTIGKIRHRNL  878 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~-------~-----------------~~~~~E~~~l~~l~h~ni  878 (1109)
                      ...||+|+||.||+|...+|+.||||++....... .       .                 ....+|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999988889999999986532111 1       1                 122459999999988776


Q ss_pred             eeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEEeccCCCCeeeCC
Q 001275          879 VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL-HYDCDPPIVHRDIKPENILLDS  957 (1109)
Q Consensus       879 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk~~NIll~~  957 (1109)
                      .....+..  ...++||||++++++.......   ..+++.....++.|++.+++|+ |   +.+|+||||||+||+++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence            44333322  2348999999998776543221   2478899999999999999999 7   78999999999999998 


Q ss_pred             CCcEEEecccCCcccC
Q 001275          958 EMEPHISDFGIAKLLD  973 (1109)
Q Consensus       958 ~~~~kl~DfGla~~~~  973 (1109)
                      ++.++++|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=2.6e-19  Score=211.05  Aligned_cols=252  Identities=20%  Similarity=0.240  Sum_probs=180.5

Q ss_pred             CCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHH--hcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTI--GKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++...+.+|++.|=+|.+|+.+.|. |+||++.+....-....|.++++-.  ...+|||++++.-+-......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            5667888999999999999999887 7999996665555555555544443  444899999998887777788999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC-CCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD-KSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~-~~~  976 (1109)
                      +.+ +|+|.+..   ++.+...+.+-|+.|+..|+..+|   ..+|+|||||.+|||++.-.-+.|+||.--+... ..+
T Consensus       103 vkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            976 99998865   335777888899999999999999   9999999999999999999999999997654321 112


Q ss_pred             CCceeeeccc----CcccccccccccC----------C-CCccCcchhhHHHHHHHHhC-CCCCCCCccccccHHHHHHH
Q 001275          977 ASTTSISVVG----TIGYIAPENAFTT----------A-KSKESDVYSYGVVLLELITR-KKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       977 ~~~~~~~~~g----t~~y~aPE~~~~~----------~-~~~~sDvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      .+.....+..    -..|.|||-+...          . .+++-||||+||++.|+++- +++|.-        .+...-
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL~aY  247 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQLLAY  247 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHHHhH
Confidence            2222222222    2369999955431          1 46789999999999999985 666632        111111


Q ss_pred             hhcCccccccccch-hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1041 VWSDTEEINDIVDL-SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ....     + .++ ...++.     ++  ..+..+++.|++.||++|.++++.++.-+..
T Consensus       248 r~~~-----~-~~~e~~Le~I-----ed--~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  248 RSGN-----A-DDPEQLLEKI-----ED--VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             hccC-----c-cCHHHHHHhC-----cC--ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            0000     0 011 111111     11  1455678899999999999999999986654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=3.6e-18  Score=194.20  Aligned_cols=216  Identities=24%  Similarity=0.414  Sum_probs=161.6

Q ss_pred             HhcCCCCceeeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-EEecc
Q 001275          870 IGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI-VHRDI  948 (1109)
Q Consensus       870 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~Dl  948 (1109)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+..  ....++|.....++.++++|++|+|   ..+| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeee
Confidence            4678999999999999999999999999999999999976  2345899999999999999999999   4454 89999


Q ss_pred             CCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCC-------CCccCcchhhHHHHHHHHhCC
Q 001275          949 KPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA-------KSKESDVYSYGVVLLELITRK 1021 (1109)
Q Consensus       949 k~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDvwSlGvil~elltg~ 1021 (1109)
                      +++|.+++..+.+|++|||+.................-..-|.|||.+....       .+.++||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            9999999999999999999988664311111122223445799999887641       367899999999999999999


Q ss_pred             CCCCCCccccc--cHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1022 KALDPSYKERT--DIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1022 ~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .||+.......  .+..+++..  ...    ..-|.+...      .+...++..++.+||..+|++||+++++-..++.
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~--~~~----~~rP~i~~~------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKG--GSN----PFRPSIELL------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             CccccccccCChHHHHHHHHhc--CCC----CcCcchhhh------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            99976432222  222222220  111    111111100      0223367888889999999999999999988877


Q ss_pred             CCC
Q 001275         1100 ASV 1102 (1109)
Q Consensus      1100 ~~~ 1102 (1109)
                      +..
T Consensus       224 ~~~  226 (484)
T KOG1023|consen  224 INK  226 (484)
T ss_pred             hcc
Confidence            633

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=3.9e-18  Score=172.99  Aligned_cols=188  Identities=14%  Similarity=0.116  Sum_probs=138.9

Q ss_pred             CCCceeecccCeEEEEEEeCCCcEEEEEEeeeccccc---ChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEEEe
Q 001275          822 NAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR---GSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+...|++|+||+||.+.. ++.+++.+.+.......   ....+.+|++++++++ |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998766 57787777664333211   1225789999999995 5889999886    446999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEecc-CCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDI-KPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      ++|.+|.+....          ....++.|++++++++|   ..+|+|||| ||+||++++++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998754321          11357789999999999   899999999 7999999999999999999998654332


Q ss_pred             CC----ce-------eeecccCcccccccccccC-CCC-ccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          977 AS----TT-------SISVVGTIGYIAPENAFTT-AKS-KESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       977 ~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      ..    ..       ......++.|++|+-..-- ..+ ...+.++-|.-+|.++|++.+....
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            10    00       1123467778888733221 222 5678899999999999999887543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=9.9e-18  Score=174.03  Aligned_cols=141  Identities=20%  Similarity=0.233  Sum_probs=110.8

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeeccccc--------------------C-----hHHHHHHHHHHhcCCCCce
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR--------------------G-----SLSMKREIQTIGKIRHRNL  878 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~-----~~~~~~E~~~l~~l~h~ni  878 (1109)
                      ...||+|+||.||+|...+|+.||||++.......                    .     ...+.+|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999987789999999986542110                    0     1124678999999999987


Q ss_pred             eeEeeEEecCCceeEEEEeccCCCHHHH-HhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeC
Q 001275          879 VRLEDFWLRKDCGIIMYRYMENGSLRDV-LHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLD  956 (1109)
Q Consensus       879 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~  956 (1109)
                      .....+...  ..++||||++++++... +..    ..++.....+++.+++.++.++|   + .+|+||||||+||+++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE
Confidence            554444332  34899999998865433 332    23677889999999999999999   7 8999999999999999


Q ss_pred             CCCcEEEecccCCcccCC
Q 001275          957 SEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~  974 (1109)
                       ++.++|+|||++.....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             88999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=5e-20  Score=209.23  Aligned_cols=282  Identities=24%  Similarity=0.257  Sum_probs=134.3

Q ss_pred             eecCCCccc-ccCCCCCCCCCCCcEeeccCccccC----CCCccccccCccceeccccccccccCCcccccccccceecc
Q 001275          100 IDLSSNNFS-GNIPPKLGNCSALEYLDLSTNGFTG----DIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFL  174 (1109)
Q Consensus       100 L~L~~n~l~-~~~p~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  174 (1109)
                      |+|..+.++ +..+..+..+..|++|+++++.++.    .++..+...++|++|+++++.+.+ .+..+           
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~-----------   70 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL-----------   70 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH-----------
Confidence            455555555 2333344455556666666666532    133344445555555555554431 01000           


Q ss_pred             cccccccccccccCCCcccceeecccccCCCCcccccccccC---ccEEEeccccccC----cCchhcccc-cccccccc
Q 001275          175 NNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYR---LQELYLNENKLMG----FLPESLSNL-ENLVYLDV  246 (1109)
Q Consensus       175 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~~~~l~~l-~~L~~L~L  246 (1109)
                            ..++..+..+++|++|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|+.|++
T Consensus        71 ------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L  144 (319)
T cd00116          71 ------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL  144 (319)
T ss_pred             ------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEc
Confidence                  123344445556666666666665544444444444   6666666666552    122233344 45555555


Q ss_pred             cCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCc----CCccccccccccEEEcCCCC
Q 001275          247 GDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGS----IPSSFGLLARLSSLDLSENQ  322 (1109)
Q Consensus       247 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~  322 (1109)
                      ++|.+++....                    .++..+..+++|++|++++|.+++.    ++..+..+++|+.|++++|.
T Consensus       145 ~~n~l~~~~~~--------------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~  204 (319)
T cd00116         145 GRNRLEGASCE--------------------ALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG  204 (319)
T ss_pred             CCCcCCchHHH--------------------HHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCc
Confidence            55555421110                    0111222333444444444444321    11222233355555555555


Q ss_pred             CCCC----CCCccccccccceeeccCcccCCCCCcccc-----CCCCccEEEccCccccc----cCchHHHhhcccceee
Q 001275          323 LSGK----IPPELGKCKYLTVLHLYANQLEGEIPDELG-----QLSNLQDLELFDNRLTG----EFPVSIWRIASLEYLL  389 (1109)
Q Consensus       323 l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~  389 (1109)
                      +++.    ++..+..+++|++|++++|.+++.....+.     ..++|++|++++|.+++    .+...+..+++|++++
T Consensus       205 i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~  284 (319)
T cd00116         205 LTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELD  284 (319)
T ss_pred             cChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEE
Confidence            4422    122334455566666666555542222221     12566677777766652    1223344456677777


Q ss_pred             ccCCccCCC----Cchhhhcc-CCCCeEEccCCcC
Q 001275          390 VYNNNLLGK----LPLEMTEL-KQLKNISLYNNQF  419 (1109)
Q Consensus       390 l~~N~l~~~----~~~~~~~l-~~L~~L~L~~N~l  419 (1109)
                      +++|.+...    ....+... +.|++|++.+|++
T Consensus       285 l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         285 LRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            777777644    22333333 5777777777754

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=7.1e-18  Score=204.51  Aligned_cols=196  Identities=18%  Similarity=0.226  Sum_probs=163.2

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC---CCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR---HRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .+.|.+.+.+|+|+||+||+|...+|+.||+|+-+..    ...+|.-=.+++.|++   -+-|..+..++.-.+..++|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~----~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPP----NPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCC----CceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            3567788899999999999998888999999976332    2333433345555555   23455566666677888999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-------CCcEEEeccc
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-------EMEPHISDFG  967 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~kl~DfG  967 (1109)
                      +||.+.|+|.+++..   ...++|..++.++.|+++.+++||   ..+||||||||+|.++..       ...++|+|||
T Consensus       773 ~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            999999999999984   345899999999999999999999   999999999999999942       3458999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCC
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKA 1023 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p 1023 (1109)
                      .+..+.-.....+..+.++|-.+--+|...++.+++++|-|.++.+++-|+.|++.
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99988766566677788999999999999999999999999999999999999863

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=7.3e-20  Score=207.87  Aligned_cols=162  Identities=25%  Similarity=0.320  Sum_probs=72.9

Q ss_pred             cCCcEEEeecCCCCCc----CCccccccccccEEEcCCCCCCCC----CCCccccccccceeeccCcccCCCC----Ccc
Q 001275          287 SSLTHLDIVGSKLTGS----IPSSFGLLARLSSLDLSENQLSGK----IPPELGKCKYLTVLHLYANQLEGEI----PDE  354 (1109)
Q Consensus       287 ~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~----p~~  354 (1109)
                      ++|+.|++++|.+++.    ++..+..+++|++|++++|.+++.    ++..+..+++|+.|++++|.+++..    +..
T Consensus       137 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~  216 (319)
T cd00116         137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET  216 (319)
T ss_pred             CCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHH
Confidence            4555666666655532    122344445566666666655531    1222333345555555555554321    122


Q ss_pred             ccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcc----cCCccccCC
Q 001275          355 LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSG----VIPQSLGIN  430 (1109)
Q Consensus       355 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~~  430 (1109)
                      +..+++|++|++++|++++.....+...                   .....++|+.|++++|.++.    .+...+..+
T Consensus       217 ~~~~~~L~~L~ls~n~l~~~~~~~l~~~-------------------~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~  277 (319)
T cd00116         217 LASLKSLEVLNLGDNNLTDAGAAALASA-------------------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK  277 (319)
T ss_pred             hcccCCCCEEecCCCcCchHHHHHHHHH-------------------HhccCCCceEEEccCCCCCcHHHHHHHHHHhcC
Confidence            3334445555555555443222222211                   00012455555555555541    122223334


Q ss_pred             CCCceEEecCCccccc----CCCCcccC-ccceEEECCCccc
Q 001275          431 SSLMQLDFINNSFTGE----IPPNLCFG-KQLRVLNMGQNQF  467 (1109)
Q Consensus       431 ~~L~~L~ls~N~l~~~----~p~~~~~~-~~L~~L~L~~N~l  467 (1109)
                      ++|+++|+++|.++..    ....+... ..|+.|++.+|.+
T Consensus       278 ~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         278 ESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             CCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            5566666666666543    22222222 5666677666653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.72  E-value=1.3e-17  Score=176.49  Aligned_cols=197  Identities=20%  Similarity=0.279  Sum_probs=135.1

Q ss_pred             CCCceeeEeeEEecC---------------------------CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHH
Q 001275          874 RHRNLVRLEDFWLRK---------------------------DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIAL  926 (1109)
Q Consensus       874 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  926 (1109)
                      +|||||++.++|.+.                           ...|+||.-.+. +|.+|+....    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            599999998876531                           134788887764 8999987644    45566778899


Q ss_pred             HHHHHHHHhhcCCCCCeEEeccCCCCeeeC--CCC--cEEEecccCCcccCCCC----CCceeeecccCccccccccccc
Q 001275          927 GAAHALAYLHYDCDPPIVHRDIKPENILLD--SEM--EPHISDFGIAKLLDKSP----ASTTSISVVGTIGYIAPENAFT  998 (1109)
Q Consensus       927 ~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~--~~kl~DfGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~  998 (1109)
                      |+++|+.|||   +.+|.|||+|++|||+.  +|+  ...|+|||++---+...    .........|.-.-||||+...
T Consensus       349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999   99999999999999993  343  46899999875332211    1111223467778999997764


Q ss_pred             CCC------CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHH
Q 001275          999 TAK------SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDV 1072 (1109)
Q Consensus       999 ~~~------~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l 1072 (1109)
                      .+-      -.|+|.|+.|.+.||+++...||+...+..-+...+                   .+...+.........+
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y-------------------qe~qLPalp~~vpp~~  486 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY-------------------QESQLPALPSRVPPVA  486 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh-------------------hhhhCCCCcccCChHH
Confidence            331      459999999999999999999997521111111110                   0000111112233456


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1073 LLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1073 ~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .+++...++.||.+|++..-+...+
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHH
Confidence            6678889999999999876555544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.70  E-value=2.5e-17  Score=176.44  Aligned_cols=234  Identities=21%  Similarity=0.271  Sum_probs=145.7

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCC----------CceeeEeeEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRH----------RNLVRLEDFWL  886 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~  886 (1109)
                      .+...+.||.|+++.||.+++. +++.+|+|.+......  ...+++++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3455678999999999999775 5899999998655422  234567777766655432          12222222221


Q ss_pred             c---------CC--------ceeEEEEeccCCCHHHHHhc---cCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEE
Q 001275          887 R---------KD--------CGIIMYRYMENGSLRDVLHS---ITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVH  945 (1109)
Q Consensus       887 ~---------~~--------~~~lv~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  945 (1109)
                      .         ..        ..+++|+-+. ++|.+++..   ... ...+....++.+..|+++.+++||   +.++||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence            1         11        2256777774 588877643   111 112445566777799999999999   899999


Q ss_pred             eccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCccccccccccc--------CCCCccCcchhhHHHHHHH
Q 001275          946 RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT--------TAKSKESDVYSYGVVLLEL 1017 (1109)
Q Consensus       946 ~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvil~el 1017 (1109)
                      +||+|+|++++++|.++++||+.....+..     ......+..|.|||....        ..++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999877644321     111345678999996643        2468899999999999999


Q ss_pred             HhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCC
Q 001275         1018 ITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNR 1087 (1109)
Q Consensus      1018 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 1087 (1109)
                      ++++.||+.........           ..+.              ...+....+..++..+++.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~-----------~~f~--------------~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPE-----------WDFS--------------RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSG-----------GGGT--------------TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCcccccc-----------ccch--------------hcCCcCHHHHHHHHHHccCCcccC
Confidence            99999997542221100           0010              112334455667779999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.70  E-value=3.2e-18  Score=193.63  Aligned_cols=187  Identities=26%  Similarity=0.290  Sum_probs=155.5

Q ss_pred             eeecccCeEEEEE----EeCCCcEEEEEEeeecccccCh-HHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEEEecc
Q 001275          826 VIGRGAHGIVYKA----SLGPNAVFAVKKLAFRGHKRGS-LSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYME  899 (1109)
Q Consensus       826 ~lG~G~~g~Vy~~----~~~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  899 (1109)
                      ++|+|.||.|+.+    ..+.+..||.|...+....... .....|-.++..++ ||.+|++...+..+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            3799999999976    3345778888887544322211 14456778888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST  979 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~  979 (1109)
                      +|.+...+....   .++..........++-+++++|   +.+|+|||+|++||+++.+|.+++.|||+++..-....  
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999998876543   3677777788889999999999   99999999999999999999999999999986644322  


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                          .+||..|||||++.  .....+|.||||++++||+||..||..
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                28999999999888  567789999999999999999999865

>PRK10345 hypothetical protein; Provisional

Probab=99.67  E-value=3.8e-16  Score=162.53  Aligned_cols=137  Identities=20%  Similarity=0.245  Sum_probs=104.6

Q ss_pred             CCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcC-----CCCceeeEeeEEecCC---c-e
Q 001275          821 LNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-----RHRNLVRLEDFWLRKD---C-G  891 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~  891 (1109)
                      +...+.||+|+||.||. .-.++. .+||++.... ....+.+.+|+++++++     .||||++++|++..+.   . .
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34567899999999996 333344 4788875432 23456799999999999     5799999999998764   3 2


Q ss_pred             eEEEEe--ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEEeccCCCCeeeCC----CCcEEEe
Q 001275          892 IIMYRY--MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHAL-AYLHYDCDPPIVHRDIKPENILLDS----EMEPHIS  964 (1109)
Q Consensus       892 ~lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~  964 (1109)
                      .+|+||  +++|+|.+++....    +++.  ..++.+++.++ +|||   +.+|+||||||+||+++.    ++.++|+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            378999  56899999996532    4444  35677778777 9999   999999999999999974    3479999


Q ss_pred             cccCC
Q 001275          965 DFGIA  969 (1109)
Q Consensus       965 DfGla  969 (1109)
                      ||+-+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95433

>smart00090 RIO RIO-like kinase

Probab=99.63  E-value=1.1e-15  Score=163.35  Aligned_cols=144  Identities=17%  Similarity=0.135  Sum_probs=111.2

Q ss_pred             hCCCCCceeecccCeEEEEEE--eCCCcEEEEEEeeeccccc-----------------------ChHHHHHHHHHHhcC
Q 001275          819 ENLNAKHVIGRGAHGIVYKAS--LGPNAVFAVKKLAFRGHKR-----------------------GSLSMKREIQTIGKI  873 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l  873 (1109)
                      .-|.+.+.||+|+||.||+|.  ..+|+.||+|.+.......                       ....+.+|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347788999999999999997  5689999999985432110                       012357899999999


Q ss_pred             CCC--ceeeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEEeccCC
Q 001275          874 RHR--NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP-IVHRDIKP  950 (1109)
Q Consensus       874 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlk~  950 (1109)
                      .+.  .+.+++++    ...++||||++++++..+....   ..........++.|++.++++||   +.+ |+|||+||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp  177 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE  177 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence            753  34444443    2358999999998887654221   12455667899999999999999   889 99999999


Q ss_pred             CCeeeCCCCcEEEecccCCcccC
Q 001275          951 ENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       951 ~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      +||+++ ++.++++|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987554

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.62  E-value=2.5e-15  Score=159.50  Aligned_cols=135  Identities=20%  Similarity=0.337  Sum_probs=113.0

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEeeeccccc-------ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR-------GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.||+|++|.||+|.. .+..+++|+........       ....+.+|++++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5699999999999987 57788899764322111       123577899999999999988877777777888999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++|++|.+++....      + .+..++.+++.++.++|   ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986522      2 78899999999999999   89999999999999999 78999999998874

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.62  E-value=2.1e-15  Score=157.98  Aligned_cols=146  Identities=16%  Similarity=0.140  Sum_probs=112.6

Q ss_pred             HHHHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccc---------------------cChHHHHHHHHHHh
Q 001275          813 QVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHK---------------------RGSLSMKREIQTIG  871 (1109)
Q Consensus       813 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~  871 (1109)
                      ++......|...+.||+|+||.||+|...+|+.||||++......                     .....+.+|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            334444458888999999999999998888999999987543210                     01123677899999


Q ss_pred             cCCCCc--eeeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccC
Q 001275          872 KIRHRN--LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIK  949 (1109)
Q Consensus       872 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  949 (1109)
                      .+.|++  +.+.++    ....++||||+++++|.+....         .....++.++++++.++|   ..+|+|||||
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCC
Confidence            987774  444443    2456899999999998765321         234578899999999999   8999999999


Q ss_pred             CCCeeeCCCCcEEEecccCCcccCC
Q 001275          950 PENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       950 ~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |+||++++++.++|+|||.+.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.60  E-value=2.5e-15  Score=157.84  Aligned_cols=131  Identities=21%  Similarity=0.328  Sum_probs=106.2

Q ss_pred             eeecccCeEEEEEEeCCCcEEEEEEeeeccccc-------ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          826 VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR-------GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       826 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .||+|+||.||+|... +..+++|+........       ...++.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            3899999999999854 6788999864332111       1245778999999999887665555555667789999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      +|++|.+++....      .    .++.+++++++++|   ..+++|||++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~------~----~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN------D----ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH------H----HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999875421      0    78999999999999   89999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PLN03150 hypothetical protein; Provisional

Probab=99.60  E-value=1.8e-15  Score=184.43  Aligned_cols=153  Identities=35%  Similarity=0.568  Sum_probs=122.0

Q ss_pred             hccCChhhHHHHHHHHHhccCCCCcccCCCCCCCCC---CceeeeEEecCC--C--CcEEEEEecccCCccccCCcccCC
Q 001275           22 SVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDST---PCQWVGIECDDD--A--HNVVSFNLSSYGVSGQLGPEIGHL   94 (1109)
Q Consensus        22 ~~~~~~~~~~all~~~~~~~~~~~~~l~sW~~~~~~---~c~w~gv~C~~~--~--~~v~~l~l~~~~l~~~~~~~l~~l   94 (1109)
                      ..++.+.|.+||+++|+++.. +..  .+|+++ +|   +|.|.||+|+..  .  .+|+.|+|+++++.|.+|+.+++|
T Consensus       366 ~~~t~~~~~~aL~~~k~~~~~-~~~--~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L  441 (623)
T PLN03150        366 ESKTLLEEVSALQTLKSSLGL-PLR--FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL  441 (623)
T ss_pred             ccccCchHHHHHHHHHHhcCC-ccc--CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence            345677899999999999954 322  489763 21   127999999632  2  258889999999999999889999


Q ss_pred             CCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccc-cccceec
Q 001275           95 SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRI-LGLQYVF  173 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~  173 (1109)
                      ++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+++|++|++|+|++|+++|.+|..+..+ .++..++
T Consensus       442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~  521 (623)
T PLN03150        442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN  521 (623)
T ss_pred             CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence            999999999999998899889999999999999999998888888899999999999998888888877653 3455666


Q ss_pred             ccccc
Q 001275          174 LNNNS  178 (1109)
Q Consensus       174 Ls~n~  178 (1109)
                      +.+|.
T Consensus       522 ~~~N~  526 (623)
T PLN03150        522 FTDNA  526 (623)
T ss_pred             ecCCc
Confidence            66654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.59  E-value=5.6e-15  Score=178.50  Aligned_cols=139  Identities=20%  Similarity=0.298  Sum_probs=112.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecc-cc------cChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HK------RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      ...|...+.||+|+||+||+|.+..... ++|+...+. ..      ....++.+|++++.+++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~-v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDA-VIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccc-eeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            3455678899999999999998765444 444322111 11      113468899999999999999988888877778


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++||||+++++|.+++.           ....++.+++++++|||   +.+|+|||+||+||++ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999999885           34678999999999999   8999999999999999 67899999999997


Q ss_pred             cc
Q 001275          971 LL  972 (1109)
Q Consensus       971 ~~  972 (1109)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.58  E-value=3.8e-16  Score=173.66  Aligned_cols=124  Identities=29%  Similarity=0.452  Sum_probs=109.8

Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..|+.|++++..+|.+|+...+.....++.....++.|++.|++|      ++.+|||+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            568999999999999999876666678899999999999999998      57899999999999999999999999998


Q ss_pred             cccCCCC----CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh
Q 001275          970 KLLDKSP----ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019 (1109)
Q Consensus       970 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt 1019 (1109)
                      .......    .....+...||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8765544    2234455689999999999999999999999999999999997

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.56  E-value=6.3e-16  Score=171.23  Aligned_cols=173  Identities=29%  Similarity=0.452  Sum_probs=118.1

Q ss_pred             CCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEec
Q 001275          503 VLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVS  582 (1109)
Q Consensus       503 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls  582 (1109)
                      --...||+.|++. ++|..+..+..|+.+.|.+|.+. .+|..+++|..|++|||+.|+++ .+|..++.|+ |++|-++
T Consensus        76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s  151 (722)
T KOG0532|consen   76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS  151 (722)
T ss_pred             chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence            3456677777776 66777777777777777777776 56777777777777777777777 6676666665 6777777


Q ss_pred             CccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccc
Q 001275          583 FNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGR  662 (1109)
Q Consensus       583 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~  662 (1109)
                      +|+++ .+|..++....|..||.+.|.+. .+|.-++++.+|+.|.+..|++. .+|++++.|+ | ..||+|+|+++ .
T Consensus       152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-L-i~lDfScNkis-~  225 (722)
T KOG0532|consen  152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-L-IRLDFSCNKIS-Y  225 (722)
T ss_pred             cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-e-eeeecccCcee-e
Confidence            77776 66777776667777777777766 56666666777777777777666 5666666554 2 24666777666 6


Q ss_pred             cCcchhhcccCCeEEccCCcccc
Q 001275          663 IPSDLEKLSKLEQLDISSNNLTG  685 (1109)
Q Consensus       663 ip~~l~~l~~L~~L~Ls~N~l~g  685 (1109)
                      ||-.|.+|+.|++|-|.+|.|+.
T Consensus       226 iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  226 LPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             cchhhhhhhhheeeeeccCCCCC
Confidence            66666666666666666666663

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.56  E-value=5.3e-16  Score=171.81  Aligned_cols=181  Identities=28%  Similarity=0.467  Sum_probs=165.3

Q ss_pred             ccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCccccccccccee
Q 001275          524 NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSIL  603 (1109)
Q Consensus       524 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L  603 (1109)
                      +++--...||+.|++. ++|.++..+..|+.|.|.+|.|. .+|..++++..|++|||+.|+++ .+|..++.++ |+.|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl  148 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL  148 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence            4556677899999999 78999999999999999999999 89999999999999999999999 8999998886 8999


Q ss_pred             ccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcc
Q 001275          604 KLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNL  683 (1109)
Q Consensus       604 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l  683 (1109)
                      .+++|+++ .+|..++.+..|..||.+.|++. .+|..++.+.+|+ .|++.+|++. .+|+++..| .|..||+|.|++
T Consensus       149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr-~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki  223 (722)
T KOG0532|consen  149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLR-DLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI  223 (722)
T ss_pred             EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHH-HHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence            99999999 89999999999999999999998 8999999999995 7999999999 799999955 589999999999


Q ss_pred             cccCCC-CCccccceEEeeeccccccccchhhh
Q 001275          684 TGTLSP-LSNIHSLVEVNVSYNLFTGPVPETLM  715 (1109)
Q Consensus       684 ~g~~~~-l~~~~~l~~l~~~~n~l~g~~p~~~~  715 (1109)
                      + .||- +..|+.|++|-|.+|+|.. .|.++.
T Consensus       224 s-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC  254 (722)
T KOG0532|consen  224 S-YLPVDFRKMRHLQVLQLENNPLQS-PPAQIC  254 (722)
T ss_pred             e-ecchhhhhhhhheeeeeccCCCCC-ChHHHH
Confidence            9 6665 9999999999999999995 465543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.55  E-value=2.3e-15  Score=178.38  Aligned_cols=165  Identities=30%  Similarity=0.420  Sum_probs=117.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|+.++.|..|+||.||..+++. .+.+|.| +.+..      .+.+-  ++.....|.+|                  
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccc------hhhhc--cccccCCccee------------------
Confidence            468889999999999999997764 4566663 31110      01110  22222233322                  


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC-
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~-  976 (1109)
                         |+-.+.++..+.   +...        .+.+++|+|   +.+|||||+||+|.+|+.-|++|++|||++++--... 
T Consensus       136 ---gDc~tllk~~g~---lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP---LPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcccCCC---Ccch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               344444444332   2222        267899999   9999999999999999999999999999987532110 


Q ss_pred             ------------CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          977 ------------ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       977 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                                  ........+||+.|+|||++....|...+|.|++|+|+||.+.|+.||+..
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence                        001122358999999999999999999999999999999999999999765

>PLN03150 hypothetical protein; Provisional

Probab=99.52  E-value=8.9e-15  Score=178.36  Aligned_cols=111  Identities=34%  Similarity=0.520  Sum_probs=76.5

Q ss_pred             hhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCC-CCccccceEEeee
Q 001275          624 LLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVS  702 (1109)
Q Consensus       624 L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~  702 (1109)
                      ++.|+|++|.+.|.+|..++.+++| ..|+|++|+|+|.+|..++++++|+.|||++|+|+|.+|. ++.+++|+.|+++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L-~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHL-QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCC-CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            4556666666666677667766666 3577777777777777777777777777777777777776 7777777777777


Q ss_pred             ccccccccchhhhhc-cCCCCCCCCCCCcccccc
Q 001275          703 YNLFTGPVPETLMNL-LGPSPSSFSGNPSLCVKC  735 (1109)
Q Consensus       703 ~n~l~g~~p~~~~~~-~~~~~~~~~gn~~~c~~~  735 (1109)
                      +|.|+|.+|..+... .......+.||+++||.+
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            777777777665432 112234578999999844

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.50  E-value=8.3e-14  Score=144.74  Aligned_cols=138  Identities=19%  Similarity=0.209  Sum_probs=98.8

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeeccccc-ChHH----------------------HHHHHHHHhcCCCCc--e
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR-GSLS----------------------MKREIQTIGKIRHRN--L  878 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~----------------------~~~E~~~l~~l~h~n--i  878 (1109)
                      .+.||+|+||+||+|...+++.||||++....... ....                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988889999999885432111 1111                      135666666664432  4


Q ss_pred             eeEeeEEecCCceeEEEEeccCCCHHH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeC
Q 001275          879 VRLEDFWLRKDCGIIMYRYMENGSLRD-VLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLD  956 (1109)
Q Consensus       879 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~  956 (1109)
                      .+.+++    ...++||||++++++.. .+....    .. .....++.+++.++.++|   . .+|+|||+||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE
Confidence            444433    24689999999954321 111111    11 557789999999999999   7 8999999999999999


Q ss_pred             CCCcEEEecccCCcccCC
Q 001275          957 SEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~  974 (1109)
                       ++.++++|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             89999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.48  E-value=1.8e-13  Score=136.71  Aligned_cols=135  Identities=20%  Similarity=0.201  Sum_probs=112.3

Q ss_pred             CCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCC--CceeeEeeEEecCCceeEEEEeccC
Q 001275          823 AKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH--RNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       823 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      +.+.+|+|.++.||++...+ ..+++|.......   ...+.+|+.++..++|  .++++++++....+..++++||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35679999999999998865 7789998743322   4578899999999976  5899999888877889999999998


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      +.+..+          +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        78 ~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            766543          4566778899999999999944335799999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.45  E-value=5.8e-13  Score=142.78  Aligned_cols=137  Identities=18%  Similarity=0.234  Sum_probs=106.0

Q ss_pred             Cceee-cccCeEEEEEEeCCCcEEEEEEeeecc------------cccChHHHHHHHHHHhcCCCCce--eeEeeEEecC
Q 001275          824 KHVIG-RGAHGIVYKASLGPNAVFAVKKLAFRG------------HKRGSLSMKREIQTIGKIRHRNL--VRLEDFWLRK  888 (1109)
Q Consensus       824 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  888 (1109)
                      ..++| .|+.|+||.+... +..+++|++....            .......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45688 8999999999876 6778999874321            01223567899999999998774  6777764432


Q ss_pred             C----ceeEEEEeccC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          889 D----CGIIMYRYMEN-GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       889 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                      .    ..++|+||+++ .+|.+++...    .++..    .+.++++++.+||   +.+|+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence            2    22599999997 6999988642    24433    3568899999999   999999999999999999999999


Q ss_pred             ecccCCccc
Q 001275          964 SDFGIAKLL  972 (1109)
Q Consensus       964 ~DfGla~~~  972 (1109)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988753

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=1.4e-13  Score=160.92  Aligned_cols=198  Identities=36%  Similarity=0.531  Sum_probs=122.4

Q ss_pred             eEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhccc-ccceeecccccccccCCccccCCCCccEEEecCc
Q 001275          506 HLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLV-SLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN  584 (1109)
Q Consensus       506 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N  584 (1109)
                      .++++.|.+. ..+..+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            3555555553 22333444455666666666665 3455555553 6666666666665 45555566666666666666


Q ss_pred             cccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccC
Q 001275          585 LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIP  664 (1109)
Q Consensus       585 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip  664 (1109)
                      +++ .+|...+..+.|+.|++++|+++ .+|..+.....|++|++++|++. .+|..+..+..+. .|.+++|++. .+|
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~-~l~l~~n~~~-~~~  248 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS-GLELSNNKLE-DLP  248 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhccccc-ccccCCceee-ecc
Confidence            666 45555555666666666666666 56665555556777777777543 4556666666663 4667777766 446


Q ss_pred             cchhhcccCCeEEccCCcccccCCCCCccccceEEeeeccccccccch
Q 001275          665 SDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPE  712 (1109)
Q Consensus       665 ~~l~~l~~L~~L~Ls~N~l~g~~~~l~~~~~l~~l~~~~n~l~g~~p~  712 (1109)
                      ..+++++.+++|++++|.++ .++.++.+.+|+.+++++|.++..+|.
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~-~i~~~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             chhccccccceecccccccc-ccccccccCccCEEeccCccccccchh
Confidence            67777777777777777777 455577777777777777777766664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=2.7e-14  Score=171.29  Aligned_cols=258  Identities=22%  Similarity=0.284  Sum_probs=189.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe--CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL--GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ..|...+.||+|+|+.|-....  .....+|+|.+.... ..........|..+-+.+. |+|++++++...+.+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4567778899999999998855  334556666654332 2223344556888888886 99999999999999999999


Q ss_pred             EEeccCCCHHHHH-hccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecccCCccc
Q 001275          895 YRYMENGSLRDVL-HSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLL  972 (1109)
Q Consensus       895 ~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~  972 (1109)
                      .+|.++|++.+.+ +...  ...+....-..+.|+..++.|+|.  ..+++|||+||+|.+++..+ ..+++|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999999887 4322  124555667889999999999994  56899999999999999999 9999999999987


Q ss_pred             CC-CCCCceeeeccc-CcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          973 DK-SPASTTSISVVG-TIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       973 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      .. ..........+| ++.|+|||...+..+ ....|+||.|+++.-+++|..|++...........|.....    .. 
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~----~~-  250 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG----RF-  250 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc----cc-
Confidence            76 455555556778 999999998888544 78899999999999999999998755433333222221110    00 


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                              .....   ........++..+++..+|..|.+.+++...
T Consensus       251 --------~~~~~---~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  251 --------TQLPW---NSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             --------ccCcc---ccCChhhhhcccccccCCchhcccccccccc
Confidence                    00001   1111223445568888999999998887654

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=2.3e-13  Score=159.14  Aligned_cols=175  Identities=35%  Similarity=0.475  Sum_probs=87.7

Q ss_pred             CCCceEEecCCcccccCCCCcccCc-cceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEe
Q 001275          431 SSLMQLDFINNSFTGEIPPNLCFGK-QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDV  509 (1109)
Q Consensus       431 ~~L~~L~ls~N~l~~~~p~~~~~~~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~L  509 (1109)
                      +.++.|++.+|.++ .+|+...... +|+.|++++|++. .+|..++.+++|+.|++++|+++...+.....+.|+.|++
T Consensus       116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~l  193 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDL  193 (394)
T ss_pred             cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheec
Confidence            44555555555554 4444444442 5555555555555 3334445555555555555555533333335555555555


Q ss_pred             ecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCC
Q 001275          510 SRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGS  589 (1109)
Q Consensus       510 s~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~  589 (1109)
                      ++|+++ .+|..+.....|++|++++|++. ..+..+.++.++..|.+++|++. .++..++.+++++.|++++|+++ .
T Consensus       194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~  269 (394)
T COG4886         194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-S  269 (394)
T ss_pred             cCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-c
Confidence            555555 44544444444555555555322 23445555555555555555555 23444555555555555555555 2


Q ss_pred             CCcccccccccceeccccccccC
Q 001275          590 IPSSLRSWKSLSILKLSENHFTG  612 (1109)
Q Consensus       590 ~p~~~~~l~~L~~L~L~~N~l~~  612 (1109)
                      ++. ++.+.+++.|++++|.++.
T Consensus       270 i~~-~~~~~~l~~L~~s~n~~~~  291 (394)
T COG4886         270 ISS-LGSLTNLRELDLSGNSLSN  291 (394)
T ss_pred             ccc-ccccCccCEEeccCccccc
Confidence            332 4445555555555555543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=8.5e-13  Score=137.43  Aligned_cols=216  Identities=23%  Similarity=0.332  Sum_probs=147.2

Q ss_pred             HHHHHHHhcCCCCceeeEeeEEecCC-----ceeEEEEeccCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhhc
Q 001275          864 KREIQTIGKIRHRNLVRLEDFWLRKD-----CGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHY  937 (1109)
Q Consensus       864 ~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~  937 (1109)
                      ..-+..+-++.|-|+|++..||.+..     +..+++|||+.|++..++++.+. ...+......++..||..||.||| 
T Consensus       115 ~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-  193 (458)
T KOG1266|consen  115 RAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-  193 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-
Confidence            33455566678999999999987643     46899999999999999987432 334666777899999999999999 


Q ss_pred             CCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC--CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHH
Q 001275          938 DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK--SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLL 1015 (1109)
Q Consensus       938 ~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ 1015 (1109)
                      .+++.|+|+++.-+-|++..++-+|++----......  ...........+-++|.|||+-.....+.++|||+||+...
T Consensus       194 s~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  194 SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             ccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence            4589999999999999999999888753211111000  00011112235678999999888788888999999999999


Q ss_pred             HHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001275         1016 ELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095 (1109)
Q Consensus      1016 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 1095 (1109)
                      ||..+...-.........-.......+       ..-++                .-...+..|++.+|..||+|++++.
T Consensus       274 emailEiq~tnseS~~~~ee~ia~~i~-------~len~----------------lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  274 EMAILEIQSTNSESKVEVEENIANVII-------GLENG----------------LQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HHHHheeccCCCcceeehhhhhhhhee-------eccCc----------------cccCcCcccccCCCCCCcchhhhhc
Confidence            999887532111000000000000000       00000                0012445899999999999999999


Q ss_pred             HhhhCCCC
Q 001275         1096 QLVDASVP 1103 (1109)
Q Consensus      1096 ~L~~~~~~ 1103 (1109)
                      |...+.+.
T Consensus       331 HpllfeVh  338 (458)
T KOG1266|consen  331 HPLLFEVH  338 (458)
T ss_pred             Cceeeecc
Confidence            98776554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.29  E-value=1.3e-11  Score=143.91  Aligned_cols=142  Identities=22%  Similarity=0.266  Sum_probs=100.8

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeeccccc---------------------------------------ChHHHH
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR---------------------------------------GSLSMK  864 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------~~~~~~  864 (1109)
                      .+.||+|++|.||+|+..+|+.||||+......+.                                       .+-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            46799999999999999999999999874321000                                       001345


Q ss_pred             HHHHHHhcCC-----CCceeeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH-HHHHhhcC
Q 001275          865 REIQTIGKIR-----HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH-ALAYLHYD  938 (1109)
Q Consensus       865 ~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~  938 (1109)
                      +|++.+.+++     ++++.-..-++......++||||++|+++.++......  ..+   +.+++..+++ .+..+|  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~~---~~~ia~~~~~~~l~ql~--  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GLD---RKALAENLARSFLNQVL--  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CCC---HHHHHHHHHHHHHHHHH--
Confidence            5666666652     33333222222334567999999999999887653211  122   3456666665 467888  


Q ss_pred             CCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          939 CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       939 ~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                       ..+++|+|++|.||+++.++.++++|||++..+.
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             8899999999999999999999999999998664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=3.3e-11  Score=137.60  Aligned_cols=250  Identities=25%  Similarity=0.250  Sum_probs=177.3

Q ss_pred             CCCCCceeec--ccCeEEEEEEe---CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCcee
Q 001275          820 NLNAKHVIGR--GAHGIVYKASL---GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       820 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  892 (1109)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|+-.... ......+-.+|+..-+.+ .|++.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556677999  99999999965   467889999743222 223334456788887777 5999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEeccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH----ALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFG  967 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfG  967 (1109)
                      +-+|++. .++.++.+....  .++....+.+..+..+    |+.++|   ...++|-|+||.||+...+ ..++++|||
T Consensus       195 iqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcc
Confidence            9999986 688888876432  2445555666666666    999999   9999999999999999999 889999999


Q ss_pred             CCcccCCCCCCce---eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          968 IAKLLDKSPASTT---SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       968 la~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      +...+........   .....|...|++||.. ...++.++|+|++|.++.+..++-......+...          |..
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------W~~  337 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS----------WSQ  337 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC----------ccc
Confidence            9988766542221   1223677889999954 5677899999999999999999987764432110          111


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .+.   ...+.   +...    .-..++...+..|++.+|..|++.+++..+
T Consensus       338 ~r~---~~ip~---e~~~----~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  338 LRQ---GYIPL---EFCE----GGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ccc---ccCch---hhhc----CcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            111   00100   0000    001122225668999999999998887653

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.12  E-value=1e-11  Score=127.57  Aligned_cols=110  Identities=25%  Similarity=0.265  Sum_probs=63.7

Q ss_pred             CCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEE
Q 001275          501 NPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFD  580 (1109)
Q Consensus       501 ~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  580 (1109)
                      .|.++.|++|+|.|+ .+. .+..+.+|+.||||+|.++ .+-.+-..|-+.++|+|++|.|+.  -+.+.+|-+|..||
T Consensus       306 ~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYSLvnLD  380 (490)
T KOG1259|consen  306 APKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET--LSGLRKLYSLVNLD  380 (490)
T ss_pred             ccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh--hhhhHhhhhheecc
Confidence            344555555555554 222 2455556666666666665 334444555566666666666552  12355566666777


Q ss_pred             ecCccccCCC-CcccccccccceeccccccccCCCcc
Q 001275          581 VSFNLLNGSI-PSSLRSWKSLSILKLSENHFTGGIPT  616 (1109)
Q Consensus       581 ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~  616 (1109)
                      +++|+|...- -..|++++.|+.+.|.+|.+.+ +|+
T Consensus       381 l~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~-~vd  416 (490)
T KOG1259|consen  381 LSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG-SVD  416 (490)
T ss_pred             ccccchhhHHHhcccccccHHHHHhhcCCCccc-cch
Confidence            7777765211 1567788888888888888873 444

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.11  E-value=3.2e-12  Score=134.96  Aligned_cols=249  Identities=22%  Similarity=0.284  Sum_probs=143.9

Q ss_pred             CcccCCCCccEeecCCCcccc----cCCCCCCCCCCCcEeeccCcc---ccCCCCc-------cccccCccceecccccc
Q 001275           89 PEIGHLSKLQTIDLSSNNFSG----NIPPKLGNCSALEYLDLSTNG---FTGDIPD-------NFENLQNLQYLNLYGNL  154 (1109)
Q Consensus        89 ~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~n~---l~~~~p~-------~l~~L~~L~~L~L~~n~  154 (1109)
                      +.+..+..+++++|++|.|..    .+.+.+.+.++|++.++|+--   ....+|+       .+...++|++||||+|.
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA  103 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA  103 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence            334556666677777766653    234445556667776666521   2223343       23455678888888887


Q ss_pred             ccccCCccc----ccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCc
Q 001275          155 LDGEIPEPL----FRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGF  230 (1109)
Q Consensus       155 l~~~~p~~l----~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  230 (1109)
                      +....+..+    ..+..|++|.|.||.+...--..++.  .|.+|.  .|.       -++.-++|+++..++|++...
T Consensus       104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~  172 (382)
T KOG1909|consen  104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENG  172 (382)
T ss_pred             cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccc
Confidence            765444443    34456778888777765222222211  122221  111       122334566666666666533


Q ss_pred             C----chhcccccccccccccCcccCC----cccccccCCCCcchhccccccccCC----CCcccccccCCcEEEeecCC
Q 001275          231 L----PESLSNLENLVYLDVGDNNLEG----RINFGSEKCKNLTFLDLSYNRFSGG----ISPNLGNCSSLTHLDIVGSK  298 (1109)
Q Consensus       231 ~----~~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~  298 (1109)
                      .    ...|...+.|+.+.++.|.|..    .....+..+++|++|||.+|-|+..    +...+..+++|+.|++++|.
T Consensus       173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl  252 (382)
T KOG1909|consen  173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL  252 (382)
T ss_pred             cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence            2    2345555666666666666642    1234456677777777777777632    33455667778888888887


Q ss_pred             CCCcCCccc-----cccccccEEEcCCCCCCC----CCCCccccccccceeeccCcccC
Q 001275          299 LTGSIPSSF-----GLLARLSSLDLSENQLSG----KIPPELGKCKYLTVLHLYANQLE  348 (1109)
Q Consensus       299 l~~~~~~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~  348 (1109)
                      +......+|     ...++|++|.+.+|.++.    .+...+...+.|+.|+|++|.+.
T Consensus       253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            775443332     235788888888888863    12334455788888888888883

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.11  E-value=2.5e-11  Score=142.03  Aligned_cols=221  Identities=31%  Similarity=0.339  Sum_probs=158.3

Q ss_pred             CCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceee
Q 001275          477 SCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLN  556 (1109)
Q Consensus       477 ~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  556 (1109)
                      .+..+..+.++.|.+......+..+.+|+.|++.+|+|. .+...+..+.+|++|++|+|+|+..  ..+..++.|+.|+
T Consensus        70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~  146 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN  146 (414)
T ss_pred             HhHhHHhhccchhhhhhhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhhe
Confidence            344555555666666643444777788888999999988 3444477788899999999998865  3566777799999


Q ss_pred             cccccccccCCccccCCCCccEEEecCccccCCCCcc-cccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCC
Q 001275          557 ISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSS-LRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLG  635 (1109)
Q Consensus       557 L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  635 (1109)
                      +++|.|+.  ...+..+.+|+.+++++|+++..-+ . ...+.+++.+++.+|.+.  ....+..+..+..+++..|+++
T Consensus       147 l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  147 LSGNLISD--ISGLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             eccCcchh--ccCCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccce
Confidence            99999883  2345558899999999999984433 2 577888999999999887  2345566777777899999887


Q ss_pred             CCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCCCCccccceEEeeecccccc
Q 001275          636 GEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTG  708 (1109)
Q Consensus       636 g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~l~~~~~l~~l~~~~n~l~g  708 (1109)
                      -.-+-....+.++ ..+++++|.+. .+|..+..+..+..||+++|+++. +..+.....+..+..++|.+..
T Consensus       222 ~~~~l~~~~~~~L-~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~-~~~~~~~~~~~~~~~~~~~~~~  291 (414)
T KOG0531|consen  222 KLEGLNELVMLHL-RELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISN-LEGLERLPKLSELWLNDNKLAL  291 (414)
T ss_pred             eccCcccchhHHH-HHHhcccCccc-cccccccccccccccchhhccccc-cccccccchHHHhccCcchhcc
Confidence            3222111111124 46889999988 676788889999999999999883 3335555666777777777653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.10  E-value=2e-10  Score=117.27  Aligned_cols=127  Identities=19%  Similarity=0.243  Sum_probs=94.4

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCcee-eEeeEEecCCceeEEEEeccCCC
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV-RLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      .+.++.|.++.||+++.. +..|++|.......  ....+.+|+.+++.+.+.+++ +++.+.  .+..++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence            356899999999999876 77899997643221  233567899999988655544 444433  334689999999987


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP-----IVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      +.+.    .    .   ....++.+++++++.||   ..+     ++|||++|.||+++ ++.++++|||.+.
T Consensus        78 l~~~----~----~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTE----D----F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc----c----c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            7543    0    0   11245678999999999   555     59999999999999 6789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.07  E-value=4.4e-11  Score=122.87  Aligned_cols=136  Identities=28%  Similarity=0.261  Sum_probs=110.2

Q ss_pred             CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCcc
Q 001275          498 FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLE  577 (1109)
Q Consensus       498 ~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  577 (1109)
                      +.....|++||||+|.|+ .+.+++.-.+.++.|++|+|.|...  +.+..|.+|+.||||+|.++ .+-.+-.+|-+.+
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK  355 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK  355 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence            334456889999999998 7888888899999999999999832  44888899999999999988 6666667788999


Q ss_pred             EEEecCccccCCCCcccccccccceeccccccccCC-CcchhhhhhhhhhhhcccCcCCCCCCC
Q 001275          578 VFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGG-IPTFISELEKLLELQLGGNQLGGEIPP  640 (1109)
Q Consensus       578 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~g~ip~  640 (1109)
                      .|.|+.|.|..  -+.++.+-+|..||+++|++... -...|++|+-|+.+.|.+|.+. .+|+
T Consensus       356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~-~~vd  416 (490)
T KOG1259|consen  356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA-GSVD  416 (490)
T ss_pred             eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc-ccch
Confidence            99999999863  24577788899999999999732 2346888999999999999998 4554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.06  E-value=1.4e-10  Score=136.52  Aligned_cols=147  Identities=17%  Similarity=0.207  Sum_probs=94.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccc---------------------c------------------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHK---------------------R------------------  858 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------~------------------  858 (1109)
                      ..|+. +.+|+|++|.||+|+..+ |+.||||+......+                     .                  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 789999999999999887 999999998533100                     0                  


Q ss_pred             ChHHHHHHHHHHhcCC----CCceeeEeeEEe-cCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHH-HH
Q 001275          859 GSLSMKREIQTIGKIR----HRNLVRLEDFWL-RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH-AL  932 (1109)
Q Consensus       859 ~~~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L  932 (1109)
                      .+-++.+|+..+.+++    +...+.+-.++. .....++||||++|+.+.++-.-...  ..+.+   .++...++ -+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~--g~d~~---~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA--GTDMK---LLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc--CCCHH---HHHHHHHHHHH
Confidence            0112445555555552    333344333332 24567899999999999875321111  12211   12221111 12


Q ss_pred             HHhhcCCCCCeEEeccCCCCeeeCCCC----cEEEecccCCcccCC
Q 001275          933 AYLHYDCDPPIVHRDIKPENILLDSEM----EPHISDFGIAKLLDK  974 (1109)
Q Consensus       933 ~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfGla~~~~~  974 (1109)
                      ..+.   ..+++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       274 ~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2333   56899999999999999888    999999999887754

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.06  E-value=2.2e-11  Score=142.58  Aligned_cols=106  Identities=25%  Similarity=0.334  Sum_probs=49.4

Q ss_pred             CCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCccccee
Q 001275          117 NCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEAL  196 (1109)
Q Consensus       117 ~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L  196 (1109)
                      .+..++.+++..|.+.. +-..+..+++|+.|++.+|+|. .+...+..+.+|++|++++|+|+...  .+..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhh
Confidence            44555556666666652 3334555666666666666665 22222444555555555555554221  13333334444


Q ss_pred             ecccccCCCCcccccccccCccEEEecccccc
Q 001275          197 WLFSNRLSGTIPESIGNCYRLQELYLNENKLM  228 (1109)
Q Consensus       197 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  228 (1109)
                      ++++|.++..  ..+..+..|+.+++++|+++
T Consensus       146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~  175 (414)
T KOG0531|consen  146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIV  175 (414)
T ss_pred             eeccCcchhc--cCCccchhhhcccCCcchhh
Confidence            4444444321  22233344444444444443

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.05  E-value=2.9e-12  Score=135.25  Aligned_cols=254  Identities=24%  Similarity=0.267  Sum_probs=138.4

Q ss_pred             CCCCCCCCcEeeccCccccC----CCCccccccCccceeccccc---cccccCCcccccccccceecccccccccccccc
Q 001275          114 KLGNCSALEYLDLSTNGFTG----DIPDNFENLQNLQYLNLYGN---LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRN  186 (1109)
Q Consensus       114 ~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~L~~L~~L~L~~n---~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~  186 (1109)
                      .+..+..+++|+||+|.+..    .+...+.+.++|+.-++++-   ++..++|+.+.-                 +.+.
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~-----------------l~~a   87 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKM-----------------LSKA   87 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHH-----------------HHHH
Confidence            45567888888888888863    24455667778888777763   222234433211                 1223


Q ss_pred             cCCCcccceeecccccCCCCcccc----cccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCC
Q 001275          187 VGDLKEVEALWLFSNRLSGTIPES----IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKC  262 (1109)
Q Consensus       187 l~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  262 (1109)
                      +-..++|++|+||+|.+....+..    +.++..|++|+|.+|.+.-.....++.  .|..|.  .|+       ....-
T Consensus        88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~  156 (382)
T KOG1909|consen   88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASK  156 (382)
T ss_pred             HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCC
Confidence            344456777777777766544443    345677888888888775332222221  011111  111       11123


Q ss_pred             CCcchhccccccccCCC----CcccccccCCcEEEeecCCCCCc----CCccccccccccEEEcCCCCCCCC----CCCc
Q 001275          263 KNLTFLDLSYNRFSGGI----SPNLGNCSSLTHLDIVGSKLTGS----IPSSFGLLARLSSLDLSENQLSGK----IPPE  330 (1109)
Q Consensus       263 ~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~  330 (1109)
                      ++|+++..++|++....    ...|...+.|+.+.++.|.|...    +...|...++|+.|||.+|-++..    +...
T Consensus       157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Laka  236 (382)
T KOG1909|consen  157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKA  236 (382)
T ss_pred             cceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHH
Confidence            44555555555554322    22334445566666666655421    123455566666666666666521    2334


Q ss_pred             cccccccceeeccCcccCCCCCcccc-----CCCCccEEEccCcccccc----CchHHHhhcccceeeccCCcc
Q 001275          331 LGKCKYLTVLHLYANQLEGEIPDELG-----QLSNLQDLELFDNRLTGE----FPVSIWRIASLEYLLVYNNNL  395 (1109)
Q Consensus       331 l~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l  395 (1109)
                      +..+++|+.|+++++.+......+|.     ..++|+.|.|.+|.|+..    +...+...+.|+.|+|++|++
T Consensus       237 L~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  237 LSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL  310 (382)
T ss_pred             hcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence            55566666777776666654443332     256777777777776632    222334467777777777777

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.04  E-value=6.6e-11  Score=128.35  Aligned_cols=188  Identities=26%  Similarity=0.293  Sum_probs=113.2

Q ss_pred             CCCCceEEeecCccCCCCC--CcccccccccEEeccCCcccCCcc--hhhhcccccceeecccccccccCCccc-cCCCC
Q 001275          501 NPVLSHLDVSRNNISGAIP--SSIGNSINLTSIDFSSNKFSGLMP--QELGNLVSLVTLNISLNHVEGSLPSQL-SKCKN  575 (1109)
Q Consensus       501 ~~~L~~L~Ls~N~i~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~  575 (1109)
                      +.+|+...|.+.... ..+  .....+++++.||||+|-|....|  .-...|++|+.|+|+.|++........ ..+++
T Consensus       120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            344555555555543 222  244556777777777776664333  224557777777777777653222211 13567


Q ss_pred             ccEEEecCccccCC-CCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCC--CCchhhhhhhhhh
Q 001275          576 LEVFDVSFNLLNGS-IPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIP--PSIGALQDLSYAL  652 (1109)
Q Consensus       576 L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip--~~~~~l~~l~~~L  652 (1109)
                      |+.|.|+.+.|+-. +-.....+++|..|+|+.|...+.-.....-++.|++|||++|++. ..+  .-++.++.|. .|
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~-~L  276 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLN-QL  276 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchh-hh
Confidence            77777777777621 1123345677788888877533233334455677888888888876 344  4466777773 68


Q ss_pred             ccccccccc-ccCcc-----hhhcccCCeEEccCCcccccCCCCCc
Q 001275          653 NLSKNGLTG-RIPSD-----LEKLSKLEQLDISSNNLTGTLSPLSN  692 (1109)
Q Consensus       653 ~L~~N~l~g-~ip~~-----l~~l~~L~~L~Ls~N~l~g~~~~l~~  692 (1109)
                      +++.+.++. .+|+.     ...+++|++|+++.|++. .++.+.+
T Consensus       277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~  321 (505)
T KOG3207|consen  277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNH  321 (505)
T ss_pred             hccccCcchhcCCCccchhhhcccccceeeecccCccc-cccccch
Confidence            888888774 23444     456778888888888886 4554433

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.03  E-value=1.3e-09  Score=125.57  Aligned_cols=167  Identities=15%  Similarity=0.150  Sum_probs=126.7

Q ss_pred             EeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCH
Q 001275          839 SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW  918 (1109)
Q Consensus       839 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~  918 (1109)
                      +..++.+|.|........ .......+.++.++.++||+|+++++.+..++..|+|+|-+.  .|..+++..      ..
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~  103 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GK  103 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HH
Confidence            455688888887754433 334557888999999999999999999999999999999884  677777763      34


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCccccccccccc
Q 001275          919 NVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT  998 (1109)
Q Consensus       919 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  998 (1109)
                      ..+.-.+.||+.||.+||+  +.+++|++|.-..|+|++.|+.||++|-++........  ......--..|..|+.+..
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence            5666678999999999986  56899999999999999999999999988764432211  1111222234666664322


Q ss_pred             CCCCccCcchhhHHHHHHHHhC
Q 001275          999 TAKSKESDVYSYGVVLLELITR 1020 (1109)
Q Consensus       999 ~~~~~~sDvwSlGvil~elltg 1020 (1109)
                      ..  -..|.|-||+++||++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  346999999999999999

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.01  E-value=1.1e-10  Score=116.76  Aligned_cols=126  Identities=28%  Similarity=0.361  Sum_probs=40.1

Q ss_pred             CCCCCCCCceEEeecCccCCCCCCccc-ccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccc-cCCC
Q 001275          497 EFSKNPVLSHLDVSRNNISGAIPSSIG-NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQL-SKCK  574 (1109)
Q Consensus       497 ~~~~~~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~  574 (1109)
                      .+.+...+++|+|++|+|+ .+ +.++ .+.+|+.||||+|+|+..  ..+..++.|++|++++|+|+ .++..+ ..++
T Consensus        14 ~~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp   88 (175)
T PF14580_consen   14 QYNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLP   88 (175)
T ss_dssp             ------------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-T
T ss_pred             ccccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence            3444555677777777776 23 2344 356677777777777643  24666777777777777777 343333 3467


Q ss_pred             CccEEEecCccccCCCC-cccccccccceeccccccccCCCcc----hhhhhhhhhhhh
Q 001275          575 NLEVFDVSFNLLNGSIP-SSLRSWKSLSILKLSENHFTGGIPT----FISELEKLLELQ  628 (1109)
Q Consensus       575 ~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~  628 (1109)
                      +|+.|+|++|+|...-- ..+..+++|+.|+|.+|.++.. +.    .+..+++|+.||
T Consensus        89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD  146 (175)
T PF14580_consen   89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD  146 (175)
T ss_dssp             T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred             cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence            77777777777763211 3455677777777777777632 22    345566666665

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.01  E-value=3.2e-09  Score=108.49  Aligned_cols=137  Identities=12%  Similarity=0.157  Sum_probs=98.7

Q ss_pred             ceeecccCeEEEEEEeCC-------CcEEEEEEeeeccc-----------c---------cC-hHHH----HHHHHHHhc
Q 001275          825 HVIGRGAHGIVYKASLGP-------NAVFAVKKLAFRGH-----------K---------RG-SLSM----KREIQTIGK  872 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------~---------~~-~~~~----~~E~~~l~~  872 (1109)
                      ..||.|.-+.||.|...+       +..+|||..+....           +         .. ...+    ++|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999996543       57899998743210           0         01 1122    389999999


Q ss_pred             CCC--CceeeEeeEEecCCceeEEEEeccCCCHHH-HHhccCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEEecc
Q 001275          873 IRH--RNLVRLEDFWLRKDCGIIMYRYMENGSLRD-VLHSITPPPTLEWNVRYKIALGAAHALAYL-HYDCDPPIVHRDI  948 (1109)
Q Consensus       873 l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dl  948 (1109)
                      +..  -++.+++++    ...++||||+.++.+.. .++..    .++.+....+..+++.++.++ |   ..+|||||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            853  456666654    46789999998754422 22221    244455667889999999999 7   889999999


Q ss_pred             CCCCeeeCCCCcEEEecccCCcccC
Q 001275          949 KPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       949 k~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ++.||+++ ++.++++|||.+...+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4689999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=2.1e-10  Score=131.07  Aligned_cols=250  Identities=19%  Similarity=0.186  Sum_probs=172.6

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe--CCCcEEEEEEeeecccccCh-HHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL--GPNAVFAVKKLAFRGHKRGS-LSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      ....+|..+..||.|.|+.|++...  .++..|++|........... ..-..|+.+...+ .|.++++.+..|...+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3345788889999999999999844  46888999977443222211 2234566666666 589999988888888888


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccCCc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAK  970 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~  970 (1109)
                      |+--||+++++.......   ...++...++++..|++.++.++|   ++.++|+|+||+||++..+ +..+++|||.+.
T Consensus       342 ~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            999999999988776632   223677788899999999999999   9999999999999999886 788999999986


Q ss_pred             ccCCCCCCceeeecccCccc-ccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          971 LLDKSPASTTSISVVGTIGY-IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      .+....    .....++..| .+|+......+..++|+||||.-+.+.+++..--....       .|......      
T Consensus       416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------~~~~i~~~------  478 (524)
T KOG0601|consen  416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------QSLTIRSG------  478 (524)
T ss_pred             ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-------cceeeecc------
Confidence            432111    1111223333 35666666778899999999999999999875322110       01000000      


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ..  +.         .......+..+...+...++..||.+.+...+...
T Consensus       479 ~~--p~---------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  479 DT--PN---------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             cc--cC---------CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            00  00         00111233445557888999999999888766543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.97  E-value=8.2e-11  Score=127.64  Aligned_cols=160  Identities=21%  Similarity=0.201  Sum_probs=83.6

Q ss_pred             CCCcccceeecccccCCCCcc--cccccccCccEEEeccccccCcCc--hhcccccccccccccCcccCCcccccccCCC
Q 001275          188 GDLKEVEALWLFSNRLSGTIP--ESIGNCYRLQELYLNENKLMGFLP--ESLSNLENLVYLDVGDNNLEGRINFGSEKCK  263 (1109)
Q Consensus       188 ~~l~~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  263 (1109)
                      +++++|+...|.+.... ..+  +....+++++.|+|++|-+....+  .....|++|+.|+|+.|++.......     
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~-----  191 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSN-----  191 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcccc-----
Confidence            35667777777776665 222  245566677777777776654322  22344555555555555554221111     


Q ss_pred             CcchhccccccccCCCCcccccccCCcEEEeecCCCCCc-CCccccccccccEEEcCCCCCCCCCCCccccccccceeec
Q 001275          264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGS-IPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHL  342 (1109)
Q Consensus       264 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  342 (1109)
                                        .-..++.|+.|.|+.|.++.. +-.....+++|+.|+|..|..-..-......+..|+.|||
T Consensus       192 ------------------~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL  253 (505)
T KOG3207|consen  192 ------------------TTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL  253 (505)
T ss_pred             ------------------chhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence                              011345566666666666521 1222344566666666666422233333444556666666


Q ss_pred             cCcccCCCCC--ccccCCCCccEEEccCcccc
Q 001275          343 YANQLEGEIP--DELGQLSNLQDLELFDNRLT  372 (1109)
Q Consensus       343 ~~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~  372 (1109)
                      ++|++.. .+  ...+.++.|+.|+++.+.+.
T Consensus       254 s~N~li~-~~~~~~~~~l~~L~~Lnls~tgi~  284 (505)
T KOG3207|consen  254 SNNNLID-FDQGYKVGTLPGLNQLNLSSTGIA  284 (505)
T ss_pred             cCCcccc-cccccccccccchhhhhccccCcc
Confidence            6666653 22  23455666666666666655

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=4.7e-09  Score=102.77  Aligned_cols=133  Identities=25%  Similarity=0.347  Sum_probs=100.7

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEe-eeccccc------ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKL-AFRGHKR------GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ..+++|+-+.+|.+.+.+ ..+++|.- ++...-.      ...+..+|+.++.+.+--.|.-..-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            357899999999997764 34555533 2222111      123567899999998766665555566677888999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      ++|..|.+.+...          ...++..+-+-+.-||   ..+|||+|+.++||.+..+. +.++|||++.+-
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999999888763          2467777888889999   99999999999999998765 999999999743

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.95  E-value=7.3e-10  Score=137.97  Aligned_cols=151  Identities=25%  Similarity=0.323  Sum_probs=88.0

Q ss_pred             CCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCcc--ccCCCCccccccCccceeccccccccccCCcccccccccc
Q 001275           93 HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNG--FTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQ  170 (1109)
Q Consensus        93 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~--l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~  170 (1109)
                      .....+...+.+|.+. .++.... .+.|+.|-+..|.  +....++.|..++.|++|||++|.=-+.+|..++++-+||
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr  598 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR  598 (889)
T ss_pred             chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence            3345556666666554 3333322 2356666666664  4433333466677777777776654456777777777777


Q ss_pred             eecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccc--cCcCchhcccccccccccc
Q 001275          171 YVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKL--MGFLPESLSNLENLVYLDV  246 (1109)
Q Consensus       171 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l--~~~~~~~l~~l~~L~~L~L  246 (1109)
                      +|++++..++ .+|..+++|+.|.+|++..+.-...+|..+..+++|++|.+..-..  +...-..+.++++|+.+..
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~  675 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI  675 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence            7777777766 6666777777777777776665555555666677777776665442  2222333444555555544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.94  E-value=4.7e-09  Score=112.28  Aligned_cols=142  Identities=18%  Similarity=0.250  Sum_probs=108.5

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCC--ceeeEeeEEecCC---ceeEEEEecc
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR--NLVRLEDFWLRKD---CGIIMYRYME  899 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~---~~~lv~e~~~  899 (1109)
                      +.++.|.++.||+++..+|+.+++|.............+.+|++++..+++.  .+.+++.+....+   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            5689999999999988777889999864333222455788999999999753  4566777765532   5689999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD-----------------------------------------  938 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------  938 (1109)
                      |+++.+.+..    ..++......++.++++++.+||..                                         
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888765432    2366777778888888888888842                                         


Q ss_pred             ------------CCCCeEEeccCCCCeeeCC--CCcEEEecccCCc
Q 001275          939 ------------CDPPIVHRDIKPENILLDS--EMEPHISDFGIAK  970 (1109)
Q Consensus       939 ------------~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~  970 (1109)
                                  ....++|+|+++.||+++.  ++.+.++||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                        0245799999999999998  6678999999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.92  E-value=7.7e-10  Score=110.75  Aligned_cols=16  Identities=31%  Similarity=0.420  Sum_probs=4.6

Q ss_pred             ccCCCCeEEccCCcCc
Q 001275          405 ELKQLKNISLYNNQFS  420 (1109)
Q Consensus       405 ~l~~L~~L~L~~N~l~  420 (1109)
                      .+++|+.|+|.+|+++
T Consensus       111 ~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen  111 SLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             G-TT--EEE-TT-GGG
T ss_pred             cCCCcceeeccCCccc
Confidence            3444444444444443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.92  E-value=1.3e-08  Score=98.83  Aligned_cols=144  Identities=22%  Similarity=0.312  Sum_probs=106.8

Q ss_pred             CCceeecccCeEEEEEEeCCCcEEEEEEeeecccc-------cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          823 AKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHK-------RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       823 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ....+-+|+-+.|+++.+. |+...||.-..+...       -..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4567889999999999887 666666643222211       12356788999999987555554444566667778999


Q ss_pred             EeccC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC---cEEEecccCCcc
Q 001275          896 RYMEN-GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM---EPHISDFGIAKL  971 (1109)
Q Consensus       896 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfGla~~  971 (1109)
                      ||+++ .++.+++......+. +.+.....+..|-+.+.-||   ..+|+|+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 488888877654332 23333678889999999999   99999999999999996654   468999999864

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.89  E-value=8.1e-10  Score=137.56  Aligned_cols=250  Identities=24%  Similarity=0.240  Sum_probs=148.2

Q ss_pred             CCccEeecCCCc--ccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCccccccccccee
Q 001275           95 SKLQTIDLSSNN--FSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYV  172 (1109)
Q Consensus        95 ~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  172 (1109)
                      +.|++|-+.+|.  +....++.|..++.|++||||+|.=-+.+|..+++|-+||+|+|+++.++ .+|.++.++.+|.+|
T Consensus       545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L  623 (889)
T KOG4658|consen  545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL  623 (889)
T ss_pred             CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence            368888888886  54344455888999999999998777789999999999999999999998 899999999999999


Q ss_pred             cccccccccccccccCCCcccceeecccccCC--CCcccccccccCccEEEeccccccCcCchhcccccccc----cccc
Q 001275          173 FLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS--GTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLV----YLDV  246 (1109)
Q Consensus       173 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~----~L~L  246 (1109)
                      ++..+.-...+|..+..|.+|++|.+..-...  ...-..+.++.+|+.+.......  .+-..+..++.|.    .+.+
T Consensus       624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~  701 (889)
T KOG4658|consen  624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSI  701 (889)
T ss_pred             ccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhh
Confidence            99998876677777788999999998876522  22333445555666555543332  1122233333333    2222


Q ss_pred             cCcccCCcccccccCCCCcchhccccccccCCCCccccc------ccCCcEEEeecCCCCCcCCccccccccccEEEcCC
Q 001275          247 GDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGN------CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSE  320 (1109)
Q Consensus       247 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  320 (1109)
                      ..+... ..+..+..+.+|+.|.+.++.+..........      ++++..+...++..- ..+.+.-..++|+.|++..
T Consensus       702 ~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~  779 (889)
T KOG4658|consen  702 EGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVS  779 (889)
T ss_pred             cccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEec
Confidence            222211 22333455566666666665554322211111      111111111111111 1122222345666666666


Q ss_pred             CCCCCCCCCccccccccceeeccCcccCC
Q 001275          321 NQLSGKIPPELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       321 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                      +.....+.+....+..++.+-+..+.+.+
T Consensus       780 ~~~~e~~i~~~k~~~~l~~~i~~f~~~~~  808 (889)
T KOG4658|consen  780 CRLLEDIIPKLKALLELKELILPFNKLEG  808 (889)
T ss_pred             ccccccCCCHHHHhhhcccEEeccccccc
Confidence            55544444444444455544455555544

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.85  E-value=1.9e-09  Score=81.10  Aligned_cols=41  Identities=46%  Similarity=0.944  Sum_probs=31.5

Q ss_pred             hhhHHHHHHHHHhccCCCCcccCCCCCCC-CCCceeeeEEec
Q 001275           27 NGDGVALLSLMRHWNSVPPLIISSWNSSD-STPCQWVGIECD   67 (1109)
Q Consensus        27 ~~~~~all~~~~~~~~~~~~~l~sW~~~~-~~~c~w~gv~C~   67 (1109)
                      +.|++||++||+++..+|...+.+|+.+. .+||.|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            57999999999999887888999999874 689999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.80  E-value=7.3e-08  Score=104.56  Aligned_cols=193  Identities=13%  Similarity=0.188  Sum_probs=127.8

Q ss_pred             CCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeE------EecC-CceeE
Q 001275          822 NAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDF------WLRK-DCGII  893 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~-~~~~l  893 (1109)
                      ...+.||+|+.+.+|-.-.-.+.  +.|++....    ...-.+.+..|... .||-+-.-+.|      .-+. ....+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~--VAKIYh~Pp----pa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQ--VAKIYHAPP----PAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchhhch--hheeecCCC----chHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34567999999999975222121  345552221    11122334445454 46544331222      1111 22456


Q ss_pred             EEEeccCC-CHHHHHh---ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          894 MYRYMENG-SLRDVLH---SITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       894 v~e~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      +|..+.+. ...+++.   +.+.-+..+|...++++..++.+.+-||   ..|.+-+|+.++|+|+++++.+.+.|-..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence            77766653 2333332   2233456899999999999999999999   889999999999999999999999986544


Q ss_pred             cccCCCCCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhC-CCCCCC
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITR-KKALDP 1026 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg-~~p~~~ 1026 (1109)
                      ....   ........+|...|.+||.-.     +...+...|-|.+||++++++.| ++||.+
T Consensus       165 qi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         165 QINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             eecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            4332   222333467899999999443     44557899999999999999987 899865

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.72  E-value=3.6e-09  Score=126.73  Aligned_cols=203  Identities=22%  Similarity=0.270  Sum_probs=143.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeec--ccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFR--GHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.+...+-+-+|.++.++.+.-. .|...++|.....  -.........++-.+.-..+||-+++...-+......++|+
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            45556667888999998877432 2333333332111  11111222233333333345677777666555667889999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC-
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK-  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~-  974 (1109)
                      +|..++++...++...   ..+.+.....+..+..+.+|||   ...+.|||++|.|.+...++..+++|||......- 
T Consensus       884 ~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             HHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999998755   2444455566777889999999   77799999999999999999999999984322110 


Q ss_pred             --------------------CC----CC----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          975 --------------------SP----AS----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       975 --------------------~~----~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                                          ..    ..    .......||+.|.|||...+......+|.|+.|++++|.++|..||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                00    00    112345799999999999999999999999999999999999999975


Q ss_pred             C
Q 001275         1027 S 1027 (1109)
Q Consensus      1027 ~ 1027 (1109)
                      .
T Consensus      1038 ~ 1038 (1205)
T KOG0606|consen 1038 E 1038 (1205)
T ss_pred             c
Confidence            4

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.69  E-value=1.8e-07  Score=101.43  Aligned_cols=142  Identities=17%  Similarity=0.142  Sum_probs=100.1

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEeeecccc----------cChHHHHHHHHHHhcCCCCc--eeeEeeEEec-----
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHK----------RGSLSMKREIQTIGKIRHRN--LVRLEDFWLR-----  887 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~-----  887 (1109)
                      +.+-......|++.... |+.|.||+.......          .....+.+|+..+.++...+  +.+++++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            34444444457777664 778999976332211          11224789999998884333  3344555433     


Q ss_pred             CCceeEEEEeccCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-------CC
Q 001275          888 KDCGIIMYRYMENG-SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-------EM  959 (1109)
Q Consensus       888 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------~~  959 (1109)
                      ....++|+|++++. +|.+++.... ....+...+..++.++++.+.-||   ..+|+|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence            23468999999986 8999885322 123456677789999999999999   999999999999999975       46


Q ss_pred             cEEEecccCCcc
Q 001275          960 EPHISDFGIAKL  971 (1109)
Q Consensus       960 ~~kl~DfGla~~  971 (1109)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            799999998864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.65  E-value=1.3e-07  Score=96.45  Aligned_cols=127  Identities=23%  Similarity=0.212  Sum_probs=82.6

Q ss_pred             EEEEEEeCCCcEEEEEEeeeccc------------cc-------------ChHHHHHHHHHHhcCCCC--ceeeEeeEEe
Q 001275          834 IVYKASLGPNAVFAVKKLAFRGH------------KR-------------GSLSMKREIQTIGKIRHR--NLVRLEDFWL  886 (1109)
Q Consensus       834 ~Vy~~~~~~~~~vavK~~~~~~~------------~~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~  886 (1109)
                      .||.|...+|..+|+|.......            ..             .....++|++.|.++...  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999999999999998743210            00             012467899999999765  45666654  


Q ss_pred             cCCceeEEEEecc--CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          887 RKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY-LHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       887 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                        ...++||||++  |..+.......     ++.+....++.++++.+.. +|   ..+|||||+.+.||+++++ .+.+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEE
Confidence              24589999998  65554433321     1123345667777774444 57   8899999999999999888 9999


Q ss_pred             ecccCCcccC
Q 001275          964 SDFGIAKLLD  973 (1109)
Q Consensus       964 ~DfGla~~~~  973 (1109)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.64  E-value=2e-08  Score=82.60  Aligned_cols=61  Identities=44%  Similarity=0.645  Sum_probs=47.4

Q ss_pred             CCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccc
Q 001275           95 SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLL  155 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l  155 (1109)
                      ++|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4677888888888866666778888888888888888877777788888888888888764

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.64  E-value=1.8e-08  Score=82.83  Aligned_cols=59  Identities=34%  Similarity=0.521  Sum_probs=27.7

Q ss_pred             CCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeeccccc
Q 001275          503 VLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH  561 (1109)
Q Consensus       503 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  561 (1109)
                      +|++|++++|+|+...+..|.++++|++|++++|+++...|..|..+++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34455555555553333444445555555555555544434444444444444444443

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.57  E-value=2.1e-07  Score=96.86  Aligned_cols=136  Identities=20%  Similarity=0.194  Sum_probs=95.9

Q ss_pred             CCCceeecccCeEEEEEEeCCCcEEEEEEeeecc-----------------cc----cChHHHHHHHHHHhcCCCC--ce
Q 001275          822 NAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-----------------HK----RGSLSMKREIQTIGKIRHR--NL  878 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~----~~~~~~~~E~~~l~~l~h~--ni  878 (1109)
                      .+...||.|.-+.||.|....|.++|||.-....                 ..    ......++|+++|.++...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            4567899999999999999999999999532111                 00    1123567899999999654  67


Q ss_pred             eeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC
Q 001275          879 VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE  958 (1109)
Q Consensus       879 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~  958 (1109)
                      .+.+++    +...+||||++|-.|...-        ++.+..-.++..|++-+...-   ..||||+|+++-||++++|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~d  238 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTED  238 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecC
Confidence            777665    5668999999986654421        112222233444444444433   4689999999999999999


Q ss_pred             CcEEEecccCCccc
Q 001275          959 MEPHISDFGIAKLL  972 (1109)
Q Consensus       959 ~~~kl~DfGla~~~  972 (1109)
                      |.+.++||--+...
T Consensus       239 g~~~vIDwPQ~v~~  252 (304)
T COG0478         239 GDIVVIDWPQAVPI  252 (304)
T ss_pred             CCEEEEeCcccccC
Confidence            99999999766543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.56  E-value=1.9e-06  Score=96.53  Aligned_cols=169  Identities=20%  Similarity=0.299  Sum_probs=126.1

Q ss_pred             cCeEEEEEE-eCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec----CCceeEEEEeccC-CCHH
Q 001275          831 AHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR----KDCGIIMYRYMEN-GSLR  904 (1109)
Q Consensus       831 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~  904 (1109)
                      .-.+.||+. ..+|..|+.|++.-..... ...-..-+++++++.|.|+|++.+++..    +...++||+|.++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            346789994 4579999999983322221 2123456889999999999999998763    3357899999986 4787


Q ss_pred             HHHhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          905 DVLHSIT------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       905 ~~l~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      ++.-...            .....++...|.++.|+..||.++|   +.|..-+-|.+++|+++.+.+++|+..|....+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            7553211            1224678899999999999999999   889999999999999999999999988877666


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCC
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKK 1022 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~ 1022 (1109)
                      ..++.              +|  +.   --.+-|.=.+|.+++.+.||..
T Consensus       444 ~~d~~--------------~~--le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  444 QEDPT--------------EP--LE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCCCC--------------cc--hh---HHhhhhHHHHHHHHHHHhhccc
Confidence            54331              00  11   1236788889999999999964

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.50  E-value=5.3e-09  Score=119.80  Aligned_cols=126  Identities=30%  Similarity=0.396  Sum_probs=78.3

Q ss_pred             CcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCC-ccccccccceeec
Q 001275          264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP-ELGKCKYLTVLHL  342 (1109)
Q Consensus       264 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L  342 (1109)
                      .|.+.+.++|++. ....++.-++.|+.|+|++|+++...  .+..+++|++|||++|.++ .+|. ...++. |..|.+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence            4666677777776 44455666677777777777776432  5666777777777777776 3332 223333 777777


Q ss_pred             cCcccCCCCCccccCCCCccEEEccCcccccc-CchHHHhhcccceeeccCCccC
Q 001275          343 YANQLEGEIPDELGQLSNLQDLELFDNRLTGE-FPVSIWRIASLEYLLVYNNNLL  396 (1109)
Q Consensus       343 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~  396 (1109)
                      ++|.++..  ..+.+|.+|+.||+++|-|.+- --..++.+..|+.|+|.+|.+-
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            77776632  3456677777777777766542 1123556667777777777664

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.43  E-value=5e-08  Score=89.75  Aligned_cols=109  Identities=22%  Similarity=0.277  Sum_probs=52.6

Q ss_pred             cceeecccccccccCCcccc-CCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcc
Q 001275          552 LVTLNISLNHVEGSLPSQLS-KCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLG  630 (1109)
Q Consensus       552 L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  630 (1109)
                      |+..+|++|.+. ..|..|. +.+.++.|+|++|.|+ .+|.++..|+.|+.|+++.|.+. ..|..+..|.+|-.||..
T Consensus        55 l~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~  131 (177)
T KOG4579|consen   55 LTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP  131 (177)
T ss_pred             EEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence            333345555554 3333333 2335555555555555 45555555555555555555555 455555555566666666


Q ss_pred             cCcCCCCCCCCchhhhhhhhhhcccccccccccCc
Q 001275          631 GNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPS  665 (1109)
Q Consensus       631 ~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~  665 (1109)
                      +|.+. +||-.+..- .+.....+.++.+.+.-|.
T Consensus       132 ~na~~-eid~dl~~s-~~~al~~lgnepl~~~~~~  164 (177)
T KOG4579|consen  132 ENARA-EIDVDLFYS-SLPALIKLGNEPLGDETKK  164 (177)
T ss_pred             CCccc-cCcHHHhcc-ccHHHHHhcCCcccccCcc
Confidence            65554 444332111 1112234455555544443

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.43  E-value=2.4e-08  Score=114.59  Aligned_cols=127  Identities=28%  Similarity=0.353  Sum_probs=100.9

Q ss_pred             CCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCcc-ccCCCCccEEE
Q 001275          502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQ-LSKCKNLEVFD  580 (1109)
Q Consensus       502 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~  580 (1109)
                      ..|...+.++|.++ ....++.-++.|+.||||+|+++..  +.+..|+.|++|||++|++. .+|.. ...+. |+.|.
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence            35778889999998 6778888889999999999999854  47888999999999999998 56642 33344 99999


Q ss_pred             ecCccccCCCCcccccccccceeccccccccCCC-cchhhhhhhhhhhhcccCcCC
Q 001275          581 VSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGI-PTFISELEKLLELQLGGNQLG  635 (1109)
Q Consensus       581 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~  635 (1109)
                      +++|.++..  ..+.++++|+-|||++|-+.+.- -..++.|..|+.|.|.||.+-
T Consensus       239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            999998732  45778899999999999887642 224577888999999999875

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.41  E-value=2.7e-08  Score=102.87  Aligned_cols=64  Identities=30%  Similarity=0.375  Sum_probs=34.7

Q ss_pred             CCCCCcEeeccCcccc--CCCCccccccCccceeccccccccccCCcccccccccceecccccccc
Q 001275          117 NCSALEYLDLSTNGFT--GDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLS  180 (1109)
Q Consensus       117 ~l~~L~~L~Ls~n~l~--~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~  180 (1109)
                      ..+.+++|||.+|.|+  ..+-..+.+|+.|++|+|+.|++...|-..=..+.+|+.|.|.+..+.
T Consensus        69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~  134 (418)
T KOG2982|consen   69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLS  134 (418)
T ss_pred             HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCC
Confidence            3466677777777766  233344566677777777777666332111123345555555554443

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.40  E-value=3.1e-08  Score=91.11  Aligned_cols=136  Identities=26%  Similarity=0.381  Sum_probs=89.3

Q ss_pred             CceEEeecCccCCCCCCccc---ccccccEEeccCCcccCCcchhhh-cccccceeecccccccccCCccccCCCCccEE
Q 001275          504 LSHLDVSRNNISGAIPSSIG---NSINLTSIDFSSNKFSGLMPQELG-NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVF  579 (1109)
Q Consensus       504 L~~L~Ls~N~i~~~~p~~~~---~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  579 (1109)
                      +..++|+++++- .+++...   ....|+..+|++|.+... |..|. ..+.+++|||++|+|+ .+|.++..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~f-p~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKF-PKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhC-CHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            445666666664 3444433   334566667777777743 44443 3457778888888887 677778888888888


Q ss_pred             EecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchh
Q 001275          580 DVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGA  644 (1109)
Q Consensus       580 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~  644 (1109)
                      ++++|.|. ..|..|..+.+|-.|+..+|.+. .+|..+-.-++.-..++.++.+.+.-|.....
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa  168 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQA  168 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcccccc
Confidence            88888887 67777777888888888888877 56654322233334456777888777654433

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.35  E-value=2.4e-06  Score=89.76  Aligned_cols=108  Identities=23%  Similarity=0.320  Sum_probs=84.6

Q ss_pred             ChHHHHHHHHHHhcCCC--CceeeEeeEEecCC----ceeEEEEeccCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001275          859 GSLSMKREIQTIGKIRH--RNLVRLEDFWLRKD----CGIIMYRYMENG-SLRDVLHSITPPPTLEWNVRYKIALGAAHA  931 (1109)
Q Consensus       859 ~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~  931 (1109)
                      ......+|...+.++..  -.+.+.+++.....    ..++|+|++++. +|.+++.....   .+......++.++++.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARL  130 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHH
Confidence            34467889888888843  33455666655432    358999999984 89998876332   4556678899999999


Q ss_pred             HHHhhcCCCCCeEEeccCCCCeeeCCCC---cEEEecccCCccc
Q 001275          932 LAYLHYDCDPPIVHRDIKPENILLDSEM---EPHISDFGIAKLL  972 (1109)
Q Consensus       932 L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfGla~~~  972 (1109)
                      ++-||   ..+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   99999999999999998887   8999999987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.26  E-value=1.5e-05  Score=81.81  Aligned_cols=139  Identities=15%  Similarity=0.070  Sum_probs=102.5

Q ss_pred             eecccCeEEEEEEeCCCcEEEEEEeeec--c---cccChHHHHHHHHHHhcCCC--CceeeEeeEEecC----CceeEEE
Q 001275          827 IGRGAHGIVYKASLGPNAVFAVKKLAFR--G---HKRGSLSMKREIQTIGKIRH--RNLVRLEDFWLRK----DCGIIMY  895 (1109)
Q Consensus       827 lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~---~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~  895 (1109)
                      -|+||-+.|++...++. .+-+|+-...  .   .+-....|.+|+..+.++..  -.+.+.+.+....    ...++|+
T Consensus        26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            46789999999887744 6888876311  1   13466789999999999953  3345554222221    2358999


Q ss_pred             EeccC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc--EEEecccCCc
Q 001275          896 RYMEN-GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME--PHISDFGIAK  970 (1109)
Q Consensus       896 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfGla~  970 (1109)
                      |-+++ -+|.+++.... ....+...+..++.+++++++-||   ..++.|+|+-+.||+++.++.  ++++||--++
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97764 48999886532 224567777899999999999999   999999999999999986666  9999997665

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1109
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-51
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-46
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-51
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-46
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-48
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-46
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-27
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-27
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-27
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-24
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		7e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		5e-15
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-14
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-12
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		3e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-14
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-13
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-12
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		9e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-10
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-10
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-10
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-10
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-10
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-10
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-10
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-10
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-10
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		9e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-09
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-09
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-09
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-09
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-09
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		7e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		9e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-07
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-07
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		4e-07
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		4e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-07
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		7e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		7e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-06
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		7e-06
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-06
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		8e-06
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		5e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-06
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		8e-06
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		5e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-05
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-05
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-05
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-05
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-05
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-05
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-05
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-05
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-05
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-05
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-05
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-05
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		1e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-05
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-05
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-05
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		1e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-05
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-05
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		2e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		2e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-05
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-05
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-05
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-05
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-05
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-05
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-05
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-05
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-05
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-05
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-05
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-05
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-05
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-05
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-05
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-05
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		4e-05
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		4e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-05
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		5e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-05
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-05
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		6e-05
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		6e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		7e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-04
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2z63_A	570	Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A		1e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-04
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-04
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		4e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-04
2ft3_A	332	Crystal Structure Of The Biglycan Dimer Core Protei		5e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		5e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		6e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-04
1w8a_A	192	Third Lrr Domain Of Drosophila Slit Length = 192		7e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		7e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		8e-04
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-04
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  201 bits (510), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 192/608 (31%), Positives = 276/608 (45%), Gaps = 70/608 (11%)
Query: 41  NSVPPLIISSWNSSDSTPCQWVGIE-CDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQT 99
           NS+  L +S+ + S +    WV  + C +  H  +S N     +SG +  ++     L+ 
Sbjct: 148 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN----KISGDV--DVSRCVNLEF 201
Query: 100 IDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFEXXXXXXXXXXXXXXXDGEI 159
           +D+SSNNFS  IP  LG+CSAL++LD+S N  +GD                      G I
Sbjct: 202 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 260
Query: 160 PEPLFRILGLQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESIG------ 212
           P PL  +  LQY+ L  N  +G IP  + G    +  L L  N   G +P   G      
Sbjct: 261 P-PL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 318
Query: 213 -------------------NCYRLQELYLNENKLMGFLPESLSNLE-NLVYLDVGDNNLE 252
                                  L+ L L+ N+  G LPESL+NL  +L+ LD+  NN  
Sbjct: 319 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 378
Query: 253 GRI--NFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLL 310
           G I  N        L  L L  N F+G I P L NCS L  L +  + L+G+IPSS G L
Sbjct: 379 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 438
Query: 311 ARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNR 370
           ++L  L L  N L G+IP EL   K L  L L  N L GEIP  L   +NL  + L +NR
Sbjct: 439 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 498
Query: 371 LTGEFPVSIWRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIPQSLGIN 430
           LTGE P  I R                        L+ L  + L NN FSG IP  LG  
Sbjct: 499 LTGEIPKWIGR------------------------LENLAILKLSNNSFSGNIPAELGDC 534
Query: 431 SSLMQLDFINNSFTGEIPPNLC--FGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQ 488
            SL+ LD   N F G IP  +    GK       G+   +     +   C     ++  Q
Sbjct: 535 RSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 594
Query: 489 NQLTGALPEFS-KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG 547
              +  L   S +NP     +++     G    +  N+ ++  +D S N  SG +P+E+G
Sbjct: 595 GIRSEQLNRLSTRNPC----NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG 650
Query: 548 NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSE 607
           ++  L  LN+  N + GS+P ++   + L + D+S N L+G IP ++ +   L+ + LS 
Sbjct: 651 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 710
Query: 608 NHFTGGIP 615
           N+ +G IP
Sbjct: 711 NNLSGPIP 718

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  185 bits (469), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 205/727 (28%), Positives = 316/727 (43%), Gaps = 162/727 (22%)
Query: 47  IISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSS----YGVSG----------------- 85
           ++  W SS+  PC + G+ C DD   V S +LSS     G S                  
Sbjct: 26  LLPDW-SSNKNPCTFDGVTCRDDK--VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 82
Query: 86  --QLGPEIGHL---SKLQTIDLSSNNFSGNIPP--KLGNCSALEYLDLSTNGFTGDIPDN 138
              +   +      + L ++DLS N+ SG +     LG+CS L++L++S+N  T D P  
Sbjct: 83  NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSN--TLDFP-- 138
Query: 139 FEXXXXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL 198
                             G++   L ++  L+ + L+ NS+SG+    VG        W+
Sbjct: 139 ------------------GKVSGGL-KLNSLEVLDLSANSISGA--NVVG--------WV 169
Query: 199 FSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFG 258
            S+            C  L+ L ++ NK+ G              +DV            
Sbjct: 170 LSD-----------GCGELKHLAISGNKISG-------------DVDV------------ 193
Query: 259 SEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDL 318
             +C NL FLD+S N FS GI P LG+CS+L HLDI G+KL+G    +      L  L++
Sbjct: 194 -SRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 251
Query: 319 SENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDEL-GQLSNLQDLELFDNRLTGEFPV 377
           S NQ  G IPP     K L  L L  N+  GEIPD L G    L  L+L  N   G  P 
Sbjct: 252 SSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 309
Query: 378 SIWRIASXXXXXXXXXXXXXXXPLE-MTELKQLKNISLYNNQFSGVIPQSL-GINSSLMQ 435
                +                P++ + +++ LK + L  N+FSG +P+SL  +++SL+ 
Sbjct: 310 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 369
Query: 436 LDFI--------------------------NNSFTGEIPPNLCFGKQLRVLNMGQNQFHG 469
           LD                            NN FTG+IPP L    +L  L++  N   G
Sbjct: 370 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 429
Query: 470 PIPSLLGSCPTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINL 528
            IPS LGS   L  + L  N L G +P E      L  L +  N+++G IPS + N  NL
Sbjct: 430 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 489
Query: 529 TSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNG 588
             I  S+N+ +G +P+ +G L +L  L +S N   G++P++L  C++L   D++ NL NG
Sbjct: 490 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 549
Query: 589 SIPSSLRSWKSLSILKLSENHFTGGIPTFISXXXXXXXXXXXXXXXXXXIPPSIGALQDL 648
           +IP+++         K++ N   G    +I                        G  ++ 
Sbjct: 550 TIPAAMFKQSG----KIAANFIAGKRYVYIKND---------------------GMKKEC 584
Query: 649 SYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFT 707
             A NL +    G     L +LS     +I+S    G  SP   N  S++ +++SYN+ +
Sbjct: 585 HGAGNLLE--FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 642
Query: 708 GPVPETL 714
           G +P+ +
Sbjct: 643 GYIPKEI 649

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  200 bits (508), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 192/608 (31%), Positives = 276/608 (45%), Gaps = 70/608 (11%)
Query: 41  NSVPPLIISSWNSSDSTPCQWVGIE-CDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQT 99
           NS+  L +S+ + S +    WV  + C +  H  +S N     +SG +  ++     L+ 
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN----KISGDV--DVSRCVNLEF 204
Query: 100 IDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFEXXXXXXXXXXXXXXXDGEI 159
           +D+SSNNFS  IP  LG+CSAL++LD+S N  +GD                      G I
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 160 PEPLFRILGLQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESIG------ 212
           P PL  +  LQY+ L  N  +G IP  + G    +  L L  N   G +P   G      
Sbjct: 264 P-PL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 213 -------------------NCYRLQELYLNENKLMGFLPESLSNLE-NLVYLDVGDNNLE 252
                                  L+ L L+ N+  G LPESL+NL  +L+ LD+  NN  
Sbjct: 322 SLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381
Query: 253 GRI--NFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLL 310
           G I  N        L  L L  N F+G I P L NCS L  L +  + L+G+IPSS G L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 311 ARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNR 370
           ++L  L L  N L G+IP EL   K L  L L  N L GEIP  L   +NL  + L +NR
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 371 LTGEFPVSIWRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIPQSLGIN 430
           LTGE P  I R                        L+ L  + L NN FSG IP  LG  
Sbjct: 502 LTGEIPKWIGR------------------------LENLAILKLSNNSFSGNIPAELGDC 537
Query: 431 SSLMQLDFINNSFTGEIPPNLC--FGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQ 488
            SL+ LD   N F G IP  +    GK       G+   +     +   C     ++  Q
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQ 597
Query: 489 NQLTGALPEFS-KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG 547
              +  L   S +NP     +++     G    +  N+ ++  +D S N  SG +P+E+G
Sbjct: 598 GIRSEQLNRLSTRNPC----NITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG 653
Query: 548 NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSE 607
           ++  L  LN+  N + GS+P ++   + L + D+S N L+G IP ++ +   L+ + LS 
Sbjct: 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 608 NHFTGGIP 615
           N+ +G IP
Sbjct: 714 NNLSGPIP 721

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  184 bits (468), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 206/727 (28%), Positives = 317/727 (43%), Gaps = 162/727 (22%)
Query: 47  IISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSS----YGVSGQLGPEI----------- 91
           ++  W SS+  PC + G+ C DD   V S +LSS     G S      +           
Sbjct: 29  LLPDW-SSNKNPCTFDGVTCRDDK--VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLS 85
Query: 92  -GHL----------SKLQTIDLSSNNFSGNIPP--KLGNCSALEYLDLSTNGFTGDIPDN 138
             H+          + L ++DLS N+ SG +     LG+CS L++L++S+N  T D P  
Sbjct: 86  NSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSN--TLDFP-- 141
Query: 139 FEXXXXXXXXXXXXXXXDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL 198
                             G++   L ++  L+ + L+ NS+SG+    VG        W+
Sbjct: 142 ------------------GKVSGGL-KLNSLEVLDLSANSISGA--NVVG--------WV 172
Query: 199 FSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFG 258
            S+            C  L+ L ++ NK+ G              +DV            
Sbjct: 173 LSD-----------GCGELKHLAISGNKISG-------------DVDV------------ 196
Query: 259 SEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDL 318
             +C NL FLD+S N FS GI P LG+CS+L HLDI G+KL+G    +      L  L++
Sbjct: 197 -SRCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254
Query: 319 SENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDEL-GQLSNLQDLELFDNRLTGEFPV 377
           S NQ  G IPP     K L  L L  N+  GEIPD L G    L  L+L  N   G  P 
Sbjct: 255 SSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP 312
Query: 378 SIWRIASXXXXXXXXXXXXXXXPLE-MTELKQLKNISLYNNQFSGVIPQSL-GINSSLMQ 435
                +                P++ + +++ LK + L  N+FSG +P+SL  +++SL+ 
Sbjct: 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 372
Query: 436 LDFI--------------------------NNSFTGEIPPNLCFGKQLRVLNMGQNQFHG 469
           LD                            NN FTG+IPP L    +L  L++  N   G
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432
Query: 470 PIPSLLGSCPTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINL 528
            IPS LGS   L  + L  N L G +P E      L  L +  N+++G IPS + N  NL
Sbjct: 433 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 529 TSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNG 588
             I  S+N+ +G +P+ +G L +L  L +S N   G++P++L  C++L   D++ NL NG
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 589 SIPSSLRSWKSLSILKLSENHFTGGIPTFISXXXXXXXXXXXXXXXXXXIPPSIGALQDL 648
           +IP+++         K++ N   G    +I                        G  ++ 
Sbjct: 553 TIPAAMFKQSG----KIAANFIAGKRYVYIKND---------------------GMKKEC 587
Query: 649 SYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFT 707
             A NL +    G     L +LS     +I+S    G  SP   N  S++ +++SYN+ +
Sbjct: 588 HGAGNLLE--FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS 645
Query: 708 GPVPETL 714
           G +P+ +
Sbjct: 646 GYIPKEI 652

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  191 bits (485), Expect = 2e-48,   Method: Composition-based stats.
 Identities = 114/321 (35%), Positives = 175/321 (54%), Gaps = 22/321 (6%)
Query: 792  RRRSKQD--LEIPAQEGPS--------YLLKQVIEATENLNAKHVIGRGAHGIVYKASLG 841
            RR+  QD   ++PA+E P         + L+++  A++N + K+++GRG  G VYK  L 
Sbjct: 1    RRKKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 842  PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENG 901
               + AVK+L     + G L  + E++ I    HRNL+RL  F +     +++Y YM NG
Sbjct: 61   DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 902  SLRDVLHS-ITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEME 960
            S+   L       P L+W  R +I              CDP I+HRD+K  NILLD E E
Sbjct: 121  SVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 961  PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR 1020
              + DFG+AKL+D         +V GTIG+IAPE   T   S+++DV+ YGV+LLELIT 
Sbjct: 181  AVVGDFGLAKLMDYKDXHVXX-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 239
Query: 1021 KKALDPSYKERTD---IVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLL-VA 1076
            ++A D +     D   ++ WV+ +  + +++  +VD+ L       + +D+ ++ L+ VA
Sbjct: 240  QRAFDLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQ-----GNYKDEEVEQLIQVA 293
Query: 1077 LRCTEKKPSNRPNMRDVVRQL 1097
            L CT+  P  RP M +VVR L
Sbjct: 294  LLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  183 bits (464), Expect = 5e-46,   Method: Composition-based stats.
 Identities = 109/312 (34%), Positives = 168/312 (53%), Gaps = 20/312 (6%)
Query: 799  LEIPAQEGPS--------YLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKK 850
             ++PA+E P         + L+++  A++N   K+++GRG  G VYK  L    + AVK+
Sbjct: 2    FDVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKR 61
Query: 851  LAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS- 909
            L     + G L  + E++ I    HRNL+RL  F +     +++Y YM NGS+   L   
Sbjct: 62   LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 910  ITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIA 969
                P L+W  R +I              CDP I+HRD+K  NILLD E E  + DFG+A
Sbjct: 122  PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 970  KLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYK 1029
            KL+D         +V G IG+IAPE   T   S+++DV+ YGV+LLELIT ++A D +  
Sbjct: 182  KLMDYKDXHVXX-AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 1030 ERTD---IVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLL-VALRCTEKKPS 1085
               D   ++ WV+ +  + +++  +VD+ L       + +D+ ++ L+ VAL CT+  P 
Sbjct: 241  ANDDDVMLLDWVKGLLKE-KKLEALVDVDLQ-----GNYKDEEVEQLIQVALLCTQSSPM 294
Query: 1086 NRPNMRDVVRQL 1097
             RP M +VVR L
Sbjct: 295  ERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  122 bits (305), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 148/284 (52%), Gaps = 11/284 (3%)
Query: 816  EATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
            EAT N + K +IG G  G VYK  L   A  A+K+       +G    + EI+T+   RH
Sbjct: 36   EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRH 94
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH-SITPPPTLEWNVRYKIXXXXXXXXXX 934
             +LV L  F   ++  I++Y+YMENG+L+  L+ S  P  ++ W  R +I          
Sbjct: 95   PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    I+HRD+K  NILLD    P I+DFGI+K   +   +     V GT+GYI PE
Sbjct: 155  LHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPE 211
Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDPSY-KERTDIVGWVRSVWSDTEEINDIVD 1053
                   +++SDVYS+GVVL E++  + A+  S  +E  ++  W     ++  ++  IVD
Sbjct: 212  YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG-QLEQIVD 270
Query: 1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             +L +++   S+R +  D    A++C      +RP+M DV+ +L
Sbjct: 271  PNLADKIRPESLR-KFGD---TAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  122 bits (305), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 148/284 (52%), Gaps = 11/284 (3%)
Query: 816  EATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
            EAT N + K +IG G  G VYK  L   A  A+K+       +G    + EI+T+   RH
Sbjct: 36   EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRH 94
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH-SITPPPTLEWNVRYKIXXXXXXXXXX 934
             +LV L  F   ++  I++Y+YMENG+L+  L+ S  P  ++ W  R +I          
Sbjct: 95   PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    I+HRD+K  NILLD    P I+DFGI+K   +   +     V GT+GYI PE
Sbjct: 155  LHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPE 211
Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDPSY-KERTDIVGWVRSVWSDTEEINDIVD 1053
                   +++SDVYS+GVVL E++  + A+  S  +E  ++  W     ++  ++  IVD
Sbjct: 212  YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG-QLEQIVD 270
Query: 1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             +L +++   S+R +  D    A++C      +RP+M DV+ +L
Sbjct: 271  PNLADKIRPESLR-KFGD---TAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  121 bits (303), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 96/310 (30%), Positives = 149/310 (48%), Gaps = 20/310 (6%)
Query: 797  QDLEIPAQEGPSYLLKQVIEATENLNAKHV------IGRGAHGIVYKASLGPNAVFAVKK 850
            + LE+      S+   ++   T N + + +      +G G  G+VYK  +  N   AVKK
Sbjct: 3    KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKK 61
Query: 851  LAFR---GHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL 907
            LA       +       +EI+ + K +H NLV L  F    D   ++Y YM NGSL D L
Sbjct: 62   LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 908  HSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
              +   P L W++R KI             +     +HRDIK  NILLD      ISDFG
Sbjct: 122  SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFG 178
Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027
            +A+  +K   +     +VGT  Y+APE A     + +SD+YS+GVVLLE+IT   A+D  
Sbjct: 179  LARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD-E 236
Query: 1028 YKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNR 1087
            ++E   ++     +  + + I D +D  + +    S     V  +  VA +C  +K + R
Sbjct: 237  HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-----VEAMYSVASQCLHEKKNKR 291
Query: 1088 PNMRDVVRQL 1097
            P+++ V + L
Sbjct: 292  PDIKKVQQLL 301

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  120 bits (301), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 96/310 (30%), Positives = 149/310 (48%), Gaps = 20/310 (6%)
Query: 797  QDLEIPAQEGPSYLLKQVIEATENLNAKHV------IGRGAHGIVYKASLGPNAVFAVKK 850
            + LE+      S+   ++   T N + + +      +G G  G+VYK  +  N   AVKK
Sbjct: 3    KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKK 61
Query: 851  LAFR---GHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL 907
            LA       +       +EI+ + K +H NLV L  F    D   ++Y YM NGSL D L
Sbjct: 62   LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 908  HSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
              +   P L W++R KI             +     +HRDIK  NILLD      ISDFG
Sbjct: 122  SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFG 178
Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027
            +A+  +K   +     +VGT  Y+APE A     + +SD+YS+GVVLLE+IT   A+D  
Sbjct: 179  LARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD-E 236
Query: 1028 YKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNR 1087
            ++E   ++     +  + + I D +D  + +    S     V  +  VA +C  +K + R
Sbjct: 237  HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS-----VEAMYSVASQCLHEKKNKR 291
Query: 1088 PNMRDVVRQL 1097
            P+++ V + L
Sbjct: 292  PDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  119 bits (299), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 135/274 (49%), Gaps = 14/274 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFR---GHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            +G G  G+VYK  +  N   AVKKLA       +       +EI+ + K +H NLV L  
Sbjct: 33   MGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPI 943
            F    D   ++Y YM NGSL D L  +   P L W++R KI             +     
Sbjct: 92   FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH--- 148
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRDIK  NILLD      ISDFG+A+  +K         +VGT  Y+APE A     + 
Sbjct: 149  IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITP 207
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SD+YS+GVVLLE+IT   A+D  ++E   ++     +  + + I D +D  + +    S
Sbjct: 208  KSDIYSFGVVLLEIITGLPAVD-EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS 266
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                 V  +  VA +C  +K + RP+++ V + L
Sbjct: 267  -----VEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  112 bits (280), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 130/278 (46%), Gaps = 14/278 (5%)
Query: 828  GRGAHGIVYKASLGPNAVFAVKKLAFR---GHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            G G  G+VYK  +  N   AVKKLA       +       +EI+   K +H NLV L  F
Sbjct: 31   GEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
                D   ++Y Y  NGSL D L  +   P L W+ R KI             +     +
Sbjct: 90   SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---I 146
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRDIK  NILLD      ISDFG+A+  +K         +VGT  Y APE A     + +
Sbjct: 147  HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPK 205
Query: 1005 SDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSS 1064
            SD+YS+GVVLLE+IT   A+D  ++E   ++     +  + + I D +D    +    S 
Sbjct: 206  SDIYSFGVVLLEIITGLPAVD-EHREPQLLLDIKEEIEDEEKTIEDYIDKKXNDADSTS- 263
Query: 1065 IRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102
                V     VA +C  +K + RP+++ V + L + + 
Sbjct: 264  ----VEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXTA 297

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 93.2 bits (230), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 113/244 (46%), Gaps = 28/244 (11%)
Query: 207 IPESIGNCYRLQELYLNE-NKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNL 265
           IP S+ N   L  LY+   N L+G +P +++ L  L YL +   N+ G I     + K L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 266 TFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARL-SSLDLSENQLS 324
             LD SYN  SG + P++ +  +L  +   G++++G+IP S+G  ++L +S+ +S N+L+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 325 GKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIAS 384
           GKIPP       L  + L  N LEG+     G   N Q + L  N L  +          
Sbjct: 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-------- 238
Query: 385 XXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFT 444
                            ++   K L  + L NN+  G +PQ L     L  L+   N+  
Sbjct: 239 -----------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 445 GEIP 448
           GEIP
Sbjct: 282 GEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 105/249 (42%), Gaps = 28/249 (11%)
Query: 303 IPSSFGLLARLSSLDLSE-NQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNL 361
           IPSS   L  L+ L +   N L G IPP + K   L  L++    + G IPD L Q+  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 362 QDLELFDNRLTGEFPVSIWRIASXXXXXXXXXXXXXXXPLEMTELKQLKNISLYNNQFSG 421
             L+   N L+G  P SI                        + L  L  I+   N+ SG
Sbjct: 128 VTLDFSYNALSGTLPPSI------------------------SSLPNLVGITFDGNRISG 163
Query: 422 VIPQSLGINSSLM-QLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT 480
            IP S G  S L   +    N  TG+IPP       L  +++ +N   G    L GS   
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NLNLAFVDLSRNMLEGDASVLFGSDKN 222
Query: 481 LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
             ++ L +N L   L +   +  L+ LD+  N I G +P  +     L S++ S N   G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282
Query: 541 LMPQELGNL 549
            +PQ  GNL
Sbjct: 283 EIPQG-GNL 290

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 2/193 (1%)
Query: 400 PLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRV 459
           P  + +L QL  + + +   SG IP  L    +L+ LDF  N+ +G +PP++     L  
Sbjct: 94  PPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVG 153
Query: 460 LNMGQNQFHGPIPSLLGSCPTLWR-VILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAI 518
           +    N+  G IP   GS   L+  + + +N+LTG +P    N  L+ +D+SRN + G  
Sbjct: 154 ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDA 213
Query: 519 PSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEV 578
               G+  N   I  + N  +  +  ++G   +L  L++  N + G+LP  L++ K L  
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 579 FDVSFNLLNGSIP 591
            +VSFN L G IP
Sbjct: 273 LNVSFNNLCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 6/228 (2%)
Query: 470 PIPSLLGSCPTL-WRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSIN 527
           PIPS L + P L +  I   N L G +P   +K   L +L ++  N+SGAIP  +     
Sbjct: 67  PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 528 LTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLP-SQLSKCKNLEVFDVSFNLL 586
           L ++DFS N  SG +P  + +L +LV +    N + G++P S  S  K      +S N L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 587 NGSIPSSLRSWKSLSILKLSENHFTGGIPTFISXXXXXXXXXXXXXXXXXXIPPSIGALQ 646
            G IP +  +  +L+ + LS N   G                         +   +G  +
Sbjct: 187 TGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSK 244
Query: 647 DLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIH 694
           +L+  L+L  N + G +P  L +L  L  L++S NNL G +    N+ 
Sbjct: 245 NLN-GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 13/207 (6%)
Query: 512 NNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLS 571
           NN+ G IP +I     L  +  +    SG +P  L  + +LVTL+ S N + G+LP  +S
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 572 KCKNLEVFDVSFNLLNGSIPSSLRSWKSL-SILKLSENHFTGGI-PTFISXXXXXXXXXX 629
              NL       N ++G+IP S  S+  L + + +S N  TG I PTF +          
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSR 206
Query: 630 XXXXXXXXIPPSIGALQDLSYALNLSKNGLTGRIPSDLEK--LSK-LEQLDISSNNLTGT 686
                   +    G+ ++ +  ++L+KN L      DL K  LSK L  LD+ +N + GT
Sbjct: 207 NMLEGDASV--LFGSDKN-TQKIHLAKNSLA----FDLGKVGLSKNLNGLDLRNNRIYGT 259
Query: 687 L-SPLSNIHSLVEVNVSYNLFTGPVPE 712
           L   L+ +  L  +NVS+N   G +P+
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/284 (26%), Positives = 134/284 (47%), Gaps = 42/284 (14%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + +  + V+GRGA G+V KA      V A+K++     ++  +    E++ + ++ H N+
Sbjct: 8    KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIESESERKAFIV---ELRQLSRVNHPNI 63
Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            V+L    L   C  ++  Y E GSL +VLH   P P   +   + +              
Sbjct: 64   VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPY--YTAAHAMSWCLQCSQGVAYLH 119
Query: 939  CDPP--IVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
               P  ++HRD+KP N+LL +      I DFG A         T   +  G+  ++APE 
Sbjct: 120  SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEV 174
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALD----PSYKERTDIVGWVRSVWSDTEEINDI 1051
               +  S++ DV+S+G++L E+ITR+K  D    P++          R +W+    +++ 
Sbjct: 175  FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----------RIMWA----VHNG 220
Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                L++ +       + I+ L+   RC  K PS RP+M ++V+
Sbjct: 221  TRPPLIKNL------PKPIESLMT--RCWSKDPSQRPSMEEIVK 256

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 75/284 (26%), Positives = 134/284 (47%), Gaps = 42/284 (14%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + +  + V+GRGA G+V KA      V A+K++     ++  +    E++ + ++ H N+
Sbjct: 9    KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIESESERKAFIV---ELRQLSRVNHPNI 64
Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            V+L    L   C  ++  Y E GSL +VLH   P P   +   + +              
Sbjct: 65   VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPY--YTAAHAMSWCLQCSQGVAYLH 120
Query: 939  CDPP--IVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
               P  ++HRD+KP N+LL +      I DFG A         T   +  G+  ++APE 
Sbjct: 121  SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEV 175
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALD----PSYKERTDIVGWVRSVWSDTEEINDI 1051
               +  S++ DV+S+G++L E+ITR+K  D    P++          R +W+    +++ 
Sbjct: 176  FEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----------RIMWA----VHNG 221
Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                L++ +       + I+ L+   RC  K PS RP+M ++V+
Sbjct: 222  TRPPLIKNL------PKPIESLMT--RCWSKDPSQRPSMEEIVK 257

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 864  KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
            +RE+    ++ H+N+V + D     DC  ++  Y+E  +L + + S  P      +V   
Sbjct: 59   EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTA 113
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            I               D  IVHRDIKP+NIL+DS     I DFGIAK L ++  + T+  
Sbjct: 114  INFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN-H 171
Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043
            V+GT+ Y +PE A   A  + +D+YS G+VL E++      +P +   T +   ++ +  
Sbjct: 172  VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG----EPPFNGETAVSIAIKHIQD 227
Query: 1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLL-VALRCTEKKPSNR 1087
                +              + +R  +   L  V LR TEK  +NR
Sbjct: 228  SVPNV-------------TTDVRKDIPQSLSNVILRATEKDKANR 259

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 5/201 (2%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNL 878
            +LN K  IG G+ G V++A    + V AVK L  +  H        RE+  + ++RH N+
Sbjct: 38   DLNIKEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            V       +     I+  Y+  GSL  +LH       L+   R  +             +
Sbjct: 97   VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
             +PPIVHR++K  N+L+D +    + DFG+++L  K+    +S S  GT  ++APE    
Sbjct: 156  RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 999  TAKSKESDVYSYGVVLLELIT 1019
               +++SDVYS+GV+L EL T
Sbjct: 214  EPSNEKSDVYSFGVILWELAT 234

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 5/201 (2%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNL 878
            +LN K  IG G+ G V++A    + V AVK L  +  H        RE+  + ++RH N+
Sbjct: 38   DLNIKEKIGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            V       +     I+  Y+  GSL  +LH       L+   R  +             +
Sbjct: 97   VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-N 155
Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
             +PPIVHRD+K  N+L+D +    + DFG+++L  K+     S    GT  ++APE    
Sbjct: 156  RNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRD 213
Query: 999  TAKSKESDVYSYGVVLLELIT 1019
               +++SDVYS+GV+L EL T
Sbjct: 214  EPSNEKSDVYSFGVILWELAT 234

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 76/256 (29%), Positives = 116/256 (45%), Gaps = 27/256 (10%)
Query: 800  EIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLG-------PNAVFAVKKLA 852
            E P + G S+   + IEA+  ++ + +IG G  G V    L        P A+ A+K   
Sbjct: 33   EEPGRAGRSF--TREIEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 853  FRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP 912
                +R  LS   E   +G+  H N++RLE    R    +I+  YMENGSL   L +   
Sbjct: 90   TERQRRDFLS---EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 913  PPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
              T+      ++               D   VHRD+   N+L+DS +   +SDFG++++L
Sbjct: 147  QFTI-----MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 973  DKSP-ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            +  P A+ T+      I + APE       S  SDV+S+GVV+ E++        +Y ER
Sbjct: 202  EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL--------AYGER 253
Query: 1032 TDIVGWVRSVWSDTEE 1047
                   R V S  EE
Sbjct: 254  PYWNMTNRDVISSVEE 269

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 76/256 (29%), Positives = 116/256 (45%), Gaps = 27/256 (10%)
Query: 800  EIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLG-------PNAVFAVKKLA 852
            E P + G S+   + IEA+  ++ + +IG G  G V    L        P A+ A+K   
Sbjct: 33   EEPGRAGRSF--TREIEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 853  FRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP 912
                +R  LS   E   +G+  H N++RLE    R    +I+  YMENGSL   L +   
Sbjct: 90   TERQRRDFLS---EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 913  PPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
              T+      ++               D   VHRD+   N+L+DS +   +SDFG++++L
Sbjct: 147  QFTI-----MQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 973  DKSP-ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            +  P A+ T+      I + APE       S  SDV+S+GVV+ E++        +Y ER
Sbjct: 202  EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL--------AYGER 253
Query: 1032 TDIVGWVRSVWSDTEE 1047
                   R V S  EE
Sbjct: 254  PYWNMTNRDVISSVEE 269

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 30/280 (10%)
Query: 821  LNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKR-----EIQTIGKIRH 875
            +  + VIG G  G VYK  L  ++      +A +  K G    +R     E   +G+  H
Sbjct: 46   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             N++RLE    +    +I+  YMENG+L   L         E++V  ++           
Sbjct: 106  HNIIRLEGVISKYKPMMIITEYMENGALDKFLRE----KDGEFSV-LQLVGMLRGIAAGM 160
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT-IGYIAPE 994
                +   VHRD+   NIL++S +   +SDFG++++L+  P +T + S     I + APE
Sbjct: 161  KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054
                   +  SDV+S+G+V+ E++T        Y ER     W  S     + IND    
Sbjct: 221  AISYRKFTSASDVWSFGIVMWEVMT--------YGERPY---WELSNHEVMKAIND--GF 267
Query: 1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
             L   M   S   Q++      ++C +++ + RP   D+V
Sbjct: 268  RLPTPMDCPSAIYQLM------MQCWQQERARRPKFADIV 301

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 15/219 (6%)
Query: 814  VIEATENLNAKHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGK 872
            V   + +   K ++G GA+G+V  A+  P   + A+KK+        +L   REI+ +  
Sbjct: 6    VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL-EWNVRYKIXXXXXXX 931
             +H N++ + +             Y+    ++  LH +     L + +++Y I       
Sbjct: 66   FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS--------IS 983
                  +    ++HRD+KP N+L++S  +  + DFG+A+++D+S A  +         + 
Sbjct: 126  KVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 984  VVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
             V T  Y APE   T+AK S+  DV+S G +L EL  R+
Sbjct: 182  FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 814  VIEATENLNAKHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGK 872
            V   + +   K ++G GA+G+V  A+  P   + A+KK+        +L   REI+ +  
Sbjct: 6    VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL-EWNVRYKIXXXXXXX 931
             +H N++ + +             Y+    ++  LH +     L + +++Y I       
Sbjct: 66   FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS--------IS 983
                  +    ++HRD+KP N+L++S  +  + DFG+A+++D+S A  +           
Sbjct: 126  KVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 984  VVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
             V T  Y APE   T+AK S+  DV+S G +L EL  R+
Sbjct: 182  YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 814  VIEATENLNAKHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGK 872
            V   + +   K ++G GA+G+V  A+  P   + A+KK+        +L   REI+ +  
Sbjct: 6    VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL-EWNVRYKIXXXXXXX 931
             +H N++ + +             Y+    ++  LH +     L + +++Y I       
Sbjct: 66   FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS--------IS 983
                  +    ++HRD+KP N+L++S  +  + DFG+A+++D+S A  +           
Sbjct: 126  KVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 984  VVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
             V T  Y APE   T+AK S+  DV+S G +L EL  R+
Sbjct: 182  XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS-----MKREIQTIGKIR 874
             L  + +IG G  G VY+A    + V AVK  A R      +S     +++E +    ++
Sbjct: 8    ELTLEEIIGIGGFGKVYRAFWIGDEV-AVK--AARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            H N++ L    L++    ++  +   G L  VL     PP +  N   +I          
Sbjct: 65   HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDE 124
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEP--------HISDFGIAKLLDKSPASTTSISVVG 986
                   PI+HRD+K  NIL+  ++E          I+DFG+A+   +    TT +S  G
Sbjct: 125  AIV----PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----TTKMSAAG 176
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               ++APE    +  SK SDV+SYGV+L EL+T
Sbjct: 177  AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Composition-based stats.
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 15/215 (6%)
Query: 803  AQEGPSYLLKQVIEATENLNAKHVIGRGAHG-IVYKASLGPNAVFAVKKLAFRGHKRGSL 861
            A EGP +  KQ  +  +  + + V+G GA   ++         + A+K +A +  +    
Sbjct: 4    AVEGPRW--KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG 61
Query: 862  SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            SM+ EI  + KI+H N+V L+D +       ++ + +  G L D +  +      E +  
Sbjct: 62   SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDAS 119
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENIL---LDSEMEPHISDFGIAKLLDKSPAS 978
              I               D  IVHRD+KPEN+L   LD + +  ISDFG++K+ D  P S
Sbjct: 120  RLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGS 173
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
              S +  GT GY+APE       SK  D +S GV+
Sbjct: 174  VLS-TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG+A++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/218 (29%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHG-IVYKASLGPNAVFAVKKLAFRGHKRGSLSM 863
            E  S   KQ  +  +    K  +G GA   +V         +FAVK +  +  K    S+
Sbjct: 8    ESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSI 67
Query: 864  KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL-----HSITPPPTLEW 918
            + EI  + KI+H N+V LED +   +   ++ + +  G L D +     ++     TL  
Sbjct: 68   ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR 127
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILL---DSEMEPHISDFGIAKLLDKS 975
             V   +                  IVHRD+KPEN+L    D E +  ISDFG++K+  K 
Sbjct: 128  QVLDAVYYLHRMG-----------IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG 176
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
               +T+    GT GY+APE       SK  D +S GV+
Sbjct: 177  DVMSTA---CGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 110/248 (44%), Gaps = 48/248 (19%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLED 883
            V+G+GA G V KA    ++  +A+KK+    H    LS +  E+  +  + H+ +VR   
Sbjct: 13   VLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 884  FWL-------------RKDCGIIMYRYMENGSLRDVLHS--ITPPPTLEWNVRYKIXXXX 928
             WL             +K    I   Y ENG+L D++HS  +       W +  +I    
Sbjct: 70   AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 929  XXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS-----------PA 977
                          I+HRD+KP NI +D      I DFG+AK + +S           P 
Sbjct: 130  SYIHS-------QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 978  STTSI-SVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRKKALDP--SYKERTD 1033
            S+ ++ S +GT  Y+A E    T    E  D+YS G++  E+I       P  +  ER +
Sbjct: 183  SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY------PFSTGMERVN 236
Query: 1034 IVGWVRSV 1041
            I+  +RSV
Sbjct: 237  ILKKLRSV 244

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRN 877
            E  +    IG G +G+VYKA       FA+KK+       G  S   REI  + +++H N
Sbjct: 2    EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 878  LVRLEDFWLRKDCGIIMYRYMENG--SLRDV----LHSITPPPTLEWNVRYKIXXXXXXX 931
            +V+L D    K   ++++ +++     L DV    L S+T    L               
Sbjct: 62   IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-------------LQ 108
Query: 932  XXXXXXDC-DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                   C D  ++HRD+KP+N+L++ E E  I+DFG+A+     P    +  VV T+ Y
Sbjct: 109  LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEVV-TLWY 166
Query: 991  IAPENAFTTAK-SKESDVYSYGVVLLELI 1018
             AP+    + K S   D++S G +  E++
Sbjct: 167  RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRN 877
            E  +    IG G +G+VYKA       FA+KK+       G  S   REI  + +++H N
Sbjct: 2    EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 878  LVRLEDFWLRKDCGIIMYRYMENG--SLRDV----LHSITPPPTLEWNVRYKIXXXXXXX 931
            +V+L D    K   ++++ +++     L DV    L S+T    L               
Sbjct: 62   IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-------------LQ 108
Query: 932  XXXXXXDC-DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                   C D  ++HRD+KP+N+L++ E E  I+DFG+A+     P    +  VV T+ Y
Sbjct: 109  LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEVV-TLWY 166
Query: 991  IAPENAFTTAK-SKESDVYSYGVVLLELI 1018
             AP+    + K S   D++S G +  E++
Sbjct: 167  RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 32/76 (42%), Positives = 49/76 (64%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        + S VGT  Y++PE     + S
Sbjct: 153  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 213  KSSDLWALGCIIYQLV 228

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 803  AQEGPSYLLKQVIEATENLNAKHVIGRGAHG-IVYKASLGPNAVFAVKKLAFRGHKRGSL 861
            A EGP +  KQ  +  +  + + V+G GA   ++         + A+K +A    +    
Sbjct: 4    AVEGPRW--KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 862  SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            SM+ EI  + KI+H N+V L+D +       ++ + +  G L D +  +      E +  
Sbjct: 62   SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDAS 119
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENIL---LDSEMEPHISDFGIAKLLDKSPAS 978
              I               D  IVHRD+KPEN+L   LD + +  ISDFG++K+ D  P S
Sbjct: 120  RLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGS 173
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
              S +  GT GY+APE       SK  D +S GV+
Sbjct: 174  VLS-TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 803  AQEGPSYLLKQVIEATENLNAKHVIGRGAHG-IVYKASLGPNAVFAVKKLAFRGHKRGSL 861
            A EGP +  KQ  +  +  + + V+G GA   ++         + A+K +A    +    
Sbjct: 4    AVEGPRW--KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 862  SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            SM+ EI  + KI+H N+V L+D +       ++ + +  G L D +  +      E +  
Sbjct: 62   SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDAS 119
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENIL---LDSEMEPHISDFGIAKLLDKSPAS 978
              I               D  IVHRD+KPEN+L   LD + +  ISDFG++K+ D  P S
Sbjct: 120  RLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGS 173
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
              S +  GT GY+APE       SK  D +S GV+
Sbjct: 174  VLS-TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 65/215 (30%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 803  AQEGPSYLLKQVIEATENLNAKHVIGRGAHG-IVYKASLGPNAVFAVKKLAFRGHKRGSL 861
            A EGP +  KQ  +  +  + + V+G GA   ++         + A+K +A    +    
Sbjct: 4    AVEGPRW--KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEG 61
Query: 862  SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            SM+ EI  + KI+H N+V L+D +       ++ + +  G L D +  +      E +  
Sbjct: 62   SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDAS 119
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENIL---LDSEMEPHISDFGIAKLLDKSPAS 978
              I               D  IVHRD+KPEN+L   LD + +  ISDFG++K+ D  P S
Sbjct: 120  RLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGS 173
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
              S +  GT GY+APE       SK  D +S GV+
Sbjct: 174  VLS-TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 24/209 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRN 877
            E  +    IG G +G+VYKA       FA+KK+       G  S   REI  + +++H N
Sbjct: 2    EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 878  LVRLEDFWLRKDCGIIMYRYMENG--SLRDV----LHSITPPPTLEWNVRYKIXXXXXXX 931
            +V+L D    K   ++++ +++     L DV    L S+T    L               
Sbjct: 62   IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-------------LQ 108
Query: 932  XXXXXXDC-DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                   C D  ++HRD+KP+N+L++ E E  I+DFG+A+     P    +  +V T+ Y
Sbjct: 109  LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWY 166
Query: 991  IAPENAFTTAK-SKESDVYSYGVVLLELI 1018
             AP+    + K S   D++S G +  E++
Sbjct: 167  RAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 119/285 (41%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG+ ++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 30   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 89   GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 143
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 144  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 204  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 244
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 245  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 289

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 13   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 72   GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 126
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 127  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 187  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 227
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 228  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 40   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+  YMENGSL   L       T+      ++      
Sbjct: 99   GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 153
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 154  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 214  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 254
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 255  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 299

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 118/284 (41%), Gaps = 37/284 (13%)
Query: 824  KHVIGRGAHGIVYKASL---GPNAVF-AVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            + VIG G  G V    L   G   +F A+K L     ++       E   +G+  H N++
Sbjct: 38   EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
             LE    +    +I+  +MENGSL   L       T+      ++               
Sbjct: 98   HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV-----IQLVGMLRGIAAGMKYLA 152
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG---TIGYIAPENA 996
            D   VHRD+   NIL++S +   +SDFG+++ L+   +  T  S +G    I + APE  
Sbjct: 153  DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE--INDI-VD 1053
                 +  SDV+SYG+V+ E++        SY E        R  W  T +  IN I  D
Sbjct: 213  QYRKFTSASDVWSYGIVMWEVM--------SYGE--------RPYWDMTNQDVINAIEQD 256
Query: 1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              L   M   S   Q++      L C +K  ++RP    +V  L
Sbjct: 257  YRLPPPMDCPSALHQLM------LDCWQKDRNHRPKFGQIVNTL 294

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCG----IIMYRYMENGSLRDVLHS---ITPP 913
            L  +RE Q    + H  +V + D    +        I+  Y++  +LRD++H+   +TP 
Sbjct: 74   LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 133
Query: 914  PTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL- 972
              +E                         I+HRD+KP NI++ +     + DFGIA+ + 
Sbjct: 134  RAIE---------VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 184
Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            D   + T + +V+GT  Y++PE A   +    SDVYS G VL E++T
Sbjct: 185  DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 231

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDFW 885
            +G G +G+VYKA      + A+K++       G  S   REI  + ++ H N+V L D  
Sbjct: 29   VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
              + C  +++ +ME    +D+   +    T   + + KI                  I+H
Sbjct: 89   HSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILH 142
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RD+KP+N+L++S+    ++DFG+A+     P  + +  VV T+ Y AP+    + K   S
Sbjct: 143  RDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS 200
Query: 1006 -DVYSYGVVLLELITRK 1021
             D++S G +  E+IT K
Sbjct: 201  VDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDFW 885
            +G G +G+VYKA      + A+K++       G  S   REI  + ++ H N+V L D  
Sbjct: 29   VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
              + C  +++ +ME    +D+   +    T   + + KI                  I+H
Sbjct: 89   HSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILH 142
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RD+KP+N+L++S+    ++DFG+A+     P  + +  VV T+ Y AP+    + K   S
Sbjct: 143  RDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS 200
Query: 1006 -DVYSYGVVLLELITRK 1021
             D++S G +  E+IT K
Sbjct: 201  VDIWSIGCIFAEMITGK 217

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK----------REI 867
            EN   K ++GRG   +V +    P    +AVK +   G   GS S +          +E+
Sbjct: 17   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTG--GGSFSAEEVQELREATLKEV 74
Query: 868  QTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
              + K+  H N+++L+D +       +++  M+ G L D L   T   TL      KI  
Sbjct: 75   DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 131
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                            IVHRD+KPENILLD +M   ++DFG +  LD  P      SV G
Sbjct: 132  ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLR-SVCG 185
Query: 987  TIGYIAPE------NAFTTAKSKESDVYSYGVVLLELIT 1019
            T  Y+APE      N       KE D++S GV++  L+ 
Sbjct: 186  TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 31/76 (40%), Positives = 48/76 (63%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        + S VGT  Y++PE     +  
Sbjct: 150  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 210  KSSDLWALGCIIYQLV 225

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 31/76 (40%), Positives = 48/76 (63%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        + S VGT  Y++PE     +  
Sbjct: 154  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 214  KSSDLWALGCIIYQLV 229

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 36/291 (12%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG-------PNAVFAVKKLAFRGHKRGSLSMKREI 867
            IEA+  +  + VIG G  G V    L        P A+  +K       +R  L    E 
Sbjct: 19   IEAS-CITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLG---EA 74
Query: 868  QTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXX 927
              +G+  H N++ LE    +    +I+  YMENGSL   L       T+      ++   
Sbjct: 75   SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV-----IQLVGM 129
Query: 928  XXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVG 986
                        D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+     
Sbjct: 130  LRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046
             I + APE       +  SDV+SYG+V+ E++        SY E        R  W   E
Sbjct: 190  PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVV--------SYGE--------RPYW---E 230
Query: 1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              N  V  ++ E   + S  D    +  + L C +K+ ++RP   ++V  L
Sbjct: 231  MTNQDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCG----IIMYRYMENGSLRDVLHS---ITPP 913
            L  +RE Q    + H  +V + D    +        I+  Y++  +LRD++H+   +TP 
Sbjct: 57   LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 914  PTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL- 972
              +E                         I+HRD+KP NI++ +     + DFGIA+ + 
Sbjct: 117  RAIE---------VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167
Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            D   + T + +V+GT  Y++PE A   +    SDVYS G VL E++T
Sbjct: 168  DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCG----IIMYRYMENGSLRDVLHS---ITPP 913
            L  +RE Q    + H  +V + D    +        I+  Y++  +LRD++H+   +TP 
Sbjct: 57   LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 914  PTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL- 972
              +E                         I+HRD+KP NI++ +     + DFGIA+ + 
Sbjct: 117  RAIE---------VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167
Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            D   + T + +V+GT  Y++PE A   +    SDVYS G VL E++T
Sbjct: 168  DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 17/167 (10%)
Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCG----IIMYRYMENGSLRDVLHS---ITPP 913
            L  +RE Q    + H  +V + D    +        I+  Y++  +LRD++H+   +TP 
Sbjct: 57   LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 914  PTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL- 972
              +E                         I+HRD+KP NI++ +     + DFGIA+ + 
Sbjct: 117  RAIE---------VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167
Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            D   + T + +V+GT  Y++PE A   +    SDVYS G VL E++T
Sbjct: 168  DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK----------REI 867
            EN   K ++GRG   +V +    P    +AVK +   G   GS S +          +E+
Sbjct: 4    ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGG--GSFSAEEVQELREATLKEV 61
Query: 868  QTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
              + K+  H N+++L+D +       +++  M+ G L D L   T   TL      KI  
Sbjct: 62   DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 118
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                            IVHRD+KPENILLD +M   ++DFG +  LD  P       V G
Sbjct: 119  ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLR-EVCG 172
Query: 987  TIGYIAPE------NAFTTAKSKESDVYSYGVVLLELIT 1019
            T  Y+APE      N       KE D++S GV++  L+ 
Sbjct: 173  TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 109/248 (43%), Gaps = 48/248 (19%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLED 883
            V+G+GA G V KA    ++  +A+KK+    H    LS +  E+  +  + H+ +VR   
Sbjct: 13   VLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 884  FWL-------------RKDCGIIMYRYMENGSLRDVLHS--ITPPPTLEWNVRYKIXXXX 928
             WL             +K    I   Y EN +L D++HS  +       W +  +I    
Sbjct: 70   AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 929  XXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS-----------PA 977
                          I+HRD+KP NI +D      I DFG+AK + +S           P 
Sbjct: 130  SYIHS-------QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 978  STTSI-SVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRKKALDP--SYKERTD 1033
            S+ ++ S +GT  Y+A E    T    E  D+YS G++  E+I       P  +  ER +
Sbjct: 183  SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY------PFSTGMERVN 236
Query: 1034 IVGWVRSV 1041
            I+  +RSV
Sbjct: 237  ILKKLRSV 244

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 48/76 (63%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        + + VGT  Y++PE     +  
Sbjct: 151  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 211  KSSDLWALGCIIYQLV 226

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK----------REI 867
            EN   K ++GRG   +V +    P    +AVK +   G   GS S +          +E+
Sbjct: 17   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTG--GGSFSAEEVQELREATLKEV 74
Query: 868  QTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
              + K+  H N+++L+D +       +++  M+ G L D L   T   TL      KI  
Sbjct: 75   DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 131
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                            IVHRD+KPENILLD +M   ++DFG +  LD  P       V G
Sbjct: 132  ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLR-EVCG 185
Query: 987  TIGYIAPE------NAFTTAKSKESDVYSYGVVLLELIT 1019
            T  Y+APE      N       KE D++S GV++  L+ 
Sbjct: 186  TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 153  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 213  KSSDLWALGCIIYQLV 228

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 37/284 (13%)
Query: 824  KHVIGRGAHGIVYKASL---GPNAVF-AVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            + VIG G  G V    L   G   +F A+K L     ++       E   +G+  H N++
Sbjct: 12   EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
             LE    +    +I+  +MENGSL   L       T+      ++               
Sbjct: 72   HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV-----IQLVGMLRGIAAGMKYLA 126
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG---TIGYIAPENA 996
            D   VHR +   NIL++S +   +SDFG+++ L+   +  T  S +G    I + APE  
Sbjct: 127  DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE--INDI-VD 1053
                 +  SDV+SYG+V+ E++        SY E        R  W  T +  IN I  D
Sbjct: 187  QYRKFTSASDVWSYGIVMWEVM--------SYGE--------RPYWDMTNQDVINAIEQD 230
Query: 1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              L   M   S   Q++      L C +K  ++RP    +V  L
Sbjct: 231  YRLPPPMDCPSALHQLM------LDCWQKDRNHRPKFGQIVNTL 268

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+   MENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 156  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 216  KSSDLWALGCIIYQLV 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 151  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 211  KSSDLWALGCIIYQLV 226

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 153  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 213  KSSDLWALGCIIYQLV 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 151  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 211  KSSDLWALGCIIYQLV 226

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 153  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 213  KSSDLWALGCIIYQLV 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 153  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 213  KSSDLWALGCIIYQLV 228

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 158  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 217
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 218  KSSDLWALGCIIYQLV 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 151  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 211  KSSDLWALGCIIYQLV 226

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 154  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 214  KSSDLWALGCIIYQLV 229

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 153  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 213  KSSDLWALGCIIYQLV 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 17/167 (10%)
Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCG----IIMYRYMENGSLRDVLHS---ITPP 913
            L  +RE Q    + H  +V + D    +        I+  Y++  +LRD++H+   +TP 
Sbjct: 57   LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116
Query: 914  PTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL- 972
              +E                         I+HRD+KP NIL+ +     + DFGIA+ + 
Sbjct: 117  RAIE---------VIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIA 167
Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            D   +   + +V+GT  Y++PE A   +    SDVYS G VL E++T
Sbjct: 168  DSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 128  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 188  KSSDLWALGCIIYQLV 203

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 130  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 190  KSSDLWALGCIIYQLV 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 131  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 191  KSSDLWALGCIIYQLV 206

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 135  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 195  KSSDLWALGCIIYQLV 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 129  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 189  KSSDLWALGCIIYQLV 204

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 47/76 (61%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KPENILL+ +M   I+DFG AK+L        +   VGT  Y++PE     +  
Sbjct: 150  IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 1003 KESDVYSYGVVLLELI 1018
            K SD+++ G ++ +L+
Sbjct: 210  KSSDLWALGCIIYQLV 225

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 42   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+   MENGSL   L       T+      ++      
Sbjct: 101  GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 155
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 156  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 215
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 216  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 256
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 257  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 30/285 (10%)
Query: 815  IEATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            ++AT N++   V+G G  G V    L          A+K L     ++       E   +
Sbjct: 13   LDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
            G+  H N++RLE    +    +I+   MENGSL   L       T+      ++      
Sbjct: 72   GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV-----IQLVGMLRG 126
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIG 989
                     D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I 
Sbjct: 127  IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE       +  SDV+SYG+VL E++        SY E        R  W   E  N
Sbjct: 187  WTSPEAIAYRKFTSASDVWSYGIVLWEVM--------SYGE--------RPYW---EMSN 227
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
              V  ++ E   +    D    +  + L C +K  +NRP    +V
Sbjct: 228  QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 272

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 13/131 (9%)
Query: 893  IMYRYMENGSLRDVLHS---ITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIK 949
            I+  Y++  +LRD++H+   +TP   +E                         I+HRD+K
Sbjct: 93   IVMEYVDGVTLRDIVHTEGPMTPKRAIE---------VIADACQALNFSHQNGIIHRDVK 143
Query: 950  PENILLDSEMEPHISDFGIAKLL-DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVY 1008
            P NI++ +     + DFGIA+ + D   + T + +V+GT  Y++PE A   +    SDVY
Sbjct: 144  PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVY 203
Query: 1009 SYGVVLLELIT 1019
            S G VL E++T
Sbjct: 204  SLGCVLYEVLT 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 11/200 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVF-AVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G G +  VYK       V+ A+K++     +    +  REI  + +++H N+VRL D  
Sbjct: 13   LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSIT---PPPTLEWNVRYKIXXXXXXXXXXXXXDCDPP 942
              ++   +++ +M+N  L+  + S T    P  LE N+   +               +  
Sbjct: 73   HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNL---VKYFQWQLLQGLAFCHENK 128
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAK 1001
            I+HRD+KP+N+L++   +  + DFG+A+     P +T S  VV T+ Y AP+    +   
Sbjct: 129  ILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TLWYRAPDVLMGSRTY 186
Query: 1002 SKESDVYSYGVVLLELITRK 1021
            S   D++S G +L E+IT K
Sbjct: 187  STSIDIWSCGCILAEMITGK 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 15   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 69
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 70   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 124
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 125  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EXTAREGAKFPIKWTAPEA 183
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 184  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 13   ETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 67
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 68   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 122
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 123  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDA-EXTAREGAKFPIKWTAPEA 181
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 182  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 67
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 68   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 122
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 123  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EXTAREGAKFPIKWTAPEA 181
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 182  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 19   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 73
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 74   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 128
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 129  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EXTAREGAKFPIKWTAPEA 187
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 188  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 218

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 824  KHVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            + VIG G  G V +  L       +  A+K L     +R       E   +G+  H N++
Sbjct: 21   EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            RLE         +I+  +MENG+L   L       T+      ++               
Sbjct: 81   RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV-----IQLVGMLRGIASGMRYLA 135
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG---TIGYIAPENA 996
            +   VHRD+   NIL++S +   +SDFG+++ L+++ +  T  S +G    I + APE  
Sbjct: 136  EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 997  FTTAKSKESDVYSYGVVLLELIT 1019
                 +  SD +SYG+V+ E+++
Sbjct: 196  AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 67
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 68   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 122
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 123  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EXTAREGAKFPIKWTAPEA 181
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 182  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 14   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 68
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 69   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 123
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 124  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EXTAREGAKFPIKWTAPEA 182
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 183  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 97/235 (41%), Gaps = 27/235 (11%)
Query: 789  CLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAV 848
             L RR S  D EIP  +               +     IG G+ G VYK     +   AV
Sbjct: 21   TLGRRDSSDDWEIPDGQ---------------ITVGQRIGSGSFGTVYKGKWHGDV--AV 63
Query: 849  KKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL 907
            K L         L + K E+  + K RH N++    +  +    I+  ++ E  SL   L
Sbjct: 64   KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHL 122
Query: 908  HSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
            H I     +      K+                  I+HRD+K  NI L  ++   I DFG
Sbjct: 123  HIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 177
Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---SKESDVYSYGVVLLELIT 1019
            +A +  +   S     + G+I ++APE      K   S +SDVY++G+VL EL+T
Sbjct: 178  LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 97/235 (41%), Gaps = 27/235 (11%)
Query: 789  CLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAV 848
             L RR S  D EIP  +               +     IG G+ G VYK     +   AV
Sbjct: 20   TLGRRDSSDDWEIPDGQ---------------ITVGQRIGSGSFGTVYKGKWHGDV--AV 62
Query: 849  KKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL 907
            K L         L + K E+  + K RH N++    +  +    I+  ++ E  SL   L
Sbjct: 63   KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHL 121
Query: 908  HSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
            H I     +      K+                  I+HRD+K  NI L  ++   I DFG
Sbjct: 122  HIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 176
Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---SKESDVYSYGVVLLELIT 1019
            +A +  +   S     + G+I ++APE      K   S +SDVY++G+VL EL+T
Sbjct: 177  LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 231

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 22   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 76
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 77   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 131
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 132  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EXTAREGAKFPIKWTAPEA 190
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 191  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 221

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 21   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 75
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 76   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 130
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 131  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EXTAREGAKFPIKWTAPEA 189
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 190  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 220

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 824  KHVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            + VIG G  G V +  L       +  A+K L     +R       E   +G+  H N++
Sbjct: 19   EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            RLE         +I+  +MENG+L   L       T+      ++               
Sbjct: 79   RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV-----IQLVGMLRGIASGMRYLA 133
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG---TIGYIAPENA 996
            +   VHRD+   NIL++S +   +SDFG+++ L+++ +  T  S +G    I + APE  
Sbjct: 134  EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 997  FTTAKSKESDVYSYGVVLLELIT 1019
                 +  SD +SYG+V+ E+++
Sbjct: 194  AFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 19   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 73
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 74   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 128
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 129  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEA 187
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 188  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 218

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 23   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 77
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 78   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 132
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 133  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEA 191
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 192  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 222

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 67
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 68   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 122
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 123  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEA 181
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 182  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 8    ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 62
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 63   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 117
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 118  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEA 176
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 177  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 207

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 18   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 73   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 127
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HRD++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 128  AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEA 186
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 187  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 217

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 73/300 (24%), Positives = 127/300 (42%), Gaps = 38/300 (12%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---M 863
            P   L  VI+ +E L     IG G  G+V+          A+K +     K GS+S    
Sbjct: 16   PRGSLHMVIDPSE-LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-----KEGSMSEDDF 69
Query: 864  KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
              E + + K+ H  LV+L    L +    +++ +ME+G L D L   T            
Sbjct: 70   IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLG 127
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL-LDKSPASTTSI 982
            +              C   ++HRD+   N L+       +SDFG+ +  LD    S+T  
Sbjct: 128  MCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 184
Query: 983  SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042
                 + + +PE    +  S +SDV+S+GV++ E+ +  K     Y+ R           
Sbjct: 185  KF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENR----------- 228
Query: 1043 SDTEEINDI-VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101
            S++E + DI     L +  L S+   Q+++       C +++P +RP    ++RQL + +
Sbjct: 229  SNSEVVEDISTGFRLYKPRLASTHVYQIMN------HCWKERPEDRPAFSRLLRQLAEIA 282

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 821  LNAKHVIGRGAHGIVYKASL---GPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHR 876
            +  + VIG G  G V    L   G   +  A+K L      +       E   +G+  H 
Sbjct: 10   IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            N++ LE    +    +I+  YMENGSL   L       T+      ++            
Sbjct: 70   NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMK 124
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIGYIAPEN 995
               D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I + APE 
Sbjct: 125  YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  +  SDV+SYG+V+ E++        SY E        R  W  + +  D++  +
Sbjct: 185  IAYRKFTSASDVWSYGIVMWEVM--------SYGE--------RPYWDMSNQ--DVIK-A 225
Query: 1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            + E   +    D  I +  + L C +K+ S+RP    +V  L
Sbjct: 226  IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 38   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 97   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-----A 151
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ +LDK   S  + +     + ++A E+  
Sbjct: 152  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 212  TQKFTTKSDVWSFGVLLWELMTR 234

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 827  IGRGAHGIVYKASLGPNAVF-AVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVRL 881
            IG GA+G VYKA    +  F A+K +     + G  +S  RE+  + ++    H N+VRL
Sbjct: 12   IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 882  EDFWL--RKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
             D     R D  I +    E  +  LR  L    PPP L       +             
Sbjct: 72   MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +C   IVHRD+KPENIL+ S     ++DFG+A++     A      VV T+ Y APE   
Sbjct: 131  NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALA---PVVVTLWYRAPEVLL 184
Query: 998  TTAKSKESDVYSYGVVLLELITRK 1021
             +  +   D++S G +  E+  RK
Sbjct: 185  QSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 821  LNAKHVIGRGAHGIVYKASL---GPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHR 876
            +  + VIG G  G V    L   G   +  A+K L      +       E   +G+  H 
Sbjct: 16   IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            N++ LE    +    +I+  YMENGSL   L       T+      ++            
Sbjct: 76   NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMK 130
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIGYIAPEN 995
               D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I + APE 
Sbjct: 131  YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  +  SDV+SYG+V+ E++        SY E        R  W  + +  D++  +
Sbjct: 191  IAYRKFTSASDVWSYGIVMWEVM--------SYGE--------RPYWDMSNQ--DVIK-A 231
Query: 1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            + E   +    D  I +  + L C +K+ S+RP    +V  L
Sbjct: 232  IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 827  IGRGAHGIVYKASLGPNAVF-AVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVRL 881
            IG GA+G VYKA    +  F A+K +     + G  +S  RE+  + ++    H N+VRL
Sbjct: 12   IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 882  EDFWL--RKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
             D     R D  I +    E  +  LR  L    PPP L       +             
Sbjct: 72   MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +C   IVHRD+KPENIL+ S     ++DFG+A++     A      VV T+ Y APE   
Sbjct: 131  NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LFPVVVTLWYRAPEVLL 184
Query: 998  TTAKSKESDVYSYGVVLLELITRK 1021
             +  +   D++S G +  E+  RK
Sbjct: 185  QSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 107/248 (43%), Gaps = 48/248 (19%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLED 883
            V+G+GA G V KA    ++  +A+KK+    H    LS +  E+  +  + H+ +VR   
Sbjct: 13   VLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVXLLASLNHQYVVRYYA 69
Query: 884  FWL-------------RKDCGIIMYRYMENGSLRDVLHS--ITPPPTLEWNVRYKIXXXX 928
             WL             +K    I   Y EN +L D++HS  +       W +  +I    
Sbjct: 70   AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEAL 129
Query: 929  XXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS-----------PA 977
                          I+HR++KP NI +D      I DFG+AK + +S           P 
Sbjct: 130  SYIHSQG-------IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 978  STTSI-SVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRKKALDP--SYKERTD 1033
            S+ ++ S +GT  Y+A E    T    E  D YS G++  E I       P  +  ER +
Sbjct: 183  SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY------PFSTGXERVN 236
Query: 1034 IVGWVRSV 1041
            I+  +RSV
Sbjct: 237  ILKKLRSV 244

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 29/282 (10%)
Query: 821  LNAKHVIGRGAHGIVYKASL---GPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHR 876
            +  + VIG G  G V    L   G   +  A+K L      +       E   +G+  H 
Sbjct: 31   IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            N++ LE    +    +I+  YMENGSL   L       T+      ++            
Sbjct: 91   NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-----IQLVGMLRGIGSGMK 145
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIGYIAPEN 995
               D   VHRD+   NIL++S +   +SDFG++++L+  P A+ T+      I + APE 
Sbjct: 146  YLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  +  SDV+SYG+V+ E++        SY E        R  W  +   N  V  +
Sbjct: 206  IAYRKFTSASDVWSYGIVMWEVM--------SYGE--------RPYWDMS---NQDVIKA 246
Query: 1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            + E   +    D  I +  + L C +K+ S+RP    +V  L
Sbjct: 247  IEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 16   IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
             +    I+  ++ E  SL   LH I     +      K+                  I+H
Sbjct: 74   TKPQLAIVT-QWCEGSSLYHHLHIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIH 127
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---S 1002
            RD+K  NI L  ++   I DFG+A +  +   S     + G+I ++APE      K   S
Sbjct: 128  RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 188  FQSDVYAFGIVLYELMT 204

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 21   IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
             +    I+  ++ E  SL   LH I     +      K+                  I+H
Sbjct: 79   TKPQLAIVT-QWCEGSSLYHHLHIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIH 132
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---S 1002
            RD+K  NI L  ++   I DFG+A +  +   S     + G+I ++APE      K   S
Sbjct: 133  RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 193  FQSDVYAFGIVLYELMT 209

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 184  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 238
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP----PTLEWNVRYKIXXXXXXX 931
              LV+L    + ++   I+  YM  GSL D L   T      P L  ++  +I       
Sbjct: 239  EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYV 296
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD++  NIL+   +   ++DFG+A+L++ +   T        I + 
Sbjct: 297  ERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWT 348
Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            APE A     + +SDV+S+G++L EL T+ +   P
Sbjct: 349  APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 115/250 (46%), Gaps = 21/250 (8%)
Query: 818  TENLNAKHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSM-KREIQTIGKIRH 875
             E+    + IG G++G   K     +  +   K+L +         M   E+  + +++H
Sbjct: 5    AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 876  RNLVRLEDFWL-RKDCGI-IMYRYMENGSLRDVLHSITPPPTL---EWNVRYKIXXXXXX 930
             N+VR  D  + R +  + I+  Y E G L  V+   T        E+ +R         
Sbjct: 65   PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                   D    ++HRD+KP N+ LD +    + DFG+A++L+    ++ + + VGT  Y
Sbjct: 125  KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYY 182
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYK--ERTDIVGWVRS------VW 1042
            ++PE     + +++SD++S G +L EL     AL P +    + ++ G +R        +
Sbjct: 183  MSPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 1043 SDTEEINDIV 1052
              ++E+N+I+
Sbjct: 239  RYSDELNEII 248

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 115/243 (47%), Gaps = 27/243 (11%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSIT----PPPTLEWNVRYKIXXXXXX 930
            H N+V+L D    ++   +++ ++    L+D + +      P P ++ +  +++      
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIK-SYLFQLLQGLAF 118
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        ++HRD+KPEN+L+++E    ++DFG+A+     P  T    VV T+ Y
Sbjct: 119  CHSHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWY 169
Query: 991  IAPE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045
             APE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  
Sbjct: 170  RAPEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPD 224
Query: 1046 EEI 1048
            E +
Sbjct: 225  EVV 227

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 184  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 238
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP----PTLEWNVRYKIXXXXXXX 931
              LV+L    + ++   I+  YM  GSL D L   T      P L  ++  +I       
Sbjct: 239  EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYV 296
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD++  NIL+   +   ++DFG+A+L++ +   T        I + 
Sbjct: 297  ERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWT 348
Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            APE A     + +SDV+S+G++L EL T+ +   P
Sbjct: 349  APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 21   IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
             +    I+  ++ E  SL   LH I     +      K+                  I+H
Sbjct: 79   TKPQLAIVT-QWCEGSSLYHHLHIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIH 132
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---S 1002
            RD+K  NI L  ++   I DFG+A +  +   S     + G+I ++APE      K   S
Sbjct: 133  RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 193  FQSDVYAFGIVLYELMT 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 827  IGRGAHGIVYKASLGPNAVF-AVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVRL 881
            IG GA+G VYKA    +  F A+K +     + G  +S  RE+  + ++    H N+VRL
Sbjct: 12   IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 882  EDFWL--RKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
             D     R D  I +    E  +  LR  L    PPP L       +             
Sbjct: 72   MDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLMRQFLRGLDFLHA 130
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +C   IVHRD+KPENIL+ S     ++DFG+A++     A      VV T+ Y APE   
Sbjct: 131  NC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALD---PVVVTLWYRAPEVLL 184
Query: 998  TTAKSKESDVYSYGVVLLELITRK 1021
             +  +   D++S G +  E+  RK
Sbjct: 185  QSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 115/250 (46%), Gaps = 21/250 (8%)
Query: 818  TENLNAKHVIGRGAHGIVYKASLGPNAVFAV-KKLAFRGHKRGSLSM-KREIQTIGKIRH 875
             E+    + IG G++G   K     +    V K+L +         M   E+  + +++H
Sbjct: 5    AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 876  RNLVRLEDFWL-RKDCGI-IMYRYMENGSLRDVLHSITPPPTL---EWNVRYKIXXXXXX 930
             N+VR  D  + R +  + I+  Y E G L  V+   T        E+ +R         
Sbjct: 65   PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                   D    ++HRD+KP N+ LD +    + DFG+A++L+    ++ + + VGT  Y
Sbjct: 125  KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYY 182
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYK--ERTDIVGWVRS------VW 1042
            ++PE     + +++SD++S G +L EL     AL P +    + ++ G +R        +
Sbjct: 183  MSPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 1043 SDTEEINDIV 1052
              ++E+N+I+
Sbjct: 239  RYSDELNEII 248

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 66/235 (28%), Positives = 97/235 (41%), Gaps = 38/235 (16%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            +L    +  RG  G V+KA L  N   AVK   F    + S   +REI +   ++H NL+
Sbjct: 16   SLQLLEIKARGRFGCVWKAQL-MNDFVAVK--IFPLQDKQSWQSEREIFSTPGMKHENLL 72
Query: 880  R----------LE-DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXX 928
            +          LE + WL       +  + + GSL D L        + WN    +    
Sbjct: 73   QFIAAEKRGSNLEVELWL-------ITAFHDKGSLTDYLKG----NIITWNELCHVAETM 121
Query: 929  XXXXXXXXXDC--------DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
                     D          P I HRD K +N+LL S++   ++DFG+A   +       
Sbjct: 122  SRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD 181
Query: 981  SISVVGTIGYIAPENA-----FTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
            +   VGT  Y+APE       F        D+Y+ G+VL EL++R KA D    E
Sbjct: 182  THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 18   IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
             +    I+  ++ E  SL   LH I     +      K+                  I+H
Sbjct: 76   TKPQLAIVT-QWCEGSSLYHHLHIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIH 129
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---S 1002
            RD+K  NI L  ++   I DFG+A +  +   S     + G+I ++APE      K   S
Sbjct: 130  RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 190  FQSDVYAFGIVLYELMT 206

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 36   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 95   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 149
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 150  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 210  TQKFTTKSDVWSFGVLLWELMTR 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 21/233 (9%)
Query: 794  RSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAF 853
            + K  +    Q   SY  +  IEA+E + +   IG G+ G VYK     +    + K+  
Sbjct: 14   QEKNKIRPRGQRDSSYYWE--IEASEVMLSTR-IGSGSFGTVYKGKWHGDVAVKILKVVD 70
Query: 854  RGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP 913
               ++   + + E+  + K RH N++    + + KD   I+ ++ E  SL   LH     
Sbjct: 71   PTPEQFQ-AFRNEVAVLRKTRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETK 128
Query: 914  PTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD 973
              +     +++                  I+HRD+K  NI L   +   I DFG+A +  
Sbjct: 129  FQM-----FQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183
Query: 974  KSPASTTSISVVGTIGYIAPE-------NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   S       G++ ++APE       N F    S +SDVYSYG+VL EL+T
Sbjct: 184  RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF----SFQSDVYSYGIVLYELMT 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 96/235 (40%), Gaps = 27/235 (11%)
Query: 789  CLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAV 848
             L RR S  D EIP  +               +     IG G+ G VYK     +   AV
Sbjct: 21   TLGRRDSSDDWEIPDGQ---------------ITVGQRIGSGSFGTVYKGKWHGDV--AV 63
Query: 849  KKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL 907
            K L         L + K E+  + K RH N++    +  +    I+  ++ E  SL   L
Sbjct: 64   KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHL 122
Query: 908  HSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
            H I     +      K+                  I+HRD+K  NI L  ++   I DFG
Sbjct: 123  HIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 177
Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---SKESDVYSYGVVLLELIT 1019
            +A    +   S     + G+I ++APE      K   S +SDVY++G+VL EL+T
Sbjct: 178  LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 232

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 267  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 321
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP----PTLEWNVRYKIXXXXXXX 931
              LV+L    + ++   I+  YM  GSL D L   T      P L  ++  +I       
Sbjct: 322  EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYV 379
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD++  NIL+   +   ++DFG+A+L++ +   T        I + 
Sbjct: 380  ERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWT 431
Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            APE A     + +SDV+S+G++L EL T+ +   P
Sbjct: 432  APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 827  IGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            +GRG  G+V++A    N V    +A+K++     +     + RE++ + K+ H  +VR  
Sbjct: 13   LGRGGFGVVFEAK---NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 883  DFWLRKDC---------GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            + WL K+           + +Y  M+     ++   +    T+E   R            
Sbjct: 70   NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 934  XXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS----------PASTTSIS 983
                     ++HRD+KP NI    +    + DFG+   +D+           PA      
Sbjct: 130  AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
             VGT  Y++PE     + S + D++S G++L EL+
Sbjct: 190  QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 96/235 (40%), Gaps = 27/235 (11%)
Query: 789  CLFRRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAV 848
             L RR S  D EIP  +               +     IG G+ G VYK     +   AV
Sbjct: 13   TLGRRDSSDDWEIPDGQ---------------ITVGQRIGSGSFGTVYKGKWHGDV--AV 55
Query: 849  KKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL 907
            K L         L + K E+  + K RH N++    +  +    I+  ++ E  SL   L
Sbjct: 56   KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVT-QWCEGSSLYHHL 114
Query: 908  HSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
            H I     +      K+                  I+HRD+K  NI L  ++   I DFG
Sbjct: 115  HIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFG 169
Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---SKESDVYSYGVVLLELIT 1019
            +A    +   S     + G+I ++APE      K   S +SDVY++G+VL EL+T
Sbjct: 170  LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 224

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 184  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 238
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP----PTLEWNVRYKIXXXXXXX 931
              LV+L    + ++   I+  YM  GSL D L   T      P L  ++  +I       
Sbjct: 239  EKLVQLYAV-VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYV 296
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD++  NIL+   +   ++DFG+A+L++ +   T        I + 
Sbjct: 297  ERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWT 348
Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            APE A     + +SDV+S+G++L EL T+ +   P
Sbjct: 349  APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 383

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 37/228 (16%)
Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL---- 881
            V  RG  G V+KA L  N   AVK   F    + S   + E+ ++  ++H N+++     
Sbjct: 31   VKARGRFGCVWKAQL-LNEYVAVK--IFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 882  -------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
                    D WL       +  + E GSL D L +      + WN    I          
Sbjct: 88   KRGTSVDVDLWL-------ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAY 136
Query: 935  XXXDC-------DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
               D         P I HRDIK +N+LL + +   I+DFG+A   +   ++  +   VGT
Sbjct: 137  LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 988  IGYIAPENA-----FTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
              Y+APE       F        D+Y+ G+VL EL +R  A D    E
Sbjct: 197  RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 8    ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 62
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP----PTLEWNVRYKIXXXXXXX 931
              LV+L    + ++   I+  YM  GSL D L   T      P L  ++  +I       
Sbjct: 63   EKLVQLYAV-VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYV 120
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD++  NIL+   +   ++DFG+A+L++ +   T        I + 
Sbjct: 121  ERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EXTARQGAKFPIKWT 172
Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 173  APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 212

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 55   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 114  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 168
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 169  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 229  TQKFTTKSDVWSFGVLLWELMTR 251

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 123
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 124  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 179
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 180  PEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 240  DLIS------------------------RLLKHNPSQRPXLREVLEH 262

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 15   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 69
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP-----PPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L   T      P  ++ + +         
Sbjct: 70   EKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 129  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 178
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 179  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 219

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 56   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 115  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 169
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 170  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 230  TQKFTTKSDVWSFGVLLWELMTR 252

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 29   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 88   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 142
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 143  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 203  TQKFTTKSDVWSFGVLLWELMTR 225

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 121
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 122  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 177
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 178  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 238  DLIS------------------------RLLKHNPSQRPMLREVLEH 260

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 37   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 96   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 150
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 151  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 211  TQKFTTKSDVWSFGVLLWELMTR 233

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 11   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 65
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP----PTLEWNVRYKIXXXXXXX 931
              LV+L    + ++   I+  YM  GSL D L   T      P L  ++  +I       
Sbjct: 66   EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV-DMAAQIASGMAYV 123
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD++  NIL+   +   ++DFG+A+L++ +   T        I + 
Sbjct: 124  ERMN-------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWT 175
Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 176  APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 215

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 5    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 65   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 117
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 118  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 173
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 174  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 233
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 234  DLIS------------------------RLLKHNPSQRPMLREVLEH 256

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 10   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 70   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 122
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 123  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 178
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 179  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 238
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 239  DLIS------------------------RLLKHNPSQRPMLREVLEH 261

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 36   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 95   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 149
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 150  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 210  TQKFTTKSDVWSFGVLLWELMTR 232

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L     +G G  G V+  +   N   A+K L     K G++S +    E Q + K++H
Sbjct: 9    ESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL-----KPGTMSPESFLEEAQIMKKLKH 63
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL-----HSITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L      ++  P  ++   +         
Sbjct: 64   DKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 122
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         +HRD++  NIL+ + +   I+DFG+A+L++ +   T        I +
Sbjct: 123  RMN---------YIHRDLRSANILVGNGLICKIADFGLARLIEDN-EXTARQGAKFPIKW 172
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL+T+ +   P    R
Sbjct: 173  TAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 213

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 35   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 94   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 148
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 149  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 209  TQKFTTKSDVWSFGVLLWELMTR 231

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 118
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 119  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRA-ALCGTLDYLP 174
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 175  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 235  DLIS------------------------RLLKHNPSQRPMLREVLEH 257

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 15   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 69
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP-----PPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L   T      P  ++ + +         
Sbjct: 70   EKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 129  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EWTARQGAKFPIKW 178
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 179  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 219

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 16   IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
                  I+  ++ E  SL   LH I     +      K+                  I+H
Sbjct: 74   TAPQLAIVT-QWCEGSSLYHHLHIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIH 127
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---S 1002
            RD+K  NI L  ++   I DFG+A +  +   S     + G+I ++APE      K   S
Sbjct: 128  RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 188  FQSDVYAFGIVLYELMT 204

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + KIRH
Sbjct: 18   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKIRH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 73   EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 132  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 181
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 182  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 31/77 (40%), Positives = 48/77 (62%), Gaps = 2/77 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPENILLD E    ++DFG++K  +       + S  GT+ Y+APE       S
Sbjct: 151  IIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQGHS 208
Query: 1003 KESDVYSYGVVLLELIT 1019
              +D +SYGV++ E++T
Sbjct: 209  HSADWWSYGVLMFEMLT 225

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 37   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 96   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 150
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 151  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 211  TQKFTTKSDVWSFGVLLWELMTR 233

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 9    ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 63
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            + LVRL     ++   II   YMENGSL D L +   P  ++  +  K+           
Sbjct: 64   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT---PSGIKLTIN-KLLDMAAQIAEGM 118
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                +   +HR+++  NIL+   +   I+DFG+A+L++ +   T        I + APE 
Sbjct: 119  AFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEA 177
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
                  + +SDV+S+G++L E++T  +   P
Sbjct: 178  INYGTFTIKSDVWSFGILLTEIVTHGRIPYP 208

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 16   IGSGSFGTVYKGKWHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
             +    I+  ++ E  SL   LH I     +      K+                  I+H
Sbjct: 74   TKPQLAIVT-QWCEGSSLYHHLHIIETKFEM-----IKLIDIARQTAQGMDYLHAKSIIH 127
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK---S 1002
            RD+K  NI L  ++   I DFG+A    +   S     + G+I ++APE      K   S
Sbjct: 128  RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 188  FQSDVYAFGIVLYELMT 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A           K+ F+    K G    ++RE++    +
Sbjct: 3    ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 63   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 115
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 116  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 171
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 172  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 231
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 232  DLIS------------------------RLLKHNPSQRPMLREVLEH 254

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 34   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 93   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 147
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 148  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 208  TQKFTTKSDVWSFGVLLWELMTR 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G +   L  ++           +          
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-------KFDEQRTATYITELA 123
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 124  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 179
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 180  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 240  DLIS------------------------RLLKHNPSQRPMLREVL 260

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 96   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 155  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK-- 212
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 213  ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 270  TQKFTTKSDVWSFGVLLWELMTR 292

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 38   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 97   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-----A 151
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 152  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 212  TQKFTTKSDVWSFGVLLWELMTR 234

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 23/242 (9%)
Query: 816  EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKI 873
            E  EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++
Sbjct: 7    EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMEN--GSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
             H N+V+L D    ++   +++ ++        D       P  L  +  +++       
Sbjct: 67   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                       ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y 
Sbjct: 127  HSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYR 177
Query: 992  APE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046
            APE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E
Sbjct: 178  APEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDE 232
Query: 1047 EI 1048
             +
Sbjct: 233  VV 234

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRY--MENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ +  M+     D       P  L  +  +++        
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KPEN+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 124  SHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 174
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 175  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 1048 I 1048
            +
Sbjct: 230  V 230

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 121/296 (40%), Gaps = 42/296 (14%)
Query: 808  SYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMK 864
            S++ K+   A E+      +G+G  G VY A    +      K+ F+    K G    ++
Sbjct: 2    SHMSKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 61
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++    +RH N++RL  ++       ++  Y   G++   L  ++           + 
Sbjct: 62   REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQR 114
Query: 925  XXXXXXXXXXXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  +  
Sbjct: 115  TATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-D 170
Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVW 1042
            + GT+ Y+ PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   +
Sbjct: 171  LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 230
Query: 1043 SD--TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
             D  TE   D++                         R  +  PS RP +R+V+  
Sbjct: 231  PDFVTEGARDLIS------------------------RLLKHNPSQRPMLREVLEH 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 121
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 122  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRA-ALCGTLDYLP 177
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 178  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 238  DLIS------------------------RLLKHNPSQRPMLREVL 258

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 37   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 96   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-----A 150
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 151  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 211  TQKFTTKSDVWSFGVLLWELMTR 233

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 110/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 875  HRNLVRLEDFWLRKDCGIIMYRY--MENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ +  M+     D       P  L  +  +++        
Sbjct: 62   HPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KPEN+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 122  SHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 172
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 173  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 1048 I 1048
            +
Sbjct: 228  V 228

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 27/243 (11%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSIT----PPPTLEWNVRYKIXXXXXX 930
            H N+V+L D    ++   +++ ++ +  L+D + +      P P ++ +  +++      
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIK-SYLFQLLQGLAF 121
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y
Sbjct: 122  CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWY 172
Query: 991  IAPE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045
             APE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  
Sbjct: 173  RAPEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPD 227
Query: 1046 EEI 1048
            E +
Sbjct: 228  EVV 230

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 61/253 (24%), Positives = 115/253 (45%), Gaps = 29/253 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS------MKREIQTIGK 872
            E+    + IG G++G   K     +     K L ++    GS++      +  E+  + +
Sbjct: 6    EDYEVLYTIGTGSYGRCQKIRRKSDG----KILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 873  IRHRNLVRLEDFWL-RKDCGI-IMYRYMENGSLRDVLHSITPPPTL---EWNVRYKIXXX 927
            ++H N+VR  D  + R +  + I+  Y E G L  V+   T        E+ +R      
Sbjct: 62   LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 928  XXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
                      D    ++HRD+KP N+ LD +    + DFG+A++L+       +   VGT
Sbjct: 122  LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--EDFAKEFVGT 179
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYK--ERTDIVGWVRS----- 1040
              Y++PE     + +++SD++S G +L EL     AL P +    + ++ G +R      
Sbjct: 180  PYYMSPEQMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAFSQKELAGKIREGKFRR 235
Query: 1041 -VWSDTEEINDIV 1052
              +  ++E+N+I+
Sbjct: 236  IPYRYSDELNEII 248

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 35   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 94   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-----A 148
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 149  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 209  TQKFTTKSDVWSFGVLLWELMTR 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 32   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 91   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-----A 145
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 146  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 206  TQKFTTKSDVWSFGVLLWELMTR 228

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 42   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 101  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-----A 155
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 156  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 216  TQKFTTKSDVWSFGVLLWELMTR 238

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 118
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 119  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 174
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 175  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 235  DLIS------------------------RLLKHNPSQRPMLREVL 255

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 115/244 (47%), Gaps = 27/244 (11%)
Query: 816  EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKI 873
            E  EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++
Sbjct: 7    EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSIT----PPPTLEWNVRYKIXXXXX 929
             H N+V+L D    ++   +++ ++    L+  + +      P P ++ +  +++     
Sbjct: 67   NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIK-SYLFQLLQGLA 124
Query: 930  XXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG 989
                         ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ 
Sbjct: 125  FCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLW 175
Query: 990  YIAPE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044
            Y APE       ++TA     D++S G +  E++TR +AL P   E   +    R++ + 
Sbjct: 176  YRAPEILLGXKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTP 230
Query: 1045 TEEI 1048
             E +
Sbjct: 231  DEVV 234

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 18   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 73   EKLVQLYAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 132  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EXTARQGAKFPIKW 181
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 182  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 131/298 (43%), Gaps = 47/298 (15%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPN-AVFAVKKLAFRGHKRGSLSM-------KREIQ 868
            A   +  +  IG+G  G+V+K  L  + +V A+K L   G   G   M       +RE+ 
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL-GDSEGETEMIEKFQEFQREVF 75
Query: 869  TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXX 928
             +  + H N+V+L  + L  +   ++  ++  G L   L     P  ++W+V+ ++    
Sbjct: 76   IMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDI 131
Query: 929  XXXXXXXXXDCDPPIVHRDIKPENILLDS--EMEP---HISDFGIAKLLDKSPASTTSIS 983
                     + +PPIVHRD++  NI L S  E  P    ++DFG+++       S  S+S
Sbjct: 132  ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------QSVHSVS 184
Query: 984  -VVGTIGYIAPEN--AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
             ++G   ++APE   A   + ++++D YS+ ++L  ++T +   D     +   +  +R 
Sbjct: 185  GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR- 243
Query: 1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALR-CTEKKPSNRPNMRDVVRQL 1097
                             EE L  +I +     L   +  C    P  RP+   +V++L
Sbjct: 244  -----------------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 116/243 (47%), Gaps = 27/243 (11%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSIT----PPPTLEWNVRYKIXXXXXX 930
            H N+V+L D    ++   +++ ++ +  L+D + +      P P ++ +  +++      
Sbjct: 63   HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIK-SYLFQLLQGLAF 120
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y
Sbjct: 121  CHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWY 171
Query: 991  IAPE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045
             APE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  
Sbjct: 172  RAPEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPD 226
Query: 1046 EEI 1048
            E +
Sbjct: 227  EVV 229

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 20/169 (11%)
Query: 864  KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEW 918
            +RE+  +  ++H N+V+  + +       I+  Y E G L   +++           L+W
Sbjct: 71   RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             V+  +               D  I+HRDIK +NI L  +    + DFGIA++L+    S
Sbjct: 131  FVQICLALKHVH---------DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN----S 177
Query: 979  TTSI--SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            T  +  + +GT  Y++PE       + +SD+++ G VL EL T K A +
Sbjct: 178  TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA +     V A+KK+       G  S   REI  + ++ H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 877  NLVRLEDF------------WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            N+V+L D             +L +D    + ++M+  +L  +     P P ++ +  +++
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQD----LKKFMDASALTGI-----PLPLIK-SYLFQL 112
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
                              ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  V
Sbjct: 113  LQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEV 164
Query: 985  VGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKE 1030
            V T+ Y APE        S   D++S G +  E++TR +AL P   E
Sbjct: 165  V-TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSE 209

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 43/231 (18%)
Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA +     V A+KK+       G  S   REI  + ++ H 
Sbjct: 7    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 877  NLVRLEDF------------WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            N+V+L D             +L +D    + ++M+  +L  +     P P ++ +  +++
Sbjct: 67   NIVKLLDVIHTENKLYLVFEFLHQD----LKKFMDASALTGI-----PLPLIK-SYLFQL 116
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
                              ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  V
Sbjct: 117  LQGLAFCHSHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEV 168
Query: 985  VGTIGYIAPE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
            V T+ Y APE       ++TA     D++S G +  E++TR +AL P   E
Sbjct: 169  V-TLWYRAPEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSE 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 118
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  +  + GT+ Y+ 
Sbjct: 119  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-XLCGTLDYLP 174
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 175  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 235  DLIS------------------------RLLKHNPSQRPMLREVLEH 257

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 826  VIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR 880
            VIGRG  G VY  +L    G     AVK L  R    G +S       I K   H N++ 
Sbjct: 37   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 881  LEDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            L    LR +   +++  YM++G LR+ + + T  PT++  + + +               
Sbjct: 96   LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-----A 150
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT-IGYIAPENAF 997
                VHRD+   N +LD +    ++DFG+A+ + DK   S  + +     + ++A E+  
Sbjct: 151  SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 998  TTAKSKESDVYSYGVVLLELITR 1020
            T   + +SDV+S+GV+L EL+TR
Sbjct: 211  TQKFTTKSDVWSFGVLLWELMTR 233

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 118
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  +  + GT+ Y+ 
Sbjct: 119  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-DLCGTLDYLP 174
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 175  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 235  DLIS------------------------RLLKHNPSQRPMLREVLEH 257

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 32   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 92   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 144
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 145  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 200
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 201  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 260
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 261  DLIS------------------------RLLKHNPSQRPMLREVL 281

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 123
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 124  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 179
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 180  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 240  DLIS------------------------RLLKHNPSQRPMLREVL 260

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 18   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 73   EKLVQLYAV-VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 132  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 181
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 182  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 118
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  +  + GT+ Y+ 
Sbjct: 119  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-ELCGTLDYLP 174
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 175  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 235  DLIS------------------------RLLKHNPSQRPMLREVL 255

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 121
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 122  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 177
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 178  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 238  DLIS------------------------RLLKHNPSQRPMLREVL 258

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 18/219 (8%)
Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            V+G+G  G   K +        V K   R  +    +  +E++ +  + H N+++     
Sbjct: 17   VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
             +      +  Y++ G+LR ++ S+       W+ R                     I+H
Sbjct: 77   YKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLD------------KSPASTTSISVVGTIGYIAP 993
            RD+   N L+       ++DFG+A+L+             K P      +VVG   ++AP
Sbjct: 132  RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032
            E     +  ++ DV+S+G+VL E+I R  A DP Y  RT
Sbjct: 192  EMINGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDYLPRT 229

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 7    ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 61
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 62   EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 120
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 121  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 170
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 171  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 211

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 9    ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 63
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 64   EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 122
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 123  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 172
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 173  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 18   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 73   EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 132  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 181
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 182  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 62   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KPEN+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 122  SHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 172
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 173  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 1048 I 1048
            +
Sbjct: 228  V 228

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA +     V A+KK+       G  S   REI  + ++ H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++     +  D       P  L  +  +++          
Sbjct: 62   NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE
Sbjct: 122  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 172
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
                   ++TA     D++S G +  E++TR +AL P   E
Sbjct: 173  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSE 208

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 8    GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 67
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 68   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 128  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 184  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 63   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KPEN+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 123  SHR-------VLHRDLKPENLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 173
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 174  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 228
Query: 1048 I 1048
            +
Sbjct: 229  V 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 15   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 74
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 75   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 135  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 191  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 16   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 75
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 76   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 135
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 136  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 192  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 7    GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 66
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 67   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 126
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 127  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 183  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 14   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 73
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 74   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 134  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 190  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 23   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 83   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 135
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 136  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-TLCGTLDYLP 191
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 192  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 251
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 252  DLIS------------------------RLLKHNPSQRPMLREVL 272

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 121
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S     + GT+ Y+ 
Sbjct: 122  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRX-XLCGTLDYLP 177
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 178  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 238  DLIS------------------------RLLKHNPSQRPMLREVLEH 260

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 18   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L      +   I+M  YM  G L D L       +  P  ++   +         
Sbjct: 73   EKLVQLYAVVSEEPIYIVM-EYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 132  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 181
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 182  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 18   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 73   EKLVQLYAV-VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 132  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 181
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 182  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 14   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 73
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 74   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 134  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 190  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 118
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S     + GT+ Y+ 
Sbjct: 119  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRX-XLCGTLDYLP 174
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 175  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 235  DLIS------------------------RLLKHNPSQRPMLREVLEH 257

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 128/293 (43%), Gaps = 38/293 (12%)
Query: 814  VIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTI 870
            VI+ +E L     IG G  G+V+   LG        K+A +  + G++S +    E + +
Sbjct: 1    VIDPSE-LTFVQEIGSGQFGLVH---LG--YWLNKDKVAIKTIREGAMSEEDFIEEAEVM 54
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
             K+ H  LV+L    L +    +++ +ME+G L D L   T            +      
Sbjct: 55   MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCE 112
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL-LDKSPASTTSISVVGTIG 989
                    C   ++HRD+   N L+       +SDFG+ +  LD    S+T       + 
Sbjct: 113  GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVK 167
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE    +  S +SDV+S+GV++ E+ +  K     Y+ R           S++E + 
Sbjct: 168  WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENR-----------SNSEVVE 213
Query: 1050 DI-VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101
            DI     L +  L S+   Q+++       C +++P +RP    ++RQL + +
Sbjct: 214  DISTGFRLYKPRLASTHVYQIMN------HCWKERPEDRPAFSRLLRQLAEIA 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 114/285 (40%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 67   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 119
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     S  +T S    GT+ Y+ 
Sbjct: 120  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLP 175
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 176  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 236  DLIS------------------------RLLKHNPSQRPMLREVL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 128/293 (43%), Gaps = 38/293 (12%)
Query: 814  VIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTI 870
            VI+ +E L     IG G  G+V+   LG        K+A +  + G++S +    E + +
Sbjct: 3    VIDPSE-LTFVQEIGSGQFGLVH---LG--YWLNKDKVAIKTIREGAMSEEDFIEEAEVM 56
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
             K+ H  LV+L    L +    +++ +ME+G L D L   T            +      
Sbjct: 57   MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCE 114
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL-LDKSPASTTSISVVGTIG 989
                    C   ++HRD+   N L+       +SDFG+ +  LD    S+T       + 
Sbjct: 115  GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVK 169
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE    +  S +SDV+S+GV++ E+ +  K     Y+ R           S++E + 
Sbjct: 170  WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENR-----------SNSEVVE 215
Query: 1050 DI-VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101
            DI     L +  L S+   Q+++       C +++P +RP    ++RQL + +
Sbjct: 216  DISTGFRLYKPRLASTHVYQIMN------HCWKERPEDRPAFSRLLRQLAEIA 262

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 8    GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 67
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 68   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 127
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 128  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 184  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 14   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 73
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 74   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF 133
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 134  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 190  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 130/298 (43%), Gaps = 47/298 (15%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPN-AVFAVKKLAFRGHKRGSLSM-------KREIQ 868
            A   +  +  IG+G  G+V+K  L  + +V A+K L   G   G   M       +RE+ 
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL-GDSEGETEMIEKFQEFQREVF 75
Query: 869  TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXX 928
             +  + H N+V+L  + L  +   ++  ++  G L   L     P  ++W+V+ ++    
Sbjct: 76   IMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDI 131
Query: 929  XXXXXXXXXDCDPPIVHRDIKPENILLDS--EMEP---HISDFGIAKLLDKSPASTTSIS 983
                     + +PPIVHRD++  NI L S  E  P    ++DFG ++       S  S+S
Sbjct: 132  ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------QSVHSVS 184
Query: 984  -VVGTIGYIAPEN--AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
             ++G   ++APE   A   + ++++D YS+ ++L  ++T +   D     +   +  +R 
Sbjct: 185  GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR- 243
Query: 1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALR-CTEKKPSNRPNMRDVVRQL 1097
                             EE L  +I +     L   +  C    P  RP+   +V++L
Sbjct: 244  -----------------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 42/287 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 121
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S     + GT+ Y+ 
Sbjct: 122  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRD-DLCGTLDYLP 177
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 178  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            D++                         R  +  PS RP +R+V+  
Sbjct: 238  DLIS------------------------RLLKHNPSQRPMLREVLEH 260

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 112/285 (39%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G +   L  ++           +          
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-------KFDEQRTATYITELA 123
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +        S+    + GT+ Y+ 
Sbjct: 124  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLXGTLDYLP 179
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 180  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 240  DLIS------------------------RLLKHNPSQRPMLREVL 260

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 827  IGRGAHGIVYKASLGPNAVF-AVKKLAFRGHKRGS----LSMKREIQTIGKIR---HRNL 878
            IG GA+G VYKA    +  F A+K +       G     +S  RE+  + ++    H N+
Sbjct: 17   IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 879  VRLEDFWL--RKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            VRL D     R D  I +    E  +  LR  L    PPP L       +          
Sbjct: 77   VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLMRQFLRGLDF 135
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
               +C   IVHRD+KPENIL+ S     ++DFG+A++     A T    VV T+ Y APE
Sbjct: 136  LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT---PVVVTLWYRAPE 189
Query: 995  NAFTTAKSKESDVYSYGVVLLELITRK 1021
                +  +   D++S G +  E+  RK
Sbjct: 190  VLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMEN--GSLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++     +  D       P  L  +  +++        
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 124  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 174
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 175  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 1048 I 1048
            +
Sbjct: 230  V 230

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 62   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y A
Sbjct: 122  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRA 172
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 173  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 1048 I 1048
            +
Sbjct: 228  V 228

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K      + RE+Q + +     +V     F
Sbjct: 14   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+                  I+
Sbjct: 74   YSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREKHK--IM 127
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S +
Sbjct: 128  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQ 183
Query: 1005 SDVYSYGVVLLELITRKKALDP 1026
            SD++S G+ L+E+   +  + P
Sbjct: 184  SDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K      + RE+Q + +     +V     F
Sbjct: 14   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+                  I+
Sbjct: 74   YSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREKHK--IM 127
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S +
Sbjct: 128  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQ 183
Query: 1005 SDVYSYGVVLLELITRKKALDP 1026
            SD++S G+ L+E+   +  + P
Sbjct: 184  SDIWSMGLSLVEMAVGRYPIPP 205

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K      + RE+Q + +     +V     F
Sbjct: 14   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+                  I+
Sbjct: 74   YSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREKHK--IM 127
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S +
Sbjct: 128  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQ 183
Query: 1005 SDVYSYGVVLLELITRKKALDP 1026
            SD++S G+ L+E+   +  + P
Sbjct: 184  SDIWSMGLSLVEMAVGRYPIPP 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 72/293 (24%), Positives = 128/293 (43%), Gaps = 38/293 (12%)
Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQ 868
            K VI+ +E L     IG G  G+V+   LG        K+A +  + G++S +    E +
Sbjct: 4    KWVIDPSE-LTFVQEIGSGQFGLVH---LG--YWLNKDKVAIKTIREGAMSEEDFIEEAE 57
Query: 869  TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXX 928
             + K+ H  LV+L    L +    +++ +ME+G L D L   T            +    
Sbjct: 58   VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDV 115
Query: 929  XXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT 987
                      C   ++HRD+   N L+       +SDFG+ + +LD    S+T       
Sbjct: 116  CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--P 170
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            + + +PE    +  S +SDV+S+GV++ E+ +  K     Y+ R           S++E 
Sbjct: 171  VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENR-----------SNSEV 216
Query: 1048 INDI-VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
            + DI     L +  L S+   Q+++       C  ++P +RP    ++RQL +
Sbjct: 217  VEDISTGFRLYKPRLASTHVYQIMN------HCWRERPEDRPAFSRLLRQLAE 263

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 118
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  +  + GT+ Y+ 
Sbjct: 119  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-DLCGTLDYLP 174
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 175  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 235  DLIS------------------------RLLKHNPSQRPMLREVL 255

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGH 856
            P+ E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L     
Sbjct: 3    PSGEAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 61
Query: 857  KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITP 912
             + +  +  E   +  + + ++ RL    L     +IM + M  G L D +      I  
Sbjct: 62   PKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGS 120
Query: 913  PPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
               L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL
Sbjct: 121  QYLLNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 171
Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                    +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 172  GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE
Sbjct: 123  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 173
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 174  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 227

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K      + RE+Q + +     +V     F
Sbjct: 14   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIXXXXXXXXXXXXXDCDPPI 943
            +   +  I M  +M+ GSL  VL      P  +   V   +                  I
Sbjct: 74   YSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK------I 126
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S 
Sbjct: 127  MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSV 182
Query: 1004 ESDVYSYGVVLLELITRKKALDP 1026
            +SD++S G+ L+E+   +  + P
Sbjct: 183  QSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 877  NLVRLEDFWLRKDCGIIMYRYMEN--GSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE
Sbjct: 123  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 173
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 174  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 227

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 877  NLVRLEDFWLRKDCGIIMYRYMEN--GSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE
Sbjct: 122  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 172
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 173  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 226

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 14   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTL 73
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 74   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 134  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 190  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 29/77 (37%), Positives = 49/77 (63%), Gaps = 2/77 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPENILLD E    ++DFG++K  +       + S  GT+ Y+APE       +
Sbjct: 148  IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 1003 KESDVYSYGVVLLELIT 1019
            + +D +S+GV++ E++T
Sbjct: 206  QSADWWSFGVLMFEMLT 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 29/77 (37%), Positives = 49/77 (63%), Gaps = 2/77 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPENILLD E    ++DFG++K  +       + S  GT+ Y+APE       +
Sbjct: 147  IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 1003 KESDVYSYGVVLLELIT 1019
            + +D +S+GV++ E++T
Sbjct: 205  QSADWWSFGVLMFEMLT 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 29/77 (37%), Positives = 49/77 (63%), Gaps = 2/77 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPENILLD E    ++DFG++K  +       + S  GT+ Y+APE       +
Sbjct: 147  IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 1003 KESDVYSYGVVLLELIT 1019
            + +D +S+GV++ E++T
Sbjct: 205  QSADWWSFGVLMFEMLT 221

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 877  NLVRLEDFWLRKDCGIIMYRYMEN--GSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE
Sbjct: 123  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 173
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 174  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 227

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 29/279 (10%)
Query: 821  LNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR 876
            +  + VIG G  G V    L      +   A+K L     ++       E   +G+  H 
Sbjct: 45   IKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHP 104
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            N+V LE    R    +I+  +MENG+L   L       T+      ++            
Sbjct: 105  NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV-----IQLVGMLRGIAAGMR 159
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIGYIAPEN 995
               D   VHRD+   NIL++S +   +SDFG++++++  P A  T+      + + APE 
Sbjct: 160  YLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  +  SDV+SYG+V+ E++        SY E        R  W  + +  D++  +
Sbjct: 220  IQYRKFTSASDVWSYGIVMWEVM--------SYGE--------RPYWDMSNQ--DVIK-A 260
Query: 1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            + E   + +  D    +  + L C +K+ + RP    +V
Sbjct: 261  IEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIV 299

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 109/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE
Sbjct: 122  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 172
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 173  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 14   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 73
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 74   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI- 982
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  + 
Sbjct: 134  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 189
Query: 983  SVVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 190  EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 67   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 119
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S    ++ GT+ Y+ 
Sbjct: 120  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRD-TLCGTLDYLP 175
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 176  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 236  DLIS------------------------RLLKHNPSQRPMLREVL 256

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 116/285 (40%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 67   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 119
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  +  + GT+ Y+ 
Sbjct: 120  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRT-DLCGTLDYLP 175
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 176  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 236  DLIS------------------------RLLKHNPSQRPMLREVL 256

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       
Sbjct: 15   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL 74
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 75   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 134
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI- 982
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  + 
Sbjct: 135  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 190
Query: 983  SVVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 191  EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 5    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMEN--GSLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 65   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 124
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 125  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 175
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 176  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 230
Query: 1048 I 1048
            +
Sbjct: 231  V 231

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 8    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 68   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 120
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +        S+    + GT+ Y+ 
Sbjct: 121  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRXXLCGTLDYLP 176
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 177  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 236
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 237  DLIS------------------------RLLKHNPSQRPMLREVL 257

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMEN--GSLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 124  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 174
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 175  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 1048 I 1048
            +
Sbjct: 230  V 230

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 121  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 171
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 172  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 1048 I 1048
            +
Sbjct: 227  V 227

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 127/290 (43%), Gaps = 38/290 (13%)
Query: 814  VIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTI 870
            VI+ +E L     IG G  G+V+   LG        K+A +  + G++S +    E + +
Sbjct: 3    VIDPSE-LTFVQEIGSGQFGLVH---LG--YWLNKDKVAIKTIREGAMSEEDFIEEAEVM 56
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXX 930
             K+ H  LV+L    L +    +++ +ME+G L D L +       E      +      
Sbjct: 57   MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE-----TLLGMCLD 111
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL-LDKSPASTTSISVVGTIG 989
                     +  ++HRD+   N L+       +SDFG+ +  LD    S+T       + 
Sbjct: 112  VCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--PVK 169
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
            + +PE    +  S +SDV+S+GV++ E+ +  K     Y+ R           S++E + 
Sbjct: 170  WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENR-----------SNSEVVE 215
Query: 1050 DI-VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098
            DI     L +  L S+   Q+++       C +++P +RP    ++RQL 
Sbjct: 216  DISTGFRLYKPRLASTHVYQIMN------HCWKERPEDRPAFSRLLRQLA 259

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 8/220 (3%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK 864
            GP  +  QV +          IG GA+G+V  A    N V  A++K++   H+       
Sbjct: 14   GPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTL 73
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYK 923
            REI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y 
Sbjct: 74   REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF 133
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +             +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++
Sbjct: 134  LYQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 984  -VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
              V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 190  EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/232 (27%), Positives = 100/232 (43%), Gaps = 31/232 (13%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            +NL    +IGRG +G VYK SL    V AVK  +F    R +   ++ I  +  + H N+
Sbjct: 13   DNLKLLELIGRGRYGAVYKGSLDERPV-AVKVFSFA--NRQNFINEKNIYRVPLMEHDNI 69
Query: 879  VR--LEDFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
             R  + D  +  D     +++  Y  NGSL   L   T     +W    ++         
Sbjct: 70   ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLA 125
Query: 934  XXXXDC------DPPIVHRDIKPENILLDSEMEPHISDFGIA------KLLDKSPASTTS 981
                +        P I HRD+   N+L+ ++    ISDFG++      +L+        +
Sbjct: 126  YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 982  ISVVGTIGYIAPE--NAFTTAKSKES-----DVYSYGVVLLELITRKKALDP 1026
            IS VGTI Y+APE        +  ES     D+Y+ G++  E+  R   L P
Sbjct: 186  ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 121  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 171
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 172  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 1048 I 1048
            +
Sbjct: 227  V 227

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 18   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 73   EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD+   NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 132  RMN---------YVHRDLAAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 181
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 182  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K    + + RE+Q + +     +V     F
Sbjct: 14   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+                  I+
Sbjct: 74   YSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREKHK--IM 127
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S +
Sbjct: 128  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQ 183
Query: 1005 SDVYSYGVVLLELITRKKALDP 1026
            SD++S G+ L+E+   +  + P
Sbjct: 184  SDIWSMGLSLVEMAVGRYPIPP 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 124  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 174
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 175  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 1048 I 1048
            +
Sbjct: 230  V 230

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 63   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 123  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 173
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 174  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 228
Query: 1048 I 1048
            +
Sbjct: 229  V 229

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 28/155 (18%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRD+KP NI L    +  I DFG+   L      T S    GT+ Y++PE   +    
Sbjct: 157  LIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYG 213
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
            KE D+Y+ G++L EL+        + K  TD                       + + ++
Sbjct: 214  KEVDLYALGLILAELLHVCDTAFETSKFFTD-----------------------LRDGII 250
Query: 1063 SSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            S I D+    LL  L    KKP +RPN  +++R L
Sbjct: 251  SDIFDKKEKTLLQKL--LSKKPEDRPNTSEILRTL 283

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K      + RE+Q + +     +V     F
Sbjct: 76   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIXXXXXXXXXXXXXDCDPPI 943
            +   +  I M  +M+ GSL  VL      P  +   V   +                  I
Sbjct: 136  YSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK------I 188
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S 
Sbjct: 189  MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSV 244
Query: 1004 ESDVYSYGVVLLELITRKKALDP 1026
            +SD++S G+ L+E+   +  + P
Sbjct: 245  QSDIWSMGLSLVEMAVGRYPIPP 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 12/202 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K      + RE+Q + +     +V     F
Sbjct: 41   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+                  I+
Sbjct: 101  YSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREKHK--IM 154
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    T  S +
Sbjct: 155  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQ 210
Query: 1005 SDVYSYGVVLLELITRKKALDP 1026
            SD++S G+ L+E+   +  + P
Sbjct: 211  SDIWSMGLSLVEMAVGRYPIPP 232

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 115/285 (40%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 32   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 92   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 144
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S     + GT+ Y+ 
Sbjct: 145  NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRD-DLCGTLDYLP 200
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 201  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 260
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 261  DLIS------------------------RLLKHNPSQRPMLREVL 281

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 120/284 (42%), Gaps = 36/284 (12%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 66   RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 118
Query: 934  XXXXDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ 
Sbjct: 119  NALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRA-ALCGTLDYLP 174
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052
            PE        ++ D++S GV+  E +  K    P ++  T         + DT +    V
Sbjct: 175  PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANT---------YQDTYKRISRV 221
Query: 1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            + +   + +    RD +  +L       +  PS RP +R+V+  
Sbjct: 222  EFTF-PDFVTEGARDLISRLL-------KHNPSQRPMLREVLEH 257

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y APE
Sbjct: 122  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRAPE 172
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 173  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 226

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 121  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 171
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 172  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 1048 I 1048
            +
Sbjct: 227  V 227

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 62   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 121
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 122  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 172
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 173  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 227
Query: 1048 I 1048
            +
Sbjct: 228  V 228

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 63   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 122
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 123  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 173
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 174  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 228
Query: 1048 I 1048
            +
Sbjct: 229  V 229

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ H 
Sbjct: 4    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 877  NLVRLEDFWLRKDCGIIMYRYMEN--GSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 64   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y APE
Sbjct: 124  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRAPE 174
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 175  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 228

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ ++        D       P  L  +  +++        
Sbjct: 61   HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 121  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 171
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 172  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 226
Query: 1048 I 1048
            +
Sbjct: 227  V 227

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y APE
Sbjct: 122  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRAPE 172
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 173  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 226

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 185  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGNMSPEAFLQEAQVMKKLRH 239
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  GSL D L       +  P  ++   +         
Sbjct: 240  EKLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 298
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+ +L++ +   T        I +
Sbjct: 299  RMN---------YVHRDLRAANILVGENLVCKVADFGLGRLIEDN-EYTARQGAKFPIKW 348
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
             APE A     + +SDV+S+G++L EL T+ +   P
Sbjct: 349  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 384

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 21   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 77
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L +       E     K+            
Sbjct: 78   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQA-----HAERIDHIKLLQYTSQICKGME 131
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 132  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 190
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 191  SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V K    P+ +   +KL     K      + RE+Q + +     +V     F
Sbjct: 24   LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+                  I+
Sbjct: 84   YSDGEISICM-EHMDGGSLDQVLKEAKRIPE---EILGKVSIAVLRGLAYLREKHQ--IM 137
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y+APE    T  S +
Sbjct: 138  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMAPERLQGTHYSVQ 193
Query: 1005 SDVYSYGVVLLEL-ITRKKALDPSYKERTDIVG 1036
            SD++S G+ L+EL + R     P  KE   I G
Sbjct: 194  SDIWSMGLSLVELAVGRYPIPPPDAKELEAIFG 226

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 121
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I++FG +     +P+S  + ++ GT+ Y+ 
Sbjct: 122  NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRT-TLCGTLDYLP 177
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 178  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 237
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 238  DLIS------------------------RLLKHNPSQRPMLREVL 258

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKL-------AFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G G  G+V+K S  P+ +   +KL       A R        + RE+Q + +     +V
Sbjct: 33   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ------IIRELQVLHECNSPYIV 86
Query: 880  RLED-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
                 F+   +  I M  +M+ GSL  VL      P     +  K+              
Sbjct: 87   GFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREK 142
Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
                I+HRD+KP NIL++S  E  + DFG++  L  S A+    S VGT  Y++PE    
Sbjct: 143  --HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQG 196
Query: 999  TAKSKESDVYSYGVVLLEL 1017
            T  S +SD++S G+ L+E+
Sbjct: 197  THYSVQSDIWSMGLSLVEM 215

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 23/241 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIR 874
            + EN      IG G +G+VYKA       V A+KK+       G  S   REI  + ++ 
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            H N+V+L D    ++   +++ +++       D       P  L  +  +++        
Sbjct: 64   HPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 123
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      ++HRD+KP+N+L+++E    ++DFG+A+     P  T    VV T+ Y A
Sbjct: 124  SHR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYXHEVV-TLWYRA 174
Query: 993  PE-----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            PE       ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E 
Sbjct: 175  PEILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEV 229
Query: 1048 I 1048
            +
Sbjct: 230  V 230

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 117/285 (41%), Gaps = 42/285 (14%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKI 873
            A E+      +G+G  G VY A    +      K+ F+    K G    ++RE++    +
Sbjct: 8    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
            RH N++RL  ++       ++  Y   G++   L  ++           +          
Sbjct: 68   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELA 120
Query: 934  XXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                 C    ++HRDIKPEN+LL S  E  I++FG +     +P+S  + ++ GT+ Y+ 
Sbjct: 121  NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRT-TLCGTLDYLP 176
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEIN 1049
            PE        ++ D++S GV+  E +  K   +  +Y+E    +  V   + D  TE   
Sbjct: 177  PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 236
Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
            D++                         R  +  PS RP +R+V+
Sbjct: 237  DLIS------------------------RLLKHNPSQRPMLREVL 257

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 20   IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
             +    I+  ++ E  SL   LH+      ++     K+                  I+H
Sbjct: 78   TKPQLAIVT-QWCEGSSLYHHLHASETKFEMK-----KLIDIARQTARGMDYLHAKSIIH 131
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE---NAFTTAKS 1002
            RD+K  NI L  +    I DFG+A +  +   S     + G+I ++APE      +   S
Sbjct: 132  RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 192  FQSDVYAFGIVLYELMT 208

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 130/298 (43%), Gaps = 47/298 (15%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPN-AVFAVKKLAFRGHKRGSLSM-------KREIQ 868
            A   +  +  IG+G  G+V+K  L  + +V A+K L   G   G   M       +RE+ 
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL-GDSEGETEMIEKFQEFQREVF 75
Query: 869  TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXX 928
             +  + H N+V+L  + L  +   ++  ++  G L   L     P  ++W+V+ ++    
Sbjct: 76   IMSNLNHPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDI 131
Query: 929  XXXXXXXXXDCDPPIVHRDIKPENILLDS--EMEP---HISDFGIAKLLDKSPASTTSIS 983
                     + +PPIVHRD++  NI L S  E  P    ++DF +++       S  S+S
Sbjct: 132  ALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------QSVHSVS 184
Query: 984  -VVGTIGYIAPEN--AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
             ++G   ++APE   A   + ++++D YS+ ++L  ++T +   D     +   +  +R 
Sbjct: 185  GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR- 243
Query: 1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALR-CTEKKPSNRPNMRDVVRQL 1097
                             EE L  +I +     L   +  C    P  RP+   +V++L
Sbjct: 244  -----------------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 24/221 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 18   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LV+L    + ++   I+  YM  G L D L       +  P  ++   +         
Sbjct: 73   EKLVQLYAV-VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         VHRD++  NIL+   +   ++DFG+A+L++ +   T        I +
Sbjct: 132  RMN---------YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKW 181
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
             APE A     + +SDV+S+G++L EL T+ +   P    R
Sbjct: 182  TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 49   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 105
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 106  KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 159
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 160  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 218
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 219  SLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 36   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 92
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 93   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 146
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 147  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 205
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 206  SLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 2    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPT 915
            +  +  E   +  + + ++ RL    L     +IM + M  G L D +     +I     
Sbjct: 61   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL 119
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 120  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 171  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 19   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 78
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 79   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 138
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 139  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 194
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 195  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 11   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 71   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 131  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 187  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 74
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 75   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 128
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV----GTIGYIA 992
                   +HRD+   NIL+++E    I DFG+ K+L   P       V       I + A
Sbjct: 129  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL---PQDKEFFKVKEPGESPIFWYA 185
Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE+   +  S  SDV+S+GVVL EL T
Sbjct: 186  PESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 74
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 75   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 128
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 129  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 187
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 188  SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 36   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 92
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 93   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 146
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 147  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 205
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 206  SLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 17   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 73
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 74   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 127
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 128  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 186
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 187  SLTESKFSVASDVWSFGVVLYELFT 211

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 827  IGRGAHGIVYKASLGPNA--VFAVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVR 880
            IG GA+G V+KA    N     A+K++  +  + G  LS  RE+  +  +    H N+VR
Sbjct: 19   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 881  LEDFWL-----RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            L D        R+    +++ +++   L   L  +  P      ++  +           
Sbjct: 79   LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                   +VHRD+KP+NIL+ S  +  ++DFG+A++     A T   SVV T+ Y APE 
Sbjct: 138  SHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVTLWYRAPEV 190
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
               ++ +   D++S G +  E+  RK    P ++  +D+
Sbjct: 191  LLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDV 225

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 827  IGRGAHGIVYKASLGPNA--VFAVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVR 880
            IG GA+G V+KA    N     A+K++  +  + G  LS  RE+  +  +    H N+VR
Sbjct: 19   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 881  LEDFWL-----RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            L D        R+    +++ +++   L   L  +  P      ++  +           
Sbjct: 79   LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                   +VHRD+KP+NIL+ S  +  ++DFG+A++     A T   SVV T+ Y APE 
Sbjct: 138  SHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVTLWYRAPEV 190
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
               ++ +   D++S G +  E+  RK    P ++  +D+
Sbjct: 191  LLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDV 225

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 16   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 72
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 73   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 126
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 127  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 185
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 186  SLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 25   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 81
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 82   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 135
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 136  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 194
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 195  SLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 13   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 73   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 133  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 189  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 18   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 74
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 75   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 128
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 129  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 187
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 188  SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 24   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 80
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 81   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 134
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 135  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 193
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 194  SLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 21   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 77
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 78   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 131
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 132  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 190
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 191  SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 22   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 78
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 79   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 132
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 133  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 191
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 192  SLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 31   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 90
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 91   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 150
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 151  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 206
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 207  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 11   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 71   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 131  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 186
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 187  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 23   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 79
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 80   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 133
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 134  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 192
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 193  SLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKR---EIQTIGKIRH 875
            E+L  +  +G G  G V+ A+   +   AVK +     K GS+S++    E   +  ++H
Sbjct: 15   ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-----KPGSMSVEAFLAEANVMKTLQH 69
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPTLEWNVRYKIXXXXXXX 931
              LV+L    + K+   I+  +M  GSL D L S      P P L  +   +I       
Sbjct: 70   DKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEGMAFI 127
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        +HRD++  NIL+ + +   I+DFG+A++++ +   T        I + 
Sbjct: 128  EQRN-------YIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWT 179
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE     + + +SDV+S+G++L+E++T
Sbjct: 180  APEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 38/293 (12%)
Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQ 868
            K VI+ +E L     IG G  G+V+   LG        K+A +  + G++S +    E +
Sbjct: 2    KWVIDPSE-LTFVQEIGSGQFGLVH---LG--YWLNKDKVAIKTIREGAMSEEDFIEEAE 55
Query: 869  TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXX 928
             + K+ H  LV+L    L +    ++  +ME+G L D L   T            +    
Sbjct: 56   VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDV 113
Query: 929  XXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT 987
                      C   ++HRD+   N L+       +SDFG+ + +LD    S+T       
Sbjct: 114  CEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF--P 168
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            + + +PE    +  S +SDV+S+GV++ E+ +  K     Y+ R           S++E 
Sbjct: 169  VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENR-----------SNSEV 214
Query: 1048 INDI-VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
            + DI     L +  L S+   Q+++       C  ++P +RP    ++RQL +
Sbjct: 215  VEDISTGFRLYKPRLASTHVYQIMN------HCWRERPEDRPAFSRLLRQLAE 261

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A++++  +   +  L +  EI  + + ++ N+V   D +
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  Y+  GSL DV+               +I                  ++H
Sbjct: 87   LVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSNQVIH 139
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK +NILL  +    ++DFG    +  +P  +   ++VGT  ++APE     A   + 
Sbjct: 140  RDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++ +E+I
Sbjct: 198  DIWSLGIMAIEMI 210

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ + K+P           + ++APE+ F    S 
Sbjct: 221  IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+SYGV+L E+ +   +  P  +   D    +R                  E M + 
Sbjct: 281  KSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLR------------------EGMRMR 322
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
            +      ++  + L C  + P  RP   ++V +L D
Sbjct: 323  APEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGD 358

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +G     RE+Q + K+ H N+VRL  F
Sbjct: 27   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 82   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 140
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 141  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 195
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 196  GATDYTSSIDVWSAGCVLAELL 217

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 5    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +IM + M  G L D +      I     
Sbjct: 64   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL 122
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 123  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 11   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 71   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 131  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 187  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 3    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +IM + M  G L D +      I     
Sbjct: 62   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL 120
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 121  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 172  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +G     RE+Q + K+ H N+VRL  F
Sbjct: 27   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 82   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 140
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 141  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 195
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 196  GATDYTSSIDVWSAGCVLAELL 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 4    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +IM + M  G L D +      I     
Sbjct: 63   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL 121
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 122  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 173  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 59/227 (25%), Positives = 98/227 (43%), Gaps = 20/227 (8%)
Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGH 856
            P+   P+    ++++ TE L    V+G GA G VYK    P         A+K L     
Sbjct: 22   PSGTAPNQAQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG 80
Query: 857  KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITP 912
             + ++    E   +  + H +LVRL    L     ++  + M +G L + +H    +I  
Sbjct: 81   PKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLEYVHEHKDNIGS 139
Query: 913  PPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
               L W V+                  +  +VHRD+   N+L+ S     I+DFG+A+LL
Sbjct: 140  QLLLNWCVQIAKGMMYLE---------ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 190
Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            +       +      I ++A E       + +SDV+SYGV + EL+T
Sbjct: 191  EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 827  IGRGAHGIVYKASLGPNA--VFAVKKLAFRGHKRG-SLSMKREIQTIGKIR---HRNLVR 880
            IG GA+G V+KA    N     A+K++  +  + G  LS  RE+  +  +    H N+VR
Sbjct: 19   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 881  LEDFWL-----RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            L D        R+    +++ +++   L   L  +  P      ++  +           
Sbjct: 79   LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                   +VHRD+KP+NIL+ S  +  ++DFG+A++     A T   SVV T+ Y APE 
Sbjct: 138  SHR----VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVTLWYRAPEV 190
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
               ++ +   D++S G +  E+  RK    P ++  +D+
Sbjct: 191  LLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDV 225

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+ K+       G  S   REI  + ++ H 
Sbjct: 3    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE
Sbjct: 123  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 173
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 174  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 227

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 23/239 (9%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHR 876
            EN      IG G +G+VYKA       V A+ K+       G  S   REI  + ++ H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 877  NLVRLEDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXX 934
            N+V+L D    ++   +++ ++        D       P  L  +  +++          
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 935  XXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                    ++HRD+KP+N+L+++E    ++DFG+A+     P  T +  VV T+ Y APE
Sbjct: 122  R-------VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 172
Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
                   ++TA     D++S G +  E++TR +AL P   E   +    R++ +  E +
Sbjct: 173  ILLGCKYYSTA----VDIWSLGCIFAEMVTR-RALFPGDSEIDQLFRIFRTLGTPDEVV 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 66/291 (22%), Positives = 112/291 (38%), Gaps = 58/291 (19%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            +IG G  G V+KA    +   + +K++ +   K      +RE++ + K+ H N+V     
Sbjct: 18   LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK-----AEREVKALAKLDHVNIVHYNGC 72
Query: 885  W----------------LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXX 928
            W                 +  C  I   + + G+L   +        L+     K+    
Sbjct: 73   WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLD-----KVLALE 126
Query: 929  XXXXXXXXXDC--DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                     D      +++RD+KP NI L    +  I DFG+   L        S    G
Sbjct: 127  LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS---KG 183
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046
            T+ Y++PE   +    KE D+Y+ G++L EL+        + K  TD             
Sbjct: 184  TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD------------- 230
Query: 1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                      + + ++S I D+    LL  L    KKP +RPN  +++R L
Sbjct: 231  ----------LRDGIISDIFDKKEKTLLQKL--LSKKPEDRPNTSEILRTL 269

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A++  +  + AVKK+  R  +R  L +  E+  +   +H N+V + + +
Sbjct: 32   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-LFNEVVIMRDYQHENVVEMYNSY 90
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  ++E G+L D++       T       +I                  ++H
Sbjct: 91   LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 143
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K       +  VGT  ++APE         E 
Sbjct: 144  RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEV 201
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 202  DIWSLGIMVIEMV 214

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +G     RE+Q + K+ H N+VRL  F
Sbjct: 27   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 82   FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 140
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 141  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 195
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 196  GATDYTSSIDVWSAGCVLAELL 217

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKR---EIQTIGKIRH 875
            E+L  +  +G G  G V+ A+   +   AVK +     K GS+S++    E   +  ++H
Sbjct: 188  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-----KPGSMSVEAFLAEANVMKTLQH 242
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPTLEWNVRYKIXXXXXXX 931
              LV+L    + K+   I+  +M  GSL D L S      P P L   + +         
Sbjct: 243  DKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMA 298
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        +HRD++  NIL+ + +   I+DFG+A++++ +   T        I + 
Sbjct: 299  FIEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVIEDN-EYTAREGAKFPIKWT 352
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE     + + +SDV+S+G++L+E++T
Sbjct: 353  APEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 14/222 (6%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 31   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 90
Query: 866  EIQTIGKIRHRNLVRLEDF----WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            EI+ + + RH N++ + D      + +   + +  ++    L  +L +            
Sbjct: 91   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 150
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
            Y+I                  ++HRD+KP N+LL++  +  I DFG+A++ D     T  
Sbjct: 151  YQILRGLKYIHSAN-------VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 203
Query: 982  IS-VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
            ++  V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 204  LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 102/249 (40%), Gaps = 30/249 (12%)
Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYK-ASLGPNAVFAVKKLAFRGHKRGS 860
            P  E P +   +  E  +  + K VIGRG   +V +         FAVK +     +   
Sbjct: 79   PEDELPDWAAAK--EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136
Query: 861  LSM-------KREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP 912
              +       +RE   + ++  H +++ L D +       +++  M  G L D L   T 
Sbjct: 137  EQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TE 193
Query: 913  PPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
               L       I             +    IVHRD+KPENILLD  M+  +SDFG +  L
Sbjct: 194  KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHL 250
Query: 973  DKSPASTTSISVVGTIGYIAPE------NAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            +  P       + GT GY+APE      +       KE D+++ GV+L  L+    A  P
Sbjct: 251  E--PGEKLR-ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL----AGSP 303
Query: 1027 SYKERTDIV 1035
             +  R  I+
Sbjct: 304  PFWHRRQIL 312

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 3    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +IM + M  G L D +      I     
Sbjct: 62   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYL 120
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 121  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 172  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 11   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 71   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 131  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTE 186
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 187  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKR---EIQTIGKIRH 875
            E+L  +  +G G  G V+ A+   +   AVK +     K GS+S++    E   +  ++H
Sbjct: 182  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-----KPGSMSVEAFLAEANVMKTLQH 236
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPTLEWNVRYKIXXXXXXX 931
              LV+L    + K+   I+  +M  GSL D L S      P P L   + +         
Sbjct: 237  DKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL---IDFSAQIAEGMA 292
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        +HRD++  NIL+ + +   I+DFG+A++  K P           I + 
Sbjct: 293  FIEQRN-----YIHRDLRAANILVSASLVCKIADFGLARVGAKFP-----------IKWT 336
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE     + + +SDV+S+G++L+E++T
Sbjct: 337  APEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A++  +  + AVKK+  R  +R  L +  E+  +   +H N+V + + +
Sbjct: 28   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-LFNEVVIMRDYQHENVVEMYNSY 86
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  ++E G+L D++       T       +I                  ++H
Sbjct: 87   LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 139
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K       +  VGT  ++APE         E 
Sbjct: 140  RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEV 197
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 198  DIWSLGIMVIEMV 210

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 89/193 (46%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A++++  +   +  L +  EI  + + ++ N+V   D +
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  Y+  GSL DV+       T       +I                  ++H
Sbjct: 87   LVGDELWVVMEYLAGGSLTDVV-------TETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK +NILL  +    ++DFG    +  +P  +    +VGT  ++APE     A   + 
Sbjct: 140  RDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++ +E+I
Sbjct: 198  DIWSLGIMAIEMI 210

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 26/222 (11%)
Query: 811  LKQVIEATENLNAKHV------IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK 864
            +KQ    T +LN +        +G GA G VYKA     +V A  K+     +       
Sbjct: 23   MKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYM 82
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
             EI  +    H N+V+L D +  ++   I+  +   G++  V+  +  P T       +I
Sbjct: 83   VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT-----ESQI 137
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI-- 982
                           D  I+HRD+K  NIL   + +  ++DFG+      S  +T +I  
Sbjct: 138  QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV------SAKNTRTIQR 191
Query: 983  --SVVGTIGYIAPENAF-TTAKSK----ESDVYSYGVVLLEL 1017
              S +GT  ++APE     T+K +    ++DV+S G+ L+E+
Sbjct: 192  RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 45/225 (20%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G+G  G V      P      A+ AVK+L   G  +     +REIQ +  +    +V+ 
Sbjct: 31   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 89
Query: 882  EDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
                    R+   ++M  Y+ +G LRD L             R++               
Sbjct: 90   RGVSYGPGRQSLRLVM-EYLPSGCLRDFLQ------------RHRARLDASRLLLYSSQI 136
Query: 939  C-------DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD--------KSPASTTSIS 983
            C           VHRD+   NIL++SE    I+DFG+AKLL         + P  +    
Sbjct: 137  CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---- 192
Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR-KKALDPS 1027
                I + APE+      S++SDV+S+GVVL EL T   K+  PS
Sbjct: 193  ---PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A++  +  + AVKK+  R  +R  L +  E+  +   +H N+V + + +
Sbjct: 39   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-LFNEVVIMRDYQHENVVEMYNSY 97
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  ++E G+L D++       T       +I                  ++H
Sbjct: 98   LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 150
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K       +  VGT  ++APE         E 
Sbjct: 151  RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEV 208
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 209  DIWSLGIMVIEMV 221

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 89/193 (46%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A++++  +   +  L +  EI  + + ++ N+V   D +
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  Y+  GSL DV+       T       +I                  ++H
Sbjct: 87   LVGDELWVVMEYLAGGSLTDVV-------TETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK +NILL  +    ++DFG    +  +P  +    +VGT  ++APE     A   + 
Sbjct: 140  RDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++ +E+I
Sbjct: 198  DIWSLGIMAIEMI 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 32   IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
             +    I+  ++ E  SL   LH+      ++     K+                  I+H
Sbjct: 90   TKPQLAIVT-QWCEGSSLYHHLHASETKFEMK-----KLIDIARQTARGMDYLHAKSIIH 143
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE---NAFTTAKS 1002
            RD+K  NI L  +    I DFG+A    +   S     + G+I ++APE      +   S
Sbjct: 144  RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 204  FQSDVYAFGIVLYELMT 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 98/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 11   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 70
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ + + RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 71   EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 131  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTE 186
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 187  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 45/225 (20%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G+G  G V      P      A+ AVK+L   G  +     +REIQ +  +    +V+ 
Sbjct: 19   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 77
Query: 882  EDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
                    R+   ++M  Y+ +G LRD L             R++               
Sbjct: 78   RGVSYGPGRQSLRLVM-EYLPSGCLRDFLQ------------RHRARLDASRLLLYSSQI 124
Query: 939  C-------DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD--------KSPASTTSIS 983
            C           VHRD+   NIL++SE    I+DFG+AKLL         + P  +    
Sbjct: 125  CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---- 180
Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR-KKALDPS 1027
                I + APE+      S++SDV+S+GVVL EL T   K+  PS
Sbjct: 181  ---PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 64/219 (29%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G+G  G V      P      A+ AVK+L   G  +     +REIQ +  +    +V+ 
Sbjct: 15   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 73
Query: 882  EDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
                    R +  ++M  Y+ +G LRD L             R++               
Sbjct: 74   RGVSYGPGRPELRLVM-EYLPSGCLRDFLQ------------RHRARLDASRLLLYSSQI 120
Query: 939  C-------DPPIVHRDIKPENILLDSEMEPHISDFGIAKL--LDKSPASTTSISVVGTIG 989
            C           VHRD+   NIL++SE    I+DFG+AKL  LDK             I 
Sbjct: 121  CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPG-QSPIF 179
Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITR-KKALDPS 1027
            + APE+      S++SDV+S+GVVL EL T   K+  PS
Sbjct: 180  WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 218

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A++++  +   +  L +  EI  + + ++ N+V   D +
Sbjct: 29   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 87
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  Y+  GSL DV+               +I                  ++H
Sbjct: 88   LVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSNQVIH 140
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK +NILL  +    ++DFG    +  +P  +    +VGT  ++APE     A   + 
Sbjct: 141  RDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++ +E+I
Sbjct: 199  DIWSLGIMAIEMI 211

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A++     + AVKK+  R  +R  L +  E+  +   +H N+V + + +
Sbjct: 37   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-LFNEVVIMRDYQHENVVEMYNSY 95
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  ++E G+L D++       T       +I                  ++H
Sbjct: 96   LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 148
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K       +  VGT  ++APE         E 
Sbjct: 149  RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEV 206
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 207  DIWSLGIMVIEMV 219

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 25/241 (10%)
Query: 793  RRSKQDLEI-----PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA--- 844
            RR  Q+ E+     P+ E P+  L ++++ TE    K V+G GA G VYK    P     
Sbjct: 19   RRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKV 77
Query: 845  --VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS 902
                A+ +L      + +  +  E   +  + + ++ RL    L     +I  + M  G 
Sbjct: 78   KIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGC 136
Query: 903  LRDVLH----SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE 958
            L D +     +I     L W V+                  D  +VHRD+   N+L+ + 
Sbjct: 137  LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTP 187
Query: 959  MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
                I+DFG+AKLL        +      I ++A E+      + +SDV+SYGV + EL+
Sbjct: 188  QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 247
Query: 1019 T 1019
            T
Sbjct: 248  T 248

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 45/225 (20%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G+G  G V      P      A+ AVK+L   G  +     +REIQ +  +    +V+ 
Sbjct: 18   LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 76
Query: 882  EDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
                    R+   ++M  Y+ +G LRD L             R++               
Sbjct: 77   RGVSYGPGRQSLRLVM-EYLPSGCLRDFLQ------------RHRARLDASRLLLYSSQI 123
Query: 939  C-------DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD--------KSPASTTSIS 983
            C           VHRD+   NIL++SE    I+DFG+AKLL         + P  +    
Sbjct: 124  CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS---- 179
Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITR-KKALDPS 1027
                I + APE+      S++SDV+S+GVVL EL T   K+  PS
Sbjct: 180  ---PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 13   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ +   RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 73   EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 133  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 188
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 189  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/84 (41%), Positives = 49/84 (58%), Gaps = 8/84 (9%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK- 1001
            I+HRD+KP+NILLD     HI+DF IA +L   P  T   ++ GT  Y+APE  F++ K 
Sbjct: 136  IIHRDMKPDNILLDEHGHVHITDFNIAAML---PRETQITTMAGTKPYMAPE-MFSSRKG 191
Query: 1002 ---SKESDVYSYGVVLLELITRKK 1022
               S   D +S GV   EL+  ++
Sbjct: 192  AGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 46/226 (20%)
Query: 820  NLNAKHVIGRGAHGIV---YKASLGPNAVFAV--KKLAFRGHKRGSLSMKREIQTIGKIR 874
            N      +G G+ G V   Y  + G      +  KK+  +   +G +  +REI  +  +R
Sbjct: 15   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI--EREISYLRLLR 72
Query: 875  HRNLVRLEDFWLRKDCGIIMYRY--------------MENGSLRDVLHSITPPPTLEWNV 920
            H ++++L D    KD  I++  Y              M     R     I     +E+  
Sbjct: 73   HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIIS--AVEYCH 130
Query: 921  RYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
            R+KI                   VHRD+KPEN+LLD  +   I+DFG++ ++       T
Sbjct: 131  RHKI-------------------VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 171
Query: 981  SISVVGTIGYIAPEN-AFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            S    G+  Y APE  +       E DV+S GV+L  ++ R+   D
Sbjct: 172  S---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A++     + AVKK+  R  +R  L +  E+  +   +H N+V + + +
Sbjct: 82   IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-LFNEVVIMRDYQHENVVEMYNSY 140
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  ++E G+L D++       T       +I                  ++H
Sbjct: 141  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 193
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K       +  VGT  ++APE         E 
Sbjct: 194  RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEV 251
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 252  DIWSLGIMVIEMV 264

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 46/226 (20%)
Query: 820  NLNAKHVIGRGAHGIV---YKASLGPNAVFAV--KKLAFRGHKRGSLSMKREIQTIGKIR 874
            N      +G G+ G V   Y  + G      +  KK+  +   +G +  +REI  +  +R
Sbjct: 14   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI--EREISYLRLLR 71
Query: 875  HRNLVRLEDFWLRKDCGIIMYRY--------------MENGSLRDVLHSITPPPTLEWNV 920
            H ++++L D    KD  I++  Y              M     R     I     +E+  
Sbjct: 72   HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIIS--AVEYCH 129
Query: 921  RYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
            R+KI                   VHRD+KPEN+LLD  +   I+DFG++ ++       T
Sbjct: 130  RHKI-------------------VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170
Query: 981  SISVVGTIGYIAPEN-AFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            S    G+  Y APE  +       E DV+S GV+L  ++ R+   D
Sbjct: 171  S---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 46/226 (20%)
Query: 820  NLNAKHVIGRGAHGIV---YKASLGPNAVFAV--KKLAFRGHKRGSLSMKREIQTIGKIR 874
            N      +G G+ G V   Y  + G      +  KK+  +   +G +  +REI  +  +R
Sbjct: 5    NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI--EREISYLRLLR 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRY--------------MENGSLRDVLHSITPPPTLEWNV 920
            H ++++L D    KD  I++  Y              M     R     I     +E+  
Sbjct: 63   HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIIS--AVEYCH 120
Query: 921  RYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
            R+KI                   VHRD+KPEN+LLD  +   I+DFG++ ++       T
Sbjct: 121  RHKI-------------------VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 161
Query: 981  SISVVGTIGYIAPEN-AFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            S    G+  Y APE  +       E DV+S GV+L  ++ R+   D
Sbjct: 162  S---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 46/226 (20%)
Query: 820  NLNAKHVIGRGAHGIV---YKASLGPNAVFAV--KKLAFRGHKRGSLSMKREIQTIGKIR 874
            N      +G G+ G V   Y  + G      +  KK+  +   +G +  +REI  +  +R
Sbjct: 9    NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI--EREISYLRLLR 66
Query: 875  HRNLVRLEDFWLRKDCGIIMYRY--------------MENGSLRDVLHSITPPPTLEWNV 920
            H ++++L D    KD  I++  Y              M     R     I     +E+  
Sbjct: 67   HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIIS--AVEYCH 124
Query: 921  RYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
            R+KI                   VHRD+KPEN+LLD  +   I+DFG++ ++       T
Sbjct: 125  RHKI-------------------VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 165
Query: 981  SISVVGTIGYIAPEN-AFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            S    G+  Y APE  +       E DV+S GV+L  ++ R+   D
Sbjct: 166  S---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 26/222 (11%)
Query: 811  LKQVIEATENLNAKHV------IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK 864
            +KQ    T +LN +        +G GA G VYKA     +V A  K+     +       
Sbjct: 23   MKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYM 82
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
             EI  +    H N+V+L D +  ++   I+  +   G++  V+  +  P T       +I
Sbjct: 83   VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT-----ESQI 137
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI-- 982
                           D  I+HRD+K  NIL   + +  ++DFG+      S  +T  I  
Sbjct: 138  QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV------SAKNTRXIQR 191
Query: 983  --SVVGTIGYIAPENAF-TTAKSK----ESDVYSYGVVLLEL 1017
              S +GT  ++APE     T+K +    ++DV+S G+ L+E+
Sbjct: 192  RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLED 883
            +G G  G V+      +   AVK L     K G++S++    E   +  ++H  LVRL  
Sbjct: 21   LGAGQFGEVWMGYYNNSTKVAVKTL-----KPGTMSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
               R++   I+  YM  GSL D L S     +  P  ++++ +                 
Sbjct: 76   VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN----- 130
Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
                 +HRD++  N+L+   +   I+DFG+A++++ +   T        I + APE    
Sbjct: 131  ----YIHRDLRAANVLVSESLMCKIADFGLARVIEDN-EYTAREGAKFPIKWTAPEAINF 185
Query: 999  TAKSKESDVYSYGVVLLELITRKKALDP 1026
               + +SDV+S+G++L E++T  K   P
Sbjct: 186  GCFTIKSDVWSFGILLYEIVTYGKIPYP 213

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 42/293 (14%)
Query: 824  KHVIGRGAHGIVYKA---SLGPN------AVFAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            K  +G GA G V+ A   +L P       AV A+K       K      +RE + +  ++
Sbjct: 20   KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK----DFQREAELLTNLQ 75
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR----------YKI 924
            H ++V+        D  I+++ YM++G L   L +  P   +  + +           ++
Sbjct: 76   HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
                               VHRD+   N L+ + +   I DFG+++ +  +         
Sbjct: 136  LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044
            +  I ++ PE+      + ESDV+S+GV+L E+ T  K   P ++             S+
Sbjct: 196  MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK--QPWFQ------------LSN 241
Query: 1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            TE I  I    ++E   V     +V DV+   L C +++P  R N++++ + L
Sbjct: 242  TEVIECITQGRVLERPRVCP--KEVYDVM---LGCWQREPQQRLNIKEIYKIL 289

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 8/219 (3%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKR 865
            P  +  QV +          IG GA+G+V  A    N V  A+KK++   H+       R
Sbjct: 13   PEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR 72
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKI 924
            EI+ +   RH N++ + D         +   Y+    +   L+ +     L  + + Y +
Sbjct: 73   EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                         +    ++HRD+KP N+LL++  +  I DFG+A++ D     T  ++ 
Sbjct: 133  YQILRGLKYIHSAN----VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTE 188
Query: 984  VVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
             V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 189  YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGS--LSMKREIQTIGKIRHRNLVRLED 883
            IG G+ G VY A    N+ V A+KK+++ G +       + +E++ + K+RH N ++   
Sbjct: 62   IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPI 943
             +LR+    ++  Y   GS  D+L  +   P  E  +                 +    +
Sbjct: 122  CYLREHTAWLVMEYC-LGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSHN----M 175
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+K  NILL       + DFG A ++  +PA+      VGT  ++APE      + +
Sbjct: 176  IHRDVKAGNILLSEPGLVKLGDFGSASIM--APANX----FVGTPYWMAPEVILAMDEGQ 229
Query: 1004 ---ESDVYSYGVVLLELITRKKAL 1024
               + DV+S G+  +EL  RK  L
Sbjct: 230  YDGKVDVWSLGITCIELAERKPPL 253

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 33/241 (13%)
Query: 827  IGRGAHGIVYKAS------LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            IG GA G V++A         P  + AVK L            +RE   + +  + N+V+
Sbjct: 55   IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------------------PPTLEWN 919
            L           +++ YM  G L + L S++P                     PP L   
Sbjct: 115  LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST 979
             +  I               +   VHRD+   N L+   M   I+DFG+++ +  +    
Sbjct: 175  EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 980  TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSY-KERTDIVGWV 1038
               +    I ++ PE+ F    + ESDV++YGVVL E+ +    L P Y     +++ +V
Sbjct: 232  ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY--GLQPYYGMAHEEVIYYV 289
Query: 1039 R 1039
            R
Sbjct: 290  R 290

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 22/222 (9%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVK-----KLAFRGHKRG 859
            G  +++    + ++N + K  +G+GA  +V +       + FA K     KL+ R  ++ 
Sbjct: 16   GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK- 74
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
               ++RE +   K++H N+VRL D    +    +++  +  G L + +  +      E +
Sbjct: 75   ---LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEAD 129
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSP 976
              + I                  IVHR++KPEN+LL S+ +     ++DFG+A  ++ S 
Sbjct: 130  ASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185
Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            A        GT GY++PE       SK  D+++ GV+L  L+
Sbjct: 186  AWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 5    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +     +I     
Sbjct: 64   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 122
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 123  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 16/216 (7%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKK-LAFRGHKRGSLSM 863
            G   L  Q +E  ENL    ++G G++G+V K  +     + A+KK L     K      
Sbjct: 15   GTENLYFQSMEKYENLG---LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA 71
Query: 864  KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
             REI+ + ++RH NLV L +   +K    +++ ++++  L D+   + P       + Y+
Sbjct: 72   MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL--ELFPN-----GLDYQ 124
Query: 924  IXXXXXXXXXXXXXDCDP-PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
            +              C    I+HRDIKPENIL+       + DFG A+ L  +P      
Sbjct: 125  VVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYD- 182
Query: 983  SVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLEL 1017
              V T  Y APE      K  K  DV++ G ++ E+
Sbjct: 183  DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 2    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +     +I     
Sbjct: 61   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 119
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 120  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 171  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 27   VIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFK---NRELQIMRKLDHCNIVRLRYF 81
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 82   FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 140
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 141  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 195
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 196  GATDYTSSIDVWSAGCVLAELL 217

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGS--LSMKREIQTIGKIRHRNLVRLED 883
            IG G+ G VY A    N+ V A+KK+++ G +       + +E++ + K+RH N ++   
Sbjct: 23   IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPI 943
             +LR+    ++  Y   GS  D+L  +   P  E     +I                  +
Sbjct: 83   CYLREHTAWLVMEYC-LGSASDLL-EVHKKPLQE----VEIAAVTHGALQGLAYLHSHNM 136
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+K  NILL       + DFG A ++  +PA+      VGT  ++APE      + +
Sbjct: 137  IHRDVKAGNILLSEPGLVKLGDFGSASIM--APANX----FVGTPYWMAPEVILAMDEGQ 190
Query: 1004 ---ESDVYSYGVVLLELITRKKAL 1024
               + DV+S G+  +EL  RK  L
Sbjct: 191  YDGKVDVWSLGITCIELAERKPPL 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 4    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +IM + M  G L D +      I     
Sbjct: 63   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL 121
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG AKLL   
Sbjct: 122  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 173  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 12   EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 70
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +     +I     
Sbjct: 71   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 129
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 130  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 180
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 181  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 5    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +     +I     
Sbjct: 64   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 122
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 123  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A++  +  + AVKK+  R  +R  L +  E+  +   +H N+V + + +
Sbjct: 159  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL-LFNEVVIMRDYQHENVVEMYNSY 217
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  ++E G+L D++       T       +I                  ++H
Sbjct: 218  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIAAVCLAVLQALSVLHAQGVIH 270
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K       +  VGT  ++APE         E 
Sbjct: 271  RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPELISRLPYGPEV 328
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 329  DIWSLGIMVIEMV 341

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 4    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +IM + M  G L D +      I     
Sbjct: 63   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYL 121
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG AKLL   
Sbjct: 122  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 173  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 89/193 (46%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A++++  +   +  L +  EI  + + ++ N+V   D +
Sbjct: 29   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 87
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  Y+  GSL DV+               +I                  ++H
Sbjct: 88   LVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLHSNQVIH 140
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            R+IK +NILL  +    ++DFG    +  +P  +   ++VGT  ++APE     A   + 
Sbjct: 141  RNIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++ +E+I
Sbjct: 199  DIWSLGIMAIEMI 211

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 19   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 75
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  Y+  GSLRD L         E     K+            
Sbjct: 76   KYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGME 129
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV----GTIGYIA 992
                   +HR++   NIL+++E    I DFG+ K+L   P       V       I + A
Sbjct: 130  YLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVL---PQDKEYYKVKEPGESPIFWYA 186
Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE+   +  S  SDV+S+GVVL EL T
Sbjct: 187  PESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 11/218 (5%)
Query: 808  SYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKRE 866
            S LL+   E  EN + + V+G+G +GIVY      N V  A+K++  R   R S  +  E
Sbjct: 12   SDLLEYDYEYDENGD-RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEE 69
Query: 867  IQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
            I     ++H+N+V+    +       I    +  GSL  +L S   P  L+ N +  I  
Sbjct: 70   IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQ-TIGF 126
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVV 985
                         D  IVHRDIK +N+L+++      ISDFG +K L      T + +  
Sbjct: 127  YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-- 184
Query: 986  GTIGYIAPE--NAFTTAKSKESDVYSYGVVLLELITRK 1021
            GT+ Y+APE  +       K +D++S G  ++E+ T K
Sbjct: 185  GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 98/213 (46%), Gaps = 10/213 (4%)
Query: 816  EATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL--SMKREIQTIGK 872
            E  E+    +++G+G+   VY+A S+      A+K +  +   +  +   ++ E++   +
Sbjct: 8    EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
            ++H +++ L +++   +   ++     NG +   L +   P + E   R+ +        
Sbjct: 68   LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARHFMHQIITGML 126
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
                      I+HRD+   N+LL   M   I+DFG+A  L K P      ++ GT  YI+
Sbjct: 127  YLHSHG----ILHRDLTLSNLLLTRNMNIKIADFGLATQL-KMPHEK-HYTLCGTPNYIS 180
Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
            PE A  +A   ESDV+S G +   L+  +   D
Sbjct: 181  PEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 88/193 (45%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A+        AVKK+  R  +R  L +  E+  +    H N+V +   +
Sbjct: 53   IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL-LFNEVVIMRDYHHDNVVDMYSSY 111
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  D   ++  ++E G+L D++       T       +I               +  ++H
Sbjct: 112  LVGDELWVVMEFLEGGALTDIV-------THTRMNEEQIATVCLSVLRALSYLHNQGVIH 164
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL S+    +SDFG    + K       +  VGT  ++APE         E 
Sbjct: 165  RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXL--VGTPYWMAPEVISRLPYGTEV 222
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E+I
Sbjct: 223  DIWSLGIMVIEMI 235

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 826  VIGRGAHGIVY--KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            V+G GA   V+  K  L    +FA+K +      R S S++ EI  + KI+H N+V LED
Sbjct: 16   VLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDS-SLENEIAVLKKIKHENIVTLED 73
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC--DP 941
             +       ++ + +  G L D +        LE  V  +                  + 
Sbjct: 74   IYESTTHYYLVMQLVSGGELFDRI--------LERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 942  PIVHRDIKPENILL---DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
             IVHRD+KPEN+L    +   +  I+DFG++K+      ST      GT GY+APE    
Sbjct: 126  GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA----CGTPGYVAPEVLAQ 181
Query: 999  TAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
               SK  D +S GV+   L+       P Y+E
Sbjct: 182  KPYSKAVDCWSIGVITYILLC---GYPPFYEE 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 20/223 (8%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGS 860
             P+    ++++ TE L    V+G GA G VYK    P         A+K L      + +
Sbjct: 3    APNQAQLRILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN 61
Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPTL 916
            +    E   +  + H +LVRL    L     ++  + M +G L + +H    +I     L
Sbjct: 62   VEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLEYVHEHKDNIGSQLLL 120
Query: 917  EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
             W V+                  +  +VHRD+   N+L+ S     I+DFG+A+LL+   
Sbjct: 121  NWCVQIAKGMMYLE---------ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 171
Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                +      I ++A E       + +SDV+SYGV + EL+T
Sbjct: 172  KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 59/123 (47%), Gaps = 5/123 (4%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IV+RD+KPENILLD      ISD G+A  +   P   T    VGT+GY+APE       +
Sbjct: 307  IVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYK--ERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060
               D ++ G +L E+I  +       K  +R ++   V+ V  +  E       SL  ++
Sbjct: 364  FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 1061 LVS 1063
            L  
Sbjct: 424  LCK 426

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 45/77 (58%), Gaps = 5/77 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPENILLD      I+DFG AK +        +  + GT  YIAPE   T   +
Sbjct: 127  IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 1003 KESDVYSYGVVLLELIT 1019
            K  D +S+G+++ E++ 
Sbjct: 182  KSIDWWSFGILIYEMLA 198

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 8    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 66
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I     
Sbjct: 67   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 125
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 126  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 176
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 177  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 20/228 (8%)
Query: 801  IPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRG 855
            I + E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L    
Sbjct: 5    IRSGEAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----IT 911
              + +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I 
Sbjct: 64   SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG 122
Query: 912  PPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
                L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKL
Sbjct: 123  SQYLLNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173
Query: 972  LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            L        +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 59/123 (47%), Gaps = 5/123 (4%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IV+RD+KPENILLD      ISD G+A  +   P   T    VGT+GY+APE       +
Sbjct: 307  IVYRDLKPENILLDDHGHIRISDLGLAVHV---PEGQTIKGRVGTVGYMAPEVVKNERYT 363
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYK--ERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060
               D ++ G +L E+I  +       K  +R ++   V+ V  +  E       SL  ++
Sbjct: 364  FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQL 423
Query: 1061 LVS 1063
            L  
Sbjct: 424  LCK 426

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 12/197 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ G VYK     +   AVK L         L + K E+  + K RH N++    + 
Sbjct: 32   IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
                  I+  ++ E  SL   LH+      ++     K+                  I+H
Sbjct: 90   TAPQLAIVT-QWCEGSSLYHHLHASETKFEMK-----KLIDIARQTARGMDYLHAKSIIH 143
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE---NAFTTAKS 1002
            RD+K  NI L  +    I DFG+A    +   S     + G+I ++APE      +   S
Sbjct: 144  RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDVY++G+VL EL+T
Sbjct: 204  FQSDVYAFGIVLYELMT 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 90/215 (41%), Gaps = 23/215 (10%)
Query: 826  VIGRGAHGIVYKASLGPNAVF-AVKKLAFRGHKRGSLSMKREIQTIGK-------IRHRN 877
            VIG+G+ G V  A      VF AVK L     K+  L  K E   + +       ++H  
Sbjct: 45   VIGKGSFGKVLLARHKAEEVFYAVKVL----QKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            LV L   +   D    +  Y+  G L    H       LE   R+               
Sbjct: 101  LVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +    IV+RD+KPENILLDS+    ++DFG+ K  +    ++T+ +  GT  Y+APE   
Sbjct: 159  N----IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032
                 +  D +  G VL E++     L P Y   T
Sbjct: 213  KQPYDRTVDWWCLGAVLYEMLY---GLPPFYSRNT 244

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED-F 884
            +G G  G+V+K S  P+ +   +KL     K      + RE+Q + +     +V     F
Sbjct: 17   LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +   +  I M  +M+ GSL  VL      P     +  K+                  I+
Sbjct: 77   YSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYLREKHK--IM 130
Query: 945  HRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            HRD+KP NIL++S  E  + DFG++ +L+D+      +   VGT  Y++PE    T  S 
Sbjct: 131  HRDVKPSNILVNSRGEIKLCDFGVSGQLIDE-----MANEFVGTRSYMSPERLQGTHYSV 185
Query: 1004 ESDVYSYGVVLLELITRKKALDP 1026
            +SD++S G+ L+E+   +    P
Sbjct: 186  QSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 20/228 (8%)
Query: 801  IPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRG 855
            I + E P+  L ++++ TE    K V+  GA G VYK    P         A+K+L    
Sbjct: 5    IRSGEAPNQALLRILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----IT 911
              + +  +  E   +  + + ++ RL    L     +IM + M  G L D +      I 
Sbjct: 64   SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIG 122
Query: 912  PPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
                L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKL
Sbjct: 123  SQYLLNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173
Query: 972  LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            L        +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 27   EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 85
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I     
Sbjct: 86   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 144
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 145  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 195
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 196  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 4    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I     
Sbjct: 63   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 121
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 122  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 173  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 5    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I     
Sbjct: 64   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 122
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 123  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 826  VIGRGAHGIVYKASLG-PNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
             IG GA+G+V  A         A+KK+  AF        ++ RE++ +   +H N++ ++
Sbjct: 62   TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHFKHDNIIAIK 120
Query: 883  DFWLRKDCGI-------IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            D  LR            ++   ME+  L  ++HS + P TLE +VRY +           
Sbjct: 121  DI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHS-SQPLTLE-HVRYFLYQLLRGLKYMH 176
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI--SVVGTIGYIAP 993
                   ++HRD+KP N+L++   E  I DFG+A+ L  SPA         V T  Y AP
Sbjct: 177  SAQ----VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 994  ENAFTTAKSKES-DVYSYGVVLLELITRKK 1022
            E   +  +  ++ D++S G +  E++ R++
Sbjct: 233  ELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 2    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I     
Sbjct: 61   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 119
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 120  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 171  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 826  VIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            V+G+G +GIVY      N V  A+K++  R   R S  +  EI     ++H+N+V+    
Sbjct: 15   VLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +       I    +  GSL  +L S   P  L+ N +  I               D  IV
Sbjct: 74   FSENGFIKIFMEQVPGGSLSALLRSKWGP--LKDNEQ-TIGFYTKQILEGLKYLHDNQIV 130
Query: 945  HRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--NAFTTAK 1001
            HRDIK +N+L+++      ISDFG +K L      T + +  GT+ Y+APE  +      
Sbjct: 131  HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIIDKGPRGY 188
Query: 1002 SKESDVYSYGVVLLELITRK 1021
             K +D++S G  ++E+ T K
Sbjct: 189  GKAADIWSLGCTIIEMATGK 208

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 10/157 (6%)
Query: 863  MKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY 922
            +KREIQ +   RH ++++L           ++  Y+  G L D +        +E    +
Sbjct: 58   IKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF 117
Query: 923  KIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
            +                   +VHRD+KPEN+LLD+ M   I+DFG++ ++       TS 
Sbjct: 118  QQILSAVDYCHRHM------VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS- 170
Query: 983  SVVGTIGYIAPEN-AFTTAKSKESDVYSYGVVLLELI 1018
               G+  Y APE  +       E D++S GV+L  L+
Sbjct: 171  --CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 28   VIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFK---NRELQIMRKLDHCNIVRLRYF 82
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 83   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 141
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 142  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 196
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 197  GATDYTSSIDVWSAGCVLAELL 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 27   VIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFK---NRELQIMRKLDHCNIVRLRYF 81
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 82   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 140
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 141  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 195
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 196  GATDYTSSIDVWSAGCVLAELL 217

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 27   VIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFK---NRELQIMRKLDHCNIVRLRYF 81
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 82   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 140
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 141  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 195
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 196  GATDYTSSIDVWSAGCVLAELL 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 32   VIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFK---NRELQIMRKLDHCNIVRLRYF 86
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 87   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 145
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 146  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 200
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 201  GATDYTSSIDVWSAGCVLAELL 222

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 827  IGRGAHGIVYKASLGP-----NAVFAVKKLAF--RGHKRGSLSMKREIQTIGKIRHRNLV 879
            +G+G  G V      P       V AVKKL      H R     +REI+ +  ++H N+V
Sbjct: 21   LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHDNIV 77
Query: 880  RLEDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
            + +       R++  +IM  ++  GSLR+ L         E     K+            
Sbjct: 78   KYKGVCYSAGRRNLKLIM-EFLPYGSLREYLQKHK-----ERIDHIKLLQYTSQICKGME 131
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPE 994
                   +HRD+   NIL+++E    I DFG+ K+L +       +   G   I + APE
Sbjct: 132  YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEXXKVKEPGESPIFWYAPE 190
Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
            +   +  S  SDV+S+GVVL EL T
Sbjct: 191  SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 31   VIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFK---NRELQIMRKLDHCNIVRLRYF 85
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 86   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 144
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 145  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 199
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 200  GATDYTSSIDVWSAGCVLAELL 221

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 20/223 (8%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGS 860
            G   +L ++ + TE L    V+G G  G V+K    P          +K +  +  ++  
Sbjct: 1    GAMKVLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF 59
Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPTL 916
             ++   +  IG + H ++VRL          ++  +Y+  GSL D +     ++ P   L
Sbjct: 60   QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLL 118
Query: 917  EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
             W V+                  +  +VHR++   N+LL S  +  ++DFG+A LL    
Sbjct: 119  NWGVQIAKGMYYLE---------EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                       I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 170  KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 27   VIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFK---NRELQIMRKLDHCNIVRLRYF 81
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 82   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 140
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 141  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 195
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 196  GATDYTSSIDVWSAGCVLAELL 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 827  IGRGAHGIVYKASLG-PNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            IG GA+G+V  A         A+KK+  AF        ++ RE++ +   +H N++ ++D
Sbjct: 62   IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHFKHDNIIAIKD 120
Query: 884  FWLRKDCGI-------IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
              LR            ++   ME+  L  ++HS + P TLE +VRY +            
Sbjct: 121  I-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHS-SQPLTLE-HVRYFLYQLLRGLKYMHS 176
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI--SVVGTIGYIAPE 994
                  ++HRD+KP N+L++   E  I DFG+A+ L  SPA         V T  Y APE
Sbjct: 177  AQ----VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 995  NAFTTAKSKES-DVYSYGVVLLELITRKK 1022
               +  +  ++ D++S G +  E++ R++
Sbjct: 233  LMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 40   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 94
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 95   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 153
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 154  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 208
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 209  GATDYTSSIDVWSAGCVLAELL 230

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 10/195 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
            +G GA G+V++ +          K     H+    ++++EIQT+  +RH  LV L D + 
Sbjct: 165  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 887  RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHR 946
              +  +++Y +M  G L + +       + +  V Y                     VH 
Sbjct: 225  DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHL 279
Query: 947  DIKPENILLDSEM--EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            D+KPENI+  ++   E  + DFG+   LD  P  +  ++  GT  + APE A        
Sbjct: 280  DLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVT-TGTAEFAAPEVAEGKPVGYY 336
Query: 1005 SDVYSYGVVLLELIT 1019
            +D++S GV+   L++
Sbjct: 337  TDMWSVGVLSYILLS 351

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 46   VIGNGSFGVVYQAKLCDSGELVAIKKVL--QDKRFK---NRELQIMRKLDHCNIVRLRYF 100
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 101  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 159
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 160  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 214
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 215  GATDYTSSIDVWSAGCVLAELL 236

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 20/228 (8%)
Query: 801  IPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRG 855
            I + E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L    
Sbjct: 5    IRSGEAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SIT 911
              + +  +  E   +  + + ++ RL    L     +I  + M  G L D +     +I 
Sbjct: 64   SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG 122
Query: 912  PPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
                L W V+                  D  +VHRD+   N+L+ +     I+DFG AKL
Sbjct: 123  SQYLLNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGRAKL 173
Query: 972  LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            L        +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 2    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I     
Sbjct: 61   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYL 119
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 120  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 171  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 18/241 (7%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKIRH 875
            E+ +    +G+G  G VY A    +      K+ F+    K G    ++RE++    +RH
Sbjct: 12   EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             N++RL  ++       ++  Y   G++   L  ++           +            
Sbjct: 72   PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------RFDEQRTATYITELANA 124
Query: 936  XXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
               C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S  + ++ GT+ Y+ PE
Sbjct: 125  LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRT-TLCGTLDYLPPE 180
Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEINDI 1051
                    ++ D++S GV+  E +      +  +Y+E    +  V   + D  TE   D+
Sbjct: 181  MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDL 240
Query: 1052 V 1052
            +
Sbjct: 241  I 241

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGS 860
             P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + +
Sbjct: 7    APNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN 65
Query: 861  LSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPTL 916
              +  E   +  + + ++ RL    L     +IM + M  G L D +     +I     L
Sbjct: 66   KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLL 124
Query: 917  EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
             W V+                  D  +VHRD+   N+L+ +     I+DFG AKLL    
Sbjct: 125  NWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEE 175
Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 176  KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 35   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 89
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 90   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 148
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 149  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 203
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 204  GATDYTSSIDVWSAGCVLAELL 225

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 39   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 94   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 152
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 153  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 207
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 208  GATDYTSSIDVWSAGCVLAELL 229

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 55   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 109
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 110  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 168
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 169  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 223
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 224  GATDYTSSIDVWSAGCVLAELL 245

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 8/199 (4%)
Query: 827  IGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG GA+G+V  A         A+KK++   H+       REIQ + + RH N++ + D  
Sbjct: 51   IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN-VRYKIXXXXXXXXXXXXXDCDPPIV 944
                   +   Y+    +   L+ +     L  + + Y +             +    ++
Sbjct: 111  RASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN----VL 166
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS-VVGTIGYIAPENAF-TTAKS 1002
            HRD+KP N+L+++  +  I DFG+A++ D     T  ++  V T  Y APE    +   +
Sbjct: 167  HRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYT 226
Query: 1003 KESDVYSYGVVLLELITRK 1021
            K  D++S G +L E+++ +
Sbjct: 227  KSIDIWSVGCILAEMLSNR 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/303 (22%), Positives = 129/303 (42%), Gaps = 27/303 (8%)
Query: 802  PAQE-GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGS 860
            PA E  P++  K+ ++   +L      G G  G V      P      +++A +  K  S
Sbjct: 9    PATEVDPTHFEKRFLKRIRDL------GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES 62
Query: 861  -----LSMKREIQTIGKIRHRNLVRLEDFWLRKDCG---IIMYRYMENGSLRDVLHSITP 912
                   +K+EI+ +  + H N+V+ +     +D G    ++  ++ +GSL++ L     
Sbjct: 63   GGNHIADLKKEIEILRNLYHENIVKYKGI-CTEDGGNGIKLIMEFLPSGSLKEYLPKNKN 121
Query: 913  PPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
               L+  ++Y +                   VHRD+   N+L++SE +  I DFG+ K +
Sbjct: 122  KINLKQQLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176
Query: 973  DKSPASTTSISVVGT-IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            +      T      + + + APE    +     SDV+S+GV L EL+T   +        
Sbjct: 177  ETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236
Query: 1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
              ++G      + T  +N     +L E   +    +   +V  +  +C E +PSNR + +
Sbjct: 237  LKMIGPTHGQMTVTRLVN-----TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQ 291
Query: 1092 DVV 1094
            +++
Sbjct: 292  NLI 294

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 61   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 116  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 174
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 175  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 229
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 230  GATDYTSSIDVWSAGCVLAELL 251

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 63   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 117
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 118  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 176
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 177  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 231
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 232  GATDYTSSIDVWSAGCVLAELL 253

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 65   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 119
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 120  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 178
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 179  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 233
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 234  GATDYTSSIDVWSAGCVLAELL 255

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 61   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 116  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 174
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 175  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 229
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 230  GATDYTSSIDVWSAGCVLAELL 251

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 106  VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 160
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 161  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 219
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 220  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 274
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 275  GATDYTSSIDVWSAGCVLAELL 296

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKIRHRNLVRLED 883
            +G+G  G VY A    N      K+ F+    K G    ++REI+    +RH N++R+ +
Sbjct: 22   LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLH---------SITPPPTLEWNVRYKIXXXXXXXXXX 934
            ++  +    +M  +   G L   L          S T    L   + Y            
Sbjct: 82   YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY------------ 129
Query: 935  XXXDC-DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
                C +  ++HRDIKPEN+L+  + E  I+DFG +     +P S     + GT+ Y+ P
Sbjct: 130  ----CHERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAP-SLRRRXMCGTLDYLPP 181
Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKKALD-PSYKE 1030
            E        ++ D++  GV+  E +      D PS+ E
Sbjct: 182  EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 826  VIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L  +  + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 39   VIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIVRLRYF 93
Query: 885  WL----RKDCGII--MYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXD 938
            +     +KD   +  +  Y+     R   H      TL   +  K+              
Sbjct: 94   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-IYVKLYMYQLFRSLAYIHS 152
Query: 939  CDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 153  FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSXICSRYYRAPELIF 207
Query: 998  -TTAKSKESDVYSYGVVLLELI 1018
              T  +   DV+S G VL EL+
Sbjct: 208  GATDYTSSIDVWSAGCVLAELL 229

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 34/218 (15%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKIRHRNLVRLED 883
            +G+G  G VY A    N      K+ F+    K G    ++REI+    +RH N++R+ +
Sbjct: 23   LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLH---------SITPPPTLEWNVRYKIXXXXXXXXXX 934
            ++  +    +M  +   G L   L          S T    L   + Y            
Sbjct: 83   YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY------------ 130
Query: 935  XXXDC-DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
                C +  ++HRDIKPEN+L+  + E  I+DFG +     +P S     + GT+ Y+ P
Sbjct: 131  ----CHERKVIHRDIKPENLLMGYKGELKIADFGWSV---HAP-SLRRRXMCGTLDYLPP 182
Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKKALD-PSYKE 1030
            E        ++ D++  GV+  E +      D PS+ E
Sbjct: 183  EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 220

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHG--IVYKASLGPNAVFAVKKLAFR--GHKRGSLSMKREIQTIGKI 873
            ++    + V+G+G+ G  I+ K  +      AVK ++ R    K    S+ RE+Q + ++
Sbjct: 25   SDRYKGQRVLGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
             H N+++L +F+  K    ++      G L D +  I+     E +    I         
Sbjct: 84   DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITY 141
Query: 934  XXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGY 990
                     IVHRD+KPEN+LL+S+ +     I DFG++   +   AS      +GT  Y
Sbjct: 142  MHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYY 194
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE    T   K  DV+S GV+L  L++
Sbjct: 195  IAPEVLHGTYDEK-CDVWSTGVILYILLS 222

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 87/195 (44%), Gaps = 10/195 (5%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
            +G GA G+V++ +          K     H+    ++++EIQT+  +RH  LV L D + 
Sbjct: 59   LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 887  RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHR 946
              +  +++Y +M  G L + +       + +  V Y                     VH 
Sbjct: 119  DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-----YVHL 173
Query: 947  DIKPENILLDSEM--EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            D+KPENI+  ++   E  + DFG+   LD  P  +  ++  GT  + APE A        
Sbjct: 174  DLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVT-TGTAEFAAPEVAEGKPVGYY 230
Query: 1005 SDVYSYGVVLLELIT 1019
            +D++S GV+   L++
Sbjct: 231  TDMWSVGVLSYILLS 245

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHGIVY----KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI 873
            ++    + V+G+G+ G V     K +    AV  + K   +  K    S+ RE+Q + ++
Sbjct: 49   SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQL 107
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
             H N+++L +F+  K    ++      G L D +  I+     E +    I         
Sbjct: 108  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITY 165
Query: 934  XXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGY 990
                     IVHRD+KPEN+LL+S+ +     I DFG++   +   AS      +GT  Y
Sbjct: 166  MHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYY 218
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE    T   K  DV+S GV+L  L++
Sbjct: 219  IAPEVLHGTYDEK-CDVWSTGVILYILLS 246

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHGIVY----KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI 873
            ++    + V+G+G+ G V     K +    AV  + K   +  K    S+ RE+Q + ++
Sbjct: 48   SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQL 106
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
             H N+++L +F+  K    ++      G L D +  I+     E +    I         
Sbjct: 107  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITY 164
Query: 934  XXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGY 990
                     IVHRD+KPEN+LL+S+ +     I DFG++   +   AS      +GT  Y
Sbjct: 165  MHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKMKDKIGTAYY 217
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE    T   K  DV+S GV+L  L++
Sbjct: 218  IAPEVLHGTYDEK-CDVWSTGVILYILLS 245

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 59/224 (26%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 2    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +     +I     
Sbjct: 61   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 119
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG AKLL   
Sbjct: 120  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 170
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 171  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 19/265 (7%)
Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS-LGPNAVFA----VKKLAFRGH 856
            PA+E P  L+               +G+G     ++ S      VFA     K L  + H
Sbjct: 2    PAKEIPEVLVDPRSRRRYVRGR--FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH 59
Query: 857  KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL 916
            +R  +SM  EI     + H+++V    F+   D   ++       SL + LH      T 
Sbjct: 60   QREKMSM--EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT- 115
Query: 917  EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
            E   RY +                  ++HRD+K  N+ L+ ++E  I DFG+A  ++   
Sbjct: 116  EPEARYYLRQIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD- 170
Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVG 1036
                  ++ GT  YIAPE       S E DV+S G ++  L+  K   + S  + T  + 
Sbjct: 171  -GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLR 228
Query: 1037 WVRSVWSDTEEINDIVDLSLMEEML 1061
              ++ +S  + IN +   SL+++ML
Sbjct: 229  IKKNEYSIPKHINPVA-ASLIQKML 252

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/297 (21%), Positives = 126/297 (42%), Gaps = 26/297 (8%)
Query: 807  PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGS-----L 861
            P++  K+ ++   +L      G G  G V      P      +++A +  K  S      
Sbjct: 3    PTHFEKRFLKRIRDL------GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 56
Query: 862  SMKREIQTIGKIRHRNLVRLEDFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEW 918
             +K+EI+ +  + H N+V+ +     +D G    ++  ++ +GSL++ L        L+ 
Sbjct: 57   DLKKEIEILRNLYHENIVKYKGI-CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 115
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             ++Y +                   VHRD+   N+L++SE +  I DFG+ K ++     
Sbjct: 116  QLKYAVQICKGMDYLGSRQ-----YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEX 170
Query: 979  TTSISVVGT-IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGW 1037
             T      + + + APE    +     SDV+S+GV L EL+T   +          ++G 
Sbjct: 171  XTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 230
Query: 1038 VRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094
                 + T  +N     +L E   +    +   +V  +  +C E +PSNR + ++++
Sbjct: 231  THGQMTVTRLVN-----TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 282

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 19/265 (7%)
Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS-LGPNAVFA----VKKLAFRGH 856
            PA+E P  L+               +G+G     ++ S      VFA     K L  + H
Sbjct: 2    PAKEIPEVLVDPRSRRRYVRGR--FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH 59
Query: 857  KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL 916
            +R  +SM  EI     + H+++V    F+   D   ++       SL + LH      T 
Sbjct: 60   QREKMSM--EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT- 115
Query: 917  EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
            E   RY +                  ++HRD+K  N+ L+ ++E  I DFG+A  ++   
Sbjct: 116  EPEARYYLRQIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD- 170
Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVG 1036
                  ++ GT  YIAPE       S E DV+S G ++  L+  K   + S  + T  + 
Sbjct: 171  -GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLR 228
Query: 1037 WVRSVWSDTEEINDIVDLSLMEEML 1061
              ++ +S  + IN +   SL+++ML
Sbjct: 229  IKKNEYSIPKHINPVA-ASLIQKML 252

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 57/241 (23%), Positives = 104/241 (43%), Gaps = 18/241 (7%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKIRH 875
            E+ +    +G+G  G VY A    +      K+ F+    K G    ++RE++    +RH
Sbjct: 12   EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             N++RL  ++       ++  Y   G++   L  ++           +            
Sbjct: 72   PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------RFDEQRTATYITELANA 124
Query: 936  XXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
               C    ++HRDIKPEN+LL S  E  I+DFG +     +P+S    ++ GT+ Y+ PE
Sbjct: 125  LSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRD-TLCGTLDYLPPE 180
Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDP-SYKERTDIVGWVRSVWSD--TEEINDI 1051
                    ++ D++S GV+  E +      +  +Y+E    +  V   + D  TE   D+
Sbjct: 181  MIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDL 240
Query: 1052 V 1052
            +
Sbjct: 241  I 241

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 112/265 (42%), Gaps = 19/265 (7%)
Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS-LGPNAVFA----VKKLAFRGH 856
            PA+E P  L+               +G+G     ++ S      VFA     K L  + H
Sbjct: 6    PAKEIPEVLVDPRSRRRYVRGR--FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH 63
Query: 857  KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL 916
            +R  +SM  EI     + H+++V    F+   D   ++       SL + LH      T 
Sbjct: 64   QREKMSM--EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT- 119
Query: 917  EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
            E   RY +                  ++HRD+K  N+ L+ ++E  I DFG+A  ++   
Sbjct: 120  EPEARYYLRQIVLGCQYLHRNR----VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD- 174
Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVG 1036
                  ++ GT  YIAPE       S E DV+S G ++  L+  K   + S  + T  + 
Sbjct: 175  -GERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLR 232
Query: 1037 WVRSVWSDTEEINDIVDLSLMEEML 1061
              ++ +S  + IN +   SL+++ML
Sbjct: 233  IKKNEYSIPKHINPVA-ASLIQKML 256

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHGIVY----KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI 873
            ++    + V+G+G+ G V     K +    AV  + K   +  K    S+ RE+Q + ++
Sbjct: 25   SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQL 83
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX 933
             H N+ +L +F+  K    ++      G L D +  I+     E +    I         
Sbjct: 84   DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVDAARIIRQVLSGITY 141
Query: 934  XXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGY 990
                     IVHRD+KPEN+LL+S+ +     I DFG++   +   AS      +GT  Y
Sbjct: 142  XHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE---ASKKXKDKIGTAYY 194
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE    T   K  DV+S GV+L  L++
Sbjct: 195  IAPEVLHGTYDEK-CDVWSTGVILYILLS 222

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 100/226 (44%), Gaps = 15/226 (6%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G +G V+KA +   + + A+K++       G  S   REI  + +++H+N+VRL D 
Sbjct: 10   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPP--PTLEWNVRYKIXXXXXXXXXXXXXDCDPP 942
             L  D  + +     +  L+    S      P +  +  +++                  
Sbjct: 70   -LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN------- 121
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAK 1001
            ++HRD+KP+N+L++   E  ++DFG+A+     P    S  VV T+ Y  P+  F     
Sbjct: 122  VLHRDLKPQNLLINRNGELKLADFGLARAFG-IPVRCYSAEVV-TLWYRPPDVLFGAKLY 179
Query: 1002 SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            S   D++S G +  EL    + L P       +    R + + TEE
Sbjct: 180  STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEE 225

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + L     IG+G  G V       N V AVK +      +  L+   E   + ++RH NL
Sbjct: 12   KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQAFLA---EASVMTQLRHSNL 67
Query: 879  VRLEDFWLRKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            V+L    + +  G+ I+  YM  GSL D L S      L  +   K              
Sbjct: 68   VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +     VHRD+   N+L+  +    +SDFG+ K      AS+T  +    + + APE   
Sbjct: 127  N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 178
Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
              A S +SDV+S+G++L E+ +
Sbjct: 179  EAAFSTKSDVWSFGILLWEIYS 200

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 19/223 (8%)
Query: 805  EGPSYLLKQVIEA-TENLNAKHVIGRGAHG--IVYKASLGPNAVFAVKKLAFR--GHKRG 859
            +GP   ++      ++    + V+G+G+ G  I+ K  +      AVK ++ R    K  
Sbjct: 17   QGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQEC-AVKVISKRQVKQKTD 75
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
              S+ RE+Q + ++ H N+++L +F+  K    ++      G L D +  I+     E +
Sbjct: 76   KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--ISRKRFSEVD 133
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSP 976
                I                  IVHRD+KPEN+LL+S+ +     I DFG++   +   
Sbjct: 134  AARIIRQVLSGITYMHKNK----IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--- 186
Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            AS      +GT  YIAPE    T   K  DV+S GV+L  L++
Sbjct: 187  ASKKMKDKIGTAYYIAPEVLHGTYDEK-CDVWSTGVILYILLS 228

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 67/289 (23%), Positives = 117/289 (40%), Gaps = 37/289 (12%)
Query: 820  NLNAKHVIGRGAHGIVYKA---SLGPNA---VFAVKKLAFRGHKRGSLSMKREIQTIGKI 873
            N+  K  +G GA G V+ A   +L P     + AVK L             RE + +  +
Sbjct: 14   NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK-DASDNARKDFHREAELLTNL 72
Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKI 924
            +H ++V+     +  D  I+++ YM++G L   L +  P         PPT     + ++
Sbjct: 73   QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTEL--TQSQM 130
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
                               VHRD+   N L+   +   I DFG+++ +  +         
Sbjct: 131  LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044
            +  I ++ PE+      + ESDV+S GVVL E+ T  K   P Y+             S+
Sbjct: 191  MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK--QPWYQ------------LSN 236
Query: 1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             E I  I    +++       R    +V  + L C +++P  R N++ +
Sbjct: 237  NEVIECITQGRVLQRP-----RTCPQEVYELMLGCWQREPHMRKNIKGI 280

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 96/224 (42%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E  + +L ++ + TE L    V+G G  G V+K    P          +K +  +  ++ 
Sbjct: 18   EKANKVLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS 76
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPT 915
              ++   +  IG + H ++VRL          ++  +Y+  GSL D +     ++ P   
Sbjct: 77   FQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLL 135
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                     +VHR++   N+LL S  +  ++DFG+A LL   
Sbjct: 136  LNWGVQIAKGMYYLEEHG---------MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 186
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                        I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 187  DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 18/280 (6%)
Query: 824  KHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            + VIG GA  +V  A   P     A+K++     +     + +EIQ + +  H N+V   
Sbjct: 15   QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 74
Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNV--RYKIXXXXXXXXXXXXXDCD 940
              ++ KD   ++ + +  GS+ D++  I      +  V     I                
Sbjct: 75   TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 134
Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS---ISVVGTIGYIAPE-NA 996
               +HRD+K  NILL  +    I+DFG++  L      T +    + VGT  ++APE   
Sbjct: 135  NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 194
Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056
                   ++D++S+G+  +EL T        Y +   +   + ++ +D   +   V    
Sbjct: 195  QVRGYDFKADIWSFGITAIELATGAA----PYHKYPPMKVLMLTLQNDPPSLETGVQDKE 250
Query: 1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            M +    S R       +++L C +K P  RP   +++R 
Sbjct: 251  MLKKYGKSFRK------MISL-CLQKDPEKRPTAAELLRH 283

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 18/280 (6%)
Query: 824  KHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            + VIG GA  +V  A   P     A+K++     +     + +EIQ + +  H N+V   
Sbjct: 20   QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNV--RYKIXXXXXXXXXXXXXDCD 940
              ++ KD   ++ + +  GS+ D++  I      +  V     I                
Sbjct: 80   TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS---ISVVGTIGYIAPE-NA 996
               +HRD+K  NILL  +    I+DFG++  L      T +    + VGT  ++APE   
Sbjct: 140  NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056
                   ++D++S+G+  +EL T        Y +   +   + ++ +D   +   V    
Sbjct: 200  QVRGYDFKADIWSFGITAIELATGAA----PYHKYPPMKVLMLTLQNDPPSLETGVQDKE 255
Query: 1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
            M +    S R       +++L C +K P  RP   +++R 
Sbjct: 256  MLKKYGKSFRK------MISL-CLQKDPEKRPTAAELLRH 288

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 818  TENLNAKHVIGRGAHGIVYKASLGPNA------VFAVKKLAFRGHKRGSLSMKREIQTIG 871
            ++N + K  +G+GA  +V +             +   KKL+ R  ++    ++RE +   
Sbjct: 5    SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK----LEREARICR 60
Query: 872  KIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
            K++H N+VRL D    +    +++  +  G L + +  +      E +  + I       
Sbjct: 61   KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESI 118
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTI 988
                       IVHR++KPEN+LL S+ +     ++DFG+A  ++ S A        GT 
Sbjct: 119  AYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 171
Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            GY++PE       SK  D+++ GV+L  L+
Sbjct: 172  GYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 818  TENLNAKHVIGRGAHGIVYKASLGPNA------VFAVKKLAFRGHKRGSLSMKREIQTIG 871
            ++N + K  +G+GA  +V +             +   KKL+ R  ++    ++RE +   
Sbjct: 4    SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK----LEREARICR 59
Query: 872  KIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
            K++H N+VRL D    +    +++  +  G L + +  +      E +  + I       
Sbjct: 60   KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESI 117
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTI 988
                       IVHR++KPEN+LL S+ +     ++DFG+A  ++ S A        GT 
Sbjct: 118  AYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 170
Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            GY++PE       SK  D+++ GV+L  L+
Sbjct: 171  GYLSPEVLKKDPYSKPVDIWACGVILYILL 200

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 818  TENLNAKHVIGRGAHGIVYKASLGPNA------VFAVKKLAFRGHKRGSLSMKREIQTIG 871
            ++N + K  +G+GA  +V +             +   KKL+ R  ++    ++RE +   
Sbjct: 5    SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK----LEREARICR 60
Query: 872  KIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
            K++H N+VRL D    +    +++  +  G L + +  +      E +  + I       
Sbjct: 61   KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAREFYSEADASHCIQQILESI 118
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTI 988
                       IVHR++KPEN+LL S+ +     ++DFG+A  ++ S A        GT 
Sbjct: 119  AYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTP 171
Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            GY++PE       SK  D+++ GV+L  L+
Sbjct: 172  GYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 30/235 (12%)
Query: 811  LKQVIEATENLNAKHV------IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK 864
            +KQ    T +LN +        +G GA G VYKA     +V A  K+     +       
Sbjct: 23   MKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYM 82
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
             EI  +    H N+V+L D +  ++   I+  +   G++  V+  +  P T       +I
Sbjct: 83   VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT-----ESQI 137
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS- 983
                           D  I+HRD+K  NIL   + +  ++DFG+      S  +T  I  
Sbjct: 138  QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV------SAKNTRXIQR 191
Query: 984  ---VVGTIGYIAPENAF-TTAKSK----ESDVYSYGVVLLELITRKKALDPSYKE 1030
                +GT  ++APE     T+K +    ++DV+S G+ L+E+      ++P + E
Sbjct: 192  RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM----AEIEPPHHE 242

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+G GA G VYK    P         A+K+L      + 
Sbjct: 4    EAPNQALLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I     
Sbjct: 63   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 121
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG AKLL   
Sbjct: 122  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 173  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 19/211 (9%)
Query: 827  IGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +GRGA  IVY+    G    +A+K L     K+    ++ EI  + ++ H N+++L++ +
Sbjct: 61   LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK---IVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
                   ++   +  G L D +  +      E +    +               +  IVH
Sbjct: 118  ETPTEISLVLELVTGGELFDRI--VEKGYYSERDAADAVKQILEAVAYLH----ENGIVH 171
Query: 946  RDIKPENILLDS---EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            RD+KPEN+L  +   +    I+DFG++K+++      T   V GT GY APE     A  
Sbjct: 172  RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGTPGYCAPEILRGCAYG 228
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTD 1033
             E D++S G++   L+      +P Y ER D
Sbjct: 229  PEVDMWSVGIITYILLC---GFEPFYDERGD 256

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 7    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 64   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 121  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 174  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 230  PWKKIDSAPLALLHKILVEN 249

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 95/226 (42%), Gaps = 44/226 (19%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKI-- 873
              E+L     IGRGA+G V K    P+  + AVK++      R ++  K + Q +  +  
Sbjct: 20   TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI------RSTVDEKEQKQLLMDLDV 73
Query: 874  --RHRNLVRLEDFW---LRK-DCGIIM----------YRYMENGSLRDVLHSITPPPTLE 917
              R  +   +  F+    R+ DC I M          Y+Y+ +     VL  + P   L 
Sbjct: 74   VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYS-----VLDDVIPEEILG 128
Query: 918  WNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA 977
                 KI             +    I+HRDIKP NILLD      + DFGI+  L  S A
Sbjct: 129  -----KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181
Query: 978  STTSISVVGTIGYIAPENAFTTAKSK----ESDVYSYGVVLLELIT 1019
             T      G   Y+APE    +A  +     SDV+S G+ L EL T
Sbjct: 182  KTRD---AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 7    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 64   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 121  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 174  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 230  PWKKIDSAPLALLHKILVEN 249

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
             E+ +    +G GA+G V  A   +   AV AVK +  +       ++K+EI     + H
Sbjct: 6    VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXXX 931
             N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++       
Sbjct: 65   ENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                       I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+
Sbjct: 122  HGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 992  APENAFTTAKSKES-DVYSYGVVLLELIT 1019
            APE         E  DV+S G+VL  ++ 
Sbjct: 175  APELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
             E+ +    +G GA+G V  A   +   AV AVK +  +       ++K+EI     + H
Sbjct: 6    VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXXX 931
             N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++       
Sbjct: 65   ENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                       I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+
Sbjct: 122  HGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 992  APENAFTTAKSKES-DVYSYGVVLLELIT 1019
            APE         E  DV+S G+VL  ++ 
Sbjct: 175  APELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
             E+ +    +G GA+G V  A   +   AV AVK +  +       ++K+EI     + H
Sbjct: 6    VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXXX 931
             N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++       
Sbjct: 65   ENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                       I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+
Sbjct: 122  HGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 992  APENAFTTAKSKES-DVYSYGVVLLELIT 1019
            APE         E  DV+S G+VL  ++ 
Sbjct: 175  APELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 20/228 (8%)
Query: 801  IPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRG 855
            I + E P+  L ++++ TE    K V+  GA G VYK    P         A+K+L    
Sbjct: 5    IRSGEAPNQALLRILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----IT 911
              + +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I 
Sbjct: 64   SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG 122
Query: 912  PPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
                L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKL
Sbjct: 123  SQYLLNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173
Query: 972  LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            L        +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
             E+ +    +G GA+G V  A   +   AV AVK +  +       ++K+EI     + H
Sbjct: 5    VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNH 63
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXXX 931
             N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++       
Sbjct: 64   ENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                       I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+
Sbjct: 121  HGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 992  APENAFTTAKSKES-DVYSYGVVLLELIT 1019
            APE         E  DV+S G+VL  ++ 
Sbjct: 174  APELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 818  TENLNAKHVIGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
             E+ +    +G GA+G V  A   +   AV AVK +  +       ++K+EI     + H
Sbjct: 6    VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXXX 931
             N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++       
Sbjct: 65   ENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                       I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+
Sbjct: 122  HGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 992  APENAFTTAKSKES-DVYSYGVVLLELIT 1019
            APE         E  DV+S G+VL  ++ 
Sbjct: 175  APELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 10/157 (6%)
Query: 863  MKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY 922
            +KREIQ +   RH ++++L           ++  Y+  G L D +        +E    +
Sbjct: 58   IKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF 117
Query: 923  KIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
            +                   +VHRD+KPEN+LLD+ M   I+DFG++ ++        S 
Sbjct: 118  QQILSAVDYCHRHM------VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS- 170
Query: 983  SVVGTIGYIAPEN-AFTTAKSKESDVYSYGVVLLELI 1018
               G+  Y APE  +       E D++S GV+L  L+
Sbjct: 171  --CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 20/224 (8%)
Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-----FAVKKLAFRGHKRG 859
            E P+  L ++++ TE    K V+  GA G VYK    P         A+K+L      + 
Sbjct: 2    EAPNQALLRILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPT 915
            +  +  E   +  + + ++ RL    L     +I  + M  G L D +      I     
Sbjct: 61   NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYL 119
Query: 916  LEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L W V+                  D  +VHRD+   N+L+ +     I+DFG+AKLL   
Sbjct: 120  LNWCVQIAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
Query: 976  PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 +      I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 171  EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 33/119 (27%), Positives = 64/119 (53%), Gaps = 17/119 (14%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPENI+L+ +    ++DFG+ K  +     T + +  GTI Y+APE    +  +
Sbjct: 142  IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 1003 KESDVYSYGVVLLELIT---------RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052
            +  D +S G ++ +++T         RKK +D   K + ++  ++      T+E  D++
Sbjct: 200  RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL------TQEARDLL 252

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 827  IGRGAHGIVYK-ASLGPNAVFA-----VKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+GA  +V +     P   +A      KKL+ R H++    ++RE +    ++H N+VR
Sbjct: 39   LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQK----LEREARICRLLKHPNIVR 94
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCD 940
            L D    +    +++  +  G L + +  +      E +  + I             D  
Sbjct: 95   LHDSISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIHQILESVNHIHQHD-- 150
Query: 941  PPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
              IVHRD+KPEN+LL S+ +     ++DFG+A  ++            GT GY++PE   
Sbjct: 151  --IVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGEQQAWFGFAGTPGYLSPEVLR 206
Query: 998  TTAKSKESDVYSYGVVLLELI 1018
                 K  D+++ GV+L  L+
Sbjct: 207  KDPYGKPVDIWACGVILYILL 227

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 7    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 64   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 121  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 174  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 230  PWKKIDSAPLALLHKILVEN 249

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 7    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 64   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 121  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 174  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 230  PWKKIDSAPLALLHKILVEN 249

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 5    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 62   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 119  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 172  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 228  PWKKIDSAPLALLHKILVEN 247

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 31/85 (36%), Positives = 48/85 (56%), Gaps = 6/85 (7%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAK--LLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
            I++RD+K +N++LDSE    I+DFG+ K  ++D      T+    GT  YIAPE      
Sbjct: 141  IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD----GVTTREFCGTPDYIAPEIIAYQP 196
Query: 1001 KSKESDVYSYGVVLLELITRKKALD 1025
              K  D ++YGV+L E++  +   D
Sbjct: 197  YGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 17/240 (7%)
Query: 827  IGRGAHGIVYKAS-LGPNAVFA----VKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G+G     ++ S      VFA     K L  + H+R  +SM  EI     + H+++V  
Sbjct: 49   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVGF 106
Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDP 941
              F+   D   ++       SL + LH      T E   RY +                 
Sbjct: 107  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT-EPEARYYLRQIVLGCQYLHRNR--- 161
Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             ++HRD+K  N+ L+ ++E  I DFG+A  ++          + GT  YIAPE       
Sbjct: 162  -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGH 218
Query: 1002 SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEML 1061
            S E DV+S G ++  L+  K   + S  + T  +   ++ +S  + IN +   SL+++ML
Sbjct: 219  SFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEYSIPKHINPVA-ASLIQKML 276

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E+ +    +G GA+G V    L  N V     AVK +  +       ++K+EI     + 
Sbjct: 6    EDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIXXXXXX 930
            H N+V+   F+  +  G I Y ++E  S  ++   I P    P        +++      
Sbjct: 63   HENVVK---FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                        I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y
Sbjct: 120  LHGIG-------ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 991  IAPENAFTTAKSKE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSD 1044
            +APE      K +E      DV+S G+VL  ++  +   D       +   W  +  + +
Sbjct: 173  VAPE----LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 228
Query: 1045 TEEINDIVDLSLMEEMLVSS 1064
              +  D   L+L+ ++LV +
Sbjct: 229  PWKKIDSAPLALLHKILVEN 248

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 17/240 (7%)
Query: 827  IGRGAHGIVYKAS-LGPNAVFA----VKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G+G     ++ S      VFA     K L  + H+R  +SM  EI     + H+++V  
Sbjct: 47   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVGF 104
Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDP 941
              F+   D   ++       SL + LH      T E   RY +                 
Sbjct: 105  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT-EPEARYYLRQIVLGCQYLHRNR--- 159
Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             ++HRD+K  N+ L+ ++E  I DFG+A  ++          + GT  YIAPE       
Sbjct: 160  -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--GERKKVLCGTPNYIAPEVLSKKGH 216
Query: 1002 SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEML 1061
            S E DV+S G ++  L+  K   + S  + T  +   ++ +S  + IN +   SL+++ML
Sbjct: 217  SFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEYSIPKHINPVA-ASLIQKML 274

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            +L+++ EI+ + K+ H  ++++++F+  +D  I++   ME G L D +  +      E  
Sbjct: 198  ALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV--VGNKRLKEAT 254
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSP 976
             +                  +  I+HRD+KPEN+LL S+ E     I+DFG +K+L ++ 
Sbjct: 255  CKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 310
Query: 977  ASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033
               T   + GT  Y+APE   +  T   ++  D +S GV+L   ++      P  + RT 
Sbjct: 311  LMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS---GYPPFSEHRTQ 364
Query: 1034 I----------VGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
            +            ++  VW++  E      L L++++LV
Sbjct: 365  VSLKDQITSGKYNFIPEVWAEVSEKA----LDLVKKLLV 399

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 818  TENLNAKHVIGRGAHGIV----YKASLGPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGK 872
             E+ +   VIGRGA G V    +KAS     V+A+K L+ F   KR   +   E + I  
Sbjct: 74   AEDYDVVKVIGRGAFGEVQLVRHKAS---QKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 873  IRHRNLVRLEDFWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
              +   V       + D  + M   YM  G L +++ +   P   +W   Y         
Sbjct: 131  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE--KWAKFYTAEVVLALD 188
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                       ++HRD+KP+N+LLD      ++DFG    +D++       + VGT  YI
Sbjct: 189  AIHSMG-----LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVHCDTAVGTPDYI 242
Query: 992  APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            +PE            +E D +S GV L E++ 
Sbjct: 243  SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV 274

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 17/240 (7%)
Query: 827  IGRGAHGIVYKAS-LGPNAVFA----VKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            +G+G     ++ S      VFA     K L  + H+R  +SM  EI     + H+++V  
Sbjct: 23   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVVGF 80
Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDP 941
              F+   D   ++       SL + LH      T E   RY +                 
Sbjct: 81   HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALT-EPEARYYLRQIVLGCQYLHRNR--- 135
Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             ++HRD+K  N+ L+ ++E  I DFG+A  ++        +   GT  YIAPE       
Sbjct: 136  -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKKGH 192
Query: 1002 SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEML 1061
            S E DV+S G ++  L+  K   + S  + T  +   ++ +S  + IN +   SL+++ML
Sbjct: 193  SFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEYSIPKHINPVAA-SLIQKML 250

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E++     +G G  G V+      +   AVK L     K G++S++    E   +  ++H
Sbjct: 12   ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-----KPGTMSVQAFLEEANLMKTLQH 66
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS-----ITPPPTLEWNVRYKIXXXXXX 930
              LVRL     +++   I+  +M  GSL D L S     +  P  ++++ +         
Sbjct: 67   DKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 126
Query: 931  XXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
                         +HRD++  N+L+   +   I+DFG+A++++ +   T        I +
Sbjct: 127  RKN---------YIHRDLRAANVLVSESLMCKIADFGLARVIEDN-EYTAREGAKFPIKW 176
Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
             APE       + +S+V+S+G++L E++T  K   P
Sbjct: 177  TAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYP 212

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 20/218 (9%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGSLSMKR 865
            L ++++ TE    K V+G GA G VYK    P         A+K+L      + +  +  
Sbjct: 2    LLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPTLEWNVR 921
            E   +  + + ++ RL    L     +I  + M  G L D +     +I     L W V+
Sbjct: 61   EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 119
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
                              D  +VHRD+   N+L+ +     I+DFG+AKLL        +
Sbjct: 120  IAKGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                  I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 171  EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 39/222 (17%)
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            +L+++ EI+ + K+ H  ++++++F+  +D  I++   ME G L D +           N
Sbjct: 65   ALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVG---------N 114
Query: 920  VRYK---IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLD 973
             R K                   +  I+HRD+KPEN+LL S+ E     I+DFG +K+L 
Sbjct: 115  KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 174
Query: 974  KSPASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
            ++    T   + GT  Y+APE   +  T   ++  D +S GV+L   ++      P  + 
Sbjct: 175  ETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS---GYPPFSEH 228
Query: 1031 RTDI----------VGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
            RT +            ++  VW++  E      L L++++LV
Sbjct: 229  RTQVSLKDQITSGKYNFIPEVWAEVSEKA----LDLVKKLLV 266

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 33/119 (27%), Positives = 63/119 (52%), Gaps = 17/119 (14%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPENI+L+ +    ++DFG+ K  +     T +    GTI Y+APE    +  +
Sbjct: 142  IIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCGTIEYMAPEILMRSGHN 199
Query: 1003 KESDVYSYGVVLLELIT---------RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052
            +  D +S G ++ +++T         RKK +D   K + ++  ++      T+E  D++
Sbjct: 200  RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL------TQEARDLL 252

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPEN+LLD +    ISD G+A  ++     T +    GT G++APE        
Sbjct: 310  IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 1003 KESDVYSYGVVLLELITRK 1021
               D ++ GV L E+I  +
Sbjct: 368  FSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPEN+LLD +    ISD G+A  ++     T +    GT G++APE        
Sbjct: 310  IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 1003 KESDVYSYGVVLLELITRK 1021
               D ++ GV L E+I  +
Sbjct: 368  FSVDYFALGVTLYEMIAAR 386

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            +L+++ EI+ + K+ H  ++++++F+  +D  I++   ME G L D +  +      E  
Sbjct: 184  ALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV--VGNKRLKEAT 240
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSP 976
             +                  +  I+HRD+KPEN+LL S+ E     I+DFG +K+L ++ 
Sbjct: 241  CKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
Query: 977  ASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033
               T   + GT  Y+APE   +  T   ++  D +S GV+L   ++      P  + RT 
Sbjct: 297  LMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS---GYPPFSEHRTQ 350
Query: 1034 I----------VGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
            +            ++  VW++  E      L L++++LV
Sbjct: 351  VSLKDQITSGKYNFIPEVWAEVSEKA----LDLVKKLLV 385

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 18/216 (8%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 12   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 67   PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 127  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPES 181
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKA----LDPS 1027
                  S +SDV+++GV+L E+ T   +    +DPS
Sbjct: 182  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPEN+LLD +    ISD G+A  ++     T +    GT G++APE        
Sbjct: 310  IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 1003 KESDVYSYGVVLLELITRK 1021
               D ++ GV L E+I  +
Sbjct: 368  FSVDYFALGVTLYEMIAAR 386

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 15/226 (6%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G +G V+KA +   + + A+K++       G  S   REI  + +++H+N+VRL D 
Sbjct: 10   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPP--PTLEWNVRYKIXXXXXXXXXXXXXDCDPP 942
             L  D  + +     +  L+    S      P +  +  +++                  
Sbjct: 70   -LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN------- 121
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAK 1001
            ++HRD+KP+N+L++   E  +++FG+A+     P    S  VV T+ Y  P+  F     
Sbjct: 122  VLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWYRPPDVLFGAKLY 179
Query: 1002 SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            S   D++S G +  EL    + L P       +    R + + TEE
Sbjct: 180  STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 20/218 (9%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA-----VFAVKKLAFRGHKRGSLSMKR 865
            L ++++ TE    K V+G GA G VYK    P         A+K+L      + +  +  
Sbjct: 5    LLRILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 63
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SITPPPTLEWNVR 921
            E   +  + + ++ RL    L     +I  + M  G L D +     +I     L W V+
Sbjct: 64   EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 122
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
                              D  +VHRD+   N+L+ +     I+DFG+AKLL        +
Sbjct: 123  IAEGMNYLE---------DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                  I ++A E+      + +SDV+SYGV + EL+T
Sbjct: 174  EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPEN+LLD +    ISD G+A  ++     T +    GT G++APE        
Sbjct: 310  IIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 1003 KESDVYSYGVVLLELITRK 1021
               D ++ GV L E+I  +
Sbjct: 368  FSVDYFALGVTLYEMIAAR 386

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            +L+++ EI+ + K+ H  ++++++F+  +D  I++   ME G L D +  +      E  
Sbjct: 59   ALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV--VGNKRLKEAT 115
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSP 976
             +                  +  I+HRD+KPEN+LL S+ E     I+DFG +K+L ++ 
Sbjct: 116  CKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 977  ASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033
               T   + GT  Y+APE   +  T   ++  D +S GV+L   ++      P  + RT 
Sbjct: 172  LMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS---GYPPFSEHRTQ 225
Query: 1034 I----------VGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
            +            ++  VW++  E      L L++++LV
Sbjct: 226  VSLKDQITSGKYNFIPEVWAEVSEKA----LDLVKKLLV 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 221  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 275
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 276  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HR++   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 336  KKN----FIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 390
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 391  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 426
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 427  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 469

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + L     IG+G  G V       N V AVK +      +  L+   E   + ++RH NL
Sbjct: 6    KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQAFLA---EASVMTQLRHSNL 61
Query: 879  VRLEDFWLRKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            V+L    + +  G+ I+  YM  GSL D L S      L  +   K              
Sbjct: 62   VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEG 120
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +     VHRD+   N+L+  +    +SDFG+ K      AS+T  +    + + APE   
Sbjct: 121  N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 172
Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
                S +SDV+S+G++L E+ +
Sbjct: 173  EKKFSTKSDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 14/202 (6%)
Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + L     IG+G  G V       N V AVK +      +  L+   E   + ++RH NL
Sbjct: 21   KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQAFLA---EASVMTQLRHSNL 76
Query: 879  VRLEDFWLRKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            V+L    + +  G+ I+  YM  GSL D L S      L  +   K              
Sbjct: 77   VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
            +     VHRD+   N+L+  +    +SDFG+ K      AS+T  +    + + APE   
Sbjct: 136  N---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 187
Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
                S +SDV+S+G++L E+ +
Sbjct: 188  EKKFSTKSDVWSFGILLWEIYS 209

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            VIG G+ G+V++A L  +   A+KK+     KR      RE+Q +  ++H N+V L+ F+
Sbjct: 47   VIGNGSFGVVFQAKLVESDEVAIKKVL--QDKRFK---NRELQIMRIVKHPNVVDLKAFF 101
Query: 886  L----RKDCGII--MYRYMENGSLRDVLHSI----TPPPTLEWNVRYKIXXXXXXXXXXX 935
                 +KD   +  +  Y+     R   H      T P  L     Y++           
Sbjct: 102  YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                   I HRDIKP+N+LLD       + DFG AK+L    A   ++S + +  Y APE
Sbjct: 162  -------ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI---AGEPNVSXICSRYYRAPE 211
Query: 995  NAF-TTAKSKESDVYSYGVVLLELI 1018
              F  T  +   D++S G V+ EL+
Sbjct: 212  LIFGATNYTTNIDIWSTGCVMAELM 236

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            +L+++ EI+ + K+ H  ++++++F+  +D  I++   ME G L D +  +      E  
Sbjct: 59   ALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV--VGNKRLKEAT 115
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSP 976
             +                  +  I+HRD+KPEN+LL S+ E     I+DFG +K+L ++ 
Sbjct: 116  CKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 977  ASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033
               T   + GT  Y+APE   +  T   ++  D +S GV+L   ++      P  + RT 
Sbjct: 172  LMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS---GYPPFSEHRTQ 225
Query: 1034 I----------VGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
            +            ++  VW++  E      L L++++LV
Sbjct: 226  VSLKDQITSGKYNFIPEVWAEVSEKA----LDLVKKLLV 260

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 170  IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 230  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 271
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 272  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 170  IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 230  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 271
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 272  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 16/162 (9%)
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            +L+++ EI+ + K+ H  ++++++F+  +D  I++   ME G L D +  +      E  
Sbjct: 58   ALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV--VGNKRLKEAT 114
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSP 976
             +                  +  I+HRD+KPEN+LL S+ E     I+DFG +K+L ++ 
Sbjct: 115  CKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 170
Query: 977  ASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLL 1015
               T   + GT  Y+APE   +  T   ++  D +S GV+L 
Sbjct: 171  LMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 209

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 170  IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 230  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 271
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 272  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 16/162 (9%)
Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            +L+++ EI+ + K+ H  ++++++F+  +D  I++   ME G L D +  +      E  
Sbjct: 59   ALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV--VGNKRLKEAT 115
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSP 976
             +                  +  I+HRD+KPEN+LL S+ E     I+DFG +K+L ++ 
Sbjct: 116  CKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 977  ASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLL 1015
               T   + GT  Y+APE   +  T   ++  D +S GV+L 
Sbjct: 172  LMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 161  IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 221  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 262
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 263  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 161  IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 221  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 262
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 263  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 16/222 (7%)
Query: 158 EIPEPLFRIL-GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYR 216
           EI +  F+ L  L  + L NN +S   P     L ++E L+L  N+L   +PE +     
Sbjct: 66  EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT-- 122
Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE--GRINFGSEKCKNLTFL---DLS 271
           LQEL ++EN++        + L  ++ +++G N L+  G  N   +  K L+++   D +
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 272 YNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPEL 331
                 G+ P      SLT L + G+K+T    +S   L  L+ L LS N +S      L
Sbjct: 183 ITTIPQGLPP------SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236
Query: 332 GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG 373
               +L  LHL  N+L  ++P  L     +Q + L +N ++ 
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 169 LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLM 228
           L  + L NN +S   P     L ++E L+L  N+L   +PE +     LQEL ++EN++ 
Sbjct: 78  LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT--LQELRVHENEIT 134
Query: 229 GFLPESLSNLENLVYLDVGDNNLE--GRINFGSEKCKNLTFL---DLSYNRFSGGISPNL 283
                  + L  ++ +++G N L+  G  N   +  K L+++   D +      G+ P  
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP-- 192
Query: 284 GNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLY 343
               SLT L + G+K+T    +S   L  L+ L LS N +S      L    +L  LHL 
Sbjct: 193 ----SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 344 ANQLEGEIPDELGQLSNLQDLELFDNRLTG 373
            N+L  ++P  L     +Q + L +N ++ 
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 166  IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 225
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 226  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFXRRLKEGTRMR 267
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 268  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 10/128 (7%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+APE      K 
Sbjct: 125  ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE----LLKR 180
Query: 1003 KE-----SDVYSYGVVLLELITRKKALDPSYKERTDIVGWV-RSVWSDTEEINDIVDLSL 1056
            +E      DV+S G+VL  ++  +   D       +   W  +  + +  +  D   L+L
Sbjct: 181  REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 1057 MEEMLVSS 1064
            + ++LV +
Sbjct: 241  LHKILVEN 248

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 260  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 314
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 315  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 374
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HR++   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 375  KKN----FIHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 429
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 430  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 465
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 466  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 508

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-----------YKIXX 926
            ++ L     +     ++  Y   G+LR+ L +   PP LE++               +  
Sbjct: 96   IINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                             +HRD+   N+L+  +    I+DFG+A+ +        + +   
Sbjct: 155  CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRL 214
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 215  PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFR-GHKRGSLSMKREIQTIGKIR-HRNLVRLE 882
            V+G GAH  V    +L  +  +AVK +  + GH R  +   RE++ + + + HRN++ L 
Sbjct: 20   VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGHRNVLELI 77
Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPP 942
            +F+  +D   +++  M  GS+   +H       LE +V  +                +  
Sbjct: 78   EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH------NKG 131
Query: 943  IVHRDIKPENILLD--SEMEP-HISDFGIAKLL----DKSPASTTS-ISVVGTIGYIAPE 994
            I HRD+KPENIL +  +++ P  I DFG+   +    D SP ST   ++  G+  Y+APE
Sbjct: 132  IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 995  --NAFTTAKS---KESDVYSYGVVLLELIT 1019
               AF+   S   K  D++S GV+L  L++
Sbjct: 192  VVEAFSEEASIYDKRCDLWSLGVILYILLS 221

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 15   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 69
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 70   PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 130  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPES 184
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 185  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 220
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 221  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 263

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 51/302 (16%)
Query: 804  QEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLS 862
            Q  P+Y  K  +E T+ +  KH +G G +G VY+      ++  AVK L     K  ++ 
Sbjct: 13   QGSPNYD-KWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTME 65
Query: 863  MK---REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            ++   +E   + +I+H NLV+L     R+    I+  +M  G+L D L            
Sbjct: 66   VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 125
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST 979
            + Y               +     +HRD+   N L+       ++DFG+++L+      T
Sbjct: 126  LLYMATQISSAMEYLEKKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYT 180
Query: 980  TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVR 1039
                    I + APE+      S +SDV+++GV+L E+ T   +  P             
Sbjct: 181  AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------ 228
Query: 1040 SVWSDTEEINDIVDLSLMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMR 1091
                        +DLS + E+L    R        ++V +++     C +  PS+RP+  
Sbjct: 229  ------------IDLSQVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFA 273
Query: 1092 DV 1093
            ++
Sbjct: 274  EI 275

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 77   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-----------YKIXX 926
            ++ L     +     ++  Y   G+LR+ L +   PP LE++               +  
Sbjct: 137  IINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                             +HRD+   N+L+  +    I+DFG+A+ +        + +   
Sbjct: 196  CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 255
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 256  PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 14   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 69   PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 129  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 183
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 184  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 219
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 220  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 14   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 69   PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 129  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 183
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 184  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 219
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 220  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 262

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 943  IVHRDIKPENILLD---SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            I+HRD+KPENI+L      +   I D G AK LD+    T     VGT+ Y+APE     
Sbjct: 142  IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---EFVGTLQYLAPELLEQK 198
Query: 1000 AKSKESDVYSYGVVLLELITRKKALDPSYK 1029
              +   D +S+G +  E IT  +   P+++
Sbjct: 199  KYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 943  IVHRDIKPENILLD---SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            I+HRD+KPENI+L      +   I D G AK LD+    T     VGT+ Y+APE     
Sbjct: 143  IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT---EFVGTLQYLAPELLEQK 199
Query: 1000 AKSKESDVYSYGVVLLELITRKKALDPSYK 1029
              +   D +S+G +  E IT  +   P+++
Sbjct: 200  KYTVTVDYWSFGTLAFECITGFRPFLPNWQ 229

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 19   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 74   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 134  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPES 188
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 189  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 224
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 225  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 267

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 33/81 (40%), Positives = 47/81 (58%), Gaps = 9/81 (11%)
Query: 943  IVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
            +VH+D+KPENIL   +  PH    I DFG+A+L      ST +    GT  Y+APE  F 
Sbjct: 145  VVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAPE-VFK 199
Query: 999  TAKSKESDVYSYGVVLLELIT 1019
               + + D++S GVV+  L+T
Sbjct: 200  RDVTFKCDIWSAGVVMYFLLT 220

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 45/80 (56%)
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            D  +VHRD+   N+L+ S     I+DFG+A+LLD       +      I ++A E+    
Sbjct: 137  DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 1000 AKSKESDVYSYGVVLLELIT 1019
              + +SDV+SYGV + EL+T
Sbjct: 197  RFTHQSDVWSYGVTVWELMT 216

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 14   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 69   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 129  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 183
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 184  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 219
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 220  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 18/216 (8%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 12   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 67   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 127  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPES 181
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKA----LDPS 1027
                  S +SDV+++GV+L E+ T   +    +DPS
Sbjct: 182  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 14   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 69   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 129  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 183
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 184  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 219
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 220  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 19   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 74   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 133
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 134  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 188
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 189  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 224
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 225  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 267

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 52/201 (25%), Positives = 91/201 (45%), Gaps = 21/201 (10%)
Query: 827  IGRGAHGIV---YKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            IG+GA  +V    K   G      +   KKL+ R H++    ++RE +    ++H N+VR
Sbjct: 12   IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK----LEREARICRLLKHSNIVR 67
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCD 940
            L D    +    +++  +  G L + +  +      E +  + I                
Sbjct: 68   LHDSISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIQQILEAVLHCHQMG-- 123
Query: 941  PPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
              +VHRD+KPEN+LL S+ +     ++DFG+A  ++            GT GY++PE   
Sbjct: 124  --VVHRDLKPENLLLASKCKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 998  TTAKSKESDVYSYGVVLLELI 1018
              A  K  D+++ GV+L  L+
Sbjct: 180  KEAYGKPVDIWACGVILYILL 200

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLE 882
            IG G++G+V+K  +     + A+KK  F   +   +  K   REI+ + +++H NLV L 
Sbjct: 11   IGEGSYGVVFKCRNRDTGQIVAIKK--FLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPP 942
            + + RK    +++ Y ++  L ++       P  E  V+                +C   
Sbjct: 69   EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVP--EHLVKSITWQTLQAVNFCHKHNC--- 123
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAK 1001
             +HRD+KPENIL+       + DFG A+LL  +  S      V T  Y +PE     T  
Sbjct: 124  -IHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 1002 SKESDVYSYGVVLLELIT 1019
                DV++ G V  EL++
Sbjct: 181  GPPVDVWAIGCVFAELLS 198

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 170  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 230  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 271
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 272  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-----------YKIXX 926
            ++ L     +     ++  Y   G+LR+ L +   PP LE++               +  
Sbjct: 96   IINLLGACTQDGPLYVIVEYASKGNLREYLQA-REPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                             +HRD+   N+L+  +    I+DFG+A+ +        + +   
Sbjct: 155  CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 215  PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 19   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 74   PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 134  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 188
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 189  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 224
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 225  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 267

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 15   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 69
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 70   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 129
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 130  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPES 184
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 185  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 220
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 221  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 16   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 71   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 131  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPES 185
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 186  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 221
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 222  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 264

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 19   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 74   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 134  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 188
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 189  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 224
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 225  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 19   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 73
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 74   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 133
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 134  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 188
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 189  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 224
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 225  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 14   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 69   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 129  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 183
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 184  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 219
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 220  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 18   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 72
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 73   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 132
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 133  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 187
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 188  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 223
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 224  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 266

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 14   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 68
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 69   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 128
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 129  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 183
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 184  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 219
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 220  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 16   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 71   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 131  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 185
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 186  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 221
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 222  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 49/286 (17%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G +G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 16   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 70
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 71   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 130
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 131  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 185
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                  S +SDV+++GV+L E+ T   +  P                         +DLS
Sbjct: 186  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLS 221
Query: 1056 LMEEMLVSSIR--------DQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+L    R        ++V +++     C +  PS+RP+  ++
Sbjct: 222  QVYELLEKDYRMERPEGCPEKVYELMRA---CWQWNPSDRPSFAEI 264

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 18/216 (8%)
Query: 820  NLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++  KH +G G  G VY+      ++  AVK L     K  ++ ++   +E   + +I+H
Sbjct: 12   DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIKH 66
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             NLV+L     R+    I+  +M  G+L D L            + Y             
Sbjct: 67   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 126
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
              +     +HRD+   N L+       ++DFG+++L+      T        I + APE+
Sbjct: 127  KKN----FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPES 181
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKA----LDPS 1027
                  S +SDV+++GV+L E+ T   +    +DPS
Sbjct: 182  LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPS 217

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 14/196 (7%)
Query: 825  HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
              IG+G  G V       N V AVK +      +  L+   E   + ++RH NLV+L   
Sbjct: 199  QTIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQAFLA---EASVMTQLRHSNLVQLLGV 254
Query: 885  WLRKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPI 943
             + +  G+ I+  YM  GSL D L S      L  +   K              +     
Sbjct: 255  IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            VHRD+   N+L+  +    +SDFG+ K      AS+T  +    + + APE       S 
Sbjct: 311  VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+S+G++L E+ +
Sbjct: 366  KSDVWSFGILLWEIYS 381

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 220  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 280  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 321
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 322  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 207  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 266
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 267  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 308
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 309  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 222  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 282  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 323
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 324  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 213  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 273  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 314
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 315  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 172  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 231
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 232  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 273
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 274  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 161  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 221  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 262
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 263  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 215  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 275  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 316
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 317  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 170  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 230  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 271
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 272  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 161  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 221  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 262
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 263  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL  +    I DFG+A+ + K P           + ++APE  F    + 
Sbjct: 166  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 225
Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVS 1063
            +SDV+S+GV+L E+ +   +  P  K                  I++     L E   + 
Sbjct: 226  QSDVWSFGVLLWEIFSLGASPYPGVK------------------IDEEFCRRLKEGTRMR 267
Query: 1064 SIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +      ++    L C   +PS RP   ++V  L
Sbjct: 268  APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 25   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-----------YKIXX 926
            ++ L     +     ++  Y   G+LR+ L +   PP LE++               +  
Sbjct: 85   IINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                             +HRD+   N+L+  +    I+DFG+A+ +        + +   
Sbjct: 144  CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 203
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 204  PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 29   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-----------YKIXX 926
            ++ L     +     ++  Y   G+LR+ L +   PP LE++               +  
Sbjct: 89   IINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                             +HRD+   N+L+  +    I+DFG+A+ +        + +   
Sbjct: 148  CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 207
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 208  PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 53/294 (18%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIR-HRNLVRLE 882
            +G+GA+GIV+K+       V AVKK+  AF+       +  REI  + ++  H N+V L 
Sbjct: 17   LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75
Query: 883  DFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
            +  LR D      +++ YME   L  V+ +    P  +  V Y++               
Sbjct: 76   NV-LRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---- 129
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI----------------- 982
               ++HRD+KP NILL++E    ++DFG+++        T +I                 
Sbjct: 130  ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 983  --SVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVR 1039
                V T  Y APE    + K +K  D++S G +L E++  K     S            
Sbjct: 187  LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS------------ 234
Query: 1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
            S  +  E I  ++D    E+  V SI+      ++ +L+  EK    + N RD+
Sbjct: 235  STMNQLERIIGVIDFPSNED--VESIQSPFAKTMIESLK--EKVEIRQSNKRDI 284

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 827  IGRGAHGIVYKASLGPNA------VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+GA  +V +    P        +   KKL+ R H++    ++RE +    ++H N+VR
Sbjct: 12   LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK----LEREARICRLLKHPNIVR 67
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCD 940
            L D    +    +++  +  G L + +  +      E +  + I                
Sbjct: 68   LHDSISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIQQILESVNHCHLNG-- 123
Query: 941  PPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
              IVHRD+KPEN+LL S+ +     ++DFG+A  ++            GT GY++PE   
Sbjct: 124  --IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 998  TTAKSKESDVYSYGVVLLELI 1018
                 K  D+++ GV+L  L+
Sbjct: 180  KDPYGKPVDMWACGVILYILL 200

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 88/217 (40%), Gaps = 36/217 (16%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL----- 881
            IG+G  G V++       V AVK  + R  +  S   + EI     +RH N++       
Sbjct: 50   IGKGRFGEVWRGKWRGEEV-AVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADN 106
Query: 882  ------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
                     WL  D       Y E+GSL D L+  T   T+E  ++  +           
Sbjct: 107  KDNGTWTQLWLVSD-------YHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHM 157
Query: 936  X---XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS---VVGTIG 989
                    P I HRD+K +NIL+       I+D G+A   D S   T  I+    VGT  
Sbjct: 158  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD-SATDTIDIAPNHRVGTKR 216
Query: 990  YIAPE------NAFTTAKSKESDVYSYGVVLLELITR 1020
            Y+APE      N       K +D+Y+ G+V  E+  R
Sbjct: 217  YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 28   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-----------YKIXX 926
            ++ L     +     ++  Y   G+LR+ L +   PP LE++               +  
Sbjct: 88   IINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                             +HRD+   N+L+  +    I+DFG+A+ +        + +   
Sbjct: 147  CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 206
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 207  PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 101/245 (41%), Gaps = 35/245 (14%)
Query: 793  RRSKQDLEIPAQEGP-SYLLKQVIEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKK 850
            RR K  LE      P +  +KQ+    E+     VIGRGA G V    L   + VFA+K 
Sbjct: 47   RREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKI 106
Query: 851  L-AFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS 909
            L  +   KR   +  RE + +       LV  +  W+      + Y + ++ +L  V+  
Sbjct: 107  LNKWEMLKRAETACFREERDV-------LVNGDSKWIT----TLHYAFQDDNNLYLVMDY 155
Query: 910  ITPPPTL-----------EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE 958
                  L           E   R+ +                   VHRDIKP+NIL+D  
Sbjct: 156  YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH----YVHRDIKPDNILMDMN 211
Query: 959  MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--NAFTTAKSK---ESDVYSYGVV 1013
                ++DFG    L +     +S++ VGT  YI+PE   A    K +   E D +S GV 
Sbjct: 212  GHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 1014 LLELI 1018
            + E++
Sbjct: 271  MYEML 275

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 95/227 (41%), Gaps = 21/227 (9%)
Query: 799  LEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVY-KASLGPNAVFAVKKLAFRGHK 857
            ++ PA  GP  L   ++  ++       IG G  G+         N + AVK +  RG K
Sbjct: 1    MDRPAVSGPMDL--PIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-RGEK 57
Query: 858  RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE 917
              + ++KREI     +RH N+VR ++  L      I+  Y   G L + + +       E
Sbjct: 58   IAA-NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 116
Query: 918  WNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPH--ISDFGIAK--LLD 973
                ++                   + HRD+K EN LLD    P   I DFG +K  +L 
Sbjct: 117  ARFFFQQLISGVSYCHAMQ------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 170
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELIT 1019
              P ST     VGT  YIAPE         K +DV+S GV L  ++ 
Sbjct: 171  SQPKST-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-----------YKIXX 926
            ++ L     +     ++  Y   G+LR+ L +   PP LE++               +  
Sbjct: 96   IINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 927  XXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                             +HRD+   N+L+  +    I+DFG+A+ +        + +   
Sbjct: 155  CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 215  PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 37/310 (11%)
Query: 805  EGPSYLLKQVIEATE--NLNAKHVIGRGAHGIVYKA---SLGPNA---VFAVKKLAFRGH 856
            E P Y     +   +  ++  K  +G GA G V+ A   +L P     + AVK L     
Sbjct: 25   ENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EAS 83
Query: 857  KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL 916
            +      +RE + +  ++H+++VR           ++++ YM +G L   L S  P   L
Sbjct: 84   ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 917  EWNVR---------YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
                           ++                   VHRD+   N L+   +   I DFG
Sbjct: 144  LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203
Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027
            +++ +  +         +  I ++ PE+      + ESDV+S+GVVL E+ T  K   P 
Sbjct: 204  MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK--QPW 261
Query: 1028 YKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNR 1087
            Y+             S+TE I+ I     +E       R    +V  +   C +++P  R
Sbjct: 262  YQ------------LSNTEAIDCITQGRELERP-----RACPPEVYAIMRGCWQREPQQR 304
Query: 1088 PNMRDVVRQL 1097
             +++DV  +L
Sbjct: 305  HSIKDVHARL 314

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 41/300 (13%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 36   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW------NVRYKIXXXXXXX 931
            ++ L     +     ++  Y   G+LR+ L +   PP LE+      N   ++       
Sbjct: 96   IINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 932  XXXXXXD-----CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                             +HRD+   N+L+  +    I+DFG+A+ +        + +   
Sbjct: 155  CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046
             + ++APE  F    + +SDV+S+GV+L E+ T   +  P           V  ++   +
Sbjct: 215  PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--------VEELFKLLK 266
Query: 1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTS 1106
            E + +   S     L   +RD           C    PS RP  + +V  L D  V +TS
Sbjct: 267  EGHRMDKPSNCTNELYMMMRD-----------CWHAVPSQRPTFKQLVEDL-DRIVALTS 314

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 89/213 (41%), Gaps = 10/213 (4%)
Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK 864
            G   L  Q ++  E       IG+G+ G V+K        V A+K +     +     ++
Sbjct: 14   GTENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ 73
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            +EI  + +     + +    +L+     I+  Y+  GS  D+L    P P  E  +   +
Sbjct: 74   QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATIL 130
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
                               +HRDIK  N+LL    E  ++DFG+A  L  +     +   
Sbjct: 131  REILKGLDYLHSEKK----IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-- 184
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLEL 1017
            VGT  ++APE    +A   ++D++S G+  +EL
Sbjct: 185  VGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 822  NAKHVIGRGAHGIVYKASLGPNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN 877
            ++  VIG+G  G+VY       A      A+K L+     +   +  RE   +  + H N
Sbjct: 24   HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 878  LVRLEDFWLRKDCGI--IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
            ++ L    L  + G+  ++  YM +G L   + S    PT++  + + +           
Sbjct: 84   VLALIGIMLPPE-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 936  XXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVG-TIGYIAP 993
                +   VHRD+   N +LD      ++DFG+A+ +LD+   S          + + A 
Sbjct: 141  ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197
Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYK 1029
            E+  T   + +SDV+S+GV+L EL+TR     P Y+
Sbjct: 198  ESLQTYRFTTKSDVWSFGVLLWELLTRGA---PPYR 230

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 64/222 (28%), Positives = 92/222 (41%), Gaps = 21/222 (9%)
Query: 799  LEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIV-YKASLGPNAVFAVKKLAFRGHK 857
            ++ PA  GP  L   ++  ++       IG G  G+         N + AVK +  RG K
Sbjct: 1    MDRPAVAGPMDL--PIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIE-RGEK 57
Query: 858  RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE 917
                ++KREI     +RH N+VR ++  L      I+  Y   G L + + +       E
Sbjct: 58   IDE-NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 116
Query: 918  WNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPH--ISDFGIAK--LLD 973
                ++                   + HRD+K EN LLD    P   I+DFG +K  +L 
Sbjct: 117  ARFFFQQLISGVSYAHAMQ------VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLH 170
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVL 1014
              P S      VGT  YIAPE         K +DV+S GV L
Sbjct: 171  SQPKSA-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 55/206 (26%), Positives = 83/206 (40%), Gaps = 28/206 (13%)
Query: 827  IGRGAHGIVYKASLGPNAV------FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            IGRG+   VYK       V         +KL     +R     K E + +  ++H N+VR
Sbjct: 34   IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR----FKEEAEXLKGLQHPNIVR 89
Query: 881  LEDFWLR----KDCGIIMYRYMENGSLRDVLH--SITPPPTLEWNVRYKIXXXXXXXXXX 934
              D W      K C +++     +G+L+  L    +     L    R  +          
Sbjct: 90   FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 935  XXXDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
                  PPI+HRD+K +NI +        I D G+A L   S A     +V+GT  + AP
Sbjct: 150  ------PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFXAP 199
Query: 994  ENAFTTAKSKESDVYSYGVVLLELIT 1019
            E  +     +  DVY++G   LE  T
Sbjct: 200  E-XYEEKYDESVDVYAFGXCXLEXAT 224

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGS-----LSMKREIQTIGKIRHRNLVR 880
            +G G    VYKA     N + A+KK+   GH+  +      +  REI+ + ++ H N++ 
Sbjct: 18   LGEGQFATVYKARDKNTNQIVAIKKIKL-GHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 881  LEDFWLRKDCGIIMYRYMENG---SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            L D +  K    +++ +ME      ++D    +TP           I             
Sbjct: 77   LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS---------HIKAYMLMTLQGLEY 127
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I+HRD+KP N+LLD      ++DFG+AK    SP       VV T  Y APE  F
Sbjct: 128  LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV-TRWYRAPELLF 185
Query: 998  -TTAKSKESDVYSYGVVLLELITR 1020
                     D+++ G +L EL+ R
Sbjct: 186  GARMYGVGVDMWAVGCILAELLLR 209

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 827  IGRGAHG-IVYKASLG-----PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G     PN V   AVK L     ++    +  E++ +  I +H+N
Sbjct: 21   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW------------------N 919
            ++ L     +     ++  Y   G+LR+ L +   PP LE+                  +
Sbjct: 81   IINLLGACTQDGPLYVIVEYASKGNLREYLQA-RRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST 979
              Y++                   +HRD+   N+L+  +    I+DFG+A+ +       
Sbjct: 140  CAYQVARGMEYLASKK-------CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 980  TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             + +    + ++APE  F    + +SDV+S+GV+L E+ T
Sbjct: 193  KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 2/92 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRD+K  N+ L+ +M+  I DFG+A  ++       ++   GT  YIAPE       S
Sbjct: 163  VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL--CGTPNYIAPEVLCKKGHS 220
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
             E D++S G +L  L+  K   + S  + T I
Sbjct: 221  FEVDIWSLGCILYTLLVGKPPFETSCLKETYI 252

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/82 (37%), Positives = 43/82 (52%), Gaps = 8/82 (9%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRD+KP NILLD   +  + DFGI+  L    A   S    G   Y+APE       +
Sbjct: 146  VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPERIDPPDPT 202
Query: 1003 K-----ESDVYSYGVVLLELIT 1019
            K      +DV+S G+ L+EL T
Sbjct: 203  KPDYDIRADVWSLGISLVELAT 224

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 35/286 (12%)
Query: 827  IGRGAHGIVYKA---SLGPNA---VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G GA G V+ A   +L P     + AVK L     +      +RE + +  ++H+++VR
Sbjct: 26   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVR 84
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---------YKIXXXXXXX 931
                       ++++ YM +G L   L S  P   L               ++       
Sbjct: 85   FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD+   N L+   +   I DFG+++ +  +         +  I ++
Sbjct: 145  AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 204
Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051
             PE+      + ESDV+S+GVVL E+ T  K   P Y+             S+TE I+ I
Sbjct: 205  PPESILYRKFTTESDVWSFGVVLWEIFTYGK--QPWYQ------------LSNTEAIDCI 250
Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                 +E       R    +V  +   C +++P  R +++DV  +L
Sbjct: 251  TQGRELERP-----RACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 35/286 (12%)
Query: 827  IGRGAHGIVYKA---SLGPNA---VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G GA G V+ A   +L P     + AVK L     +      +RE + +  ++H+++VR
Sbjct: 20   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVR 78
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---------YKIXXXXXXX 931
                       ++++ YM +G L   L S  P   L               ++       
Sbjct: 79   FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD+   N L+   +   I DFG+++ +  +         +  I ++
Sbjct: 139  AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 198
Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051
             PE+      + ESDV+S+GVVL E+ T  K   P Y+             S+TE I+ I
Sbjct: 199  PPESILYRKFTTESDVWSFGVVLWEIFTYGK--QPWYQ------------LSNTEAIDCI 244
Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                 +E       R    +V  +   C +++P  R +++DV  +L
Sbjct: 245  TQGRELERP-----RACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 46/193 (23%), Positives = 88/193 (45%), Gaps = 11/193 (5%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A    +    AVK +  R  +R  L +  E+  +   +H N+V +   +
Sbjct: 53   IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVVEMYKSY 111
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L  +   ++  +++ G+L D++  +            +I                  ++H
Sbjct: 112  LVGEELWVLMEFLQGGALTDIVSQVRLNEE-------QIATVCEAVLQALAYLHAQGVIH 164
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK ++ILL  +    +SDFG    + K       +  VGT  ++APE    +  + E 
Sbjct: 165  RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXL--VGTPYWMAPEVISRSLYATEV 222
Query: 1006 DVYSYGVVLLELI 1018
            D++S G++++E++
Sbjct: 223  DIWSLGIMVIEMV 235

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRHRNLVRLED 883
            +G G  G+V           AVK +     K GS+S     +E QT+ K+ H  LV+   
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVKMI-----KEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHS----ITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
               ++    I+  Y+ NG L + L S    + P   LE  + Y +               
Sbjct: 71   VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLE--MCYDVCEGMAFLESHQ---- 124
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGT---IGYIAPEN 995
                +HRD+   N L+D ++   +SDFG+ + +LD        +S VGT   + + APE 
Sbjct: 125  ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-----YVSSVGTKFPVKWSAPEV 176
Query: 996  AFTTAKSKESDVYSYGVVLLELITRKK 1022
                  S +SDV+++G+++ E+ +  K
Sbjct: 177  FHYFKYSSKSDVWAFGILMWEVFSLGK 203

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 827  IGRGAHGIVYKASLGPNA------VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+GA  +V +    P        +   KKL+ R H++    ++RE +    ++H N+VR
Sbjct: 12   LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK----LEREARICRLLKHPNIVR 67
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCD 940
            L D    +    +++  +  G L + +  +      E +  + I                
Sbjct: 68   LHDSISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASHCIQQILESVNHCHLNG-- 123
Query: 941  PPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
              IVHRD+KPEN+LL S+ +     ++DFG+A  ++            GT GY++PE   
Sbjct: 124  --IVHRDLKPENLLLASKSKGAAVKLADFGLA--IEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 998  TTAKSKESDVYSYGVVLLELI 1018
                 K  D+++ GV+L  L+
Sbjct: 180  KDPYGKPVDMWACGVILYILL 200

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL--EDF 884
            +G+G +G V++      +V AVK  + R  +  S   + EI     +RH N++     D 
Sbjct: 16   VGKGRYGEVWRGLWHGESV-AVKIFSSRDEQ--SWFRETEIYNTVLLRHDNILGFIASDM 72
Query: 885  WLRKDCG--IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXX---XXXXXXXXXXDC 939
              R       ++  Y E+GSL D L   T  P L   +R  +                  
Sbjct: 73   TSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA--LRLAVSAACGLAHLHVEIFGTQG 130
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS---VVGTIGYIAPENA 996
             P I HRD K  N+L+ S ++  I+D G+A ++    +    I     VGT  Y+APE  
Sbjct: 131  KPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 997  FTTAKS------KESDVYSYGVVLLELITR 1020
                ++      K +D++++G+VL E+  R
Sbjct: 190  DEQIRTDCFESYKWTDIWAFGLVLWEIARR 219

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 27/75 (36%), Positives = 42/75 (56%), Gaps = 1/75 (1%)
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRD+KPENIL+ ++   ++ DFGIA        +    + VGT+ Y APE    +  +  
Sbjct: 157  HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG-NTVGTLYYXAPERFSESHATYR 215
Query: 1005 SDVYSYGVVLLELIT 1019
            +D+Y+   VL E +T
Sbjct: 216  ADIYALTCVLYECLT 230

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 190  IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 1004 ESDVYSYGVVLLELIT 1019
            ESDV+SYG+ L EL +
Sbjct: 250  ESDVWSYGIFLWELFS 265

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 820  NLNAKHVIGRGAHGIVYKAS---LGP-NAVF--AVKKLAFRGHKRGSLSMKREIQTIGKI 873
            NL     +G GA G V +A+   LG  +AV   AVK L    H     ++  E++ +  +
Sbjct: 47   NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 874  -RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP-----------PTLEWNVR 921
             +H N+V L          +++  Y   G L + L    PP           P  + + R
Sbjct: 107  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
              +                   +HRD+   N+LL +     I DFG+A+ +         
Sbjct: 167  -DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             +    + ++APE+ F    + +SDV+SYG++L E+ +
Sbjct: 226  GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 2/92 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRD+K  N+ L+ +M+  I DFG+A  ++        +   GT  YIAPE       S
Sbjct: 147  VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL--CGTPNYIAPEVLCKKGHS 204
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
             E D++S G +L  L+  K   + S  + T I
Sbjct: 205  FEVDIWSLGCILYTLLVGKPPFETSCLKETYI 236

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 2/92 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRD+K  N+ L+ +M+  I DFG+A  ++        +   GT  YIAPE       S
Sbjct: 163  VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL--CGTPNYIAPEVLCKKGHS 220
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
             E D++S G +L  L+  K   + S  + T I
Sbjct: 221  FEVDIWSLGCILYTLLVGKPPFETSCLKETYI 252

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN-AFTTAK 1001
            +VHRD+KPEN+LLD+ M   I+DFG++ ++        S    G+  Y APE  +     
Sbjct: 137  VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRLYA 193
Query: 1002 SKESDVYSYGVVLLELI 1018
              E D++S GV+L  L+
Sbjct: 194  GPEVDIWSSGVILYALL 210

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFR-GHKRGSLSMKREIQTIGKIR-HRNLVRLE 882
            V+G GAH  V    +L  +  +AVK +  + GH R  +   RE++ + + + HRN++ L 
Sbjct: 20   VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGHRNVLELI 77
Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPP 942
            +F+  +D   +++  M  GS+   +H       LE +V  +                +  
Sbjct: 78   EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH------NKG 131
Query: 943  IVHRDIKPENILLD--SEMEP-HISDF----GIAKLLDKSPASTTS-ISVVGTIGYIAPE 994
            I HRD+KPENIL +  +++ P  I DF    GI    D SP ST   ++  G+  Y+APE
Sbjct: 132  IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 995  --NAFTTAKS---KESDVYSYGVVLLELIT 1019
               AF+   S   K  D++S GV+L  L++
Sbjct: 192  VVEAFSEEASIYDKRCDLWSLGVILYILLS 221

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 2/77 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+K +N++LDSE    I+DFG+ K  +      T+    GT  YIAPE        
Sbjct: 463  IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 520
Query: 1003 KESDVYSYGVVLLELIT 1019
            K  D +++GV+L E++ 
Sbjct: 521  KSVDWWAFGVLLYEMLA 537

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 47/196 (23%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 827  IGRGAHGIVYK--ASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            +G G +  VYK  + L  N V A+K++     +    +  RE+  +  ++H N+V L D 
Sbjct: 10   LGEGTYATVYKGKSKLTDNLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
               +    +++ Y++   L+  L        +  NV+  +                  ++
Sbjct: 69   IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKLFLFQLLRGLAYCHRQK----VL 122
Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAKSK 1003
            HRD+KP+N+L++   E  ++DFG+A+   KS  + T  + V T+ Y  P+    +T  S 
Sbjct: 123  HRDLKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180
Query: 1004 ESDVYSYGVVLLELIT 1019
            + D++  G +  E+ T
Sbjct: 181  QIDMWGVGCIFYEMAT 196

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 34/80 (42%), Positives = 47/80 (58%), Gaps = 7/80 (8%)
Query: 943  IVHRDIKPENILLDS---EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            IVHRD+KPENILL+S   + +  I DFG++    +   +T     +GT  YIAPE    T
Sbjct: 142  IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRGT 198
Query: 1000 AKSKESDVYSYGVVLLELIT 1019
               K  DV+S GV+L  L++
Sbjct: 199  YDEK-CDVWSAGVILYILLS 217

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 34/80 (42%), Positives = 47/80 (58%), Gaps = 7/80 (8%)
Query: 943  IVHRDIKPENILLDS---EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            IVHRD+KPENILL+S   + +  I DFG++    +   +T     +GT  YIAPE    T
Sbjct: 142  IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPEVLRGT 198
Query: 1000 AKSKESDVYSYGVVLLELIT 1019
               K  DV+S GV+L  L++
Sbjct: 199  YDEK-CDVWSAGVILYILLS 217

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 826  VIGRGAHGIVYKA----SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            ++G G++G V +     +L   AV  +KK   R    G  ++K+EIQ + ++RH+N+++L
Sbjct: 12   LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 882  EDFWLRKDCGIIMYRYMENG--SLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
             D  L  +    MY  ME     ++++L S+   P   + V                   
Sbjct: 72   VDV-LYNEEKQKMYMVMEYCVCGMQEMLDSV---PEKRFPVCQAHGYFCQLIDGLEYLHS 127
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--NAF 997
               IVH+DIKP N+LL +     IS  G+A+ L    A  T  +  G+  +  PE  N  
Sbjct: 128  QG-IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
             T    + D++S GV L  + T
Sbjct: 187  DTFSGFKVDIWSAGVTLYNITT 208

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 183  IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 242
Query: 1004 ESDVYSYGVVLLELIT 1019
            ESDV+SYG+ L EL +
Sbjct: 243  ESDVWSYGIFLWELFS 258

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 2/92 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRD+K  N+ L+ +M+  I DFG+A  ++        +   GT  YIAPE       S
Sbjct: 163  VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL--CGTPNYIAPEVLCKKGHS 220
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
             E D++S G +L  L+  K   + S  + T I
Sbjct: 221  FEVDIWSLGCILYTLLVGKPPFETSCLKETYI 252

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 185  IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 244
Query: 1004 ESDVYSYGVVLLELIT 1019
            ESDV+SYG+ L EL +
Sbjct: 245  ESDVWSYGIFLWELFS 260

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 820  NLNAKHVIGRGAHGIVY-----KASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIG 871
            ++  KH +G G +G VY     K SL      AVK L     K  ++ ++   +E   + 
Sbjct: 33   DITMKHKLGGGQYGEVYVGVWKKYSL----TVAVKTL-----KEDTMEVEEFLKEAAVMK 83
Query: 872  KIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
            +I+H NLV+L      +    I+  YM  G+L D L            + Y         
Sbjct: 84   EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                  +     +HRD+   N L+       ++DFG+++L+      T        I + 
Sbjct: 144  EYLEKKN----FIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWT 198
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      S +SDV+++GV+L E+ T
Sbjct: 199  APESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 167  IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226
Query: 1004 ESDVYSYGVVLLELIT 1019
            ESDV+SYG+ L EL +
Sbjct: 227  ESDVWSYGIFLWELFS 242

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)
Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMK--REIQTIGKIRHRNLVR 880
            +  +G G+ G V  A+        A+K ++ +  K+  + M+  REI  +  +RH ++++
Sbjct: 14   RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPP----------TLEWNVRYKIXXX 927
            L D  +     I+M      G L D +     +T              +E+  R+KI   
Sbjct: 74   LYDV-ITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI--- 129
Query: 928  XXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
                            VHRD+KPEN+LLD  +   I+DFG++ ++       TS    G+
Sbjct: 130  ----------------VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGS 170
Query: 988  IGYIAPE--NAFTTAKSKESDVYSYGVVLLELITRKKALDPSY 1028
              Y APE  N    A   E DV+S G+VL  ++  +   D  +
Sbjct: 171  PNYAAPEVINGKLYA-GPEVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 40/76 (52%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   NILL       I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 190  IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 1004 ESDVYSYGVVLLELIT 1019
            ESDV+SYG+ L EL +
Sbjct: 250  ESDVWSYGIFLWELFS 265

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 21/212 (9%)
Query: 818  TENLNAKHVIGRGAHGIV----YKASLGPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGK 872
             E+     VIGRGA G V    +K++     V+A+K L+ F   KR   +   E + I  
Sbjct: 73   AEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 873  IRHRNLVRLEDFWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
              +   V    +  + D  + M   YM  G L +++ +   P   +W   Y         
Sbjct: 130  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWARFYTAEVVLALD 187
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        +HRD+KP+N+LLD      ++DFG    ++K        + VGT  YI
Sbjct: 188  AIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYI 241
Query: 992  APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            +PE            +E D +S GV L E++ 
Sbjct: 242  SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D   A       V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDEMA-----GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 22/210 (10%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL--EDF 884
            +G+G +G V++ S     V AVK  + R  K  S   + E+     +RH N++     D 
Sbjct: 45   VGKGRYGEVWRGSWQGENV-AVKIFSSRDEK--SWFRETELYNTVMLRHENILGFIASDM 101
Query: 885  WLRKDCG--IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX-XDCDP 941
              R       ++  Y E GSL D L   T        +   I                 P
Sbjct: 102  TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 161
Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-----VGTIGYIAPENA 996
             I HRD+K +NIL+    +  I+D G+A +  +   ST  + V     VGT  Y+APE  
Sbjct: 162  AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ---STNQLDVGNNPRVGTKRYMAPEVL 218
Query: 997  FTTAK------SKESDVYSYGVVLLELITR 1020
              T +       K  D++++G+VL E+  R
Sbjct: 219  DETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 45/75 (60%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        + ++ GT  Y+APE   +   +
Sbjct: 183  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGATWTLCGTPEYLAPEIILSKGYN 237
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 238  KAVDWWALGVLIYEM 252

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D   A       V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDEMA-----GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 10/86 (11%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKS----------PASTTSISVVGTIGYIA 992
            ++HRD+KP NI    +    + DFG+   +D+           PA  T    VGT  Y++
Sbjct: 185  LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 993  PENAFTTAKSKESDVYSYGVVLLELI 1018
            PE       S + D++S G++L EL+
Sbjct: 245  PEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 28/76 (36%), Positives = 44/76 (57%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+K +N++LDSE    I+DFG+ K  +      T+    GT  YIAPE        
Sbjct: 142  IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIAYQPYG 199
Query: 1003 KESDVYSYGVVLLELI 1018
            K  D +++GV+L E++
Sbjct: 200  KSVDWWAFGVLLYEML 215

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 10/192 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+G+ G VYK        V A+K +     +     +++EI  + +     + R    +
Sbjct: 27   IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L+     I+  Y+  GS  D+L     P  LE      I             +     +H
Sbjct: 87   LKSTKLWIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSERK---IH 139
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK  N+LL  + +  ++DFG+A  L  +         VGT  ++APE    +A   ++
Sbjct: 140  RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQSAYDFKA 197
Query: 1006 DVYSYGVVLLEL 1017
            D++S G+  +EL
Sbjct: 198  DIWSLGITAIEL 209

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 21/212 (9%)
Query: 818  TENLNAKHVIGRGAHGIV----YKASLGPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGK 872
             E+     VIGRGA G V    +K++     V+A+K L+ F   KR   +   E + I  
Sbjct: 68   AEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 873  IRHRNLVRLEDFWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
              +   V    +  + D  + M   YM  G L +++ +   P   +W   Y         
Sbjct: 125  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWARFYTAEVVLALD 182
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        +HRD+KP+N+LLD      ++DFG    ++K        + VGT  YI
Sbjct: 183  AIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYI 236
Query: 992  APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            +PE            +E D +S GV L E++ 
Sbjct: 237  SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 21/212 (9%)
Query: 818  TENLNAKHVIGRGAHGIV----YKASLGPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGK 872
             E+     VIGRGA G V    +K++     V+A+K L+ F   KR   +   E + I  
Sbjct: 73   AEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 129
Query: 873  IRHRNLVRLEDFWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
              +   V    +  + D  + M   YM  G L +++ +   P   +W   Y         
Sbjct: 130  FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE--KWARFYTAEVVLALD 187
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        +HRD+KP+N+LLD      ++DFG    ++K        + VGT  YI
Sbjct: 188  AIHSMG-----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGTPDYI 241
Query: 992  APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            +PE            +E D +S GV L E++ 
Sbjct: 242  SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 817  ATENLNAKHV------IGRGAHGIV---YKASLGPN---AVFAVKKLAFRGHKRGSLSMK 864
             TENL  + +      +G+GA  +V    K   G      +   KKL+ R H++    ++
Sbjct: 14   GTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK----LE 69
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE +    ++H N+VRL D    +    +++  +  G L + +  +      E +  + I
Sbjct: 70   REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCI 127
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTS 981
                              +VHRD+KPEN+LL S+++     ++DFG+A  ++        
Sbjct: 128  QQILEAVLHCHQMG----VVHRDLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAW 181
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
                GT GY++PE        K  D+++ GV+L  L+
Sbjct: 182  FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 218

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 78/182 (42%), Gaps = 18/182 (9%)
Query: 843  NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS 902
            N + AVK +  RG K    ++KREI     +RH N+VR ++  L      I+  Y   G 
Sbjct: 43   NELVAVKYIE-RGEKIDE-NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 100
Query: 903  LRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPH 962
            L + + +       E    ++                   + HRD+K EN LLD    P 
Sbjct: 101  LFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ------VCHRDLKLENTLLDGSPAPR 154
Query: 963  --ISDFGIAK--LLDKSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLEL 1017
              I DFG +K  +L   P ST     VGT  YIAPE         K +DV+S GV L  +
Sbjct: 155  LKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 209
Query: 1018 IT 1019
            + 
Sbjct: 210  LV 211

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 85/192 (44%), Gaps = 10/192 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+G+ G V+K        V A+K +     +     +++EI  + +     + +    +
Sbjct: 31   IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L+     I+  Y+  GS  D+L +    P  E+ +   +                   +H
Sbjct: 91   LKGSKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKK----IH 143
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK  N+LL  + +  ++DFG+A  L  +     +   VGT  ++APE    +A   ++
Sbjct: 144  RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIQQSAYDSKA 201
Query: 1006 DVYSYGVVLLEL 1017
            D++S G+  +EL
Sbjct: 202  DIWSLGITAIEL 213

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 40/219 (18%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL----- 881
            IG+G  G V++       V AVK  + R  +  S   + EI     +RH N++       
Sbjct: 12   IGKGRFGEVWRGKWRGEEV-AVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADN 68
Query: 882  ------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX---X 932
                     WL  D       Y E+GSL D L+  T   T+E  ++  +           
Sbjct: 69   KDNGTWTQLWLVSD-------YHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHM 119
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-----VGT 987
                    P I HRD+K +NIL+       I+D G+A   D   ++T +I +     VGT
Sbjct: 120  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGT 176
Query: 988  IGYIAPE------NAFTTAKSKESDVYSYGVVLLELITR 1020
              Y+APE      N       K +D+Y+ G+V  E+  R
Sbjct: 177  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 40/219 (18%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL----- 881
            IG+G  G V++       V AVK  + R  +  S   + EI     +RH N++       
Sbjct: 11   IGKGRFGEVWRGKWRGEEV-AVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 882  ------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX---X 932
                     WL  D       Y E+GSL D L+  T   T+E  ++  +           
Sbjct: 68   KDNGTWTQLWLVSD-------YHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHM 118
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-----VGT 987
                    P I HRD+K +NIL+       I+D G+A   D   ++T +I +     VGT
Sbjct: 119  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGT 175
Query: 988  IGYIAPE------NAFTTAKSKESDVYSYGVVLLELITR 1020
              Y+APE      N       K +D+Y+ G+V  E+  R
Sbjct: 176  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 40/219 (18%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL----- 881
            IG+G  G V++       V AVK  + R  +  S   + EI     +RH N++       
Sbjct: 37   IGKGRFGEVWRGKWRGEEV-AVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADN 93
Query: 882  ------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX---X 932
                     WL  D       Y E+GSL D L+  T   T+E  ++  +           
Sbjct: 94   KDNGTWTQLWLVSD-------YHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHM 144
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-----VGT 987
                    P I HRD+K +NIL+       I+D G+A   D   ++T +I +     VGT
Sbjct: 145  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGT 201
Query: 988  IGYIAPE------NAFTTAKSKESDVYSYGVVLLELITR 1020
              Y+APE      N       K +D+Y+ G+V  E+  R
Sbjct: 202  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 40/219 (18%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL----- 881
            IG+G  G V++       V AVK  + R  +  S   + EI     +RH N++       
Sbjct: 17   IGKGRFGEVWRGKWRGEEV-AVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADN 73
Query: 882  ------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX---X 932
                     WL  D       Y E+GSL D L+  T   T+E  ++  +           
Sbjct: 74   KDNGTWTQLWLVSD-------YHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHM 124
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-----VGT 987
                    P I HRD+K +NIL+       I+D G+A   D   ++T +I +     VGT
Sbjct: 125  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGT 181
Query: 988  IGYIAPE------NAFTTAKSKESDVYSYGVVLLELITR 1020
              Y+APE      N       K +D+Y+ G+V  E+  R
Sbjct: 182  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 40/219 (18%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL----- 881
            IG+G  G V++       V AVK  + R  +  S   + EI     +RH N++       
Sbjct: 14   IGKGRFGEVWRGKWRGEEV-AVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADN 70
Query: 882  ------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX---X 932
                     WL  D       Y E+GSL D L+  T   T+E  ++  +           
Sbjct: 71   KDNGTWTQLWLVSD-------YHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHM 121
Query: 933  XXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-----VGT 987
                    P I HRD+K +NIL+       I+D G+A   D   ++T +I +     VGT
Sbjct: 122  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD---SATDTIDIAPNHRVGT 178
Query: 988  IGYIAPE------NAFTTAKSKESDVYSYGVVLLELITR 1020
              Y+APE      N       K +D+Y+ G+V  E+  R
Sbjct: 179  KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFA---VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVR 880
            +G G   IV K    G    +A   +KK      +RG     ++RE+  + +IRH N++ 
Sbjct: 20   LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW------NVRYKIXXXXXXX 931
            L D +  K   +++   +  G L D L    S+T     ++       V Y         
Sbjct: 80   LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---- 135
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L  +  P+    + DFGIA    K  A     ++ GT
Sbjct: 136  -----------IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGT 181
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 182  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFA---VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVR 880
            +G G   IV K    G    +A   +KK      +RG     ++RE+  + +IRH N++ 
Sbjct: 13   LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW------NVRYKIXXXXXXX 931
            L D +  K   +++   +  G L D L    S+T     ++       V Y         
Sbjct: 73   LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---- 128
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L  +  P+    + DFGIA    K  A     ++ GT
Sbjct: 129  -----------IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGT 174
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 175  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Composition-based stats.
 Identities = 26/99 (26%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRDIKP N+ + +     + D G+ +    S  +T + S+VGT  Y++PE       +
Sbjct: 157  VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041
             +SD++S G +L E+   +    P Y ++ ++    + +
Sbjct: 215  FKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKI 250

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 22/210 (10%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL--EDF 884
            +G+G +G V++ S     V AVK  + R  K  S   + E+     +RH N++     D 
Sbjct: 16   VGKGRYGEVWRGSWQGENV-AVKIFSSRDEK--SWFRETELYNTVMLRHENILGFIASDM 72
Query: 885  WLRKDCG--IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX-XDCDP 941
              R       ++  Y E GSL D L   T        +   I                 P
Sbjct: 73   TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-----VGTIGYIAPENA 996
             I HRD+K +NIL+    +  I+D G+A +  +   ST  + V     VGT  Y+APE  
Sbjct: 133  AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ---STNQLDVGNNPRVGTKRYMAPEVL 189
Query: 997  FTTAK------SKESDVYSYGVVLLELITR 1020
              T +       K  D++++G+VL E+  R
Sbjct: 190  DETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 22/210 (10%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL--EDF 884
            +G+G +G V++ S     V AVK  + R  K  S   + E+     +RH N++     D 
Sbjct: 16   VGKGRYGEVWRGSWQGENV-AVKIFSSRDEK--SWFRETELYNTVMLRHENILGFIASDM 72
Query: 885  WLRKDCG--IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX-XDCDP 941
              R       ++  Y E GSL D L   T        +   I                 P
Sbjct: 73   TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132
Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-----VGTIGYIAPENA 996
             I HRD+K +NIL+    +  I+D G+A +  +   ST  + V     VGT  Y+APE  
Sbjct: 133  AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ---STNQLDVGNNPRVGTKRYMAPEVL 189
Query: 997  FTTAK------SKESDVYSYGVVLLELITR 1020
              T +       K  D++++G+VL E+  R
Sbjct: 190  DETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 83/192 (43%), Gaps = 10/192 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+G+ G V+K        V A+K +     +     +++EI  + +     + +    +
Sbjct: 15   IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L+     I+  Y+  GS  D+L    P P  E  +   +                   +H
Sbjct: 75   LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKK----IH 127
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK  N+LL    E  ++DFG+A  L  +     +   VGT  ++APE    +A   ++
Sbjct: 128  RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQSAYDSKA 185
Query: 1006 DVYSYGVVLLEL 1017
            D++S G+  +EL
Sbjct: 186  DIWSLGITAIEL 197

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 15/207 (7%)
Query: 818  TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRH 875
             E  N   ++G+G+ G V K         +AVK +     K + + ++ RE++ + K+ H
Sbjct: 21   AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXX 935
             N+++L +         I+      G L D +  I      E +    I           
Sbjct: 81   PNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 936  XXDCDPPIVHRDIKPENILLDS---EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
              +    IVHRD+KPENILL+S   + +  I DFG++    +   +T     +GT  YIA
Sbjct: 139  KHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIA 191
Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE    T   K  DV+S GV+L  L++
Sbjct: 192  PEVLRGTYDEK-CDVWSAGVILYILLS 217

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 45/75 (60%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        + ++ GT  Y+APE   +   +
Sbjct: 148  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEIILSKGYN 202
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 203  KAVDWWALGVLIYEM 217

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 45/75 (60%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        + ++ GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 30/79 (37%), Positives = 46/79 (58%), Gaps = 3/79 (3%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--NAFTTA 1000
            I++RDIK ENILLDS     ++DFG++K    +  +  +    GTI Y+AP+      + 
Sbjct: 180  IIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 1001 KSKESDVYSYGVVLLELIT 1019
              K  D +S GV++ EL+T
Sbjct: 239  HDKAVDWWSLGVLMYELLT 257

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 62/303 (20%), Positives = 117/303 (38%), Gaps = 41/303 (13%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 8    AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 68   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 123
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 124  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041
               +  + +++PE+      +  SDV+S+GVVL E+ T     +  Y+  +         
Sbjct: 183  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---EQPYQGLS--------- 230
Query: 1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALR-CTEKKPSNRPNMRDVVRQLVDA 1100
                   N+ V   +ME  L+    D   D+LL  +R C +  P  RP+  +++  + + 
Sbjct: 231  -------NEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEE 282
Query: 1101 SVP 1103
              P
Sbjct: 283  MEP 285

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       IG GA+G V  A      +  AVKKL+  F+ 
Sbjct: 7    SQERPTFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 67   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 121
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 122  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDXELKILDFGL 176
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 177  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 85/198 (42%), Gaps = 17/198 (8%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDF 884
            +G G+  I  K      N  FAVK ++    KR   + ++EI  +     H N+V+L + 
Sbjct: 19   LGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIV 944
            +  +    ++   +  G L + +         E +   +                D  +V
Sbjct: 75   FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH------DVGVV 128
Query: 945  HRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
            HRD+KPEN+L   E   +E  I DFG A+L  K P +    +   T+ Y APE       
Sbjct: 129  HRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 1002 SKESDVYSYGVVLLELIT 1019
             +  D++S GV+L  +++
Sbjct: 187  DESCDLWSLGVILYTMLS 204

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 25   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 84
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 85   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 139
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 140  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 194
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 195  ARHTDDE-----MXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 183  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 238  KAVDWWALGVLIYEM 252

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKXQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 183  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 238  KAVDWWALGVLIYEM 252

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 4    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 64   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 118
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 119  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 173
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 174  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 3/165 (1%)
Query: 159 IPEPLF-RILGLQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESIGNCYR 216
           +P   F R+  L+ ++LN+N L  ++P  +  +LK +E LW+  N+L             
Sbjct: 52  LPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVN 110
Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS 276
           L EL L+ N+L    P    +L  L YL +G N L+       +K  +L  L L  N+  
Sbjct: 111 LAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK 170
Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN 321
                     + L  L +  ++L      +F  L +L  L L EN
Sbjct: 171 RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 81/189 (42%), Gaps = 4/189 (2%)
Query: 182 SIPRNV-GDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
           +IP N+  D K+++   L SN+LS    ++     +L+ LYLN+NKL          L+N
Sbjct: 30  AIPSNIPADTKKLD---LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN 86
Query: 241 LVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT 300
           L  L V DN L+       ++  NL  L L  N+          + + LT+L +  ++L 
Sbjct: 87  LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 301 GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSN 360
                 F  L  L  L L  NQL         K   L  L L  NQL+         L  
Sbjct: 147 SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 361 LQDLELFDN 369
           L+ L+L +N
Sbjct: 207 LKMLQLQEN 215

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 7e-06,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 17   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 77   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 132
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 133  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 191
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 192  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 10/192 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+G+ G V+K        V A+K +     +     +++EI  + +     + +    +
Sbjct: 30   IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L+     I+  Y+  GS  D+L    P P  E  +   +                   +H
Sbjct: 90   LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKK----IH 142
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK  N+LL    E  ++DFG+A  L  +         VGT  ++APE    +A   ++
Sbjct: 143  RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQSAYDSKA 200
Query: 1006 DVYSYGVVLLEL 1017
            D++S G+  +EL
Sbjct: 201  DIWSLGITAIEL 212

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKXQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDXELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 4    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 64   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 118
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 119  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 173
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 174  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++ +  + H N+V+L +    +    ++  Y   G + D L +       E   +++ 
Sbjct: 62   REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 925  XXXXXXXXXXXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    IVHRD+K EN+LLD++M   I+DFG +   ++        +
Sbjct: 121  ------QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDT 171
Query: 984  VVGTIGYIAPENAFTTAKSK--ESDVYSYGVVLLELIT 1019
              G+  Y APE  F   K    E DV+S GV+L  L++
Sbjct: 172  FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/241 (24%), Positives = 107/241 (44%), Gaps = 31/241 (12%)
Query: 794  RSKQDLEIPAQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAV 848
            R    LE+ +QE P++    L K + E  E       +G GA+G V  A      +  AV
Sbjct: 17   RGSHMLEM-SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 75
Query: 849  KKLA--FRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYME 899
            KKL+  F+   H + +    RE++ +  ++H N++ L D +     L +   + +  ++ 
Sbjct: 76   KKLSRPFQSIIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 132
Query: 900  NGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEM 959
               L ++   +      + +V++ I             D    I+HRD+KP N+ ++ + 
Sbjct: 133  GADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDC 185
Query: 960  EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELI 1018
            E  I DFG+A+  D           V T  Y APE         ++ D++S G ++ EL+
Sbjct: 186  ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 1019 T 1019
            T
Sbjct: 241  T 241

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IV+RD+K +NILLD +    I+DFG+ K      A T      GT  YIAPE       +
Sbjct: 140  IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEF--CGTPDYIAPEILLGQKYN 197
Query: 1003 KESDVYSYGVVLLELI 1018
               D +S+GV+L E++
Sbjct: 198  HSVDWWSFGVLLYEML 213

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 1/117 (0%)
Query: 158 EIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYR 216
           E+   LFR L  LQY++L +N+L         DL  +  L+L  NR+S     +    + 
Sbjct: 118 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 177
Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
           L  L L++N++    P +  +L  L+ L +  NNL           + L +L L+ N
Sbjct: 178 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 234

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 7/204 (3%)
Query: 170 QYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNEN-KLM 228
           Q +FL+ N +S     +    + +  LWL SN L+     +      L++L L++N +L 
Sbjct: 34  QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 93
Query: 229 GFLPESLSNLENL--VYLD-VGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGN 285
              P +   L  L  ++LD  G   L   +  G    + L   D +          +LGN
Sbjct: 94  SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 153
Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
              LTHL + G++++     +F  L  L  L L +N+++   P        L  L+L+AN
Sbjct: 154 ---LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 210
Query: 346 QLEGEIPDELGQLSNLQDLELFDN 369
            L     + L  L  LQ L L DN
Sbjct: 211 NLSALPTEALAPLRALQYLRLNDN 234

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++ +  + H N+V+L +    +    ++  Y   G + D L  +      E   R K 
Sbjct: 62   REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL--VAHGRMKEKEARAKF 119
Query: 925  XXXXXXXXXXXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    IVHRD+K EN+LLD++M   I+DFG +   ++        +
Sbjct: 120  RQIVSAVQY-----CHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDT 171
Query: 984  VVGTIGYIAPENAFTTAKSK--ESDVYSYGVVLLELIT 1019
              G+  Y APE  F   K    E DV+S GV+L  L++
Sbjct: 172  FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 4    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 64   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 118
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 119  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 173
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 174  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 1/117 (0%)
Query: 158 EIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYR 216
           E+   LFR L  LQY++L +N+L         DL  +  L+L  NR+S     +    + 
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
           L  L L++N++    P +  +L  L+ L +  NNL           + L +L L+ N
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 7/204 (3%)
Query: 170 QYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNEN-KLM 228
           Q +FL+ N +S     +    + +  LWL SN L+     +      L++L L++N +L 
Sbjct: 35  QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 229 GFLPESLSNLENL--VYLD-VGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGN 285
              P +   L  L  ++LD  G   L   +  G    + L   D +          +LGN
Sbjct: 95  SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154
Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
              LTHL + G++++     +F  L  L  L L +N+++   P        L  L+L+AN
Sbjct: 155 ---LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 346 QLEGEIPDELGQLSNLQDLELFDN 369
            L     + L  L  LQ L L DN
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDN 235

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 14   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQS 73
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 74   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 128
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 129  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 183
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 184  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 14   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 73
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 74   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 128
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 129  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 183
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 184  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 14   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 73
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 74   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 128
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 129  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 183
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 184  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLAGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 7    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 67   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 121
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 122  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 176
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 177  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 32/85 (37%), Positives = 45/85 (52%), Gaps = 6/85 (7%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK- 1001
            IVHRD+K EN+LLD +M   I+DFG +   ++        +  G+  Y APE  F   K 
Sbjct: 135  IVHRDLKAENLLLDGDMNIKIADFGFS---NEFTVGNKLDTFCGSPPYAAPE-LFQGKKY 190
Query: 1002 -SKESDVYSYGVVLLELITRKKALD 1025
               E DV+S GV+L  L++     D
Sbjct: 191  DGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 8    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 68   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 122
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 123  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 177
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 178  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++ +  + H N+V+L +    +    ++  Y   G + D L +       E   +++ 
Sbjct: 62   REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 925  XXXXXXXXXXXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    IVHRD+K EN+LLD++M   I+DFG +   ++        +
Sbjct: 121  ------QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDT 171
Query: 984  VVGTIGYIAPENAFTTAKSK--ESDVYSYGVVLLELIT 1019
              G+  Y APE  F   K    E DV+S GV+L  L++
Sbjct: 172  FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 7    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 67   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 121
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 122  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDXELKILDFGL 176
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 177  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 7    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 66
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 67   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 121
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 122  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 176
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 177  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 42/76 (55%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   N+LL +     I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 180  IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+SYG++L E+ +
Sbjct: 240  QSDVWSYGILLWEIFS 255

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 1    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 60
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 61   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 115
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 116  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 170
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 171  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 13   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 72
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 73   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 127
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 128  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDXELKILDFGL 182
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 183  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 22   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 81
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 82   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 136
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 137  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 191
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 192  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 59/240 (24%), Positives = 106/240 (44%), Gaps = 37/240 (15%)
Query: 794  RSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVKKLA 852
            RS  ++++ A   P+ + + V           ++G G +G VYK   +    + A+K + 
Sbjct: 9    RSLDEIDLSALRDPAGIFELV----------ELVGNGTYGQVYKGRHVKTGQLAAIKVMD 58
Query: 853  FRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK------DCGIIMYRYMENGSLRD 905
              G +   +  K+EI  + K   HRN+      +++K      D   ++  +   GS+ D
Sbjct: 59   VTGDEEEEI--KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 906  VLHSITPPPTL--EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHI 963
            ++ + T   TL  EW     I                  ++HRDIK +N+LL    E  +
Sbjct: 117  LIKN-TKGNTLKEEW-----IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170
Query: 964  SDFGIAKLLDKSPASTTSISVVGTIGYIAP------ENAFTTAKSKESDVYSYGVVLLEL 1017
             DFG++  LD++     +   +GT  ++AP      EN   T   K SD++S G+  +E+
Sbjct: 171  VDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEM 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 105/261 (40%), Gaps = 42/261 (16%)
Query: 824  KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLE 882
            K V+G GA G +    +  N   AVK++             RE+Q + +   H N++R  
Sbjct: 29   KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD----REVQLLRESDEHPNVIRY- 83
Query: 883  DFWLRKD----------CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXX 932
             F   KD          C   +  Y+E    +D  H    P TL       +        
Sbjct: 84   -FCTEKDRQFQYIAIELCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLN- 138
Query: 933  XXXXXDCDPPIVHRDIKPENILL-----DSEMEPHISDFGIAKLLDKSPASTTSIS-VVG 986
                      IVHRD+KP NIL+       +++  ISDFG+ K L     S +  S V G
Sbjct: 139  ----------IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188
Query: 987  TIGYIAPENAFTTAKSKES---DVYSYGVVLLELITR-KKALDPSYKERTDI-VGWVRSV 1041
            T G+IAPE      K   +   D++S G V   +I+        S + + +I +G     
Sbjct: 189  TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248
Query: 1042 WSDTEEINDIVDLSLMEEMLV 1062
                E+  D++   L+E+M+ 
Sbjct: 249  CLHPEKHEDVIARELIEKMIA 269

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 10/192 (5%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+G+ G V+K        V A+K +     +     +++EI  + +     + +    +
Sbjct: 15   IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVH 945
            L+     I+  Y+  GS  D+L    P P  E  +   +                   +H
Sbjct: 75   LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSEKK----IH 127
Query: 946  RDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES 1005
            RDIK  N+LL    E  ++DFG+A  L  +         VGT  ++APE    +A   ++
Sbjct: 128  RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXF--VGTPFWMAPEVIKQSAYDSKA 185
Query: 1006 DVYSYGVVLLEL 1017
            D++S G+  +EL
Sbjct: 186  DIWSLGITAIEL 197

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 21   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 80
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 81   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 135
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 136  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 190
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 191  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 42/76 (55%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   N+LL +     I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 174  IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 233
Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+SYG++L E+ +
Sbjct: 234  QSDVWSYGILLWEIFS 249

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++ +  + H N+V+L +    +    ++  Y   G + D L +       E   +++ 
Sbjct: 62   REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 925  XXXXXXXXXXXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    IVHRD+K EN+LLD++M   I+DFG +   ++        +
Sbjct: 121  ------QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDA 171
Query: 984  VVGTIGYIAPENAFTTAKSK--ESDVYSYGVVLLELIT 1019
              G   Y APE  F   K    E DV+S GV+L  L++
Sbjct: 172  FCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 943  IVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            IVHRD+KPEN+LL+S+ +     I DFG++ + +        +   GT  YIAPE     
Sbjct: 157  IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYIAPE-VLRK 212
Query: 1000 AKSKESDVYSYGVVLLELIT 1019
               ++ DV+S GV+L  L+ 
Sbjct: 213  KYDEKCDVWSIGVILFILLA 232

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAF----RGHKRGSLSMKREIQTIG----KIRHRN 877
            +GRGA+G+V K    P+  + AVK++      +  KR  + +   ++T+        +  
Sbjct: 59   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            L R  D W+   C  +M   ++    + +    T P  +   +   I             
Sbjct: 119  LFREGDVWI---CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 174
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 ++HRD+KP N+L+++  +  + DFGI+  L  S A T      G   Y+APE   
Sbjct: 175  -----VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTID---AGCKPYMAPERIN 226
Query: 998  TTAKSK----ESDVYSYGVVLLEL 1017
                 K    +SD++S G+ ++EL
Sbjct: 227  PELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 13   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 72
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 73   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 127
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 128  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 182
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 183  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 30/76 (39%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IV+RD+K +NILLD +    I+DFG+ K      A T      GT  YIAPE       +
Sbjct: 139  IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF--CGTPDYIAPEILLGQKYN 196
Query: 1003 KESDVYSYGVVLLELI 1018
               D +S+GV+L E++
Sbjct: 197  HSVDWWSFGVLLYEML 212

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 9    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 69   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 123
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 124  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 179  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 8    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L +++ 
Sbjct: 68   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
                    + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 125  C---QKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 177
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 178  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 4    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 63
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 64   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 118
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 119  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDSELKILDFGL 173
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 174  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 155  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 210  KAVDWWALGVLIYEM 224

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 155  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 210  KAVDWWALGVLIYEM 224

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 157  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 211
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 212  KAVDWWALGVLIYEM 226

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 149  LIYRDLKPENLLIDEQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 203
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 204  KAVDWWALGVLIYEM 218

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 42/76 (55%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   N+LL +     I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 182  IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 241
Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+SYG++L E+ +
Sbjct: 242  QSDVWSYGILLWEIFS 257

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 45/75 (60%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG+AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLMIDQQGYIQVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 44/220 (20%)
Query: 162 PLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELY 221
           PL  +  L  + +NNN ++   P  + +L  +  L LF+N+++   P  + N   L  L 
Sbjct: 80  PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 135
Query: 222 LNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISP 281
           L+ N +      +LS L +L            ++NF S +  +L               P
Sbjct: 136 LSSNTISDI--SALSGLTSL-----------QQLNFSSNQVTDL--------------KP 168
Query: 282 NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD---LSENQLSGKIPPELGKCKYLT 338
            L N ++L  LDI  +K+     S   +LA+L++L+    + NQ+S   P  LG    L 
Sbjct: 169 -LANLTTLERLDISSNKV-----SDISVLAKLTNLESLIATNNQISDITP--LGILTNLD 220
Query: 339 VLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
            L L  NQL+      L  L+NL DL+L +N+++   P+S
Sbjct: 221 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 258

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 42/76 (55%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   N+LL +     I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 186  IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 245
Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+SYG++L E+ +
Sbjct: 246  QSDVWSYGILLWEIFS 261

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 827  IGRGAHG-IVYKASLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G +          AVK L     ++    +  E++ +  I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX-XXX 936
            ++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I             
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINRVPEEQMTFKDL 159
Query: 937  XDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
              C   +            +HRD+   N+L+       I+DFG+A+ ++       + + 
Sbjct: 160  VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 220  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 42/76 (55%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+   N+LL +     I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 186  IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 245
Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+SYG++L E+ +
Sbjct: 246  QSDVWSYGILLWEIFS 261

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLXGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 88/197 (44%), Gaps = 15/197 (7%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGH--KRG-SLSMKREIQTIGKIRHRNLVRLED 883
            +G+G  G VY A    +      K+ F+    K G    ++REI+    + H N++RL +
Sbjct: 31   LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 884  FWLRKDCGIIMYRYMENGSL-RDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPP 942
            ++  +    ++  Y   G L +++  S T        +  ++                  
Sbjct: 91   YFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK------- 143
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            ++HRDIKPEN+LL  + E  I+DFG +        S    ++ GT+ Y+ PE       +
Sbjct: 144  VIHRDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEGRMHN 199
Query: 1003 KESDVYSYGVVLLELIT 1019
            ++ D++  GV+  EL+ 
Sbjct: 200  EKVDLWCIGVLCYELLV 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 22   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 81
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 82   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 136
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 137  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 191
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 192  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 70/151 (46%), Gaps = 4/151 (2%)
Query: 220 LYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGI 279
           L L  NKL      +L  L NL YL +  N L+   N   +K  NL  L L  N+     
Sbjct: 68  LALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLP 125
Query: 280 SPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTV 339
                  ++LT+L++  ++L       F  L  L+ LDLS NQL         K   L  
Sbjct: 126 DGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKD 185
Query: 340 LHLYANQLEGEIPDEL-GQLSNLQDLELFDN 369
           L LY NQL+  +PD +  +L++LQ + L DN
Sbjct: 186 LRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 8    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 67
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 68   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 122
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 123  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDSELKILDFGL 177
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 178  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/79 (39%), Positives = 45/79 (56%), Gaps = 7/79 (8%)
Query: 943  IVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            IVHRDIKPENILL+++   +   I DFG++    K       +   GT  YIAPE     
Sbjct: 167  IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---GTAYYIAPE-VLKK 222
Query: 1000 AKSKESDVYSYGVVLLELI 1018
              +++ DV+S GV++  L+
Sbjct: 223  KYNEKCDVWSCGVIMYILL 241

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 8    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 67
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L +++ 
Sbjct: 68   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 124
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
                    + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 125  C---QKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 177
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 178  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++ +  + H N+V+L +    +    ++  Y   G + D L  +      E   R K 
Sbjct: 60   REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKF 117
Query: 925  XXXXXXXXXXXXXDC-DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    IVHRD+K EN+LLD++M   I+DFG +   ++        +
Sbjct: 118  RQIVSAVQY-----CHQKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDT 169
Query: 984  VVGTIGYIAPENAFTTAKSK--ESDVYSYGVVLLELIT 1019
              G+  Y APE  F   K    E DV+S GV+L  L++
Sbjct: 170  FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 206

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFA---VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVR 880
            +G G   IV K    G    +A   +KK      +RG     ++RE+  + +IRH N++ 
Sbjct: 34   LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW------NVRYKIXXXXXXX 931
            L D +  K   +++   +  G L D L    S+T     ++       V Y         
Sbjct: 94   LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL-------- 145
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L  +  P+    + DFGIA    K  A     ++ GT
Sbjct: 146  -------HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEFKNIFGT 195
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 196  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L +++ 
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 118
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
            S       + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 119  S---QKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDSELKILDFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
             +  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  CRHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 46/212 (21%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 827  IGRGAHG-IVYKASLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G +          AVK L     ++    +  E++ +  I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP---------PTLEWNVRYK-IXXX 927
            ++ L     +     ++  Y   G+LR+ L +  PP            E  + +K +   
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 928  XXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
                            +HRD+   N+L+       I+DFG+A+ ++       + +    
Sbjct: 163  TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLP 222
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 223  VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 12   SQERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 71
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 72   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 126
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 127  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 181
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 182  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 21   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 80
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 81   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 135
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 136  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 190
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 191  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++ +  + H N+V+L +    +    ++  Y   G + D L  +      E   R K 
Sbjct: 63   REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKF 120
Query: 925  XXXXXXXXXXXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    IVHRD+K EN+LLD++M   I+DFG +   ++        +
Sbjct: 121  RQIVSAVQY-----CHQKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDA 172
Query: 984  VVGTIGYIAPENAFTTAKSK--ESDVYSYGVVLLELIT 1019
              G   Y APE  F   K    E DV+S GV+L  L++
Sbjct: 173  FCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 209

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 39   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 96
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K+ H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 97   MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 156
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 157  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 217  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 275

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++ +  + H N+V+L +    +    ++  Y   G + D L +       E   +++ 
Sbjct: 62   REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR- 120
Query: 925  XXXXXXXXXXXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    IVHRD+K EN+LLD++M   I+DFG +   ++         
Sbjct: 121  ------QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDE 171
Query: 984  VVGTIGYIAPENAFTTAKSK--ESDVYSYGVVLLELIT 1019
              G+  Y APE  F   K    E DV+S GV+L  L++
Sbjct: 172  FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 208

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 940  DPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
            D  I+HRD+KPEN+LL S+       + DFG+A  L +S     +   VGT  ++APE  
Sbjct: 148  DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES--GLVAGGRVGTPHFMAPEVV 205
Query: 997  FTTAKSKESDVYSYGVVLLELIT 1019
                  K  DV+  GV+L  L++
Sbjct: 206  KREPYGKPVDVWGCGVILFILLS 228

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 827  IGRGAHG-IVYKASLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G +          AVK L     ++    +  E++ +  I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX-XXX 936
            ++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I             
Sbjct: 103  IIHLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINRVPEEQMTFKDL 159
Query: 937  XDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
              C   +            +HRD+   N+L+       I+DFG+A+ ++       + + 
Sbjct: 160  VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 220  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
            RE++ +  + H N+V+L +    +    ++  Y   G + D L +       E   +++ 
Sbjct: 55   REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR- 113
Query: 925  XXXXXXXXXXXXXDCDPP-IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
                          C    IVHRD+K EN+LLD++M   I+DFG +   ++        +
Sbjct: 114  ------QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDT 164
Query: 984  VVGTIGYIAPENAFTTAKSK--ESDVYSYGVVLLELIT 1019
              G+  Y APE  F   K    E DV+S GV+L  L++
Sbjct: 165  FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVS 201

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 22   SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 81
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 82   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 136
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 137  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 191
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 192  ARHTDDE-----MXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 827  IGRGAHG-IVYKASLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G +          AVK L     ++    +  E++ +  I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX-XXX 936
            ++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I             
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINRVPEEQMTFKDL 159
Query: 937  XDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
              C   +            +HRD+   N+L+       I+DFG+A+ ++       + + 
Sbjct: 160  VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 220  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 818  TENLNAKHVIGRGAHGIVYK------ASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIG 871
            TE       +G+GA  +V +             +   KKL+ R H++    ++RE +   
Sbjct: 10   TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK----LEREARICR 65
Query: 872  KIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
             ++H N+VRL D    +    +++  +  G L + +  +      E +  + I       
Sbjct: 66   LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI--VAREYYSEADASHCIQQILEAV 123
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTI 988
                       +VHR++KPEN+LL S+++     ++DFG+A  ++            GT 
Sbjct: 124  LHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTP 177
Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            GY++PE        K  D+++ GV+L  L+
Sbjct: 178  GYLSPEVLRKDPYGKPVDLWACGVILYILL 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 45/75 (60%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG+AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLMIDQQGYIKVTDFGLAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/208 (20%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+ +             AVK +      R  +    E   +      ++VR
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIXXXXXXX 931
            L     +    +++   M +G L+  L S+ P         PPTL+  ++          
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD+   N ++  +    I DFG+ + + ++         +  + ++
Sbjct: 145  YLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      +  SD++S+GVVL E+ +
Sbjct: 200  APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
             +  + H+N++ L + +     L +   + +   + + +L  V+        + + + Y+
Sbjct: 76   LMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-LLYQ 134
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +                  I+HRD+KP NI++ S+    I DFG+A+    S   T    
Sbjct: 135  MLXGIKHLHSAG-------IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT---P 184
Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
             V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 185  YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 226

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 24/75 (32%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIKVADFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+K +N+LLDSE    ++D+G+ K     P  TTS +  GT  YIAPE        
Sbjct: 174  IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNYIAPEILRGEDYG 231
Query: 1003 KESDVYSYGVVLLELITRKKALD 1025
               D ++ GV++ E++  +   D
Sbjct: 232  FSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 827  IGRGAHG-IVYKASLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G +          AVK L     ++    +  E++ +  I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX-XXX 936
            ++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I             
Sbjct: 103  IINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINRVPEEQMTFKDL 159
Query: 937  XDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
              C   +            +HRD+   N+L+       I+DFG+A+ ++       + + 
Sbjct: 160  VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 220  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 45/220 (20%)
Query: 162 PLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELY 221
           PL  +  L  + +NNN ++   P  + +L  +  L LF+N+++   P  + N   L  L 
Sbjct: 80  PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 135
Query: 222 LNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISP 281
           L+ N +      +LS L +L            ++NFG++                  + P
Sbjct: 136 LSSNTISDI--SALSGLTSL-----------QQLNFGNQVTD---------------LKP 167
Query: 282 NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD---LSENQLSGKIPPELGKCKYLT 338
            L N ++L  LDI  +K+     S   +LA+L++L+    + NQ+S   P  LG    L 
Sbjct: 168 -LANLTTLERLDISSNKV-----SDISVLAKLTNLESLIATNNQISDITP--LGILTNLD 219
Query: 339 VLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
            L L  NQL+      L  L+NL DL+L +N+++   P+S
Sbjct: 220 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 257

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLMIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 76   LMKXVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLXQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 226

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 39   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 96
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 97   MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 156
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 157  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 217  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 275

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 16   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 73
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 74   MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 133
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEME---PHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 134  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 193
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 194  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 827  IGRGAHG-IVYKASLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G +          AVK L     ++    +  E++ +  I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX-XXX 936
            ++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I             
Sbjct: 103  IITLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINRVPEEQMTFKDL 159
Query: 937  XDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
              C   +            +HRD+   N+L+       I+DFG+A+ ++       + + 
Sbjct: 160  VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 220  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 45/220 (20%)
Query: 162 PLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELY 221
           PL  +  L  + +NNN ++   P  + +L  +  L LF+N+++   P  + N   L  L 
Sbjct: 80  PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 135
Query: 222 LNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISP 281
           L+ N +      +LS L +L            ++NFG++                  + P
Sbjct: 136 LSSNTISDI--SALSGLTSL-----------QQLNFGNQVTD---------------LKP 167
Query: 282 NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD---LSENQLSGKIPPELGKCKYLT 338
            L N ++L  LDI  +K+     S   +LA+L++L+    + NQ+S   P  LG    L 
Sbjct: 168 -LANLTTLERLDISSNKV-----SDISVLAKLTNLESLIATNNQISDITP--LGILTNLD 219
Query: 339 VLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
            L L  NQL+      L  L+NL DL+L +N+++   P+S
Sbjct: 220 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 257

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 3/97 (3%)
Query: 279 ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLT 338
           IS N+     LT L + G+ LT  +P+    L+ L  LDLS N+L+  +P ELG C  L 
Sbjct: 239 ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS-LPAELGSCFQLK 296
Query: 339 VLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEF 375
             + + N +   +P E G L NLQ L +  N L  +F
Sbjct: 297 YFYFFDNMVTT-LPWEFGNLCNLQFLGVEGNPLEKQF 332

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 93/227 (40%), Gaps = 21/227 (9%)
Query: 799  LEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVY-KASLGPNAVFAVKKLAFRGHK 857
            ++ PA  GP  L   ++  ++       IG G  G+         N + AVK +  RG K
Sbjct: 1    MDRPAVSGPMDL--PIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-RGEK 57
Query: 858  RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE 917
                ++KREI     +RH N+VR ++  L      I+  Y   G L + + +       E
Sbjct: 58   IDE-NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 116
Query: 918  WNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPH--ISDFGIAK--LLD 973
                ++                   + HRD+K EN LLD    P   I  FG +K  +L 
Sbjct: 117  ARFFFQQLISGVSYCHAMQ------VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH 170
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELIT 1019
              P ST     VGT  YIAPE         K +DV+S GV L  ++ 
Sbjct: 171  SQPKST-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 43/78 (55%), Gaps = 7/78 (8%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGYIAPEN-AFTTA 1000
            +V+RD+KP NILLD      ISD G+A     K P ++     VGT GY+APE      A
Sbjct: 313  VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 1001 KSKESDVYSYGVVLLELI 1018
                +D +S G +L +L+
Sbjct: 368  YDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 43/78 (55%), Gaps = 7/78 (8%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGYIAPEN-AFTTA 1000
            +V+RD+KP NILLD      ISD G+A     K P ++     VGT GY+APE      A
Sbjct: 313  VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 1001 KSKESDVYSYGVVLLELI 1018
                +D +S G +L +L+
Sbjct: 368  YDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 43/78 (55%), Gaps = 7/78 (8%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGYIAPEN-AFTTA 1000
            +V+RD+KP NILLD      ISD G+A     K P ++     VGT GY+APE      A
Sbjct: 312  VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 366
Query: 1001 KSKESDVYSYGVVLLELI 1018
                +D +S G +L +L+
Sbjct: 367  YDSSADWFSLGCMLFKLL 384

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 13   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 73   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS---- 128
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 129  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 188  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 98/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 25   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K+ H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 83   MEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 142
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 143  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 202
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 203  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 261

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 43/78 (55%), Gaps = 7/78 (8%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIA-KLLDKSPASTTSISVVGTIGYIAPEN-AFTTA 1000
            +V+RD+KP NILLD      ISD G+A     K P ++     VGT GY+APE      A
Sbjct: 313  VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 367
Query: 1001 KSKESDVYSYGVVLLELI 1018
                +D +S G +L +L+
Sbjct: 368  YDSSADWFSLGCMLFKLL 385

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 24   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 82   MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 142  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 202  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 260

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKVVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLSQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLVGIKHLHSAG-------IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S GV++ E+I
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 16   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 76   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 131
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 132  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 191  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 867  IQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
            ++ IGK  H+N++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I  
Sbjct: 86   MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINR 140
Query: 927  XXXXXXX-XXXXDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLD 973
                         C   +            +HRD+   N+L+       I+DFG+A+ ++
Sbjct: 141  VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                   + +    + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 201  NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 14   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 74   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 129
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 130  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 189  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 17   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 77   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 132
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 133  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 191
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 192  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 26/212 (12%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL-------V 879
            IG+G +G V+        V AVK   F   +  S   + EI     +RH N+       +
Sbjct: 45   IGKGRYGEVWMGKWRGEKV-AVK--VFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK-IXXXXXXXXXXXXXD 938
            +    W +     ++  Y ENGSL D L S T        + Y  +              
Sbjct: 102  KGTGSWTQL---YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIA-KLL-DKSPASTTSISVVGTIGYIAPE-- 994
              P I HRD+K +NIL+       I+D G+A K + D +       + VGT  Y+ PE  
Sbjct: 159  GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 995  ------NAFTTAKSKESDVYSYGVVLLELITR 1020
                  N F +     +D+YS+G++L E+  R
Sbjct: 219  DESLNRNHFQSYIM--ADMYSFGLILWEVARR 248

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 24   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 82   MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 142  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 202  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 260

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 827  IGRGAHG-IVYKASLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G +          AVK L     ++    +  E++ +  I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX-XXX 936
            ++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I             
Sbjct: 103  IINLLGACTQDGPLYVIVAYASKGNLREYLRA-RRPPGMEYS--YDINRVPEEQMTFKDL 159
Query: 937  XDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
              C   +            +HRD+   N+L+       I+DFG+A+ ++       + + 
Sbjct: 160  VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 220  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG--HKRGSLSMKRE 866
            K + E  E       +G GA+G V  A         AVKKL+  F+   H + +    RE
Sbjct: 11   KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY---RE 67
Query: 867  IQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            ++ +  ++H N++ L D +     L +   + +  ++    L ++   +      + +V+
Sbjct: 68   LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQ 124
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
            + I             D    I+HRD+KP N+ ++ + E  I DFG+A+  D   A    
Sbjct: 125  FLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA---- 176
Query: 982  ISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
               V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 177  -GFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 41   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 98
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 99   MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 158
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 159  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 218
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 219  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 277

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLIIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIIISKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 65   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 122
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 123  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 183  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 243  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 301

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I D+G+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDYGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 9    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 69   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 123
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 124  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+       +      V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 179  AR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 10   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 70   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 125
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 126  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 185  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 25/227 (11%)
Query: 810  LLKQVIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRG--HKRGSLS 862
            L K V E  + L     +G GA+G V   Y A L      AVKKL+  F+   H R +  
Sbjct: 11   LNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTY- 67
Query: 863  MKREIQTIGKIRHRNLVRLED-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL-EWNV 920
              RE++ +  ++H N++ L D F            Y+    +   L++I     L + +V
Sbjct: 68   --RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHV 125
Query: 921  RYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
            ++ +                  I+HRD+KP N+ ++ + E  I DFG+A+  D+      
Sbjct: 126  QFLVYQLLRGLKYIHSAG----IIHRDLKPSNVAVNEDCELRILDFGLARQADEE----- 176
Query: 981  SISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRKKALDP 1026
                V T  Y APE         ++ D++S G ++ EL+ + KAL P
Sbjct: 177  MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFP 222

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 9    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 69   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 123
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 124  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+       +      V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 179  AR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 45/83 (54%), Gaps = 2/83 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+K +N+LLDSE    ++D+G+ K     P  TTS    GT  YIAPE        
Sbjct: 131  IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS-XFCGTPNYIAPEILRGEDYG 188
Query: 1003 KESDVYSYGVVLLELITRKKALD 1025
               D ++ GV++ E++  +   D
Sbjct: 189  FSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 31/186 (16%)
Query: 848  VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            +KK   +  +RG     ++RE+  + +I+H N++ L + +  K   I++   +  G L D
Sbjct: 44   IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 906  VL---HSITPPPTLEW-----NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDS 957
             L    S+T     E+     N  Y +                  I H D+KPENI+L  
Sbjct: 104  FLAEKESLTEEEATEFLKQILNGVYYLHSLQ--------------IAHFDLKPENIMLLD 149
Query: 958  EMEP----HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
               P     I DFG+A  +D         ++ GT  ++APE         E+D++S GV+
Sbjct: 150  RNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 1014 LLELIT 1019
               L++
Sbjct: 207  TYILLS 212

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 867  IQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
            ++ IGK  H+N++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I  
Sbjct: 94   MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINR 148
Query: 927  XXXXXXX-XXXXDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLD 973
                         C   +            +HRD+   N+L+       I+DFG+A+ ++
Sbjct: 149  VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                   + +    + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 209  NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 9    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 68
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 69   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 123
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+
Sbjct: 124  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGL 178
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+       +      V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 179  AR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 45   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 105  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 160
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 161  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 219
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 220  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 827  IGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            IG GA GIV   +   LG N   AVKKL+  F+       +  RE+  +  + H+N++ L
Sbjct: 30   IGSGAQGIVCAAFDTVLGINV--AVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 86
Query: 882  EDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
             + +     L +   + +   + + +L  V+H       + + + Y++            
Sbjct: 87   LNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSY-LLYQMLCGIKHLHSAG- 144
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV--VGTIGYIAPE 994
                  I+HRD+KP NI++ S+    I DFG+A+      AST  +    V T  Y APE
Sbjct: 145  ------IIHRDLKPSNIVVKSDCTLKILDFGLAR-----TASTNFMMTPYVVTRYYRAPE 193
Query: 995  NAFTTAKSKESDVYSYGVVLLELI 1018
                    +  D++S G ++ EL+
Sbjct: 194  VILGMGYKENVDIWSVGCIMGELV 217

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 31/228 (13%)
Query: 812  KQVIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRG--HKRGSLSMK 864
            K V E  + L     +G GA+G V   Y A L      AVKKL+  F+   H R +    
Sbjct: 21   KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTY--- 75
Query: 865  REIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            RE++ +  ++H N++ L D +     +     + +   +    L +++ S          
Sbjct: 76   RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF 135
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST 979
            + Y++                  I+HRD+KP N+ ++ + E  I DFG+A+  D+     
Sbjct: 136  LVYQLLRGLKYIHSAG-------IIHRDLKPSNVAVNEDSELRILDFGLARQADEE---- 184
Query: 980  TSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRKKALDP 1026
                 V T  Y APE         ++ D++S G ++ EL+ + KAL P
Sbjct: 185  -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFP 230

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 163  LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 218  KAVDWWALGVLIYEM 232

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ ++
Sbjct: 217  KAVDWWALGVLIYQM 231

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+++D +    ++DFG AK +        +  + GT  Y+APE   +   +
Sbjct: 162  LIYRDLKPENLMIDQQGYIKVTDFGFAKRV-----KGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 25   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 83   MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 142
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 143  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 202
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 203  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 261

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 6/80 (7%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--NAFTTAK 1001
            VHRDIKP+N+LLD      ++DFG    ++      +S++ VGT  YI+PE   A     
Sbjct: 213  VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA-VGTPDYISPEILQAMEDGM 271
Query: 1002 SK---ESDVYSYGVVLLELI 1018
             K   E D +S GV + E++
Sbjct: 272  GKYGPECDWWSLGVCMYEML 291

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVVAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKVVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLSQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLVGIKHLHSAG-------IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S GV++ E+I
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 867  IQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
            ++ IGK  H+N++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I  
Sbjct: 83   MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINR 137
Query: 927  XXXXXXX-XXXXDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLD 973
                         C   +            +HRD+   N+L+       I+DFG+A+ ++
Sbjct: 138  VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                   + +    + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 198  NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 867  IQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
            ++ IGK  H+N++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I  
Sbjct: 81   MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA-RRPPGMEYS--YDINR 135
Query: 927  XXXXXXX-XXXXDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLD 973
                         C   +            +HRD+   N+L+       I+DFG+A+ ++
Sbjct: 136  VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                   + +    + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 196  NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 45/83 (54%), Gaps = 2/83 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+K +N+LLDSE    ++D+G+ K     P  TTS    GT  YIAPE        
Sbjct: 127  IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS-XFCGTPNYIAPEILRGEDYG 184
Query: 1003 KESDVYSYGVVLLELITRKKALD 1025
               D ++ GV++ E++  +   D
Sbjct: 185  FSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 39   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFL 96
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 97   MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 156
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 157  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 217  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 275

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 41/248 (16%)
Query: 792  RRRSKQDLEIPAQEGPSYLLKQVIEATE-------NLNAKHVIGRGAHGIVYKASLGPNA 844
            +R S   ++IPA   P     +++ A +        ++   ++G G  G V+K       
Sbjct: 57   KRTSALAVDIPAPPAP--FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114
Query: 845  V-FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSL 903
            +  A K +  RG K     +K EI  + ++ H NL++L D +  K+  +++  Y++ G L
Sbjct: 115  LKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 904  RDVL----HSITPPPTLEW------NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENI 953
             D +    +++T   T+ +       +R+                    I+H D+KPENI
Sbjct: 174  FDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---------------ILHLDLKPENI 218
Query: 954  LLDSEMEPHIS--DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYG 1011
            L  +     I   DFG+A+     P     ++  GT  ++APE       S  +D++S G
Sbjct: 219  LCVNRDAKQIKIIDFGLARRY--KPREKLKVN-FGTPEFLAPEVVNYDFVSFPTDMWSVG 275
Query: 1012 VVLLELIT 1019
            V+   L++
Sbjct: 276  VIAYMLLS 283

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 16   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 76   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 131
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 132  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 191  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 23   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 83   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS---- 138
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 139  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 198  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 45/83 (54%), Gaps = 2/83 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+K +N+LLDSE    ++D+G+ K     P  TTS    GT  YIAPE        
Sbjct: 142  IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS-XFCGTPNYIAPEILRGEDYG 199
Query: 1003 KESDVYSYGVVLLELITRKKALD 1025
               D ++ GV++ E++  +   D
Sbjct: 200  FSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 45/77 (58%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +VHRD+   NIL+    +  ISDFG+++ + +  +          + ++A E+ F    +
Sbjct: 171  LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDV+S+GV+L E++T
Sbjct: 231  TQSDVWSFGVLLWEIVT 247

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 46/218 (21%), Positives = 86/218 (39%), Gaps = 20/218 (9%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 23   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 83   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 138
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N ++  +    I DFG+ + + ++      
Sbjct: 139  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +  + +++PE+      +  SDV+S+GVVL E+ T
Sbjct: 198  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 45/77 (58%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +VHRD+   NIL+    +  ISDFG+++ + +  +          + ++A E+ F    +
Sbjct: 171  LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDV+S+GV+L E++T
Sbjct: 231  TQSDVWSFGVLLWEIVT 247

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 31   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 88
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 89   MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 148
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 149  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 208
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 209  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 267

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 6/80 (7%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--NAFTTAK 1001
            VHRDIKP+N+LLD      ++DFG    ++      +S++ VGT  YI+PE   A     
Sbjct: 197  VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA-VGTPDYISPEILQAMEDGM 255
Query: 1002 SK---ESDVYSYGVVLLELI 1018
             K   E D +S GV + E++
Sbjct: 256  GKYGPECDWWSLGVCMYEML 275

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 28/223 (12%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 15   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 68
Query: 869  TIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK 923
             +  + H+N++ L + +     L +   + +   + + +L  V+        + + + Y+
Sbjct: 69   LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-LLYQ 127
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            +                  I+HRD+KP NI++ S+    I DFG+A+    S   T    
Sbjct: 128  MLXGIKHLHSAG-------IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT---P 177
Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
             V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 178  YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 219

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 25   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 82
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 83   MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 142
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 143  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRK 202
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 203  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 261

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 42   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 99
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 100  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 159
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 160  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 219
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 220  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 278

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 76/177 (42%), Gaps = 19/177 (10%)
Query: 851  LAFRGHKRGSL---SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL 907
            +A +  +RG+    +++REI     +RH N+VR ++  L      I+  Y   G L + +
Sbjct: 48   VAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI 107
Query: 908  HSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPH--ISD 965
             +       E    ++                   I HRD+K EN LLD    P   I D
Sbjct: 108  CNAGRFSEDEARFFFQQLLSGVSYCHSMQ------ICHRDLKLENTLLDGSPAPRLKICD 161
Query: 966  FGIAK--LLDKSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELIT 1019
            FG +K  +L   P ST     VGT  YIAPE         K +DV+S GV L  ++ 
Sbjct: 162  FGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 76   LMKXVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLCQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 226

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 31/186 (16%)
Query: 848  VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            +KK   +  +RG     ++RE+  + +I+H N++ L + +  K   I++   +  G L D
Sbjct: 44   IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 906  VL---HSITPPPTLEW-----NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDS 957
             L    S+T     E+     N  Y +                  I H D+KPENI+L  
Sbjct: 104  FLAEKESLTEEEATEFLKQILNGVYYLHSLQ--------------IAHFDLKPENIMLLD 149
Query: 958  EMEP----HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
               P     I DFG+A  +D         ++ GT  ++APE         E+D++S GV+
Sbjct: 150  RNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 1014 LLELIT 1019
               L++
Sbjct: 207  TYILLS 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 45/77 (58%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +VHRD+   NIL+    +  ISDFG+++ + +  +          + ++A E+ F    +
Sbjct: 171  LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 1003 KESDVYSYGVVLLELIT 1019
             +SDV+S+GV+L E++T
Sbjct: 231  TQSDVWSFGVLLWEIVT 247

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 31/186 (16%)
Query: 848  VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            +KK   +  +RG     ++RE+  + +I+H N++ L + +  K   I++   +  G L D
Sbjct: 44   IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 906  VL---HSITPPPTLEW-----NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDS 957
             L    S+T     E+     N  Y +                  I H D+KPENI+L  
Sbjct: 104  FLAEKESLTEEEATEFLKQILNGVYYLHSLQ--------------IAHFDLKPENIMLLD 149
Query: 958  EMEP----HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
               P     I DFG+A  +D         ++ GT  ++APE         E+D++S GV+
Sbjct: 150  RNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 1014 LLELIT 1019
               L++
Sbjct: 207  TYILLS 212

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 43/75 (57%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK- 1001
            I+HRDIKP N+L+  +    I+DFG++     S A  +  + VGT  ++APE+   T K 
Sbjct: 158  IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS--NTVGTPAFMAPESLSETRKI 215
Query: 1002 --SKESDVYSYGVVL 1014
               K  DV++ GV L
Sbjct: 216  FSGKALDVWAMGVTL 230

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 827  IGRGAHG-IVYKASLGPN-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRN 877
            +G GA G +V   ++G +          AVK L     ++    +  E++ +  I +H+N
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXX-XXX 936
            ++ L     +     ++  Y   G+LR+ L +   PP +E++  Y I             
Sbjct: 103  IINLLGACTQDGPLYVIVGYASKGNLREYLRA-RRPPGMEYS--YDINRVPEEQMTFKDL 159
Query: 937  XDCDPPI------------VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
              C   +            +HRD+   N+L+       I+DFG+A+ ++       + + 
Sbjct: 160  VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 220  RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 31/186 (16%)
Query: 848  VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            +KK   +  +RG     ++RE+  + +I+H N++ L + +  K   I++   +  G L D
Sbjct: 43   IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 906  VL---HSITPPPTLEW-----NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDS 957
             L    S+T     E+     N  Y +                  I H D+KPENI+L  
Sbjct: 103  FLAEKESLTEEEATEFLKQILNGVYYLHSLQ--------------IAHFDLKPENIMLLD 148
Query: 958  EMEP----HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
               P     I DFG+A  +D         ++ GT  ++APE         E+D++S GV+
Sbjct: 149  RNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205
Query: 1014 LLELIT 1019
               L++
Sbjct: 206  TYILLS 211

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 48/186 (25%), Positives = 81/186 (43%), Gaps = 31/186 (16%)
Query: 848  VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            +KK   +  +RG     ++RE+  + +I+H N++ L + +  K   I++   +  G L D
Sbjct: 44   IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103
Query: 906  VL---HSITPPPTLEW-----NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDS 957
             L    S+T     E+     N  Y +                  I H D+KPENI+L  
Sbjct: 104  FLAEKESLTEEEATEFLKQILNGVYYLHSLQ--------------IAHFDLKPENIMLLD 149
Query: 958  EMEP----HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVV 1013
               P     I DFG+A  +D         ++ GT  ++APE         E+D++S GV+
Sbjct: 150  RNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
Query: 1014 LLELIT 1019
               L++
Sbjct: 207  TYILLS 212

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 15/178 (8%)
Query: 848  VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            +KK   R  +RG     ++RE+  + ++ H N++ L D +  +   +++   +  G L D
Sbjct: 45   IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 906  VLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENI-LLDSEME-PHI 963
             L         E     K                   I H D+KPENI LLD  +  PHI
Sbjct: 105  FLAQKESLSEEEATSFIKQILDGVNYLHTKK------IAHFDLKPENIMLLDKNIPIPHI 158
Query: 964  S--DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               DFG+A  ++         ++ GT  ++APE         E+D++S GV+   L++
Sbjct: 159  KLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 815 IEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKR-GSLSMKREIQTIGK 872
           ++  +N   KH+IGRG++G VY A     N   A+KK+            + REI  + +
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 873 IRHRNLVRLEDFWLRKDCGII--MYRYME--NGSLRDVLHSITPPPTLEWNVRYKIXXXX 928
           ++   ++RL D  + +D      +Y  +E  +  L+ +    TP    E +V+  +    
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFK--TPIFLTEQHVKTILYNLL 141
Query: 929 XXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD 973
                      +  I+HRD+KP N LL+ +    I DFG+A+ ++
Sbjct: 142 LGEKFIH----ESGIIHRDLKPANCLLNQDCSVKICDFGLARTIN 182

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 15/178 (8%)
Query: 848  VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            +KK   R  +RG     ++RE+  + ++ H N++ L D +  +   +++   +  G L D
Sbjct: 45   IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 906  VLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENI-LLDSEME-PHI 963
             L         E     K                   I H D+KPENI LLD  +  PHI
Sbjct: 105  FLAQKESLSEEEATSFIKQILDGVNYLHTKK------IAHFDLKPENIMLLDKNIPIPHI 158
Query: 964  S--DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               DFG+A  ++         ++ GT  ++APE         E+D++S GV+   L++
Sbjct: 159  KLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 15/178 (8%)
Query: 848  VKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
            +KK   R  +RG     ++RE+  + ++ H N++ L D +  +   +++   +  G L D
Sbjct: 45   IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 906  VLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENI-LLDSEME-PHI 963
             L         E     K                   I H D+KPENI LLD  +  PHI
Sbjct: 105  FLAQKESLSEEEATSFIKQILDGVNYLHTKK------IAHFDLKPENIMLLDKNIPIPHI 158
Query: 964  S--DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               DFG+A  ++         ++ GT  ++APE         E+D++S GV+   L++
Sbjct: 159  KLIDFGLAHEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/168 (22%), Positives = 70/168 (41%), Gaps = 22/168 (13%)
Query: 867  IQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXX 926
            ++ IGK  H+N++ L     +     ++  Y   G+LR+ L +  PP      + Y    
Sbjct: 140  MKMIGK--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP-----GMEYSYDI 192
Query: 927  XXXXXXXXXXXD---------------CDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
                       D                    +HRD+   N+L+       I+DFG+A+ 
Sbjct: 193  NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 972  LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            ++       + +    + ++APE  F    + +SDV+S+GV++ E+ T
Sbjct: 253  INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLXQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLXGIKHLHSAG-------IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 810  LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG--HKRGSLSMK 864
            L K + E  E       +G GA+G V  A         AVKKL+  F+   H + +    
Sbjct: 9    LAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY--- 65
Query: 865  REIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            RE++ +  ++H N++ L D +     L +   + +  ++    L +++         + +
Sbjct: 66   RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---AKLTDDH 122
Query: 920  VRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST 979
            V++ I             D    I+HRD+KP N+ ++ + E  I DFG+A+  D      
Sbjct: 123  VQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 174
Query: 980  TSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
                 V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 175  -MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 13/240 (5%)
Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLG--PNA----VFAVKKLAFRGHKRGSLSMK 864
            LK+V    +N+     +G GA G VY+  +   PN       AVK L     ++  L   
Sbjct: 51   LKEV--PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 108
Query: 865  REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-K 923
             E   I K  H+N+VR     L+     I+   M  G L+  L    P P+   ++    
Sbjct: 109  MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 168
Query: 924  IXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLLDKSPASTT 980
            +               +   +HRDI   N LL          I DFG+A+ + ++     
Sbjct: 169  LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 228
Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040
                +  + ++ PE       + ++D +S+GV+L E+ +      PS K   +++ +V S
Sbjct: 229  GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTS 287

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 62/303 (20%), Positives = 116/303 (38%), Gaps = 41/303 (13%)
Query: 817  ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            A E +     +G+G+ G+VY+          P    A+K +      R  +    E   +
Sbjct: 10   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVR 921
             +    ++VRL     +    +++   M  G L+  L S+ P         PP+L     
Sbjct: 70   KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS---- 125
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
             K+                   VHRD+   N  +  +    I DFG+ + + ++      
Sbjct: 126  -KMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041
               +  + +++PE+      +  SDV+S+GVVL E+ T     +  Y+  +         
Sbjct: 185  GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA---EQPYQGLS--------- 232
Query: 1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALR-CTEKKPSNRPNMRDVVRQLVDA 1100
                   N+ V   +ME  L+    D   D+LL  +R C +  P  RP+  +++  + + 
Sbjct: 233  -------NEQVLRFVMEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEE 284
Query: 1101 SVP 1103
              P
Sbjct: 285  MEP 287

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 44/220 (20%)
Query: 162 PLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELY 221
           PL  +  L  + +NNN ++   P  + +L  +  L LF+N+++   P  + N   L  L 
Sbjct: 80  PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 135
Query: 222 LNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISP 281
           L+ N +      +LS L +L            +++F S +  +L               P
Sbjct: 136 LSSNTISDI--SALSGLTSL-----------QQLSFSSNQVTDL--------------KP 168
Query: 282 NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD---LSENQLSGKIPPELGKCKYLT 338
            L N ++L  LDI  +K+     S   +LA+L++L+    + NQ+S   P  LG    L 
Sbjct: 169 -LANLTTLERLDISSNKV-----SDISVLAKLTNLESLIATNNQISDITP--LGILTNLD 220
Query: 339 VLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
            L L  NQL+      L  L+NL DL+L +N+++   P+S
Sbjct: 221 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 258

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 44/220 (20%)
Query: 162 PLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELY 221
           PL  +  L  + +NNN ++   P  + +L  +  L LF+N+++   P  + N   L  L 
Sbjct: 80  PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 135
Query: 222 LNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISP 281
           L+ N +      +LS L +L            +++F S +  +L               P
Sbjct: 136 LSSNTISDI--SALSGLTSL-----------QQLSFSSNQVTDL--------------KP 168
Query: 282 NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD---LSENQLSGKIPPELGKCKYLT 338
            L N ++L  LDI  +K+     S   +LA+L++L+    + NQ+S   P  LG    L 
Sbjct: 169 -LANLTTLERLDISSNKV-----SDISVLAKLTNLESLIATNNQISDITP--LGILTNLD 220
Query: 339 VLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
            L L  NQL+      L  L+NL DL+L +N+++   P+S
Sbjct: 221 ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS 258

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG--HKRGSLSMKRE 866
            K + E  E       +G GA+G V  A      +  AVKKL+  F+   H + +    RE
Sbjct: 13   KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY---RE 69
Query: 867  IQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            ++ +  ++H N++ L D +     L +   + +  ++    L ++   +      + +V+
Sbjct: 70   LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQ 126
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
            + I             D    I+HRD+KP N+ ++ + E  I DFG+A+  D        
Sbjct: 127  FLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----M 177
Query: 982  ISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
               V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 178  TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 7/204 (3%)
Query: 170 QYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMG 229
           Q +FL+ N +S     +    + +  LWL SN L+G    +      L++L L++N  + 
Sbjct: 34  QRIFLHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLR 93
Query: 230 FL-PESLSNLENL--VYLD-VGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGN 285
            + P +   L +L  ++LD  G   L   +  G    + L   D +          +LGN
Sbjct: 94  VVDPTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQALPDNTFRDLGN 153
Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
              LTHL + G+++      +F  L  L  L L +N ++   P        L  L+L+AN
Sbjct: 154 ---LTHLFLHGNRIPSVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFAN 210
Query: 346 QLEGEIPDELGQLSNLQDLELFDN 369
            L     + L  L +LQ L L DN
Sbjct: 211 NLSMLPAEVLVPLRSLQYLRLNDN 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 60   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 113
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 114  LMKCVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLCQVIQMELDHERMSY 168
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 169  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 221  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 264

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 805  EGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG-- 855
            E P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+   
Sbjct: 1    ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSI 910
            H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++   +
Sbjct: 61   HAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---V 114
Query: 911  TPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK 970
                  + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+A+
Sbjct: 115  KCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLAR 170
Query: 971  LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
              D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 171  HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 19   LGSGQFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 78   TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 135  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 181  PAFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 43/75 (57%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT  Y+AP    +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEYLAPAIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL-EWNVRYKI 924
            EI  + ++ H N++++ D +  ++ G       ++GS  D+   I   P L E    Y  
Sbjct: 79   EIAILSRVEHANIIKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 925  XXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
                         D    I+HRDIK ENI++  +    + DFG A  L++     T    
Sbjct: 137  RQLVSAVGYLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---F 189
Query: 985  VGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELI 1018
             GTI Y APE       +  E +++S GV L  L+
Sbjct: 190  CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 812  KQVIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRG--HKRGSLSMK 864
            K V E  + L     +G GA+G V   Y A L      AVKKL+  F+   H R +    
Sbjct: 21   KTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKV--AVKKLSRPFQSLIHARRTY--- 75
Query: 865  REIQTIGKIRHRNLVRLED-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL-EWNVRY 922
            RE++ +  ++H N++ L D F            Y+    +   L++I     L + +V++
Sbjct: 76   RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF 135
Query: 923  KIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
             +                  I+HRD+KP N+ ++ + E  I DFG+A+  D+        
Sbjct: 136  LVYQLLRGLKYIHSAG----IIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MT 186
Query: 983  SVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELITRKKALDP 1026
              V T  Y APE         ++ D++S G ++ EL+ + KAL P
Sbjct: 187  GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-QGKALFP 230

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 30/230 (13%)
Query: 805  EGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG-- 855
            E P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+   
Sbjct: 1    ERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 60
Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSI 910
            H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++   +
Sbjct: 61   HAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---V 114
Query: 911  TPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK 970
                  + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG+A+
Sbjct: 115  KCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLAR 170
Query: 971  LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
              D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 171  HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 26/219 (11%)
Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG--HKRGSLSMKRE 866
            K + E  E       +G GA+G V  A      +  AVKKL+  F+   H + +    RE
Sbjct: 11   KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY---RE 67
Query: 867  IQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            ++ +  ++H N++ L D +     L +   + +  ++    L ++   +      + +V+
Sbjct: 68   LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQ 124
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
            + I             D    I+HRD+KP N+ ++ + E  I DFG+A+  D        
Sbjct: 125  FLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----M 175
Query: 982  ISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
               V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 176  TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 2/74 (2%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRDIK  NILL++E    ++DFG+A  L    A      V+GT  ++APE       + 
Sbjct: 147  IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRN--XVIGTPFWMAPEVIQEIGYNC 204
Query: 1004 ESDVYSYGVVLLEL 1017
             +D++S G+  +E+
Sbjct: 205  VADIWSLGITAIEM 218

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 92/227 (40%), Gaps = 21/227 (9%)
Query: 799  LEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVY-KASLGPNAVFAVKKLAFRGHK 857
            ++ PA  GP  L   ++  ++       IG G  G+         N + AVK +  RG K
Sbjct: 1    MDRPAVSGPMDL--PIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIE-RGEK 57
Query: 858  RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE 917
                ++KREI     +RH N+VR ++  L      I+  Y   G L + + +       E
Sbjct: 58   IDE-NVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 116
Query: 918  WNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPH--ISDFGIAK--LLD 973
                ++                   + HRD+K EN LLD    P   I  FG +K  +L 
Sbjct: 117  ARFFFQQLISGVSYCHAMQ------VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLH 170
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELIT 1019
              P  T     VGT  YIAPE         K +DV+S GV L  ++ 
Sbjct: 171  SQPKDT-----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLV 212

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 24   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 77
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 78   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 132
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    +  S
Sbjct: 133  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTS 181
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
               +  V T  Y APE        +  D++S G ++ E+I
Sbjct: 182  FMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 35/118 (29%), Positives = 54/118 (45%), Gaps = 17/118 (14%)
Query: 943  IVHRDIKPENILLDSEMEPHI---SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            I HRD+KPEN+L  S+ +  +   +DFG AK   ++   T       T  Y+APE     
Sbjct: 130  IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVLGPE 185
Query: 1000 AKSKESDVYSYGVVLLELI--------TRKKALDPSYKERTDI--VGWVRSVWSDTEE 1047
               K  D++S GV++  L+           +A+ P  K R  +   G+    WS+  E
Sbjct: 186  KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 243

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 35/118 (29%), Positives = 54/118 (45%), Gaps = 17/118 (14%)
Query: 943  IVHRDIKPENILLDSEMEPHI---SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            I HRD+KPEN+L  S+ +  +   +DFG AK   ++   T       T  Y+APE     
Sbjct: 149  IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY----TPYYVAPEVLGPE 204
Query: 1000 AKSKESDVYSYGVVLLELI--------TRKKALDPSYKERTDI--VGWVRSVWSDTEE 1047
               K  D++S GV++  L+           +A+ P  K R  +   G+    WS+  E
Sbjct: 205  KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE 262

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 39/177 (22%)
Query: 943  IVHRDIKPENILLDSE-------------MEPHISDFGIAKLLDKSPAS--TTSISVVGT 987
            I+HRD+KP+NIL+ +              +   ISDFG+ K LD   +S  T   +  GT
Sbjct: 136  IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 988  IGYIAPE-----NAFTTAK--SKESDVYSYGVVLLELITR-KKALDPSYKERTDIVGWVR 1039
             G+ APE     N   T +  ++  D++S G V   ++++ K      Y   ++I   +R
Sbjct: 196  SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI---IR 252
Query: 1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
             ++S  +E+  + D SL+ E   + +  Q+ID            P  RP    V+R 
Sbjct: 253  GIFS-LDEMKCLHDRSLIAE--ATDLISQMID----------HDPLKRPTAMKVLRH 296

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 43/208 (20%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+ +             AVK +      R  +    E   +      ++VR
Sbjct: 22   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIXXXXXXX 931
            L     +    +++   M +G L+  L S+ P         PPTL+  ++          
Sbjct: 82   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD+   N ++  +    I DFG+ + + ++         +  + ++
Sbjct: 142  YLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      +  SD++S+GVVL E+ +
Sbjct: 197  APESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 43/208 (20%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+ +             AVK +      R  +    E   +      ++VR
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIXXXXXXX 931
            L     +    +++   M +G L+  L S+ P         PPTL+  ++          
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD+   N ++  +    I DFG+ + + ++         +  + ++
Sbjct: 145  YLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      +  SD++S+GVVL E+ +
Sbjct: 200  APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 35/200 (17%)
Query: 200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE------- 252
           +N+L+   P  + N  +L ++ +N N++    P  L+NL NL  L + +N +        
Sbjct: 76  NNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKN 131
Query: 253 ----GRINFGSEKCKNLTFL-------DLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG 301
                R+   S    +++ L        LS+      + P L N ++L  LDI  +K+  
Sbjct: 132 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKP-LANLTTLERLDISSNKV-- 188
Query: 302 SIPSSFGLLARLSSLD---LSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL 358
              S   +LA+L++L+    + NQ+S   P  LG    L  L L  NQL+      L  L
Sbjct: 189 ---SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASL 241
Query: 359 SNLQDLELFDNRLTGEFPVS 378
           +NL DL+L +N+++   P+S
Sbjct: 242 TNLTDLDLANNQISNLAPLS 261

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 35/200 (17%)
Query: 200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE------- 252
           +N+L+   P  + N  +L ++ +N N++    P  L+NL NL  L + +N +        
Sbjct: 77  NNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLKN 132
Query: 253 ----GRINFGSEKCKNLTFL-------DLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG 301
                R+   S    +++ L        LS+      + P L N ++L  LDI  +K+  
Sbjct: 133 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKP-LANLTTLERLDISSNKV-- 189
Query: 302 SIPSSFGLLARLSSLD---LSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL 358
              S   +LA+L++L+    + NQ+S   P  LG    L  L L  NQL+      L  L
Sbjct: 190 ---SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASL 242
Query: 359 SNLQDLELFDNRLTGEFPVS 378
           +NL DL+L +N+++   P+S
Sbjct: 243 TNLTDLDLANNQISNLAPLS 262

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KP NI++ S+    I DFG+A+    S   T     V T  Y APE        
Sbjct: 141  IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYK 197
Query: 1003 KESDVYSYGVVLLELITRKKALDP 1026
            +  D++S G ++ E++ R K L P
Sbjct: 198  ENVDIWSVGCIMGEMV-RHKILFP 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KP NI++ S+    I DFG+A+    S   T     V T  Y APE        
Sbjct: 141  IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYK 197
Query: 1003 KESDVYSYGVVLLELITRKKALDP 1026
            +  D++S G ++ E++ R K L P
Sbjct: 198  ENVDIWSVGCIMGEMV-RHKILFP 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.0 bits (110), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 30/84 (35%), Positives = 44/84 (52%), Gaps = 4/84 (4%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KP NI++ S+    I DFG+A+    S   T     V T  Y APE        
Sbjct: 140  IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYYRAPEVILGMGYK 196
Query: 1003 KESDVYSYGVVLLELITRKKALDP 1026
            +  D++S G ++ E++ R K L P
Sbjct: 197  ENVDIWSVGCIMGEMV-RHKILFP 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 60   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 113
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 114  LMKCVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLCQVIQMELDHERMSY 168
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 169  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 221  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 264

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 24/202 (11%)
Query: 827  IGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            IG GA GIV   +   LG N   AVKKL+  F+       +  RE+  +  + H+N++ L
Sbjct: 32   IGSGAQGIVCAAFDTVLGINV--AVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 88
Query: 882  EDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXX 936
             + +     L +   + +   + + +L  V+H       + + + Y++            
Sbjct: 89   LNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSY-LLYQMLCGIKHLHSAG- 146
Query: 937  XDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
                  I+HRD+KP NI++ S+    I DFG+A+    +  +      V T  Y APE  
Sbjct: 147  ------IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVI 197
Query: 997  FTTAKSKESDVYSYGVVLLELI 1018
                 +   D++S G ++ EL+
Sbjct: 198  LGMGYAANVDIWSVGCIMGELV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 21   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 74
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 75   LMKCVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLCQVIQMELDHERMSY 129
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 130  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 181
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 182  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG--HKRGSLSMKRE 866
            K + E  E       +G GA+G V  A         AVKKL+  F+   H + +    RE
Sbjct: 11   KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY---RE 67
Query: 867  IQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            ++ +  ++H N++ L D +     L +   + +  ++    L ++   +      + +V+
Sbjct: 68   LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQ 124
Query: 922  YKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
            + I             D    I+HRD+KP N+ ++ + E  I DFG+A+  D        
Sbjct: 125  FLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----M 175
Query: 982  ISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
               V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 176  TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I  FG+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILGFGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 23   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 76
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 77   LMKCVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLCQVIQMELDHERMSY 131
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 132  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 184  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 227

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLCQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 226

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 23   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 76
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 77   LMKCVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLCQVIQMELDHERMSY 131
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 132  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 184  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 227

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 38/228 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  ++M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIISLLNVFTPQKTLEEF---QDVYLVME--LMDANLCQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026
            T     V T  Y APE        +  D++S G ++ E++ R K L P
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 226

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKVVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLSQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLVGIKHLHSAG-------IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S G ++ E+I
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 2/79 (2%)
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            D  I++RD+K +N+LLD E    ++DFG+ K  +      T+ +  GT  YIAPE     
Sbjct: 142  DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 1000 AKSKESDVYSYGVVLLELI 1018
                  D ++ GV+L E++
Sbjct: 200  LYGPAVDWWAMGVLLYEML 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Composition-based stats.
 Identities = 27/80 (33%), Positives = 44/80 (55%), Gaps = 6/80 (7%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KP N+ ++ + E  I DFG+A+      A +     V T  Y APE      + 
Sbjct: 149  IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 1003 KES-DVYSYGVVLLELITRK 1021
             ++ D++S G ++ E+IT K
Sbjct: 204  TQTVDIWSVGCIMAEMITGK 223

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 19   LGSGVFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 78   TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 135  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 181  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 16   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 69
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 70   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 124
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 125  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 176
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
            T     V T  Y APE        +  D++S G ++ E++  K
Sbjct: 177  T---PYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 19   LGSGQFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 78   TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 135  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 181  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKVVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLSQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S G ++ E+I
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 27   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 80
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 81   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 135
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 136  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 187
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
            T     V T  Y APE        +  D++S G ++ E++  K
Sbjct: 188  T---PYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 19   LGSGQFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 78   TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 135  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 181  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 19   LGSGQFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 78   TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 135  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 181  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 18   LGSGQFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 77   TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 133
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 134  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 179
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 180  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRHRNLVRLED 883
            +G G  G+V           A+K +     K GS+S      E + +  + H  LV+L  
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 884  FWLRKDCGIIMYRYMENGSL----RDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
               ++    I+  YM NG L    R++ H       LE                      
Sbjct: 87   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE---------MCKDVCEAMEYLE 137
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAFT 998
                +HRD+   N L++ +    +SDFG+++ +LD     T+S+     + +  PE    
Sbjct: 138  SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--ETSSVGSKFPVRWSPPEVLMY 195
Query: 999  TAKSKESDVYSYGVVLLELITRKK 1022
            +  S +SD++++GV++ E+ +  K
Sbjct: 196  SKFSSKSDIWAFGVLMWEIYSLGK 219

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 19   LGSGKFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 78   TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 135  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 181  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 8/203 (3%)
Query: 819  ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN 877
            E+L     IGRG  G V+   L   N + AVK               +E + + +  H N
Sbjct: 114  EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            +VRL     +K    I+   ++ G     L   T    L      ++             
Sbjct: 174  IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENA 996
             C    +HRD+   N L+  +    ISDFG+++   D   A++  +  V  + + APE  
Sbjct: 232  KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV-PVKWTAPEAL 287
Query: 997  FTTAKSKESDVYSYGVVLLELIT 1019
                 S ESDV+S+G++L E  +
Sbjct: 288  NYGRYSSESDVWSFGILLWETFS 310

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLSQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S G ++ E+I
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I D G+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDAGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 6/85 (7%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK- 1001
            IVHRD+K EN+LLD++    I+DFG +   ++        +  G   Y APE  F   K 
Sbjct: 134  IVHRDLKAENLLLDADXNIKIADFGFS---NEFTFGNKLDAFCGAPPYAAPE-LFQGKKY 189
Query: 1002 -SKESDVYSYGVVLLELITRKKALD 1025
               E DV+S GV+L  L++     D
Sbjct: 190  DGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 23/75 (30%), Positives = 43/75 (57%), Gaps = 5/75 (6%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK +        +  + GT   +APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWXLCGTPEALAPEIILSKGYN 216
Query: 1003 KESDVYSYGVVLLEL 1017
            K  D ++ GV++ E+
Sbjct: 217  KAVDWWALGVLIYEM 231

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A         AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DF +
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFYL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLSQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S G ++ E+I
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 19   LGSGQFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 78   TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 135  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 181  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S G ++ E+I
Sbjct: 183  TPE---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 34/233 (14%)
Query: 804  QEGPSY----LLKQVIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FR 854
            +E P++    L K + E  E       +G GA+G V   Y    G     AVKKL+  F+
Sbjct: 32   KERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLK--IAVKKLSRPFQ 89
Query: 855  G--HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVL 907
               H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++ 
Sbjct: 90   SIIHAKRTY---RELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNI- 145
Query: 908  HSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFG 967
              +      + +V++ I             D    I+HRD+KP N+ ++ + E  I DFG
Sbjct: 146  --VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDFG 199
Query: 968  IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            +A+  D           V T  Y APE          + D++S G ++ EL+T
Sbjct: 200  LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I D G+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDRGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RD+K EN++LD +    I+DFG+ K   K  A  T  +  GT  Y+APE        
Sbjct: 270  VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYG 327
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 328  RAVDWWGLGVVMYEMM 343

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S G ++ E+I
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 19/197 (9%)
Query: 827  IGRGAHGIVYK---ASLG-PNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVR 880
            +G G   IV K    S G   A   +KK   R  +RG     ++RE+  + ++ H N++ 
Sbjct: 20   LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCD 940
            L D +  +   +++   +  G L D L         E     K                 
Sbjct: 80   LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT------ 133
Query: 941  PPIVHRDIKPENI-LLDSEME-PHIS--DFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
              I H D+KPENI LLD  +  PHI   DFG+A  ++         ++ GT  ++APE  
Sbjct: 134  KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIV 190
Query: 997  FTTAKSKESDVYSYGVV 1013
                   E+D++S GV+
Sbjct: 191  NYEPLGLEADMWSIGVI 207

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 42/76 (55%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RD+K EN++LD +    I+DFG+ K   K  A  T  +  GT  Y+APE        
Sbjct: 273  VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYG 330
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 331  RAVDWWGLGVVMYEMM 346

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 19/197 (9%)
Query: 827  IGRGAHGIVYK---ASLG-PNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVR 880
            +G G   IV K    S G   A   +KK   R  +RG     ++RE+  + ++ H N++ 
Sbjct: 20   LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCD 940
            L D +  +   +++   +  G L D L         E     K                 
Sbjct: 80   LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT------ 133
Query: 941  PPIVHRDIKPENI-LLDSEME-PHIS--DFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
              I H D+KPENI LLD  +  PHI   DFG+A  ++         ++ GT  ++APE  
Sbjct: 134  KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIV 190
Query: 997  FTTAKSKESDVYSYGVV 1013
                   E+D++S GV+
Sbjct: 191  NYEPLGLEADMWSIGVI 207

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 25/204 (12%)
Query: 827  IGRGAHGIVYKASLGPNA-VFAVKKLAF----RGHKRGSLSMKREIQTIG----KIRHRN 877
            +GRGA+G+V K    P+  + AVK++      +  KR  + +   ++T+        +  
Sbjct: 15   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            L R  D W+   C  +M   ++    + +    T P  +   +   I             
Sbjct: 75   LFREGDVWI---CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 ++HRD+KP N+L+++  +  + DFGI+  L    A        G   Y+APE   
Sbjct: 131  -----VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID---AGCKPYMAPERIN 182
Query: 998  TTAKSK----ESDVYSYGVVLLEL 1017
                 K    +SD++S G+ ++EL
Sbjct: 183  PELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)
Query: 803  AQEGPSY----LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAV-FAVKKLA--FRG 855
            +QE P++    L K + E  E       +G GA+G V  A      +  AVKKL+  F+ 
Sbjct: 2    SQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS 61
Query: 856  --HKRGSLSMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLH 908
              H + +    RE++ +  ++H N++ L D +     L +   + +  ++    L ++  
Sbjct: 62   IIHAKRTY---RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-- 116
Query: 909  SITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
             +      + +V++ I             D    I+HRD+KP N+ ++ + E  I D G+
Sbjct: 117  -VKCQKLTDDHVQFLIYQILRGLKYIHSAD----IIHRDLKPSNLAVNEDCELKILDGGL 171
Query: 969  AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-DVYSYGVVLLELIT 1019
            A+  D           V T  Y APE         ++ D++S G ++ EL+T
Sbjct: 172  ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 7/186 (3%)
Query: 189 DLKEVEALWLFSNRLS--GTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDV 246
           DL  +E L L  N LS  G   +S      L+ L L+ N ++  +  +   LE L +LD 
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 403
Query: 247 GDNNLEGRINFGSE-KCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGS-IP 304
             +NL+    F      +NL +LD+S+       +      SSL  L + G+    + +P
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 305 SSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDEL-GQLSNLQD 363
             F  L  L+ LDLS+ QL    P        L VL++ +NQL+  +PD +  +L++LQ 
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQK 522
Query: 364 LELFDN 369
           + L  N
Sbjct: 523 IWLHTN 528

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 28/77 (36%), Positives = 41/77 (53%), Gaps = 1/77 (1%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG-TIGYIAPENAFTTAKS 1002
            VHRD+   N+LL +     ISDFG++K L    +  T+ S     + + APE       S
Sbjct: 132  VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 1003 KESDVYSYGVVLLELIT 1019
              SDV+SYGV + E ++
Sbjct: 192  SRSDVWSYGVTMWEALS 208

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 8/203 (3%)
Query: 819  ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN 877
            E+L     IGRG  G V+   L   N + AVK               +E + + +  H N
Sbjct: 114  EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXX 937
            +VRL     +K    I+   ++ G     L   T    L      ++             
Sbjct: 174  IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENA 996
             C    +HRD+   N L+  +    ISDFG+++   D   A++  +  V  + + APE  
Sbjct: 232  KC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV-PVKWTAPEAL 287
Query: 997  FTTAKSKESDVYSYGVVLLELIT 1019
                 S ESDV+S+G++L E  +
Sbjct: 288  NYGRYSSESDVWSFGILLWETFS 310

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RDIK EN++LD +    I+DFG+ K  +      T  +  GT  Y+APE        
Sbjct: 129  VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 187  RAVDWWGLGVVMYEMM 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RDIK EN++LD +    I+DFG+ K  +      T  +  GT  Y+APE        
Sbjct: 126  VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 184  RAVDWWGLGVVMYEMM 199

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RDIK EN++LD +    I+DFG+ K  +      T  +  GT  Y+APE        
Sbjct: 126  VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 184  RAVDWWGLGVVMYEMM 199

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 43/208 (20%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+ +             AVK +      R  +    E   +      ++VR
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIXXXXXXX 931
            L     +    +++   M +G L+  L S+ P         PPTL+  ++          
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD+   N ++  +    I DFG+ + + ++         +  + ++
Sbjct: 145  YLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      +  SD++S+GVVL E+ +
Sbjct: 200  APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 7/79 (8%)
Query: 943  IVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            IVHRD+KPEN+LL+S+       I DFG++   +        +   GT  YIAPE     
Sbjct: 125  IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYIAPE-VLRK 180
Query: 1000 AKSKESDVYSYGVVLLELI 1018
               ++ DV+S GV+L  L+
Sbjct: 181  KYDEKCDVWSCGVILYILL 199

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 23   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 76
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 77   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 131
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 132  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S G ++ E+I
Sbjct: 184  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRHRNLVRLED 883
            +G G  G+V           A+K +     K GS+S      E + +  + H  LV+L  
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 884  FWLRKDCGIIMYRYMENGSL----RDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC 939
               ++    I+  YM NG L    R++ H       LE                      
Sbjct: 87   VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE---------MCKDVCEAMEYLE 137
Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAFT 998
                +HRD+   N L++ +    +SDFG+++ +LD     T+S+     + +  PE    
Sbjct: 138  SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMY 195
Query: 999  TAKSKESDVYSYGVVLLELITRKK 1022
            +  S +SD++++GV++ E+ +  K
Sbjct: 196  SKFSSKSDIWAFGVLMWEIYSLGK 219

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/208 (20%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+ +             AVK +      R  +    E   +      ++VR
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIXXXXXXX 931
            L     +    +++   M +G L+  L S+ P         PPTL+  ++          
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHR++   N ++  +    I DFG+ + + ++         +  + ++
Sbjct: 145  YLNAKK-----FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      +  SD++S+GVVL E+ +
Sbjct: 200  APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/208 (20%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+ +             AVK +      R  +    E   +      ++VR
Sbjct: 26   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIXXXXXXX 931
            L     +    +++   M +G L+  L S+ P         PPTL+  ++          
Sbjct: 86   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHR++   N ++  +    I DFG+ + + ++         +  + ++
Sbjct: 146  YLNAKK-----FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      +  SD++S+GVVL E+ +
Sbjct: 201  APESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 30/83 (36%), Positives = 40/83 (48%), Gaps = 12/83 (14%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IVH D+KP N L+   M   I DFGIA  +     S    S VGT+ Y+ PE     + S
Sbjct: 176  IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 1003 KES-----------DVYSYGVVL 1014
            +E+           DV+S G +L
Sbjct: 235  RENGKSKSKISPKSDVWSLGCIL 257

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 37/220 (16%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+    S   
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 979  TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELI 1018
            T     V T  Y APE        +  D++S G ++ E+I
Sbjct: 183  T---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/79 (37%), Positives = 43/79 (54%), Gaps = 7/79 (8%)
Query: 943  IVHRDIKPENILLDSEMEP---HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            IVHRD+KPEN+LL+S+       I DFG++   +        +   GT  YIAPE     
Sbjct: 142  IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYIAPE-VLRK 197
Query: 1000 AKSKESDVYSYGVVLLELI 1018
               ++ DV+S GV+L  L+
Sbjct: 198  KYDEKCDVWSCGVILYILL 216

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 37/212 (17%)
Query: 827  IGRGAHGIVYK-----ASLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLV 879
            +G G   +V K       L   A F +KK   +  +RG     ++RE+  + +I+H N++
Sbjct: 19   LGSGQFAVVKKCREKSTGLQYAAKF-IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEW-----NVRYKIXXXXXXX 931
             L + +  K   I++   +  G L D L    S+T     E+     N  Y +       
Sbjct: 78   TLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--- 134
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGT 987
                       I H D+KPENI+L     P     I DFG+A  +D         ++ GT
Sbjct: 135  -----------IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGT 180
Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
              ++APE         E+D++S GV+   L++
Sbjct: 181  PEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 43/208 (20%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+ +             AVK +      R  +    E   +      ++VR
Sbjct: 24   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIXXXXXXX 931
            L     +    +++   M +G L+  L S+ P         PPTL+  ++          
Sbjct: 84   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD+   N ++  +    I DFG+ + + ++         +  + ++
Sbjct: 144  YLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      +  SD++S+GVVL E+ +
Sbjct: 199  APESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 43/208 (20%), Positives = 84/208 (40%), Gaps = 20/208 (9%)
Query: 827  IGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR 880
            +G+G+ G+VY+ +             AVK +      R  +    E   +      ++VR
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITP---------PPTLEWNVRYKIXXXXXXX 931
            L     +    +++   M +G L+  L S+ P         PPTL+  ++          
Sbjct: 85   LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
                        VHRD+   N ++  +    I DFG+ + + ++         +  + ++
Sbjct: 145  YLNAKK-----FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE+      +  SD++S+GVVL E+ +
Sbjct: 200  APESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 827  IGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G G +G+V+ A     +   A+KK+     +    ++ REI+ I ++ H N+V++ +  
Sbjct: 19   LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFEIL 77
Query: 886  ------LRKDCG--------IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXX 931
                  L  D G         I+  YME     D+ + +   P LE + R  +       
Sbjct: 78   GPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHARLFMYQLLRGL 133
Query: 932  XXXXXXDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSISV-VGTIG 989
                  +    ++HRD+KP N+ +++E +   I DFG+A+++D   +    +S  + T  
Sbjct: 134  KYIHSAN----VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 990  YIAPENAFT-TAKSKESDVYSYGVVLLELITRK 1021
            Y +P    +    +K  D+++ G +  E++T K
Sbjct: 190  YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 43/226 (19%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+       +
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLAR------TA 176
Query: 979  TTSISV---VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
             TS  +   V T  Y APE        +  D++S G ++ E++  K
Sbjct: 177  GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 6/80 (7%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +VHRD+KP N+ ++ + E  I DFG+A+  D   A  T   V  T  Y APE   +    
Sbjct: 147  VVHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVV--TRWYRAPEVILSWMHY 201
Query: 1003 KES-DVYSYGVVLLELITRK 1021
             ++ D++S G ++ E++T K
Sbjct: 202  NQTVDIWSVGCIMAEMLTGK 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPENAFTTA 1000
             VHRD+   N+LL ++    ISDFG++K L ++  +       G   + + APE      
Sbjct: 490  FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 1001 KSKESDVYSYGVVLLELIT 1019
             S +SDV+S+GV++ E  +
Sbjct: 549  FSSKSDVWSFGVLMWEAFS 567

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 23/76 (30%), Positives = 41/76 (53%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            VHRD+   N+L+       I DFG+A+ +          +    + ++APE+ F    + 
Sbjct: 194  VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 253
Query: 1004 ESDVYSYGVVLLELIT 1019
            +SDV+SYG++L E+ +
Sbjct: 254  KSDVWSYGILLWEIFS 269

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 3/79 (3%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT--IGYIAPENAFTTA 1000
             VHRD+   N+LL ++    ISDFG++K L ++  +       G   + + APE      
Sbjct: 491  FVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 1001 KSKESDVYSYGVVLLELIT 1019
             S +SDV+S+GV++ E  +
Sbjct: 550  FSSKSDVWSFGVLMWEAFS 568

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RDIK EN++LD +    I+DFG+ K  +      T     GT  Y+APE        
Sbjct: 126  VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 184  RAVDWWGLGVVMYEMM 199

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RDIK EN++LD +    I+DFG+ K  +      T     GT  Y+APE        
Sbjct: 126  VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 184  RAVDWWGLGVVMYEMM 199

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RDIK EN++LD +    I+DFG+ K  +      T     GT  Y+APE        
Sbjct: 131  VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 189  RAVDWWGLGVVMYEMM 204

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 1/78 (1%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV-VGTIGYIAPENAFTTAK 1001
             VHR++   N+LL +     ISDFG++K L    +  T+ S     + + APE       
Sbjct: 457  FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 1002 SKESDVYSYGVVLLELIT 1019
            S  SDV+SYGV + E ++
Sbjct: 517  SSRSDVWSYGVTMWEALS 534

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RDIK EN++LD +    I+DFG+ K  +      T     GT  Y+APE        
Sbjct: 126  VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 184  RAVDWWGLGVVMYEMM 199

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RD+K EN++LD +    I+DFG+ K   K  A+       GT  Y+APE        
Sbjct: 130  VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYLAPEVLEDNDYG 187
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 188  RAVDWWGLGVVMYEMM 203

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RD+K EN++LD +    I+DFG+ K   K  A+       GT  Y+APE        
Sbjct: 131  VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYLAPEVLEDNDYG 188
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 189  RAVDWWGLGVVMYEMM 204

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Composition-based stats.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 2/76 (2%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RD+K EN++LD +    I+DFG+ K   K  A+       GT  Y+APE        
Sbjct: 132  VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYLAPEVLEDNDYG 189
Query: 1003 KESDVYSYGVVLLELI 1018
            +  D +  GVV+ E++
Sbjct: 190  RAVDWWGLGVVMYEMM 205

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRN--LVRLED 883
            IG G    V++       ++A+K +        +L S + EI  + K++  +  ++RL D
Sbjct: 20   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE-WNVRYKIXXXXXXXXXXXXXDCDPP 942
            + +       +Y  ME G++ D+   +    +++ W  +                     
Sbjct: 80   YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---- 131
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IVH D+KP N L+   M   I DFGIA  +     S    S VGT+ Y+ PE     + S
Sbjct: 132  IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 190
Query: 1003 KES-----------DVYSYGVVLLELITRK 1021
            +E+           DV+S G +L  +   K
Sbjct: 191  RENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 83/197 (42%), Gaps = 19/197 (9%)
Query: 827  IGRGAHGIVYK---ASLG-PNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVR 880
            +G G   IV K    S G   A   +KK   R  +RG     ++RE+  + ++ H N++ 
Sbjct: 20   LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCD 940
            L D +  +   +++   +  G L D L         E     K                 
Sbjct: 80   LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT------ 133
Query: 941  PPIVHRDIKPENI-LLDSEME-PHIS--DFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
              I H D+KPENI LLD  +  PHI   DFG+A  ++         ++ GT  ++APE  
Sbjct: 134  KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NIFGTPEFVAPEIV 190
Query: 997  FTTAKSKESDVYSYGVV 1013
                   E+D++S GV+
Sbjct: 191  NYEPLGLEADMWSIGVI 207

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 11/96 (11%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-------NA 996
            VHRDIKP+NILLD      ++DFG    L ++  +  S+  VGT  Y++PE         
Sbjct: 184  VHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032
             T +   E D ++ GV   E+   +    P Y + T
Sbjct: 243  GTGSYGPECDWWALGVFAYEMFYGQT---PFYADST 275

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 43/226 (19%)
Query: 814  VIEATENLNAKHVIGRGAHGIV---YKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQ 868
            V++  +NL     IG GA GIV   Y A L  N   A+KKL+  F+       +  RE+ 
Sbjct: 22   VLKRYQNLKP---IGSGAQGIVCAAYDAILERNV--AIKKLSRPFQNQTHAKRAY-RELV 75
Query: 869  TIGKIRHRNLV----------RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
             +  + H+N++           LE+F   +D  I+M   + + +L  V+        + +
Sbjct: 76   LMKCVNHKNIIGLLNVFTPQKSLEEF---QDVYIVME--LMDANLCQVIQMELDHERMSY 130
Query: 919  NVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
             + Y++                  I+HRD+KP NI++ S+    I DFG+A+       +
Sbjct: 131  -LLYQMLCGIKHLHSAG-------IIHRDLKPSNIVVKSDCTLKILDFGLAR------TA 176
Query: 979  TTSISV---VGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
             TS  +   V T  Y APE        +  D++S G ++ E++  K
Sbjct: 177  GTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 6/80 (7%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +VHRD+KP N+ ++ + E  I DFG+A+  D   A  T   V  T  Y APE   +    
Sbjct: 165  VVHRDLKPGNLAVNEDCELKILDFGLARHAD---AEMTGYVV--TRWYRAPEVILSWMHY 219
Query: 1003 KES-DVYSYGVVLLELITRK 1021
             ++ D++S G ++ E++T K
Sbjct: 220  NQTVDIWSVGCIMAEMLTGK 239

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 25/248 (10%)
Query: 452 CFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKN-PVLSHL--- 507
           CF  QL+ L++      G +PS +     L +++L  N         + N P L+HL   
Sbjct: 273 CF-TQLQELDLTATHLKG-LPSGMKGLNLLKKLVLSVNHFDQLCQISAANFPSLTHLYIR 330
Query: 508 -DVSRNNISGAIPSSIGNSINLTSIDFSSNKF--SGLMPQELGNLVSLVTLNISLNHVEG 564
            +V + ++       +GN   L ++D S N    S     +L NL  L TLN+S N   G
Sbjct: 331 GNVKKLHLGVGCLEKLGN---LQTLDLSHNDIEASDCCSLQLKNLSHLQTLNLSHNEPLG 387
Query: 565 SLPSQLSKCKNLEVFDVSFNLLNGSIPSS-LRSWKSLSILKL-------SENHFTGGIPT 616
                  +C  LE+ D++F  L+ + P S  ++   L +L L       S  H   G+P 
Sbjct: 388 LQSQAFKECPQLELLDLAFTRLHINAPQSPFQNLHFLQVLNLTYCFLDTSNQHLLAGLPV 447
Query: 617 FISXXXXXXXXXXXXXXXXXXIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQL 676
            +                   +  ++G+L+     L LS  GL          L K+  +
Sbjct: 448 -LRHLNLKGNHFQDGTITKTNLLQTVGSLE----VLILSSCGLLSIDQQAFHSLGKMSHV 502
Query: 677 DISSNNLT 684
           D+S N+LT
Sbjct: 503 DLSHNSLT 510

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRN--LVRLED 883
            IG G    V++       ++A+K +        +L S + EI  + K++  +  ++RL D
Sbjct: 36   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE-WNVRYKIXXXXXXXXXXXXXDCDPP 942
            + +       +Y  ME G++ D+   +    +++ W  +                     
Sbjct: 96   YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---- 147
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IVH D+KP N L+   M   I DFGIA  +     S    S VGT+ Y+ PE     + S
Sbjct: 148  IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 1003 KES-----------DVYSYGVVLLELITRK 1021
            +E+           DV+S G +L  +   K
Sbjct: 207  RENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 7/200 (3%)
Query: 174 LNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPE 233
           L NN +S     +   L+ + AL L +N++S    ++     +LQ+LY+++N L+   P 
Sbjct: 61  LQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPN 120
Query: 234 SLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRF-SGGISPNLGNCSSLTHL 292
             S   +LV L + DN +           +N+  +++  N   + G  P   +   L +L
Sbjct: 121 LPS---SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL 177
Query: 293 DIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIP 352
            I  +KLTG IP    L   L+ L L  N++      +L +   L  L L  NQ+     
Sbjct: 178 RISEAKLTG-IPKD--LPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIEN 234
Query: 353 DELGQLSNLQDLELFDNRLT 372
             L  L  L++L L +N+L+
Sbjct: 235 GSLSFLPTLRELHLDNNKLS 254

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRN--LVRLED 883
            IG G    V++       ++A+K +        +L S + EI  + K++  +  ++RL D
Sbjct: 16   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE-WNVRYKIXXXXXXXXXXXXXDCDPP 942
            + +       +Y  ME G++ D+   +    +++ W  +                     
Sbjct: 76   YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---- 127
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IVH D+KP N L+   M   I DFGIA  +     S    S VGT+ Y+ PE     + S
Sbjct: 128  IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 1003 KES-----------DVYSYGVVLLELITRK 1021
            +E+           DV+S G +L  +   K
Sbjct: 187  RENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRHRNLVRLED 883
            +G G  G+V           A+K +     K GS+S      E + +  + H  LV+L  
Sbjct: 23   LGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC---- 939
               ++    I+  YM NG L + L  +          R++              +     
Sbjct: 78   VCTKQRPIFIITEYMANGCLLNYLREM----------RHRFQTQQLLEMCKDVCEAMEYL 127
Query: 940  -DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAF 997
                 +HRD+   N L++ +    +SDFG+++ +LD     T+S+     + +  PE   
Sbjct: 128  ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 185
Query: 998  TTAKSKESDVYSYGVVLLELITRKK 1022
             +  S +SD++++GV++ E+ +  K
Sbjct: 186  YSKFSSKSDIWAFGVLMWEIYSLGK 210

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRHRNLVRLED 883
            +G G  G+V           A+K +     K GS+S      E + +  + H  LV+L  
Sbjct: 16   LGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC---- 939
               ++    I+  YM NG L + L  +          R++              +     
Sbjct: 71   VCTKQRPIFIITEYMANGCLLNYLREM----------RHRFQTQQLLEMCKDVCEAMEYL 120
Query: 940  -DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAF 997
                 +HRD+   N L++ +    +SDFG+++ +LD     T+S+     + +  PE   
Sbjct: 121  ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 178
Query: 998  TTAKSKESDVYSYGVVLLELITRKK 1022
             +  S +SD++++GV++ E+ +  K
Sbjct: 179  YSKFSSKSDIWAFGVLMWEIYSLGK 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRHRNLVRLED 883
            +G G  G+V           A+K +     K GS+S      E + +  + H  LV+L  
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC---- 939
               ++    I+  YM NG L + L  +          R++              +     
Sbjct: 72   VCTKQRPIFIITEYMANGCLLNYLREM----------RHRFQTQQLLEMCKDVCEAMEYL 121
Query: 940  -DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAF 997
                 +HRD+   N L++ +    +SDFG+++ +LD     T+S+     + +  PE   
Sbjct: 122  ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 179
Query: 998  TTAKSKESDVYSYGVVLLELITRKK 1022
             +  S +SD++++GV++ E+ +  K
Sbjct: 180  YSKFSSKSDIWAFGVLMWEIYSLGK 204

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 45/205 (21%), Positives = 86/205 (41%), Gaps = 26/205 (12%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS---MKREIQTIGKIRHRNLVRLED 883
            +G G  G+V           A+K +     K GS+S      E + +  + H  LV+L  
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDC---- 939
               ++    I+  YM NG L + L  +          R++              +     
Sbjct: 67   VCTKQRPIFIITEYMANGCLLNYLREM----------RHRFQTQQLLEMCKDVCEAMEYL 116
Query: 940  -DPPIVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAF 997
                 +HRD+   N L++ +    +SDFG+++ +LD     T+S+     + +  PE   
Sbjct: 117  ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLM 174
Query: 998  TTAKSKESDVYSYGVVLLELITRKK 1022
             +  S +SD++++GV++ E+ +  K
Sbjct: 175  YSKFSSKSDIWAFGVLMWEIYSLGK 199

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRN--LVRLED 883
            IG G    V++       ++A+K +        +L S + EI  + K++  +  ++RL D
Sbjct: 17   IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE-WNVRYKIXXXXXXXXXXXXXDCDPP 942
            + +       +Y  ME G++ D+   +    +++ W  +                     
Sbjct: 77   YEITDQ---YIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---- 128
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IVH D+KP N L+   M   I DFGIA  +     S    S VGT+ Y+ PE     + S
Sbjct: 129  IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 1003 KES-----------DVYSYGVVLLELITRK 1021
            +E+           DV+S G +L  +   K
Sbjct: 188  RENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            +G G +G VYKA     N   A+K++     + G      RE+  + +++HRN++ L+  
Sbjct: 42   LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIXXXXXXXXXXXXXDCDP-PI 943
                    +++ Y EN    D+   +   P    +V  ++              C     
Sbjct: 102  IHHNHRLHLIFEYAEN----DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSRRC 153
Query: 944  VHRDIKPENILL---DSEMEP--HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
            +HRD+KP+N+LL   D+   P   I DFG+A+     P    +  ++ T+ Y  PE    
Sbjct: 154  LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEII-TLWYRPPEILLG 211
Query: 999  TAKSKES-DVYSYGVVLLELITR 1020
            +     S D++S   +  E++ +
Sbjct: 212  SRHYSTSVDIWSIACIWAEMLMK 234

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 105/248 (42%), Gaps = 52/248 (20%)
Query: 827  IGRGAHGIVYKAS----LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            IG G    VY A+    +GP    A+K L    H    + +  E+Q +     ++ V   
Sbjct: 29   IGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGV 85
Query: 883  DFWLRK-DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR-YKIXXXXXXXXXXXXXDCD 940
             +  RK D  +I   Y+E+ S  D+L+S++     E+ +  +K                 
Sbjct: 86   KYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG-------- 137
Query: 941  PPIVHRDIKPENILLDSEMEPH-ISDFGIAK--------LL---------DKSPASTTSI 982
              IVHRD+KP N L +  ++ + + DFG+A+        LL         ++   +  SI
Sbjct: 138  --IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI 195
Query: 983  SV---------VGTIGYIAPENAFTTAKSKES--DVYSYGVVLLELITRKKALDPSYKER 1031
             +          GT G+ APE   T   ++ +  D++S GV+ L L++ +    P YK  
Sbjct: 196  CLSRRQQVAPRAGTPGFRAPE-VLTKCPNQTTAIDMWSAGVIFLSLLSGRY---PFYKAS 251
Query: 1032 TDIVGWVR 1039
             D+    +
Sbjct: 252  DDLTALAQ 259

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +VH+D+   N+L+  ++   ISD G+ + +  +       + +  I ++APE       S
Sbjct: 149  VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 208
Query: 1003 KESDVYSYGVVLLELITRKKALDP--SYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060
             +SD++SYGVVL E+ +    L P   Y  + D+V  +R+                    
Sbjct: 209  IDSDIWSYGVVLWEVFSY--GLQPYCGYSNQ-DVVEMIRN------------------RQ 247
Query: 1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            ++    D    V  + + C  + PS RP  +D+  +L
Sbjct: 248  VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 42/90 (46%), Gaps = 12/90 (13%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            IVH D+KP N L+   M   I DFGIA  +     S    S VGT+ Y+ PE     + S
Sbjct: 176  IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 1003 KES-----------DVYSYGVVLLELITRK 1021
            +E+           DV+S G +L  +   K
Sbjct: 235  RENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 31/165 (18%)
Query: 281 PNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE--LGKCKYLT 338
           P + +C   T +D  G  L   IP    L    + L L++N+L G+I  +   G+  +L 
Sbjct: 3   PAMCHCEGTT-VDCTGRGLK-EIPRDIPL--HTTELLLNDNEL-GRISSDGLFGRLPHLV 57
Query: 339 VLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASXXXXXXXXXXXXXX 398
            L L  NQL G  P+     S++Q+L+L +N+        I  I++              
Sbjct: 58  KLELKRNQLTGIEPNAFEGASHIQELQLGENK--------IKEISNKM------------ 97
Query: 399 XPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
                  L QLK ++LY+NQ S V+P S    +SL  L+  +N F
Sbjct: 98  ----FLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Composition-based stats.
 Identities = 59/226 (26%), Positives = 84/226 (37%), Gaps = 18/226 (7%)
Query: 803  AQEGPSYLLKQVIEATENLNAKHVIGRGAHGIV----YKASLGPNAVFAVKKLA--FRGH 856
            A EGP   L  +I   ++L     +G G+ G+V    + A  G     AVK L       
Sbjct: 3    AGEGPLQSLTCLI-GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ 61
Query: 857  KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL 916
                    RE+  +  + HRNL+RL    L     ++       GSL D L        L
Sbjct: 62   PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGHFLL 120
Query: 917  EWNVRYKIXXXXXXXXXXXXXDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL---D 973
                RY +                   +HRD+   N+LL +     I DFG+ + L   D
Sbjct: 121  GTLSRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175
Query: 974  KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                      V     + APE+  T   S  SD + +GV L E+ T
Sbjct: 176  DHXVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 35/173 (20%)
Query: 943  IVHRDIKPENILLDSE-------------MEPHISDFGIAKLLDKSPASTTS--ISVVGT 987
            I+HRD+KP+NIL+ +              +   ISDFG+ K LD           +  GT
Sbjct: 154  IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 988  IGYIAPENAFTTAK---SKESDVYSYGVVLLELITR-KKALDPSYKERTDIVGWVRSVWS 1043
             G+ APE    + K   ++  D++S G V   ++++ K      Y   ++I   +R ++S
Sbjct: 214  SGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI---IRGIFS 270
Query: 1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
              +E+  + D SL+ E   + +  Q+ID            P  RP    V+R 
Sbjct: 271  -LDEMKCLHDRSLIAE--ATDLISQMID----------HDPLKRPTAMKVLRH 310

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 21/78 (26%), Positives = 40/78 (51%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
             +HRD+   N +L  +M   ++DFG++K +               + +IA E+      +
Sbjct: 168  FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT 227
Query: 1003 KESDVYSYGVVLLELITR 1020
             +SDV+++GV + E+ TR
Sbjct: 228  SKSDVWAFGVTMWEIATR 245

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 35/173 (20%)
Query: 943  IVHRDIKPENILLDSE-------------MEPHISDFGIAKLLDKSPASTTS--ISVVGT 987
            I+HRD+KP+NIL+ +              +   ISDFG+ K LD           +  GT
Sbjct: 154  IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 988  IGYIAPENAFTTAK---SKESDVYSYGVVLLELITR-KKALDPSYKERTDIVGWVRSVWS 1043
             G+ APE    + K   ++  D++S G V   ++++ K      Y   ++I   +R ++S
Sbjct: 214  SGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI---IRGIFS 270
Query: 1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
              +E+  + D SL+ E   + +  Q+ID            P  RP    V+R 
Sbjct: 271  -LDEMKCLHDRSLIAE--ATDLISQMID----------HDPLKRPTAMKVLRH 310

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +VH+D+   N+L+  ++   ISD G+ + +  +       + +  I ++APE       S
Sbjct: 166  VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 225
Query: 1003 KESDVYSYGVVLLELITRKKALDP--SYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060
             +SD++SYGVVL E+ +    L P   Y  + D+V  +R+                    
Sbjct: 226  IDSDIWSYGVVLWEVFSY--GLQPYCGYSNQ-DVVEMIRN------------------RQ 264
Query: 1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            ++    D    V  + + C  + PS RP  +D+  +L
Sbjct: 265  VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/76 (30%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
             VHRDI   N+L+ S     + DFG+++ ++ S     S   +  I ++APE+      +
Sbjct: 132  FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL-PIKWMAPESINFRRFT 190
Query: 1003 KESDVYSYGVVLLELI 1018
              SDV+ +GV + E++
Sbjct: 191  SASDVWMFGVCMWEIL 206

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 30/161 (18%)
Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA----FTT 999
            VHRDI   NIL+ S     + DFG+++ ++       S++ +  I +++PE+     FTT
Sbjct: 131  VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL-PIKWMSPESINFRRFTT 189
Query: 1000 AKSKESDVYSYGVVLLELITRKKALDPSY-KERTDIVGWVRSVWSDTEEINDIVDLSLME 1058
            A    SDV+ + V + E+++  K   P +  E  D++G +       E+ + +    L  
Sbjct: 190  A----SDVWMFAVCMWEILSFGK--QPFFWLENKDVIGVL-------EKGDRLPKPDLCP 236
Query: 1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
             +L +           +  RC +  PS+RP   ++V  L D
Sbjct: 237  PVLYT-----------LMTRCWDYDPSDRPRFTELVCSLSD 266

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 30/216 (13%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
            +G GA G VYKA        A  K+     +        EI+ +    H  +V+L   + 
Sbjct: 19   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 887  RKDCGIIMYRYMENGSLRDVLHSIT---PPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPI 943
                  IM  +   G++  ++  +      P ++   R  +                  I
Sbjct: 79   HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--------I 130
Query: 944  VHRDIKPENILLDSEMEPHISDFGIA----KLLDKSPASTTSISVVGTIGYIAPENAFT- 998
            +HRD+K  N+L+  E +  ++DFG++    K L K        S +GT  ++APE     
Sbjct: 131  IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMCE 184
Query: 999  ----TAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
                T    ++D++S G+ L+E+      ++P + E
Sbjct: 185  TMKDTPYDYKADIWSLGITLIEM----AQIEPPHHE 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 9e-04,   Method: Composition-based stats.
 Identities = 48/216 (22%), Positives = 87/216 (40%), Gaps = 30/216 (13%)
Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL 886
            +G GA G VYKA        A  K+     +        EI+ +    H  +V+L   + 
Sbjct: 27   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 887  RKDCGIIMYRYMENGSLRDVLHSIT---PPPTLEWNVRYKIXXXXXXXXXXXXXDCDPPI 943
                  IM  +   G++  ++  +      P ++   R  +                  I
Sbjct: 87   HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--------I 138
Query: 944  VHRDIKPENILLDSEMEPHISDFGIA----KLLDKSPASTTSISVVGTIGYIAPENAFT- 998
            +HRD+K  N+L+  E +  ++DFG++    K L K        S +GT  ++APE     
Sbjct: 139  IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMCE 192
Query: 999  ----TAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
                T    ++D++S G+ L+E+      ++P + E
Sbjct: 193  TMKDTPYDYKADIWSLGITLIEM----AQIEPPHHE 224

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1109
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	0.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-111
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-89
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-72
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-57
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-54
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-108
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-95
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-75
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-96
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-89
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-74
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-72
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-17
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-94
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-87
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-79
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-59
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-38
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-20
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-85
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-77
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-72
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-60
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-59
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-84
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-84
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-69
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-65
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-54
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-44
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-81
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-78
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-71
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-58
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-42
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-65
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-62
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-61
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-61
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-50
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-56
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-51
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-55
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-43
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-38
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-54
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-53
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-52
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-51
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-47
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-46
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-45
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-20
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-40
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-27
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-50
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-50
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-40
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-24
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-16
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-47
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-46
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-45
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-40
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-40
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-28
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-04
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-46
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-46
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-45
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-33
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-33
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-26
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-20
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-17
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-07
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-43
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-38
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	8e-29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-26
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-43
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-24
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-08
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-43
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-41
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-40
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-27
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-36
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-32
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-37
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-36
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-34
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-27
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-06
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-36
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	7e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	9e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-18
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-35
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-27
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-19
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-14
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-22
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-30
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-28
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-12
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-32
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-30
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-05
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-32
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-25
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-22
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-19
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-17
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-31
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-27
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	6e-23
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-30
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-30
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-04
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-30
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-29
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-27
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-26
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	9e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-08
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-26
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-25
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-05
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-19
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-24
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-24
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-24
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-23
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-23
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-23
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-23
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-23
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-22
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-12
3uqc_A	286	Probable conserved transmembrane protein; structur	9e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-21
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-14
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-15
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-08
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-19
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-19
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-19
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-18
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-07
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-13
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-09
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-05
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-17
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-17
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	8e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-10
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-06
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-16
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-16
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-10
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-07
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-07
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-10
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-15
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-04
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-13
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-08
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-04
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	9e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	8e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-04
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-10
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-09
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-04
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	5e-09
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	4e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	8e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-08
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	7e-08
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-07
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-06
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	1e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  625 bits (1613), Expect = 0.0
 Identities = 220/774 (28%), Positives = 349/774 (45%), Gaps = 65/774 (8%)

Query: 17  ALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSF 76
           +       +L  +   L+S           ++  W+S+   PC + G+ C D    V S 
Sbjct: 1   SFQASPSQSLYREIHQLISFKDVLP--DKNLLPDWSSN-KNPCTFDGVTCRD--DKVTSI 55

Query: 77  NLSSYGVSGQLG--------------------------PEIGHLSKLQTIDLSSNNFSGN 110
           +LSS  ++                                    + L ++DLS N+ SG 
Sbjct: 56  DLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGP 115

Query: 111 IPPK--LGNCSALEYLDLSTNGFTGDIPD-NFENLQNLQYLNLYGNLLDGEIPEPLFRIL 167
           +     LG+CS L++L++S+N             L +L+ L+L  N + G          
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175

Query: 168 G---LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNE 224
           G   L+++ ++ N +SG +   V     +E L + SN  S  IP  +G+C  LQ L ++ 
Sbjct: 176 GCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISG 232

Query: 225 NKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNL- 283
           NKL G    ++S    L  L++  N   G I       K+L +L L+ N+F+G I   L 
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPI--PPLPLKSLQYLSLAENKFTGEIPDFLS 290

Query: 284 GNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHL 342
           G C +LT LD+ G+   G++P  FG  + L SL LS N  SG++P + L K + L VL L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350

Query: 343 YANQLEGEIPDELGQLS-NLQDLELFDNRLTGEFPVSIWRI--ASLEYLLVYNNNLLGKL 399
             N+  GE+P+ L  LS +L  L+L  N  +G    ++ +    +L+ L + NN   GK+
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410

Query: 400 PLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRV 459
           P  ++   +L ++ L  N  SG IP SLG  S L  L    N   GEIP  L + K L  
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLET 470

Query: 460 LNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAI 518
           L +  N   G IPS L +C  L  + L  N+LTG +P    +   L+ L +S N+ SG I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530

Query: 519 PSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEV 578
           P+ +G+  +L  +D ++N F+G +P  +       +  I+ N + G     +      + 
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKE 586

Query: 579 FDVSFNLLN--GSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG 636
              + NLL   G     L    + +   ++   + G           ++ L +  N L G
Sbjct: 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646

Query: 637 EIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTL-SPLSNIHS 695
            IP  IG++  L   LNL  N ++G IP ++  L  L  LD+SSN L G +   +S +  
Sbjct: 647 YIPKEIGSMPYLFI-LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705

Query: 696 LVEVNVSYNLFTGPVPET--LMNLLGPSPSSFSGNPSLC----VKCLSSTDSSC 743
           L E+++S N  +GP+PE           P+ F  NP LC     +C  S     
Sbjct: 706 LTEIDLSNNNLSGPIPEMGQFETF---PPAKFLNNPGLCGYPLPRCDPSNADGY 756

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  362 bits (930), Expect = e-111
 Identities = 139/680 (20%), Positives = 229/680 (33%), Gaps = 43/680 (6%)

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD 156
            +  D S    +  +P  L   + +  L+L+ N        NF     L  L++  N + 
Sbjct: 6   HEVADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 157 GEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYR 216
              PE   ++  L+ + L +N LS    +       +  L L SN +             
Sbjct: 63  KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEG--RINFGSEKCKNLTFLDLSYNR 274
           L  L L+ N L      +   LENL  L + +N ++             +L  L+LS N+
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182

Query: 275 FSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGL---LARLSSLDLSENQLSGKIPPEL 331
                         L  L +   +L  S+     L      + +L LS +QLS       
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242

Query: 332 GKCKY--LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLL 389
              K+  LT+L L  N L     D    L  L+   L  N +   F  S+  + ++ YL 
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302

Query: 390 VYNNNLLGKL---------PLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFIN 440
           +  +     +               LK L+++++ +N   G+         +L  L   N
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN 362

Query: 441 NSFTGEIPPNLCFG----KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALP 496
           +  +     N  F       L +LN+ +N+              L  + L  N++   L 
Sbjct: 363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422

Query: 497 --EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGL--MPQELGNLVSL 552
             E+     +  + +S N       +S     +L  +         +   P     L +L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482

Query: 553 VTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLN--------GSIPSSLRSWKSLSILK 604
             L++S N++       L   + LE+ D+  N L         G     L+    L IL 
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542

Query: 605 LSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIP 664
           L  N F         +L +L  + LG N L             L   LNL KN +T    
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS-LNLQKNLITSVEK 601

Query: 665 SDLEK-LSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPS 723
                    L +LD+  N    T     +I   V      N     +PE   + L  +P 
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCT---CESIAWFVNWI---NETHTNIPELSSHYLCNTPP 655

Query: 724 SFSGNPSLCVKCLSSTDSSC 743
            + G P       S  DS+ 
Sbjct: 656 HYHGFPVRLFDTSSCKDSAH 675

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  301 bits (773), Expect = 2e-89
 Identities = 104/563 (18%), Positives = 189/563 (33%), Gaps = 45/563 (7%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQN--LQYL 148
                 L T+DLS N  S            L+ L LS N       +  +   N  L+ L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176

Query: 149 NLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGD---LKEVEALWLFSNRLSG 205
            L  N +    P     I  L  +FLNN  L  S+   +        +  L L +++LS 
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 206 TIPESIGNC--YRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCK 263
           T   +        L  L L+ N L     +S + L  L Y  +  NN++   +       
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
           N+ +L+L  +     IS                  L      SF  L  L  L++ +N +
Sbjct: 297 NVRYLNLKRSFTKQSISLA---------------SLPKIDDFSFQWLKCLEHLNMEDNDI 341

Query: 324 SGKIPPELGKCKYLTVLHLYANQLEGEIPDELG----QLSNLQDLELFDNRLTGEFPVSI 379
            G           L  L L  +                 S L  L L  N+++     + 
Sbjct: 342 PGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF 401

Query: 380 WRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDF 438
             +  LE L +  N +  +L  +    L+ +  I L  N++  +   S  +  SL +L  
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461

Query: 439 INNSFTG--EIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALP 496
              +       P      + L +L++  N        +L     L  + L+ N L     
Sbjct: 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA---- 517

Query: 497 EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLN 556
                       + ++   G     +    +L  ++  SN F  +  +   +L  L  ++
Sbjct: 518 -----------RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566

Query: 557 ISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLR-SWKSLSILKLSENHFTGGIP 615
           + LN++     S  +   +L+  ++  NL+          ++++L+ L +  N F     
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

Query: 616 TFISELEKLLELQLGGNQLGGEI 638
           +    +  + E      +L    
Sbjct: 627 SIAWFVNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  254 bits (650), Expect = 2e-72
 Identities = 96/482 (19%), Positives = 168/482 (34%), Gaps = 42/482 (8%)

Query: 288 SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQL 347
           S    D    KLT  +P    L   ++ L+L+ NQL         +   LT L +  N +
Sbjct: 5   SHEVADCSHLKLT-QVPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 348 EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELK 407
               P+   +L  L+ L L  N L+     +     +L  L + +N++         + K
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 408 QLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGK--QLRVLNMGQN 465
            L  + L +N  S     +     +L +L   NN         L       L+ L +  N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 466 QFHGPIPSLLGSCPTLWRVILKQNQLTGALPE----FSKNPVLSHLDVSRNNISGAIPSS 521
           Q     P    +   L+ + L   QL  +L E       N  + +L +S + +S    ++
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 522 IGN--SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVF 579
                  NLT +D S N  + +       L  L    +  N+++      L    N+   
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301

Query: 580 DVSFNLLNGSI---------PSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLG 630
           ++  +    SI           S +  K L  L + +N   G      + L  L  L L 
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361

Query: 631 GNQLGGEIPPSIGALQDLSY----ALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGT 686
            +        +      L++     LNL+KN ++         L  LE LD+  N +   
Sbjct: 362 NSFTSLRTLTN-ETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420

Query: 687 LSP--LSNIHSLVEVNVSYNLFTGPVPETLMNL---------------LGPSPSSFSGNP 729
           L+      + ++ E+ +SYN +      +   +               +  SPS F    
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

Query: 730 SL 731
           +L
Sbjct: 481 NL 482

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  210 bits (537), Expect = 2e-57
 Identities = 88/398 (22%), Positives = 143/398 (35%), Gaps = 41/398 (10%)

Query: 72  NVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGF 131
           N+   +LS   ++         L +L+   L  NN        L     + YL+L  +  
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308

Query: 132 TGDIPDN---------FENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGS 182
              I            F+ L+ L++LN+  N + G        ++ L+Y+ L+N+  S  
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368

Query: 183 IPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLV 242
              N       E     ++               L  L L +NK+     ++ S L +L 
Sbjct: 369 TLTN-------ETFVSLAHS-------------PLHILNLTKNKISKIESDAFSWLGHLE 408

Query: 243 YLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG 301
            LD+G N +   +        +N+  + LSYN++      +     SL  L +    L  
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468

Query: 302 --SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLE--------GEI 351
             S PS F  L  L+ LDLS N ++      L   + L +L L  N L         G  
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528

Query: 352 PDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKN 411
              L  LS+L  L L  N            +  L+ + +  NNL             LK+
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588

Query: 412 ISLYNNQFSGVIPQSLGIN-SSLMQLDFINNSFTGEIP 448
           ++L  N  + V  +  G    +L +LD   N F     
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  199 bits (509), Expect = 7e-54
 Identities = 75/419 (17%), Positives = 132/419 (31%), Gaps = 52/419 (12%)

Query: 71  HNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNI---------PPKLGNCSAL 121
             +  F L    +       +  L  ++ ++L  +    +I                  L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331

Query: 122 EYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD-GEIPEPLFRILG---LQYVFLNNN 177
           E+L++  N   G   + F  L NL+YL+L  +      +    F  L    L  + L  N
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN 391

Query: 178 SLSGSIPRNVGDLKEVEALWLFSNRLSGTIP-ESIGNCYRLQELYLNENKLMGFLPESLS 236
            +S         L  +E L L  N +   +  +       + E+YL+ NK +     S +
Sbjct: 392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFA 451

Query: 237 NLENLVYLDVGDNNLEGRINFGSE--KCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDI 294
            + +L  L +    L+   +  S     +NLT LDLS N  +      L     L  LD+
Sbjct: 452 LVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511

Query: 295 VGSKLT--------GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQ 346
             + L         G        L+ L  L+L  N               L ++ L  N 
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNN 571

Query: 347 LEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTEL 406
           L            +L+ L L  N +T                                  
Sbjct: 572 LNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF-----------------------GPAF 608

Query: 407 KQLKNISLYNNQFSGVIPQSLG----INSSLMQLDFINNSFTGEIPPNLCFGKQLRVLN 461
           + L  + +  N F             IN +   +  +++ +    PP+   G  +R+ +
Sbjct: 609 RNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHY-HGFPVRLFD 666

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  350 bits (899), Expect = e-108
 Identities = 105/655 (16%), Positives = 207/655 (31%), Gaps = 86/655 (13%)

Query: 49  SSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFS 108
             W++ +       G           +FN        Q G  +    ++  + L     S
Sbjct: 37  EIWDALNGKNWSQQGFGTQ--PGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGAS 94

Query: 109 GNIPPKLGNCSALEYLDLSTNGFTGD----IPDNFENLQNLQYLNLYGNLLDGEIPEPLF 164
           G +P  +G  + LE L L ++G   +     P       + +              +   
Sbjct: 95  GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDP 154

Query: 165 R--ILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYL 222
           R     L    +N++    SI ++     +   +   SN ++  + +++    +L++ Y+
Sbjct: 155 REDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYM 213

Query: 223 NENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPN 282
             +  +          EN  Y            +   +  K+LT +++        +   
Sbjct: 214 GNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268

Query: 283 LGNCSSLTHLDIVGSKLT--------GSIPSSFGLLARLSSLDLSENQL-SGKIPPELGK 333
           L     +  +++  ++              +   +  ++  + +  N L +  +   L K
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK 328

Query: 334 CKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYN 392
            K L +L    NQLEG++P   G    L  L L  N++T   P +       +E L   +
Sbjct: 329 MKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAH 386

Query: 393 NNLLGKLP--LEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPN 450
           N  L  +P   +   +  +  I    N+   V  ++                    + P 
Sbjct: 387 NK-LKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF-----------------DPLDPT 428

Query: 451 LCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVS 510
              G  +  +N+  NQ       L  +   L  + L  N LT  +P+             
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPK------------- 474

Query: 511 RNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQ-ELGNLVSLVTLNISLNHVEGSLPSQ 569
             N       +  N+  LTSID   NK + L        L  LV +++S N      P+Q
Sbjct: 475 --NSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQ 531

Query: 570 LSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQL 629
                 L+ F +                          N      P  I+    L +LQ+
Sbjct: 532 PLNSSTLKGFGIRNQRD------------------AQGNRTLREWPEGITLCPSLTQLQI 573

Query: 630 GGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT 684
           G N +   +   I    ++S  L++  N       S +    +     +  +   
Sbjct: 574 GSNDIRK-VNEKI--TPNISV-LDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  316 bits (811), Expect = 3e-95
 Identities = 88/564 (15%), Positives = 178/564 (31%), Gaps = 68/564 (12%)

Query: 210 SIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEG-RINFGSEKCKNLTFL 268
           S+ +  R+  L L      G +P+++  L  L  L +G +  +     FG +        
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 269 ---DLSYNRFSGGISPNLG--NCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
                    +           + S L    I       SI  S  +  + + +    N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 324 SGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIA 383
           +  +   + +   L   ++  +    E   E  +  N +       +      +    + 
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLK 249

Query: 384 SLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
            L  + VYN   L KLP  +  L +++ I++  N+                         
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ------------- 296

Query: 444 TGEIPPNLCFGKQLRVLNMGQNQF-HGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNP 502
                 +   G++++++ +G N     P+ + L     L  +    NQL G LP F    
Sbjct: 297 ---ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEI 353

Query: 503 VLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGL-MPQELGNLVSLVTLNISLNH 561
            L+ L+++ N I+    +  G +  + ++ F+ NK   +    +  ++  +  ++ S N 
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNE 413

Query: 562 VEG-------SLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG-- 612
           +          L     K  N+   ++S N ++        +   LS + L  N  T   
Sbjct: 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIP 473

Query: 613 -----GIPTFISELEKLLELQLGGNQLGGEIPPSIGA--LQDLSYALNLSKNGLTGRIPS 665
                           L  + L  N+L   +     A  L  L   ++LS N  +   P+
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG-IDLSYNSFSK-FPT 530

Query: 666 DLEKLSKLEQLDI------SSNNLTGTL-SPLSNIHSLVEVNVSYNLFTGPVPETLM--- 715
                S L+   I        N         ++   SL ++ +  N     V E +    
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNI 589

Query: 716 --------NLLGPSPSSFSGNPSL 731
                     +    S        
Sbjct: 590 SVLDIKDNPNISIDLSYVCPYIEA 613

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  259 bits (664), Expect = 8e-75
 Identities = 70/445 (15%), Positives = 151/445 (33%), Gaps = 62/445 (13%)

Query: 89  PEIGHLSKLQTIDLSSNNFSG-------------------NIPPKLGNCSALEYLDLSTN 129
             +  L+KL+   + ++ F                         K  N   L  +++   
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259

Query: 130 GFTGDIPDNFENLQNLQYLNLYGNLL--------DGEIPEPLFRILGLQYVFLNNNSL-S 180
                +P   + L  +Q +N+  N          D +          +Q +++  N+L +
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319

Query: 181 GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
             +  ++  +K++  L    N+L G +P   G+  +L  L L  N++           E 
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQ 378

Query: 241 LVYLDVGDNNLEG-RINFGSEKCKNLTFLDLSYNRFSG-------GISPNLGNCSSLTHL 292
           +  L    N L+     F ++    ++ +D SYN            + P      +++ +
Sbjct: 379 VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438

Query: 293 DIVGSKLTGSIPSSFGLLARLSSLDLSENQLSG-------KIPPELGKCKYLTVLHLYAN 345
           ++  ++++      F   + LSS++L  N L+                   LT + L  N
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498

Query: 346 QLEGEIPDEL--GQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL------LVYNNNLLG 397
           +L   + D+     L  L  ++L  N  +  FP      ++L+            N  L 
Sbjct: 499 KLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR 556

Query: 398 KLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQL 457
           + P  +T    L  + + +N    V  +      ++  LD  +N         +C   + 
Sbjct: 557 EWPEGITLCPSLTQLQIGSNDIRKVNEKIT---PNISVLDIKDNPNISIDLSYVCPYIEA 613

Query: 458 RVLNMGQNQFHGPIPSLLGSCPTLW 482
            +  +  ++        +  C  L 
Sbjct: 614 GMYMLFYDK-----TQDIRGCDALD 633

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  318 bits (818), Expect = 1e-96
 Identities = 119/570 (20%), Positives = 200/570 (35%), Gaps = 32/570 (5%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
              + +DLS N           +   L+ LDLS           +++L +L  L L GN 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 155 LDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRL-SGTIPESIGN 213
           +          +  LQ +     +L+      +G LK ++ L +  N + S  +PE   N
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENL----VYLDVGDNNLEGRINFGSEKCKNLTFLD 269
              L+ L L+ NK+       L  L  +    + LD+  N +   I  G+ K   L  L 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206

Query: 270 LSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSI---PSSFGLLARLSSLDLSENQLS- 324
           L  N  S  +    +   + L    +V  +              L  L +L + E +L+ 
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 325 -----GKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI 379
                  I         ++   L +  +E             Q LEL + +         
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ---FPT 321

Query: 380 WRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ--FSGVIPQSLGINSSLMQLD 437
            ++ SL+ L   +N           +L  L+ + L  N   F G   QS    +SL  LD
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 438 FINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIP-SLLGSCPTLWRVILKQNQLTGALP 496
              N     +  N    +QL  L+   +        S+  S   L  + +       A  
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 497 E-FSKNPVLSHLDVSRNNISGAI-PSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVT 554
             F+    L  L ++ N+      P       NLT +D S  +   L P    +L SL  
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498

Query: 555 LNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSW-KSLSILKLSENHFTGG 613
           LN+S N+             +L+V D S N +  S    L+ +  SL+ L L++N F   
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558

Query: 614 IPT--FISELEKLLELQLGGNQLGGEIPPS 641
                F+  ++   +L +   ++    P  
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATPSD 588

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  299 bits (768), Expect = 2e-89
 Identities = 121/583 (20%), Positives = 208/583 (35%), Gaps = 44/583 (7%)

Query: 140 ENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF 199
           E + N+ Y  +  N    +IP+ L      + + L+ N L      +     E++ L L 
Sbjct: 5   EVVPNITYQCMELNFY--KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60

Query: 200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS 259
              +      +  +   L  L L  N +      + S L +L  L   + NL    NF  
Sbjct: 61  RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

Query: 260 EKCKNLTFLDLSYNRFSGG-ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLS---- 314
              K L  L++++N      +     N ++L HLD+  +K+     +   +L ++     
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180

Query: 315 SLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE-LGQLSNLQDLELFDNRLTG 373
           SLDLS N ++  I P   K   L  L L  N     +    +  L+ L+   L       
Sbjct: 181 SLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

Query: 374 EFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSL 433
           E  +  +  ++LE L                 L   +    Y + +   I       +++
Sbjct: 240 EGNLEKFDKSALEGL---------------CNLTIEEFRLAYLDYYLDDIIDLFNCLTNV 284

Query: 434 MQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTG 493
                ++ +       +  +    + L +   +F       L S   L       N+   
Sbjct: 285 SSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGN 339

Query: 494 ALPEFSKNPVLSHLDVSRNNIS--GAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVS 551
           A       P L  LD+SRN +S  G    S   + +L  +D S N    +       L  
Sbjct: 340 AFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQ 397

Query: 552 LVTLNISLNHVEGSLP-SQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHF 610
           L  L+   ++++     S     +NL   D+S      +         SL +LK++ N F
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457

Query: 611 TGGI-PTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEK 669
                P   +EL  L  L L   QL    P +  +L  L   LN+S N          + 
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV-LNMSHNNFFSLDTFPYKC 516

Query: 670 LSKLEQLDISSNNLTG----TLSPLSNIHSLVEVNVSYNLFTG 708
           L+ L+ LD S N++       L    +  SL  +N++ N F  
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPS--SLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  256 bits (656), Expect = 5e-74
 Identities = 93/502 (18%), Positives = 167/502 (33%), Gaps = 44/502 (8%)

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
           +   LDLS+N      S +  +   L  LD+   ++      ++  L+ LS+L L+ N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 324 SGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG-EFPVSIWRI 382
                        L  L      L       +G L  L++L +  N +   + P     +
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 383 ASLEYLLVYNNNLLGKLPLEMTELKQLKN----ISLYNNQFSGVIPQSLGINSSLMQLDF 438
            +LE+L + +N +      ++  L Q+      + L  N  + + P +      L +L  
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLHKLTL 207

Query: 439 INNSFTGEIPPNLCFG-KQLRVLNMGQNQFHG------PIPSLLGSCPTLWRVILKQNQL 491
            NN  +  +      G   L V  +   +F           S L     L     +   L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267

Query: 492 TGALPE----FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG 547
              L +    F+    +S   +    I      S   +     ++  + KF      +L 
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLK 325

Query: 548 NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLN--GSIPSSLRSWKSLSILKL 605
           +L  L   +    +             +LE  D+S N L+  G    S     SL  L L
Sbjct: 326 SLKRLTFTSNKGGN-----AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 606 SENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSI-GALQDLSYALNLSKNGLTGRIP 664
           S N     + +    LE+L  L    + L      S+  +L++L Y L++S         
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDISHTHTRVAFN 438

Query: 665 SDLEKLSKLEQLDISSNNLTGTLSP--LSNIHSLVEVNVSYNLFTGPVPETLMNL----- 717
                LS LE L ++ N+      P   + + +L  +++S        P    +L     
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498

Query: 718 --------LGPSPSSFSGNPSL 731
                          +    SL
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSL 520

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  252 bits (646), Expect = 1e-72
 Identities = 97/523 (18%), Positives = 171/523 (32%), Gaps = 54/523 (10%)

Query: 71  HNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNF-SGNIPPKLGNCSALEYLDLSTN 129
            ++         ++      IGHL  L+ ++++ N   S  +P    N + LE+LDLS+N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 130 GFTGDIPDNFENLQNLQY----LNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPR 185
                   +   L  +      L+L  N ++  I    F+ + L  + L NN  S ++ +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218

Query: 186 NV-GDLKEVEALWLFSNRLSGTI---PESIGNCYRLQELYLNENKL------MGFLPESL 235
                L  +E   L                     L  L + E +L      +  + +  
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278

Query: 236 SNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIV 295
           + L N+    +    +E   +F          L+L   +F    +  L +   LT     
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS-- 334

Query: 296 GSKLTGSIPSSFGLLARLSSLDLSENQLS--GKIPPELGKCKYLTVLHLYANQLEGEIPD 353
                G    S   L  L  LDLS N LS  G           L  L L  N +   +  
Sbjct: 335 ---NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS 390

Query: 354 ELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNIS 413
               L  L+ L+   + L      S++                         L+ L  + 
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFL-----------------------SLRNLIYLD 427

Query: 414 LYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPN-LCFGKQLRVLNMGQNQFHGPIP 472
           + +              SSL  L    NSF     P+     + L  L++ Q Q     P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 473 SLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSI-NLTS 530
           +   S  +L  + +  N         +     L  LD S N+I  +    + +   +L  
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547

Query: 531 IDFSSNKFSGLMPQE--LGNLVSLVTLNISLNHVEGSLPSQLS 571
           ++ + N F+     +  L  +     L + +  +E + PS   
Sbjct: 548 LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQ 590

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  110 bits (276), Expect = 7e-25
 Identities = 41/233 (17%), Positives = 72/233 (30%), Gaps = 53/233 (22%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI-PDNFENLQNLQYLN 149
              L  L  +D+S  +            S+LE L ++ N F  +  PD F  L+NL +L+
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 150 LYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPE 209
           L                                                   +L    P 
Sbjct: 477 LSQ------------------------------------------------CQLEQLSPT 488

Query: 210 SIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRI-NFGSEKCKNLTFL 268
           +  +   LQ L ++ N            L +L  LD   N++             +L FL
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 548

Query: 269 DLSYNRFSGGISPN--LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLS 319
           +L+ N F+        L        L +   ++  + PS    +  + SL+++
Sbjct: 549 NLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 86.6 bits (215), Expect = 1e-17
 Identities = 25/127 (19%), Positives = 46/127 (36%), Gaps = 3/127 (2%)

Query: 90  EIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLN 149
               L  L  +DLS        P    + S+L+ L++S N F       ++ L +LQ L+
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524

Query: 150 LYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRN--VGDLKEVEALWLFSNRLSGT 206
              N +     + L      L ++ L  N  + +      +  +K+   L +   R+   
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584

Query: 207 IPESIGN 213
            P     
Sbjct: 585 TPSDKQG 591

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  303 bits (779), Expect = 1e-94
 Identities = 116/309 (37%), Positives = 179/309 (57%), Gaps = 14/309 (4%)

Query: 795  SKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFR 854
            +++D E+   +   + L+++  A++N + K+++GRG  G VYK  L    + AVK+L   
Sbjct: 6    AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 65

Query: 855  GHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP-P 913
              + G L  + E++ I    HRNL+RL  F +     +++Y YM NGS+   L       
Sbjct: 66   RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125

Query: 914  PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD 973
            P L+W  R +IALG+A  LAYLH  CDP I+HRD+K  NILLD E E  + DFG+AKL+D
Sbjct: 126  PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185

Query: 974  --KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALD---PSY 1028
               +  +T    V GTIG+IAPE   T   S+++DV+ YGV+LLELIT ++A D    + 
Sbjct: 186  YKDTHVTTA---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

Query: 1029 KERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP 1088
             +   ++ WV+ +  + +++  +VD+ L          ++V  ++ VAL CT+  P  RP
Sbjct: 243  DDDVMLLDWVKGLLKE-KKLEALVDVDLQGNY----KDEEVEQLIQVALLCTQSSPMERP 297

Query: 1089 NMRDVVRQL 1097
             M +VVR L
Sbjct: 298  KMSEVVRML 306

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  300 bits (770), Expect = 3e-87
 Identities = 98/657 (14%), Positives = 199/657 (30%), Gaps = 86/657 (13%)

Query: 16  VALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVS 75
           V + L+       D  AL ++    +       S   ++      W             +
Sbjct: 257 VPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-------------N 303

Query: 76  FNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI 135
           FN        Q G ++ +  ++  + L+     G +P  +G  + L+ L   T+  T   
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 136 PDNFENLQNLQYLNLYGNLLDGEIPE------PLFRILGLQYVFLNNNSLSGSIPRNVGD 189
               +            + +     +          +  L    +N N     I ++   
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423

Query: 190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDN 249
             +   +   +NR++  I ++I    +LQ +Y   +              N  Y      
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY-----A 477

Query: 250 NLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG-------- 301
                        K+LT ++L        +   L +   L  L+I  ++           
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537

Query: 302 -SIPSSFGLLARLSSLDLSENQLSGKIPPE--LGKCKYLTVLHLYANQLEGEIPDELGQL 358
             +        ++    +  N L    P    L K   L +L    N++     +  G  
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTN 594

Query: 359 SNLQDLELFDNRLTGEFPVSIWRIAS-LEYLLVYNNNLLGKLP--LEMTELKQLKNISLY 415
             L DL+L  N++  E P         +E L   +N  L  +P       +  + ++   
Sbjct: 595 VKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK-LKYIPNIFNAKSVYVMGSVDFS 652

Query: 416 NNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLL 475
            N+          I+ S+     IN                   + +  N+       L 
Sbjct: 653 YNKIGSEGR---NISCSMDDYKGIN----------------ASTVTLSYNEIQKFPTELF 693

Query: 476 GSCPTLWRVILKQNQLT--------GALPEFSKNPVLSHLDVSRNNISGAIPSSI--GNS 525
            +   +  +IL  N +T             +    +L+ +D+  N ++  +         
Sbjct: 694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTL 752

Query: 526 INLTSIDFSSNKFSGLMPQELGNLVSLVTLNISL------NHVEGSLPSQLSKCKNLEVF 579
             L+++D S N FS   P +  N   L    I        N +    P+ ++ C +L   
Sbjct: 753 PYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811

Query: 580 DVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGG-IPTFISELEKLLE-LQLGGNQL 634
            +  N +   +   L     L IL +++N      + +    +E  +  L     Q 
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  276 bits (708), Expect = 6e-79
 Identities = 83/548 (15%), Positives = 174/548 (31%), Gaps = 57/548 (10%)

Query: 201 NRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSE 260
           +         + N  R+  L L      G +P+++  L  L  L  G ++         +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 261 KCKNLTFLDLSYNRFSGGISPNLG------NCSSLTHLDIVGSKLTGSIPSSFGLLARLS 314
           +       +   +R                N S L    I  +     I     +  + +
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 315 SLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGE 374
            +    N+++  I   + +   L +++   +    +      + +N         +    
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY-----AKQYEN 482

Query: 375 FPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLM 434
             +S   +  L  + +YN   + +LP  + +L +L+++++  N+                
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR--- 539

Query: 435 QLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHG-PIPSLLGSCPTLWRVILKQNQLTG 493
                       +  +   G ++++  MG N     P  + L     L  +    N++  
Sbjct: 540 ------------LADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR- 586

Query: 494 ALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSI-NLTSIDFSSNKFSGLMPQ-ELGNLVS 551
            L  F  N  L+ L +  N I   IP         +  + FS NK   +       ++  
Sbjct: 587 HLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV 645

Query: 552 LVTLNISLNH-----VEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS 606
           + +++ S N         S      K  N     +S+N +         +   +S + LS
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILS 705

Query: 607 ENHFT-------GGIPTFISELEKLLELQLGGNQLGGEIPPSI--GALQDLSYALNLSKN 657
            N  T                   L  + L  N+L   +        L  LS  +++S N
Sbjct: 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSN-MDVSYN 763

Query: 658 GLTGRIPSDLEKLSKLEQLDI------SSNNLTGTL-SPLSNIHSLVEVNVSYNLFTGPV 710
             +   P+     S+L+   I        N +     + ++   SL+++ +  N     V
Sbjct: 764 CFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-V 821

Query: 711 PETLMNLL 718
            E L   L
Sbjct: 822 DEKLTPQL 829

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  219 bits (560), Expect = 2e-59
 Identities = 66/511 (12%), Positives = 144/511 (28%), Gaps = 43/511 (8%)

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG 277
             + +   +   ++ +  +       LD  +          +    N  F +   + +  
Sbjct: 255 ANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGD 313

Query: 278 GISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYL 337
               +L N   +T L + G    G +P + G L  L  L    +  +        +    
Sbjct: 314 QPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTP 373

Query: 338 TVLHLYANQLEGEIPDE-LGQLSNLQDLELFDNRLTGE---FPVSIWRIASLEYLLVYN- 392
            +     +++        L     L   +L  + +       P+      SL+   + N 
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL 433

Query: 393 NNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLC 452
            N +  +   +  L +L+ I   N+ F+         +++                 +  
Sbjct: 434 TNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENEELSWS 488

Query: 453 FGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRN 512
             K L  + +        +P  L   P L  + +  N+   A    +             
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD------------ 536

Query: 513 NISGAIPSSIGNSINLTSIDFSSNKFSGLMP-QELGNLVSLVTLNISLNHVEGSLPSQLS 571
                +         +       N          L  +V L  L+   N V   L +   
Sbjct: 537 --WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FG 592

Query: 572 KCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP--TFISELEKLLELQL 629
               L    + +N +             +  L  S N     IP       +  +  +  
Sbjct: 593 TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDF 651

Query: 630 GGNQLGG---EIPPSIGALQDLS-YALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT- 684
             N++G     I  S+   + ++   + LS N +           S +  + +S+N +T 
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711

Query: 685 -------GTLSPLSNIHSLVEVNVSYNLFTG 708
                         N + L  +++ +N  T 
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  153 bits (388), Expect = 4e-38
 Identities = 63/432 (14%), Positives = 134/432 (31%), Gaps = 40/432 (9%)

Query: 316 LDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEF 375
           +D+        +    G  + +     Y+         E   +   +   + DN+LT + 
Sbjct: 198 MDIGVATCDSAVWLPAGTYQ-VVAYTTYSQSGIKRSELETQSVRG-ESFTVIDNKLTKDA 255

Query: 376 PVSIWRIASLEYL------------LVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVI 423
            V I    + EY+            L   N       +  T      N +   + +    
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQP 315

Query: 424 PQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWR 483
              L  N  +  L        G +P  +    +L+VL+ G +              T   
Sbjct: 316 GVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDM 375

Query: 484 VILKQNQLTGALPE--FSKNPVLSHLDVSRNNIS-----GAIPSSIGNSINLTSIDFSSN 536
              +++++     +     +  L+  D+ ++ I+       I      S+  T I   +N
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435

Query: 537 KFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRS 596
           + + +  + +  L  L  +  + +          +   + E  +  +     +   S  +
Sbjct: 436 RITFI-SKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSN 489

Query: 597 WKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG---------EIPPSIGALQD 647
            K L+ ++L        +P F+ +L +L  L +  N+             +         
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549

Query: 648 LSYALNLSKNGLTGRIPS-DLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLF 706
           +     +  N L     S  L+K+ KL  LD   N +   L        L ++ + YN  
Sbjct: 550 IQI-FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYNQI 607

Query: 707 TGPVPETLMNLL 718
              +PE      
Sbjct: 608 EE-IPEDFCAFT 618

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 94.9 bits (236), Expect = 6e-20
 Identities = 28/250 (11%), Positives = 69/250 (27%), Gaps = 25/250 (10%)

Query: 489 NQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGN 548
            +        + + +  + +   +         + N+  +T +  +     G +P  +G 
Sbjct: 286 WRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQ 345

Query: 549 LVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPS-SLRSWKSLSILKLSE 607
           L  L  L+   +    S      +    ++ +   + +        L   + L++  L +
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405

Query: 608 NHFT-----GGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGR 662
           +          I        K  ++    N++   I  +I  L  L   +  + +  T  
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQI-IYFANSPFTYD 463

Query: 663 IPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFTGPVPETLMNLLGPS 721
             +        E  +              SN+  L +V +                +   
Sbjct: 464 NIA-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC-----------PNMTQL 507

Query: 722 PSSFSGNPSL 731
           P      P L
Sbjct: 508 PDFLYDLPEL 517

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 78.4 bits (193), Expect = 9e-15
 Identities = 35/340 (10%), Positives = 83/340 (24%), Gaps = 28/340 (8%)

Query: 405 ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQ 464
              +LK + +   + S         N   M +          +P            +   
Sbjct: 169 VTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYS--- 225

Query: 465 NQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGN 524
                       S        +  N+LT            +++ +     +  I      
Sbjct: 226 QSGIKRSELETQSVRGE-SFTVIDNKLTKD----------ANVPIQLKETAEYIKDYKAL 274

Query: 525 SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN 584
                ++D  + ++         + ++    N  L+         L     +    ++  
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333

Query: 585 LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGA 644
              G +P ++     L +L    +  T     F  E       +   +++          
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393

Query: 645 LQDLSYALNLSKNGLT-----GRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEV 699
                   +L ++ +        I  D     K  Q+   +N +T     +  +  L  +
Sbjct: 394 YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQII 453

Query: 700 NVSYNLFTGPVPETLM--------NLLGPSPSSFSGNPSL 731
             + + FT                        S+S    L
Sbjct: 454 YFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDL 493

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  286 bits (734), Expect = 8e-85
 Identities = 107/533 (20%), Positives = 190/533 (35%), Gaps = 17/533 (3%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
            +  + ++ S N               L +LDL+         D F++   L  L L  N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
            L       L     L+++F     +S      + + K +E+L+L SN +S         
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENL--VYLDVGDNNLEGRINFGSEKCKNLTFLDLS 271
             +L+ L    N +     E +S+L+    + L++  N++ G I  G+        L+  
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210

Query: 272 YNRFSGGISPNLGNCS--SLTHLDIVGSKLTGSIPSSFGLLARLS--SLDLSENQLSGKI 327
             +    I   L N +  SL              P+ F  L  +S  S++L ++      
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270

Query: 328 PPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEY 387
                    L  L L A  L  E+P  L  LS L+ L L  N+      +S     SL +
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 388 LLVYNNNLLGKLPLEMTE-LKQLKNISLYNNQ--FSGVIPQSLGINSSLMQLDFINNSFT 444
           L +  N    +L     E L+ L+ + L ++    S      L   S L  L+   N   
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389

Query: 445 GEIPPNLCFGKQLRVLNMGQNQFHG-PIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNP 502
                      QL +L++   +       S   +   L  + L  + L  +  + F   P
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449

Query: 503 VLSHLDVSRNNISGAI---PSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISL 559
            L HL++  N+         +S+     L  +  S    S +      +L  +  +++S 
Sbjct: 450 ALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509

Query: 560 NHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG 612
           N +  S    LS  K +   +++ N ++  +PS L        + L +N    
Sbjct: 510 NRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  265 bits (680), Expect = 3e-77
 Identities = 113/553 (20%), Positives = 195/553 (35%), Gaps = 24/553 (4%)

Query: 196 LWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRI 255
               +  L+  IP ++ N    + L  + N L      + S L NL +LD+    +    
Sbjct: 17  YNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 256 NFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSS 315
               +    L  L L+ N         L    +L HL  + + ++            L S
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 316 LDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLEL--FDNRLTG 373
           L L  N +S    P+    + L VL    N +     +++  L    +L L    N +  
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA- 192

Query: 374 EFPVSIWRIASLEYLLVYNNNLLGKLP--LEMTELKQLKNISLYNNQFSGVIPQSLGI-- 429
                 +  A  + L       L  +   L+ + ++ L   +  +     + P       
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
             S+  ++   + F             L+ L++        +PS L    TL +++L  N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSAN 311

Query: 490 QLTGALPE-FSKNPVLSHLDVSRNNISGAIPS-SIGNSINLTSIDFSSNK--FSGLMPQE 545
           +         S  P L+HL +  N     + +  + N  NL  +D S +    S     +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371

Query: 546 LGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP-SSLRSWKSLSILK 604
           L NL  L +LN+S N           +C  LE+ D++F  L      S  ++   L +L 
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431

Query: 605 LSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSY--ALNLSKNGLTGR 662
           LS +            L  L  L L GN           +LQ L     L LS   L+  
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491

Query: 663 IPSDLEKLSKLEQLDISSNNLTG-TLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPS 721
                  L  +  +D+S N LT  ++  LS++  +  +N++ N  +  +P  L  L    
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPIL--SQ 548

Query: 722 PSSF--SGNPSLC 732
             +     NP  C
Sbjct: 549 QRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  252 bits (645), Expect = 2e-72
 Identities = 100/556 (17%), Positives = 188/556 (33%), Gaps = 43/556 (7%)

Query: 92  GHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLY 151
               +L T+ L++N         L    AL++L     G +        N + L+ L L 
Sbjct: 78  QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137

Query: 152 GNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKE--VEALWLFSNRLSGTIPE 209
            N +        F    L+ +   NN++      ++  L++    +L L  N ++  I  
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEP 196

Query: 210 SIGNCYRLQELYLNENKLMGFLPESLSN--LENLVYLDVGDNNLEG--RINFGSEKCKNL 265
              +    Q L     + +  + + L N  +++L      D + E      F      ++
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256

Query: 266 TFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSG 325
             ++L  + F    S      S L  LD+  + L+  +PS    L+ L  L LS N+   
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN 315

Query: 326 KIPPELGKCKYLTVLHLYANQLEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSIWRIAS 384
                      LT L +  N    E+    L  L NL++L+L  + +             
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET----------- 364

Query: 385 LEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFT 444
                           L++  L  L++++L  N+   +  ++      L  LD       
Sbjct: 365 -----------SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413

Query: 445 GEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTG----ALPEFS 499
            +   +       L+VLN+  +        L    P L  + L+ N              
Sbjct: 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ 473

Query: 500 KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISL 559
               L  L +S  ++S     +  +   +  +D S N+ +    + L +L  +  LN++ 
Sbjct: 474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLAS 532

Query: 560 NHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSS-LRSWKSLSILKLSENHFTGGIPTFI 618
           NH+   LPS L         ++  N L+ +  +     W      K +         T  
Sbjct: 533 NHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEW-----YKENMQKLEDTEDTLC 587

Query: 619 SELEKLLELQLGGNQL 634
                L  ++L    L
Sbjct: 588 ENPPLLRGVRLSDVTL 603

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  226 bits (578), Expect = 2e-63
 Identities = 85/461 (18%), Positives = 150/461 (32%), Gaps = 35/461 (7%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
           + +   L+++ L SN+ S    PK      L+ LD   N       ++  +LQ    L+L
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184

Query: 151 YGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
                                  LN N ++  I     D    ++L     +    I + 
Sbjct: 185 N----------------------LNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKG 221

Query: 211 IGNC--YRLQELYLNENKLMGFLPESLSNLE--NLVYLDVGDNNLEGRINFGSEKCKNLT 266
           + N     L      +       P     L   ++  +++  +      +        L 
Sbjct: 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ 281

Query: 267 FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGK 326
            LDL+    S  +   L   S+L  L +  +K       S      L+ L +  N    +
Sbjct: 282 ELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340

Query: 327 IPPE-LGKCKYLTVLHLYANQLE--GEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIA 383
           +    L   + L  L L  + +E       +L  LS+LQ L L  N        +     
Sbjct: 341 LGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP 400

Query: 384 SLEYLLVYNNNLLGKLPLE-MTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNS 442
            LE L +    L  K        L  LK ++L ++       Q      +L  L+   N 
Sbjct: 401 QLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNH 460

Query: 443 FTGEI---PPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFS 499
           F         +L    +L +L +              S   +  V L  N+LT +  E  
Sbjct: 461 FPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520

Query: 500 KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
            +    +L+++ N+IS  +PS +       +I+   N    
Sbjct: 521 SHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  216 bits (553), Expect = 3e-60
 Identities = 88/456 (19%), Positives = 165/456 (36%), Gaps = 27/456 (5%)

Query: 77  NLSSYGVSGQLGPEIGHLSKLQTIDLS-SNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI 135
           +  +  +      ++  L +   + L+ + N    I P   + +  + L+         I
Sbjct: 159 DFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVI 218

Query: 136 PDN--FENLQNLQYLNLYGNLLDGEIPEPLFRILG---LQYVFLNNNSLSGSIPRNVGDL 190
                   +Q+L          + +I   +F  L    ++ + L  +             
Sbjct: 219 FKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCF 277

Query: 191 KEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNN 250
             ++ L L +  LS  +P  +     L++L L+ NK       S SN  +L +L +  N 
Sbjct: 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336

Query: 251 LEGRINFGS-EKCKNLTFLDLSYNR--FSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSF 307
               +  G  E  +NL  LDLS++    S   +  L N S L  L++  ++       +F
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396

Query: 308 GLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLEL 366
               +L  LDL+  +L  K           L VL+L  + L+         L  LQ L L
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456

Query: 367 FDNRLTGEFPVSIWRIA---SLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVI 423
             N            +     LE L++   +L        T LK + ++ L +N+ +   
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516

Query: 424 PQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLW- 482
            ++L  +   + L+  +N  +  +P  L    Q R +N+ QN           +C  ++ 
Sbjct: 517 IEALS-HLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLD-------CTCSNIYF 568

Query: 483 RVILKQNQLTGALPE---FSKNPVLSHLDVSRNNIS 515
               K+N       E       P+L  + +S   +S
Sbjct: 569 LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  214 bits (547), Expect = 2e-59
 Identities = 89/439 (20%), Positives = 150/439 (34%), Gaps = 18/439 (4%)

Query: 291 HLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGE 350
             +     L   IP    L      L+ S N L         +   LT L L   Q+   
Sbjct: 16  TYNCENLGLN-EIPG--TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 351 IPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLK 410
             D       L  L L  N L      ++    +L++L      +     + +   K L+
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 411 NISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRV--LNMGQNQFH 468
           ++ L +N  S +          L  LDF NN+       ++   +Q     LN+  N   
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192

Query: 469 GPIPSLLGSCPTLWRVILKQNQLTGALPE---FSKNPVLSHLDVSRNNISGAIPSSIGN- 524
           G I            +     Q    + +    S    L        +     P+     
Sbjct: 193 G-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 525 -SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSF 583
             +++ SI+   + F  +          L  L+++  H+   LPS L     L+   +S 
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310

Query: 584 NLLNGSIPSSLRSWKSLSILKLSENHFTGGIPT-FISELEKLLELQLGGNQLGGEIPPSI 642
           N        S  ++ SL+ L +  N     + T  +  LE L EL L  + +        
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCN 369

Query: 643 GALQDLS--YALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTG--TLSPLSNIHSLVE 698
             L++LS   +LNLS N          ++  +LE LD++   L      SP  N+H L  
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429

Query: 699 VNVSYNLFTGPVPETLMNL 717
           +N+S++L      +    L
Sbjct: 430 LNLSHSLLDISSEQLFDGL 448

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  275 bits (705), Expect = 2e-84
 Identities = 100/312 (32%), Positives = 158/312 (50%), Gaps = 24/312 (7%)

Query: 797  QDLEIPAQEGPSYLLKQVIEATEN------LNAKHVIGRGAHGIVYKASLGPNAVFAVKK 850
            + LE+      S+   ++   T N          + +G G  G+VYK  +    V AVKK
Sbjct: 3    KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKK 61

Query: 851  LAFRGHKRGSLSMKR----EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDV 906
            LA       +  +K+    EI+ + K +H NLV L  F    D   ++Y YM NGSL D 
Sbjct: 62   LA-AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120

Query: 907  LHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDF 966
            L  +   P L W++R KIA GAA+ + +LH   +   +HRDIK  NILLD      ISDF
Sbjct: 121  LSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDF 177

Query: 967  GIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALD 1025
            G+A+  +K   +  +  +VGT  Y+APE      + + +SD+YS+GVVLLE+IT   A+D
Sbjct: 178  GLARASEKFAQTVMTSRIVGTTAYMAPE--ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

Query: 1026 PSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPS 1085
               + +  ++     +  + + I D +D  + +     +    V  +  VA +C  +K +
Sbjct: 236  EHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMND-----ADSTSVEAMYSVASQCLHEKKN 289

Query: 1086 NRPNMRDVVRQL 1097
             RP+++ V + L
Sbjct: 290  KRPDIKKVQQLL 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  274 bits (702), Expect = 7e-84
 Identities = 89/355 (25%), Positives = 148/355 (41%), Gaps = 60/355 (16%)

Query: 29  DGVALLSLMRHWNSVPPLIISSWN-SSDSTPCQWVGIECDDDAH--NVVSFNLSSYGVSG 85
           D  ALL + +   +  P  +SSW  ++D     W+G+ CD D     V + +LS   +  
Sbjct: 7   DKQALLQIKKDLGN--PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64

Query: 86  QLG--PEIGHLSKLQTIDLSS-NNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENL 142
                  + +L  L  + +   NN  G IPP +   + L YL ++    +G IPD    +
Sbjct: 65  PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124

Query: 143 QNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNR 202
           + L  L+                           N+LSG++P ++  L  +  +    NR
Sbjct: 125 KTLVTLDFS------------------------YNALSGTLPPSISSLPNLVGITFDGNR 160

Query: 203 LSGTIPESIGNCYRL-QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEK 261
           +SG IP+S G+  +L   + ++ N+L G +P + +NL                       
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL----------------------- 197

Query: 262 CKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN 321
             NL F+DLS N   G  S   G+  +   + +  + L   +    GL   L+ LDL  N
Sbjct: 198 --NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNN 254

Query: 322 QLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFP 376
           ++ G +P  L + K+L  L++  N L GEIP + G L         +N+     P
Sbjct: 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  233 bits (596), Expect = 4e-69
 Identities = 78/337 (23%), Positives = 120/337 (35%), Gaps = 56/337 (16%)

Query: 231 LPESLSNLENLV----YLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG--GISPNLG 284
           + + L N   L       D  +    G +     +   +  LDLS         I  +L 
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 285 NCSSLTHLDIVGS-KLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLY 343
           N   L  L I G   L G IP +   L +L  L ++   +SG IP  L + K L  L   
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133

Query: 344 ANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM 403
            N L G +P  +  L NL  +    NR++G  P S    + L   +              
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM-------------- 179

Query: 404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMG 463
                    ++  N+ +G IP +                       NL     L  +++ 
Sbjct: 180 ---------TISRNRLTGKIPPTFA---------------------NL----NLAFVDLS 205

Query: 464 QNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIG 523
           +N   G    L GS     ++ L +N L   L +   +  L+ LD+  N I G +P  + 
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265

Query: 524 NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLN 560
               L S++ S N   G +PQ  GNL        + N
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  223 bits (570), Expect = 1e-65
 Identities = 81/327 (24%), Positives = 127/327 (38%), Gaps = 56/327 (17%)

Query: 411 NISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGE--IPPNLCFGKQLRVLNM-GQNQF 467
                N  + GV+  +      +  LD    +      IP +L     L  L + G N  
Sbjct: 30  TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89

Query: 468 HGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSIN 527
            GPIP  +     L                        +L ++  N+SGAIP  +     
Sbjct: 90  VGPIPPAIAKLTQL-----------------------HYLYITHTNVSGAIPDFLSQIKT 126

Query: 528 LTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLN 587
           L ++DFS N  S                        G+LP  +S   NL       N ++
Sbjct: 127 LVTLDFSYNALS------------------------GTLPPSISSLPNLVGITFDGNRIS 162

Query: 588 GSIPSSLRSWKSLS-ILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQ 646
           G+IP S  S+  L   + +S N  TG IP   + L  L  + L  N L G+     G+ +
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDK 221

Query: 647 DLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNL 705
           +    ++L+KN L   +   +     L  LD+ +N + GTL   L+ +  L  +NVS+N 
Sbjct: 222 NTQK-IHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279

Query: 706 FTGPVPETLMNLLGPSPSSFSGNPSLC 732
             G +P+   NL     S+++ N  LC
Sbjct: 280 LCGEIPQGG-NLQRFDVSAYANNKCLC 305

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  191 bits (489), Expect = 1e-54
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 6/218 (2%)

Query: 71  HNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNG 130
             +    ++   VSG +   +  +  L T+D S N  SG +PP + +   L  +    N 
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160

Query: 131 FTGDIPDNFENLQNL-QYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGD 189
            +G IPD++ +   L   + +  N L G+IP      L L +V L+ N L G      G 
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDASVLFGS 219

Query: 190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDN 249
            K  + + L  N L+  +   +G    L  L L  N++ G LP+ L+ L+ L  L+V  N
Sbjct: 220 DKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278

Query: 250 NLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCS 287
           NL G I  G    +       + N+   G    L  C+
Sbjct: 279 NLCGEIPQGG-NLQRFDVSAYANNKCLCGSP--LPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  162 bits (412), Expect = 3e-44
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 11/210 (5%)

Query: 517 AIPSSIGNSINLTS----IDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGS--LPSQL 570
            I   +GN   L+S     D  +  + G++         +  L++S  ++     +PS L
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 571 SKCKNLEVFDVS-FNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQL 629
           +    L    +   N L G IP ++     L  L ++  + +G IP F+S+++ L+ L  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 630 GGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQ-LDISSNNLTGTLS 688
             N L G +PPSI +L +L   +    N ++G IP      SKL   + IS N LTG + 
Sbjct: 133 SYNALSGTLPPSISSLPNLVG-ITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191

Query: 689 P-LSNIHSLVEVNVSYNLFTGPVPETLMNL 717
           P  +N+ +L  V++S N+  G       + 
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSD 220

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  268 bits (687), Expect = 1e-81
 Identities = 108/298 (36%), Positives = 159/298 (53%), Gaps = 23/298 (7%)

Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            L  + EAT N + K +IG G  G VYK  L   A  A+K+       +G    + EI+T+
Sbjct: 31   LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT-PESSQGIEEFETEIETL 89

Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH-SITPPPTLEWNVRYKIALGAA 929
               RH +LV L  F   ++  I++Y+YMENG+L+  L+ S  P  ++ W  R +I +GAA
Sbjct: 90   SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL---LDKSPASTTSISVVG 986
              L YLH      I+HRD+K  NILLD    P I+DFGI+K    LD++  ST    V G
Sbjct: 150  RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV---VKG 203

Query: 987  TIGYIAPENAFT---TAKSKESDVYSYGVVLLELITRKKALDPSY-KERTDIVGWVRSVW 1042
            T+GYI PE       T K   SDVYS+GVVL E++  + A+  S  +E  ++  W     
Sbjct: 204  TLGYIDPEYFIKGRLTEK---SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE-S 259

Query: 1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
             +  ++  IVD +L +++   S+R         A++C      +RP+M DV+ +L  A
Sbjct: 260  HNNGQLEQIVDPNLADKIRPESLR----KFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  267 bits (685), Expect = 6e-78
 Identities = 104/537 (19%), Positives = 181/537 (33%), Gaps = 30/537 (5%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
           S  + IDLS N           N S L++LDLS           +  L +L  L L GN 
Sbjct: 32  SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSG-TIPESIG 212
           +        F  L  L+ +      L+      +G L  ++ L +  N +    +P    
Sbjct: 92  IQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 213 NCYRLQELYLNENKLMGFLPESLSNLENL----VYLDVGDNNLEGRINFGSEKCKNLTFL 268
           N   L  + L+ N +       L  L       + LD+  N ++  I   + +   L  L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHEL 209

Query: 269 DLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSI------PSSFGLLARLS--SLDLS 319
            L  N  S  I    L N + L    ++  +           PS    L  ++     L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 320 ENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI 379
                     +      ++ + L    ++    +++ +    Q L +   +L        
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ---FPT 324

Query: 380 WRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI--NSSLMQLD 437
             +  L+ L +  N     +  +   L  L  + L  N  S     S      +SL  LD
Sbjct: 325 LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 438 FINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIP-SLLGSCPTLWRVILKQNQLTGALP 496
              N     +  N    ++L+ L+   +        S   S   L  + +          
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441

Query: 497 E-FSKNPVLSHLDVSRNNISGAIPSSI-GNSINLTSIDFSSNKFSGLMPQELGNLVSLVT 554
             F     L+ L ++ N+      S++  N+ NLT +D S  +   +       L  L  
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501

Query: 555 LNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT 611
           LN+S N++     S  ++  +L   D SFN +  S        KSL+   L+ N   
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  247 bits (632), Expect = 8e-71
 Identities = 109/572 (19%), Positives = 195/572 (34%), Gaps = 44/572 (7%)

Query: 99  TIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGE 158
           T        S  +P  +   S+ + +DLS N        +F N   LQ+L+L    ++  
Sbjct: 15  TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET- 70

Query: 159 IPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRL 217
           I +  +  L  L  + L  N +    P +   L  +E L     +L+      IG    L
Sbjct: 71  IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130

Query: 218 QELYLNENKLMGF-LPESLSNLENLVYLDVGDNNL----EGRINFGSEKCKNLTFLDLSY 272
           ++L +  N +    LP   SNL NLV++D+  N +       + F  E  +    LD+S 
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190

Query: 273 NRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGL-LARLSSLDLSENQLSGKIPPEL 331
           N     I         L  L + G+  + +I  +    LA L    L   +   +     
Sbjct: 191 NPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE----- 244

Query: 332 GKCKYLTVLHLYANQLEGEIPDELGQLSNLQ--DLELFDNRLTGEFPVSIWRIASLEYLL 389
                          LE   P  +  L ++   +  L       +  V    +A++  + 
Sbjct: 245 -------------RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291

Query: 390 VYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPP 449
           +   ++  K   ++ +  + +++S+   Q        L     L  L    N  +  I  
Sbjct: 292 LAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGS--ISF 344

Query: 450 NLCFGKQLRVLNMGQNQFH--GPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHL 507
                  L  L++ +N     G          +L  + L  N        F     L HL
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHL 404

Query: 508 DVSRNNISGAIP-SSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
           D   + +      S+  +   L  +D S              L SL TL ++ N  + + 
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464

Query: 567 PSQ-LSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLL 625
            S   +   NL   D+S   L         +   L +L +S N+      +  ++L  L 
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLS 524

Query: 626 ELQLGGNQLGGEIPPSIGALQDLSYALNLSKN 657
            L    N++           + L++  NL+ N
Sbjct: 525 TLDCSFNRIETSKGILQHFPKSLAF-FNLTNN 555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  212 bits (542), Expect = 1e-58
 Identities = 87/501 (17%), Positives = 161/501 (32%), Gaps = 43/501 (8%)

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
           +   +DLS+N      S +  N S L  LD+   ++      ++  L  LS+L L+ N +
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

Query: 324 SGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG-EFPVSIWRI 382
               P        L  L     +L       +GQL  L+ L +  N +   + P     +
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152

Query: 383 ASLEYLLVYNNNLLGKLPLEMTELKQLKN----ISLYNNQFSGVIPQSLGINSSLMQLDF 438
            +L ++ +  N +      ++  L++       + +  N     I         L +L  
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTL 211

Query: 439 INNSFTGEIPPNLCFG-KQLRVLNMGQNQFHG------PIPSLLGSCPTLWRVILK--QN 489
             N  +  I          L V  +   +F          PS++     +     +    
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271

Query: 490 QLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGN 548
                    F     +S + ++  +I       +       S+     +          +
Sbjct: 272 NDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF---PTLD 326

Query: 549 LVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWK--SLSILKLS 606
           L  L +L +++N   GS+  +     +L   D+S N L+ S   S       SL  L LS
Sbjct: 327 LPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384

Query: 607 ENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPS-IGALQDLSYALNLSKNGLTGRIPS 665
            N     +      LE+L  L    + L      S   +L+ L Y L++S          
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY-LDISYTNTKIDFDG 442

Query: 666 DLEKLSKLEQLDISSNNLTGTLSP--LSNIHSLVEVNVSYNLFTGPVPETLMNL------ 717
               L+ L  L ++ N+          +N  +L  +++S              L      
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502

Query: 718 -------LGPSPSSFSGNPSL 731
                  L    S ++   SL
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSL 523

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  189 bits (482), Expect = 7e-51
 Identities = 76/425 (17%), Positives = 131/425 (30%), Gaps = 48/425 (11%)

Query: 84  SGQLGPEIGHLSKLQTIDLSSNNFSG---------------------------NIPPKLG 116
           S +L     +L+ L  +DLS N                                I  +  
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201

Query: 117 NCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNLLDGEIPEPLFRI--------L 167
               L  L L  N  + +I     +NL  L    L       E    +F          +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261

Query: 168 GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKL 227
            +    L   +           L  V A+ L    +     E +   ++ Q L +   +L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319

Query: 228 MGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS--GGISPNLGN 285
             F    L  L+    L +  N         +    +L++LDLS N  S  G  S +   
Sbjct: 320 KQFPTLDLPFLK---SLTLTMNKGSISFKKVA--LPSLSYLDLSRNALSFSGCCSYSDLG 374

Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYA 344
            +SL HLD+  +     + ++F  L  L  LD   + L            + L  L +  
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433

Query: 345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWR-IASLEYLLVYNNNLLGKLPLEM 403
              + +       L++L  L++  N        +++    +L +L +    L        
Sbjct: 434 TNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493

Query: 404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMG 463
             L +L+ +++ +N    +         SL  LD   N           F K L   N+ 
Sbjct: 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT 553

Query: 464 QNQFH 468
            N   
Sbjct: 554 NNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  164 bits (418), Expect = 1e-42
 Identities = 62/305 (20%), Positives = 105/305 (34%), Gaps = 12/305 (3%)

Query: 72  NVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGF 131
            +  F L+          +   L+ +  + L+  +        +      + L +     
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQL 319

Query: 132 TGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLK 191
               P    +L  L+ L L  N     I      +  L Y+ L+ N+LS S   +  DL 
Sbjct: 320 K-QFP--TLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374

Query: 192 --EVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPES-LSNLENLVYLDVGD 248
              +  L L  N     +  +      LQ L    + L      S   +LE L+YLD+  
Sbjct: 375 TNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433

Query: 249 NNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSF 307
            N +   +       +L  L ++ N F      N   N ++LT LD+   +L       F
Sbjct: 434 TNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493

Query: 308 GLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELF 367
             L RL  L++S N L         +   L+ L    N++E           +L    L 
Sbjct: 494 DTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT 553

Query: 368 DNRLT 372
           +N + 
Sbjct: 554 NNSVA 558

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  222 bits (568), Expect = 3e-65
 Identities = 77/302 (25%), Positives = 125/302 (41%), Gaps = 31/302 (10%)

Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR 876
             +  L    V  RG  G V+KA L    V AVK   F    + S   + E+ ++  ++H 
Sbjct: 22   QSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKI--FPIQDKQSWQNEYEVYSLPGMKHE 78

Query: 877  NLVRL-----EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHA 931
            N+++          +  D   ++  + E GSL D L +      + WN    IA   A  
Sbjct: 79   NILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARG 133

Query: 932  LAYLHYD-------CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
            LAYLH D         P I HRDIK +N+LL + +   I+DFG+A   +   ++  +   
Sbjct: 134  LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193

Query: 985  VGTIGYIAPENA-----FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVR 1039
            VGT  Y+APE       F        D+Y+ G+VL EL +R  A D    E   ++ +  
Sbjct: 194  VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--YMLPFEE 251

Query: 1040 SVWSD--TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVAL--RCTEKKPSNRPNMRDVVR 1095
             +      E++ ++V       +L    +      +L      C +     R +   V  
Sbjct: 252  EIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

Query: 1096 QL 1097
            ++
Sbjct: 312  RI 313

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  219 bits (559), Expect = 2e-62
 Identities = 97/478 (20%), Positives = 176/478 (36%), Gaps = 35/478 (7%)

Query: 138 NFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALW 197
               L       L    +   +      +  +  +  +   +       V  L  +  + 
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQIN 74

Query: 198 LFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINF 257
             +N+L+   P  + N  +L ++ +N N++       L+NL NL  L + +N +      
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTLFNNQITDIDPL 130

Query: 258 GSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD 317
                 NL  L+LS N  S      L   +SL  L   G+++T   P     L  L  LD
Sbjct: 131 K--NLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183

Query: 318 LSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPV 377
           +S N++S      L K   L  L    NQ+    P  LG L+NL +L L  N+L      
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IG 237

Query: 378 SIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLD 437
           ++  + +L  L + NN +    PL    L +L  + L  NQ S + P  L   ++L  L+
Sbjct: 238 TLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISP--LAGLTALTNLE 293

Query: 438 FINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE 497
              N         +   K L  L +  N      P  + S   L R+    N+++  +  
Sbjct: 294 LNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSS 348

Query: 498 FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNI 557
            +    ++ L    N IS   P  + N   +T +  +   ++        N+    T+  
Sbjct: 349 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKN 406

Query: 558 SLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP 615
               +    P+ +S   +    D+++NL +        ++     +      F+G + 
Sbjct: 407 VTGAL--IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  215 bits (549), Expect = 6e-61
 Identities = 95/479 (19%), Positives = 181/479 (37%), Gaps = 35/479 (7%)

Query: 233 ESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHL 292
            + + L   +   +G  N+   ++        +T L              +   ++LT +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73

Query: 293 DIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIP 352
           +   ++LT   P     L +L  + ++ NQ++      L     LT L L+ NQ+    P
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP 129

Query: 353 DELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNI 412
             L  L+NL  LEL  N ++     ++  + SL+ L    N +    PL    L  L+ +
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLA--NLTTLERL 182

Query: 413 SLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIP 472
            + +N+ S +    L   ++L  L   NN  +   P  +     L  L++  NQ      
Sbjct: 183 DISSNKVSDISV--LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGT 238

Query: 473 SLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSID 532
             L S   L  + L  NQ++  L   S    L+ L +  N IS    S +     LT+++
Sbjct: 239 --LASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLE 293

Query: 533 FSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPS 592
            + N+   +    + NL +L  L +  N++    P  +S    L+      N ++    S
Sbjct: 294 LNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VS 347

Query: 593 SLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYAL 652
           SL +  +++ L    N  +   P  ++ L ++ +L L               +   +   
Sbjct: 348 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405

Query: 653 NLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVP 711
           N++   +    P+ +       + DI+ N  + T          V +      F+G V 
Sbjct: 406 NVTGALIA---PATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  214 bits (548), Expect = 7e-61
 Identities = 108/483 (22%), Positives = 179/483 (37%), Gaps = 35/483 (7%)

Query: 64  IECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEY 123
           I  D      +   L    V+         L ++ T+              +   + L  
Sbjct: 17  IFTDTALAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQ 72

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
           ++ S N  T   P   +NL  L  + +  N +      PL  +  L  + L NN ++   
Sbjct: 73  INFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDID 128

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
           P  + +L  +  L L SN +S     ++     LQ+L            + L+NL  L  
Sbjct: 129 P--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLER 181

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI 303
           LD+  N +         K  NL  L  + N+ S      LG  ++L  L + G++L    
Sbjct: 182 LDISSNKVSDISVLA--KLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD-- 235

Query: 304 PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQD 363
             +   L  L+ LDL+ NQ+S   P  L     LT L L ANQ+    P  L  L+ L +
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTN 291

Query: 364 LELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVI 423
           LEL +N+L       I  + +L YL +Y NN+    P+    L +L+ +  YNN+ S V 
Sbjct: 292 LELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDVS 347

Query: 424 PQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWR 483
              L   +++  L   +N  +   P  L    ++  L +    +     +   +      
Sbjct: 348 S--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP-N 402

Query: 484 VILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMP 543
            +        A    S     +  D++ N  S              +I   +  FSG + 
Sbjct: 403 TVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461

Query: 544 QEL 546
           Q L
Sbjct: 462 QPL 464

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  184 bits (468), Expect = 4e-50
 Identities = 93/408 (22%), Positives = 172/408 (42%), Gaps = 32/408 (7%)

Query: 310 LARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
           LA      L +  ++  +         +T L      ++    D +  L+NL  +   +N
Sbjct: 23  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNN 78

Query: 370 RLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI 429
           +LT   P+    +  L  +L+ NN +    PL    L  L  ++L+NNQ + + P  L  
Sbjct: 79  QLTDITPLK--NLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITDIDP--LKN 132

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
            ++L +L+  +N+ +      L     L+ L+ G NQ     P  L +  TL R+ +  N
Sbjct: 133 LTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSN 187

Query: 490 QLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNL 549
           +++  +   +K   L  L  + N IS   P  +G   NL  +  + N+   +    L +L
Sbjct: 188 KVSD-ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASL 242

Query: 550 VSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENH 609
            +L  L+++ N +    P  LS    L    +  N ++   P  L    +L+ L+L+EN 
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298

Query: 610 FTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEK 669
                 + IS L+ L  L L  N +    P  + +L  L   L    N ++    S L  
Sbjct: 299 LED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFYNNKVSD--VSSLAN 351

Query: 670 LSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
           L+ +  L    N ++  L+PL+N+  + ++ ++   +T        N+
Sbjct: 352 LTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAWTNAPVNYKANV 398

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  200 bits (512), Expect = 4e-56
 Identities = 108/548 (19%), Positives = 187/548 (34%), Gaps = 98/548 (17%)

Query: 87  LGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQ 146
           + P     + LQ     S+N +  +P +  N  +      + + +  + P      + + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 147 YLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGT 206
              L   L                 + LNN  LS                         +
Sbjct: 62  VSRLRDCLD-----------RQAHELELNNLGLS-------------------------S 85

Query: 207 IPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLT 266
           +PE   +   L+ L  + N L   LPE   +L++L+  +     L       S+    L 
Sbjct: 86  LPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL-------SDLPPLLE 134

Query: 267 FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGK 326
           +L +S N+      P L N S L  +D+  + L   +P    L   L  +    NQL   
Sbjct: 135 YLGVSNNQLEK--LPELQNSSFLKIIDVDNNSLK-KLPD---LPPSLEFIAAGNNQLE-- 186

Query: 327 IPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLE 386
             PEL    +LT ++   N L+ ++PD      +L+ +   +N L  E P  +  +  L 
Sbjct: 187 ELPELQNLPFLTAIYADNNSLK-KLPDLPL---SLESIVAGNNILE-ELP-ELQNLPFLT 240

Query: 387 YLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGE 446
            +   NN  L  LP        L+ +++ +N  +  +P+      SL  LD   N F+  
Sbjct: 241 TIYADNNL-LKTLP---DLPPSLEALNVRDNYLTD-LPELPQ---SLTFLDVSENIFS-G 291

Query: 447 IPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSH 506
           +         L  LN   N+    I SL    P+L  + +  N+L   LP       L  
Sbjct: 292 LSELP---PNLYYLNASSNE----IRSLCDLPPSLEELNVSNNKLI-ELPALPPR--LER 341

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
           L  S N+++  +P       NL  +    N      P    ++  L   +         L
Sbjct: 342 LIASFNHLA-EVPELPQ---NLKQLHVEYNPLREF-PDIPESVEDLRMNS--------HL 388

Query: 567 PSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLE 626
                  +NL+   V  N L    P      +S+  L+++               +KL +
Sbjct: 389 AEVPELPQNLKQLHVETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLED 444

Query: 627 LQLGGNQL 634
                +  
Sbjct: 445 DVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  185 bits (473), Expect = 6e-51
 Identities = 118/517 (22%), Positives = 180/517 (34%), Gaps = 84/517 (16%)

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
           PRNV     ++     S+ L+  +P    N     E Y   ++     P        +  
Sbjct: 5   PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI 303
             + D              +    L+L+    S  +     +   L  L    + LT  +
Sbjct: 63  SRLRDC-----------LDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-EL 106

Query: 304 PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQD 363
           P     L  L   + +   LS   P        L  L +  NQLE ++P EL   S L+ 
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKI 157

Query: 364 LELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVI 423
           +++ +N L  + P       SLE++   NN  L +LP E+  L  L  I   NN     +
Sbjct: 158 IDVDNNSLK-KLPDL---PPSLEFIAAGNNQ-LEELP-ELQNLPFLTAIYADNNSLK-KL 210

Query: 424 PQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWR 483
           P       SL  +   NN       P L     L  +    N     +P L  S   L  
Sbjct: 211 PDLPL---SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALN- 263

Query: 484 VILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMP 543
             ++ N LT  LPE  ++  L+ LDVS N  SG +        NL  ++ SSN+   L  
Sbjct: 264 --VRDNYLT-DLPELPQS--LTFLDVSENIFSG-LSELPP---NLYYLNASSNEIRSL-- 312

Query: 544 QELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSIL 603
                  SL  LN+S N +   LP+       LE    SFN L   +P      ++L  L
Sbjct: 313 --CDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELP---QNLKQL 362

Query: 604 KLSENHFTGGIPTFISELEKLL----------------ELQLGGNQLGGEIPPSIGALQD 647
            +  N      P     +E L                 +L +  N L  E P    +++D
Sbjct: 363 HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL-REFPDIPESVED 420

Query: 648 LSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT 684
               L ++   +        E   KLE      ++  
Sbjct: 421 ----LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  154 bits (391), Expect = 3e-40
 Identities = 89/416 (21%), Positives = 149/416 (35%), Gaps = 62/416 (14%)

Query: 304 PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQD 363
           P +      L       + L+ ++P E    K  T  +   ++ E   P   G+   +  
Sbjct: 5   PRNVSNT-FLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 364 LELFDNRLTG------------EFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKN 411
             L D                   P        LE L+   N+ L +LP     LK L  
Sbjct: 63  SRLRDCLDRQAHELELNNLGLSSLPEL---PPHLESLVASCNS-LTELPELPQSLKSLLV 118

Query: 412 ISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPI 471
            +      S + P        L  L   NN    ++P  L     L+++++  N     +
Sbjct: 119 DNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-L 168

Query: 472 PSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSI 531
           P L  S   +       NQL   LPE    P L+ +    N++   +P       +L SI
Sbjct: 169 PDLPPSLEFIA---AGNNQLE-ELPELQNLPFLTAIYADNNSLK-KLPDLPL---SLESI 220

Query: 532 DFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP 591
              +N    L   EL NL  L T+    N ++ +LP       +LE  +V  N L   +P
Sbjct: 221 VAGNNILEEL--PELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVRDNYLT-DLP 273

Query: 592 SSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYA 651
              +S   L + +   +  +            L  L    N++   +     +L++    
Sbjct: 274 ELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEI-RSLCDLPPSLEE---- 321

Query: 652 LNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFT 707
           LN+S N L   +P+      +LE+L  S N+L   +  L    +L +++V YN   
Sbjct: 322 LNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL--PQNLKQLHVEYNPLR 370

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  202 bits (515), Expect = 2e-55
 Identities = 111/526 (21%), Positives = 185/526 (35%), Gaps = 33/526 (6%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
              + +DLS N           +   L+ LDLS           +++L +L  L L GN 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRL-SGTIPESIG 212
           +   +    F  L  LQ +     +L+      +G LK ++ L +  N + S  +PE   
Sbjct: 88  IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 213 NCYRLQELYLNENKLMGFLPESLSNLENL----VYLDVGDNNLEGRINFGSEKCKNLTFL 268
           N   L+ L L+ NK+       L  L  +    + LD+  N +   I  G+ K   L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKL 205

Query: 269 DLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGS---IPSSFGLLARLSSLDLSENQLS 324
            L  N  S  +    +   + L    +V  +              L  L +L + E +L+
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 325 G------KIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
                   I         ++   L +  +E  + D        Q LEL + +        
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSY-NFGWQHLELVNCKFGQ---FP 320

Query: 379 IWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ--FSGVIPQSLGINSSLMQL 436
             ++ SL+ L   +N           +L  L+ + L  N   F G   QS    +SL  L
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 437 DFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHG-PIPSLLGSCPTLWRVILKQNQLTGAL 495
           D   N     +  N    +QL  L+   +        S+  S   L  + +       A 
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437

Query: 496 PE-FSKNPVLSHLDVSRNNISGAIPSSI-GNSINLTSIDFSSNKFSGLMPQELGNLVSLV 553
              F+    L  L ++ N+        I     NLT +D S  +   L P    +L SL 
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ 497

Query: 554 TLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSS--LRSW 597
            LN++ N ++        +  +L+   +  N  + S P    L  W
Sbjct: 498 VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRW 543

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  199 bits (507), Expect = 2e-54
 Identities = 117/578 (20%), Positives = 206/578 (35%), Gaps = 61/578 (10%)

Query: 139 FENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL 198
            E + N+ Y  +  N    +IP+ L      + + L+ N L      +     E++ L L
Sbjct: 4   VEVVPNITYQCMELNFY--KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 199 FSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFG 258
               +      +  +   L  L L  N +      + S L +L  L   + NL    NF 
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 259 SEKCKNLTFLDLSYNRF-SGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLS--- 314
               K L  L++++N   S  +     N ++L HLD+  +K+     +   +L ++    
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179

Query: 315 -SLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE-LGQLSNLQDLELFDNRLT 372
            SLDLS N ++  I P   K   L  L L  N     +    +  L+ L+   L      
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE-- 236

Query: 373 GEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSS 432
                      +   L  ++ + L  L      L   +    Y + +   I       ++
Sbjct: 237 ---------FRNEGNLEKFDKSALEGL----CNLTIEEFRLAYLDYYLDDIIDLFNCLTN 283

Query: 433 LMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLT 492
           +     ++ +       +  +    + L +   +F       L S   L       N+  
Sbjct: 284 VSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKGG 338

Query: 493 GALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSL 552
                    P L  LD+SRN +S                      F G   Q      SL
Sbjct: 339 N-AFSEVDLPSLEFLDLSRNGLS----------------------FKGCCSQSDFGTTSL 375

Query: 553 VTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSS-LRSWKSLSILKLSENHFT 611
             L++S N V  ++ S     + LE  D   + L      S   S ++L  L +S  H  
Sbjct: 376 KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

Query: 612 GGIPTFISELEKLLELQLGGNQLGGEIPPSI-GALQDLSYALNLSKNGLTGRIPSDLEKL 670
                  + L  L  L++ GN       P I   L++L++ L+LS+  L    P+    L
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLEQLSPTAFNSL 493

Query: 671 SKLEQLDISSNNLTGTLSP--LSNIHSLVEVNVSYNLF 706
           S L+ L+++SN L  ++       + SL ++ +  N +
Sbjct: 494 SSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  171 bits (436), Expect = 3e-45
 Identities = 95/497 (19%), Positives = 161/497 (32%), Gaps = 45/497 (9%)

Query: 259 SEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDL 318
            E   N+T+       F   I  NL    S  +LD+  + L      SF     L  LDL
Sbjct: 4   VEVVPNITY-QCMELNFYK-IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 319 SENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
           S  ++            +L+ L L  N ++         LS+LQ L   +  L       
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 379 IWRIASLEYLLVYNNNLL-GKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSL---- 433
           I  + +L+ L V +N +   KLP   + L  L+++ L +N+   +    L +   +    
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179

Query: 434 MQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPS----------LLGSCPTLWR 483
           + LD   N     I P      +L  L +  N     +            +       +R
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238

Query: 484 VILKQNQLTGALPEFSKNPVLSHLDVSRNNISG-AIPSSIGNSINLTSIDFSSNKFSGLM 542
                 +   +  E   N  +    ++  +     I        N++S    S     + 
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298

Query: 543 P-QELGNLVSLVTLNISLNHVEGSLPSQL----------------SKCKNLEVFDVSFNL 585
                     L  +N             L                    +LE  D+S N 
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358

Query: 586 LN--GSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSI- 642
           L+  G    S     SL  L LS N     + +    LE+L  L    + L      S+ 
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 643 GALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP--LSNIHSLVEVN 700
            +L++L Y L++S              LS LE L ++ N+      P   + + +L  ++
Sbjct: 418 LSLRNLIY-LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 701 VSYNLFTGPVPETLMNL 717
           +S        P    +L
Sbjct: 477 LSQCQLEQLSPTAFNSL 493

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  165 bits (419), Expect = 5e-43
 Identities = 85/445 (19%), Positives = 152/445 (34%), Gaps = 33/445 (7%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFT-GDIPDNFENLQNLQYLNLY 151
            LS LQ +     N +      +G+   L+ L+++ N      +P+ F NL NL++L+L 
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 152 GNLLDGEIPEPLFRILGLQYVF----LNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTI 207
            N +       L  +  +  +     L+ N ++  I         +  L L +N  S  +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNV 216

Query: 208 PE-SIGNCYRLQELYLNENKLMG---FLPESLSNLENLVYLDVGDNNLEGRINFGSE--- 260
            +  I     L+   L   +            S LE L  L + +  L     +  +   
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276

Query: 261 ---KCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD 317
                 N++   L           +        HL++V  K           L  L  L 
Sbjct: 277 LFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ---FPTLKLKSLKRLT 331

Query: 318 LSENQLSGKIPPELGKCKYLTVLHLYANQLE--GEIPDELGQLSNLQDLELFDNRLTGEF 375
            + N+              L  L L  N L   G         ++L+ L+L  N +    
Sbjct: 332 FTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 388

Query: 376 PVSIWRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQFSGVIPQSLGINSSLM 434
             +   +  LE+L   ++NL       +   L+ L  + + +              SSL 
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448

Query: 435 QLDFINNSFTGEIPPNLCFGK--QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLT 492
            L    NSF     P++ F +   L  L++ Q Q     P+   S  +L  + +  NQL 
Sbjct: 449 VLKMAGNSFQENFLPDI-FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507

Query: 493 GALPE--FSKNPVLSHLDVSRNNIS 515
            ++P+  F +   L  + +  N   
Sbjct: 508 -SVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  151 bits (382), Expect = 2e-38
 Identities = 79/408 (19%), Positives = 141/408 (34%), Gaps = 37/408 (9%)

Query: 84  SGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEY----LDLSTNGFTGDIPDNF 139
           S +L     +L+ L+ +DLSSN         L     +      LDLS N      P  F
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197

Query: 140 ENLQNLQYLNLYGNLLDGEIPEPLF------RILGLQYVFLNNNSLSGSIPRNVGDLKEV 193
           + +  L  L L  N     + +          +  L      N        ++   L+ +
Sbjct: 198 KEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA--LEGL 254

Query: 194 EALWLFSNRLSG------TIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVG 247
             L +   RL+        I +       +    L    +        S      +L++ 
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELV 312

Query: 248 DNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT--GSIPS 305
           +        F + K K+L  L  + N+     + +  +  SL  LD+  + L+  G    
Sbjct: 313 NCKFG---QFPTLKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367

Query: 306 SFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE--LGQLSNLQD 363
           S      L  LDLS N +   +       + L  L    + L+ ++ +      L NL  
Sbjct: 368 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIY 425

Query: 364 LELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQFSGV 422
           L++        F      ++SLE L +  N+       ++ TEL+ L  + L   Q   +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485

Query: 423 IPQSLGINSSLMQLDFINNSFTGEIPPNLCFG--KQLRVLNMGQNQFH 468
            P +    SSL  L+  +N     +P  + F     L+ + +  N + 
Sbjct: 486 SPTAFNSLSSLQVLNMASNQLK-SVPDGI-FDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 73.6 bits (181), Expect = 2e-13
 Identities = 30/119 (25%), Positives = 54/119 (45%), Gaps = 5/119 (4%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLY 151
            L  L  +D+S  +            S+LE L ++ N F  +   + F  L+NL +L+L 
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478

Query: 152 GNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIP 208
              L+ ++    F  L  LQ + + +N L  S+P  +   L  ++ +WL +N    + P
Sbjct: 479 QCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  204 bits (521), Expect = 1e-54
 Identities = 130/711 (18%), Positives = 243/711 (34%), Gaps = 87/711 (12%)

Query: 98  QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDG 157
           +       N +  +P  L   +  E L LS N        +F  L+ LQ L L       
Sbjct: 7   RIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62

Query: 158 EIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTI--PESIGN 213
            I +  FR L  L+ + L ++ +   +  +    L  +  L L+   LS  +       N
Sbjct: 63  TIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121

Query: 214 CYRLQELYLNENKLMGF-LPESLSNLENLVYLDVGDNNLEG--RINFGSEKCKNLTFLDL 270
              L  L L++N++    L  S   L +L  +D   N +           + K L+F  L
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181

Query: 271 SYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE 330
           + N     +S + G C +                        L  LD+S N  +      
Sbjct: 182 AANSLYSRVSVDWGKCMNPFR------------------NMVLEILDVSGNGWT------ 217

Query: 331 LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI---WRIASLEY 387
                 + +   ++N +       L    ++       + +  +   +       +S+ +
Sbjct: 218 ------VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRH 270

Query: 388 LLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEI 447
           L + +  +          LK LK ++L  N+ + +  ++     +L  L+   N    E+
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-EL 329

Query: 448 PPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSH 506
             +  +G  ++  +++ +N               L  + L+ N LT         P +  
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPD 385

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQE-LGNLVSLVTLNISLNHVEGS 565
           + +S N +     +    ++    I  S N+   L     L  +  L  L ++ N     
Sbjct: 386 IFLSGNKLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSC 441

Query: 566 LPSQL-SKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKL 624
              Q  S+  +LE   +  N+L  +  + L                          L  L
Sbjct: 442 SGDQTPSENPSLEQLFLGENMLQLAWETELC-------------------WDVFEGLSHL 482

Query: 625 LELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT 684
             L L  N L    P     L  L   L+L+ N LT    +DL   + LE LDIS N L 
Sbjct: 483 QVLYLNHNYLNSLPPGVFSHLTALRG-LSLNSNRLTVLSHNDL--PANLEILDISRNQLL 539

Query: 685 GTLSPLSNIHSLVEVNVSYNLFTGPVP-ETLMNLLGPSPSSFSGNPSLCVKCLSSTDSSC 743
              +P     SL  +++++N F       T +N L  +  + +G P+           S 
Sbjct: 540 -APNP-DVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPA---DIYCVYPDSF 594

Query: 744 FGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRR 794
            G S           ++ L  +K  +  +  ++   L ++ +++   FR  
Sbjct: 595 SGVSLFSLSTEGCDEEEVLKSLKFSLFIV-CTVTLTLFLMTILTVTKFRGF 644

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  180 bits (457), Expect = 1e-46
 Identities = 99/553 (17%), Positives = 187/553 (33%), Gaps = 45/553 (8%)

Query: 77  NLSSYGVSGQLGPEI-GHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGD 134
            L S      +  E   +L  L+ +DL S+     + P        L  L L   G +  
Sbjct: 54  ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDA 112

Query: 135 I--PDNFENLQNLQYLNLYGNLLDGEIPEPLFRIL-GLQYVFLNNNSLSGSIPRNVGDL- 190
           +     F NL+ L  L+L  N +      P F  L  L+ +  ++N +       +  L 
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172

Query: 191 -KEVEALWLFSNRLSGTIPESIGNCYR-LQELYLNENKLMGFLPESLSNLENLVYLDVGD 248
            K +    L +N L   +    G C    + + L    +         N   +       
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDV-------SGNGWTVDITGNFS 225

Query: 249 NNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNL---GNCSSLTHLDIVGSKLTGSIPS 305
           N +     F      ++      ++        N       SS+ HLD+    +      
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFSLNSR 284

Query: 306 SFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLE 365
            F  L  L  L+L+ N+++            L VL+L  N L          L  +  ++
Sbjct: 285 VFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID 344

Query: 366 LFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQ 425
           L  N +      +   +  L+ L + +N L       +  +  + +I L  N+   +   
Sbjct: 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKI 399

Query: 426 SLGINSSLMQLDFINNSFTGEIPPNLCFG--KQLRVLNMGQNQFHG-PIPSLLGSCPTLW 482
           +L    +   +    N     +           L++L + QN+F            P+L 
Sbjct: 400 NL----TANLIHLSENRLEN-LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454

Query: 483 RVILKQNQLTGALPE------FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSN 536
           ++ L +N L  A         F     L  L ++ N ++   P    +   L  +  +SN
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514

Query: 537 KFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP-SSLR 595
           + + L   +L    +L  L+IS N +    P       +L V D++ N        S+  
Sbjct: 515 RLTVLSHNDL--PANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECELSTFI 569

Query: 596 SWKSLSILKLSEN 608
           +W + + + ++  
Sbjct: 570 NWLNHTNVTIAGP 582

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  190 bits (484), Expect = 1e-53
 Identities = 74/314 (23%), Positives = 123/314 (39%), Gaps = 44/314 (14%)

Query: 817  ATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR 876
              +NL    +IGRG +G VYK SL    V AVK   F    R +   ++ I  +  + H 
Sbjct: 11   DLDNLKLLELIGRGRYGAVYKGSLDERPV-AVKV--FSFANRQNFINEKNIYRVPLMEHD 67

Query: 877  NLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
            N+ R              +    ++  Y  NGSL   L       T +W    ++A    
Sbjct: 68   NIARFIVGDERVTADGRMEYL--LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVT 121

Query: 930  HALAYLHYD------CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA------ 977
              LAYLH +        P I HRD+   N+L+ ++    ISDFG++  L  +        
Sbjct: 122  RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181

Query: 978  STTSISVVGTIGYIAPE-------NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030
               +IS VGTI Y+APE            +  K+ D+Y+ G++  E+  R   L P    
Sbjct: 182  DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241

Query: 1031 RTDIVGWVRSVWSD--TEEINDIVD-----LSLMEEMLVSSIRDQVIDVLLVALRCTEKK 1083
                + +   V +    E++  +V          E    +S+  + +   +    C ++ 
Sbjct: 242  PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI--EDCWDQD 299

Query: 1084 PSNRPNMRDVVRQL 1097
               R   +    ++
Sbjct: 300  AEARLTAQXAEERM 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  186 bits (474), Expect = 1e-52
 Identities = 78/285 (27%), Positives = 130/285 (45%), Gaps = 40/285 (14%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + +  + V+GRGA G+V KA      V A+K++     ++   +   E++ + ++ H N+
Sbjct: 8    KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIESESERK---AFIVELRQLSRVNHPNI 63

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            V+L    L   C ++M  Y E GSL +VLH   P P           L  +  +AYLH  
Sbjct: 64   VKLYGACLNPVC-LVM-EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 939  CDPPIVHRDIKPENILLDSEME-PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                ++HRD+KP N+LL +      I DFG A  +      T   +  G+  ++APE   
Sbjct: 122  QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFE 176

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE--EINDIVD-- 1053
             +  S++ DV+S+G++L E+ITR+K   P + E       +     +     +   +   
Sbjct: 177  GSNYSEKCDVFSWGIILWEVITRRK---P-FDEIGGPAFRIMWAVHNGTRPPLIKNLPKP 232

Query: 1054 -LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              SLM                    RC  K PS RP+M ++V+ +
Sbjct: 233  IESLMT-------------------RCWSKDPSQRPSMEEIVKIM 258

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  180 bits (460), Expect = 4e-51
 Identities = 61/300 (20%), Positives = 129/300 (43%), Gaps = 55/300 (18%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPN--AVFAVKKLAFRGHKRGSLSM------KREIQTI 870
              +  +  IG+G  G+V+K  L  +   V A+K L     +  +  +      +RE+  +
Sbjct: 19   NEIEYEKQIGKGGFGLVHKGRLVKDKSVV-AIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH 930
              + H N+V+L          ++M  ++  G L   L        ++W+V+ ++ L  A 
Sbjct: 78   SNLNHPNIVKLYGLMHNPPR-MVM-EFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIAL 133

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH-----ISDFGIAKLLDKSPASTTSISVV 985
             + Y+  + +PPIVHRD++  NI L S  E       ++DFG+++         +   ++
Sbjct: 134  GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLL 187

Query: 986  GTIGYIAPE--NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI-VGWVRSVW 1042
            G   ++APE   A   + ++++D YS+ ++L  ++T +    P + E +   + ++  + 
Sbjct: 188  GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---P-FDEYSYGKIKFINMIR 243

Query: 1043 SDTE--EINDIVD---LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             +     I +       +++E                    C    P  RP+   +V++L
Sbjct: 244  EEGLRPTIPEDCPPRLRNVIE-------------------LCWSGDPKKRPHFSYIVKEL 284

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  180 bits (459), Expect = 1e-50
 Identities = 79/315 (25%), Positives = 134/315 (42%), Gaps = 61/315 (19%)

Query: 795  SKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFR 854
               D++IP  +               LN K  IG G+ G V++A    + V AVK L  +
Sbjct: 28   DGDDMDIPWCD---------------LNIKEKIGAGSFGTVHRAEWHGSDV-AVKILMEQ 71

Query: 855  GHKRGSLSM-KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP 913
                  ++   RE+  + ++RH N+V       +     I+  Y+  GSL  +LH     
Sbjct: 72   DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR 131

Query: 914  PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD 973
              L+   R  +A   A  + YLH + +PPIVHR++K  N+L+D +    + DFG+++L  
Sbjct: 132  EQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190

Query: 974  KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK---KALDPS--- 1027
             +  S+   S  GT  ++APE       +++SDVYS+GV+L EL T +     L+P+   
Sbjct: 191  STFLSSK--SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248

Query: 1028 -----YKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEK 1082
                   +R +I   +    +            ++E                    C   
Sbjct: 249  AAVGFKCKRLEIPRNLNPQVAA-----------IIE-------------------GCWTN 278

Query: 1083 KPSNRPNMRDVVRQL 1097
            +P  RP+   ++  L
Sbjct: 279  EPWKRPSFATIMDLL 293

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  187 bits (477), Expect = 1e-50
 Identities = 93/521 (17%), Positives = 195/521 (37%), Gaps = 34/521 (6%)

Query: 174 LNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPE 233
             + S + SIP  +     +++L L  N+++      +  C  LQ L L  +++     +
Sbjct: 12  GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68

Query: 234 SLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG-GISPNLGNCSSLTHL 292
           +  +L +L +LD+ DN+L    +       +L +L+L  N +   G++    N ++L  L
Sbjct: 69  AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128

Query: 293 DIVGSKLTGSIP-SSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEI 351
            I   +    I    F  L  L+ L++    L       L   + +  L L+ ++    +
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188

Query: 352 PDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKN 411
                 LS+++ LEL D  L       +        +                EL +L  
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248

Query: 412 I--SLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHG 469
               L   +F       LG  +               +         +R L++ Q     
Sbjct: 249 YILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV--------TIRRLHIPQFYLFY 300

Query: 470 PIPSLLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAI---PSSIGN 524
            + ++      + R+ ++ +++   +P         L  LD+S N +        +  G 
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

Query: 525 SINLTSIDFSSNKFSGL--MPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVS 582
             +L ++  S N    +    + L  L +L +L+IS N     +P      + +   ++S
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418

Query: 583 FNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSI 642
              +   + + +    +L +L +S N+      +F   L +L EL +  N+L  +  P  
Sbjct: 419 STGIR-VVKTCIPQ--TLEVLDVSNNNLD----SFSLFLPRLQELYISRNKL--KTLPDA 469

Query: 643 GALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNL 683
                L   + +S+N L        ++L+ L+++ + +N  
Sbjct: 470 SLFPVLLV-MKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  181 bits (462), Expect = 8e-49
 Identities = 96/530 (18%), Positives = 191/530 (36%), Gaps = 35/530 (6%)

Query: 117 NCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRIL-GLQYVFLN 175
           +C A    D  +  FT  IP        ++ L+L  N +   I     R    LQ + L 
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILK 58

Query: 176 NNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGF-LPE 233
           ++ ++ +I  +    L  +E L L  N LS       G    L+ L L  N      +  
Sbjct: 59  SSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 234 SLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHL 292
              NL NL  L +G+      I         +L  L++         S +L +   + HL
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 293 DIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIP 352
            +  S+    +     +L+ +  L+L +  L+      L   +  + +   A +      
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 353 DELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNI 412
           +   +L  L    L  + +          +  L       ++++ +L     E   ++ +
Sbjct: 238 ESFNELLKLLRYILELSEVE----FDDCTLNGLGDFNPSESDVVSELGK--VETVTIRRL 291

Query: 413 SLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQF---H 468
            +        +     +   + ++   N+     +P +     K L  L++ +N     +
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEY 350

Query: 469 GPIPSLLGSCPTLWRVILKQNQLTGALPE----FSKNPVLSHLDVSRNNISGAIPSSIGN 524
               +  G+ P+L  ++L QN L  ++ +          L+ LD+SRN     +P S   
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408

Query: 525 SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN 584
              +  ++ SS     +   +     +L  L++S N+++ S    L     L+   +S N
Sbjct: 409 PEKMRFLNLSSTGIRVV---KTCIPQTLEVLDVSNNNLD-SFSLFLP---RLQELYISRN 461

Query: 585 LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQL 634
            L  ++P +      L ++K+S N            L  L ++ L  N  
Sbjct: 462 KLK-TLPDASLF-PVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  178 bits (453), Expect = 1e-47
 Identities = 99/527 (18%), Positives = 182/527 (34%), Gaps = 52/527 (9%)

Query: 94  LSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
            + ++++DLS N  +  I    L  C+ L+ L L ++       D F +L +L++L+L  
Sbjct: 25  TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD 83

Query: 153 NLLDGEIPEPLFRIL-GLQYVFLNNNSLSGSIPRN--VGDLKEVEALWLFSNRLSGTIPE 209
           N L   +    F  L  L+Y+ L  N    ++       +L  ++ L + +      I  
Sbjct: 84  NHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141

Query: 210 -SIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL 268
                   L EL +    L  +  +SL ++ ++ +L +  +     +   ++   ++ +L
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYL 201

Query: 269 DLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIP 328
           +L     +      L      + +  +  + +     SF  L +L    L          
Sbjct: 202 ELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE--------- 252

Query: 329 PELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL 388
                   +       N L    P E   +S L  +E                  ++  L
Sbjct: 253 -----LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV----------------TIRRL 291

Query: 389 LVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIP 448
            +    L   L    + L+++K I++ N++   V         SL  LD   N    E  
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYL 351

Query: 449 PN-LCFGK--QLRVLNMGQNQFH--GPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPV 503
            N  C G    L+ L + QN          +L +   L  + + +N              
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEK 411

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE 563
           +  L++S   I   + + I     L  +D S+N            L  L  L IS N ++
Sbjct: 412 MRFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLDSFSL----FLPRLQELYISRNKLK 464

Query: 564 GSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHF 610
            +LP   S    L V  +S N L            SL  + L  N +
Sbjct: 465 -TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  173 bits (440), Expect = 8e-46
 Identities = 94/487 (19%), Positives = 177/487 (36%), Gaps = 33/487 (6%)

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
            +  LDLS+N+ +     +L  C++L  L +  S++      +F  L  L  LDLS+N L
Sbjct: 27  AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 324 SGKIPPE-LGKCKYLTVLHLYANQL-EGEIPDELGQLSNLQDLELFD-NRLTGEFPVSIW 380
           S  +     G    L  L+L  N      +      L+NLQ L + +    +    +   
Sbjct: 87  S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFA 145

Query: 381 RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFIN 440
            + SL  L +   +L       +  ++ + +++L+ ++ + ++     I SS+  L+  +
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205

Query: 441 NSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSK 500
            +        L   +    +     +              L R IL+ +++     EF  
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV-----EFDD 260

Query: 501 NPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLN 560
             +    D + +            ++ +  +          +      L  +  + +  +
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320

Query: 561 HVEGSLPSQLSKCKNLEVFDVSFNLLNGSI---PSSLRSWKSLSILKLSENHFT--GGIP 615
            V     S     K+LE  D+S NL+        +   +W SL  L LS+NH        
Sbjct: 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTG 380

Query: 616 TFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQ 675
             +  L+ L  L +  N     +P S    + + + LNLS  G+   + + +     LE 
Sbjct: 381 EILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF-LNLSSTGIR-VVKTCI--PQTLEV 435

Query: 676 LDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLL-----------GPSPSS 724
           LD+S+NNL    S    +  L E+ +S N        +L  +L                 
Sbjct: 436 LDVSNNNLD---SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGI 492

Query: 725 FSGNPSL 731
           F    SL
Sbjct: 493 FDRLTSL 499

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  172 bits (437), Expect = 2e-45
 Identities = 94/474 (19%), Positives = 175/474 (36%), Gaps = 36/474 (7%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLN 149
           +   + LQ + L S+  +  I      +  +LE+LDLS N  +      F  L +L+YLN
Sbjct: 46  LRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104

Query: 150 LYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTI 207
           L GN         LF  L  LQ + + N      I R     L  +  L + +  L    
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164

Query: 208 PESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEG---RINFGSEKCKN 264
            +S+ +   +  L L+ ++    L      L ++ YL++ D NL           E    
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224

Query: 265 LTFLDLSYNRFSGG-------ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSS-- 315
           +  L    +  +         +   +   S +   D   + L    PS   +++ L    
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284

Query: 316 ------LDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
                 L + +  L   +       + +  + +  +++          L +L+ L+L +N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344

Query: 370 RLTGEF---PVSIWRIASLEYLLVYNNNL--LGKLPLEMTELKQLKNISLYNNQFSGVIP 424
            +  E+           SL+ L++  N+L  + K    +  LK L ++ +  N F   +P
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMP 403

Query: 425 QSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRV 484
            S      +  L+  +      +    C  + L VL++  N         L   P L  +
Sbjct: 404 DSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNLDS-FSLFL---PRLQEL 456

Query: 485 ILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKF 538
            + +N+L   LP+ S  PVL  + +SRN +            +L  I   +N +
Sbjct: 457 YISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  152 bits (387), Expect = 5e-39
 Identities = 93/460 (20%), Positives = 169/460 (36%), Gaps = 36/460 (7%)

Query: 285 NCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYA 344
           +C +    D      T SIPS  GL A + SLDLS N+++     +L  C  L VL L +
Sbjct: 3   SCDASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLG-KLPLEM 403
           +++     D    L +L+ L+L DN L+         ++SL+YL +  N      +    
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119

Query: 404 TELKQLKNISLY-NNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPN-LCFGKQLRVLN 461
             L  L+ + +     FS +        +SL +L+    S         L   + +  L 
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLT 178

Query: 462 MGQNQFHGPIPSLLGSCPTLWRVILKQNQLTG-ALPEFSKNPVLSHLDVSRNNIS----- 515
           +  ++    +        ++  + L+   L          + V S +       S     
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238

Query: 516 --GAIPSSIGNSINLTSIDFSSNKFSGL---------MPQELGNL--VSLVTLNISLNHV 562
               +   +   + L+ ++F     +GL         +  ELG +  V++  L+I   ++
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298

Query: 563 EGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGI---PTFIS 619
              L +  S  + ++   V  + +     S  +  KSL  L LSEN              
Sbjct: 299 FYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKG 358

Query: 620 ELEKLLELQLGGNQLGGEIPPSIGALQDLSY--ALNLSKNGLTGRIPSDLEKLSKLEQLD 677
               L  L L  N L   +  +   L  L    +L++S+N     +P   +   K+  L+
Sbjct: 359 AWPSLQTLVLSQNHL-RSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLN 416

Query: 678 ISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
           +SS  +   +       +L  ++VS N         L  L
Sbjct: 417 LSSTGI--RVVKTCIPQTLEVLDVSNNNLDS-FSLFLPRL 453

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  152 bits (385), Expect = 7e-39
 Identities = 66/413 (15%), Positives = 138/413 (33%), Gaps = 24/413 (5%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQN 144
            +     +L+ LQT+ + +      I        ++L  L++           + +++++
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173

Query: 145 LQYLNLYGNLLDGEIPEPLFRIL-GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRL 203
           + +L L+ +     + E    IL  ++Y+ L + +L+      +   +    +   + R 
Sbjct: 174 IHHLTLHLSES-AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232

Query: 204 SGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCK 263
           S    ES     +L    L  +++         +       D   +  +     G  +  
Sbjct: 233 SVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETV 286

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
            +  L +        +S        +  + +  SK+     S    L  L  LDLSEN +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346

Query: 324 SGKIPPE---LGKCKYLTVLHLYANQLE--GEIPDELGQLSNLQDLELFDNRLTGEFPVS 378
             +        G    L  L L  N L    +  + L  L NL  L++  N      P S
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS 405

Query: 379 IWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDF 438
                 + +L + +   +  +   +   + L+ + + NN         L     L +L  
Sbjct: 406 CQWPEKMRFLNLSSTG-IRVVKTCI--PQTLEVLDVSNNNLD-SFSLFL---PRLQELYI 458

Query: 439 INNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQL 491
             N     +P        L V+ + +NQ       +     +L ++ L  N  
Sbjct: 459 SRNKLK-TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 93.6 bits (233), Expect = 9e-20
 Identities = 49/256 (19%), Positives = 86/256 (33%), Gaps = 37/256 (14%)

Query: 72  NVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLG-NCSALEYLDLSTNG 130
            +   ++  + +   L      L K++ I + ++     +P     +  +LE+LDLS N 
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENL 345

Query: 131 FTGDIPDN---FENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV 187
              +   N        +LQ L L  N L          +     + L   +L        
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLR--------SMQKTGEILLTLKNL-------- 389

Query: 188 GDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVG 247
                  +L +  N     +P+S     +++ L L+   +          LE    LDV 
Sbjct: 390 ------TSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLE---VLDVS 439

Query: 248 DNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSF 307
           +NNL    +  S     L  L +S N+      P+      L  + I  ++L       F
Sbjct: 440 NNNL----DSFSLFLPRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQLKSVPDGIF 493

Query: 308 GLLARLSSLDLSENQL 323
             L  L  + L  N  
Sbjct: 494 DRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 16/64 (25%), Positives = 25/64 (39%), Gaps = 2/64 (3%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
            L +LQ + +S N       P       L  + +S N         F+ L +LQ + L+ 
Sbjct: 449 FLPRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506

Query: 153 NLLD 156
           N  D
Sbjct: 507 NPWD 510

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  181 bits (462), Expect = 2e-50
 Identities = 71/307 (23%), Positives = 126/307 (41%), Gaps = 21/307 (6%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
             I +L+ L+ ++L+ N  +   P  L N   L  L + TN  T       +NL NL+ L
Sbjct: 60  QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLREL 115

Query: 149 NLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIP 208
            L  + +      PL  +  +  + L  N     +   + ++  +  L +  +++    P
Sbjct: 116 YLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP 172

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL 268
             I N   L  L LN N++       L++L +L Y     N +             L  L
Sbjct: 173 --IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITPVA--NMTRLNSL 226

Query: 269 DLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIP 328
            +  N+ +      L N S LT L+I  ++++    ++   L +L  L++  NQ+S    
Sbjct: 227 KIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--I 280

Query: 329 PELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL 388
             L     L  L L  NQL  E  + +G L+NL  L L  N +T   P++   ++ ++  
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSA 338

Query: 389 LVYNNNL 395
              N  +
Sbjct: 339 DFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  179 bits (456), Expect = 8e-50
 Identities = 79/392 (20%), Positives = 139/392 (35%), Gaps = 50/392 (12%)

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
           L           PD   +L       L    +          +  +  + +    ++ SI
Sbjct: 5   LATLPAPINQIFPD--ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SI 59

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
              +  L  +E L L  N+++   P  + N  +L  LY+  NK+      +L NL NL  
Sbjct: 60  Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRE 114

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI 303
           L + ++N+             +  L+L  N     +SP L N + L +L +  SK+    
Sbjct: 115 LYLNEDNISDISPLA--NLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVT 171

Query: 304 PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQD 363
           P     L  L SL L+ NQ+       L     L     Y NQ+    P  +  ++ L  
Sbjct: 172 P--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNS 225

Query: 364 LELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVI 423
           L++ +N++T         ++ L                    L QL  + +  NQ S + 
Sbjct: 226 LKIGNNKITD--------LSPLA------------------NLSQLTWLEIGTNQISDI- 258

Query: 424 PQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWR 483
             ++   + L  L+  +N  +      L    QL  L +  NQ       ++G    L  
Sbjct: 259 -NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315

Query: 484 VILKQNQLTGALPEFSKNPVLSHLDVSRNNIS 515
           + L QN +T  +   +    +   D +   I 
Sbjct: 316 LFLSQNHITD-IRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  177 bits (451), Expect = 4e-49
 Identities = 70/418 (16%), Positives = 146/418 (34%), Gaps = 74/418 (17%)

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS 276
              L      +    P   ++L   +   +   ++   +    E+ +++T L ++  + +
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKVA 57

Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKY 336
                 +   ++L +L++ G+++T   P     L +L++L +  N+++      L     
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111

Query: 337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLL 396
           L  L+L  + +    P  L  L+ +  L L  N                           
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL------------------------ 145

Query: 397 GKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQ 456
                 ++ +  L  +++  ++   V P        +  L                    
Sbjct: 146 -SDLSPLSNMTGLNYLTVTESKVKDVTP--------IANL------------------TD 178

Query: 457 LRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISG 516
           L  L++  NQ     P  L S  +L       NQ+T  +   +    L+ L +  N I+ 
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITD 235

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
             P  + N   LT ++  +N+ S +    + +L  L  LN+  N +     S L+    L
Sbjct: 236 LSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQL 634
               ++ N L       +    +L+ L LS+NH T   P  ++ L K+         +
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  176 bits (449), Expect = 6e-49
 Identities = 71/396 (17%), Positives = 143/396 (36%), Gaps = 50/396 (12%)

Query: 168 GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKL 227
           G   +      ++   P    DL E     L    ++  +         + +L +   K+
Sbjct: 1   GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56

Query: 228 MGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCS 287
                + +  L NL YL++  N +             LT L +  N+ +      L N +
Sbjct: 57  ASI--QGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQNLT 110

Query: 288 SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQL 347
           +L  L +    ++   P     L ++ SL+L  N         L     L  L +  +++
Sbjct: 111 NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV 167

Query: 348 EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELK 407
           +   P  +  L++L  L L  N++    P  +  + SL Y   Y N +    P+    + 
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMT 221

Query: 408 QLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQF 467
           +L ++ + NN+ + + P                          L    QL  L +G NQ 
Sbjct: 222 RLNSLKIGNNKITDLSP--------------------------LANLSQLTWLEIGTNQI 255

Query: 468 HGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSIN 527
                + +     L  + +  NQ++  +   +    L+ L ++ N +       IG   N
Sbjct: 256 SDI--NAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312

Query: 528 LTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE 563
           LT++  S N  + + P  L +L  + + + +   ++
Sbjct: 313 LTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  168 bits (427), Expect = 5e-46
 Identities = 73/372 (19%), Positives = 151/372 (40%), Gaps = 27/372 (7%)

Query: 313 LSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT 372
            ++L      ++ +I P            L    +   +     +L ++  L +   ++ 
Sbjct: 2   AATLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 373 GEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSS 432
                 I  + +LEYL +  N +    PL    L +L N+ +  N+ +     +L   ++
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKIT--DISALQNLTN 111

Query: 433 LMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLT 492
           L +L    ++ +      L    ++  LN+G N       S L +   L  + + ++++ 
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK 168

Query: 493 GALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSL 552
             +   +    L  L ++ N I    P  + +  +L       N+ + + P  + N+  L
Sbjct: 169 D-VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223

Query: 553 VTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG 612
            +L I  N +    P  L+    L   ++  N ++    ++++    L +L +  N  + 
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279

Query: 613 GIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSK 672
              + ++ L +L  L L  NQLG E    IG L +L+  L LS+N +T   P  L  LSK
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT-LFLSQNHITDIRP--LASLSK 334

Query: 673 LEQLDISSNNLT 684
           ++  D ++  + 
Sbjct: 335 MDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  167 bits (426), Expect = 8e-46
 Identities = 76/368 (20%), Positives = 138/368 (37%), Gaps = 26/368 (7%)

Query: 337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLL 396
              L      +    PD    L+      L    +T    V+   + S+  L+V    + 
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 397 GKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQ 456
               +E   L  L+ ++L  NQ + + P  L     L  L    N  T      L     
Sbjct: 58  SIQGIE--YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111

Query: 457 LRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISG 516
           LR L + ++      P  L +   ++ + L  N     L   S    L++L V+ + +  
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD 169

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
             P  I N  +L S+  + N+   + P  L +L SL      +N +    P  ++    L
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG 636
               +  N +    P  L +   L+ L++  N  +      + +L KL  L +G NQ+  
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279

Query: 637 EIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSL 696
                +  L  L+  L L+ N L       +  L+ L  L +S N++T  + PL+++  +
Sbjct: 280 --ISVLNNLSQLNS-LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKM 335

Query: 697 VEVNVSYN 704
              + +  
Sbjct: 336 DSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  149 bits (380), Expect = 9e-40
 Identities = 70/359 (19%), Positives = 145/359 (40%), Gaps = 27/359 (7%)

Query: 361 LQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
              L      +   FP +   +A     ++   ++   +  E  EL+ +  + +   + +
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57

Query: 421 GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT 480
            +  Q +   ++L  L+   N  T   P  L    +L  L +G N+        L +   
Sbjct: 58  SI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA--LQNLTN 111

Query: 481 LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
           L  + L ++ ++  +   +    +  L++  N+      S + N   L  +  + +K   
Sbjct: 112 LRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD 169

Query: 541 LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL 600
           +    + NL  L +L+++ N +E   P  L+   +L  F    N +    P  + +   L
Sbjct: 170 V--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223

Query: 601 SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT 660
           + LK+  N  T   P  ++ L +L  L++G NQ+      ++  L  L   LN+  N ++
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKM-LNVGSNQIS 278

Query: 661 GRIPSDLEKLSKLEQLDISSNNLTGT-LSPLSNIHSLVEVNVSYNLFTGPVP-ETLMNL 717
               S L  LS+L  L +++N L    +  +  + +L  + +S N  T   P  +L  +
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKM 335

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  112 bits (283), Expect = 5e-27
 Identities = 41/188 (21%), Positives = 73/188 (38%), Gaps = 12/188 (6%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
             I +L+ L ++ L+ N      P  L + ++L Y     N  T        N+  L  L
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSL 226

Query: 149 NLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIP 208
            +  N +      PL  +  L ++ +  N +S      V DL +++ L + SN++S    
Sbjct: 227 KIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--I 280

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL 268
             + N  +L  L+LN N+L     E +  L NL  L +  N++             +   
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSA 338

Query: 269 DLSYNRFS 276
           D +     
Sbjct: 339 DFANQVIK 346

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  179 bits (456), Expect = 2e-50
 Identities = 73/320 (22%), Positives = 119/320 (37%), Gaps = 69/320 (21%)

Query: 818  TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN 877
              ++     +G+G +G V++ S     V AVK   F      S   + E+     +RH N
Sbjct: 7    ARDITLLECVGKGRYGEVWRGSWQGENV-AVKI--FSSRDEKSWFRETELYNTVMLRHEN 63

Query: 878  LVRL-----EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHAL 932
            ++                 +I   Y E GSL D L       TL+     +I L  A  L
Sbjct: 64   ILGFIASDMTSRHSSTQLWLIT-HYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGL 118

Query: 933  AYLHYD-----CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS--TTSISVV 985
            A+LH +       P I HRD+K +NIL+    +  I+D G+A +  +S       +   V
Sbjct: 119  AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 986  GTIGYIAPE------NAFTTAKSKESDVYSYGVVLLELITRKKA---------------- 1023
            GT  Y+APE              K  D++++G+VL E+  R  +                
Sbjct: 179  GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238

Query: 1024 LDPSYKERTDIVGW------VRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVAL 1077
             DPS+++   +V        + + W     +  +    LM+E                  
Sbjct: 239  NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK--LMKE------------------ 278

Query: 1078 RCTEKKPSNRPNMRDVVRQL 1097
             C  + PS R     + + L
Sbjct: 279  -CWYQNPSARLTALRIKKTL 297

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  179 bits (456), Expect = 5e-50
 Identities = 65/340 (19%), Positives = 109/340 (32%), Gaps = 29/340 (8%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
               H S  + +    +         L         D +             N  N Q  
Sbjct: 6   HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIE 61

Query: 149 NLYGNLLDGEIPEPLFRI--LGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGT 206
              G  L     + L      G   + L +  L    P     L  ++ + + +  L   
Sbjct: 62  TRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118

Query: 207 IPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLT 266
           +P+++     L+ L L  N L   LP S+++L  L  L +                  LT
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACP-------------ELT 164

Query: 267 FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGK 326
            L           S       +L  L +  + +  S+P+S   L  L SL +  + LS  
Sbjct: 165 ELPEPLASTD--ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220

Query: 327 IPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFD-NRLTGEFPVSIWRIASL 385
           + P +     L  L L         P   G  + L+ L L D + L    P+ I R+  L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQL 279

Query: 386 EYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQ 425
           E L +     L +LP  + +L     I +  +  + +   
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  165 bits (420), Expect = 3e-45
 Identities = 52/342 (15%), Positives = 100/342 (29%), Gaps = 34/342 (9%)

Query: 115 LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFL 174
             + S  E L    +       D     Q     +                      +  
Sbjct: 8   HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN-----SNNPQIET 62

Query: 175 NNNSLSGSIPRNVGDLKEV--EALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLP 232
                  +    + D  +    AL L S  L    P+       LQ + ++   LM  LP
Sbjct: 63  RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LP 120

Query: 233 ESLSNLENLVYLDVGDNNLE---GRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSL 289
           +++     L  L +  N L      I         L  L +        +   L +  + 
Sbjct: 121 DTMQQFAGLETLTLARNPLRALPASI----ASLNRLRELSIRACPELTELPEPLASTDA- 175

Query: 290 THLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG 349
                               L  L SL L    +   +P  +   + L  L +  + L  
Sbjct: 176 --------------SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS- 219

Query: 350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQL 409
            +   +  L  L++L+L        +P      A L+ L++ + + L  LPL++  L QL
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279

Query: 410 KNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNL 451
           + + L        +P  +    +   +    +    ++  + 
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPH-LQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  151 bits (384), Expect = 2e-40
 Identities = 54/386 (13%), Positives = 105/386 (27%), Gaps = 76/386 (19%)

Query: 205 GTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKN 264
           G+      +    + LY   +  +    + LS  +     D    +        + +  N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS-------AWRQAN 54

Query: 265 LTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLAR--LSSLDLSENQ 322
                +                 +L                      +    +L+L    
Sbjct: 55  SNNPQIETR-----------TGRALKAT-----------ADLLEDATQPGRVALELRSVP 92

Query: 323 LSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRI 382
           L  + P +  +  +L  + + A  L  E+PD + Q + L+ L L  N L    P SI  +
Sbjct: 93  LP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149

Query: 383 ASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNS 442
             L  L +     L +LP  +                            +L  L      
Sbjct: 150 NRLRELSIRACPELTELPEPLASTD---------------ASGEHQGLVNLQSLRLEWTG 194

Query: 443 FTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNP 502
               +P ++   + L+ L +  +     +   +   P L                     
Sbjct: 195 IR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL--------------------- 231

Query: 503 VLSHLDVSRNNISGAIPSSIGNSINLTSIDFSS-NKFSGLMPQELGNLVSLVTLNISLNH 561
               LD+         P   G    L  +     +    L P ++  L  L  L++    
Sbjct: 232 --EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL-PLDIHRLTQLEKLDLRGCV 288

Query: 562 VEGSLPSQLSKCKNLEVFDVSFNLLN 587
               LPS +++     +  V  +L  
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  146 bits (371), Expect = 1e-38
 Identities = 60/327 (18%), Positives = 104/327 (31%), Gaps = 19/327 (5%)

Query: 181 GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
           GS   +       E L+   +       + +    R      N            +N  N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSNN 57

Query: 241 LVYLDVGDNNLEGRIN-FGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKL 299
                     L+   +            L+L                S L H+ I  + L
Sbjct: 58  PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116

Query: 300 TGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQ-- 357
              +P +    A L +L L+ N L   +P  +     L  L + A     E+P+ L    
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174

Query: 358 -------LSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLK 410
                  L NLQ L L    +    P SI  + +L+ L + N+ L   L   +  L +L+
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232

Query: 411 NISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGP 470
            + L         P   G  + L +L   + S    +P ++    QL  L++        
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292

Query: 471 IPSLLGSCPTLWRVILKQNQLTGALPE 497
           +PSL+   P    +++  +        
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  144 bits (366), Expect = 5e-38
 Identities = 58/370 (15%), Positives = 111/370 (30%), Gaps = 53/370 (14%)

Query: 281 PNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVL 340
            +  + S   +L   GS              R  + D +    + +            + 
Sbjct: 6   HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-NSNN---PQIE 61

Query: 341 HLYANQLEGEIPDELGQLS--NLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGK 398
                 L+    D L   +      LEL    L  +FP   +R++ L+++ +    L  +
Sbjct: 62  TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-ME 118

Query: 399 LPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLR 458
           LP  M +   L+ ++L  N     +P S+   + L +L         E+P  L       
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177

Query: 459 VLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAI 518
                 N                                      L  L +    I  ++
Sbjct: 178 EHQGLVN--------------------------------------LQSLRLEWTGIR-SL 198

Query: 519 PSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEV 578
           P+SI N  NL S+   ++  S L    + +L  L  L++       + P        L+ 
Sbjct: 199 PASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257

Query: 579 FDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG-- 636
             +       ++P  +     L  L L        +P+ I++L     + +  +      
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317

Query: 637 -EIPPSIGAL 645
              P +  A 
Sbjct: 318 QHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  128 bits (325), Expect = 1e-32
 Identities = 63/359 (17%), Positives = 118/359 (32%), Gaps = 56/359 (15%)

Query: 384 SLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
             E L    +  L      +++ ++  N        +         NS+  Q++      
Sbjct: 13  GRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-----NSNNPQIETRTGRA 67

Query: 444 TGEIPPNLCFGKQ--LRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKN 501
                  L    Q     L +         P                 +L+         
Sbjct: 68  LKATADLLEDATQPGRVALELRSVPLPQ-FPDQAF-------------RLSH-------- 105

Query: 502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
             L H+ +    +   +P ++     L ++  + N    L P  + +L  L  L+I    
Sbjct: 106 --LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACP 161

Query: 562 VEGSLPSQLSKC---------KNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG 612
               LP  L+            NL+   + +  +  S+P+S+ + ++L  LK+  +  + 
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA 220

Query: 613 GIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLS-KNGLTGRIPSDLEKLS 671
            +   I  L KL EL L G       PP  G    L   L L   + L   +P D+ +L+
Sbjct: 221 -LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR-LILKDCSNLL-TLPLDIHRLT 277

Query: 672 KLEQLDISSNNLTGTL-SPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNP 729
           +LE+LD+        L S ++ + +   + V  +L           L    P +    P
Sbjct: 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHL--------QAQLDQHRPVARPAEP 328

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  102 bits (257), Expect = 8e-24
 Identities = 35/265 (13%), Positives = 78/265 (29%), Gaps = 26/265 (9%)

Query: 455 KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNI 514
                L    +    P   +L      +     +          +          +   +
Sbjct: 12  SGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNN---PQIETRTGRAL 68

Query: 515 SGAIPSSIGN--SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSK 572
             A    + +       +++  S       P +   L  L  + I    +   LP  + +
Sbjct: 69  K-ATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQ 125

Query: 573 CKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGN 632
              LE   ++ N L  ++P+S+ S   L  L +        +P  ++  +          
Sbjct: 126 FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD---------- 174

Query: 633 QLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSN 692
                       L +L   L L   G+   +P+ +  L  L+ L I ++ L+     + +
Sbjct: 175 -----ASGEHQGLVNLQS-LRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHH 227

Query: 693 IHSLVEVNVSYNLFTGPVPETLMNL 717
           +  L E+++         P      
Sbjct: 228 LPKLEELDLRGCTALRNYPPIFGGR 252

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 81.1 bits (201), Expect = 2e-16
 Identities = 27/167 (16%), Positives = 51/167 (30%), Gaps = 49/167 (29%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNL 145
            L   I +L  L+++ + ++  S  + P + +   LE LDL       + P  F     L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255

Query: 146 QYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSG 205
           + L L                        + ++L                          
Sbjct: 256 KRLILK-----------------------DCSNLL------------------------- 267

Query: 206 TIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE 252
           T+P  I    +L++L L     +  LP  ++ L     + V  +   
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (449), Expect = 5e-49
 Identities = 81/328 (24%), Positives = 123/328 (37%), Gaps = 70/328 (21%)

Query: 810  LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQT 869
            LL Q   A + +     IG+G +G V+        V AVK   F   +  S   + EI  
Sbjct: 29   LLVQRTIA-KQIQMVKQIGKGRYGEVWMGKWRGEKV-AVKV--FFTTEEASWFRETEIYQ 84

Query: 870  IGKIRHRNLVRL-----EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
               +RH N++       +         +I   Y ENGSL D L S     TL+     K+
Sbjct: 85   TVLMRHENILGFIAADIKGTGSWTQLYLIT-DYHENGSLYDYLKS----TTLDAKSMLKL 139

Query: 925  ALGAAHALAYLHYD-----CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD--KSPA 977
            A  +   L +LH +       P I HRD+K +NIL+       I+D G+A       +  
Sbjct: 140  AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199

Query: 978  STTSISVVGTIGYIAPE--NAFTTAKSKES----DVYSYGVVLLELITRKKA-------- 1023
                 + VGT  Y+ PE  +        +S    D+YS+G++L E+  R  +        
Sbjct: 200  DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

Query: 1024 --------LDPSYKERTDIVGW------VRSVWSDTEEINDIVDLSLMEEMLVSSIRDQV 1069
                     DPSY++  +IV          + WS  E +  +    LM E          
Sbjct: 260  LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGK--LMTE---------- 307

Query: 1070 IDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                     C    P++R     V + L
Sbjct: 308  ---------CWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (443), Expect = 3e-48
 Identities = 78/328 (23%), Positives = 118/328 (35%), Gaps = 70/328 (21%)

Query: 810  LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQT 869
            LL Q   A   +  +  IG+G  G V++       V AVK   F   +  S   + EI  
Sbjct: 34   LLVQRTIA-RTIVLQESIGKGRFGEVWRGKWRGEEV-AVKI--FSSREERSWFREAEIYQ 89

Query: 870  IGKIRHRNLVRL-----EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKI 924
               +RH N++       +D        ++   Y E+GSL D L+      T+      K+
Sbjct: 90   TVMLRHENILGFIAADNKDNGTWTQLWLVS-DYHEHGSLFDYLNR----YTVTVEGMIKL 144

Query: 925  ALGAAHALAYLHYD-----CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD--KSPA 977
            AL  A  LA+LH +       P I HRD+K +NIL+       I+D G+A   D      
Sbjct: 145  ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

Query: 978  STTSISVVGTIGYIAPE------NAFTTAKSKESDVYSYGVVLLELITRKKA-------- 1023
                   VGT  Y+APE      N       K +D+Y+ G+V  E+  R           
Sbjct: 205  DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264

Query: 1024 --------LDPSYKERTDIVGW------VRSVWSDTEEINDIVDLSLMEEMLVSSIRDQV 1069
                     DPS +E   +V        + + W   E +  +    +M E          
Sbjct: 265  LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK--IMRE---------- 312

Query: 1070 IDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                     C     + R     + + L
Sbjct: 313  ---------CWYANGAARLTALRIKKTL 331

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  172 bits (437), Expect = 4e-48
 Identities = 75/302 (24%), Positives = 126/302 (41%), Gaps = 63/302 (20%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
              L  + +IG G  G VY+A    + V AVK       +  S +++   +E +    ++H
Sbjct: 7    AELTLEEIIGIGGFGKVYRAFWIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 876  RNLVRLEDFWLRKDC-GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
             N++ L    L++    ++M  +   G L  VL        +  ++    A+  A  + Y
Sbjct: 66   PNIIALRGVCLKEPNLCLVM-EFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNY 120

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPH--------ISDFGIAKLLDKSPASTTSISVVG 986
            LH +   PI+HRD+K  NIL+  ++E          I+DFG+A+   +    TT +S  G
Sbjct: 121  LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----TTKMSAAG 176

Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK---KALDPSY--------KERTDIV 1035
               ++APE    +  SK SDV+SYGV+L EL+T +   + +D           K    I 
Sbjct: 177  AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236

Query: 1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                  ++            LME                    C    P +RP+  +++ 
Sbjct: 237  STCPEPFAK-----------LME-------------------DCWNPDPHSRPSFTNILD 266

Query: 1096 QL 1097
            QL
Sbjct: 267  QL 268

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  170 bits (433), Expect = 1e-47
 Identities = 61/297 (20%), Positives = 102/297 (34%), Gaps = 59/297 (19%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRN 877
            + LN    +     G ++K     N +  VK L  R    R S     E   +    H N
Sbjct: 10   KQLNFLTKLNENHSGELWKGRWQGNDI-VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 878  LVRLE---DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            ++ +             +I   +M  GSL +VLH  T    ++ +   K AL  A  +A+
Sbjct: 69   VLPVLGACQSPPAPHPTLIT-HWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAF 126

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            LH   +P I    +   ++++D +M   IS   +         S  S   +    ++APE
Sbjct: 127  LH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE 178

Query: 995  ---NAFTTAKSKESDVYSYGVVLLELITRK---KALDPSY--------KERTDIVGWVRS 1040
                       + +D++S+ V+L EL+TR+     L              R  I   +  
Sbjct: 179  ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238

Query: 1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              S            LM+                    C  + P+ RP    +V  L
Sbjct: 239  HVSK-----------LMK-------------------ICMNEDPAKRPKFDMIVPIL 265

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  173 bits (439), Expect = 3e-46
 Identities = 60/461 (13%), Positives = 148/461 (32%), Gaps = 25/461 (5%)

Query: 135 IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVE 194
           I +  +N    +   +  + L   +         ++ + L+ N LS     ++    ++E
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 195 ALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGR 254
            L L SN L       + +   L+ L LN N +     + L    ++  L   +NN+   
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-- 112

Query: 255 INFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG-SIPSSFGLLARL 313
                 + +    + L+ N+ +     + G  S + +LD+  +++   +          L
Sbjct: 113 -RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 314 SSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG 373
             L+L  N +   +  ++     L  L L +N+L   +  E    + +  + L +N+L  
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227

Query: 374 EFPVSIWRIASLEYLLVYNNNL-LGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSS 432
               ++    +LE+  +  N    G L    ++ ++++   +       +  Q+    + 
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT--VAKQTVKKLTGQNEEECTV 285

Query: 433 LMQLDFINNSFTGEIPPNLCFGKQLRVLNM----GQNQFHGPIPSLLGSCPTLWRVILKQ 488
                +          P       L+        GQ      +     +      +   +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345

Query: 489 NQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG 547
            Q    + +   +      L+  +  +   + +       L      +     L      
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIEL-QHATE 404

Query: 548 NLVSLVTLNISLN-HVEGSLPSQLSKCKNLEVFDVSFNLLN 587
               L  L   +  + E  +  Q  +   +  +D+  +   
Sbjct: 405 EQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  169 bits (429), Expect = 6e-45
 Identities = 67/499 (13%), Positives = 156/499 (31%), Gaps = 24/499 (4%)

Query: 182 SIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENL 241
           +I     +    +   +  + L   +     + + ++EL L+ N L       L+    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 242 VYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG 301
             L++  N L   ++        L  LDL+ N         L    S+  L    + ++ 
Sbjct: 61  ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 302 SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG-EIPDELGQLSN 360
            +  S        ++ L+ N+++     + G    +  L L  N+++     +       
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 361 LQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
           L+ L L  N +  +    +   A L+ L + +N L   +  E      +  ISL NN+  
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 421 GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT 480
            +I ++L  + +L   D   N F      +  F K  RV  + +             C  
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 481 LWRVILKQNQLTGALPEFS------KNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFS 534
                            F+      K    + L    +     +     N      ID  
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQARQREIDAL 344

Query: 535 SNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSL 594
             ++  ++ Q      + +TL      ++  + +       L+              ++ 
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404

Query: 595 RSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNL 654
                  +  + + +    +     +   + +  +  ++   ++      L+ L+   +L
Sbjct: 405 EQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE-TQLAEENARLKKLNGEADL 463

Query: 655 SKNGLTGRIPSDLEKLSKL 673
           +       +   + +   L
Sbjct: 464 ALASANATLQELVVREQNL 482

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  166 bits (422), Expect = 4e-44
 Identities = 72/432 (16%), Positives = 150/432 (34%), Gaps = 25/432 (5%)

Query: 92  GHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLY 151
                ++ +DLS N  S      L   + LE L+LS+N    +  D  E+L  L+ L+L 
Sbjct: 31  QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLN 88

Query: 152 GNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESI 211
            N +  E+         ++ +   NN++S  +  +    +  + ++L +N+++       
Sbjct: 89  NNYV-QELLVGPS----IETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDE 140

Query: 212 GNCYRLQELYLNENKLMGF-LPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDL 270
           G   R+Q L L  N++      E  ++ + L +L++  N +   +         L  LDL
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDL 198

Query: 271 SYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE 330
           S N+ +  + P   + + +T + +  +KL   I  +      L   DL  N        +
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256

Query: 331 LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT----GEFPVSIWRIASLE 386
               K   V  +    ++        + +                       I       
Sbjct: 257 F-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEH 315

Query: 387 YLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGE 446
            LL    +   +L  E     + + I     Q+  VI Q      + + L+    +   +
Sbjct: 316 ALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQ 375

Query: 447 IPPNLCFGKQLRVLN---MGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPV 503
           +        +L       +GQ +              L R I+K+ +      +  +N  
Sbjct: 376 VSNGRRAHAELDGTLQQAVGQIELQHATEEQSPL--QLLRAIVKRYEEMYVEQQSVQNNA 433

Query: 504 LSHLDVSRNNIS 515
           +   D+ ++  +
Sbjct: 434 IRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  166 bits (421), Expect = 7e-44
 Identities = 74/436 (16%), Positives = 137/436 (31%), Gaps = 22/436 (5%)

Query: 278 GISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYL 337
            I     N +      +  S L  ++ S       +  LDLS N LS     +L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 338 TVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLG 397
            +L+L +N L  E  D L  LS L+ L+L +N +       +    S+E L   NNN+  
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112

Query: 398 KLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG--K 455
           ++       +  KNI L NN+ + +     G  S +  LD   N     +          
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASSD 169

Query: 456 QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNIS 515
            L  LN+  N  +  +   +     L  + L  N+L    PEF     ++ + +  N + 
Sbjct: 170 TLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227

Query: 516 GAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKN 575
             I  ++  S NL   D   N F     ++     +     ++   V+        +C  
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 576 LEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG----GIPTFISELEKLLELQLGG 631
             +                    +L   + +     G     +        +  E+    
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345

Query: 632 NQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLS 691
            Q    +   +   +     L   K  L  ++ +     ++L+     +           
Sbjct: 346 EQYR-TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE 404

Query: 692 NIHSLVEVNVSYNLFT 707
               L  +      + 
Sbjct: 405 EQSPLQLLRAIVKRYE 420

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  154 bits (391), Expect = 4e-40
 Identities = 55/447 (12%), Positives = 145/447 (32%), Gaps = 21/447 (4%)

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
                 ++ +     ++    +  ++  LD+ G+ L+    +      +L  L+LS N L
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

Query: 324 SGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIA 383
                 +L     L  L L  N ++     EL    +++ L   +N ++     S  +  
Sbjct: 71  YE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQ-- 120

Query: 384 SLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGV-IPQSLGINSSLMQLDFINNS 442
             + + + NN +     L+     +++ + L  N+   V   +    + +L  L+   N 
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180

Query: 443 FTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNP 502
              ++   + F  +L+ L++  N+    +     S   +  + L+ N+L         + 
Sbjct: 181 IY-DVKGQVVF-AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQ 237

Query: 503 VLSHLDVSRNNIS-GAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
            L H D+  N    G +      +  + ++         L  Q           +     
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYC 295

Query: 562 VEGSLPSQLSKCKNLEVFDVSFNLLNGS----IPSSLRSWKSLSILKLSENHFTGGIPTF 617
            E        +   L+  + +     GS    +     +      +   +  +   I   
Sbjct: 296 CEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQV 355

Query: 618 ISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLD 677
               +  + L+     L  ++     A  +L   L  +   +  +  ++ +   +L +  
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAI 415

Query: 678 ISSNNLTGTLSPLSNIHSLVEVNVSYN 704
           +               +++ + ++  +
Sbjct: 416 VKRYEEMYVEQQSVQNNAIRDWDMYQH 442

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  153 bits (389), Expect = 8e-40
 Identities = 60/419 (14%), Positives = 122/419 (29%), Gaps = 22/419 (5%)

Query: 302 SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNL 361
           +I        R     ++++ L   +         +  L L  N L      +L   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 362 QDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSG 421
           + L L  N L     + +  +++L  L + NN +      E+     ++ +   NN  S 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113

Query: 422 VIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHG-PIPSLLGSCPT 480
           V   S         +   NN  T     +     +++ L++  N+        L  S  T
Sbjct: 114 V---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 481 LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
           L  + L+ N +   +        L  LD+S N ++  +     ++  +T I   +NK   
Sbjct: 171 LEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL 228

Query: 541 LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL 600
           +  + L    +L   ++  N             KN  V  V+   +      +       
Sbjct: 229 I-EKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286

Query: 601 SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYAL---NLSKN 657
           ++              F   L  L   +       G     +   ++        +  K 
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKE 346

Query: 658 GLTGRIPSDLEKLSKLEQLDISSNNLT----GTLSPLSNIHSLVEVNVSYNLFTGPVPE 712
                I     +      L+     L           + +   ++  V          E
Sbjct: 347 QYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEE 405

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  120 bits (302), Expect = 1e-28
 Identities = 40/300 (13%), Positives = 89/300 (29%), Gaps = 15/300 (5%)

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
            +        ++S    +         ++ L++  N       + L     L  + L  N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 490 QLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNL 549
            L     +      L  LD++ N +       +    ++ ++  ++N  S +        
Sbjct: 69  VLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV---SCSRG 119

Query: 550 VSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNG-SIPSSLRSWKSLSILKLSEN 608
                + ++ N +             ++  D+  N ++  +      S  +L  L L  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 609 HFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLE 668
                +   +    KL  L L  N+L   + P   +   +++ ++L  N L   I   L 
Sbjct: 180 FIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNNKLV-LIEKALR 234

Query: 669 KLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGN 728
               LE  D+  N             +     V+         +       P+   +   
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 19/158 (12%), Positives = 42/158 (26%), Gaps = 2/158 (1%)

Query: 85  GQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQN 144
            +L  E  + ++ + ID     +   I        A   L+         + +       
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385

Query: 145 LQYLNLYGNLLDGEIPEPLFRILGLQY-VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRL 203
           L    L   +   E+         LQ    +        + +       +    ++ ++ 
Sbjct: 386 LD-GTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444

Query: 204 SGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENL 241
           +    E+        E  L        L E +   +NL
Sbjct: 445 TQLAEENARLKKLNGEADLALASANATLQELVVREQNL 482

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  165 bits (421), Expect = 9e-46
 Identities = 78/310 (25%), Positives = 123/310 (39%), Gaps = 42/310 (13%)

Query: 792  RRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKL 851
             R +  D EIP  +               +     IG G+ G VYK       V AVK L
Sbjct: 12   SRDAADDWEIPDGQ---------------ITVGQRIGSGSFGTVYKGKWH-GDV-AVKML 54

Query: 852  AFRGHKRGSLSM-KREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSI 910
                     L   K E+  + K RH N++    +       I+  ++ E  SL   LH+ 
Sbjct: 55   NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHA- 112

Query: 911  TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK 970
                  E      IA   A  + YLH      I+HRD+K  NI L  +    I DFG+A 
Sbjct: 113  -SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168

Query: 971  LLDKSPASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027
               +   S     + G+I ++APE      +   S +SDVY++G+VL EL+T +    P 
Sbjct: 169  EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL---P- 224

Query: 1028 YKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNR 1087
            Y    +    +  V   +        LS     + S+   ++  ++     C +KK   R
Sbjct: 225  YSNINNRDQIIEMVGRGS--------LSPDLSKVRSNCPKRMKRLM---AECLKKKRDER 273

Query: 1088 PNMRDVVRQL 1097
            P+   ++ ++
Sbjct: 274  PSFPRILAEI 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  164 bits (417), Expect = 4e-45
 Identities = 68/296 (22%), Positives = 117/296 (39%), Gaps = 45/296 (15%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
             +L    V+G+G  G   K +        V K   R  +    +  +E++ +  + H N+
Sbjct: 10   SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69

Query: 879  VRLED-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            ++     +  K    I   Y++ G+LR ++ S        W+ R   A   A  +AYLH 
Sbjct: 70   LKFIGVLYKDKRLNFIT-EYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH- 125

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD------------KSPASTTSISVV 985
                 I+HRD+   N L+       ++DFG+A+L+             K P      +VV
Sbjct: 126  --SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 986  GTIGYIAPE----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041
            G   ++APE     ++        DV+S+G+VL E+I R  A DP Y  RT   G     
Sbjct: 184  GNPYWMAPEMINGRSYDEK----VDVFSFGIVLCEIIGRVNA-DPDYLPRTMDFG----- 233

Query: 1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                      +++    +       +       + +RC +  P  RP+   +   L
Sbjct: 234  ----------LNVRGFLDRYCPP--NCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  162 bits (413), Expect = 1e-43
 Identities = 76/339 (22%), Positives = 138/339 (40%), Gaps = 28/339 (8%)

Query: 87  LGPEIGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQN 144
            G E   L+  + +   ++     +P   L +   +E L+L+      +I    F     
Sbjct: 37  FGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHT 94

Query: 145 LQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNR 202
           +Q L +  N +   +P  +F+ +  L  + L  N LS S+PR +  +  ++  L + +N 
Sbjct: 95  IQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 152

Query: 203 LSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKC 262
           L     ++      LQ L L+ N+L       LS + +L + +V  N L           
Sbjct: 153 LERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIP 204

Query: 263 KNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQ 322
             +  LD S+N  +  +   +     LT L +  + LT    +       L  +DLS N+
Sbjct: 205 IAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNE 259

Query: 323 LSGKIPPE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWR 381
           L  KI      K + L  L++  N+L   +      +  L+ L+L  N L      +  +
Sbjct: 260 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316

Query: 382 IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
              LE L + ++N +  L L       LKN++L +N + 
Sbjct: 317 FDRLENLYL-DHNSIVTLKLST--HHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  160 bits (408), Expect = 5e-43
 Identities = 66/353 (18%), Positives = 139/353 (39%), Gaps = 28/353 (7%)

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNLL 155
              + +           +    +  + +    +     +P    ++ + ++ LNL    +
Sbjct: 23  FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI 81

Query: 156 DGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESI-G 212
           + EI    F     +Q +++  N++   +P +V  ++  +  L L  N LS ++P  I  
Sbjct: 82  E-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 138

Query: 213 NCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSY 272
           N  +L  L ++ N L     ++     +L  L +  N L   ++       +L   ++SY
Sbjct: 139 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSY 195

Query: 273 NRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELG 332
           N  S      L    ++  LD   + +   +     +   L+ L L  N L+      L 
Sbjct: 196 NLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLL 245

Query: 333 KCKYLTVLHLYANQLEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVY 391
               L  + L  N+LE +I      ++  L+ L + +NRL     +    I +L+ L + 
Sbjct: 246 NYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303

Query: 392 NNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFT 444
           +N+LL  +     +  +L+N+ L +N    +    L  + +L  L   +N + 
Sbjct: 304 HNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  147 bits (374), Expect = 1e-38
 Identities = 75/354 (21%), Positives = 135/354 (38%), Gaps = 28/354 (7%)

Query: 121 LEYLDLSTNGFTGDIPDNFE--NLQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNN 177
             + D+  +  T D+   FE   L N + +    + +  ++P  L      ++ + LN+ 
Sbjct: 21  CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79

Query: 178 SLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESI-GNCYRLQELYLNENKLMGFLPESL 235
            +   I          ++ L++  N +   +P  +  N   L  L L  N L        
Sbjct: 80  QIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 137

Query: 236 SNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDI 294
            N   L  L + +NNLE RI   + +   +L  L LS NR +     +L    SL H ++
Sbjct: 138 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT---HVDLSLIPSLFHANV 193

Query: 295 VGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE 354
             + L+     +  +   +  LD S N ++  +   +     LT+L L  N L  +    
Sbjct: 194 SYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-W 243

Query: 355 LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISL 414
           L     L +++L  N L         ++  LE L + NN  L  L L    +  LK + L
Sbjct: 244 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDL 302

Query: 415 YNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFH 468
            +N     + ++      L  L   +NS    +  +      L+ L +  N + 
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTH--HTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (346), Expect = 6e-35
 Identities = 68/360 (18%), Positives = 132/360 (36%), Gaps = 25/360 (6%)

Query: 206 TIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKN 264
            I  ++       +++++      +       L N   +   ++ +  ++     +  + 
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 265 LTFLDLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
           +  L+L+  +    I         ++  L +  + +    P  F  +  L+ L L  N L
Sbjct: 71  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129

Query: 324 SGKIPPEL-GKCKYLTVLHLYANQLEGEIPDELGQ-LSNLQDLELFDNRLTGEFPVSIWR 381
           S  +P  +      LT L +  N LE  I D+  Q  ++LQ+L+L  NRLT    V +  
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSL 184

Query: 382 IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN 441
           I SL +  V  N L       +     ++ +   +N  + V      +N  L  L   +N
Sbjct: 185 IPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQHN 236

Query: 442 SFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKN 501
           + T      L     L  +++  N+    +         L R+ +  N+L          
Sbjct: 237 NLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPI 294

Query: 502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
           P L  LD+S N++   +  +      L ++    N    L   +L    +L  L +S N 
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHND 350

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  133 bits (336), Expect = 1e-33
 Identities = 69/384 (17%), Positives = 125/384 (32%), Gaps = 47/384 (12%)

Query: 135 IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV-GDLKEV 193
           I  N +       +++     D         +   + V   N+++   +P  +    ++V
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 194 EALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEG 253
           E L L   ++      +    + +Q+LY+  N +    P    N+  L  L +  N+L  
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130

Query: 254 RINFGS-EKCKNLTFLDLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLA 311
            +  G       LT L +S N     I  +     +SL +L +  ++LT  +     L+ 
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIP 186

Query: 312 RLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRL 371
            L   ++S N LS      L     +  L    N +   +         L  L+L  N L
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238

Query: 372 TGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINS 431
           T          A L                       L  + L  N+   ++        
Sbjct: 239 T--------DTAWL------------------LNYPGLVEVDLSYNELEKIMYHPFVKMQ 272

Query: 432 SLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQL 491
            L +L   NN     +         L+VL++  N     +         L  + L  N +
Sbjct: 273 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI 330

Query: 492 TGALPEFSKNPVLSHLDVSRNNIS 515
              L   S +  L +L +S N+  
Sbjct: 331 V-TLK-LSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  131 bits (332), Expect = 5e-33
 Identities = 65/384 (16%), Positives = 128/384 (33%), Gaps = 24/384 (6%)

Query: 302 SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNL 361
            I S+         + +           E        ++    + +       L     +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 362 QDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQFS 420
           + L L D ++      +     +++ L +   N +  LP  +   +  L  + L  N  S
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYM-GFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130

Query: 421 GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCP 479
            +          L  L   NN+    I  +       L+ L +  N+    +   L   P
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIP 186

Query: 480 TLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS 539
           +L+   +  N L+      +    +  LD S N+I+  +   +  ++ LT +    N  +
Sbjct: 187 SLFHANVSYNLLS----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT 239

Query: 540 GLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKS 599
                 L N   LV +++S N +E  +     K + LE   +S N L  ++    +   +
Sbjct: 240 DT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296

Query: 600 LSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGL 659
           L +L LS NH    +     + ++L  L L  N +   +         L   L LS N  
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKL--STHHTLKN-LTLSHNDW 351

Query: 660 TGRIPSDLEKLSKLEQLDISSNNL 683
                S       + +  +   + 
Sbjct: 352 DC--NSLRALFRNVARPAVDDADQ 373

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  111 bits (280), Expect = 2e-26
 Identities = 72/344 (20%), Positives = 132/344 (38%), Gaps = 50/344 (14%)

Query: 383 ASLEYLLVYNNNLLGKLPLEMTE------LKQLKNISLYNNQFSGVIPQSLGINSSLMQL 436
           ++L+Y  V+ +  +     ++        L   K ++  N+    +    L     +  L
Sbjct: 15  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 74

Query: 437 DFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGAL 495
           +  +     EI          ++ L MG N      P +  + P L  ++L++N L+ +L
Sbjct: 75  NLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SL 132

Query: 496 PE--FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLV 553
           P   F   P L+ L +S NN+      +   + +L ++  SSN+ + +   +L  + SL 
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLF 189

Query: 554 TLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGG 613
             N+S N +     S L+    +E  D S N +N  +   +     L+ILKL  N+ T  
Sbjct: 190 HANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLTD- 240

Query: 614 IPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKL 673
                     L+E+ L  N+L  +I                              K+ +L
Sbjct: 241 TAWL-LNYPGLVEVDLSYNELE-KIMYHP------------------------FVKMQRL 274

Query: 674 EQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
           E+L IS+N L         I +L  +++S+N     V       
Sbjct: 275 ERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQF 317

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 92.0 bits (229), Expect = 8e-20
 Identities = 38/177 (21%), Positives = 70/177 (39%), Gaps = 12/177 (6%)

Query: 77  NLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIP 136
           +L    VS  L   +     ++ +D S N+ +  +         L  L L  N  T    
Sbjct: 187 SLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--T 241

Query: 137 DNFENLQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEA 195
               N   L  ++L  N L+ +I    F  +  L+ ++++NN L  ++      +  ++ 
Sbjct: 242 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299

Query: 196 LWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE 252
           L L  N L   +  +     RL+ LYL+ N ++      LS    L  L +  N+ +
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 84.7 bits (210), Expect = 2e-17
 Identities = 42/234 (17%), Positives = 78/234 (33%), Gaps = 14/234 (5%)

Query: 487 KQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQEL 546
           +Q +          + V   + +                 N   + F ++    L    L
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65

Query: 547 GNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS 606
            +   +  LN++   +E       +    ++   + FN +    P   ++   L++L L 
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125

Query: 607 ENHFTGGIPTFI-SELEKLLELQLGGNQLGGEIPPSIGALQDLSY--ALNLSKNGLTGRI 663
            N  +  +P  I     KL  L +  N L   I       Q  +    L LS N LT  +
Sbjct: 126 RNDLS-SLPRGIFHNTPKLTTLSMSNNNL-ERIED--DTFQATTSLQNLQLSSNRLT-HV 180

Query: 664 PSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
              L  +  L   ++S N L+ TL+    +  L   + S+N          + L
Sbjct: 181 DLSL--IPSLFHANVSYNLLS-TLAIPIAVEEL---DASHNSINVVRGPVNVEL 228

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 81.2 bits (201), Expect = 3e-16
 Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 9/160 (5%)

Query: 92  GHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLY 151
               +L  + L  NN +      L N   L  +DLS N     +   F  +Q L+ L + 
Sbjct: 223 PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280

Query: 152 GNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESI 211
            N L   +      I  L+ + L++N L   + RN      +E L+L  N +  T+   +
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--L 335

Query: 212 GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
              + L+ L L+ N        +L    N+    V D + 
Sbjct: 336 STHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQ 373

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 79.7 bits (197), Expect = 1e-15
 Identities = 47/264 (17%), Positives = 88/264 (33%), Gaps = 22/264 (8%)

Query: 471 IPSLLGSCPTLWRV-ILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLT 529
           I S L      + V I  Q Q      E         +    + +     + + +   + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 530 SIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGS 589
            ++ +  +   +         ++  L +  N +    P        L V  +  N L+  
Sbjct: 73  LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132

Query: 590 IPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSI-GALQ-- 646
                 +   L+ L +S N+              L  LQL  N+L   +  S+  +L   
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVDLSLIPSLFHA 191

Query: 647 DLSY-------------ALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNI 693
           ++SY              L+ S N +   +   +    +L  L +  NNLT   + L N 
Sbjct: 192 NVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNY 247

Query: 694 HSLVEVNVSYNLFTGPVPETLMNL 717
             LVEV++SYN     +    + +
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKM 271

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 51.6 bits (124), Expect = 8e-07
 Identities = 20/95 (21%), Positives = 30/95 (31%), Gaps = 4/95 (4%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNL 145
            L      +  L+ +DLS N+   ++         LE L L  N     +         L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 341

Query: 146 QYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLS 180
           + L L  N  D      LFR +    V   +    
Sbjct: 342 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCK 376

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  160 bits (407), Expect = 1e-43
 Identities = 51/336 (15%), Positives = 125/336 (37%), Gaps = 23/336 (6%)

Query: 135 IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVE 194
           I +  +N    +   +  + L   +         ++ + L+ N LS     ++    ++E
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 195 ALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGR 254
            L L SN L     + + +   L+ L LN N +     + L    ++  L   +NN+   
Sbjct: 62  LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-- 112

Query: 255 INFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG-SIPSSFGLLARL 313
                 + +    + L+ N+ +     + G  S + +LD+  +++   +          L
Sbjct: 113 -RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 314 SSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG 373
             L+L  N +   +  ++     L  L L +N+L   +  E    + +  + L +N+L  
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227

Query: 374 EFPVSIWRIASLEYLLVYNNNL-LGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSS 432
               ++    +LE+  +  N    G L    ++ ++++ ++    +    +        +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK---LTGQNEEECT 284

Query: 433 LMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFH 468
           +  L         ++P         R++ +G +  H
Sbjct: 285 VPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  143 bits (363), Expect = 8e-38
 Identities = 56/293 (19%), Positives = 115/293 (39%), Gaps = 18/293 (6%)

Query: 86  QLGPEIGH-LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQN 144
           Q    +      ++ +DLS N  S      L   + LE L+LS+N    +  D  E+L  
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD-LESLST 81

Query: 145 LQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS 204
           L+ L+L  N +  E+         ++ +   NN++S  +  +    +  + ++L +N+++
Sbjct: 82  LRTLDLNNNYV-QELLVGPS----IETLHAANNNIS-RVSCSR--GQGKKNIYLANNKIT 133

Query: 205 GTIPESIGNCYRLQELYLNENKLMGF-LPESLSNLENLVYLDVGDNNLEGRINFGSEKCK 263
                  G   R+Q L L  N++      E  ++ + L +L++  N +   +  G     
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK-GQVVFA 191

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
            L  LDLS N+ +  + P   + + +T + +  +KL   I  +      L   DL  N  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 324 SGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFP 376
                      K   V  +    ++ ++  +  +   +  L  +      + P
Sbjct: 250 HC-GTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLP 300

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (356), Expect = 7e-37
 Identities = 53/288 (18%), Positives = 105/288 (36%), Gaps = 16/288 (5%)

Query: 182 SIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENL 241
           +I     +    +   +  + L   +     + + ++EL L+ N L       L+    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 242 VYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG 301
             L++  N L   ++  S     L  LDL+ N         L    S+  L    + ++ 
Sbjct: 61  ELLNLSSNVLYETLDLES--LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 302 SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG-EIPDELGQLSN 360
            +  S        ++ L+ N+++     + G    +  L L  N+++     +       
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 361 LQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
           L+ L L  N +  +    +   A L+ L + +N L   +  E      +  ISL NN+  
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 421 GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFH 468
            +I ++L  + +L   D   N F      +  F K  RV  + +    
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  131 bits (332), Expect = 1e-33
 Identities = 53/330 (16%), Positives = 105/330 (31%), Gaps = 17/330 (5%)

Query: 302 SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNL 361
           +I        R     ++++ L   +         +  L L  N L      +L   + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 362 QDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSG 421
           + L L  N L     + +  +++L  L + NN +      E+     ++ +   NN  S 
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR 113

Query: 422 VIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHG-PIPSLLGSCP 479
           V   S         +   NN  T  +         +++ L++  N+        L  S  
Sbjct: 114 V---SCSRGQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 480 TLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS 539
           TL  + L+ N +   +        L  LD+S N ++  +     ++  +T I   +NK  
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 540 GLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKS 599
            +  + L    +L   ++  N        +    KN  V  V+   +      +      
Sbjct: 228 LI-EKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285

Query: 600 LSILKLSENHFTGGIPTFISELEKLLELQL 629
            ++              F   L  L     
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  117 bits (295), Expect = 8e-29
 Identities = 40/279 (14%), Positives = 87/279 (31%), Gaps = 17/279 (6%)

Query: 431 SSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
           +        ++S   +   +L      ++ L++  N       + L     L  + L  N
Sbjct: 10  NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 490 QLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNL 549
            L     +      L  LD++ N +       +    ++ ++  ++N  S +        
Sbjct: 69  VLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRV---SCSRG 119

Query: 550 VSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNG-SIPSSLRSWKSLSILKLSEN 608
                + ++ N +             ++  D+  N ++  +      S  +L  L L  N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179

Query: 609 HFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLE 668
                +   +    KL  L L  N+L   + P   +   +++ ++L  N L   I   L 
Sbjct: 180 FIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNNKLV-LIEKALR 234

Query: 669 KLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFT 707
               LE  D+  N             +     V+     
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  109 bits (275), Expect = 3e-26
 Identities = 45/249 (18%), Positives = 92/249 (36%), Gaps = 16/249 (6%)

Query: 471 IPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLT 529
           I  +  +        +  + L  AL         +  LD+S N +S    + +     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 530 SIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGS 589
            ++ SSN        +L +L +L TL+++ N+V      +L    ++E    + N ++  
Sbjct: 62  LLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113

Query: 590 IPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG-EIPPSIGALQDL 648
           +  S    +    + L+ N  T           ++  L L  N++          +   L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171

Query: 649 SYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTG 708
            + LNL  N +   +   +   +KL+ LD+SSN L        +   +  +++  N    
Sbjct: 172 EH-LNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL 228

Query: 709 PVPETLMNL 717
            + + L   
Sbjct: 229 -IEKALRFS 236

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 34/193 (17%), Positives = 69/193 (35%), Gaps = 13/193 (6%)

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
           AI     N         + +     +     +  ++  L++S N +     + L+    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG 636
           E+ ++S N+L       L S  +L  L L+ N+        +     +  L    N +  
Sbjct: 61  ELLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 637 EIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP--LSNIH 694
            +  S    Q     + L+ N +T     D    S+++ LD+  N +         ++  
Sbjct: 113 RVSCSR--GQGKKN-IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 695 SLVEVNVSYNLFT 707
           +L  +N+ YN   
Sbjct: 170 TLEHLNLQYNFIY 182

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 22/104 (21%), Positives = 31/104 (29%), Gaps = 23/104 (22%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGD----------- 134
            +GPE    + +  I L +N     I   L     LE+ DL  NGF              
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 135 -----------IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRIL 167
                      +    E    +  L  YG     ++P P    L
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  166 bits (422), Expect = 3e-43
 Identities = 105/581 (18%), Positives = 206/581 (35%), Gaps = 53/581 (9%)

Query: 87  LGPEIGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQN 144
            G E   L+  + +   ++     +P   L +   +E L+L+      +I    F     
Sbjct: 43  FGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHT 100

Query: 145 LQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNR 202
           +Q L +  N +   +P  +F+ +  L  + L  N LS S+PR +  +  ++  L + +N 
Sbjct: 101 IQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158

Query: 203 LSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKC 262
           L     ++      LQ L L+ N+L       LS + +L + +V  N L           
Sbjct: 159 LERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIP 210

Query: 263 KNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQ 322
             +  LD S+N  +  +   +     LT L +  + LT    +       L  +DLS N+
Sbjct: 211 IAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNE 265

Query: 323 LSGKIPPE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWR 381
           L  KI      K + L  L++  N+L   +      +  L+ L+L  N L      +  +
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 322

Query: 382 IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN 441
              LE L + +N+ +  L L       LKN++L +N +         +  ++ +    + 
Sbjct: 323 FDRLENLYLDHNS-IVTLKLST--HHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDA 377

Query: 442 SFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKN 501
               +I   L  G   +  +        P    L     L  V+ K  +  G     + +
Sbjct: 378 DQHCKIDYQLEHGLCCKESDK-------PYLDRLLQYIALTSVVEKVQRAQGRCS--ATD 428

Query: 502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
            + S   +S            GN      ++    +   L  +++     L  L+  ++ 
Sbjct: 429 TINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEID- 487

Query: 562 VEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISEL 621
                        NL  + +  + L  S  +  + +  L   +  +   T    T     
Sbjct: 488 ------------TNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTEADAK 535

Query: 622 EKLLE-LQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTG 661
           +K  E L+     L  ++        +L    +L +  +  
Sbjct: 536 QKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  132 bits (334), Expect = 3e-32
 Identities = 73/540 (13%), Positives = 164/540 (30%), Gaps = 84/540 (15%)

Query: 158 EIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRL 217
            I   L        V ++  +           L   + +   ++ +       + +  ++
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFS 276
           + L LN+ ++      + +    +  L +G N +   +     +    LT L L  N   
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND-- 134

Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCK 335
                       L+ L              F    +L++L +S N L  +I  +      
Sbjct: 135 ------------LSSLP----------RGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 171

Query: 336 YLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL 395
            L  L L +N+L   +   L  + +L    +  N L+                       
Sbjct: 172 SLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS----------------------- 205

Query: 396 LGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGK 455
                  +     ++ +   +N  + V      +N  L  L   +N+ T      L    
Sbjct: 206 ------TLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQHNNLTD--TAWLLNYP 254

Query: 456 QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNIS 515
            L  +++  N+    +         L R+ +  N+L          P L  LD+S N++ 
Sbjct: 255 GLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL 314

Query: 516 GAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGS----LPSQLS 571
             +  +      L ++    N    L   +L    +L  L +S N  + +    L   ++
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWDCNSLRALFRNVA 370

Query: 572 K---------CKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELE 622
           +         CK     +          P   R  + +++  + E           S  +
Sbjct: 371 RPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEK--VQRAQGRCSATD 428

Query: 623 KLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNN 682
            +  +Q   + +  +    +   + L   +N  +  +       +++   L+ L    + 
Sbjct: 429 TINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDT 488

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  108 bits (272), Expect = 1e-24
 Identities = 73/345 (21%), Positives = 133/345 (38%), Gaps = 52/345 (15%)

Query: 383 ASLEYLLVYNNNLLGKLPLEMTE------LKQLKNISLYNNQFSGVIPQSLGINSSLMQL 436
           ++L+Y  V+ +  +     ++        L   K ++  N+    +    L     +  L
Sbjct: 21  SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELL 80

Query: 437 DFINNSFTGEIPPNLCFG--KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGA 494
           +  +     EI     F     ++ L MG N      P +  + P L  ++L++N L+ +
Sbjct: 81  NLNDLQIE-EIDTY-AFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 137

Query: 495 LPE--FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSL 552
           LP   F   P L+ L +S NN+      +   + +L ++  SSN+ + +   +L  + SL
Sbjct: 138 LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSL 194

Query: 553 VTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG 612
              N+S N +     S L+    +E  D S N +N  +   +     L+ILKL  N+ T 
Sbjct: 195 FHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD 246

Query: 613 GIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSK 672
                      L+E+ L  N+L  +I                              K+ +
Sbjct: 247 -TAWL-LNYPGLVEVDLSYNELE-KIMYHP------------------------FVKMQR 279

Query: 673 LEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
           LE+L IS+N L         I +L  +++S+N     V       
Sbjct: 280 LERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQF 323

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 43/298 (14%), Positives = 85/298 (28%), Gaps = 23/298 (7%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNL 145
            L      +  L+ +DLS N+   ++         LE L L  N     +         L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTL 347

Query: 146 QYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVG--------DLKEVEALW 197
           + L L  N  D      LFR +    V   +           G           +    +
Sbjct: 348 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQY 407

Query: 198 LFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINF 257
           +    +   +  + G C     +   ++       +    L+    L+   N L   +  
Sbjct: 408 IALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ- 466

Query: 258 GSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD 317
                  LT   +   +   G+   +   ++L    +    L  S  +   +   L    
Sbjct: 467 ------QLTNEQIQQEQLLQGLHAEI--DTNLRRYRLPKDGLARSSDNLNKVFTHLKERQ 518

Query: 318 LSENQLSGKIPPEL-GKCKYLTVLHLYANQLEGEIPDELG-QLSNLQDLELFDNRLTG 373
             + + +     E   K K    L      LE ++ ++   Q    Q+  L   ++  
Sbjct: 519 AFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQ 576

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  158 bits (402), Expect = 5e-43
 Identities = 66/315 (20%), Positives = 112/315 (35%), Gaps = 57/315 (18%)

Query: 797  QDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH 856
            Q+ +IP ++               L    +IG+G  G VY        V A++ +     
Sbjct: 26   QEWDIPFEQ---------------LEIGELIGKGRFGQVYHGRWH-GEV-AIRLIDIERD 68

Query: 857  KRGSLSM-KREIQTIGKIRHRNLVRLEDFWLRKDC-GIIMYRYMENGSLRDVLHSITPPP 914
                L   KRE+    + RH N+V      +      II     +  +L  V+       
Sbjct: 69   NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT-SLCKGRTLYSVVRD--AKI 125

Query: 915  TLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL--- 971
             L+ N   +IA      + YLH      I+H+D+K +N+  D   +  I+DFG+  +   
Sbjct: 126  VLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181

Query: 972  LDKSPASTTSISVVGTIGYIAPE---------NAFTTAKSKESDVYSYGVVLLELITRKK 1022
            L             G + ++APE                SK SDV++ G +  EL  R+ 
Sbjct: 182  LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241

Query: 1023 ALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEK 1082
               P +K                E I   +   +   +    +  ++ D+L   L C   
Sbjct: 242  ---P-FKT------------QPAEAIIWQMGTGMKPNLSQIGMGKEISDIL---LFCWAF 282

Query: 1083 KPSNRPNMRDVVRQL 1097
            +   RP    ++  L
Sbjct: 283  EQEERPTFTKLMDML 297

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  157 bits (399), Expect = 4e-41
 Identities = 78/308 (25%), Positives = 134/308 (43%), Gaps = 14/308 (4%)

Query: 95  SKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYG 152
           ++ + +DL  N     +      +   LE L+L+ N  +  +    F NL NL+ L L  
Sbjct: 32  TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRS 89

Query: 153 NLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPES 210
           N L   IP  +F  L  L  + ++ N +   +   +  DL  +++L +  N L      +
Sbjct: 90  NRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147

Query: 211 IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLD 269
                 L++L L +  L     E+LS+L  L+ L +   N+   I   S ++   L  L+
Sbjct: 148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLE 206

Query: 270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS-SFGLLARLSSLDLSENQLSGKIP 328
           +S+  +   ++PN     +LT L I    LT ++P  +   L  L  L+LS N +S  I 
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIE 264

Query: 329 PE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEY 387
              L +   L  + L   QL    P     L+ L+ L +  N+LT         + +LE 
Sbjct: 265 GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLET 324

Query: 388 LLVYNNNL 395
           L++ +N L
Sbjct: 325 LILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  153 bits (389), Expect = 7e-40
 Identities = 64/285 (22%), Positives = 110/285 (38%), Gaps = 12/285 (4%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
               L+ ++L+ N  S  + P    N   L  L L +N     IP   F  L NL  L++
Sbjct: 54  SFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDI 111

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIP 208
             N +   + + +F+ L  L+ + + +N L   I       L  +E L L    L+    
Sbjct: 112 SENKI-VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPT 169

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL 268
           E++ + + L  L L    +      S   L  L  L++        +        NLT L
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229

Query: 269 DLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKI 327
            +++   +  +    + +   L  L++  + ++    S    L RL  + L   QL+  +
Sbjct: 230 SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VV 287

Query: 328 PPE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRL 371
            P       YL VL++  NQL          + NL+ L L  N L
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  133 bits (336), Expect = 5e-33
 Identities = 73/352 (20%), Positives = 126/352 (35%), Gaps = 41/352 (11%)

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGS 182
           +      F   +P+        + L+L  N +   + +  F     L+ + LN N +S +
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRI-KTLNQDEFASFPHLEELELNENIVS-A 70

Query: 183 IPRNV-GDLKEVEALWLFSNRLSGTIPESI-GNCYRLQELYLNENKLMGFLPESLSNLEN 240
           +      +L  +  L L SNRL   IP  +      L +L ++ENK++  L     +L N
Sbjct: 71  VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129

Query: 241 LVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKL 299
           L  L+VGDN+L   I+  +     +L  L L                  LT +       
Sbjct: 130 LKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN--------------LTSIP------ 168

Query: 300 TGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQLEGEIPDELGQL 358
                 +   L  L  L L    ++  I      +   L VL +        +       
Sbjct: 169 ----TEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223

Query: 359 SNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNN 417
            NL  L +    LT    +++  +  L +L +  N  +  +   M  EL +L+ I L   
Sbjct: 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP-ISTIEGSMLHELLRLQEIQLVGG 282

Query: 418 QFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFH 468
           Q + V P +    + L  L+   N  T  +  ++      L  L +  N   
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  133 bits (336), Expect = 6e-33
 Identities = 82/352 (23%), Positives = 128/352 (36%), Gaps = 42/352 (11%)

Query: 172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFL 231
           V  +      ++P  +    E   L L  NR+     +   +   L+EL LNEN +    
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 232 PESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPNL-GNCSSL 289
           P + +NL NL  L +  N L+  I  G      NLT LD+S N+    +   +  +  +L
Sbjct: 73  PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNL 130

Query: 290 THLDIVGSKLTGSIPS-SFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQL 347
             L++  + L   I   +F  L  L  L L +  L+  IP E L     L VL L    +
Sbjct: 131 KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNI 188

Query: 348 EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM-TEL 406
                    +L  L+ LE+           +     +L  L + + NL   +P      L
Sbjct: 189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHL 247

Query: 407 KQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQN 465
             L+ ++L  N  S +    L     L ++  +       + P    G   LRVLN    
Sbjct: 248 VYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLN---- 302

Query: 466 QFHGPIPSLLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNIS 515
                               +  NQLT  L E  F     L  L +  N ++
Sbjct: 303 --------------------VSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  132 bits (335), Expect = 7e-33
 Identities = 59/300 (19%), Positives = 109/300 (36%), Gaps = 5/300 (1%)

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
               LDL  NR          +   L  L++  + ++   P +F  L  L +L L  N+L
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 324 SGKIPPE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRI 382
              IP         LT L +  N++   +      L NL+ LE+ DN L      +   +
Sbjct: 93  K-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGL 151

Query: 383 ASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNS 442
            SLE L +   NL       ++ L  L  + L +   + +   S      L  L+  +  
Sbjct: 152 NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211

Query: 443 FTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE--FSK 500
           +   + PN  +G  L  L++            +     L  + L  N ++  +      +
Sbjct: 212 YLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHE 270

Query: 501 NPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLN 560
              L  + +    ++   P +      L  ++ S N+ + L      ++ +L TL +  N
Sbjct: 271 LLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  115 bits (289), Expect = 6e-27
 Identities = 79/410 (19%), Positives = 130/410 (31%), Gaps = 88/410 (21%)

Query: 281 PNLGNCS-SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTV 339
           P    CS     +     +   ++P   G+      LDL +N++      E     +L  
Sbjct: 4   PPRCECSAQDRAVLCHRKRFV-AVPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEE 60

Query: 340 LHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKL 399
           L L  N +    P     L NL+ L L  NRL                           +
Sbjct: 61  LELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-------------------------LI 95

Query: 400 PLEM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQL 457
           PL + T L  L  + +  N+   ++        +L  L+  +N     I      G   L
Sbjct: 96  PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSL 154

Query: 458 RVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISG 516
             L + +          L     L  + L+   +       F +   L  L++S      
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
            +  +    +NLTS+  +    + +    + +LV L  LN+S N                
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP--------------- 259

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG 636
                                    I  +  +            L +L E+QL G QL  
Sbjct: 260 -------------------------ISTIEGSMLHE--------LLRLQEIQLVGGQLA- 285

Query: 637 EIPPSIGALQDLSY--ALNLSKNGLTGRIPSDL-EKLSKLEQLDISSNNL 683
            + P   A + L+Y   LN+S N LT  +   +   +  LE L + SN L
Sbjct: 286 VVEP--YAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  114 bits (288), Expect = 8e-27
 Identities = 68/333 (20%), Positives = 122/333 (36%), Gaps = 18/333 (5%)

Query: 408 QLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQ 466
           Q + +  +  +F   +P+  GI +    LD   N     +  +       L  L + +N 
Sbjct: 12  QDRAVLCHRKRFV-AVPE--GIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENI 67

Query: 467 FHGPIPSLLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSIGN 524
                P    +   L  + L+ N+L   +P   F+    L+ LD+S N I   +     +
Sbjct: 68  VSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126

Query: 525 SINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN 584
             NL S++   N    +  +    L SL  L +   ++       LS    L V  +   
Sbjct: 127 LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186

Query: 585 LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGA 644
            +N     S +    L +L++S   +   +         L  L +    L   +P    A
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPY--LA 243

Query: 645 LQDLSY--ALNLSKNGLTGRIPSD-LEKLSKLEQLDISSNNLTGTLSP--LSNIHSLVEV 699
           ++ L Y   LNLS N ++  I    L +L +L+++ +    L   + P     ++ L  +
Sbjct: 244 VRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVL 301

Query: 700 NVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLC 732
           NVS N  T        ++          NP  C
Sbjct: 302 NVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 66.7 bits (163), Expect = 2e-11
 Identities = 30/132 (22%), Positives = 59/132 (44%), Gaps = 8/132 (6%)

Query: 77  NLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDI 135
            +S +     + P   +   L ++ ++  N +  +P   + +   L +L+LS N  +  I
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TI 263

Query: 136 PDN-FENLQNLQYLNLYGNLLDGEIPEPLFRIL-GLQYVFLNNNSLSGSIPRNV-GDLKE 192
             +    L  LQ + L G  L   +    FR L  L+ + ++ N L+ ++  +V   +  
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGN 321

Query: 193 VEALWLFSNRLS 204
           +E L L SN L+
Sbjct: 322 LETLILDSNPLA 333

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  151 bits (384), Expect = 2e-38
 Identities = 74/348 (21%), Positives = 131/348 (37%), Gaps = 46/348 (13%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
            + + T+ +  NN + ++P        L  L++S N  T  +P     L  L   +    
Sbjct: 60  PAHITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT 114

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
            L            GL  +++  N L+ S+P     L+E   L +  N+L+ ++P     
Sbjct: 115 HLPALPS-------GLCKLWIFGNQLT-SLPVLPPGLQE---LSVSDNQLA-SLPALPSE 162

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
              L +L+   N+L   LP   S L+ L    V DN L             L  L    N
Sbjct: 163 ---LCKLWAYNNQL-TSLPMLPSGLQEL---SVSDNQLA----SLPTLPSELYKLWAYNN 211

Query: 274 RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGK 333
           R +  +         L  L + G++LT S+P        L  L +S N+L+  +P     
Sbjct: 212 RLTS-LPALPSG---LKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLT-SLPMLPSG 262

Query: 334 CKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNN 393
              L  L +Y NQL   +P+ L  LS+   + L  N L+ E  +   R   +     Y+ 
Sbjct: 263 ---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR--EITSAPGYSG 315

Query: 394 NLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN 441
            ++       +  ++ + + L    +  ++P   G  +   +      
Sbjct: 316 PIIRFDMAGASAPRETRALHLAAADW--LVPAREGEPAPADRWHMFGQ 361

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  151 bits (382), Expect = 4e-38
 Identities = 72/372 (19%), Positives = 132/372 (35%), Gaps = 46/372 (12%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
            +    +++  +  +  +P  L     +  L +  N  T  +P     L+ L    + GN
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
            L   +P     +L L         L          L +   LW+F N+L+ ++P     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPS----GLCK---LWIFGNQLT-SLPVLPPG 142

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
              LQEL +++N+L   LP   S L     L   +N L   +         L  L +S N
Sbjct: 143 ---LQELSVSDNQL-ASLPALPSELCK---LWAYNNQLT-SL---PMLPSGLQELSVSDN 191

Query: 274 RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGK 333
           + +  +         L  L    ++LT S+P+   L + L  L +S N+L+  +P    +
Sbjct: 192 QLA-SLPTLPSE---LYKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLTS-LPVLPSE 242

Query: 334 CKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNN 393
              L  L +  N+L   +P        L  L ++ N+LT   P S+  ++S   + +  N
Sbjct: 243 ---LKELMVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 394 NLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCF 453
            L  +    + E+      S    +F      +     +L       +            
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA--AADWLVPAREGEPAP 352

Query: 454 GKQLRVLNMGQN 465
             +  +     N
Sbjct: 353 ADRWHMFGQEDN 364

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  144 bits (364), Expect = 8e-36
 Identities = 77/355 (21%), Positives = 137/355 (38%), Gaps = 50/355 (14%)

Query: 262 CKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN 321
                 L++  +  +  +   L     +T L I  + LT S+P+       L +L++S N
Sbjct: 39  NNGNAVLNVGESGLTT-LPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGN 91

Query: 322 QLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL--------------SNLQDLELF 367
           QL+  +P        L++       L   +P  L +L                LQ+L + 
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQELSVS 149

Query: 368 DNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSL 427
           DN+L    P      + L  L  YNN L   LP+  + L++L   S+ +NQ +  +P   
Sbjct: 150 DNQLA-SLPALP---SELCKLWAYNNQL-TSLPMLPSGLQEL---SVSDNQLA-SLPTLP 200

Query: 428 GINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK 487
                L +L   NN  T  +P        L+ L +  N+    +P L      L  +++ 
Sbjct: 201 S---ELYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLTS-LPVLPSE---LKELMVS 249

Query: 488 QNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG 547
            N+LT +LP       L  L V RN ++  +P S+ +  + T+++   N  S    Q L 
Sbjct: 250 GNRLT-SLPMLPSG--LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALR 305

Query: 548 NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSI--PSSLRSWKSL 600
            + S    +  +   + +  S   + + L     +  L+      P+    W   
Sbjct: 306 EITSAPGYSGPIIRFDMAGASAPRETRALH-LAAADWLVPAREGEPAPADRWHMF 359

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  143 bits (361), Expect = 2e-35
 Identities = 78/392 (19%), Positives = 131/392 (33%), Gaps = 67/392 (17%)

Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
            +    L++  S LT ++P      A +++L + +N L+  +P    +   L  L +  N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPE---LRTLEVSGN 91

Query: 346 QLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTE 405
           QL   +P     L  L         L           + L  L ++ N L   LP     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQL-TSLP---VL 139

Query: 406 LKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQN 465
              L+ +S+ +NQ +  +P        L +L   NN  T  +P        L+ L++  N
Sbjct: 140 PPGLQELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPS---GLQELSVSDN 191

Query: 466 QFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNS 525
           Q    +P+L      LW      N+LT +LP       L  L VS N ++ ++P      
Sbjct: 192 QLAS-LPTLPSELYKLW---AYNNRLT-SLPALPSG--LKELIVSGNRLT-SLPVLPSE- 242

Query: 526 INLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNL 585
             L  +  S N+ + L P     L+SL                            V  N 
Sbjct: 243 --LKELMVSGNRLTSL-PMLPSGLLSL---------------------------SVYRNQ 272

Query: 586 LNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGAL 645
           L   +P SL    S + + L  N  +      + E+           +       +    
Sbjct: 273 LT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRET 331

Query: 646 QDLSYALNLSKNGLTGRIPSDLEKLSKLEQLD 677
           + L  A            P+  ++     Q D
Sbjct: 332 RALHLAAADWLVPAREGEPAPADRWHMFGQED 363

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  134 bits (339), Expect = 1e-32
 Identities = 81/392 (20%), Positives = 127/392 (32%), Gaps = 96/392 (24%)

Query: 318 LSENQLSGKIPPELGKCKY--LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEF 375
             E++    +  ++  C      VL++  + L   +PD L    ++  L + DN LT   
Sbjct: 21  AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SL 76

Query: 376 PVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQ 435
           P        L  L V  N L   LP+    L +L   S        +        S L +
Sbjct: 77  PALP---PELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLPALP-------SGLCK 125

Query: 436 LDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGAL 495
           L    N  T  +P        L+ L++  NQ    +P+L                     
Sbjct: 126 LWIFGNQLT-SLPVLP---PGLQELSVSDNQLAS-LPALPSE------------------ 162

Query: 496 PEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTL 555
                   L  L    N ++ ++P        L  +  S N+ + L P     L  L   
Sbjct: 163 --------LCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLASL-PTLPSELYKLWAY 209

Query: 556 NISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP 615
           N  L     SLP+  S                            L  L +S N  T  +P
Sbjct: 210 NNRLT----SLPALPS---------------------------GLKELIVSGNRLTS-LP 237

Query: 616 TFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQ 675
              SEL+   EL + GN+L   +P     L  L    ++ +N LT R+P  L  LS    
Sbjct: 238 VLPSELK---ELMVSGNRLT-SLPMLPSGLLSL----SVYRNQLT-RLPESLIHLSSETT 288

Query: 676 LDISSNNLTGTLSPLSNIHSLVEVNVSYNLFT 707
           +++  N L+     L  +  +           
Sbjct: 289 VNLEGNPLSE--RTLQALREITSAPGYSGPII 318

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  128 bits (324), Expect = 7e-31
 Identities = 66/333 (19%), Positives = 113/333 (33%), Gaps = 65/333 (19%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNL 145
            L      L +L        +            S L  L +  N  T  +P     LQ L
Sbjct: 95  SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLPPGLQEL 146

Query: 146 QYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSG 205
                                       +++N L+ S+P    +L +   LW ++N+L+ 
Sbjct: 147 S---------------------------VSDNQLA-SLPALPSELCK---LWAYNNQLT- 174

Query: 206 TIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNL 265
           ++P        LQEL +++N+L   LP   S L  L       NN   R+         L
Sbjct: 175 SLPMLPSG---LQELSVSDNQLA-SLPTLPSELYKLWAY----NN---RLTSLPALPSGL 223

Query: 266 TFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSG 325
             L +S NR +  +         L  L + G++LT S+P    L + L SL +  NQL+ 
Sbjct: 224 KELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT- 274

Query: 326 KIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASL 385
           ++P  L      T ++L  N L  E   +  +   +     +   +              
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLS-ERTLQALR--EITSAPGYSGPIIRFDMAGASAPRET 331

Query: 386 EYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ 418
             L +   + L  +P    E        ++  +
Sbjct: 332 RALHLAAADWL--VPAREGEPAPADRWHMFGQE 362

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  144 bits (365), Expect = 7e-37
 Identities = 87/470 (18%), Positives = 166/470 (35%), Gaps = 68/470 (14%)

Query: 119 SALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNS 178
                   +          + E L  L  L+ + + +                       
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI---------------------TD 56

Query: 179 LSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNL 238
           ++G     +  L  +  L   SN ++ T+   +     L  L  + NKL       ++ L
Sbjct: 57  MTG-----IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTNL---DVTPL 105

Query: 239 ENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSK 298
             L YL+   N L         +   LT+L+ + N  +     ++ + + LT LD   +K
Sbjct: 106 TKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNK 159

Query: 299 LTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL 358
               +        +L++LD S N+++     ++ + K L  L+   N +  ++   L Q 
Sbjct: 160 KITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQN 211

Query: 359 SNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ 418
             L  L+   N+LT E  V+   +  L Y     N L     L+++ L +L  +      
Sbjct: 212 IQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTD 265

Query: 419 FSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSL-LGS 477
              +    L  N+ L+           E+  ++    QL +L+         I  L L  
Sbjct: 266 LLEI---DLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAG----ITELDLSQ 316

Query: 478 CPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNK 537
            P L  + L   +LT  L   S N  L  L     +I     SS+G    L +   +  +
Sbjct: 317 NPKLVYLYLNNTELT-ELD-VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQ 372

Query: 538 FSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLN 587
              +  + L N    +T+ +S + ++        +  +  V+D + N + 
Sbjct: 373 TITMPKETLTNN--SLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  141 bits (357), Expect = 8e-36
 Identities = 84/460 (18%), Positives = 155/460 (33%), Gaps = 45/460 (9%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
              L+ L ++D  +++ + ++   +   + L  L  ++N  T  +        NL YL  
Sbjct: 38  EEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92

Query: 151 YGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
             N L       +  +  L Y+  + N L+     +V     +  L    N L+  I   
Sbjct: 93  DSNKLTN---LDVTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT-EID-- 143

Query: 211 IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDL 270
           + +  +L EL  + NK +  L   ++    L  LD   N +   ++    + K L  L+ 
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE-LDVS--QNKLLNRLNC 198

Query: 271 SYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE 330
             N  +     +L     LT LD   +KLT  I      L +L+  D S N L+ ++   
Sbjct: 199 DTNNIT---KLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD-- 249

Query: 331 LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLV 390
           +     LT LH     L  EI   L   + L   +    R   E  V+      L  L  
Sbjct: 250 VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVTHNT--QLYLLDC 304

Query: 391 YNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPN 450
               +     L++++  +L  + L N + + +    +  N+ L  L  +N     +    
Sbjct: 305 QAAGI---TELDLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQ-DFSS- 356

Query: 451 LCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTG----ALPEFSKNPVLSH 506
           +     L      + Q        L +      V        G      P        + 
Sbjct: 357 VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQAT 416

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQEL 546
             ++  N+S   P+      +       +       PQ +
Sbjct: 417 NTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQPI 456

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  136 bits (344), Expect = 4e-34
 Identities = 74/369 (20%), Positives = 138/369 (37%), Gaps = 40/369 (10%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
             I  L+ L  +  +SNN +  +   L   + L YL   +N  T ++      L  L YL
Sbjct: 58  TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111

Query: 149 NLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIP 208
           N   N L       + +   L Y+    N+L+  I   V    ++  L    N+    + 
Sbjct: 112 NCDTNKL---TKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL 268
             +    +L  L  + NK+       +S  + L  L+   NN+  +++    +   LTFL
Sbjct: 166 --VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLDLN--QNIQLTFL 217

Query: 269 DLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIP 328
           D S N+ +     ++   + LT+ D   + LT  +  S   L++L++L   +  L  +I 
Sbjct: 218 DCSSNKLT---EIDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL-EID 270

Query: 329 PELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL 388
             L     L        +   E+  ++   + L  L+     +T    + + +   L YL
Sbjct: 271 --LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYL 323

Query: 389 LVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIP 448
            + N  L  +L +  +   +LK++S  N          +G   +L             +P
Sbjct: 324 YLNNTELT-ELDV--SHNTKLKSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTI-TMP 377

Query: 449 PNLCFGKQL 457
                   L
Sbjct: 378 KETLTNNSL 386

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  127 bits (322), Expect = 3e-31
 Identities = 78/406 (19%), Positives = 152/406 (37%), Gaps = 40/406 (9%)

Query: 313 LSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT 372
            +S   +  ++         +   LT L  + + +       + +L+ L  L    N +T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77

Query: 373 GEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSS 432
               +S  +  +L YL   +N L     L++T L +L  ++   N+ + +    +  N  
Sbjct: 78  -TLDLS--QNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKL---DVSQNPL 128

Query: 433 LMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLT 492
           L  L+   N+ T EI  +     QL  L+   N+    +   +     L  +    N++T
Sbjct: 129 LTYLNCARNTLT-EIDVSHN--TQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

Query: 493 GALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSL 552
               + S+N +L+ L+   NNI+  +   +  +I LT +D SSNK + +   ++  L  L
Sbjct: 184 EL--DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQL 235

Query: 553 VTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG 612
              + S+N +   L   +S    L         L   I  +     +  ++         
Sbjct: 236 TYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EIDLT----HNTQLIYFQAEGCRK 287

Query: 613 GIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSK 672
                ++   +L  L      +  E+   +     L Y L L+   LT  +  D+   +K
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVY-LYLNNTELT-EL--DVSHNTK 340

Query: 673 LEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLL 718
           L+ L   + ++    S +  I +L     +         ETL N  
Sbjct: 341 LKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPKETLTNNS 385

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  115 bits (291), Expect = 2e-27
 Identities = 75/349 (21%), Positives = 127/349 (36%), Gaps = 35/349 (10%)

Query: 359 SNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ 418
            N          +     +S  ++A+L  L  +N+++     +E  +L  L  +   +N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIE--KLTGLTKLICTSNN 75

Query: 419 FSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSC 478
            + +    L  N++L  L   +N  T  +        +L  LN   N+    +   +   
Sbjct: 76  ITTL---DLSQNTNLTYLACDSNKLT-NLDVTPL--TKLTYLNCDTNKLT-KLD--VSQN 126

Query: 479 PTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKF 538
           P L  +   +N LT    + S N  L+ LD   N     +   +     LT++D S NK 
Sbjct: 127 PLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182

Query: 539 SGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWK 598
           + L   ++     L  LN   N++   L   L++   L   D S N L   I   +    
Sbjct: 183 TEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLT 233

Query: 599 SLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNG 658
            L+    S N  T  +   +S L KL  L      L  EI   +     L   +     G
Sbjct: 234 QLTYFDCSVNPLTE-LD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQL---IYFQAEG 284

Query: 659 LTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFT 707
                  D+   ++L  LD  +  +T  L  LS    LV + ++    T
Sbjct: 285 CRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT 331

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  109 bits (273), Expect = 4e-25
 Identities = 54/338 (15%), Positives = 106/338 (31%), Gaps = 30/338 (8%)

Query: 90  EIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLN 149
           ++ H ++L  +D   N         +   + L  LD S N  T ++       + L  LN
Sbjct: 143 DVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLN 197

Query: 150 LYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPE 209
              N +  ++   L + + L ++  ++N L+  I   V  L ++       N L+  +  
Sbjct: 198 CDTNNIT-KL--DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDV 250

Query: 210 SIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD 269
           S     +L  L+  +  L+      L++   L+Y           ++        L  LD
Sbjct: 251 S--TLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKELDVT--HNTQLYLLD 303

Query: 270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP 329
                 +     +L     L +L +  ++LT  +        +L SL      +      
Sbjct: 304 CQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD--FS 355

Query: 330 ELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLL 389
            +GK   L        Q    +P E    ++L         L  +F   +        + 
Sbjct: 356 SVGKIPALNNNFEAEGQTI-TMPKETLTNNSL--TIAVSPDLLDQFGNPMNIEPGDGGVY 412

Query: 390 VYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSL 427
               N +    L           +  N    G +    
Sbjct: 413 DQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPF 450

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 74.7 bits (184), Expect = 5e-14
 Identities = 44/230 (19%), Positives = 80/230 (34%), Gaps = 19/230 (8%)

Query: 488 QNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG 547
           +   T +  ++  +   +    +   +      S      LTS+D  ++  + +    + 
Sbjct: 4   KAGQTQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIE 61

Query: 548 NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSE 607
            L  L  L  + N++  +L   LS+  NL       N L  ++   +     L+ L    
Sbjct: 62  KLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDT 115

Query: 608 NHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDL 667
           N  T  +   +S+   L  L    N L  EI   +     L+  L+   N        D+
Sbjct: 116 NKLT-KLD--VSQNPLLTYLNCARNTL-TEID--VSHNTQLTE-LDCHLNKKIT--KLDV 166

Query: 668 EKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
              ++L  LD S N +T     +S    L  +N   N  T       + L
Sbjct: 167 TPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNITKLDLNQNIQL 214

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.7 bits (119), Expect = 4e-06
 Identities = 25/176 (14%), Positives = 49/176 (27%), Gaps = 11/176 (6%)

Query: 68  DDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLS 127
           D  HN       + G       ++ H ++L  +D  +   +  +   L     L YL L+
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLN 326

Query: 128 TNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV 187
               T ++     +   L+ L+     +  +    + +I  L   F             +
Sbjct: 327 NTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETL 381

Query: 188 GDLKEVEALWLFSNRLSG---TIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
            +     A+        G    I    G  Y      +    L    P       +
Sbjct: 382 TNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTS 437

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  139 bits (352), Expect = 3e-36
 Identities = 61/290 (21%), Positives = 112/290 (38%), Gaps = 29/290 (10%)

Query: 97  LQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNL 154
              +DL +N  +  I      N   L  L L  N  +  I    F  L  L+ L L  N 
Sbjct: 54  TALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111

Query: 155 LDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRL-SGTIPESI- 211
           L  E+PE + +   LQ + ++ N ++  + ++V   L ++  + L +N L S  I     
Sbjct: 112 LK-ELPEKMPK--TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167

Query: 212 GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDL 270
               +L  + + +  +         +L  L +LD   N +  +++  S +   NL  L L
Sbjct: 168 QGMKKLSYIRIADTNITTIPQGLPPSLTEL-HLD--GNKIT-KVDAASLKGLNNLAKLGL 223

Query: 271 SYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP 329
           S+N  S  +    L N   L  L +  +KL   +P        +  + L  N +S  I  
Sbjct: 224 SFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS 280

Query: 330 E-------LGKCKYLTVLHLYANQLE-GEIPDEL-GQLSNLQDLELFDNR 370
                     K    + + L++N ++  EI       +     ++L + +
Sbjct: 281 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  133 bits (336), Expect = 4e-34
 Identities = 75/334 (22%), Positives = 135/334 (40%), Gaps = 50/334 (14%)

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD 156
           L+ +  S       +P  L        LDL  N  T     +F+NL+NL  L L  N + 
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI- 88

Query: 157 GEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCY 215
            +I    F  L  L+ ++L+ N L   +P             +                 
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELPEK-----------MPKT-------------- 122

Query: 216 RLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL-EGRINFGS-EKCKNLTFLDLSYN 273
            LQEL ++EN++        + L  ++ +++G N L    I  G+ +  K L+++ ++  
Sbjct: 123 -LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181

Query: 274 RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS-SFGLLARLSSLDLSENQLSGKIPPE-L 331
             +  I   L    SLT L + G+K+T  + + S   L  L+ L LS N +S  +    L
Sbjct: 182 NIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSL 236

Query: 332 GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT----GEF--PVSIWRIASL 385
               +L  LHL  N+L  ++P  L     +Q + L +N ++     +F  P    + AS 
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASY 295

Query: 386 EYLLVYNNNL-LGKLPLEM-TELKQLKNISLYNN 417
             + +++N +   ++       +     + L N 
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  123 bits (311), Expect = 7e-31
 Identities = 63/309 (20%), Positives = 124/309 (40%), Gaps = 24/309 (7%)

Query: 169 LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLM 228
           L+ V  ++  L   +P+++    +   L L +N+++        N   L  L L  NK+ 
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 229 GFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPN-LGNCS 287
              P + + L  L  L +  N L+       +  K L  L +  N  +  +  +     +
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK---ELPEKMPKTLQELRVHENEIT-KVRKSVFNGLN 145

Query: 288 SLTHLDIVGSKLTGSI--PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
            +  +++  + L  S     +F  + +LS + +++  ++  IP  L     LT LHL  N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202

Query: 346 QLEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMT 404
           ++  ++    L  L+NL  L L  N ++     S+     L  L + NN L+ K+P  + 
Sbjct: 203 KIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260

Query: 405 ELKQLKNISLYNNQFSGVIPQSLGIN------SSLMQLDFINNSFT-GEIPPNLCFG-KQ 456
           + K ++ + L+NN  S +              +S   +   +N     EI P+       
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320

Query: 457 LRVLNMGQN 465
              + +G  
Sbjct: 321 RAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  110 bits (277), Expect = 2e-26
 Identities = 48/239 (20%), Positives = 94/239 (39%), Gaps = 17/239 (7%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
            L KL+ + LS N     +P K+     L+ L +  N  T      F  L  +  + L  
Sbjct: 98  PLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154

Query: 153 NLL-DGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
           N L    I    F+ +  L Y+ + + +++ +IP+ +     +  L L  N+++     S
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS 211

Query: 211 IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDL 270
           +     L +L L+ N +      SL+N  +L  L + +N L  ++  G    K +  + L
Sbjct: 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270

Query: 271 SYNRFSG------GISPNLGNCSSLTHLDIVGSKLTGSI--PSSFGLLARLSSLDLSEN 321
             N  S                +S + + +  + +      PS+F  +   +++ L   
Sbjct: 271 HNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 99.7 bits (249), Expect = 9e-23
 Identities = 59/313 (18%), Positives = 111/313 (35%), Gaps = 31/313 (9%)

Query: 264 NLTFLDLSYNRFS---GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSE 320
           +L  +  S          + P+         LD+  +K+T      F  L  L +L L  
Sbjct: 32  HLRVVQCSDLGLEKVPKDLPPDT------ALLDLQNNKITEIKDGDFKNLKNLHTLILIN 85

Query: 321 NQLSGKIPPE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI 379
           N++S KI P        L  L+L  NQL+ E+P+++     LQ+L + +N +T       
Sbjct: 86  NKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVF 141

Query: 380 WRIASLEYLLVYNNNL-LGKLPLEM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLD 437
             +  +  + +  N L    +       +K+L  I + +   + +         SL +L 
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP---PSLTELH 198

Query: 438 FINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALP 496
              N  T ++      G   L  L +  N         L + P L  + L  N+L   +P
Sbjct: 199 LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256

Query: 497 E-FSKNPVLSHLDVSRNNISG------AIPSSIGNSINLTSIDFSSNK--FSGLMPQELG 547
              + +  +  + +  NNIS         P       + + +   SN   +  + P    
Sbjct: 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 316

Query: 548 NLVSLVTLNISLN 560
            +     + +   
Sbjct: 317 CVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 53/305 (17%), Positives = 110/305 (36%), Gaps = 36/305 (11%)

Query: 440 NNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-F 498
           +     ++P +L       +L++  N+          +   L  +IL  N+++   P  F
Sbjct: 40  DLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 96

Query: 499 SKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNIS 558
           +    L  L +S+N +   +P  +     L  +    N+ + +       L  ++ + + 
Sbjct: 97  APLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELG 153

Query: 559 LNHVEGSL--PSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPT 616
            N ++ S          K L    ++   +  +IP  L    SL+ L L  N  T  +  
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKITK-VDA 209

Query: 617 FI-SELEKLLELQLGGNQLGGEIPPSIGALQDLSY--ALNLSKNGLTGRIPSDLEKLSKL 673
                L  L +L L  N +   +    G+L +  +   L+L+ N L  ++P  L     +
Sbjct: 210 ASLKGLNNLAKLGLSFNSIS-AVDN--GSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265

Query: 674 EQLDISSNNLT-------GTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFS 726
           + + + +NN++             +   S   V++  N      P     +    PS+F 
Sbjct: 266 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN------PVQYWEI---QPSTFR 316

Query: 727 GNPSL 731
                
Sbjct: 317 CVYVR 321

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 36/146 (24%), Positives = 57/146 (39%), Gaps = 15/146 (10%)

Query: 92  GHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLN 149
           G    L  + L  N  +  +    L   + L  L LS N  +  + +    N  +L+ L+
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELH 246

Query: 150 LYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV-------GDLKEVEALWLFSNR 202
           L  N L  ++P  L     +Q V+L+NN++S +I  N                + LFSN 
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNP 304

Query: 203 LSGT-IPESIGNC-YRLQELYLNENK 226
           +    I  S   C Y    + L   K
Sbjct: 305 VQYWEIQPSTFRCVYVRAAVQLGNYK 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  136 bits (345), Expect = 3e-35
 Identities = 60/289 (20%), Positives = 113/289 (39%), Gaps = 28/289 (9%)

Query: 97  LQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNL 154
              +DL +N+ S  +          L  L L  N  +  I +  F  L+ LQ L +  N 
Sbjct: 56  TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNH 113

Query: 155 LDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRL-SGTIPESIG 212
           L  EIP  L     L  + +++N +   +P+ V   L+ +  + +  N L +        
Sbjct: 114 LV-EIPPNLPS--SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169

Query: 213 NCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLS 271
           +  +L  L ++E KL G   +    L  L +LD   N ++  I      +   L  L L 
Sbjct: 170 DGLKLNYLRISEAKLTGIPKDLPETLNEL-HLD--HNKIQ-AIELEDLLRYSKLYRLGLG 225

Query: 272 YNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE 330
           +N+    I    L    +L  L +  +KL+  +P+    L  L  + L  N ++ K+   
Sbjct: 226 HNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

Query: 331 -------LGKCKYLTVLHLYANQLE-GEIPDELGQ-LSNLQDLELFDNR 370
                    K  Y   + L+ N +   E+     + +++   ++  + +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  119 bits (301), Expect = 2e-29
 Identities = 68/310 (21%), Positives = 124/310 (40%), Gaps = 25/310 (8%)

Query: 169 LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLM 228
           L+ V  ++  L  ++P+ +    +   L L +N +S    +       L  L L  NK+ 
Sbjct: 35  LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 229 GFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPN-LGNCS 287
               ++ S L  L  L +  N+L            +L  L +  NR    +         
Sbjct: 92  KIHEKAFSPLRKLQKLYISKNHLV---EIPPNLPSSLVELRIHDNRIR-KVPKGVFSGLR 147

Query: 288 SLTHLDIVGSKLTGSI--PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
           ++  +++ G+ L  S   P +F  L +L+ L +SE +L+  IP +L   + L  LHL  N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203

Query: 346 QLEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMT 404
           +++  I  E L + S L  L L  N++      S+  + +L  L + NN  L ++P  + 
Sbjct: 204 KIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK-LSRVPAGLP 261

Query: 405 ELKQLKNISLYNNQFSGVIPQS------LGINSSLMQLDFINNSFT-GEIPPNLCFG-KQ 456
           +LK L+ + L+ N  + V              +    +   NN     E+ P        
Sbjct: 262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321

Query: 457 LRVLNMGQNQ 466
              +  G  +
Sbjct: 322 RLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  112 bits (282), Expect = 5e-27
 Identities = 52/240 (21%), Positives = 94/240 (39%), Gaps = 18/240 (7%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
            L KLQ + +S N+    IPP L   S+L  L +  N         F  L+N+  + + G
Sbjct: 100 PLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156

Query: 153 NLL-DGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESI 211
           N L +       F  L L Y+ ++   L+  IP+++   + +  L L  N++     E +
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDL 213

Query: 212 GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLS 271
               +L  L L  N++      SLS L  L  L + +N L  R+  G    K L  + L 
Sbjct: 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272

Query: 272 YNRFSGGISPN-------LGNCSSLTHLDIVGSKLTGSI--PSSFGLLARLSSLDLSENQ 322
            N  +  +  N           +    + +  + +      P++F  +    ++     +
Sbjct: 273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 90.5 bits (225), Expect = 1e-19
 Identities = 57/312 (18%), Positives = 108/312 (34%), Gaps = 35/312 (11%)

Query: 432 SLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQL 491
            L  +   +      +P  +       +L++  N               L+ ++L  N++
Sbjct: 34  HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 492 TGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLV 550
           +    + FS    L  L +S+N++   IP ++    +L  +    N+   +       L 
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147

Query: 551 SLVTLNISLNHV-EGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENH 609
           ++  + +  N +              L    +S   L   IP  L   ++L+ L L  N 
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNK 204

Query: 610 FTGGIPTFI-SELEKLLELQLGGNQLGGEIPPSIGALQDLSY--ALNLSKNGLTGRIPSD 666
               I         KL  L LG NQ+   I    G+L  L     L+L  N L+ R+P+ 
Sbjct: 205 IQA-IELEDLLRYSKLYRLGLGHNQIR-MIEN--GSLSFLPTLRELHLDNNKLS-RVPAG 259

Query: 667 LEKLSKLEQLDISSNNLT-------GTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLG 719
           L  L  L+ + + +NN+T         +           +++  N      P     +  
Sbjct: 260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNN------PVPYWEV-- 311

Query: 720 PSPSSFSGNPSL 731
             P++F      
Sbjct: 312 -QPATFRCVTDR 322

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 57/255 (22%), Positives = 100/255 (39%), Gaps = 21/255 (8%)

Query: 472 PSLLGSCPT-----LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSI 526
           P+    CP      L  V      L     E S +   + LD+  N+IS           
Sbjct: 21  PTYSAMCPFGCHCHLRVVQCSDLGLKAVPKEISPD--TTLLDLQNNDISELRKDDFKGLQ 78

Query: 527 NLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLL 586
           +L ++   +NK S +  +    L  L  L IS NH+   +P  L    +L    +  N +
Sbjct: 79  HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRI 135

Query: 587 NGSIPSSLRSWKSLSILKLSENHFT-GGIPTFISELEKLLELQLGGNQLGGEIPPSIGAL 645
                      ++++ +++  N     G      +  KL  L++   +L   IP      
Sbjct: 136 RKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPK--DLP 192

Query: 646 QDLSYALNLSKNGLTGRIPS-DLEKLSKLEQLDISSNNLTGTLSP--LSNIHSLVEVNVS 702
           + L+  L+L  N +   I   DL + SKL +L +  N +   +    LS + +L E+++ 
Sbjct: 193 ETLNE-LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLD 249

Query: 703 YNLFTGPVPETLMNL 717
            N  +  VP  L +L
Sbjct: 250 NNKLSR-VPAGLPDL 263

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 73.1 bits (180), Expect = 8e-14
 Identities = 30/146 (20%), Positives = 49/146 (33%), Gaps = 15/146 (10%)

Query: 92  GHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLN 149
                L  + L  N     I  + L   S L  L L  N     I +     L  L+ L+
Sbjct: 190 DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELH 247

Query: 150 LYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV-------GDLKEVEALWLFSNR 202
           L  N L   +P  L  +  LQ V+L+ N+++  +  N                + LF+N 
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305

Query: 203 LS-GTIPESIGNC-YRLQELYLNENK 226
           +    +  +   C      +     K
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNYK 331

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  134 bits (340), Expect = 5e-35
 Identities = 55/218 (25%), Positives = 99/218 (45%), Gaps = 28/218 (12%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +GRG  G+V++A +   +  +A+K++     +     + RE++ + K+ H  +VR  + 
Sbjct: 12   CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 885  WLRKDCG-------------IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHA 931
            WL K+               I M +     +L+D ++        E +V   I L  A A
Sbjct: 72   WLEKNTTEKLQPSSPKVYLYIQM-QLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS----------PASTTS 981
            + +LH      ++HRD+KP NI    +    + DFG+   +D+           PA    
Sbjct: 131  VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               VGT  Y++PE     + S + D++S G++L EL+ 
Sbjct: 188  TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  134 bits (338), Expect = 2e-33
 Identities = 85/382 (22%), Positives = 141/382 (36%), Gaps = 41/382 (10%)

Query: 97  LQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNL 154
           +  +DLS N+ +  +          L++L +        I +N F  L +L  L L  N 
Sbjct: 32  VNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSL-SGSIPRNV-GDLKEVEALWLFSNRLSGTIPESI 211
              ++    F  L  L+ + L   +L    +  N    L  +E L L  N +    P S 
Sbjct: 91  FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 212 -GNCYRLQELYLNENKLMGFLPESLSNLE--NLVYLDVGDNNLE--GRINFGSEKC---- 262
             N  R   L L  NK+     E L N +  +   L +    L+       G EKC    
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209

Query: 263 --KNLTFLDLSYNR--------FSGGISPNLGNCSSLTHLDIVGSKLTGSI-----PSSF 307
              ++T LDLS N         F   I+        L++   +GS    +        +F
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269

Query: 308 GLLAR--LSSLDLSENQLSGKIPPEL-GKCKYLTVLHLYANQLEGEIPDE-LGQLSNLQD 363
             L    + + DLS++++   +   +      L  L L  N++  +I D     L++L  
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327

Query: 364 LELFDNRLTGEFPVSI-WRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQFSG 421
           L L  N L       +   +  LE L +  N+ +  L  +    L  LK ++L  NQ   
Sbjct: 328 LNLSQNFLG-SIDSRMFENLDKLEVLDLSYNH-IRALGDQSFLGLPNLKELALDTNQLKS 385

Query: 422 VIPQSLGINSSLMQLDFINNSF 443
           V        +SL ++    N +
Sbjct: 386 VPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  124 bits (314), Expect = 2e-30
 Identities = 73/363 (20%), Positives = 127/363 (34%), Gaps = 43/363 (11%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKL-GNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
            L  LQ + +        I        S+L  L L  N F   +    F  L NL+ L L
Sbjct: 52  RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTL 110

Query: 151 YGNLL-DGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSNRLSGTI 207
               L    +    F+ L  L+ + L +N++    P +    ++    L L  N++  +I
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SI 169

Query: 208 PESI---GNCYRLQELYLNENKL--------MGFLPESLSNLENLVYLDVGDNNLEGRIN 256
            E             L L+   L              +     ++  LD+  N  +  + 
Sbjct: 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA 229

Query: 257 ---FGSEKCKNLTFLDLSYNR-----FSGGISPNLGNC-------SSLTHLDIVGSKLTG 301
              F +     +  L LS +      F      +  N        S +   D+  SK+  
Sbjct: 230 KRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF- 288

Query: 302 SIPS-SFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQLEGEIPDEL-GQL 358
           ++    F     L  L L++N+++ KI         +L  L+L  N L G I   +   L
Sbjct: 289 ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENL 346

Query: 359 SNLQDLELFDNRLTGEFPVSI-WRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYN 416
             L+ L+L  N +           + +L+ L +  N  L  +P  +   L  L+ I L+ 
Sbjct: 347 DKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQ-LKSVPDGIFDRLTSLQKIWLHT 404

Query: 417 NQF 419
           N +
Sbjct: 405 NPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  117 bits (296), Expect = 6e-28
 Identities = 69/379 (18%), Positives = 125/379 (32%), Gaps = 40/379 (10%)

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRF 275
           +  + L+ N +      S S L++L +L V        I   +     +L  L L YN+F
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91

Query: 276 SGGISPN-LGNCSSLTHLDIVGSKLTGSI--PSSFGLLARLSSLDLSENQLSGKIPPE-- 330
              +        ++L  L +    L G++   + F  L  L  L L +N +  KI P   
Sbjct: 92  L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASF 149

Query: 331 LGKCKYLTVLHLYANQLEGEIPDELGQL--SNLQDLELFDNRLTGEFPVSI--------W 380
               +   VL L  N+++    ++L      +   L L    L       +        +
Sbjct: 150 FLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPF 209

Query: 381 RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGIN---------- 430
           +  S+  L +  N     +     +      I       S  +  S G            
Sbjct: 210 KNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269

Query: 431 -----SSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTLWRV 484
                S +   D   +     +  ++      L  L + QN+ +    +       L ++
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328

Query: 485 ILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSI-GNSINLTSIDFSSNKFSGL 541
            L QN L  ++    F     L  LD+S N+I  A+         NL  +   +N+   +
Sbjct: 329 NLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSV 386

Query: 542 MPQELGNLVSLVTLNISLN 560
                  L SL  + +  N
Sbjct: 387 PDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  110 bits (278), Expect = 1e-25
 Identities = 78/425 (18%), Positives = 136/425 (32%), Gaps = 69/425 (16%)

Query: 287 SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPEL-GKCKYLTVLHLYAN 345
           + + ++D+  + +     +SF  L  L  L + +      I          L +L L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 346 QLEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM- 403
           Q   ++       L+NL+ L L    L G                         L     
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAV-----------------------LSGNFF 125

Query: 404 TELKQLKNISLYNNQFSGVIPQSLGIN-SSLMQLDFINNSFTGEIPPNL---CFGKQLRV 459
             L  L+ + L +N    + P S  +N      LD   N     I         GK   +
Sbjct: 126 KPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTL 184

Query: 460 LNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIP 519
           L +            L      W    K            KN  ++ LD+S N    ++ 
Sbjct: 185 LRLSSIT--------LQDMNEYWLGWEKCGN-------PFKNTSITTLDLSGNGFKESMA 229

Query: 520 SSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVF 579
               ++I  T       K   L+     N+ S        +    +      +   ++  
Sbjct: 230 KRFFDAIAGT-------KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG--LEASGVKTC 280

Query: 580 DVSFNLLNGSIPSSLRSW-KSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEI 638
           D+S + +  ++  S+ S    L  L L++N            L  LL+L L  N L G I
Sbjct: 281 DLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSI 338

Query: 639 PPSIGALQDLSY--ALNLSKNGLTGRIPSDL-EKLSKLEQLDISSNNLT----GTLSPLS 691
                  ++L     L+LS N +   +       L  L++L + +N L     G    L+
Sbjct: 339 DS--RMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLT 395

Query: 692 NIHSL 696
           ++  +
Sbjct: 396 SLQKI 400

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 68.6 bits (168), Expect = 4e-12
 Identities = 43/174 (24%), Positives = 73/174 (41%), Gaps = 14/174 (8%)

Query: 33  LLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEI- 91
           + SL+   +          N  D     + G+E    A  V + +LS   +   L   + 
Sbjct: 241 IQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE----ASGVKTCDLSKSKIF-ALLKSVF 295

Query: 92  GHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLN 149
            H + L+ + L+ N  +  I        + L  L+LS N     I    FENL  L+ L+
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLD 353

Query: 150 LYGNLLDGEIPEPLFRIL-GLQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
           L  N +   + +  F  L  L+ + L+ N L  S+P  + D L  ++ +WL +N
Sbjct: 354 LSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  129 bits (327), Expect = 2e-33
 Identities = 62/290 (21%), Positives = 112/290 (38%), Gaps = 56/290 (19%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            +IG G  G V+KA        + +K++     K  +   +RE++ + K+ H N+V     
Sbjct: 18   LIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 885  WLRKDCG-----------------IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            W   D                   I M  + + G+L   +         +      +   
Sbjct: 73   WDGFDYDPETSSKNSSRSKTKCLFIQM-EFCDKGTLEQWIEKRRGEKLDKVLALE-LFEQ 130

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
                + Y+H      +++RD+KP NI L    +  I DFG+   L      T      GT
Sbjct: 131  ITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR---SKGT 184

Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            + Y++PE   +    KE D+Y+ G++L EL+     +  +  E +               
Sbjct: 185  LRYMSPEQISSQDYGKEVDLYALGLILAELLH----VCDTAFETSKF------------- 227

Query: 1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              D+ D  +  ++     +  ++  LL       KKP +RPN  +++R L
Sbjct: 228  FTDLRDGII-SDIFDKKEKT-LLQKLL------SKKPEDRPNTSEILRTL 269

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  129 bits (325), Expect = 5e-33
 Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 42/278 (15%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED 883
             IGRG+   VYK          A  +L  R   +      K E + +  ++H N+VR  D
Sbjct: 33   EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 884  FWLRKDCG-----IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
             W     G     ++    M +G+L+  L        ++  V           L +LH  
Sbjct: 93   SWESTVKGKKCIVLVT-ELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH-T 147

Query: 939  CDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--- 994
              PPI+HRD+K +NI +        I D G+A L   S A     +V+GT  ++APE   
Sbjct: 148  RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE 203

Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054
              +  +     DVY++G+ +LE+ T +      Y E  +     R V S  +        
Sbjct: 204  EKYDES----VDVYAFGMCMLEMATSE----YPYSECQNAAQIYRRVTSGVKPA------ 249

Query: 1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRD 1092
               +++ +  +++ +         C  +    R +++D
Sbjct: 250  -SFDKVAIPEVKEII-------EGCIRQNKDERYSIKD 279

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  135 bits (341), Expect = 8e-33
 Identities = 61/285 (21%), Positives = 98/285 (34%), Gaps = 55/285 (19%)

Query: 826  VIGRGAHGIVYKA---SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
             I  G  G +Y A   ++    V  +K L   G          E Q + ++ H ++V++ 
Sbjct: 87   CIAHGGLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 883  DFWLRKDCGIIMYRY--ME--NG-SLRDVLHS-ITPPPTLEWNVRYKIALGAAHALAYLH 936
            +F    D       Y  ME   G SL+      +     +         L    AL+YLH
Sbjct: 146  NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------YLLEILPALSYLH 199

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
                  +V+ D+KPENI+L  E +  + D G    ++          + GT G+ APE  
Sbjct: 200  ---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPEIV 249

Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056
              T  +  +D+Y+ G  L  L       +  Y +                         L
Sbjct: 250  -RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------------GL 284

Query: 1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-NMRDVVRQLVDA 1100
             E+  V    D    +L    R  +  P  R     ++  QL   
Sbjct: 285  PEDDPVLKTYDSYGRLL---RRAIDPDPRQRFTTAEEMSAQLTGV 326

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  128 bits (324), Expect = 1e-32
 Identities = 77/311 (24%), Positives = 127/311 (40%), Gaps = 67/311 (21%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSM--------KREIQTIGKIRHRN 877
            +G G    V+ A  L  +   AVK L      R  L+         +RE Q    + H  
Sbjct: 20   LGFGGMSEVHLARDLRDHRDVAVKVL------RADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 878  LVRLEDF-WLRKDCGIIMYRYME--NG-SLRDVLHS---ITPPPTLEWNVRYKIALGAAH 930
            +V + D        G + Y  ME  +G +LRD++H+   +TP   +E      +   A  
Sbjct: 74   IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQ 127

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI-SVVGTIG 989
            AL + H      I+HRD+KP NI++ +     + DFGIA+ +  S  S T   +V+GT  
Sbjct: 128  ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184

Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKK------ALDPSYKERTDIVGWVRSVWS 1043
            Y++PE A   +    SDVYS G VL E++T +        +  +Y+   +      +   
Sbjct: 185  YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 244

Query: 1044 D-TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN----MRDVVRQLV 1098
              + +++ +V                        L+   K P NR      MR  + ++ 
Sbjct: 245  GLSADLDAVV------------------------LKALAKNPENRYQTAAEMRADLVRVH 280

Query: 1099 DASVPMTSKYV 1109
            +   P   K +
Sbjct: 281  NGEPPEAPKVL 291

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (323), Expect = 1e-32
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 44/214 (20%)

Query: 826  VIGRGAHGIVYKA--SLGPNAVFAVKKL--------AFRGHKRGSLSMKREIQTIGKIRH 875
            ++GRG  G VY+A  ++    V A+K +         FR   R    M+RE +T G+++ 
Sbjct: 41   LVGRGGMGDVYEAEDTVRERIV-ALKLMSETLSSDPVFR--TR----MQREARTAGRLQE 93

Query: 876  RNLVRLEDFWLRKDCG-------IIMYRYMENGSLRDVLHS---ITPPPTLEWNVRYKIA 925
             ++V + DF      G       + M R +    L  +L     + PP  +       I 
Sbjct: 94   PHVVPIHDF------GEIDGQLYVDM-RLINGVDLAAMLRRQGPLAPPRAVA------IV 140

Query: 926  LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
                 AL   H        HRD+KPENIL+ ++   ++ DFGIA        +    + V
Sbjct: 141  RQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG-NTV 196

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            GT+ Y+APE    +  +  +D+Y+   VL E +T
Sbjct: 197  GTLYYMAPERFSESHATYRADIYALTCVLYECLT 230

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (319), Expect = 3e-32
 Identities = 79/306 (25%), Positives = 128/306 (41%), Gaps = 62/306 (20%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSM--------KREIQTIGKIRHRN 877
            +G G    VY A     N   A+K +                    +RE+    ++ H+N
Sbjct: 19   LGGGGMSTVYLAEDTILNIKVAIKAI------FIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 878  LVRLEDFWLRKDCG-IIMYRYMENGSLRDVLHS---ITPPPTLEWNVRYKIALGAAHALA 933
            +V + D     DC  ++M  Y+E  +L + + S   ++    +               + 
Sbjct: 73   IVSMIDVDEEDDCYYLVM-EYIEGPTLSEYIESHGPLSVDTAIN------FTNQILDGIK 125

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            + H   D  IVHRDIKP+NIL+DS     I DFGIAK L ++  + T+  V+GT+ Y +P
Sbjct: 126  HAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN-HVLGTVQYFSP 181

Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKK------ALDPSYKERTDIVGWVRSVWSDTEE 1047
            E A   A  + +D+YS G+VL E++  +       A+  + K   D V  V +      +
Sbjct: 182  EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT------D 235

Query: 1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN----MRDVVRQLVDASVP 1103
            +   +  SL            VI      LR TEK  +NR      M+D +  ++  +  
Sbjct: 236  VRKDIPQSL----------SNVI------LRATEKDKANRYKTIQEMKDDLSSVLHENRA 279

Query: 1104 MTSKYV 1109
                Y 
Sbjct: 280  NEDVYE 285

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  126 bits (319), Expect = 4e-32
 Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 40/224 (17%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            V+G+GA G V KA +   +  +A+KK+     K  ++    E+  +  + H+ +VR    
Sbjct: 13   VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI--LSEVMLLASLNHQYVVRYYAA 70

Query: 885  WLRKDCG--------------IIMYRYMENGSLRDVLHS--ITPPPTLEWNVRYKIALGA 928
            WL +                 I M  Y ENG+L D++HS  +       W +  +I    
Sbjct: 71   WLERRNFVKPMTAVKKKSTLFIQM-EYCENGTLYDLIHSENLNQQRDEYWRLFRQILE-- 127

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI------ 982
              AL+Y+H      I+HRD+KP NI +D      I DFG+AK + +S             
Sbjct: 128  --ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 983  ------SVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELIT 1019
                  S +GT  Y+A E    T   +++ D+YS G++  E+I 
Sbjct: 183  SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  131 bits (331), Expect = 4e-32
 Identities = 87/468 (18%), Positives = 167/468 (35%), Gaps = 32/468 (6%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
            K   +++S N  S      + + S L  L +S N         F+  Q L+YL+L  N 
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 155 LDGEIPEPLFRILGLQYVFLNNNSLSGSIPRN--VGDLKEVEALWLFSNRLSGTIPESIG 212
           L           + L+++ L+ N+   ++P     G++ +++ L L +  L  +    I 
Sbjct: 81  LVK---ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136

Query: 213 NCYRLQE-LYLNENKLMGFLPESLSNL--ENLVYLDVGDNNLEGRINFGSEKCKNLTFLD 269
           +    +  L L E       PE L +   E+L  +   +      ++   +   NL   +
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196

Query: 270 LSYNRFSGGISPNLGNCSSL------THLDIVGSKLTGSIPSSFGLLARLSS---LDLSE 320
           +         S  L   + L      ++L +   + T +       L   ++     +S 
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256

Query: 321 NQLSGKIPPELG-----KCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEF 375
            +L G++            K L++  + ++             SN+       +      
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316

Query: 376 PVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI---NSS 432
            +   +I+   +L   NN L   +      L +L+ + L  NQ    + +   +     S
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKS 375

Query: 433 LMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQL 491
           L QLD   NS + +     C   K L  LNM  N     I   L   P +  + L  N++
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI 433

Query: 492 TGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKF 538
             ++P+   K   L  L+V+ N +            +L  I   +N +
Sbjct: 434 K-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  131 bits (330), Expect = 5e-32
 Identities = 95/539 (17%), Positives = 179/539 (33%), Gaps = 84/539 (15%)

Query: 172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFL 231
           V  + N L   +P+++   ++   L +  N +S      I +  +L+ L ++ N++    
Sbjct: 5   VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 232 PESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTH 291
                  + L YLD+  N L            NL  LDLS+N F                
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV---KISCHPTVNLKHLDLSFNAFD--------------- 103

Query: 292 LDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEI 351
                      I   FG +++L  L LS   L       +       VL +       + 
Sbjct: 104 --------ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155

Query: 352 PDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKN 411
             +   L +     L     T +    I            + ++     LE++ +K +  
Sbjct: 156 --DPEGLQDFNTESLHIVFPTNKEFHFIL-----------DVSVKTVANLELSNIKCVLE 202

Query: 412 ISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEI---PPNLCFGKQLRVLNMGQNQFH 468
            +  +   S  I   L  N  L  L   N   T         L +   +   ++   +  
Sbjct: 203 DNKCSYFLS--ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260

Query: 469 GPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPV------LSHLDVSRNNISGAIPSSI 522
           G +              L  +Q+   +  F ++ +      ++  + + +          
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 523 GNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVS 582
                   +DFS+N  +  + +  G+L  L TL + +N ++  L       K  E+    
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS------KIAEMTT-- 371

Query: 583 FNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFI-SELEKLLELQLGGNQLGGEIPPS 641
                          KSL  L +S+N  +        S  + LL L +  N L   I   
Sbjct: 372 -------------QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 642 IGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT----GTLSPLSNIHSL 696
           +     +   L+L  N +   IP  + KL  L++L+++SN L     G    L+++  +
Sbjct: 419 L--PPRIKV-LDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  124 bits (313), Expect = 6e-30
 Identities = 72/444 (16%), Positives = 158/444 (35%), Gaps = 36/444 (8%)

Query: 285 NCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYA 344
           + S           L   +P    L  + + L++S+N +S     ++     L +L +  
Sbjct: 6   DRSKN--------GLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISH 54

Query: 345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLG-KLPLEM 403
           N+++            L+ L+L  N+L     +S     +L++L +  N      +  E 
Sbjct: 55  NRIQYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEF 111

Query: 404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMG 463
             + QLK + L            +   +    L  +  ++  +  P     + L+  N  
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP-----EGLQDFNTE 166

Query: 464 QNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIG 523
                 P          +    +   +L+            +      + ++    +   
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELS----NIKCVLEDNKCSYFLSILAKLQTNPKL 222

Query: 524 NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQL-----SKCKNLEV 578
           +++ L +I+ + N F  ++  +L    ++   +IS   ++G L  +      +  K L +
Sbjct: 223 SNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSI 280

Query: 579 FDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEI 638
             V  ++           + +++I   + +          S++   L L    N L   +
Sbjct: 281 HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTV 340

Query: 639 PPSIGALQDLSYALNLSKNGLT--GRIPSDLEKLSKLEQLDISSNNLTGTLSP--LSNIH 694
             + G L +L   L L  N L    +I     ++  L+QLDIS N+++        S   
Sbjct: 341 FENCGHLTELET-LILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399

Query: 695 SLVEVNVSYNLFTGPVPETLMNLL 718
           SL+ +N+S N+ T  +   L   +
Sbjct: 400 SLLSLNMSSNILTDTIFRCLPPRI 423

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  121 bits (305), Expect = 6e-29
 Identities = 67/398 (16%), Positives = 132/398 (33%), Gaps = 50/398 (12%)

Query: 92  GHLSKLQTIDLSSNNF-SGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
                L+ +DLS N F +  I  + GN S L++L LST            +L   + L +
Sbjct: 87  HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLV 146

Query: 151 YGNLLDGEIPEPLFRILG---LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTI 207
            G     +      +      L  VF  N      +  +V  +  +E   +         
Sbjct: 147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKC 206

Query: 208 PESIGNCYR---------------------------------LQELYLNENKLMG----- 229
              +    +                                 +    ++  KL G     
Sbjct: 207 SYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266

Query: 230 FLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSL 289
               S ++L+ L    V  +      ++  E   N+   + + +             S  
Sbjct: 267 DFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326

Query: 290 THLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELG---KCKYLTVLHLYANQ 346
            HLD   + LT ++  + G L  L +L L  NQL  ++        + K L  L +  N 
Sbjct: 327 LHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNS 385

Query: 347 LEGEIPDEL-GQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTE 405
           +  +          +L  L +  N LT      +     ++ L +++N +   +P ++ +
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVK 442

Query: 406 LKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
           L+ L+ +++ +NQ   V        +SL ++    N +
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 86.1 bits (213), Expect = 2e-17
 Identities = 37/178 (20%), Positives = 73/178 (41%), Gaps = 6/178 (3%)

Query: 77  NLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFT--GD 134
           N +  G           +S    +D S+N  +  +    G+ + LE L L  N       
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSK 365

Query: 135 IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEV 193
           I +    +++LQ L++  N +  +  +        L  + +++N L+ +I R +     +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRI 423

Query: 194 EALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
           + L L SN++  +IP+ +     LQEL +  N+L          L +L  + +  N  
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 19/64 (29%), Positives = 36/64 (56%), Gaps = 3/64 (4%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYG 152
             +++ +DL SN    +IP ++    AL+ L++++N     +PD  F+ L +LQ + L+ 
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHT 477

Query: 153 NLLD 156
           N  D
Sbjct: 478 NPWD 481

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (320), Expect = 7e-32
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 14/203 (6%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED 883
             IG G+ G      S      + +K++             +RE+  +  ++H N+V+  +
Sbjct: 31   KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE---WNVRYKIALGAAHALAYLHYDCD 940
             +       I+  Y E G L   +++       E    +   +I L    AL ++H   D
Sbjct: 91   SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL----ALKHVH---D 143

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              I+HRDIK +NI L  +    + DFGIA++L+ +       + +GT  Y++PE      
Sbjct: 144  RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACIGTPYYLSPEICENKP 201

Query: 1001 KSKESDVYSYGVVLLELITRKKA 1023
             + +SD+++ G VL EL T K A
Sbjct: 202  YNNKSDIWALGCVLYELCTLKHA 224

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  125 bits (315), Expect = 7e-32
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 19/210 (9%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED 883
             IG G++G   K        +   K+L +          +  E+  + +++H N+VR  D
Sbjct: 13   TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 884  FWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTL--E---WNVRYKIALGAAHALAYL 935
              + +      I+M  Y E G L  V+   T       E     V  ++ L    AL   
Sbjct: 73   RIIDRTNTTLYIVM-EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL----ALKEC 127

Query: 936  HYDCDPP--IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            H   D    ++HRD+KP N+ LD +    + DFG+A++L+   +     + VGT  Y++P
Sbjct: 128  HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFVGTPYYMSP 185

Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKKA 1023
            E     + +++SD++S G +L EL      
Sbjct: 186  EQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  125 bits (317), Expect = 8e-32
 Identities = 54/260 (20%), Positives = 92/260 (35%), Gaps = 19/260 (7%)

Query: 98  QTIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
             I  +S   +     IP       +   L+L +N         F+ L  L  L+L  N 
Sbjct: 10  TEIRCNSKGLTSVPTGIPS------SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNG 63

Query: 155 LD-GEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESI- 211
           L               L+Y+ L+ N +  ++  N   L+++E L    + L      S+ 
Sbjct: 64  LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122

Query: 212 GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDL 270
            +   L  L ++            + L +L  L +  N+ +         + +NLTFLDL
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 271 SYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP 329
           S  +    +SP    + SSL  L++  +         +  L  L  LD S N +      
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240

Query: 330 EL--GKCKYLTVLHLYANQL 347
           +        L  L+L  N  
Sbjct: 241 QELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  105 bits (265), Expect = 6e-25
 Identities = 50/240 (20%), Positives = 90/240 (37%), Gaps = 36/240 (15%)

Query: 93  HLSKLQTIDLSSNN--FSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
            L++L  + LSSN   F G         ++L+YLDLS NG    +  NF  L+ L++L+ 
Sbjct: 50  KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIP 208
             + L       +F  L  L Y+ +++          +   L  +E L +  N       
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFL 167

Query: 209 ESI-GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLT 266
             I      L  L L++ +L    P + ++L +L  L++  NN    ++    +   +L 
Sbjct: 168 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQ 226

Query: 267 FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSS--FGLLARLSSLDLSENQLS 324
            LD S N                            +          + L+ L+L++N  +
Sbjct: 227 VLDYSLNHIM-------------------------TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 59/264 (22%), Positives = 101/264 (38%), Gaps = 17/264 (6%)

Query: 286 CS-SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP-ELGKCKYLTVLHLY 343
           CS S T +      LT S+P+  G+ +  + L+L  N+L   +P     K   LT L L 
Sbjct: 5   CSCSGTEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLS 60

Query: 344 ANQLE--GEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPL 401
           +N L   G         ++L+ L+L  N +      +   +  LE+L   ++NL      
Sbjct: 61  SNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 119

Query: 402 EM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRV 459
            +   L+ L  + + +              SSL  L    NSF     P++    + L  
Sbjct: 120 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179

Query: 460 LNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGA 517
           L++ Q Q     P+   S  +L  + +  N    +L    +     L  LD S N+I   
Sbjct: 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-T 237

Query: 518 IPSSI--GNSINLTSIDFSSNKFS 539
                      +L  ++ + N F+
Sbjct: 238 SKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 58/240 (24%), Positives = 93/240 (38%), Gaps = 19/240 (7%)

Query: 479 PTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNIS--GAIPSSIGNSINLTSIDFSS 535
            +  R+ L+ N+L       F K   L+ L +S N +S  G    S   + +L  +D S 
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87

Query: 536 NKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQ--LSKCKNLEVFDVSFNLLNGSIPSS 593
           N    +       L  L  L+   ++++  +         +NL   D+S      +    
Sbjct: 88  NGVITM-SSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145

Query: 594 LRSWKSLSILKLSENHFTGGIPTFI-SELEKLLELQLGGNQLGGEIPPSIGALQDLSY-- 650
                SL +LK++ N F       I +EL  L  L L   QL  ++ P   A   LS   
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP--TAFNSLSSLQ 202

Query: 651 ALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT----GTLSPLSNIHSLVEVNVSYNLF 706
            LN+S N          + L+ L+ LD S N++       L       SL  +N++ N F
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP--SSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 81.6 bits (202), Expect = 8e-17
 Identities = 56/236 (23%), Positives = 86/236 (36%), Gaps = 11/236 (4%)

Query: 383 ASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ--FSGVIPQSLGINSSLMQLDFIN 440
           +S   L + +N L         +L QL  +SL +N   F G   QS    +SL  LD   
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87

Query: 441 NSFTGEIPPNLCFGKQLRVLNMGQNQFHG-PIPSLLGSCPTLWRVILKQNQLTGALPE-- 497
           N     +  N    +QL  L+   +        S+  S   L  + +             
Sbjct: 88  NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI 145

Query: 498 FSKNPVLSHLDVSRNNISGAIPSSI-GNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLN 556
           F+    L  L ++ N+        I     NLT +D S  +   L P    +L SL  LN
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205

Query: 557 ISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSL--RSWKSLSILKLSENHF 610
           +S N+             +L+V D S N +  +           SL+ L L++N F
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  127 bits (322), Expect = 2e-31
 Identities = 72/259 (27%), Positives = 112/259 (43%), Gaps = 16/259 (6%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
           ++   +  +    S  +P  +   S   YL+L  N       D F +L +L+ L L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESI- 211
           +  +I    F  L  L  + L +N L+  IP      L ++  LWL +N +  +IP    
Sbjct: 111 I-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167

Query: 212 GNCYRLQELYLNE-NKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDL 270
                L  L L E  KL      +   L NL YL++G  N++   N        L  L++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNL--TPLVGLEELEM 225

Query: 271 SYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP 329
           S N F   I P      SSL  L ++ S+++    ++F  LA L  L+L+ N LS  +P 
Sbjct: 226 SGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPH 283

Query: 330 E-LGKCKYLTVLHLYANQL 347
           +     +YL  LHL+ N  
Sbjct: 284 DLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  112 bits (283), Expect = 2e-26
 Identities = 57/279 (20%), Positives = 102/279 (36%), Gaps = 34/279 (12%)

Query: 144 NLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNR 202
               +      L  E+P+ +      +Y+ L  N++   I  +    L  +E L L  N 
Sbjct: 55  QFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNS 110

Query: 203 LSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EK 261
           +      +      L  L L +N L      +   L  L  L + +N +E  I   +  +
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169

Query: 262 CKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN 321
             +L  LDL                  L ++             +F  L  L  L+L   
Sbjct: 170 VPSLMRLDLG-------------ELKKLEYIS----------EGAFEGLFNLKYLNLGMC 206

Query: 322 QLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWR 381
            +     P L     L  L +  N      P     LS+L+ L + +++++     +   
Sbjct: 207 NIKD--MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDG 264

Query: 382 IASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQF 419
           +ASL  L + +NN L  LP ++ T L+ L  + L++N +
Sbjct: 265 LASLVELNLAHNN-LSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (269), Expect = 1e-24
 Identities = 54/279 (19%), Positives = 92/279 (32%), Gaps = 36/279 (12%)

Query: 169 LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLM 228
              V      LS  +P+ +        L L  N +     ++  + + L+ L L  N + 
Sbjct: 56  FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112

Query: 229 GFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPN-LGNC 286
                + + L +L  L++ DN L   I  G+ E    L  L L  N     I        
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRV 170

Query: 287 SSLTHLDIVGSKLTGSIPS-SFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
            SL  LD+   K    I   +F  L  L  L+L    +     P L     L  L +  N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGN 228

Query: 346 QLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM-T 404
                 P     LS+L+ L + +++++                          +      
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVS-------------------------LIERNAFD 263

Query: 405 ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
            L  L  ++L +N  S +          L++L   +N +
Sbjct: 264 GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 93.7 bits (233), Expect = 4e-20
 Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 7/184 (3%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLY 151
            L+ L T++L  N  +  IP       S L  L L  N         F  + +L  L+L 
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG 179

Query: 152 GNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
                  I E  F  L  L+Y+ L   ++   +P N+  L  +E L +  N      P S
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGS 237

Query: 211 IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLD 269
                 L++L++  +++      +   L +LV L++  NNL   +        + L  L 
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELH 296

Query: 270 LSYN 273
           L +N
Sbjct: 297 LHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 92.9 bits (231), Expect = 8e-20
 Identities = 42/163 (25%), Positives = 68/163 (41%), Gaps = 9/163 (5%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
           +LSKL+ + L +N    +IP        +L  LDL        I +  FE L NL+YLNL
Sbjct: 145 YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIP 208
               +  ++P      L  L+ + ++ N     I       L  ++ LW+ ++++S    
Sbjct: 204 GMCNIK-DMPN--LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIER 259

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
            +      L EL L  N L     +  + L  LV L +  N  
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.0 bits (226), Expect = 4e-19
 Identities = 63/296 (21%), Positives = 100/296 (33%), Gaps = 60/296 (20%)

Query: 200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS 259
              LS  +P+ I +    + L L EN +     ++  +L +L  L +G N++  +I  G+
Sbjct: 63  RRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGA 118

Query: 260 -EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDL 318
                +L  L+L  N               LT +             +F  L++L  L L
Sbjct: 119 FNGLASLNTLELFDNW--------------LTVIP----------SGAFEYLSKLRELWL 154

Query: 319 SENQLSGKIPPE-LGKCKYLTVLHLY-ANQLEGEIPDELGQLSNLQDLELFDNRLTGEFP 376
             N +   IP     +   L  L L    +LE         L NL+ L L    +     
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK---- 209

Query: 377 VSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQL 436
                + +L                  T L  L+ + +  N F  + P S    SSL +L
Sbjct: 210 ----DMPNL------------------TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKL 247

Query: 437 DFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQL 491
             +N+  +  I  N   G   L  LN+  N        L      L  + L  N  
Sbjct: 248 WVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 56/263 (21%), Positives = 94/263 (35%), Gaps = 21/263 (7%)

Query: 479 PTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNK 537
               +V+  +  L+  +P+    N    +L++  NNI      +  +  +L  +    N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIPSN--TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 538 FSGLMPQELGNLVSLVTLNISLNHVEGSLPSQ-LSKCKNLEVFDVSFNLLNGSIPS-SLR 595
              +       L SL TL +  N +   +PS        L    +  N +  SIPS +  
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168

Query: 596 SWKSLSILKLSENHFTGGIP--TFISELEKLLELQLGGNQLGGEIPPSIGALQDLSY--A 651
              SL  L L E      I    F   L  L  L LG   +       +  L  L     
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAF-EGLFNLKYLNLGMCNI-----KDMPNLTPLVGLEE 222

Query: 652 LNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP--LSNIHSLVEVNVSYNLFTGP 709
           L +S N      P     LS L++L + ++ ++  +       + SLVE+N+++N  +  
Sbjct: 223 LEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSL 281

Query: 710 VPETLMNLLGPSPSSFSGNPSLC 732
             +    L          NP  C
Sbjct: 282 PHDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 82.1 bits (203), Expect = 3e-16
 Identities = 63/325 (19%), Positives = 103/325 (31%), Gaps = 81/325 (24%)

Query: 287 SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYAN 345
           +  + +      L+  +P   G+ +    L+L EN +   I  +      +L VL L  N
Sbjct: 54  NQFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109

Query: 346 QLEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM- 403
            +  +I       L++L  LELFDN LT                          +P    
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-------------------------VIPSGAF 143

Query: 404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMG 463
             L +L+ + L NN    +   +     SLM+LD         I                
Sbjct: 144 EYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGA------------ 191

Query: 464 QNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIG 523
              F G           L  + L    +   +P  +    L  L++S N+     P S  
Sbjct: 192 ---FEG--------LFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFH 239

Query: 524 NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSF 583
              +L  +   +++ S +       L SLV LN++ N++  SLP                
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLP---------------- 282

Query: 584 NLLNGSIPSSLRSWKSLSILKLSEN 608
                         + L  L L  N
Sbjct: 283 -------HDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 57.8 bits (140), Expect = 1e-08
 Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 4/93 (4%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQY 147
           P +  L  L+ +++S N+F   I P      S+L+ L +  +  +    + F+ L +L  
Sbjct: 212 PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270

Query: 148 LNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSL 179
           LNL  N L   +P  LF  L  L  + L++N  
Sbjct: 271 LNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  129 bits (326), Expect = 3e-31
 Identities = 59/290 (20%), Positives = 100/290 (34%), Gaps = 38/290 (13%)

Query: 94  LSKLQTIDLSSNNFSG---NIPPKLGNC-SALEYLDLST---NGFTGDIPDNFENLQNLQ 146
           L       LS N+F            +     E   L     N     + +    +    
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62

Query: 147 YLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGT 206
            L L    L   +P+ L     +  + +  N+L  S+P     L+    L    NRLS T
Sbjct: 63  ELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLEY---LDACDNRLS-T 114

Query: 207 IPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLT 266
           +PE   +   L+ L ++ N+L   LPE  + LE   Y++  +N L        E   +L 
Sbjct: 115 LPELPAS---LKHLDVDNNQLT-MLPELPALLE---YINADNNQLTML----PELPTSLE 163

Query: 267 FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSS----LDLSENQ 322
            L +  N+ +  +     +   L  LD+  + L  S+P+                  EN+
Sbjct: 164 VLSVRNNQLTF-LPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENR 218

Query: 323 LSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT 372
           ++  IP  +        + L  N L   I + L Q +   D        +
Sbjct: 219 IT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  115 bits (290), Expect = 7e-27
 Identities = 64/334 (19%), Positives = 106/334 (31%), Gaps = 37/334 (11%)

Query: 282 NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLH 341
           +L   S    +    S       S++    + +    + N+    +  E       + L 
Sbjct: 12  SLSQNSFYNTI----SGTYADYFSAWDKWEKQALPGENRNEAV-SLLKE-CLINQFSELQ 65

Query: 342 LYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPL 401
           L    L   +PD L     +  LE+  N L    P      ASLEYL   +N L   LP 
Sbjct: 66  LNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELP---ASLEYLDACDNRL-STLPE 117

Query: 402 EMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLN 461
               LK L    + NNQ + ++P+       L  ++  NN  T  +P        L VL+
Sbjct: 118 LPASLKHLD---VDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPT---SLEVLS 166

Query: 462 MGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-----FSKNPVLSHLDVSRNNISG 516
           +  NQ    +P L  S   L    +  N L  +LP                    N I+ 
Sbjct: 167 VRNNQLTF-LPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT- 220

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
            IP +I +     +I    N  S  + + L    +    +    +       Q +     
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS-MSDGQQNTLHRP 279

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHF 610
               V+            + W +    + +    
Sbjct: 280 LADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS 313

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  103 bits (258), Expect = 6e-23
 Identities = 54/270 (20%), Positives = 97/270 (35%), Gaps = 37/270 (13%)

Query: 423 IPQSLGINSSLMQLDFINN--SFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSC-- 478
           I   +  N SL Q  F N       +        ++  +    +N+      SLL  C  
Sbjct: 3   IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNE----AVSLLKECLI 58

Query: 479 PTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNK 537
                + L +  L+ +LP        ++ L++++N +  ++P    +   L  +D   N+
Sbjct: 59  NQFSELQLNRLNLS-SLPDNLPPQ--ITVLEITQNALI-SLPELPAS---LEYLDACDNR 111

Query: 538 FSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSW 597
            S L P+   +L  L   ++  N +   LP   +    LE  +   N L   +P    S 
Sbjct: 112 LSTL-PELPASLKHL---DVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSL 162

Query: 598 KSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLS---YALNL 654
           + LS   +  N  T  +P     LE    L +  N L   +P                  
Sbjct: 163 EVLS---VRNNQLTF-LPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214

Query: 655 SKNGLTGRIPSDLEKLSKLEQLDISSNNLT 684
            +N +T  IP ++  L     + +  N L+
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLS 243

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  123 bits (310), Expect = 8e-31
 Identities = 59/318 (18%), Positives = 116/318 (36%), Gaps = 49/318 (15%)

Query: 802  PAQEGPSYLLKQVIE-ATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG 859
             +     Y    ++    ++      +G G    V     L     +A+K++     ++ 
Sbjct: 11   SSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQD 69

Query: 860  SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG-----IIMYRYMENGSLRDVLHSITPPP 914
                +RE        H N++RL  + LR+        +++  + + G+L + +  +    
Sbjct: 70   REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL-PFFKRGTLWNEIERLKDKG 128

Query: 915  TL--EWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
                E  +   + LG    L  +H        HRD+KP NILL  E +P + D G     
Sbjct: 129  NFLTEDQIL-WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184

Query: 973  DKSPASTTS-------ISVVGTIGYIAPE------NAFTTAKSKESDVYSYGVVLLELIT 1019
                  +          +   TI Y APE      +     +   +DV+S G VL  ++ 
Sbjct: 185  CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER---TDVWSLGCVLYAMMF 241

Query: 1020 RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRC 1079
             +   D  +++             D+  +     LS+ +    SS   Q+++ ++     
Sbjct: 242  GEGPYDMVFQK------------GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMT---- 285

Query: 1080 TEKKPSNRPNMRDVVRQL 1097
                P  RP++  ++ QL
Sbjct: 286  --VDPHQRPHIPLLLSQL 301

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  122 bits (307), Expect = 2e-30
 Identities = 65/279 (23%), Positives = 103/279 (36%), Gaps = 47/279 (16%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVK--KLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRL 881
             +G G++G V+K  S     ++AVK     FRG  +       E+ +  K+ +H   VRL
Sbjct: 64   RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 882  EDFWLRKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
            E  W        +Y   E    SL+    +       E  V          ALA+LH   
Sbjct: 123  EQAWEEGGI---LYLQTELCGPSLQQHCEAWGASLP-EAQVW-GYLRDTLLALAHLH--- 174

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE---NA 996
               +VH D+KP NI L       + DFG+   L  + A        G   Y+APE    +
Sbjct: 175  SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGS 231

Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056
            + TA    +DV+S G+ +LE+    +                  +    E    +    L
Sbjct: 232  YGTA----ADVFSLGLTILEVACNME------------------LPHGGEGWQQLRQGYL 269

Query: 1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
              E   + +  ++  VL   +   E  P  R     ++ 
Sbjct: 270  PPEFT-AGLSSELRSVL---VMMLEPDPKLRATAEALLA 304

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  124 bits (313), Expect = 2e-30
 Identities = 63/259 (24%), Positives = 108/259 (41%), Gaps = 16/259 (6%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
           ++   +     N    +P  +   +    L+L  N       ++F++L++L+ L L  N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESI- 211
           +   I    F  L  L  + L +N L+ +IP      L +++ LWL +N +  +IP    
Sbjct: 100 I-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156

Query: 212 GNCYRLQELYLNE-NKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDL 270
                L+ L L E  +L      +   L NL YL++   NL    N        L  LDL
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNL--TPLIKLDELDL 214

Query: 271 SYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP 329
           S N  S  I P        L  L ++ S++     ++F  L  L  ++L+ N L+  +P 
Sbjct: 215 SGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPH 272

Query: 330 E-LGKCKYLTVLHLYANQL 347
           +      +L  +HL+ N  
Sbjct: 273 DLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  110 bits (278), Expect = 9e-26
 Identities = 61/265 (23%), Positives = 102/265 (38%), Gaps = 14/265 (5%)

Query: 136 PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV-GDLKEVE 194
           P           +      L  E+P+ +      + + L+ N +   I  N    L+ +E
Sbjct: 36  PSVCSCSNQFSKVICVRKNLR-EVPDGIST--NTRLLNLHENQIQ-IIKVNSFKHLRHLE 91

Query: 195 ALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGR 254
            L L  N +      +      L  L L +N+L      +   L  L  L + +N +E  
Sbjct: 92  ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-S 150

Query: 255 INFGS-EKCKNLTFLDLS-YNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLA 311
           I   +  +  +L  LDL    R S  IS       S+L +L++    L   IP +   L 
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLI 207

Query: 312 RLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNR 370
           +L  LDLS N LS  I P       +L  L +  +Q++    +    L +L ++ L  N 
Sbjct: 208 KLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266

Query: 371 LTGEFPVSIWRIASLEYLLVYNNNL 395
           LT         +  LE + +++N  
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 92.5 bits (230), Expect = 9e-20
 Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 9/163 (5%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKL-GNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
           +LSKL+ + L +N    +IP        +L  LDL        I +  FE L NL+YLNL
Sbjct: 134 YLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIP 208
               L  EIP      L  L  + L+ N LS +I       L  ++ LW+  +++     
Sbjct: 193 AMCNLR-EIPN--LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIER 248

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
            +  N   L E+ L  N L     +  + L +L  + +  N  
Sbjct: 249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 11/186 (5%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
            L+ L T++L  N  +  IP       S L+ L L  N     IP   F  + +L+ L+L
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167

Query: 151 YG-NLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIP 208
                L   I E  F  L  L+Y+ L   +L   IP N+  L +++ L L  N LS   P
Sbjct: 168 GELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP 224

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTF 267
            S      LQ+L++ ++++      +  NL++LV +++  NNL   +         +L  
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLER 283

Query: 268 LDLSYN 273
           + L +N
Sbjct: 284 IHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 83.3 bits (206), Expect = 1e-16
 Identities = 61/265 (23%), Positives = 97/265 (36%), Gaps = 20/265 (7%)

Query: 477 SC-PTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSS 535
           SC     +VI  +  L   +P+   +     L++  N I     +S  +  +L  +  S 
Sbjct: 40  SCSNQFSKVICVRKNLR-EVPD-GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSR 97

Query: 536 NKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQ-LSKCKNLEVFDVSFNLLNGSIPSSL 594
           N    +       L +L TL +  N +  ++P+        L+   +  N +  SIPS  
Sbjct: 98  NHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYA 155

Query: 595 -RSWKSLSILKLSENHFTGGIP--TFISELEKLLELQLGGNQLGGEIPPSIGALQDLSY- 650
                SL  L L E      I    F   L  L  L L    L       I  L  L   
Sbjct: 156 FNRIPSLRRLDLGELKRLSYISEGAF-EGLSNLRYLNLAMCNL-----REIPNLTPLIKL 209

Query: 651 -ALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP--LSNIHSLVEVNVSYNLFT 707
             L+LS N L+   P   + L  L++L +  + +   +      N+ SLVE+N+++N  T
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268

Query: 708 GPVPETLMNLLGPSPSSFSGNPSLC 732
               +    L          NP  C
Sbjct: 269 LLPHDLFTPLHHLERIHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 79.4 bits (196), Expect = 2e-15
 Identities = 63/302 (20%), Positives = 101/302 (33%), Gaps = 59/302 (19%)

Query: 287 SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYAN 345
           +  + +  V   L   +P   G+      L+L ENQ+   I        ++L +L L  N
Sbjct: 43  NQFSKVICVRKNLR-EVPD--GISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98

Query: 346 QLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM-T 404
            +          L+NL  LELFDNRLT                          +P     
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLT-------------------------TIPNGAFV 133

Query: 405 ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGK--QLRVLNM 462
            L +LK + L NN    +   +     SL +LD         I     F     LR LN+
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG-AFEGLSNLRYLNL 192

Query: 463 GQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSI 522
                                           +P  +    L  LD+S N++S   P S 
Sbjct: 193 AMCNLR-------------------------EIPNLTPLIKLDELDLSGNHLSAIRPGSF 227

Query: 523 GNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVS 582
              ++L  +    ++   +      NL SLV +N++ N++        +   +LE   + 
Sbjct: 228 QGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH 287

Query: 583 FN 584
            N
Sbjct: 288 HN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 76.7 bits (189), Expect = 1e-14
 Identities = 50/280 (17%), Positives = 98/280 (35%), Gaps = 35/280 (12%)

Query: 359 SNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ 418
           +    +      L  E P  I    +   L ++ N +          L+ L+ + L  N 
Sbjct: 43  NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 419 FSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGS 477
              +   +    ++L  L+  +N  T  IP        +L+ L +  N            
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158

Query: 478 CPTLWRVILKQ-NQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFS 534
            P+L R+ L +  +L+  + E  F     L +L+++  N+   IP+ +   I L  +D S
Sbjct: 159 IPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLS 215

Query: 535 SNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSL 594
            N  S + P     L+ L  L +  + ++  +                         ++ 
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE-----------------------RNAF 251

Query: 595 RSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQL 634
            + +SL  + L+ N+ T       + L  L  + L  N  
Sbjct: 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 57.8 bits (140), Expect = 9e-09
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 4/93 (4%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQY 147
           P +  L KL  +DLS N+ S  I P        L+ L +  +       + F+NLQ+L  
Sbjct: 201 PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVE 259

Query: 148 LNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSL 179
           +NL  N L   +P  LF  L  L+ + L++N  
Sbjct: 260 INLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 15/65 (23%), Positives = 28/65 (43%), Gaps = 2/65 (3%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLY 151
            L  LQ + +  +     I      N  +L  ++L+ N  T    D F  L +L+ ++L+
Sbjct: 229 GLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLH 287

Query: 152 GNLLD 156
            N  +
Sbjct: 288 HNPWN 292

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  124 bits (311), Expect = 3e-30
 Identities = 35/234 (14%), Positives = 70/234 (29%), Gaps = 42/234 (17%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS--MKREIQTIGKIR-------- 874
            V+G+       +A        F V    F      +    MK E+  +  +R        
Sbjct: 85   VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 875  -----------------HRNLVRL----EDFWLRKDCGIIMYRYMENGSLRDVLHS-ITP 912
                              + ++R+     D W+     +         +  +VL S  + 
Sbjct: 145  KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 913  PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL 972
              +L  + R ++ L     LA LH      +VH  ++P +I+LD      ++ F      
Sbjct: 205  HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 973  DKSPASTTSISVVGTIGYIAPE-----NAFTTAKSKESDVYSYGVVLLELITRK 1021
              + A +            A           T  +   D ++ G+ +  +    
Sbjct: 262  G-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  121 bits (305), Expect = 4e-30
 Identities = 62/284 (21%), Positives = 109/284 (38%), Gaps = 44/284 (15%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNL--VRLE 882
             IG G    V++       ++A+K +        +L S + EI  + K++  +   +RL 
Sbjct: 35   QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 883  DFWLRKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            D+ +       +Y  ME  N  L   L          W  +         A+  +H    
Sbjct: 95   DYEITDQY---IYMVMECGNIDLNSWLKKKKSID--PWERKS-YWKNMLEAVHTIH---Q 145

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE------ 994
              IVH D+KP N L+   M   + DFGIA  +     S    S VGT+ Y+ PE      
Sbjct: 146  HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
                     +  S +SDV+S G +L  +   K      +++  + +           +++
Sbjct: 205  SSRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIINQI----------SKLH 250

Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             I+D +   E         + DVL     C ++ P  R ++ ++
Sbjct: 251  AIIDPNHEIEFP-DIPEKDLQDVL---KCCLKRDPKQRISIPEL 290

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  125 bits (316), Expect = 4e-30
 Identities = 102/530 (19%), Positives = 197/530 (37%), Gaps = 73/530 (13%)

Query: 99  TIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGE 158
            +D S+ N + ++P         + L LS N  +     +   L  L+ L L  N +   
Sbjct: 35  MVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-S 90

Query: 159 IPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES--IGNCY 215
           +   +F     L+Y+ +++N L  +I      +  +  L L  N     +P     GN  
Sbjct: 91  LDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLT 146

Query: 216 RLQELYLNENKLMGFLPESLSNLE-NLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNR 274
           +L  L L+  K        +++L  + + LD+   +++      S +  N T L L ++ 
Sbjct: 147 KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIK-GGETESLQIPNTTVLHLVFHP 205

Query: 275 FSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKC 334
            S        + ++L HL                   +LS++ L++      +       
Sbjct: 206 NSLFSVQVNMSVNALGHL-------------------QLSNIKLNDENCQRLMTFLSELT 246

Query: 335 KYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNN 394
           +  T+L++                  LQ +E        +     W    +EYL +YN  
Sbjct: 247 RGPTLLNV-----------------TLQHIETTWKCSV-KLFQFFW-PRPVEYLNIYNLT 287

Query: 395 LLGKLPLEM-----TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTG-EIP 448
           +  ++  E      T LK L    + N  F         + S   +++    S +     
Sbjct: 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE---ALYSVFAEMNIKMLSISDTPFI 344

Query: 449 PNLCFGK--QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPV--- 503
             +C         LN  QN F   +     +   L  +IL++N L     + +       
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMS 403

Query: 504 -LSHLDVSRNNI-SGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
            L  LDVS N++ S A   +   + ++  ++ SSN  +G + + L     +  L++  N 
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNR 461

Query: 562 VEGSLPSQLSKCKNLEVFDVSFNLLNGSIP-SSLRSWKSLSILKLSENHF 610
           +  S+P  ++  + L+  +V+ N L  S+P        SL  + L +N +
Sbjct: 462 IM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  123 bits (311), Expect = 2e-29
 Identities = 98/506 (19%), Positives = 179/506 (35%), Gaps = 83/506 (16%)

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRF 275
            + L L++N +       +S L  L  L +  N +   ++F      ++L +LD+S+NR 
Sbjct: 54  TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR- 111

Query: 276 SGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL-SGKIPPELGKC 334
                        L ++             S   +A L  LDLS N      +  E G  
Sbjct: 112 -------------LQNI-------------SCCPMASLRHLDLSFNDFDVLPVCKEFGNL 145

Query: 335 KYLTVLHLYANQLEGEIPDELGQLS-NLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNN 393
             LT L L A +        +  L  +   L+L    + G    S+    +    LV++ 
Sbjct: 146 TKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205

Query: 394 NLLGKLPLEM----TELKQLKNISLYNNQFSGVIPQSLGI--NSSLMQLDFINNSFTGEI 447
           N L  + + M        QL NI L +     ++     +    +L+ +   +   T + 
Sbjct: 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC 265

Query: 448 P---PNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPV- 503
                   + + +  LN+        I     +        L    +   +  FSK  + 
Sbjct: 266 SVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY 325

Query: 504 -----LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNIS 558
                ++   +S ++          +  + T ++F+ N F+  + Q    L  L TL + 
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385

Query: 559 LNHVEGSLPS---QLSKCKNLEVFDVSFNLLNGSIPSSLRSW-KSLSILKLSENHFTGGI 614
            N ++ +            +LE  DVS N LN        +W +S+ +L LS N  TG +
Sbjct: 386 RNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444

Query: 615 PTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLE 674
             F     K+  L L  N++                            IP D+  L  L+
Sbjct: 445 --FRCLPPKVKVLDLHNNRIM--------------------------SIPKDVTHLQALQ 476

Query: 675 QLDISSNNLT----GTLSPLSNIHSL 696
           +L+++SN L     G    L+++  +
Sbjct: 477 ELNVASNQLKSVPDGVFDRLTSLQYI 502

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  116 bits (292), Expect = 4e-27
 Identities = 83/446 (18%), Positives = 156/446 (34%), Gaps = 36/446 (8%)

Query: 93  HLSKLQTIDLSSNNFSGNIPP----KLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
            LS+L+ + LS N    ++         +   LEYLD+S N     I      + +L++L
Sbjct: 74  FLSELRVLRLSHNRIR-SLDFHVFLFNQD---LEYLDVSHNRLQN-IS--CCPMASLRHL 126

Query: 149 NLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVE-ALWLFSNRLSGT 206
           +L  N  D       F  L  L ++ L+           V  L      L L S  + G 
Sbjct: 127 DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGG 186

Query: 207 IPESI--GNCYRLQELYLNENKLMGFLPESLSNLENLV--YLDVGDNNLEGRINFGSEKC 262
             ES+   N   L  ++   +     +  S++ L +L    + + D N +  + F SE  
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246

Query: 263 KNLTFLDLSYNRFSGGISP-----NLGNCSSLTHLDIVGSKLTGSIP-----SSFGLLAR 312
           +  T L+++                      + +L+I    +T  I       S   L  
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306

Query: 313 LSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT 372
           L    +                  + +  L  +             S+   L    N  T
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT 366

Query: 373 GEFPVSIWRIASLEYLLVYNNNL--LGKLPLEMTELKQLKNISLYNNQF-SGVIPQSLGI 429
                    +  L+ L++  N L    K+ L    +  L+ + +  N   S    ++   
Sbjct: 367 DSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
             S++ L+  +N  TG +    C   +++VL++  N+    IP  +     L  + +  N
Sbjct: 427 AESILVLNLSSNMLTGSVFR--CLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASN 483

Query: 490 QLTGALPE--FSKNPVLSHLDVSRNN 513
           QL  ++P+  F +   L ++ +  N 
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  113 bits (283), Expect = 6e-26
 Identities = 79/453 (17%), Positives = 145/453 (32%), Gaps = 34/453 (7%)

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQ 322
               L LS N  S    P++   S L  L +  +++  S+    F     L  LD+S N+
Sbjct: 53  RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111

Query: 323 LSGKIPPELGKCKYLTVLHLYANQLEGEIPD--ELGQLSNLQDLELFDNRLTGEFPVSIW 380
           L   I         L  L L  N  +  +P   E G L+ L  L L   +      + + 
Sbjct: 112 LQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVA 167

Query: 381 RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFIN 440
            +     LL   +  +     E  ++     + L  +  S    Q     ++L  L   N
Sbjct: 168 HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227

Query: 441 NSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSK 500
                E        ++L        +    +   L    T W+  +K       L +F  
Sbjct: 228 IKLNDE------NCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVK-------LFQFFW 274

Query: 501 NPVLSHLDVSRNNISGAIPSSIGNSIN-----LTSIDFSSNKFSGLMPQELGNLVSLVTL 555
              + +L++    I+  I              L      +  F             +   
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334

Query: 556 NISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP 615
            +S++              +    + + N+   S+     + K L  L L  N       
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF 393

Query: 616 TFISELEKLLELQLGGNQLG----GEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLS 671
                 + +  L+     L          +    + +   LNLS N LTG +   L    
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV-LNLSSNMLTGSVFRCL--PP 450

Query: 672 KLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYN 704
           K++ LD+ +N +      ++++ +L E+NV+ N
Sbjct: 451 KVKVLDLHNNRIMSIPKDVTHLQALQELNVASN 483

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  103 bits (257), Expect = 9e-23
 Identities = 67/399 (16%), Positives = 131/399 (32%), Gaps = 54/399 (13%)

Query: 92  GHLSKLQTIDLSSNNF-SGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
             ++ L+ +DLS N+F    +  + GN + L +L LS   F      +   + +L    +
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCI 174

Query: 151 YGNLLDGEIPEPLFRILG------LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS 204
             +L+   I       L       L  VF  N+  S  +  +V  L  ++   +  N  +
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234

Query: 205 GTIPESIGNC-------------------------------YRLQELYLNENKLMG---- 229
                +  +                                  ++ L +    +      
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294

Query: 230 -FLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSS 288
                S + L++L+   V +                +    LS +           + SS
Sbjct: 295 EEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSS 354

Query: 289 LTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQL- 347
            T L+   +  T S+      L RL +L L  N L           K ++ L      L 
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLN 413

Query: 348 ---EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMT 404
                          ++  L L  N LTG     +     ++ L ++NN ++  +P ++T
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVT 470

Query: 405 ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
            L+ L+ +++ +NQ   V        +SL  +   +N +
Sbjct: 471 HLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 55.6 bits (134), Expect = 6e-08
 Identities = 43/204 (21%), Positives = 72/204 (35%), Gaps = 8/204 (3%)

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQL-SKCKN 575
            +P  +       ++  S N  S L   ++  L  L  L +S N +  SL   +    ++
Sbjct: 45  HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101

Query: 576 LEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG-GIPTFISELEKLLELQLGGNQL 634
           LE  DVS N L  +I        SL  L LS N F    +      L KL  L L   + 
Sbjct: 102 LEYLDVSHNRL-QNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158

Query: 635 GGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIH 694
                  +  L      L+L    + G     L+  +      +   N   ++    +++
Sbjct: 159 RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN 218

Query: 695 SLVEVNVSYNLFTGPVPETLMNLL 718
           +L  + +S         + LM  L
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFL 242

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  120 bits (302), Expect = 1e-29
 Identities = 60/284 (21%), Positives = 106/284 (37%), Gaps = 44/284 (15%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNL--VRLE 882
             IG G    V++       ++A+K +        +L S + EI  + K++  +   +RL 
Sbjct: 16   QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 883  DFWLRKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            D+ +       +Y  ME  N  L   L          W  +         A+  +H    
Sbjct: 76   DYEITDQY---IYMVMECGNIDLNSWLKKKKSID--PWERKS-YWKNMLEAVHTIH---Q 126

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE------ 994
              IVH D+KP N L+  +    + DFGIA  +     S    S VGT+ Y+ PE      
Sbjct: 127  HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
                     +  S +SDV+S G +L  +   K      +++  + +  + ++     EI 
Sbjct: 186  SSRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIINQISKLHAIIDPNHEIE 241

Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
                               + DVL     C ++ P  R ++ ++
Sbjct: 242  FPDIPE-----------KDLQDVL---KCCLKRDPKQRISIPEL 271

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  120 bits (301), Expect = 2e-29
 Identities = 30/304 (9%), Positives = 72/304 (23%), Gaps = 54/304 (17%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL--SMKREIQTIGKIRHRNLVRL- 881
             +  G   +V+    +     FA+K          S    +        ++   +     
Sbjct: 69   PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 882  ---------------------------EDFWLRKDCGIIMYRYMENGSLRDVLHSITP-P 913
                                       +D+ +     ++    ++   L   L  +    
Sbjct: 129  DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 914  PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD 973
                    + +        A L       +VH    P+N+ +  +    + D        
Sbjct: 189  GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 974  KSPASTTSISVVGTIGYIAPE--NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
                 T   +    + Y   E  NA T   +   + +  G+ +  +          +   
Sbjct: 243  --KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF----LPFGLV 296

Query: 1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
            T  +       S      D +          + + D V  ++    R        R    
Sbjct: 297  TPGIKGSWKRPSLRVPGTDSLAFG-----SCTPLPDFVKTLI---GRFLNFDRRRRLLPL 348

Query: 1092 DVVR 1095
            + + 
Sbjct: 349  EAME 352

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  120 bits (302), Expect = 3e-29
 Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 44/284 (15%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNL--VRLE 882
             IG G    V++       ++A+K +        +L S + EI  + K++  +   +RL 
Sbjct: 63   QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 883  DFWLRKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            D+ +       +Y  ME  N  L   L          W  +         A+  +H    
Sbjct: 123  DYEITDQY---IYMVMECGNIDLNSWLKKKKSID--PWERKS-YWKNMLEAVHTIH---Q 173

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE------ 994
              IVH D+KP N L+  +    + DFGIA  +     S    S VG + Y+ PE      
Sbjct: 174  HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 995  -----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049
                     +  S +SDV+S G +L  +   K      +++  + +           +++
Sbjct: 233  SSRENGKSKSKISPKSDVWSLGCILYYMTYGK----TPFQQIINQI----------SKLH 278

Query: 1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             I+D +   E         + DVL     C ++ P  R ++ ++
Sbjct: 279  AIIDPNHEIEFP-DIPEKDLQDVL---KCCLKRDPKQRISIPEL 318

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (298), Expect = 7e-29
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)

Query: 825  HVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR-LE 882
              +G G  G+V+K S  P   V A K +           + RE+Q + +     +V    
Sbjct: 39   SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
             F+   +  I M  +M+ GSL  VL      P  E  +  K+++     L YL       
Sbjct: 99   AFYSDGEISICM-EHMDGGSLDQVLKKAGRIP--E-QILGKVSIAVIKGLTYLREKHK-- 152

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I+HRD+KP NIL++S  E  + DFG++  L  S A++     VGT  Y++PE    T  S
Sbjct: 153  IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----FVGTRSYMSPERLQGTHYS 208

Query: 1003 KESDVYSYGVVLLELIT 1019
             +SD++S G+ L+E+  
Sbjct: 209  VQSDIWSMGLSLVEMAV 225

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (295), Expect = 7e-29
 Identities = 46/208 (22%), Positives = 88/208 (42%), Gaps = 19/208 (9%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRL 881
              IGRG    VY+A  L      A+KK+        +      +EI  + ++ H N+++ 
Sbjct: 38   KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 882  EDFWLRKDC-GIIMYRYMENGSLRDVLHSITPPPTL--E---WNVRYKIALGAAHALAYL 935
               ++  +   I++    + G L  ++        L  E   W    ++      AL ++
Sbjct: 98   YASFIEDNELNIVL-ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHM 152

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
            H      ++HRDIKP N+ + +     + D G+ +       +    S+VGT  Y++PE 
Sbjct: 153  H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH--SLVGTPYYMSPER 207

Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKA 1023
                  + +SD++S G +L E+   +  
Sbjct: 208  IHENGYNFKSDIWSLGCLLYEMAALQSP 235

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  116 bits (293), Expect = 9e-29
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            V+G+G +GIVY    L      A+K++  R   R S  +  EI     ++H+N+V+    
Sbjct: 29   VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGS 87

Query: 885  WLRKDCGIIMYRYMENGSLRDVL-HSITPPPTLEWNVR---YKIALGAAHALAYLHYDCD 940
            +       I    +  GSL  +L     P    E  +     +I  G    L YLH   D
Sbjct: 88   FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG----LKYLH---D 140

Query: 941  PPIVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE--NAF 997
              IVHRDIK +N+L+++      ISDFG +K L     +  + +  GT+ Y+APE  +  
Sbjct: 141  NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKG 198

Query: 998  TTAKSKESDVYSYGVVLLELITRK 1021
                 K +D++S G  ++E+ T K
Sbjct: 199  PRGYGKAADIWSLGCTIIEMATGK 222

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (291), Expect = 2e-28
 Identities = 48/212 (22%), Positives = 82/212 (38%), Gaps = 23/212 (10%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
              ++G+GA   V++        +FA+K        R      RE + + K+ H+N+V+L 
Sbjct: 14   SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 883  DFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
                        +IM  +   GSL  VL   +    L  +    +       + +L    
Sbjct: 74   AIEEETTTRHKVLIM-EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129

Query: 940  DPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSISVVGTIGYIAPE- 994
            +  IVHR+IKP NI+     +      ++DFG A+ L+      +   + GT  Y+ P+ 
Sbjct: 130  ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDM 186

Query: 995  -----NAFTTAK--SKESDVYSYGVVLLELIT 1019
                       K      D++S GV      T
Sbjct: 187  YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (295), Expect = 4e-28
 Identities = 60/282 (21%), Positives = 103/282 (36%), Gaps = 41/282 (14%)

Query: 824  KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLE 882
            K V+G GA G +    +  N   AVK++             RE+Q + +   H N++R  
Sbjct: 29   KDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNVIRYF 84

Query: 883  DFWLRKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
                 +      Y  +E    +L++ +                +       LA+LH    
Sbjct: 85   CTEKDRQF---QYIAIELCAATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---S 136

Query: 941  PPIVHRDIKPENILL-----DSEMEPHISDFGIAKLLDKSPASTTSIS-VVGTIGYIAPE 994
              IVHRD+KP NIL+       +++  ISDFG+ K L     S +  S V GT G+IAPE
Sbjct: 137  LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 995  ---NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051
                      +   D++S G V   +I+        + +       +       + ++  
Sbjct: 197  MLSEDCKENPTYTVDIFSAGCVFYYVISEGS---HPFGKSLQRQANILLGACSLDCLHPE 253

Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
                ++   L+               +     P  RP+ + V
Sbjct: 254  KHEDVIARELIE--------------KMIAMDPQKRPSAKHV 281

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  115 bits (289), Expect = 7e-28
 Identities = 47/204 (23%), Positives = 78/204 (38%), Gaps = 19/204 (9%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            +  +GRG+ G V++          AVKK+              E+     +    +V L 
Sbjct: 63   QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------FRVEELVACAGLSSPRIVPLY 116

Query: 883  DFWLRKDC-GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
                      I M   +E GSL  ++  +   P  E    Y     A   L YLH     
Sbjct: 117  GAVREGPWVNIFM-ELLEGGSLGQLIKQMGCLP--EDRALY-YLGQALEGLEYLHTRR-- 170

Query: 942  PIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSI---SVVGTIGYIAPENAF 997
             I+H D+K +N+LL S+     + DFG A  L       + +    + GT  ++APE   
Sbjct: 171  -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 998  TTAKSKESDVYSYGVVLLELITRK 1021
                  + D++S   ++L ++   
Sbjct: 230  GKPCDAKVDIWSSCCMMLHMLNGC 253

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  115 bits (288), Expect = 1e-27
 Identities = 40/261 (15%), Positives = 78/261 (29%), Gaps = 53/261 (20%)

Query: 803  AQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL 861
                P  +  ++ E    L    V+G+       +A        F V    F      + 
Sbjct: 57   NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 116

Query: 862  S--MKREIQTIGKIR-------------------------HRNLVRL----EDFWLRKDC 890
               MK E+  +  +R                          + ++R+     D W+    
Sbjct: 117  IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176

Query: 891  GIIMYRYMENGSLRDVLHS-ITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIK 949
             +         +  +VL S  +   +L  + R ++ L     LA LH      +VH  ++
Sbjct: 177  FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR 233

Query: 950  PENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-----------NAFT 998
            P +I+LD      ++ F                    + G+  PE               
Sbjct: 234  PVDIVLDQRGGVFLTGFEHLVRDGARV------VSSVSRGFEPPELEARRATISYHRDRR 287

Query: 999  TAKSKESDVYSYGVVLLELIT 1019
            T  +   D ++ G+V+  +  
Sbjct: 288  TLMTFSFDAWALGLVIYWIWC 308

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (289), Expect = 3e-27
 Identities = 61/302 (20%), Positives = 114/302 (37%), Gaps = 60/302 (19%)

Query: 824  KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLE 882
            + ++G G+ G V           AVK++              EI+ + +   H N++R  
Sbjct: 20   EKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 883  DFWLRKDCGIIMYRYME--NGSLRDVLHSITPPPTLEWNVRYKIALGAAH-------ALA 933
                       +Y  +E  N +L+D+   +      + N++ +               +A
Sbjct: 76   CSETTDRF---LYIALELCNLNLQDL---VESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPH-------------ISDFGIAKLL--DKSPAS 978
            +LH      I+HRD+KP+NIL+ +                  ISDFG+ K L   +S   
Sbjct: 130  HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 979  TTSISVVGTIGYIAPE-------NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            T   +  GT G+ APE              ++  D++S G V   ++++ K     + ++
Sbjct: 187  TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK---HPFGDK 243

Query: 1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
                        ++  I  I  L  M+ +   S+  +  D  L++ +  +  P  RP   
Sbjct: 244  YSR---------ESNIIRGIFSLDEMKCLHDRSLIAEATD--LIS-QMIDHDPLKRPTAM 291

Query: 1092 DV 1093
             V
Sbjct: 292  KV 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  113 bits (285), Expect = 5e-27
 Identities = 48/212 (22%), Positives = 82/212 (38%), Gaps = 23/212 (10%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
              ++G+GA   V++        +FA+K        R      RE + + K+ H+N+V+L 
Sbjct: 14   SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 883  DFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
                        +IM  +   GSL  VL   +    L  +    +       + +L    
Sbjct: 74   AIEEETTTRHKVLIM-EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--- 129

Query: 940  DPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTTSISVVGTIGYIAPE- 994
            +  IVHR+IKP NI+     +      ++DFG A+ L+      +   + GT  Y+ P+ 
Sbjct: 130  ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDM 186

Query: 995  -----NAFTTAK--SKESDVYSYGVVLLELIT 1019
                       K      D++S GV      T
Sbjct: 187  YERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  112 bits (283), Expect = 6e-27
 Identities = 65/314 (20%), Positives = 121/314 (38%), Gaps = 24/314 (7%)

Query: 74  VSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTG 133
           V   + S               +      SS + + +IP   G   A++ LDLS N  T 
Sbjct: 10  VLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRITY 66

Query: 134 DIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLK 191
               + +   NLQ L L  N ++  I E  F  LG L+++ L+ N LS ++  +    L 
Sbjct: 67  ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS 124

Query: 192 EVEALWLFSNRLSGTIPESI--GNCYRLQELYLNENKLMGFLPE-SLSNLENLVYLDVGD 248
            +  L L  N    T+ E+    +  +LQ L +        +     + L  L  L++  
Sbjct: 125 SLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183

Query: 249 NNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPNL-GNCSSLTHLDIVG--------SK 298
           ++L+      S +  +N++ L L   +    +        SS+  L++          S+
Sbjct: 184 SDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSE 241

Query: 299 LTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL 358
           L+    +S        ++ +++  L  ++   L +   L  L    NQL+        +L
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRL 300

Query: 359 SNLQDLELFDNRLT 372
           ++LQ + L  N   
Sbjct: 301 TSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  105 bits (264), Expect = 2e-24
 Identities = 57/287 (19%), Positives = 114/287 (39%), Gaps = 22/287 (7%)

Query: 172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFL 231
              ++ SL+ SIP  +   + V++L L +NR++      +  C  LQ L L  N +    
Sbjct: 36  CKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92

Query: 232 PESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPN--LGNCSS 288
            +S S+L +L +LD+  N L   ++    +   +LTFL+L  N +   +       + + 
Sbjct: 93  EDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTK 150

Query: 289 LTHLDIVGSKLTGSIPS-SFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQ 346
           L  L +        I    F  L  L  L++  + L     P+ L   + ++ L L+  Q
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQ 209

Query: 347 LEGEIPDEL-GQLSNLQDLELFDNRLTGEFPVSI--------WRIASLEYLLVYNNNLLG 397
               + +      S+++ LEL D  L       +         +  +   + + + +L  
Sbjct: 210 HI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF- 267

Query: 398 KLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFT 444
           ++   + ++  L  +    NQ   V        +SL ++    N + 
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.4 bits (209), Expect = 2e-17
 Identities = 58/272 (21%), Positives = 103/272 (37%), Gaps = 20/272 (7%)

Query: 440 NNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-- 497
           + S    IP  L     ++ L++  N+      S L  C  L  ++L  N +   + E  
Sbjct: 40  SGSLN-SIPSGLTEA--VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95

Query: 498 FSKNPVLSHLDVSRNNISGAIPSSI-GNSINLTSIDFSSNKFSGLMPQEL-GNLVSLVTL 555
           FS    L HLD+S N +S  + SS      +LT ++   N +  L    L  +L  L  L
Sbjct: 96  FSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL 154

Query: 556 NISLNHVEGSLPSQ-LSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGI 614
            +        +  +  +    LE  ++  + L    P SL+S +++S L L        +
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL 214

Query: 615 PTFISELEKLLELQLGGNQLGGEIPPSI--GALQDLSYALNLSKNGLTG----RIPSDLE 668
             F+     +  L+L    L       +  G    L          +T     ++   L 
Sbjct: 215 EIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN 274

Query: 669 KLSKLEQLDISSNNLT----GTLSPLSNIHSL 696
           ++S L +L+ S N L     G    L+++  +
Sbjct: 275 QISGLLELEFSRNQLKSVPDGIFDRLTSLQKI 306

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 67/413 (16%), Positives = 126/413 (30%), Gaps = 120/413 (29%)

Query: 275 FSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGK 333
                +    +C            L  SIPS  GL   + SLDLS N+++  I    L +
Sbjct: 19  KEESSNQASLSCDRNGICKGSSGSLN-SIPS--GLTEAVKSLDLSNNRIT-YISNSDLQR 74

Query: 334 CKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNN 393
           C  L  L L +N +     D    L +L+ L+L                         + 
Sbjct: 75  CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL-------------------------SY 109

Query: 394 NLLGKLPLEM-TELKQLKNISLYNNQFSGVIPQSLGIN-SSLMQLDFINNSFTGEIPPNL 451
           N L  L       L  L  ++L  N +  +   SL  + + L  L   N     +I    
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169

Query: 452 CFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSR 511
                                                         F+    L  L++  
Sbjct: 170 ----------------------------------------------FAGLTFLEELEIDA 183

Query: 512 NNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLS 571
           +++    P S+ +  N++ +     +   L+   +    S+  L +    ++    S+LS
Sbjct: 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243

Query: 572 KCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGG 631
                       N        SL    +   +K+++      +   ++++  LLEL+   
Sbjct: 244 --------TGETN--------SLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286

Query: 632 NQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT 684
           NQL   +P  I                         ++L+ L+++ + +N   
Sbjct: 287 NQLKS-VPDGI------------------------FDRLTSLQKIWLHTNPWD 314

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (277), Expect = 1e-26
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 15/202 (7%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVRLED 883
             +GRGA+G+V K    P   + AVK++    + +    +  ++    + +     V    
Sbjct: 14   ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 884  FWLRK-DCGIIMYRYMENGSLRDVLHSITPPP-TLEWNVRYKIALGAAHALAYLHYDCDP 941
               R+ D  I M   M + SL      +     T+  ++  KIA+    AL +LH     
Sbjct: 74   ALFREGDVWICM-ELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE----NAF 997
             ++HRD+KP N+L+++  +  + DFGI+  L    A        G   Y+APE       
Sbjct: 131  -VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI---DAGCKPYMAPERINPELN 186

Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
                S +SD++S G+ ++EL  
Sbjct: 187  QKGYSVKSDIWSLGITMIELAI 208

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  110 bits (277), Expect = 1e-26
 Identities = 69/308 (22%), Positives = 118/308 (38%), Gaps = 60/308 (19%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSM-----KREIQ 868
              L     +G G  G V      P         AVK L     K  S        K+EI+
Sbjct: 21   RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-----KPESGGNHIADLKKEIE 75

Query: 869  TIGKIRHRNLVRLEDFWLRKDCG---IIMYRYMENGSLRDVL----HSITPPPTLEWNVR 921
             +  + H N+V+ +            +IM  ++ +GSL++ L    + I     L++   
Sbjct: 76   ILRNLYHENIVKYKGICTEDGGNGIKLIM-EFLPSGSLKEYLPKNKNKINLKQQLKY--- 131

Query: 922  YKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
               A+     + YL    Y      VHRD+   N+L++SE +  I DFG+ K ++    +
Sbjct: 132  ---AVQICKGMDYLGSRQY------VHRDLAARNVLVESEHQVKIGDFGLTKAIE----T 178

Query: 979  TTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYK 1029
                  V           APE    + F  A    SDV+S+GV L EL+T   +      
Sbjct: 179  DKEYYTVKDDRDSPVFWYAPECLMQSKFYIA----SDVWSFGVTLHELLTYCDSDSSPMA 234

Query: 1030 ERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN 1089
                ++G      + T  +N + +   +             +V  +  +C E +PSNR +
Sbjct: 235  LFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCP-----DEVYQLMRKCWEFQPSNRTS 289

Query: 1090 MRDVVRQL 1097
             ++++   
Sbjct: 290  FQNLIEGF 297

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  111 bits (281), Expect = 1e-26
 Identities = 69/358 (19%), Positives = 118/358 (32%), Gaps = 80/358 (22%)

Query: 753  DYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQEGPSYLLK 812
            D+  S QQ L K                         L R   K    +           
Sbjct: 83   DHLLSTQQPLTKKS--------------------GVVLHRAVPKDKWVLNH--------- 113

Query: 813  QVIEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIG 871
                  E+L     IGRG  G V+   L   N + AVK               +E + + 
Sbjct: 114  ------EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILK 167

Query: 872  KIRHRNLVRLEDFWLRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH 930
            +  H N+VRL     +K    I+M   ++ G     L +      L      ++   AA 
Sbjct: 168  QYSHPNIVRLIGVCTQKQPIYIVM-ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAA 224

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             + YL        +HRD+   N L+  +    ISDFG+++            +  G +  
Sbjct: 225  GMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD-----GVYAASGGLRQ 276

Query: 991  I-----APE----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041
            +     APE      +++     SDV+S+G++L E  +      P Y             
Sbjct: 277  VPVKWTAPEALNYGRYSSE----SDVWSFGILLWETFS--LGASP-YPN----------- 318

Query: 1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
             S+ +    +     +    +    D V  ++    +C   +P  RP+   + ++L  
Sbjct: 319  LSNQQTREFVEKGGRLPCPELCP--DAVFRLM---EQCWAYEPGQRPSFSTIYQELQS 371

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (279), Expect = 2e-26
 Identities = 37/251 (14%), Positives = 84/251 (33%), Gaps = 22/251 (8%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS----MKREIQTIGKIRHRNL 878
             H++G GA   VY+A     N     +K   +  K  +        + ++ +        
Sbjct: 70   HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPP--TLEWNVRYKIALGAAHALAYLH 936
            ++     L ++  +++      G+L + ++     P   +   +    A+   + +  +H
Sbjct: 130  MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPH-----------ISDFGIAKLLDKSPASTTSISVV 985
               D  I+H DIKP+N +L +                + D G +  +   P  T   +  
Sbjct: 190  ---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045
             T G+   E       + + D +     +  ++        +        G  R +    
Sbjct: 247  ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP-HL 305

Query: 1046 EEINDIVDLSL 1056
            +  N+   + L
Sbjct: 306  DMWNEFFHVML 316

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  115 bits (288), Expect = 2e-26
 Identities = 60/208 (28%), Positives = 86/208 (41%), Gaps = 20/208 (9%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            K  +G G  G V +          A+K+       +       EIQ + K+ H N+V   
Sbjct: 19   KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 883  DF-------WLRKDCGIIMYRYMENGSLRDVLHSITPPPTL-EWNVRYKIALGAAHALAY 934
            +               + M  Y E G LR  L+       L E  +R  +    + AL Y
Sbjct: 79   EVPDGLQKLAPNDLPLLAM-EYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRY 136

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVVGTIGYI 991
            LH   +  I+HRD+KPENI+L    +     I D G AK LD+    T     VGT+ Y+
Sbjct: 137  LH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF---VGTLQYL 190

Query: 992  APENAFTTAKSKESDVYSYGVVLLELIT 1019
            APE       +   D +S+G +  E IT
Sbjct: 191  APELLEQKKYTVTVDYWSFGTLAFECIT 218

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  109 bits (275), Expect = 3e-26
 Identities = 63/210 (30%), Positives = 91/210 (43%), Gaps = 16/210 (7%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHR 876
            E+L     IGRGA+G V K    P   + AVK++     ++    +  ++  + +     
Sbjct: 22   EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 877  NLVRLEDFWLRK-DCGIIMYRYMENGSLRDVLHSITP--PPTLEWNVRYKIALGAAHALA 933
             +V+      R+ DC I M   M + S       +       +   +  KI L    AL 
Sbjct: 82   YIVQFYGALFREGDCWICM-ELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            +L  +    I+HRDIKP NILLD      + DFGI+  L  S A T      G   Y+AP
Sbjct: 140  HLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAP 194

Query: 994  E----NAFTTAKSKESDVYSYGVVLLELIT 1019
            E    +A        SDV+S G+ L EL T
Sbjct: 195  ERIDPSASRQGYDVRSDVWSLGITLYELAT 224

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (274), Expect = 6e-26
 Identities = 62/241 (25%), Positives = 96/241 (39%), Gaps = 52/241 (21%)

Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA------VFAVKKLAFRGHKR 858
            E P+  L ++++ TE      V+G GA G VYK    P        V A+K+L     + 
Sbjct: 2    EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKEL-----RE 54

Query: 859  GSLSMK-----REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----S 909
             +          E   +  + + ++ RL    L     +I  + M  G L D +     +
Sbjct: 55   ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 113

Query: 910  ITPPPTLEWNVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDF 966
            I     L W       +  A  + YL           VHRD+   N+L+ +     I+DF
Sbjct: 114  IGSQYLLNW------CVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDF 161

Query: 967  GIAKLLDKSPASTTSISVVGT---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            G+AKLL        +    G    I ++A E      +T      SDV+SYGV + EL+T
Sbjct: 162  GLAKLLGAEEKEYHA---EGGKVPIKWMALESILHRIYTHQ----SDVWSYGVTVWELMT 214

Query: 1020 R 1020
             
Sbjct: 215  F 215

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  107 bits (270), Expect = 7e-26
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 15/199 (7%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS--MKREIQTIGKIRHRNLVRL 881
              +G+G  G VY A       + A+K L     ++  +   ++RE++    +RH N++RL
Sbjct: 15   RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 882  -EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
               F       +I+  Y   G++   L  ++     E      I    A+AL+Y H    
Sbjct: 75   YGYFHDATRVYLIL-EYAPLGTVYRELQKLSKFD--EQRTATYITE-LANALSYCHSKR- 129

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              ++HRDIKPEN+LL S  E  I+DFG +     S  +       GT+ Y+ PE      
Sbjct: 130  --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPEMIEGRM 183

Query: 1001 KSKESDVYSYGVVLLELIT 1019
              ++ D++S GV+  E + 
Sbjct: 184  HDEKVDLWSLGVLCYEFLV 202

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  109 bits (273), Expect = 8e-26
 Identities = 66/319 (20%), Positives = 120/319 (37%), Gaps = 49/319 (15%)

Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGS 860
              ++   ++ + V      L  + V+  G    VY+A  +G    +A+K+L     +  +
Sbjct: 11   SGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKN 69

Query: 861  LSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRY-----ME--NGSLRDVLHSITP 912
             ++ +E+  + K+  H N+V+               +       E   G L + L  +  
Sbjct: 70   RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129

Query: 913  PPTL-EWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
               L    V  KI      A+ ++H    PPI+HRD+K EN+LL ++    + DFG A  
Sbjct: 130  RGPLSCDTVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187

Query: 972  LDKSPASTTS----------ISVVGTIGYIAPENAFTTAK---SKESDVYSYGVVLLELI 1018
            +   P  + S          I+   T  Y  PE     +     ++ D+++ G +L  L 
Sbjct: 188  ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247

Query: 1019 TRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALR 1078
             R+   +   K R  IV                   S+       ++   +I  +L    
Sbjct: 248  FRQHPFEDGAKLR--IVN---------------GKYSIPPHDTQYTVFHSLIRAMLQ--- 287

Query: 1079 CTEKKPSNRPNMRDVVRQL 1097
                 P  R ++ +VV QL
Sbjct: 288  ---VNPEERLSIAEVVHQL 303

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (268), Expect = 3e-25
 Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 17/202 (8%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVR-LE 882
             +G G  G V+K        V AVK++   G+K  +  +  ++  + K      +V+   
Sbjct: 32   EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
             F    D  I M   M   + +           +   +  K+ +    AL YL       
Sbjct: 92   TFITNTDVFIAM-ELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHG-- 145

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE-----NAF 997
            ++HRD+KP NILLD   +  + DFGI+  L    A   S    G   Y+APE     +  
Sbjct: 146  VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---AGCAAYMAPERIDPPDPT 202

Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
                   +DV+S G+ L+EL T
Sbjct: 203  KPDYDIRADVWSLGISLVELAT 224

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  105 bits (265), Expect = 4e-25
 Identities = 70/320 (21%), Positives = 114/320 (35%), Gaps = 84/320 (26%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSMK----REIQT 869
             +L     +G+G  G V      P       V AVKKL     +  +        REI+ 
Sbjct: 10   RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----QHSTEEHLRDFEREIEI 64

Query: 870  IGKIRHRNLVRLEDFWLRKDCG---IIMYRYMENGSLRDVL----HSITPPPTLEWNVRY 922
            +  ++H N+V+ +            +IM  Y+  GSLRD L      I     L++    
Sbjct: 65   LKSLQHDNIVKYKGVCYSAGRRNLKLIM-EYLPYGSLRDYLQKHKERIDHIKLLQY---- 119

Query: 923  KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST 979
                     + YL    Y      +HRD+   NIL+++E    I DFG+ K+L +     
Sbjct: 120  --TSQICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171

Query: 980  TSISVVGT---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032
                       I + APE    + F+ A    SDV+S+GVVL EL T  +       E  
Sbjct: 172  KVKE--PGESPIFWYAPESLTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFM 225

Query: 1033 DIVGWVRSVWSDTEEINDIVDL---------------SLMEEMLVSSIRDQVIDVLLVAL 1077
             ++G  +        + +++                  +M                    
Sbjct: 226  RMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIM-------------------T 266

Query: 1078 RCTEKKPSNRPNMRDVVRQL 1097
             C     + RP+ RD+  ++
Sbjct: 267  ECWNNNVNQRPSFRDLALRV 286

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  106 bits (266), Expect = 4e-25
 Identities = 70/306 (22%), Positives = 112/306 (36%), Gaps = 58/306 (18%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMK-----REIQ 868
              L     +G G  G V          G   + AVK L     K  +         +EI 
Sbjct: 31   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-----KADAGPQHRSGWKQEID 85

Query: 869  TIGKIRHRNLVRLEDFWLRKDCG---IIMYRYMENGSLRDVL--HSITPPPTLEWNVRYK 923
             +  + H ++++ +            ++M  Y+  GSLRD L  HSI     L +     
Sbjct: 86   ILRTLYHEHIIKYKGCCEDAGAASLQLVM-EYVPLGSLRDYLPRHSIGLAQLLLF----- 139

Query: 924  IALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
             A      +AYL   HY      +HRD+   N+LLD++    I DFG+AK + +      
Sbjct: 140  -AQQICEGMAYLHAQHY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---- 188

Query: 981  SISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
                V   G       APE      F  A    SDV+S+GV L EL+T   +      + 
Sbjct: 189  EYYRVREDGDSPVFWYAPECLKEYKFYYA----SDVWSFGVTLYELLTHCDSSQSPPTKF 244

Query: 1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
             +++G  +   +       +     +             +V  +   C E + S RP   
Sbjct: 245  LELIGIAQGQMTVLRLTELLERGERLPRPDKCP-----AEVYHLMKNCWETEASFRPTFE 299

Query: 1092 DVVRQL 1097
            +++  L
Sbjct: 300  NLIPIL 305

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  105 bits (265), Expect = 4e-25
 Identities = 60/244 (24%), Positives = 89/244 (36%), Gaps = 50/244 (20%)

Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHK 857
             A EGP   L  +I   + L     +G G+ G+V +       G     AVK L     K
Sbjct: 2    SAGEGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-----K 55

Query: 858  RGSLSMK-------REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH-- 908
               LS         RE+  +  + HRNL+RL    L     ++       GSL D L   
Sbjct: 56   PDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKH 114

Query: 909  --SITPPPTLEWNVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHI 963
                       +      A+  A  + YL    +      +HRD+   N+LL +     I
Sbjct: 115  QGHFLLGTLSRY------AVQVAEGMGYLESKRF------IHRDLAARNLLLATRDLVKI 162

Query: 964  SDFGIAKLLDKSPASTTSISVVGT---IGYIAPE----NAFTTAKSKESDVYSYGVVLLE 1016
             DFG+ + L ++                 + APE      F+ A    SD + +GV L E
Sbjct: 163  GDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHA----SDTWMFGVTLWE 216

Query: 1017 LITR 1020
            + T 
Sbjct: 217  MFTY 220

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  108 bits (271), Expect = 5e-25
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 36/211 (17%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVK-----KLAFRGHKRGS--LSMKREIQTIGKIRH 875
               +G GA G V  A         A++     K A    +     L+++ EI+ + K+ H
Sbjct: 140  SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA------ 929
              ++++++F+  +D  I++   ME G L D +           N R K A          
Sbjct: 200  PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVG---------NKRLKEATCKLYFYQML 249

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVVG 986
             A+ YLH   +  I+HRD+KPEN+LL S+ E     I+DFG +K+L ++    T   + G
Sbjct: 250  LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCG 303

Query: 987  TIGYIAPE---NAFTTAKSKESDVYSYGVVL 1014
            T  Y+APE   +  T   ++  D +S GV+L
Sbjct: 304  TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  110 bits (275), Expect = 6e-25
 Identities = 47/230 (20%), Positives = 97/230 (42%), Gaps = 16/230 (6%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
            ++    +L   + +  +       ++++ +  + +     +    + L N+  L L GN
Sbjct: 20  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 75

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
            L  +I +PL  +  L ++FL+ N +   +  ++ DLK++++L L  N +S  I   + +
Sbjct: 76  KLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVH 129

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
             +L+ LYL  NK+       LS L  L  L + DN +   +         L  L LS N
Sbjct: 130 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSKN 185

Query: 274 RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
             S  +   L    +L  L++   +      +    L   +++  ++  L
Sbjct: 186 HIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 96.3 bits (239), Expect = 1e-20
 Identities = 46/256 (17%), Positives = 94/256 (36%), Gaps = 18/256 (7%)

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS 276
           + E       +    P         +  ++   ++   +     +  ++  +  + +   
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK 56

Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKY 336
             +   +    ++T L + G+KLT  I      L  L  L L EN++   +   L   K 
Sbjct: 57  -SVQ-GIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKK 110

Query: 337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLL 396
           L  L L  N +  +I   L  L  L+ L L +N++T    +S  R+  L+ L + +N + 
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS 166

Query: 397 GKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQ 456
             +PL    L +L+N+ L  N  S +  ++L    +L  L+  +     +   +      
Sbjct: 167 DIVPLA--GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 457 LRVLNMGQNQFHGPIP 472
              +         P  
Sbjct: 223 PNTVKNTDGSLVTPEI 238

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.8 bits (235), Expect = 5e-20
 Identities = 44/236 (18%), Positives = 93/236 (39%), Gaps = 21/236 (8%)

Query: 485 ILKQNQLT--GALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLM 542
           I     +        F++       ++ + +++ A+        ++  I  +++    + 
Sbjct: 5   ITVSTPIKQIFPDDAFAE---TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV- 58

Query: 543 PQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI 602
            Q +  L ++  L ++ N +   +   L+  KNL    +  N +   + SSL+  K L  
Sbjct: 59  -QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKS 113

Query: 603 LKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGR 662
           L L  N  +      +  L +L  L LG N++       +  L  L   L+L  N ++  
Sbjct: 114 LSLEHNGIS--DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDT-LSLEDNQISD- 167

Query: 663 IPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLL 718
               L  L+KL+ L +S N+++  L  L+ + +L  + +              NL+
Sbjct: 168 -IVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 91.7 bits (227), Expect = 4e-19
 Identities = 51/274 (18%), Positives = 98/274 (35%), Gaps = 23/274 (8%)

Query: 361 LQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS 420
           + +       +   FP      A      +   ++   +     EL  +  I   N+   
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56

Query: 421 GVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSL--LGSC 478
            V  Q +    ++ +L    N  T +I P L   K L  L + +N+    I  L  L   
Sbjct: 57  SV--QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENK----IKDLSSLKDL 108

Query: 479 PTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKF 538
             L  + L+ N ++  +      P L  L +  N I+    + +     L ++    N+ 
Sbjct: 109 KKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 165

Query: 539 SGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWK 598
           S ++P  L  L  L  L +S NH+   L   L+  KNL+V ++          +   +  
Sbjct: 166 SDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 599 SLSILKLSENHFTGGIPTFISELEKLLELQLGGN 632
             + +K ++       P  IS+     +  +  +
Sbjct: 222 VPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.4 bits (221), Expect = 2e-18
 Identities = 42/210 (20%), Positives = 92/210 (43%), Gaps = 14/210 (6%)

Query: 64  IECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEY 123
               ++ +++     ++  +   +   I +L  +  + L+ N  + +I P L N   L +
Sbjct: 36  AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGW 91

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
           L L  N    D+  + ++L+ L+ L+L  N +  +I   L  +  L+ ++L NN ++  I
Sbjct: 92  LFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DI 146

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
              +  L +++ L L  N++S  I   +    +LQ LYL++N +      +L+ L+NL  
Sbjct: 147 T-VLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDV 201

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
           L++       +             +  +  
Sbjct: 202 LELFSQECLNKPINHQSNLVVPNTVKNTDG 231

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 87.5 bits (216), Expect = 9e-18
 Identities = 41/201 (20%), Positives = 77/201 (38%), Gaps = 16/201 (7%)

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE 563
           +         I    P            +      +  + Q    L S+  +  + + ++
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56

Query: 564 GSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEK 623
            S+   +    N+    ++ N L   I   L + K+L  L L EN         + +L+K
Sbjct: 57  -SV-QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKK 110

Query: 624 LLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNL 683
           L  L L  N +  +I   +  L  L   L L  N +T    + L +L+KL+ L +  N +
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLES-LYLGNNKIT--DITVLSRLTKLDTLSLEDNQI 165

Query: 684 TGTLSPLSNIHSLVEVNVSYN 704
           +  + PL+ +  L  + +S N
Sbjct: 166 S-DIVPLAGLTKLQNLYLSKN 185

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 79.4 bits (195), Expect = 3e-15
 Identities = 36/161 (22%), Positives = 65/161 (40%), Gaps = 10/161 (6%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
           + +L  L  + L  N    ++   L +   L+ L L  NG + DI +   +L  L+ L L
Sbjct: 83  LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYL 138

Query: 151 YGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
             N +       L R+  L  + L +N +S  I   +  L +++ L+L  N +  +   +
Sbjct: 139 GNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI--SDLRA 192

Query: 211 IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
           +     L  L L   + +       SNL     +   D +L
Sbjct: 193 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  106 bits (267), Expect = 6e-25
 Identities = 44/218 (20%), Positives = 79/218 (36%), Gaps = 32/218 (14%)

Query: 826  VIGRGAHGIVY---------------KASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
             + +G    +                K+ L     F          K      K E+Q I
Sbjct: 38   TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 871  GKIRHRNLVRL-EDFWLRKDCGIIMYRYMENGSL------RDVLHSITPPPTLEWNVRYK 923
              I++   +          +  II   YMEN S+        VL            ++  
Sbjct: 98   TDIKNEYCLTCEGIITNYDEVYIIY-EYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 924  IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSIS 983
            I     ++ +Y+H + +  I HRD+KP NIL+D      +SDFG ++ +       +   
Sbjct: 157  IK-SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210

Query: 984  VVGTIGYIAPE--NAFTTAKSKESDVYSYGVVLLELIT 1019
              GT  ++ PE  +  ++    + D++S G+ L  +  
Sbjct: 211  -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  104 bits (263), Expect = 7e-25
 Identities = 46/214 (21%), Positives = 92/214 (42%), Gaps = 34/214 (15%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            ++L     +G G  G+V           A+K +     K GS+S      E + +  + H
Sbjct: 24   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-----KEGSMSEDEFIEEAKVMMNLSH 78

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
              LV+L     ++    I+  YM NG L + L  +      +  +  ++      A+ YL
Sbjct: 79   EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL--EMCKDVCEAMEYL 136

Query: 936  ---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---IG 989
                +      +HRD+   N L++ +    +SDFG+++ +          S VG+   + 
Sbjct: 137  ESKQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVL----DDEYTSSVGSKFPVR 186

Query: 990  YIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            +  PE    + F++     SD++++GV++ E+ +
Sbjct: 187  WSPPEVLMYSKFSSK----SDIWAFGVLMWEIYS 216

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  105 bits (263), Expect = 7e-25
 Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 20/234 (8%)

Query: 99  TIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLL 155
           T              IP       A + + L  N  +     +F   +NL  L L+ N+L
Sbjct: 15  TTSCPQQGLQAVPVGIPA------ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68

Query: 156 DGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESI-G 212
              I    F  L  L+ + L++N+   S+       L  +  L L    L   +   +  
Sbjct: 69  -ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFR 126

Query: 213 NCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLS 271
               LQ LYL +N L     ++  +L NL +L +  N +   +   +     +L  L L 
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLH 185

Query: 272 YNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQL 323
            NR +  + P+   +   L  L +  + L+ ++P+     L  L  L L++N  
Sbjct: 186 QNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  101 bits (253), Expect = 1e-23
 Identities = 45/204 (22%), Positives = 76/204 (37%), Gaps = 11/204 (5%)

Query: 97  LQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLL 155
            Q I L  N  S ++P      C  L  L L +N         F  L  L+ L+L  N  
Sbjct: 34  SQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 156 DGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESI-G 212
              +    F  LG L  + L+   L   +   +   L  ++ L+L  N L   +P+    
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150

Query: 213 NCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLS 271
           +   L  L+L+ N++      +   L +L  L +  N +   ++  +      L  L L 
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLF 209

Query: 272 YNRFSGGISPN-LGNCSSLTHLDI 294
            N  S  +    L    +L +L +
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRL 232

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (252), Expect = 2e-23
 Identities = 58/251 (23%), Positives = 91/251 (36%), Gaps = 32/251 (12%)

Query: 172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFL 231
                  L  ++P  +      + ++L  NR+S     S   C  L  L+L+ N L    
Sbjct: 16  TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 232 PESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPNLGNCSSLT 290
             + + L  L  LD+ DN     ++  +      L  L L                  L 
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG--------------LQ 118

Query: 291 HLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQLEG 349
            L           P  F  LA L  L L +N L   +P +       LT L L+ N++  
Sbjct: 119 ELG----------PGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS 167

Query: 350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLE-MTELKQ 408
                   L +L  L L  NR+    P +   +  L  L ++ NN L  LP E +  L+ 
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN-LSALPTEALAPLRA 226

Query: 409 LKNISLYNNQF 419
           L+ + L +N +
Sbjct: 227 LQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  100 bits (251), Expect = 2e-23
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 9/186 (4%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
               L  + L SN  +  I        + LE LDLS N     +    F  L  L  L+L
Sbjct: 54  ACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIP 208
               L  E+   LFR L  LQY++L +N+L  ++P +   DL  +  L+L  NR+S    
Sbjct: 113 DRCGL-QELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPE 170

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTF 267
            +    + L  L L++N++    P +  +L  L+ L +  NNL   +   +    + L +
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQY 229

Query: 268 LDLSYN 273
           L L+ N
Sbjct: 230 LRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.8 bits (239), Expect = 9e-22
 Identities = 53/163 (32%), Positives = 76/163 (46%), Gaps = 7/163 (4%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
            L+ L+ +DLS N    ++ P        L  L L   G   ++    F  L  LQYL L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIP 208
             N L   +P+  FR LG L ++FL+ N +S S+P      L  ++ L L  NR++   P
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
            +  +  RL  LYL  N L     E+L+ L  L YL + DN  
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 45/203 (22%), Positives = 73/203 (35%), Gaps = 16/203 (7%)

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE 563
              + +  N IS    +S     NLT +   SN  + +       L  L  L++S N   
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 564 GSLPSQ-LSKCKNLEVFDVSFNLLNGSIPS-SLRSWKSLSILKLSENHFTGGIPTFI-SE 620
            S+          L    +    L   +     R   +L  L L +N     +P     +
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151

Query: 621 LEKLLELQLGGNQLGGEIPPSIGALQDLSY--ALNLSKNGLTGRIPSD-LEKLSKLEQLD 677
           L  L  L L GN++   +P    A + L     L L +N +   +       L +L  L 
Sbjct: 152 LGNLTHLFLHGNRI-SSVPE--RAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207

Query: 678 ISSNNLT----GTLSPLSNIHSL 696
           + +NNL+      L+PL  +  L
Sbjct: 208 LFANNLSALPTEALAPLRALQYL 230

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 46/256 (17%), Positives = 84/256 (32%), Gaps = 35/256 (13%)

Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
                        L  ++P   G+ A    + L  N++S         C+ LT+L L++N
Sbjct: 10  NEPKVTTSCPQQGLQ-AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSN 66

Query: 346 QLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM-T 404
            L          L+ L+ L+L                         +N  L  +      
Sbjct: 67  VLARIDAAAFTGLALLEQLDL------------------------SDNAQLRSVDPATFH 102

Query: 405 ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMG 463
            L +L  + L       + P      ++L  L   +N+    +P +       L  L + 
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLH 161

Query: 464 QNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSS 521
            N+             +L R++L QN++   +    F     L  L +  NN+S A+P+ 
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219

Query: 522 I-GNSINLTSIDFSSN 536
                  L  +  + N
Sbjct: 220 ALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 46/252 (18%), Positives = 84/252 (33%), Gaps = 37/252 (14%)

Query: 315 SLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGE 374
           +    +  L   +P  +        + L+ N++            NL  L L  N L   
Sbjct: 15  TTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 375 FPVSIWRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQFSGVIPQSLGINSSL 433
              +   +A LE L + +N  L  +       L +L  + L                   
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ------------- 118

Query: 434 MQLDFINNSFTGEIPPNLCFGK--QLRVLNMGQNQFHGPIPS-LLGSCPTLWRVILKQNQ 490
                       E+ P L F     L+ L +  N     +P         L  + L  N+
Sbjct: 119 ------------ELGPGL-FRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNR 164

Query: 491 LTGALPE--FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGN 548
           ++ ++PE  F     L  L + +N ++   P +  +   L ++   +N  S L  + L  
Sbjct: 165 IS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAP 223

Query: 549 LVSLVTLNISLN 560
           L +L  L ++ N
Sbjct: 224 LRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 45/206 (21%), Positives = 75/206 (36%), Gaps = 10/206 (4%)

Query: 409 LKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQF 467
            + I L+ N+ S V   S     +L  L   +N     I      G   L  L++  N  
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92

Query: 468 HGPIPS-LLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSI-G 523
              +          L  + L +  L   L    F     L +L +  N +  A+P     
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150

Query: 524 NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSF 583
           +  NLT +    N+ S +  +    L SL  L +  N V    P        L    +  
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210

Query: 584 NLLNGSIPSS-LRSWKSLSILKLSEN 608
           N L+ ++P+  L   ++L  L+L++N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 17/66 (25%), Positives = 25/66 (37%), Gaps = 4/66 (6%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
            L  L  + L  N  + ++ P    +   L  L L  N  +  +P      L+ LQYL L
Sbjct: 175 GLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRL 232

Query: 151 YGNLLD 156
             N   
Sbjct: 233 NDNPWV 238

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (263), Expect = 7e-25
 Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 40/216 (18%)

Query: 824  KHVIGRGAHGIVYKASLGPNA----VFAVKKLAFRGHKRGSLSMKR-----EIQTIGKIR 874
               +G G  G V +           V A+K L     K+G+          E Q + ++ 
Sbjct: 15   DIELGCGNFGSVRQGVYRMRKKQIDV-AIKVL-----KQGTEKADTEEMMREAQIMHQLD 68

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            +  +VRL      +   ++M      G L   L        +  +   ++    +  + Y
Sbjct: 69   NPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKY 125

Query: 935  L---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---I 988
            L   ++      VHRD+   N+LL +     ISDFG++K L    +  T+ S       +
Sbjct: 126  LEEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPL 177

Query: 989  GYIAPE----NAFTTAKSKESDVYSYGVVLLELITR 1020
             + APE      F++     SDV+SYGV + E ++ 
Sbjct: 178  KWYAPECINFRKFSSR----SDVWSYGVTMWEALSY 209

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  105 bits (263), Expect = 8e-25
 Identities = 49/260 (18%), Positives = 91/260 (35%), Gaps = 18/260 (6%)

Query: 64  IECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEY 123
           I  D    N +        V+         L  + T+       +  I   +   + L  
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIG 67

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
           L+L  N  T D+    +NL  +  L L GN L  +    +  +  ++ + L +  ++   
Sbjct: 68  LELKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
           P  +  L  ++ L+L  N+++      +     LQ L +   ++       L+NL  L  
Sbjct: 124 P--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTT 177

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI 303
           L   DN +            NL  + L  N+ S  +SP L N S+L  + +    +T   
Sbjct: 178 LKADDNKISDISPL--ASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQP 233

Query: 304 PSSFGLLARLSSLDLSENQL 323
                 L   + +       
Sbjct: 234 VFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  103 bits (259), Expect = 3e-24
 Identities = 56/283 (19%), Positives = 114/283 (40%), Gaps = 20/283 (7%)

Query: 140 ENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF 199
             L N   +    + +          + G+  +      ++ +I   V  L  +  L L 
Sbjct: 16  PALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELK 71

Query: 200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS 259
            N+++   P  + N  ++ EL L+ N L      +++ L+++  LD+    +        
Sbjct: 72  DNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPL-- 125

Query: 260 EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLS 319
               NL  L L  N+ +  ISP L   ++L +L I  ++++  + +    L++L++L   
Sbjct: 126 AGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKAD 181

Query: 320 ENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI 379
           +N++S  I P L     L  +HL  NQ+    P  L   SNL  + L +  +T +     
Sbjct: 182 DNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYN 237

Query: 380 WRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGV 422
             +      +V   +     P  +++     + +L  N  S +
Sbjct: 238 NNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  103 bits (259), Expect = 3e-24
 Identities = 64/338 (18%), Positives = 108/338 (31%), Gaps = 53/338 (15%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
           L+    I    +N +  +     +   +  L     G T  I    + L NL  L L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
            +                       L+      + +L ++  L L  N L      +I  
Sbjct: 74  QI---------------------TDLA-----PLKNLTKITELELSGNPL--KNVSAIAG 105

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
              ++ L L   ++       L+ L NL  L +  N +            NL +L +   
Sbjct: 106 LQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISPL--AGLTNLQYLSIGNA 161

Query: 274 RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGK 333
           + S  ++P L N S LT L    +K++  I S    L  L  + L  NQ+S  + P L  
Sbjct: 162 QVS-DLTP-LANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQIS-DVSP-LAN 215

Query: 334 CKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNN 393
              L ++ L    +  +       L     ++          P +I      +     + 
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIA--PATI-----SDNGTYASP 268

Query: 394 NLLGKLPLEMTEL----KQLKNISLYNNQFSGVIPQSL 427
           NL   L   +  +     Q          FSG + Q L
Sbjct: 269 NLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTVTQPL 306

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 63/304 (20%), Positives = 116/304 (38%), Gaps = 43/304 (14%)

Query: 233 ESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHL 292
                L N + +  G +N+   +         +T L       +      +   ++L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTT--IEGVQYLNNLIGL 68

Query: 293 DIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIP 352
           ++  +++T  + +    L +++ L+LS N L   +   +   + +  L L + Q+    P
Sbjct: 69  ELKDNQIT-DL-APLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP 124

Query: 353 DELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNI 412
             L  LSNLQ L L  N++T         I+ L                    L  L+ +
Sbjct: 125 --LAGLSNLQVLYLDLNQIT--------NISPLA------------------GLTNLQYL 156

Query: 413 SLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIP 472
           S+ N Q S + P  L   S L  L   +N  + +I P L     L  +++  NQ     P
Sbjct: 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP 212

Query: 473 SLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSID 532
             L +   L+ V L    +T   P F  N ++    V   + +   P++I ++    S +
Sbjct: 213 --LANTSNLFIVTLTNQTITN-QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPN 269

Query: 533 FSSN 536
            + N
Sbjct: 270 LTWN 273

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 88.2 bits (219), Expect = 5e-19
 Identities = 47/244 (19%), Positives = 99/244 (40%), Gaps = 17/244 (6%)

Query: 475 LGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFS 534
             +     ++   ++ +T      +    ++ L      ++      +    NL  ++  
Sbjct: 15  DPALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71

Query: 535 SNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSL 594
            N+ + L P  L NL  +  L +S N +     S ++  ++++  D++   +    P  L
Sbjct: 72  DNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--L 125

Query: 595 RSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNL 654
               +L +L L  N  T   P  ++ L  L  L +G  Q+  ++ P +  L  L+  L  
Sbjct: 126 AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTT-LKA 180

Query: 655 SKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETL 714
             N ++    S L  L  L ++ + +N ++  +SPL+N  +L  V ++    T       
Sbjct: 181 DDNKISD--ISPLASLPNLIEVHLKNNQIS-DVSPLANTSNLFIVTLTNQTITNQPVFYN 237

Query: 715 MNLL 718
            NL+
Sbjct: 238 NNLV 241

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 86.3 bits (214), Expect = 3e-18
 Identities = 43/194 (22%), Positives = 83/194 (42%), Gaps = 15/194 (7%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
             + +L+K+  ++LS N    N+   +    +++ LDL++   T D+      L NLQ L
Sbjct: 79  APLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT-DVT-PLAGLSNLQVL 134

Query: 149 NLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIP 208
            L  N +   I  PL  +  LQY+ + N  +S  +   + +L ++  L    N++S    
Sbjct: 135 YLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKISDI-- 188

Query: 209 ESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL 268
             + +   L E++L  N++       L+N  NL  + + +  +    N       NL   
Sbjct: 189 SPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT---NQPVFYNNNLVVP 243

Query: 269 DLSYNRFSGGISPN 282
           ++        I+P 
Sbjct: 244 NVVKGPSGAPIAPA 257

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  104 bits (261), Expect = 9e-25
 Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 36/215 (16%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIR 874
              L     IG G  G+V+       + V A+K +     + G++S +    E + + K+ 
Sbjct: 8    SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI-----REGAMSEEDFIEEAEVMMKLS 61

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            H  LV+L    L +    ++  +ME+G L D L +       E  +   + L     +AY
Sbjct: 62   HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL--GMCLDVCEGMAY 119

Query: 935  L---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---I 988
            L           +HRD+   N L+       +SDFG+ + +          S  GT   +
Sbjct: 120  LEEACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPV 169

Query: 989  GYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
             + +PE    + +++     SDV+S+GV++ E+ +
Sbjct: 170  KWASPEVFSFSRYSSK----SDVWSFGVLMWEVFS 200

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (261), Expect = 1e-24
 Identities = 48/214 (22%), Positives = 92/214 (42%), Gaps = 34/214 (15%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E +     +G G  G+V           AVK +     K GS+S     +E QT+ K+ H
Sbjct: 8    EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-----KEGSMSEDEFFQEAQTMMKLSH 62

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
              LV+      ++    I+  Y+ NG L + L S          +  ++       +A+L
Sbjct: 63   PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL--EMCYDVCEGMAFL 120

Query: 936  ---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---IG 989
                +      +HRD+   N L+D ++   +SDFG+ + +      ++     GT   + 
Sbjct: 121  ESHQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVK 170

Query: 990  YIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            + APE      +++     SDV+++G+++ E+ +
Sbjct: 171  WSAPEVFHYFKYSSK----SDVWAFGILMWEVFS 200

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  104 bits (261), Expect = 1e-24
 Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 14/198 (7%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS--MKREIQTIGKIRHRNLVRLED 883
            +G+G+   VY+A S+      A+K +  +   +  +   ++ E++   +++H +++ L +
Sbjct: 19   LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
            ++   +   ++     NG +   L +   P + E   R+ +       + YLH      I
Sbjct: 79   YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARHFMH-QIITGMLYLHSHG---I 133

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS--TTSISVVGTIGYIAPENAFTTAK 1001
            +HRD+   N+LL   M   I+DFG+A  L   P     T     GT  YI+PE A  +A 
Sbjct: 134  LHRDLTLSNLLLTRNMNIKIADFGLATQLK-MPHEKHYTL---CGTPNYISPEIATRSAH 189

Query: 1002 SKESDVYSYGVVLLELIT 1019
              ESDV+S G +   L+ 
Sbjct: 190  GLESDVWSLGCMFYTLLI 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  104 bits (262), Expect = 2e-24
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 50/218 (22%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVK-----KLAFRGHKRGS--LSMKREIQTIGKIRH 875
               +G GA G V  A         A+K     K A    +     L+++ EI+ + K+ H
Sbjct: 15   SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AA 929
              ++++++F+  +D  I++   ME G L D                  +           
Sbjct: 75   PCIIKIKNFFDAEDYYIVL-ELMEGGELFD----------------KVVGNKRLKEATCK 117

Query: 930  H-------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPAST 979
                    A+ YLH   +  I+HRD+KPEN+LL S+ E     I+DFG +K+L ++    
Sbjct: 118  LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174

Query: 980  TSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVL 1014
            T   + GT  Y+APE   +  T   ++  D +S GV+L
Sbjct: 175  T---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (262), Expect = 2e-24
 Identities = 74/359 (20%), Positives = 120/359 (33%), Gaps = 97/359 (27%)

Query: 791  FRRRSKQDLEIPAQEGPSYLLKQVIEAT---------ENLNAKHVIGRGAHGIVYKASL- 840
            +      D +IP  E   +                   +L     +G+G  G V      
Sbjct: 4    YHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYD 63

Query: 841  ----GPNAVFAVKKLAFRGHKRGSLSMK----REIQTIGKIRHRNLVRLEDFWLRKDCG- 891
                    V AVKKL     +  +        REI+ +  ++H N+V+ +          
Sbjct: 64   PLQDNTGEVVAVKKL-----QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118

Query: 892  --IIMYRYMENGSLRDVL----HSITPPPTLEWNVRYKIALGAAHALAYL---HYDCDPP 942
              +IM  Y+  GSLRD L      I     L++             + YL    Y     
Sbjct: 119  LKLIM-EYLPYGSLRDYLQKHKERIDHIKLLQY------TSQICKGMEYLGTKRY----- 166

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE--- 994
             +HRD+   NIL+++E    I DFG+ K+L +          V   G       APE   
Sbjct: 167  -IHRDLATRNILVENENRVKIGDFGLTKVLPQD----KEYYKVKEPGESPIFWYAPESLT 221

Query: 995  -NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053
             + F+ A    SDV+S+GVVL EL T  +       E   ++G  +        + +++ 
Sbjct: 222  ESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

Query: 1054 L---------------SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                             +M                     C     + RP+ RD+  ++
Sbjct: 278  NNGRLPRPDGCPDEIYMIM-------------------TECWNNNVNQRPSFRDLALRV 317

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (262), Expect = 2e-24
 Identities = 54/240 (22%), Positives = 91/240 (37%), Gaps = 53/240 (22%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVK----KLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            K  IG+G++G+V  A      A+ A+K        + + +    +K E++ + K+ H N+
Sbjct: 31   KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 879  VRLEDFWLRKDC-GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG---------- 927
             RL + +  +    ++M      G L D L+      T +  +                 
Sbjct: 91   ARLYEVYEDEQYICLVM-ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 928  --------------------AAH-------ALAYLHYDCDPPIVHRDIKPENILLDSEME 960
                                 ++       AL YLH   +  I HRDIKPEN L  +   
Sbjct: 150  INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206

Query: 961  PH--ISDFGIAKLLDKSPASTTSI--SVVGTIGYIAPE--NAFTTAKSKESDVYSYGVVL 1014
                + DFG++K   K          +  GT  ++APE  N    +   + D +S GV+L
Sbjct: 207  FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  103 bits (258), Expect = 3e-24
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 15/198 (7%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS--MKREIQTIGKIRHRNLVRL- 881
             +G+G  G VY A       + A+K L     ++  +   ++REI+    +RH N++R+ 
Sbjct: 21   PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
              F  RK   +++  +   G L   L         E      +    A AL Y H     
Sbjct: 81   NYFHDRKRIYLML-EFAPRGELYKELQKHGRFD--EQRSATFMEE-LADALHYCHERK-- 134

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             ++HRDIKPEN+L+  + E  I+DFG +         T      GT+ Y+ PE       
Sbjct: 135  -VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM----CGTLDYLPPEMIEGKTH 189

Query: 1002 SKESDVYSYGVVLLELIT 1019
             ++ D++  GV+  E + 
Sbjct: 190  DEKVDLWCAGVLCYEFLV 207

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  103 bits (258), Expect = 3e-24
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 38/222 (17%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMK-----REIQT 869
               ++  VIG+G  G+VY              A+K L      R +   +     RE   
Sbjct: 21   VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-----SRITEMQQVEAFLREGLL 75

Query: 870  IGKIRHRNLVRLEDFWLRKD--CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            +  + H N++ L    L  +    +++  YM +G L   + S    PT++  +     L 
Sbjct: 76   MRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLI--SFGLQ 132

Query: 928  AAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
             A  + YL    +      VHRD+   N +LD      ++DFG+A+ +      +     
Sbjct: 133  VARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186

Query: 985  VGT--IGYIAPE----NAFTTAKSKESDVYSYGVVLLELITR 1020
                 + + A E      FTT     SDV+S+GV+L EL+TR
Sbjct: 187  HARLPVKWTALESLQTYRFTTK----SDVWSFGVLLWELLTR 224

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  102 bits (257), Expect = 4e-24
 Identities = 46/216 (21%), Positives = 83/216 (38%), Gaps = 44/216 (20%)

Query: 826  VIGRGAHGIVYKASLGPNAVF---AVKKLAFRGHKRGSLS------MKREIQTIGKIRHR 876
             +G G  G V K       V    AVK L     K  +        +  E   + ++ + 
Sbjct: 24   ELGSGNFGTVKKGYYQMKKVVKTVAVKIL-----KNEANDPALKDELLAEANVMQQLDNP 78

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVL--HSITPPPTLEWNVRYKIALGAAHALAY 934
             +VR+      +   ++M    E G L   L  +       +      ++    +  + Y
Sbjct: 79   YIVRMIGICEAESWMLVME-MAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKY 132

Query: 935  L---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---I 988
            L   ++      VHRD+   N+LL ++    ISDFG++K L        + +       +
Sbjct: 133  LEESNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPV 184

Query: 989  GYIAPE----NAFTTAKSKESDVYSYGVVLLELITR 1020
             + APE      F++     SDV+S+GV++ E  + 
Sbjct: 185  KWYAPECINYYKFSSK----SDVWSFGVLMWEAFSY 216

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  102 bits (257), Expect = 5e-24
 Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 38/222 (17%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKR-----EIQT 869
              ++   VIGRG  G VY  +L    G     AVK L      R +   +      E   
Sbjct: 25   LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-----NRITDIGEVSQFLTEGII 79

Query: 870  IGKIRHRNLVRLEDFWLRKDC--GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            +    H N++ L    LR +    +++  YM++G LR+ + + T  PT++  +     L 
Sbjct: 80   MKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKHGDLRNFIRNETHNPTVKDLI--GFGLQ 136

Query: 928  AAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
             A  + YL    +      VHRD+   N +LD +    ++DFG+A+ +      +     
Sbjct: 137  VAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190

Query: 985  VGT--IGYIAPE----NAFTTAKSKESDVYSYGVVLLELITR 1020
                 + ++A E      FTT     SDV+S+GV+L EL+TR
Sbjct: 191  GAKLPVKWMALESLQTQKFTTK----SDVWSFGVLLWELMTR 228

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  102 bits (256), Expect = 5e-24
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 41/221 (18%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKR-----EIQT 869
            E++    ++G G  G VY+       G     AVK       K+      +     E   
Sbjct: 12   EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-----KKDCTLDNKEKFMSEAVI 66

Query: 870  IGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
            +  + H ++V+L      +   IIM      G L   L        +   V Y  +L   
Sbjct: 67   MKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNSLKVLTLVLY--SLQIC 123

Query: 930  HALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
             A+AYL   +       VHRDI   NIL+ S     + DFG+++ ++       S     
Sbjct: 124  KAMAYLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS----V 173

Query: 987  T---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELITR 1020
            T   I +++PE      FTTA    SDV+ + V + E+++ 
Sbjct: 174  TRLPIKWMSPESINFRRFTTA----SDVWMFAVCMWEILSF 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  103 bits (259), Expect = 5e-24
 Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 21/203 (10%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS--MKREIQTIGKIRHRNLVRL 881
              +G+G     ++        VFA K +      +      M  EI     + H+++V  
Sbjct: 47   RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
              F+   D   ++       SL ++     ++T     E   RY +         YLH +
Sbjct: 107  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALT-----EPEARYYLR-QIVLGCQYLHRN 160

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL--DKSPASTTSISVVGTIGYIAPENA 996
                ++HRD+K  N+ L+ ++E  I DFG+A  +  D            GT  YIAPE  
Sbjct: 161  R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL----CGTPNYIAPEVL 213

Query: 997  FTTAKSKESDVYSYGVVLLELIT 1019
                 S E DV+S G ++  L+ 
Sbjct: 214  SKKGHSFEVDVWSIGCIMYTLLV 236

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (256), Expect = 6e-24
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 23/204 (11%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS--MKREIQTIGKIRHRNLVRL 881
              +G+G     ++        VFA K +      +      M  EI     + H+++V  
Sbjct: 21   RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 882  ED-FWLRKDCGIIMYRYMENGSLRDVL---HSITPPPTLEWNVRYKIALGAAHALAYLHY 937
               F       +++       SL ++     ++T     E   RY +         YLH 
Sbjct: 81   HGFFEDNDFVFVVL-ELCRRRSLLELHKRRKALT-----EPEARYYLR-QIVLGCQYLHR 133

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL--DKSPASTTSISVVGTIGYIAPEN 995
            +    ++HRD+K  N+ L+ ++E  I DFG+A  +  D            GT  YIAPE 
Sbjct: 134  NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL----CGTPNYIAPEV 186

Query: 996  AFTTAKSKESDVYSYGVVLLELIT 1019
                  S E DV+S G ++  L+ 
Sbjct: 187  LSKKGHSFEVDVWSIGCIMYTLLV 210

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (258), Expect = 7e-24
 Identities = 62/241 (25%), Positives = 96/241 (39%), Gaps = 52/241 (21%)

Query: 805  EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNA------VFAVKKLAFRGHKR 858
            E P+  L ++++ TE      V+G GA G VYK    P        V A+K+L     + 
Sbjct: 2    EAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKEL-----RE 54

Query: 859  GSLSMK-----REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL----HS 909
             +          E   +  + + ++ RL    L     +I  + M  G L D +     +
Sbjct: 55   ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN 113

Query: 910  ITPPPTLEWNVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDF 966
            I     L W       +  A  + YL           VHRD+   N+L+ +     I+DF
Sbjct: 114  IGSQYLLNW------CVQIAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDF 161

Query: 967  GIAKLLDKSPASTTSISVVGT---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            G+AKLL        +    G    I ++A E      +T      SDV+SYGV + EL+T
Sbjct: 162  GLAKLLGAEEKEYHA---EGGKVPIKWMALESILHRIYTHQ----SDVWSYGVTVWELMT 214

Query: 1020 R 1020
             
Sbjct: 215  F 215

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (258), Expect = 7e-24
 Identities = 58/239 (24%), Positives = 93/239 (38%), Gaps = 50/239 (20%)

Query: 806  GPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVF-----AVKKLAFRGHKRGS 860
            G   +L ++ + TE L    V+G G  G V+K    P          +K +     +  S
Sbjct: 1    GAMKVLARIFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-----EDKS 54

Query: 861  LSMK-----REIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLH----SIT 911
                       +  IG + H ++VRL          ++  +Y+  GSL D +     ++ 
Sbjct: 55   GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALG 113

Query: 912  PPPTLEWNVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGI 968
            P   L W       +  A  + YL           VHR++   N+LL S  +  ++DFG+
Sbjct: 114  PQLLLNW------GVQIAKGMYYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGV 161

Query: 969  AKLLDKSPASTTSISVVGT---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELITR 1020
            A LL                  I ++A E      +T      SDV+SYGV + EL+T 
Sbjct: 162  ADLLPPDDKQLLY---SEAKTPIKWMALESIHFGKYTHQ----SDVWSYGVTVWELMTF 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  101 bits (255), Expect = 8e-24
 Identities = 57/220 (25%), Positives = 86/220 (39%), Gaps = 41/220 (18%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKR-----EIQT 869
            E +     IG G  G V++        P    A+K       K  +    R     E  T
Sbjct: 15   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-----KNCTSDSVREKFLQEALT 69

Query: 870  IGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
            + +  H ++V+L          IIM      G LR  L        L   + Y  A   +
Sbjct: 70   MRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLDLASLILY--AYQLS 126

Query: 930  HALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
             ALAYL    +      VHRDI   N+L+ S     + DFG+++ ++ S     S     
Sbjct: 127  TALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS----K 176

Query: 987  T---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
                I ++APE      FT+A    SDV+ +GV + E++ 
Sbjct: 177  GKLPIKWMAPESINFRRFTSA----SDVWMFGVCMWEILM 212

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  106 bits (266), Expect = 8e-24
 Identities = 59/314 (18%), Positives = 107/314 (34%), Gaps = 42/314 (13%)

Query: 728  NPSLCVKCLSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVLVMLGLVS 787
               L      +  +S    ++        +H   L   +  +  L S   T         
Sbjct: 243  ADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSP 302

Query: 788  CCLFRRRSKQDLEIPAQEGPSYLLKQ--VIEATENLNAKHVIGRGAHGIVYKASL----G 841
                       +       P  L  +   ++    L A   +G G  G V +        
Sbjct: 303  DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362

Query: 842  PNAVFAVKKLAFRGHKRGSLSMKR-----EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR 896
               V A+K L     K+G+          E Q + ++ +  +VRL      +   ++M  
Sbjct: 363  QIDV-AIKVL-----KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM-E 415

Query: 897  YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENI 953
                G L   L        +  +   ++    +  + YL   ++      VHR++   N+
Sbjct: 416  MAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRNLAARNV 467

Query: 954  LLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---IGYIAPE----NAFTTAKSKESD 1006
            LL +     ISDFG++K L    +  T+ S       + + APE      F++     SD
Sbjct: 468  LLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFRKFSSR----SD 521

Query: 1007 VYSYGVVLLELITR 1020
            V+SYGV + E ++ 
Sbjct: 522  VWSYGVTMWEALSY 535

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (259), Expect = 9e-24
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 38/220 (17%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKR-----EIQT 869
             N++   V+G G  G V    L          A+K L     K G    +R     E   
Sbjct: 45   TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-----KVGYTEKQRRDFLGEASI 99

Query: 870  IGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
            +G+  H N++RLE    +    +I+  YMENGSL   L       T+   V   +  G A
Sbjct: 100  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG--MLRGIA 157

Query: 930  HALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
              + YL    Y      VHRD+   NIL++S +   +SDFG+ ++L+  P +  +    G
Sbjct: 158  SGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--G 209

Query: 987  T---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
                I + +PE      FT+A    SDV+SYG+VL E+++
Sbjct: 210  GKIPIRWTSPEAIAYRKFTSA----SDVWSYGIVLWEVMS 245

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (255), Expect = 9e-24
 Identities = 43/222 (19%), Positives = 76/222 (34%), Gaps = 37/222 (16%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKK--LAFRGHKRGSLSMKREIQTIGKI-RHRNLVRL 881
             IG G  G V+K        ++A+K+      G      +  RE+     + +H ++VR 
Sbjct: 18   KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVL--HSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
               W   D  +I   Y   GSL D +  +        E  ++  + L     L Y+H   
Sbjct: 77   FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-DLLLQVGRGLRYIH--- 132

Query: 940  DPPIVHRDIKPENILLDSEMEPH-------------------ISDFGIAKLLDKSPASTT 980
               +VH DIKP NI +     P+                   I D G    +        
Sbjct: 133  SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---- 188

Query: 981  SISVVGTIGYIAPE-NAFTTAKSKESDVYSYGVVLLELITRK 1021
                 G   ++A E          ++D+++  + ++     +
Sbjct: 189  --VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  102 bits (256), Expect = 1e-23
 Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 35/250 (14%)

Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPT 915
                  +   +I+ +     +N V        K    I  +     +L+D ++       
Sbjct: 101  SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160

Query: 916  LEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
             E  V   I +  A A+ +LH      ++HRD+KP NI    +    + DFG+   +D+ 
Sbjct: 161  REHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217

Query: 976  PASTTSI----------SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALD 1025
                T +            VGT  Y++PE       S + D++S G++L EL+       
Sbjct: 218  EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277

Query: 1026 PSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPS 1085
                ER  I             I D+ +L     +L +    Q   ++          P+
Sbjct: 278  ----ERVRI-------------ITDVRNLKF--PLLFTQKYPQEHMMV---QDMLSPSPT 315

Query: 1086 NRPNMRDVVR 1095
             RP   D++ 
Sbjct: 316  ERPEATDIIE 325

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  101 bits (253), Expect = 1e-23
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E L     +G G  G V+      +   AVK L     K+GS+S      E   + +++H
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLMKQLQH 67

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
            + LVRL     ++   II   YMENGSL D L +      L  N    +A   A  +A++
Sbjct: 68   QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 936  ---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---IG 989
               +Y      +HRD++  NIL+   +   I+DFG+A+L++         +  G    I 
Sbjct: 126  EERNY------IHRDLRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIK 175

Query: 990  YIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            + APE      FT      SDV+S+G++L E++T
Sbjct: 176  WTAPEAINYGTFTIK----SDVWSFGILLTEIVT 205

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  101 bits (253), Expect = 1e-23
 Identities = 41/234 (17%), Positives = 82/234 (35%), Gaps = 61/234 (26%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVF--------AVKKLAFRGHKRGSLSMK----RE 866
            E+L     +G+G    ++K        +         +K L      +   +        
Sbjct: 8    EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL-----DKAHRNYSESFFEA 62

Query: 867  IQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIAL 926
               + K+ H++LV      +  D  I++  +++ GSL   L        + W +  ++A 
Sbjct: 63   ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAK 120

Query: 927  GAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPH--------ISDFGIAKLLD-- 973
              A A+ +L           +H ++  +NILL  E +          +SD GI+  +   
Sbjct: 121  QLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174

Query: 974  ---KSPASTTSISVVGTIGYIAPE-----NAFTTAKSKESDVYSYGVVLLELIT 1019
               +             I ++ PE          A    +D +S+G  L E+ +
Sbjct: 175  DILQER-----------IPWVPPECIENPKNLNLA----TDKWSFGTTLWEICS 213

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  101 bits (255), Expect = 2e-23
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 38/220 (17%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKR-----EIQT 869
              ++ + +IG G  G V    L      +   A+K L     K G    +R     E   
Sbjct: 49   SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-----KAGYTERQRRDFLSEASI 103

Query: 870  IGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
            +G+  H N++RLE    R    +I+  YMENGSL   L +              +  G  
Sbjct: 104  MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVG 161

Query: 930  HALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
              + YL    Y      VHRD+   N+L+DS +   +SDFG++++L+  P +  + +  G
Sbjct: 162  AGMRYLSDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--G 213

Query: 987  T---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
                I + APE      F++A    SDV+S+GVV+ E++ 
Sbjct: 214  GKIPIRWTAPEAIAFRTFSSA----SDVWSFGVVMWEVLA 249

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  102 bits (257), Expect = 2e-23
 Identities = 74/313 (23%), Positives = 127/313 (40%), Gaps = 61/313 (19%)

Query: 747  SNLRPCDYHSSHQQGLNK--VKIVVIALGSSLLTVLVMLGLVSCCLFRRRSKQDLEIPAQ 804
            S + P  +H  H           +++  GS  L  +  +  +S  L+++   ++L     
Sbjct: 2    SPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGA 61

Query: 805  EGPSYLLKQV-------------IEATENLNAKHVIGRGAHGIVYKASL----GPNAVFA 847
                  L  +               ++  ++   VIGRG  G VY  +L    G     A
Sbjct: 62   NTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA 121

Query: 848  VKKLAFRGHKRGSLSMKR-----EIQTIGKIRHRNLVRLEDFWLRKDC--GIIMYRYMEN 900
            VK L      R +   +      E   +    H N++ L    LR +    +++  YM++
Sbjct: 122  VKSL-----NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL-PYMKH 175

Query: 901  GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDS 957
            G LR+ + + T  PT++  +     L  A  + +L    +      VHRD+   N +LD 
Sbjct: 176  GDLRNFIRNETHNPTVKDLI--GFGLQVAKGMKFLASKKF------VHRDLAARNCMLDE 227

Query: 958  EMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDV 1007
            +    ++DFG+A+ + DK   S  +     T   +     A E      FTT     SDV
Sbjct: 228  KFTVKVADFGLARDMYDKEFDSVHN----KTGAKLPVKWMALESLQTQKFTTK----SDV 279

Query: 1008 YSYGVVLLELITR 1020
            +S+GV+L EL+TR
Sbjct: 280  WSFGVLLWELMTR 292

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (253), Expect = 2e-23
 Identities = 59/210 (28%), Positives = 88/210 (41%), Gaps = 45/210 (21%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
              V+G GA   V+         +FA+K +  +       S++ EI  + KI+H N+V LE
Sbjct: 14   MEVLGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 883  D-FWLRKDCGIIM---------YRYMENGSL-----RDVLHSITPPPTLEWNVRYKIALG 927
            D +       ++M          R +E G         V+  +                 
Sbjct: 73   DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV----------------- 115

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISV 984
               A+ YLH   +  IVHRD+KPEN+L  +  E     I+DFG++K+      ST     
Sbjct: 116  -LSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----A 167

Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
             GT GY+APE       SK  D +S GV+ 
Sbjct: 168  CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  101 bits (253), Expect = 2e-23
 Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 52/233 (22%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMK------REIQ 868
              L    ++G G  G V + +L    G +   AVK +     K  + S +       E  
Sbjct: 34   NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-----KLDNSSQREIEEFLSEAA 88

Query: 869  TIGKIRHRNLVRL------EDFWLRKDCGIIMYRYMENGSLRDVLHSI---TPPPTLEWN 919
             +    H N++RL                +I+  +M+ G L   L      T P  +   
Sbjct: 89   CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL-PFMKYGDLHTYLLYSRLETGPKHIPLQ 147

Query: 920  VRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
               K  +  A  + YL   ++      +HRD+   N +L  +M   ++DFG++K +    
Sbjct: 148  TLLKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIY--- 198

Query: 977  ASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELITR 1020
              +      G I  +     A E      +T+    +SDV+++GV + E+ TR
Sbjct: 199  --SGDYYRQGRIAKMPVKWIAIESLADRVYTS----KSDVWAFGVTMWEIATR 245

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  100 bits (252), Expect = 2e-23
 Identities = 55/194 (28%), Positives = 98/194 (50%), Gaps = 13/194 (6%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG+GA G VY A  +      A++++  +   +  L +  EI  + + ++ N+V   D +
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMRENKNPNIVNYLDSY 86

Query: 886  LRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            L  D   ++M  Y+  GSL DV   +T     E  +   +      AL +LH +    ++
Sbjct: 87   LVGDELWVVM-EYLAGGSLTDV---VTETCMDEGQIAA-VCRECLQALEFLHSN---QVI 138

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRDIK +NILL  +    ++DFG    +  +P  +   ++VGT  ++APE     A   +
Sbjct: 139  HRDIKSDNILLGMDGSVKLTDFGFCAQI--TPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 1005 SDVYSYGVVLLELI 1018
             D++S G++ +E+I
Sbjct: 197  VDIWSLGIMAIEMI 210

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (252), Expect = 3e-23
 Identities = 54/194 (27%), Positives = 96/194 (49%), Gaps = 13/194 (6%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G+ GIV  A         AVK +  R  +R  L +  E+  +   +H N+V +   +
Sbjct: 53   IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-LFNEVVIMRDYQHFNVVEMYKSY 111

Query: 886  LRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            L  +   ++M  +++ G+L D+   ++     E  +   +      ALAYLH      ++
Sbjct: 112  LVGEELWVLM-EFLQGGALTDI---VSQVRLNEEQIAT-VCEAVLQALAYLH---AQGVI 163

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRDIK ++ILL  +    +SDFG    + K        S+VGT  ++APE    +  + E
Sbjct: 164  HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLVGTPYWMAPEVISRSLYATE 221

Query: 1005 SDVYSYGVVLLELI 1018
             D++S G++++E++
Sbjct: 222  VDIWSLGIMVIEMV 235

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  101 bits (254), Expect = 4e-23
 Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 38/212 (17%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVK---KLAFRGHKRGSL-SMKREIQTIGKIRHRNL 878
              VIG+G   +V +         FAVK      F      S   +KRE      ++H ++
Sbjct: 29   CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH-- 930
            V L + +       +++ +M+   L   +            V+   A        A+H  
Sbjct: 89   VELLETYSSDGMLYMVFEFMDGADLCFEI------------VKRADAGFVYSEAVASHYM 136

Query: 931  -----ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSI 982
                 AL Y H D +  I+HRD+KP  +LL S+       +  FG+A  L +S       
Sbjct: 137  RQILEALRYCH-DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 983  SVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
              VGT  ++APE        K  DV+  GV+L
Sbjct: 194  --VGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (251), Expect = 4e-23
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 52/221 (23%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRL 881
            + V+G GAH  V    +L  +  +AVK +  +        + RE++ + + + HRN++ L
Sbjct: 18   EDVLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 882  EDFWLRKDCGIIMYRYMENGSL---------------RDVLHSITPPPTLEWNVRYKIAL 926
             +F+  +D   +++  M  GS+                 V+  +                
Sbjct: 77   IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV---------------- 120

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSIS 983
              A AL +LH   +  I HRD+KPENIL +   +     I DF +   +  +   +   +
Sbjct: 121  --ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 984  -----VVGTIGYIAPE--NAFTTAKS---KESDVYSYGVVL 1014
                   G+  Y+APE   AF+   S   K  D++S GV+L
Sbjct: 176  PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  100 bits (252), Expect = 4e-23
 Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 39/221 (17%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVF-----AVKKLAFRGHKRGSLSMKR-----EIQ 868
              +  + VIG G  G VYK  L  ++       A+K L     K G    +R     E  
Sbjct: 44   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-----KAGYTEKQRVDFLGEAG 98

Query: 869  TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGA 928
             +G+  H N++RLE    +    +I+  YMENG+L   L                +  G 
Sbjct: 99   IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGI 156

Query: 929  AHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
            A  + YL   +Y      VHRD+   NIL++S +   +SDFG++++L+  P +T + S  
Sbjct: 157  AAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-- 208

Query: 986  GT---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            G    I + APE      FT+A    SDV+S+G+V+ E++T
Sbjct: 209  GGKIPIRWTAPEAISYRKFTSA----SDVWSFGIVMWEVMT 245

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 99.6 bits (249), Expect = 5e-23
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 48/223 (21%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIR 874
             ++  KH +G G +G VY+      +   AVK L     K  ++ ++   +E   + +I+
Sbjct: 13   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 67

Query: 875  HRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            H NLV+L         F+      II   +M  G+L D L        +   V   +A  
Sbjct: 68   HPNLVQLLGVCTREPPFY------IIT-EFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQ 119

Query: 928  AAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV 984
             + A+ YL   ++      +HRD+   N L+       ++DFG+++L+     +  +   
Sbjct: 120  ISSAMEYLEKKNF------IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--- 170

Query: 985  VGT---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELITR 1020
             G    I + APE    N F+      SDV+++GV+L E+ T 
Sbjct: 171  -GAKFPIKWTAPESLAYNKFSIK----SDVWAFGVLLWEIATY 208

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  102 bits (256), Expect = 5e-23
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 184  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 238

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
              LV+L      +   I+   YM  GSL D L        L       +A   A  +AY+
Sbjct: 239  EKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV 296

Query: 936  ---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
               +Y      VHRD++  NIL+   +   ++DFG+A+L++ +  +    +    I + A
Sbjct: 297  ERMNY------VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTA 349

Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE A     + +SDV+S+G++L EL T
Sbjct: 350  PEAALYGRFTIKSDVWSFGILLTELTT 376

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 47/231 (20%), Positives = 97/231 (41%), Gaps = 16/231 (6%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
             ++    +L   + +  +       ++++ +  + +     +    + L N+  L L G
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77

Query: 153 NLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIG 212
           N L  +I +PL  +  L ++FL+ N +   +  ++ DLK++++L L  N +S  I   + 
Sbjct: 78  NKLT-DI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLV 131

Query: 213 NCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSY 272
           +  +L+ LYL  NK+       LS L  L  L + DN +   +         L  L LS 
Sbjct: 132 HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPL--AGLTKLQNLYLSK 187

Query: 273 NRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
           N  S  +   L    +L  L++   +      +    L   +++  ++  L
Sbjct: 188 NHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 43/234 (18%), Positives = 94/234 (40%), Gaps = 16/234 (6%)

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE 563
               ++ + +++     +     ++  I  +++    +  Q +  L ++  L ++ N + 
Sbjct: 26  TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT 81

Query: 564 GSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEK 623
             +   L+  KNL    +  N +   + SSL+  K L  L L  N  +      +  L +
Sbjct: 82  -DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS--DINGLVHLPQ 135

Query: 624 LLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNL 683
           L  L LG N++       +  L  L   L+L  N ++      L  L+KL+ L +S N++
Sbjct: 136 LESLYLGNNKI--TDITVLSRLTKLDT-LSLEDNQISD--IVPLAGLTKLQNLYLSKNHI 190

Query: 684 TGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCLS 737
           +  L  L+ + +L  + +              NL+ P+    +    +  + +S
Sbjct: 191 S-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 46/219 (21%), Positives = 96/219 (43%), Gaps = 17/219 (7%)

Query: 64  IECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEY 123
               ++ +++     ++  +   +   I +L  +  + L+ N  + +I P L N   L +
Sbjct: 39  AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGW 94

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
           L L  N    D+  + ++L+ L+ L+L  N +       L  +  L+ ++L NN ++  I
Sbjct: 95  LFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DI 149

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
              +  L +++ L L  N++S  I   +    +LQ LYL++N +      +L+ L+NL  
Sbjct: 150 T-VLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDV 204

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPN 282
           L++        +N       NL   +   N     ++P 
Sbjct: 205 LELFSQEC---LNKPINHQSNLVVPNTVKNTDGSLVTPE 240

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 42/203 (20%), Positives = 79/203 (38%), Gaps = 16/203 (7%)

Query: 502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
           P+ S        I                 +      +  + Q    L S+  +  + + 
Sbjct: 2   PLGSETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSD 57

Query: 562 VEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISEL 621
           ++ S+   +    N+    ++ N L   I   L + K+L  L L EN       + + +L
Sbjct: 58  IK-SV-QGIQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK--DLSSLKDL 111

Query: 622 EKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSN 681
           +KL  L L  N +  +I   +  L  L   L L  N +T    + L +L+KL+ L +  N
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLES-LYLGNNKIT--DITVLSRLTKLDTLSLEDN 166

Query: 682 NLTGTLSPLSNIHSLVEVNVSYN 704
            ++  + PL+ +  L  + +S N
Sbjct: 167 QIS-DIVPLAGLTKLQNLYLSKN 188

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 40/186 (21%), Positives = 73/186 (39%), Gaps = 13/186 (6%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
           + +L  L  + L  N    ++   L +   L+ L L  NG + DI +   +L  L+ L L
Sbjct: 86  LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYL 141

Query: 151 YGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
             N +       L R+  L  + L +N +S  I   +  L +++ L+L  N +S     +
Sbjct: 142 GNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDL--RA 195

Query: 211 IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL---EGRINFGSEKCKNLTF 267
           +     L  L L   + +       SNL     +   D +L   E   + G  +  N+ +
Sbjct: 196 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKW 255

Query: 268 LDLSYN 273
               + 
Sbjct: 256 HLPEFT 261

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.8 bits (247), Expect = 8e-23
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 24/202 (11%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            K  +G GA G V+            +K +     +     ++ EI+ +  + H N++++ 
Sbjct: 27   KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86

Query: 883  D-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY------KIALGAAHALAYL 935
            + F    +  I+M    E G L + + S                   ++     +ALAY 
Sbjct: 87   EVFEDYHNMYIVM-ETCEGGELLERIVSAQARGK-----ALSEGYVAELMKQMMNALAYF 140

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
            H      +VH+D+KPENIL           I DFG+A+L      ST      GT  Y+A
Sbjct: 141  H---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMA 194

Query: 993  PENAFTTAKSKESDVYSYGVVL 1014
            PE  F    + + D++S GVV+
Sbjct: 195  PE-VFKRDVTFKCDIWSAGVVM 215

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  100 bits (252), Expect = 8e-23
 Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 31/238 (13%)

Query: 792  RRRSKQDLEIPAQEGPSYLLKQVIEATENLNA------KHVIGRGAHGIVYKA-SLGPNA 844
            +R S   ++IPA   P +  + V      +N+        ++G G  G V+K        
Sbjct: 57   KRTSALAVDIPAPPAP-FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGL 115

Query: 845  VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLR 904
              A K +  R   +    +K EI  + ++ H NL++L D +  K+  +++  Y++ G L 
Sbjct: 116  KLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174

Query: 905  DVL----HSITPPPTLEWNVRY--KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE 958
            D +    +++T     E +     K        + ++H      I+H D+KPENIL  + 
Sbjct: 175  DRIIDESYNLT-----ELDTILFMKQICEG---IRHMH---QMYILHLDLKPENILCVNR 223

Query: 959  MEPHI--SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
                I   DFG+A+               GT  ++APE       S  +D++S GV+ 
Sbjct: 224  DAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  102 bits (256), Expect = 8e-23
 Identities = 53/207 (25%), Positives = 88/207 (42%), Gaps = 27/207 (13%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRL 881
               +G GA+G V        +   A+K +        S S +  E+  +  + H N+++L
Sbjct: 42   VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY------KIALGAAHALAYL 935
             DF+  K    ++    + G L D +             ++       I       + YL
Sbjct: 102  YDFFEDKRNYYLVMECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYL 152

Query: 936  HYDCDPPIVHRDIKPENILLDSEME---PHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
            H      IVHRD+KPEN+LL+S+ +     I DFG++ + +           +GT  YIA
Sbjct: 153  H---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIA 206

Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE        ++ DV+S GV+L  L+ 
Sbjct: 207  PE-VLRKKYDEKCDVWSIGVILFILLA 232

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  102 bits (256), Expect = 9e-23
 Identities = 62/292 (21%), Positives = 120/292 (41%), Gaps = 47/292 (16%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIR 874
             ++  KH +G G +G VY+      +   AVK L     K  ++ ++   +E   + +I+
Sbjct: 220  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-----KEDTMEVEEFLKEAAVMKEIK 274

Query: 875  HRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            H NLV+L         F+      II   +M  G+L D L        +   V   +A  
Sbjct: 275  HPNLVQLLGVCTREPPFY------IIT-EFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQ 326

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
             + A+ YL        +HR++   N L+       ++DFG+++L+     +  + +    
Sbjct: 327  ISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-P 382

Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047
            I + APE+      S +SDV+++GV+L E+ T   +  P                  ++ 
Sbjct: 383  IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--------------IDLSQV 428

Query: 1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
               +     ME        ++V +++     C +  PS+RP+  ++ +    
Sbjct: 429  YELLEKDYRMERPEGCP--EKVYELM---RACWQWNPSDRPSFAEIHQAFET 475

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 99.7 bits (249), Expect = 1e-22
 Identities = 73/314 (23%), Positives = 116/314 (36%), Gaps = 73/314 (23%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMK----REIQT 869
             +L     +G+G  G V             A+ AVK+L     +      +    REIQ 
Sbjct: 23   RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-----QHSGPDQQRDFQREIQI 77

Query: 870  IGKIRHRNLVRLE---DFWLRKDCGIIMYRYMENGSLRDVL----HSITPPPTLEWNVRY 922
            +  +    +V+         R+   ++M  Y+ +G LRD L      +     L +    
Sbjct: 78   LKALHSDFIVKYRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQRHRARLDASRLLLY---- 132

Query: 923  KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD------ 973
              +      + YL           VHRD+   NIL++SE    I+DFG+AKLL       
Sbjct: 133  --SSQICKGMEYLGSRRC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 184

Query: 974  ------KSPASTTSISVVGTIGYIAPE----NAFTTAKSKESDVYSYGVVLLELITRKKA 1023
                  +SP           I + APE    N F+      SDV+S+GVVL EL T    
Sbjct: 185  VVREPGQSP-----------IFWYAPESLSDNIFSRQ----SDVWSFGVVLYELFTYCDK 229

Query: 1024 LDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKK 1083
                  E   ++G  R V + +  +  + +   +             +V  +   C    
Sbjct: 230  SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACP-----AEVHELMKLCWAPS 284

Query: 1084 PSNRPNMRDVVRQL 1097
            P +RP+   +  QL
Sbjct: 285  PQDRPSFSALGPQL 298

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (250), Expect = 1e-22
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 44/209 (21%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSM-KREIQTIGKIRHRNLVRL 881
            +  +GRGA  IVY+    G    +A+K L     K     + + EI  + ++ H N+++L
Sbjct: 58   ESELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKL 113

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH----- 930
            ++ +       ++   +  G L D +                +  G      AA      
Sbjct: 114  KEIFETPTEISLVLELVTGGELFDRI----------------VEKGYYSERDAADAVKQI 157

Query: 931  --ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVV 985
              A+AYLH   +  IVHRD+KPEN+L  +        I+DFG++K+++      T   V 
Sbjct: 158  LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VC 211

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
            GT GY APE     A   E D++S G++ 
Sbjct: 212  GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  101 bits (254), Expect = 1e-22
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 34/214 (15%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G G  G V+ A+   +   AVK +     K GS+S++    E   +  ++H
Sbjct: 188  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-----KPGSMSVEAFLAEANVMKTLQH 242

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
              LV+L     ++   II   +M  GSL D L S               +   A  +A++
Sbjct: 243  DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI 300

Query: 936  ---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT---IG 989
               +Y      +HRD++  NIL+ + +   I+DFG+A++++ +  +       G    I 
Sbjct: 301  EQRNY------IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIK 350

Query: 990  YIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            + APE     +FT      SDV+S+G++L+E++T
Sbjct: 351  WTAPEAINFGSFTIK----SDVWSFGILLMEIVT 380

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 48/234 (20%), Positives = 90/234 (38%), Gaps = 53/234 (22%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMK------REIQ 868
            +      ++G+G  G V +A L    G     AVK L     K   ++        RE  
Sbjct: 23   QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-----KADIIASSDIEEFLREAA 77

Query: 869  TIGKIRHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITP---PPTLEW 918
             + +  H ++ +L                 +I+  +M++G L   L +      P  L  
Sbjct: 78   CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL-PFMKHGDLHAFLLASRIGENPFNLPL 136

Query: 919  NVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
                +  +  A  + YL   ++      +HRD+   N +L  +M   ++DFG+++ +   
Sbjct: 137  QTLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIY-- 188

Query: 976  PASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELITR 1020
               +      G    +     A E    N +T      SDV+++GV + E++TR
Sbjct: 189  ---SGDYYRQGCASKLPVKWLALESLADNLYTV----HSDVWAFGVTMWEIMTR 235

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG GA  +V  A         A+K++     +     + +EIQ + +  H N+V     
Sbjct: 22   VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 885  WLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNV--RYKIAL---GAAHALAYLHYD 938
            ++ KD   ++M + +  GS+ D++  I      +  V     IA         L YLH +
Sbjct: 82   FVVKDELWLVM-KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI---SVVGTIGYIAPEN 995
                 +HRD+K  NILL  +    I+DFG++  L      T +    + VGT  ++APE 
Sbjct: 141  ---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE- 196

Query: 996  AFTTAKSKE----SDVYSYGVVLLELIT 1019
                 + +     +D++S+G+  +EL T
Sbjct: 197  --VMEQVRGYDFKADIWSFGITAIELAT 222

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =   99 bits (249), Expect = 2e-22
 Identities = 41/207 (19%), Positives = 79/207 (38%), Gaps = 19/207 (9%)

Query: 826  VIGRGAH--GIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRL 881
            VIG+G      V  A          V+++         ++ ++ E+       H N+V  
Sbjct: 32   VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91

Query: 882  EDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
               ++  +   ++   +M  GS +D++ +       E  + Y I  G   AL Y+H+   
Sbjct: 92   RATFIADNELWVVT-SFMAYGSAKDLICTHFMDGMNELAIAY-ILQGVLKALDYIHHM-- 147

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA-----STTSISVVGTIGYIAPE- 994
               VHR +K  +IL+  + + ++S       +                 V  + +++PE 
Sbjct: 148  -GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 995  --NAFTTAKSKESDVYSYGVVLLELIT 1019
                     +K SD+YS G+   EL  
Sbjct: 207  LQQNLQGYDAK-SDIYSVGITACELAN 232

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
              IG+G+ G V+K        V A+K +     +     +++EI  + +     + +   
Sbjct: 28   EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87

Query: 884  FWLRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
             +L+     IIM  Y+  GS  D+L    P P  E  +   I       L YLH +    
Sbjct: 88   SYLKDTKLWIIM-EYLGGGSALDLLE---PGPLDETQIAT-ILREILKGLDYLHSE---K 139

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
             +HRDIK  N+LL    E  ++DFG+A  L  +       + VGT  ++APE    +A  
Sbjct: 140  KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQSAYD 197

Query: 1003 KESDVYSYGVVLLELITRK 1021
             ++D++S G+  +EL   +
Sbjct: 198  SKADIWSLGITAIELARGE 216

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 97.6 bits (244), Expect = 2e-22
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 50/214 (23%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVK-----KLAFRGHKRGSLSMKREIQTIGKIRHRN 877
            K  +G+GA  +V +         FA K     KL+ R  ++    ++RE +   K++H N
Sbjct: 11   KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK----LEREARICRKLQHPN 66

Query: 878  LVRLED-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH 930
            +VRL D         ++    +  G L + +                +A        A+H
Sbjct: 67   IVRLHDSIQEESFHYLVF-DLVTGGELFEDI----------------VAREFYSEADASH 109

Query: 931  -------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTT 980
                   ++AY H      IVHR++KPEN+LL S+ +     ++DFG+A  ++ S A   
Sbjct: 110  CIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166

Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
                 GT GY++PE       SK  D+++ GV+L
Sbjct: 167  ---FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (252), Expect = 2e-22
 Identities = 57/221 (25%), Positives = 89/221 (40%), Gaps = 52/221 (23%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK--REIQTIGKIRHR 876
            + L     IG+G  G V       N V AVK +     K  + +     E   + ++RH 
Sbjct: 193  KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCI-----KNDATAQAFLAEASVMTQLRHS 246

Query: 877  NLVRLE--------DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGA 928
            NLV+L           +      I+   YM  GSL D L S      L  +   K +L  
Sbjct: 247  NLVQLLGVIVEEKGGLY------IVT-EYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDV 298

Query: 929  AHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
              A+ YL   ++      VHRD+   N+L+  +    +SDFG+ K    +          
Sbjct: 299  CEAMEYLEGNNF------VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------- 344

Query: 986  GT---IGYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
                 + + APE      F+T     SDV+S+G++L E+ +
Sbjct: 345  TGKLPVKWTAPEALREKKFSTK----SDVWSFGILLWEIYS 381

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  101 bits (253), Expect = 2e-22
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 16/202 (7%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFR--GHKRGSLSMKREIQTIGKIRHRNLVR 880
            + V+G+G+ G V            AVK ++ R    K    S+ RE+Q + ++ H N+++
Sbjct: 31   QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            L +F+  K    ++      G L D + S       E +   +I       + Y+H    
Sbjct: 91   LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS--EVDAA-RIIRQVLSGITYMH---K 144

Query: 941  PPIVHRDIKPENILLDSEME---PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
              IVHRD+KPEN+LL+S+ +     I DFG++   + S         +GT  YIAPE   
Sbjct: 145  NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KIGTAYYIAPE-VL 200

Query: 998  TTAKSKESDVYSYGVVLLELIT 1019
                 ++ DV+S GV+L  L++
Sbjct: 201  HGTYDEKCDVWSTGVILYILLS 222

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  101 bits (253), Expect = 2e-22
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 20/207 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK---REIQTIGKIRH 875
            E+L  +  +G+G  G V+  +       A+K L     K G++S +   +E Q + K+RH
Sbjct: 267  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-----KPGTMSPEAFLQEAQVMKKLRH 321

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
              LV+L      +   I+   YM  GSL D L        L       +A   A  +AY+
Sbjct: 322  EKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV 379

Query: 936  ---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
               +Y      VHRD++  NIL+   +   ++DFG+A+L++ +  +    +    I + A
Sbjct: 380  ERMNY------VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTA 432

Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE A     + +SDV+S+G++L EL T
Sbjct: 433  PEAALYGRFTIKSDVWSFGILLTELTT 459

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 34/212 (16%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMK--REIQTIGKIRHR 876
            + L     IG+G  G V       N V AVK +     K  + +     E   + ++RH 
Sbjct: 21   KELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCI-----KNDATAQAFLAEASVMTQLRHS 74

Query: 877  NLVRLEDFWLRKDCG--IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            NLV+L    + +  G  I+   YM  GSL D L S      L  +   K +L    A+ Y
Sbjct: 75   NLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEY 132

Query: 935  L---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
            L   ++      VHRD+   N+L+  +    +SDFG+ K    +   T  + V  T    
Sbjct: 133  LEGNNF------VHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWT---- 181

Query: 992  APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            APE      F+T     SDV+S+G++L E+ +
Sbjct: 182  APEALREKKFSTK----SDVWSFGILLWEIYS 209

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 98.5 bits (246), Expect = 3e-22
 Identities = 55/239 (23%), Positives = 85/239 (35%), Gaps = 55/239 (23%)

Query: 800  EIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKR 858
             +        L +  I+ T+    K  IG G++ +  +      N  FAVK +     K 
Sbjct: 3    TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KS 58

Query: 859  GSLSMKREIQTIGK-IRHRNLVRLEDFWLRKDCG-IIMYRYMENGSL------------- 903
                   EI+ + +  +H N++ L+D +       ++    M+ G L             
Sbjct: 59   -KRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT-ELMKGGELLDKILRQKFFSER 116

Query: 904  --RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP 961
                VL +I                     + YLH      +VHRD+KP NIL   E   
Sbjct: 117  EASAVLFTI------------------TKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155

Query: 962  H----ISDFGIAKLL--DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
                 I DFG AK L  +     T       T  ++APE           D++S GV+L
Sbjct: 156  PESIRICDFGFAKQLRAENGLLMT----PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 98.1 bits (245), Expect = 3e-22
 Identities = 42/200 (21%), Positives = 80/200 (40%), Gaps = 25/200 (12%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
               +GRG  GIV++         +  K +  +G  +  +  K+EI  +   RHRN++ L 
Sbjct: 10   AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV--KKEISILNIARHRNILHLH 67

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY--KIALGAAH----ALAYLH 936
            + +   +  ++++ ++    + + +                 +  +   H    AL +LH
Sbjct: 68   ESFESMEELVMIFEFISGLDIFERI--------NTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPH--ISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                  I H DI+PENI+  +       I +FG A+ L           +     Y APE
Sbjct: 120  ---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPE 173

Query: 995  NAFTTAKSKESDVYSYGVVL 1014
                   S  +D++S G ++
Sbjct: 174  VHQHDVVSTATDMWSLGTLV 193

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 98.5 bits (246), Expect = 4e-22
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 48/235 (20%)

Query: 802  PAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKAS-LGPNAVFAVK-----KLAFRG 855
                G  +++    + ++N + K  +G+GA  +V +         FA K     KL+ R 
Sbjct: 12   QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD 71

Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPT 915
             ++    ++RE +   K++H N+VRL D    +    +++  +  G L + +        
Sbjct: 72   FQK----LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-------- 119

Query: 916  LEWNVRYKIALG------AAH-------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH 962
                    +A        A+H       ++AY H      IVHR++KPEN+LL S+ +  
Sbjct: 120  --------VAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGA 168

Query: 963  ---ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
               ++DFG+A  ++ S A        GT GY++PE       SK  D+++ GV+L
Sbjct: 169  AVKLADFGLAIEVNDSEAWHG---FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 39/214 (18%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVK--------KLAFRGHKRGSLSMKREIQTIGKI- 873
            K ++GRG   +V +         +AVK          +    +    +  +E+  + K+ 
Sbjct: 22   KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 81

Query: 874  RHRNLVRLED-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY------KIAL 926
             H N+++L+D +       ++    M+ G L D L            V        KI  
Sbjct: 82   GHPNIIQLKDTYETNTFFFLVF-DLMKKGELFDYLTE---------KVTLSEKETRKIMR 131

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
                 +  LH      IVHRD+KPENILLD +M   ++DFG +  LD          V G
Sbjct: 132  ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCG 185

Query: 987  TIGYIAPE------NAFTTAKSKESDVYSYGVVL 1014
            T  Y+APE      N       KE D++S GV++
Sbjct: 186  TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.8 bits (244), Expect = 4e-22
 Identities = 57/232 (24%), Positives = 84/232 (36%), Gaps = 52/232 (22%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKR-----EI 867
            +N+     +G GA G VY+  +            AVK L                   E 
Sbjct: 30   KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSEQDELDFLMEA 84

Query: 868  QTIGKIRHRNLVRLEDFWLRKD-CGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRY 922
              I K  H+N+VR     L+     I+M   M  G L+  L    P    P +L      
Sbjct: 85   LIISKFNHQNIVRCIGVSLQSLPRFILM-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143

Query: 923  KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSP 976
             +A   A    YL   H+      +HRDI   N LL          I DFG+A+ + +  
Sbjct: 144  HVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-- 195

Query: 977  ASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
                S    G    +      PE      FT+    ++D +S+GV+L E+ +
Sbjct: 196  ---ASYYRKGGCAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIFS 240

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.6 bits (246), Expect = 4e-22
 Identities = 45/214 (21%), Positives = 77/214 (35%), Gaps = 45/214 (21%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVK-----KLAFRGHKRGSLSMKREIQTIGKIRHRN 877
               +G G   IV K         +A K     +            ++RE+  + ++ H N
Sbjct: 17   GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH- 930
            ++ L D +  +   +++   +  G L D L                          A   
Sbjct: 77   IITLHDVYENRTDVVLILELVSGGELFDFL----------------AQKESLSEEEATSF 120

Query: 931  ------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTT 980
                   + YLH      I H D+KPENI+L  +  P     + DFG+A  ++       
Sbjct: 121  IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177

Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
               + GT  ++APE         E+D++S GV+ 
Sbjct: 178  ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 96.5 bits (241), Expect = 5e-22
 Identities = 51/214 (23%), Positives = 82/214 (38%), Gaps = 45/214 (21%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVK-----KLAFRGHKRGSLSMKREIQTIGKIRHRN 877
               +G G   IV K    G    +A K     +L+          ++RE+  + +IRH N
Sbjct: 10   GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH- 930
            ++ L D +  K   +++   +  G L D L                          A   
Sbjct: 70   IITLHDIFENKTDVVLILELVSGGELFDFL----------------AEKESLTEDEATQF 113

Query: 931  ------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTT 980
                   + YLH      I H D+KPENI+L  +  P+    + DFGIA  ++       
Sbjct: 114  LKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170

Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
               + GT  ++APE         E+D++S GV+ 
Sbjct: 171  ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.8 bits (249), Expect = 6e-22
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 33/210 (15%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRL 881
              ++G+G+ G V K         +AVK +     K     ++ RE++ + K+ H N+++L
Sbjct: 27   VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 882  EDFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEWNVRY------KIALGAAHAL 932
             +    +D     I+       G L D +             R+      +I       +
Sbjct: 87   FEIL--EDSSSFYIVG-ELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGI 134

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEME---PHISDFGIAKLLDKSPASTTSISVVGTIG 989
             Y+H      IVHRD+KPENILL+S+ +     I DFG++    ++         +GT  
Sbjct: 135  TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIGTAY 188

Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            YIAPE        ++ DV+S GV+L  L++
Sbjct: 189  YIAPE-VLRGTYDEKCDVWSAGVILYILLS 217

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 96.9 bits (241), Expect = 7e-22
 Identities = 55/275 (20%), Positives = 88/275 (32%), Gaps = 22/275 (8%)

Query: 92  GHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDN---FENLQNLQYL 148
           G  S    +              +    +L+ L +        I         +  LQ L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 149 NLYGNLLDGEIPEPLFRI--LGLQYVFLNNNSLSG--SIPRNVGDLKE--VEALWLFSNR 202
            L    + G  P PL       L  + L N S +   +    +    +  ++ L +    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 203 LSGTIPESIGNCYRLQELYLNENKLMG-------FLPESLSNLENLVYLDVGDNNLEGRI 255
                 E +     L  L L++N  +G         P     L+ L   + G     G  
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220

Query: 256 NFGSEKCKNLTFLDLSYNRFSGGISP-NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLS 314
           +  +     L  LDLS+N         +    S L  L++  + L   +P   GL A+LS
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK--GLPAKLS 277

Query: 315 SLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG 349
            LDLS N+L     P   +   +  L L  N    
Sbjct: 278 VLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 96.5 bits (240), Expect = 9e-22
 Identities = 61/292 (20%), Positives = 95/292 (32%), Gaps = 39/292 (13%)

Query: 384 SLEYLLVYNNNLLGKLP-LEMTELKQLKNISLYNNQFSGVIPQSLGIN---SSLMQLDFI 439
           SLEYLL   +         ++ +   LK +++   +    I          S L +L   
Sbjct: 44  SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103

Query: 440 NNSFTGEIPPNL--CFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE 497
           N   TG  PP L    G  L +LN+    +      L      L                
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWL---------------- 147

Query: 498 FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG-------LMPQELGNLV 550
               P L  L +++ +        +     L+++D S N   G       L P +   L 
Sbjct: 148 ---KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 551 SLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSW-KSLSILKLSENH 609
            L   N  +    G   +  +    L+  D+S N L  +  +    W   L+ L LS   
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 610 FTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTG 661
               +P  +    KL  L L  N+L     PS   L  +   L+L  N    
Sbjct: 265 LK-QVPKGLP--AKLSVLDLSYNRLDR--NPSPDELPQVGN-LSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 92.3 bits (229), Expect = 2e-20
 Identities = 45/248 (18%), Positives = 81/248 (32%), Gaps = 23/248 (9%)

Query: 480 TLWRVILKQNQLTG----ALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSI--NLTSIDF 533
           +L R+ ++  ++                L  L +    ++G  P  +  +   +L  ++ 
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 534 SSNKFSGLMPQELGNLV-----SLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNG 588
            +  ++      L  L       L  L+I+  H       Q+     L   D+S N   G
Sbjct: 129 RNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187

Query: 589 SIPSS----LRSWKSLSILKLSENHFT---GGIPTFISELEKLLELQLGGNQLGGEIPPS 641
                       + +L +L L         G      +   +L  L L  N L       
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247

Query: 642 IGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNV 701
                    +LNLS  GL  ++P  L   +KL  LD+S N L         +  +  +++
Sbjct: 248 SCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDELPQVGNLSL 303

Query: 702 SYNLFTGP 709
             N F   
Sbjct: 304 KGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.2 bits (208), Expect = 1e-17
 Identities = 53/296 (17%), Positives = 85/296 (28%), Gaps = 39/296 (13%)

Query: 236 SNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPN---LGNCSSLTHL 292
                   L   D   +        K  +L  L +   R    I      +   S L  L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 293 DIVGSKLTGSIPSSFGLLA--RLSSLDLSENQLSG--KIPPELGKC--KYLTVLHLYANQ 346
            +   ++TG+ P          L+ L+L     +       EL +     L VL +    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 347 LEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI----WRIASLEYLLVYNNNLLGKLPLE 402
                 +++     L  L+L DN   GE  +       +  +L+ L + N  +       
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM------- 213

Query: 403 MTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLN 461
                            SGV          L  LD  +NS         C    QL  LN
Sbjct: 214 --------------ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259

Query: 462 MGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGA 517
           +           L      L  + L  N+L    P   + P + +L +  N    +
Sbjct: 260 LSFTGLKQVPKGLP---AKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 39/230 (16%), Positives = 73/230 (31%), Gaps = 19/230 (8%)

Query: 506 HLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQ---ELGNLVSLVTLNISLNHV 562
            L            + I  S++L  +   + +    +      +  +  L  L +    V
Sbjct: 48  LLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEV 107

Query: 563 EGSLPSQLSKC--KNLEVFDVSFNLLNG--SIPSSLRSW--KSLSILKLSENHFTGGIPT 616
            G+ P  L +    +L + ++         +  + L+ W    L +L +++ H       
Sbjct: 108 TGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167

Query: 617 FISELEKLLELQLGGNQLGGEI-------PPSIGALQDLSYALNLSKNGLTGRIPSDLEK 669
            +     L  L L  N   GE        P     LQ L+   N      +G   +    
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL-RNAGMETPSGVCSALAAA 226

Query: 670 LSKLEQLDISSNNLTGTLSPLSNIH--SLVEVNVSYNLFTGPVPETLMNL 717
             +L+ LD+S N+L       S      L  +N+S+             L
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKL 276

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.8 bits (163), Expect = 7e-12
 Identities = 34/149 (22%), Positives = 49/149 (32%), Gaps = 13/149 (8%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNC----SALEYLDLSTNGFT---GDIPDNFEN 141
            ++     L T+DLS N   G        C      L+ L L   G     G        
Sbjct: 167 EQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAA 226

Query: 142 LQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFS 200
              LQ L+L  N L      P       L  + L+   L   +P+ +    ++  L L  
Sbjct: 227 RVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSY 283

Query: 201 NRLSGTIPESIGNCYRLQELYLNENKLMG 229
           NRL    P S     ++  L L  N  + 
Sbjct: 284 NRLD-RNP-SPDELPQVGNLSLKGNPFLD 310

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 96.0 bits (239), Expect = 9e-22
 Identities = 35/268 (13%), Positives = 73/268 (27%), Gaps = 58/268 (21%)

Query: 826  VIGRGAHGIVYKA---SLGPNAVFAVKKLAFRGHKRGSLS--MKREIQTIGKIRHRNLVR 880
              G       ++A   +L    V A+  +  +G     +          + +I    + R
Sbjct: 38   FHGGVPPLQFWQALDTALD-RQV-ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            + D    +  G+++  ++  GSL++V  +   P         +     A A    H    
Sbjct: 96   VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-----AIRAMQSLAAAADAAH---R 147

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              +      P  +         +S  G   L                   +   N     
Sbjct: 148  AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDANP---- 181

Query: 1001 KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060
               + D+   G  L  L+  +  L         +   +     DT      ++ + ++  
Sbjct: 182  ---QDDIRGIGASLYALLVNRWPLP-----EAGVRSGLAPAERDTAG--QPIEPADIDRD 231

Query: 1061 LVSSIRDQVIDVLLVALRCTEKKPSNRP 1088
            +   I         VA R  +     R 
Sbjct: 232  IPFQISA-------VAARSVQGDGGIRS 252

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.6 bits (241), Expect = 9e-22
 Identities = 45/214 (21%), Positives = 77/214 (35%), Gaps = 45/214 (21%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVK-----KLAFRGHKRGSLSMKREIQTIGKIRHRN 877
               +G G   IV K         +A K     +            ++RE+  + ++ H N
Sbjct: 17   GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH- 930
            ++ L D +  +   +++   +  G L D L                          A   
Sbjct: 77   VITLHDVYENRTDVVLILELVSGGELFDFL----------------AQKESLSEEEATSF 120

Query: 931  ------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTT 980
                   + YLH      I H D+KPENI+L  +  P     + DFG+A  ++       
Sbjct: 121  IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177

Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
               + GT  ++APE         E+D++S GV+ 
Sbjct: 178  ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 96.7 bits (241), Expect = 9e-22
 Identities = 55/244 (22%), Positives = 107/244 (43%), Gaps = 33/244 (13%)

Query: 792  RRRSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKK 850
              RS  ++++ A   P+ + + V           ++G G +G VYK   +    + A+K 
Sbjct: 7    PARSLDEIDLSALRDPAGIFELV----------ELVGNGTYGQVYKGRHVKTGQLAAIKV 56

Query: 851  LAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG-------IIMYRYMENGS 902
            +   G +   +  K+EI  + K   HRN+      +++K+         ++M  +   GS
Sbjct: 57   MDVTGDEEEEI--KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM-EFCGAGS 113

Query: 903  LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH 962
            + D++ +       E  + Y I       L++LH      ++HRDIK +N+LL    E  
Sbjct: 114  VTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169

Query: 963  ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKES-----DVYSYGVVLLEL 1017
            + DFG++  LD++       + +GT  ++APE          +     D++S G+  +E+
Sbjct: 170  LVDFGVSAQLDRTVGRRN--TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

Query: 1018 ITRK 1021
                
Sbjct: 228  AEGA 231

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  100 bits (250), Expect = 1e-21
 Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 35/217 (16%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKR-----EIQT 869
            E +     IG G  G V++        P    A+K       K  +    R     E  T
Sbjct: 390  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-----KNCTSDSVREKFLQEALT 444

Query: 870  IGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
            + +  H ++V+L          IIM      G LR  L        L   + Y  A   +
Sbjct: 445  MRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKFSLDLASLILY--AYQLS 501

Query: 930  HALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
             ALAYL    +      VHRDI   N+L+ S     + DFG+++ ++ S     S   + 
Sbjct: 502  TALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL- 554

Query: 987  TIGYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
             I ++APE      FT+A    SDV+ +GV + E++ 
Sbjct: 555  PIKWMAPESINFRRFTSA----SDVWMFGVCMWEILM 587

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.0 bits (242), Expect = 1e-21
 Identities = 50/200 (25%), Positives = 81/200 (40%), Gaps = 23/200 (11%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRL 881
            K V+G G +G V +          A+K L            ++E+    +     ++V +
Sbjct: 34   KQVLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKA--RQEVDHHWQASGGPHIVCI 87

Query: 882  ----EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
                E+    K C +I+   ME G L   +         E     +I      A+ +LH 
Sbjct: 88   LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH- 145

Query: 938  DCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
                 I HRD+KPEN+L  S+ +     ++DFG AK   ++   T       T  Y+APE
Sbjct: 146  --SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAPE 199

Query: 995  NAFTTAKSKESDVYSYGVVL 1014
                    K  D++S GV++
Sbjct: 200  VLGPEKYDKSCDMWSLGVIM 219

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 24/200 (12%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
               +G GA G+V++        VF  K +    +     ++K EI  + ++ H  L+ L 
Sbjct: 56   LEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLH 114

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVL----HSITPPPTLEWNVRY--KIALGAAHALAYLH 936
            D +  K   +++  ++  G L D +    + ++     E  V    + A      L ++H
Sbjct: 115  DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS-----EAEVINYMRQACEG---LKHMH 166

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPH--ISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
               +  IVH DIKPENI+ +++      I DFG+A  L+             T  + APE
Sbjct: 167  ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPE 220

Query: 995  NAFTTAKSKESDVYSYGVVL 1014
                      +D+++ GV+ 
Sbjct: 221  IVDREPVGFYTDMWAIGVLG 240

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 16/203 (7%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +G GA G VYKA +    A+ A K +  +  +        EI+ +    H  +V+L   
Sbjct: 26   ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHPYIVKLLGA 84

Query: 885  WLRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
            +       I++  +   G++  ++  +    T E  ++  +      AL +LH      I
Sbjct: 85   YYHDGKLWIMI-EFCPGGAVDAIMLELDRGLT-EPQIQV-VCRQMLEALNFLHSK---RI 138

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+K  N+L+  E +  ++DFG++    K+       S +GT  ++APE         
Sbjct: 139  IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD--SFIGTPYWMAPEVVMCETMKD 196

Query: 1004 ES-----DVYSYGVVLLELITRK 1021
                   D++S G+ L+E+   +
Sbjct: 197  TPYDYKADIWSLGITLIEMAQIE 219

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 13/199 (6%)

Query: 825  HVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
              +G G++G VYKA       + A+K++      +    + +EI  + +    ++V+   
Sbjct: 35   EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSPHVVKYYG 91

Query: 884  FWLRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
             + +     I+M  Y   GS+ D++  +      E  +   I       L YLH+     
Sbjct: 92   SYFKNTDLWIVM-EYCGAGSVSDIIR-LRNKTLTEDEIAT-ILQSTLKGLEYLHFM---R 145

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
             +HRDIK  NILL++E    ++DFG+A  L  + A     +V+GT  ++APE       +
Sbjct: 146  KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN--TVIGTPFWMAPEVIQEIGYN 203

Query: 1003 KESDVYSYGVVLLELITRK 1021
              +D++S G+  +E+   K
Sbjct: 204  CVADIWSLGITAIEMAEGK 222

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 96.7 bits (241), Expect = 2e-21
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 56/222 (25%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVK-------KLAFRGHKRGSLSMKREIQTIGKIR- 874
            K VIGRG   +V +         FAVK       +L+    +    + +RE   + ++  
Sbjct: 99   KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 875  HRNLVRLED-FWLRKDCGIIMYRYMENGSL---------------RDVLHSITPPPTLEW 918
            H +++ L D +       ++    M  G L               R ++ S+        
Sbjct: 159  HPHIITLIDSYESSSFMFLVF-DLMRKGELFDYLTEKVALSEKETRSIMRSLL------- 210

Query: 919  NVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS 978
                        A+++LH      IVHRD+KPENILLD  M+  +SDFG +  L+     
Sbjct: 211  -----------EAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256

Query: 979  TTSISVVGTIGYIAPE------NAFTTAKSKESDVYSYGVVL 1014
                 + GT GY+APE      +       KE D+++ GV+L
Sbjct: 257  RE---LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 73/320 (22%), Positives = 129/320 (40%), Gaps = 86/320 (26%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMK----REIQ 868
             ++  K  +G GA G V+ A            + AVK L     K  +L+ +    RE +
Sbjct: 15   RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-----KDPTLAARKDFQREAE 69

Query: 869  TIGKIRHRNLVRL------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY 922
             +  ++H ++V+        D  +     ++   YM++G L   L +  P   +  + + 
Sbjct: 70   LLTNLQHEHIVKFYGVCGDGDPLI-----MVF-EYMKHGDLNKFLRAHGPDAMILVDGQP 123

Query: 923  K-------------IALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDF 966
            +             IA   A  + YL   H+      VHRD+   N L+ + +   I DF
Sbjct: 124  RQAKGELGLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDF 177

Query: 967  GIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLEL 1017
            G+++ +  +         VG    +      PE      FTT    ESDV+S+GV+L E+
Sbjct: 178  GMSRDVYSTDYYR-----VGGHTMLPIRWMPPESIMYRKFTT----ESDVWSFGVILWEI 228

Query: 1018 ITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVAL 1077
             T      P ++             S+TE I  I    ++E         +V DV+   L
Sbjct: 229  FT--YGKQPWFQ------------LSNTEVIECITQGRVLERP--RVCPKEVYDVM---L 269

Query: 1078 RCTEKKPSNRPNMRDVVRQL 1097
             C +++P  R N++++ + L
Sbjct: 270  GCWQREPQQRLNIKEIYKIL 289

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 95.4 bits (238), Expect = 2e-21
 Identities = 49/211 (23%), Positives = 84/211 (39%), Gaps = 47/211 (22%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRL 881
               +G G+  I  K      N  FAVK ++    KR   + ++EI  +     H N+V+L
Sbjct: 16   DKPLGEGSFSICRKCVHKKSNQAFAVKIIS----KRMEANTQKEITALKLCEGHPNIVKL 71

Query: 882  EDFWLRKDCGIIMYRYMENGSL---------------RDVLHSITPPPTLEWNVRYKIAL 926
             + +  +    ++   +  G L                 ++  +                
Sbjct: 72   HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL---------------- 115

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSIS 983
                A++++H   D  +VHRD+KPEN+L   E +     I DFG A+L    P +    +
Sbjct: 116  --VSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKT 168

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
               T+ Y APE        +  D++S GV+L
Sbjct: 169  PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 98.2 bits (245), Expect = 2e-21
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 38/218 (17%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLA------------FRGHKRGSLSMKREIQTI 870
               +G GA+G V        ++  A+K +              +  ++    +  EI  +
Sbjct: 41   VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 871  GKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY------KI 924
              + H N+++L D +  K    ++  + E G L + + +           ++       I
Sbjct: 101  KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANI 151

Query: 925  ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME---PHISDFGIAKLLDKSPASTTS 981
                   + YLH      IVHRDIKPENILL+++       I DFG++    K       
Sbjct: 152  MKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD- 207

Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +GT  YIAPE       +++ DV+S GV++  L+ 
Sbjct: 208  --RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLC 242

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 98.4 bits (245), Expect = 3e-21
 Identities = 52/237 (21%), Positives = 91/237 (38%), Gaps = 46/237 (19%)

Query: 800  EIPAQEGPSYLLKQVIEATENLNAK----HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFR 854
                     Y  + V    +++         +G GA G+V++         FA K +   
Sbjct: 134  NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193

Query: 855  GHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPP 914
             H+    ++++EIQT+  +RH  LV L D +   +  +++Y +M  G L +         
Sbjct: 194  -HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE--------- 243

Query: 915  TLEWNVRYKIALGAAH---------------ALAYLHYDCDPPIVHRDIKPENILLDSEM 959
                    K+A                     L ++H   +   VH D+KPENI+  ++ 
Sbjct: 244  --------KVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKR 292

Query: 960  EPHI--SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
               +   DFG+   LD   +        GT  + APE A        +D++S GV+ 
Sbjct: 293  SNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.4 bits (243), Expect = 3e-21
 Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 47/213 (22%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVK-----KLAFRGHKRGSLSMKREIQTIGKIRHRN 877
               +G+GA  +V +   +     +A       KL+ R H++    ++RE +    ++H N
Sbjct: 16   FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK----LEREARICRLLKHPN 71

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH- 930
            +VRL D    +    +++  +  G L + +                +A        A+H 
Sbjct: 72   IVRLHDSISEEGHHYLIFDLVTGGELFEDI----------------VAREYYSEADASHC 115

Query: 931  ------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTS 981
                  A+ + H      +VHR++KPEN+LL S+++     ++DFG+A  ++    +   
Sbjct: 116  IQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172

Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
                GT GY++PE        K  D+++ GV+L
Sbjct: 173  F--AGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 96.7 bits (241), Expect = 3e-21
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 40/215 (18%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A L     + A+KK+     KR      RE+Q + K+ H N+VRL  F
Sbjct: 61   VIGNGSFGVVYQAKLCDSGELVAIKKV--LQDKRFKN---RELQIMRKLDHCNIVRLRYF 115

Query: 885  WL-----RKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH-------- 930
            +      + +  + ++  Y+      + ++ +          R K  L   +        
Sbjct: 116  FYSSGEKKDEVYLNLVLDYVP-----ETVYRV-----ARHYSRAKQTLPVIYVKLYMYQL 165

Query: 931  --ALAYLHYDCDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGT 987
              +LAY+H      I HRDIKP+N+LLD +     + DFG AK L +   + + I    +
Sbjct: 166  FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---S 219

Query: 988  IGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
              Y APE  F     +   DV+S G VL EL+  +
Sbjct: 220  RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 48/214 (22%), Positives = 77/214 (35%), Gaps = 45/214 (21%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVK-----KLAFRGHKRGSLSMKREIQTIGKIRHRN 877
               +G G   +V K         +A K     +            ++RE+  + +I+H N
Sbjct: 16   GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH- 930
            ++ L + +  K   I++   +  G L D L                          A   
Sbjct: 76   VITLHEVYENKTDVILILELVAGGELFDFL----------------AEKESLTEEEATEF 119

Query: 931  ------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLLDKSPASTT 980
                   + YLH      I H D+KPENI+L     P     I DFG+A  +D       
Sbjct: 120  LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176

Query: 981  SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
               + GT  ++APE         E+D++S GV+ 
Sbjct: 177  ---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 95.0 bits (237), Expect = 4e-21
 Identities = 55/259 (21%), Positives = 99/259 (38%), Gaps = 58/259 (22%)

Query: 795  SKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVF---AVKKL 851
             K       +  P   +  V++   ++  + VIG G  G V KA +  + +    A+K++
Sbjct: 2    KKHHHHHHGKNNPDPTIYPVLDW-NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM 60

Query: 852  AFRGHKRGSLSMKR-----EIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRD 905
                 K  +          E++ + K+  H N++ L      +    +   Y  +G+L D
Sbjct: 61   -----KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115

Query: 906  VLHSITPPPTLEWNVRY-------------KIALGAAHALAYL---HYDCDPPIVHRDIK 949
             L       T                      A   A  + YL    +      +HRD+ 
Sbjct: 116  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF------IHRDLA 169

Query: 950  PENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTA 1000
              NIL+       I+DFG+++  +        + V  T+G +     A E    + +TT 
Sbjct: 170  ARNILVGENYVAKIADFGLSRGQE--------VYVKKTMGRLPVRWMAIESLNYSVYTT- 220

Query: 1001 KSKESDVYSYGVVLLELIT 1019
                SDV+SYGV+L E+++
Sbjct: 221  ---NSDVWSYGVLLWEIVS 236

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 93.8 bits (234), Expect = 4e-21
 Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 43/210 (20%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVKKLA-FRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
              ++G+G+ G V K         +AVK +       + + ++ RE++ + K+ H N+++L
Sbjct: 27   VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 882  ED-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG------AAH---- 930
             +         I+       G L D +                I         AA     
Sbjct: 87   FEILEDSSSFYIVG-ELYTGGELFDEI----------------IKRKRFSEHDAARIIKQ 129

Query: 931  ---ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISV 984
                + Y+H      IVHRD+KPENILL+S+ +     I DFG++    ++         
Sbjct: 130  VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---R 183

Query: 985  VGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
            +GT  YIAPE        ++ DV+S GV+L
Sbjct: 184  IGTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 95.9 bits (239), Expect = 5e-21
 Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 41/215 (19%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            VIG G+ G+V++A L  +   A+KK+     KR      RE+Q +  ++H N+V L+ F+
Sbjct: 47   VIGNGSFGVVFQAKLVESDEVAIKKV--LQDKRFKN---RELQIMRIVKHPNVVDLKAFF 101

Query: 886  L----RKDCGII----------MYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGA 928
                 +KD   +          +YR       R         P L   ++   Y++    
Sbjct: 102  YSNGDKKDEVFLNLVLEYVPETVYRAS-----RHYAKLKQTMPMLL--IKLYMYQLLRS- 153

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEP-HISDFGIAKLLDKSPASTTSISVVGT 987
               LAY+H      I HRDIKP+N+LLD       + DFG AK+L     + + I    +
Sbjct: 154  ---LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC---S 204

Query: 988  IGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
              Y APE  F     +   D++S G V+ EL+  +
Sbjct: 205  RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 95.2 bits (237), Expect = 5e-21
 Identities = 55/232 (23%), Positives = 83/232 (35%), Gaps = 52/232 (22%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKR-----EI 867
            +N+     +G GA G VY+  +            AVK L                   E 
Sbjct: 71   KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSEQDELDFLMEA 125

Query: 868  QTIGKIRHRNLVRLEDFWLRKD-CGIIMYRYMENGSLRDVLHSITP----PPTLEWNVRY 922
              I K  H+N+VR     L+     I++   M  G L+  L    P    P +L      
Sbjct: 126  LIISKFNHQNIVRCIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184

Query: 923  KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSP 976
             +A   A    YL   H+      +HRDI   N LL          I DFG+A+ + +  
Sbjct: 185  HVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR-- 236

Query: 977  ASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
                     G    +      PE      FT+    ++D +S+GV+L E+ +
Sbjct: 237  ---AGYYRKGGCAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIFS 281

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.4 bits (233), Expect = 5e-21
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 53/222 (23%)

Query: 818  TENLNAK----HVIGRGAHGIVYKAS-LGPNAVFAVK---KLAFRGHKRGSLSMKREIQT 869
              ++N      + IGRG+ G V  A   G     A K   K       R     K+EI+ 
Sbjct: 4    KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEI 59

Query: 870  IGKIRHRNLVRLED-FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG- 927
            +  + H N++RL + F    D  ++M      G L + +                +    
Sbjct: 60   MKSLDHPNIIRLYETFEDNTDIYLVM-ELCTGGELFERV----------------VHKRV 102

Query: 928  -----AAH-------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLL 972
                 AA        A+AY H      + HRD+KPEN L  ++       + DFG+A   
Sbjct: 103  FRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159

Query: 973  DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVL 1014
                   T    VGT  Y++P+         E D +S GV++
Sbjct: 160  KPGKMMRT---KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 94.4 bits (235), Expect = 8e-21
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGS--LSMKREIQTIGKIRHRNLVRL 881
              IG G+ G VY A  +  + V A+KK+++ G +       + +E++ + K+RH N ++ 
Sbjct: 60   REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 882  EDFWLRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
               +LR+    ++M  Y   GS  D+L  +   P  E  +   +  GA   LAYLH    
Sbjct: 120  RGCYLREHTAWLVM-EYCL-GSASDLLE-VHKKPLQEVEIAA-VTHGALQGLAYLHSH-- 173

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              ++HRD+K  NILL       + DFG A ++        + S VGT  ++APE      
Sbjct: 174  -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMD 226

Query: 1001 KS---KESDVYSYGVVLLELITRK 1021
            +     + DV+S G+  +EL  RK
Sbjct: 227  EGQYDGKVDVWSLGITCIELAERK 250

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 36/185 (19%), Positives = 61/185 (32%), Gaps = 10/185 (5%)

Query: 190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDN 249
            K      L  +  +     +      L  + L    +       +    N+  L + + 
Sbjct: 22  FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76

Query: 250 NLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGL 309
           +             NL  L +     +    PNL   +SLT LDI  S    SI +    
Sbjct: 77  HATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134

Query: 310 LARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
           L +++S+DLS N     I P L     L  L++  + +       +     L  L  F  
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191

Query: 370 RLTGE 374
            + G+
Sbjct: 192 TIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 24/162 (14%), Positives = 62/162 (38%), Gaps = 7/162 (4%)

Query: 90  EIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLN 149
               ++ L  I L++ N + ++   +     ++ L ++    T +  +    L NL+ L 
Sbjct: 39  TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLR 94

Query: 150 LYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPE 209
           + G  +  +    L  +  L  + +++++   SI   +  L +V ++ L  N     I  
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M 153

Query: 210 SIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
            +     L+ L +  + +  +    + +   L  L      +
Sbjct: 154 PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 36/206 (17%), Positives = 67/206 (32%), Gaps = 12/206 (5%)

Query: 120 ALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSL 179
           A E   L  +    +IPD     +      L  +         +     L Y+ L N ++
Sbjct: 2   AAEQTGLKASQDNVNIPD--STFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINV 56

Query: 180 SGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLE 239
           +  +   +     ++ L + +   +      I     L+ L +    +      +LS L 
Sbjct: 57  T-DLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLT 112

Query: 240 NLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKL 299
           +L  LD+  +  +  I         +  +DLSYN     I P L     L  L+I    +
Sbjct: 113 SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGV 171

Query: 300 TGSIPSSFGLLARLSSLDLSENQLSG 325
                       +L+ L      + G
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 26/157 (16%), Positives = 64/157 (40%), Gaps = 8/157 (5%)

Query: 548 NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSE 607
              + +   +  +       +Q+    +L    ++   +   + + +    ++  L ++ 
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 608 NHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDL 667
            H T      IS L  L  L++ G  +  +  P++  L  L+  L++S +     I + +
Sbjct: 76  IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL-LDISHSAHDDSILTKI 132

Query: 668 EKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYN 704
             L K+  +D+S N     + PL  +  L  +N+ ++
Sbjct: 133 NTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFD 169

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 27/162 (16%), Positives = 60/162 (37%), Gaps = 7/162 (4%)

Query: 547 GNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS 606
             + SL  + ++  +V   L + +    N++   ++         + +    +L  L++ 
Sbjct: 41  AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIM 96

Query: 607 ENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSD 666
               T      +S L  L  L +  +     I   I  L  ++  ++LS NG    I   
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS-IDLSYNGAITDI-MP 154

Query: 667 LEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTG 708
           L+ L +L+ L+I  + +      + +   L ++        G
Sbjct: 155 LKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 76.5 bits (189), Expect = 7e-16
 Identities = 25/192 (13%), Positives = 66/192 (34%), Gaps = 10/192 (5%)

Query: 255 INFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLS 314
           +N      K      L  +  +  I+      +SLT++ +    +T  + +       + 
Sbjct: 15  VNIPDSTFKAYLNGLLGQSSTAN-ITE--AQMNSLTYITLANINVT-DL-TGIEYAHNIK 69

Query: 315 SLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGE 374
            L ++    +    P +     L  L +    +  +    L  L++L  L++  +     
Sbjct: 70  DLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127

Query: 375 FPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLM 434
               I  +  +  + +  N  +  +   +  L +LK++++  +         +     L 
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLN 184

Query: 435 QLDFINNSFTGE 446
           QL   + +  G+
Sbjct: 185 QLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 25/134 (18%), Positives = 52/134 (38%), Gaps = 5/134 (3%)

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE 563
           +  L ++  + +    + I    NL  +       +      L  L SL  L+IS +  +
Sbjct: 68  IKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125

Query: 564 GSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEK 623
            S+ ++++    +   D+S+N     I   L++   L  L +  +         I +  K
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPK 182

Query: 624 LLELQLGGNQLGGE 637
           L +L      +GG+
Sbjct: 183 LNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 35/198 (17%), Positives = 73/198 (36%), Gaps = 11/198 (5%)

Query: 344 ANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM 403
           A+Q    IPD         +  L  +       ++  ++ SL Y+ + N N+     +E 
Sbjct: 10  ASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIE- 63

Query: 404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMG 463
                +K++++ N   +   P  +   S+L +L  +    T +  PNL     L +L++ 
Sbjct: 64  -YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120

Query: 464 QNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIG 523
            +     I + + + P +  + L  N     +      P L  L++  + +       I 
Sbjct: 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDY--RGIE 178

Query: 524 NSINLTSIDFSSNKFSGL 541
           +   L  +   S    G 
Sbjct: 179 DFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 68.8 bits (169), Expect = 2e-13
 Identities = 23/115 (20%), Positives = 48/115 (41%), Gaps = 3/115 (2%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
           I  LS L+ + +   + + +  P L   ++L  LD+S +     I      L  +  ++L
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 151 YGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSG 205
             N    +I  PL  +  L+ + +  + +       + D  ++  L+ FS  + G
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 18/101 (17%), Positives = 43/101 (42%), Gaps = 6/101 (5%)

Query: 618 ISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLD 677
            +++  L  + L    +  ++   I    ++   L ++    T    + +  LS LE+L 
Sbjct: 40  EAQMNSLTYITLANINVT-DLTG-IEYAHNIKD-LTINNIHATN--YNPISGLSNLERLR 94

Query: 678 ISSNNLTGT-LSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
           I   ++T   +  LS + SL  +++S++     +   +  L
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 18/99 (18%), Positives = 39/99 (39%), Gaps = 7/99 (7%)

Query: 619 SELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDI 678
           S  +  L   LG +        +   +  L+Y + L+   +T    + +E    ++ L I
Sbjct: 20  STFKAYLNGLLGQSSTA---NITEAQMNSLTY-ITLANINVTD--LTGIEYAHNIKDLTI 73

Query: 679 SSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
           ++ + T   +P+S + +L  + +     T      L  L
Sbjct: 74  NNIHAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGL 111

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 59/276 (21%), Positives = 92/276 (33%), Gaps = 57/276 (20%)

Query: 99  TIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLL 155
           T      NF     N+P       + + LDLS N        +F +   LQ L+L    +
Sbjct: 11  TYQCMELNFYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 64

Query: 156 DGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESI-GNC 214
              I +  ++                        L  +  L L  N +  ++        
Sbjct: 65  Q-TIEDGAYQ-----------------------SLSHLSTLILTGNPIQ-SLALGAFSGL 99

Query: 215 YRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYN 273
             LQ+L   E  L       + +L+ L  L+V  N ++            NL  LDLS N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 274 RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGK 333
           +     S    +   L  + ++                   SLDLS N ++  I P   K
Sbjct: 160 KIQ---SIYCTDLRVLHQMPLL-----------------NLSLDLSLNPMN-FIQPGAFK 198

Query: 334 CKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
              L  L L  NQL+        +L++LQ + L  N
Sbjct: 199 EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 40/196 (20%), Positives = 72/196 (36%), Gaps = 26/196 (13%)

Query: 93  HLSKLQTIDLSSNNFSGNIPP----KLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQY 147
              +LQ +DLS       I       L +   L  L L+ N     +    F  L +LQ 
Sbjct: 50  SFPELQVLDLSRCEIQ-TIEDGAYQSLSH---LSTLILTGNPIQ-SLALGAFSGLSSLQK 104

Query: 148 LNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVG---DLKEVEALWLFSNRL 203
           L      L   +       L  L+ + + +N +  S         +L  +E L L SN++
Sbjct: 105 LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKI 161

Query: 204 SGTIPESI-GNCYRLQ----ELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFG 258
             +I  +     +++      L L+ N +    P +   +  L  L +  N L+  +  G
Sbjct: 162 Q-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLK-SVPDG 218

Query: 259 S-EKCKNLTFLDLSYN 273
             ++  +L  + L  N
Sbjct: 219 IFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 44/204 (21%), Positives = 80/204 (39%), Gaps = 19/204 (9%)

Query: 506 HLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGS 565
           +LD+S N +      S  +   L  +D S  +   +      +L  L TL ++ N ++ S
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-S 90

Query: 566 LPSQL-SKCKNLEVFDVSFNLLNGSIPSSL-RSWKSLSILKLSENHFTGGIP---TFISE 620
           L     S   +L+        L  S+ +      K+L  L ++ N           F S 
Sbjct: 91  LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQS-FKLPEYF-SN 147

Query: 621 LEKLLELQLGGNQLGGEIPPSI----GALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQL 676
           L  L  L L  N++   I  +       +  L+ +L+LS N +   I     K  +L++L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKEL 205

Query: 677 DISSNNLT----GTLSPLSNIHSL 696
            + +N L     G    L+++  +
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKI 229

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 40/232 (17%), Positives = 74/232 (31%), Gaps = 35/232 (15%)

Query: 337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT----GEFPVSIWRIASLEYLLVYN 392
              L L  N L             LQ L+L    +     G +      ++ L  L++  
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY----QSLSHLSTLILTG 85

Query: 393 NNLLGKLPLEM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNL 451
           N  +  L L   + L  L+ +       + +    +G   +L +L+  +N          
Sbjct: 86  NP-IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPE 143

Query: 452 CFGK--QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLS-HLD 508
            F     L  L++  N+        + S                 L    + P+L+  LD
Sbjct: 144 YFSNLTNLEHLDLSSNK--------IQSIY------------CTDLRVLHQMPLLNLSLD 183

Query: 509 VSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLN 560
           +S N ++  I       I L  +   +N+   +       L SL  + +  N
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 32/117 (27%), Positives = 56/117 (47%), Gaps = 10/117 (8%)

Query: 92  GHLSKLQTIDLSSNNFSGNIPPKL-GNCSALEYLDLSTNGFTGDIPDN-FENLQNLQY-- 147
           GHL  L+ ++++ N       P+   N + LE+LDLS+N     I       L  +    
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLN 179

Query: 148 --LNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
             L+L  N ++  I    F+ + L+ + L+ N L  S+P  + D L  ++ +WL +N
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 39/195 (20%), Positives = 71/195 (36%), Gaps = 37/195 (18%)

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
            IP ++    +  ++D S N    L      +   L  L++S   ++ ++          
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDG------- 70

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFI-SELEKLLELQLGGNQLG 635
             +    +L              LS L L+ N     +     S L  L +L      L 
Sbjct: 71  -AYQ---SL------------SHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA 113

Query: 636 GEIPPSI-GALQDLSYALNLSKNGLTGRIPSD--LEKLSKLEQLDISSNNLTGTLSP--L 690
             +     G L+ L   LN++ N +            L+ LE LD+SSN +  ++    L
Sbjct: 114 -SLENFPIGHLKTLKE-LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL 169

Query: 691 SNIHSLVEVNVSYNL 705
             +H +  +N+S +L
Sbjct: 170 RVLHQMPLLNLSLDL 184

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 60/229 (26%), Positives = 95/229 (41%), Gaps = 50/229 (21%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVK---------------------KLAFRGHKRGSLSM- 863
            IG+G++G+V  A +   N  +A+K                          G         
Sbjct: 21   IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 864  ---KREIQTIGKIRHRNLVRLEDFW-LRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEW 918
                +EI  + K+ H N+V+L +      +  + M +  +  G + +V    T  P  E 
Sbjct: 81   EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV---PTLKPLSED 137

Query: 919  NVRYK---IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
              R+    +  G    + YLHY     I+HRDIKP N+L+  +    I+DFG++     S
Sbjct: 138  QARFYFQDLIKG----IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 976  PA--STTSISVVGTIGYIAPENAFTTAKS---KESDVYSYGVVLLELIT 1019
             A  S T    VGT  ++APE+   T K    K  DV++ GV L   + 
Sbjct: 191  DALLSNT----VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.5 bits (233), Expect = 2e-20
 Identities = 45/226 (19%), Positives = 84/226 (37%), Gaps = 36/226 (15%)

Query: 816  EATENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            +  +    + + G+G  G V            A+KK+      R      + +Q +  + 
Sbjct: 20   KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQDPRFRNRELQIMQDLAVLH 77

Query: 875  HRNLVRLEDFWLRKD-------CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            H N+V+L+ ++              ++  Y+      D LH            R ++A  
Sbjct: 78   HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRC-----CRNYYRRQVAPP 127

Query: 928  AAH----------ALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSP 976
                         ++  LH      + HRDIKP N+L++       + DFG AK L  S 
Sbjct: 128  PILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186

Query: 977  ASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
             +    + + +  Y APE  F     +   D++S G +  E++  +
Sbjct: 187  PNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 92.7 bits (231), Expect = 2e-20
 Identities = 60/235 (25%), Positives = 92/235 (39%), Gaps = 54/235 (22%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMK----REIQ 868
             ++  K  +G GA G V+ A            + AVK L     K  S S +    RE +
Sbjct: 41   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-----KEASESARQDFQREAE 95

Query: 869  TIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVL------------HSITPPPTL 916
             +  ++H+++VR           ++++ YM +G L   L                 P  L
Sbjct: 96   LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155

Query: 917  EWNVRYKIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD 973
                   +A   A  + YL   H+      VHRD+   N L+   +   I DFG+++ + 
Sbjct: 156  GLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209

Query: 974  KSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
                  T    VG    +      PE      FTT    ESDV+S+GVVL E+ T
Sbjct: 210  S-----TDYYRVGGRTMLPIRWMPPESILYRKFTT----ESDVWSFGVVLWEIFT 255

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 46/203 (22%), Positives = 81/203 (39%), Gaps = 25/203 (12%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVK-----KLAFRGHKRGSLSMKREIQTIGKIR----H 875
            ++G+G  G V+    L      A+K     ++        S++   E+  + K+     H
Sbjct: 38   LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
              ++RL D++  ++  +++         +D+   IT    L              A+ + 
Sbjct: 98   PGVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155

Query: 936  HYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            H      +VHRDIK ENIL+D       + DFG   LL   P +       GT  Y  PE
Sbjct: 156  HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF----DGTRVYSPPE 208

Query: 995  NAFTTAKS---KESDVYSYGVVL 1014
              + +        + V+S G++L
Sbjct: 209  --WISRHQYHALPATVWSLGILL 229

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 47/237 (19%), Positives = 82/237 (34%), Gaps = 56/237 (23%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKR-----EI 867
              +     +G    G VYK  L            A+K L     K  +    R     E 
Sbjct: 9    SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-----KDKAEGPLREEFRHEA 63

Query: 868  QTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK---- 923
                +++H N+V L     +     +++ Y  +G L + L   +P   +      +    
Sbjct: 64   MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 924  ---------IALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
                     +    A  + YL   H       VH+D+   N+L+  ++   ISD G+ + 
Sbjct: 124  ALEPPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 972  LDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
            +            +     +     APE      F+      SD++SYGVVL E+ +
Sbjct: 178  VYA-----ADYYKLLGNSLLPIRWMAPEAIMYGKFSID----SDIWSYGVVLWEVFS 225

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 93.3 bits (232), Expect = 4e-20
 Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 64/255 (25%)

Query: 793  RRSKQDLEIPAQEGPSYLLKQVIEATENLNAKH------VIGRGAHGIVYKA-SLGPNAV 845
                Q    P Q+ P + +K  ++  +N           V+G G +G V +  +      
Sbjct: 30   HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89

Query: 846  FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRL----EDFWLRKDCG-IIMYRYME 899
            FA+K L      +     +RE++   +  +  ++VR+    E+ +  + C  I+M   ++
Sbjct: 90   FALKML------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM-ECLD 142

Query: 900  NGSL-----------------RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
             G L                  +++ SI                    A+ YLH      
Sbjct: 143  GGELFSRIQDRGDQAFTEREASEIMKSI------------------GEAIQYLH---SIN 181

Query: 943  IVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            I HRD+KPEN+L  S+       ++DFG AK      + TT      T  Y+APE     
Sbjct: 182  IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPE 238

Query: 1000 AKSKESDVYSYGVVL 1014
               K  D++S GV++
Sbjct: 239  KYDKSCDMWSLGVIM 253

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 44/229 (19%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKR-----EI 867
            E +     +G+G+ G+VY+          P    A+K +        +   +R     E 
Sbjct: 25   EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRERIEFLNEA 79

Query: 868  QTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR------ 921
              + +    ++VRL     +    +++   M  G L+  L S+ P       +       
Sbjct: 80   SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139

Query: 922  -YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT 980
              ++A   A  +AYL+       VHRD+   N ++  +    I DFG+ + + +     T
Sbjct: 140  MIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-----T 191

Query: 981  SISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELITR 1020
                 G  G +     +PE      FTT     SDV+S+GVVL E+ T 
Sbjct: 192  DYYRKGGKGLLPVRWMSPESLKDGVFTT----YSDVWSFGVVLWEIATL 236

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 33/212 (15%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVK---KLAFRGHKRGSLSMKREIQTIGKIRHRNLVRL 881
            ++G G++G V +          AVK   K   R    G  ++K+EIQ + ++RH+N+++L
Sbjct: 12   LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 882  EDFWL---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH-------- 930
             D      ++   ++M  Y   G ++++L S+            +  +  AH        
Sbjct: 72   VDVLYNEEKQKMYMVM-EYCVCG-MQEMLDSV---------PEKRFPVCQAHGYFCQLID 120

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             L YLH      IVH+DIKP N+LL +     IS  G+A+ L    A  T  +  G+  +
Sbjct: 121  GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 991  IAPENAFTTAKS---KESDVYSYGVVLLELIT 1019
              PE       +    + D++S GV L  + T
Sbjct: 178  QPPE-IANGLDTFSGFKVDIWSAGVTLYNITT 208

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 90.7 bits (226), Expect = 7e-20
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK------REIQTIGKIRHRNL 878
            ++G G+   V  A  L  +  +A+K L     KR  +         RE   + ++ H   
Sbjct: 37   ILGEGSFSTVVLARELATSREYAIKIL----EKRHIIKENKVPYVTRERDVMSRLDHPFF 92

Query: 879  VRLEDFWLRKDCG---IIMYRYMENGSLRDVLHSITPPPTLEWNVRY---KIALGAAHAL 932
            V+L  ++  +D       +  Y +NG L   +  I      E   R+   +I      AL
Sbjct: 93   VKL--YFTFQDDEKLYFGL-SYAKNGELLKYIRKIGSFD--ETCTRFYTAEIVS----AL 143

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
             YLH      I+HRD+KPENILL+ +M   I+DFG AK+L        + S VGT  Y++
Sbjct: 144  EYLH-GKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 993  PENAFTTAKSKESDVYSYGVVLLELIT 1019
            PE     +  K SD+++ G ++ +L+ 
Sbjct: 201  PELLTEKSACKSSDLWALGCIIYQLVA 227

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 90.8 bits (226), Expect = 1e-19
 Identities = 45/199 (22%), Positives = 80/199 (40%), Gaps = 17/199 (8%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHR-NLVR 880
               +GRG   +V +  S      +A K L  R   +     +  EI  +   +    ++ 
Sbjct: 34   SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY--KIALGAAHALAYLHYD 938
            L + +      I++  Y   G +  +          E +V    K  L     + YLH  
Sbjct: 94   LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG---VYYLH-- 148

Query: 939  CDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                IVH D+KP+NILL S        I DFG+++ +  +        ++GT  Y+APE 
Sbjct: 149  -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEI 204

Query: 996  AFTTAKSKESDVYSYGVVL 1014
                  +  +D+++ G++ 
Sbjct: 205  LNYDPITTATDMWNIGIIA 223

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 91.4 bits (227), Expect = 1e-19
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 34/231 (14%)

Query: 812  KQVIEATENLNAKHVIGRGAHGIVYKA---SLGPNAVFAVKKLAFRGHKRGSLSMKREIQ 868
            ++V +  E    K  +GRG +G VYKA       +  +A+K++   G    S+S  REI 
Sbjct: 16   ERVEDLFEYEGCK--VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIA 70

Query: 869  TIGKIRHRNLVRLED-FWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVRYKIAL 926
             + +++H N++ L+  F    D  + + + Y E+  L  ++         +  V+    L
Sbjct: 71   LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQ----L 125

Query: 927  GAAH----------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPH----ISDFGIAKLL 972
                           + YLH      ++HRD+KP NIL+  E        I+D G A+L 
Sbjct: 126  PRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

Query: 973  DKSPAS-TTSISVVGTIGYIAPENAF-TTAKSKESDVYSYGVVLLELITRK 1021
            +           VV T  Y APE        +K  D+++ G +  EL+T +
Sbjct: 183  NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.6 bits (225), Expect = 2e-19
 Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 52/237 (21%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +G G+ GIV +         FA+KK       R      RE+  +  + H N+++L D+
Sbjct: 14   TLGTGSFGIVCEVFDIESGKRFALKK--VLQDPRYKN---RELDIMKVLDHVNIIKLVDY 68

Query: 885  W------LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY---------------- 922
            +        K            G    V +            +Y                
Sbjct: 69   FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 923  ------KIALGAAH----------ALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISD 965
                    ++              A+ ++H      I HRDIKP+N+L++S+     + D
Sbjct: 129  KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 966  FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            FG AK L  S  S    + + +  Y APE      + +   D++S G V  ELI  K
Sbjct: 186  FGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 90.5 bits (225), Expect = 3e-19
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 50/233 (21%)

Query: 813  QVIEATENLNAKH-----VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-- 864
             V +  E++N  H      IG+G+ G V          ++A+K +    +K+  +     
Sbjct: 4    PVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM----NKQKCVERNEV 59

Query: 865  ----REIQTIGKIRHRNLVRLE-DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
                +E+Q +  + H  LV L   F   +D  +++   +  G LR   H       L+ N
Sbjct: 60   RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV-DLLLGGDLR--YH-------LQQN 109

Query: 920  VRYK----------IALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA 969
            V +K          + +    AL YL    +  I+HRD+KP+NILLD     HI+DF IA
Sbjct: 110  VHFKEETVKLFICELVM----ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIA 162

Query: 970  KLLDKSPASTTSISVVGTIGYIAPE---NAFTTAKSKESDVYSYGVVLLELIT 1019
             +L +    T   ++ GT  Y+APE   +      S   D +S GV   EL+ 
Sbjct: 163  AMLPR---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 90.8 bits (226), Expect = 5e-19
 Identities = 84/476 (17%), Positives = 141/476 (29%), Gaps = 93/476 (19%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNC-SALEYLDLSTNGFT----GDIPDNFENLQNLQYLN 149
             +Q++D+     S     +L       + + L   G T     DI         L  LN
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 150 LYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGT--- 206
           L  N L       + + L        +  +              + L L +  L+G    
Sbjct: 63  LRSNELGDVGVHCVLQGLQT-----PSCKI--------------QKLSLQNCCLTGAGCG 103

Query: 207 -IPESIGNCYRLQELYLNENKL-----MGFLPESLSNLENLVYLDVGDNNL--EGRINFG 258
            +  ++     LQEL+L++N L            L     L  L +   +L         
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163

Query: 259 S--EKCKNLTFLDLSYNRFSGGISPNLG-----NCSSLTHLDIVGSKLT----GSIPSSF 307
           S      +   L +S N  +      L      +   L  L +    +T      +    
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223

Query: 308 GLLARLSSLDLSENQLSGK-----IPPELGKCKYLTVLHLYANQLEGE----IPDELGQL 358
              A L  L L  N+L         P  L     L  L ++   +  +    +   L   
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283

Query: 359 SNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ 418
            +L++L L  N L  E    +         L+                 QL+++ + +  
Sbjct: 284 ESLKELSLAGNELGDEGARLLCE------TLLEPG-------------CQLESLWVKSCS 324

Query: 419 FSGV----IPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-----KQLRVLNMGQNQFH- 468
           F+          L  N  L++L   NN         LC G       LRVL +       
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384

Query: 469 ---GPIPSLLGSCPTLWRVILKQNQLTG----ALPEFSKNP--VLSHLDVSRNNIS 515
                + + L +  +L  + L  N L       L E  + P  +L  L +     S
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 90.4 bits (225), Expect = 5e-19
 Identities = 78/477 (16%), Positives = 138/477 (28%), Gaps = 94/477 (19%)

Query: 263 KNLTFLDLSYNRFS-GGISPNLGNCSSLTHLDIVGSKLT----GSIPSSFGLLARLSSLD 317
            ++  LD+     S    +  L        + +    LT      I S+  +   L+ L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 318 LSENQLSGKIPPELGKC-----KYLTVLHLYANQLEGE----IPDELGQLSNLQDLELFD 368
           L  N+L       + +        +  L L    L G     +   L  L  LQ+L L D
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 369 NRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS----GVIP 424
           N L          +  L   L+                 +L+ + L     S      + 
Sbjct: 123 NLLGDAG------LQLLCEGLLDPQ-------------CRLEKLQLEYCSLSAASCEPLA 163

Query: 425 QSLGINSSLMQLDFINNSFTGEIPPNLCFG-----KQLRVLNMGQNQFH----GPIPSLL 475
             L       +L   NN         LC G      QL  L +            +  ++
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223

Query: 476 GSCPTLWRVILKQNQLTG------ALPEFSKNPVLSHLDVSRNNIS----GAIPSSIGNS 525
            S  +L  + L  N+L               +  L  L +    I+    G +   +   
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAK 283

Query: 526 INLTSIDFSSNKFSGLMPQELGNLV-----SLVTLNISLNHV--EG--SLPSQLSKCKNL 576
            +L  +  + N+      + L   +      L +L +              S L++ + L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343

Query: 577 EVFDVSFNLLNGS----IPSSLRSW-KSLSILKLSENHFTG-GIPTFISELEK---LLEL 627
               +S N L  +    +   L      L +L L++   +     +  + L     L EL
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403

Query: 628 QLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT 684
            L  N LG         +  L  ++                    LEQL +     +
Sbjct: 404 DLSNNCLGDA------GILQLVESVRQPG--------------CLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 87.7 bits (218), Expect = 4e-18
 Identities = 79/456 (17%), Positives = 144/456 (31%), Gaps = 69/456 (15%)

Query: 217 LQELYLNENKLM-GFLPESLSNLENLVYLDVGDNNL--EGRINFGS--EKCKNLTFLDLS 271
           +Q L +   +L      E L  L+    + + D  L      +  S       L  L+L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 272 YNRFSG----GISPNLGNCS-SLTHLDIVGSKLT----GSIPSSFGLLARLSSLDLSENQ 322
            N         +   L   S  +  L +    LT    G + S+   L  L  L LS+N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 323 LSGKIPPELGK-----CKYLTVLHLYANQLEGE----IPDELGQLSNLQDLELFDNRLTG 373
           L       L +        L  L L    L       +   L    + ++L + +N +  
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184

Query: 374 EFPVSIWRI-----ASLEYLLVYNNNL----LGKLPLEMTELKQLKNISLYNNQF--SGV 422
                + +        LE L + +  +       L   +     L+ ++L +N+    G+
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244

Query: 423 I---PQSLGINSSLMQLDFINNSFTGE----IPPNLCFGKQLRVLNMGQNQFHGP----- 470
               P  L  +S L  L       T +    +   L   + L+ L++  N+         
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304

Query: 471 IPSLLGSCPTLWRVILKQNQLTGALPEF-----SKNPVLSHLDVSRNNI--SGAIPSSIG 523
             +LL     L  + +K    T A         ++N  L  L +S N +  +G      G
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364

Query: 524 ---NSINLTSIDFSSNKFS--GLMP--QELGNLVSLVTLNISLNHVEGS----LPSQLSK 572
                  L  +  +    S          L    SL  L++S N +  +    L   + +
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 424

Query: 573 CK-NLEVFDVSFNLLN----GSIPSSLRSWKSLSIL 603
               LE   +     +      + +  +   SL ++
Sbjct: 425 PGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 460

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 86.9 bits (216), Expect = 8e-18
 Identities = 82/451 (18%), Positives = 138/451 (30%), Gaps = 100/451 (22%)

Query: 313 LSSLDLSENQLSGKIPPELGKC-KYLTVLHLYANQLEGE----IPDELGQLSNLQDLELF 367
           + SLD+   +LS     EL    +   V+ L    L       I   L     L +L L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 368 DNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS----GVI 423
            N L          +  +   L   +              +++ +SL N   +    GV+
Sbjct: 65  SNELGDVG------VHCVLQGLQTPSC-------------KIQKLSLQNCCLTGAGCGVL 105

Query: 424 PQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWR 483
             +L    +L +L   +N         LC G                   LL     L +
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEG-------------------LLDPQCRLEK 146

Query: 484 VILKQNQLTGA-----LPEFSKNPVLSHLDVSRNNISGAIPSSIG-----NSINLTSIDF 533
           + L+   L+ A            P    L VS N+I+ A    +      +   L ++  
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206

Query: 534 SSNKFSGLMPQELGNLV----SLVTLNISLNHVEGS-----LPSQLSKCKNLEVFDVSFN 584
            S   +    ++L  +V    SL  L +  N +         P  L     L    +   
Sbjct: 207 ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266

Query: 585 LLN----GSIPSSLRSWKSLSILKLSENHFTG-GIPTFISELEK----LLELQLGGNQLG 635
            +     G +   LR+ +SL  L L+ N     G       L +    L  L +      
Sbjct: 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT 326

Query: 636 GEIPPSIGALQDLSYA---------LNLSKNGLTGRIPSDL-----EKLSKLEQLDISSN 681
                        S           L +S N L      +L     +  S L  L ++  
Sbjct: 327 AA------CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380

Query: 682 NLTGT-----LSPLSNIHSLVEVNVSYNLFT 707
           +++ +      + L   HSL E+++S N   
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 84.6 bits (210), Expect = 4e-17
 Identities = 83/473 (17%), Positives = 149/473 (31%), Gaps = 82/473 (17%)

Query: 72  NVVSFNLSSYGVSGQLGPEIGH-LSKLQTIDLSSNNFS----GNIPPKLGNCSALEYLDL 126
           ++ S ++    +S     E+   L + Q + L     +     +I   L    AL  L+L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 127 STNGFTGD----IPDNFENLQ-NLQYLNLYGNLLDGEIPEPLFRILG----LQYVFLNNN 177
            +N         +    +     +Q L+L    L G     L   L     LQ + L++N
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 178 SLSGSIPRNVGDLKE-----VEALWLFSNRLSGTIPESIG----NCYRLQELYLNENKL- 227
            L  +  + + +        +E L L    LS    E +          +EL ++ N + 
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 228 ---MGFLPESL-SNLENLVYLDVGDNNL--EGRINFGS--EKCKNLTFLDLSYNRFSGG- 278
              +  L + L  +   L  L +    +  +   +         +L  L L  N+     
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243

Query: 279 ---ISPNLGNCS-SLTHLDIVGSKLT----GSIPSSFGLLARLSSLDLSENQLSGKIPPE 330
              + P L + S  L  L I    +T    G +         L  L L+ N+L  +    
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303

Query: 331 LGK-----CKYLTVLHLYANQLEGE----IPDELGQLSNLQDLELFDNRLTGEFPVSIWR 381
           L +        L  L + +              L Q   L +L++ +NRL       +  
Sbjct: 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA---GVRE 360

Query: 382 IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGV----IPQSLGINSSLMQLD 437
           +      L                   L+ + L +   S      +  +L  N SL +LD
Sbjct: 361 LCQ---GLGQPG-------------SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 404

Query: 438 FINNSFTGEIPPNLCFGKQ-----LRVLNMGQNQF----HGPIPSLLGSCPTL 481
             NN         L    +     L  L +    +       + +L    P+L
Sbjct: 405 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 457

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 70.4 bits (173), Expect = 1e-12
 Identities = 54/297 (18%), Positives = 98/297 (32%), Gaps = 41/297 (13%)

Query: 429 INSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFH----GPIPSLLGSCPTLWR 483
           ++  +  LD      +      L    +Q +V+ +            I S L   P L  
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60

Query: 484 VILKQNQLTG----ALPEF--SKNPVLSHLDVSRNNIS----GAIPSSIGNSINLTSIDF 533
           + L+ N+L       + +   + +  +  L +    ++    G + S++     L  +  
Sbjct: 61  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 120

Query: 534 SSNKFSGLMPQELGNLV-----SLVTLNISLNHV--EG--SLPSQLSKCKNLEVFDVSFN 584
           S N       Q L   +      L  L +    +       L S L    + +   VS N
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 585 LLNGS----IPSSLRSWK-SLSILKLSENHFTG-GIPTFISELEK---LLELQLGGNQLG 635
            +N +    +   L+     L  LKL     T          +     L EL LG N+LG
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240

Query: 636 GEIPPSIG-ALQDLSYA---LNLSKNGLTGR----IPSDLEKLSKLEQLDISSNNLT 684
                 +   L   S     L + + G+T +    +   L     L++L ++ N L 
Sbjct: 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 53.0 bits (128), Expect = 3e-07
 Identities = 40/240 (16%), Positives = 84/240 (35%), Gaps = 40/240 (16%)

Query: 501 NPVLSHLDVSRNNISGAIPSSIGNSI-NLTSIDFSSNKFSGLMPQELGNLV----SLVTL 555
           +  +  LD+    +S A  + +   +     +       +    +++ + +    +L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 556 NISLNHVEGSLPSQLSKC-----KNLEVFDVSFNLLN----GSIPSSLRSWKSLSILKLS 606
           N+  N +       + +        ++   +    L     G + S+LR+  +L  L LS
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 607 ENHFT-GGIPTFISELE----KLLELQLGGNQLGGE----IPPSIGALQDLSYALNLSKN 657
           +N     G+      L     +L +LQL    L       +   + A  D    L +S N
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKE-LTVSNN 180

Query: 658 GLTGRIPSDLEKLS--------KLEQLDISSNNLTGT-----LSPLSNIHSLVEVNVSYN 704
            +     + +  L         +LE L + S  +T          +++  SL E+ +  N
Sbjct: 181 DIN---EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN 237

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 88.2 bits (219), Expect = 7e-19
 Identities = 53/205 (25%), Positives = 83/205 (40%), Gaps = 23/205 (11%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVK-----KLAFRGHKRGSLSMK--REIQTIGKIRHRNL 878
            +G GA G V+ A     N    VK     K+            K   EI  + ++ H N+
Sbjct: 32   LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 879  VRLEDFW-LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            +++ D +  +    ++M ++     L      I   P L+  +   I      A+ YL  
Sbjct: 92   IKVLDIFENQGFFQLVMEKHGSGLDLFAF---IDRHPRLDEPLASYIFRQLVSAVGYLRL 148

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I+HRDIK ENI++  +    + DFG A  L++     T     GTI Y APE   
Sbjct: 149  KD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEYCAPE--V 200

Query: 998  TTAKS---KESDVYSYGVVLLELIT 1019
                     E +++S GV L  L+ 
Sbjct: 201  LMGNPYRGPELEMWSLGVTLYTLVF 225

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 87.8 bits (218), Expect = 9e-19
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 23/206 (11%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVK-----KLAFRGHKRGSLSMKREIQTIGKIRHR--N 877
            ++G G  G VY    +  N   A+K     +++  G       +  E+  + K+      
Sbjct: 50   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            ++RL D++ R D  +++    E    +D+   IT    L+  +          A+ + H 
Sbjct: 110  VIRLLDWFERPDSFVLILERPEPV--QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167

Query: 938  DCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
                 ++HRDIK ENIL+D    E  + DFG   LL  +  +       GT  Y  PE  
Sbjct: 168  CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTRVYSPPE-- 218

Query: 997  FTTAKS---KESDVYSYGVVLLELIT 1019
            +        + + V+S G++L +++ 
Sbjct: 219  WIRYHRYHGRSAAVWSLGILLYDMVC 244

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 85.6 bits (213), Expect = 3e-18
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 17/204 (8%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDF 884
            IG G +G V+KA +   + + A+K++       G   S  REI  + +++H+N+VRL D 
Sbjct: 10   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLHYDCDP 941
                    +++ + +   L+    S       E  V+   +++  G    L + H     
Sbjct: 70   LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE-IVKSFLFQLLKG----LGFCHSRN-- 121

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTA 1000
             ++HRD+KP+N+L++   E  +++FG+A+     P    S  VV T+ Y  P+  F    
Sbjct: 122  -VLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWYRPPDVLFGAKL 178

Query: 1001 KSKESDVYSYGVVLLELITRKKAL 1024
             S   D++S G +  EL    + L
Sbjct: 179  YSTSIDMWSAGCIFAELANAGRPL 202

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.6 bits (217), Expect = 4e-18
 Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 42/215 (19%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVKKL--AFRGH---KRGSLSMKREIQTIGKIRHRNLV 879
             IG GA GIV  A     +   A+KKL   F+     KR      RE+  +  + H+N++
Sbjct: 69   PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR----AYRELVLMKCVNHKNII 124

Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDV----------LHSITPPPTLEWNVR---YKIAL 926
             L +         +          +DV          L  +         +    Y++  
Sbjct: 125  SLLN---------VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 175

Query: 927  GAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVG 986
            G    + +LH      I+HRD+KP NI++ S+    I DFG+A+    S   T     V 
Sbjct: 176  G----IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VV 225

Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
            T  Y APE        +  D++S G ++ E++  K
Sbjct: 226  TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 85.3 bits (212), Expect = 6e-18
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            IG G++G+V+K  +     + A+KK            +  REI+ + +++H NLV L + 
Sbjct: 11   IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSI--TPPPTLEWNVR---YKIALGAAHALAYLHYDC 939
            + RK    +++ Y +      VLH +        E  V+   ++        + + H   
Sbjct: 71   FRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQA----VNFCHKHN 122

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-T 998
                +HRD+KPENIL+       + DFG A+LL   P+      V  T  Y +PE     
Sbjct: 123  ---CIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYRSPELLVGD 177

Query: 999  TAKSKESDVYSYGVVLLELITRK 1021
            T      DV++ G V  EL++  
Sbjct: 178  TQYGPPVDVWAIGCVFAELLSGV 200

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 41/209 (19%), Positives = 71/209 (33%), Gaps = 12/209 (5%)

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRF 275
            Q L L E  L      + SNL N+  + V  +    ++   S      +T +++   R 
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 276 SGGISPN-LGNCSSLTHLDIVGSKLTGSIP--SSFGLLARLSSLDLSENQLSGKIPPEL- 331
              I P+ L     L  L I  + L    P  +          L++++N     IP    
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 332 -GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWR--IASLEYL 388
            G C     L LY N     +       + L  + L  N+         +    +    L
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 389 LVYNNNLLGKLPLE-MTELKQLKNISLYN 416
            V   ++   LP + +  LK+L   + + 
Sbjct: 211 DVSQTSVT-ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 31/168 (18%), Positives = 68/168 (40%), Gaps = 10/168 (5%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKL-GNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
           +L  +  I +S +     +      N S + ++++        I  +  + L  L++L +
Sbjct: 53  NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112

Query: 151 YGNLLDGEIPEP--LFRILGLQYVFLNNNSLSGSIPRNV--GDLKEVEALWLFSNRLSGT 206
           +   L    P+   ++       + + +N    SIP N   G   E   L L++N  + +
Sbjct: 113 FNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-S 170

Query: 207 IPESIGNCYRLQELYLNENKLMGFLPE-SLSNL-ENLVYLDVGDNNLE 252
           +     N  +L  +YLN+NK +  + + +   +      LDV   ++ 
Sbjct: 171 VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 42/260 (16%), Positives = 90/260 (34%), Gaps = 42/260 (16%)

Query: 95  SKLQTIDLSSNNFSG--NIPPKLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLY 151
            + +   ++  +     ++PP      + + L L        IP + F NL N+  + + 
Sbjct: 11  HQEEDFRVTCKDIQRIPSLPP------STQTLKLIETHLR-TIPSHAFSNLPNISRIYVS 63

Query: 152 GNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESI 211
            ++   ++    F                        +L +V  + + + R    I    
Sbjct: 64  IDVTLQQLESHSFY-----------------------NLSKVTHIEIRNTRNLTYIDPDA 100

Query: 212 -GNCYRLQELYLNENKLMGFLPES-LSNLENLVYLDVGDNNLEGRINFGS--EKCKNLTF 267
                 L+ L +    L  F   + + + +    L++ DN     I   +    C     
Sbjct: 101 LKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160

Query: 268 LDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS-SF-GLLARLSSLDLSENQLSG 325
           L L  N F+  +     N + L  + +  +K    I   +F G+ +  S LD+S+  ++ 
Sbjct: 161 LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT- 218

Query: 326 KIPPE-LGKCKYLTVLHLYA 344
            +P + L   K L   + + 
Sbjct: 219 ALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 46/279 (16%), Positives = 84/279 (30%), Gaps = 61/279 (21%)

Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYA 344
           C       +    +   IPS   L     +L L E  L   IP         ++ +++  
Sbjct: 10  CHQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64

Query: 345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM- 403
           +            L  L+    F N L+            + ++ + N   L  +  +  
Sbjct: 65  D----------VTLQQLES-HSFYN-LS-----------KVTHIEIRNTRNLTYIDPDAL 101

Query: 404 TELKQLKNISLYNNQFSGVIPQSLGINS--SLMQLDFINNSFTGEIPPNLCFG--KQLRV 459
            EL  LK + ++N     + P    + S      L+  +N +   IP N   G   +   
Sbjct: 102 KELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160

Query: 460 LNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIP 519
           L +  N F   +                      A         L  + +++N     I 
Sbjct: 161 LKLYNNGFTS-VQG-------------------YAF----NGTKLDAVYLNKNKYLTVID 196

Query: 520 SSI--GNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLN 556
                G     + +D S    + L  + L +L  L+  N
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 33/212 (15%), Positives = 68/212 (32%), Gaps = 14/212 (6%)

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE 563
                V+  +I   IPS      +  ++         +      NL ++  + +S++   
Sbjct: 13  EEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTL 68

Query: 564 GSLPSQL-SKCKNLEVFDVSFNLLNGSIPSS-LRSWKSLSILKLSENHFTGGIP--TFIS 619
             L S        +   ++        I    L+    L  L +         P  T + 
Sbjct: 69  QQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127

Query: 620 ELEKLLELQLGGNQLGGEIPP-SIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDI 678
             +    L++  N     IP  +   L + +  L L  NG T  +       +KL+ + +
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186

Query: 679 SSNNLTGTLSP--LSNIHS-LVEVNVSYNLFT 707
           + N     +       ++S    ++VS    T
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 22/115 (19%), Positives = 45/115 (39%), Gaps = 8/115 (6%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKL--GNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
           +        ++++ N +  +IP     G C+    L L  NGFT  +     N   L  +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184

Query: 149 NLYGNLLDGEIPEPLFRIL--GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSN 201
            L  N     I +  F  +  G   + ++  S++ ++P     L+ ++ L   + 
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 85.9 bits (213), Expect = 7e-18
 Identities = 54/214 (25%), Positives = 83/214 (38%), Gaps = 40/214 (18%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKL--AFRGH---KRGSLSMKREIQTIGKIRHRNLV 879
             IG GA GIV  A         A+KKL   F+     KR      RE+  +  + H+N++
Sbjct: 32   PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR----AYRELVLMKCVNHKNII 87

Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDV----------LHSITPPPTLEWNVRYKI--ALG 927
             L +         +          +DV          L  +         + Y +   L 
Sbjct: 88   GLLN---------VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML- 137

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
                + +LH      I+HRD+KP NI++ S+    I DFG+A+    S   T     V T
Sbjct: 138  --CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVT 189

Query: 988  IGYIAPENAFTTAKSKESDVYSYGVVLLELITRK 1021
              Y APE        +  D++S G ++ E+I   
Sbjct: 190  RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.0 bits (211), Expect = 8e-18
 Identities = 51/238 (21%), Positives = 86/238 (36%), Gaps = 59/238 (24%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
             NL     +G GA G V +A+             AVK L    H     ++  E++ +  
Sbjct: 46   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 873  I-RHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY-- 922
            + +H N+V L                 +I   Y   G L + L   +     +       
Sbjct: 106  LGQHENIVNLLGACTHGGPVL------VIT-EYCCYGDLLNFLRRKSRVLETDPAFAIAN 158

Query: 923  ---------KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK 970
                       +   A  +A+L   +       +HRD+   N+LL +     I DFG+A+
Sbjct: 159  STASTRDLLHFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLAR 212

Query: 971  LLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLELIT 1019
             +        S  +V     +     APE      +T     +SDV+SYG++L E+ +
Sbjct: 213  DIMN-----DSNYIVKGNARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIFS 261

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.4 bits (212), Expect = 1e-17
 Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 29/215 (13%)

Query: 825  HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSM-------K---REIQTIGKIR 874
              I  G++G V           A+K++        ++++       K   REI+ +    
Sbjct: 28   RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 875  HRNLVRLEDFWLRKDCGI-----IMYRYMENGSLRDVLHSITPPPTLEWNVRYKI--ALG 927
            H N++ L D ++  +        ++   M    L  V+H      + + +++Y +   L 
Sbjct: 88   HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQ-HIQYFMYHIL- 144

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGT 987
                L  LH   +  +VHRD+ P NILL    +  I DF +A+        T     V  
Sbjct: 145  --LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---HYVTH 196

Query: 988  IGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
              Y APE        +K  D++S G V+ E+  RK
Sbjct: 197  RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 49/233 (21%), Positives = 98/233 (42%), Gaps = 19/233 (8%)

Query: 64  IECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEY 123
           +  D    N V  NL    V+  +      LS +Q  +  ++N   ++   +   + L+ 
Sbjct: 12  VFPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKE 67

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
           L LS N  + D+    ++L  L+ L++  N L  +    +     L  +FL+NN L    
Sbjct: 68  LHLSHNQIS-DL-SPLKDLTKLEELSVNRNRL--KNLNGI-PSACLSRLFLDNNELRD-- 120

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
             ++  LK +E L + +N+L  +I   +G   +L+ L L+ N++       L+ L+ + +
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNW 176

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISP-NLGNCSSLTHLDIV 295
           +D+        +N   +    L   +   +     ISP  + N  S     ++
Sbjct: 177 IDLTGQKC---VNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVL 226

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 55/294 (18%), Positives = 109/294 (37%), Gaps = 50/294 (17%)

Query: 138 NFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALW 197
               L N    NL    +          + G+Q    +N+++  S+   +     ++ L 
Sbjct: 14  PDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELH 69

Query: 198 LFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINF 257
           L  N++S  +   + +  +L+EL +N N+L     ++L+ + +                 
Sbjct: 70  LSHNQIS-DL-SPLKDLTKLEELSVNRNRL-----KNLNGIPSA---------------- 106

Query: 258 GSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLD 317
                  L+ L L  N         L +  +L  L I  +KL  SI    G L++L  LD
Sbjct: 107 ------CLSRLFLDNNELR-DTDS-LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLD 156

Query: 318 LSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPV 377
           L  N+++      L + K +  + L   +   E      +L     ++  D R      +
Sbjct: 157 LHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW-----I 209

Query: 378 SIWRIASLEYLLVYNNNLLGKLPLEMTEL----KQLKNISLYNNQFSGVIPQSL 427
           S + I++       +  +L +LP+   E+     +  N+      F G + Q +
Sbjct: 210 SPYYISNGGSY--VDGCVLWELPVYTDEVSYKFSEYINVGETEAIFDGTVTQPI 261

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 33/160 (20%), Positives = 63/160 (39%), Gaps = 15/160 (9%)

Query: 546 LGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKL 605
              L + V  N+    V         +   ++ F+   + +  S+ + ++ + +L  L L
Sbjct: 15  DPGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70

Query: 606 SENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLS-YALNLSKNGLTGRIP 664
           S N  +    + + +L KL EL +  N+L      ++  +       L L  N L     
Sbjct: 71  SHNQISD--LSPLKDLTKLEELSVNRNRLK-----NLNGIPSACLSRLFLDNNELRD--T 121

Query: 665 SDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYN 704
             L  L  LE L I +N L  ++  L  +  L  +++  N
Sbjct: 122 DSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGN 160

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 40/200 (20%), Positives = 75/200 (37%), Gaps = 19/200 (9%)

Query: 520 SSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVF 579
                  N    +      + L+ Q+   L  +   N   ++++ SL   +    NL+  
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68

Query: 580 DVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELE--KLLELQLGGNQLGGE 637
            +S N +  S  S L+    L  L ++ N         ++ +    L  L L  N+L   
Sbjct: 69  HLSHNQI--SDLSPLKDLTKLEELSVNRNRLKN-----LNGIPSACLSRLFLDNNEL--R 119

Query: 638 IPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLV 697
              S+  L++L   L++  N L       L  LSKLE LD+  N +T     L+ +  + 
Sbjct: 120 DTDSLIHLKNLEI-LSIRNNKLKS--IVMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVN 175

Query: 698 EVNVSYNLFTGPVPETLMNL 717
            ++++         +    L
Sbjct: 176 WIDLTGQKCVNEPVKYQPEL 195

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 41/223 (18%), Positives = 75/223 (33%), Gaps = 23/223 (10%)

Query: 485 ILKQNQLT--GALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLM 542
           I +   +      P  +        ++ + +++     S      + + +  ++    L 
Sbjct: 3   IQRPTPINQVFPDPGLAN---AVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQSLA 57

Query: 543 PQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI 602
              +    +L  L++S N +  S  S L     LE   V+ N L             LS 
Sbjct: 58  G--MQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPS---ACLSR 110

Query: 603 LKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGR 662
           L L  N         +  L+ L  L +  N+L   I   +G L  L   L+L  N +T  
Sbjct: 111 LFLDNNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEV-LDLHGNEITN- 164

Query: 663 IPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNL 705
               L +L K+  +D++         P+     L   N   + 
Sbjct: 165 -TGGLTRLKKVNWIDLTGQKC--VNEPVKYQPELYITNTVKDP 204

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 83.7 bits (208), Expect = 1e-17
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G +G+VYKA       FA+KK+       G   +  REI  + +++H N+V+L D  
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLHYDCDPP 942
              K   ++++ +++   L+ +L             +    ++  G    +AY H      
Sbjct: 70   HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV-TAKSFLLQLLNG----IAYCHDRR--- 120

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAK 1001
            ++HRD+KP+N+L++ E E  I+DFG+A+     P    +  +V T+ Y AP+    +   
Sbjct: 121  VLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVLMGSKKY 178

Query: 1002 SKESDVYSYGVVLLELITRK 1021
            S   D++S G +  E++   
Sbjct: 179  STTIDIWSVGCIFAEMVNGT 198

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 48/213 (22%), Positives = 92/213 (43%), Gaps = 25/213 (11%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +G G +G+V+ A     +   A+KK+      +      REI+ I ++ H N+V++ + 
Sbjct: 18   PLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEI 76

Query: 885  WLRKDCGIIMYRYMENGSLRDV----------LHSITPPPTLEWN-VRYKI--ALGAAHA 931
             L      +         L  V          L ++     L     R  +   L     
Sbjct: 77   -LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL---RG 132

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSIS-VVGTIG 989
            L Y+H      ++HRD+KP N+ +++E +   I DFG+A+++D   +    +S  + T  
Sbjct: 133  LKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 990  YIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            Y +P    +    +K  D+++ G +  E++T K
Sbjct: 190  YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLEDF 884
            +G G++G+V K  +     + A+KK       +    +  REI+ + ++RH NLV L + 
Sbjct: 33   VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLHYDCDP 941
              +K    +++ ++++ ++ D L    P       V+   ++I  G    + + H     
Sbjct: 93   CKKKKRWYLVFEFVDH-TILDDLELF-PNGLDYQVVQKYLFQIING----IGFCHSHN-- 144

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             I+HRDIKPENIL+       + DFG A+ L  +P       V  T  Y APE      K
Sbjct: 145  -IIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRAPELLVGDVK 201

Query: 1002 -SKESDVYSYGVVLLELITRK 1021
              K  DV++ G ++ E+   +
Sbjct: 202  YGKAVDVWAIGCLVTEMFMGE 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 83.8 bits (208), Expect = 2e-17
 Identities = 56/200 (28%), Positives = 101/200 (50%), Gaps = 16/200 (8%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G G +G+VYKA      + A+K++       G   +  REI  + ++ H N+V L D  
Sbjct: 29   VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLHYDCDPP 942
              + C  +++ +ME   L+ VL         +  ++   Y++  G    +A+ H      
Sbjct: 89   HSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRG----VAHCHQHR--- 139

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAK 1001
            I+HRD+KP+N+L++S+    ++DFG+A+     P  + +  VV T+ Y AP+    +   
Sbjct: 140  ILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPDVLMGSKKY 197

Query: 1002 SKESDVYSYGVVLLELITRK 1021
            S   D++S G +  E+IT K
Sbjct: 198  STSVDIWSIGCIFAEMITGK 217

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.0 bits (213), Expect = 3e-17
 Identities = 56/198 (28%), Positives = 86/198 (43%), Gaps = 12/198 (6%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            V+G+G  G V    +     ++A KKL       ++G      E Q + K+  R +V L 
Sbjct: 191  VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +  KD   ++   M  G L+  ++ +      E    +  A      L  LH      
Sbjct: 251  YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLH---RER 306

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAK-LLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
            IV+RD+KPENILLD      ISD G+A  + +           VGT+GY+APE       
Sbjct: 307  IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG----RVGTVGYMAPEVVKNERY 362

Query: 1002 SKESDVYSYGVVLLELIT 1019
            +   D ++ G +L E+I 
Sbjct: 363  TFSPDWWALGCLLYEMIA 380

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 46/277 (16%), Positives = 83/277 (29%), Gaps = 43/277 (15%)

Query: 98  QTIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
           +      +  +    ++P           L              F    +L+ + +  N 
Sbjct: 12  RVFLCQESKVTEIPSDLPRNA------IELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
           +   I   +F  L  L  + +                          N L    PE+  N
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKA-----------------------NNLLYINPEAFQN 102

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS--EKCKNLTFLDLS 271
              LQ L ++   +         +    V LD+ DN     I   S          L L+
Sbjct: 103 LPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162

Query: 272 YNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS-SFGLLARLSSLDLSENQLSGKIPPE 330
            N     I  +  N + L  L++  +     +P+  F   +    LD+S  ++   +P  
Sbjct: 163 KNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSY 220

Query: 331 -LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLEL 366
            L   K L     Y  +   ++P  L +L  L +  L
Sbjct: 221 GLENLKKLRARSTYNLK---KLPT-LEKLVALMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 39/187 (20%), Positives = 63/187 (33%), Gaps = 11/187 (5%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
           +L KL  I +   N    I P+   N   L+YL +S  G    +PD    +      L++
Sbjct: 77  NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135

Query: 151 YGNLLDGEIPEPLFRILG--LQYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTI 207
             N+    I    F  L      ++LN N +   I  +     +  E     +N L    
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP 194

Query: 208 PESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTF 267
            +          L ++  ++       L NL+ L        NL+       EK   L  
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPTL--EKLVALME 250

Query: 268 LDLSYNR 274
             L+Y  
Sbjct: 251 ASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.3 bits (206), Expect = 4e-17
 Identities = 48/252 (19%), Positives = 92/252 (36%), Gaps = 15/252 (5%)

Query: 172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFL 231
                + ++  IP ++   +    L     +L      +      L+++ +++N ++  +
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 232 PES-LSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSGGISPNLGNCSSL 289
                SNL  L  + +   N    IN  + +   NL +L +S          +  +    
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130

Query: 290 THLDIVGSKLTGSIPS-SF-GLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQ 346
             LDI  +    +I   SF GL      L L++N +  +I        +   +     N 
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNN 189

Query: 347 LEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTE 405
           LE E+P++     S    L++   R+    P       +L+ L   +   L KLP  + +
Sbjct: 190 LE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLE--NLKKLRARSTYNLKKLPT-LEK 244

Query: 406 LKQLKNISLYNN 417
           L  L   SL   
Sbjct: 245 LVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 47/208 (22%), Positives = 74/208 (35%), Gaps = 12/208 (5%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
               L+ I++S N+    I      N   L  + +        I    F+NL NLQYL +
Sbjct: 52  GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNV--GDLKEVEALWLFSNRLSGTI 207
               +   +P+           + + +N    +I RN   G   E   LWL  N +   I
Sbjct: 112 SNTGI-KHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EI 169

Query: 208 PESIGNCYRLQELYLNENKLMGFLPE-SLSNLENLVYLDVGDNNLEGRINFGSEKCKNLT 266
             S  N  +L EL L++N  +  LP          V LD+    +    ++G E  K L 
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 229

Query: 267 FLDLSYNRFSGGISPNLGNCSSLTHLDI 294
                  +      P L    +L    +
Sbjct: 230 ARSTYNLK----KLPTLEKLVALMEASL 253

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 48/256 (18%), Positives = 88/256 (34%), Gaps = 17/256 (6%)

Query: 194 EALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEG 253
                  ++++  IP  +       EL     KL      + S   +L  +++  N++  
Sbjct: 12  RVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68

Query: 254 RINFGS-EKCKNLTFLDLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPS-SFGLL 310
            I          L  + +        I+P    N  +L +L I  + +   +P       
Sbjct: 69  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127

Query: 311 ARLSSLDLSENQLSGKIPPEL--GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFD 368
            +   LD+ +N     I      G      +L L  N ++ EI +     + L +L L D
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186

Query: 369 -NRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLE-MTELKQLKNISLYNNQFSGVIPQS 426
            N L           +    L +    +   LP   +  LK+L+  S YN +    +P +
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-T 241

Query: 427 LGINSSLMQLDFINNS 442
           L    +LM+      S
Sbjct: 242 LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 57/266 (21%), Positives = 98/266 (36%), Gaps = 31/266 (11%)

Query: 452 CFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDV 509
           C  +          +    +P           +     +L   + +  FS    L  +++
Sbjct: 9   CSNRVFLCQESKVTEIPSDLP------RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEI 61

Query: 510 SRNNISGAIPSSI-GNSINLTSIDFS-SNKFSGLMPQELGNLVSLVTLNISLNHVEGSLP 567
           S+N++   I + +  N   L  I    +N    + P+   NL +L  L IS   ++  LP
Sbjct: 62  SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP 120

Query: 568 SQL-SKCKNLEVFDVSFNLLNGSIPS----SLRSWKSLSILKLSENHFTGGIPTFISELE 622
                      + D+  N+   +I       L       IL L++N     I        
Sbjct: 121 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF--ESVILWLNKNGIQE-IHNSAFNGT 177

Query: 623 KLLELQL-GGNQLGGEIPPSIGALQDLSYA--LNLSKNGLTGRIPSD-LEKLSKLEQLDI 678
           +L EL L   N L  E+P         S    L++S+  +   +PS  LE L KL     
Sbjct: 178 QLDELNLSDNNNLE-ELPN--DVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRAR-- 231

Query: 679 SSNNLTGTLSPLSNIHSLVEVNVSYN 704
           S+ NL   L  L  + +L+E +++Y 
Sbjct: 232 STYNLK-KLPTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 71.4 bits (175), Expect = 4e-13
 Identities = 43/218 (19%), Positives = 73/218 (33%), Gaps = 13/218 (5%)

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
                + ++  IPS +    N   + F   K   +          L  + IS N V   +
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 567 PSQ-LSKCKNLEVFDVS-FNLLNGSIPSS-LRSWKSLSILKLSENHFTGGIPTFI-SELE 622
            +   S    L    +   N L   I     ++  +L  L +S       +P        
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSL 128

Query: 623 KLLELQLGGNQLGGEIPP-SIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSN 681
           + + L +  N     I   S   L   S  L L+KNG+   I +     ++L++L++S N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187

Query: 682 NLTGTLSP--LSNIHSLVEVNVSYNLFTGPVPETLMNL 717
           N    L           V +++S           L NL
Sbjct: 188 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 225

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 57.9 bits (140), Expect = 8e-09
 Identities = 33/231 (14%), Positives = 68/231 (29%), Gaps = 13/231 (5%)

Query: 409 LKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNM-GQNQ 466
              +     +   +   +      L +++   N     I  ++     +L  + +   N 
Sbjct: 32  AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91

Query: 467 FHGPIPSLLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSI-- 522
                P    + P L  +++    +   LP+     +     LD+  N     I  +   
Sbjct: 92  LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150

Query: 523 GNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVS 582
           G S     +  + N    +                  N++E              + D+S
Sbjct: 151 GLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 210

Query: 583 FNLLNGSIPS-SLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGN 632
              ++ S+PS  L + K L             +PT   +L  L+E  L   
Sbjct: 211 RTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTL-EKLVALMEASLTYP 256

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 82.2 bits (204), Expect = 3e-17
 Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 22/202 (10%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G GA+G V  A +       AVK +  +       ++K+EI     + H N+V+     
Sbjct: 15   LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 886  L-RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK----IALGAAHALAYLHYDCD 940
                   + +  Y   G L D +      P  E + +      +A      + YLH    
Sbjct: 75   REGNIQYLFL-EYCSGGELFDRIEPDIGMP--EPDAQRFFHQLMA-----GVVYLHGIG- 125

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+APE      
Sbjct: 126  --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE--LLKR 181

Query: 1001 KS---KESDVYSYGVVLLELIT 1019
            +    +  DV+S G+VL  ++ 
Sbjct: 182  REFHAEPVDVWSCGIVLTAMLA 203

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.0 bits (206), Expect = 3e-17
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK----REI---QTIGKIRHRNL 878
            IG GA+G VYKA         A+K +       G   +     RE+   + +    H N+
Sbjct: 17   IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 879  VRLED----FWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALA 933
            VRL D        ++  + + + +++   LR  L    PP      ++  +       L 
Sbjct: 77   VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DLMRQFLRGLD 134

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            +LH +C   IVHRD+KPENIL+ S     ++DFG+A++      + T + VV T+ Y AP
Sbjct: 135  FLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALTPV-VV-TLWYRAP 188

Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRK 1021
            E    +  +   D++S G +  E+  RK
Sbjct: 189  EVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.9 bits (203), Expect = 4e-17
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 17/205 (8%)

Query: 96  KLQTIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
              ++D SS   +    NIP      +  + LDL +N  +      F  L  L+ L L  
Sbjct: 17  NKNSVDCSSKKLTAIPSNIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLND 70

Query: 153 NLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSNRLSGTIPES 210
           N L   +P  +F+ L  L+ +++ +N L  ++P  V D L  +  L L  N+L  ++P  
Sbjct: 71  NKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPR 127

Query: 211 I-GNCYRLQELYLNENKLMGFLPESL-SNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL 268
           +  +  +L  L L  N+L   LP+ +   L +L  L + +N L+       +K   L  L
Sbjct: 128 VFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTL 186

Query: 269 DLSYNRFSGGISPNLGNCSSLTHLD 293
            L  N+          +   L  L 
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQ 211

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 10/162 (6%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKL-GNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
            L+KL+ + L+ N     +P  +      LE L ++ N     +P   F+ L NL  L L
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSNRLSGTIP 208
             N L   +P  +F  L  L Y+ L  N L  S+P+ V D L  ++ L L++N+L   +P
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVP 173

Query: 209 ESI-GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDN 249
           E        L+ L L+ N+L      +  +LE L  L + +N
Sbjct: 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 12/184 (6%)

Query: 264 NLTFLDLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSEN 321
           +   LDL  N+ S  +        + L  L +  +KL  ++P+  F  L  L +L +++N
Sbjct: 38  DTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95

Query: 322 QLSGKIPPEL-GKCKYLTVLHLYANQLEGEIPDEL-GQLSNLQDLELFDNRLTGEFPVSI 379
           +L   +P  +  +   L  L L  NQL+  +P  +   L+ L  L L  N L    P  +
Sbjct: 96  KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152

Query: 380 W-RIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLD 437
           + ++ SL+ L +YNN  L ++P     +L +LK + L NNQ   V   +      L  L 
Sbjct: 153 FDKLTSLKELRLYNNQ-LKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211

Query: 438 FINN 441
              N
Sbjct: 212 LQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 49/171 (28%), Positives = 76/171 (44%), Gaps = 15/171 (8%)

Query: 287 SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP----ELGKCKYLTVLHL 342
           +    LD+  +KL+     +F  L +L  L L++N+L   +P     EL     L  L +
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN---LETLWV 92

Query: 343 YANQLEGEIPDEL-GQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNLLGKLP 400
             N+L+  +P  +  QL NL +L L  N+L    P  ++  +  L YL +  N L   LP
Sbjct: 93  TDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLP 149

Query: 401 LEM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPN 450
             +  +L  LK + LYNNQ   V   +    + L  L   NN     +P  
Sbjct: 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 23/192 (11%)

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQL-SKCKN 575
           AIPS+I    +   +D  SNK S L  +    L  L  L ++ N ++ +LP+ +  + KN
Sbjct: 30  AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 576 LEVFDVSFNLLNGSIPSSLRSW-KSLSILKLSENHFTGGIPTFI-SELEKLLELQLGGNQ 633
           LE   V+ N L  ++P  +     +L+ L+L  N     +P  +   L KL  L LG N+
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNE 144

Query: 634 LGGEIPPSI----GALQDLSYALNLSKNGLTGRIPSDL-EKLSKLEQLDISSNNLT---- 684
           L   +P  +     +L++L     L  N L  R+P    +KL++L+ L + +N L     
Sbjct: 145 LQ-SLPKGVFDKLTSLKELR----LYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPE 198

Query: 685 GTLSPLSNIHSL 696
           G    L  +  L
Sbjct: 199 GAFDSLEKLKML 210

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 51/213 (23%), Positives = 78/213 (36%), Gaps = 49/213 (23%)

Query: 337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNL 395
              L L +N+L         +L+ L+ L L DN+L    P  I+  + +LE L V +N  
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK- 96

Query: 396 LGKLPLEM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFG 454
           L  LP+ +  +L  L  + L  NQ                            +PP + F 
Sbjct: 97  LQALPIGVFDQLVNLAELRLDRNQLK-------------------------SLPPRV-FD 130

Query: 455 K--QLRVLNMGQNQFHGPIPSL-------LGSCPTLWRVILKQNQLTGALPE--FSKNPV 503
              +L  L++G N+    + SL       L S   L    L  NQL   +PE  F K   
Sbjct: 131 SLTKLTYLSLGYNE----LQSLPKGVFDKLTSLKELR---LYNNQLK-RVPEGAFDKLTE 182

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSN 536
           L  L +  N +      +  +   L  +    N
Sbjct: 183 LKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 54/202 (26%), Positives = 82/202 (40%), Gaps = 36/202 (17%)

Query: 486 LKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSI-GNSINLTSIDFSSNKFSGLM 542
           L+ N+L+ +LP   F +   L  L ++ N +   +P+ I     NL ++  + NK   L 
Sbjct: 44  LQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALP 101

Query: 543 PQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI 602
                 LV+L  L +  N ++ SLP          VFD   +L              L+ 
Sbjct: 102 IGVFDQLVNLAELRLDRNQLK-SLPP--------RVFD---SLTK------------LTY 137

Query: 603 LKLSENHFTGGIPTFI-SELEKLLELQLGGNQLGGEIPPSIGALQDLS--YALNLSKNGL 659
           L L  N     +P  +  +L  L EL+L  NQL   +P   GA   L+    L L  N L
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPE--GAFDKLTELKTLKLDNNQL 193

Query: 660 TGRIPSDLEKLSKLEQLDISSN 681
                   + L KL+ L +  N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 56/253 (22%), Positives = 90/253 (35%), Gaps = 80/253 (31%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-------GPNAVFAVKKLAFRGHKRGSLSMKR-----E 866
            +NL     +G G  G V KA+        G   V AVK L     K  +   +      E
Sbjct: 23   KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKML-----KENASPSELRDLLSE 76

Query: 867  IQTIGKIRHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
               + ++ H ++++L                 +I+  Y + GSLR  L            
Sbjct: 77   FNVLKQVNHPHVIKLYGACSQDGPLL------LIV-EYAKYGSLRGFLRESRKVGPGYLG 129

Query: 920  VRY---------------------KIALGAAHALAYL---HYDCDPPIVHRDIKPENILL 955
                                      A   +  + YL           VHRD+   NIL+
Sbjct: 130  SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILV 183

Query: 956  DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESD 1006
                +  ISDFG+++ + +         V  + G I     A E    + +TT    +SD
Sbjct: 184  AEGRKMKISDFGLSRDVYE-----EDSYVKRSQGRIPVKWMAIESLFDHIYTT----QSD 234

Query: 1007 VYSYGVVLLELIT 1019
            V+S+GV+L E++T
Sbjct: 235  VWSFGVLLWEIVT 247

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.7 bits (205), Expect = 5e-17
 Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 23/206 (11%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLEDF 884
            +G G +G VYKA     N   A+K++     + G   +  RE+  + +++HRN++ L+  
Sbjct: 42   LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLHYDCDP 941
                    +++ Y EN  L+  +     P      ++   Y++  G    + + H     
Sbjct: 102  IHHNHRLHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLING----VNFCH---SR 151

Query: 942  PIVHRDIKPENILLDSEMEPH-----ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
              +HRD+KP+N+LL            I DFG+A+     P    +  ++ T+ Y  PE  
Sbjct: 152  RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWYRPPEIL 209

Query: 997  F-TTAKSKESDVYSYGVVLLELITRK 1021
              +   S   D++S   +  E++ + 
Sbjct: 210  LGSRHYSTSVDIWSIACIWAEMLMKT 235

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.3 bits (204), Expect = 7e-17
 Identities = 52/247 (21%), Positives = 86/247 (34%), Gaps = 73/247 (29%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL--------GPNAVFAVKKLAFRGHKRGSLSMKR----- 865
            + L     +G GA G V  A                AVK L     K  +          
Sbjct: 35   DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLSDLVS 89

Query: 866  EIQTIGKI-RHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE 917
            E++ +  I +H+N++ L          +      +I+  Y   G+LR+ L +  PP    
Sbjct: 90   EMEMMKMIGKHKNIINLLGACTQDGPLY------VIV-EYASKGNLREYLRARRPPGMEY 142

Query: 918  WNVRY-------------KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEP 961
                                    A  + YL           +HRD+   N+L+      
Sbjct: 143  SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVM 196

Query: 962  HISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGV 1012
             I+DFG+A+ ++             T G +     APE      +T     +SDV+S+GV
Sbjct: 197  KIADFGLARDINN-----IDYYKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGV 247

Query: 1013 VLLELIT 1019
            ++ E+ T
Sbjct: 248  LMWEIFT 254

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 82.4 bits (204), Expect = 7e-17
 Identities = 60/250 (24%), Positives = 91/250 (36%), Gaps = 74/250 (29%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMK----REIQ 868
             N+     IG GA G V++A         P  + AVK L     +  S  M+    RE  
Sbjct: 47   NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML----KEEASADMQADFQREAA 102

Query: 869  TIGKIRHRNLVRL------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY 922
             + +  + N+V+L                ++   YM  G L + L S++P      +   
Sbjct: 103  LMAEFDNPNIVKLLGVCAVGKPMC-----LLF-EYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 923  ---------------------KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSE 958
                                  IA   A  +AYL    +      VHRD+   N L+   
Sbjct: 157  LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGEN 210

Query: 959  MEPHISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYS 1009
            M   I+DFG+++ +                  I      PE    N +TT    ESDV++
Sbjct: 211  MVVKIADFGLSRNIYS-----ADYYKADGNDAIPIRWMPPESIFYNRYTT----ESDVWA 261

Query: 1010 YGVVLLELIT 1019
            YGVVL E+ +
Sbjct: 262  YGVVLWEIFS 271

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 82.8 bits (205), Expect = 8e-17
 Identities = 62/335 (18%), Positives = 110/335 (32%), Gaps = 58/335 (17%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGN----IPPKLGNCSALEYLDLSTNGFTGDIPDNF-- 139
            +   +     ++ I LS N         +   + +   LE  + S   FTG + D    
Sbjct: 23  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI-FTGRVKDEIPE 81

Query: 140 ---------ENLQNLQYLNLYGNLLDGEIPEPLFRILG----LQYVFLNNNSLSGSIPRN 186
                         L  + L  N       EPL   L     L++++L+NN L       
Sbjct: 82  ALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG------ 135

Query: 187 VGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKL----MGFLPESLSNLENLV 242
                      +        + +   N   L+ +    N+L    M    ++  +   L 
Sbjct: 136 -----PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 190

Query: 243 YLDVGDNNL-----EGRINFGSEKCKNLTFLDLSYNRFSG----GISPNLGNCSSLTHLD 293
            + +  N +     E  +  G   C+ L  LDL  N F+      ++  L +  +L  L 
Sbjct: 191 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250

Query: 294 IVGSKLTG----SIPSSFGLLA--RLSSLDLSENQLSGKIPPELG-----KCKYLTVLHL 342
           +    L+     ++  +F  L    L +L L  N++       L      K   L  L L
Sbjct: 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 310

Query: 343 YANQL--EGEIPDELGQ-LSNLQDLELFDNRLTGE 374
             N+   E ++ DE+ +  S     EL +     E
Sbjct: 311 NGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEE 345

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 79.0 bits (195), Expect = 1e-15
 Identities = 52/356 (14%), Positives = 111/356 (31%), Gaps = 78/356 (21%)

Query: 313 LSSLDLSENQLSGK----IPPELGKCKYLTVLHLYANQLEGE----IPDELGQLSNLQDL 364
           +    L  + ++ +    +   L +   +  + L  N +  E    + + +    +L+  
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 365 ELFDN---RLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS- 420
           E  D    R+  E P ++  +                    + +  +L  + L +N F  
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQ-----------------ALLKCPKLHTVRLSDNAFGP 108

Query: 421 -GVIP--QSLGINSSLMQLDFINNSFTGE-------------IPPNLCFGKQLRVLNMGQ 464
               P    L  ++ L  L   NN    +             +         LR +  G+
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168

Query: 465 NQFHGP----IPSLLGSCPTLWRVILKQNQLT-----GALPE-FSKNPVLSHLDVSRNNI 514
           N+              S   L  V + QN +        L E  +    L  LD+  N  
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228

Query: 515 SG----AIPSSIGNSINLTSIDFSSNKFS-------GLMPQELGNLVSLVTLNISLNHV- 562
           +     A+  ++ +  NL  +  +    S            +L N+  L TL +  N + 
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI-GLQTLRLQYNEIE 287

Query: 563 -EG--SLPSQL-SKCKNLEVFDVSFNLLN------GSIPSSLRSWKSLSILKLSEN 608
            +   +L + +  K  +L   +++ N  +        I     +     + +L + 
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDM 343

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 24/203 (11%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLEDF 884
            +G GA+G V  A +       AVK +            +K+EI     + H N+V+    
Sbjct: 15   LGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 885  WL-RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK----IALGAAHALAYLHYDC 939
                    + +  Y   G L D +      P  E + +      +A      + YLH   
Sbjct: 74   RREGNIQYLFL-EYCSGGELFDRIEPDIGMP--EPDAQRFFHQLMA-----GVVYLHGIG 125

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
               I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+APE     
Sbjct: 126  ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE--LLK 180

Query: 1000 AKS---KESDVYSYGVVLLELIT 1019
             +    +  DV+S G+VL  ++ 
Sbjct: 181  RREFHAEPVDVWSCGIVLTAMLA 203

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 82.3 bits (204), Expect = 1e-16
 Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 22/239 (9%)

Query: 794  RSKQDLEIPAQEGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKL- 851
                 +   A  GP  +  QV +          IG GA+G+V  A         A+KK+ 
Sbjct: 2    HHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS 61

Query: 852  AFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW----LRKDCGI-IMYRYMENGSLRDV 906
             F  H+       REI+ + + RH N++ + D      + +   + I+   ME   L  +
Sbjct: 62   PFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKL 119

Query: 907  LHSITPPPTLEWNVRYKI--ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHIS 964
            L +         ++ Y +   L     L Y+H      ++HRD+KP N+LL++  +  I 
Sbjct: 120  LKT---QHLSNDHICYFLYQIL---RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKIC 170

Query: 965  DFGIAKLLDKSPASTTSISV-VGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            DFG+A++ D     T  ++  V T  Y APE    +   +K  D++S G +L E+++ +
Sbjct: 171  DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 58/248 (23%), Positives = 84/248 (33%), Gaps = 75/248 (30%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKR-----EI 867
              L+    +G GA G V +A+             AVK L     K  +   +R     E+
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-----KPSAHLTEREALMSEL 77

Query: 868  QTIGKI-RHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWN 919
            + +  +  H N+V L                 +I   Y   G L + L            
Sbjct: 78   KVLSYLGNHMNIVNLLGACTIGGPTL------VIT-EYCCYGDLLNFLRRKRDSFICSKT 130

Query: 920  VR-------------------YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME 960
                                 Y++A G A  LA  +       +HRD+   NILL     
Sbjct: 131  SPAIMEDDELALDLEDLLSFSYQVAKGMAF-LASKNC------IHRDLAARNILLTHGRI 183

Query: 961  PHISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYG 1011
              I DFG+A+ +        S  VV     +     APE      +T     ESDV+SYG
Sbjct: 184  TKICDFGLARDIKN-----DSNYVVKGNARLPVKWMAPESIFNCVYTF----ESDVWSYG 234

Query: 1012 VVLLELIT 1019
            + L EL +
Sbjct: 235  IFLWELFS 242

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 83.7 bits (207), Expect = 1e-16
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            V+GRG  G V+   +     ++A KKL       ++G      E + + K+  R +V L 
Sbjct: 192  VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251

Query: 883  -DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTL--EWNVRY---KIALGAAHALAYLH 936
              F  + D  ++M   M  G +R  ++++        E    +   +I       L +LH
Sbjct: 252  YAFETKTDLCLVM-TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLH 306

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
                  I++RD+KPEN+LLD +    ISD G+A    K+  + T     GT G++APE  
Sbjct: 307  ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTK-GYAGTPGFMAPELL 361

Query: 997  FTTAKSKESDVYSYGVVLLELIT 1019
                     D ++ GV L E+I 
Sbjct: 362  LGEEYDFSVDYFALGVTLYEMIA 384

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 82.0 bits (203), Expect = 1e-16
 Identities = 51/247 (20%), Positives = 85/247 (34%), Gaps = 73/247 (29%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL--------GPNAVFAVKKLAFRGHKRGSLSM-----KR 865
            + L     +G G  G V  A                AVK L     K  +          
Sbjct: 81   DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-----KDDATEKDLSDLVS 135

Query: 866  EIQTIGKI-RHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLE 917
            E++ +  I +H+N++ L          +      +I+  Y   G+LR+ L +  PP    
Sbjct: 136  EMEMMKMIGKHKNIINLLGACTQDGPLY------VIV-EYASKGNLREYLRARRPPGMEY 188

Query: 918  WNVRY-------------KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEP 961
                                    A  + YL           +HRD+   N+L+      
Sbjct: 189  SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVM 242

Query: 962  HISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGV 1012
             I+DFG+A+ ++             T G +     APE      +T     +SDV+S+GV
Sbjct: 243  KIADFGLARDINN-----IDYYKKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGV 293

Query: 1013 VLLELIT 1019
            ++ E+ T
Sbjct: 294  LMWEIFT 300

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 44/140 (31%), Positives = 64/140 (45%), Gaps = 8/140 (5%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQY 147
              G L  L T+DLS N    ++P       AL  LD+S N  T  +P      L  LQ 
Sbjct: 71  QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQE 128

Query: 148 LNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSNRLSG 205
           L L GN L   +P  L      L+ + L NN+L+  +P  + + L+ ++ L L  N L  
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY- 185

Query: 206 TIPESIGNCYRLQELYLNEN 225
           TIP+     + L   +L+ N
Sbjct: 186 TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 47/206 (22%), Positives = 70/206 (33%), Gaps = 19/206 (9%)

Query: 94  LSKLQTIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
           ++    ++    N +    ++P           L LS N               L  LNL
Sbjct: 9   VASHLEVNCDKRNLTALPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPE 209
               L       +   L  L  + L++N L  S+P     L  +  L +  NRL+ ++P 
Sbjct: 63  DRAELTK---LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117

Query: 210 SI-GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTF 267
                   LQELYL  N+L    P  L+    L  L + +NNL   +  G     +NL  
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176

Query: 268 LDLSYNRFSGGISPNLGNCSSLTHLD 293
           L L  N     I         L    
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAF 201

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 49/211 (23%), Positives = 71/211 (33%), Gaps = 15/211 (7%)

Query: 139 FENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGD-LKEVEALW 197
              + +   +N     L   +P  L +      + L+ N L  +           +  L 
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLY-TFSLATLMPYTRLTQLN 61

Query: 198 LFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINF 257
           L    L+  +    G    L  L L+ N+L   LP     L  L  LDV  N L   +  
Sbjct: 62  LDRAELT-KLQVD-GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPL 117

Query: 258 GS-EKCKNLTFLDLSYNRFSGGISPNL-GNCSSLTHLDIVGSKLTGSIPSS-FGLLARLS 314
           G+      L  L L  N     + P L      L  L +  + LT  +P+     L  L 
Sbjct: 118 GALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLD 175

Query: 315 SLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
           +L L EN L   IP        L    L+ N
Sbjct: 176 TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 50/186 (26%), Positives = 75/186 (40%), Gaps = 13/186 (6%)

Query: 285 NCS-SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLY 343
           +   S   ++     LT ++P    L    + L LSEN L       L     LT L+L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 344 ANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM 403
             +L  ++    G L  L  L+L  N+L    P+    + +L  L V  N  L  LPL  
Sbjct: 64  RAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR-LTSLPLGA 119

Query: 404 -TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGK--QLRVL 460
              L +L+ + L  N+   + P  L     L +L   NN+ T E+P  L       L  L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGL-LNGLENLDTL 177

Query: 461 NMGQNQ 466
            + +N 
Sbjct: 178 LLQENS 183

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 52/231 (22%), Positives = 80/231 (34%), Gaps = 38/231 (16%)

Query: 310 LARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
           +A    ++  +  L+  +PP+L K    T+LHL  N L       L   + L  L L   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 370 RLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI 429
            LT +  V    +  L  L + +N  L  LPL    L  L  + +  N+ +         
Sbjct: 66  ELT-KLQVD-GTLPVLGTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLT--------- 113

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGK--QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK 487
                            +P         +L+ L +  N+     P LL   P L ++ L 
Sbjct: 114 ----------------SLPLGA-LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA 156

Query: 488 QNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSN 536
            N LT  LP    +    L  L +  N++   IP     S  L       N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 11/190 (5%)

Query: 497 EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLN 556
           E SK      ++  + N++ A+P  +    + T +  S N         L     L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 557 ISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPT 616
           +    +   L         L   D+S N L  S+P   ++  +L++L +S N  T     
Sbjct: 62  LDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLG 118

Query: 617 FISELEKLLELQLGGNQLGGEIPPSI-GALQDLSYALNLSKNGLTGRIPSDL-EKLSKLE 674
            +  L +L EL L GN+L   +PP +      L   L+L+ N LT  +P+ L   L  L+
Sbjct: 119 ALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEK-LSLANNNLT-ELPAGLLNGLENLD 175

Query: 675 QLDISSNNLT 684
            L +  N+L 
Sbjct: 176 TLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 10/204 (4%)

Query: 431 SSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQ 490
           +S ++++    + T  +PP+L   K   +L++ +N  +    + L     L ++ L + +
Sbjct: 10  ASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

Query: 491 LTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLV 550
           LT  L      PVL  LD+S N +  ++P        LT +D S N+ + L    L  L 
Sbjct: 67  LT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124

Query: 551 SLVTLNISLNHVEGSLPSQL-SKCKNLEVFDVSFNLLNGSIPSSL-RSWKSLSILKLSEN 608
            L  L +  N ++ +LP  L +    LE   ++ N L   +P+ L    ++L  L L EN
Sbjct: 125 ELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQEN 182

Query: 609 HFTGGIPTFISELEKLLELQLGGN 632
                IP        L    L GN
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 33/112 (29%), Positives = 45/112 (40%), Gaps = 10/112 (8%)

Query: 589 SIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDL 648
           ++P  L      +IL LSEN         +    +L +L L   +L        G L  L
Sbjct: 24  ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVL 79

Query: 649 SYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT----GTLSPLSNIHSL 696
              L+LS N L   +P   + L  L  LD+S N LT    G L  L  +  L
Sbjct: 80  GT-LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 25/209 (11%)

Query: 827  IGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRG-SLSMKREI---QTIGKIRHRNLVR 880
            IG GA+G V+KA          A+K++  +  + G  LS  RE+   + +    H N+VR
Sbjct: 19   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78

Query: 881  LED----FWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHAL 932
            L D        ++  + + + +++   L   L  +  P      ++   +++  G    L
Sbjct: 79   LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG----L 133

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
             +LH      +VHRD+KP+NIL+ S  +  ++DFG+A++     A T   SVV T+ Y A
Sbjct: 134  DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVTLWYRA 187

Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRK 1021
            PE    ++ +   D++S G +  E+  RK
Sbjct: 188  PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.6 bits (202), Expect = 2e-16
 Identities = 61/200 (30%), Positives = 86/200 (43%), Gaps = 31/200 (15%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            IG G  G+           + AVK +  RG      +++REI     +RH N+VR ++  
Sbjct: 28   IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDE-NVQREIINHRSLRHPNIVRFKEVI 85

Query: 886  L-RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYK----IALGAAHALAYLHYDCD 940
            L      IIM  Y   G L + + +       E   R+     ++      ++Y H    
Sbjct: 86   LTPTHLAIIM-EYASGGELYERICNAGRFS--EDEARFFFQQLLS-----GVSYCHSMQ- 136

Query: 941  PPIVHRDIKPENILLDSEMEPH--ISDFGIAKL-LDKSPASTTSISVVGTIGYIAPENAF 997
              I HRD+K EN LLD    P   I DFG +K  +  S   +T    VGT  YIAPE   
Sbjct: 137  --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPE--V 188

Query: 998  TTAKS---KESDVYSYGVVL 1014
               +    K +DV+S GV L
Sbjct: 189  LLRQEYDGKIADVWSCGVTL 208

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 81.2 bits (201), Expect = 2e-16
 Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 37/212 (17%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
             +G GA+G V  A         A+KKL   F+  +  +    RE+  +  ++H N++ L 
Sbjct: 31   HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 883  DFWLRKDCGIIMYRYMENGSLRDV----------LHSITPPPTLEWNVRYKI--ALGAAH 930
            D         +        +  D           L  I      E  ++Y +   L    
Sbjct: 90   D---------VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQML---K 137

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             L Y+H      +VHRD+KP N+ ++ + E  I DFG+A+  D     T     V T  Y
Sbjct: 138  GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMT---GYVVTRWY 189

Query: 991  IAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
             APE   +    ++  D++S G ++ E++T K
Sbjct: 190  RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 83.4 bits (206), Expect = 2e-16
 Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 25/205 (12%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKL-----AFRGHKRGSLSMKREIQTIGKIRHRNLV 879
            +IGRG  G VY         ++A+K L       +  +  +L+ +  +  +       +V
Sbjct: 196  IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 880  RLE-DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY---KIALGAAHALAYL 935
             +   F        I+   M  G L   L         E ++R+   +I L     L ++
Sbjct: 256  CMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFS--EADMRFYAAEIIL----GLEHM 308

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
            H   +  +V+RD+KP NILLD      ISD G+A    K          VGT GY+APE 
Sbjct: 309  H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEV 361

Query: 996  AFTTAK-SKESDVYSYGVVLLELIT 1019
                      +D +S G +L +L+ 
Sbjct: 362  LQKGVAYDSSADWFSLGCMLFKLLR 386

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 54/246 (21%), Positives = 84/246 (34%), Gaps = 72/246 (29%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRG-SLSMK----REI 867
            + L     +GRGA G V +A              AVK L     K G + S       E+
Sbjct: 27   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-----KEGATHSEHRALMSEL 81

Query: 868  QTIGKI-RHRNLVRL--------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEW 918
            + +  I  H N+V L                  +I+  + + G+L   L S         
Sbjct: 82   KILIHIGHHLNVVNLLGACTKPGGPLM------VIV-EFCKFGNLSTYLRSKRNEFVPYK 134

Query: 919  NVRY-------------KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPH 962
                               +   A  + +L           +HRD+   NILL  +    
Sbjct: 135  VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVK 188

Query: 963  ISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVV 1013
            I DFG+A+ + K         V      +     APE      +T     +SDV+S+GV+
Sbjct: 189  ICDFGLARDIYK-----DPDYVRKGDARLPLKWMAPETIFDRVYTI----QSDVWSFGVL 239

Query: 1014 LLELIT 1019
            L E+ +
Sbjct: 240  LWEIFS 245

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.3 bits (201), Expect = 3e-16
 Identities = 54/243 (22%), Positives = 89/243 (36%), Gaps = 65/243 (26%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL---------GPNAVFAVKKLAFRGHKRGSLSMKREIQT 869
            + L     +G GA G V  A               V AVK L     ++    +  E++ 
Sbjct: 69   DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV-AVKMLKSDATEKDLSDLISEMEM 127

Query: 870  IGKI-RHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR 921
            +  I +H+N++ L          +      +I+  Y   G+LR+ L +  PP        
Sbjct: 128  MKMIGKHKNIINLLGACTQDGPLY------VIV-EYASKGNLREYLQARRPPGLEYSYNP 180

Query: 922  Y-------------KIALGAAHALAYL---HYDCDPPIVHRDIKPENILLDSEMEPHISD 965
                            A   A  + YL           +HRD+   N+L+  +    I+D
Sbjct: 181  SHNPEEQLSSKDLVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIAD 234

Query: 966  FGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYGVVLLE 1016
            FG+A+ +              T G +     APE      +T     +SDV+S+GV+L E
Sbjct: 235  FGLARDIHH-----IDYYKKTTNGRLPVKWMAPEALFDRIYTH----QSDVWSFGVLLWE 285

Query: 1017 LIT 1019
            + T
Sbjct: 286  IFT 288

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 80.7 bits (200), Expect = 3e-16
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 14/201 (6%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK----REIQTIGKIRHRNLVRL 881
            +G G    VYKA     N + A+KK+           +     REI+ + ++ H N++ L
Sbjct: 18   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
             D +  K    +++ +ME   L  ++           +++    L     L YLH     
Sbjct: 78   LDAFGHKSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIK-AYMLMTLQGLEYLHQHW-- 132

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTA 1000
             I+HRD+KP N+LLD      ++DFG+AK    SP    +  VV T  Y APE  F    
Sbjct: 133  -ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TRWYRAPELLFGARM 189

Query: 1001 KSKESDVYSYGVVLLELITRK 1021
                 D+++ G +L EL+ R 
Sbjct: 190  YGVGVDMWAVGCILAELLLRV 210

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 80.0 bits (198), Expect = 5e-16
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 31/216 (14%)

Query: 825  HVIGRGAHGIVYKASLGP-NAVFAVKKL-AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
             ++G GA+G+V  A+  P   + A+KK+  F      +L   REI+ +   +H N++ + 
Sbjct: 17   SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIF 75

Query: 883  DF----WLRKDCGI-IMYRYMENGSLRDVLHSITPPPTL-EWNVRYKI--ALGAAHALAY 934
            +            + I+   M+     D LH +     L + +++Y I   L    A+  
Sbjct: 76   NIQRPDSFENFNEVYIIQELMQ----TD-LHRVISTQMLSDDHIQYFIYQTL---RAVKV 127

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV--------VG 986
            LH      ++HRD+KP N+L++S  +  + DFG+A+++D+S A  +  +         V 
Sbjct: 128  LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184

Query: 987  TIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            T  Y APE   T+AK S+  DV+S G +L EL  R+
Sbjct: 185  TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 79.9 bits (197), Expect = 7e-16
 Identities = 47/183 (25%), Positives = 80/183 (43%), Gaps = 17/183 (9%)

Query: 200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPE-SLSNLENLVYLDVGDNNLEGRINFG 258
             +L   +P+S+ +      L L+ N L     E + + L NL  L +  N+L   I+  
Sbjct: 27  KQQLP-NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSE 82

Query: 259 S-EKCKNLTFLDLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPS-SFGLLARLSS 315
           +     NL +LDLS N     +      +  +L  L +  + +   +   +F  +A+L  
Sbjct: 83  AFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQK 140

Query: 316 LDLSENQLSGKIPPE----LGKCKYLTVLHLYANQLEGEIPDELGQLSNL--QDLELFDN 369
           L LS+NQ+S + P E      K   L +L L +N+L+     +L +L       L L +N
Sbjct: 141 LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

Query: 370 RLT 372
            L 
Sbjct: 200 PLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 38/142 (26%), Positives = 64/142 (45%), Gaps = 13/142 (9%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
            L+ L ++ LS N+ +  I  +       L YLDLS+N     + +  F +LQ L+ L L
Sbjct: 62  RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIP----RNVGDLKEVEALWLFSNRLSG 205
           Y N +   +    F  +  LQ ++L+ N +S   P    ++   L ++  L L SN+L  
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177

Query: 206 TIPESIGNCYRLQE--LYLNEN 225
                +       +  LYL+ N
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 74.5 bits (183), Expect = 3e-14
 Identities = 39/175 (22%), Positives = 66/175 (37%), Gaps = 14/175 (8%)

Query: 158 EIPEPLFRILGLQYVFLNNNSLSGSIPRNV--GDLKEVEALWLFSNRLSGTIPESI-GNC 214
            +P+ L        + L++N+LS  +        L  + +L L  N L+  I        
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 215 YRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYN 273
             L+ L L+ N L        S+L+ L  L + +N++   ++  + E    L  L LS N
Sbjct: 88  PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146

Query: 274 R---FSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLS--SLDLSENQL 323
           +   F   +  +      L  LD+  +KL     +    L       L L  N L
Sbjct: 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 48/189 (25%), Positives = 73/189 (38%), Gaps = 43/189 (22%)

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQE-LGNLVSLVTLNISLNHVEGSLPSQ-LSKCK 574
            +P S+        +D S N  S L  +     L +L +L +S NH+   + S+      
Sbjct: 32  NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 575 NLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQL 634
           NL   D+S N L+ ++                          F S+L+ L  L L  N +
Sbjct: 89  NLRYLDLSSNHLH-TLDEF----------------------LF-SDLQALEVLLLYNNHI 124

Query: 635 GGEIPPSIGALQDLSY--ALNLSKNGLTGRIP----SDLEKLSKLEQLDISSNNLT---- 684
              +     A +D++    L LS+N ++ R P     D  KL KL  LD+SSN L     
Sbjct: 125 V-VVDR--NAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPL 180

Query: 685 GTLSPLSNI 693
             L  L   
Sbjct: 181 TDLQKLPAW 189

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 43/162 (26%), Positives = 72/162 (44%), Gaps = 13/162 (8%)

Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKY--LTVLHLY 343
           C+S   L     +L  ++P    L +  + LDLS N LS ++  E    +   L  L L 
Sbjct: 18  CASNI-LSCSKQQLP-NVPQ--SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLS 72

Query: 344 ANQLEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSI-WRIASLEYLLVYNNNLLGKLPL 401
            N L   I  E    + NL+ L+L  N L       +   + +LE LL+YNN++   +  
Sbjct: 73  HNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDR 129

Query: 402 EM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNS 442
               ++ QL+ + L  NQ S    + +   + L +L  ++ S
Sbjct: 130 NAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 11/119 (9%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLY 151
            +  L+ +DLSSN+    +      +  ALE L L  N       + FE++  LQ L L 
Sbjct: 86  PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLS 144

Query: 152 GNLLDGEIPEPLFRILG----LQYVFLNNNSLSGSIPRNVGD---LKEVEALWLFSNRL 203
            N +    P  L +       L  + L++N L   +P              L+L +N L
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 34/178 (19%), Positives = 56/178 (31%), Gaps = 40/178 (22%)

Query: 589 SIPSSLRSWKSLSILKLSENHFTGGIP-TFISELEKLLELQLGGNQLGGEIPPSIGALQD 647
           ++P SL S    ++L LS N+ +        + L  L  L L  N L   I     A   
Sbjct: 32  NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISS--EAFVP 86

Query: 648 LSY--ALNLSKNGLTGRIPSD-LEKLSKLEQLDISSNNLT-------------------- 684
           +     L+LS N L   +       L  LE L + +N++                     
Sbjct: 87  VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145

Query: 685 --------GTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL--LGPSPSSFSGNPSLC 732
                     +   + +  L+ +++S N         L  L     +      NP  C
Sbjct: 146 NQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 51.8 bits (124), Expect = 7e-07
 Identities = 37/165 (22%), Positives = 60/165 (36%), Gaps = 11/165 (6%)

Query: 479 PTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSI-GNSINLTSIDFSS 535
                + L  N L+    E   ++   L  L +S N+++  I S       NL  +D SS
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSS 97

Query: 536 NKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP---- 591
           N    L      +L +L  L +  NH+     +       L+   +S N ++   P    
Sbjct: 98  NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156

Query: 592 SSLRSWKSLSILKLSENHFTGGIPTFISELEKLLE--LQLGGNQL 634
                   L +L LS N       T + +L   ++  L L  N L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 80.6 bits (199), Expect = 7e-16
 Identities = 57/211 (27%), Positives = 81/211 (38%), Gaps = 32/211 (15%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIG------KIRHRNL 878
            VIGRGA G V        + VFA+K L    +K   L                    + +
Sbjct: 81   VIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNGDSKWI 136

Query: 879  VRLE-DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY--KIALGAAHALAYL 935
              L   F    +  ++M  Y   G L  +L         E    Y  ++ +    A+  +
Sbjct: 137  TTLHYAFQDDNNLYLVM-DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI----AIDSV 191

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            H       VHRDIKP+NIL+D     HI  +DFG    L +     +S   VGT  YI+P
Sbjct: 192  H---QLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSS-VAVGTPDYISP 245

Query: 994  E-----NAFTTAKSKESDVYSYGVVLLELIT 1019
            E              E D +S GV + E++ 
Sbjct: 246  EILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 78.8 bits (195), Expect = 8e-16
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 15/202 (7%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG--SLSMKREIQTIGKIRHRNLVRLED 883
            +G G +  VYK  +       A+K++     + G  S ++ REI  + +++H N+VRL D
Sbjct: 13   LGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAI-REISLMKELKHENIVRLYD 70

Query: 884  FWLRKDCGIIMYRYMEN---GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
                ++   +++ +M+N     +       TP       V+          LA+ H +  
Sbjct: 71   VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK-YFQWQLLQGLAFCHENK- 128

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TT 999
              I+HRD+KP+N+L++   +  + DFG+A+     P +T S  VV T+ Y AP+    + 
Sbjct: 129  --ILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYRAPDVLMGSR 184

Query: 1000 AKSKESDVYSYGVVLLELITRK 1021
              S   D++S G +L E+IT K
Sbjct: 185  TYSTSIDIWSCGCILAEMITGK 206

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 80.6 bits (198), Expect = 1e-15
 Identities = 48/268 (17%), Positives = 85/268 (31%), Gaps = 16/268 (5%)

Query: 176 NNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESL 235
           N+ L     R +    + +   +                 +L    L+  K    L   L
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSEL 368

Query: 236 SNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSL--THLD 293
            + + L  L+  +      I         L +   +   FS      L     +   +LD
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS-----TLKAVDPMRAAYLD 423

Query: 294 IVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPD 353
            + SK            A +  L L+   L+  +   L +   +T L L  N+L   +P 
Sbjct: 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPP 480

Query: 354 ELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLP--LEMTELKQLKN 411
            L  L  L+ L+  DN L       +  +  L+ LL+  NN L +      +    +L  
Sbjct: 481 ALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLL-CNNRLQQSAAIQPLVSCPRLVL 537

Query: 412 ISLYNNQFSGVIPQSLGINSSLMQLDFI 439
           ++L  N           +   L  +  I
Sbjct: 538 LNLQGNSLCQEEGIQERLAEMLPSVSSI 565

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 76.7 bits (188), Expect = 2e-14
 Identities = 41/262 (15%), Positives = 78/262 (29%), Gaps = 35/262 (13%)

Query: 37  MRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSK 96
                 +P   ++      +    W          +     +           +     +
Sbjct: 298 HVWLCDLPAASLNDQLPQHTFRVIW-------TGSDSQKECVLLKDRPECWCRDSATDEQ 350

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQY----LNLYG 152
           L   +LS    S  +  +L +C  L+ L+         I      L  L Y    L  + 
Sbjct: 351 LFRCELSVEK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS 409

Query: 153 NLLDGEI-----------------PEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEA 195
            L   +                           ++ + L +  L+  +  ++  L  V  
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTH 467

Query: 196 LWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRI 255
           L L  NRL   +P ++     L+ L  ++N L     + ++NL  L  L + +N L+   
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSA 524

Query: 256 NFGS-EKCKNLTFLDLSYNRFS 276
                  C  L  L+L  N   
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 75.9 bits (186), Expect = 3e-14
 Identities = 40/229 (17%), Positives = 72/229 (31%), Gaps = 14/229 (6%)

Query: 481 LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNIS-----GAIPSSIGNSINLTSIDFSS 535
           +W   L    L   LP+ +   + +  D  +  +                  L   + S 
Sbjct: 299 VWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSV 358

Query: 536 NKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLR 595
            K S ++  EL +   L  L         ++   +     L     +    +        
Sbjct: 359 EK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLK---AV 414

Query: 596 SWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLS 655
                + L    + F         E   +  L L    L   +   +  L  +++ L+LS
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTH-LDLS 471

Query: 656 KNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYN 704
            N L   +P  L  L  LE L  S N L   +  ++N+  L E+ +  N
Sbjct: 472 HNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNN 518

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.0 bits (155), Expect = 1e-10
 Identities = 40/212 (18%), Positives = 64/212 (30%), Gaps = 9/212 (4%)

Query: 352 PDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKN 411
             +      L   EL   + T      +     L+ L   N   L  + L M  L  L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 412 ISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPI 471
                  FS +             LD + + F  E          +RVL++         
Sbjct: 401 EKETLQYFSTLK---AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLC 457

Query: 472 PSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSI 531
              L     +  + L  N+L    P  +    L  L  S N +   +   + N   L  +
Sbjct: 458 H--LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQEL 513

Query: 532 DFSSNKFSGL-MPQELGNLVSLVTLNISLNHV 562
              +N+       Q L +   LV LN+  N +
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.9 bits (152), Expect = 4e-10
 Identities = 31/181 (17%), Positives = 61/181 (33%), Gaps = 36/181 (19%)

Query: 69  DAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLST 128
           D       +        +        + ++ + L+  + +  +   L     + +LDLS 
Sbjct: 415 DPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSH 472

Query: 129 NGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVG 188
           N     +P     L+ L+ L    N L+                         ++   V 
Sbjct: 473 NRLR-ALPPALAALRCLEVLQASDNALE-------------------------NVD-GVA 505

Query: 189 DLKEVEALWLFSNRLSG-TIPESIGNCYRLQELYLNENKLM------GFLPESLSNLENL 241
           +L  ++ L L +NRL      + + +C RL  L L  N L         L E L ++ ++
Sbjct: 506 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 565

Query: 242 V 242
           +
Sbjct: 566 L 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.5 bits (151), Expect = 5e-10
 Identities = 42/316 (13%), Positives = 87/316 (27%), Gaps = 18/316 (5%)

Query: 378 SIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLD 437
               +    ++      L       +T   ++  + L  ++    +        +     
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299

Query: 438 FINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE 497
           ++ +     +   L       +     +Q       L        R      QL      
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKE--CVLLKDRPECWCRDSATDEQLFRCELS 357

Query: 498 FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNI 557
             K+ VL     S   +    P +    + +      +        + L    +L  ++ 
Sbjct: 358 VEKSTVLQSELESCKELQELEPENKWCLLTIIL-LMRALDPLLYEKETLQYFSTLKAVDP 416

Query: 558 --------SLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENH 609
                     +           +  ++ V  ++   L  ++   L     ++ L LS N 
Sbjct: 417 MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNR 474

Query: 610 FTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTG-RIPSDLE 668
               +P  ++ L  L  LQ   N L  E    +  L  L   L L  N L        L 
Sbjct: 475 LRA-LPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQE-LLLCNNRLQQSAAIQPLV 530

Query: 669 KLSKLEQLDISSNNLT 684
              +L  L++  N+L 
Sbjct: 531 SCPRLVLLNLQGNSLC 546

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 56/248 (22%), Positives = 90/248 (36%), Gaps = 70/248 (28%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
            ENL    V+G GA G V  A+       G +   AVK L  +       ++  E++ + +
Sbjct: 45   ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 873  I-RHRNLVRL-------EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR--- 921
            +  H N+V L          +      +I   Y   G L + L S     + +       
Sbjct: 105  LGSHENIVNLLGACTLSGPIY------LIF-EYCCYGDLLNYLRSKREKFSEDEIEYENQ 157

Query: 922  ---------------------YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME 960
                                 Y++A G    L +         VHRD+   N+L+     
Sbjct: 158  KRLEEEEDLNVLTFEDLLCFAYQVAKGMEF-LEFKSC------VHRDLAARNVLVTHGKV 210

Query: 961  PHISDFGIAKLLDKSPASTTSISVVGTIGYI-----APE----NAFTTAKSKESDVYSYG 1011
              I DFG+A+ +        S  VV     +     APE      +T     +SDV+SYG
Sbjct: 211  VKICDFGLARDIMS-----DSNYVVRGNARLPVKWMAPESLFEGIYTI----KSDVWSYG 261

Query: 1012 VVLLELIT 1019
            ++L E+ +
Sbjct: 262  ILLWEIFS 269

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 54/198 (27%), Positives = 82/198 (41%), Gaps = 16/198 (8%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLEDF 884
            IG+G    V  A  +      A+K +        SL  + RE++ +  + H N+V+L + 
Sbjct: 23   IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
               +    ++  Y   G + D L +       E   R         A+ Y H      IV
Sbjct: 83   IETEKTLYLIMEYASGGEVFDYLVAHGRMK--EKEAR-SKFRQIVSAVQYCHQKR---IV 136

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS-- 1002
            HRD+K EN+LLD++M   I+DFG +                G   Y APE      K   
Sbjct: 137  HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYAAPE--LFQGKKYD 191

Query: 1003 -KESDVYSYGVVLLELIT 1019
              E DV+S GV+L  L++
Sbjct: 192  GPEVDVWSLGVILYTLVS 209

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.4 bits (196), Expect = 2e-15
 Identities = 55/213 (25%), Positives = 78/213 (36%), Gaps = 34/213 (15%)

Query: 826  VIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIG------KIRHRNL 878
            VIGRGA   V    +     V+A+K +    +K   L                    R +
Sbjct: 68   VIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLVNGDRRWI 123

Query: 879  VRLE-DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRY--KIALGAAHALAYL 935
             +L   F       ++M  Y   G L  +L         E    Y  +I +    A+  +
Sbjct: 124  TQLHFAFQDENYLYLVM-EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM----AIDSV 178

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
            H       VHRDIKP+NILLD     HI  +DFG    L       +    VGT  Y++P
Sbjct: 179  H---RLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSL-VAVGTPDYLSP 232

Query: 994  E-------NAFTTAKSKESDVYSYGVVLLELIT 1019
            E          T +   E D ++ GV   E+  
Sbjct: 233  EILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.0 bits (193), Expect = 2e-15
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 827  IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMK-REIQTIGKIRHRNLVRLED- 883
            IG+G  G V+KA         A+KK+     K G      REI+ +  ++H N+V L + 
Sbjct: 25   IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84

Query: 884  ------FWLRKDCGIIM-YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
                   + R    I + + + E+  L  +L ++    TL   ++ ++     + L Y+H
Sbjct: 85   CRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK-RVMQMLLNGLYYIH 141

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI--SVVGTIGYIAPE 994
                  I+HRD+K  N+L+  +    ++DFG+A+    +  S  +   + V T+ Y  PE
Sbjct: 142  ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198

Query: 995  NAF-TTAKSKESDVYSYGVVLLELITRK 1021
                        D++  G ++ E+ TR 
Sbjct: 199  LLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 77.3 bits (191), Expect = 4e-15
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 10/93 (10%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTI 988
            AL +LH      I++RDIK ENILLDS    H+  +DFG++K               GTI
Sbjct: 171  ALEHLH---KLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAY-DFCGTI 224

Query: 989  GYIAPE--NAFTTAKSKESDVYSYGVVLLELIT 1019
             Y+AP+      +   K  D +S GV++ EL+T
Sbjct: 225  EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.9 bits (190), Expect = 4e-15
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 34/210 (16%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-----RHRNLVR 880
            +GRG +  V++A  +  N    VK L     K+    +KREI    KI        N++ 
Sbjct: 44   LGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREI----KILENLRGGPNIIT 95

Query: 881  LEDFWLRKDCGIIMY--RYMENGSLRDVLHSITPPPTLEWNVRYKI--ALGAAHALAYLH 936
            L D               ++ N   + +  ++T       ++R+ +   L    AL Y H
Sbjct: 96   LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDY-----DIRFYMYEIL---KALDYCH 147

Query: 937  YDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                  I+HRD+KP N+++D E  +  + D+G+A+              V +  +  PE 
Sbjct: 148  ---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPEL 201

Query: 996  AFTTAK-SKESDVYSYGVVLLELITRKKAL 1024
                       D++S G +L  +I RK+  
Sbjct: 202  LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 16/200 (8%)

Query: 827  IGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
            +G G +  VYK      + + A+K++     +    +  RE+  +  ++H N+V L D  
Sbjct: 10   LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69

Query: 886  LRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR---YKIALGAAHALAYLHYDCDPP 942
              +    +++ Y++   L+  L           NV+   +++  G    LAY H      
Sbjct: 70   HTEKSLTLVFEYLDK-DLKQYLDD-CGNIINMHNVKLFLFQLLRG----LAYCH---RQK 120

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF-TTAK 1001
            ++HRD+KP+N+L++   E  ++DFG+A+     P  T    VV T+ Y  P+    +T  
Sbjct: 121  VLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDILLGSTDY 178

Query: 1002 SKESDVYSYGVVLLELITRK 1021
            S + D++  G +  E+ T +
Sbjct: 179  STQIDMWGVGCIFYEMATGR 198

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.4 bits (191), Expect = 6e-15
 Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 12/95 (12%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTI 988
            AL  +H       +HRD+KP+N+LLD     H+  +DFG    ++K        + VGT 
Sbjct: 180  ALDAIH---SMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCD-TAVGTP 233

Query: 989  GYIAPE----NAFTTAKSKESDVYSYGVVLLELIT 1019
             YI+PE            +E D +S GV L E++ 
Sbjct: 234  DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.9 bits (185), Expect = 9e-15
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 23/202 (11%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMK--REIQTIGKIRHRNLVRLED 883
            +G G  G V            AVK L  +  +   +  K  REIQ +   RH ++++L  
Sbjct: 19   LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 884  FW-LRKDCGIIMYRYMENGSLRD--VLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
                  D  ++M  Y+  G L D    H            +  ++     A+ Y H    
Sbjct: 79   VISTPTDFFMVME-YVSGGELFDYICKHGRVEEMEARRLFQQILS-----AVDYCHRHM- 131

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              +VHRD+KPEN+LLD+ M   I+DFG++ ++       TS    G+  Y APE    + 
Sbjct: 132  --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE--VISG 184

Query: 1001 KS---KESDVYSYGVVLLELIT 1019
            +     E D++S GV+L  L+ 
Sbjct: 185  RLYAGPEVDIWSCGVILYALLC 206

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.4 bits (186), Expect = 2e-14
 Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 40/239 (16%)

Query: 802  PAQEG--PSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKL--AFRGH 856
            PA+ G     + K   E          +G GA+G V  A  G   A  A+KKL   F+  
Sbjct: 6    PARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-S 64

Query: 857  KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDV---------- 906
            +  +    RE++ +  +RH N++ L D         +           D           
Sbjct: 65   ELFAKRAYRELRLLKHMRHENVIGLLD---------VFTPDETLDDFTDFYLVMPFMGTD 115

Query: 907  LHSITPPPTLEW-NVRYKI--ALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI 963
            L  +     L    +++ +   L     L Y+H      I+HRD+KP N+ ++ + E  I
Sbjct: 116  LGKLMKHEKLGEDRIQFLVYQML---KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKI 169

Query: 964  SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
             DFG+A+  D     T     V T  Y APE      + ++  D++S G ++ E+IT K
Sbjct: 170  LDFGLARQAD--SEMT---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.9 bits (187), Expect = 2e-14
 Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 4/89 (4%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH + +  +V+RD+K EN++LD +    I+DFG+ K       +T   +  GT  Y
Sbjct: 260  ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMK-TFCGTPEY 315

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            +APE        +  D +  GVV+ E++ 
Sbjct: 316  LAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.1 bits (183), Expect = 3e-14
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 9/91 (9%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTI 988
            AL +LH      I++RD+KPENILLD   E HI  +DFG++K            S  GT+
Sbjct: 138  ALDHLH---SLGIIYRDLKPENILLDE--EGHIKLTDFGLSK-ESIDHEKKAY-SFCGTV 190

Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             Y+APE       ++ +D +S+GV++ E++T
Sbjct: 191  EYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.2 bits (185), Expect = 3e-14
 Identities = 55/255 (21%), Positives = 97/255 (38%), Gaps = 68/255 (26%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVKKL--AFRGH---KRGSLSMKREIQTIGKIRHRN 877
            +H+IG G++G V +A       V A+KK+   F      KR    + REI  + ++ H +
Sbjct: 58   RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR----ILREIAILNRLNHDH 113

Query: 878  LVRLEDFWLRKDCGI-----IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH-- 930
            +V++ D  + KD        ++    +     D    +          R  + L   H  
Sbjct: 114  VVKVLDIVIPKDVEKFDELYVVLEIAD----SD-FKKL---------FRTPVYLTELHIK 159

Query: 931  --------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
                     + Y+H      I+HRD+KP N L++ +    + DFG+A+ +D      + +
Sbjct: 160  TLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQL 216

Query: 983  SV-------------------------VGTIGYIAPENAFTTAK-SKESDVYSYGVVLLE 1016
             +                         V T  Y APE        ++  DV+S G +  E
Sbjct: 217  PISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276

Query: 1017 LITRKKALDPSYKER 1031
            L+   K     + +R
Sbjct: 277  LLNMIKENVAYHADR 291

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.7 bits (182), Expect = 4e-14
 Identities = 30/91 (32%), Positives = 52/91 (57%), Gaps = 9/91 (9%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTI 988
            AL +LH      I++RD+KPENI+L+   + H+  +DFG+ K       + T  +  GTI
Sbjct: 133  ALGHLH---QKGIIYRDLKPENIMLNH--QGHVKLTDFGLCK-ESIHDGTVTH-TFCGTI 185

Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             Y+APE    +  ++  D +S G ++ +++T
Sbjct: 186  EYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 38/213 (17%)

Query: 826  VIGRGAHGIVYKASLGP-NAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
             +G GA+G V  A         AVKKL   F+     +    RE++ +  ++H N++ L 
Sbjct: 36   PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 883  DFWLRKDCGIIMYRYMENGSLRDV----------LHSITPPPTL-EWNVRYKI--ALGAA 929
            D         +           DV          L++I     L + +V++ I   L   
Sbjct: 95   D---------VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL--- 142

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIG 989
              L Y+H      I+HRD+KP N+ ++ + E  I DFG+A+        T     V T  
Sbjct: 143  RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMT---GYVATRW 194

Query: 990  YIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
            Y APE        ++  D++S G ++ EL+T +
Sbjct: 195  YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 29/134 (21%), Positives = 56/134 (41%), Gaps = 11/134 (8%)

Query: 98  QTIDLSSNNFSGNIPPK--LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNL 154
             + L++N F+  +           L  ++ S N  T DI +  FE    +  + L  N 
Sbjct: 35  AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNR 92

Query: 155 LDGEIPEPLFRIL-GLQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSNRLSGTIPESI- 211
           L+  +   +F+ L  L+ + L +N ++  +  +    L  V  L L+ N+++ T+     
Sbjct: 93  LE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAF 149

Query: 212 GNCYRLQELYLNEN 225
              + L  L L  N
Sbjct: 150 DTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 28/138 (20%), Positives = 60/138 (43%), Gaps = 15/138 (10%)

Query: 264 NLTFLDLSYNRFSGGISPN--LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN 321
               L L+ N F+  +           L  ++   +K+T     +F   + ++ + L+ N
Sbjct: 33  YTAELRLNNNEFTV-LEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 322 QLSGKIPPEL-GKCKYLTVLHLYANQLEGEIPDEL-GQLSNLQDLELFDNRLT----GEF 375
           +L   +  ++    + L  L L +N++   + ++    LS+++ L L+DN++T    G F
Sbjct: 92  RLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAF 149

Query: 376 PVSIWRIASLEYLLVYNN 393
                 + SL  L +  N
Sbjct: 150 D----TLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 34/163 (20%), Positives = 66/163 (40%), Gaps = 18/163 (11%)

Query: 285 NCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE--LGKCKYLTVLHL 342
           +CS+         KL   IP    +    + L L+ N+ +  +       K   L  ++ 
Sbjct: 17  DCSNQ--------KLN-KIPE--HIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINF 64

Query: 343 YANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSI-WRIASLEYLLVYNNNLLGKLPL 401
             N++           S + ++ L  NRL       +   + SL+ L++ +N +   +  
Sbjct: 65  SNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI-TCVGN 122

Query: 402 EM-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
           +    L  ++ +SLY+NQ + V P +     SL  L+ + N F
Sbjct: 123 DSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 23/116 (19%), Positives = 51/116 (43%), Gaps = 14/116 (12%)

Query: 93  HLSKLQTIDLSSNNFSGNIPP----KLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQY 147
            L +L+ I+ S+N  + +I             +  + L++N    ++    F+ L++L+ 
Sbjct: 55  KLPQLRKINFSNNKIT-DIEEGAFEGASG---VNEILLTSNRLE-NVQHKMFKGLESLKT 109

Query: 148 LNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
           L L  N +   +    F  L  ++ + L +N ++ ++     D L  +  L L +N
Sbjct: 110 LMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 11/129 (8%)

Query: 170 QYVFLNNNSLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESI-GNCYRLQELYLNENKL 227
             + LNNN  +      +   L ++  +   +N+++  I E        + E+ L  N+L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 228 MGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFS---GGISPNL 283
                +    LE+L  L +  N +   +   S     ++  L L  N+ +    G    L
Sbjct: 94  ENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL 152

Query: 284 GNCSSLTHL 292
               SL+ L
Sbjct: 153 ---HSLSTL 158

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 28/115 (24%), Positives = 49/115 (42%), Gaps = 12/115 (10%)

Query: 589 SIPSSLRSWKSLSILKLSENHFTGGIPTFI-SELEKLLELQLGGNQLGGEIPPSIGALQD 647
            IP  +      + L+L+ N FT    T I  +L +L ++    N++  +I    GA + 
Sbjct: 25  KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE--GAFEG 79

Query: 648 LS--YALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT----GTLSPLSNIHSL 696
            S    + L+ N L        + L  L+ L + SN +T     +   LS++  L
Sbjct: 80  ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 25/133 (18%), Positives = 46/133 (34%), Gaps = 18/133 (13%)

Query: 575 NLEVFDVSFNLLNGSIPSS--LRSWKSLSILKLSENHFTGGIP--TFISELEKLLELQLG 630
                 ++ N     + ++   +    L  +  S N  T  I    F      + E+ L 
Sbjct: 33  YTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD-IEEGAF-EGASGVNEILLT 89

Query: 631 GNQLGGEIPPSIGALQDLS--YALNLSKNGLTGRIPSDL-EKLSKLEQLDISSNNLT--- 684
            N+L   +       + L     L L  N +T  + +D    LS +  L +  N +T   
Sbjct: 90  SNRLE-NVQH--KMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVA 145

Query: 685 -GTLSPLSNIHSL 696
            G    L ++ +L
Sbjct: 146 PGAFDTLHSLSTL 158

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 19/68 (27%), Positives = 28/68 (41%), Gaps = 8/68 (11%)

Query: 93  HLSKLQTIDLSSNNFSGNIPP----KLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
            L  L+T+ L SN  +  +       L +   +  L L  N  T   P  F+ L +L  L
Sbjct: 103 GLESLKTLMLRSNRIT-CVGNDSFIGLSS---VRLLSLYDNQITTVAPGAFDTLHSLSTL 158

Query: 149 NLYGNLLD 156
           NL  N  +
Sbjct: 159 NLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.2 bits (97), Expect = 8e-04
 Identities = 25/133 (18%), Positives = 55/133 (41%), Gaps = 9/133 (6%)

Query: 507 LDVSRNNISGAIPSSIGNSI-NLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGS 565
           L ++ N  +    + I   +  L  I+FS+NK + +          +  + ++ N +E +
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95

Query: 566 LPSQL-SKCKNLEVFDVSFNLLNGSIPS-SLRSWKSLSILKLSENHFTGGIP--TFISEL 621
           +  ++    ++L+   +  N +   + + S     S+ +L L +N  T  +    F + L
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT-L 152

Query: 622 EKLLELQLGGNQL 634
             L  L L  N  
Sbjct: 153 HSLSTLNLLANPF 165

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.4 bits (183), Expect = 6e-14
 Identities = 56/250 (22%), Positives = 94/250 (37%), Gaps = 63/250 (25%)

Query: 824  KHVIGRGAHGIVYKASLGP-NAVFAVKKL--AFRGH---KRGSLSMKREIQTIGKIRHRN 877
            KH+IGRG++G VY A         A+KK+   F      KR    + REI  + +++   
Sbjct: 31   KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR----ILREITILNRLKSDY 86

Query: 878  LVRLEDFWLRKDCGI-----IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH-- 930
            ++RL D  +  D        I+    +     D L  +          +  I L   H  
Sbjct: 87   IIRLYDLIIPDDLLKFDELYIVLEIAD----SD-LKKL---------FKTPIFLTEEHIK 132

Query: 931  --------ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
                       ++H   +  I+HRD+KP N LL+ +    + DFG+A+ ++    +    
Sbjct: 133  TILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 983  SV--------------------VGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
             +                    V T  Y APE        +K  D++S G +  EL+   
Sbjct: 190  DLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249

Query: 1022 KALDPSYKER 1031
            ++       R
Sbjct: 250  QSHINDPTNR 259

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 26/203 (12%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMK--REIQTIGKIRHRNLVRLED 883
            +G G+ G V  A+        A+K ++ +  K+  + M+  REI  +  +RH ++++L D
Sbjct: 17   LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 884  FWLRKDCGIIMYRYME--NGSLRD--VLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
                      +   +E   G L D  V              +  I      A+ Y H   
Sbjct: 77   VITTPT---DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AIEYCHRHK 128

Query: 940  DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
               IVHRD+KPEN+LLD  +   I+DFG++ ++       TS    G+  Y APE     
Sbjct: 129  ---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPE--VIN 180

Query: 1000 AKS---KESDVYSYGVVLLELIT 1019
             K     E DV+S G+VL  ++ 
Sbjct: 181  GKLYAGPEVDVWSCGIVLYVMLV 203

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 46/201 (22%), Positives = 78/201 (38%), Gaps = 45/201 (22%)

Query: 824  KHVIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRL 881
              V+G G +G V +         FA+K L      +     +RE++   +  +  ++VR+
Sbjct: 23   SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 76

Query: 882  ----EDFWLRKDCG-IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
                E+ +  + C  I+M   ++ G L   +         E     +I      A+ YLH
Sbjct: 77   VDVYENLYAGRKCLLIVM-ECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVVGTIGYIAP 993
               +  I HRD+KPEN+L  S+       ++DFG AK                   Y   
Sbjct: 135  -SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------------KY--- 175

Query: 994  ENAFTTAKSKESDVYSYGVVL 1014
                     K  D++S GV++
Sbjct: 176  --------DKSCDMWSLGVIM 188

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 73.3 bits (180), Expect = 2e-13
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 21/201 (10%)

Query: 827  IGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMK--REIQTIGKIRHRNLVRLED 883
            +G G  G V            AVK L  +  +   +  K  REIQ +   RH ++++L  
Sbjct: 24   LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 884  FWLRKDCGIIMYRYMENGSLRD--VLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
                     ++  Y+  G L D    +            +  ++      + Y H     
Sbjct: 84   VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GVDYCHRHM-- 136

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
             +VHRD+KPEN+LLD+ M   I+DFG++ ++       TS    G+  Y APE    + +
Sbjct: 137  -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPE--VISGR 190

Query: 1002 S---KESDVYSYGVVLLELIT 1019
                 E D++S GV+L  L+ 
Sbjct: 191  LYAGPEVDIWSSGVILYALLC 211

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 72.3 bits (178), Expect = 2e-13
 Identities = 39/91 (42%), Positives = 51/91 (56%), Gaps = 9/91 (9%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTI 988
            AL YLH      IV+RD+KPENILLDS  + HI  +DFG+ K  +    STTS +  GT 
Sbjct: 151  ALGYLH---SLNIVYRDLKPENILLDS--QGHIVLTDFGLCK-ENIEHNSTTS-TFCGTP 203

Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             Y+APE        +  D +  G VL E++ 
Sbjct: 204  EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.5 bits (176), Expect = 3e-13
 Identities = 32/89 (35%), Positives = 47/89 (52%), Gaps = 5/89 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH      +V+RDIK EN++LD +    I+DFG+ K    S  +T   +  GT  Y
Sbjct: 117  ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMK-TFCGTPEY 171

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            +APE        +  D +  GVV+ E++ 
Sbjct: 172  LAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.7 bits (174), Expect = 5e-13
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             L +L       I++RD+K +N++LDSE    I+DFG+ K  +     TT  +  GT  Y
Sbjct: 133  GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDY 187

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE        K  D +++GV+L E++ 
Sbjct: 188  IAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.7 bits (174), Expect = 5e-13
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 5/89 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             L +LH      IV+RD+K +NILLD +    I+DFG+ K  +    + T+ +  GT  Y
Sbjct: 130  GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTN-TFCGTPDY 184

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE       +   D +S+GV+L E++ 
Sbjct: 185  IAPEILLGQKYNHSVDWWSFGVLLYEMLI 213

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.7 bits (174), Expect = 5e-13
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH   +  I++RD+K +N+LLDSE    ++D+G+ K     P  TTS +  GT  Y
Sbjct: 122  ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNY 176

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE           D ++ GV++ E++ 
Sbjct: 177  IAPEILRGEDYGFSVDWWALGVLMFEMMA 205

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 70.3 bits (173), Expect = 7e-13
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL +LH   D  I++RD+K +N+LLD E    ++DFG+ K        TT+ +  GT  Y
Sbjct: 136  ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTA-TFCGTPDY 190

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE           D ++ GV+L E++ 
Sbjct: 191  IAPEILQEMLYGPAVDWWAMGVLLYEMLC 219

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.5 bits (173), Expect = 9e-13
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
            AL YLH   +  I++RD+K +N+LLDSE    ++D+G+ K     P  TTS +  GT  Y
Sbjct: 165  ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTS-TFCGTPNY 219

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE           D ++ GV++ E++ 
Sbjct: 220  IAPEILRGEDYGFSVDWWALGVLMFEMMA 248

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 71.2 bits (174), Expect = 1e-12
 Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 5/89 (5%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             L +L       I++RD+K +N++LDSE    I+DFG+ K  +     TT  +  GT  Y
Sbjct: 454  GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTK-TFCGTPDY 508

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            IAPE        K  D +++GV+L E++ 
Sbjct: 509  IAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 69.1 bits (170), Expect = 1e-12
 Identities = 38/91 (41%), Positives = 53/91 (58%), Gaps = 12/91 (13%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTI 988
            AL YLH   D  I++RD+KPENILLD     HI  +DFG AK +       T  ++ GT 
Sbjct: 118  ALEYLH-SKD--IIYRDLKPENILLDK--NGHIKITDFGFAKYVP----DVTY-TLCGTP 167

Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             YIAPE   T   +K  D +S+G+++ E++ 
Sbjct: 168  DYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 56/237 (23%)

Query: 170 QYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMG 229
               L   S++         L  ++ +   ++ +     + I     ++ L L  NKL  
Sbjct: 22  IKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKL-- 75

Query: 230 FLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS---GGISPNLGNC 286
                +S L+ L                      NLT+L L+ N+      G+   L N 
Sbjct: 76  ---HDISALKELT---------------------NLTYLILTGNQLQSLPNGVFDKLTN- 110

Query: 287 SSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQLSGKIPP----ELGKCKYLTVLH 341
             L  L +V ++L  S+P   F  L  L+ L+L+ NQL   +P     +L     LT L 
Sbjct: 111 --LKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTN---LTELD 163

Query: 342 LYANQLEGEIPDEL-GQLSNLQDLELFDNRLT----GEFPVSIWRIASLEYLLVYNN 393
           L  NQL+  +P+ +  +L+ L+DL L+ N+L     G F     R+ SL+Y+ +++N
Sbjct: 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFD----RLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 50/208 (24%), Positives = 98/208 (47%), Gaps = 20/208 (9%)

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG 277
            +  L +  +      + + L ++  +   +++++       +   N+ +L L  N+   
Sbjct: 22  IKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQGI--QYLPNVRYLALGGNKLH- 76

Query: 278 GISPNLG---NCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQLSGKIPPEL-G 332
               ++      ++LT+L + G++L  S+P+  F  L  L  L L ENQL   +P  +  
Sbjct: 77  ----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFD 130

Query: 333 KCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVY 391
           K   LT L+L  NQL+        +L+NL +L+L  N+L    P  ++ ++  L+ L +Y
Sbjct: 131 KLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLY 189

Query: 392 NNNLLGKLPLEMTE-LKQLKNISLYNNQ 418
            N L   +P  + + L  L+ I L++N 
Sbjct: 190 QNQLKS-VPDGVFDRLTSLQYIWLHDNP 216

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 16/146 (10%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLG---NCSALEYLDLSTNGFTGDIPDN-FENLQN 144
             I +L  ++ + L  N         +      + L YL L+ N     +P+  F+ L N
Sbjct: 57  QGIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQS-LPNGVFDKLTN 110

Query: 145 LQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSNR 202
           L+ L L  N L   +P+ +F  L  L Y+ L +N L  S+P+ V D L  +  L L  N+
Sbjct: 111 LKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQ 168

Query: 203 LSGTIPESI-GNCYRLQELYLNENKL 227
           L  ++PE +     +L++L L +N+L
Sbjct: 169 LQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 54.3 bits (131), Expect = 7e-08
 Identities = 36/114 (31%), Positives = 52/114 (45%), Gaps = 10/114 (8%)

Query: 93  HLSKLQTIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLN 149
            L+ L+ + L  N        +  KL N   L YL+L+ N         F+ L NL  L+
Sbjct: 107 KLTNLKELVLVENQLQSLPDGVFDKLTN---LTYLNLAHNQLQSLPKGVFDKLTNLTELD 163

Query: 150 LYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
           L  N L   +PE +F  L  L+ + L  N L  S+P  V D L  ++ +WL  N
Sbjct: 164 LSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 44/209 (21%), Positives = 81/209 (38%), Gaps = 33/209 (15%)

Query: 428 GINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK 487
              +  ++ +    S T  +  N        + N    +    I  L    P +  + L 
Sbjct: 16  DAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYL----PNVRYLALG 71

Query: 488 QNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSI-NLTSIDFSSNKFSGLMPQEL 546
            N+L   +    +   L++L ++ N +  ++P+ + + + NL  +    N+   L     
Sbjct: 72  GNKLH-DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVF 129

Query: 547 GNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS 606
             L +L  LN++ N ++ SLP          VFD    L N            L+ L LS
Sbjct: 130 DKLTNLTYLNLAHNQLQ-SLPKG--------VFD---KLTN------------LTELDLS 165

Query: 607 ENHFTGGIPTFI-SELEKLLELQLGGNQL 634
            N     +P  +  +L +L +L+L  NQL
Sbjct: 166 YNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.2 bits (170), Expect = 2e-12
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 8/89 (8%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
               YLH   D  +++RD+KPEN+L+D +    ++DFG AK +       T  ++ GT   
Sbjct: 153  TFEYLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTW-TLCGTPEA 204

Query: 991  IAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            +APE   +   +K  D ++ GV++ E+  
Sbjct: 205  LAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 41/158 (25%), Positives = 72/158 (45%), Gaps = 12/158 (7%)

Query: 268 LDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQLSGK 326
           LDL     +          + LT L++  ++L  ++ +  F  L  L +L L+ NQL+  
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 327 IPP----ELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-R 381
           +P      L +   L  L+L  NQL+        +L+ L++L L  N+L    P   + +
Sbjct: 98  LPLGVFDHLTQ---LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153

Query: 382 IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQF 419
           + +L+ L +  N L          L +L+ I+L+ NQF
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 44/182 (24%), Positives = 68/182 (37%), Gaps = 36/182 (19%)

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG 277
           ++L L    L      +   L  L +L++  N L+       +    L  L L+ N+ + 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 278 GISPNLGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQLSGKIPP----ELG 332
                                   S+P   F  L +L  L L  NQL   +P      L 
Sbjct: 97  ------------------------SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131

Query: 333 KCKYLTVLHLYANQLEGEIPDEL-GQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVY 391
           K   L  L L  NQL+  IP     +L+NLQ L L  N+L      +  R+  L+ + ++
Sbjct: 132 K---LKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF 187

Query: 392 NN 393
            N
Sbjct: 188 GN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 6/155 (3%)

Query: 98  QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDG 157
           + +DL S   +          + L +L+L  N         F++L  L  L L  N L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96

Query: 158 EIPEPLFRIL-GLQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSNRLSGTIPESI-GNC 214
            +P  +F  L  L  ++L  N L  S+P  V D L +++ L L +N+L  +IP       
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154

Query: 215 YRLQELYLNENKLMGFLPESLSNLENLVYLDVGDN 249
             LQ L L+ N+L      +   L  L  + +  N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 34/113 (30%), Positives = 56/113 (49%), Gaps = 8/113 (7%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKL-GNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNL 150
            L++L T+ L++N  + ++P  +  + + L+ L L  N     +P   F+ L  L+ L L
Sbjct: 81  DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRL 138

Query: 151 YGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
             N L   IP   F  L  LQ + L+ N L  S+P    D L +++ + LF N
Sbjct: 139 NTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 39/147 (26%), Positives = 60/147 (40%), Gaps = 10/147 (6%)

Query: 281 PNLGNCS---SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYL 337
             +  C+       +D  G  L  S+PS  G+ A    LDL    L+            L
Sbjct: 5   ETVTGCTCNEGKKEVDCQGKSLD-SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKL 61

Query: 338 TVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNLL 396
           T L+L  NQL+         L+ L  L L +N+L    P+ ++  +  L+ L +  N  L
Sbjct: 62  TWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQ-L 119

Query: 397 GKLPLEM-TELKQLKNISLYNNQFSGV 422
             LP  +   L +LK + L  NQ   +
Sbjct: 120 KSLPSGVFDRLTKLKELRLNTNQLQSI 146

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 40/158 (25%), Positives = 63/158 (39%), Gaps = 12/158 (7%)

Query: 290 THLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPEL-GKCKYLTVLHLYANQL- 347
             LD+  + L     ++F  L +L+ L+L  NQL   +   +      L  L L  NQL 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 348 --EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNLLGKLPLEM- 403
                + D    L+ L  L L  N+L    P  ++ R+  L+ L +  N L   +P    
Sbjct: 97  SLPLGVFD---HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAF 151

Query: 404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN 441
            +L  L+ +SL  NQ   V   +      L  +    N
Sbjct: 152 DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 44/176 (25%), Positives = 69/176 (39%), Gaps = 43/176 (24%)

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
           ++PS I    +   +D  S   + L       L  L  LN+  N ++ +L +        
Sbjct: 28  SVPSGI--PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSA-------- 76

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT---GGIPTFISELEKLLELQLGGNQ 633
            VFD                   L  L L+ N       G+      L +L +L LGGNQ
Sbjct: 77  GVFD---------------DLTELGTLGLANNQLASLPLGVFD---HLTQLDKLYLGGNQ 118

Query: 634 LGGEIPP----SIGALQDLSYALNLSKNGLTGRIPSDL-EKLSKLEQLDISSNNLT 684
           L   +P      +  L++L     L+ N L   IP+   +KL+ L+ L +S+N L 
Sbjct: 119 LK-SLPSGVFDRLTKLKEL----RLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ 168

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 31/154 (20%), Positives = 58/154 (37%), Gaps = 28/154 (18%)

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFS 276
            E+ L +N +    P + S  + L  +D+ +N +   +   + +  ++L  L L  N+  
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNK-- 91

Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPEL-GKCK 335
                       +T L            S F  L  L  L L+ N+++  +  +      
Sbjct: 92  ------------ITELP----------KSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLH 128

Query: 336 YLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
            L +L LY N+L+         L  +Q + L  N
Sbjct: 129 NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 33/165 (20%), Positives = 61/165 (36%), Gaps = 32/165 (19%)

Query: 110 NIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILG- 168
           N+P        +  + L  N      P  F   + L+ ++L  N +  E+    F+ L  
Sbjct: 29  NLPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 169 LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLM 228
           L  + L  N ++  +P+++ +             L             LQ L LN NK+ 
Sbjct: 82  LNSLVLYGNKIT-ELPKSLFE------------GLF-----------SLQLLLLNANKIN 117

Query: 229 GFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
               ++  +L NL  L + DN L+          + +  + L+ N
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 35/135 (25%), Positives = 57/135 (42%), Gaps = 28/135 (20%)

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
              KL+ IDLS+N  S  + P                         F+ L++L  L LYG
Sbjct: 54  PYKKLRRIDLSNNQIS-ELAPDA-----------------------FQGLRSLNSLVLYG 89

Query: 153 NLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSNRLSGTIPES 210
           N +  E+P+ LF  L  LQ + LN N ++  +  +    L  +  L L+ N+L      +
Sbjct: 90  NKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147

Query: 211 IGNCYRLQELYLNEN 225
                 +Q ++L +N
Sbjct: 148 FSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)

Query: 285 NCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLY 343
           +C            LT  IP+   L   ++ + L +N +   IPP      K L  + L 
Sbjct: 17  DCRGK--------GLT-EIPT--NLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLS 64

Query: 344 ANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNLLGKLPLE 402
            NQ+    PD    L +L  L L+ N++T E P S++  + SL+ LL+  N +   L ++
Sbjct: 65  NNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVD 122

Query: 403 M-TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
              +L  L  +SLY+N+   +   +     ++  +    N F
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 11/114 (9%)

Query: 589 SIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDL 648
            IP++L    +++ ++L +N      P   S  +KL  + L  NQ+  E+ P   A Q L
Sbjct: 25  EIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP--DAFQGL 79

Query: 649 S--YALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT----GTLSPLSNIHSL 696
               +L L  N +T    S  E L  L+ L +++N +          L N++ L
Sbjct: 80  RSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.3 bits (113), Expect = 8e-06
 Identities = 34/168 (20%), Positives = 57/168 (33%), Gaps = 33/168 (19%)

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL 576
            IP+++     +T I    N    + P        L  +++S N +   L          
Sbjct: 25  EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP-------- 73

Query: 577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFI-SELEKLLELQLGGNQLG 635
           + F              L   +SL+ L L  N  T  +P  +   L  L  L L  N++ 
Sbjct: 74  DAFQ------------GL---RSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN 117

Query: 636 GEIPPSIGALQDLSY--ALNLSKNGLTGRIPSDLEKLSKLEQLDISSN 681
             +     A QDL     L+L  N L          L  ++ + ++ N
Sbjct: 118 -CLRV--DAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 30/128 (23%), Positives = 54/128 (42%), Gaps = 4/128 (3%)

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
           + + +N I    P +      L  ID S+N+ S L P     L SL +L +  N +   L
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95

Query: 567 PSQL-SKCKNLEVFDVSFNLLNGSIPS-SLRSWKSLSILKLSENHFTGGIPTFISELEKL 624
           P  L     +L++  ++ N +N  +   + +   +L++L L +N          S L  +
Sbjct: 96  PKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154

Query: 625 LELQLGGN 632
             + L  N
Sbjct: 155 QTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 16/68 (23%), Positives = 25/68 (36%), Gaps = 8/68 (11%)

Query: 93  HLSKLQTIDLSSNNFSGNIPP----KLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
            L  LQ + L++N  +  +       L N   L  L L  N         F  L+ +Q +
Sbjct: 102 GLFSLQLLLLNANKIN-CLRVDAFQDLHN---LNLLSLYDNKLQTIAKGTFSPLRAIQTM 157

Query: 149 NLYGNLLD 156
           +L  N   
Sbjct: 158 HLAQNPFI 165

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.6 bits (98), Expect = 7e-04
 Identities = 30/142 (21%), Positives = 59/142 (41%), Gaps = 9/142 (6%)

Query: 423 IPQSLGINSSLMQLDFINNSFTGEIPPNLCFG-KQLRVLNMGQNQFHGPIPSLLGSCPTL 481
           IP    +  ++ ++    N+    IPP      K+LR +++  NQ     P       +L
Sbjct: 26  IPT--NLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 482 WRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSIGNSI-NLTSIDFSSNKF 538
             ++L  N++T  LP+  F     L  L ++ N I+  +       + NL  +    NK 
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL 140

Query: 539 SGLMPQELGNLVSLVTLNISLN 560
             +       L ++ T++++ N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.8 bits (166), Expect = 6e-12
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 45/228 (19%)

Query: 825  HVIGRGAHGIVYKASLGP-NAVFAVKKL--AFRGH---KRGSLSMKREIQTIGKIR-HRN 877
              +G+GA+GIV+K+       V AVKK+  AF+     +R      REI  + ++  H N
Sbjct: 15   KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR----TFREIMILTELSGHEN 70

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDV-LHSITPPPTLEWN-VRYKI--ALGAAHALA 933
            +V L +  LR D    +Y   +     +  LH++     LE    +Y +   +     + 
Sbjct: 71   IVNLLNV-LRADNDRDVYLVFD---YMETDLHAVIRANILEPVHKQYVVYQLI---KVIK 123

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISV--------- 984
            YLH      ++HRD+KP NILL++E    ++DFG+++        T +I +         
Sbjct: 124  YLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180

Query: 985  ----------VGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRK 1021
                      V T  Y APE    + K +K  D++S G +L E++  K
Sbjct: 181  DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 65.3 bits (158), Expect = 9e-11
 Identities = 86/579 (14%), Positives = 179/579 (30%), Gaps = 148/579 (25%)

Query: 134 DIPDNFEN-LQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKE 192
           D+ D  ++ L   +  ++          + +   L L +  L+       + + V ++  
Sbjct: 37  DVQDMPKSILSKEEIDHII------MSKDAVSGTLRLFWTLLSKQE--EMVQKFVEEVLR 88

Query: 193 VEALWLFSN-RLSGTIPESIGNCY--RLQELYLNENKLMGFLP------ESLSNLENLVY 243
           +   +L S  +     P  +   Y  +   LY N+N++  F        +    L   + 
Sbjct: 89  INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY-NDNQV--FAKYNVSRLQPYLKLRQALL 145

Query: 244 -LDVGDN-NLEGRINFG-----SEKCKNLTFLDLSYNRFSGGIS-PNLGNCSSLTHLDIV 295
            L    N  ++G +  G      + C +         +    I   NL NC+S   +  +
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC----KMDFKIFWLNLKNCNSPETVLEM 201

Query: 296 GSKLTGSIPSSFGLLA-RLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE 354
             KL   I  ++   +   S++ L  + +  ++       + L     Y N L   +   
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL-------RRLLKSKPYENCLL--VLLN 252

Query: 355 LGQLSNLQDLELFDNR----LT--------------------GEFPVSIWRIASLEYLLV 390
           +    N +    F+      LT                        +++        LL 
Sbjct: 253 V---QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309

Query: 391 YNNNLLGKLPLEMTEL---------KQLKN-ISLYNN-QFSGVIPQSLGINSSLMQLDFI 439
           Y +     LP E+            + +++ ++ ++N +       +  I SSL  L+  
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE-- 367

Query: 440 NNSFTGEIPPNL--CFGKQLRVLNMGQNQFHGPIPS-LLGSCPTLW--------RVILKQ 488
                   P      F  +L V     +     IP+ LL     +W         V++ +
Sbjct: 368 --------PAEYRKMF-DRLSVFPPSAH-----IPTILLS---LIWFDVIKSDVMVVVNK 410

Query: 489 NQLTGALPEFSKNPVLS----HLDVSRN-NISGAIPSSIGNSINLTSIDFSSNKFSGLMP 543
                 + +  K   +S    +L++        A+  SI +  N+    F S+      P
Sbjct: 411 LHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK-TFDSDDLI---P 466

Query: 544 QELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFD------VSFNLLNGSIPSSLRSW 597
             L             +H    +   L   ++ E         + F  L   I     +W
Sbjct: 467 PYLDQYF--------YSH----IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW 514

Query: 598 KS-------LSILKLSENHFTGGIPTF---ISELEKLLE 626
            +       L  LK  + +     P +   ++ +   L 
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP 553

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 6e-04
 Identities = 87/647 (13%), Positives = 179/647 (27%), Gaps = 196/647 (30%)

Query: 531  IDFSSN----KFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLL 586
            +DF +     ++  ++       V     N     V+    S LSK    E  D   +++
Sbjct: 7    MDFETGEHQYQYKDILSVFEDAFVD----NFDCKDVQDMPKSILSK----EEID---HII 55

Query: 587  NGSIPSSL-RSWKSLSILKLSENHFTGGIPTFISELEK-----LLE-LQLGGNQLGGEIP 639
                  ++  + +    L   +      +  F+ E+ +     L+  ++    Q      
Sbjct: 56   M--SKDAVSGTLRLFWTLLSKQEE---MVQKFVEEVLRINYKFLMSPIKTEQRQ------ 104

Query: 640  PSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNI--H--- 694
            PS    +      +   N        ++ +L    +L      L   L P  N+      
Sbjct: 105  PS-MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL---RQALLE-LRPAKNVLIDGVL 159

Query: 695  -----SLV-EVNVSYNL---FTGPV----------PETLMNLLGPSPSSFSGNPSLCVKC 735
                  +  +V +SY +       +          PET++ +L            L  + 
Sbjct: 160  GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEML----------QKLLYQI 209

Query: 736  LSSTDSSCFGTSNLRPCDYHSSHQQGLNKVKIVVIALGSSLLTVL--VMLGLVSCCLFRR 793
              +  S    +SN++       H       +++      + L VL  V            
Sbjct: 210  DPNWTSRSDHSSNIK----LRIHSIQAELRRLLKSKPYENCLLVLLNV------------ 253

Query: 794  RSKQDLEIPAQEGPSYLL-----KQVIEATENLNAKHV-IGRGAHGIVYKASLGPNAVFA 847
            ++ +     A      +L     KQV +        H+ +   +  +          +  
Sbjct: 254  QNAKAWN--AFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKS---LLL 308

Query: 848  VKKLAFRGHKRGSLSMKREIQT--------IGKIRHRNLVRLEDFWLRKDC---GIIM-- 894
             K L     +   L   RE+ T        I +     L    D W   +C     I+  
Sbjct: 309  -KYL---DCRPQDL--PREVLTTNPRRLSIIAESIRDGLATW-DNWKHVNCDKLTTIIES 361

Query: 895  -YRYMENGSLRDVLHSIT--------PPPTLE--WN--------------VRYKIALGAA 929
                +E    R +   ++        P   L   W                +Y +     
Sbjct: 362  SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP 421

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPH---ISDFGIAKLLDKSPASTTSISVVG 986
                          ++ ++K +   L++E   H   +  + I K  D        +    
Sbjct: 422  KESTISIPS-----IYLELKVK---LENEYALHRSIVDHYNIPKTFDSDDLIPPYLD--- 470

Query: 987  TIGYI---------APENA--------------FTTAKSKESDVYSYGV-----VLLELI 1018
               Y            E+               F   K +               L +L 
Sbjct: 471  --QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK 528

Query: 1019 TRKKAL---DPSYKER-TDIVGWVRSVWSDT--EEINDIVDLSLMEE 1059
              K  +   DP Y+     I+ ++  +  +    +  D++ ++LM E
Sbjct: 529  FYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAE 575

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 40/179 (22%), Positives = 69/179 (38%), Gaps = 33/179 (18%)

Query: 219 ELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGG 278
           EL+     +   +  +LS L+   +L +  NN+E +I+      +NL  L L  N     
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-- 83

Query: 279 ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLT 338
                                   I +   +   L  L +S NQ++  +   + K   L 
Sbjct: 84  -----------------------KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLR 118

Query: 339 VLHLYANQLE--GEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL 395
           VL++  N++   GEI D+L  L  L+DL L  N L  ++  +         ++    NL
Sbjct: 119 VLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 59.3 bits (144), Expect = 5e-10
 Identities = 38/189 (20%), Positives = 71/189 (37%), Gaps = 43/189 (22%)

Query: 94  LSKLQTIDLSSNNFSG--NIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLY 151
            ++ + ++L          +   L    A ++L LSTN     I  +   ++NL+ L+L 
Sbjct: 22  ATEAEKVELH-GMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLG 78

Query: 152 GNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESI 211
            NL+         +I  L                    L+E   LW+  N+++ ++   I
Sbjct: 79  RNLIK--------KIENLD--------------AVADTLEE---LWISYNQIA-SL-SGI 111

Query: 212 GNCYRLQELYLNENKLMGFLP-ESLSNLENLVYLDVGDNNLEGRINFGSE---------- 260
                L+ LY++ NK+  +   + L+ L+ L  L +  N L       +           
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171

Query: 261 KCKNLTFLD 269
           +  NL  LD
Sbjct: 172 RLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 31/165 (18%), Positives = 57/165 (34%), Gaps = 38/165 (23%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
           +  L   + + LS+NN    I   L     L  L L  N     I +       L+ L +
Sbjct: 44  LSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100

Query: 151 YGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
             N +       + +++ L+ ++++NN         + +  E++ L              
Sbjct: 101 SYNQI--ASLSGIEKLVNLRVLYMSNN--------KITNWGEIDKL-------------- 136

Query: 211 IGNCYRLQELYLNENKLMGFLPES----------LSNLENLVYLD 245
                +L++L L  N L     E+          +  L NL  LD
Sbjct: 137 -AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 32/122 (26%), Positives = 56/122 (45%), Gaps = 18/122 (14%)

Query: 590 IPSSLRSWKSLSILKLSENHFTGGIPTF--ISELEKLLELQLGGNQLGGEIPPSIGALQD 647
           + ++L + K+   L LS N     I     +S +E L  L LG N +       I  L  
Sbjct: 40  MDATLSTLKACKHLALSTN----NIEKISSLSGMENLRILSLGRNLI-----KKIENLDA 90

Query: 648 LSYA---LNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLT--GTLSPLSNIHSLVEVNVS 702
           ++     L +S N +   + S +EKL  L  L +S+N +T  G +  L+ +  L ++ ++
Sbjct: 91  VADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148

Query: 703 YN 704
            N
Sbjct: 149 GN 150

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 63.6 bits (154), Expect = 1e-10
 Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 4/93 (4%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQ 146
             +     L  + + +     ++  + L     L  L +  +G    +  + F     L 
Sbjct: 25  HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83

Query: 147 YLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSL 179
            LNL  N L+  +     + L LQ + L+ N L
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.7 bits (131), Expect = 7e-08
 Identities = 20/111 (18%), Positives = 30/111 (27%), Gaps = 3/111 (2%)

Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYA 344
               + L                    L+ L +   Q    +    L     L  L +  
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL 395
           + L    PD       L  L L  N L         +  SL+ L++  N L
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.6 bits (128), Expect = 2e-07
 Identities = 26/86 (30%), Positives = 36/86 (41%), Gaps = 2/86 (2%)

Query: 263 KNLTFLDLSYNRFSGGISPN-LGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN 321
           +NLT L +   +    +    L     L +L IV S L    P +F    RLS L+LS N
Sbjct: 31  ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90

Query: 322 QLSGKIPPELGKCKYLTVLHLYANQL 347
            L   +  +  +   L  L L  N L
Sbjct: 91  ALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 4/102 (3%)

Query: 104 SNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNLLDGEIPEP 162
           + + + +    L     L  L +        +       L  L+ L +  + L   +   
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 163 LFRIL-GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRL 203
            F     L  + L+ N+L  S+         ++ L L  N L
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 15/101 (14%), Positives = 40/101 (39%), Gaps = 2/101 (1%)

Query: 176 NNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIP-ESIGNCYRLQELYLNENKLMGFLPES 234
               +     ++   + +  L++ + +    +    +     L+ L + ++ L    P++
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 235 LSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRF 275
                 L  L++  N LE  +++ + +  +L  L LS N  
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 7e-06
 Identities = 24/135 (17%), Positives = 41/135 (30%), Gaps = 27/135 (20%)

Query: 118 CSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNN 177
                 L  + +G   D   +    +NL  L +                        N  
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYI-----------------------ENQQ 42

Query: 178 SLSGSIPRNV-GDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLS 236
            L   +       L E+  L +  + L    P++     RL  L L+ N L     +++ 
Sbjct: 43  HLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ 101

Query: 237 NLENLVYLDVGDNNL 251
            L +L  L +  N L
Sbjct: 102 GL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 7e-06
 Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 10/94 (10%)

Query: 614 IPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSY--ALNLSKNGLTGRIPSD-LEKL 670
               +   E L EL +   Q    +      L+ L     L + K+GL   +  D     
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLEL--RDLRGLGELRNLTIVKSGLR-FVAPDAFHFT 79

Query: 671 SKLEQLDISSNNLT----GTLSPLSNIHSLVEVN 700
            +L +L++S N L      T+  LS    ++  N
Sbjct: 80  PRLSRLNLSFNALESLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 19/101 (18%), Positives = 36/101 (35%), Gaps = 2/101 (1%)

Query: 369 NRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM-TELKQLKNISLYNNQFSGVIPQSL 427
                +    +    +L  L + N   L  L L     L +L+N+++  +    V P + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 428 GINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFH 468
                L +L+   N+    +      G  L+ L +  N  H
Sbjct: 77  HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 22/96 (22%), Positives = 34/96 (35%), Gaps = 2/96 (2%)

Query: 517 AIPSSIGNSINLTSIDFSSNK-FSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKN 575
                +  + NLT +   + +    L  ++L  L  L  L I  + +    P        
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 576 LEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT 611
           L   ++SFN L  S+        SL  L LS N   
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 20/99 (20%), Positives = 36/99 (36%), Gaps = 6/99 (6%)

Query: 637 EIPPSIGALQDLSYALNLSKNGLTGRIPS-DLEKLSKLEQLDISSNNLTGTLSP--LSNI 693
           +    +   ++L+  L +        +   DL  L +L  L I  + L   ++P      
Sbjct: 22  DSLHHLPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFT 79

Query: 694 HSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLC 732
             L  +N+S+N     +    +  L       SGNP  C
Sbjct: 80  PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHC 117

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 62.6 bits (152), Expect = 5e-10
 Identities = 69/489 (14%), Positives = 141/489 (28%), Gaps = 76/489 (15%)

Query: 72  NVVSFNLSSYGVSGQLGPEIGHLS----KLQTIDLSSNNFSGNIPPKLG-NCSALEYLDL 126
           +   FNL   G  G + P I  +S     L+ I L     + +    +  +    + L L
Sbjct: 78  HFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVL 137

Query: 127 S-TNGFTGD-IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRIL----GLQYVFLNNNSLS 180
           S   GF+ D +       +NL+ L+L  + +D      L         L  + ++     
Sbjct: 138 SSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC---- 193

Query: 181 GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLEN 240
             +   V       AL                 C  L+ L LN    +  L   L     
Sbjct: 194 --LASEVSF----SALERLVT-----------RCPNLKSLKLNRAVPLEKLATLLQRAPQ 236

Query: 241 LVYLDVG------DNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDI 294
           L  L  G        ++   ++     CK L  L   ++     +      CS LT L++
Sbjct: 237 LEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL 296

Query: 295 VGSKLTG-SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPD 353
             + +    +        +L  L + +      +      CK L  L +     E  + +
Sbjct: 297 SYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRV--FPSEPFVME 354

Query: 354 ELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL----LGKLPLEMTELKQL 409
               L+    + +                  LE +L +   +    L  +      + + 
Sbjct: 355 PNVALTEQGLVSVSMG------------CPKLESVLYFCRQMTNAALITIARNRPNMTRF 402

Query: 410 KNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHG 469
           +   +       +  + L  +     +              +   K LR L++       
Sbjct: 403 RLCIIEPKAPDYLTLEPL--DIGFGAI--------------VEHCKDLRRLSLSGLLTDK 446

Query: 470 PIPSLLGSCPTLWRVILKQNQLTGA-LPEFSKN-PVLSHLDVSR-NNISGAIPSSIGNSI 526
               +      +  + +     +   +         L  L++        A+ ++     
Sbjct: 447 VFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLE 506

Query: 527 NLTSIDFSS 535
            + S+  SS
Sbjct: 507 TMRSLWMSS 515

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 60.3 bits (146), Expect = 3e-09
 Identities = 64/471 (13%), Positives = 140/471 (29%), Gaps = 60/471 (12%)

Query: 260 EKCKNLTFLDLSYNRF---------------SGGISPNLGNCSSLTHLDIVGSKLTGSIP 304
            +   +  ++L                       I     + + L  + +    +T    
Sbjct: 63  RRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTD--- 119

Query: 305 SSFGLLAR----LSSLDLSE-NQLSGKIPPELGK-CKYLTVLHLYANQLEGEIPDELGQL 358
               L+A+       L LS     S      +   C+ L  L L  + ++      L   
Sbjct: 120 DCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHF 179

Query: 359 S----NLQDLELFD--NRLTGEFPVSIWRIA----SLEYLLVYNNNLLGKLPLEMTELKQ 408
                +L  L +    + ++     ++ R+     +L+ L +     L KL   +    Q
Sbjct: 180 PDTYTSLVSLNISCLASEVSFS---ALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQ 236

Query: 409 LKNISLY------NNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNM 462
           L+ +                +  +L     L  L    ++    +P       +L  LN+
Sbjct: 237 LEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNL 296

Query: 463 GQNQFHGP-IPSLLGSCPTLWRVILKQNQLT-GALPEFSKN-PVLSHLDVSRNNISGAIP 519
                    +  LL  CP L + +   + +    L   +     L  L V     S    
Sbjct: 297 SYATVQSYDLVKLLCQCPKL-QRLWVLDYIEDAGLEVLASTCKDLRELRVFP---SEPFV 352

Query: 520 SSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPS----QLSKCKN 575
                ++    +   S     L  + +      +T N +L  +  + P+    +L   + 
Sbjct: 353 MEPNVALTEQGLVSVSMGCPKL--ESVLYFCRQMT-NAALITIARNRPNMTRFRLCIIEP 409

Query: 576 LEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLG 635
                ++   L+    + +   K L  L LS            +  +K+  L +      
Sbjct: 410 KAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDS 469

Query: 636 GEIPPSIGA-LQDLSYALNLSKNGLTGR-IPSDLEKLSKLEQLDISSNNLT 684
                 + +    L   L +       + + ++  KL  +  L +SS +++
Sbjct: 470 DLGMHHVLSGCDSLRK-LEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 5/106 (4%)

Query: 98  QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDG 157
             + L  N F+  +P +L N   L  +DLS N  +     +F N+  L  L L  N L  
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-R 91

Query: 158 EIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
            IP   F  L  L+ + L+ N +S  +P    + L  +  L + +N
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 5/106 (4%)

Query: 266 TFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSG 325
           T L L  N+F+  +   L N   LT +D+  ++++     SF  + +L +L LS N+L  
Sbjct: 34  TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92

Query: 326 KIPPEL-GKCKYLTVLHLYANQLEGEIPDEL-GQLSNLQDLELFDN 369
            IPP      K L +L L+ N +   +P+     LS L  L +  N
Sbjct: 93  -IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 32/139 (23%), Positives = 51/139 (36%), Gaps = 38/139 (27%)

Query: 285 NCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYA 344
            CS+          L   +P   G+   ++ L L  NQ +  +P EL   K+LT++ L  
Sbjct: 16  RCSN--------KGLK-VLPK--GIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSN 63

Query: 345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMT 404
           N++          ++ L  L L  NRL                           +P    
Sbjct: 64  NRISTLSNQSFSNMTQLLTLILSYNRLRC-------------------------IPPRTF 98

Query: 405 E-LKQLKNISLYNNQFSGV 422
           + LK L+ +SL+ N  S V
Sbjct: 99  DGLKSLRLLSLHGNDISVV 117

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 11/115 (9%)

Query: 182 SIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENL 241
            +P+ +   ++V  L+L  N+ +  +P+ + N   L  + L+ N++     +S SN+  L
Sbjct: 24  VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80

Query: 242 VYLDVGDNNLEGRINFGS-EKCKNLTFLDLSYNRFSG---GISPNLGNCSSLTHL 292
           + L +  N L   I   + +  K+L  L L  N  S    G   +L   S+L+HL
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDL---SALSHL 131

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 5/130 (3%)

Query: 122 EYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLS 180
           + L L  N  T   P  F++L NL+ L L  N L   +P  +F  L  L  + L  N L+
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 181 GSIPRNVGD-LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLE 239
             +P  V D L  ++ L++  N+L+  +P  I     L  L L++N+L      +   L 
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS 159

Query: 240 NLVYLDVGDN 249
           +L +  +  N
Sbjct: 160 SLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 13/142 (9%)

Query: 286 CS-SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYA 344
           CS S T +D    +   S+P+  G+      L L +NQ++   P        L  L+L +
Sbjct: 17  CSCSGTTVDCRSKRHA-SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGS 73

Query: 345 NQL---EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNLLGKLP 400
           NQL      + D    L+ L  L+L  N+LT   P +++ R+  L+ L +  N L  +LP
Sbjct: 74  NQLGALPVGVFD---SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELP 128

Query: 401 LEMTELKQLKNISLYNNQFSGV 422
             +  L  L +++L  NQ   +
Sbjct: 129 RGIERLTHLTHLALDQNQLKSI 150

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 44/157 (28%), Positives = 65/157 (41%), Gaps = 35/157 (22%)

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNL----EGRINFGSEKCKNLTFLDLSYN 273
           Q LYL++N++    P    +L NL  L +G N L     G  +        LT LDL  N
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD----SLTQLTVLDLGTN 98

Query: 274 RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQLSGKIPPELG 332
                                   +LT  +PS+ F  L  L  L +  N+L+ ++P  + 
Sbjct: 99  ------------------------QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE 132

Query: 333 KCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
           +  +LT L L  NQL+        +LS+L    LF N
Sbjct: 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 60.4 bits (145), Expect = 1e-09
 Identities = 31/193 (16%), Positives = 65/193 (33%), Gaps = 21/193 (10%)

Query: 197 WLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRIN 256
              S      +   +     L  L +     +    +   NL++L  +  G        +
Sbjct: 154 QEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE-IISGGLPDSVVED 212

Query: 257 FGSEKCKNLTFLDLSYNRFSGGISPNL---------GNCSSLTHLDIVGSKLTGSIPSSF 307
                  NL  L L       G   ++             +L  L IV ++    +   F
Sbjct: 213 ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272

Query: 308 G---LLARLSSLDLSENQLSGK----IPPELGKCKYLTVLHLYANQLEGE----IPDELG 356
               +L +L ++D+S   L+ +    +   + K K+L  +++  N L  E    +   L 
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLP 332

Query: 357 QLSNLQDLELFDN 369
              ++ D + +D+
Sbjct: 333 MKIDVSDSQEYDD 345

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.5 bits (109), Expect = 3e-05
 Identities = 14/85 (16%), Positives = 35/85 (41%), Gaps = 7/85 (8%)

Query: 92  GHLSKLQTIDLSSNNFSGNIPPKLGNC---SALEYLDLSTNGFTGD----IPDNFENLQN 144
                L+ + +        +            LE +D+S    T +    + D+ + +++
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 145 LQYLNLYGNLLDGEIPEPLFRILGL 169
           L+++N+  N L  E+ + L + L +
Sbjct: 309 LKFINMKYNYLSDEMKKELQKSLPM 333

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.1 bits (108), Expect = 5e-05
 Identities = 25/181 (13%), Positives = 54/181 (29%), Gaps = 23/181 (12%)

Query: 396 LGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGK 455
              L   +  +  L N+ +       +  +      +L  L+ I+      +  ++    
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSD 217

Query: 456 --QLRVL-------NMGQNQFHGPIPSLL--GSCPTLWRVILKQNQLTG----ALPEFSK 500
              L  L       + G +        L      P L  + +   +          E   
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277

Query: 501 NPVLSHLDVSRNNISG----AIPSSIGNSINLTSIDFSSNKFSGLMPQELGN-LVSLVTL 555
            P L  +D+S   ++      +   +    +L  I+   N  S  M +EL   L   + +
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDV 337

Query: 556 N 556
           +
Sbjct: 338 S 338

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 45.7 bits (107), Expect = 6e-05
 Identities = 22/162 (13%), Positives = 51/162 (31%), Gaps = 21/162 (12%)

Query: 133 GDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGD--- 189
            D+    + +  L  L + G      +         L+ + + +  L  S+  ++     
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 190 --LKEVEALWLFSNRLSGTIPESI------GNCYRLQELYLNENKLMGFLPESLSN---L 238
             L+++       +                     L+ L + + +    + E       L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 239 ENLVYLDVGDNNLEGR----INFGSEKCKNLTFLDLSYNRFS 276
             L  +D+    L       +    +K K+L F+++ YN  S
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.6 bits (104), Expect = 1e-04
 Identities = 26/216 (12%), Positives = 62/216 (28%), Gaps = 26/216 (12%)

Query: 477 SCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSN 536
            C  +   I++  +            +              +   +     L ++     
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182

Query: 537 KFSGLMPQELGNLVSLV--TLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSL 594
               +  +   NL SL   +  +  + VE  L S L   + L ++    +       +  
Sbjct: 183 NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242

Query: 595 RSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLS--YAL 652
           R          S++ F             L  L +   +    +         L     +
Sbjct: 243 RPL-------FSKDRFP-----------NLKWLGIVDAEEQNVVVEMFLESDILPQLETM 284

Query: 653 NLSKNGLTGR----IPSDLEKLSKLEQLDISSNNLT 684
           ++S   LT      +   ++K+  L+ +++  N L+
Sbjct: 285 DISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 53/347 (15%), Positives = 108/347 (31%), Gaps = 67/347 (19%)

Query: 115 LGNCSALEYLDLSTNGFTGD----IPDNF-ENLQNLQYLNLYGNLLDGEIPEPLFRILG- 168
                 +  LDLS N         +   F     ++  LNL GN L  +  + L +IL  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 169 ----LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNE 224
               +  + L+ N LS             ++       L+          + +  L L  
Sbjct: 78  IPANVTSLNLSGNFLS------------YKSSDELVKTLA-------AIPFTITVLDLGW 118

Query: 225 NKL----MGFLPESLSNLE-NLVYLDVGDNNL--EGRINFGS---EKCKNLTFLDLSYNR 274
           N           ++ SNL  ++  L++  N+L  +              N+  L+L  N 
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178

Query: 275 FS----GGISPNL-GNCSSLTHLDIVGSKLT--GSIPSSFGLLA---RLSSLDLSENQLS 324
            +      ++  L    +S+T LD+  + L        ++   +    + SL+L  N L 
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238

Query: 325 GK----IPPELGKCKYLTVLHLYANQLEGEIPDE--------LGQLSNLQDLELFDNRLT 372
           G     +       K+L  ++L  + +   +  E           +  +  ++     + 
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

Query: 373 GEFPVSIWRIA-----SLEYLLVYNNNLLGKLPLEMTELKQLKNISL 414
               + I  +        +   + N  L+     +           L
Sbjct: 298 PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDEL 344

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 66/350 (18%), Positives = 110/350 (31%), Gaps = 74/350 (21%)

Query: 262 CKNLTFLDLSYNRFSG----GISPNLGNC-SSLTHLDIVGSKLTGSIPSSFGLLAR---- 312
              +T LDLS N         +     N  +S+T L++ G+ L      +   L +    
Sbjct: 21  PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG---FKNSDELVQILAA 77

Query: 313 ----LSSLDLSENQLSGKIPPELGK-----CKYLTVLHLYANQLEGEIPDELGQL----- 358
               ++SL+LS N LS K   EL K        +TVL L  N    +   E  Q      
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 359 SNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ 418
           +++  L L  N L  +   S   +     +L                   + +++L  N 
Sbjct: 138 ASITSLNLRGNDLGIK---SSDELIQ---ILAAIP-------------ANVNSLNLRGNN 178

Query: 419 FSGVIPQSLG-----INSSLMQLDFINNSFTGEIPPNLCFG-----KQLRVLNMGQNQFH 468
            +      L      I +S+  LD   N    +    L +        +  LN+  N  H
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238

Query: 469 GP----IPSLLGSCPTLWRVILKQNQLTGALPE--------FSKNPVLSHLDVSRNNISG 516
           GP    +  L  S   L  V L  + +     E        F     +  +D +   I  
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298

Query: 517 AIPSSIGNSI-----NLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
           +    I N I             +     +  Q+    +  + +   L  
Sbjct: 299 SHSIPISNLIRELSGKADVPSLLNQ--CLIFAQKHQTNIEDLNIPDELRE 346

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 48/333 (14%), Positives = 105/333 (31%), Gaps = 56/333 (16%)

Query: 407 KQLKNISLYNNQFSGVIPQSLG-----INSSLMQLDFINNSFTGEIPPNLCFG-----KQ 456
             + ++ L  N    +    L        +S+  L+   NS   +    L          
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81

Query: 457 LRVLNMGQNQFHGP----IPSLLGSCP-TLWRVILKQNQLTG----ALPEF--SKNPVLS 505
           +  LN+  N         +   L + P T+  + L  N  +        +   +    ++
Sbjct: 82  VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141

Query: 506 HLDVSRNNISGAIPSSIGNSI-----NLTSIDFSSNKFSGLMPQELGNLV-----SLVTL 555
            L++  N++       +   +     N+ S++   N  +     EL   +     S+ +L
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSL 201

Query: 556 NISLNHVEGS----LPSQLSKCKN-LEVFDVSFNLLNGS----IPSSLRSWKSLSILKLS 606
           ++S N +       L    S   N +   ++  N L+G     +     S K L  + L 
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261

Query: 607 ENHFTG-------GIPTFISELEKLLELQLGGNQLGGEIPPSIG-ALQDLSY---ALNLS 655
            +            +      ++K++ +   G ++       I   +++LS      +L 
Sbjct: 262 YDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLL 321

Query: 656 KNGLT-----GRIPSDLEKLSKLEQLDISSNNL 683
              L           DL    +L +   +   L
Sbjct: 322 NQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 45/297 (15%), Positives = 88/297 (29%), Gaps = 58/297 (19%)

Query: 427 LGINSSLMQLDFINNSFTGEIPPNLCFG-----KQLRVLNMGQNQFHGPIPSLLGSCPTL 481
             I   +  LD   N+        L          +  LN+  N   G       +   L
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL-GFK-----NSDEL 71

Query: 482 WRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSI-----NLTSIDFSSN 536
            +++                  ++ L++S N +S      +  ++      +T +D   N
Sbjct: 72  VQILAAIPA------------NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN 119

Query: 537 KFSGLMPQELGNLV-----SLVTLNISLNHVEGSLPSQLSKC-----KNLEVFDVSFNLL 586
            FS     E          S+ +LN+  N +      +L +       N+   ++  N L
Sbjct: 120 DFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179

Query: 587 N----GSIPSSLRSW-KSLSILKLSENHFT-GGIPTFISELE----KLLELQLGGNQLGG 636
                  +   L S   S++ L LS N                    ++ L L  N L G
Sbjct: 180 ASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239

Query: 637 EIPPSIGALQDLSYA---LNLSKNGLTGRIPSDLEKLSK-------LEQLDISSNNL 683
               ++  L+D       + L  + +        + L         +  +D +   +
Sbjct: 240 PSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 38/323 (11%), Positives = 95/323 (29%), Gaps = 65/323 (20%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLG-----NCSALEYLDLSTNGFTGD----IPDNFENLQ-N 144
           + + +++LS N+       +L        + +  L+LS N  +      +      +   
Sbjct: 51  ASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT 110

Query: 145 LQYLNLYGNLLDGEIPEPLFRIL-----GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF 199
           +  L+L  N    +      +        +  + L  N L             +++    
Sbjct: 111 ITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG------------IKSSDEL 158

Query: 200 SNRLSGTIPESIGNCYRLQELYLNENKL----MGFLPESLSNL-ENLVYLDVGDNNL--E 252
              L+            +  L L  N L       L + L+++  ++  LD+  N L  +
Sbjct: 159 IQILAAI------PA-NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLK 211

Query: 253 GRINFGS---EKCKNLTFLDLSYNRFSG----GISPNLGNCSSLTHLDI-------VGSK 298
                         ++  L+L  N   G     +     +   L  + +       +  +
Sbjct: 212 SYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKE 271

Query: 299 LTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGK-----CKYLTVLHLYANQL-----E 348
              ++ ++F  + ++  +D +  ++       +            V  L    L      
Sbjct: 272 QCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKH 331

Query: 349 GEIPDELGQLSNLQDLELFDNRL 371
               ++L     L++       L
Sbjct: 332 QTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 51.6 bits (124), Expect = 7e-07
 Identities = 50/278 (17%), Positives = 93/278 (33%), Gaps = 55/278 (19%)

Query: 499 SKNPVLSHLDVSRNNISGAIPSSIG-----NSINLTSIDFSSNKFSGLMPQELG-----N 548
           S    ++ LD+S NN+       +         ++TS++ S N        EL       
Sbjct: 19  SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78

Query: 549 LVSLVTLNISLNHVEG----SLPSQLSKCK-NLEVFDVSFNLLNGS----IPSSLRSW-K 598
             ++ +LN+S N +       L   L+     + V D+ +N  +         +  +   
Sbjct: 79  PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138

Query: 599 SLSILKLSENHFTG-GIPTFISELE----KLLELQLGGNQLGGEIPPSIGALQDLSYA-- 651
           S++ L L  N          I  L      +  L L GN L      S     +L+    
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA-----SKNC-AELAKFLA 192

Query: 652 --------LNLSKNGLTGRIPSDLEKL-----SKLEQLDISSNNLTGT-----LSPLSNI 693
                   L+LS N L  +  ++L  +     + +  L++  N L G           ++
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252

Query: 694 HSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSL 731
             L  V + Y++      E    L     ++F     +
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALG----AAFPNIQKI 286

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 30/109 (27%), Positives = 45/109 (41%), Gaps = 9/109 (8%)

Query: 98  QTIDLSSNNFSGNIPPK--LGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNL 154
             + L+ N     I      G    L  L+L  N  T  I  N FE   ++Q L L  N 
Sbjct: 32  TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK 89

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
           +  EI   +F  L  L+ + L +N +S  +     + L  + +L L SN
Sbjct: 90  I-KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 36/141 (25%), Positives = 65/141 (46%), Gaps = 11/141 (7%)

Query: 284 GNCS-SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE--LGKCKYLTVL 340
             C    T +D  G  L   IP    +    + L L++N+L  +I  +   G+  +L  L
Sbjct: 4   AMCHCEGTTVDCTGRGLK-EIPR--DIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKL 59

Query: 341 HLYANQLEGEIPDEL-GQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNLLGK 398
            L  NQL   I        S++Q+L+L +N++  E    ++  +  L+ L +Y+N +   
Sbjct: 60  ELKRNQLT-GIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCV 117

Query: 399 LPLEMTELKQLKNISLYNNQF 419
           +P     L  L +++L +N F
Sbjct: 118 MPGSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 31/114 (27%), Positives = 49/114 (42%), Gaps = 19/114 (16%)

Query: 266 TFLDLSYNRFSGGISPN--LGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQ 322
           T L L+ N     IS +   G    L  L++  ++LT  I  + F   + +  L L EN+
Sbjct: 32  TELLLNDNELGR-ISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK 89

Query: 323 LSGKIPP----ELGKCKYLTVLHLYANQLEGEIPDELG---QLSNLQDLELFDN 369
           +  +I       L +   L  L+LY NQ+   +    G    L++L  L L  N
Sbjct: 90  IK-EISNKMFLGLHQ---LKTLNLYDNQISC-VMP--GSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 18/69 (26%), Positives = 27/69 (39%), Gaps = 10/69 (14%)

Query: 93  HLSKLQTIDLSSNNFSGNIPP----KLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQY 147
             S +Q + L  N     I       L     L+ L+L  N  +  +    FE+L +L  
Sbjct: 76  GASHIQELQLGENKIK-EISNKMFLGLHQ---LKTLNLYDNQISC-VMPGSFEHLNSLTS 130

Query: 148 LNLYGNLLD 156
           LNL  N  +
Sbjct: 131 LNLASNPFN 139

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 31/111 (27%), Positives = 48/111 (43%), Gaps = 6/111 (5%)

Query: 189 DLKEVEALWLFSNRLS-GTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVG 247
              +V+ L L ++R + G +         L+ L      L      +L  L  L  L++ 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 248 DNNLEGRINFGSEKCKNLTFLDLSYNRFS--GGISPNLGNCSSLTHLDIVG 296
           DN + G +   +EKC NLT L+LS N+      I P L    +L  LD+  
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFN 122

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 36/136 (26%), Positives = 62/136 (45%), Gaps = 7/136 (5%)

Query: 258 GSEKCKNLTFLDLSYNRFS-GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSL 316
            +    ++  L L  +R + G +         L  L  +   LT SI ++   L +L  L
Sbjct: 12  RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKL 69

Query: 317 DLSENQLSGKIPPELGKCKYLTVLHLYANQLEG-EIPDELGQLSNLQDLELFDNRLTGEF 375
           +LS+N++SG +     KC  LT L+L  N+++     + L +L NL+ L+LF+  +T   
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129

Query: 376 ---PVSIWRIASLEYL 388
                    +  L YL
Sbjct: 130 DYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 7/135 (5%)

Query: 140 ENLQNLQYLNLYGN-LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL 198
               +++ L L  +   +G++         L+++   N  L+ SI  N+  L +++ L L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLEL 71

Query: 199 FSNRLSGTIPESIGNCYRLQELYLNENKLMGFL-PESLSNLENLVYLDVGDNNLEGRINF 257
             NR+SG +      C  L  L L+ NK+      E L  LENL  LD+ +  +    ++
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDY 131

Query: 258 GS---EKCKNLTFLD 269
                +    LT+LD
Sbjct: 132 RENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 27/103 (26%), Positives = 40/103 (38%), Gaps = 4/103 (3%)

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
           LD SR+N  G +         L  +   +   + +    L  L  L  L +S N V G L
Sbjct: 24  LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGL 80

Query: 567 PSQLSKCKNLEVFDVSFNLLNG-SIPSSLRSWKSLSILKLSEN 608
                KC NL   ++S N +   S    L+  ++L  L L   
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 30/130 (23%), Positives = 48/130 (36%), Gaps = 7/130 (5%)

Query: 455 KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNI 514
           K+L + N   N   G +  L      L  +      LT ++    K   L  L++S N +
Sbjct: 20  KELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRV 76

Query: 515 SGAIPSSIGNSINLTSIDFSSNKFSGLM-PQELGNLVSLVTLNISLNHV---EGSLPSQL 570
           SG +        NLT ++ S NK   L   + L  L +L +L++    V        +  
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVF 136

Query: 571 SKCKNLEVFD 580
                L   D
Sbjct: 137 KLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 24/90 (26%), Positives = 41/90 (45%), Gaps = 7/90 (7%)

Query: 91  IGHLSKLQTIDLSSNNFS--GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
                +L+ +   +   +   N+P      + L+ L+LS N  +G +    E   NL +L
Sbjct: 38  TDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93

Query: 149 NLYGNLL-DGEIPEPLFRILGLQYVFLNNN 177
           NL GN + D    EPL ++  L+ + L N 
Sbjct: 94  NLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 28/107 (26%), Positives = 53/107 (49%), Gaps = 4/107 (3%)

Query: 313 LSSLDLSENQLS-GKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRL 371
           +  L L  ++ + GK+     + + L  L      L   I + L +L+ L+ LEL DNR+
Sbjct: 19  VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRV 76

Query: 372 TGEFPVSIWRIASLEYLLVYNNNLLGKLPLE-MTELKQLKNISLYNN 417
           +G   V   +  +L +L +  N +     +E + +L+ LK++ L+N 
Sbjct: 77  SGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 35/144 (24%), Positives = 54/144 (37%), Gaps = 28/144 (19%)

Query: 541 LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL 600
           L  +   ++  LV  N   N  EG L     + + LE        L  SI ++L     L
Sbjct: 11  LRNRTPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKL 66

Query: 601 SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT 660
             L+LS+N  +GG+     +   L  L L GN+        I  L  +            
Sbjct: 67  KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTIEP---------- 108

Query: 661 GRIPSDLEKLSKLEQLDISSNNLT 684
                 L+KL  L+ LD+ +  +T
Sbjct: 109 ------LKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.8 bits (96), Expect = 4e-04
 Identities = 26/125 (20%), Positives = 50/125 (40%), Gaps = 10/125 (8%)

Query: 326 KIPPELGK--CKYLTVLHLYANQL-EGEIPDELGQLSNLQDLELFDNRLT--GEFPVSIW 380
           +I  EL       +  L L  ++  EG++     +   L+ L   +  LT     P    
Sbjct: 6   RIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP---- 61

Query: 381 RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGV-IPQSLGINSSLMQLDFI 439
           ++  L+ L + +N + G L +   +   L +++L  N+   +   + L    +L  LD  
Sbjct: 62  KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLF 121

Query: 440 NNSFT 444
           N   T
Sbjct: 122 NCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.0 bits (94), Expect = 9e-04
 Identities = 25/90 (27%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 620 ELEKLLELQLGGNQLG-GEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDI 678
               + EL L  ++   G++       ++L + L+    GLT  I ++L KL+KL++L++
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEF-LSTINVGLT-SI-ANLPKLNKLKKLEL 71

Query: 679 SSNNLTGTLSPLS-NIHSLVEVNVSYNLFT 707
           S N ++G L  L+    +L  +N+S N   
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 59.6 bits (144), Expect = 5e-09
 Identities = 69/478 (14%), Positives = 148/478 (30%), Gaps = 57/478 (11%)

Query: 9   LLLFSSFVALSLRSVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDD 68
           L         +L   N        +  +  +   +  +       SD    +        
Sbjct: 80  LKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARA-- 137

Query: 69  DAHNVVSFNLSS-YGVSGQ-LGPEIGHLSKLQTIDLSSNNFSGNIPPKLG----NCSALE 122
              ++ +  L    G +   L   + H  K++T+ +  ++FS      L     + ++LE
Sbjct: 138 --DDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195

Query: 123 YLDLSTNGFTGDIPDN-----FENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNN 177
            L+     F   I          N ++L  + + G+    E+         L+     + 
Sbjct: 196 VLNFYMTEFA-KISPKDLETIARNCRSLVSVKV-GDFEILELVGFFKAAANLEEFCGGSL 253

Query: 178 SLSGSIPRNVGDLKEVEALWLFSNRLSG--TIPESIGNCYRLQELYLNENKLMG-FLPES 234
           +    +P    +L     L        G   +P       ++++L L    L        
Sbjct: 254 NEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTL 313

Query: 235 LSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLG---------- 284
           +    NL  L+  +   +  +   ++ CK L  L +       G+    G          
Sbjct: 314 IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373

Query: 285 --NCSSLTHLDIVGSKLT----GSIPSSFGLLARLSSLDLSENQLSGKIPPELG------ 332
              C  L ++ +  S +T     SI +    L     + L   +    +P + G      
Sbjct: 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLI 433

Query: 333 KCKYLTVLHLYANQLEGEIPDE----LGQL-SNLQDLELFDNRLTGEFPVSIWRIAS--- 384
            CK L     Y    +G + D     +GQ   N++ + L     + E    +   +    
Sbjct: 434 GCKKLRRFAFYLR--QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE---GLMEFSRGCP 488

Query: 385 -LEYLLVYNNNLLGK-LPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFIN 440
            L+ L +       + +   +T+L  L+ + +   + S      + +      ++ I 
Sbjct: 489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIP 546

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 66/482 (13%), Positives = 140/482 (29%), Gaps = 65/482 (13%)

Query: 259 SEKCKNLTFLDLSYNR---------------FSGGISPNLGNCSSLTHLDIVGSKLT--G 301
           S +  NL  L L                    +  ++    N   L  +      ++   
Sbjct: 69  SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLD 128

Query: 302 SIPSSFGLLARLSSLDLSE-NQLSGKIPPELGK-CKYLTVLHLYANQLEGEIPDELGQLS 359
               +      L +L L + +  +      +   C+ +  L +  +    +    L +L+
Sbjct: 129 LDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELA 188

Query: 360 -NLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ 418
            +   LE+ +  +T    +S      LE +     +L          +K + +  +    
Sbjct: 189 QHNTSLEVLNFYMTEFAKIS---PKDLETIARNCRSL--------VSVK-VGDFEILELV 236

Query: 419 FSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSC 478
                  +L             +    E   NL F ++L  L +     +  +P L    
Sbjct: 237 GFFKAAANL---EEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFA 292

Query: 479 PTLWRVILKQNQLT--GALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSN 536
             + ++ L    L          K P L  L+         +         L  +     
Sbjct: 293 AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIE-- 350

Query: 537 KFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLN----GSIPS 592
              G   Q + +   LV+        +  L +    C+ LE   V  + +      SI +
Sbjct: 351 --RGADEQGMEDEEGLVS--------QRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400

Query: 593 SLRSWKSLSILKLSE-NHFTG-----GIPTFISELEKL--LELQLGGNQLGGEIPPSIGA 644
            L++     ++ L      T      G+ + +   +KL      L    L       IG 
Sbjct: 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQ 460

Query: 645 LQDLSYALNLSKNGLTGR-IPSDLEKLSKLEQLDISSNNLT--GTLSPLSNIHSLVEVNV 701
                  + L   G +   +         L++L++     +     + ++ + SL  + V
Sbjct: 461 YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWV 520

Query: 702 SY 703
             
Sbjct: 521 QG 522

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 46.5 bits (110), Expect = 5e-05
 Identities = 52/339 (15%), Positives = 104/339 (30%), Gaps = 38/339 (11%)

Query: 407 KQLKNISLYN-NQFSGVIPQSLGIN-SSLMQLDFINNSFTGEIPPNLCF----GKQLRVL 460
             L+ + L   + F+     S+  +   +  L    +SF+ +    L         L VL
Sbjct: 138 DDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVL 197

Query: 461 NMGQNQFHG----PIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISG 516
           N    +F       + ++  +C +L  V +   ++   +  F     L        N   
Sbjct: 198 NFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDI 257

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGL--MPQELGNLVSLVTLNIS-LNHVEGSLPSQLSKC 573
            +P    N +    +      + G   MP        +  L++           + + KC
Sbjct: 258 GMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKC 317

Query: 574 KNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELE----------- 622
            NLEV +    + +  +    +  K L  L++       G+      +            
Sbjct: 318 PNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGC 377

Query: 623 -KLLELQLGGNQLGGEIPPSIGA---------LQDLSYALNLSKNGLTGRIPSDLEKLSK 672
            +L  + +  + +  E   SIG          L  L     ++   L   + S L    K
Sbjct: 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKK 437

Query: 673 LEQLDISSNNLTGTLSPLSNI----HSLVEVNVSYNLFT 707
           L +          T   LS I     ++  + + Y   +
Sbjct: 438 LRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGES 476

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 34/167 (20%), Positives = 52/167 (31%), Gaps = 45/167 (26%)

Query: 233 ESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHL 292
              +N      LD+    +   I            +D S N                   
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---------------- 55

Query: 293 DIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLE--GE 350
                KL G     F LL RL +L ++ N++             LT L L  N L   G+
Sbjct: 56  -----KLDG-----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 105

Query: 351 IPDELGQLSNLQDLELFDNRLTGEFPVS---------IWRIASLEYL 388
           + D L  L +L  L +  N      PV+         I+++  +  L
Sbjct: 106 L-DPLASLKSLTYLCILRN------PVTNKKHYRLYVIYKVPQVRVL 145

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 27/138 (19%), Positives = 55/138 (39%), Gaps = 9/138 (6%)

Query: 137 DNFENLQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGDLKEVEA 195
             + N    + L+L G  +   + E L   L     +  ++N +   +      L+ ++ 
Sbjct: 13  AQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKT 68

Query: 196 LWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLP-ESLSNLENLVYLDVGDNNLEGR 254
           L + +NR+             L EL L  N L+     + L++L++L YL +  N +  +
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 128

Query: 255 INFGS---EKCKNLTFLD 269
            ++      K   +  LD
Sbjct: 129 KHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 29/161 (18%), Positives = 53/161 (32%), Gaps = 31/161 (19%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
            +  +  + + +DL        I          + +D S N     + D F  L+ L+ L
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69

Query: 149 NLYGNLLDGEIPEPLFRIL-GLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTI 207
            +  N +   I E L + L  L  + L NNSL         +L +++ L           
Sbjct: 70  LVNNNRIC-RIGEGLDQALPDLTELILTNNSLV--------ELGDLDPL----------- 109

Query: 208 PESIGNCYRLQELYLNEN---KLMGFLPESLSNLENLVYLD 245
                +   L  L +  N       +    +  +  +  LD
Sbjct: 110 ----ASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 22/113 (19%), Positives = 41/113 (36%), Gaps = 6/113 (5%)

Query: 186 NVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLD 245
              +      L L   ++   I        +   +  ++N++     +    L  L  L 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLL 70

Query: 246 VGDNNLEGRINFGSEKCKNLTFLDLSYNRFS--GGISPNLGNCSSLTHLDIVG 296
           V +N +        +   +LT L L+ N     G + P L +  SLT+L I+ 
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILR 122

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 26/130 (20%), Positives = 45/130 (34%), Gaps = 6/130 (4%)

Query: 455 KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNI 514
            + R L++   +    I +L  +      +    N++   L  F     L  L V+ N I
Sbjct: 19  VRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRI 76

Query: 515 SGAIPSSIGNSINLTSIDFSSNKFSGLMP-QELGNLVSLVTLNISLN---HVEGSLPSQL 570
                       +LT +  ++N    L     L +L SL  L I  N   + +      +
Sbjct: 77  CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVI 136

Query: 571 SKCKNLEVFD 580
            K   + V D
Sbjct: 137 YKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 29/140 (20%), Positives = 52/140 (37%), Gaps = 30/140 (21%)

Query: 280 SPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTV 339
           +    N      LD+ G K+   I +    L +  ++D S+N++                
Sbjct: 12  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--------------- 55

Query: 340 LHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL--LG 397
                 +L+G        L  L+ L + +NR+          +  L  L++ NN+L  LG
Sbjct: 56  ------KLDG-----FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104

Query: 398 KLPLEMTELKQLKNISLYNN 417
            L   +  LK L  + +  N
Sbjct: 105 DL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 25/106 (23%), Positives = 37/106 (34%), Gaps = 4/106 (3%)

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE 563
              LD+    I   I +         +IDFS N+   L       L  L TL ++ N + 
Sbjct: 21  DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC 77

Query: 564 GSLPSQLSKCKNLEVFDVSFNLLNG-SIPSSLRSWKSLSILKLSEN 608
                      +L    ++ N L        L S KSL+ L +  N
Sbjct: 78  RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 26/132 (19%), Positives = 43/132 (32%), Gaps = 10/132 (7%)

Query: 316 LDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT--G 373
           + L+   +  +   +         L L   ++   I +    L     ++  DN +    
Sbjct: 2   VKLTAELIE-QAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD 58

Query: 374 EFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGV-IPQSLGINSS 432
            FP     +  L+ LLV NN +          L  L  + L NN    +     L    S
Sbjct: 59  GFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114

Query: 433 LMQLDFINNSFT 444
           L  L  + N  T
Sbjct: 115 LTYLCILRNPVT 126

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 9e-09
 Identities = 28/97 (28%), Positives = 47/97 (48%), Gaps = 3/97 (3%)

Query: 923  KIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI 982
              +   A  + +L        +HRD+   NILL  +    I DFG+A+ + K P      
Sbjct: 197  CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 983  SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                 + ++APE  F    + +SDV+S+GV+L E+ +
Sbjct: 254  DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 57.0 bits (138), Expect = 2e-08
 Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 23/205 (11%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR------NL 878
            +IG+G+ G V KA         A+K +  +  K      + E++ +  +          +
Sbjct: 61   LIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 879  VRLEDFWLRKD--CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
            V L+  ++ ++  C  +++  +   +L D+L +           R K A     AL +L 
Sbjct: 119  VHLKRHFMFRNHLC--LVFEMLSY-NLYDLLRNTNFRGVSLNLTR-KFAQQMCTALLFLA 174

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHIS--DFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
               +  I+H D+KPENILL +     I   DFG +               + +  Y +PE
Sbjct: 175  TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-----CQLGQRIYQYIQSRFYRSPE 228

Query: 995  NAFTTAKSKESDVYSYGVVLLELIT 1019
                       D++S G +L+E+ T
Sbjct: 229  VLLGMPYDLAIDMWSLGCILVEMHT 253

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 47/138 (34%), Positives = 73/138 (52%), Gaps = 20/138 (14%)

Query: 266 TFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQLS 324
           T+LDL  N      +      +SLT L + G+KL  S+P+  F  L  L+ L+LS NQL 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 325 GKIPP----ELGKCKYLTVLHLYANQLEGEIPDEL-GQLSNLQDLELFDNRLT----GEF 375
             +P     +L +   L  L L  NQL+  +PD +  +L+ L+DL L+ N+L     G F
Sbjct: 90  -SLPNGVFDKLTQ---LKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVF 144

Query: 376 PVSIWRIASLEYLLVYNN 393
                R+ SL+Y+ +++N
Sbjct: 145 D----RLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 42/131 (32%), Positives = 66/131 (50%), Gaps = 6/131 (4%)

Query: 122 EYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILG-LQYVFLNNNSLS 180
            YLDL TN         F+ L +L  L L GN L   +P  +F  L  L Y+ L+ N L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 181 GSIPRNVGD-LKEVEALWLFSNRLSGTIPESI-GNCYRLQELYLNENKLMGFLPESLSNL 238
            S+P  V D L +++ L L +N+L  ++P+ +     +L++L L +N+L          L
Sbjct: 90  -SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 147

Query: 239 ENLVYLDVGDN 249
            +L Y+ + DN
Sbjct: 148 TSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 8/140 (5%)

Query: 286 CS-SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYA 344
           CS S T ++      T S+P+  G+ A+ + LDL  N L         +   LT L+L  
Sbjct: 5   CSCSGTTVECYSQGRT-SVPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGG 61

Query: 345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNLLGKLPLEM 403
           N+L+        +L++L  L L  N+L    P  ++ ++  L+ L +  N  L  LP  +
Sbjct: 62  NKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQ-LQSLPDGV 119

Query: 404 -TELKQLKNISLYNNQFSGV 422
             +L QLK++ LY NQ   V
Sbjct: 120 FDKLTQLKDLRLYQNQLKSV 139

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 46/158 (29%), Positives = 66/158 (41%), Gaps = 36/158 (22%)

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG 277
             L L  N L          L +L  L +G N L+   N    K  +LT+L+LS N    
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN---- 86

Query: 278 GISPNLGNCSSLTHLDIVGSKLTGSIPSS-FGLLARLSSLDLSENQLSGKIPP----ELG 332
                               +L  S+P+  F  L +L  L L+ NQL   +P     +L 
Sbjct: 87  --------------------QLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLT 124

Query: 333 KCKYLTVLHLYANQLEGEIPDE-LGQLSNLQDLELFDN 369
           +   L  L LY NQL+  +PD    +L++LQ + L DN
Sbjct: 125 Q---LKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 9/140 (6%)

Query: 189 DLKEVEALWLFSNRLS-GTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVG 247
               V  L L + + + G I         L+ L L    L+     +L  L  L  L++ 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 248 DNNLEGRINFGSEKCKNLTFLDLSYNRFS--GGISPNLGNCSSLTHLDIVG---SKLTGS 302
           +N + G ++  +EK  NLT L+LS N+      + P L     L  LD+     + L   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVTNLNDY 138

Query: 303 IPSSFGLLARLSSLDLSENQ 322
             S F LL +L+ LD  + +
Sbjct: 139 RESVFKLLPQLTYLDGYDRE 158

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 9/127 (7%)

Query: 267 FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGK 326
            LD   +   G I        +L  L ++   L  S+ S+   L +L  L+LSEN++ G 
Sbjct: 30  VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGG 86

Query: 327 IPPELGKCKYLTVLHLYANQLE--GEIPDELGQLSNLQDLELFDNRLTGEF---PVSIWR 381
           +     K   LT L+L  N+L+    + + L +L  L+ L+LF+  +T            
Sbjct: 87  LDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKL 145

Query: 382 IASLEYL 388
           +  L YL
Sbjct: 146 LPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.1 bits (125), Expect = 8e-08
 Identities = 36/158 (22%), Positives = 52/158 (32%), Gaps = 31/158 (19%)

Query: 117 NCSALEYLDLSTNGFT-GDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLN 175
             +A+  L L       G I        NL++L+L    L          +  L      
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------SVSNLPK---- 69

Query: 176 NNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLP-ES 234
                         L +++ L L  NR+ G +         L  L L+ NKL      E 
Sbjct: 70  --------------LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP 115

Query: 235 LSNLENLVYLDVGDN---NLEGRINFGSEKCKNLTFLD 269
           L  LE L  LD+ +    NL        +    LT+LD
Sbjct: 116 LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 4/110 (3%)

Query: 310 LARLSSLDLSENQLS-GKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFD 368
            A +  L L   + + GKI     +   L  L L    L   + + L +L  L+ LEL +
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80

Query: 369 NRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLE-MTELKQLKNISLYNN 417
           NR+ G   +   ++ +L +L +  N L     LE + +L+ LK++ L+N 
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 26/103 (25%), Positives = 38/103 (36%), Gaps = 4/103 (3%)

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
           LD  ++N  G I       +NL  +   +     +    L  L  L  L +S N + G L
Sbjct: 31  LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGL 87

Query: 567 PSQLSKCKNLEVFDVSFNLLNG-SIPSSLRSWKSLSILKLSEN 608
                K  NL   ++S N L   S    L+  + L  L L   
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 9/94 (9%)

Query: 91  IGHLSKLQTIDLSSNNFS--GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
                 L+ + L +       N+P        L+ L+LS N   G +    E L NL +L
Sbjct: 45  TAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100

Query: 149 NLYGNLLD--GEIPEPLFRILGLQYVFLNNNSLS 180
           NL GN L     + EPL ++  L+ + L N  ++
Sbjct: 101 NLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 7e-05
 Identities = 30/130 (23%), Positives = 48/130 (36%), Gaps = 7/130 (5%)

Query: 455 KQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNI 514
           ++L + N   N   G I  L      L  + L    L  ++    K P L  L++S N I
Sbjct: 27  RELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRI 83

Query: 515 SGAIPSSIGNSINLTSIDFSSNKFSGLMP-QELGNLVSLVTLNISLN---HVEGSLPSQL 570
            G +        NLT ++ S NK   +   + L  L  L +L++      ++     S  
Sbjct: 84  FGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVF 143

Query: 571 SKCKNLEVFD 580
                L   D
Sbjct: 144 KLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 31/138 (22%), Positives = 52/138 (37%), Gaps = 27/138 (19%)

Query: 548 NLVSLVTLNISLNH-VEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS 606
              ++  L +      +G +    ++  NLE   +    L  S+ S+L     L  L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 607 ENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSD 666
           EN   GG+     +L  L  L L GN+        +  +  L                  
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTLEP---------------- 115

Query: 667 LEKLSKLEQLDISSNNLT 684
           L+KL  L+ LD+ +  +T
Sbjct: 116 LKKLECLKSLDLFNCEVT 133

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 53.4 bits (129), Expect = 3e-08
 Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 6/107 (5%)

Query: 122 EYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLF-RILGLQYVFLNNNSLS 180
             L+L +N         F+ L  L  L+L  N +   +P+ +F ++  L  ++L+ N L 
Sbjct: 31  TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89

Query: 181 GSIPRNVGD-LKEVEALWLFSNRLSGTIPESI-GNCYRLQELYLNEN 225
            S+P  V D L +++ L L +N+L  ++P+ I      LQ+++L+ N
Sbjct: 90  -SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 36/116 (31%), Positives = 63/116 (54%), Gaps = 18/116 (15%)

Query: 287 SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP----ELGKCKYLTVLHL 342
           SS T L++  +KL       F  L +L+ L LS+NQ+   +P     +L K   LT+L+L
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK---LTILYL 83

Query: 343 YANQLEGEIPDEL-GQLSNLQDLELFDNRLT----GEFPVSIWRIASLEYLLVYNN 393
           + N+L+  +P+ +  +L+ L++L L  N+L     G F     R+ SL+ + ++ N
Sbjct: 84  HENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFD----RLTSLQKIWLHTN 134

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 55.3 bits (132), Expect = 5e-08
 Identities = 32/217 (14%), Positives = 52/217 (23%), Gaps = 56/217 (25%)

Query: 827  IGRGAHGIVYKASLGPNAVFAVKKLAFRG-------HKRGSLSMKREI---QTIGKIRHR 876
            IG G  G V++       V A+K +A  G       H++    +  EI   + +  +   
Sbjct: 28   IGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 877  NLVRLEDFWLRKDCGIIMYRYME------------NGSLRDVLHSITP------------ 912
               R E F        +   Y               GS  D                   
Sbjct: 87   VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 913  --------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHIS 964
                               I      +LA           HRD+   N+LL       + 
Sbjct: 147  GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLH 204

Query: 965  DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
                 K              + + G       +T ++
Sbjct: 205  YTLNGKSST-----------IPSCGLQVSIIDYTLSR 230

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 52.2 bits (126), Expect = 7e-08
 Identities = 35/109 (32%), Positives = 49/109 (44%), Gaps = 13/109 (11%)

Query: 98  QTIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
            T+D S  + +     IP      +  + L L  N  T   P  F+ L  L  L+L  N 
Sbjct: 12  TTVDCSGKSLASVPTGIP------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQ 65

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
           L   +P  +F  L  L  + LN+N L  SIPR   D LK +  +WL +N
Sbjct: 66  LT-VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 10/88 (11%)

Query: 287 SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP----ELGKCKYLTVLHL 342
           ++   L +  +++T   P  F  L +L+ LDL  NQL+  +P     +L +   LT L L
Sbjct: 30  TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ---LTQLSL 85

Query: 343 YANQLEGEIPDE-LGQLSNLQDLELFDN 369
             NQL+  IP      L +L  + L +N
Sbjct: 86  NDNQLKS-IPRGAFDNLKSLTHIWLLNN 112

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 13/109 (11%)

Query: 98  QTIDLSSNNFS---GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
             ++  +   +     IP      +  + L L+ N  T   P  F++L NLQ L    N 
Sbjct: 15  TLVNCQNIRLASVPAGIP------TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNK 68

Query: 155 LDGEIPEPLFRILG-LQYVFLNNNSLSGSIPRNVGD-LKEVEALWLFSN 201
           L   IP  +F  L  L  + LN+N L  SIPR   D LK +  ++L++N
Sbjct: 69  LT-AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 14/90 (15%)

Query: 287 SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP----ELGKCKYLTVLHL 342
           +    L +  +++T   P  F  L  L  L  + N+L+  IP     +L +   LT L L
Sbjct: 33  TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ---LTQLDL 88

Query: 343 YANQLEGEIPDELG---QLSNLQDLELFDN 369
             N L+  IP   G    L +L  + L++N
Sbjct: 89  NDNHLKS-IPR--GAFDNLKSLTHIYLYNN 115

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.0 bits (130), Expect = 2e-07
 Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 37/211 (17%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR------NL 878
            VIG+G+ G V KA     +   A+K +  R  KR       EI+ +  +R +      N+
Sbjct: 104  VIGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 879  VRLEDFWLRKD--C------GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH 930
            + + + +  ++  C       + +Y  ++    +           L   VR K A     
Sbjct: 162  IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGF------SLPL---VR-KFAHSILQ 211

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHIS--DFGIAKLLDKSPASTTSISVVGTI 988
             L  LH      I+H D+KPENILL  +    I   DFG +    +        + + + 
Sbjct: 212  CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSR 263

Query: 989  GYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
             Y APE           D++S G +L EL+T
Sbjct: 264  FYRAPEVILGARYGMPIDMWSLGCILAELLT 294

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 51/258 (19%), Positives = 97/258 (37%), Gaps = 48/258 (18%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR---------- 874
             +G G    V+ A  +  N   A+K    RG K  + + + EI+ + ++           
Sbjct: 26   KLGWGHFSTVWLAKDMVNNTHVAMK--IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 875  -HRNLVRLED-FWLRKDCGI---IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAA 929
               ++++L D F  +   G+   +++  +   +L  ++            V+ +I+    
Sbjct: 84   GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLL 141

Query: 930  HALAYLHYDCDPPIVHRDIKPENILLDSEMEPH------ISDFGIAKLLDKSPASTTSIS 983
              L Y+H  C   I+H DIKPEN+L++    P       I+D G A             +
Sbjct: 142  LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYDEHYTN 194

Query: 984  VVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043
             + T  Y +PE          +D++S   ++ ELIT     +P                 
Sbjct: 195  SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD---------------E 239

Query: 1044 DTEEINDIVDLSLMEEML 1061
                  D   ++ + E+L
Sbjct: 240  GHSYTKDDDHIAQIIELL 257

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 37/180 (20%), Positives = 57/180 (31%), Gaps = 71/180 (39%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSE-------------------------------- 958
             L YLH  C   I+H DIKPENILL                                   
Sbjct: 158  GLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 959  -----------------MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK 1001
                             ++  I+D G A  + K    T  I    T  Y + E    +  
Sbjct: 216  TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQ---TRQYRSLEVLIGSGY 270

Query: 1002 SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEML 1061
            +  +D++S   +  EL T     +P   E           ++  E+      ++L+ E+L
Sbjct: 271  NTPADIWSTACMAFELATGDYLFEPHSGEE----------YTRDEDH-----IALIIELL 315

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 48.9 bits (117), Expect = 6e-06
 Identities = 45/307 (14%), Positives = 88/307 (28%), Gaps = 51/307 (16%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLG-----NCSALEYLDLSTNGFTGD-IPDNFENLQNLQY 147
           LS L+ ++L+    +      +         AL+ ++L++       +          + 
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 148 LNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGT- 206
           L L  N L  E           +        L   +  +   +     L L +N L+   
Sbjct: 131 LGLQLNSLGPE---------ACK-------DLRDLLLHDQCQITT---LRLSNNPLTAAG 171

Query: 207 ---IPESIGNCYRLQELYLNENKL----MGFLPESLSNLENLVYLDVGDNNL--EGRINF 257
              + E +     +  L L    L    +  L   L     L  L+V  N       +  
Sbjct: 172 VAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231

Query: 258 GS--EKCKNLTFLDLSYNRFS----GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLA 311
                +  +L  L L +N  S      +    G       + +  S   G+  S +  + 
Sbjct: 232 ARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVV--SLTEGTAVSEYWSVI 289

Query: 312 RLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL----SNLQDLELF 367
            LS +  + N         + +   L +  L  ++     P    QL      ++ L   
Sbjct: 290 -LSEVQRNLNSWD---RARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQ 345

Query: 368 DNRLTGE 374
                  
Sbjct: 346 LGSSGSP 352

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 32/177 (18%), Positives = 61/177 (34%), Gaps = 53/177 (29%)

Query: 827 IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW 885
           IG G  G++Y A         A   +     + G L    E++   ++  ++ ++     
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL--FSELKFYQRVAKKDCIKKWIER 102

Query: 886 LRKD---------CGIIM-----YRYM--------------ENG--SLRDVLHSITPPPT 915
            + D          G+       YR+M              +NG      VL        
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVL-------- 154

Query: 916 LEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP--HISDFGIAK 970
                  ++ +     L Y+H +     VH DIK  N+LL  +     +++D+G++ 
Sbjct: 155 -------QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 47/279 (16%), Positives = 83/279 (29%), Gaps = 56/279 (20%)

Query: 72  NVVSFNLSSYGVSGQLGPEIG-HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLS-TN 129
            V   +LS+  +       I    SKLQ + L     S  I   L   S L  L+LS  +
Sbjct: 94  RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153

Query: 130 GFTGD-IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVG 188
           GF+   +     +   L  LNL                            +  ++     
Sbjct: 154 GFSEFALQTLLSSCSRLDELNLSWCFD------------------FTEKHVQVAVAHVSE 195

Query: 189 DLKEVEALWLFSNRLSGTIPESIG-NCYRLQELYLNENKLMGFLPESLSNLENLVYLDVG 247
            + ++  L  +   L  +   ++   C  L  L L+++ ++    +              
Sbjct: 196 TITQLN-LSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK--NDCFQEFFQ------- 245

Query: 248 DNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPN----LGNCSSLTHLDIVGSKLTGSI 303
                            L  L LS       I P     LG   +L  L + G    G++
Sbjct: 246 --------------LNYLQHLSLSRCY---DIIPETLLELGEIPTLKTLQVFGIVPDGTL 288

Query: 304 PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHL 342
                L   L  L ++ +  +    P +G  K   +  +
Sbjct: 289 QL---LKEALPHLQINCSHFTTIARPTIGNKKNQEIWGI 324

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 46/230 (20%), Positives = 94/230 (40%), Gaps = 15/230 (6%)

Query: 197 WLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRIN 256
                 ++G +       +R    ++++     F P  + ++ +L    +  + L G ++
Sbjct: 57  KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHM-DLSNSVIEVSTLHGILS 115

Query: 257 FGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVG-SKLT-GSIPSSFGLLARLS 314
               +C  L  L L   R S  I   L   S+L  L++ G S  +  ++ +     +RL 
Sbjct: 116 ----QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171

Query: 315 SLDLSE-NQLSGKIPPEL--GKCKYLTVLHL--YANQLEGEIPDELGQ-LSNLQDLELFD 368
            L+LS     + K          + +T L+L  Y   L+      L +   NL  L+L D
Sbjct: 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 231

Query: 369 -NRLTGEFPVSIWRIASLEYL-LVYNNNLLGKLPLEMTELKQLKNISLYN 416
              L  +     +++  L++L L    +++ +  LE+ E+  LK + ++ 
Sbjct: 232 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.2 bits (99), Expect = 8e-04
 Identities = 41/277 (14%), Positives = 91/277 (32%), Gaps = 33/277 (11%)

Query: 436 LDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGAL 495
           LD    +   ++   L   + +      ++    P+             +         L
Sbjct: 52  LDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110

Query: 496 PEFSKN-PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVT 554
                    L +L +    +S  I +++  + NL  ++ S                S  +
Sbjct: 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG--------------CSGFS 156

Query: 555 LNISLNHVEGSLPSQLSKCKNLEVFDVSF--NLLNGSIPSSL-RSWKSLSILKLSENHFT 611
              +L  +       LS C  L+  ++S+  +     +  ++    ++++ L LS     
Sbjct: 157 -EFALQTL-------LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 208

Query: 612 ---GGIPTFISELEKLLELQLGG-NQLGGEIPPSIGALQDLSYALNLSK-NGLTGRIPSD 666
                + T +     L+ L L     L  +       L  L + L+LS+   +      +
Sbjct: 209 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH-LSLSRCYDIIPETLLE 267

Query: 667 LEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSY 703
           L ++  L+ L +      GTL  L      +++N S+
Sbjct: 268 LGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSH 304

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 46.2 bits (110), Expect = 4e-05
 Identities = 53/225 (23%), Positives = 86/225 (38%), Gaps = 43/225 (19%)

Query: 826  VIGRGAHGIVYKAS-LGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR-----NLV 879
             +G G  G V     +     +AVK +  R  K+ + S K E   + KI++      N+V
Sbjct: 42   KMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 880  RLEDFWLRKD--CGIIMYRYMENGSLRDVL--HSITP-PPTLEWNVRYKIALGAAHALAY 934
            +    ++  D  C +I        SL +++  ++           ++    +    AL Y
Sbjct: 100  KYHGKFMYYDHMC-LIFEPL--GPSLYEIITRNNYNGFHIED---IK-LYCIEILKALNY 152

Query: 935  LHYDCDPPIVHRDIKPENILLDS----EMEPHISDFGIAKLLDKSPASTTSI-------- 982
            L       + H D+KPENILLD     +    +      K +      +T I        
Sbjct: 153  LR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 983  --------SVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
                    S++ T  Y APE          SD++S+G VL EL T
Sbjct: 210  TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.2 bits (110), Expect = 4e-05
 Identities = 50/225 (22%), Positives = 83/225 (36%), Gaps = 47/225 (20%)

Query: 826  VIGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR------N 877
             +G G  G V +        +  A+K +  R   +   + + EI  + KI+ +       
Sbjct: 26   NLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 878  LVRLEDFWLRKD--CGIIMYRYMENGSLRDVL--HSITPPPTLEWNVRYKIALGAAHALA 933
             V + D++      C I      +N    + L  ++  P P     VR  +A    HAL 
Sbjct: 84   CVLMSDWFNFHGHMC-IAFELLGKN--TFEFLKENNFQPYPLPH--VR-HMAYQLCHALR 137

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPH-------------------ISDFGIAKLLDK 974
            +LH   +  + H D+KPENIL  +                        ++DFG A     
Sbjct: 138  FLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----- 189

Query: 975  SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
            +       ++V T  Y  PE       ++  DV+S G +L E   
Sbjct: 190  TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 45.5 bits (108), Expect = 6e-05
 Identities = 30/176 (17%), Positives = 60/176 (34%), Gaps = 48/176 (27%)

Query: 827 IGRGAHGIVYKA---------SLGPNAVFAVK------KLAFRGHKRGSLSMKREIQ--- 868
             R   GI+Y+A         S      F++K      +L    +     +   ++    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 869 TIGKIRHRNLVRLEDFWLRKDCGIIMYRY--ME--NGSLRDVLHSITPPPTLEWNVR--- 921
            +       +     F + +D     YR+  +     SL+  L         + + +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQD----KYRFLVLPSLGRSLQSAL---------DVSPKHVL 156

Query: 922 -----YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP--HISDFGIAK 970
                 ++A     AL +LH +     VH ++  ENI +D E +    ++ +G A 
Sbjct: 157 SERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 45.1 bits (107), Expect = 7e-05
 Identities = 14/42 (33%), Positives = 22/42 (52%), Gaps = 5/42 (11%)

Query: 931 ALAYLHYDCDPPIVHRDIKPENILLDSEMEP--HISDFGIAK 970
            L Y+H       VH DIK  N+LL+ +     ++ D+G+A 
Sbjct: 164 ILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.4 bits (103), Expect = 3e-04
 Identities = 27/108 (25%), Positives = 39/108 (36%), Gaps = 27/108 (25%)

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHIS-------------------DFGIAKL 971
            ++ +LH      + H D+KPENIL                             DFG A  
Sbjct: 130  SVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-- 184

Query: 972  LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT 1019
               +       ++V T  Y APE       S+  DV+S G +L+E   
Sbjct: 185  ---TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	1109
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.98
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.94
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.92
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.9
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.87
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.84
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.83
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.8
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.79
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.78
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.77
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.77
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.76
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.76
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.74
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.74
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.74
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.74
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.74
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.72
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.72
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.7
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.69
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.68
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.66
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.59
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.58
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.56
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.56
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.56
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.54
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.53
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.52
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.5
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.48
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.48
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.45
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.42
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.41
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.35
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.34
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.23
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.23
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.22
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.18
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.14
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.13
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.03
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.9
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.85
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.81
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.8
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.8
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.75
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.73
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.53
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.36
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.3
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.27
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.26
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.1
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.96
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.95
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.75
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.67
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.66
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.53
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.49
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.43
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.18
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.11
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.02
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.0
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.62
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.53
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.49
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.45
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.41
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	95.98
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	95.96
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.67
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.41
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.24
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.94
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.93
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.27
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	90.34

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.6e-96  Score=929.65  Aligned_cols=700  Identities=30%  Similarity=0.473  Sum_probs=650.6

Q ss_pred             hccCChhhHHHHHHHHHhccCCCCcccCCCCCCCCCCceeeeEEecCCCCcEEEEEecccCCccc---cCCcccCCCCcc
Q 001275           22 SVNALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQ---LGPEIGHLSKLQ   98 (1109)
Q Consensus        22 ~~~~~~~~~~all~~~~~~~~~~~~~l~sW~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~---~~~~l~~l~~L~   98 (1109)
                      ...+.++|++||++||+++. ||. .+++|+. +.+||+|.||+|+  +++|++++|+++++.|.   +++++++|++|+
T Consensus         6 ~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~-~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~   80 (768)
T 3rgz_A            6 PSQSLYREIHQLISFKDVLP-DKN-LLPDWSS-NKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLE   80 (768)
T ss_dssp             --CCHHHHHHHHHHHHTTCS-CTT-SSTTCCT-TSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCC
T ss_pred             cccCCHHHHHHHHHHHhhCC-Ccc-cccCCCC-CCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccc
Confidence            33456889999999999997 666 8999985 4579999999998  68999999999999998   999999999999


Q ss_pred             EeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCc--cccccCccceeccccccccccCCccc-ccccccceeccc
Q 001275           99 TIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPD--NFENLQNLQYLNLYGNLLDGEIPEPL-FRILGLQYVFLN  175 (1109)
Q Consensus        99 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~--~l~~L~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls  175 (1109)
                      .++++.|.+. .+|..++.+++|++|||++|.++|.+|.  .++++++|++|+|++|.+++.+|..+ .++++|++|+++
T Consensus        81 ~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls  159 (768)
T 3rgz_A           81 SLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS  159 (768)
T ss_dssp             EEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred             ccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence            9999999886 4678999999999999999999999998  99999999999999999999988877 889999999999


Q ss_pred             ccccccccccc---cCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccC
Q 001275          176 NNSLSGSIPRN---VGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE  252 (1109)
Q Consensus       176 ~n~l~~~~p~~---l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  252 (1109)
                      +|++++..|..   ++++++|++|++++|++++.+|.  +++++|++|+|++|++++.+|. ++++++|++|++++|+++
T Consensus       160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~  236 (768)
T 3rgz_A          160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLS  236 (768)
T ss_dssp             SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCC
T ss_pred             CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCC
Confidence            99999988887   89999999999999999987764  8899999999999999998887 999999999999999999


Q ss_pred             CcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCcccccc-ccccEEEcCCCCCCCCCCCcc
Q 001275          253 GRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLL-ARLSSLDLSENQLSGKIPPEL  331 (1109)
Q Consensus       253 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~l  331 (1109)
                      +.++..+..+++|++|+|++|++++.+|..  .+++|++|++++|++++.+|..+... ++|++|++++|++++.+|..|
T Consensus       237 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~  314 (768)
T 3rgz_A          237 GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF  314 (768)
T ss_dssp             SCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred             CcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence            999999999999999999999999877765  88999999999999999999988775 999999999999999999999


Q ss_pred             ccccccceeeccCcccCCCCCcc-ccCCCCccEEEccCccccccCchHHHhhc-ccceeeccCCccCCCCchhhhc--cC
Q 001275          332 GKCKYLTVLHLYANQLEGEIPDE-LGQLSNLQDLELFDNRLTGEFPVSIWRIA-SLEYLLVYNNNLLGKLPLEMTE--LK  407 (1109)
Q Consensus       332 ~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~--l~  407 (1109)
                      +++++|++|++++|++++.+|.. ++.+++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..  ++
T Consensus       315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~  394 (768)
T 3rgz_A          315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKN  394 (768)
T ss_dssp             GGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTC
T ss_pred             hcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccC
Confidence            99999999999999999888876 99999999999999999999999999998 9999999999999999988877  88


Q ss_pred             CCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhcc
Q 001275          408 QLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK  487 (1109)
Q Consensus       408 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~  487 (1109)
                      +|+.|++++|++++.+|..++.+++|++|++++|.+++.+|..+..+++|++|++++|++.+.+|..++.+++|+.|+++
T Consensus       395 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  474 (768)
T 3rgz_A          395 TLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD  474 (768)
T ss_dssp             CCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred             CccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccC
Q 001275          488 QNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL  566 (1109)
Q Consensus       488 ~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  566 (1109)
                      +|++++.+|. +..+++|++|++++|++++.+|.+++++++|++|+|++|+++|.+|..++++++|++|++++|+++|.+
T Consensus       475 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~i  554 (768)
T 3rgz_A          475 FNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTI  554 (768)
T ss_dssp             SSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBC
T ss_pred             CCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcC
Confidence            9999998887 899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCCccEEEecCc----------------------cccCCCCcccccccccceeccccccccCCCcchhhhhhhh
Q 001275          567 PSQLSKCKNLEVFDVSFN----------------------LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKL  624 (1109)
Q Consensus       567 p~~l~~l~~L~~L~ls~N----------------------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  624 (1109)
                      |..+..+..+..+++..+                      .+.|..|..+..+..++.++++.|.++|.+|..++.+++|
T Consensus       555 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L  634 (768)
T 3rgz_A          555 PAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM  634 (768)
T ss_dssp             CGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCC
T ss_pred             ChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccc
Confidence            999888766655544431                      2556777888888999999999999999999999999999


Q ss_pred             hhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCC-CCccccceEEeeec
Q 001275          625 LELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSY  703 (1109)
Q Consensus       625 ~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~~  703 (1109)
                      +.|||++|+++|.+|.+++.++.| ..|+|++|+++|.||..++++++|++||||+|+|+|.+|. ++.+++|+.||+|+
T Consensus       635 ~~LdLs~N~l~g~ip~~l~~l~~L-~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~  713 (768)
T 3rgz_A          635 MFLDMSYNMLSGYIPKEIGSMPYL-FILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN  713 (768)
T ss_dssp             CEEECCSSCCBSCCCGGGGGCTTC-CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCS
T ss_pred             cEEECcCCcccccCCHHHhccccC-CEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcC
Confidence            999999999999999999999999 4799999999999999999999999999999999999998 99999999999999


Q ss_pred             cccccccch--hhhhccCCCCCCCCCCCccccccc
Q 001275          704 NLFTGPVPE--TLMNLLGPSPSSFSGNPSLCVKCL  736 (1109)
Q Consensus       704 n~l~g~~p~--~~~~~~~~~~~~~~gn~~~c~~~~  736 (1109)
                      |+|+|+||.  ++.+|   +..+|.|||++||.++
T Consensus       714 N~l~g~iP~~~~~~~~---~~~~~~gN~~Lcg~~l  745 (768)
T 3rgz_A          714 NNLSGPIPEMGQFETF---PPAKFLNNPGLCGYPL  745 (768)
T ss_dssp             SEEEEECCSSSSGGGS---CGGGGCSCTEEESTTS
T ss_pred             CcccccCCCchhhccC---CHHHhcCCchhcCCCC
Confidence            999999995  34455   7788999999999886

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4.4e-79  Score=773.27  Aligned_cols=625  Identities=31%  Similarity=0.474  Sum_probs=582.4

Q ss_pred             ecccCCccc--cCCcccCCCCccEeecCCCcccccCCC--CCCCCCCCcEeeccCccccCCCCccc-cccCccceecccc
Q 001275           78 LSSYGVSGQ--LGPEIGHLSKLQTIDLSSNNFSGNIPP--KLGNCSALEYLDLSTNGFTGDIPDNF-ENLQNLQYLNLYG  152 (1109)
Q Consensus        78 l~~~~l~~~--~~~~l~~l~~L~~L~L~~n~l~~~~p~--~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~L~~L~~L~L~~  152 (1109)
                      +..+...+.  +++.++.+++|++|+|++|.++|.+|.  .++++++|++|||++|.+++.+|..+ .++++|++|+|++
T Consensus        81 ~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~  160 (768)
T 3rgz_A           81 SLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA  160 (768)
T ss_dssp             EEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred             ccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence            333334443  448899999999999999999999998  99999999999999999999888876 8999999999999


Q ss_pred             ccccccCCcc---cccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccC
Q 001275          153 NLLDGEIPEP---LFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMG  229 (1109)
Q Consensus       153 n~l~~~~p~~---l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  229 (1109)
                      |.+++..|..   +.++++|++|++++|++++..|.  +.+++|++|+|++|++++.+|. ++++++|++|+|++|++++
T Consensus       161 n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~  237 (768)
T 3rgz_A          161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSG  237 (768)
T ss_dssp             SCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCS
T ss_pred             CccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCC
Confidence            9999888877   78999999999999999987764  8899999999999999998887 9999999999999999999


Q ss_pred             cCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccc-cCCcEEEeecCCCCCcCCcccc
Q 001275          230 FLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNC-SSLTHLDIVGSKLTGSIPSSFG  308 (1109)
Q Consensus       230 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~  308 (1109)
                      .+|.++.++++|++|++++|++++.+|..  .+++|++|+|++|++++.+|..+... ++|++|++++|++++.+|..|+
T Consensus       238 ~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~  315 (768)
T 3rgz_A          238 DFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG  315 (768)
T ss_dssp             CHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGG
T ss_pred             cccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHh
Confidence            99999999999999999999999877765  88999999999999999999988775 9999999999999999999999


Q ss_pred             ccccccEEEcCCCCCCCCCCCc-cccccccceeeccCcccCCCCCccccCCC-CccEEEccCccccccCchHHHh--hcc
Q 001275          309 LLARLSSLDLSENQLSGKIPPE-LGKCKYLTVLHLYANQLEGEIPDELGQLS-NLQDLELFDNRLTGEFPVSIWR--IAS  384 (1109)
Q Consensus       309 ~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~--l~~  384 (1109)
                      .+++|++|++++|+++|.+|.. ++++++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..  +++
T Consensus       316 ~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~  395 (768)
T 3rgz_A          316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT  395 (768)
T ss_dssp             GCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCC
T ss_pred             cCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCC
Confidence            9999999999999999888876 99999999999999999999999999987 9999999999999999998887  889


Q ss_pred             cceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCC
Q 001275          385 LEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQ  464 (1109)
Q Consensus       385 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~  464 (1109)
                      |++|++++|.+++.+|..+.++++|+.|++++|++++.+|..++.+++|++|++++|.+++.+|..+..+++|++|++++
T Consensus       396 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~  475 (768)
T 3rgz_A          396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF  475 (768)
T ss_dssp             CCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred             ccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCCCCccchhhccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcc
Q 001275          465 NQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMP  543 (1109)
Q Consensus       465 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  543 (1109)
                      |++.+.+|..++.+++|+.|++++|++++.+|. ++.+++|++|++++|+++|.+|..++++++|++|++++|+++|.+|
T Consensus       476 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip  555 (768)
T 3rgz_A          476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP  555 (768)
T ss_dssp             SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCC
T ss_pred             CcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCC
Confidence            999999999999999999999999999998887 9999999999999999999999999999999999999999999999


Q ss_pred             hhhhcccccceeecccc----------------------cccccCCccccCCCCccEEEecCccccCCCCcccccccccc
Q 001275          544 QELGNLVSLVTLNISLN----------------------HVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLS  601 (1109)
Q Consensus       544 ~~~~~l~~L~~L~L~~N----------------------~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~  601 (1109)
                      .+++.+..+..+++..+                      .+.+..|..+..+..++.++++.|.++|.+|..++.+++|+
T Consensus       556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~  635 (768)
T 3rgz_A          556 AAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM  635 (768)
T ss_dssp             GGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCC
T ss_pred             hHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhcccccc
Confidence            99998887777665542                      24566777888888999999999999999999999999999


Q ss_pred             eeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCC
Q 001275          602 ILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSN  681 (1109)
Q Consensus       602 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N  681 (1109)
                      .|+|++|+++|.+|..++.+++|+.|+|++|+++|.||.++++++.| +.|||++|+++|.||..+++++.|++||||+|
T Consensus       636 ~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L-~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N  714 (768)
T 3rgz_A          636 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL-NILDLSSNKLDGRIPQAMSALTMLTEIDLSNN  714 (768)
T ss_dssp             EEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC-CEEECCSSCCEECCCGGGGGCCCCSEEECCSS
T ss_pred             EEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCC-CEEECCCCcccCcCChHHhCCCCCCEEECcCC
Confidence            99999999999999999999999999999999999999999999999 58999999999999999999999999999999


Q ss_pred             cccccCCCCCccccceEEeeeccc-ccc
Q 001275          682 NLTGTLSPLSNIHSLVEVNVSYNL-FTG  708 (1109)
Q Consensus       682 ~l~g~~~~l~~~~~l~~l~~~~n~-l~g  708 (1109)
                      +|+|.||..+.+..+....+.+|+ +-|
T Consensus       715 ~l~g~iP~~~~~~~~~~~~~~gN~~Lcg  742 (768)
T 3rgz_A          715 NLSGPIPEMGQFETFPPAKFLNNPGLCG  742 (768)
T ss_dssp             EEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred             cccccCCCchhhccCCHHHhcCCchhcC
Confidence            999999987777666666666664 444

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.5e-63  Score=625.38  Aligned_cols=590  Identities=21%  Similarity=0.179  Sum_probs=376.2

Q ss_pred             EecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceecccccccc
Q 001275           77 NLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD  156 (1109)
Q Consensus        77 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~  156 (1109)
                      ++++.+++ .+|..+.  +++++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.++
T Consensus        10 ~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~   86 (680)
T 1ziw_A           10 DCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS   86 (680)
T ss_dssp             ECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC
T ss_pred             ECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC
Confidence            33444443 3565554  78999999999999877778999999999999999999888888999999999999999998


Q ss_pred             ccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcc
Q 001275          157 GEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLS  236 (1109)
Q Consensus       157 ~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~  236 (1109)
                      +..+..+.++++|++|++++|++++..|..|+++++|++|++++|.+++..|..++++++|++|++++|++++..+..+.
T Consensus        87 ~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  166 (680)
T 1ziw_A           87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELD  166 (680)
T ss_dssp             CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHG
T ss_pred             ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhh
Confidence            54445688899999999999999877778889999999999999999988888888999999999999999888777665


Q ss_pred             --cccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccc---cccCCcEEEeecCCCCCcCCccccccc
Q 001275          237 --NLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLG---NCSSLTHLDIVGSKLTGSIPSSFGLLA  311 (1109)
Q Consensus       237 --~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~n~l~~~~~~~~~~l~  311 (1109)
                        .+++|++|++++|++++..+..+..+++|+.|++++|.+.+.....+.   ..++|+.|++++|.+++..|..|..++
T Consensus       167 ~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~  246 (680)
T 1ziw_A          167 IFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK  246 (680)
T ss_dssp             GGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGG
T ss_pred             ccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccC
Confidence              457888888888888888888888888888888888776632221111   236777888888877777777777765


Q ss_pred             c--ccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceee
Q 001275          312 R--LSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLL  389 (1109)
Q Consensus       312 ~--L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  389 (1109)
                      .  |+.|++++|++++..|..|+.+++|++|++++|++.+..|..+..+++|++|++++|...+.++.            
T Consensus       247 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~------------  314 (680)
T 1ziw_A          247 WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL------------  314 (680)
T ss_dssp             GSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC----------------
T ss_pred             cCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccc------------
Confidence            4  77888887777777777777777777777777777777777777777777777777655432210            


Q ss_pred             ccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccC--CCCccc--CccceEEECCCc
Q 001275          390 VYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEI--PPNLCF--GKQLRVLNMGQN  465 (1109)
Q Consensus       390 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~--p~~~~~--~~~L~~L~L~~N  465 (1109)
                         +.+.......+..+++|+.|++++|++++..|..+..+++|++|++++|.++...  +..+..  ..+|+.|++++|
T Consensus       315 ---~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n  391 (680)
T 1ziw_A          315 ---ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN  391 (680)
T ss_dssp             -----CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTS
T ss_pred             ---ccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCC
Confidence               0000001113445555666666666665555555555556666666655543211  111211  135666666666


Q ss_pred             ccccCCCcccCCCCccchhhccCcccCCCCC--CCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCccc--CC
Q 001275          466 QFHGPIPSLLGSCPTLWRVILKQNQLTGALP--EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS--GL  541 (1109)
Q Consensus       466 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~--~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~--~~  541 (1109)
                      ++.+..|..+..+++|+.|++++|++++.+|  .|..+++|++|++++|++++..+..+..+++|+.|++++|+++  +.
T Consensus       392 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  471 (680)
T 1ziw_A          392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS  471 (680)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTC
T ss_pred             CCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccccc
Confidence            6665555555555555555555555554333  2555666666666666666555666666666666666666654  34


Q ss_pred             cchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCC--------cccccccccceeccccccccCC
Q 001275          542 MPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP--------SSLRSWKSLSILKLSENHFTGG  613 (1109)
Q Consensus       542 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~  613 (1109)
                      +|..++.+++|++|+|++|++++..|..+..+++|++|++++|++++..+        ..|..+++|+.|+|++|+++..
T Consensus       472 ~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i  551 (680)
T 1ziw_A          472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI  551 (680)
T ss_dssp             SSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCC
Confidence            55556666666666666666665555556666666666666666553211        1234444444444444444421


Q ss_pred             CcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchh-hcccCCeEEccCCcccc
Q 001275          614 IPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLE-KLSKLEQLDISSNNLTG  685 (1109)
Q Consensus       614 ~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g  685 (1109)
                      .+..|..+++|+.|+|++|++++..|..+..++.| ..|+|++|+|++..|..++ .+++|+.|+|++|++..
T Consensus       552 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c  623 (680)
T 1ziw_A          552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL-KSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC  623 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCB
T ss_pred             CHHHcccccCcceeECCCCCCCcCCHhHhCCCCCC-CEEECCCCcCCccChhHhcccccccCEEEccCCCccc
Confidence            11234444444444444444442222223333333 2344444444433333333 34444444444444443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=6.8e-63  Score=619.55  Aligned_cols=580  Identities=21%  Similarity=0.218  Sum_probs=476.9

Q ss_pred             CceeeeEEecC---------CCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccC
Q 001275           58 PCQWVGIECDD---------DAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLST  128 (1109)
Q Consensus        58 ~c~w~gv~C~~---------~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~  128 (1109)
                      .|.++.|.|..         -..+++.|+++++.+.+..+..++++++|++|+|++|.+++..|..++++++|++|+|++
T Consensus         3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~   82 (680)
T 1ziw_A            3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH   82 (680)
T ss_dssp             -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred             eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence            35566677753         124799999999999987777899999999999999999999999999999999999999


Q ss_pred             ccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcc
Q 001275          129 NGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIP  208 (1109)
Q Consensus       129 n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p  208 (1109)
                      |++++..+..|+++++|++|+|++|.+++..|..+.++++|++|++++|.+++..|..++++++|++|++++|.+++..+
T Consensus        83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  162 (680)
T 1ziw_A           83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKS  162 (680)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCH
T ss_pred             CccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCH
Confidence            99997666689999999999999999997777889999999999999999999999999999999999999999998888


Q ss_pred             cccc--cccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccc---cCCCCcchhccccccccCCCCccc
Q 001275          209 ESIG--NCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS---EKCKNLTFLDLSYNRFSGGISPNL  283 (1109)
Q Consensus       209 ~~l~--~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~~  283 (1109)
                      ..++  .+++|++|++++|++++..|..|..+++|+.|++++|++.......+   ...++|+.|++++|.+++..+..|
T Consensus       163 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~  242 (680)
T 1ziw_A          163 EELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF  242 (680)
T ss_dssp             HHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTT
T ss_pred             HHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHh
Confidence            7765  45899999999999999999999999999999999998864332221   134789999999999999989999


Q ss_pred             ccccC--CcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCC-----CCCc---
Q 001275          284 GNCSS--LTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG-----EIPD---  353 (1109)
Q Consensus       284 ~~l~~--L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----~~p~---  353 (1109)
                      .+++.  |+.|++++|++++..|..|+.+++|++|++++|++++..|..|.++++|+.|++++|...+     .+|.   
T Consensus       243 ~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~  322 (680)
T 1ziw_A          243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD  322 (680)
T ss_dssp             GGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECT
T ss_pred             hccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccCh
Confidence            88865  9999999999999889999999999999999999999999999999999999999887654     2333   


Q ss_pred             -cccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCC--Cchhhhcc--CCCCeEEccCCcCcccCCcccc
Q 001275          354 -ELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGK--LPLEMTEL--KQLKNISLYNNQFSGVIPQSLG  428 (1109)
Q Consensus       354 -~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~  428 (1109)
                       .+..+++|++|++++|++++..+..+..+++|++|++++|.+...  .+..+..+  ++|+.|++++|++++..|..+.
T Consensus       323 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~  402 (680)
T 1ziw_A          323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS  402 (680)
T ss_dssp             TTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTT
T ss_pred             hhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhh
Confidence             678889999999999999988888888999999999999886432  22334433  5889999999999988888888


Q ss_pred             CCCCCceEEecCCcccccCC-CCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccC--CCCCC-CCCCCCC
Q 001275          429 INSSLMQLDFINNSFTGEIP-PNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLT--GALPE-FSKNPVL  504 (1109)
Q Consensus       429 ~~~~L~~L~ls~N~l~~~~p-~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~--~~~~~-~~~~~~L  504 (1109)
                      .+++|++|++++|.+++.+| ..+..+++|++|++++|++.+..+..+..+++|+.|++++|.++  +..|. |..+++|
T Consensus       403 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L  482 (680)
T 1ziw_A          403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL  482 (680)
T ss_dssp             TCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC
T ss_pred             CCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC
Confidence            88999999999999887666 56777888899999999888888888888888888888888876  34444 7777888


Q ss_pred             ceEEeecCccCCCCCCcccccccccEEeccCCcccCCcc--------hhhhcccccceeecccccccccCCccccCCCCc
Q 001275          505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMP--------QELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL  576 (1109)
Q Consensus       505 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  576 (1109)
                      ++|++++|+|++..|..+.++++|++|+|++|++++..+        ..++.+++|++|+|++|+++...+..|..+++|
T Consensus       483 ~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L  562 (680)
T 1ziw_A          483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL  562 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCc
Confidence            888888888887767777788888888888888775422        236667777777777777774333457777777


Q ss_pred             cEEEecCccccCCCCcccccccccceeccccccccCCCcchhh-hhhhhhhhhcccCcCCCC
Q 001275          577 EVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFIS-ELEKLLELQLGGNQLGGE  637 (1109)
Q Consensus       577 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~g~  637 (1109)
                      +.|||++|+|++..+..|..+++|+.|+|++|++++..|..+. .+++|+.|++++|++...
T Consensus       563 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            7777777777755555566777777777777777766666565 566677777777766643

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=3.7e-58  Score=568.68  Aligned_cols=523  Identities=19%  Similarity=0.175  Sum_probs=394.9

Q ss_pred             ccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCccccc
Q 001275           86 QLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFR  165 (1109)
Q Consensus        86 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~  165 (1109)
                      .+|..+.  +++++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..+.+
T Consensus        26 ~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~  103 (606)
T 3t6q_A           26 EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG  103 (606)
T ss_dssp             SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSS
T ss_pred             cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcc
Confidence            3454443  36899999999999988999999999999999999999988999999999999999999999888999999


Q ss_pred             ccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccc--c
Q 001275          166 ILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLV--Y  243 (1109)
Q Consensus       166 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~--~  243 (1109)
                      +++|++|++++|++++..+..++++++|++|++++|++++..+..+..+++|++|++++|++++..|..|+.+++|+  .
T Consensus       104 l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~  183 (606)
T 3t6q_A          104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS  183 (606)
T ss_dssp             CTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEE
T ss_pred             cccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeE
Confidence            99999999999999988788999999999999999999986555555699999999999999998899999999999  8


Q ss_pred             ccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCC-----cCCccccccc--cccEE
Q 001275          244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG-----SIPSSFGLLA--RLSSL  316 (1109)
Q Consensus       244 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----~~~~~~~~l~--~L~~L  316 (1109)
                      |++++|++++..+..+.. .+|++|++++|.   ..+..+..+.+++...+.-+.+.+     ..+..|..+.  +|+.|
T Consensus       184 L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L  259 (606)
T 3t6q_A          184 LNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI  259 (606)
T ss_dssp             EECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEE
T ss_pred             EecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEE
Confidence            999999999877766654 689999999886   334555566655555554433321     2233444443  67888


Q ss_pred             EcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccC
Q 001275          317 DLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLL  396 (1109)
Q Consensus       317 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  396 (1109)
                      ++++|.+++..+..|+.+++|++|++++|+++ .+|..+..+++|++|++++|++++..|..+..+++|++|++++|.+.
T Consensus       260 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~  338 (606)
T 3t6q_A          260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR  338 (606)
T ss_dssp             ECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSC
T ss_pred             EeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcc
Confidence            88888888777777888888888888888887 67777888888888888888888766777777777777777777777


Q ss_pred             CCCch-hhhccCCCCeEEccCCcCcccC--CccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCc
Q 001275          397 GKLPL-EMTELKQLKNISLYNNQFSGVI--PQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPS  473 (1109)
Q Consensus       397 ~~~~~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~  473 (1109)
                      +.+|. .+..+++|+.|++++|++++..  |..++.+++|++|++++|.+++..|..+..+++|++|++++|++.+..|.
T Consensus       339 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  418 (606)
T 3t6q_A          339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ  418 (606)
T ss_dssp             CBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTC
T ss_pred             cccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccc
Confidence            55544 3677777777777777776654  55666666666666666666666666666666666666666665544332


Q ss_pred             ccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCC---cchhhhccc
Q 001275          474 LLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGL---MPQELGNLV  550 (1109)
Q Consensus       474 ~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~  550 (1109)
                      .                      .+..+++|++|++++|.+++..|..++.+++|++|++++|++++.   .+..++.++
T Consensus       419 ~----------------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~  476 (606)
T 3t6q_A          419 S----------------------PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG  476 (606)
T ss_dssp             C----------------------TTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCT
T ss_pred             h----------------------hhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCC
Confidence            1                      155566666666666666666666666677777777777766652   224566677


Q ss_pred             ccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcc
Q 001275          551 SLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLG  630 (1109)
Q Consensus       551 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~  630 (1109)
                      +|++|++++|++++..|..+..+++|+.|||++|++++..|..+..+++| .|+|++|++++..|..+..+++|+.|+++
T Consensus       477 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  555 (606)
T 3t6q_A          477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLR  555 (606)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECT
T ss_pred             CccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCC
Confidence            77777777777776666777777777777777777777667777777777 77777777776666667777777777777


Q ss_pred             cCcCCCCC
Q 001275          631 GNQLGGEI  638 (1109)
Q Consensus       631 ~N~l~g~i  638 (1109)
                      +|++.+..
T Consensus       556 ~N~~~c~c  563 (606)
T 3t6q_A          556 QNPLDCTC  563 (606)
T ss_dssp             TCCEECSG
T ss_pred             CCCccccC
Confidence            77776543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=4.9e-58  Score=567.65  Aligned_cols=529  Identities=20%  Similarity=0.202  Sum_probs=407.6

Q ss_pred             CCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccc
Q 001275          103 SSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGS  182 (1109)
Q Consensus       103 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~  182 (1109)
                      ++..++ .+|..+.  +.+++|||++|.+++..|..|+++++|++|+|++|.+++..|..+.++++|++|+|++|++++.
T Consensus        20 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~   96 (606)
T 3t6q_A           20 ENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM   96 (606)
T ss_dssp             TTSCCS-SCCTTSC--TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEE
T ss_pred             CCCCcc-cCcCCCC--CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccccc
Confidence            344555 5676664  4799999999999988899999999999999999999988899999999999999999999988


Q ss_pred             cccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCC
Q 001275          183 IPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKC  262 (1109)
Q Consensus       183 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  262 (1109)
                      .|..|+++++|++|++++|++++..|..|+++++|++|++++|++++..+..+..+++|++|++++|++++..+..+..+
T Consensus        97 ~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  176 (606)
T 3t6q_A           97 AETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL  176 (606)
T ss_dssp             CTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTT
T ss_pred             ChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhh
Confidence            89999999999999999999998878889999999999999999998665566669999999999999998888888888


Q ss_pred             CCcc--hhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCC-----CCCCcccccc
Q 001275          263 KNLT--FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSG-----KIPPELGKCK  335 (1109)
Q Consensus       263 ~~L~--~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----~~p~~l~~l~  335 (1109)
                      ++|+  .|++++|.+++..+..+.. .+|+.|++++|.   .++..+..+.++....+..+.+.+     ..+..+..+.
T Consensus       177 ~~L~~l~L~l~~n~l~~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~  252 (606)
T 3t6q_A          177 QQATNLSLNLNGNDIAGIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC  252 (606)
T ss_dssp             TTCCSEEEECTTCCCCEECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred             cccceeEEecCCCccCccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence            8888  7889999988766666544 678888888886   345555556555554444333321     1122233332


Q ss_pred             --ccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEE
Q 001275          336 --YLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNIS  413 (1109)
Q Consensus       336 --~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  413 (1109)
                        +|+.|++++|.+++..+..|+.+++|++|++++|+++ .+|..+..+++|++|++++|.+.+..|..+..+++|+.|+
T Consensus       253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  331 (606)
T 3t6q_A          253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS  331 (606)
T ss_dssp             GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEE
T ss_pred             cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEE
Confidence              4566666666666555555566666666666666655 4455555555555555555555544444555555555555


Q ss_pred             ccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCC--CcccCCCCccchhhccCccc
Q 001275          414 LYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPI--PSLLGSCPTLWRVILKQNQL  491 (1109)
Q Consensus       414 L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~l~l~~N~l  491 (1109)
                      +++|++.+.+|..                       .+..+++|++|++++|++.+..  |..++.+++|+.|++++|++
T Consensus       332 l~~n~~~~~~~~~-----------------------~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l  388 (606)
T 3t6q_A          332 IKGNTKRLELGTG-----------------------CLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEP  388 (606)
T ss_dssp             CCSCSSCCBCCSS-----------------------TTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSC
T ss_pred             CCCCCcccccchh-----------------------hhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcC
Confidence            5555554433332                       1444445555555555554433  44555555666666666666


Q ss_pred             CCCCCC-CCCCCCCceEEeecCccCCCCCCc-ccccccccEEeccCCcccCCcchhhhcccccceeeccccccccc---C
Q 001275          492 TGALPE-FSKNPVLSHLDVSRNNISGAIPSS-IGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGS---L  566 (1109)
Q Consensus       492 ~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~  566 (1109)
                      ++..|. |..+++|++|++++|++++..|.. +.++++|++|++++|++++..|..++.+++|++|++++|++++.   .
T Consensus       389 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  468 (606)
T 3t6q_A          389 LSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK  468 (606)
T ss_dssp             EEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECS
T ss_pred             CcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCcccccc
Confidence            555554 777888999999999998776654 89999999999999999999999999999999999999999873   3


Q ss_pred             CccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhh
Q 001275          567 PSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQ  646 (1109)
Q Consensus       567 p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~  646 (1109)
                      +..+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..+..+++| .|+|++|++++.+|..++.++
T Consensus       469 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~  547 (606)
T 3t6q_A          469 TNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILS  547 (606)
T ss_dssp             SCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHH
T ss_pred             chhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCC
Confidence            4679999999999999999999999999999999999999999999999999999999 999999999988888899999


Q ss_pred             hhhhhhcccccccccccC
Q 001275          647 DLSYALNLSKNGLTGRIP  664 (1109)
Q Consensus       647 ~l~~~L~L~~N~l~g~ip  664 (1109)
                      +| ..|++++|.+++..+
T Consensus       548 ~L-~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          548 QQ-RTINLRQNPLDCTCS  564 (606)
T ss_dssp             TS-SEEECTTCCEECSGG
T ss_pred             CC-CEEeCCCCCccccCC
Confidence            99 579999999997665

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.8e-58  Score=571.10  Aligned_cols=500  Identities=18%  Similarity=0.255  Sum_probs=306.6

Q ss_pred             CChhhHHHHHHHHHhccCCCCcc-------cCCCCCCCCCCcee---eeEEecCCCCcEEEEEecccCCccccCCcccCC
Q 001275           25 ALNGDGVALLSLMRHWNSVPPLI-------ISSWNSSDSTPCQW---VGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHL   94 (1109)
Q Consensus        25 ~~~~~~~all~~~~~~~~~~~~~-------l~sW~~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l   94 (1109)
                      ....|++||.+++++++++.+..       ..+|+.+ .+||.|   .||+|+.. +||++|+|+++++.|.+|+++++|
T Consensus        27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L  104 (636)
T 4eco_A           27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQL  104 (636)
T ss_dssp             HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGC
T ss_pred             hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcC
Confidence            34579999999999987665443       3489865 679999   99999865 899999999999999999999999


Q ss_pred             CCccEeecCCCccc------c------cCCCCCCCCCCCcEeeccCccccCCCCccccc-cCccceeccccccccccCCc
Q 001275           95 SKLQTIDLSSNNFS------G------NIPPKLGNCSALEYLDLSTNGFTGDIPDNFEN-LQNLQYLNLYGNLLDGEIPE  161 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~------~------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~-L~~L~~L~L~~n~l~~~~p~  161 (1109)
                      ++|++|+|++|.+.      |      .+|...  +..|+ +++++|.+.+.+|..+.. +.++..+++....+..    
T Consensus       105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~----  177 (636)
T 4eco_A          105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK----  177 (636)
T ss_dssp             TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCC----
T ss_pred             ccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccc----
Confidence            99999999999872      2      333322  56677 888888888887777663 2344444444322210    


Q ss_pred             ccccccccceeccc--ccccccccccccCCCcccceeecccccCCCC-----------------cccccc--cccCccEE
Q 001275          162 PLFRILGLQYVFLN--NNSLSGSIPRNVGDLKEVEALWLFSNRLSGT-----------------IPESIG--NCYRLQEL  220 (1109)
Q Consensus       162 ~l~~l~~L~~L~Ls--~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-----------------~p~~l~--~l~~L~~L  220 (1109)
                        .....++.+.+.  +|+++| +|..|+++++|++|+|++|++++.                 +|..++  ++++|++|
T Consensus       178 --~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L  254 (636)
T 4eco_A          178 --SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV  254 (636)
T ss_dssp             --CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred             --ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEE
Confidence              111122222222  355555 555555555555555555555553                 555555  55556666


Q ss_pred             EeccccccCcCchhcccccccccccccCcc-cCC-cccccccCC------CCcchhccccccccCCCCc--ccccccCCc
Q 001275          221 YLNENKLMGFLPESLSNLENLVYLDVGDNN-LEG-RINFGSEKC------KNLTFLDLSYNRFSGGISP--NLGNCSSLT  290 (1109)
Q Consensus       221 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~~~~--~~~~l~~L~  290 (1109)
                      +|++|++.+.+|+.|+++++|++|++++|+ +++ .+|..+..+      ++|++|+|++|+++ .+|.  .++++++|+
T Consensus       255 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~  333 (636)
T 4eco_A          255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLG  333 (636)
T ss_dssp             EEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCC
T ss_pred             EecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCC
Confidence            666555555555555555556666666555 555 455544443      56666666666665 4555  566666666


Q ss_pred             EEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccc-cceeeccCcccCCCCCccccCCC--CccEEEcc
Q 001275          291 HLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKY-LTVLHLYANQLEGEIPDELGQLS--NLQDLELF  367 (1109)
Q Consensus       291 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~L~  367 (1109)
                      +|++++|+++|.+| .|+.+++|++|++++|+++ .+|..++.+++ |++|++++|+++ .+|..+..++  +|++|+++
T Consensus       334 ~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls  410 (636)
T 4eco_A          334 MLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFS  410 (636)
T ss_dssp             EEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECC
T ss_pred             EEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECc
Confidence            66666666665555 5566666666666666665 55555666666 666666666665 4555555433  56666666


Q ss_pred             CccccccCchHHH-------hhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccC-C-------CC
Q 001275          368 DNRLTGEFPVSIW-------RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI-N-------SS  432 (1109)
Q Consensus       368 ~N~l~~~~~~~~~-------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~-------~~  432 (1109)
                      +|++++..|..+.       .+++|++|++++|++++..+..+..+++|+.|+|++|+++ .+|..+.. .       ++
T Consensus       411 ~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~  489 (636)
T 4eco_A          411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYL  489 (636)
T ss_dssp             SSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGG
T ss_pred             CCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCC
Confidence            6666655555555       4556666666666666333333444666666666666666 34433322 1       16


Q ss_pred             CceEEecCCcccccCCCCcc--cCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEee
Q 001275          433 LMQLDFINNSFTGEIPPNLC--FGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVS  510 (1109)
Q Consensus       433 L~~L~ls~N~l~~~~p~~~~--~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls  510 (1109)
                      |++|++++|.++ .+|..+.  .+++|+.|+|++|+|++ +|..++.+++|+.|++++|+                 +++
T Consensus       490 L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~-----------------~ls  550 (636)
T 4eco_A          490 LTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR-----------------DAQ  550 (636)
T ss_dssp             CCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB-----------------CTT
T ss_pred             ccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc-----------------ccc
Confidence            666666666666 5666555  66666666666666665 56666666666666665443                 234


Q ss_pred             cCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeeccccccc
Q 001275          511 RNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE  563 (1109)
Q Consensus       511 ~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  563 (1109)
                      +|++.+.+|..++++++|++|+|++|++ +.+|..+.  ++|++|+|++|++.
T Consensus       551 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~  600 (636)
T 4eco_A          551 GNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI  600 (636)
T ss_dssp             CCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred             cCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence            5555555555555555566666666655 34555444  45666666666544

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-56  Score=569.21  Aligned_cols=526  Identities=21%  Similarity=0.197  Sum_probs=287.0

Q ss_pred             EeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeeccccc
Q 001275          123 YLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNR  202 (1109)
Q Consensus       123 ~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~  202 (1109)
                      ..|.++++++ .+|.   -.++|++|+|++|.+++..|..+.++++|++|+|++|.+.+.+                   
T Consensus         8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i-------------------   64 (844)
T 3j0a_A            8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI-------------------   64 (844)
T ss_dssp             EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEE-------------------
T ss_pred             EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCcccc-------------------
Confidence            4455555555 3443   2345555555555555444555555555555555555333333                   


Q ss_pred             CCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCccccc--ccCCCCcchhccccccccCCCC
Q 001275          203 LSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFG--SEKCKNLTFLDLSYNRFSGGIS  280 (1109)
Q Consensus       203 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~~~  280 (1109)
                          .|..|+++++|++|+|++|++++..|++|.++++|++|+|++|++++..+..  +..+++|++|+|++|.+++..+
T Consensus        65 ----~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~  140 (844)
T 3j0a_A           65 ----DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL  140 (844)
T ss_dssp             ----CTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCC
T ss_pred             ----CHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccccccc
Confidence                1444555555555555555555545555555555555555555555433322  5555555556666665554433


Q ss_pred             -cccccccCCcEEEeecCCCCCcCCcccccc--ccccEEEcCCCCCCCCCCCccccccc------cceeeccCcccCCCC
Q 001275          281 -PNLGNCSSLTHLDIVGSKLTGSIPSSFGLL--ARLSSLDLSENQLSGKIPPELGKCKY------LTVLHLYANQLEGEI  351 (1109)
Q Consensus       281 -~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~------L~~L~L~~N~l~~~~  351 (1109)
                       ..|+++++|++|++++|.+++..+..++.+  ++|+.|++++|.+.+..|..++.+.+      |+.|++++|.+++..
T Consensus       141 ~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~  220 (844)
T 3j0a_A          141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI  220 (844)
T ss_dssp             CGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTT
T ss_pred             chhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhH
Confidence             356666666666666666666666666655  66666677776666666665555544      677777777766666


Q ss_pred             CccccCC---CCccEEEccCcccc---------ccCchHHHhh--cccceeeccCCccCCCCchhhhccCCCCeEEccCC
Q 001275          352 PDELGQL---SNLQDLELFDNRLT---------GEFPVSIWRI--ASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNN  417 (1109)
Q Consensus       352 p~~l~~l---~~L~~L~L~~N~l~---------~~~~~~~~~l--~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N  417 (1109)
                      +..+...   ++++.|.++.+.+.         +..+..+..+  ++|+.|++++|.+.+..|..+..+++|+.|+|++|
T Consensus       221 ~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  300 (844)
T 3j0a_A          221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYN  300 (844)
T ss_dssp             TSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESC
T ss_pred             HHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCC
Confidence            6555432   45666666643322         2222222222  44555555555555545555555555555555555


Q ss_pred             cCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCC
Q 001275          418 QFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE  497 (1109)
Q Consensus       418 ~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  497 (1109)
                      ++++..|..+..+++|++|++++|.+++..|..+..+++|+.|++++|++.+..+..+..+++|+.|++++|++++.   
T Consensus       301 ~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i---  377 (844)
T 3j0a_A          301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI---  377 (844)
T ss_dssp             CCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC---
T ss_pred             cCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc---
Confidence            55555555555555555555555555544455555555555555555555544444444455555555555544421   


Q ss_pred             CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCcc
Q 001275          498 FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLE  577 (1109)
Q Consensus       498 ~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  577 (1109)
                       ..+++|+.|++++|+++ .+|..   ..+++.|++++|++++...                       +..+..+++|+
T Consensus       378 -~~~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~-----------------------~~~~~~l~~L~  429 (844)
T 3j0a_A          378 -HFIPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDI-----------------------LYFLLRVPHLQ  429 (844)
T ss_dssp             -SSCCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTT-----------------------HHHHTTCTTCC
T ss_pred             -cCCCCcchhccCCCCcc-ccccc---ccccceeecccCccccCch-----------------------hhhhhcCCccc
Confidence             11444455555555554 23322   2334444455444443211                       11233445555


Q ss_pred             EEEecCccccCCCCc-ccccccccceecccccccc-----CCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhh
Q 001275          578 VFDVSFNLLNGSIPS-SLRSWKSLSILKLSENHFT-----GGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYA  651 (1109)
Q Consensus       578 ~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~  651 (1109)
                      .|+|++|++++..+. .+..+++|+.|+|++|.++     +..|..+..+++|+.|+|++|++++.+|..++.++.| ..
T Consensus       430 ~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~  508 (844)
T 3j0a_A          430 ILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL-RG  508 (844)
T ss_dssp             EEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC-SE
T ss_pred             eeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh-he
Confidence            555555555533222 2333455555555555554     2334455666666666666666666666666666666 35


Q ss_pred             hcccccccccccCcchhhcccCCeEEccCCcccccCCCCCccccceEEeeeccccccccc
Q 001275          652 LNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVP  711 (1109)
Q Consensus       652 L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~l~~~~~l~~l~~~~n~l~g~~p  711 (1109)
                      |+|++|+|++..|..+.  ++|+.|||++|+|+|.+|..  +.+|+.+++++|++.+..+
T Consensus       509 L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          509 LSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             EEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred             eECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence            77777777754444444  78888888888888887762  3468888899998887665

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.1e-56  Score=555.53  Aligned_cols=526  Identities=20%  Similarity=0.177  Sum_probs=369.0

Q ss_pred             EEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccc
Q 001275           76 FNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLL  155 (1109)
Q Consensus        76 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l  155 (1109)
                      ++.++.+++ .+|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+
T Consensus        16 ~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l   92 (606)
T 3vq2_A           16 YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI   92 (606)
T ss_dssp             EECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             eEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcc
Confidence            445555554 3555553  7899999999999988888999999999999999999988888999999999999999999


Q ss_pred             cccCCcccccccccceecccccccccccccccCCCcccceeecccccCCC-CcccccccccCccEEEeccccccCcCchh
Q 001275          156 DGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSG-TIPESIGNCYRLQELYLNENKLMGFLPES  234 (1109)
Q Consensus       156 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  234 (1109)
                      ++..|..+.++++|++|++++|++++..+..++++++|++|++++|++++ .+|..|+++++|++|++++|++++..+..
T Consensus        93 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~  172 (606)
T 3vq2_A           93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND  172 (606)
T ss_dssp             CCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTT
T ss_pred             cccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhh
Confidence            98889999999999999999999998877889999999999999999986 57999999999999999999999988888


Q ss_pred             cccccccc----cccccCcccCCcccccccCCCCcchhcccccccc-CCCCcccccccCCcEEEeecCCCCCc------C
Q 001275          235 LSNLENLV----YLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS-GGISPNLGNCSSLTHLDIVGSKLTGS------I  303 (1109)
Q Consensus       235 l~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~------~  303 (1109)
                      |+.+++|+    +|++++|++++..+..+... +|++|++++|.++ +..+..+.++++|+.+++..+.+.+.      .
T Consensus       173 ~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~  251 (606)
T 3vq2_A          173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE  251 (606)
T ss_dssp             THHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred             hhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccC
Confidence            88888776    69999999987766666555 8999999999886 35667788888888888876655421      1


Q ss_pred             Cccccccc--cccEEEc-CCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHH
Q 001275          304 PSSFGLLA--RLSSLDL-SENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIW  380 (1109)
Q Consensus       304 ~~~~~~l~--~L~~L~L-s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~  380 (1109)
                      +..+..+.  .++.+++ ..|.+.+.+|. +..+++|+.|++++|.+. .+| .+..+++|++|++++|++ +.+| .+ 
T Consensus       252 ~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-  325 (606)
T 3vq2_A          252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-  325 (606)
T ss_dssp             GGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-
T ss_pred             hHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-
Confidence            11222222  3455555 55666666665 667777777777777775 344 566667777777777776 3555 33 


Q ss_pred             hhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCccc--CCccccCCCCCceEEecCCcccccCCCCcccCccce
Q 001275          381 RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGV--IPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLR  458 (1109)
Q Consensus       381 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~  458 (1109)
                      .+++|+.|++++|...+..  .+..+++|+.|++++|++++.  +|..++.+++|++|++++|.+++ +|..+..+++|+
T Consensus       326 ~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~  402 (606)
T 3vq2_A          326 DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQ  402 (606)
T ss_dssp             CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCC
T ss_pred             CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCC
Confidence            6666666666666444322  445566666666666666554  25555555666666666666553 334555555555


Q ss_pred             EEECCCcccccCCC-cccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCc
Q 001275          459 VLNMGQNQFHGPIP-SLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNK  537 (1109)
Q Consensus       459 ~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~  537 (1109)
                      .|++++|++.+..| ..                       +..+++|++|++++|++++.+|..++++++|++|++++|+
T Consensus       403 ~L~l~~n~l~~~~~~~~-----------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  459 (606)
T 3vq2_A          403 HLDFQHSTLKRVTEFSA-----------------------FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS  459 (606)
T ss_dssp             EEECTTSEEESTTTTTT-----------------------TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCE
T ss_pred             eeECCCCccCCccChhh-----------------------hhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCc
Confidence            55555555554433 23                       5555566666666666665566666666666666666666


Q ss_pred             ccC-CcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcc
Q 001275          538 FSG-LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPT  616 (1109)
Q Consensus       538 l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  616 (1109)
                      +++ .+|..++.+++|++|+|++|++++..|..+..+++|+.|++++|++++..|..|..+++|+.|+|++|+++ .+|.
T Consensus       460 l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~  538 (606)
T 3vq2_A          460 FKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKG  538 (606)
T ss_dssp             EGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEES
T ss_pred             CCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCH
Confidence            665 24555666666666666666666655666666666666666666666555666666666666666666666 5555


Q ss_pred             hhhhhh-hhhhhhcccCcCCCCC
Q 001275          617 FISELE-KLLELQLGGNQLGGEI  638 (1109)
Q Consensus       617 ~~~~l~-~L~~L~l~~N~l~g~i  638 (1109)
                      .+..++ +|+.|++++|++.+..
T Consensus       539 ~~~~l~~~L~~l~l~~N~~~c~c  561 (606)
T 3vq2_A          539 ILQHFPKSLAFFNLTNNSVACIC  561 (606)
T ss_dssp             CGGGSCTTCCEEECCSCCCCCSS
T ss_pred             hHhhhcccCcEEEccCCCcccCC
Confidence            566654 3666666666666433

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=5.6e-57  Score=558.15  Aligned_cols=542  Identities=21%  Similarity=0.192  Sum_probs=392.5

Q ss_pred             cceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEecc
Q 001275          145 LQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNE  224 (1109)
Q Consensus       145 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~  224 (1109)
                      .++++.+++.++ .+|..+.  ++|++|++++|++++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus        13 ~~~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~   89 (606)
T 3vq2_A           13 NITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTG   89 (606)
T ss_dssp             TTEEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CCceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCC
Confidence            356778888777 6676554  5777777777777776666777777777777777777766677777777777777777


Q ss_pred             ccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccC-CCCcccccccCCcEEEeecCCCCCcC
Q 001275          225 NKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG-GISPNLGNCSSLTHLDIVGSKLTGSI  303 (1109)
Q Consensus       225 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~  303 (1109)
                      |++++..|++|+++++|++|++++|++++..+..+..+++|++|+|++|.+++ .+|..|+++++|++|++++|++++..
T Consensus        90 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~  169 (606)
T 3vq2_A           90 NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT  169 (606)
T ss_dssp             CCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEEC
T ss_pred             CcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecC
Confidence            77777767777777777777777777776665666666666666666666664 34666666666666666666666655


Q ss_pred             Ccccccccccc----EEEcCCCCCCCCCCCccccccccceeeccCcccC-CCCCccccCCCCccEEEccCccccccCchH
Q 001275          304 PSSFGLLARLS----SLDLSENQLSGKIPPELGKCKYLTVLHLYANQLE-GEIPDELGQLSNLQDLELFDNRLTGEFPVS  378 (1109)
Q Consensus       304 ~~~~~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  378 (1109)
                      +..|+.+++|+    +|++++|.+++..+..+... +|+.|++++|.+. +..|..+.++++|+.+++..+.+.+..   
T Consensus       170 ~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~---  245 (606)
T 3vq2_A          170 VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER---  245 (606)
T ss_dssp             TTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC---
T ss_pred             hhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC---
Confidence            66565555544    56666666664444343333 5666666666554 234445555555555555443332110   


Q ss_pred             HHhhcccceeeccCCccCCCCchhhhccC--CCCeEEc-cCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCc
Q 001275          379 IWRIASLEYLLVYNNNLLGKLPLEMTELK--QLKNISL-YNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGK  455 (1109)
Q Consensus       379 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L-~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~  455 (1109)
                                     .+....+..+..+.  .++.+++ ..|.+++.+|. +..+++|+.|++++|.++ .+| .+..++
T Consensus       246 ---------------~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~  307 (606)
T 3vq2_A          246 ---------------NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHF  307 (606)
T ss_dssp             ---------------CCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTC
T ss_pred             ---------------cccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccc
Confidence                           00001111111111  3444555 55666666655 666666666666666665 344 556666


Q ss_pred             cceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCC--CCCcccccccccEEec
Q 001275          456 QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGA--IPSSIGNSINLTSIDF  533 (1109)
Q Consensus       456 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~--~p~~~~~l~~L~~L~L  533 (1109)
                      +|+.|++++|++ +.+|..  .+++|+.|++++|+..+.. .+..+++|++|++++|++++.  +|..+..+++|++|++
T Consensus       308 ~L~~L~l~~n~l-~~lp~~--~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L  383 (606)
T 3vq2_A          308 KWQSLSIIRCQL-KQFPTL--DLPFLKSLTLTMNKGSISF-KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL  383 (606)
T ss_dssp             CCSEEEEESCCC-SSCCCC--CCSSCCEEEEESCSSCEEC-CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEEC
T ss_pred             cCCEEEcccccC-cccccC--CCCccceeeccCCcCccch-hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeEC
Confidence            677777777776 456633  6677777777777554433 467788899999999999866  3788889999999999


Q ss_pred             cCCcccCCcchhhhcccccceeecccccccccCC-ccccCCCCccEEEecCccccCCCCcccccccccceeccccccccC
Q 001275          534 SSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLP-SQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG  612 (1109)
Q Consensus       534 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  612 (1109)
                      ++|++++ +|..++.+++|++|++++|++++..| ..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++
T Consensus       384 ~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  462 (606)
T 3vq2_A          384 SFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD  462 (606)
T ss_dssp             CSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGG
T ss_pred             CCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCC
Confidence            9999885 66888999999999999999998877 688899999999999999999899999999999999999999997


Q ss_pred             C-CcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCCCC
Q 001275          613 G-IPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLS  691 (1109)
Q Consensus       613 ~-~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~l~  691 (1109)
                      . +|..++.+++|+.|+|++|++++.+|..++.+++| ..|+|++|++++.+|..++++++|++|||++|+|+..++.+.
T Consensus       463 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~  541 (606)
T 3vq2_A          463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL-QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ  541 (606)
T ss_dssp             GEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGG
T ss_pred             cchHHhhccCCCCCEEECCCCcCCccChhhhcccccC-CEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHh
Confidence            4 78889999999999999999998889999999999 479999999999899999999999999999999995444488


Q ss_pred             ccc-cceEEeeeccccccccc-hhhhhc
Q 001275          692 NIH-SLVEVNVSYNLFTGPVP-ETLMNL  717 (1109)
Q Consensus       692 ~~~-~l~~l~~~~n~l~g~~p-~~~~~~  717 (1109)
                      .++ +|+.+++++|++.+..+ .++..|
T Consensus       542 ~l~~~L~~l~l~~N~~~c~c~~~~~~~~  569 (606)
T 3vq2_A          542 HFPKSLAFFNLTNNSVACICEHQKFLQW  569 (606)
T ss_dssp             GSCTTCCEEECCSCCCCCSSTTHHHHTT
T ss_pred             hhcccCcEEEccCCCcccCCccHHHHHH
Confidence            886 59999999999998777 445555

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.3e-56  Score=559.93  Aligned_cols=501  Identities=18%  Similarity=0.277  Sum_probs=309.6

Q ss_pred             ccCChhhHHHHHHHHHhccCCCCcccCCCCCCC----CCC--cee------------eeEEecCCCCcEEEEEecccCCc
Q 001275           23 VNALNGDGVALLSLMRHWNSVPPLIISSWNSSD----STP--CQW------------VGIECDDDAHNVVSFNLSSYGVS   84 (1109)
Q Consensus        23 ~~~~~~~~~all~~~~~~~~~~~~~l~sW~~~~----~~~--c~w------------~gv~C~~~~~~v~~l~l~~~~l~   84 (1109)
                      +++..+|++||++||+++.+ |     +|+.++    .+|  |.|            .||+|+. .+||++|+|+++++.
T Consensus       264 ~~~~~~d~~ALl~~k~~l~~-~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~  336 (876)
T 4ecn_A          264 TAEYIKDYKALKAIWEALDG-K-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAK  336 (876)
T ss_dssp             CCHHHHHHHHHHHHHHHTTG-G-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCE
T ss_pred             cccchHHHHHHHHHHHHcCC-C-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCC
Confidence            34567899999999999953 4     787654    334  999            9999987 689999999999999


Q ss_pred             cccCCcccCCCCccEeec-CCCcccccCCCCCCCCC-CCc-----Ee---------ec-cCcccc-----------CCCC
Q 001275           85 GQLGPEIGHLSKLQTIDL-SSNNFSGNIPPKLGNCS-ALE-----YL---------DL-STNGFT-----------GDIP  136 (1109)
Q Consensus        85 ~~~~~~l~~l~~L~~L~L-~~n~l~~~~p~~l~~l~-~L~-----~L---------~L-s~n~l~-----------~~~p  136 (1109)
                      |.+|++|++|++|++|+| ++|.++|..|....... .+.     .+         +. ....+.           ...+
T Consensus       337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~  416 (876)
T 4ecn_A          337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP  416 (876)
T ss_dssp             EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred             CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence            999999999999999999 88999887553211110 000     00         00 000000           0011


Q ss_pred             ccccccCccceecccc--ccccccCCcccccccccceeccccccccc-----------------ccccccC--CCcccce
Q 001275          137 DNFENLQNLQYLNLYG--NLLDGEIPEPLFRILGLQYVFLNNNSLSG-----------------SIPRNVG--DLKEVEA  195 (1109)
Q Consensus       137 ~~l~~L~~L~~L~L~~--n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-----------------~~p~~l~--~l~~L~~  195 (1109)
                      ........++.+.+..  |.+++ +|..++++++|++|+|++|++++                 .+|..++  ++++|++
T Consensus       417 i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~  495 (876)
T 4ecn_A          417 IKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTD  495 (876)
T ss_dssp             CCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCE
T ss_pred             cccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCE
Confidence            1112233444444444  66665 67777777777777777777776                 4777777  8888888


Q ss_pred             eecccccCCCCcccccccccCccEEEecccc-ccC-cCchhccccc-------ccccccccCcccCCcccc--cccCCCC
Q 001275          196 LWLFSNRLSGTIPESIGNCYRLQELYLNENK-LMG-FLPESLSNLE-------NLVYLDVGDNNLEGRINF--GSEKCKN  264 (1109)
Q Consensus       196 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~~~~l~~l~-------~L~~L~L~~N~l~~~~~~--~~~~l~~  264 (1109)
                      |+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+++++       +|++|+|++|+++ .+|.  .+..+++
T Consensus       496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~  574 (876)
T 4ecn_A          496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVK  574 (876)
T ss_dssp             EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTT
T ss_pred             EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCC
Confidence            8888888888888888888888888888887 777 6777766665       7777777777777 5555  6666777


Q ss_pred             cchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCcccccccc-ccEEEcCCCCCCCCCCCccccccc--cceee
Q 001275          265 LTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLAR-LSSLDLSENQLSGKIPPELGKCKY--LTVLH  341 (1109)
Q Consensus       265 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~Ls~N~l~~~~p~~l~~l~~--L~~L~  341 (1109)
                      |++|+|++|+++ .+| .|+.+++|+.|++++|+++ .+|..+..+++ |+.|+|++|+++ .+|..+..++.  |+.|+
T Consensus       575 L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~  650 (876)
T 4ecn_A          575 LGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVD  650 (876)
T ss_dssp             CCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEE
T ss_pred             CCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEE
Confidence            777777777766 555 6666777777777777776 56666666666 777777777766 56666655543  77777


Q ss_pred             ccCcccCCCCCccc---c--CCCCccEEEccCccccccCchHHH-hhcccceeeccCCccCCCCchhhhc--------cC
Q 001275          342 LYANQLEGEIPDEL---G--QLSNLQDLELFDNRLTGEFPVSIW-RIASLEYLLVYNNNLLGKLPLEMTE--------LK  407 (1109)
Q Consensus       342 L~~N~l~~~~p~~l---~--~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~--------l~  407 (1109)
                      |++|++.+.+|...   .  .+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|+++ .+|..+..        ++
T Consensus       651 Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~  728 (876)
T 4ecn_A          651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTY  728 (876)
T ss_dssp             CCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGG
T ss_pred             CcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccC
Confidence            77777766554321   2  2336666666666666 3444433 5666666666666666 34433222        12


Q ss_pred             CCCeEEccCCcCcccCCcccc--CCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhh
Q 001275          408 QLKNISLYNNQFSGVIPQSLG--INSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVI  485 (1109)
Q Consensus       408 ~L~~L~L~~N~l~~~~p~~~~--~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~  485 (1109)
                      +|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|.|++ +|..+..+++|+.|+|++|+                  +
T Consensus       729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------------------~  788 (876)
T 4ecn_A          729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------------------D  788 (876)
T ss_dssp             GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB------------------C
T ss_pred             CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC------------------C
Confidence            5555666666555 4455554  55555555555555554 45555555555555555543                  2


Q ss_pred             ccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeeccccc
Q 001275          486 LKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH  561 (1109)
Q Consensus       486 l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  561 (1109)
                      +++|++.+.+|. +..+++|++|+|++|+| +.+|..+.  ++|+.|||++|++....+..+.....+..+.|.+|.
T Consensus       789 ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~  862 (876)
T 4ecn_A          789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK  862 (876)
T ss_dssp             TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCT
T ss_pred             cccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCC
Confidence            334444444443 44455555555555555 34444443  345555555555544333444433334444444443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-55  Score=556.39  Aligned_cols=521  Identities=21%  Similarity=0.233  Sum_probs=359.8

Q ss_pred             EecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC-CccccccCccceeccccccc
Q 001275           77 NLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI-PDNFENLQNLQYLNLYGNLL  155 (1109)
Q Consensus        77 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~L~~L~~L~L~~n~l  155 (1109)
                      +.++++++. +|.   ..++|++|||++|.+++..|..|+++++|++|||++|.+.+.+ |..|+++++|++|+|++|.+
T Consensus        10 dcs~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l   85 (844)
T 3j0a_A           10 FYRFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI   85 (844)
T ss_dssp             EESCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCC
T ss_pred             EccCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcC
Confidence            445555554 454   4578999999999999888999999999999999999666555 77899999999999999999


Q ss_pred             cccCCcccccccccceecccccccccccccc--cCCCcccceeecccccCCCCcc-cccccccCccEEEeccccccCcCc
Q 001275          156 DGEIPEPLFRILGLQYVFLNNNSLSGSIPRN--VGDLKEVEALWLFSNRLSGTIP-ESIGNCYRLQELYLNENKLMGFLP  232 (1109)
Q Consensus       156 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~  232 (1109)
                      ++..|..+.++++|++|+|++|.+++.+|..  |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+
T Consensus        86 ~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~  165 (844)
T 3j0a_A           86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCE  165 (844)
T ss_dssp             CEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCS
T ss_pred             cccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCH
Confidence            9888999999999999999999999877665  8999999999999999987765 578999999999999999999889


Q ss_pred             hhcccc--cccccccccCcccCCcccccccCCCC------cchhccccccccCCCCcccccc---cCCcEEEeecCCC--
Q 001275          233 ESLSNL--ENLVYLDVGDNNLEGRINFGSEKCKN------LTFLDLSYNRFSGGISPNLGNC---SSLTHLDIVGSKL--  299 (1109)
Q Consensus       233 ~~l~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~------L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~n~l--  299 (1109)
                      ..+..+  ++|+.|++++|.+.+..+..+..+.+      |++|++++|.+++..+..+...   .+++.|.++.+.+  
T Consensus       166 ~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~  245 (844)
T 3j0a_A          166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA  245 (844)
T ss_dssp             GGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBC
T ss_pred             HHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccc
Confidence            998888  88999999999999887777766655      8888888888887777666543   5677777764332  


Q ss_pred             -------CCcCCcccccc--ccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCcc
Q 001275          300 -------TGSIPSSFGLL--ARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNR  370 (1109)
Q Consensus       300 -------~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  370 (1109)
                             .+..+..|..+  ++|+.|++++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+
T Consensus       246 ~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~  325 (844)
T 3j0a_A          246 GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNL  325 (844)
T ss_dssp             SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCC
T ss_pred             cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCC
Confidence                   22222233332  345555555555554445555555555555555555554444455555555555555555


Q ss_pred             ccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCC
Q 001275          371 LTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPN  450 (1109)
Q Consensus       371 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~  450 (1109)
                      +++..|..+..+++|++|++++|.+.+..+..|..+++|+.|+|++|.+++.     ..+++|+.|++++|+++ .+   
T Consensus       326 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l---  396 (844)
T 3j0a_A          326 LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TL---  396 (844)
T ss_dssp             CSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CC---
T ss_pred             CCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-cc---
Confidence            5544444444555555555555555444444444455555555555554421     11344444444444444 22   


Q ss_pred             cccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCC--CCCCCCCceEEeecCccCCCCCC-ccccccc
Q 001275          451 LCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPS-SIGNSIN  527 (1109)
Q Consensus       451 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~--~~~~~~L~~L~Ls~N~i~~~~p~-~~~~l~~  527 (1109)
                                           |..   ..+++.+++++|++++....  +..+++|++|+|++|++++..+. .+..+++
T Consensus       397 ---------------------~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  452 (844)
T 3j0a_A          397 ---------------------PKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS  452 (844)
T ss_dssp             ---------------------CCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTT
T ss_pred             ---------------------ccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCc
Confidence                                 222   23344455555555543221  44667777777777777754433 3455677


Q ss_pred             ccEEeccCCccc-----CCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccce
Q 001275          528 LTSIDFSSNKFS-----GLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI  602 (1109)
Q Consensus       528 L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  602 (1109)
                      |+.|+|++|+++     +..|..|..+++|++|+|++|++++..|..+..+++|+.|||++|+|++..|..+.  ++|+.
T Consensus       453 L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~  530 (844)
T 3j0a_A          453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEI  530 (844)
T ss_dssp             CCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCE
T ss_pred             cccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccE
Confidence            777777777776     34445677788888888888888877777788888888888888888866555555  78888


Q ss_pred             eccccccccCCCcchhhhhhhhhhhhcccCcCCCCCC
Q 001275          603 LKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIP  639 (1109)
Q Consensus       603 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip  639 (1109)
                      |+|++|++++..|..+.   +|+.|++++|++....+
T Consensus       531 L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          531 LDISRNQLLAPNPDVFV---SLSVLDITHNKFICECE  564 (844)
T ss_dssp             EEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSS
T ss_pred             EECCCCcCCCCChhHhC---CcCEEEecCCCcccccc
Confidence            88888888887777654   67788888888876544

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-51  Score=504.89  Aligned_cols=516  Identities=19%  Similarity=0.175  Sum_probs=402.8

Q ss_pred             cceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccC
Q 001275          169 LQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGD  248 (1109)
Q Consensus       169 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~  248 (1109)
                      .+.++.++.+++ .+|..+.  +++++|+|++|++++..+.+|+++++|++|+|++|++++..+.+|.++++|++|+|++
T Consensus         9 ~~~~~c~~~~l~-~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~   85 (570)
T 2z63_A            9 NITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG   85 (570)
T ss_dssp             TTEEECCSSCCS-SCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CcEEEeCCCCcc-ccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcC
Confidence            345666666666 5666553  5788999999999888888889999999999999998888888888999999999999


Q ss_pred             cccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCC-cCCccccccccccEEEcCCCCCCCCC
Q 001275          249 NNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG-SIPSSFGLLARLSSLDLSENQLSGKI  327 (1109)
Q Consensus       249 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~  327 (1109)
                      |++++..+..|..+++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+.+++|++|++++|++++..
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~  165 (570)
T 2z63_A           86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY  165 (570)
T ss_dssp             CCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEEC
T ss_pred             CcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceec
Confidence            99888878888888889999999888887666678888888888888888886 36888888888888888888888777


Q ss_pred             CCcccccccc----ceeeccCcccCCCCCccccCCCCccEEEccCccccc-cCchHHHhhcccceeeccCCccCCCCchh
Q 001275          328 PPELGKCKYL----TVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG-EFPVSIWRIASLEYLLVYNNNLLGKLPLE  402 (1109)
Q Consensus       328 p~~l~~l~~L----~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  402 (1109)
                      |..++.+++|    +.|++++|.+++..|..+... +|++|++++|.... .++..+..++.++.+.+.-+.+...    
T Consensus       166 ~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~----  240 (570)
T 2z63_A          166 CTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE----  240 (570)
T ss_dssp             GGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCC----
T ss_pred             HHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCc----
Confidence            7788888888    788888888887777666655 78888888875432 3455566666666666544332210    


Q ss_pred             hhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCC-cccccCCCCcccCccceEEECCCcccccCCCcccCCCCcc
Q 001275          403 MTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN-SFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTL  481 (1109)
Q Consensus       403 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N-~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L  481 (1109)
                          ..++  .+..+.+.+     +.. ..++.+++++| .+.+.+|..+..+++|+.|++++|++. .+|..+..+ +|
T Consensus       241 ----~~l~--~~~~~~~~~-----l~~-l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L  306 (570)
T 2z63_A          241 ----GNLE--KFDKSALEG-----LCN-LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GW  306 (570)
T ss_dssp             ----SSCE--ECCTTTTGG-----GGG-SEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CC
T ss_pred             ----hhhh--hcchhhhcc-----ccc-cchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-Cc
Confidence                0000  111111110     001 12455556555 555566666666666666666666665 456666666 67


Q ss_pred             chhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCc--chhhhcccccceeeccc
Q 001275          482 WRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLM--PQELGNLVSLVTLNISL  559 (1109)
Q Consensus       482 ~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~  559 (1109)
                      +.|++++|+++ .+|. ..+++|++|++++|.+.+..+.  ..+++|++|++++|++++..  |..+..+++|++|++++
T Consensus       307 ~~L~l~~n~~~-~l~~-~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~  382 (570)
T 2z63_A          307 QHLELVNCKFG-QFPT-LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF  382 (570)
T ss_dssp             SEEEEESCBCS-SCCB-CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCS
T ss_pred             cEEeeccCccc-ccCc-ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCC
Confidence            77777777766 3333 4677889999999998876665  77889999999999998654  78889999999999999


Q ss_pred             ccccccCCccccCCCCccEEEecCccccCCCC-cccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCC-CC
Q 001275          560 NHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP-SSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLG-GE  637 (1109)
Q Consensus       560 N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-g~  637 (1109)
                      |++++..+ .+..+++|+.|++++|++++..| ..+..+++|++|++++|++++..|..+..+++|+.|+|++|+++ +.
T Consensus       383 n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  461 (570)
T 2z63_A          383 NGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF  461 (570)
T ss_dssp             CSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred             Cccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCcccc
Confidence            99985444 48899999999999999997766 57889999999999999999888999999999999999999998 67


Q ss_pred             CCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCC-CCccccceEEeeeccccccccch
Q 001275          638 IPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFTGPVPE  712 (1109)
Q Consensus       638 ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~~n~l~g~~p~  712 (1109)
                      +|..++.+++| ..|+|++|++++..|..+.++++|++|+|++|++++.+|. +..+++|+.+++++|+++|.+|.
T Consensus       462 ~p~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          462 LPDIFTELRNL-TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             ECSCCTTCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             chhhhhcccCC-CEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            99999999999 4799999999988899999999999999999999988776 88999999999999999999883

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=501.43  Aligned_cols=497  Identities=19%  Similarity=0.177  Sum_probs=367.9

Q ss_pred             cCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccc
Q 001275           87 LGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRI  166 (1109)
Q Consensus        87 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l  166 (1109)
                      +|..+  .+++++|+|++|++++..+..|.++++|++|||++|++++..|..|+++++|++|+|++|.+++..|..+..+
T Consensus        22 ip~~l--~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l   99 (570)
T 2z63_A           22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGL   99 (570)
T ss_dssp             CCSSS--CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTC
T ss_pred             cCCCc--cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCc
Confidence            45443  2578999999999998888899999999999999999998888899999999999999999997778899999


Q ss_pred             cccceecccccccccccccccCCCcccceeecccccCCC-CcccccccccCccEEEeccccccCcCchhccccccc----
Q 001275          167 LGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSG-TIPESIGNCYRLQELYLNENKLMGFLPESLSNLENL----  241 (1109)
Q Consensus       167 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L----  241 (1109)
                      ++|++|++++|++++..+..++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..+..++.+++|    
T Consensus       100 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~  179 (570)
T 2z63_A          100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN  179 (570)
T ss_dssp             TTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCC
T ss_pred             cccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhh
Confidence            999999999999997666679999999999999999987 479999999999999999999998888899999888    


Q ss_pred             ccccccCcccCCcccccccCCCCcchhccccccccC-CCCcccccccCCcEEEeecCCCCC------cCCccccccc--c
Q 001275          242 VYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG-GISPNLGNCSSLTHLDIVGSKLTG------SIPSSFGLLA--R  312 (1109)
Q Consensus       242 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~--~  312 (1109)
                      +.|++++|.+++..+..+... +|+.|++++|.... ..+..+..+++++.+.+....+..      .....+..+.  .
T Consensus       180 ~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~  258 (570)
T 2z63_A          180 LSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT  258 (570)
T ss_dssp             CEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSE
T ss_pred             hhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccc
Confidence            889999999998877777665 79999998885442 234556667777776665433321      1122233332  2


Q ss_pred             ccEEEcCCC-CCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeecc
Q 001275          313 LSSLDLSEN-QLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVY  391 (1109)
Q Consensus       313 L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  391 (1109)
                      ++.+++++| .+.+.+|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|+++ .+|.  ..+++|+.|+++
T Consensus       259 l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~  333 (570)
T 2z63_A          259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFT  333 (570)
T ss_dssp             EEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEE
T ss_pred             hhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCc
Confidence            345555555 455556666666666666666666665 455555555 6666666666665 3433  244555555555


Q ss_pred             CCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCC
Q 001275          392 NNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPI  471 (1109)
Q Consensus       392 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~  471 (1109)
                      +|.+.+..+.  ..+++|+.|++++|++++..                      ..|..+..+++|++|++++|++.+..
T Consensus       334 ~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~----------------------~~~~~~~~~~~L~~L~l~~n~l~~~~  389 (570)
T 2z63_A          334 SNKGGNAFSE--VDLPSLEFLDLSRNGLSFKG----------------------CCSQSDFGTTSLKYLDLSFNGVITMS  389 (570)
T ss_dssp             SCBSCCBCCC--CBCTTCCEEECCSSCCBEEE----------------------EEEHHHHTCSCCCEEECCSCSEEEEE
T ss_pred             CCcccccccc--ccCCCCCEEeCcCCccCccc----------------------cccccccccCccCEEECCCCcccccc
Confidence            5555443333  44455555555555554332                      00333344444555555555544333


Q ss_pred             CcccCCCCccchhhccCcccCCCCC--CCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCccc-CCcchhhhc
Q 001275          472 PSLLGSCPTLWRVILKQNQLTGALP--EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS-GLMPQELGN  548 (1109)
Q Consensus       472 p~~~~~l~~L~~l~l~~N~l~~~~~--~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~  548 (1109)
                      +. +..+++|+.|++++|++++.++  .+..+++|++|++++|++++.+|..+.++++|++|++++|+++ +.+|..++.
T Consensus       390 ~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~  468 (570)
T 2z63_A          390 SN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE  468 (570)
T ss_dssp             EE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred             cc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhc
Confidence            32 5555555555555555555544  3777888889999999888888888889999999999999987 568888899


Q ss_pred             ccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcc
Q 001275          549 LVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPT  616 (1109)
Q Consensus       549 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  616 (1109)
                      +++|++|++++|++++..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++..|.
T Consensus       469 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            99999999999999988888999999999999999999988778889999999999999999987775

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=9.4e-51  Score=496.23  Aligned_cols=489  Identities=19%  Similarity=0.217  Sum_probs=348.1

Q ss_pred             CceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCc
Q 001275           58 PCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPD  137 (1109)
Q Consensus        58 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~  137 (1109)
                      .|.|.|| |+...          ++++ .+|+.+.  ++|++|+|++|++++..|..|+++++|++|+|++|++++..|.
T Consensus         3 ~C~~~~~-c~~~~----------~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~   68 (549)
T 2z81_A            3 SCDASGV-CDGRS----------RSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD   68 (549)
T ss_dssp             EECTTSE-EECTT----------SCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred             cCCCCce-EECCC----------Cccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence            5999998 96533          2333 4666554  7899999999999988899999999999999999999988889


Q ss_pred             cccccCccceeccccccccccCCcccccccccceeccccccccc-ccccccCCCcccceeecccccCCCCcc-ccccccc
Q 001275          138 NFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSG-SIPRNVGDLKEVEALWLFSNRLSGTIP-ESIGNCY  215 (1109)
Q Consensus       138 ~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~  215 (1109)
                      .|+++++|++|+|++|.+++..|..+.++++|++|++++|++++ ..|..++++++|++|++++|++.+.+| ..|++++
T Consensus        69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~  148 (549)
T 2z81_A           69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT  148 (549)
T ss_dssp             TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred             hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence            99999999999999999997777779999999999999999986 457789999999999999998555555 6899999


Q ss_pred             CccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCC--C-cccccccCCcEE
Q 001275          216 RLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGI--S-PNLGNCSSLTHL  292 (1109)
Q Consensus       216 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~-~~~~~l~~L~~L  292 (1109)
                      +|++|++++|++++..|..+.++++|++|++++|.+.......+..+++|++|++++|++++..  + .....+++|+.|
T Consensus       149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L  228 (549)
T 2z81_A          149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL  228 (549)
T ss_dssp             EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEE
T ss_pred             ccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccce
Confidence            9999999999999989999999999999999999987655544567889999999999988642  1 223457788889


Q ss_pred             EeecCCCCCcCC----ccccccccccEEEcCCCCCCCCC------CCccccccccceeeccCcccCCC-----CCccccC
Q 001275          293 DIVGSKLTGSIP----SSFGLLARLSSLDLSENQLSGKI------PPELGKCKYLTVLHLYANQLEGE-----IPDELGQ  357 (1109)
Q Consensus       293 ~L~~n~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~~------p~~l~~l~~L~~L~L~~N~l~~~-----~p~~l~~  357 (1109)
                      ++++|.+++..+    ..+..+++|+.|++++|.+.+..      ...+..+.+|+.|++.++.+...     ++..+..
T Consensus       229 ~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~  308 (549)
T 2z81_A          229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL  308 (549)
T ss_dssp             EEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHH
T ss_pred             eccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhh
Confidence            998888876443    33456678888888888776431      12234455566666666554321     0111122


Q ss_pred             CCCccEEEccCccccccCchHH-HhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceE
Q 001275          358 LSNLQDLELFDNRLTGEFPVSI-WRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQL  436 (1109)
Q Consensus       358 l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  436 (1109)
                      .++|+.|++++|+++ .+|..+ ..+++|++|++++|++++.+|..                     +..++.+++|++|
T Consensus       309 ~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~---------------------~~~~~~l~~L~~L  366 (549)
T 2z81_A          309 LEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKN---------------------SACKGAWPSLQTL  366 (549)
T ss_dssp             STTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHH---------------------HTCTTSSTTCCEE
T ss_pred             cccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccc---------------------hhhhhccccCcEE
Confidence            334555555555544 344333 23455555555555544433221                     1123344444445


Q ss_pred             EecCCcccccCC--CCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCcc
Q 001275          437 DFINNSFTGEIP--PNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNI  514 (1109)
Q Consensus       437 ~ls~N~l~~~~p--~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i  514 (1109)
                      ++++|++++..+  ..+..+++|++|++++|+++ .+|..++.+++|++|++++|++++....+  .++|++|++++|+|
T Consensus       367 ~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~--~~~L~~L~Ls~N~l  443 (549)
T 2z81_A          367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCI--PQTLEVLDVSNNNL  443 (549)
T ss_dssp             ECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTS--CTTCSEEECCSSCC
T ss_pred             EccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchh--cCCceEEECCCCCh
Confidence            555544443211  22444455555555555554 34445555555555555555555332222  25789999999999


Q ss_pred             CCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCC
Q 001275          515 SGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP  591 (1109)
Q Consensus       515 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p  591 (1109)
                      ++.+    .++++|++|+|++|+|+ .+|. .+.+++|++|+|++|++++..|..+..+++|+.|++++|.+++..|
T Consensus       444 ~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          444 DSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             SCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             hhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            8643    57888999999999998 5665 5678999999999999998888889999999999999999987655

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=3.1e-51  Score=506.46  Aligned_cols=507  Identities=19%  Similarity=0.256  Sum_probs=404.2

Q ss_pred             ChhhHHHHHHHHHhccCCCCcccCCCCCCC---CCCceeee-EEecCC--CCcEEEEEecccCCccccCCcccCCCCccE
Q 001275           26 LNGDGVALLSLMRHWNSVPPLIISSWNSSD---STPCQWVG-IECDDD--AHNVVSFNLSSYGVSGQLGPEIGHLSKLQT   99 (1109)
Q Consensus        26 ~~~~~~all~~~~~~~~~~~~~l~sW~~~~---~~~c~w~g-v~C~~~--~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~   99 (1109)
                      ...+...-.++++-+.....   ..|...+   +..|.|.. ..|..=  ..-|++-            .    -.+++.
T Consensus        25 ~~~~~~d~~aL~~~~~~~~~---~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~------------~----~~~V~~   85 (636)
T 4eco_A           25 TAEYIKDYLALKEIWDALNG---KNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN------------S----NGRVTG   85 (636)
T ss_dssp             CCHHHHHHHHHHHHHHHTTG---GGCCCCC------CCCCCSSCGGGTTCCTTEEEC------------T----TCCEEE
T ss_pred             hhhHHHHHHHHHHHHHHcCC---CCcccCCcCCccCCCCCCCCCcccccCCCCeEEc------------C----CCCEEE
Confidence            34444566777777755432   4787433   22357952 222211  1235440            0    047889


Q ss_pred             eecCCCcccccCCCCCCCCCCCcEeeccCccc------cC------CCCccccccCccceeccccccccccCCcccccc-
Q 001275          100 IDLSSNNFSGNIPPKLGNCSALEYLDLSTNGF------TG------DIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRI-  166 (1109)
Q Consensus       100 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l------~~------~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l-  166 (1109)
                      |+|++|+++|.+|+++++|++|++|||++|.+      .+      .+|...  +.+|+ ++++.|.+.+.+|..+..+ 
T Consensus        86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~  162 (636)
T 4eco_A           86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLI  162 (636)
T ss_dssp             EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHH
T ss_pred             EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHH
Confidence            99999999999999999999999999999977      22      344433  56777 8888888888777777643 


Q ss_pred             cccceecccccccccccccccCCCcccceeecc--cccCCCCcccccccccCccEEEeccccccCc--------------
Q 001275          167 LGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF--SNRLSGTIPESIGNCYRLQELYLNENKLMGF--------------  230 (1109)
Q Consensus       167 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~--~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--------------  230 (1109)
                      .++..+++....+..      .....++.+.+.  .|++++ +|..|+++++|++|+|++|++++.              
T Consensus       163 ~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~  235 (636)
T 4eco_A          163 KDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA  235 (636)
T ss_dssp             HHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred             HHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchh
Confidence            345555555433331      112234444443  689998 999999999999999999999986              


Q ss_pred             ---Cchhcc--cccccccccccCcccCCcccccccCCCCcchhcccccc-ccC-CCCcccccc------cCCcEEEeecC
Q 001275          231 ---LPESLS--NLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNR-FSG-GISPNLGNC------SSLTHLDIVGS  297 (1109)
Q Consensus       231 ---~~~~l~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l------~~L~~L~L~~n  297 (1109)
                         +|+.++  ++++|++|+|++|++.+.+|..+..+++|++|+|++|+ +++ .+|..++.+      ++|++|++++|
T Consensus       236 ~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n  315 (636)
T 4eco_A          236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN  315 (636)
T ss_dssp             HHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred             cccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCC
Confidence               899999  99999999999999999999999999999999999998 998 889888876      99999999999


Q ss_pred             CCCCcCCc--cccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCC-ccEEEccCcccccc
Q 001275          298 KLTGSIPS--SFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSN-LQDLELFDNRLTGE  374 (1109)
Q Consensus       298 ~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~  374 (1109)
                      +++ .+|.  .++.+++|++|++++|+++|.+| .++.+++|++|++++|+++ .+|..+..+++ |++|++++|+++ .
T Consensus       316 ~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~  391 (636)
T 4eco_A          316 NLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-Y  391 (636)
T ss_dssp             CCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-S
T ss_pred             cCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-c
Confidence            999 7888  99999999999999999999999 9999999999999999999 88999999999 999999999999 7


Q ss_pred             CchHHHhhc--ccceeeccCCccCCCCchhhh-------ccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccc
Q 001275          375 FPVSIWRIA--SLEYLLVYNNNLLGKLPLEMT-------ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTG  445 (1109)
Q Consensus       375 ~~~~~~~l~--~L~~L~l~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~  445 (1109)
                      +|..+..+.  +|++|++++|.+++.+|..+.       .+++|+.|++++|++++..+..+..+++|++|++++|.++ 
T Consensus       392 lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-  470 (636)
T 4eco_A          392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-  470 (636)
T ss_dssp             CCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-
T ss_pred             cchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-
Confidence            888877655  899999999999999999888       8889999999999999544444556899999999999999 


Q ss_pred             cCCCCcccCc--------cceEEECCCcccccCCCcccC--CCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccC
Q 001275          446 EIPPNLCFGK--------QLRVLNMGQNQFHGPIPSLLG--SCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNIS  515 (1109)
Q Consensus       446 ~~p~~~~~~~--------~L~~L~L~~N~l~~~~p~~~~--~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~  515 (1109)
                      .+|..+....        +|++|+|++|+++ .+|..+.  .+++|+.|++++|++++.+..+..+++|++|+|++|+  
T Consensus       471 ~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~--  547 (636)
T 4eco_A          471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQR--  547 (636)
T ss_dssp             BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCB--
T ss_pred             CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCc--
Confidence            6776655433        9999999999999 6787776  6666666555555555532235555555555555554  


Q ss_pred             CCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccC
Q 001275          516 GAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNG  588 (1109)
Q Consensus       516 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~  588 (1109)
                                      ++++|++.+.+|..++++++|++|+|++|++ +.+|..+.  ++|+.|||++|++..
T Consensus       548 ----------------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          548 ----------------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS  601 (636)
T ss_dssp             ----------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred             ----------------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence                            3478999999999999999999999999999 58898877  899999999998874

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2e-49  Score=484.56  Aligned_cols=484  Identities=20%  Similarity=0.195  Sum_probs=371.3

Q ss_pred             eecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceeccccccc
Q 001275          100 IDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSL  179 (1109)
Q Consensus       100 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l  179 (1109)
                      .|.+++.++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|++++|++
T Consensus        10 c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   86 (549)
T 2z81_A           10 CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL   86 (549)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCcc
Confidence            467788887 6777664  7899999999999988888999999999999999999988888899999999999999999


Q ss_pred             ccccccccCCCcccceeecccccCCC-CcccccccccCccEEEeccccc-cCcCchhcccccccccccccCcccCCcccc
Q 001275          180 SGSIPRNVGDLKEVEALWLFSNRLSG-TIPESIGNCYRLQELYLNENKL-MGFLPESLSNLENLVYLDVGDNNLEGRINF  257 (1109)
Q Consensus       180 ~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  257 (1109)
                      ++..|..|+++++|++|++++|++++ ..|..++++++|++|++++|++ +...+..|.++++|++|++++|++++..+.
T Consensus        87 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  166 (549)
T 2z81_A           87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ  166 (549)
T ss_dssp             CSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred             CccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence            98888889999999999999999986 3577888999999999999984 444446788888888888888888887777


Q ss_pred             cccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcC--C-ccccccccccEEEcCCCCCCCCCC----Cc
Q 001275          258 GSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI--P-SSFGLLARLSSLDLSENQLSGKIP----PE  330 (1109)
Q Consensus       258 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~-~~~~~l~~L~~L~Ls~N~l~~~~p----~~  330 (1109)
                      .+..+++|++|+++.|.+.......+..+++|++|++++|++++..  | .....+++|+.|++++|.+++..+    ..
T Consensus       167 ~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~  246 (549)
T 2z81_A          167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL  246 (549)
T ss_dssp             TTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGG
T ss_pred             hhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHH
Confidence            7888888888888888776332222345777777777777777542  1 223345667777777776654322    23


Q ss_pred             cccccccceeeccCcccCCCC------CccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhh
Q 001275          331 LGKCKYLTVLHLYANQLEGEI------PDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMT  404 (1109)
Q Consensus       331 l~~l~~L~~L~L~~N~l~~~~------p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  404 (1109)
                      +..+++|+.+++++|.+.+..      ...+..+++|+.|++.++.+....                   ....++..+.
T Consensus       247 ~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~-------------------~~~~l~~~~~  307 (549)
T 2z81_A          247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFY-------------------LFYDLSTVYS  307 (549)
T ss_dssp             GGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGG-------------------GSCCCCHHHH
T ss_pred             hhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhh-------------------hcccchhhhh
Confidence            345566666666666665421      112334455555555555443210                   0011233344


Q ss_pred             ccCCCCeEEccCCcCcccCCccc-cCCCCCceEEecCCcccccCC---CCcccCccceEEECCCcccccCCC--cccCCC
Q 001275          405 ELKQLKNISLYNNQFSGVIPQSL-GINSSLMQLDFINNSFTGEIP---PNLCFGKQLRVLNMGQNQFHGPIP--SLLGSC  478 (1109)
Q Consensus       405 ~l~~L~~L~L~~N~l~~~~p~~~-~~~~~L~~L~ls~N~l~~~~p---~~~~~~~~L~~L~L~~N~l~~~~p--~~~~~l  478 (1109)
                      ...+|+.|++++|+++ .+|..+ ..+++|++|++++|.+++.+|   ..+..+++|++|++++|++++..+  ..+..+
T Consensus       308 ~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l  386 (549)
T 2z81_A          308 LLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL  386 (549)
T ss_dssp             HSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred             hcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence            4567778888888776 556555 467788888888888887664   346778999999999999986543  568899


Q ss_pred             CccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecc
Q 001275          479 PTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNIS  558 (1109)
Q Consensus       479 ~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~  558 (1109)
                      ++|+.|++++|++++.++.+..+++|++|++++|+|+ .+|..+.  ++|++|+|++|++++.+    +.+++|++|+|+
T Consensus       387 ~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls  459 (549)
T 2z81_A          387 KNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYIS  459 (549)
T ss_dssp             TTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECC
T ss_pred             CCCCEEECCCCCCccCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECC
Confidence            9999999999999976666899999999999999998 4555543  68999999999999753    578999999999


Q ss_pred             cccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCc
Q 001275          559 LNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP  615 (1109)
Q Consensus       559 ~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  615 (1109)
                      +|+|+ .+|. ...+++|++|||++|+|++..|..+..+++|+.|++++|++++..|
T Consensus       460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            99999 6776 5679999999999999999888899999999999999999998776

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.8e-50  Score=449.92  Aligned_cols=265  Identities=25%  Similarity=0.391  Sum_probs=204.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|...++||+|+||+||+|++.      +++.||||++.. ......++|.+|++++++++|||||+++|+|.+.+..+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC-CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45667789999999999999764      478899999853 34445678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc
Q 001275          893 IMYRYMENGSLRDVLHSITP------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME  960 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  960 (1109)
                      +|||||++|+|.++++....            ...++|.+++.++.|||+||+|||   +++||||||||+|||+++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence            99999999999999986532            245899999999999999999999   889999999999999999999


Q ss_pred             EEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHH
Q 001275          961 PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      +||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.....  .++...+.
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~  274 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCIT  274 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHHHHH
Confidence            99999999997755444444445689999999999999999999999999999999999 8999864321  12222221


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCCCC
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKY 1108 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1108 (1109)
                      .   .. .. .  .           ......++.+++.+||+.||++||||+||+++|+.+. +.++.|
T Consensus       275 ~---g~-~~-~--~-----------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~-~~pp~~  324 (329)
T 4aoj_A          275 Q---GR-EL-E--R-----------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA-QAPPVY  324 (329)
T ss_dssp             H---TC-CC-C--C-----------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH-HSCC--
T ss_pred             c---CC-CC-C--C-----------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh-hCCccc
Confidence            1   10 00 0  0           1112345677888999999999999999999999873 334444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.9e-50  Score=446.32  Aligned_cols=258  Identities=23%  Similarity=0.320  Sum_probs=210.6

Q ss_pred             CCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      +++..++||+|+||+||+|.+.      +++.||||++.........++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4556788999999999999763      5688999999766555667789999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc
Q 001275          894 MYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME  960 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~  960 (1109)
                      |||||++|+|.++++....             ...++|..+++++.|||+||+|||   +.+||||||||+|||+++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCC
Confidence            9999999999999975432             235899999999999999999999   889999999999999999999


Q ss_pred             EEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHH
Q 001275          961 PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      +||+|||+|+...............||++|||||++.++.|+.++|||||||++|||+| |+.||....  ..++...+.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--~~~~~~~i~  261 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQDVVEMIR  261 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--HHHHHHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHH
Confidence            99999999987654433333345689999999999999999999999999999999999 889986532  122222221


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .   .. .. .             ....+..++.+++.+||+.||++||||+||+++|+..
T Consensus       262 ~---~~-~~-~-------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          262 N---RQ-VL-P-------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             T---TC-CC-C-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             c---CC-CC-C-------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1   10 00 0             0112234577788999999999999999999999865

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.8e-49  Score=493.74  Aligned_cols=365  Identities=23%  Similarity=0.335  Sum_probs=256.5

Q ss_pred             CCCCCcCCccccccccccEEEcCCCCCCC-----------------CCCCccc--cccccceeeccCcccCCCCCccccC
Q 001275          297 SKLTGSIPSSFGLLARLSSLDLSENQLSG-----------------KIPPELG--KCKYLTVLHLYANQLEGEIPDELGQ  357 (1109)
Q Consensus       297 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~l~--~l~~L~~L~L~~N~l~~~~p~~l~~  357 (1109)
                      |++++ +|..|+.+++|+.|+|++|++++                 .+|+.++  ++++|++|+|++|.+.+.+|..+++
T Consensus       435 N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~  513 (876)
T 4ecn_A          435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD  513 (876)
T ss_dssp             CEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG
T ss_pred             Ccccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC
Confidence            66665 66667777777777777777765                 4788877  8888888888888888888888888


Q ss_pred             CCCccEEEccCcc-ccc-cCchHHHhhc-------ccceeeccCCccCCCCch--hhhccCCCCeEEccCCcCcccCCcc
Q 001275          358 LSNLQDLELFDNR-LTG-EFPVSIWRIA-------SLEYLLVYNNNLLGKLPL--EMTELKQLKNISLYNNQFSGVIPQS  426 (1109)
Q Consensus       358 l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~  426 (1109)
                      +++|++|+|++|+ +++ .+|..+..++       +|++|++++|+++ .+|.  .+.++++|+.|+|++|+++ .+| .
T Consensus       514 L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~  590 (876)
T 4ecn_A          514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-A  590 (876)
T ss_dssp             CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-C
T ss_pred             CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-h
Confidence            8888888888887 887 7888888776       7888888888777 6666  7777777777777777777 666 6


Q ss_pred             ccCCCCCceEEecCCcccccCCCCcccCcc-ceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCc
Q 001275          427 LGINSSLMQLDFINNSFTGEIPPNLCFGKQ-LRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLS  505 (1109)
Q Consensus       427 ~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~  505 (1109)
                      ++.+++|++|++++|.++ .+|..+..+++ |+.|+|++|+++ .+|..+..++.                     ++|+
T Consensus       591 ~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~---------------------~~L~  647 (876)
T 4ecn_A          591 FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV---------------------YVMG  647 (876)
T ss_dssp             CCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCS---------------------SCEE
T ss_pred             hcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhcccc---------------------CCCC
Confidence            777777777777777777 66766777666 777777777776 55555444322                     2255


Q ss_pred             eEEeecCccCCCCCCc---cc--ccccccEEeccCCcccCCcchhh-hcccccceeecccccccccCCccccC-------
Q 001275          506 HLDVSRNNISGAIPSS---IG--NSINLTSIDFSSNKFSGLMPQEL-GNLVSLVTLNISLNHVEGSLPSQLSK-------  572 (1109)
Q Consensus       506 ~L~Ls~N~i~~~~p~~---~~--~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~-------  572 (1109)
                      +|++++|++++.+|..   ++  .+.+|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|+ .+|..+..       
T Consensus       648 ~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~  725 (876)
T 4ecn_A          648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYK  725 (876)
T ss_dssp             EEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCT
T ss_pred             EEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhcccccccc
Confidence            5555555555444322   22  2235666777777666 344443 35667777777777766 45544332       


Q ss_pred             -CCCccEEEecCccccCCCCcccc--cccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhh
Q 001275          573 -CKNLEVFDVSFNLLNGSIPSSLR--SWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLS  649 (1109)
Q Consensus       573 -l~~L~~L~ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~  649 (1109)
                       |++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+                
T Consensus       726 nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~----------------  787 (876)
T 4ecn_A          726 NTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR----------------  787 (876)
T ss_dssp             TGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB----------------
T ss_pred             ccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC----------------
Confidence             237778888888777 6777776  77788888888888775 67777777788888877776                


Q ss_pred             hhhcccccccccccCcchhhcccCCeEEccCCcccccCCC-CCccccceEEeeeccccccccchhh
Q 001275          650 YALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFTGPVPETL  714 (1109)
Q Consensus       650 ~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~-l~~~~~l~~l~~~~n~l~g~~p~~~  714 (1109)
                         ++++|++++.+|..++++++|+.|+|++|+| +.+|. +.  ++|+.|++++|++...-+..+
T Consensus       788 ---~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~  847 (876)
T 4ecn_A          788 ---DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSV  847 (876)
T ss_dssp             ---CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGG
T ss_pred             ---CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHc
Confidence               4567777777777777777777777777777 56666 43  577777777777765444433

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2e-50  Score=446.61  Aligned_cols=258  Identities=25%  Similarity=0.395  Sum_probs=209.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|...+.||+|+||+||+|++.      +++.||||++.. ......++|.+|++++++++|||||+++|+|.+++..+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~-~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC-CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            46778899999999999999763      478899999853 33445678999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEE
Q 001275          893 IMYRYMENGSLRDVLHSIT----------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH  962 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  962 (1109)
                      +|||||++|+|.++++..+          ....++|..++.++.|||+||+|||   +++||||||||+|||+++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            9999999999999997643          2356999999999999999999999   88999999999999999999999


Q ss_pred             EecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHh
Q 001275          963 ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       963 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      |+|||+|+...............||++|||||++.+..|+.++|||||||++|||+| |+.||.....  .++...+.. 
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~-  245 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECITQ-  245 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHH-
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc-
Confidence            999999987654433333334579999999999999999999999999999999999 8999865321  122222211 


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                        ... . .             .......++.+++.+||+.||++||||+|+++.|+++
T Consensus       246 --~~~-~-~-------------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          246 --GRV-L-Q-------------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             --TCC-C-C-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCC-C-C-------------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              100 0 0             0112234567788899999999999999999999876

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=438.85  Aligned_cols=260  Identities=26%  Similarity=0.362  Sum_probs=199.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +++...++||+|+||+||+|++.+  .||||+++... .....+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            467778999999999999998763  58999885432 23345679999999999999999999999864 568999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |++|+|.++++...  ..++|..+..|+.|||+||+|||   +++||||||||+|||+++++.+||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999997643  35999999999999999999999   88999999999999999999999999999987754443


Q ss_pred             CceeeecccCccccccccccc---CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAFT---TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      .......+||+.|||||++.+   +.|+.++|||||||++|||+||+.||...... ..+...+.....         .+
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-~~~~~~~~~~~~---------~p  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-DQIIFMVGRGYA---------SP  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHTTCC---------CC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-HHHHHHHhcCCC---------CC
Confidence            334445689999999999864   46899999999999999999999999643211 111111111100         11


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ...     ........++.+++.+||+.||++||||+||+++|+.+.
T Consensus       258 ~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          258 DLS-----KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             CST-----TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             Ccc-----cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            000     001122345677888999999999999999999987653

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=472.23  Aligned_cols=459  Identities=20%  Similarity=0.192  Sum_probs=210.8

Q ss_pred             ceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccc
Q 001275          146 QYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNEN  225 (1109)
Q Consensus       146 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  225 (1109)
                      ++||+++|.++ .+|..+.  ++|++|++++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            35666666665 4555444  45555555555555544455555555555555555555444555555555555555555


Q ss_pred             cccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCc
Q 001275          226 KLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS  305 (1109)
Q Consensus       226 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  305 (1109)
                      ++++ +|..  .+++|++|++++|++++.                       .+|..|+++++|++|++++|++++   .
T Consensus        80 ~l~~-lp~~--~l~~L~~L~L~~N~l~~~-----------------------~~p~~~~~l~~L~~L~L~~n~l~~---~  130 (520)
T 2z7x_B           80 KLVK-ISCH--PTVNLKHLDLSFNAFDAL-----------------------PICKEFGNMSQLKFLGLSTTHLEK---S  130 (520)
T ss_dssp             CCCE-EECC--CCCCCSEEECCSSCCSSC-----------------------CCCGGGGGCTTCCEEEEEESSCCG---G
T ss_pred             ceee-cCcc--ccCCccEEeccCCccccc-----------------------cchhhhccCCcceEEEecCcccch---h
Confidence            5542 2222  444444444444444431                       233444444444444444444443   2


Q ss_pred             cccccccc--cEEEcCCCCC--CCCCCCcccccc-ccceeeccCcccCCCCCc-cccCCCCccEEEccCcc-------cc
Q 001275          306 SFGLLARL--SSLDLSENQL--SGKIPPELGKCK-YLTVLHLYANQLEGEIPD-ELGQLSNLQDLELFDNR-------LT  372 (1109)
Q Consensus       306 ~~~~l~~L--~~L~Ls~N~l--~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~-------l~  372 (1109)
                      .++.+++|  +.|++++|.+  .+..|..+..+. ....+++++|++.+.++. .+..+++|+.|++++|.       +.
T Consensus       131 ~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~  210 (520)
T 2z7x_B          131 SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL  210 (520)
T ss_dssp             GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHH
T ss_pred             hccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceee
Confidence            23334444  4444444444  344444444333 122334444444433322 23334444444444443       22


Q ss_pred             ccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCc-
Q 001275          373 GEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNL-  451 (1109)
Q Consensus       373 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~-  451 (1109)
                      +.+| .+..+++|+.|++++|.+++..+..+..                    .+ ..++|++|++++|.++|.+|..+ 
T Consensus       211 ~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~--------------------~~-~~~~L~~L~l~~n~l~~~~p~~~~  268 (520)
T 2z7x_B          211 SILA-KLQTNPKLSNLTLNNIETTWNSFIRILQ--------------------LV-WHTTVWYFSISNVKLQGQLDFRDF  268 (520)
T ss_dssp             HHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHH--------------------HH-HTSSCSEEEEEEEEEESCCCCCCC
T ss_pred             cchh-hhccccchhhccccccccCHHHHHHHHH--------------------Hh-hhCcccEEEeecccccCccccchh
Confidence            2222 2333333333333333332211111100                    00 01234444444444444444443 


Q ss_pred             ----ccCccceEEECCCcccccCCC-cccCCC---CccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCccc
Q 001275          452 ----CFGKQLRVLNMGQNQFHGPIP-SLLGSC---PTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIG  523 (1109)
Q Consensus       452 ----~~~~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~  523 (1109)
                          ..+++|+.+++++|.+  .+| ..+..+   .+|+.|++++|++... +.+..+++|++|++++|++++.+|..++
T Consensus       269 ~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  345 (520)
T 2z7x_B          269 DYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHM-LCPSKISPFLHLDFSNNLLTDTVFENCG  345 (520)
T ss_dssp             CCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCC-CCCSSCCCCCEEECCSSCCCTTTTTTCC
T ss_pred             hcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccc-cchhhCCcccEEEeECCccChhhhhhhc
Confidence                4444555555555544  222 121111   1222222222222211 1113444555555555555555555555


Q ss_pred             ccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcc-cccccccce
Q 001275          524 NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSS-LRSWKSLSI  602 (1109)
Q Consensus       524 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~  602 (1109)
                      ++++|++|++++|++++..                      .+|..++.+++|++||+++|++++.+|.. +..+++|+.
T Consensus       346 ~l~~L~~L~L~~N~l~~l~----------------------~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~  403 (520)
T 2z7x_B          346 HLTELETLILQMNQLKELS----------------------KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS  403 (520)
T ss_dssp             CCSSCCEEECCSSCCCBHH----------------------HHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred             cCCCCCEEEccCCccCccc----------------------cchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence            5555555555555555310                      23334444455555555555555434432 444555555


Q ss_pred             eccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCc
Q 001275          603 LKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNN  682 (1109)
Q Consensus       603 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~  682 (1109)
                      |++++|++++.+|..+.  ++|+                         .|+|++|+++ .+|..+.++++|++|||++|+
T Consensus       404 L~Ls~N~l~~~~~~~l~--~~L~-------------------------~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~  455 (520)
T 2z7x_B          404 LNMSSNILTDTIFRCLP--PRIK-------------------------VLDLHSNKIK-SIPKQVVKLEALQELNVASNQ  455 (520)
T ss_dssp             EECCSSCCCGGGGGSCC--TTCC-------------------------EEECCSSCCC-CCCGGGGGCTTCCEEECCSSC
T ss_pred             EECcCCCCCcchhhhhc--ccCC-------------------------EEECCCCccc-ccchhhhcCCCCCEEECCCCc
Confidence            55555555544444321  2333                         3444444444 555556666677777777777


Q ss_pred             ccccCCC-CCccccceEEeeeccccccccc
Q 001275          683 LTGTLSP-LSNIHSLVEVNVSYNLFTGPVP  711 (1109)
Q Consensus       683 l~g~~~~-l~~~~~l~~l~~~~n~l~g~~p  711 (1109)
                      |++.++. +..+++|+.|++++|++++..+
T Consensus       456 l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          456 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCccCHHHhccCCcccEEECcCCCCcccCC
Confidence            7743333 6667777777777777777665

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.4e-47  Score=474.78  Aligned_cols=551  Identities=21%  Similarity=0.166  Sum_probs=363.7

Q ss_pred             CcccCCCCCCCCCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEe
Q 001275           45 PLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYL  124 (1109)
Q Consensus        45 ~~~l~sW~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  124 (1109)
                      ...+++|+.+.  |..|..+.|......|   +.++.+++ .+|+.+-  +.+++|||++|+|++..|.+|+++++|++|
T Consensus        10 ~~~~~~~~~~~--p~~~~~c~~~~~~~~~---~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L   81 (635)
T 4g8a_A           10 DDKLAAANSSI--PESWEPCVEVVPNITY---QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL   81 (635)
T ss_dssp             -----------------CCSEEEETTTEE---ECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cchhhcccCCC--CCCCCCccccCCCCEE---ECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEE
Confidence            34566776543  3556666665433322   44555554 3565442  478999999999998888899999999999


Q ss_pred             eccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCC
Q 001275          125 DLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS  204 (1109)
Q Consensus       125 ~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~  204 (1109)
                      ||++|+|++..|.+|.+|++|++|+|++|+|++..+..+.++++|++|+|++|++++..+..|+++++|++|+|++|+++
T Consensus        82 ~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~  161 (635)
T 4g8a_A           82 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ  161 (635)
T ss_dssp             ECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccc
Confidence            99999999888889999999999999999999666677899999999999999999877788999999999999999998


Q ss_pred             C-CcccccccccCccEEEeccccccCcCchhcccccccc----cccccCcccCCcccccccCCCCcchhccccccccCC-
Q 001275          205 G-TIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLV----YLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGG-  278 (1109)
Q Consensus       205 ~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-  278 (1109)
                      + .+|..++.+++|++|+|++|++++..+..|..+++++    .++++.|.++...+..+ ....++.+++++|..... 
T Consensus       162 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~  240 (635)
T 4g8a_A          162 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNV  240 (635)
T ss_dssp             CCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHH
T ss_pred             cCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccc
Confidence            6 4688899999999999999999999898888877665    46788888886555444 344567788887765532 


Q ss_pred             CCcccccccCCcEEEeecCCC------CCcCCccccccccccEEEcCCCCCCC---CCCCccccccccceeeccCcccCC
Q 001275          279 ISPNLGNCSSLTHLDIVGSKL------TGSIPSSFGLLARLSSLDLSENQLSG---KIPPELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       279 ~~~~~~~l~~L~~L~L~~n~l------~~~~~~~~~~l~~L~~L~Ls~N~l~~---~~p~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                      .+..+..+..++...+..+..      .......+..+..+..+++..+....   ..+..+..+.+++.+++.+|.+..
T Consensus       241 ~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~  320 (635)
T 4g8a_A          241 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIER  320 (635)
T ss_dssp             HHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEE
T ss_pred             cchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccc
Confidence            234456666777666654332      22333445555666666655544321   233455666677777777777664


Q ss_pred             CCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcc--cCCccc
Q 001275          350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSG--VIPQSL  427 (1109)
Q Consensus       350 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~  427 (1109)
                      .  ..+....+|+.|++.+|.+.+..+   ..+..|+.+++++|.+...  .....+++|+.|++++|.+..  ..+..+
T Consensus       321 ~--~~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~  393 (635)
T 4g8a_A          321 V--KDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSD  393 (635)
T ss_dssp             C--GGGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHH
T ss_pred             c--cccccchhhhhhhcccccccCcCc---ccchhhhhcccccccCCCC--cccccccccccchhhccccccccccccch
Confidence            3  234556677777777777764332   2345667777777766532  233456777777777777643  344455


Q ss_pred             cCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCC-cccCCCCccchhhccCcccCCCCCC-CCCCCCCc
Q 001275          428 GINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIP-SLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLS  505 (1109)
Q Consensus       428 ~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~L~  505 (1109)
                      ....+|++|+++.|.+.. .+..+..+.+|+.+++++|++....+ ..+..+++++.++++.|++++..+. +..++.|+
T Consensus       394 ~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~  472 (635)
T 4g8a_A          394 FGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE  472 (635)
T ss_dssp             HSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCC
T ss_pred             hhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhh
Confidence            566677777777776663 34455666677777777666554333 3455566666666666666655554 55556666


Q ss_pred             eEEeecCcc-CCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCc
Q 001275          506 HLDVSRNNI-SGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN  584 (1109)
Q Consensus       506 ~L~Ls~N~i-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N  584 (1109)
                      .|++++|++ .+.+|..|..+++|++|||++|+|++..|..|+++++|++|+|++|+|++..|..|..+++|++|||++|
T Consensus       473 ~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N  552 (635)
T 4g8a_A          473 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN  552 (635)
T ss_dssp             EEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTS
T ss_pred             hhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCC
Confidence            666666653 2345556666666666666666666665666666666666666666666555556666666666666666


Q ss_pred             cccCCCCcccccc-cccceeccccccccC
Q 001275          585 LLNGSIPSSLRSW-KSLSILKLSENHFTG  612 (1109)
Q Consensus       585 ~l~~~~p~~~~~l-~~L~~L~L~~N~l~~  612 (1109)
                      +|++..|..+..+ ++|+.|+|++|+++.
T Consensus       553 ~l~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          553 HIMTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             CCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             cCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            6666666666555 456666666666654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=469.30  Aligned_cols=451  Identities=20%  Similarity=0.210  Sum_probs=306.4

Q ss_pred             cEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccc
Q 001275          122 EYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSN  201 (1109)
Q Consensus       122 ~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N  201 (1109)
                      ++||+++|+++ .+|..+.  ++|++|+|++|.+++..|..+.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus         3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N   79 (520)
T 2z7x_B            3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN   79 (520)
T ss_dssp             CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred             ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence            58999999999 5888776  89999999999999877789999999999999999999988999999999999999999


Q ss_pred             cCCCCcccccccccCccEEEeccccccC-cCchhcccccccccccccCcccCCcccccccCCCCc--chhccccccccCC
Q 001275          202 RLSGTIPESIGNCYRLQELYLNENKLMG-FLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNL--TFLDLSYNRFSGG  278 (1109)
Q Consensus       202 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~Ls~N~l~~~  278 (1109)
                      +++ .+|..  .+++|++|+|++|++++ .+|..|+++++|++|++++|++++   ..+..+++|  ++|++++|.+.+ 
T Consensus        80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~-  152 (520)
T 2z7x_B           80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG-  152 (520)
T ss_dssp             CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT-
T ss_pred             cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc-
Confidence            999 56766  89999999999999998 468999999999999999998875   233344444  555555554400 


Q ss_pred             CCcccccccCCcEEEeecCCCCCcCCccccccc-cccEEEcCCCCCCCCCCC-ccccccccceeeccCcc-------cCC
Q 001275          279 ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLA-RLSSLDLSENQLSGKIPP-ELGKCKYLTVLHLYANQ-------LEG  349 (1109)
Q Consensus       279 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~-------l~~  349 (1109)
                                           ++..|..+..+. +...+++++|++.+.++. .+.++++|+.|++++|.       +.+
T Consensus       153 ---------------------~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~  211 (520)
T 2z7x_B          153 ---------------------EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS  211 (520)
T ss_dssp             ---------------------SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHH
T ss_pred             ---------------------cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeec
Confidence                                 444444444433 233456667766654443 56677778888888776       555


Q ss_pred             CCCccccCCCCccEEEccCccccccCchHHH---hhcccceeeccCCccCCCCchhh-----hccCCCCeEEccCCcCcc
Q 001275          350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIW---RIASLEYLLVYNNNLLGKLPLEM-----TELKQLKNISLYNNQFSG  421 (1109)
Q Consensus       350 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~  421 (1109)
                      .+| .++.+++|+.|++++|.+++..+..+.   ..++|++|++++|+++|.+|..+     ..+++|+.+++++|.+  
T Consensus       212 ~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--  288 (520)
T 2z7x_B          212 ILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--  288 (520)
T ss_dssp             HHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--
T ss_pred             chh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--
Confidence            555 678888888888888888764443332   24578888888888888888877     7788888888888888  


Q ss_pred             cCC-ccccCC---CCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCC--CC
Q 001275          422 VIP-QSLGIN---SSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTG--AL  495 (1109)
Q Consensus       422 ~~p-~~~~~~---~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~  495 (1109)
                      .+| ..++..   .+|++|++++|.+....  ....+++|++|++++|++++.+|..++.+++|+.|++++|++++  .+
T Consensus       289 ~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~  366 (520)
T 2z7x_B          289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKI  366 (520)
T ss_dssp             CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHH
T ss_pred             ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccc
Confidence            445 444433   56888888888776322  11456677777777777776666666666555555555555554  22


Q ss_pred             CC-CCCCCCCceEEeecCccCCCCCC-cccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCC
Q 001275          496 PE-FSKNPVLSHLDVSRNNISGAIPS-SIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKC  573 (1109)
Q Consensus       496 ~~-~~~~~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  573 (1109)
                      |. +..+++|++|++++|++++.+|. .+..+++|++|++++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..+
T Consensus       367 ~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l  443 (520)
T 2z7x_B          367 AEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKL  443 (520)
T ss_dssp             HHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGC
T ss_pred             hHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcC
Confidence            22 45555555555555555543333 244555555555555555544444433  44555555555555 445444455


Q ss_pred             CCccEEEecCccccCCCCcc-cccccccceeccccccccC
Q 001275          574 KNLEVFDVSFNLLNGSIPSS-LRSWKSLSILKLSENHFTG  612 (1109)
Q Consensus       574 ~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~  612 (1109)
                      ++|++|++++|+|+ .+|.. +..+++|+.|++++|++++
T Consensus       444 ~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          444 EALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             TTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcc
Confidence            55555555555555 33332 4445555555555555544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.8e-47  Score=425.07  Aligned_cols=252  Identities=23%  Similarity=0.361  Sum_probs=206.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.|+..++||+|+||+||+|+.. +|+.||||++... .......+.+|++++++++|||||++++++.+++..|+||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG-GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC-chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            46888899999999999999764 6899999999544 334456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |++|+|.++++..    .+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.+.....
T Consensus       153 ~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          153 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            9999999999763    3899999999999999999999   89999999999999999999999999999997754322


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.....  ......+......  ...        
T Consensus       226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~--~~~--------  291 (346)
T 4fih_A          226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP--RLK--------  291 (346)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSSCC--CCS--------
T ss_pred             --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC--CCC--------
Confidence              22346899999999999999999999999999999999999999964321  1111111111000  000        


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                            .......++.+++.+||+.||++|||++|+++|=+
T Consensus       292 ------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~  326 (346)
T 4fih_A          292 ------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  326 (346)
T ss_dssp             ------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             ------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence                  00111234566778999999999999999999744

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.4e-48  Score=437.31  Aligned_cols=266  Identities=22%  Similarity=0.301  Sum_probs=213.3

Q ss_pred             HHHHHhhCCCCCceeecccCeEEEEEEeCC------CcEEEEEEeeecccccChHHHHHHHHHHhcCCC-CceeeEeeEE
Q 001275          813 QVIEATENLNAKHVIGRGAHGIVYKASLGP------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH-RNLVRLEDFW  885 (1109)
Q Consensus       813 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~  885 (1109)
                      +.....++|++.++||+|+||+||+|.+..      ++.||||++.........++|.+|++++.+++| ||||+++|+|
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            333345788999999999999999997542      367999999655555556789999999999965 8999999999


Q ss_pred             ecC-CceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCC
Q 001275          886 LRK-DCGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPE  951 (1109)
Q Consensus       886 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  951 (1109)
                      .+. +..++|||||++|+|.++++....             ...++|..++.++.|||+||+|||   +++||||||||+
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~  214 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR  214 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCcc
Confidence            764 568999999999999999976421             345899999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccc
Q 001275          952 NILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKE 1030 (1109)
Q Consensus       952 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~ 1030 (1109)
                      |||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||..... 
T Consensus       215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~-  293 (353)
T 4ase_A          215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-  293 (353)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred             ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999997765544444445689999999999999999999999999999999998 8999864321 


Q ss_pred             cccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1031 RTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ...+...+....    .. .             .......++.+++.+||+.||++|||++|++++|+++
T Consensus       294 ~~~~~~~i~~g~----~~-~-------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          294 DEEFCRRLKEGT----RM-R-------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             SHHHHHHHHHTC----CC-C-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCC----CC-C-------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            112222221110    00 0             0011234567788899999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.7e-48  Score=429.76  Aligned_cols=268  Identities=24%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC----ceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD----CGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  894 (1109)
                      ++|...++||+|+||+||+|++. |+.||||++...  ......+++|+..+.+++|||||+++++|.+++    ..++|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~--~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc--chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            45677889999999999999885 899999998432  222233455677777899999999999998754    46999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD-----CDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ||||++|+|.++++..    .++|+.+.+++.|+++||+|||..     +.++||||||||+|||+++++.+||+|||+|
T Consensus        80 ~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999864    389999999999999999999942     1349999999999999999999999999999


Q ss_pred             cccCCCCCC--ceeeecccCcccccccccccC------CCCccCcchhhHHHHHHHHhCCCCCCCCccccc---------
Q 001275          970 KLLDKSPAS--TTSISVVGTIGYIAPENAFTT------AKSKESDVYSYGVVLLELITRKKALDPSYKERT--------- 1032 (1109)
Q Consensus       970 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~--------- 1032 (1109)
                      +........  ......+||+.|||||++.+.      .++.++|||||||++|||+||+.|+........         
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            876544322  122346899999999998764      367899999999999999999887643221111         


Q ss_pred             -cHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1033 -DIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1033 -~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                       ...........      ...++.+....   ...+....+.+++.+||+.||++||||+||+++|+++..
T Consensus       236 ~~~~~~~~~~~~------~~~rp~~p~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          236 PSVEEMRKVVCE------QKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTT------SCCCCCCCGGG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhc------ccCCCCCCccc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence             11111111110      00111111111   122455678889999999999999999999999987643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.6e-47  Score=419.91  Aligned_cols=249  Identities=22%  Similarity=0.324  Sum_probs=206.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.++||+|+||+||+|+. .+++.||||++....  .......+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999976 568999999996432  2344567999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||++||+|.++++..+   .+++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999998754   4899999999999999999999   899999999999999999999999999999987654


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .........+||+.|||||++.+..|+.++||||+||++|||++|+.||.....     ...........-.+.      
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~~~~~p------  254 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKIIKLEYDFP------  254 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCCCC------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCC------
Confidence            444444557899999999999999999999999999999999999999965321     111111111111110      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 1094 (1109)
                             ....   .++.+++.+|++.||++|||++|++
T Consensus       255 -------~~~s---~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          255 -------EKFF---PKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -------TTCC---HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -------cccC---HHHHHHHHHHccCCHhHCcChHHHc
Confidence                   0112   2355677899999999999999853

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=7.9e-46  Score=461.10  Aligned_cols=525  Identities=21%  Similarity=0.178  Sum_probs=392.8

Q ss_pred             EeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccc
Q 001275           99 TIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNS  178 (1109)
Q Consensus        99 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~  178 (1109)
                      +.+=++-+++ .+|..+.  +++++|||++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~  111 (635)
T 4g8a_A           35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP  111 (635)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence            3455555676 6787653  589999999999998778899999999999999999997777789999999999999999


Q ss_pred             cccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCc-CchhcccccccccccccCcccCCcccc
Q 001275          179 LSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGF-LPESLSNLENLVYLDVGDNNLEGRINF  257 (1109)
Q Consensus       179 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~  257 (1109)
                      +++..+..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++. .|..+..+++|++|++++|++++..+.
T Consensus       112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  191 (635)
T 4g8a_A          112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT  191 (635)
T ss_dssp             CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred             CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence            9987778899999999999999999988888899999999999999999864 688899999999999999999998888


Q ss_pred             cccCCCCcc----hhccccccccCCCCcccccccCCcEEEeecCCCCCc-CCccccccccccEEEcCCCC------CCCC
Q 001275          258 GSEKCKNLT----FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGS-IPSSFGLLARLSSLDLSENQ------LSGK  326 (1109)
Q Consensus       258 ~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~------l~~~  326 (1109)
                      .+..+.+++    .++++.|.++...+..+ ....++.+++.+|..... .+..+..+..++...+..+.      +...
T Consensus       192 ~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~  270 (635)
T 4g8a_A          192 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF  270 (635)
T ss_dssp             GGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred             cccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccc
Confidence            877665544    57889999986554444 445678899998876633 34556677777776664333      3334


Q ss_pred             CCCccccccccceeeccCcccCC---CCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhh
Q 001275          327 IPPELGKCKYLTVLHLYANQLEG---EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM  403 (1109)
Q Consensus       327 ~p~~l~~l~~L~~L~L~~N~l~~---~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  403 (1109)
                      ....+..+..+...++..+....   ..+..+..+.+++.+++.+|.+...  ..+....+|+.|++.+|.+.+..+.  
T Consensus       271 ~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~--  346 (635)
T 4g8a_A          271 DKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL--  346 (635)
T ss_dssp             CTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC--
T ss_pred             cccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc--
Confidence            44566667777777766554432   2234455677888888888887743  2355567888888888888754433  


Q ss_pred             hccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccc--cCCCCcccCccceEEECCCcccccCCCcccCCCCcc
Q 001275          404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTG--EIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTL  481 (1109)
Q Consensus       404 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~--~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L  481 (1109)
                       .+..|+.+++++|.+....  ....+++|+.|++++|.+..  ..+..+....+|+.++++.|.+.. .+..+..++.|
T Consensus       347 -~l~~L~~l~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L  422 (635)
T 4g8a_A          347 -KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQL  422 (635)
T ss_dssp             -BCTTCCEEEEESCCSCCBC--CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTC
T ss_pred             -cchhhhhcccccccCCCCc--ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccc
Confidence             4567888888888876432  34467788888888888753  344455566778888888887764 44556667777


Q ss_pred             chhhccCcccCCCCCC--CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCccc-CCcchhhhcccccceeecc
Q 001275          482 WRVILKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS-GLMPQELGNLVSLVTLNIS  558 (1109)
Q Consensus       482 ~~l~l~~N~l~~~~~~--~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~  558 (1109)
                      +.++++.|+.....+.  +..+..++.++++.|++.+..|..+..++.|+.|+|++|++. +.+|..|..+++|++|+|+
T Consensus       423 ~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls  502 (635)
T 4g8a_A          423 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS  502 (635)
T ss_dssp             CEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred             cchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECC
Confidence            7777777776655443  667777777777777777777777777777777777777643 3456667777777777777


Q ss_pred             cccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhh-hhhhhhhcccCcCC
Q 001275          559 LNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISEL-EKLLELQLGGNQLG  635 (1109)
Q Consensus       559 ~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~  635 (1109)
                      +|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..+..+ ++|+.|+|++|++.
T Consensus       503 ~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~  580 (635)
T 4g8a_A          503 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  580 (635)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred             CCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence            777777677777777777777777777776666677777777777777777777677777666 56777777777766

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1e-47  Score=430.28  Aligned_cols=252  Identities=22%  Similarity=0.369  Sum_probs=199.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.... .......+.+|++++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5789999999999999999976 468999999996543 23345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |++||+|.++++..+ ...+++..++.++.||+.||+|||   +++||||||||+|||+++++.+||+|||+|+......
T Consensus       104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            999999999997643 345789999999999999999999   8999999999999999999999999999998764321


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                        ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.....     ...+.......  ....     
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~~--~~~~-----  245 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----KNLVLKIISGS--FPPV-----  245 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTC--CCCC-----
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHcCC--CCCC-----
Confidence              122346799999999999999999999999999999999999999965321     11121111110  0000     


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                           ....   ..++.+++.+||+.||++|||++|+++|
T Consensus       246 -----~~~~---s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          246 -----SLHY---SYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -----CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CccC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 0011   2345667889999999999999999976

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.8e-47  Score=420.94  Aligned_cols=252  Identities=21%  Similarity=0.250  Sum_probs=200.5

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.|...++||+|+||+||+|+. .+|+.||||++.....      ..+|++++++++|||||++++++.+++..|+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4577788999999999999976 4689999999854321      24799999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~~~~  976 (1109)
                      ++||+|.++++..+   .+++..+..++.||+.||+|||   +++||||||||+|||++.++ .+||+|||+|+.+....
T Consensus       132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999998754   4899999999999999999999   99999999999999999987 69999999999775433


Q ss_pred             CCc---eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          977 AST---TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       977 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...   .....+||+.|||||++.+..|+.++||||+||++|||+||+.||......  .+...+..   ......++  
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~~---~~~~~~~~--  278 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCLKIAS---EPPPIREI--  278 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHHHHHH---SCCGGGGS--
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHc---CCCCchhc--
Confidence            221   223457999999999999999999999999999999999999999654222  11111111   11000000  


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              +   .....++.+++.+||+.||++|||++|+++++..+
T Consensus       279 --------~---~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          279 --------P---PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             --------C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------C---ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                    1   11223456677899999999999999999988654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.1e-47  Score=414.43  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=195.4

Q ss_pred             CCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEec----CCceeEEE
Q 001275          822 NAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR----KDCGIIMY  895 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  895 (1109)
                      +..++||+|+||+||+|... +++.||+|++.... .......|.+|++++++++|||||+++++|..    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999764 68899999986543 23345679999999999999999999999865    34579999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeccCCCCeeeCC-CCcEEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP--IVHRDIKPENILLDS-EMEPHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~  972 (1109)
                      |||++|+|.++++...   .+++..+..++.||+.||+|||   +++  ||||||||+|||++. ++.+||+|||+|+..
T Consensus       109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            9999999999998754   4899999999999999999999   666  999999999999974 799999999999864


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ...    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....    .............      
T Consensus       183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~~~~~~~i~~~~~------  247 (290)
T 3fpq_A          183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVK------  247 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCC------
T ss_pred             CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----HHHHHHHHHcCCC------
Confidence            322    2334689999999998764 699999999999999999999999964321    1122222111110      


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       +....       .....++.+++.+||+.||++|||++|+++|-+
T Consensus       248 -~~~~~-------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          248 -PASFD-------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             -CGGGG-------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             -CCCCC-------ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence             00000       011234566888999999999999999998743

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=426.20  Aligned_cols=252  Identities=23%  Similarity=0.363  Sum_probs=206.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.|+..++||+|+||+||+|+.. +|+.||||++... .......+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST-TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            56889999999999999999764 6899999999644 334456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      |+||+|.++++..    .+++..+..++.||+.||+|||   +++||||||||+|||++.++.+||+|||+|+.+.....
T Consensus       230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            9999999999753    3899999999999999999999   89999999999999999999999999999997754322


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.....  ......+......  ...   .    
T Consensus       303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~~~~~--~~~---~----  369 (423)
T 4fie_A          303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLPP--RLK---N----  369 (423)
T ss_dssp             --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCC--CCS---C----
T ss_pred             --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHcCCCC--CCc---c----
Confidence              22346899999999999999999999999999999999999999964321  1111111111000  000   0    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                             ......++.+++.+||+.||++|||++|+++|=+
T Consensus       370 -------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~  403 (423)
T 4fie_A          370 -------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  403 (423)
T ss_dssp             -------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             -------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHH
Confidence                   0111234556778999999999999999999743

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5e-46  Score=404.37  Aligned_cols=249  Identities=24%  Similarity=0.327  Sum_probs=190.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+|++.+.||+|+||+||+|.. .+|+.||||++....  .......+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999976 468999999986443  2334567999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+ +|+|.+++...+   .+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 679999997654   4999999999999999999999   899999999999999999999999999999876443


Q ss_pred             CCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      .   .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||....     .................    
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~~~~~~p~----  233 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISNGVYTLPK----  233 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTCCCCCT----
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCCCCCCC----
Confidence            2   2234689999999999998886 589999999999999999999996432     11222221111111111    


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               ...   .++.+++.+|++.||++|||++|+++|=+
T Consensus       234 ---------~~s---~~~~~li~~~L~~dP~~R~s~~eil~hpw  265 (275)
T 3hyh_A          234 ---------FLS---PGAAGLIKRMLIVNPLNRISIHEIMQDDW  265 (275)
T ss_dssp             ---------TSC---HHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred             ---------CCC---HHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence                     111   23556778999999999999999999754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.8e-46  Score=411.22  Aligned_cols=255  Identities=23%  Similarity=0.407  Sum_probs=192.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc-------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC-------  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------  890 (1109)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.....+...+.+.+|++++++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4588899999999999999976 46899999999766555556789999999999999999999999876543       


Q ss_pred             -----eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEec
Q 001275          891 -----GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISD  965 (1109)
Q Consensus       891 -----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  965 (1109)
                           .|+||||+++|+|.++++........++..++.++.|+++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                 6899999999999999987655455678889999999999999999   89999999999999999999999999


Q ss_pred             ccCCcccCCCCCCc----------eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHH
Q 001275          966 FGIAKLLDKSPAST----------TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV 1035 (1109)
Q Consensus       966 fGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 1035 (1109)
                      ||+|+.+.......          .....+||+.|||||++.+..|+.++||||+||++|||++   ||....    +..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence            99998775432211          1234579999999999999999999999999999999996   664211    111


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..........       -+.        ..........+++.+||+.||++|||+.|+++|-+
T Consensus       235 ~~~~~~~~~~-------~p~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~  282 (299)
T 4g31_A          235 RTLTDVRNLK-------FPP--------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV  282 (299)
T ss_dssp             HHHHHHHTTC-------CCH--------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHhcCC-------CCC--------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            1111111000       000        11222334556888999999999999999998643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.7e-46  Score=409.57  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=196.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe----CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|++.+.||+|+||+||+|+.    ..++.||||++.... .......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999975    247889999985433 22234468899999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||++||+|.++++..+   .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999998754   4899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ....  .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.....     ................   
T Consensus       178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~~~~~p~---  247 (304)
T 3ubd_A          178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMTMILKAKLGMPQ---  247 (304)
T ss_dssp             ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCT---
T ss_pred             CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHHHHHcCCCCCCC---
Confidence            3322  22346899999999999999999999999999999999999999965321     1111111111111100   


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLV 1098 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~ 1098 (1109)
                                ..   ..++.+++.+||+.||++|||     ++|+++|=+
T Consensus       248 ----------~~---s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~  284 (304)
T 3ubd_A          248 ----------FL---SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF  284 (304)
T ss_dssp             ----------TS---CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred             ----------cC---CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence                      11   234556788999999999998     578887643

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.3e-44  Score=442.51  Aligned_cols=455  Identities=20%  Similarity=0.212  Sum_probs=271.8

Q ss_pred             CCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeec
Q 001275          119 SALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL  198 (1109)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  198 (1109)
                      ...+++|+++|++++ +|..+.  ++|++|+|++|.+++..|..+.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus        31 ~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  107 (562)
T 3a79_B           31 ELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV  107 (562)
T ss_dssp             --CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence            344788888888884 666553  67888888888877666667777777777777777777666777777777777777


Q ss_pred             ccccCCCCcccccccccCccEEEeccccccCc-CchhcccccccccccccCcccCCcccccccCCCCcchhccccccccC
Q 001275          199 FSNRLSGTIPESIGNCYRLQELYLNENKLMGF-LPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG  277 (1109)
Q Consensus       199 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  277 (1109)
                      ++|+++ .+|..  .+++|++|+|++|++++. .|..|+++++|++|++++|++++.   .+..+++|            
T Consensus       108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L------------  169 (562)
T 3a79_B          108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHL------------  169 (562)
T ss_dssp             TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTS------------
T ss_pred             CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhc------------
Confidence            777776 45544  566777777777776653 345666666666666666665531   12222222            


Q ss_pred             CCCcccccccCCcEEEeecCCC--CCcCCccccccc-cccEEEcCCCCCCCCCCC-ccccccccceeeccCcc-----cC
Q 001275          278 GISPNLGNCSSLTHLDIVGSKL--TGSIPSSFGLLA-RLSSLDLSENQLSGKIPP-ELGKCKYLTVLHLYANQ-----LE  348 (1109)
Q Consensus       278 ~~~~~~~~l~~L~~L~L~~n~l--~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~-----l~  348 (1109)
                                +|++|++++|++  ++..|..+..+. ..-.+++++|.+.+.++. .+..+++|+.|++++|+     +.
T Consensus       170 ----------~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~  239 (562)
T 3a79_B          170 ----------HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM  239 (562)
T ss_dssp             ----------CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHH
T ss_pred             ----------eeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHH
Confidence                      225555555555  445555554433 111446666666554443 34556677777777664     22


Q ss_pred             CCCCccccCCCCccEEEccCccccccCchHH---HhhcccceeeccCCccCCCCchhh-----hccCCCCeEEccCCcCc
Q 001275          349 GEIPDELGQLSNLQDLELFDNRLTGEFPVSI---WRIASLEYLLVYNNNLLGKLPLEM-----TELKQLKNISLYNNQFS  420 (1109)
Q Consensus       349 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~  420 (1109)
                      + .+..+..+++|+.|+++++.+++.....+   ....+|++|++++|.++|.+|..+     ..++.|+.++++.|.+ 
T Consensus       240 ~-~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-  317 (562)
T 3a79_B          240 T-FLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-  317 (562)
T ss_dssp             H-HHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-
T ss_pred             H-HHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-
Confidence            1 12346667777888877777664322211   123478888888888887777776     6666677777777766 


Q ss_pred             ccCC-cccc---CCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCC-
Q 001275          421 GVIP-QSLG---INSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGAL-  495 (1109)
Q Consensus       421 ~~~p-~~~~---~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-  495 (1109)
                       .+| ..+.   ...+|++|++++|.+....  ....+++|++|++++|++++.+|..++.+++|+.|++++|++++.. 
T Consensus       318 -~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  394 (562)
T 3a79_B          318 -LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK  394 (562)
T ss_dssp             -SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH
T ss_pred             -ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCccc
Confidence             344 2222   2256777888887775322  1145667777777777777666666666666666666666666432 


Q ss_pred             -C-CCCCCCCCceEEeecCccCCCCCC-cccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccC
Q 001275          496 -P-EFSKNPVLSHLDVSRNNISGAIPS-SIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSK  572 (1109)
Q Consensus       496 -~-~~~~~~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~  572 (1109)
                       | .+..+++|++|++++|++++.+|. .+..+++|++|++++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..
T Consensus       395 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~  471 (562)
T 3a79_B          395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTH  471 (562)
T ss_dssp             HHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTS
T ss_pred             chhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcC
Confidence             2 255666666666666666653333 355566666666666666555444433  45555555555555 45554445


Q ss_pred             CCCccEEEecCccccCCCCcc-cccccccceeccccccccCC
Q 001275          573 CKNLEVFDVSFNLLNGSIPSS-LRSWKSLSILKLSENHFTGG  613 (1109)
Q Consensus       573 l~~L~~L~ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~  613 (1109)
                      +++|+.|||++|+|+ .+|.. +..+++|+.|++++|++++.
T Consensus       472 l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          472 LQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             SCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred             CCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCC
Confidence            555555555555555 34433 55555555555555555543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.7e-44  Score=422.17  Aligned_cols=426  Identities=26%  Similarity=0.279  Sum_probs=221.0

Q ss_pred             CcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhc
Q 001275          190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD  269 (1109)
Q Consensus       190 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  269 (1109)
                      .+.|++|++++|.+ +.+|.+|+++++|++|++++|++++.+|.+++++++|+.+++.+|..           .++++|+
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L~   77 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHELE   77 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEEE
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEEE
Confidence            46778888888887 67787788888888888888888777787787777777777766542           3567777


Q ss_pred             cccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCC
Q 001275          270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       270 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                      +++|.+++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++++ +|..   .++|++|++++|++++
T Consensus        78 l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~  145 (454)
T 1jl5_A           78 LNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK  145 (454)
T ss_dssp             CTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS
T ss_pred             ecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC
Confidence            77777775 2321   3567777777777775 4433   3667777777777764 2321   1567777777777764


Q ss_pred             CCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccC
Q 001275          350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI  429 (1109)
Q Consensus       350 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  429 (1109)
                       +| .++.+++|++|++++|++++ +|..+   .+|++|++++|++++ +| .+..+++|+.|++++|++++ +|...  
T Consensus       146 -lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--  214 (454)
T 1jl5_A          146 -LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--  214 (454)
T ss_dssp             -CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--
T ss_pred             -Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--
Confidence             55 46777777777777777664 44322   356666666666654 33 35556666666666666554 23211  


Q ss_pred             CCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEe
Q 001275          430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDV  509 (1109)
Q Consensus       430 ~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~L  509 (1109)
                       ++|++|++++|.++ .+|. +..+++|++|++                        ++|++++. |.  ..++|++|++
T Consensus       215 -~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l------------------------~~N~l~~l-~~--~~~~L~~L~l  264 (454)
T 1jl5_A          215 -LSLESIVAGNNILE-ELPE-LQNLPFLTTIYA------------------------DNNLLKTL-PD--LPPSLEALNV  264 (454)
T ss_dssp             -TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC------------------------CSSCCSSC-CS--CCTTCCEEEC
T ss_pred             -CcccEEECcCCcCC-cccc-cCCCCCCCEEEC------------------------CCCcCCcc-cc--cccccCEEEC
Confidence             34555555555554 3332 444444444444                        44444432 22  1256777777


Q ss_pred             ecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCC
Q 001275          510 SRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGS  589 (1109)
Q Consensus       510 s~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~  589 (1109)
                      ++|++++ +|..   .++|++|++++|++++. |..   .++|++|++++|++++ ++..   .++|+.|++++|++++ 
T Consensus       265 ~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-  331 (454)
T 1jl5_A          265 RDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-  331 (454)
T ss_dssp             CSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-
T ss_pred             CCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-
Confidence            7777774 4543   25677777777777752 211   1567788888887774 2221   1578888888888885 


Q ss_pred             CCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCC--CCCCCchhhhhhhhhhcccccccccccCcch
Q 001275          590 IPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG--EIPPSIGALQDLSYALNLSKNGLTGRIPSDL  667 (1109)
Q Consensus       590 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g--~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l  667 (1109)
                      +|..   +++|+.|++++|+++ .+|.   .+++|+.|++++|++++  .+|.+++.         |+.|++.|.+|.. 
T Consensus       332 lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~---------L~~n~~~~~i~~~-  394 (454)
T 1jl5_A          332 LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVED---------LRMNSHLAEVPEL-  394 (454)
T ss_dssp             CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE---------EECCC---------
T ss_pred             cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHh---------hhhcccccccccc-
Confidence            6654   477888888888888 5676   36788888888888887  67776643         4567888888874 


Q ss_pred             hhcccCCeEEccCCcccc--cCCCCCccccceEEeeeccccccccchhhhhc
Q 001275          668 EKLSKLEQLDISSNNLTG--TLSPLSNIHSLVEVNVSYNLFTGPVPETLMNL  717 (1109)
Q Consensus       668 ~~l~~L~~L~Ls~N~l~g--~~~~l~~~~~l~~l~~~~n~l~g~~p~~~~~~  717 (1109)
                        +++|+.|||++|+++|  .+|.     .++.|.+++|.+.+++|.+...+
T Consensus       395 --~~~L~~L~ls~N~l~~~~~iP~-----sl~~L~~~~~~~~~~~~~~~~~~  439 (454)
T 1jl5_A          395 --PQNLKQLHVETNPLREFPDIPE-----SVEDLRMNSERVVDPYEFAHETT  439 (454)
T ss_dssp             ----------------------------------------------------
T ss_pred             --cCcCCEEECCCCcCCccccchh-----hHhheeCcCcccCCccccCHHHh
Confidence              5789999999999997  5653     46677788999988887554443

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=3.4e-44  Score=438.69  Aligned_cols=451  Identities=18%  Similarity=0.191  Sum_probs=283.4

Q ss_pred             EEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccc
Q 001275           74 VSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN  153 (1109)
Q Consensus        74 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n  153 (1109)
                      ..++++++++++ +|..+.  ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus        34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  110 (562)
T 3a79_B           34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN  110 (562)
T ss_dssp             CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence            567888888875 776664  78999999999998877788899999999999999999888888999999999999999


Q ss_pred             cccccCCcccccccccceeccccccccc-ccccccCCCcccceeecccccCCCCcccccccccCc--cEEEeccccc--c
Q 001275          154 LLDGEIPEPLFRILGLQYVFLNNNSLSG-SIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRL--QELYLNENKL--M  228 (1109)
Q Consensus       154 ~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l--~  228 (1109)
                      +++ .+|..  .+++|++|++++|++++ .+|..|+++++|++|++++|++++.   .++.+++|  ++|++++|++  +
T Consensus       111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~  184 (562)
T 3a79_B          111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK  184 (562)
T ss_dssp             CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred             cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence            988 67766  78888999999988886 3467888888888888888888753   45555555  8888888888  7


Q ss_pred             CcCchhccccc--ccccccccCcccCCccc-ccccCCCCcchhcccccc-----ccCCCCcccccccCCcEEEeecCCCC
Q 001275          229 GFLPESLSNLE--NLVYLDVGDNNLEGRIN-FGSEKCKNLTFLDLSYNR-----FSGGISPNLGNCSSLTHLDIVGSKLT  300 (1109)
Q Consensus       229 ~~~~~~l~~l~--~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~-----l~~~~~~~~~~l~~L~~L~L~~n~l~  300 (1109)
                      +..|..+..++  .| .+++++|.+.+.++ ..+..+++|+.|++++|+     +.+ ....+..+++|+.|+++++.+.
T Consensus       185 ~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L~~L~L~~~~l~  262 (562)
T 3a79_B          185 GGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTLLNVTLQHIETT  262 (562)
T ss_dssp             SSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSCEEEEEEEEEEC
T ss_pred             ccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcceEEEecCCcCc
Confidence            77787777654  33 45667777665433 234556667777777664     111 1223455566666666655554


Q ss_pred             CcCCcc---ccccccccEEEcCCCCCCCCCCCcc-----ccccccceeeccCcccCCCCCccccCCCCccEEEccCcccc
Q 001275          301 GSIPSS---FGLLARLSSLDLSENQLSGKIPPEL-----GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLT  372 (1109)
Q Consensus       301 ~~~~~~---~~~l~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  372 (1109)
                      +.....   ....++|++|++++|+++|.+|..+     .+++.|+.++++.|.+  .+|.                   
T Consensus       263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~-------------------  321 (562)
T 3a79_B          263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSK-------------------  321 (562)
T ss_dssp             HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCH-------------------
T ss_pred             HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecCh-------------------
Confidence            321100   0111255555555555555555444     4444444444444443  2221                   


Q ss_pred             ccCchHHHhh---cccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccc--cC
Q 001275          373 GEFPVSIWRI---ASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTG--EI  447 (1109)
Q Consensus       373 ~~~~~~~~~l---~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~--~~  447 (1109)
                          ..+..+   .+|+.|++++|.+....  ....+++|+.|++++|++++.+|..++.+++|++|++++|.+++  .+
T Consensus       322 ----~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  395 (562)
T 3a79_B          322 ----EALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKV  395 (562)
T ss_dssp             ----HHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHH
T ss_pred             ----hhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccc
Confidence                222221   34555555555543211  01344555555555555555555555555555555555555554  22


Q ss_pred             CCCcccCccceEEECCCcccccCCCc-ccCCCCccchhhccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCccccc
Q 001275          448 PPNLCFGKQLRVLNMGQNQFHGPIPS-LLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNS  525 (1109)
Q Consensus       448 p~~~~~~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l  525 (1109)
                      |..+..+++|++|++++|++++.+|. .+..+++|+.|++++|++++..|. +.  ++|++|++++|+|+ .+|..+..+
T Consensus       396 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l  472 (562)
T 3a79_B          396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHL  472 (562)
T ss_dssp             HHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSS
T ss_pred             hhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCC
Confidence            33445555555555555555553332 355555666666666666544433 22  56777777777776 566666677


Q ss_pred             ccccEEeccCCcccCCcchh-hhcccccceeecccccccccC
Q 001275          526 INLTSIDFSSNKFSGLMPQE-LGNLVSLVTLNISLNHVEGSL  566 (1109)
Q Consensus       526 ~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~  566 (1109)
                      ++|++|+|++|+|++ +|.. +..+++|+.|++++|.+.+..
T Consensus       473 ~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c  513 (562)
T 3a79_B          473 QALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTC  513 (562)
T ss_dssp             CCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred             CCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCc
Confidence            777777777777774 4444 777777777777777776543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.6e-43  Score=413.66  Aligned_cols=429  Identities=23%  Similarity=0.280  Sum_probs=187.4

Q ss_pred             cCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccce
Q 001275           92 GHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQY  171 (1109)
Q Consensus        92 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  171 (1109)
                      ...++|++|++++|++ |.+|++++++++|++|++++|.++|.+|..++++++|+.+++++|..           .++++
T Consensus         8 ~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~   75 (454)
T 1jl5_A            8 VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHE   75 (454)
T ss_dssp             ---------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSE
T ss_pred             cccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCE
Confidence            3456777777777777 56777777777777777777777777777777777777666666542           35666


Q ss_pred             ecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCccc
Q 001275          172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL  251 (1109)
Q Consensus       172 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l  251 (1109)
                      |++++|++++ +|..   .++|++|++++|++++ +|..   +++|++|++++|++++. |..   .++|++|++++|++
T Consensus        76 L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l  143 (454)
T 1jl5_A           76 LELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQL  143 (454)
T ss_dssp             EECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCC
T ss_pred             EEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCC
Confidence            7777776664 3331   2456666666666664 4432   25566666666666542 111   13555555555555


Q ss_pred             CCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcc
Q 001275          252 EGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPEL  331 (1109)
Q Consensus       252 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l  331 (1109)
                      ++ +| .+..+++|++|++++|++++ +|..+   .+|++|++++|++++ +| .++.+++|+.|++++|++++ +|...
T Consensus       144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~  214 (454)
T 1jl5_A          144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP  214 (454)
T ss_dssp             SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC
T ss_pred             CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc
Confidence            54 23 35555555555555555553 22221   245555555555543 23 34445555555555555443 22221


Q ss_pred             ccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCe
Q 001275          332 GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKN  411 (1109)
Q Consensus       332 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  411 (1109)
                         ++|++|++++|+++ .+|. ++.+++|++|++++|++++ +|                        ..   .++|+.
T Consensus       215 ---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~------------------------~~---~~~L~~  261 (454)
T 1jl5_A          215 ---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LP------------------------DL---PPSLEA  261 (454)
T ss_dssp             ---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS-CC------------------------SC---CTTCCE
T ss_pred             ---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc-cc------------------------cc---ccccCE
Confidence               24444555555444 3332 4444444555554444442 22                        21   244555


Q ss_pred             EEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCccc
Q 001275          412 ISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQL  491 (1109)
Q Consensus       412 L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  491 (1109)
                      |++++|++++ +|..   .++|++|++++|.+++. |..   .++|++|++++|++++ ++..   .++|+.|++++|++
T Consensus       262 L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l  329 (454)
T 1jl5_A          262 LNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKL  329 (454)
T ss_dssp             EECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCC
T ss_pred             EECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcc
Confidence            5555555553 3322   24555555555555541 110   1355566666666553 1111   13556666666666


Q ss_pred             CCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccC--CcchhhhcccccceeecccccccccCCcc
Q 001275          492 TGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG--LMPQELGNLVSLVTLNISLNHVEGSLPSQ  569 (1109)
Q Consensus       492 ~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  569 (1109)
                      ++. |..  +++|++|++++|+++ .+|.   .+++|++|++++|++++  .+|.+++.+        +.|.+.+.+|..
T Consensus       330 ~~l-p~~--~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~  394 (454)
T 1jl5_A          330 IEL-PAL--PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL  394 (454)
T ss_dssp             SCC-CCC--CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC--------
T ss_pred             ccc-ccc--CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc
Confidence            652 321  467888888888887 4565   36778888888888887  566666543        346666667763


Q ss_pred             ccCCCCccEEEecCccccC--CCCcccccccccceeccccccccCCCcchhhhhh
Q 001275          570 LSKCKNLEVFDVSFNLLNG--SIPSSLRSWKSLSILKLSENHFTGGIPTFISELE  622 (1109)
Q Consensus       570 l~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  622 (1109)
                         +++|+.||+++|++++  .+|.+      ++.|.+.+|.+.+.+|.+.....
T Consensus       395 ---~~~L~~L~ls~N~l~~~~~iP~s------l~~L~~~~~~~~~~~~~~~~~~~  440 (454)
T 1jl5_A          395 ---PQNLKQLHVETNPLREFPDIPES------VEDLRMNSERVVDPYEFAHETTD  440 (454)
T ss_dssp             -------------------------------------------------------
T ss_pred             ---cCcCCEEECCCCcCCccccchhh------HhheeCcCcccCCccccCHHHhh
Confidence               4788888899888887  66644      45566788888877766554443

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.5e-43  Score=397.16  Aligned_cols=202  Identities=25%  Similarity=0.398  Sum_probs=172.2

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      ..++|++.++||+|+||+||+|+.+    +++.||+|++...   ....++.+|+++++++ +|||||++++++.+.+..
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~---~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT---SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT---SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc---cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4578999999999999999999652    4688999988432   3345788999999998 699999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccCCc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAK  970 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla~  970 (1109)
                      |+||||+++|+|.++++.      +++.++..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            999999999999999853      889999999999999999999   8999999999999999877 799999999998


Q ss_pred             ccCCCCCC--------------------------ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCC
Q 001275          971 LLDKSPAS--------------------------TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKA 1023 (1109)
Q Consensus       971 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p 1023 (1109)
                      ........                          ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432211                          112235799999999998876 489999999999999999999999


Q ss_pred             CCCCccc
Q 001275         1024 LDPSYKE 1030 (1109)
Q Consensus      1024 ~~~~~~~ 1030 (1109)
                      |.+...+
T Consensus       247 f~~~~~~  253 (361)
T 4f9c_A          247 FYKASDD  253 (361)
T ss_dssp             SSCCSSH
T ss_pred             CCCCCCH
Confidence            9765443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.1e-41  Score=405.72  Aligned_cols=364  Identities=19%  Similarity=0.183  Sum_probs=257.5

Q ss_pred             CCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC-CccccccCccceeccccccccccCCcccccccccceec
Q 001275           95 SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI-PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVF  173 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  173 (1109)
                      ++|++|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..+.++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            78999999999999888999999999999999999998655 56799999999999999999988899999999999999


Q ss_pred             ccccccccccccc--cCCCcccceeecccccCCCCcccc-cccccCccEEEeccccccCcCchhcccc--cccccccccC
Q 001275          174 LNNNSLSGSIPRN--VGDLKEVEALWLFSNRLSGTIPES-IGNCYRLQELYLNENKLMGFLPESLSNL--ENLVYLDVGD  248 (1109)
Q Consensus       174 Ls~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~l~~l--~~L~~L~L~~  248 (1109)
                      +++|++++..|..  |+++++|++|+|++|++++..|.. ++++++|++|++++|++++..+..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            9999999866665  899999999999999999888876 8899999999999999999888888877  6788888888


Q ss_pred             cccCCcccccc--------cCCCCcchhccccccccCCCCcccccc---cCCcEEEeecCCCCCcCCccccccccccEEE
Q 001275          249 NNLEGRINFGS--------EKCKNLTFLDLSYNRFSGGISPNLGNC---SSLTHLDIVGSKLTGSIPSSFGLLARLSSLD  317 (1109)
Q Consensus       249 N~l~~~~~~~~--------~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  317 (1109)
                      |.+.+..+..+        ..+++|++|++++|++++..+..+...   ++|+.|++++|.+.+..              
T Consensus       190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------  255 (455)
T 3v47_A          190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------  255 (455)
T ss_dssp             CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------
T ss_pred             CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------
Confidence            88876554432        234555555666555555444444332   45555555555443211              


Q ss_pred             cCCCCCCCCCCCccccc--cccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCcc
Q 001275          318 LSENQLSGKIPPELGKC--KYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL  395 (1109)
Q Consensus       318 Ls~N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  395 (1109)
                      +..+.+.+..+..+..+  ++|+.|++++|++.+..|..++.+++|++|+|++|++++..|..+..+++|++|++++|.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  335 (455)
T 3v47_A          256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL  335 (455)
T ss_dssp             TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence            11112222222223222  4566666666666666666666666666666666666655555666666666666666666


Q ss_pred             CCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCC
Q 001275          396 LGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIP  472 (1109)
Q Consensus       396 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p  472 (1109)
                      ++..|..+..+++|++|+|++|++++..|..+..+++|++|++++|++++..+..+..+++|++|++++|++++..|
T Consensus       336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            65556666666666666666666666666666666666666666666665444455556666666666666665444

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=7.3e-43  Score=393.09  Aligned_cols=293  Identities=27%  Similarity=0.467  Sum_probs=225.8

Q ss_pred             cCChhhHHHHHHHHHhccCCCCcccCCCCCCCCCCce--eeeEEecCCC--CcEEEEEecccCCcc--ccCCcccCCCCc
Q 001275           24 NALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQ--WVGIECDDDA--HNVVSFNLSSYGVSG--QLGPEIGHLSKL   97 (1109)
Q Consensus        24 ~~~~~~~~all~~~~~~~~~~~~~l~sW~~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L   97 (1109)
                      .|.++|++||++||+++. +|. .+++|+.+ .+||.  |.||+|+..+  ++|+.++++++.++|  .+|+.++++++|
T Consensus         2 ~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L   78 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTT-CCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHhcC-Ccc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence            599999999999999995 454 78999764 46888  9999998755  789999999999998  888899999999


Q ss_pred             cEeecCC-CcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccc
Q 001275           98 QTIDLSS-NNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNN  176 (1109)
Q Consensus        98 ~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~  176 (1109)
                      ++|+|++ |++.+.+|..|+++++|++|+|++|++++.+|..|.++++|++|+|++|.+++.+|..+..+++|++|++++
T Consensus        79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  158 (313)
T 1ogq_A           79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG  158 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred             CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence            9999995 888888888899999999999999999888888888888999999888888888888888888888888888


Q ss_pred             cccccccccccCCCc-ccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcc
Q 001275          177 NSLSGSIPRNVGDLK-EVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRI  255 (1109)
Q Consensus       177 n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  255 (1109)
                      |++++.+|..++.++ +|++|++++|++++.+|..++.++ |++|++++|++++..|..|.++++|++|++++|++++.+
T Consensus       159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  237 (313)
T 1ogq_A          159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL  237 (313)
T ss_dssp             SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred             CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence            888877777777776 777777777777777777777766 777777777777666666666666666666666665443


Q ss_pred             cccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcccccc
Q 001275          256 NFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCK  335 (1109)
Q Consensus       256 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  335 (1109)
                      +.                         +..+++|++|++++|++++.+|..+..+++|++|+|++|+++|.+|.. +.++
T Consensus       238 ~~-------------------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~  291 (313)
T 1ogq_A          238 GK-------------------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQ  291 (313)
T ss_dssp             GG-------------------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGG
T ss_pred             Cc-------------------------ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-cccc
Confidence            33                         344455555555555555555666666666666666666666555554 5566


Q ss_pred             ccceeeccCcc
Q 001275          336 YLTVLHLYANQ  346 (1109)
Q Consensus       336 ~L~~L~L~~N~  346 (1109)
                      +|+.|++++|+
T Consensus       292 ~L~~l~l~~N~  302 (313)
T 1ogq_A          292 RFDVSAYANNK  302 (313)
T ss_dssp             GSCGGGTCSSS
T ss_pred             ccChHHhcCCC
Confidence            66666666665

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=399.90  Aligned_cols=273  Identities=22%  Similarity=0.299  Sum_probs=201.5

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecC------Cc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------DC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  890 (1109)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+++|++++|||||++++++...      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5788999999999999999976 5799999999854332 23345788999999999999999999987643      56


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .|+|||||+ |+|.+++...+   .+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            799999996 68999997643   4999999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCC--CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          971 LLDKSPA--STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       971 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      .+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.... ....+.............
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHHHHHHCCCCGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhcCCCChH
Confidence            7643321  2233457899999999998875 46999999999999999999999996532 111222222221111111


Q ss_pred             cccccchhhhHHh---h--------hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1048 INDIVDLSLMEEM---L--------VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~---~--------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ....+........   .        ....+....++.+++.+|++.||++|||++|+++|=+-
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  348 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL  348 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence            1000000000000   0        00001112356678889999999999999999998543

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=8.6e-41  Score=398.05  Aligned_cols=363  Identities=20%  Similarity=0.202  Sum_probs=246.0

Q ss_pred             CCCcEeeccCccccCCCCccccccCccceeccccccccccC-CcccccccccceecccccccccccccccCCCcccceee
Q 001275          119 SALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEI-PEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALW  197 (1109)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~  197 (1109)
                      ++|++|||++|.+++..|..|+++++|++|+|++|.+.+.+ |..+..+++|++|+|++|++++..|..|+++++|++|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            78999999999999888999999999999999999997665 56788899999999999999988899999999999999


Q ss_pred             cccccCCCCcccc--cccccCccEEEeccccccCcCchh-cccccccccccccCcccCCcccccccCC--CCcchhcccc
Q 001275          198 LFSNRLSGTIPES--IGNCYRLQELYLNENKLMGFLPES-LSNLENLVYLDVGDNNLEGRINFGSEKC--KNLTFLDLSY  272 (1109)
Q Consensus       198 L~~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~  272 (1109)
                      |++|++++.+|..  |+.+++|++|+|++|++++..|.. +.++++|++|++++|++++..+..+..+  .+|+.|++++
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~  189 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS  189 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence            9999998866555  889999999999999999887776 7889999999999999888777777665  6788888888


Q ss_pred             ccccCCCCccc--------ccccCCcEEEeecCCCCCcCCcccccc---ccccEEEcCCCCCCCCCCCccccccccceee
Q 001275          273 NRFSGGISPNL--------GNCSSLTHLDIVGSKLTGSIPSSFGLL---ARLSSLDLSENQLSGKIPPELGKCKYLTVLH  341 (1109)
Q Consensus       273 N~l~~~~~~~~--------~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  341 (1109)
                      |.+.+..+..+        ..+++|++|++++|++++..|..+...   ++|+.|++++|.+.+..              
T Consensus       190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------  255 (455)
T 3v47_A          190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------  255 (455)
T ss_dssp             CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------
T ss_pred             CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------
Confidence            88776544332        244566666666666666555555443   55666666666544321              


Q ss_pred             ccCcccCCCCCccccC--CCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcC
Q 001275          342 LYANQLEGEIPDELGQ--LSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQF  419 (1109)
Q Consensus       342 L~~N~l~~~~p~~l~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  419 (1109)
                      +..+.+.+..+..+..  .++|++|++++|++++..|.                        .+..+++|+.|++++|++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~------------------------~~~~l~~L~~L~Ls~n~l  311 (455)
T 3v47_A          256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKS------------------------VFSHFTDLEQLTLAQNEI  311 (455)
T ss_dssp             TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTT------------------------TTTTCTTCCEEECTTSCC
T ss_pred             cchhhhccCcccccccccccCceEEEecCccccccchh------------------------hcccCCCCCEEECCCCcc
Confidence            1111122111222221  23455555555555544444                        444445555555555555


Q ss_pred             cccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCC-C
Q 001275          420 SGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-F  498 (1109)
Q Consensus       420 ~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~  498 (1109)
                      ++..|..++.+++|++|++++|.+++..|..+..+++|++|+|++|++++..|..+..+++|++|++++|++++.++. +
T Consensus       312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  391 (455)
T 3v47_A          312 NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIF  391 (455)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred             cccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHh
Confidence            544444454555555555555555444444455555555555555555555555555555555555555666554444 5


Q ss_pred             CCCCCCceEEeecCccCCCCC
Q 001275          499 SKNPVLSHLDVSRNNISGAIP  519 (1109)
Q Consensus       499 ~~~~~L~~L~Ls~N~i~~~~p  519 (1109)
                      ..+++|++|++++|++++..|
T Consensus       392 ~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          392 DRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTCTTCCEEECCSSCBCCCTT
T ss_pred             ccCCcccEEEccCCCcccCCC
Confidence            667777777777777776655

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.6e-41  Score=379.83  Aligned_cols=292  Identities=39%  Similarity=0.689  Sum_probs=235.1

Q ss_pred             CCCcccHHHHHHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeE
Q 001275          805 EGPSYLLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF  884 (1109)
Q Consensus       805 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  884 (1109)
                      ....+..+++..++++|...+.||+|+||+||+|+..+++.||||++...........+.+|++++++++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            34567889999999999999999999999999999888999999998665555555579999999999999999999999


Q ss_pred             EecCCceeEEEEeccCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          885 WLRKDCGIIMYRYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       885 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                      +...+..++||||+++|+|.++++.... ...+++..+..++.|++.||+|||..+..+|+||||||+||+++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            9999999999999999999999987542 345999999999999999999999433339999999999999999999999


Q ss_pred             ecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC---ccccccHHHHHHH
Q 001275          964 SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS---YKERTDIVGWVRS 1040 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~---~~~~~~~~~~~~~ 1040 (1109)
                      +|||+++...... ........||+.|+|||++.+..++.++||||+||++|||++|+.||+..   .........|+..
T Consensus       176 ~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          176 GDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             CCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             ccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999998765432 22333456999999999999889999999999999999999999999531   1223334445444


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      .... .......+......    .......++.+++.+||+.||++|||++|++++|++...
T Consensus       255 ~~~~-~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          255 LLKE-KKLEALVDVDLQGN----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTSS-CCSTTSSCTTCTTS----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             Hhhc-hhhhhhcChhhccc----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            3322 22333333332221    234566788899999999999999999999999987644

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.4e-41  Score=400.76  Aligned_cols=252  Identities=23%  Similarity=0.272  Sum_probs=200.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHH---HHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSM---KREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.....  ......+   .+++.+++.++|||||++++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57899999999999999999764 689999999954321  2222233   34467778889999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +||||++||+|.+++...+   .+++..+..++.||+.||+|||   +.+||||||||+|||++.+|.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999998754   4899999999999999999999   999999999999999999999999999999877


Q ss_pred             CCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      .....    ...+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.....  .+................  
T Consensus       343 ~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~--~~~~~i~~~i~~~~~~~p--  414 (689)
T 3v5w_A          343 SKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--KDKHEIDRMTLTMAVELP--  414 (689)
T ss_dssp             SSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC--CCHHHHHHHHHHCCCCCC--
T ss_pred             CCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHhhcCCCCCCC--
Confidence            54322    23689999999999864 5799999999999999999999999964321  122222222111111110  


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~ 1098 (1109)
                                 ....   .++.+++.+|++.||++|++     ++|+++|-+
T Consensus       415 -----------~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          415 -----------DSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             -----------TTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             -----------ccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence                       1112   23556777999999999998     799988764

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.9e-40  Score=390.80  Aligned_cols=320  Identities=20%  Similarity=0.178  Sum_probs=165.3

Q ss_pred             CcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCccccc
Q 001275          206 TIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGN  285 (1109)
Q Consensus       206 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  285 (1109)
                      ..+..++++++|++|++++|.+++. | .+..+++|++|++++|++++. +  +..+++|++|++++|++++. +  +++
T Consensus        33 ~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~  104 (457)
T 3bz5_A           33 TDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTP  104 (457)
T ss_dssp             TSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred             ccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCC
Confidence            3334444455555555555555443 2 344555555555555555442 1  44455555555555555542 1  555


Q ss_pred             ccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEE
Q 001275          286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLE  365 (1109)
Q Consensus       286 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  365 (1109)
                      +++|++|++++|++++. |  ++.+++|++|++++|++++. +  ++.+++|++|++++|+..+.+  .++.+++|++|+
T Consensus       105 l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~  176 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD  176 (457)
T ss_dssp             CTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred             CCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence            55555555555555542 2  55556666666666666542 2  555566666666666443333  255566666666


Q ss_pred             ccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccc
Q 001275          366 LFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTG  445 (1109)
Q Consensus       366 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~  445 (1109)
                      +++|++++ +|  +..+++|+.|++++|++++.   .+..+++|+.|++++|++++ +|  ++.+++|++|++++|.+++
T Consensus       177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~  247 (457)
T 3bz5_A          177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE  247 (457)
T ss_dssp             CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred             CCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence            66666654 33  44555566666666655543   25556666666666666665 34  5556666666666666664


Q ss_pred             cCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCccccc
Q 001275          446 EIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNS  525 (1109)
Q Consensus       446 ~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l  525 (1109)
                      ..   +..+++|+.|++++|++              +.+++++|++.+.+| ++.+++|+.|++++|...+.+|.   ..
T Consensus       248 ~~---~~~l~~L~~L~l~~n~L--------------~~L~l~~n~~~~~~~-~~~l~~L~~L~Ls~n~~l~~l~~---~~  306 (457)
T 3bz5_A          248 LD---VSTLSKLTTLHCIQTDL--------------LEIDLTHNTQLIYFQ-AEGCRKIKELDVTHNTQLYLLDC---QA  306 (457)
T ss_dssp             CC---CTTCTTCCEEECTTCCC--------------SCCCCTTCTTCCEEE-CTTCTTCCCCCCTTCTTCCEEEC---TT
T ss_pred             cC---HHHCCCCCEEeccCCCC--------------CEEECCCCccCCccc-ccccccCCEEECCCCcccceecc---CC
Confidence            32   23345556666555432              234455555444443 34445555555555555444443   12


Q ss_pred             ccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCcccc
Q 001275          526 INLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLN  587 (1109)
Q Consensus       526 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~  587 (1109)
                      .+|+.|++++|             ++|++|++++|++++ ++  ++.+++|+.||+++|+|+
T Consensus       307 ~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~  352 (457)
T 3bz5_A          307 AGITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQ  352 (457)
T ss_dssp             CCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCC
T ss_pred             CcceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCC
Confidence            33444444433             344555555555554 22  444555555555555554

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.1e-41  Score=379.63  Aligned_cols=276  Identities=35%  Similarity=0.565  Sum_probs=223.2

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .++++|+..+.||+|+||+||+|...+++.||||++... .......+.+|++++++++||||+++++++...+..++||
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            456789999999999999999999888999999987433 3344567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||+++|+|.+++..... ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999976432 235899999999999999999999   88999999999999999999999999999986544


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc-cccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE-RTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......|...... .......++
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  270 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVD  270 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCCSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHHHhcC
Confidence            33333333456899999999999999999999999999999999999999754322 2233333322221 122233333


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      +.....    ...+...++.+++.+||+.||++||+++|++++|+.+
T Consensus       271 ~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          271 PNLADK----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             SSCTTC----SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhccc----cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            332211    1245567788899999999999999999999999876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.5e-40  Score=399.89  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=205.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++... .......+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            5799999999999999999976 46899999998543 333456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC--CcEEEecccCCcccCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE--MEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfGla~~~~~~  975 (1109)
                      |+||+|.+++....  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999996532  34899999999999999999999   8999999999999999854  89999999999987543


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                         ......+||+.|||||++.+..|+.++||||+||++|||++|+.||......     ...............    .
T Consensus       311 ---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-----~~~~~i~~~~~~~~~----~  378 (573)
T 3uto_A          311 ---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLRNVKSCDWNMDD----S  378 (573)
T ss_dssp             ---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTTCCCCCS----G
T ss_pred             ---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHHHhCCCCCCc----c
Confidence               2334468999999999999999999999999999999999999999653221     111111111111100    0


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .     .....   .++.+++.+||+.||++||++.|+++|=+
T Consensus       379 ~-----~~~~s---~~~~dli~~~L~~dp~~R~t~~e~l~Hpw  413 (573)
T 3uto_A          379 A-----FSGIS---EDGKDFIRKLLLADPNTRMTIHQALEHPW  413 (573)
T ss_dssp             G-----GTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             c-----ccCCC---HHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence            0     01112   23556778999999999999999999754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-39  Score=365.09  Aligned_cols=286  Identities=34%  Similarity=0.534  Sum_probs=229.8

Q ss_pred             CCCcccHHHHHHHhhCCCCC------ceeecccCeEEEEEEeCCCcEEEEEEeeecc---cccChHHHHHHHHHHhcCCC
Q 001275          805 EGPSYLLKQVIEATENLNAK------HVIGRGAHGIVYKASLGPNAVFAVKKLAFRG---HKRGSLSMKREIQTIGKIRH  875 (1109)
Q Consensus       805 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h  875 (1109)
                      ....|.+.++..++.+|...      +.||+|+||+||+|.. +++.||||++....   .......+.+|++++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            44678899999999999887      8999999999999987 58899999985432   22335678999999999999


Q ss_pred             CceeeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee
Q 001275          876 RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL  955 (1109)
Q Consensus       876 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  955 (1109)
                      |||+++++++...+..++||||+++|+|.+++........+++..++.++.|+++||+|||   +.+|+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEE
Confidence            9999999999999999999999999999999986555556999999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHH
Q 001275          956 DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV 1035 (1109)
Q Consensus       956 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 1035 (1109)
                      ++++.+||+|||+++...............||+.|+|||.+.+ .++.++||||+|+++|+|++|+.||...... ....
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLL  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTT
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHH
Confidence            9999999999999987654433333334579999999997765 5789999999999999999999999754322 2222


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .+..........+.+.++...     ..........+.+++.+||+.||++||+++|++++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKM-----NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSC-----SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHHHhhhhhhhhhhhccccc-----cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            333322222222223323221     1122345567888999999999999999999999998863

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=5.5e-39  Score=379.86  Aligned_cols=373  Identities=20%  Similarity=0.185  Sum_probs=247.2

Q ss_pred             cccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCC
Q 001275          241 LVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSE  320 (1109)
Q Consensus       241 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  320 (1109)
                      ++..........+..+..+..+++|++|++++|.+++. | .+..+++|++|++++|++++. |  ++.+++|++|++++
T Consensus        20 l~~~~~~~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~   94 (457)
T 3bz5_A           20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDS   94 (457)
T ss_dssp             HHHHHHHHTTCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCS
T ss_pred             HHHHHHHhcCcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcC
Confidence            33333344444545555667777888888888887754 3 577777888888888887764 3  67777788888888


Q ss_pred             CCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCc
Q 001275          321 NQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLP  400 (1109)
Q Consensus       321 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  400 (1109)
                      |++++. +  ++++++|++|++++|++++ +|  ++.+++|++|++++|++++. +  +..+++|++|++++|+..+.+ 
T Consensus        95 N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~-  164 (457)
T 3bz5_A           95 NKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL-  164 (457)
T ss_dssp             SCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC-
T ss_pred             CCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc-
Confidence            887753 3  7777778888888887775 33  67777788888887777753 2  666777777777777555444 


Q ss_pred             hhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCc
Q 001275          401 LEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPT  480 (1109)
Q Consensus       401 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~  480 (1109)
                       .+..+++|+.|++++|++++ +|  ++.+++|++|++++|.+++.   .+..+++|++|++++|++++ +|  ++.+++
T Consensus       165 -~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~  234 (457)
T 3bz5_A          165 -DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQ  234 (457)
T ss_dssp             -CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTT
T ss_pred             -ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCC
Confidence             36667777777777777775 33  66667777777777777654   25566667777777777765 34  556666


Q ss_pred             cchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccc
Q 001275          481 LWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLN  560 (1109)
Q Consensus       481 L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  560 (1109)
                      |+.|++++|++++.+  +..+++|+.|++++|+              |+.|++++|++.+.+|  ++.+++|+.|++++|
T Consensus       235 L~~L~l~~N~l~~~~--~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n  296 (457)
T 3bz5_A          235 LTYFDCSVNPLTELD--VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHN  296 (457)
T ss_dssp             CSEEECCSSCCSCCC--CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTC
T ss_pred             CCEEEeeCCcCCCcC--HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCC
Confidence            666666666666543  3445556666655542              4556677777666665  456677777777777


Q ss_pred             cccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCC
Q 001275          561 HVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPP  640 (1109)
Q Consensus       561 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~  640 (1109)
                      ...+.+|..   ..+|+.|++++|             ++|+.|++++|++++ ++  ++.+++|+.|++++|+++| +| 
T Consensus       297 ~~l~~l~~~---~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~-l~-  355 (457)
T 3bz5_A          297 TQLYLLDCQ---AAGITELDLSQN-------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD-FS-  355 (457)
T ss_dssp             TTCCEEECT---TCCCSCCCCTTC-------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB-CT-
T ss_pred             cccceeccC---CCcceEechhhc-------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC-cc-
Confidence            766666642   244444444443             467777777777775 33  6677777777777777774 22 


Q ss_pred             CchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCC
Q 001275          641 SIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP  689 (1109)
Q Consensus       641 ~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~  689 (1109)
                            .+ ..|++++|.++|.     +++..|+.+||++|+|+|.||+
T Consensus       356 ------~L-~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~  392 (457)
T 3bz5_A          356 ------SV-GKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSP  392 (457)
T ss_dssp             ------TG-GGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCT
T ss_pred             ------cc-ccccccCCcEEec-----ceeeecCccccccCcEEEEcCh
Confidence                  23 2466777777765     3566677777777777777765

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9e-40  Score=376.78  Aligned_cols=259  Identities=21%  Similarity=0.358  Sum_probs=210.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe--------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL--------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  889 (1109)
                      ++|.+.+.||+|+||+||+|+.        .++..||||++...........+.+|+++++++ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            6788899999999999999975        245679999986554445566799999999999 8999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ..++||||+++|+|.+++.....             ...+++..++.++.|+++||+|||   +.+|+||||||+||+++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEEC
Confidence            99999999999999999986542             235899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1109)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....  ..+.
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--~~~~  315 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELF  315 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Confidence            999999999999987655433333334567889999999999999999999999999999999 9999864321  1122


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..+.....    . .             .......++.+++.+||+.||++||+++|++++|+++
T Consensus       316 ~~~~~~~~----~-~-------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          316 KLLKEGHR----M-D-------------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             HHHHTTCC----C-C-------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcCCC----C-C-------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111000    0 0             0011223466788899999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.7e-40  Score=372.28  Aligned_cols=263  Identities=27%  Similarity=0.349  Sum_probs=205.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc----eeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC----GIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv  894 (1109)
                      .+|++.++||+|+||+||+|+.. ++.||||++...  ......+.+|+.++++++||||+++++++.....    .++|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            67889999999999999999877 799999998432  2334456779999999999999999999987543    5999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC----------CeEEeccCCCCeeeCCCCcEEEe
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP----------PIVHRDIKPENILLDSEMEPHIS  964 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~----------~ivH~Dlk~~NIll~~~~~~kl~  964 (1109)
                      |||+++|+|.++++..    .+++..++.++.|+++||+|||   +.          +|+||||||+||+++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            9999999999999763    3899999999999999999999   77          99999999999999999999999


Q ss_pred             cccCCcccCCCCCCceeeecccCcccccccccccC-----CCCccCcchhhHHHHHHHHhCCCCCCCCcccccc------
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT-----AKSKESDVYSYGVVLLELITRKKALDPSYKERTD------ 1033 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~------ 1033 (1109)
                      |||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||.........      
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999877554433333446799999999998863     4567899999999999999999999754322111      


Q ss_pred             -----HHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1034 -----IVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1034 -----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                           ...+........      ..+......   .......++.+++.+||+.||++|||++|+++.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~------~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKK------KRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CSSCCHHHHHHHHTTSC------CCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhccc------CCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 111111110000      000000000   0123445688899999999999999999999999875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.4e-39  Score=359.01  Aligned_cols=253  Identities=22%  Similarity=0.336  Sum_probs=205.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|+..+.||+|+||+||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc-cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            6799999999999999999975 56899999998543 334456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999999764    3889999999999999999999   88999999999999999999999999999987654322


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........   ...   ....    
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~---~~~---~~~~----  238 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATN---GTP---ELQN----  238 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHH---CSC---CCSC----
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhC---CCC---CCCC----
Confidence              2234679999999999999999999999999999999999999996432111 11111100   000   0000    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                             .......+.+++.+||+.||++||+++|+++|-+-
T Consensus       239 -------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~  273 (297)
T 3fxz_A          239 -------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL  273 (297)
T ss_dssp             -------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             -------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhh
Confidence                   01112345667889999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=359.82  Aligned_cols=279  Identities=20%  Similarity=0.232  Sum_probs=214.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC--ceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD--CGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  895 (1109)
                      ++|.+.++||+|+||+||+|... +++.||||++...........+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999775 489999999965555556678899999999999999999999988765  679999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee----CCCCcEEEecccCCcc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL----DSEMEPHISDFGIAKL  971 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfGla~~  971 (1109)
                      ||+++|+|.+++........+++..++.++.|+++||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999987655555999999999999999999999   8899999999999999    7788899999999987


Q ss_pred             cCCCCCCceeeecccCcccccccccc--------cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAF--------TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      ......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.+.................
T Consensus       166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            754432   22357999999999876        5778999999999999999999999997543322221111111111


Q ss_pred             Cc-ccccccc---chhh--hH--HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCC
Q 001275         1044 DT-EEINDIV---DLSL--ME--EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVP 1103 (1109)
Q Consensus      1044 ~~-~~~~~~~---d~~~--~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1103 (1109)
                      .. .....+.   ....  ..  .............+.+++.+|++.||++||+++|++++..+...+
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            10 0000000   0000  00  000011234455677788899999999999999999999887554

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2e-39  Score=364.54  Aligned_cols=259  Identities=29%  Similarity=0.391  Sum_probs=199.5

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ..+|++.+.||+|+||+||+|+.. ++.||||++..... ......+.+|++++++++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            367888999999999999999874 88899999854432 2334578899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP--IVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |+++|+|.+++........+++..++.++.|+++||+|||   +.+  |+||||||+||+++.++.+||+|||+++....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999999999987543334899999999999999999999   888  99999999999999999999999999985543


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.... ......     
T Consensus       192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~--~~~~~~~~~~-~~~~~~-----  261 (309)
T 3p86_A          192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA--QVVAAVGFKC-KRLEIP-----  261 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH--HHHHHHHHSC-CCCCCC-----
T ss_pred             cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcC-CCCCCC-----
Confidence            21  2223457999999999999999999999999999999999999999653211  1111111100 000000     


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                                 .....++.+++.+||+.||++||+++|+++.|+.+.
T Consensus       262 -----------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          262 -----------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             -----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                       111234667888999999999999999999998763

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=358.57  Aligned_cols=258  Identities=24%  Similarity=0.422  Sum_probs=206.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...++||+|+||+||+|... +++.||+|++. .........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI-RFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEES-CCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEec-cCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            57888999999999999999774 68999999873 33445567899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.++++...  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999998743  34899999999999999999999   88999999999999999999999999999987654322


Q ss_pred             Cc------------eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          978 ST------------TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       978 ~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      ..            ......||+.|+|||++.+..++.++||||||+++|||++|..|+...............      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~------  237 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR------  237 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh------
Confidence            11            111457999999999999999999999999999999999999988643222111100000      


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                               ........   .....++.+++.+||+.||++||+++|+++.|+.+
T Consensus       238 ---------~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          238 ---------GFLDRYCP---PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ---------HHHHHTCC---TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------ccccccCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     00000000   11223466788899999999999999999999875

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.9e-38  Score=355.33  Aligned_cols=265  Identities=22%  Similarity=0.309  Sum_probs=212.0

Q ss_pred             CcccHHHHHHHhhC----------CCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCC
Q 001275          807 PSYLLKQVIEATEN----------LNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH  875 (1109)
Q Consensus       807 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h  875 (1109)
                      +.++.+++..+++.          |+..++||+|+||.||+|... +|+.||||++... .......+.+|+.++++++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-TCCSHHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc-chhHHHHHHHHHHHHHhCCC
Confidence            45677777777764          666778999999999999876 7999999998543 34456678999999999999


Q ss_pred             CceeeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee
Q 001275          876 RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL  955 (1109)
Q Consensus       876 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  955 (1109)
                      |||+++++++...+..++||||+++|+|.+++...    .+++..+..++.|+++||+|||   +.+|+||||||+||++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll  174 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILL  174 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEE
Confidence            99999999999999999999999999999998753    3899999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHH
Q 001275          956 DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV 1035 (1109)
Q Consensus       956 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 1035 (1109)
                      +.++.+||+|||+++.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ....
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~--~~~~  250 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP--VQAM  250 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHH
T ss_pred             CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHH
Confidence            9999999999999987654322  22346799999999999999999999999999999999999999964321  1111


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ..+....          .+....      ......++.+++.+||+.||++||+++|++++-+-
T Consensus       251 ~~~~~~~----------~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  298 (321)
T 2c30_A          251 KRLRDSP----------PPKLKN------SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL  298 (321)
T ss_dssp             HHHHHSS----------CCCCTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             HHHhcCC----------CCCcCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            1111100          000000      01112345667889999999999999999997654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-38  Score=360.11  Aligned_cols=250  Identities=23%  Similarity=0.267  Sum_probs=204.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .+|.+.+.||+|+||.||+|.. .+|+.||||++.... .......+.+|++++++++||||+++++++...+..++|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5789999999999999999977 679999999985543 22345578899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++...+   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           95 YASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             CCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            999999999997654   3899999999999999999999   8899999999999999999999999999998664432


Q ss_pred             CCceeeecccCcccccccccccCCCC-ccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKS-KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                         ......||+.|+|||++.+..++ .++||||+||++|||++|+.||.....     ................     
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~p~-----  235 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRERVLRGKYRIPF-----  235 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCCT-----
T ss_pred             ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCCC-----
Confidence               22346799999999999988874 899999999999999999999965321     1111111111110100     


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                 ....++.+++.+|++.||++|||++|+++|-+
T Consensus       236 -----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          236 -----------YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             -----------TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             -----------CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence                       11234556788999999999999999999854

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=364.61  Aligned_cols=257  Identities=26%  Similarity=0.392  Sum_probs=205.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .+|.+.+.||+|+||+||+|...    .+..||||++...........+.+|++++++++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999874    45569999986554555567899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.++++...  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       129 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             eeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999999997543  35899999999999999999999   88999999999999999999999999999987754


Q ss_pred             CCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          975 SPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       975 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  +....+   ..... ..   
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~---~~~~~-~~---  274 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--DVISSV---EEGYR-LP---  274 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHH---HTTCC-CC---
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHH---HcCCC-CC---
Confidence            3222 22233456889999999998999999999999999999999 99998643211  111111   11100 00   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                 .......++.+++.+||+.||++||+++|+++.|+.+
T Consensus       275 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          275 -----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             -----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                       0011223566788899999999999999999999876

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.7e-39  Score=363.86  Aligned_cols=257  Identities=23%  Similarity=0.314  Sum_probs=204.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57889999999999999999765 78999999986554444456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        87 ~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999987543   4899999999999999999999   89999999999999999999999999999986643332


Q ss_pred             CceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      ........||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+...    ....    .+  
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~~----~~--  230 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYL----NP--  230 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT----CTTS----TT--
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc----cccC----Cc--
Confidence            222334689999999999988776 789999999999999999999997543322222221111    0000    00  


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                              ......++.+++.+|++.||++|||++|++++-+-
T Consensus       231 --------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~  265 (323)
T 3tki_A          231 --------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWY  265 (323)
T ss_dssp             --------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             --------cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence                    01112345568889999999999999999988653

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-39  Score=373.06  Aligned_cols=269  Identities=22%  Similarity=0.300  Sum_probs=212.8

Q ss_pred             cHHHHHHHhhCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEe
Q 001275          810 LLKQVIEATENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLE  882 (1109)
Q Consensus       810 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  882 (1109)
                      .........++|.+.+.||+|+||.||+|++      .+++.||||++.........+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            3444445568899999999999999999963      346889999996544444556799999999999 799999999


Q ss_pred             eEEecCCc-eeEEEEeccCCCHHHHHhccCC-------------------------------------------------
Q 001275          883 DFWLRKDC-GIIMYRYMENGSLRDVLHSITP-------------------------------------------------  912 (1109)
Q Consensus       883 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------  912 (1109)
                      +++...+. .++||||+++|+|.++++....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99987654 8999999999999999986532                                                 


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          913 --------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       913 --------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                                    ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                          122889999999999999999999   889999999999999999999999999999876554444


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......||+.|+|||++.+..++.++|||||||++|||++ |+.||...... ......+....  ....         
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~--~~~~---------  317 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFCRRLKEGT--RMRA---------  317 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHHTC--CCCC---------
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-HHHHHHHHcCC--CCCC---------
Confidence            44445678999999999999999999999999999999998 99998653221 11111111100  0000         


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             ......++.+++.+||+.||++||+++|++++|+++
T Consensus       318 -------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          318 -------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence                   001123466788899999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.1e-39  Score=375.13  Aligned_cols=257  Identities=22%  Similarity=0.276  Sum_probs=205.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...+.||+|+||+||+|... +++.||||++..........++.+|++++++++||||+++++++...+..++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            57888899999999999999886 78999999985443333445688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.++++...  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       194 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          194 VQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             CTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            99999999997643  24889999999999999999999   89999999999999999999999999999986543211


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....  ......+..    ....   ..   
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~----~~~~---~~---  336 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEK----GGRL---PC---  336 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHT----TCCC---CC---
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc----CCCC---CC---
Confidence            111112345778999999998899999999999999999998 8888864321  111111111    0000   00   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              ......++.+++.+||+.||++|||++|+++.|+++
T Consensus       337 --------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          337 --------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence                    011223466788899999999999999999999875

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.3e-37  Score=369.00  Aligned_cols=345  Identities=28%  Similarity=0.376  Sum_probs=194.0

Q ss_pred             CCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCccccccccccee
Q 001275           93 HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYV  172 (1109)
Q Consensus        93 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L  172 (1109)
                      .+++|+.|+++++.+.. +| .+..+++|++|+|++|.+++..|  +.++++|++|+|++|.+++..|  +.++++|++|
T Consensus        44 ~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  117 (466)
T 1o6v_A           44 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGL  117 (466)
T ss_dssp             HHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEE
Confidence            45667777777777763 44 36677777777777777775433  7777777777777777764333  6667777777


Q ss_pred             cccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccC
Q 001275          173 FLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE  252 (1109)
Q Consensus       173 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  252 (1109)
                      ++++|++++..+  ++.+++|++|++++|.+++. + .++.+++|++|+++ |.+.+..  .+.++++|++|++++|+++
T Consensus       118 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~  190 (466)
T 1o6v_A          118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVS  190 (466)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCC
Confidence            777777765432  66677777777777766642 2 36666677777764 4444332  2666666666666666665


Q ss_pred             CcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccc
Q 001275          253 GRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELG  332 (1109)
Q Consensus       253 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  332 (1109)
                      +..  .+..+++|++|++++|.+++..+  ++.+++|+.|++++|++++.  ..+..+++|+.|++++|.+++..|  +.
T Consensus       191 ~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~  262 (466)
T 1o6v_A          191 DIS--VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS  262 (466)
T ss_dssp             CCG--GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred             CCh--hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence            432  24555566666666665554333  44555555555555555532  234555555555555555554332  55


Q ss_pred             cccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeE
Q 001275          333 KCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNI  412 (1109)
Q Consensus       333 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  412 (1109)
                      .+++|+.|++++|++++..+  +..+++|++|++++|++++..+  +..+++|+.|++++|++++..|  +..+++|+.|
T Consensus       263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L  336 (466)
T 1o6v_A          263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL  336 (466)
T ss_dssp             TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred             cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence            55555555555555553322  4555555555555555554222  4445555555555555554333  4445555555


Q ss_pred             EccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccc
Q 001275          413 SLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFH  468 (1109)
Q Consensus       413 ~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~  468 (1109)
                      ++++|++++.  ..++.+++|++|++++|.+++..|  +..+++|+.|++++|+++
T Consensus       337 ~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~  388 (466)
T 1o6v_A          337 FFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT  388 (466)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred             ECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence            5555555433  234444444444444444444333  344444444444444444

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-39  Score=366.26  Aligned_cols=265  Identities=26%  Similarity=0.397  Sum_probs=211.0

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      .++|...+.||+|+||.||+|+..      +++.||||++...........+.+|++++++++||||+++++++...+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            478999999999999999999774      34889999986554444566799999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCC
Q 001275          892 IIMYRYMENGSLRDVLHSITP---------------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKP  950 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~  950 (1109)
                      ++||||+++|+|.+++.....                     ...+++..++.++.|+++||+|||   +.+|+||||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp  202 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLAT  202 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCc
Confidence            999999999999999976432                     146899999999999999999999   88999999999


Q ss_pred             CCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCcc
Q 001275          951 ENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYK 1029 (1109)
Q Consensus       951 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~ 1029 (1109)
                      +||++++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            999999999999999999987644333233344578999999999999999999999999999999999 9999864321


Q ss_pred             ccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCC
Q 001275         1030 ERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMT 1105 (1109)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1105 (1109)
                      .  ..   ........  ....             ......++.+++.+||+.||++||++.|++++|+++.....
T Consensus       283 ~--~~---~~~~~~~~--~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          283 E--EV---IYYVRDGN--ILAC-------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             H--HH---HHHHHTTC--CCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             H--HH---HHHHhCCC--cCCC-------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            1  11   11111110  0000             01112346678889999999999999999999999865544

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.4e-39  Score=368.50  Aligned_cols=257  Identities=27%  Similarity=0.410  Sum_probs=195.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .+|...+.||+|+||+||+|+..    ++..||||++..........++.+|++++++++||||+++++++...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57899999999999999999764    57789999986544445566899999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.++++...  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       125 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999999997643  35899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          975 SPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       975 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....  .+....+..   .. ..    
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i~~---~~-~~----  269 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDE---GY-RL----  269 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHHHT---TE-EC----
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CC-CC----
Confidence            3221 12223356788999999999999999999999999999998 9999864321  111111111   00 00    


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                ........++.+++.+||+.||++||+++|+++.|+++
T Consensus       270 ----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          270 ----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             ----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                      00011234567788899999999999999999999765

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.5e-37  Score=366.48  Aligned_cols=343  Identities=27%  Similarity=0.379  Sum_probs=248.0

Q ss_pred             cEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccc
Q 001275           72 NVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLY  151 (1109)
Q Consensus        72 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~  151 (1109)
                      +++.+++.++++.. ++ .+..+++|++|+|++|.+++..|  ++.+++|++|++++|.+++..|  ++++++|++|+|+
T Consensus        47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~  120 (466)
T 1o6v_A           47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF  120 (466)
T ss_dssp             TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred             cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence            46677777776654 33 46777788888888887775543  7777888888888887775443  7778888888888


Q ss_pred             cccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcC
Q 001275          152 GNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFL  231 (1109)
Q Consensus       152 ~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  231 (1109)
                      +|.+++. |. +.++++|++|++++|.+++. + .++.+++|++|+++ |.+.+..+  ++++++|++|++++|.+++. 
T Consensus       121 ~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-  192 (466)
T 1o6v_A          121 NNQITDI-DP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI-  192 (466)
T ss_dssp             SSCCCCC-GG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC-
T ss_pred             CCCCCCC-hH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCC-
Confidence            8877743 32 77777888888888877753 3 47777788888875 45554332  77777888888888877754 


Q ss_pred             chhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccc
Q 001275          232 PESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLA  311 (1109)
Q Consensus       232 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  311 (1109)
                       ..+..+++|++|++++|++++..+  +..+++|++|++++|++++.  +.+..+++|+.|++++|.+++..+  +..++
T Consensus       193 -~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~  265 (466)
T 1o6v_A          193 -SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT  265 (466)
T ss_dssp             -GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred             -hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCC
Confidence             347777788888888887776655  56677788888888877753  356777788888888888776544  67777


Q ss_pred             cccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeecc
Q 001275          312 RLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVY  391 (1109)
Q Consensus       312 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  391 (1109)
                      +|+.|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|++|++++|++++..|  +..+++|+.|+++
T Consensus       266 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~  339 (466)
T 1o6v_A          266 KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY  339 (466)
T ss_dssp             TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred             CCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence            88888888887775433  7777788888888888775433  6777788888888888776544  6677788888888


Q ss_pred             CCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccc
Q 001275          392 NNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTG  445 (1109)
Q Consensus       392 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~  445 (1109)
                      +|.+++.  ..+..+++|+.|++++|++++..|  +..+++|++|++++|.+++
T Consensus       340 ~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          340 NNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             SSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             CCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            8877754  457777788888888888877666  6777778888888888775

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.2e-38  Score=359.13  Aligned_cols=255  Identities=23%  Similarity=0.406  Sum_probs=202.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-------
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-------  889 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  889 (1109)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.........+.+.+|++++++++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            357889999999999999999875 789999999976555556678999999999999999999999986543       


Q ss_pred             --------------------------------------------------ceeEEEEeccCCCHHHHHhccCCCCCCCHH
Q 001275          890 --------------------------------------------------CGIIMYRYMENGSLRDVLHSITPPPTLEWN  919 (1109)
Q Consensus       890 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~  919 (1109)
                                                                        ..++||||+++|+|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999999886665667888


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC----------ceeeecccCcc
Q 001275          920 VRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS----------TTSISVVGTIG  989 (1109)
Q Consensus       920 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~----------~~~~~~~gt~~  989 (1109)
                      .++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999   889999999999999999999999999999877544211          12234579999


Q ss_pred             cccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHH
Q 001275          990 YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQV 1069 (1109)
Q Consensus       990 y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 1069 (1109)
                      |+|||++.+..++.++||||+||++|||++|..|+.    +.   ..........       ..+        .......
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~----~~---~~~~~~~~~~-------~~~--------~~~~~~~  299 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM----ER---VRIITDVRNL-------KFP--------LLFTQKY  299 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH----HH---HHHHHHHHTT-------CCC--------HHHHHHC
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh----HH---HHHHHHhhcc-------CCC--------cccccCC
Confidence            999999999999999999999999999999876531    10   1111110000       000        0112223


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1070 IDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1070 ~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .++.+++.+||+.||++||+++|+++|-
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~~~  327 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIENA  327 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHHST
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhhch
Confidence            4556788899999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=364.20  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=208.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCc
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  890 (1109)
                      .++|...+.||+|+||+||+|..      .+++.||||++...........+.+|+++++++ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            46788899999999999999975      345689999996555555667899999999999 89999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCC
Q 001275          891 GIIMYRYMENGSLRDVLHSITPP--------------------PTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKP  950 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~  950 (1109)
                      .++||||+++|+|.+++......                    ..+++..++.++.|+++||+|||   +.+|+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCh
Confidence            99999999999999999865421                    24799999999999999999999   88999999999


Q ss_pred             CCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCcc
Q 001275          951 ENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYK 1029 (1109)
Q Consensus       951 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~ 1029 (1109)
                      +||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999987654443333344568889999999999999999999999999999998 9999865422


Q ss_pred             ccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCC
Q 001275         1030 ERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPM 1104 (1109)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~ 1104 (1109)
                      . ......+.....    . .  .           ......++.+++.+||+.||++||+++|++++|+......
T Consensus       281 ~-~~~~~~~~~~~~----~-~--~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          281 D-ANFYKLIQNGFK----M-D--Q-----------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             S-HHHHHHHHTTCC----C-C--C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             H-HHHHHHHhcCCC----C-C--C-----------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            1 111111111100    0 0  0           0111234667888999999999999999999999875543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=369.03  Aligned_cols=259  Identities=22%  Similarity=0.360  Sum_probs=210.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe--------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL--------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  889 (1109)
                      ++|.+.++||+|+||+||+|..        ..++.||||++...........+.+|+++++++ +||||+++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            6788899999999999999975        234679999986555555567899999999999 9999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||   +.+|+||||||+||+++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEc
Confidence            99999999999999999986542             235899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1109)
                      +++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....  ....
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--~~~~  303 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EELF  303 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--HHHH
Confidence            999999999999987755433333344567899999999999999999999999999999999 9999864321  1111


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..+..   ... . .  .           ......++.+++.+||+.||++||+++|++++|+++
T Consensus       304 ~~~~~---~~~-~-~--~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          304 KLLKE---GHR-M-D--K-----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             HHHHT---TCC-C-C--C-----------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHc---CCC-C-C--C-----------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11111   100 0 0  0           011123466788899999999999999999999876

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.6e-38  Score=348.19  Aligned_cols=256  Identities=21%  Similarity=0.301  Sum_probs=208.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|+..+.||+|+||+||+|+..++..||+|++...  .....++.+|++++++++||||+++++++...+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG--SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT--TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hheeeeeeeccCCCceEEEEEecCceeEEEEEeccC--CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            578889999999999999999998889999998543  334567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++....  ..+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus        86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~  159 (268)
T 3sxs_A           86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-Y  159 (268)
T ss_dssp             TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-E
T ss_pred             CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-h
Confidence            9999999997643  24899999999999999999999   8899999999999999999999999999998765432 2


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......     ...........    ...+.  
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~----~~~~~--  228 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVSQGHR----LYRPH--  228 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTTCC----CCCCT--
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHHHcCCC----CCCCC--
Confidence            22334566788999999998899999999999999999999 99998643221     11111111100    00000  


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                               ....++.+++.+||+.||++||+++|++++|+.+..
T Consensus       229 ---------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          229 ---------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                     012246678889999999999999999999998743

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-38  Score=361.04  Aligned_cols=256  Identities=23%  Similarity=0.356  Sum_probs=198.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcE----EEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|+..++||+|+||+||+|.+. +++.    ||+|.+...........+.+|++++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            56888999999999999999764 3443    58887755555566778999999999999999999999998754 789


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      |+||+++|+|.+++....  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        94 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            999999999999998743  34899999999999999999999   8899999999999999999999999999998776


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....  ......+....    ...   
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~----~~~---  239 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGE----RLP---  239 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTC----CCC---
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHHcCC----CCC---
Confidence            5544444445567889999999999999999999999999999999 9999865422  12222211110    000   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .           ......++.+++.+||+.||++||+++|++++|+.+
T Consensus       240 ~-----------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          240 Q-----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             C-----------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             C-----------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0           011223567788899999999999999999999764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-38  Score=350.75  Aligned_cols=254  Identities=22%  Similarity=0.353  Sum_probs=206.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|+..+.||+|+||+||+|...+++.||+|++...  .....++.+|++++++++||||+++++++.+.+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc--ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            578889999999999999999988999999998533  334567999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++....  ..+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus        88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  161 (269)
T 4hcu_A           88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  161 (269)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-c
Confidence            9999999997643  35899999999999999999999   8899999999999999999999999999998664321 1


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......     ...........    ...+   
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~~~~~~----~~~~---  229 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFR----LYKP---  229 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTTCC----CCCC---
T ss_pred             ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHhcCcc----CCCC---
Confidence            12223467788999999999999999999999999999999 89998643211     11111111100    0000   


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              .....++.+++.+||+.||++||+++|++++|+++
T Consensus       230 --------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          230 --------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence                    01123466788899999999999999999999875

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-37  Score=357.00  Aligned_cols=255  Identities=20%  Similarity=0.284  Sum_probs=205.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-----ChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-----GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      .++|.+.+.||+|+||+||+|... +|+.||+|.+.......     ....+.+|+.++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            367889999999999999999765 68999999996543322     346789999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC----cEEEeccc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM----EPHISDFG  967 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG  967 (1109)
                      ++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999997533   4899999999999999999999   88999999999999998877    79999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      +++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||......     ............
T Consensus       165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----~~~~~i~~~~~~  236 (361)
T 2yab_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANITAVSYD  236 (361)
T ss_dssp             SCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTTCCC
T ss_pred             CceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCCC
Confidence            9987654322   23457999999999999999999999999999999999999999653211     111111111000


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .    +...     .   .....++.+++.+|++.||++|||++|+++|-+
T Consensus       237 ~----~~~~-----~---~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  275 (361)
T 2yab_A          237 F----DEEF-----F---SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (361)
T ss_dssp             C----CHHH-----H---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             C----Cchh-----c---cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence            0    1000     0   111234566788999999999999999998754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-37  Score=352.72  Aligned_cols=251  Identities=21%  Similarity=0.258  Sum_probs=204.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|+||+||+|+.. +++.||+|++....  .......+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57888999999999999999775 68999999986432  2344567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999999997643   4899999999999999999999   889999999999999999999999999999864332


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ...............      
T Consensus       159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~p------  225 (337)
T 1o6l_A          159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEEIRFP------  225 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC------
T ss_pred             C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCCC------
Confidence            2  122346899999999999999999999999999999999999999964321     111111111110000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                             ...   ..++.+++.+|++.||++||     +++|+++|-.
T Consensus       226 -------~~~---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~  263 (337)
T 1o6l_A          226 -------RTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             -------TTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             -------CCC---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence                   011   23456677899999999999     8999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=9e-38  Score=351.60  Aligned_cols=268  Identities=22%  Similarity=0.319  Sum_probs=203.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccccc-ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.++||+|+||+||+|+..+++.||+|++....... ....+.+|++++++++||||+++++++...+..++||||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  100 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF  100 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence            6788999999999999999999889999999986543332 245788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++ +|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       101 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A          101 MEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR  174 (311)
T ss_dssp             CSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred             CCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence            985 8888887543  34899999999999999999999   88999999999999999999999999999987643322


Q ss_pred             CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-ccccccc---
Q 001275          978 STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-EEINDIV--- 1052 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--- 1052 (1109)
                        ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .............. .......   
T Consensus       175 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          175 --SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-DQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-THHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             --cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHHCCCChHHhhhhhccc
Confidence              2233578999999998876 56899999999999999999999999654322 22222222111110 0000000   


Q ss_pred             ----------chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1053 ----------DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1053 ----------d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                                +.......    ......++.+++.+|++.||++|||++|+++|-+-
T Consensus       252 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  304 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSI----IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF  304 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHH----STTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             hhhhcccccccCCcHHHh----CcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence                      00000000    11122456778889999999999999999997543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-38  Score=359.01  Aligned_cols=260  Identities=22%  Similarity=0.341  Sum_probs=210.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      .++|...+.||+|+||.||+|..      .+++.||||++...........+.+|++++++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            36788899999999999999975      345889999986544445557789999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCC
Q 001275          892 IIMYRYMENGSLRDVLHSITP---------------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKP  950 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~  950 (1109)
                      ++||||+++|+|.+++.....                     ...+++..++.++.|+++||+|||   +.+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999986542                     124889999999999999999999   88999999999


Q ss_pred             CCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCcc
Q 001275          951 ENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYK 1029 (1109)
Q Consensus       951 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~ 1029 (1109)
                      +||++++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987755433333334567889999999999889999999999999999999 9999865322


Q ss_pred             ccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1030 ERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .  .....+....    .. ..             ......++.+++.+||+.||++||+++|++++|+++
T Consensus       259 ~--~~~~~~~~~~----~~-~~-------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 E--RLFNLLKTGH----RM-ER-------------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             G--GHHHHHHTTC----CC-CC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H--HHHHHhhcCC----cC-CC-------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1  1221111100    00 00             011223466788899999999999999999999876

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-39  Score=369.60  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=207.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|.+.++||+|+||+||+|.+.      +++.||||++...........+.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            56888999999999999999743      467899999865545555667899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC---cEEEec
Q 001275          893 IMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM---EPHISD  965 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~D  965 (1109)
                      +||||+++|+|.++++....    ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999976532    245899999999999999999999   88999999999999999555   599999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcC
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      ||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.....  ......+   ...
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--~~~~~~i---~~~  302 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFV---TSG  302 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHH---HTT
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH---HcC
Confidence            999986533322223334578999999999999999999999999999999998 9898864321  1111111   111


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .. .    +.          .......+.+++.+||+.||++||+++|++++|+.+
T Consensus       303 ~~-~----~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          303 GR-M----DP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CC-C----CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-C----CC----------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            00 0    00          011123466788899999999999999999999764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.3e-37  Score=348.97  Aligned_cols=265  Identities=26%  Similarity=0.348  Sum_probs=200.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhc--CCCCceeeEeeEEecC----Cce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK--IRHRNLVRLEDFWLRK----DCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~  891 (1109)
                      .++|+..+.||+|+||+||+|+. +++.||||++..    .....+.+|.+++..  ++||||+++++++...    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46799999999999999999988 589999999843    233455566666655  7999999999986543    457


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD-----CDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                      ++||||+++|+|.++++..    .+++..++.++.|++.||+|||..     ++.+|+||||||+||+++.++.+||+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            9999999999999999643    489999999999999999999932     2578999999999999999999999999


Q ss_pred             cCCcccCCCCCCc--eeeecccCcccccccccccC------CCCccCcchhhHHHHHHHHhC----------CCCCCCCc
Q 001275          967 GIAKLLDKSPAST--TSISVVGTIGYIAPENAFTT------AKSKESDVYSYGVVLLELITR----------KKALDPSY 1028 (1109)
Q Consensus       967 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvil~elltg----------~~p~~~~~ 1028 (1109)
                      |+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9998664433221  12234799999999998876      445799999999999999999          77775543


Q ss_pred             cccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1029 KERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ................. ..... .    ...   .......++.+++.+||+.||++|||++|+++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~-~----~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQ-QRPNI-P----NRW---FSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCHHHHHHHHTTSC-CCCCC-C----GGG---GGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcchhhhhHHHhccC-CCCCC-C----hhh---ccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            33333222222211111 00010 0    000   0123456678899999999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.4e-38  Score=348.94  Aligned_cols=261  Identities=27%  Similarity=0.395  Sum_probs=203.5

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++.....  ......+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            5788899999999999999976 4689999999854332  223467899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999998654   4899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .. .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......    ..........        +.
T Consensus       165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----~~~~~~~~~~--------~~  231 (294)
T 4eqm_A          165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS----IAIKHIQDSV--------PN  231 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH----HHHHHHSSCC--------CC
T ss_pred             cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHhhccC--------CC
Confidence            22 22234579999999999999999999999999999999999999996532211    1111111000        00


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhhCCC
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-NMRDVVRQLVDASV 1102 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~ 1102 (1109)
                      .... ..   ......+.+++.+|++.||++|| +++++.+.|+.+..
T Consensus       232 ~~~~-~~---~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 VTTD-VR---KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHH-SC---TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             cchh-cc---cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            0000 01   11223466788899999999998 89999999988744

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.2e-38  Score=375.66  Aligned_cols=262  Identities=23%  Similarity=0.367  Sum_probs=211.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|...+.||+|+||+||+|...+++.||||++...  ......+.+|++++++++||||+++++++. .+..++||||+
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC--CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            568888999999999999999988999999998532  345678999999999999999999999986 66789999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.++++... ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus       265 ~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~  339 (454)
T 1qcf_A          265 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  339 (454)
T ss_dssp             TTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence            9999999997532 124788999999999999999999   8899999999999999999999999999998764321 1


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......+|+.|+|||++....++.++|||||||++|||++ |+.||.....  .+....+.....       ...    
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~-------~~~----  406 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR-------MPR----  406 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHTCC-------CCC----
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC-------CCC----
Confidence            11223456789999999999999999999999999999999 9999864321  111111111100       000    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCCCC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKY 1108 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1108 (1109)
                             ......++.+++.+||+.||++||+++++++.|+++.....++|
T Consensus       407 -------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~~  450 (454)
T 1qcf_A          407 -------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQY  450 (454)
T ss_dssp             -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCSS
T ss_pred             -------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccccc
Confidence                   01123456778889999999999999999999999977766665

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.6e-38  Score=355.55  Aligned_cols=261  Identities=21%  Similarity=0.334  Sum_probs=211.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      ++|...+.||+|+||+||+|+.      .+++.||||++...........+.+|+++++++ +||||+++++++...+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            5788899999999999999974      356889999986554444557799999999999 999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          892 IIMYRYMENGSLRDVLHSITP---------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ++||||+++|+|.+++.....               ...+++..++.++.|+++||+|||   +.+|+||||||+||+++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~  179 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEc
Confidence            999999999999999986542               124899999999999999999999   88999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1109)
                      .++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ....
T Consensus       180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~  258 (313)
T 1t46_A          180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFY  258 (313)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hHHH
Confidence            999999999999987765544333344567889999999999999999999999999999999 99998654221 1111


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ..+......      . .           ......++.+++.+|++.||++||+++|++++|++..
T Consensus       259 ~~~~~~~~~------~-~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          259 KMIKEGFRM------L-S-----------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             HHHHHTCCC------C-C-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCCCC------C-C-----------cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            111111100      0 0           0111234667888999999999999999999998763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-38  Score=355.96  Aligned_cols=274  Identities=23%  Similarity=0.319  Sum_probs=201.9

Q ss_pred             hCCCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC--Cce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  891 (1109)
                      ++|++.+.||+|+||+||+|++     .+++.||||++.. ........+.+|++++++++||||+++++++...  ...
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            6788899999999999999974     3688999999843 2334456789999999999999999999998654  457


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            99999999999999997643  24899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ....... .......+|..|+|||.+.+..++.++||||+|+++|||++|..|+......   .................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTCCTHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCccccchhHHH
Confidence            6543221 2223346778899999999999999999999999999999999987543211   00000000000000000


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      . ..................++.+++.+||+.||++|||++|+++.|+++..
T Consensus       241 ~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          241 L-IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             H-HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H-HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            0 00000000000111223457778889999999999999999999987643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=349.95  Aligned_cols=255  Identities=23%  Similarity=0.306  Sum_probs=204.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-----cChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-----RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      .++|...+.||+|+||.||+|... +++.||+|.+......     .....+.+|++++++++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356889999999999999999775 6899999998654322     2356799999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC----cEEEeccc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM----EPHISDFG  967 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG  967 (1109)
                      ++||||+++|+|.+++...   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999999753   34899999999999999999999   89999999999999999887    79999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      +++.......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||......  .....+..   ....
T Consensus       164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~---~~~~  235 (326)
T 2y0a_A          164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSA---VNYE  235 (326)
T ss_dssp             TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHH---TCCC
T ss_pred             CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHh---cCCC
Confidence            9987653322   22357999999999999999999999999999999999999999653211  11111111   0000


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .    ...    .    .......+.+++.+|++.||++|||++|+++|-+
T Consensus       236 ~----~~~----~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          236 F----EDE----Y----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             C----CHH----H----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             c----Ccc----c----cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            0    000    0    0111234566888999999999999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.5e-37  Score=346.87  Aligned_cols=273  Identities=21%  Similarity=0.325  Sum_probs=204.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|+..++||+|+||+||+|... +++.||+|++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888999999999999999775 68999999986544333 34678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++ ++.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9986 6666665432  34899999999999999999999   8899999999999999999999999999998764332


Q ss_pred             CCceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc-cccc--
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI-NDIV-- 1052 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-- 1052 (1109)
                        .......||+.|+|||++.+.. ++.++||||+||++|||++|+.|+........................ ....  
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence              2223457899999999988766 799999999999999999999987654433332322222211111000 0000  


Q ss_pred             -chh---h--hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1053 -DLS---L--MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1053 -d~~---~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                       +..   .  ..............++.+++.+|++.||++|||++|+++|-+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  286 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence             000   0  0000000011223445678889999999999999999997553

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5e-38  Score=357.78  Aligned_cols=260  Identities=21%  Similarity=0.346  Sum_probs=208.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC--------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecC
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG--------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRK  888 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  888 (1109)
                      .++|...+.||+|+||+||+|+..        +++.||||++...........+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367889999999999999999763        56789999986554445566789999999999 899999999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL  955 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  955 (1109)
                      +..++||||+++|+|.+++.....             ...+++..++.++.|+++||+|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999986542             234899999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccH
Q 001275          956 DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDI 1034 (1109)
Q Consensus       956 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1109)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....  ...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~  268 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EEL  268 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--HHH
Confidence            9999999999999987755433333334567889999999998889999999999999999999 9999864321  111


Q ss_pred             HHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1035 VGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1035 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ...+......     ..             ......++.+++.+||+.||++||+++|++++|+++
T Consensus       269 ~~~~~~~~~~-----~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          269 FKLLKEGHRM-----DK-------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHHHHHTCCC-----CC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCC-----CC-------------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111111000     00             011123466788899999999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.4e-37  Score=349.22  Aligned_cols=274  Identities=22%  Similarity=0.321  Sum_probs=193.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|+..+.||+|+||+||+|... +++.||+|++...........+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467999999999999999999764 5899999999766555566788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          897 YMENGSLRDVLHSIT---PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      |++ |+|.+++....   ....+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 59999986532   2235899999999999999999999   8899999999999999999999999999998764


Q ss_pred             CCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc-ccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI-NDI 1051 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1051 (1109)
                      ....  ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ................. ...
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhh
Confidence            3321  2233578999999999876 46899999999999999999999999654221 11111111111100000 000


Q ss_pred             -------------cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 -------------VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 -------------~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                   ....+..............++.+++.+|++.||++|||++|+++|-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~  296 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW  296 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence                         00000000000000112245777888999999999999999998743

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.4e-38  Score=349.38  Aligned_cols=254  Identities=19%  Similarity=0.312  Sum_probs=203.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|+..+.||+|+||+||+|+..++..||+|++...  .....++.+|++++++++||||+++++++...+..++||||+
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT--SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC--CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            578889999999999999999998999999998533  334567999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus       102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~  175 (283)
T 3gen_A          102 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y  175 (283)
T ss_dssp             TTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-c
Confidence            9999999997633  24899999999999999999999   8899999999999999999999999999998664321 1


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......  ...   ..........    .+   
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~---~~~~~~~~~~----~~---  243 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETA---EHIAQGLRLY----RP---  243 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH---HHHHTTCCCC----CC---
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHH---HHHhcccCCC----CC---
Confidence            12223457788999999999999999999999999999998 99998653211  111   1111110000    00   


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              .....++.+++.+||+.||++||+++|++++|.++
T Consensus       244 --------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          244 --------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             --------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                    01123466788899999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.5e-38  Score=355.79  Aligned_cols=260  Identities=19%  Similarity=0.336  Sum_probs=190.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCC----cEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce-
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPN----AVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG-  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  891 (1109)
                      .++|...+.||+|+||+||+|.....    ..||||++.... .......+.+|++++++++||||+++++++...+.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            46799999999999999999976543    279999985432 333456799999999999999999999999877655 


Q ss_pred             -----eEEEEeccCCCHHHHHhccC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          892 -----IIMYRYMENGSLRDVLHSIT---PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       892 -----~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                           ++||||+++|+|.+++....   ....+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999996532   2225899999999999999999999   889999999999999999999999


Q ss_pred             ecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhh
Q 001275          964 SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      +|||+++...............+|+.|+|||.+.+..++.++||||+||++|||++ |+.||......  .....+   .
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~---~  253 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNYL---I  253 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHH---H
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--HHHHHH---h
Confidence            99999987655443333444567889999999999999999999999999999999 88888653221  111111   1


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .... .              ........++.+++.+||+.||++||++.|+++.|+++
T Consensus       254 ~~~~-~--------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          254 GGNR-L--------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             TTCC-C--------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCC-C--------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1000 0              00011223467788899999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-37  Score=351.11  Aligned_cols=254  Identities=19%  Similarity=0.289  Sum_probs=204.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|.+.+.||+|+||+||+|... +++.||+|.+...  ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            367888999999999999999765 5789999988532  3334568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC--CCcEEEecccCCcccCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS--EMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~  974 (1109)
                      |+++|+|.+++....  ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.  ++.+||+|||+++....
T Consensus        82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999997533  35899999999999999999999   889999999999999987  78999999999987754


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......     .............    +.
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~----~~  224 (321)
T 1tki_A          157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNAEYTF----DE  224 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCCC----CH
T ss_pred             CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHcCCCCC----Ch
Confidence            32   234467999999999999888899999999999999999999999653221     1111111110000    00


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .        .......++.+++.+|++.||++|||+.|+++|-+
T Consensus       225 ~--------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          225 E--------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             H--------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             h--------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            0        01112234667888999999999999999999764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-37  Score=353.19  Aligned_cols=257  Identities=22%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcE----EEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|+..++||+|+||+||+|... +++.    ||+|.+...........+.+|+.++++++||||+++++++. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            46888899999999999999764 3443    77787754444445567789999999999999999999986 566899


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999997642  34888999999999999999999   8899999999999999999999999999999876


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............+|..|+|||++.+..++.++||||+||++|||++ |+.||.....  ......+....  ......  
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~--~~~~~~--  240 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKGE--RLAQPQ--  240 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHHHTTC--BCCCCT--
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHHHcCC--CCCCCC--
Confidence            5544444455678889999999999999999999999999999999 9999865321  11222111100  000000  


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                                    ....++.+++.+||+.||++||+++|++++|+++.
T Consensus       241 --------------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          241 --------------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             --------------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             --------------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                          01123556888999999999999999999998753

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-37  Score=346.26  Aligned_cols=271  Identities=22%  Similarity=0.345  Sum_probs=201.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...+.||+|+||+||+|+..+++.||+|++..... ......+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            46888999999999999999988899999999854432 23346788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++ +|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            985 9999987643  34899999999999999999999   8899999999999999999999999999998764322 


Q ss_pred             CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc-ccccc----
Q 001275          978 STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE-EINDI---- 1051 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---- 1051 (1109)
                       .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ................ .....    
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHHCCCChhhchhhhccc
Confidence             122335789999999988764 589999999999999999999999965422 1122222221111000 00000    


Q ss_pred             -cchhhhH--Hh-hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 -VDLSLME--EM-LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 -~d~~~~~--~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       .++....  .. ..........++.+++.+|++.||++|||++|+++|-+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence             0000000  00 00000112244667888999999999999999998754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=363.33  Aligned_cols=276  Identities=20%  Similarity=0.242  Sum_probs=211.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC--ceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD--CGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~  895 (1109)
                      ++|.+.++||+|+||+||+|... +++.||||++...........+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888999999999999999775 589999999965555556678889999999999999999999998765  679999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee----CCCCcEEEecccCCcc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL----DSEMEPHISDFGIAKL  971 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~DfGla~~  971 (1109)
                      ||+++|+|.+++........+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999987655455999999999999999999999   8899999999999999    7778899999999987


Q ss_pred             cCCCCCCceeeecccCccccccccccc--------CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFT--------TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      .....   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.+.................
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            65432   2223579999999998865        567889999999999999999999997543322222111111111


Q ss_pred             Ccc-cccccc---chhh--hH--HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1044 DTE-EINDIV---DLSL--ME--EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1044 ~~~-~~~~~~---d~~~--~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ... ....+.   ....  ..  .............+.+++.+|++.||++||+++|+++.+.++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            110 000000   0000  00  000011234455677788899999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.8e-38  Score=354.02  Aligned_cols=249  Identities=22%  Similarity=0.326  Sum_probs=201.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+|.+.+.||+|+||+||+|.. .+++.||+|++....  .......+.+|+++++.++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5788899999999999999976 578999999985432  2233467899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+ +|+|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 689999987644   3899999999999999999999   889999999999999999999999999999876543


Q ss_pred             CCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..   .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||........               ...+...
T Consensus       162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~  223 (336)
T 3h4j_B          162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC  223 (336)
T ss_dssp             BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS
T ss_pred             cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC
Confidence            22   223579999999999988876 7899999999999999999999965321110               0000000


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..   ..+.   ....++.+++.+|++.||++|||++|+++|-+
T Consensus       224 ~~---~~p~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          224 VY---VMPD---FLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             CC---CCCT---TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             CC---CCcc---cCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence            00   0000   11234566888999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.4e-37  Score=355.93  Aligned_cols=256  Identities=21%  Similarity=0.273  Sum_probs=200.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|+..++||+|+||+||+|+.. +++.||+|++....  .......+.+|..++.++ +||||+++++++...+..++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            67899999999999999999765 57899999986543  223345688999999887 899999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus       132 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999998644   4899999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc----ccHHHHHHHhhcCcccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER----TDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......    .................  
T Consensus       206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--  281 (396)
T 4dc2_A          206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--  281 (396)
T ss_dssp             TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC--
T ss_pred             CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC--
Confidence            22  22334689999999999999999999999999999999999999996432111    00111111111110000  


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM------RDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~L~ 1098 (1109)
                                    ......++.+++.+|++.||++||++      +|+++|-.
T Consensus       282 --------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf  321 (396)
T 4dc2_A          282 --------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  321 (396)
T ss_dssp             --------------CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred             --------------CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence                          01112345667889999999999985      68877654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-37  Score=344.77  Aligned_cols=248  Identities=24%  Similarity=0.308  Sum_probs=203.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|+||+||+|+.. +|+.||+|++....  .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57888999999999999999775 68999999986432  2234567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999998643   4899999999999999999999   899999999999999999999999999999866432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                           .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ...............      
T Consensus       160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~p------  223 (318)
T 1fot_A          160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILNAELRFP------  223 (318)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHCCCCCC------
T ss_pred             -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCCCC------
Confidence                 1235799999999999999999999999999999999999999965321     111111111110000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                             ...   ..++.+++.+|++.||++||     +++|+++|-+
T Consensus       224 -------~~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~  261 (318)
T 1fot_A          224 -------PFF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW  261 (318)
T ss_dssp             -------TTS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -------CCC---CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence                   011   13456677899999999999     8999998754

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-38  Score=359.67  Aligned_cols=265  Identities=20%  Similarity=0.312  Sum_probs=210.3

Q ss_pred             HHHhhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC
Q 001275          815 IEATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK  888 (1109)
Q Consensus       815 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  888 (1109)
                      ....++|...+.||+|+||.||+|...      +++.||+|.+...........+.+|++++++++||||+++++++...
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            345578999999999999999999654      36889999986544444556789999999999999999999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          889 DCGIIMYRYMENGSLRDVLHSIT-------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                      +..++||||+++|+|.++++...       ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeE
Confidence            99999999999999999997532       1235789999999999999999999   8899999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||+++...............+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....  ..   ....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~---~~~~  252 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQ---VLRF  252 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--HH---HHHH
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--HH---HHHH
Confidence            9999999986644322222233467889999999999999999999999999999999 8888854321  11   1111


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      .....  ....             .......+.+++.+|++.||++||++.|++++|++...
T Consensus       253 ~~~~~--~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          253 VMEGG--LLDK-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHTTC--CCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHcCC--cCCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            11110  0000             01122346678889999999999999999999988633

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.2e-38  Score=370.81  Aligned_cols=262  Identities=26%  Similarity=0.361  Sum_probs=205.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|...++||+|+||+||+|.+.++..||||++...  .....++.+|++++++++||||+++++++.. +..++||||+
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccC--CCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            567888999999999999999998889999998533  2345689999999999999999999999876 6789999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.++++... ...+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++...... .
T Consensus       261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            9999999997532 234889999999999999999999   8999999999999999999999999999998764332 1


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......+|..|+|||++.+..++.++|||||||++|||++ |+.||.....  .+....+.   ....    .      
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~---~~~~----~------  400 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVE---RGYR----M------  400 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHH---TTCC----C------
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHH---cCCC----C------
Confidence            22234567889999999999999999999999999999999 8988864321  11111111   1100    0      


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCCCC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKY 1108 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1108 (1109)
                           .........+.+++.+||+.||++|||++++++.|+++.....++|
T Consensus       401 -----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~  446 (452)
T 1fmk_A          401 -----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  446 (452)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence                 0001123456678889999999999999999999999877666655

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=353.49  Aligned_cols=252  Identities=23%  Similarity=0.313  Sum_probs=202.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....  .......+.+|++++++++|||||++++++...+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            57889999999999999999765 58899999985432  2334567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999998643   4899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCCceeeecccCccccccccccc---CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAFT---TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .   ......||+.|+|||++.+   ..++.++||||+||++|||++|+.||......  .................   
T Consensus       169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~p---  240 (384)
T 4fr4_A          169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST--SSKEIVHTFETTVVTYP---  240 (384)
T ss_dssp             C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS--CHHHHHHHHHHCCCCCC---
T ss_pred             C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc--cHHHHHHHHhhcccCCC---
Confidence            2   2234689999999999874   45899999999999999999999999643221  11111111111100000   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-MRDVVRQL 1097 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L 1097 (1109)
                                   .....++.+++.+|++.||++||+ ++++.+|-
T Consensus       241 -------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp  273 (384)
T 4fr4_A          241 -------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFP  273 (384)
T ss_dssp             -------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSG
T ss_pred             -------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcCh
Confidence                         111234667888999999999998 78887654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-36  Score=346.32  Aligned_cols=270  Identities=24%  Similarity=0.302  Sum_probs=201.9

Q ss_pred             HHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcC--CCCceeeEeeEEecC----
Q 001275          815 IEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI--RHRNLVRLEDFWLRK----  888 (1109)
Q Consensus       815 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----  888 (1109)
                      ....++|++.+.||+|+||+||+|+.. ++.||||++...    ....+.+|.+++...  +||||+++++++...    
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            344578999999999999999999887 899999998422    233455566665554  999999999999877    


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--------CeEEeccCCCCeeeCCCCc
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP--------PIVHRDIKPENILLDSEME  960 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~ivH~Dlk~~NIll~~~~~  960 (1109)
                      ...++||||+++|+|.++++..    .+++..++.++.|++.||+|||   +.        +|+||||||+||+++.++.
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCC
Confidence            6789999999999999999764    3899999999999999999999   66        9999999999999999999


Q ss_pred             EEEecccCCcccCCCCCCc--eeeecccCcccccccccccCCCCcc------CcchhhHHHHHHHHhC----------CC
Q 001275          961 PHISDFGIAKLLDKSPAST--TSISVVGTIGYIAPENAFTTAKSKE------SDVYSYGVVLLELITR----------KK 1022 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvil~elltg----------~~ 1022 (1109)
                      +||+|||+++.........  ......||+.|+|||++.+..++.+      +|||||||++|||++|          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            9999999998664432221  1124579999999999987776655      9999999999999999          55


Q ss_pred             CCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1023 ALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1023 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      ||.....................  .    .+......   .......++.+++.+||+.||++||+++|++++|+++..
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKK--L----RPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSC--C----CCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhhc--c----Cccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            55433222222222111111000  0    00000000   012455668889999999999999999999999998754


Q ss_pred             CCC
Q 001275         1103 PMT 1105 (1109)
Q Consensus      1103 ~~~ 1105 (1109)
                      ...
T Consensus       332 ~~~  334 (337)
T 3mdy_A          332 SQD  334 (337)
T ss_dssp             TTT
T ss_pred             hcc
Confidence            433

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.5e-37  Score=355.00  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=199.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .++|+..++||+|+||+||+|+.. +++.||||++....  .......+.+|.+++..+ +||||+++++++...+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            367999999999999999999765 58999999986432  233456688999999988 79999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+...
T Consensus       102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999997654   3899999999999999999999   8899999999999999999999999999998543


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||......     ...............   
T Consensus       176 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~~~~~p~---  245 (353)
T 3txo_A          176 CNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDEVVYPT---  245 (353)
T ss_dssp             C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCCCT---
T ss_pred             cCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCCCCCCC---
Confidence            222  2233468999999999999999999999999999999999999999653211     111111111110100   


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHhh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM------RDVVRQLV 1098 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~L~ 1098 (1109)
                                .   ...++.+++.+|++.||++||++      +|+++|-+
T Consensus       246 ----------~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~  283 (353)
T 3txo_A          246 ----------W---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF  283 (353)
T ss_dssp             ----------T---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred             ----------C---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence                      0   11235567789999999999998      78887654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.4e-37  Score=353.92  Aligned_cols=256  Identities=22%  Similarity=0.307  Sum_probs=204.2

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ..++|.+.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3568999999999999999999764 689999999864432 23345788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC---cEEEecccCCcc
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM---EPHISDFGIAKL  971 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfGla~~  971 (1109)
                      |||+++|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++   .+||+|||+++.
T Consensus       107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999987543   4899999999999999999999   88999999999999998654   599999999987


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ......   .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.....  ......+..   ......  
T Consensus       181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--~~~~~~i~~---~~~~~~--  250 (362)
T 2bdw_A          181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--HRLYAQIKA---GAYDYP--  250 (362)
T ss_dssp             CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---TCCCCC--
T ss_pred             ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh---CCCCCC--
Confidence            653322   2346799999999999999999999999999999999999999965321  111111111   100000  


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       .+.         ......++.+++.+|++.||++||++.|+++|-+
T Consensus       251 -~~~---------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  287 (362)
T 2bdw_A          251 -SPE---------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  287 (362)
T ss_dssp             -TTG---------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHH
T ss_pred             -ccc---------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence             000         0111234566888999999999999999998743

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.5e-37  Score=353.54  Aligned_cols=254  Identities=22%  Similarity=0.305  Sum_probs=189.0

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|.+.+.||+|+||+||+|+.. +++.||||++....   ....+.+|++++++++||||+++++++...+..++|||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            467889999999999999999876 57899999985432   34568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCcEEEecccCCcccC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EMEPHISDFGIAKLLD  973 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGla~~~~  973 (1109)
                      |+++|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999997643   4899999999999999999999   889999999999999975   8899999999998664


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........    ...........   ..
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~i~~~~~~~---~~  272 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM----FRRILNCEYYF---IS  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH----HHHHHTTCCCC---CT
T ss_pred             ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH----HHHHHhCCCcc---CC
Confidence            322   223457999999999999999999999999999999999999999654322111    11111110000   00


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      +         .......++.+++.+|++.||++||++.|+++|-+-
T Consensus       273 ~---------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~  309 (349)
T 2w4o_A          273 P---------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV  309 (349)
T ss_dssp             T---------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             c---------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            0         001122346678889999999999999999997543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=361.11  Aligned_cols=257  Identities=19%  Similarity=0.258  Sum_probs=203.7

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ..++|++.+.||+|+||+||+|.. .+|+.||+|++..... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            457799999999999999999965 5789999999865432 23345789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC---CCCcEEEecccCCcc
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD---SEMEPHISDFGIAKL  971 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfGla~~  971 (1109)
                      |||+++|+|.+++....   .+++..+..++.|+++|++|||   +.+|+||||||+||+++   .++.+||+|||+++.
T Consensus        89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999999997643   4899999999999999999999   88999999999999998   467899999999987


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ......  ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....  ......+..   ......  
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--~~~~~~i~~---~~~~~~--  233 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--HRLYQQIKA---GAYDFP--  233 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHH---TCCCCC--
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHh---CCCCCC--
Confidence            654322  22346899999999999999999999999999999999999999965321  111111111   100000  


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       .+.         ......++.+++.+|++.||++||+++|+++|-+
T Consensus       234 -~~~---------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          234 -SPE---------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             -TTT---------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             -ccc---------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence             000         0111234566788999999999999999998743

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-36  Score=339.04  Aligned_cols=253  Identities=23%  Similarity=0.431  Sum_probs=199.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccC------hHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRG------SLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      ++|+..+.||+|+||+||+|+. .+++.||+|++........      ...+.+|++++++++||||+++++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5788899999999999999977 5789999999854433222      267899999999999999999999986544  


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeccCCCCeeeCCCCc-----EEEe
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP--IVHRDIKPENILLDSEME-----PHIS  964 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~-----~kl~  964 (1109)
                      ++||||+++|+|.+++....  ..+++..++.++.|+++|++|||   +.+  |+||||||+||+++.++.     +||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            79999999999999887543  35899999999999999999999   788  999999999999988776     9999


Q ss_pred             cccCCcccCCCCCCceeeecccCcccccccccc--cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPENAF--TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      |||+++....     ......||+.|+|||++.  ...++.++||||+||++|||++|+.||..................
T Consensus       172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~  246 (287)
T 4f0f_A          172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG  246 (287)
T ss_dssp             CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred             CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence            9999984432     233467999999999884  455689999999999999999999999754332221111111110


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ...    ..             ......++.+++.+||+.||++||+++|+++.|+++
T Consensus       247 ~~~----~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 LRP----TI-------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCC----CC-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCC----CC-------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            000    00             011123466788899999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-37  Score=348.20  Aligned_cols=270  Identities=22%  Similarity=0.326  Sum_probs=204.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC--Cce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  891 (1109)
                      ++|+..+.||+|+||.||+|++     .+++.||+|++...........+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999983     468999999997665556667899999999999999999999999876  567


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            99999999999999996543  34899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc--cc
Q 001275          972 LDKSPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE--EI 1048 (1109)
Q Consensus       972 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 1048 (1109)
                      ....... .......||..|+|||.+.+..++.++||||+|+++|||++|+.|+.....      ...........  ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA------LFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH------HHHHHHCSCCGGGHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh------HHhhccCCcccccCH
Confidence            7544322 222345788899999999999999999999999999999999988642211      00000000000  00


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..+ ..................++.+++.+||+.||++|||++|+++.|+++
T Consensus       250 ~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          250 TRL-VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH-HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            000 000000000000112234577788899999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-37  Score=353.73  Aligned_cols=256  Identities=21%  Similarity=0.270  Sum_probs=203.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc----cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG----HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|++.+.||+|+||+||+|.. .+++.||||++....    .......+.+|++++++++||||+++++++...+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            5789999999999999999976 468999999985432    12245679999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc---EEEecccCC
Q 001275          894 MYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME---PHISDFGIA  969 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfGla  969 (1109)
                      ||||+++|+|.+++.... ....+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            999999999998886532 2335899999999999999999999   889999999999999987654   999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      +.......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ...   .........  
T Consensus       181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~---~~i~~~~~~--  250 (351)
T 3c0i_A          181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLF---EGIIKGKYK--  250 (351)
T ss_dssp             EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHH---HHHHHTCCC--
T ss_pred             eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHH---HHHHcCCCC--
Confidence            87754322  22345799999999999999999999999999999999999999965311   111   111110000  


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                        ..+..        ......++.+++.+|++.||++||++.|+++|-
T Consensus       251 --~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  288 (351)
T 3c0i_A          251 --MNPRQ--------WSHISESAKDLVRRMLMLDPAERITVYEALNHP  288 (351)
T ss_dssp             --CCHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --CCccc--------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence              00000        011123466788899999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=351.82  Aligned_cols=257  Identities=23%  Similarity=0.349  Sum_probs=198.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcE----EEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAV----FAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|+..++||+|+||+||+|... +++.    ||+|.+...........+.+|++++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            57888999999999999999764 4443    57777655555566778999999999999999999999998654 789


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      |+||+++|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            999999999999998643  34899999999999999999999   8899999999999999999999999999998775


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............+|+.|+|||.+.+..++.++||||+||++|||++ |+.||......  .....+....    ...   
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~~~~~~~~~~----~~~---  239 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE----RLP---  239 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTTC----CCC---
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC----CCC---
Confidence            5444333444567889999999999999999999999999999999 99998654221  2222211110    000   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .           ......++.+++.+||+.||++||+++|+++.|+++.
T Consensus       240 ~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          240 Q-----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             C-----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            0           0111234667888999999999999999999998763

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-37  Score=347.52  Aligned_cols=261  Identities=26%  Similarity=0.379  Sum_probs=193.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.++||+|+||+||+|+...  .||+|++..... ......+.+|++++++++||||+++++++ ..+..++||||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~  100 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW  100 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence            678999999999999999998653  589999854432 23346789999999999999999999965 45668999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A          101 CEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             CCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             cCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999996543  35899999999999999999999   88999999999999999999999999999986654333


Q ss_pred             CceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ........||+.|+|||.+.   +..++.++||||+|+++|||++|+.||...... ......+...... ......   
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~---  250 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLS-PDLSKV---  250 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHHHHTSCC-CCTTSS---
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHHhcccccC-cchhhc---
Confidence            33334467999999999886   667889999999999999999999999653221 1122221111000 000000   


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                                ......++.+++.+||+.||++||+++|+++.|+++..
T Consensus       251 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          251 ----------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ----------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                      01123456778889999999999999999999998853

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-37  Score=343.17  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=191.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc---ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH---KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|+||+||+|... ++.||||++.....   ......+.+|++++++++||||+++++++...+..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57888999999999999999876 88999998854332   233467899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC---eEEeccCCCCeeeCC--------CCcEEEe
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP---IVHRDIKPENILLDS--------EMEPHIS  964 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~Dlk~~NIll~~--------~~~~kl~  964 (1109)
                      ||+++++|.+++...    .+++..++.++.|+++|++|||   +.+   |+||||||+||+++.        ++.+||+
T Consensus        86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999998642    4899999999999999999999   666   999999999999986        6789999


Q ss_pred             cccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      |||+++.......    ....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.......     ........
T Consensus       159 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~  229 (271)
T 3dtc_A          159 DFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYGVAMN  229 (271)
T ss_dssp             CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHTS
T ss_pred             cCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHhhhcC
Confidence            9999986643322    23579999999999999999999999999999999999999996532111     11111100


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .... ..             ......++.+++.+||+.||++||+++|++++|+++
T Consensus       230 ~~~~-~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          230 KLAL-PI-------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCCC-CC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCC-CC-------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            0000 00             011123466788899999999999999999999863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1e-37  Score=345.94  Aligned_cols=255  Identities=22%  Similarity=0.308  Sum_probs=193.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|+..+.||+|+||+||+|....    +..||+|++...........+.+|+.++++++||||+++++++. .+..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            578889999999999999997643    45799998755444445567899999999999999999999984 5678999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++....  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999999997643  34899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ... .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......  +....+...  .....     
T Consensus       169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~~~~~i~~~--~~~~~-----  238 (281)
T 1mp8_A          169 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENG--ERLPM-----  238 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTT--CCCCC-----
T ss_pred             ccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--HHHHHHHcC--CCCCC-----
Confidence            322 12233467889999999999999999999999999999997 88898654221  222111110  00000     


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                 ......++.+++.+|++.||++||+++|++++|+++
T Consensus       239 -----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          239 -----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             -----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                       011223466788899999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.8e-38  Score=353.81  Aligned_cols=266  Identities=22%  Similarity=0.308  Sum_probs=211.2

Q ss_pred             HHHHHhhCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEE
Q 001275          813 QVIEATENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFW  885 (1109)
Q Consensus       813 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  885 (1109)
                      +.....++|.+.+.||+|+||+||+|..      .+++.||||++...........+.+|++++.++ +||||+++++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            3334457899999999999999999964      356889999986554444556789999999999 799999999998


Q ss_pred             ecCC-ceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCC
Q 001275          886 LRKD-CGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPE  951 (1109)
Q Consensus       886 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  951 (1109)
                      ...+ ..++||||+++|+|.+++.....             ...+++..++.++.|+++||+|||   +.+|+||||||+
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~  177 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR  177 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccc
Confidence            7754 48999999999999999986543             123789999999999999999999   889999999999


Q ss_pred             CeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccc
Q 001275          952 NILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKE 1030 (1109)
Q Consensus       952 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~ 1030 (1109)
                      ||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+|+++|||++ |+.||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            99999999999999999987755444333444678899999999999999999999999999999998 99998653221


Q ss_pred             cccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1031 RTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       ......+....  ....                ......++.+++.+||+.||++||+++|++++|+.+
T Consensus       258 -~~~~~~~~~~~--~~~~----------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          258 -EEFCRRLKEGT--RMRA----------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             -HHHHHHHHHTC--CCCC----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHhccCc--cCCC----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             11111111100  0000                001123466788899999999999999999999875

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=364.10  Aligned_cols=309  Identities=23%  Similarity=0.213  Sum_probs=268.4

Q ss_pred             cCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccc
Q 001275           87 LGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRI  166 (1109)
Q Consensus        87 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l  166 (1109)
                      +|..+  .+++++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..+..+.++
T Consensus        26 ip~~~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  103 (477)
T 2id5_A           26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGL  103 (477)
T ss_dssp             CCSCC--CTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTC
T ss_pred             CCCCC--CCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCC
Confidence            45544  3589999999999998888999999999999999999998889999999999999999999995555667899


Q ss_pred             cccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccc
Q 001275          167 LGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDV  246 (1109)
Q Consensus       167 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  246 (1109)
                      ++|++|+|++|++++..|..|.++++|++|++++|.+++..|..|+++++|++|+|++|++++..+..|.++++|+.|++
T Consensus       104 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l  183 (477)
T 2id5_A          104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL  183 (477)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEE
T ss_pred             CCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeC
Confidence            99999999999999888999999999999999999999888899999999999999999999888888999999999999


Q ss_pred             cCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCC
Q 001275          247 GDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGK  326 (1109)
Q Consensus       247 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  326 (1109)
                      ++|++++..+..+..+++|++|++++|.+.+.++..+....+|+.|++++|+++...+..|..+++|+.|+|++|.+++.
T Consensus       184 ~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  263 (477)
T 2id5_A          184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI  263 (477)
T ss_dssp             ESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEE
T ss_pred             CCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCcc
Confidence            99999988888888899999999999888777777776677888888888888865556788888888888888888877


Q ss_pred             CCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCC
Q 001275          327 IPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLG  397 (1109)
Q Consensus       327 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~  397 (1109)
                      .+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|+.|++++|.+..
T Consensus       264 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             CTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             ChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence            77788888888888888888888778888888888888888888886666666777778888888777764

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.1e-36  Score=354.47  Aligned_cols=351  Identities=19%  Similarity=0.133  Sum_probs=231.4

Q ss_pred             cCCCCCCCCCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeecc
Q 001275           48 ISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLS  127 (1109)
Q Consensus        48 l~sW~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls  127 (1109)
                      +++|.....|||.|.++.|.....+|     ............-..++++++|++++|.++...+..+..+++|++|+|+
T Consensus         3 ~~~~~~~~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~   77 (390)
T 3o6n_A            3 VKPRQPEYKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN   77 (390)
T ss_dssp             ----CCEECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred             cCCCCCccceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence            57888766555556666664222122     2212122222233457888999999998885444447888999999999


Q ss_pred             CccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCc
Q 001275          128 TNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTI  207 (1109)
Q Consensus       128 ~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  207 (1109)
                      +|.+++..+..|+++++|++|+|++|.+++..|..+.++++|++|++++|+++...+..|+++++|++|++++|++++..
T Consensus        78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~  157 (390)
T 3o6n_A           78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE  157 (390)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred             CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence            99998777778899999999999999988777777888888888888888888554455688888888888888888777


Q ss_pred             ccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCccccccc
Q 001275          208 PESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCS  287 (1109)
Q Consensus       208 p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  287 (1109)
                      |..|+++++|++|++++|++++.   .+..+++|+.|++++|.+++.     ...++|++|++++|.++.. +..  ..+
T Consensus       158 ~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~  226 (390)
T 3o6n_A          158 DDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP--VNV  226 (390)
T ss_dssp             TTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCS
T ss_pred             hhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc--ccc
Confidence            77788888888888888888765   355667778888888877643     2234677777777777643 222  235


Q ss_pred             CCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEcc
Q 001275          288 SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELF  367 (1109)
Q Consensus       288 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  367 (1109)
                      +|+.|++++|++++.  ..++.+++|++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|+
T Consensus       227 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~  303 (390)
T 3o6n_A          227 ELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLS  303 (390)
T ss_dssp             SCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECC
T ss_pred             cccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECC
Confidence            667777777776643  456666667777777776666666666666666666666666663 45455566666666666


Q ss_pred             CccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcc
Q 001275          368 DNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSG  421 (1109)
Q Consensus       368 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  421 (1109)
                      +|+++ .+|..+..+++|++|++++|++++. +  +..+++|+.|++++|++++
T Consensus       304 ~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          304 HNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             SSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             CCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence            66666 3555556666666666666666533 1  4445555555555555543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-37  Score=364.65  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=201.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC-ceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD-CGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  897 (1109)
                      ++|...+.||+|+||+||+|... ++.||||++...   .....+.+|++++++++||||+++++++...+ ..++||||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC---TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc---hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            56788899999999999999887 789999998533   24568999999999999999999999987765 78999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.++++... ...+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++...... 
T Consensus       269 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            99999999998753 234789999999999999999999   8899999999999999999999999999998553221 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                          ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....  .+....+..   .. ..    .   
T Consensus       344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~---~~-~~----~---  406 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEK---GY-KM----D---  406 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT--TTHHHHHHT---TC-CC----C---
T ss_pred             ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CC-CC----C---
Confidence                12367889999999999999999999999999999998 9999864321  122221111   00 00    0   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .......++.+++.+||+.||++||+++|+++.|+++
T Consensus       407 -------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          407 -------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   0011234567788899999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=347.27  Aligned_cols=253  Identities=29%  Similarity=0.464  Sum_probs=195.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|++.+.||+|+||+||+|+.. ++.||||++..   ......+.+|++++++++||||+++++++.  +..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES---ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS---TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC---hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            56888899999999999999886 78899998742   234567899999999999999999999876  4589999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc-EEEecccCCcccCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME-PHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~kl~DfGla~~~~~~~~  977 (1109)
                      ++|+|.++++.......+++..++.++.|+++||+|||..+..+|+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999987654456889999999999999999999322289999999999999988886 799999999765432  


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........   .......  ....      
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~--~~~~------  225 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGT--RPPL------  225 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHHTTC--CCCC------
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHhcCC--CCCc------
Confidence               1234689999999999999999999999999999999999999965322211111   1110000  0000      


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .......+.+++.+||+.||++||+++|++++|+.+
T Consensus       226 -------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          226 -------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             -------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                   011123466788899999999999999999999865

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.7e-37  Score=356.55  Aligned_cols=255  Identities=23%  Similarity=0.277  Sum_probs=194.5

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|.+.+.||+|+||+||+|+.. +++.||||++...  ......+.+|+.++++++||||+++++++...+..++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS--TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC--ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            357899999999999999999775 7899999998532  3334678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc--EEEecccCCcccCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME--PHISDFGIAKLLDK  974 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfGla~~~~~  974 (1109)
                      |+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.  +||+|||+++....
T Consensus        97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            999999999997644   3899999999999999999999   899999999999999987765  99999999974432


Q ss_pred             CCCCceeeecccCcccccccccccCCCCcc-CcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKE-SDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ..   ......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||..... ....................   
T Consensus       171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~---  243 (361)
T 3uc3_A          171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PRDYRKTIQRILSVKYSIPD---  243 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-----CCCHHHHHHHHHTTCCCCCT---
T ss_pred             cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc-HHHHHHHHHHHhcCCCCCCC---
Confidence            21   2234579999999999988887655 8999999999999999999965322 22222222222211111100   


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                 ......++.+++.+||+.||++|||+.|+++|-+
T Consensus       244 -----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          244 -----------DIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             -----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             -----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence                       0011234567888999999999999999999854

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.9e-37  Score=341.45  Aligned_cols=257  Identities=23%  Similarity=0.316  Sum_probs=207.0

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|++.+.||+|+||.||+|... +++.||+|++...........+.+|++++++++||||+++++++...+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467899999999999999999775 6899999998655544556789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.+++...   ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.+.......
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999998653   34899999999999999999999   8899999999999999999999999999998654332


Q ss_pred             CCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .........||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||............+...    ....    .. 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~----~~-  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYL----NP-  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT----CTTS----TT-
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc----cccc----Cc-
Confidence            2222334578999999999987775 789999999999999999999997543322222222110    0000    00 


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               ......++.+++.+|++.||++||+++|++++-+
T Consensus       231 ---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  264 (276)
T 2yex_A          231 ---------WKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (276)
T ss_dssp             ---------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             ---------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence                     0111234566888999999999999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=347.16  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=194.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc-------------------------cChHHHHHHHHHHhc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK-------------------------RGSLSMKREIQTIGK  872 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~  872 (1109)
                      ++|.+.+.||+|+||+||+|.. .+++.||||++......                         .....+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            5788899999999999999976 46889999998543211                         123568899999999


Q ss_pred             CCCCceeeEeeEEec--CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCC
Q 001275          873 IRHRNLVRLEDFWLR--KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKP  950 (1109)
Q Consensus       873 l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~  950 (1109)
                      ++||||+++++++..  .+..++||||+++|+|.++...    ..+++..+..++.|+++||+|||   +.+|+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            999999999999986  5678999999999999876543    35899999999999999999999   88999999999


Q ss_pred             CCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCC---CCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          951 ENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA---KSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       951 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      +||+++.++.+||+|||+++......  .......||+.|+|||.+.+..   ++.++||||+||++|||++|+.||...
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999999998765432  2223457999999999988765   378899999999999999999999643


Q ss_pred             ccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1028 YKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ..     ..+............   +           ......++.+++.+||+.||++||+++|+++|-
T Consensus       244 ~~-----~~~~~~~~~~~~~~~---~-----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp  294 (298)
T 2zv2_A          244 RI-----MCLHSKIKSQALEFP---D-----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP  294 (298)
T ss_dssp             SH-----HHHHHHHHHCCCCCC---S-----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCH
T ss_pred             cH-----HHHHHHHhcccCCCC---C-----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCc
Confidence            21     111111111100000   0           011123466788899999999999999998763

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-36  Score=340.13  Aligned_cols=260  Identities=15%  Similarity=0.185  Sum_probs=205.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|.+.+.||+|+||+||+|.. .+++.||||++....   ....+.+|+++++++ +|+|++++++++......++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            5788999999999999999975 678999999885332   234578899999999 79999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc-----EEEecccCCcc
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME-----PHISDFGIAKL  971 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DfGla~~  971 (1109)
                      |+ +++|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 999999998643  34899999999999999999999   899999999999999987776     99999999987


Q ss_pred             cCCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          972 LDKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       972 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      .......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~  238 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN--KQKYERIGEKKQ  238 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH--HHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc--HHHHHHHHhhcc
Confidence            6543221     122346799999999999999999999999999999999999999975322111  111110000000


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                            ... ...    .......++.+++.+||+.||++||+++|+++.|+++
T Consensus       239 ------~~~-~~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          239 ------STP-LRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             ------HSC-HHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ------Ccc-HHH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence                  000 000    0011234577788899999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.4e-37  Score=347.02  Aligned_cols=259  Identities=15%  Similarity=0.214  Sum_probs=204.9

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|.+.+.||+|+||+||+|.. .+++.||||++....   ....+.+|+++++++ +||||+++++++...+..++|||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            5788899999999999999976 578999999885432   234588999999999 99999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc-----EEEecccCCcc
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME-----PHISDFGIAKL  971 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~kl~DfGla~~  971 (1109)
                      |+ +|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 999999998642  35899999999999999999999   889999999999999998887     99999999987


Q ss_pred             cCCCCCCc-----eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          972 LDKSPAST-----TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       972 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      +.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  +...........  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~--  235 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKERYQKIGDT--  235 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHHHHHHHHH--
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHHHHHHHhh--
Confidence            64432211     123468999999999999999999999999999999999999999754211  111111111000  


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              ..  ............++.+++.+||+.||.+||+++++++.|+++
T Consensus       236 --------~~--~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          236 --------KR--ATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             --------HH--HSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             --------hc--cCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence                    00  000000001112677888899999999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-36  Score=347.82  Aligned_cols=248  Identities=19%  Similarity=0.249  Sum_probs=204.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++....  .......+.+|++++++++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57889999999999999999775 68999999985432  2234567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999998654   3899999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                           .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ...............      
T Consensus       195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~~p------  258 (350)
T 1rdq_E          195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEKIVSGKVRFP------  258 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC------
T ss_pred             -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHHHHHcCCCCCC------
Confidence                 1235799999999999999999999999999999999999999964321     111111111110000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~ 1098 (1109)
                             .   ....++.+++.+|++.||++||+     ++|+++|-.
T Consensus       259 -------~---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          259 -------S---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             -------T---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             -------C---CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence                   0   11234566788999999999998     899998765

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=352.83  Aligned_cols=255  Identities=22%  Similarity=0.314  Sum_probs=195.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCC--CceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRH--RNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||+||+|...+++.||||++..... ......+.+|++++.+++|  +||+++++++...+..++||
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~   88 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM   88 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence            56888999999999999999988899999999864432 2334678999999999976  99999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      | +.+|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++ ++.+||+|||+++.....
T Consensus        89 e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           89 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             C-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             e-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            9 56789999998743   4899999999999999999999   88999999999999997 678999999999877544


Q ss_pred             CCCceeeecccCccccccccccc-----------CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          976 PASTTSISVVGTIGYIAPENAFT-----------TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........    .......
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~  236 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LHAIIDP  236 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHHHHCT
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----HHHHhcC
Confidence            33333345689999999998865           67899999999999999999999999643222111    1111111


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .... ..          ..   ....++.+++.+||+.||++|||++|+++|-+-
T Consensus       237 ~~~~-~~----------~~---~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~  277 (343)
T 3dbq_A          237 NHEI-EF----------PD---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  277 (343)
T ss_dssp             TSCC-CC----------CC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             Cccc-CC----------cc---cCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence            0000 00          00   011345678889999999999999999988653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-37  Score=371.33  Aligned_cols=257  Identities=23%  Similarity=0.317  Sum_probs=208.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|...++||+|+||.||+|.+.. +..||||++...  .....++.+|++++++++||||++++++|...+..++||||
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc--ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            567888999999999999998764 889999998533  33467899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.++++... ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus       298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            99999999998643 345899999999999999999999   8899999999999999999999999999998764322 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....  ..+...+.....    .        
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~----~--------  438 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYR----M--------  438 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCC----C--------
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC----C--------
Confidence            122223456789999999999999999999999999999999 8888864321  122222111100    0        


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                            ........++.+++.+||+.||++||+++|+++.|+.+..
T Consensus       439 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          439 ------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                  0001122456678889999999999999999999998743

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-37  Score=353.02  Aligned_cols=254  Identities=21%  Similarity=0.274  Sum_probs=203.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|.+.+.||+|+||+||+|... +++.||+|++... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            57899999999999999999765 6889999988533 233345789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC--CCcEEEecccCCcccCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS--EMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~  975 (1109)
                      +++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999999987532  34899999999999999999999   889999999999999974  467999999999877543


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ...   ...........    +..
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--~~~---~~~i~~~~~~~----~~~  272 (387)
T 1kob_A          205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LET---LQNVKRCDWEF----DED  272 (387)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--HHH---HHHHHHCCCCC----CSS
T ss_pred             c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--HHH---HHHHHhCCCCC----Ccc
Confidence            2   22345799999999999999999999999999999999999999965321  111   11111110000    000


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .        ......++.+++.+|++.||++||+++|+++|-+
T Consensus       273 ~--------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~  307 (387)
T 1kob_A          273 A--------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW  307 (387)
T ss_dssp             T--------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             c--------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence            0        0111234667888999999999999999999754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=8.3e-38  Score=355.92  Aligned_cols=261  Identities=21%  Similarity=0.316  Sum_probs=208.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC------CcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCc
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  890 (1109)
                      .++|...+.||+|+||+||+|....      ...||+|.+...........+.+|+++++++ +||||+++++++...+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            4678889999999999999997642      2479999986554444566789999999999 89999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC
Q 001275          891 GIIMYRYMENGSLRDVLHSITP-----------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM  959 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  959 (1109)
                      .++||||+++|+|.+++.....           ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCC
Confidence            9999999999999999975321           235799999999999999999999   88999999999999999999


Q ss_pred             cEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHH
Q 001275          960 EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWV 1038 (1109)
Q Consensus       960 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1038 (1109)
                      .+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||...... ......+
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~  280 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLV  280 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHHHH
Confidence            999999999986654433333334567889999999999999999999999999999999 88888643221 1111111


Q ss_pred             HHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1039 RSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1039 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .......       .+           .....++.+++.+||+.||++||+++|++++|++.
T Consensus       281 ~~~~~~~-------~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          281 KDGYQMA-------QP-----------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             HHTCCCC-------CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCCCCC-------CC-----------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence            1111000       00           01123466788899999999999999999999865

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.6e-37  Score=361.59  Aligned_cols=265  Identities=22%  Similarity=0.251  Sum_probs=205.8

Q ss_pred             HHHHHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC
Q 001275          813 QVIEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       813 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  889 (1109)
                      +.....++|+..++||+|+||+||+|+.. +++.||+|++....  .......+.+|..++..++||||++++++|.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            33344578999999999999999999876 47899999985432  1223345889999999999999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..|+||||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence            9999999999999999997632  34899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      +....... ......+||+.|+|||++.     ...++.++||||+||++|||++|+.||......     .........
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-----~~~~~i~~~  296 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ETYGKIMNH  296 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTH
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----HHHHhhhhc
Confidence            87644322 2223468999999999987     566899999999999999999999999653211     111111100


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhhh
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSN--RPNMRDVVRQLVD 1099 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L~~ 1099 (1109)
                      .... .  -+        ........++.+++.+|++.+|++  ||+++|+++|-+-
T Consensus       297 ~~~~-~--~p--------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff  342 (437)
T 4aw2_A          297 KERF-Q--FP--------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF  342 (437)
T ss_dssp             HHHC-C--CC--------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred             cccc-c--CC--------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence            0000 0  00        000011233556777999988888  9999999998653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-37  Score=350.37  Aligned_cols=253  Identities=23%  Similarity=0.312  Sum_probs=203.2

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCcee
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  892 (1109)
                      ..++|...++||+|+||+||+|+.. +++.||+|++....  .......+.+|.+++.++ +||||+++++++.+.+..|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999875 68999999986532  233456678899999887 9999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999998643   3899999999999999999999   889999999999999999999999999999864


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .....  .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.....  .   ...............  
T Consensus       169 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~---~~~~~i~~~~~~~p~--  239 (345)
T 1xjd_A          169 MLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--E---ELFHSIRMDNPFYPR--  239 (345)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--H---HHHHHHHHCCCCCCT--
T ss_pred             ccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--H---HHHHHHHhCCCCCCc--
Confidence            33221  22346899999999999999999999999999999999999999964321  1   111111111100000  


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR-DVVRQLV 1098 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~L~ 1098 (1109)
                                 ..   ..++.+++.+|++.||++||++. |+++|-.
T Consensus       240 -----------~~---s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          240 -----------WL---EKEAKDLLVKLFVREPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             -----------TS---CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             -----------cc---CHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence                       11   13455677899999999999998 7776543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.7e-37  Score=347.92  Aligned_cols=256  Identities=22%  Similarity=0.272  Sum_probs=201.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|...+.||+|+||.||+|+.. +++.||+|++.....  ......+.+|..++.++ +||||+++++++...+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56888999999999999999775 588999999865432  22345688999999988 899999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999997643   4899999999999999999999   88999999999999999999999999999986433


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc----ccHHHHHHHhhcCcccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER----TDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......    .................  
T Consensus       163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~--  238 (345)
T 3a8x_A          163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI--  238 (345)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCC--
T ss_pred             CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCC--
Confidence            22  12234689999999999999999999999999999999999999996421110    00111111111100000  


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM------RDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~------~evl~~L~ 1098 (1109)
                                 +   .....++.+++.+|++.||++||++      +|+++|-.
T Consensus       239 -----------p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~  278 (345)
T 3a8x_A          239 -----------P---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  278 (345)
T ss_dssp             -----------C---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred             -----------C---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence                       0   0112345667889999999999995      78887754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-37  Score=344.35  Aligned_cols=274  Identities=24%  Similarity=0.295  Sum_probs=202.5

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc----ccChHHHHHHHHHHhcCC---CCceeeEeeEEecC
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH----KRGSLSMKREIQTIGKIR---HRNLVRLEDFWLRK  888 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  888 (1109)
                      ..++|++.++||+|+||+||+|.. .+++.||||++.....    ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            357899999999999999999976 5689999999864432    222456778888887774   99999999999875


Q ss_pred             C-----ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEE
Q 001275          889 D-----CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHI  963 (1109)
Q Consensus       889 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  963 (1109)
                      .     ..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence            5     4799999997 59999998644 334899999999999999999999   889999999999999999999999


Q ss_pred             ecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc
Q 001275          964 SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       964 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      +|||+++.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............
T Consensus       162 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~  237 (308)
T 3g33_A          162 ADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGL  237 (308)
T ss_dssp             CSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred             eeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            99999987643322   23467899999999999999999999999999999999999999654221 112222211110


Q ss_pred             Cc-cccccccc--hhhhH----HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1044 DT-EEINDIVD--LSLME----EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1044 ~~-~~~~~~~d--~~~~~----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .. ........  .....    ........+...++.+++.+|++.||++|||++|+++|-+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~  300 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL  300 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence            00 00000000  00000    00000011223456778889999999999999999987543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.9e-37  Score=343.85  Aligned_cols=255  Identities=20%  Similarity=0.299  Sum_probs=200.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-C-------cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-N-------AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      ++|...+.||+|+||+||+|.... +       ..||+|++.. ........+.+|++++++++||||+++++++...+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG-GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc-ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            578889999999999999996543 3       4699998843 334455779999999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc--------EE
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME--------PH  962 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~k  962 (1109)
                      .++||||+++|+|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999998643  23889999999999999999999   889999999999999998887        99


Q ss_pred             EecccCCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh
Q 001275          963 ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       963 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      |+|||++......      ....||+.|+|||++.+ ..++.++||||+|+++|||++|+.|+........ ......  
T Consensus       162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~--  232 (289)
T 4fvq_A          162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYE--  232 (289)
T ss_dssp             ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHH--
T ss_pred             eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhh--
Confidence            9999998754321      22468899999999987 7789999999999999999997665543322111 111110  


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCC
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTS 1106 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1106 (1109)
                        ........                ...++.+++.+||+.||++||+++|++++|+++..+..+
T Consensus       233 --~~~~~~~~----------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          233 --DRHQLPAP----------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             --TTCCCCCC----------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             --ccCCCCCC----------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence              11001000                012355688899999999999999999999998665443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.7e-37  Score=339.41  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=201.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  895 (1109)
                      ++|...+.||+|+||+||+|+.+ ++.||||++.... .....+.+.+|+.++++++||||+++++++...  +..++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            57888999999999999999986 8899999986543 233356789999999999999999999999887  6789999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP--IVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||+++|+|.++++... ...+++..++.++.|+++||+|||   +.+  |+||||||+||+++.++.++++|||++....
T Consensus        89 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             cccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            9999999999998643 335899999999999999999999   778  9999999999999999999999999876432


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCc---cCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSK---ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ..       ...||+.|+|||.+.+..++.   ++||||+|+++|||++|+.||.......     ............ .
T Consensus       165 ~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~-~  231 (271)
T 3kmu_A          165 SP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEGLRP-T  231 (271)
T ss_dssp             CT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHSCCCC-C
T ss_pred             cc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhcCCCC-C
Confidence            22       246899999999988765544   7999999999999999999996432211     111111000000 0


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      . .            .....++.+++.+||+.||++||+++|+++.|+++.
T Consensus       232 ~-~------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          232 I-P------------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             C-C------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             C-C------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            0 0            111234667888999999999999999999998763

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.6e-37  Score=358.97  Aligned_cols=260  Identities=22%  Similarity=0.283  Sum_probs=205.2

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ...++|...++||+|+||+||+|+.. +++.||+|++....  .......+.+|+.+++.++|||||++++++.+.+..|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            34578999999999999999999775 58899999985422  2233456889999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +||||+++|+|.++++..    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+..
T Consensus       146 lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             EEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            999999999999999763    3889999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCCceeeecccCcccccccccccCC----CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTA----KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      .... .......+||+.|+|||++.+..    ++.++||||+||++|||++|+.||.....     ..............
T Consensus       219 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~  292 (410)
T 3v8s_A          219 NKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSKIMNHKNSL  292 (410)
T ss_dssp             CTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTHHHHC
T ss_pred             ccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----hhHHHHHHhccccc
Confidence            5432 12223468999999999988765    78999999999999999999999965321     11111111100000


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHHhhhC
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSN--RPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPs~~evl~~L~~~ 1100 (1109)
                       ..           +.......++.+++.+|++.+|++  ||+++|+++|-+-.
T Consensus       293 -~~-----------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          293 -TF-----------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             -CC-----------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             -cC-----------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence             00           000011234556777999999998  99999999987643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.8e-37  Score=345.61  Aligned_cols=251  Identities=20%  Similarity=0.295  Sum_probs=193.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe----CCCcEEEEEEeeecc---cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRG---HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      ++|+..+.||+|+||+||+|+.    .+++.||+|++....   .......+.+|++++++++||||+++++++...+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            6788999999999999999977    478999999985432   123345678999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999997643   3889999999999999999999   88999999999999999999999999999985


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      .....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..............  
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~p--  241 (327)
T 3a62_A          171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-----KTIDKILKCKLNLP--  241 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHTCCCCC--
T ss_pred             cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhCCCCCC--
Confidence            43221  1223457999999999999999999999999999999999999999653211     11111111100000  


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                                 .   ....++.+++.+|++.||++||     +++|+++|-.
T Consensus       242 -----------~---~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~  279 (327)
T 3a62_A          242 -----------P---YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF  279 (327)
T ss_dssp             -----------T---TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred             -----------C---CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence                       0   1123456678899999999999     8889998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=350.41  Aligned_cols=271  Identities=20%  Similarity=0.311  Sum_probs=197.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...+.||+|+||+||+|... +++.||+|++...........+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888999999999999999775 78999999986544333333556899999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++ |+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            98 59999987643  35899999999999999999999   8899999999999999999999999999998654322 


Q ss_pred             CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC--ccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD--TEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~ 1054 (1109)
                       .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......  +....+......  ..........
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--EQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHhchhhhcc
Confidence             22234578999999998876 56799999999999999999999999654221  122222111111  0001111110


Q ss_pred             hhhHHh---------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1055 SLMEEM---------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1055 ~~~~~~---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ......         ..........++.+++.+|++.||++|||++|+++|-+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f  285 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF  285 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence            000000         000011122456778889999999999999999997543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-37  Score=340.67  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=206.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|+..+.||+|+||.||+|...+++.||+|++...  ......+.+|++++++++||||+++++++...+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG--AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--TBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEcccc--CCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            568888999999999999999988999999998543  234567999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++....  ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...... .
T Consensus        86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y  159 (267)
T ss_dssp             TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred             CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence            9999999997643  35889999999999999999999   8899999999999999999999999999998664321 1


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......+|..|+|||++.+..++.++||||+|+++|||++ |+.||.....     ............    ...+   
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i~~~~~----~~~~---  227 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTGFR----LYKP---  227 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCC----CCCC---
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHHhcCCc----CCCC---
Confidence            11223467789999999998999999999999999999999 8988864321     111111111100    0000   


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              .....++.+++.+||+.||++||+++|++++|+++
T Consensus       228 --------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          228 --------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    01123466788899999999999999999999876

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-36  Score=359.32  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=203.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.+.||+|+||.||+|+.. +|+.||||++....  .......+.+|+++++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888999999999999999775 78999999985432  2233567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999997543   4899999999999999999999   899999999999999999999999999999876543


Q ss_pred             CCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....     ................    
T Consensus       170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~p~----  237 (476)
T 2y94_A          170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFKKICDGIFYTPQ----  237 (476)
T ss_dssp             CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHHHHHTTCCCCCT----
T ss_pred             cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCCcCCCc----
Confidence            22   223579999999999988776 7899999999999999999999965321     1111111111100000    


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                  ....++.+++.+|++.||++|||++|+++|-
T Consensus       238 ------------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          238 ------------YLNPSVISLLKHMLQVDPMKRATIKDIREHE  268 (476)
T ss_dssp             ------------TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             ------------cCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence                        0113456688899999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-36  Score=346.89  Aligned_cols=252  Identities=22%  Similarity=0.282  Sum_probs=203.5

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .++|+..++||+|+||+||+|+.. +++.||+|++....  .......+.+|.+++..+ +||+|+++++++...+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467999999999999999999876 47899999986542  233456788999999988 89999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999998644   3899999999999999999999   8899999999999999999999999999998643


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ...............    
T Consensus       173 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~~~p----  241 (353)
T 2i0e_A          173 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHNVAYP----  241 (353)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC----
T ss_pred             cCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCCCCCC----
Confidence            222  123346899999999999999999999999999999999999999965321     111111111110000    


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLV 1098 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~ 1098 (1109)
                               .   ....++.+++.+|++.||++||+     ++|+++|-.
T Consensus       242 ---------~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~  279 (353)
T 2i0e_A          242 ---------K---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  279 (353)
T ss_dssp             ---------T---TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred             ---------C---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence                     0   11234566788999999999994     688887753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3e-37  Score=348.70  Aligned_cols=268  Identities=22%  Similarity=0.321  Sum_probs=203.7

Q ss_pred             CCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC--CceeE
Q 001275          821 LNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--DCGII  893 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  893 (1109)
                      |+..++||+|+||+||++.+     .+++.||||++...........+.+|++++++++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48889999999999998864     268899999996554445566799999999999999999999999874  56799


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++....    +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999997643    899999999999999999999   8899999999999999999999999999998775


Q ss_pred             CCCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ..... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.||............+...... .....+.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT-VLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH-HHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh-HHHHHHHH
Confidence            44322 12234568889999999999899999999999999999999999985432110000000000000 00000000


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .    .............++.+++.+||+.||++||+++|+++.|+.+
T Consensus       265 ~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          265 E----RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             H----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             h----cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            0    0000001112234577788899999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5e-37  Score=345.64  Aligned_cols=248  Identities=21%  Similarity=0.275  Sum_probs=192.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..++||+|+||+||+|... +++.||||++..... ......+.+|+..+.++ +||||++++++|.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999876 789999998744322 22233455566665555 8999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+ +++|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 679999887653  35899999999999999999999   889999999999999999999999999999876443


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .   ......||++|+|||++.+ .++.++|||||||++|||++|..++....    .   + .....      ....+.
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~---~-~~~~~------~~~~~~  272 (311)
T 3p1a_A          211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G---W-QQLRQ------GYLPPE  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H---H-HHHTT------TCCCHH
T ss_pred             C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H---H-HHHhc------cCCCcc
Confidence            2   2233569999999998875 78999999999999999999987764321    0   0 00000      000111


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .        ......++.+++.+|++.||++||+++|++++-+
T Consensus       273 ~--------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          273 F--------TAGLSSELRSVLVMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             H--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             c--------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence            0        0112345677888999999999999999998643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-36  Score=338.46  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=198.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...++||+|+||+||+|.. .+++.||+|++...........+.+|++++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            5788999999999999999976 468899999997666566678899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee---CCCCcEEEecccCCcccC
Q 001275          898 MENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL---DSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~~~  973 (1109)
                      +++|+|.+++.... ....+++..+..++.|+++||+|||   +.+|+||||||+||++   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            99999999886531 2245899999999999999999999   8899999999999999   456789999999998664


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...   ......||+.|+|||.+. ..++.++||||+|+++|||++|+.||......  ........   ........  
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~--~~~~~~~~---~~~~~~~~--  247 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE--EVQQKATY---KEPNYAVE--  247 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH---CCCCCCC---
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH--HHHhhhcc---CCcccccc--
Confidence            332   223457999999999875 57899999999999999999999999653211  11111110   00000000  


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                 ......++.+++.+|++.||++||+++|++++-
T Consensus       248 -----------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  280 (285)
T 3is5_A          248 -----------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE  280 (285)
T ss_dssp             ------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred             -----------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                       000123456788899999999999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.6e-37  Score=354.32  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=196.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCC--CCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIR--HRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.+.||+|+||+||+|...+++.||||++..... ......+.+|++++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            45888999999999999999988899999999865432 334567899999999996  599999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      | +.+++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++ ++.+||+|||+++.....
T Consensus       136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 56889999998744   4889999999999999999999   89999999999999995 589999999999877544


Q ss_pred             CCCceeeecccCccccccccccc-----------CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          976 PASTTSISVVGTIGYIAPENAFT-----------TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......    ..+......
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~~~~~~  283 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHAIIDP  283 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHCT
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HHHHHHhCc
Confidence            33223344679999999998865           468999999999999999999999996432211    111111111


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .... ..          ....   ..++.+++.+||+.||++||++.|+++|-+
T Consensus       284 ~~~~-~~----------~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          284 NHEI-EF----------PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             TSCC-CC----------CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             cccC-CC----------Cccc---hHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence            1000 00          0001   234667888999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-37  Score=357.30  Aligned_cols=256  Identities=24%  Similarity=0.343  Sum_probs=190.5

Q ss_pred             CCCCCceeecccCeEEEEEEeC--CC--cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec-CCceeEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG--PN--AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR-KDCGIIM  894 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  894 (1109)
                      .|...++||+|+||+||+|...  ++  ..||||.+..........++.+|+.++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3556688999999999999753  22  46899988654444556789999999999999999999998765 4578999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.++++...  ..+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999997643  34789999999999999999999   88999999999999999999999999999986643


Q ss_pred             CCCC--ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          975 SPAS--TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       975 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ....  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||....  ..+....+..   ...    .
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~--~~~~~~~~~~---~~~----~  315 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQ---GRR----L  315 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--SSCHHHHHHT---TCC----C
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC--HHHHHHHHHc---CCC----C
Confidence            3221  12234567889999999999999999999999999999999 555654321  1122221111   000    0


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..+           ......+.+++.+||+.||++||+++|++++|+++
T Consensus       316 ~~p-----------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          316 LQP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC-----------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            000           01123466788899999999999999999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4e-37  Score=354.62  Aligned_cols=267  Identities=16%  Similarity=0.214  Sum_probs=199.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC------CcEEEEEEeeecccc----------cChHHHHHHHHHHhcCCCCceeeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP------NAVFAVKKLAFRGHK----------RGSLSMKREIQTIGKIRHRNLVRL  881 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l  881 (1109)
                      .++|.+.+.||+|+||+||+|.+..      ++.||||++......          .....+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3578899999999999999997754      478999998543211          111234456677788899999999


Q ss_pred             eeEEecC----CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC-
Q 001275          882 EDFWLRK----DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD-  956 (1109)
Q Consensus       882 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-  956 (1109)
                      ++++...    ...++||||+ +|+|.+++....  ..+++..++.++.|++.||+|||   +.+|+||||||+||+++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            9998765    4479999999 999999998642  35899999999999999999999   88999999999999998 


Q ss_pred             -CCCcEEEecccCCcccCCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc
Q 001275          957 -SEMEPHISDFGIAKLLDKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE 1030 (1109)
Q Consensus       957 -~~~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~ 1030 (1109)
                       .++.+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999876432211     1112346999999999999999999999999999999999999999643222


Q ss_pred             cccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1031 RTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       ...........  ......+.++.+.    .   .....++.+++..||+.||++||+++++++.|+++
T Consensus       268 -~~~~~~~~~~~--~~~~~~~~~~~~~----~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          268 -PKYVRDSKIRY--RENIASLMDKCFP----A---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             -HHHHHHHHHHH--HHCHHHHHHHHSC----T---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             -HHHHHHHHHHh--hhhHHHHHHHhcc----c---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence             11111111111  0011111111100    0   11234567788899999999999999999998764

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.6e-37  Score=354.89  Aligned_cols=206  Identities=18%  Similarity=0.228  Sum_probs=176.4

Q ss_pred             hhCCCCCceeecc--cCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          818 TENLNAKHVIGRG--AHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ..+|++.++||+|  +||+||+|+.. +++.||||++...... .....+.+|++++++++|||||++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3678899999999  99999999875 6899999999654322 334568889999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999997643 234899999999999999999999   8899999999999999999999999999986543


Q ss_pred             CCCC-----CceeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          974 KSPA-----STTSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       974 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      ....     ........||+.|+|||++.+  ..++.++||||+||++|||++|+.||...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            2211     111122478999999999987  67899999999999999999999999653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.2e-37  Score=348.72  Aligned_cols=256  Identities=26%  Similarity=0.339  Sum_probs=192.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCce----
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG----  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  891 (1109)
                      ++|++.+.||+|+||+||+|.. .+++.||||++......  .....+.+|++++++++||||+++++++...+..    
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            5788999999999999999976 57899999998543222  2235788999999999999999999998776544    


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.++++...   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            99999999999999998644   4899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......     .........     
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~-----  235 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVRED-----  235 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCC-----
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCC-----
Confidence            6543222 22234579999999999999999999999999999999999999996532211     111111000     


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ...+.    ...   .....++.+++.+||+.||++||++.+++++-
T Consensus       236 ~~~~~----~~~---~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~  275 (311)
T 3ork_A          236 PIPPS----ARH---EGLSADLDAVVLKALAKNPENRYQTAAEMRAD  275 (311)
T ss_dssp             CCCHH----HHS---TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred             CCCcc----ccc---CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHH
Confidence            00000    000   11224466788899999999999776666543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.3e-37  Score=355.67  Aligned_cols=273  Identities=23%  Similarity=0.324  Sum_probs=193.0

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCC-CCceeeEeeEEecCC--ce
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKD--CG  891 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~  891 (1109)
                      ..++|...+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.+++++. ||||+++++++...+  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            457899999999999999999976 568999999985332 2334556789999999997 999999999997544  67


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      |+||||++ |+|.++++..    .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999998 5999998763    3889999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCC-------------------CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCcccc
Q 001275          972 LDKSPA-------------------STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031 (1109)
Q Consensus       972 ~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~ 1031 (1109)
                      ......                   .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~  237 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS-TM  237 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC-HH
Confidence            643111                   112234689999999999886 678999999999999999999999996532 11


Q ss_pred             ccHHHHHHHhhcCc-cccccccch---hhh------------------HHhh-----hchhHHHHHHHHHHHHhccCCCC
Q 001275         1032 TDIVGWVRSVWSDT-EEINDIVDL---SLM------------------EEML-----VSSIRDQVIDVLLVALRCTEKKP 1084 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~~-~~~~~~~d~---~~~------------------~~~~-----~~~~~~~~~~l~~l~~~cl~~dP 1084 (1109)
                      ..+........... .....+..+   ...                  ....     .........++.+++.+|++.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            11222211111000 000000000   000                  0000     00000123457778889999999


Q ss_pred             CCCCCHHHHHHHhh
Q 001275         1085 SNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1085 ~~RPs~~evl~~L~ 1098 (1109)
                      ++|||++|+++|-.
T Consensus       318 ~~R~t~~e~l~Hp~  331 (388)
T 3oz6_A          318 NKRISANDALKHPF  331 (388)
T ss_dssp             GGSCCHHHHTTSTT
T ss_pred             ccCCCHHHHhCCHH
Confidence            99999999999843

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.7e-37  Score=343.83  Aligned_cols=264  Identities=24%  Similarity=0.335  Sum_probs=201.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec-CCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR-KDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l  893 (1109)
                      .+|...++||+|+||+||+|...+    ...||+|.+...........+.+|+.++++++||||+++++++.. ++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            457788999999999999997642    235889988554444556778999999999999999999998654 557899


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.++++...  ..+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999997633  35789999999999999999999   8899999999999999999999999999998664


Q ss_pred             CCCC--CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          974 KSPA--STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       974 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ....  ........+|+.|+|||.+.+..++.++||||+|+++|||++|+.|+....... +.......   ....    
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-~~~~~~~~---~~~~----  251 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQ---GRRL----  251 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-THHHHHHT---TCCC----
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHHhc---CCCC----
Confidence            4321  122334567889999999999999999999999999999999555543322221 11111111   1000    


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCC
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTS 1106 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1106 (1109)
                      ..+           .....++.+++.+||+.||++||+++|+++.|+++.....+
T Consensus       252 ~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          252 LQP-----------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             CCC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             CCC-----------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            000           01123466788899999999999999999999987544433

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=362.20  Aligned_cols=318  Identities=19%  Similarity=0.186  Sum_probs=251.8

Q ss_pred             ecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccc
Q 001275          101 DLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLS  180 (1109)
Q Consensus       101 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~  180 (1109)
                      +.++++++ .+|..+.  +++++|+|++|++++..|..|.++++|++|+|++|.+++..|..+.++++|++|+|++|+++
T Consensus        17 ~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~   93 (477)
T 2id5_A           17 LCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK   93 (477)
T ss_dssp             ECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             EeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC
Confidence            33445555 5676553  68999999999999888899999999999999999999888889999999999999999998


Q ss_pred             cccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCccccccc
Q 001275          181 GSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSE  260 (1109)
Q Consensus       181 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  260 (1109)
                      +..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..|.++++|+.|++++|++++..+..+.
T Consensus        94 ~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~  173 (477)
T 2id5_A           94 LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALS  173 (477)
T ss_dssp             SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHT
T ss_pred             ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhc
Confidence            76667788899999999999999888888888999999999999998888888888888888888888888877777777


Q ss_pred             CCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcccccccccee
Q 001275          261 KCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVL  340 (1109)
Q Consensus       261 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  340 (1109)
                      .+++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|+.|++++|++++..+..+..+++|+.|
T Consensus       174 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  253 (477)
T 2id5_A          174 HLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFL  253 (477)
T ss_dssp             TCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEE
T ss_pred             ccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCee
Confidence            88888888888888877766777778888888888877776666665555677777777777775444567777777777


Q ss_pred             eccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCc
Q 001275          341 HLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS  420 (1109)
Q Consensus       341 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  420 (1109)
                      +|++|++++..+..|..+++|++|+|++|++++..|..+..+++|++|++++|++++..+..|..+++|+.|++++|+++
T Consensus       254 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  333 (477)
T 2id5_A          254 NLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA  333 (477)
T ss_dssp             ECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred             ECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence            77777777666666777777777777777777666666777777777777777777655566666677777777777665


Q ss_pred             c
Q 001275          421 G  421 (1109)
Q Consensus       421 ~  421 (1109)
                      +
T Consensus       334 c  334 (477)
T 2id5_A          334 C  334 (477)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-36  Score=335.87  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=200.3

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .++|.+.+.||+|+||+||+|... +++.||+|++....  .......+.+|++++++++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            367889999999999999999765 57789999985432  223356789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999997654   3899999999999999999999   89999999999999999999999999999865433


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..    .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......     ...............    
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~----  228 (279)
T 3fdn_A          162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKRISRVEFTFPD----  228 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCCCCT----
T ss_pred             cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-----HHHHHHHhCCCCCCC----
Confidence            22    23357899999999999999999999999999999999999999643211     111111100000000    


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                  ....++.+++.+|++.||++||+++|+++|-+
T Consensus       229 ------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          229 ------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             ------------TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             ------------cCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence                        11234556788999999999999999998865

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-36  Score=341.50  Aligned_cols=255  Identities=20%  Similarity=0.288  Sum_probs=205.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-----ChHHHHHHHHHHhcCCCCceeeEeeEEecCCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-----GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  891 (1109)
                      .++|.+.+.||+|+||.||+|... +++.||+|.+.......     ....+.+|++++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467889999999999999999775 68999999986543322     356799999999999999999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC----cEEEeccc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM----EPHISDFG  967 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfG  967 (1109)
                      ++||||+++++|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999997633   4899999999999999999999   88999999999999999887    79999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      +++.......   .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||......     ............
T Consensus       165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~  236 (321)
T 2a2a_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANITSVSYD  236 (321)
T ss_dssp             TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTTCCC
T ss_pred             cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcccc
Confidence            9987654322   23357999999999999999999999999999999999999999653211     111111111000


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                          .++..        .......+.+++.+|++.||++||+++|+++|-+
T Consensus       237 ----~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          237 ----FDEEF--------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             ----CCHHH--------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             ----cChhh--------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence                01100        0111234667888999999999999999998754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.3e-37  Score=344.11  Aligned_cols=269  Identities=24%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|+..++||+|+||+||+|... +++.||+|++...... .....+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57888999999999999999775 5899999988544322 224568899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999999887543   4899999999999999999999   8899999999999999999999999999998765332


Q ss_pred             CCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-----------
Q 001275          977 ASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD----------- 1044 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 1044 (1109)
                      .  ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......  +....+......           
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV--DQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhccccccccccccc
Confidence            2  2234578999999998876 66799999999999999999999999654221  111111111100           


Q ss_pred             ccccc--cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1045 TEEIN--DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1045 ~~~~~--~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .....  ...++..... ..........++.+++.+|++.||++|||++|+++|-+
T Consensus       233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  287 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEP-LELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY  287 (311)
T ss_dssp             CGGGTTCCCCCCSSCCC-HHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccCcCCCccccch-hhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence            00000  0000000000 00001122345677888999999999999999998754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-37  Score=341.88  Aligned_cols=256  Identities=21%  Similarity=0.305  Sum_probs=203.9

Q ss_pred             hCCCCCc-eeecccCeEEEEEEeC---CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKH-VIGRGAHGIVYKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|.+.+ .||+|+||+||+|...   ++..||||++...........+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4455555 8999999999999753   57889999986554455567899999999999999999999999 45678999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++...  ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            9999999999999753  235899999999999999999999   88999999999999999999999999999987754


Q ss_pred             CCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          975 SPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       975 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .... .......+|+.|+|||++.+..++.++||||+|+++|||++ |+.||.....  .+....+..   ... . .. 
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~---~~~-~-~~-  234 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ---GKR-M-EC-  234 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT---TCC-C-CC-
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhc---CCc-C-CC-
Confidence            3221 11223457889999999988889999999999999999998 9999865322  111111111   000 0 00 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                  ......++.+++.+||+.||++||++.|++++|+.+
T Consensus       235 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          235 ------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                        011223566788899999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.2e-37  Score=350.05  Aligned_cols=271  Identities=25%  Similarity=0.320  Sum_probs=205.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec--CCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  891 (1109)
                      ++|+..+.||+|+||.||+|++     .+++.||||++... .......+.+|++++++++||||+++++++..  ....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            5788899999999999999984     46889999998433 33445678999999999999999999999874  4568


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccccee
Confidence            999999999999999976432  4899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC--cccc
Q 001275          972 LDKSPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD--TEEI 1048 (1109)
Q Consensus       972 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~ 1048 (1109)
                      ........ ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......      .......  ....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~------~~~~~~~~~~~~~  250 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF------LRMMGCERDVPAL  250 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH------HHHCC----CCHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh------hhhcccccccccH
Confidence            75433221 2223568888999999999889999999999999999999999985422110      0000000  0000


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      ....+ ................++.+++.+||+.||++||+++|++++|+.+..
T Consensus       251 ~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          251 SRLLE-LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             HHHHH-HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            00000 000000000111223457778889999999999999999999998743

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.8e-37  Score=347.24  Aligned_cols=263  Identities=20%  Similarity=0.323  Sum_probs=195.2

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      ...++|...+.||+|+||+||+|...    .++.||+|++..... ......+.+|++++++++||||+++++++...+.
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34577888999999999999999653    345899999854432 2334678999999999999999999999987553


Q ss_pred             -----eeEEEEeccCCCHHHHHhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEE
Q 001275          891 -----GIIMYRYMENGSLRDVLHSI---TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH  962 (1109)
Q Consensus       891 -----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  962 (1109)
                           .++||||+++|+|.+++...   .....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence                 49999999999999998542   23346899999999999999999999   89999999999999999999999


Q ss_pred             EecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHh
Q 001275          963 ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       963 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      |+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.. 
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~-  264 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLLH-  264 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT-
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHHHHc-
Confidence            999999987654433333344567889999999999999999999999999999999 88888543221  11111111 


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                        ... . .             .......++.+++.+||+.||++||+++|++++|+++.
T Consensus       265 --~~~-~-~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          265 --GHR-L-K-------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             --TCC-C-C-------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCC-C-C-------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              000 0 0             00112234677888999999999999999999998763

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.5e-37  Score=349.56  Aligned_cols=270  Identities=16%  Similarity=0.191  Sum_probs=200.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccc----------cChHHHHHHHHHHhcCCCCceeeEeeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHK----------RGSLSMKREIQTIGKIRHRNLVRLEDF  884 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~  884 (1109)
                      ++|.+.+.||+|+||+||+|...    ++..||+|++......          .....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56888999999999999999875    5788999988543211          123346788999999999999999999


Q ss_pred             Eec----CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-
Q 001275          885 WLR----KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-  959 (1109)
Q Consensus       885 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-  959 (1109)
                      +..    ....++||||+ +++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence            987    67889999999 999999997654   5899999999999999999999   88999999999999998877 


Q ss_pred             -cEEEecccCCcccCCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccccc
Q 001275          960 -EPHISDFGIAKLLDKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033 (1109)
Q Consensus       960 -~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 1033 (1109)
                       .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             9999999999876432211     1113457999999999999999999999999999999999999999542222111


Q ss_pred             HHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCC
Q 001275         1034 IVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMT 1105 (1109)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1105 (1109)
                      .........       ............   ......++.+++.+||+.||++||+++|+++.|++...+..
T Consensus       270 ~~~~~~~~~-------~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  331 (345)
T 2v62_A          270 VQTAKTNLL-------DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG  331 (345)
T ss_dssp             HHHHHHHHH-------HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred             HHHHHHhhc-------ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence            111111100       000100000000   00223457778889999999999999999999998866543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.5e-37  Score=351.52  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=194.0

Q ss_pred             CceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCC
Q 001275          824 KHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      .+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            56799999999999976 468999999985432 2345678999999999999999999999999999999999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee--CCCCcEEEecccCCcccCCCCCCce
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL--DSEMEPHISDFGIAKLLDKSPASTT  980 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~kl~DfGla~~~~~~~~~~~  980 (1109)
                      |.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||++  +.++.+||+|||+++.......   
T Consensus       173 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          173 LFDRIIDES--YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             EHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            999886532  34899999999999999999999   8899999999999999  6678999999999987654322   


Q ss_pred             eeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          981 SISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       981 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+....+...       . .     
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~-------~-~-----  310 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ETLNNILACRWDLE-------D-E-----  310 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCCSC-------S-G-----
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhccCCCC-------h-h-----
Confidence            22357999999999999889999999999999999999999999654211 11111111111100       0 0     


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                         .......++.+++.+|++.||++||+++|+++|-+
T Consensus       311 ---~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          311 ---EFQDISEEAKEFISKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             ---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ---hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcC
Confidence               00111234667888999999999999999998643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-37  Score=356.48  Aligned_cols=263  Identities=21%  Similarity=0.218  Sum_probs=204.1

Q ss_pred             HHHHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          814 VIEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       814 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      .....++|+..++||+|+||+||+|+.. +++.||+|++....  .......+.+|.+++.+++||||+++++++.+.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            3344578999999999999999999874 68999999985432  12233458899999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .|+||||+++|+|.+++...+  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence            999999999999999997643  24899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccc-------cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAF-------TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      ....... ......+||+.|+|||++.       +..++.++||||+||++|||++|+.||......     ........
T Consensus       211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~  284 (412)
T 2vd5_A          211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-----ETYGKIVH  284 (412)
T ss_dssp             ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHT
T ss_pred             eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-----HHHHHHHh
Confidence            7654322 2223458999999999887       356899999999999999999999999653211     11111110


Q ss_pred             CccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHHhhh
Q 001275         1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNR---PNMRDVVRQLVD 1099 (1109)
Q Consensus      1044 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Ps~~evl~~L~~ 1099 (1109)
                      ..... .  -+..        ......++.+++.+|++ +|++|   |+++|+++|-.-
T Consensus       285 ~~~~~-~--~p~~--------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          285 YKEHL-S--LPLV--------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             HHHHC-C--CC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             cccCc-C--CCcc--------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence            00000 0  0000        00112345667779999 99998   699999988653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-37  Score=347.73  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=197.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .+|...+.||+|+||+||+|....     +..||||++...........+.+|++++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            456677899999999999996542     245999998654444455678999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++....  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            999999999999997642  35899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCC-ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          974 KSPAS-TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       974 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ..... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....  ......+   .... ...  
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~---~~~~-~~~--  270 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI---NDGF-RLP--  270 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH---HTTC-CCC--
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHH---HCCC-cCC--
Confidence            43221 12223456889999999999999999999999999999999 9999864321  1111111   1110 000  


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       .           ......++.+++.+||+.||++||+++|++++|+++
T Consensus       271 -~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          271 -T-----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             -C-----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -C-----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             0           011223466788899999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-36  Score=348.52  Aligned_cols=265  Identities=22%  Similarity=0.255  Sum_probs=201.5

Q ss_pred             HHHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc----cccChHHHHHHHHHHhcCCCCceeeEeeEEecC
Q 001275          814 VIEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG----HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK  888 (1109)
Q Consensus       814 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  888 (1109)
                      +....++|.+.+.||+|+||+||+|.. .+++.||+|++....    .......+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            456678899999999999999999976 468899999985432    234456789999999999999999999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccCC-------------------------------------CCCCCHHHHHHHHHHHHHH
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITP-------------------------------------PPTLEWNVRYKIALGAAHA  931 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~  931 (1109)
                      +..++||||+++|+|.+++.....                                     ...+++..+..++.|+++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999853110                                     1123577788999999999


Q ss_pred             HHHhhcCCCCCeEEeccCCCCeeeCCCC--cEEEecccCCcccCCCCC--CceeeecccCccccccccccc--CCCCccC
Q 001275          932 LAYLHYDCDPPIVHRDIKPENILLDSEM--EPHISDFGIAKLLDKSPA--STTSISVVGTIGYIAPENAFT--TAKSKES 1005 (1109)
Q Consensus       932 L~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~s 1005 (1109)
                      |+|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   88999999999999998776  899999999986533221  112334679999999998875  6789999


Q ss_pred             cchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCC
Q 001275         1006 DVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPS 1085 (1109)
Q Consensus      1006 DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 1085 (1109)
                      |||||||++|||++|+.||......     ..............   .+.         ......++.+++.+|++.||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~---~~~---------~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDA-----DTISQVLNKKLCFE---NPN---------YNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCTT---SGG---------GGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcccccC---Ccc---------cccCCHHHHHHHHHHcCCChh
Confidence            9999999999999999999654221     11111111110000   000         111223466788899999999


Q ss_pred             CCCCHHHHHHHhh
Q 001275         1086 NRPNMRDVVRQLV 1098 (1109)
Q Consensus      1086 ~RPs~~evl~~L~ 1098 (1109)
                      +||++.|+++|-+
T Consensus       321 ~Rps~~~~l~hp~  333 (345)
T 3hko_A          321 ERFDAMRALQHPW  333 (345)
T ss_dssp             TSCCHHHHHHSHH
T ss_pred             HCCCHHHHhcChh
Confidence            9999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=349.35  Aligned_cols=246  Identities=21%  Similarity=0.289  Sum_probs=202.1

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc-------cChHHHHHHHHHHhcCCCCceeeEeeEEecC
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK-------RGSLSMKREIQTIGKIRHRNLVRLEDFWLRK  888 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  888 (1109)
                      ..++|...+.||+|+||+||+|.. .+++.||||++......       .....+.+|++++++++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            357899999999999999999975 56889999998654321       1334577899999999999999999999999


Q ss_pred             CceeEEEEeccCC-CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          889 DCGIIMYRYMENG-SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       889 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                      +..++||||+.+| +|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 9999997643   4899999999999999999999   8899999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      +++.......   .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||......                
T Consensus       176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            9987754332   223579999999999988877 88999999999999999999998642110                


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       ........       .   ....++.+++.+|++.||++||+++|++++-+
T Consensus       237 -~~~~~~~~-------~---~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          237 -VEAAIHPP-------Y---LVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             -TTTCCCCS-------S---CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             -HhhccCCC-------c---ccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence             00000000       0   01234667888999999999999999999854

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.3e-37  Score=373.72  Aligned_cols=262  Identities=26%  Similarity=0.360  Sum_probs=210.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|...++||+|+||+||+|.+.++..||||++...  .....+|.+|++++++++|+||+++++++.+ +..++||||+
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCC--CCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            567888999999999999999998889999998543  2345689999999999999999999999876 6789999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.++++... ...+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...... .
T Consensus       344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            9999999997532 134889999999999999999999   8999999999999999999999999999998664321 1


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......++..|+|||++.+..++.++|||||||++|||++ |+.||.....  .++...+..   ... .    .    
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~~~~~i~~---~~~-~----~----  484 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER---GYR-M----P----  484 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HHHHHHHHT---TCC-C----C----
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CCC-C----C----
Confidence            11223457789999999999999999999999999999999 8988864321  111111111   100 0    0    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCCCC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKY 1108 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1108 (1109)
                            .......++.+++.+||+.||++||+++|+++.|+++.....++|
T Consensus       485 ------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~  529 (535)
T 2h8h_A          485 ------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  529 (535)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSS
T ss_pred             ------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCccc
Confidence                  001122346678889999999999999999999999977777666

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=350.80  Aligned_cols=251  Identities=14%  Similarity=0.178  Sum_probs=200.2

Q ss_pred             hhCCCCCceeecccCeEEEEE------EeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC---CCceeeEeeEEecC
Q 001275          818 TENLNAKHVIGRGAHGIVYKA------SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR---HRNLVRLEDFWLRK  888 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  888 (1109)
                      .++|.+.++||+|+||+||+|      ...+++.||||++..    ....++.+|++++.+++   |+||+++++++...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP----ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS----CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC----CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            367888999999999999999      355789999999842    34557888888888886   99999999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---------
Q 001275          889 DCGIIMYRYMENGSLRDVLHSIT--PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---------  957 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---------  957 (1109)
                      +..++||||+++|+|.++++...  ....+++..++.++.|+++||+|||   +.+||||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            99999999999999999997532  2345999999999999999999999   899999999999999998         


Q ss_pred             --CCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHH
Q 001275          958 --EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV 1035 (1109)
Q Consensus       958 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~ 1035 (1109)
                        ++.+||+|||+|+.+.............||++|+|||++.+..++.++|||||||++|||++|+.||........   
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---  293 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---  293 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence              899999999999866443344445567899999999999999999999999999999999999999854321110   


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHhhhC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNR-PNMRDVVRQLVDA 1100 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Ps~~evl~~L~~~ 1100 (1109)
                                 .........        ...+.   +.+++..|++.+|.+| |+++++.+.|++.
T Consensus       294 -----------~~~~~~~~~--------~~~~~---~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          294 -----------KPEGLFRRL--------PHLDM---WNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             -----------EECSCCTTC--------SSHHH---HHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             -----------eechhcccc--------CcHHH---HHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence                       011111100        01222   3346668999999998 6778887777654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2e-36  Score=362.07  Aligned_cols=256  Identities=26%  Similarity=0.324  Sum_probs=206.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|...++||+|+||.||+|+.. +|+.||+|++....  .......+.+|++++++++|||||++++++.+.+..|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            56888999999999999999775 68999999985532  2334567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++.... ...+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       264 Ey~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             CCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            9999999999997643 334899999999999999999999   889999999999999999999999999999876543


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..................      
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~-~~~~~i~~~i~~~~~~~p------  409 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-IKREEVERLVKEVPEEYS------  409 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC-CCHHHHHHHHHHCCCCCC------
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc-hhHHHHHHHhhcccccCC------
Confidence            2   223458999999999999989999999999999999999999999754221 111111111111110000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~ 1098 (1109)
                                .....++.+++.+|++.||++||     +++|+++|-+
T Consensus       410 ----------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          410 ----------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             ----------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             ----------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence                      01123456677899999999999     7899998754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-36  Score=345.06  Aligned_cols=252  Identities=21%  Similarity=0.294  Sum_probs=181.1

Q ss_pred             CceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEEEeccCC
Q 001275          824 KHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      .+.||+|+||+||+|... +++.||||++..    .....+.+|+.+++++. ||||+++++++.+.+..++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            478999999999999775 689999999843    23457889999999997 999999999999999999999999999


Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC---cEEEecccCCcccCCCCCC
Q 001275          902 SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM---EPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       902 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~DfGla~~~~~~~~~  978 (1109)
                      +|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++   .+||+|||+++....... 
T Consensus        92 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-  164 (325)
T 3kn6_A           92 ELFERIKKKK---HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-  164 (325)
T ss_dssp             BHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence            9999998743   4899999999999999999999   89999999999999997765   899999999986643322 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccc--cccHHHHHHHhhcCccccccccchhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKE--RTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                       ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ..................    ... 
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~----~~~-  238 (325)
T 3kn6_A          165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF----EGE-  238 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC----CSH-
T ss_pred             -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC----Ccc-
Confidence             223457899999999999999999999999999999999999999653221  111122222221111000    000 


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                             .......++.+++.+|++.||++||+++|+++|-+-
T Consensus       239 -------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~  274 (325)
T 3kn6_A          239 -------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL  274 (325)
T ss_dssp             -------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGG
T ss_pred             -------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhh
Confidence                   011123456678889999999999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.5e-36  Score=332.96  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=201.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|.+.+.||+|+||+||+|... ++..||+|++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY-FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhh-ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            467899999999999999999765 4678999998543 33456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee---CCCCcEEEecccCCcccC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL---DSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~~~  973 (1109)
                      |+++++|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999999987644   3899999999999999999999   8899999999999999   788999999999998765


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ....   .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||......  ..   ...........    .
T Consensus       161 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~---~~~~~~~~~~~----~  227 (277)
T 3f3z_A          161 PGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EV---MLKIREGTFTF----P  227 (277)
T ss_dssp             TTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHHHHHCCCCC----C
T ss_pred             Cccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--HH---HHHHHhCCCCC----C
Confidence            4322   233579999999998765 4899999999999999999999999653221  11   11111100000    0


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                       .   .    .......++.+++.+|++.||++||++.|+++|-
T Consensus       228 -~---~----~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~  263 (277)
T 3f3z_A          228 -E---K----DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE  263 (277)
T ss_dssp             -H---H----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             -c---h----hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence             0   0    0011224566788899999999999999999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-37  Score=343.14  Aligned_cols=258  Identities=23%  Similarity=0.293  Sum_probs=201.7

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CC---cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce-eEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PN---AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG-IIM  894 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  894 (1109)
                      .|...++||+|+||+||+|... ++   ..||+|.+...........+.+|++++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3455688999999999999753 22   379999885544444556789999999999999999999999876655 999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      +||+.+|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999997633  35899999999999999999999   88999999999999999999999999999986643


Q ss_pred             CCC--CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          975 SPA--STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       975 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ...  ........+|+.|+|||.+.+..++.++||||+|+++|+|++|+.|+...... .+....+......  ..    
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~--~~----  249 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRRL--PQ----  249 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCCC--CC----
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCCC--CC----
Confidence            221  12223457889999999999999999999999999999999977765443222 2222221111100  00    


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                                  .......+.+++.+|++.||++|||++|+++.|+++.
T Consensus       250 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          250 ------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             ------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                        0011234667888999999999999999999998763

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.6e-37  Score=349.67  Aligned_cols=259  Identities=24%  Similarity=0.372  Sum_probs=202.5

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|.+.+.||+|+||+||+|+.      .+++.||||++..........++.+|+.++++++||||+++++++...+..+
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            6788999999999999999974      3577899999865444555668899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCcEEEec
Q 001275          893 IMYRYMENGSLRDVLHSITP----PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EMEPHISD  965 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~D  965 (1109)
                      +||||+++|+|.+++.....    ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.   +..+||+|
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECc
Confidence            99999999999999987542    245899999999999999999999   889999999999999984   44699999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcC
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                      ||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....  ......+..   .
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~---~  261 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTS---G  261 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHT---T
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--HHHHHHHhc---C
Confidence            999986544333333334578999999999999999999999999999999998 8888864321  111111111   1


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .. .    ..          .......+.+++.+||+.||++||+++|++++++.+
T Consensus       262 ~~-~----~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          262 GR-M----DP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CC-C----CC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-C----CC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            00 0    00          011123466788899999999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.3e-37  Score=354.94  Aligned_cols=199  Identities=28%  Similarity=0.422  Sum_probs=175.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|...+.||+|+||+||+|... +++.||+|++...........+.+|++++++++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            57888999999999999999775 68999999986654455566789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP-PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      +++|+|.+++....   .+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||++...... 
T Consensus       113 ~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          113 MDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999998654   3889999999999999999999   65 8999999999999999999999999999755322 


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                         ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence               122357999999999999999999999999999999999999999754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.1e-37  Score=340.05  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=204.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .++|+..+.||+|+||+||+|...+++.||+|++...  ......+.+|++++++++||||+++++++. .+..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT--SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC--cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            3678889999999999999999988889999988432  334568999999999999999999999986 4568999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++.... ...+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++...... 
T Consensus        89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  163 (279)
T 1qpc_A           89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-  163 (279)
T ss_dssp             CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred             CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence            99999999997532 124899999999999999999999   8999999999999999999999999999998765432 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      ........++..|+|||.+.+..++.++||||+|+++|||++ |+.||......  .....+   .....    ...   
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~---~~~~~----~~~---  231 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNL---ERGYR----MVR---  231 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH---HTTCC----CCC---
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--HHHHHH---hcccC----CCC---
Confidence            112223457889999999988889999999999999999999 88888643211  111111   11100    000   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                              ......++.+++.+|++.||++||+++|+++.|+++..
T Consensus       232 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          232 --------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence                    01112346678889999999999999999999987643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6e-37  Score=339.86  Aligned_cols=256  Identities=21%  Similarity=0.279  Sum_probs=201.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .++|...+.||+|+||+||+|....    +..||+|.+...........+.+|++++++++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            3678889999999999999997532    346999998655444556789999999999999999999999864 45789


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999997643  34899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......  +....+.....  ..     
T Consensus       165 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~--~~-----  234 (281)
T 3cc6_A          165 DEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDR--LP-----  234 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCC--CC-----
T ss_pred             cccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCC--CC-----
Confidence            4321 12233567889999999998999999999999999999998 99998643221  22221111100  00     


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .+           ......+.+++.+||+.||++||+++|++++|+++
T Consensus       235 ~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          235 KP-----------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CC-----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CC-----------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            00           01123466788899999999999999999999865

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.6e-36  Score=342.91  Aligned_cols=272  Identities=24%  Similarity=0.297  Sum_probs=209.5

Q ss_pred             HHHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhc--CCCCceeeEeeEEecCC--
Q 001275          814 VIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK--IRHRNLVRLEDFWLRKD--  889 (1109)
Q Consensus       814 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~--  889 (1109)
                      -....++|.+.+.||+|+||+||+|+.. ++.||||++..    .....+.+|++++..  ++||||+++++++...+  
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            3455678999999999999999999885 89999999842    234567788888887  79999999999998876  


Q ss_pred             --ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEEeccCCCCeeeCCCCcEE
Q 001275          890 --CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD-----CDPPIVHRDIKPENILLDSEMEPH  962 (1109)
Q Consensus       890 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~k  962 (1109)
                        ..++||||+++|+|.+++...    .+++..++.++.|++.||+|||..     ++.+|+||||||+||+++.++.+|
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence              789999999999999999763    389999999999999999999932     146899999999999999999999


Q ss_pred             EecccCCcccCCCCCCc--eeeecccCcccccccccccCC------CCccCcchhhHHHHHHHHhC----------CCCC
Q 001275          963 ISDFGIAKLLDKSPAST--TSISVVGTIGYIAPENAFTTA------KSKESDVYSYGVVLLELITR----------KKAL 1024 (1109)
Q Consensus       963 l~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg----------~~p~ 1024 (1109)
                      |+|||+++.........  ......||+.|+|||++.+..      ++.++|||||||++|||++|          +.||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999998765433211  123457999999999887653      34789999999999999999          6677


Q ss_pred             CCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCC
Q 001275         1025 DPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVP 1103 (1109)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1103 (1109)
                      ............+........  .    .+......   ...+....+.+++.+||+.||++||+++|++++|+++..+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQK--L----RPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSC--C----CCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccCcCcccHHHHHHHHHHHH--h----CCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence            554333333333332221111  0    11111101   1124556788899999999999999999999999987443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3e-36  Score=334.73  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=203.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .++|++.+.||+|+||+||+|... +++.||+|++..... ......+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            367889999999999999999764 589999999865432 233467889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc---EEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME---PHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfGla~~~  972 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999887643   4899999999999999999999   889999999999999986655   999999999866


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ....   ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||......  .....+..   ......   
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~---~~~~~~---  227 (284)
T 3kk8_A          159 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKA---GAYDYP---  227 (284)
T ss_dssp             CSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH---TCCCCC---
T ss_pred             ccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHh---ccccCC---
Confidence            5432   223457999999999999999999999999999999999999999653211  11111111   000000   


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .+.         ......++.+++.+|++.||++||+++|+++|-+
T Consensus       228 ~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (284)
T 3kk8_A          228 SPE---------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW  264 (284)
T ss_dssp             TTT---------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred             chh---------hcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence            000         0111234667888999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-36  Score=360.01  Aligned_cols=252  Identities=21%  Similarity=0.253  Sum_probs=194.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|+..++||+|+||.||+|.. .+++.||||++....  .......+.+|++++++++||||+++++++...+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            5788999999999999999976 468999999986432  3334456788999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   + .+|+||||||+||+++.++.+||+|||+|+....
T Consensus       228 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          228 EYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             CCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             eeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            9999999999997644   4899999999999999999999   7 8999999999999999999999999999986433


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++|+.||......     ..............     
T Consensus       302 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~~~~~~~p-----  369 (446)
T 4ejn_A          302 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEIRFP-----  369 (446)
T ss_dssp             -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCCC-----
T ss_pred             CC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHHhCCCCCC-----
Confidence            22  2233468999999999999999999999999999999999999999653211     11111111111010     


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLVD 1099 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~~ 1099 (1109)
                                 .....++.+++.+|++.||++||     +++|+++|-.-
T Consensus       370 -----------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          370 -----------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             -----------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             -----------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence                       01123456688899999999999     99999987543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.3e-36  Score=337.73  Aligned_cols=261  Identities=23%  Similarity=0.258  Sum_probs=197.1

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .++|.+.+.||+|+||.||+|... +++.||+|++......  .....+.+|++++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            367999999999999999999765 6889999998543222  2246788999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++++|.+++....   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999998643   4899999999999999999999   88999999999999999999999999999986643


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+.   ...... ..   
T Consensus       187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~---~~~~~~-~~---  256 (309)
T 2h34_A          187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHIN---QAIPRP-ST---  256 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHH---SCCCCG-GG---
T ss_pred             ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhc---cCCCCc-cc---
Confidence            321 2223457999999999999999999999999999999999999999653211  1111111   000000 00   


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhhCCCC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-NMRDVVRQLVDASVP 1103 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~~~~ 1103 (1109)
                            .   ......++.+++.+||+.||++|| +++|+++.|+.+...
T Consensus       257 ------~---~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          257 ------V---RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             ------T---STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ------c---CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence                  0   011123456688899999999999 999999999987543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=344.32  Aligned_cols=266  Identities=21%  Similarity=0.289  Sum_probs=204.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec----CCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR----KDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  893 (1109)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++... .......+.+|++++++++||||+++++++..    ....++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            5788899999999999999976 67899999988543 33445678999999999999999999999873    346799


Q ss_pred             EEEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          894 MYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      ||||+++|+|.+++.... ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999999997632 2345899999999999999999999   889999999999999999999999999998765


Q ss_pred             CCCCCCc-------eeeecccCcccccccccccCC---CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          973 DKSPAST-------TSISVVGTIGYIAPENAFTTA---KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       973 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      .......       ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||................  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--  262 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN--  262 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence            3211100       011245799999999887554   6889999999999999999999985321111111111110  


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCC
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTS 1106 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 1106 (1109)
                        ....              ........++.+++.+||+.||++||+++|++++|+.+..+.++
T Consensus       263 --~~~~--------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          263 --QLSI--------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             --C--C--------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             --cCCC--------------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence              0000              00011223567788899999999999999999999998666554

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.4e-36  Score=359.95  Aligned_cols=268  Identities=21%  Similarity=0.246  Sum_probs=196.0

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC------
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD------  889 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  889 (1109)
                      .++|+..++||+|+||+||+|.. .+++.||||++.... .......+.+|+.++++++||||+++++++...+      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999965 468999999985432 2334567889999999999999999999996553      


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..|+||||+++ ++.+.+..     .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            46999999986 46666643     2889999999999999999999   889999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc--
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE-- 1047 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 1047 (1109)
                      +......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+...+.........  
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred             eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence            8764332   22346899999999999999999999999999999999999999965321 11111111111100000  


Q ss_pred             ----------------cccccchhhhHHhh----hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 ----------------INDIVDLSLMEEML----VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ----------------~~~~~d~~~~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                      .....-+.......    .........++.+++.+|++.||++|||++|+++|-+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  358 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  358 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChh
Confidence                            00000000000000    0001122456788889999999999999999999854

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-36  Score=351.01  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=190.4

Q ss_pred             hCCCCC-ceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhc-CCCCceeeEeeEEec----CCce
Q 001275          819 ENLNAK-HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGK-IRHRNLVRLEDFWLR----KDCG  891 (1109)
Q Consensus       819 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~  891 (1109)
                      ++|... ++||+|+||+||+|... +++.||||++..      ...+.+|++++.+ .+||||+++++++..    .+..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            455555 68999999999999765 688999999842      2467788888754 589999999999875    5678


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCcEEEecccC
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EMEPHISDFGI  968 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGl  968 (1109)
                      |+||||+++|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence            99999999999999998643 245899999999999999999999   889999999999999987   78899999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccc--cHHHHHHHhhcCcc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT--DIVGWVRSVWSDTE 1046 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 1046 (1109)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+...  . .
T Consensus       211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~--~-~  284 (400)
T 1nxk_A          211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--Q-Y  284 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT--C-C
T ss_pred             ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC--c-c
Confidence            98664322   22346789999999999999999999999999999999999999975432211  111111110  0 0


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .   ...+         .......++.+++.+||+.||++|||++|+++|-+-
T Consensus       285 ~---~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  325 (400)
T 1nxk_A          285 E---FPNP---------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  325 (400)
T ss_dssp             C---CCTT---------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             c---CCCc---------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence            0   0000         001122346678889999999999999999998643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=351.69  Aligned_cols=269  Identities=27%  Similarity=0.371  Sum_probs=194.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHH--HHHHhcCCCCceeeEeeEEec-----CCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKRE--IQTIGKIRHRNLVRLEDFWLR-----KDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~-----~~~~  891 (1109)
                      ++|.+.+.||+|+||+||+|+. +++.||||++...    ....+..|  +..+..++||||+++++++..     ....
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            5788899999999999999977 5899999998432    22334444  444556899999999986543     2256


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---------CeEEeccCCCCeeeCCCCcEE
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP---------PIVHRDIKPENILLDSEMEPH  962 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---------~ivH~Dlk~~NIll~~~~~~k  962 (1109)
                      ++||||+++|+|.+++....    .++..+..++.|+++||+|||   +.         +|+||||||+||+++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEE
Confidence            89999999999999997643    589999999999999999999   77         999999999999999999999


Q ss_pred             EecccCCcccCCCCC------CceeeecccCccccccccccc-------CCCCccCcchhhHHHHHHHHhCCCCCCCCcc
Q 001275          963 ISDFGIAKLLDKSPA------STTSISVVGTIGYIAPENAFT-------TAKSKESDVYSYGVVLLELITRKKALDPSYK 1029 (1109)
Q Consensus       963 l~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~elltg~~p~~~~~~ 1029 (1109)
                      |+|||+++.+.....      ........||+.|+|||++.+       ..++.++|||||||++|||++|+.|+.+...
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987653321      112234579999999998876       4557799999999999999999888755432


Q ss_pred             ccccHHHHHHHhhcCc--cccccc-----cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1030 ERTDIVGWVRSVWSDT--EEINDI-----VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1030 ~~~~~~~~~~~~~~~~--~~~~~~-----~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .......+........  ......     ..+....  ..........++.+++.+||+.||++|||++|+++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            2111100000000000  000000     0000000  00112234556888999999999999999999999998763

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5e-36  Score=345.16  Aligned_cols=200  Identities=26%  Similarity=0.329  Sum_probs=174.8

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-----CCceeeEeeEEecCC
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-----HRNLVRLEDFWLRKD  889 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~  889 (1109)
                      ...++|.+.++||+|+||+||+|+. .+++.||||++..  .......+..|++++++++     ||||+++++++...+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN--IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc--chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            3457899999999999999999977 5688999999842  2334456788999999996     999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC------------
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS------------  957 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~------------  957 (1109)
                      ..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.            
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             eeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhc
Confidence            999999999 899999998644 234899999999999999999999   899999999999999975            


Q ss_pred             -------------CCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCC
Q 001275          958 -------------EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKAL 1024 (1109)
Q Consensus       958 -------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~ 1024 (1109)
                                   ++.+||+|||+++......     ....||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence                         7889999999998654322     2357899999999999999999999999999999999999999


Q ss_pred             CCC
Q 001275         1025 DPS 1027 (1109)
Q Consensus      1025 ~~~ 1027 (1109)
                      ...
T Consensus       260 ~~~  262 (360)
T 3llt_A          260 RTH  262 (360)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3e-36  Score=333.61  Aligned_cols=252  Identities=22%  Similarity=0.357  Sum_probs=183.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.+.||+|+||+||+|+. .+++.||+|++....  .......+.+|++++++++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5788899999999999999976 578999999985432  2233467899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++....  ..+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             ECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             ecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            9999999999998642  35899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..  ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......     ........     ..   .
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~-----~~---~  230 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-----TLNKVVLA-----DY---E  230 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSS-----CC---C
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-----HHHHHhhc-----cc---C
Confidence            21  1223578999999999999899999999999999999999999996532111     00000000     00   0


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                           ...   ....++.+++.+|++.||++||+++|+++|-.
T Consensus       231 -----~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  265 (278)
T 3cok_A          231 -----MPS---FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF  265 (278)
T ss_dssp             -----CCT---TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred             -----Ccc---ccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence                 000   11234567888999999999999999998654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=371.87  Aligned_cols=249  Identities=21%  Similarity=0.300  Sum_probs=196.9

Q ss_pred             eeecccCeEEEEEEeC---CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccCCC
Q 001275          826 VIGRGAHGIVYKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       826 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      .||+|+||+||+|.+.   ++..||||++..........++.+|++++++++|||||+++++|.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999663   4677999999665555567789999999999999999999999976 56899999999999


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC-cee
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS-TTS  981 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~  981 (1109)
                      |.+++...  ...+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++........ ...
T Consensus       422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            99999753  345899999999999999999999   889999999999999999999999999999876443221 122


Q ss_pred             eecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHh
Q 001275          982 ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060 (1109)
Q Consensus       982 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 1060 (1109)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....  .++...+..   . ... .          
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~---~-~~~-~----------  559 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ---G-KRM-E----------  559 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHT---T-CCC-C----------
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc---C-CCC-C----------
Confidence            23456789999999999999999999999999999998 9999865422  122221111   0 000 0          


Q ss_pred             hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1061 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                         .......++.+++.+||+.||++||+++|+++.|+.+
T Consensus       560 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          560 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ---CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               0011234567788899999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.5e-37  Score=339.95  Aligned_cols=256  Identities=23%  Similarity=0.320  Sum_probs=208.1

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|+..+.||+|+||+||+|.... +..||+|++..  .......+.+|++++++++||||+++++++...+..++|||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS--CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4678889999999999999997764 78899998843  33345678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            999999999998643 345899999999999999999999   8899999999999999999999999999998765432


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                       ........+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||.....  ......+.......       .  
T Consensus       166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~~~~~~~-------~--  233 (288)
T 3kfa_A          166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRME-------R--  233 (288)
T ss_dssp             -SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCCC-------C--
T ss_pred             -cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhccCCCC-------C--
Confidence             233334567889999999999999999999999999999999 8888864321  12222211110000       0  


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                               ......++.+++.+|++.||++||+++|+++.|+..
T Consensus       234 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          234 ---------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence                     011123466788899999999999999999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.5e-36  Score=332.45  Aligned_cols=253  Identities=22%  Similarity=0.306  Sum_probs=201.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc-----cChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK-----RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|++.+.||+|+||+||+|... +++.||+|.+......     .....+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56888999999999999999776 6899999998654322     23567999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC----cEEEecccC
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM----EPHISDFGI  968 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfGl  968 (1109)
                      +||||+++++|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999997643   4899999999999999999999   88999999999999998877    899999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      +........   .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||......     ............ 
T Consensus       159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~-  229 (283)
T 3bhy_A          159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-----ETLTNISAVNYD-  229 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTCCC-
T ss_pred             ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----HHHHHhHhcccC-
Confidence            987644322   23357999999999999999999999999999999999999998653211     111111110000 


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                         .....        .......+.+++.+|++.||++||++.|+++|-
T Consensus       230 ---~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  267 (283)
T 3bhy_A          230 ---FDEEY--------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS  267 (283)
T ss_dssp             ---CCHHH--------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred             ---Ccchh--------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence               00000        011223466788899999999999999999853

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-36  Score=354.04  Aligned_cols=258  Identities=22%  Similarity=0.302  Sum_probs=193.1

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-------ccChHHHHHHHHHHhcCCCCceeeEeeEEec
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-------KRGSLSMKREIQTIGKIRHRNLVRLEDFWLR  887 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  887 (1109)
                      ...++|...+.||+|+||+||+|.. .+++.||||++.....       ......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            4467899999999999999999966 4579999999864321       1122357899999999999999999999854


Q ss_pred             CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC---CcEEEe
Q 001275          888 KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE---MEPHIS  964 (1109)
Q Consensus       888 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~  964 (1109)
                       +..++||||+++|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.+   ..+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence             55799999999999999887543   4899999999999999999999   8899999999999999654   459999


Q ss_pred             cccCCcccCCCCCCceeeecccCccccccccccc---CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT---TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      |||+++......   ......||+.|+|||++.+   ..++.++||||+||++|||++|+.||...... ......+...
T Consensus       285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i~~~  360 (419)
T 3i6u_A          285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSG  360 (419)
T ss_dssp             CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHHHTT
T ss_pred             ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHHhcC
Confidence            999998765332   2234679999999998863   66789999999999999999999999653222 1222111110


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .   .   .. .+.        .......++.+++.+|++.||++||+++|+++|-+-
T Consensus       361 ~---~---~~-~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  403 (419)
T 3i6u_A          361 K---Y---NF-IPE--------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  403 (419)
T ss_dssp             C---C---CC-CHH--------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             C---C---CC-Cch--------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence            0   0   00 000        011123446678889999999999999999998653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-36  Score=348.04  Aligned_cols=251  Identities=26%  Similarity=0.377  Sum_probs=199.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.|...+.||+|+||+||+|.. .+++.||||++.....  .....++.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999976 5789999999854332  223457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||++ |++.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 68888886533  34899999999999999999999   889999999999999999999999999999866432


Q ss_pred             CCCceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                            ....||+.|+|||++.   +..++.++|||||||++|||++|+.||......     ............  ...
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----~~~~~~~~~~~~--~~~  274 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNESP--ALQ  274 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCCC--CCC
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhcCCC--CCC
Confidence                  2357999999999884   567899999999999999999999998643211     111111111100  000


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .         ...   ...+.+++.+||+.||++||+++|++++.+-.
T Consensus       275 ~---------~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~  310 (348)
T 1u5q_A          275 S---------GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  310 (348)
T ss_dssp             C---------TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             C---------CCC---CHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence            0         011   22355677899999999999999999887654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=6.7e-36  Score=367.26  Aligned_cols=351  Identities=20%  Similarity=0.154  Sum_probs=218.9

Q ss_pred             CCCcccCCCCCCCCCCce----eeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCC
Q 001275           43 VPPLIISSWNSSDSTPCQ----WVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNC  118 (1109)
Q Consensus        43 ~~~~~l~sW~~~~~~~c~----w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l  118 (1109)
                      +....+++|..... ||.    |.++.|+.   ++   +.......  ....-..+++++.|++++|.++...+..++.+
T Consensus         4 ~~~~~l~~~~~~~~-C~~~~~~~~c~~~~~---~i---~~~~~~~~--~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l   74 (597)
T 3oja_B            4 QQRYNVKPRQPEYK-CIDSNLQYDCVFYDV---HI---DMQTQDVY--FGFEDITLNNQKIVTFKNSTMRKLPAALLDSF   74 (597)
T ss_dssp             -------CCCSEEC-CCCC--CCSEEECSC---EE---CSSCCCCE--ESCSSGGGCCCSEEEESSCEESEECTHHHHHC
T ss_pred             cccccccCCCCCCc-CcccCcCceeEecCc---ee---cccccccc--cCcccccCCCceEEEeeCCCCCCcCHHHHccC
Confidence            34456789987654 442    66665542   11   11111111  11122346788889999888886555557888


Q ss_pred             CCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeec
Q 001275          119 SALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL  198 (1109)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L  198 (1109)
                      ++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..++.+++|++|+|++|.+++..+..|+++++|++|+|
T Consensus        75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  154 (597)
T 3oja_B           75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM  154 (597)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence            88999999999888877778888888999999888888777777788888888888888888655556688888888888


Q ss_pred             ccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCC
Q 001275          199 FSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGG  278 (1109)
Q Consensus       199 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  278 (1109)
                      ++|.+++..|..|+++++|++|+|++|.+++..   +..+++|+.|++++|.+++.     ...++|+.|++++|.++..
T Consensus       155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~  226 (597)
T 3oja_B          155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV  226 (597)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCEE
T ss_pred             eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCccccc
Confidence            888888777777888888888888888877652   45566777777777777642     2234566666666666532


Q ss_pred             CCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCC
Q 001275          279 ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQL  358 (1109)
Q Consensus       279 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  358 (1109)
                      .+. +  .++|+.|++++|.+++  +..++.+++|+.|+|++|.+++.+|..|+.+++|+.|+|++|.+++ +|..+..+
T Consensus       227 ~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l  300 (597)
T 3oja_B          227 RGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI  300 (597)
T ss_dssp             ECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCC
T ss_pred             ccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccC
Confidence            221 1  2456666666666654  2445555666666666666655555556666666666666666553 34444555


Q ss_pred             CCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCc
Q 001275          359 SNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFS  420 (1109)
Q Consensus       359 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  420 (1109)
                      ++|++|+|++|+++ .+|..+..+++|++|++++|.+++..   +..+++|+.|++++|+++
T Consensus       301 ~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~  358 (597)
T 3oja_B          301 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWD  358 (597)
T ss_dssp             TTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEE
T ss_pred             CCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCC
Confidence            55555555555555 34444555555555555555554321   233344444444444443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-36  Score=345.07  Aligned_cols=256  Identities=21%  Similarity=0.312  Sum_probs=200.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcE--EEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAV--FAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|...+.||+|+||.||+|+.. ++..  +|+|++...........+.+|+++++++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57888999999999999999764 4554  4899886555555567899999999999 899999999999999999999


Q ss_pred             EEeccCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          895 YRYMENGSLRDVLHSIT-------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                      |||+++|+|.+++....             ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997643             2245899999999999999999999   8999999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||+++.....   .......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.....     ......
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~  253 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK  253 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHHHH
Confidence            99999999744321   11223467889999999988889999999999999999998 9999865321     111111


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..... ..      .        .......++.+++.+||+.||++||+++|++++|.++
T Consensus       254 ~~~~~-~~------~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          254 LPQGY-RL------E--------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             GGGTC-CC------C--------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCC-CC------C--------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11100 00      0        0011123466788899999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.1e-36  Score=337.47  Aligned_cols=260  Identities=19%  Similarity=0.317  Sum_probs=195.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+|++.+.||+|+||.||+|.. .+++.||+|++....  .......+.+|++++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5788999999999999999976 578999999985422  2233567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||+++|+|.+++.... ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999986532 2345899999999999999999999   88999999999999999999999999999986643


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......   ...........  .....  
T Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~--~~~~~--  259 (310)
T 2wqm_A          189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIEQCD--YPPLP--  259 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH---HHHHHHHHTTC--SCCCC--
T ss_pred             CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH---HHHHHHhhccc--CCCCc--
Confidence            221  2223578999999999999999999999999999999999999986432221   11111111100  00000  


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                ......++.+++.+||+.||++||+++|++++|+++
T Consensus       260 ----------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          260 ----------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             ----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                      001123466788899999999999999999999876

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-36  Score=343.55  Aligned_cols=262  Identities=21%  Similarity=0.275  Sum_probs=196.4

Q ss_pred             hCCCCC-ceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAK-HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.|.+. ++||+|+||+||+|.. .+++.||||++... .......+.+|++++.++ +||||+++++++...+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ-PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC-SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC-cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            457664 7899999999999975 46899999998543 344567889999999985 7999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc---EEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME---PHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfGla~~~  972 (1109)
                      ||+++|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.   +||+|||+++..
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999998643   4899999999999999999999   889999999999999988776   999999999865


Q ss_pred             CCCCC-----CceeeecccCccccccccccc-----CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccH--------
Q 001275          973 DKSPA-----STTSISVVGTIGYIAPENAFT-----TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDI-------- 1034 (1109)
Q Consensus       973 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~-------- 1034 (1109)
                      .....     ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||..........        
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211     111223469999999998875     557899999999999999999999997543221000        


Q ss_pred             --HHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1035 --VGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1035 --~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                        ............   .. .    ..    .......++.+++.+|++.||++||+++|+++|-+-
T Consensus       245 ~~~~~~~~i~~~~~---~~-~----~~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  299 (316)
T 2ac3_A          245 CQNMLFESIQEGKY---EF-P----DK----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV  299 (316)
T ss_dssp             HHHHHHHHHHHCCC---CC-C----HH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred             HHHHHHHHHhccCc---cc-C----ch----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence              000000000000   00 0    00    001122456778889999999999999999997653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.6e-36  Score=345.73  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=191.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHH-HhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQT-IGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|+..++||+|+||+||+|+.. +++.||+|++.....  ......+.+|..+ ++.++||||+++++++...+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            57889999999999999999775 578999999965432  2234456677776 5678999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999997644   3889999999999999999999   89999999999999999999999999999986432


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..  ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ..............    . 
T Consensus       192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~~~----~-  259 (373)
T 2r5t_A          192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKPLQL----K-  259 (373)
T ss_dssp             CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHHHHHHSCCCC----C-
T ss_pred             CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcccCC----C-
Confidence            21  122346899999999999999999999999999999999999999964321     11111111111000    0 


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR----DVVRQL 1097 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~----evl~~L 1097 (1109)
                              ....   .++.+++.+|++.||++||++.    |+.+|-
T Consensus       260 --------~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~  295 (373)
T 2r5t_A          260 --------PNIT---NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV  295 (373)
T ss_dssp             --------SSSC---HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSG
T ss_pred             --------CCCC---HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCc
Confidence                    0111   2355677899999999999974    555543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.4e-36  Score=356.61  Aligned_cols=257  Identities=22%  Similarity=0.297  Sum_probs=205.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|...++||+|+||+||+|+.. +|+.||+|++.....  ......+.+|++++++++||||+++++++...+..|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57888899999999999999875 689999999854432  234567889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          896 RYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      ||+++|+|.+++..... ...+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999999976432 345899999999999999999999   88999999999999999999999999999987654


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ...  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+............     
T Consensus       342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~~~~~~~~~i~~~~~~~p-----  413 (543)
T 3c4z_A          342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRVLEQAVTYP-----  413 (543)
T ss_dssp             TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-CCHHHHHHHHHHCCCCCC-----
T ss_pred             CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-hhHHHHHHHHhhcccCCC-----
Confidence            322  123358999999999999999999999999999999999999999754221 111122221111110000     


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM-----RDVVRQL 1097 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~L 1097 (1109)
                                 .....++.+++.+|++.||++||++     +|+++|-
T Consensus       414 -----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hp  450 (543)
T 3c4z_A          414 -----------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP  450 (543)
T ss_dssp             -----------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSG
T ss_pred             -----------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCc
Confidence                       0112345567789999999999964     7787654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-36  Score=346.22  Aligned_cols=266  Identities=21%  Similarity=0.255  Sum_probs=194.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC------c
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD------C  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  890 (1109)
                      ++|...+.||+|+||.||+|.. .+|+.||||++.... .......+.+|++++++++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            5788899999999999999976 568999999984432 2223457889999999999999999999997653      4


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .|+||||+ +++|.++++..    .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       105 ~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            59999999 78999999762    3899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      .....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+...............
T Consensus       177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred             ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCCHHHH
Confidence            76432     223578999999998887 6789999999999999999999999965321 1111111111111110000


Q ss_pred             cccchhhhHHh-----------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1050 DIVDLSLMEEM-----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1050 ~~~d~~~~~~~-----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..+........           ..........++.+++.+|++.||++|||++|+++|-.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~  310 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  310 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence            00000000000           00001122345677888999999999999999999754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.4e-36  Score=336.79  Aligned_cols=255  Identities=20%  Similarity=0.261  Sum_probs=199.4

Q ss_pred             hCCCCCc-eeecccCeEEEEEEe---CCCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKH-VIGRGAHGIVYKASL---GPNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ++|.+.+ .||+|+||+||+|..   ..++.||||++...... .....+.+|++++++++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5677777 899999999999954   34688999998544322 2356789999999999999999999999 5677899


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.+++....   .+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        95 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            999999999999998743   4899999999999999999999   8899999999999999999999999999998775


Q ss_pred             CCCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          974 KSPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       974 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ...... ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......  .....+..   . ... ..
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~---~-~~~-~~  241 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEK---G-ERM-GC  241 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT---T-CCC-CC
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc---C-CCC-CC
Confidence            443221 1223456789999999998889999999999999999999 99998653221  11111111   0 000 00


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                   ......++.+++.+||+.||++||++.|+++.|+++
T Consensus       242 -------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          242 -------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                         011223466788899999999999999999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-35  Score=333.65  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=205.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.|...+.||+|+||.||+|.. .+++.||+|++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            5688899999999999999976 468999999997665556677899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++++|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus       102 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999998652    4899999999999999999999   88999999999999999999999999999987644321


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||......  .....+...  .....    .    
T Consensus       175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~--~~~~~----~----  240 (303)
T 3a7i_A          175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIPKN--NPPTL----E----  240 (303)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHS--CCCCC----C----
T ss_pred             --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhhcC--CCCCC----c----
Confidence              223457899999999999999999999999999999999999998643211  111111110  00000    0    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                              ......+.+++.+||+.||++||+++|++++..
T Consensus       241 --------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          241 --------GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             --------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             --------cccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence                    011234667888999999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-36  Score=346.65  Aligned_cols=258  Identities=24%  Similarity=0.285  Sum_probs=202.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe----CCCcEEEEEEeeecc---cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRG---HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  890 (1109)
                      ++|.+.++||+|+||+||+|+.    .+++.||||++....   .......+.+|+++++++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5789999999999999999987    478999999985432   223345677899999999 69999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++||||+++|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999998643   4899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      ...... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...... .....+...........
T Consensus       208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~  285 (355)
T 1vzo_A          208 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSEPPY  285 (355)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCCCCC
T ss_pred             ecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc-chHHHHHHHHhccCCCC
Confidence            664322 122234579999999999885  34689999999999999999999999643221 11222222211111000


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHhhhC
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQLVDA 1100 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L~~~ 1100 (1109)
                                      .......+.+++.+||+.||++||     +++|+++|..-.
T Consensus       286 ----------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          286 ----------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             ----------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             ----------------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence                            011123456688899999999999     999999987543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.4e-36  Score=339.88  Aligned_cols=265  Identities=19%  Similarity=0.253  Sum_probs=202.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEec--CCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLR--KDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  894 (1109)
                      ++|++.+.||+|+||+||+|.. .+++.||||++.    ......+.+|++++++++ ||||+++++++..  ....++|
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~----~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC----SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEec----ccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            6788899999999999999965 578999999984    234567899999999997 9999999999987  5678999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecccCCcccC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLD  973 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~  973 (1109)
                      |||+++++|.+++..      +++..+..++.|+++||+|||   +.+|+||||||+||+++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            999999999999864      788999999999999999999   88999999999999999776 89999999998765


Q ss_pred             CCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-----cc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-----EE 1047 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~ 1047 (1109)
                      ....   .....||..|+|||++.+ ..++.++||||+||++|||++|+.||.........+...........     ..
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            4332   223578999999999877 67899999999999999999999999655433322222221110000     00


Q ss_pred             cccccchhhhH-----------H-hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1048 INDIVDLSLME-----------E-MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1048 ~~~~~d~~~~~-----------~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .....++....           . ...........++.+++.+|++.||++|||++|+++|-+-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            00000000000           0 0000011123457778889999999999999999997553

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1e-35  Score=330.52  Aligned_cols=248  Identities=21%  Similarity=0.334  Sum_probs=202.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|...+.||+|+||.||+|... +++.||+|++....  .......+.+|++++++++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57888999999999999999775 57889999985432  2233567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999998654   3899999999999999999999   899999999999999999999999999999765432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .    .....|++.|+|||++.+..++.++||||+|+++|+|++|+.||......     ..............      
T Consensus       168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~------  232 (284)
T 2vgo_A          168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIVNVDLKFP------  232 (284)
T ss_dssp             C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTCCCCC------
T ss_pred             c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHhccccCCC------
Confidence            1    22357899999999999999999999999999999999999999653211     11111111100000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                             ...   ..++.+++.+|++.||++||+++|+++|-
T Consensus       233 -------~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~h~  264 (284)
T 2vgo_A          233 -------PFL---SDGSKDLISKLLRYHPPQRLPLKGVMEHP  264 (284)
T ss_dssp             -------TTS---CHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred             -------CcC---CHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence                   011   23456688899999999999999999854

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.4e-36  Score=343.86  Aligned_cols=255  Identities=22%  Similarity=0.275  Sum_probs=198.5

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ..++|...+.||+|+||+||+|... +++.||+|++.....     ...+|++++.++ +||||+++++++.+.+..|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999765 688999999854321     245788888888 799999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC----CcEEEecccCCc
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE----MEPHISDFGIAK  970 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfGla~  970 (1109)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++..+    +.+||+|||+++
T Consensus        95 ~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           95 TELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             ECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999997643   4899999999999999999999   8899999999999998443    359999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......  ..................
T Consensus       169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~~~~~  244 (342)
T 2qr7_A          169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKFSLSG  244 (342)
T ss_dssp             ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCCCCCS
T ss_pred             cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCcccCc
Confidence            7644322  223457899999999998888999999999999999999999999753221  111222111111100000


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                          .     .   ......++.+++.+|++.||++||++.|+++|-+
T Consensus       245 ----~-----~---~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          245 ----G-----Y---WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             ----T-----T---TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             ----c-----c---cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence                0     0   0111234556778999999999999999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.4e-36  Score=333.26  Aligned_cols=261  Identities=16%  Similarity=0.219  Sum_probs=198.4

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEE-ecCCceeE
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW-LRKDCGII  893 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l  893 (1109)
                      ...++|...+.||+|+||+||+|.. .+++.||||++.....   ...+.+|++++++++|++++..++++ ...+..++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            3457899999999999999999976 6789999998644322   23578899999999888877666655 56677899


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee---CCCCcEEEecccCCc
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL---DSEMEPHISDFGIAK  970 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~  970 (1109)
                      ||||+ +|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++
T Consensus        83 v~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            99999 999999997533  24899999999999999999999   8899999999999999   788999999999998


Q ss_pred             ccCCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccc-cHH-HHHHHhhc
Q 001275          971 LLDKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT-DIV-GWVRSVWS 1043 (1109)
Q Consensus       971 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~-~~~-~~~~~~~~ 1043 (1109)
                      ........     .......||+.|+|||.+.+..++.++||||+||++|||++|+.||........ ... ........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            76543221     122346799999999999999999999999999999999999999965322111 111 11000000


Q ss_pred             CccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1044 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..            ....   ......++.+++.+||+.||++||+++|+++.|+++
T Consensus       237 ~~------------~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          237 TP------------IEVL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             SC------------HHHH---TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ch------------hhhh---hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            00            0000   011134577788899999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.5e-36  Score=352.74  Aligned_cols=201  Identities=26%  Similarity=0.370  Sum_probs=166.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC-----Cc
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-----DC  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  890 (1109)
                      .++|.+.++||+|+||+||+|... +++.||||++.... .....+++.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999764 57899999985432 223356789999999999999999999998766     56


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .|+||||++ |+|.++++...   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999987 59999997643   4899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCC--------------------ceeeecccCccccccccc-ccCCCCccCcchhhHHHHHHHHhCCCCCC
Q 001275          971 LLDKSPAS--------------------TTSISVVGTIGYIAPENA-FTTAKSKESDVYSYGVVLLELITRKKALD 1025 (1109)
Q Consensus       971 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg~~p~~ 1025 (1109)
                      ........                    ......+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76543211                    123456899999999986 56678999999999999999998655543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.6e-36  Score=329.21  Aligned_cols=250  Identities=23%  Similarity=0.307  Sum_probs=195.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|.+.+.||+|+||.||+|... +++.||||++....  .......+.+|++++++++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999999875 78999999985432  2334567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999997643   3899999999999999999999   889999999999999999999999999999876443


Q ss_pred             CCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..   .....||+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.....     ...............     
T Consensus       165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-----  231 (276)
T 2h6d_A          165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKKIRGGVFYIP-----  231 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC-----
T ss_pred             cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHHhhcCcccCc-----
Confidence            21   223578999999999988766 6899999999999999999999864321     111111111100000     


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                              .   ....++.+++.+|++.||++||+++|+++|-.
T Consensus       232 --------~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          232 --------E---YLNRSVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             --------T---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             --------h---hcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence                    0   11234566888999999999999999999743

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.4e-36  Score=333.82  Aligned_cols=250  Identities=25%  Similarity=0.380  Sum_probs=196.6

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEec----CCceeE
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR----KDCGII  893 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  893 (1109)
                      .|...+.||+|+||+||+|.. .++..||+|++.... .......+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            467778899999999999976 467889999986443 23345678999999999999999999999865    345799


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeccCCCCeeeC-CCCcEEEecccCCc
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP--IVHRDIKPENILLD-SEMEPHISDFGIAK  970 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~DfGla~  970 (1109)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+  |+||||||+||+++ .++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999998643   3889999999999999999999   777  99999999999997 78999999999997


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .....    ......||+.|+|||++. +.++.++||||+|+++|+|++|+.||......    ............    
T Consensus       181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~----  247 (290)
T 1t4h_A          181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVK----  247 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCC----
T ss_pred             ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHHHhccCC----
Confidence            55332    223457999999999776 45899999999999999999999999643221    112211111100    


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                         +...       ......++.+++.+||+.||++||+++|+++|-+
T Consensus       248 ---~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          248 ---PASF-------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             ---CGGG-------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ---cccc-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence               0000       0011234677888999999999999999998743

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=330.63  Aligned_cols=256  Identities=26%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      +|....+||+|+||+||+|.. .+++.||||.+... .......+.+|+.++++++||||+++++++...+..++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            455566899999999999976 56889999998543 3444567899999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcEEEecccCCcccCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~DfGla~~~~~~~~  977 (1109)
                      ++++|.+++.........++..+..++.|+++||+|||   +.+|+||||||+||+++. ++.+||+|||+++.......
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999987655556789999999999999999999   889999999999999987 89999999999987643221


Q ss_pred             CceeeecccCcccccccccccCC--CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          978 STTSISVVGTIGYIAPENAFTTA--KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                        ......||+.|+|||++.+..  ++.++||||||+++|||++|+.||...........  ...........       
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~-------  247 (295)
T 2clq_A          179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF--KVGMFKVHPEI-------  247 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH--HHHHHCCCCCC-------
T ss_pred             --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH--hhccccccccc-------
Confidence              123357899999999987654  78999999999999999999999853211111100  00000000000       


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                               ......++.+++.+||+.||++||+++|++++-.-
T Consensus       248 ---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~  282 (295)
T 2clq_A          248 ---------PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL  282 (295)
T ss_dssp             ---------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred             ---------cccCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence                     01112345668889999999999999999987544

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=348.92  Aligned_cols=261  Identities=17%  Similarity=0.156  Sum_probs=201.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC---------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceee---------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP---------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVR---------  880 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  880 (1109)
                      ++|.+.+.||+|+||+||+|....         ++.||+|++...      ..+.+|++++++++||||++         
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            578889999999999999997764         789999998432      36789999999999999987         


Q ss_pred             ------EeeEEec-CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCe
Q 001275          881 ------LEDFWLR-KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENI  953 (1109)
Q Consensus       881 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NI  953 (1109)
                            +++++.. .+..++||||+ +|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHE
Confidence                  6777765 67789999999 999999998642 235899999999999999999999   88999999999999


Q ss_pred             eeCCCC--cEEEecccCCcccCCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCC
Q 001275          954 LLDSEM--EPHISDFGIAKLLDKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDP 1026 (1109)
Q Consensus       954 ll~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~ 1026 (1109)
                      +++.++  .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999876432211     112335799999999999999999999999999999999999999965


Q ss_pred             CccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1027 SYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .......+............   .+.+....       ......++.+++.+||+.||++||+++|+++.|+++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPG---PFVGPCGH-------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCC---CEECTTSC-------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChh---hhhhhccc-------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            43222222222222111111   11110000       001124466788899999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.3e-35  Score=331.36  Aligned_cols=251  Identities=21%  Similarity=0.291  Sum_probs=203.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|...+.||+|+||+||+|... +++.||+|.+.....  ......+.+|++++++++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            57888999999999999999775 578899998854432  233457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++....   .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        95 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             ECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999987643   4899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..  ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||......     ...............     
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~-----  236 (294)
T 2rku_A          169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKKNEYSIPK-----  236 (294)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTCCCCCT-----
T ss_pred             cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhhccCCCcc-----
Confidence            22  223357899999999999988999999999999999999999999653211     111111111100000     


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                 .....+.+++.+|++.||++||+++|++++-.
T Consensus       237 -----------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~  268 (294)
T 2rku_A          237 -----------HINPVAASLIQKMLQTDPTARPTINELLNDEF  268 (294)
T ss_dssp             -----------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             -----------ccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence                       11134566788999999999999999998754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.1e-36  Score=344.69  Aligned_cols=279  Identities=20%  Similarity=0.227  Sum_probs=200.9

Q ss_pred             cHHHHHHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccC----------hHHHHHHHHHHhcCCCCcee
Q 001275          810 LLKQVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRG----------SLSMKREIQTIGKIRHRNLV  879 (1109)
Q Consensus       810 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv  879 (1109)
                      .++++....++|...+.||+|+||.||+|...+++.||||++........          .+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            35567777899999999999999999999988899999999855433221          26789999999999999999


Q ss_pred             eEeeEEecC-----CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCee
Q 001275          880 RLEDFWLRK-----DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENIL  954 (1109)
Q Consensus       880 ~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIl  954 (1109)
                      ++++++...     ...++||||++ |+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEE
Confidence            999998543     35799999998 68888887532  35899999999999999999999   889999999999999


Q ss_pred             eCCCCcEEEecccCCcccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCcccccc
Q 001275          955 LDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033 (1109)
Q Consensus       955 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 1033 (1109)
                      ++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ..
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~  242 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQ  242 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH
T ss_pred             EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HH
Confidence            9999999999999998543322   2234578999999998877 67899999999999999999999999754211 11


Q ss_pred             HHHHHHHhhcCccc-cccccchhhhHH-----------hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1034 IVGWVRSVWSDTEE-INDIVDLSLMEE-----------MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1034 ~~~~~~~~~~~~~~-~~~~~d~~~~~~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .............. ......+.....           ............+.+++.+|++.||++|||++|+++|-+
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            11111111100000 000000000000           000001112345677888999999999999999999854

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-35  Score=331.95  Aligned_cols=259  Identities=16%  Similarity=0.223  Sum_probs=201.2

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEE-ecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFW-LRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  895 (1109)
                      .++|+..+.||+|+||+||+|+. .+++.||||++....   ....+.+|++++++++|++++..+.++ ...+..++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            46788999999999999999976 678999999885432   234688999999999988866666555 5566779999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC---CCCcEEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD---SEMEPHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfGla~~~  972 (1109)
                      ||+ +++|.+++....  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++   .++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 899999997533  34899999999999999999999   88999999999999994   7889999999999876


Q ss_pred             CCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc-ccHHHHH-HHhhcCc
Q 001275          973 DKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER-TDIVGWV-RSVWSDT 1045 (1109)
Q Consensus       973 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~-~~~~~~~-~~~~~~~ 1045 (1109)
                      ......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ......+ .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            543321     11234579999999999999999999999999999999999999997532211 1111111 1000000


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                  ....   ......++.+++.+||+.||++||+++|+++.|+++
T Consensus       239 ------------~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          239 ------------IEVL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             ------------HHHH---TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ------------hHHH---HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence                        0000   011224577788899999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.7e-36  Score=335.02  Aligned_cols=249  Identities=23%  Similarity=0.427  Sum_probs=201.4

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec--------
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--------  887 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  887 (1109)
                      ...+|+..+.||+|+||.||+|... +++.||+|++....     ..+.+|++++++++||||+++++++..        
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            3467899999999999999999875 78999999985432     357789999999999999999998864        


Q ss_pred             --------CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC
Q 001275          888 --------KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM  959 (1109)
Q Consensus       888 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~  959 (1109)
                              ....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCC
Confidence                    345799999999999999997643 235899999999999999999999   88999999999999999999


Q ss_pred             cEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHH
Q 001275          960 EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVR 1039 (1109)
Q Consensus       960 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 1039 (1109)
                      .+||+|||++........   .....||+.|+|||.+.+..++.++||||+|+++|||++|..|+...    .   ....
T Consensus       160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~---~~~~  229 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----S---KFFT  229 (284)
T ss_dssp             EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----H---HHHH
T ss_pred             CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----H---HHHH
Confidence            999999999987654322   22357999999999999999999999999999999999999876311    0   1111


Q ss_pred             HhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1040 SVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1040 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      .....  ....             ..   ..++.+++.+||+.||++||++.|++++|+.+..
T Consensus       230 ~~~~~--~~~~-------------~~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          230 DLRDG--IISD-------------IF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HHHTT--CCCT-------------TS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             Hhhcc--cccc-------------cC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            11000  0000             11   1235567889999999999999999999988744

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.3e-36  Score=356.37  Aligned_cols=195  Identities=24%  Similarity=0.362  Sum_probs=153.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC-----Cce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-----DCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  891 (1109)
                      ++|.+.++||+|+||+||+|... +++.||||++.... .....+++.+|++++++++|||||++++++...     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            67899999999999999999664 68999999985432 223356788999999999999999999998543     468


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      |+||||++ |+|.+++....   .+++..+..++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEeccc-cchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            99999985 69999987643   4899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCC-------------------------ceeeecccCccccccccc-ccCCCCccCcchhhHHHHHHHHhC
Q 001275          972 LDKSPAS-------------------------TTSISVVGTIGYIAPENA-FTTAKSKESDVYSYGVVLLELITR 1020 (1109)
Q Consensus       972 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvil~elltg 1020 (1109)
                      .......                         ......+||+.|+|||++ .+..++.++||||+||++|||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            6432211                         123446789999999976 466799999999999999999994

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=7.3e-36  Score=344.06  Aligned_cols=272  Identities=23%  Similarity=0.303  Sum_probs=202.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC-----Cce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-----DCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  891 (1109)
                      ..+|+..+.||+|+||+||+|... +++.||||++...........+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            467899999999999999999764 68889999986544444557789999999999999999999998765     357


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++|+||++ |+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999998 5999998763    3899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCCc-eeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-ccc
Q 001275          972 LDKSPAST-TSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-EEI 1048 (1109)
Q Consensus       972 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 1048 (1109)
                      ........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+........... +..
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG-GHHHHHHHHHCSCCHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Confidence            65332211 1234579999999998665 45899999999999999999999999654221 11222211111110 000


Q ss_pred             ccccchhhhHHh----------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1049 NDIVDLSLMEEM----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1049 ~~~~d~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ....+.......          ..........++.+++.+|++.||++|||++|+++|-+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  316 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  316 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence            000000000000          00000112345677888999999999999999999765

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.4e-37  Score=337.89  Aligned_cols=259  Identities=22%  Similarity=0.354  Sum_probs=202.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEec--CCceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  893 (1109)
                      .++|+..+.||+|+||+||+|... +++.||+|++..... ......+.+|++++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367889999999999999999775 689999999865432 3345678999999999999999999998754  567899


Q ss_pred             EEEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEEeccCCCCeeeCCCCcEEEeccc
Q 001275          894 MYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDCDPP-----IVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||+|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999997643 2345899999999999999999999   666     9999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      +++......  .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.....  .+....+....     
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~i~~~~-----  232 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREGK-----  232 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHTC-----
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--HHHHHHHhhcc-----
Confidence            998764322  112235789999999999999999999999999999999999999865421  11111111100     


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ...+ .            .....++.+++.+||+.||++||+++|++++++...
T Consensus       233 ~~~~-~------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          233 FRRI-P------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             CCCC-C------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             cccC-C------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            0000 0            011234667888999999999999999999987653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.3e-36  Score=335.09  Aligned_cols=251  Identities=19%  Similarity=0.251  Sum_probs=198.5

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ..++|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|+..+.++ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999775 78999999986432 233456788999999999 99999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC--------------
Q 001275          894 MYRYMENGSLRDVLHSITP-PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE--------------  958 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--------------  958 (1109)
                      ||||+++|+|.+++..... ...+++..++.++.|+++||+|||   +.+|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999976421 235899999999999999999999   8899999999999999844              


Q ss_pred             -----CcEEEecccCCcccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccc
Q 001275          959 -----MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032 (1109)
Q Consensus       959 -----~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~ 1032 (1109)
                           ..+||+|||.+.......      ...||+.|+|||.+.+. .++.++||||+||++|||++|+.++....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence                 479999999998765432      23589999999998766 56789999999999999999987753221    


Q ss_pred             cHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1033 DIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ...... .  .......                .....++.+++.+||+.||++||+++|+++|-+-
T Consensus       236 ~~~~~~-~--~~~~~~~----------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  283 (289)
T 1x8b_A          236 QWHEIR-Q--GRLPRIP----------------QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL  283 (289)
T ss_dssp             HHHHHH-T--TCCCCCS----------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred             HHHHHH-c--CCCCCCC----------------cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence            111110 0  0000000                0112346668889999999999999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-35  Score=333.56  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|...+.||+|+||+||+|+.. +++.||+|++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS-PAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc-cccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            467889999999999999999775 6899999998543 22334578899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee---CCCCcEEEecccCCcccC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL---DSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~~~  973 (1109)
                      |+++|+|.+++....   .+++..+..++.|++.|++|||   +.+|+||||||+||++   +.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999987643   3899999999999999999999   8899999999999999   788999999999997553


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ...    .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....  ......+..   .......   
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~---~~~~~~~---  228 (304)
T 2jam_A          161 NGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--SKLFEKIKE---GYYEFES---  228 (304)
T ss_dssp             CBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHH---CCCCCCT---
T ss_pred             CCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHc---CCCCCCc---
Confidence            321    1234689999999999999999999999999999999999999865321  111111111   1000000   


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       .     .   ......++.+++.+|++.||++||+++|+++|-+
T Consensus       229 -~-----~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          229 -P-----F---WDDISESAKDFICHLLEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             -T-----T---TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             -c-----c---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence             0     0   0111234667888999999999999999998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.3e-37  Score=354.58  Aligned_cols=243  Identities=16%  Similarity=0.178  Sum_probs=187.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHH---HHHhcCCCCceeeEe-------eEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREI---QTIGKIRHRNLVRLE-------DFW  885 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~  885 (1109)
                      ++|...+.||+|+||+||+|.. .+++.||||++....  .....+.+.+|+   +.+++++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            5677889999999999999986 568999999986432  223456788999   555566899999998       666


Q ss_pred             ecCC-----------------ceeEEEEeccCCCHHHHHhccCCC----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 001275          886 LRKD-----------------CGIIMYRYMENGSLRDVLHSITPP----PTLEWNVRYKIALGAAHALAYLHYDCDPPIV  944 (1109)
Q Consensus       886 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  944 (1109)
                      ...+                 ..++||||+ +|+|.+++......    ..+++..++.++.|+++||+|||   +.+|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            5543                 278999999 68999999764321    12446888899999999999999   88999


Q ss_pred             EeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccC-----------CCCccCcchhhHHH
Q 001275          945 HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT-----------AKSKESDVYSYGVV 1013 (1109)
Q Consensus       945 H~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvi 1013 (1109)
                      ||||||+||+++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            999999999999999999999999985422     2334567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 001275         1014 LLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093 (1109)
Q Consensus      1014 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~ev 1093 (1109)
                      +|||++|+.||........               ...+...          ......++.+++.+||+.||++||++.|+
T Consensus       303 l~elltg~~Pf~~~~~~~~---------------~~~~~~~----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  357 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG---------------SEWIFRS----------CKNIPQPVRALLEGFLRYPKEDRLLPLQA  357 (377)
T ss_dssp             HHHHHHSSCCC------CC---------------SGGGGSS----------CCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred             HHHHHHCCCCCcccccccc---------------hhhhhhh----------ccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence            9999999999864321110               0000000          00112346668889999999999999999


Q ss_pred             HHH
Q 001275         1094 VRQ 1096 (1109)
Q Consensus      1094 l~~ 1096 (1109)
                      ++|
T Consensus       358 l~h  360 (377)
T 3byv_A          358 MET  360 (377)
T ss_dssp             HTS
T ss_pred             hhC
Confidence            975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-36  Score=340.12  Aligned_cols=267  Identities=22%  Similarity=0.363  Sum_probs=185.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|.+.+.||+|+||+||+|... +++.||||++..........++.+|++++++++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            367899999999999999999754 6899999988655445556678899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhcc-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          897 YMENGSLRDVLHSI-----TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      |+++|+|.+++...     .....+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence            99999999998642     12345899999999999999999999   88999999999999999999999999999986


Q ss_pred             cCCCCC---CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          972 LDKSPA---STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       972 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      ......   ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||....... ..   ..........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~---~~~~~~~~~~  246 (303)
T 2vwi_A          171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-VL---MLTLQNDPPS  246 (303)
T ss_dssp             CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HH---HHHHTSSCCC
T ss_pred             eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-HH---HHHhccCCCc
Confidence            643321   111234579999999998876 568999999999999999999999996542221 11   1111111100


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ....    .......   .....++.+++.+||+.||++||+++|+++|-.
T Consensus       247 ~~~~----~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  290 (303)
T 2vwi_A          247 LETG----VQDKEML---KKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF  290 (303)
T ss_dssp             TTC---------CCC---CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred             cccc----cccchhh---hhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            0000    0000000   111234667888999999999999999998743

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.3e-36  Score=349.16  Aligned_cols=264  Identities=25%  Similarity=0.330  Sum_probs=195.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc------ee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC------GI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~  892 (1109)
                      .+|...++||+|+||+||+|+...+..||+|++.....     ...+|++++++++||||+++++++...+.      .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            46888999999999999999998777899998854322     22379999999999999999999865443      78


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC-CCCcEEEecccCCcc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD-SEMEPHISDFGIAKL  971 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfGla~~  971 (1109)
                      +||||++++.+....+.......+++..+..++.|+++||+|||   +.+|+||||||+||+++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987544443332223345899999999999999999999   88999999999999998 799999999999987


Q ss_pred             cCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc---
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE--- 1047 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 1047 (1109)
                      ......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+...+.........   
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-IDQLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHH
Confidence            644322   2245789999999988765 589999999999999999999999965422 12222222211110000   


Q ss_pred             ----------cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 ----------INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ----------~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                ...... ........   .....++.+++.+||+.||++|||+.|+++|-.
T Consensus       268 ~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (394)
T 4e7w_A          268 TMNPNYMEHKFPQIRP-HPFSKVFR---PRTPPDAIDLISRLLEYTPSARLTAIEALCHPF  324 (394)
T ss_dssp             HHCGGGSSSCCCCCCC-CCHHHHSC---TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             hhChhhhhhccccccC-CcHHHhcc---ccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence                      000000 00001111   112345777888999999999999999999843

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.7e-36  Score=338.86  Aligned_cols=251  Identities=21%  Similarity=0.295  Sum_probs=203.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|...+.||+|+||.||+|... +++.||+|++....  .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            56888999999999999999775 57889999985443  2233557889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.+++....   .+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       121 e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999987643   4899999999999999999999   889999999999999999999999999999876433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......     ...............     
T Consensus       195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~-----  262 (335)
T 2owb_A          195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKKNEYSIPK-----  262 (335)
T ss_dssp             TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCCCCT-----
T ss_pred             cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-----HHHHHHhcCCCCCCc-----
Confidence            22  223457999999999999999999999999999999999999999653211     111111111000000     


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                 ....++.+++.+||+.||++||+++|++++-.
T Consensus       263 -----------~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~  294 (335)
T 2owb_A          263 -----------HINPVAASLIQKMLQTDPTARPTINELLNDEF  294 (335)
T ss_dssp             -----------TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             -----------cCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                       11124566888999999999999999998643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.8e-35  Score=338.71  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=204.2

Q ss_pred             HHHHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-------ChHHHHHHHHHHhcC-CCCceeeEeeE
Q 001275          814 VIEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-------GSLSMKREIQTIGKI-RHRNLVRLEDF  884 (1109)
Q Consensus       814 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l-~h~niv~l~~~  884 (1109)
                      .....++|.+.+.||+|+||.||+|... +|+.||||++.......       ....+.+|+++++++ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999875 79999999985443211       134678999999999 79999999999


Q ss_pred             EecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEe
Q 001275          885 WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHIS  964 (1109)
Q Consensus       885 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  964 (1109)
                      +...+..++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEE
Confidence            999999999999999999999997643   4899999999999999999999   8899999999999999999999999


Q ss_pred             cccCCcccCCCCCCceeeecccCccccccccccc------CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHH
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT------TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWV 1038 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1109)
                      |||++........   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....  ......+
T Consensus       243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--~~~~~~i  317 (365)
T 2y7j_A          243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ--ILMLRMI  317 (365)
T ss_dssp             CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH
T ss_pred             ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--HHHHHHH
Confidence            9999987754322   234679999999998863      3578899999999999999999999964321  1111111


Q ss_pred             HHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1039 RSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1039 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..   ....   ...+.         ......++.+++.+|++.||++||+++|+++|-+
T Consensus       318 ~~---~~~~---~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          318 ME---GQYQ---FSSPE---------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             HH---TCCC---CCHHH---------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             Hh---CCCC---CCCcc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            11   0000   00000         0111234667888999999999999999998743

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.1e-36  Score=341.53  Aligned_cols=266  Identities=23%  Similarity=0.324  Sum_probs=199.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccccc-ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKR-GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|+..+.||+|+||+||+|... +++.||||++....... ....+.+|++++++++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57888999999999999999775 58999999985443322 24567899999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.++.....   .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       105 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          105 FVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             CCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             cCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999998876433   4899999999999999999999   8899999999999999999999999999998664332


Q ss_pred             CCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-----------
Q 001275          977 ASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD----------- 1044 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 1044 (1109)
                      .  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... .............           
T Consensus       179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-DQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhhhHhhhc
Confidence            2  22335789999999988875 6899999999999999999999999654321 1111111111000           


Q ss_pred             ----ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1045 ----TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1045 ----~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                          ...............    .......++.+++.+||+.||++||+++|+++|-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLER----RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHH----HSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             cccccccCccccccchhhh----cccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                000001100000000    0112235577788899999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.6e-36  Score=335.23  Aligned_cols=255  Identities=22%  Similarity=0.310  Sum_probs=186.2

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChH-HHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .++|+..+.||+|+||+||+|.. .+++.||+|++.......... .+.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            36788999999999999999976 578999999986543333333 3445555688889999999999999999999999


Q ss_pred             EeccCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          896 RYMENGSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYLHYDCDP-PIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||++ |+|.+++... .....+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9998 4888877542 22345899999999999999999999   76 99999999999999999999999999998664


Q ss_pred             CCCCCceeeecccCccccccccc----ccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENA----FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      ....   .....||+.|+|||.+    .+..++.++||||+|+++|||++|+.||................   ...   
T Consensus       162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~---  232 (290)
T 3fme_A          162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE---PSP---  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS---CCC---
T ss_pred             cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc---CCC---
Confidence            4322   2234799999999985    56678999999999999999999999996532222111111111   000   


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .. .           ......++.+++.+|++.||++|||++|+++|-
T Consensus       233 ~~-~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp  268 (290)
T 3fme_A          233 QL-P-----------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP  268 (290)
T ss_dssp             CC-C-----------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             Cc-c-----------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence            00 0           001123466788899999999999999999854

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-35  Score=353.80  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=202.1

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ..++|++.++||+|+||+||+|... +++.||||++.... .......+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999775 78999999985433 234567789999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC---CCCcEEEecccCCcc
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD---SEMEPHISDFGIAKL  971 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfGla~~  971 (1109)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999987643   4899999999999999999999   88999999999999995   456799999999987


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      .....   ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....  .+....+..   .....   
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~---~~~~~---  241 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVET---GKYAF---  241 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---TCCCS---
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh---CCCCC---
Confidence            64432   2234579999999998875 589999999999999999999999965321  111111111   10000   


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       +..        .......++.+++.+|++.||++|||+.|+++|-+
T Consensus       242 -~~~--------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~  279 (486)
T 3mwu_A          242 -DLP--------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (486)
T ss_dssp             -CSG--------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred             -CCc--------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence             000        01111234567888999999999999999999743

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=341.96  Aligned_cols=270  Identities=24%  Similarity=0.344  Sum_probs=203.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-----CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC--ce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD--CG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  891 (1109)
                      ++|++.+.||+|+||.||+|+.     .+++.||||++.. ........+.+|++++++++||||+++++++...+  ..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS-CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            5688899999999999999974     4688999999853 33444567899999999999999999999987654  67


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||+++|+|.+++....  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            99999999999999998643  34899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc--cc
Q 001275          972 LDKSPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE--EI 1048 (1109)
Q Consensus       972 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 1048 (1109)
                      ........ ......++..|+|||.+.+..++.++||||+|+++|||++|+.|+......      +.........  ..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~------~~~~~~~~~~~~~~  268 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------FMRMIGNDKQGQMI  268 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH------HHHHHCTTCCTHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH------HHHhhccccchhhh
Confidence            75433211 112345778899999999888999999999999999999999887532110      0000000000  00


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ...+..................++.+++.+||+.||++||+++|+++.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0000000000000000112234577788899999999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.3e-35  Score=340.33  Aligned_cols=275  Identities=20%  Similarity=0.303  Sum_probs=203.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecC--------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK--------  888 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  888 (1109)
                      .+|.+.++||+|+||+||+|.. .+++.||||++..... ......+.+|++++++++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788999999999999999977 5789999999854433 23355788999999999999999999998773        


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      +..++||||+++ ++.+.+....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            457999999985 7877776543  34899999999999999999999   88999999999999999999999999999


Q ss_pred             CcccCCCCC--CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-
Q 001275          969 AKLLDKSPA--STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD- 1044 (1109)
Q Consensus       969 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 1044 (1109)
                      ++.+.....  ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......  .....+...... 
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~  248 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALISQLCGSI  248 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Confidence            987653322  122234678999999998876 45799999999999999999999999754221  111111111110 


Q ss_pred             cccc-ccccchhhhHH-----hhhchhHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1045 TEEI-NDIVDLSLMEE-----MLVSSIRD------QVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1045 ~~~~-~~~~d~~~~~~-----~~~~~~~~------~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      .... ...-.......     .......+      ....+.+++.+|++.||++|||++|+++|-+-..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            0000 00000000000     00000001      1234678888999999999999999999876543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1e-35  Score=337.81  Aligned_cols=269  Identities=18%  Similarity=0.263  Sum_probs=194.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .++|.+.++||+|+||+||+|.. .+++.||||++...... .....+.+|++++++++||||+++++++...+..++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            46799999999999999999975 47899999998544322 23456789999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee-----CCCCcEEEecccCCc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL-----DSEMEPHISDFGIAK  970 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll-----~~~~~~kl~DfGla~  970 (1109)
                      ||+++ +|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||++     ++++.+||+|||+++
T Consensus       113 e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             ECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             ecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99985 9999998654   3899999999999999999999   8899999999999999     455569999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc---
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE--- 1046 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 1046 (1109)
                      ......  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ...............   
T Consensus       186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTS
T ss_pred             ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH-HHHHHHHHHhCCCchhhh
Confidence            764332  122335789999999998875 4799999999999999999999999654221 112222211110000   


Q ss_pred             -----------ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1047 -----------EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1047 -----------~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                 .......... ......   ....++.+++.+|++.||++|||++|+++|-+--
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTL-KRVLGA---LLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCH-HHHHGG---GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhhhhhhhhhhhhhhhccccH-hhhccc---ccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence                       0000000000 000001   1124567788899999999999999999976543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.2e-36  Score=334.76  Aligned_cols=249  Identities=26%  Similarity=0.340  Sum_probs=193.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC-CceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-DCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  897 (1109)
                      ++|+..+.||+|+||+||+|+.. ++.||||++...   ...+.+.+|++++++++||||+++++++... +..++||||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            67888999999999999999876 889999988432   3456789999999999999999999997654 468999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++.... ...+++..++.++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            99999999997642 123788999999999999999999   8899999999999999999999999999998554321 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                          ....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.....  .+....+.   ... .. ..     
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~---~~~-~~-~~-----  235 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVE---KGY-KM-DA-----  235 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHT---TTC-CC-CC-----
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHh---cCC-CC-CC-----
Confidence                12367889999999999999999999999999999998 9999864321  11111111   100 00 00     


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              .......+.+++.+||+.||++||+++|+++.|+++
T Consensus       236 --------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          236 --------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence                    011223466788899999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.1e-36  Score=342.49  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=184.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEe--------cC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWL--------RK  888 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~  888 (1109)
                      .+|++.++||+|+||+||+|.. .+++.||||++... .......+.+|+.++.++. ||||+++++++.        ..
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            4788899999999999999976 46899999998433 3344567889999999996 999999999984        23


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeccCCCCeeeCCCCcEEEecc
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP--IVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                      ...++|+||++ |+|.+++........+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            34789999996 799999876544556999999999999999999999   777  999999999999999999999999


Q ss_pred             cCCcccCCCCCCc----------eeeecccCccccccccc---ccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccccc
Q 001275          967 GIAKLLDKSPAST----------TSISVVGTIGYIAPENA---FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033 (1109)
Q Consensus       967 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~ 1033 (1109)
                      |+++.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||......   
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---  259 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---  259 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence            9998765432211          11134689999999988   5677899999999999999999999998643211   


Q ss_pred             HHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1034 IVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1034 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                        .........        ..          .......+.+++.+||+.||++||+++|++++|+++
T Consensus       260 --~~~~~~~~~--------~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          260 --RIVNGKYSI--------PP----------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             --------CCC--------CT----------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HhhcCcccC--------Cc----------ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              011000000        00          000112255678899999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.5e-35  Score=353.57  Aligned_cols=253  Identities=22%  Similarity=0.281  Sum_probs=196.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .++|+..++||+|+||+||+|+.. +++.||+|++.... .......+.+|++++++++||||+++++++......++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            357889999999999999999775 68899999986543 2334567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC---CcEEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla~~~  972 (1109)
                      ||+++|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++..   +.+||+|||+++..
T Consensus       116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999999887643   3899999999999999999999   8899999999999999764   45999999999876


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ....   ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.....  ..+...+..   .....   .
T Consensus       190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~---~~~~~---~  257 (494)
T 3lij_A          190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--QEILRKVEK---GKYTF---D  257 (494)
T ss_dssp             BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---TCCCC---C
T ss_pred             CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHh---CCCCC---C
Confidence            5432   223457999999999875 5689999999999999999999999965322  111111111   10000   0


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .+.         ......++.+++.+|++.||++|||+.|+++|-
T Consensus       258 ~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp  293 (494)
T 3lij_A          258 SPE---------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHP  293 (494)
T ss_dssp             SGG---------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             chh---------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCc
Confidence            000         011123456678899999999999999999763

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-35  Score=336.84  Aligned_cols=268  Identities=18%  Similarity=0.238  Sum_probs=205.9

Q ss_pred             cccHHHHHHHhhCCCCC-ceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcC-CCCceeeEee
Q 001275          808 SYLLKQVIEATENLNAK-HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKI-RHRNLVRLED  883 (1109)
Q Consensus       808 ~~~~~~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~  883 (1109)
                      ...++......++|.+. +.||+|+||+||+|... +++.||+|++..... ......+.+|+.++.++ +||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            33344444556677776 88999999999999765 689999999865432 33466889999999999 5699999999


Q ss_pred             EEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCc
Q 001275          884 FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EME  960 (1109)
Q Consensus       884 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~  960 (1109)
                      ++...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           97 VYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             EEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCC
T ss_pred             EEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCc
Confidence            9999999999999999999999986532 345899999999999999999999   889999999999999988   789


Q ss_pred             EEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHH
Q 001275          961 PHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       961 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      +||+|||+++.......   .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......  .....+..
T Consensus       173 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~  247 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ--ETYLNISQ  247 (327)
T ss_dssp             EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred             EEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHHHh
Confidence            99999999987643322   23357999999999999999999999999999999999999999653221  11111111


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      .  .. ..    ...        ........+.+++.+|++.||++||+++|+++|-+-
T Consensus       248 ~--~~-~~----~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~  291 (327)
T 3lm5_A          248 V--NV-DY----SEE--------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL  291 (327)
T ss_dssp             T--CC-CC----CTT--------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred             c--cc-cc----Cch--------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence            0  00 00    000        001122346668889999999999999999998653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.3e-36  Score=343.28  Aligned_cols=266  Identities=20%  Similarity=0.253  Sum_probs=204.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccC----------------hHHHHHHHHHHhcCCCCceeeEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRG----------------SLSMKREIQTIGKIRHRNLVRLE  882 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------~~~~~~E~~~l~~l~h~niv~l~  882 (1109)
                      ++|.+.+.||+|+||.||+|.. +++.||+|++........                ...+.+|++++++++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            5788999999999999999988 899999999854432211                17899999999999999999999


Q ss_pred             eEEecCCceeEEEEeccCCCHHHH------HhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeee
Q 001275          883 DFWLRKDCGIIMYRYMENGSLRDV------LHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILL  955 (1109)
Q Consensus       883 ~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll  955 (1109)
                      +++...+..++||||+++|+|.++      +... ....+++..+..++.|++.||+|||   + .+|+||||||+||++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            999999999999999999999998      5432 1356899999999999999999999   7 899999999999999


Q ss_pred             CCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccC-CCCc-cCcchhhHHHHHHHHhCCCCCCCCcccccc
Q 001275          956 DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT-AKSK-ESDVYSYGVVLLELITRKKALDPSYKERTD 1033 (1109)
Q Consensus       956 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvil~elltg~~p~~~~~~~~~~ 1033 (1109)
                      +.++.+||+|||.+......    ......||+.|+|||.+.+. .++. ++||||+|+++|||++|+.||...... ..
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~  260 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VE  260 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence            99999999999999876432    23346799999999999887 5665 999999999999999999999754321 11


Q ss_pred             HHHHHHHhhcCccccc----cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1034 IVGWVRSVWSDTEEIN----DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1034 ~~~~~~~~~~~~~~~~----~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ....+   ........    ....+ ...............++.+++.+||+.||++||+++|+++|-.
T Consensus       261 ~~~~i---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          261 LFNNI---RTKNIEYPLDRNHFLYP-LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             HHHHH---TSCCCCCCCSSSSSTTT-TCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHH---hccCcCCccchhhhhcc-ccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence            11111   11110000    00000 0000000000112345677888999999999999999998754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.7e-36  Score=367.49  Aligned_cols=249  Identities=20%  Similarity=0.256  Sum_probs=194.8

Q ss_pred             ceeecccCeEEEEEEe---CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASL---GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||+||+|.+   ..++.||||++..... .....++.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999955   3467899999865432 2335689999999999999999999999964 568899999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC-c
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS-T  979 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~-~  979 (1109)
                      |+|.++++...   .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999997643   4899999999999999999999   889999999999999999999999999999877543321 2


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .+...+..   .. .. ..       
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~---~~-~~-~~-------  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEK---GE-RM-GC-------  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT---TC-CC-CC-------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc---CC-CC-CC-------
Confidence            2233467889999999999999999999999999999998 99998654221  11111111   00 00 00       


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                            ......++.+++.+||+.||++||+++++++.|+++
T Consensus       594 ------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          594 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                  011224567788899999999999999999999865

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-35  Score=345.14  Aligned_cols=265  Identities=22%  Similarity=0.310  Sum_probs=195.4

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC------
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------  888 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  888 (1109)
                      ...++|...++||+|+||+||+|.. .+++.||||++.....     ...+|++++++++||||+++++++...      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            4557899999999999999999976 5789999998853322     234799999999999999999998543      


Q ss_pred             --------------------------------CceeEEEEeccCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 001275          889 --------------------------------DCGIIMYRYMENGSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYL  935 (1109)
Q Consensus       889 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~L  935 (1109)
                                                      ...++||||++ |+|.+.+... .....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            23789999998 5888777642 2234589999999999999999999


Q ss_pred             hcCCCCCeEEeccCCCCeeeC-CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHH
Q 001275          936 HYDCDPPIVHRDIKPENILLD-SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVV 1013 (1109)
Q Consensus       936 H~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvi 1013 (1109)
                      |   +.+|+||||||+||+++ .++.+||+|||+|+.......   .....||+.|+|||.+.+. .++.++||||+||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   89999999999999997 688999999999987644332   2335789999999988775 48999999999999


Q ss_pred             HHHHHhCCCCCCCCccccccHHHHHHHhhcCcc-------------ccccccchhhhHHhhhchhHHHHHHHHHHHHhcc
Q 001275         1014 LLELITRKKALDPSYKERTDIVGWVRSVWSDTE-------------EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCT 1080 (1109)
Q Consensus      1014 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl 1080 (1109)
                      +|||++|+.||..... ...+...+........             .......... ......   ....++.+++.+|+
T Consensus       232 l~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~li~~~L  306 (383)
T 3eb0_A          232 FGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDW-RKILPE---GTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCH-HHHSCT---TCCHHHHHHHHHHC
T ss_pred             HHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccH-HhhCCC---CCCHHHHHHHHHHc
Confidence            9999999999965422 2222222221111100             0000000000 011111   12234677888999


Q ss_pred             CCCCCCCCCHHHHHHHh
Q 001275         1081 EKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1081 ~~dP~~RPs~~evl~~L 1097 (1109)
                      +.||++|||+.|+++|-
T Consensus       307 ~~dP~~R~t~~e~l~hp  323 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAHP  323 (383)
T ss_dssp             CSSGGGSCCHHHHHTSG
T ss_pred             cCChhhCCCHHHHhcCH
Confidence            99999999999999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-35  Score=341.25  Aligned_cols=267  Identities=20%  Similarity=0.238  Sum_probs=192.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC------c
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD------C  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  890 (1109)
                      ++|...+.||+|+||+||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++...+      .
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            57888999999999999999764 68899999986432 2233457889999999999999999999997655      6


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++||||+++ +|.+++..     .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             eEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7999999975 78888853     3889999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ......+............
T Consensus       176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCCHHHHT
T ss_pred             cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHH
Confidence            664321   223457999999999999999999999999999999999999999653211 1111111100000000000


Q ss_pred             ccchhh------------------hHHh----hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1051 IVDLSL------------------MEEM----LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1051 ~~d~~~------------------~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .+.+..                  ....    ..........++.+++.+|++.||++|||++|+++|-+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  321 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY  321 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence            000000                  0000    00001223456788899999999999999999999763

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-35  Score=355.88  Aligned_cols=254  Identities=25%  Similarity=0.334  Sum_probs=203.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .++|...++||+|+||+||+|... +++.||||++.....  ......+.+|++++++++||||+++++++...+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357889999999999999999775 789999999855432  34566799999999999999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee---CCCCcEEEecccCCcc
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL---DSEMEPHISDFGIAKL  971 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~  971 (1109)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999997643   4899999999999999999999   8899999999999999   5678999999999987


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ......   .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....  ......+..   ......  
T Consensus       179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~~i~~---~~~~~~--  247 (484)
T 3nyv_A          179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--YDILKKVEK---GKYTFE--  247 (484)
T ss_dssp             BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---CCCCCC--
T ss_pred             cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHc---CCCCCC--
Confidence            654322   233579999999998865 689999999999999999999999965321  111111111   100000  


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       .+         .......++.+++.+|++.||++|||++|+++|-+
T Consensus       248 -~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          248 -LP---------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             -SG---------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             -Cc---------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence             00         01112234566888999999999999999998754

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=2.8e-35  Score=361.78  Aligned_cols=336  Identities=17%  Similarity=0.169  Sum_probs=227.1

Q ss_pred             CCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEE
Q 001275          358 LSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLD  437 (1109)
Q Consensus       358 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~  437 (1109)
                      +++++.|++++|.++...+..+..+++|++|++++|.+++..|..|..+++|+.|+|++|.+++..|..|+.+++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            56777888888887765555667777777777777777776666777777777777777777776666677777777777


Q ss_pred             ecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCC
Q 001275          438 FINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGA  517 (1109)
Q Consensus       438 ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~  517 (1109)
                      |++|.|++..+..+..+++|++|+|++|++.+..|..++.+++|+.|++++|++++.                       
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------------  186 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-----------------------  186 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-----------------------
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-----------------------
Confidence            777777754444456666677777776666665555555555555555444444432                       


Q ss_pred             CCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccc
Q 001275          518 IPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSW  597 (1109)
Q Consensus       518 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l  597 (1109)
                         .++.+++|+.|++++|.+++     +....+|+.|++++|.++. +|..+.  ++|+.|+|++|++++  +..+..+
T Consensus       187 ---~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~-~~~~~~--~~L~~L~L~~n~l~~--~~~l~~l  253 (597)
T 3oja_B          187 ---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV-VRGPVN--VELTILKLQHNNLTD--TAWLLNY  253 (597)
T ss_dssp             ---CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCE-EECSCC--SCCCEEECCSSCCCC--CGGGGGC
T ss_pred             ---ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccc-cccccC--CCCCEEECCCCCCCC--ChhhccC
Confidence               13334455555555555542     1223345555666665553 222221  466666677666664  3556666


Q ss_pred             cccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEE
Q 001275          598 KSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLD  677 (1109)
Q Consensus       598 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~  677 (1109)
                      ++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++ +|..++.++.| ..|+|++|.++ .+|..++.+++|+.||
T Consensus       254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L-~~L~Ls~N~l~-~i~~~~~~l~~L~~L~  330 (597)
T 3oja_B          254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL-KVLDLSHNHLL-HVERNQPQFDRLENLY  330 (597)
T ss_dssp             TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTC-CEEECCSSCCC-CCGGGHHHHTTCSEEE
T ss_pred             CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCC-cEEECCCCCCC-ccCcccccCCCCCEEE
Confidence            777777777777776666677777777777777777763 56666667777 46888888888 6888899999999999


Q ss_pred             ccCCcccccCCCCCccccceEEeeeccccccccchhhhhccCCCCCCCCCCCccccccc
Q 001275          678 ISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCL  736 (1109)
Q Consensus       678 Ls~N~l~g~~~~l~~~~~l~~l~~~~n~l~g~~p~~~~~~~~~~~~~~~gn~~~c~~~~  736 (1109)
                      |++|+|++. | ++.+++|+.|++++|++++..+..+..  ......+.+++..|+.+.
T Consensus       331 L~~N~l~~~-~-~~~~~~L~~L~l~~N~~~~~~~~~~~~--~~~~~~~~~~~~~C~~~~  385 (597)
T 3oja_B          331 LDHNSIVTL-K-LSTHHTLKNLTLSHNDWDCNSLRALFR--NVARPAVDDADQHCKIDY  385 (597)
T ss_dssp             CCSSCCCCC-C-CCTTCCCSEEECCSSCEEHHHHHHHTT--TCCTTTBCCCCCCCCTTC
T ss_pred             CCCCCCCCc-C-hhhcCCCCEEEeeCCCCCChhHHHHHH--HHhhhccccccccCCcch
Confidence            999999864 3 667889999999999999875533222  225566889999998654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.8e-35  Score=326.95  Aligned_cols=255  Identities=24%  Similarity=0.290  Sum_probs=199.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc---ccChHHHHHHHHHHhcCCCCceeeEeeEEe--cCCce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH---KRGSLSMKREIQTIGKIRHRNLVRLEDFWL--RKDCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  891 (1109)
                      .++|.+.+.||+|+||.||+|... +++.||+|++.....   ......+.+|++++++++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999774 688999999854321   234567899999999999999999999984  44578


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||++++ +.+++.... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999976 777776543 345899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCC--CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAK--SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      ..............||+.|+|||++.+...  +.++||||+|+++|||++|+.||.....     ...............
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~~~~~~~  233 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFENIGKGSYAIP  233 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHHHhcCCCCCC
Confidence            754444444445679999999998876544  7899999999999999999999964321     111111111100000


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                                      ......+.+++.+|++.||++||+++|+++|-+
T Consensus       234 ----------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  266 (305)
T 2wtk_C          234 ----------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW  266 (305)
T ss_dssp             ----------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred             ----------------CccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence                            011234566888999999999999999998754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-35  Score=335.82  Aligned_cols=275  Identities=24%  Similarity=0.295  Sum_probs=199.0

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc----cChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK----RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      ...++|...+.||+|+||+||+|... +++.||||++......    .....+.+|++++++++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999775 5899999998543222    123468899999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++||||+++ +|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 8998887533  34788899999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-c--
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT-E-- 1046 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-- 1046 (1109)
                      .......  ......||+.|+|||++.+. .++.++||||+||++|||++|..||..... ...+........... .  
T Consensus       161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTS
T ss_pred             eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhh
Confidence            7643322  22345789999999988764 579999999999999999999988865321 112222222111100 0  


Q ss_pred             ----ccccccchhhhHHh-hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1047 ----EINDIVDLSLMEEM-LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1047 ----~~~~~~d~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                          ...+.+........ ..........++.+++.+|++.||++|||++|+++|-+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence                00000000000000 000001122457778889999999999999999998754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3e-35  Score=348.36  Aligned_cols=260  Identities=17%  Similarity=0.256  Sum_probs=201.5

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCC-CceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH-RNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|.+.++||+|+||.||+|.. .+++.||||++.....   ...+.+|+++++.++| +++..+..++...+..++|||
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS---SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc---cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            6789999999999999999976 5689999998754322   2357899999999976 566666667777888899999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee---CCCCcEEEecccCCcccC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL---DSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~kl~DfGla~~~~  973 (1109)
                      |+ +++|.+++....  ..+++..++.++.||+.||+|||   +.+||||||||+|||+   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 899999997543  34899999999999999999999   8899999999999999   588999999999998765


Q ss_pred             CCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          974 KSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       974 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      .....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ....+....      
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~~~i~------  229 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKYEKIS------  229 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--HHHHHHHHH------
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh--HHHHHHHHh------
Confidence            43321     11224689999999999999999999999999999999999999997542211  111111100      


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                          ..... ............++.+++.+||+.||++||+++++++.|+++
T Consensus       230 ----~~~~~-~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          230 ----EKKVA-TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             ----HHHHH-SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ----hcccc-ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                00000 000000011234577788899999999999999999998875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.6e-35  Score=353.13  Aligned_cols=254  Identities=23%  Similarity=0.281  Sum_probs=199.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccc------------cChHHHHHHHHHHhcCCCCceeeEeeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHK------------RGSLSMKREIQTIGKIRHRNLVRLEDF  884 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~~  884 (1109)
                      .++|.+.++||+|+||+||+|... +++.||+|++......            .....+.+|++++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467899999999999999999765 5789999998644321            335678999999999999999999999


Q ss_pred             EecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC---cE
Q 001275          885 WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM---EP  961 (1109)
Q Consensus       885 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~  961 (1109)
                      +...+..++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999999987643   3899999999999999999999   88999999999999998776   69


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      ||+|||+++......   ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.....  ...   ....
T Consensus       189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~---~~~i  259 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--QDI---IKKV  259 (504)
T ss_dssp             EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHH
T ss_pred             EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHH---HHHH
Confidence            999999998765432   223457999999999876 5689999999999999999999999965321  111   1111


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .......    +..     .   ......++.+++.+|++.||++|||++|+++|-+
T Consensus       260 ~~~~~~~----~~~-----~---~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~  304 (504)
T 3q5i_A          260 EKGKYYF----DFN-----D---WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW  304 (504)
T ss_dssp             HHCCCCC----CHH-----H---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HcCCCCC----Ccc-----c---cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence            1110000    000     0   0111234667888999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-35  Score=335.31  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=195.9

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-------ccChHHHHHHHHHHhcCCCCceeeEeeEEecC
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-------KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK  888 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  888 (1109)
                      ..++|.+.+.||+|+||.||+|... +++.||||.+.....       ......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999764 578999999854321       12234588999999999999999999998765


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc---EEEec
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME---PHISD  965 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~D  965 (1109)
                      + .++||||+++|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 899999999999999987543   4899999999999999999999   889999999999999987654   99999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      ||+++......   ......||+.|+|||++.   ...++.++||||+||++|+|++|+.||...... ..+...+....
T Consensus       161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~  236 (322)
T 2ycf_A          161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSGK  236 (322)
T ss_dssp             CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHHHTC
T ss_pred             Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHHhCc
Confidence            99998764321   122357899999999864   567899999999999999999999999654222 12222211100


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .      .. .+..        ......++.+++.+|++.||++||+++|+++|-
T Consensus       237 ~------~~-~~~~--------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~  276 (322)
T 2ycf_A          237 Y------NF-IPEV--------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  276 (322)
T ss_dssp             C------CC-CHHH--------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             c------cc-Cchh--------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence            0      00 0000        011234566788899999999999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.3e-35  Score=346.69  Aligned_cols=197  Identities=23%  Similarity=0.292  Sum_probs=169.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcC------CCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI------RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  891 (1109)
                      .+|++.++||+|+||+||+|... +++.||||++..  .......+.+|+++++.+      +|+||+++++++...+..
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC--ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            56888999999999999999664 589999999843  223345677888888777      577999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc--EEEecccCC
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME--PHISDFGIA  969 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~DfGla  969 (1109)
                      ++||||++ ++|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 69999988644 234899999999999999999999   889999999999999999887  999999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      +......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            7654322     2357899999999999999999999999999999999999998654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-35  Score=339.69  Aligned_cols=272  Identities=22%  Similarity=0.323  Sum_probs=201.1

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC-----Cce
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-----DCG  891 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  891 (1109)
                      .++|...+.||+|+||+||+|... +++.||||++...........+.+|++++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            367889999999999999999775 68999999985444444456788999999999999999999987654     567


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ++||||++ |+|.+++...    .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 5999998763    3899999999999999999999   88999999999999999999999999999987


Q ss_pred             cCCCCCCc--------eeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          972 LDKSPAST--------TSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       972 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      ........        ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ....... ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~-~~~  239 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-HQLLLIF-GII  239 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH-HHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH-HHh
Confidence            65332111        1223578999999998764 67899999999999999999999999654211 1111111 111


Q ss_pred             cCc---cccccccchhhhHHh----------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1043 SDT---EEINDIVDLSLMEEM----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1043 ~~~---~~~~~~~d~~~~~~~----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                      ...   ...............          ..........++.+++.+|++.||++||+++|+++|-+-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL  309 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence            100   000000000000000          000001223456778889999999999999999997543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-35  Score=348.48  Aligned_cols=264  Identities=25%  Similarity=0.348  Sum_probs=193.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC------ce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD------CG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~  891 (1109)
                      .+|...++||+|+||+||+|+.. +++.||||++....     ....+|++++++++|||||++++++....      ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            35788899999999999999875 58999999985332     22347999999999999999999885422      35


Q ss_pred             eEEEEeccCCCHHHHHhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccCC
Q 001275          892 IIMYRYMENGSLRDVLHSI-TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIA  969 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGla  969 (1109)
                      ++||||+++ ++.+.+... .....+++..+..++.|+++||+|||   +.+|+||||||+|||++.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            789999986 666665432 22345899999999999999999999   8999999999999999965 56899999999


Q ss_pred             cccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc--
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE-- 1046 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 1046 (1109)
                      +.......   .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ....+..++........  
T Consensus       205 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHHHCSCCHHH
T ss_pred             hhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCCHHH
Confidence            87644322   2235789999999998765 78999999999999999999999996542 22222222222111000  


Q ss_pred             ------ccccccchhh----hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1047 ------EINDIVDLSL----MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1047 ------~~~~~~d~~~----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                            ...+...+..    ......   .....++.+++.+|++.||++||++.|+++|-+
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~  339 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFR---PRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  339 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcC---CCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence                  0000000000    000000   111245677888999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.1e-35  Score=329.32  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=198.3

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ..++|...+.||+|+||.||+|... +++.||+|.+...   .....+.+|++++++++||||+++++++...+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            3467899999999999999999775 5899999998543   34567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....  ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999997432  34899999999999999999999   889999999999999999999999999999866432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .  .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.......  .......  ...   .....  
T Consensus       179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~--~~~---~~~~~--  247 (314)
T 3com_A          179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR--AIFMIPT--NPP---PTFRK--  247 (314)
T ss_dssp             B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH--SCC---CCCSS--
T ss_pred             c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHhc--CCC---cccCC--
Confidence            2  12234578999999999999999999999999999999999999986432111  0000000  000   00000  


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                               ......++.+++.+||+.||++||++.|++++-.
T Consensus       248 ---------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~  281 (314)
T 3com_A          248 ---------PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPF  281 (314)
T ss_dssp             ---------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             ---------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence                     0011234667888999999999999999998654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.3e-35  Score=338.36  Aligned_cols=279  Identities=17%  Similarity=0.238  Sum_probs=193.3

Q ss_pred             HHHHHHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          812 KQVIEATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       812 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      .+.....++|.+.+.||+|+||+||+|+.. +++.||||++...  ........+|++.+..++||||+++++++...+.
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC--TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC--ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            345566789999999999999999999774 6899999988433  2334466788888899999999999999876443


Q ss_pred             -------eeEEEEeccCCCHHHHHh-ccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-CCcE
Q 001275          891 -------GIIMYRYMENGSLRDVLH-SITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-EMEP  961 (1109)
Q Consensus       891 -------~~lv~e~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~  961 (1109)
                             .++||||+++ ++.+.+. .......+++..+..++.|++.|++|||. ++.+|+||||||+||+++. ++.+
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTS-TTTCCBCSCCCGGGEEEETTTTEE
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhC-CCCCeecCcCCHHHEEEeCCCCcE
Confidence                   7899999987 5544433 22334568899999999999999999993 3678999999999999996 8999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||+++.......   .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ........+.
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~~~~~~~~~~  247 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-AGQLHEIVRV  247 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHH
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-HHHHHHHHHH
Confidence            9999999987654322   23457899999999887654 89999999999999999999999975422 1222222222


Q ss_pred             hhcCccccccccchh-----h-------hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1041 VWSDTEEINDIVDLS-----L-------MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~-----~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ............++.     .       ..............++.+++.+|++.||++|||+.|+++|-+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  317 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY  317 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence            111110000000000     0       000001111123456778889999999999999999999854

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=7.2e-35  Score=339.28  Aligned_cols=337  Identities=17%  Similarity=0.160  Sum_probs=225.1

Q ss_pred             CCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceE
Q 001275          357 QLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQL  436 (1109)
Q Consensus       357 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  436 (1109)
                      .+++++.|++++|.++...+..+..+++|++|++++|.+++..+..+..+++|++|++++|++++..|..++.+++|++|
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            35788888888888886555556778888888888888877667777888888888888888877777777777777777


Q ss_pred             EecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCC
Q 001275          437 DFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISG  516 (1109)
Q Consensus       437 ~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~  516 (1109)
                      ++++|.++...+..+..+++|++|++++|++.+..|..+..+++|+.|++++|++++.                      
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----------------------  180 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV----------------------  180 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC----------------------
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc----------------------
Confidence            7777777744444456677777777777777665555555555555555555544432                      


Q ss_pred             CCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCccccc
Q 001275          517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRS  596 (1109)
Q Consensus       517 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~  596 (1109)
                          .++.+++|+.|++++|.+++.     ....+|++|++++|+++.. |...  .++|+.|++++|++++.  ..+..
T Consensus       181 ----~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~--~~l~~  246 (390)
T 3o6n_A          181 ----DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDT--AWLLN  246 (390)
T ss_dssp             ----CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCC--GGGGG
T ss_pred             ----ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCccc--HHHcC
Confidence                133444555555555555421     2223455555555555532 3222  25666666666666642  45666


Q ss_pred             ccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeE
Q 001275          597 WKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQL  676 (1109)
Q Consensus       597 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L  676 (1109)
                      +++|+.|+|++|.+++..|..+..+++|+.|+|++|+++ .+|..++.+++| ..|+|++|+++ .+|..++.+++|++|
T Consensus       247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L-~~L~L~~n~l~-~~~~~~~~l~~L~~L  323 (390)
T 3o6n_A          247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL-KVLDLSHNHLL-HVERNQPQFDRLENL  323 (390)
T ss_dssp             CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC-EEECSSSCCTTC-CEEECCSSCCC-CCGGGHHHHTTCSEE
T ss_pred             CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc-ccCcccCCCCCC-CEEECCCCcce-ecCccccccCcCCEE
Confidence            666666666666666666666666677777777777766 356666667777 46888888888 678888999999999


Q ss_pred             EccCCcccccCCCCCccccceEEeeeccccccccchhhhhccCCCCCCCCCCCccccccc
Q 001275          677 DISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLCVKCL  736 (1109)
Q Consensus       677 ~Ls~N~l~g~~~~l~~~~~l~~l~~~~n~l~g~~p~~~~~~~~~~~~~~~gn~~~c~~~~  736 (1109)
                      +|++|++++. | +..+++|+.|++++|++++.-...+...  .....+.+++..|..+.
T Consensus       324 ~L~~N~i~~~-~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~--~~~~~~~~~~~~c~~~~  379 (390)
T 3o6n_A          324 YLDHNSIVTL-K-LSTHHTLKNLTLSHNDWDCNSLRALFRN--VARPAVDDADQHCKIDY  379 (390)
T ss_dssp             ECCSSCCCCC-C-CCTTCCCSEEECCSSCEEHHHHHHHTTT--CCTTTBCCCCSCCCTTC
T ss_pred             ECCCCcccee-C-chhhccCCEEEcCCCCccchhHHHHHHH--HHhhcccccCceecccc
Confidence            9999999854 3 6778899999999999987543322222  24455777877786443

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.1e-36  Score=343.42  Aligned_cols=267  Identities=21%  Similarity=0.246  Sum_probs=183.5

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecC------C
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------D  889 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  889 (1109)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.... .......+.+|++++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36788899999999999999975 568999999985432 223456788999999999999999999998754      4


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      ..++|+||+ +++|.++++.    ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            579999999 6899998865    24899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc-
Q 001275          970 KLLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE- 1047 (1109)
Q Consensus       970 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 1047 (1109)
                      +.....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+............. 
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHH
Confidence            865432     234579999999999877 6789999999999999999999999965321 11122222111111100 


Q ss_pred             cccccchhhhHH----------hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1048 INDIVDLSLMEE----------MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1048 ~~~~~d~~~~~~----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ...+........          ............+.+++.+|++.||++|||++|+++|-.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~  314 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  314 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence            011100000000          000000111245677888999999999999999999854

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.3e-35  Score=362.19  Aligned_cols=252  Identities=22%  Similarity=0.284  Sum_probs=204.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .++|+..++||+|+||+||+|+.. +++.||||++....  .......+..|..++..+ +||+|+++++++.+.+..|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            467899999999999999999765 57889999986432  234456788999999988 79999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.++++..+   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~  493 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  493 (674)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred             EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence            999999999999998754   3899999999999999999999   8899999999999999999999999999998643


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ................   
T Consensus       494 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~~~~p~---  563 (674)
T 3pfq_A          494 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHNVAYPK---  563 (674)
T ss_dssp             CTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHSSCCCCCT---
T ss_pred             cCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCCCCCCc---
Confidence            3222  23346899999999999999999999999999999999999999965321     1222222211111100   


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHHHhh
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNM-----RDVVRQLV 1098 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~-----~evl~~L~ 1098 (1109)
                                   ....++.+++.+|++.||++||++     +|+++|-.
T Consensus       564 -------------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f  600 (674)
T 3pfq_A          564 -------------SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  600 (674)
T ss_dssp             -------------TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred             -------------cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence                         112345667789999999999997     88887643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=344.14  Aligned_cols=278  Identities=22%  Similarity=0.321  Sum_probs=187.0

Q ss_pred             hCCCC-CceeecccCeEEEEEEeC---CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec--CCcee
Q 001275          819 ENLNA-KHVIGRGAHGIVYKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCGI  892 (1109)
Q Consensus       819 ~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  892 (1109)
                      +.|.+ .++||+|+||+||+|+..   +++.||||++...   .....+.+|++++++++||||+++++++..  ....+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            34555 457999999999999865   5789999988432   234578899999999999999999999954  66789


Q ss_pred             EEEEeccCCCHHHHHhccC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee----CCCCcEE
Q 001275          893 IMYRYMENGSLRDVLHSIT------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL----DSEMEPH  962 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~k  962 (1109)
                      +||||+++ +|.+++....      ....+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999975 8888775321      1234899999999999999999999   8899999999999999    6778999


Q ss_pred             EecccCCcccCCCCCC-ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCcccc--------c
Q 001275          963 ISDFGIAKLLDKSPAS-TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKER--------T 1032 (1109)
Q Consensus       963 l~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~--------~ 1032 (1109)
                      |+|||+++........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.......        .
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            9999999876543211 223346899999999998874 58999999999999999999999996542210        1


Q ss_pred             cHHHHHHHhhcCccc-cccc---cchh-hhHHh-------------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001275         1033 DIVGWVRSVWSDTEE-INDI---VDLS-LMEEM-------------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094 (1109)
Q Consensus      1033 ~~~~~~~~~~~~~~~-~~~~---~d~~-~~~~~-------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 1094 (1109)
                      .+...+......... ...+   .+.. .....             ..........++.+++.+|++.||++|||++|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            111111111111000 0000   0000 00000             0000000123567788899999999999999999


Q ss_pred             HHhhhCCCC
Q 001275         1095 RQLVDASVP 1103 (1109)
Q Consensus      1095 ~~L~~~~~~ 1103 (1109)
                      +|-+-...+
T Consensus       333 ~hp~f~~~~  341 (405)
T 3rgf_A          333 QDPYFLEDP  341 (405)
T ss_dssp             TSGGGTSSS
T ss_pred             cChhhccCC
Confidence            998765433

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.7e-36  Score=345.92  Aligned_cols=255  Identities=10%  Similarity=0.044  Sum_probs=178.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHH---HHHhcCCCCceeeEe-------eEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREI---QTIGKIRHRNLVRLE-------DFW  885 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~  885 (1109)
                      .+|...+.||+|+||+||+|... +++.||||++.....  ......+.+|+   +.++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            45788899999999999999864 789999999965432  23345677785   45555 799988754       444


Q ss_pred             ecC-----------------CceeEEEEeccCCCHHHHHhccCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCCC
Q 001275          886 LRK-----------------DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVR------YKIALGAAHALAYLHYDCDPP  942 (1109)
Q Consensus       886 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~  942 (1109)
                      ...                 ...++||||++ |+|.++++....  .+.+..+      ..++.|+++||+|||   +.+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQ---SKG  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCC
Confidence            332                 23799999999 899999986432  2344455      778899999999999   899


Q ss_pred             eEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhC
Q 001275          943 IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITR 1020 (1109)
Q Consensus       943 ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg 1020 (1109)
                      |+||||||+|||++.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999865321     113567799999999987  7789999999999999999999


Q ss_pred             CCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1021 KKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1021 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      +.||..........       +.... ..........    .........++.+++.+||+.||++||+++|+++|-
T Consensus       290 ~~Pf~~~~~~~~~~-------~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  354 (371)
T 3q60_A          290 FLPFGLVTPGIKGS-------WKRPS-LRVPGTDSLA----FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP  354 (371)
T ss_dssp             SCSTTBCCTTCTTC-------CCBCC-TTSCCCCSCC----CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred             CCCCCCcCcccccc-------hhhhh-hhhccccccc----hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence            99996542221100       00000 0000000000    000011234566788899999999999999998753

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.1e-36  Score=334.17  Aligned_cols=258  Identities=24%  Similarity=0.326  Sum_probs=194.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC--CCc--EEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG--PNA--VFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|++.+.||+|+||+||+|++.  +++  .||||++....  .......+.+|++++++++||||+++++++...+ .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57888999999999999999753  333  68999885432  2334567899999999999999999999998654 88


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +|+||+++|+|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            9999999999999997642  24889999999999999999999   889999999999999999999999999999877


Q ss_pred             CCCCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          973 DKSPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       973 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ....... ......+|..|+|||.+.+..++.++||||+|+++|||++ |+.||......     .............. 
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~-  245 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHKIDKEGERLP-  245 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTSCCCCC-
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HHHHHHHccCCCCC-
Confidence            5433221 1223567889999999998889999999999999999999 99998654211     11111111110000 


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                        .           ......++.+++.+||+.||++||+++|++++|+++.
T Consensus       246 --~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          246 --R-----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             --C-----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             --C-----------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence              0           0112234667888999999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.6e-35  Score=333.10  Aligned_cols=273  Identities=23%  Similarity=0.317  Sum_probs=201.8

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe--CCCcEEEEEEeeecccc-cChHHHHHHHHHHhcC---CCCceeeEeeEEe----
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL--GPNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKI---RHRNLVRLEDFWL----  886 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  886 (1109)
                      +.++|.+.+.||+|+||+||+|..  .+++.||+|++...... .....+.+|+.+++++   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999987  46889999998654332 2334567788777766   8999999999987    


Q ss_pred             -cCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEec
Q 001275          887 -RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISD  965 (1109)
Q Consensus       887 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  965 (1109)
                       .....++||||++ |+|.+++.... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 69999998654 234899999999999999999999   88999999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD- 1044 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 1044 (1109)
                      ||+++.....   .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............. 
T Consensus       164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~  239 (326)
T 1blx_A          164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG  239 (326)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCC
T ss_pred             CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCC
Confidence            9999865432   1223457899999999999999999999999999999999999999754221 1111111111000 


Q ss_pred             ccccccccc-hhh-----hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1045 TEEINDIVD-LSL-----MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1045 ~~~~~~~~d-~~~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ......... +..     ...............+.+++.+||+.||++||+++|+++|-+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            000000000 000     000000001112344667888999999999999999998643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.1e-35  Score=331.58  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=194.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCC--CCceeeEeeEEecCCceeEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIR--HRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .++|.+.+.||+|+||.||+|...+++.||||++..... ......+.+|++++++++  |+||+++++++...+..++|
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            467888999999999999999988899999999855432 334567899999999997  59999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      || +.+++|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++ ++.+||+|||+++....
T Consensus       107 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             Ee-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            99 56789999998643   4889999999999999999999   88999999999999996 48999999999987654


Q ss_pred             CCCCceeeecccCccccccccccc-----------CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFT-----------TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWS 1043 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1109)
                      ...........||+.|+|||.+.+           ..++.++||||||+++|||++|+.||........    .......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----~~~~~~~  254 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHAIID  254 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHHHC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH----HHHHHHh
Confidence            433223334579999999998865           4678899999999999999999999965422211    1111111


Q ss_pred             CccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1044 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..... ..          ....   ..++.+++.+||+.||++||+++|++++-+
T Consensus       255 ~~~~~-~~----------~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h~~  295 (313)
T 3cek_A          255 PNHEI-EF----------PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHPY  295 (313)
T ss_dssp             TTSCC-CC----------CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ccccc-CC----------cccc---hHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence            10000 00          0001   234667888999999999999999998754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.8e-35  Score=330.10  Aligned_cols=255  Identities=21%  Similarity=0.279  Sum_probs=196.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            467889999999999999999875 5889999988543 34456788999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            999999999987633  34899999999999999999999   889999999999999999999999999987543211 


Q ss_pred             CCceeeecccCccccccccc-----ccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          977 ASTTSISVVGTIGYIAPENA-----FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                       ........||+.|+|||++     .+..++.++||||+|+++|+|++|+.||......     ...........  ...
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--~~~  242 (302)
T 2j7t_A          171 -LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSDP--PTL  242 (302)
T ss_dssp             -HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCC--CCC
T ss_pred             -ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHHHhccCC--ccc
Confidence             1111235789999999987     3667899999999999999999999998643211     11111111000  000


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..           ......++.+++.+|++.||++||+++|+++|-+
T Consensus       243 ~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  278 (302)
T 2j7t_A          243 LT-----------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF  278 (302)
T ss_dssp             SS-----------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred             CC-----------ccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence            00           0111234667888999999999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-36  Score=338.35  Aligned_cols=257  Identities=21%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             HHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEec-----
Q 001275          815 IEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLR-----  887 (1109)
Q Consensus       815 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-----  887 (1109)
                      ....++|++.+.||+|+||.||+|+. .+++.||||++...  ......+.+|+.+++++ +||||+++++++..     
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC--cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            34567899999999999999999977 46899999998543  33456789999999999 89999999999976     


Q ss_pred             -CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          888 -KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       888 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                       .+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeC
Confidence             457899999999999999998643 235889999999999999999999   889999999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      |++.......  .......||+.|+|||++.     +..++.++||||+||++|+|++|+.||......  .....+   
T Consensus       174 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~---  246 (326)
T 2x7f_A          174 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--RALFLI---  246 (326)
T ss_dssp             TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH---
T ss_pred             cCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHh---
Confidence            9998664322  1223357899999999887     567899999999999999999999998643211  111000   


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ....  ......         ...   ...+.+++.+||+.||++||+++|+++|-.
T Consensus       247 ~~~~--~~~~~~---------~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~hp~  289 (326)
T 2x7f_A          247 PRNP--APRLKS---------KKW---SKKFQSFIESCLVKNHSQRPATEQLMKHPF  289 (326)
T ss_dssp             HHSC--CCCCSC---------SCS---CHHHHHHHHHHCCSSGGGSCCHHHHHTSHH
T ss_pred             hcCc--cccCCc---------ccc---CHHHHHHHHHHhccChhhCCCHHHHhhChH
Confidence            0000  000000         011   234566788999999999999999998643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.6e-35  Score=340.10  Aligned_cols=268  Identities=20%  Similarity=0.235  Sum_probs=200.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC--------CCceeeEeeEEe---
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR--------HRNLVRLEDFWL---  886 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  886 (1109)
                      ++|.+.++||+|+||+||+|.. .+++.||||++..  .......+.+|++++++++        |+||+++++++.   
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS--AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec--CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            6788999999999999999975 5688999999842  2334567889999999985        788999999987   


Q ss_pred             -cCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeccCCCCeeeCCCC-----
Q 001275          887 -RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP-PIVHRDIKPENILLDSEM-----  959 (1109)
Q Consensus       887 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~-----  959 (1109)
                       .....++||||+ +|++.+++.... ...+++..++.++.|++.||+|||   +. +|+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence             556789999999 567777665432 235899999999999999999999   77 999999999999999775     


Q ss_pred             --------------------------------------------cEEEecccCCcccCCCCCCceeeecccCcccccccc
Q 001275          960 --------------------------------------------EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN  995 (1109)
Q Consensus       960 --------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~  995 (1109)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        7999999999876432     123478999999999


Q ss_pred             cccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccc----cHHHHHHHhhcCc------------------cccccccc
Q 001275          996 AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT----DIVGWVRSVWSDT------------------EEINDIVD 1053 (1109)
Q Consensus       996 ~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~------------------~~~~~~~d 1053 (1109)
                      +.+..++.++|||||||++|||++|+.||.+......    +....+.......                  .....+.+
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            9999999999999999999999999999976432211    1111111111000                  00000000


Q ss_pred             ---hhhhHH--hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1054 ---LSLMEE--MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1054 ---~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                         ......  ...........++.+++.+||+.||++|||++|+++|-+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence               000000  001112345567888999999999999999999998743

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.4e-35  Score=363.26  Aligned_cols=256  Identities=23%  Similarity=0.306  Sum_probs=200.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC----CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG----PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .++|...+.||+|+||+||+|.+.    .+..||+|++...........+.+|+.++++++||||+++++++. .+..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            367888899999999999999764    246799998855444444567899999999999999999999985 466899


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+++|+|.++++...  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       468 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            999999999999998643  34899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....  .+....+....  ....    
T Consensus       543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~~i~~~~--~~~~----  613 (656)
T 2j0j_A          543 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGE--RLPM----  613 (656)
T ss_dssp             C-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHHTC--CCCC----
T ss_pred             CCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHcCC--CCCC----
Confidence            4322 22233467889999999999999999999999999999997 8888864321  11111111100  0000    


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                  .......+.+++.+||+.||++||+++|+++.|+++
T Consensus       614 ------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          614 ------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                        011223566788899999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1e-34  Score=324.92  Aligned_cols=255  Identities=27%  Similarity=0.370  Sum_probs=201.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--------ccChHHHHHHHHHHhcCC-CCceeeEeeEEec
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--------KRGSLSMKREIQTIGKIR-HRNLVRLEDFWLR  887 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  887 (1109)
                      .++|...+.||+|+||.||+|... +++.||||++.....        ......+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468899999999999999999775 689999999854321        112346789999999995 9999999999999


Q ss_pred             CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          888 KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       888 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                      .+..++||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999997643   4899999999999999999999   8899999999999999999999999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccc------cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAF------TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      ++........   .....||+.|+|||++.      ...++.++||||+|+++|||++|+.||......  ..   ....
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~---~~~~  241 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LM---LRMI  241 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH---HHHH
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--HH---HHHH
Confidence            9987654322   23357899999999875      456789999999999999999999998643211  11   1111


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      .......   ..+         .......++.+++.+|++.||++||+++|+++|-.
T Consensus       242 ~~~~~~~---~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (298)
T 1phk_A          242 MSGNYQF---GSP---------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  286 (298)
T ss_dssp             HHTCCCC---CTT---------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             hcCCccc---Ccc---------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence            1110000   000         01112334667888999999999999999998654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.1e-35  Score=327.32  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=192.2

Q ss_pred             HhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec--------
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--------  887 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  887 (1109)
                      ..++|+..+.||+|+||+||+|+. .+++.||||++...  ......+.+|++++++++||||+++++++.+        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            346789999999999999999976 47899999998532  3345678899999999999999999998865        


Q ss_pred             -----CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEE
Q 001275          888 -----KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPH  962 (1109)
Q Consensus       888 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  962 (1109)
                           .+..++||||+++|+|.++++...  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+|
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEE
Confidence                 356799999999999999998633  34788999999999999999999   88999999999999999999999


Q ss_pred             EecccCCcccCCCCC------------CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCcc
Q 001275          963 ISDFGIAKLLDKSPA------------STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYK 1029 (1109)
Q Consensus       963 l~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~ 1029 (1109)
                      |+|||+++.......            ........||+.|+|||++.+. .++.++||||+||++|||++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            999999986643211            1122345789999999998764 68999999999999999998   4432211


Q ss_pred             ccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1030 ERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                          .................    ..        .......+.+++.+|++.||++||+++|+++|-+-
T Consensus       234 ----~~~~~~~~~~~~~~~~~----~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          234 ----RVNILKKLRSVSIEFPP----DF--------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             ----HHHHHHHHHSTTCCCCT----TC--------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             ----HHHHHHhccccccccCc----cc--------cccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence                11111111111100000    00        11122345678889999999999999999987543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.2e-35  Score=336.43  Aligned_cols=265  Identities=19%  Similarity=0.239  Sum_probs=196.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCce-----
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCG-----  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-----  891 (1109)
                      ++|...+.||+|+||+||+|... +++.||||++..... ......+.+|+.++++++||||+++++++...+..     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            57888999999999999999764 689999999854322 22346788999999999999999999999877654     


Q ss_pred             -eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          892 -IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       892 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                       ++||||++ |+|.+++..     .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       122 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             EEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence             99999998 588887743     3899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      .....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...+...............
T Consensus       193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-LDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred             ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCcHHHH
Confidence            65432     233578999999999887 6789999999999999999999999965321 1112222111111111000


Q ss_pred             cccchhhhHHh----h-------hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1050 DIVDLSLMEEM----L-------VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1050 ~~~d~~~~~~~----~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..+........    .       .........++.+++.+|++.||++|||++|+++|-+
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  326 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  326 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence            00000000000    0       0000112346777888999999999999999999854

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-34  Score=329.94  Aligned_cols=265  Identities=20%  Similarity=0.266  Sum_probs=201.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe--CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCC------ceeeEeeEEecCCc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL--GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR------NLVRLEDFWLRKDC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~  890 (1109)
                      ++|++.+.||+|+||+||+|..  .+++.||||++..  .......+.+|++++++++|+      +++++++++...+.
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN--VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec--CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            5788999999999999999976  3688999999843  223346788999999988665      49999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-------------
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-------------  957 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-------------  957 (1109)
                      .++||||+ +++|.+++.... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 889999997643 235889999999999999999999   889999999999999987             


Q ss_pred             ------CCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc
Q 001275          958 ------EMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031 (1109)
Q Consensus       958 ------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~ 1031 (1109)
                            ++.+||+|||+++......     ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... 
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  240 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK-  240 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-
T ss_pred             ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-
Confidence                  6689999999998654322     2357899999999999999999999999999999999999999654221 


Q ss_pred             ccHHHHHHHhhcC-cccc------cc--------ccchhhhH----H------hhhchhHHHHHHHHHHHHhccCCCCCC
Q 001275         1032 TDIVGWVRSVWSD-TEEI------ND--------IVDLSLME----E------MLVSSIRDQVIDVLLVALRCTEKKPSN 1086 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~-~~~~------~~--------~~d~~~~~----~------~~~~~~~~~~~~l~~l~~~cl~~dP~~ 1086 (1109)
                       +....+...... ....      ..        ........    .      ...........++.+++.+|++.||++
T Consensus       241 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          241 -EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             -HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             -HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence             111111111100 0000      00        00000000    0      000011234567888999999999999


Q ss_pred             CCCHHHHHHHh
Q 001275         1087 RPNMRDVVRQL 1097 (1109)
Q Consensus      1087 RPs~~evl~~L 1097 (1109)
                      |||++|+++|-
T Consensus       320 Rpt~~ell~hp  330 (339)
T 1z57_A          320 RITLREALKHP  330 (339)
T ss_dssp             SCCHHHHTTSG
T ss_pred             ccCHHHHhcCH
Confidence            99999999873

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.4e-35  Score=333.38  Aligned_cols=257  Identities=25%  Similarity=0.320  Sum_probs=177.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHH-HHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQ-TIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|...+.||+|+||.||+|... +++.||||++..........++.+|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            57888999999999999999774 689999999965544444455666666 7777899999999999999999999999


Q ss_pred             eccCCCHHHHHhcc--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          897 YMENGSLRDVLHSI--TPPPTLEWNVRYKIALGAAHALAYLHYDCDP-PIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      |+++ +|.+++...  .....+++..+..++.|+++|++|||   +. +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9985 888877531  12345899999999999999999999   77 99999999999999999999999999998664


Q ss_pred             CCCCCceeeecccCccccccccc----ccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENA----FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      ....   .....||+.|+|||++    .+..++.++||||||+++|||++|+.||........    .........  ..
T Consensus       178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~--~~  248 (327)
T 3aln_A          178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QLTQVVKGD--PP  248 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSC--CC
T ss_pred             cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HHHHHhcCC--CC
Confidence            3321   2234799999999998    466789999999999999999999999864321110    000000000  00


Q ss_pred             cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1050 DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1050 ~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .+ .    .    ........++.+++.+||+.||++||+++|++++-
T Consensus       249 ~~-~----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          249 QL-S----N----SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             CC-C----C----CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             CC-C----C----cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence            00 0    0    00011223567788899999999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.2e-34  Score=320.29  Aligned_cols=255  Identities=25%  Similarity=0.342  Sum_probs=201.8

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      ...++|++.+.||+|+||+||+|... +++.||+|++..... ......+.+|++++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34578999999999999999999775 689999999865432 3456689999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC---CcEEEecccCCc
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE---MEPHISDFGIAK  970 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~DfGla~  970 (1109)
                      |+||+++++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999999887643   3899999999999999999999   8899999999999999754   469999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      .......   .....||+.|+|||.+.+ .++.++||||+|+++|+|++|+.||.....  .+....+..   .....  
T Consensus       173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~---~~~~~--  241 (287)
T 2wei_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--YDILKRVET---GKYAF--  241 (287)
T ss_dssp             TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHH---CCCCC--
T ss_pred             eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc---CCCCC--
Confidence            6644322   223468999999998765 489999999999999999999999865321  111111111   10000  


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                        +..        .......++.+++.+|++.||++||+++|++++-
T Consensus       242 --~~~--------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  278 (287)
T 2wei_A          242 --DLP--------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (287)
T ss_dssp             --CSG--------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             --Cch--------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence              000        0011123466788899999999999999999853

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=334.70  Aligned_cols=258  Identities=21%  Similarity=0.300  Sum_probs=196.9

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|.+.+.||+|+||+||+|....  .||+|++..... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            4678899999999999999998764  489998854432 2334567889999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++++|.+++....  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++ ++.+||+|||+++......
T Consensus       110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            999999999997643  35889999999999999999999   88999999999999998 6799999999987653221


Q ss_pred             ---CCceeeecccCccccccccccc---------CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC
Q 001275          977 ---ASTTSISVVGTIGYIAPENAFT---------TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD 1044 (1109)
Q Consensus       977 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1109)
                         .........||+.|+|||++.+         ..++.++||||||+++|||++|+.||......     .........
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~  258 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQMGTG  258 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHHHHHTT
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhccC
Confidence               1122233568999999998864         45788999999999999999999999653221     111111111


Q ss_pred             ccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1045 TEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1045 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                      ..  ......            ....++.+++.+||+.||++||+++|+++.|+++..
T Consensus       259 ~~--~~~~~~------------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~  302 (319)
T 2y4i_B          259 MK--PNLSQI------------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK  302 (319)
T ss_dssp             CC--CCCCCS------------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred             CC--CCCCcC------------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            00  000000            011235668889999999999999999999998744

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.5e-35  Score=328.94  Aligned_cols=270  Identities=19%  Similarity=0.298  Sum_probs=191.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEe-----------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWL-----------  886 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  886 (1109)
                      .+|...+.||+|+||.||+|... +++.||+|++... .......+.+|++++++++||||+++++++.           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            57888999999999999999776 4899999988533 3344567899999999999999999999874           


Q ss_pred             ---cCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC-CCCcEE
Q 001275          887 ---RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD-SEMEPH  962 (1109)
Q Consensus       887 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~k  962 (1109)
                         .....++||||++ |+|.+++..    ..+++..+..++.|+++||+|||   +.+|+||||||+||+++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEE
Confidence               3456799999998 699999864    24889999999999999999999   88999999999999997 567999


Q ss_pred             EecccCCcccCCCCC-CceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHH
Q 001275          963 ISDFGIAKLLDKSPA-STTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       963 l~DfGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1109)
                      |+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~  240 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILES  240 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHh
Confidence            999999987643211 112233567999999998765 67899999999999999999999999754321 111111111


Q ss_pred             hhcCc-cccc---cccchhhhHHhh------hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1041 VWSDT-EEIN---DIVDLSLMEEML------VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1041 ~~~~~-~~~~---~~~d~~~~~~~~------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..... ....   ..+.........      .........++.+++.+|++.||++||+++|+++|-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            00000 0000   000000000000      0000112345777888999999999999999998643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.2e-35  Score=330.72  Aligned_cols=255  Identities=21%  Similarity=0.253  Sum_probs=171.8

Q ss_pred             hhCCCCC-ceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec----CCce
Q 001275          818 TENLNAK-HVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR----KDCG  891 (1109)
Q Consensus       818 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  891 (1109)
                      .++|.+. ++||+|+||+||+|... +++.||||++...     .....+....++.++||||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            4678874 46999999999999775 6899999998431     2222233344566799999999999876    4457


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCcEEEecccC
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EMEPHISDFGI  968 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGl  968 (1109)
                      ++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999998643 245899999999999999999999   889999999999999976   45599999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      ++......    .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||......... ............  
T Consensus       178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~--  250 (336)
T 3fhr_A          178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PGMKRRIRLGQY--  250 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hhHHHhhhcccc--
Confidence            98664322    22357899999999998888999999999999999999999999654221110 000000000000  


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                       .. .        .........++.+++.+|++.||++|||++|+++|-+
T Consensus       251 -~~-~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          251 -GF-P--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             -CC-C--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             -cc-C--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence             00 0        0001112334667888999999999999999999654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.3e-34  Score=331.40  Aligned_cols=201  Identities=23%  Similarity=0.313  Sum_probs=169.8

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CC-----ceeeEeeEEecCC
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HR-----NLVRLEDFWLRKD  889 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~  889 (1109)
                      ..++|.+.+.||+|+||+||+|... +++.||||++..  .......+.+|+++++.++ |+     +|+++++++...+
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN--KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS--SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec--cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            3578999999999999999999765 678999999843  2233456778888888874 44     4999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC--CCCcEEEeccc
Q 001275          890 CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD--SEMEPHISDFG  967 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DfG  967 (1109)
                      ..++||||++ |+|.+++.... ...+++..+..++.|++.||+|||.. +.+|+||||||+||+++  .++.+||+|||
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            9999999996 59999998643 23489999999999999999999931 46899999999999995  47789999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      +++......     ....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus       207 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          207 SSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             Cceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            998764321     2357899999999999999999999999999999999999999754

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.1e-33  Score=321.54  Aligned_cols=307  Identities=23%  Similarity=0.324  Sum_probs=170.0

Q ss_pred             ccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccc
Q 001275           91 IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQ  170 (1109)
Q Consensus        91 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~  170 (1109)
                      +.++++|++|++++|.+.. +| .++.+++|++|++++|++++. |. +.++++|++|+|++|.++. +| .+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred             chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence            3456777777777777763 34 377777777777777777743 33 7777777777777777763 33 466666777


Q ss_pred             eecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcc
Q 001275          171 YVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNN  250 (1109)
Q Consensus       171 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  250 (1109)
                      +|++++|++++..+  +..+++|++|++++|.....++ .+..+++|++|++++|.+++..+  +..+++|+.|++++|+
T Consensus       114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~  188 (347)
T 4fmz_A          114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ  188 (347)
T ss_dssp             EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred             EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence            77777776664322  6666666666666665443333 36666666666666666654433  5556666666666665


Q ss_pred             cCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCc
Q 001275          251 LEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE  330 (1109)
Q Consensus       251 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  330 (1109)
                      +++..+  +..+++|++|++++|.+++..+  +..+++|++|++++|++++..+  +..+++|++|++++|.+++.  +.
T Consensus       189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~  260 (347)
T 4fmz_A          189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA  260 (347)
T ss_dssp             CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GG
T ss_pred             cccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hh
Confidence            554332  4445555555555555543322  4444555555555555543222  44444555555555544432  23


Q ss_pred             cccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCC
Q 001275          331 LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLK  410 (1109)
Q Consensus       331 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  410 (1109)
                                              +..+++|++|++++|++++.  ..+..+++|+.|++++|.+++..|..+..+++|+
T Consensus       261 ------------------------~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  314 (347)
T 4fmz_A          261 ------------------------VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT  314 (347)
T ss_dssp             ------------------------GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred             ------------------------HhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence                                    44444455555555544432  2344445555555555555444444555555555


Q ss_pred             eEEccCCcCcccCCccccCCCCCceEEecCCccc
Q 001275          411 NISLYNNQFSGVIPQSLGINSSLMQLDFINNSFT  444 (1109)
Q Consensus       411 ~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~  444 (1109)
                      .|++++|++++..|  +..+++|++||+++|.|+
T Consensus       315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            55555555554433  444555555555555543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=1.1e-34  Score=328.37  Aligned_cols=283  Identities=20%  Similarity=0.219  Sum_probs=214.6

Q ss_pred             hccCChhhHHHHHHHHHhccCCCCcccCCCC---CCCCCCceeeeEEecC--------CCCcEEEEEecccCCccccCCc
Q 001275           22 SVNALNGDGVALLSLMRHWNSVPPLIISSWN---SSDSTPCQWVGIECDD--------DAHNVVSFNLSSYGVSGQLGPE   90 (1109)
Q Consensus        22 ~~~~~~~~~~all~~~~~~~~~~~~~l~sW~---~~~~~~c~w~gv~C~~--------~~~~v~~l~l~~~~l~~~~~~~   90 (1109)
                      ...+..+|++||++||+++..++.+.+.+|.   ....++|.|.|++|+.        ...+|+.|+++++.+. .+|+.
T Consensus        21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~   99 (328)
T 4fcg_A           21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ   99 (328)
T ss_dssp             --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred             ccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence            3456788999999999999888888889994   3356789999999953        3356777777777766 56666


Q ss_pred             ccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccc
Q 001275           91 IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQ  170 (1109)
Q Consensus        91 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~  170 (1109)
                      ++++++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|+|++|++.+.+|..+...    
T Consensus       100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~----  173 (328)
T 4fcg_A          100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST----  173 (328)
T ss_dssp             GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE----
T ss_pred             hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc----
Confidence            777777777777777776 66666777777777777777776 566667777777777777766666666655431    


Q ss_pred             eecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcc
Q 001275          171 YVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNN  250 (1109)
Q Consensus       171 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  250 (1109)
                                 ..+..++++++|++|+|++|+++ .+|..++++++|++|+|++|++++ +|..+.++++|++|++++|+
T Consensus       174 -----------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~  240 (328)
T 4fcg_A          174 -----------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT  240 (328)
T ss_dssp             -----------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCT
T ss_pred             -----------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCc
Confidence                       11223445777888888888877 677778888888888888888885 45568888888888888888


Q ss_pred             cCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCC
Q 001275          251 LEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLS  324 (1109)
Q Consensus       251 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  324 (1109)
                      +.+.+|..+..+++|++|+|++|.+.+.+|..+.++++|++|++++|++.+.+|..++.+++|+.+++..|.+.
T Consensus       241 ~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          241 ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             chhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            88888888888888888888888888888888888888888888888888888888888888888888877665

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.8e-35  Score=331.64  Aligned_cols=244  Identities=21%  Similarity=0.321  Sum_probs=197.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccccc-----ChHHHHHHHHHHhcCC--CCceeeEeeEEecCC
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKR-----GSLSMKREIQTIGKIR--HRNLVRLEDFWLRKD  889 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  889 (1109)
                      .++|.+.+.||+|+||+||+|.. .+++.||||++.......     ....+.+|+.++++++  |+||+++++++...+
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~  121 (320)
T 3a99_A           42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD  121 (320)
T ss_dssp             TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence            46788999999999999999975 568999999986543221     2345678999999996  599999999999999


Q ss_pred             ceeEEEEeccC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC-CCCcEEEeccc
Q 001275          890 CGIIMYRYMEN-GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD-SEMEPHISDFG  967 (1109)
Q Consensus       890 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~DfG  967 (1109)
                      ..++|+||+.+ ++|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++ +++.+||+|||
T Consensus       122 ~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          122 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            99999999986 89999997643   4899999999999999999999   89999999999999998 78899999999


Q ss_pred             CCcccCCCCCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          968 IAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       968 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      +++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....       ....    ...
T Consensus       196 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~----~~~  260 (320)
T 3a99_A          196 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR----GQV  260 (320)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH----CCC
T ss_pred             ccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhc----ccc
Confidence            998765332    223579999999999887776 788999999999999999999985321       0000    000


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..    .         ...   ..++.+++.+||+.||++||+++|++++-+
T Consensus       261 ~~----~---------~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~hp~  296 (320)
T 3a99_A          261 FF----R---------QRV---SSECQHLIRWCLALRPSDRPTFEEIQNHPW  296 (320)
T ss_dssp             CC----S---------SCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             cc----c---------ccC---CHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence            00    0         011   234566888999999999999999998754

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.1e-35  Score=342.73  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=185.9

Q ss_pred             CCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .|...++||+|+||+||.+...+|+.||||++...    ....+.+|++++.++ +|||||++++++...+..++||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            34456889999999998877778999999998432    234678999999886 8999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCC----CCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-------------CcE
Q 001275          899 ENGSLRDVLHSITPPPT----LEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-------------MEP  961 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-------------~~~  961 (1109)
                      + |+|.+++........    ..+..++.++.|++.||+|||   +.+|+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 699999986442111    133346789999999999999   8899999999999999654             489


Q ss_pred             EEecccCCcccCCCCCC--ceeeecccCccccccccccc-------CCCCccCcchhhHHHHHHHHh-CCCCCCCCcccc
Q 001275          962 HISDFGIAKLLDKSPAS--TTSISVVGTIGYIAPENAFT-------TAKSKESDVYSYGVVLLELIT-RKKALDPSYKER 1031 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~ 1031 (1109)
                      ||+|||+++........  .......||+.|+|||++.+       ..++.++||||+||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999977543221  12234579999999998875       678999999999999999999 899986432221


Q ss_pred             ccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                         ......... .......            .......++.+++.+|++.||++||++.|+++|-
T Consensus       248 ---~~i~~~~~~-~~~~~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          248 ---SNIIRGIFS-LDEMKCL------------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             ---HHHHHTCCC-CCCCTTC------------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ---HHHhcCCCC-ccccccc------------ccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence               111111110 0000000            0123345677788899999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-35  Score=327.75  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=190.7

Q ss_pred             HHHhhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc-----cChHHHHHHHHHHhcC----CCCceeeEeeE
Q 001275          815 IEATENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK-----RGSLSMKREIQTIGKI----RHRNLVRLEDF  884 (1109)
Q Consensus       815 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~niv~l~~~  884 (1109)
                      ....++|+..+.||+|+||.||+|.. .+++.||||++......     .....+.+|+.++.++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34457899999999999999999976 46889999998543321     1223456789998888    89999999999


Q ss_pred             EecCCceeEEEEe-ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC-CCCcEE
Q 001275          885 WLRKDCGIIMYRY-MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD-SEMEPH  962 (1109)
Q Consensus       885 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~k  962 (1109)
                      +...+..++|+|| +++++|.+++....   .+++..++.++.|+++||+|||   +.+|+||||||+||+++ +++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 78999999998644   3899999999999999999999   88999999999999998 889999


Q ss_pred             EecccCCcccCCCCCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh
Q 001275          963 ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       963 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                      |+|||+++......    .....||..|+|||++.+..+ +.++||||+|+++|||++|+.||....       ....  
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~--  247 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILE--  247 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH--
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhh--
Confidence            99999998765432    223579999999998887766 459999999999999999999985321       0000  


Q ss_pred             hcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1042 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                        .....    .            .....++.+++.+||+.||++||+++|++++-.-
T Consensus       248 --~~~~~----~------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~  287 (312)
T 2iwi_A          248 --AELHF----P------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM  287 (312)
T ss_dssp             --TCCCC----C------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred             --hccCC----c------------ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence              00000    0            0112345668889999999999999999997653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.5e-35  Score=354.12  Aligned_cols=266  Identities=24%  Similarity=0.271  Sum_probs=198.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec------CCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR------KDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  891 (1109)
                      .+|.+.++||+|+||+||+|.. .+|+.||||++...........+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999976 46899999988654444556678999999999999999999998765      6678


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCc---EEEecccC
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEME---PHISDFGI  968 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~kl~DfGl  968 (1109)
                      ++||||+++|+|.+++........+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||.
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999987665556889999999999999999999   889999999999999987665   99999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc--
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE-- 1046 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 1046 (1109)
                      ++.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....    ..|.........  
T Consensus       171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSNEH  243 (676)
T ss_dssp             CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC------
T ss_pred             ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccchh
Confidence            987654332   23357999999999999999999999999999999999999999754211    111110000000  


Q ss_pred             -ccccccchhhh--H--HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001275         1047 -EINDIVDLSLM--E--EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094 (1109)
Q Consensus      1047 -~~~~~~d~~~~--~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 1094 (1109)
                       ...+.......  .  .............+.+++.+|++.||++||+++|++
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence             00000000000  0  000001122345677788899999999999998744

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.6e-34  Score=329.73  Aligned_cols=265  Identities=19%  Similarity=0.247  Sum_probs=194.9

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc------
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC------  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  890 (1109)
                      ++|...+.||+|+||+||+|.. .+|+.||||++..... ......+.+|+.++++++||||+++++++...+.      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5788889999999999999976 4689999999854332 2234578899999999999999999999987654      


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++||||++ |+|.+++..     .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence            499999998 588777642     3899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc-
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI- 1048 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 1048 (1109)
                      .....     .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+.............. 
T Consensus       175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHH
T ss_pred             CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            65322     223578999999998877 67899999999999999999999999653211 11111111111000000 


Q ss_pred             ccccchhhhH---H-------hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1049 NDIVDLSLME---E-------MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1049 ~~~~d~~~~~---~-------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ..+.+.....   .       ...........++.+++.+|++.||++||+++|+++|-+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  308 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF  308 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence            0000000000   0       000001122345677888999999999999999998754

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.2e-33  Score=319.02  Aligned_cols=307  Identities=22%  Similarity=0.323  Sum_probs=218.4

Q ss_pred             CCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccc
Q 001275          115 LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVE  194 (1109)
Q Consensus       115 l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~  194 (1109)
                      +..+++|++|++++|.+.. +| .+..+++|++|+|++|.+++ +|. +..+++|++|++++|.++. + +.+..+++|+
T Consensus        40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L~  113 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-I-SALQNLTNLR  113 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCS
T ss_pred             chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-c-hHHcCCCcCC
Confidence            4456677777777777663 33 26666667777776666653 332 5555555555555555553 1 2344445555


Q ss_pred             eeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhcccccc
Q 001275          195 ALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNR  274 (1109)
Q Consensus       195 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  274 (1109)
                      +|++++|+++                        +..+  +..+++|++|++++|.....++. +..+++|++|++++|.
T Consensus       114 ~L~l~~n~i~------------------------~~~~--~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~  166 (347)
T 4fmz_A          114 ELYLNEDNIS------------------------DISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESK  166 (347)
T ss_dssp             EEECTTSCCC------------------------CCGG--GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSC
T ss_pred             EEECcCCccc------------------------Cchh--hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCC
Confidence            5555555444                        3322  44455555555555533322222 4555666666666666


Q ss_pred             ccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCcc
Q 001275          275 FSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE  354 (1109)
Q Consensus       275 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  354 (1109)
                      +.+..+  +..+++|++|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|++|++++|++++..+  
T Consensus       167 ~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--  238 (347)
T 4fmz_A          167 VKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--  238 (347)
T ss_dssp             CCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred             cCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--
Confidence            654332  6677778888888888775433  7788888899999988885543  7888999999999999985443  


Q ss_pred             ccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCc
Q 001275          355 LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLM  434 (1109)
Q Consensus       355 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~  434 (1109)
                      +..+++|++|++++|++++.  ..+..+++|++|++++|.+++.  ..+..+++|+.|++++|++++..|..++.+++|+
T Consensus       239 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~  314 (347)
T 4fmz_A          239 LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT  314 (347)
T ss_dssp             GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCS
T ss_pred             hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCC
Confidence            88999999999999999863  4688999999999999999864  4688999999999999999999999999999999


Q ss_pred             eEEecCCcccccCCCCcccCccceEEECCCcccc
Q 001275          435 QLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFH  468 (1109)
Q Consensus       435 ~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~  468 (1109)
                      +|++++|.+++..|  +..+++|+.|++++|+|+
T Consensus       315 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             EEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             EEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            99999999997766  888999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.8e-34  Score=329.06  Aligned_cols=269  Identities=19%  Similarity=0.234  Sum_probs=199.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-----------CCceeeEeeEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-----------HRNLVRLEDFWL  886 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  886 (1109)
                      .+|.+.+.||+|+||+||+|.. .+++.||||++..  .......+.+|++++++++           |+||+++++++.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG--DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC--CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            5788999999999999999976 5689999999842  2233456889999999886           899999999988


Q ss_pred             cCC----ceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeccCCCCeeeC-----
Q 001275          887 RKD----CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP-PIVHRDIKPENILLD-----  956 (1109)
Q Consensus       887 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~-----  956 (1109)
                      ..+    ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||   +. +|+||||||+||+++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence            654    679999999 8899999986432 34899999999999999999999   77 999999999999994     


Q ss_pred             -CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc----
Q 001275          957 -SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER---- 1031 (1109)
Q Consensus       957 -~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~---- 1031 (1109)
                       ..+.+||+|||+++......     ....||+.|+|||++.+..++.++||||+||++|||++|+.||.......    
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             44589999999998764321     23478999999999999999999999999999999999999997543211    


Q ss_pred             -ccHHHHHHHhhcC-----------------ccccccccch-----hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC
Q 001275         1032 -TDIVGWVRSVWSD-----------------TEEINDIVDL-----SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP 1088 (1109)
Q Consensus      1032 -~~~~~~~~~~~~~-----------------~~~~~~~~d~-----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 1088 (1109)
                       ..+..........                 ......+...     ................++.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence             1111111111000                 0000000000     0000000111234566788899999999999999


Q ss_pred             CHHHHHHHhhh
Q 001275         1089 NMRDVVRQLVD 1099 (1109)
Q Consensus      1089 s~~evl~~L~~ 1099 (1109)
                      |++|+++|-+-
T Consensus       327 t~~ell~hp~f  337 (373)
T 1q8y_A          327 DAGGLVNHPWL  337 (373)
T ss_dssp             CHHHHHTCGGG
T ss_pred             CHHHHhhChhh
Confidence            99999997543

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.6e-34  Score=323.61  Aligned_cols=253  Identities=22%  Similarity=0.303  Sum_probs=178.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChH-HHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|...+.||+|+||.||+|... +++.||||++.......... .+.++..+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            57888899999999999999775 68999999986544333333 34455567888899999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP-PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      |+ ++.+..+.....  ..+++..+..++.|+++||+|||   +. +|+||||||+||+++.++.+||+|||++......
T Consensus       105 ~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             cc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            99 456666554322  34899999999999999999999   74 9999999999999999999999999999766433


Q ss_pred             CCCceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ..   .....||+.|+|||++.     ...++.++||||||+++|||++|+.||.........    ...........  
T Consensus       179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~--  249 (318)
T 2dyl_A          179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV----LTKVLQEEPPL--  249 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHHHHHSCCCC--
T ss_pred             cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH----HHHHhccCCCC--
Confidence            21   22357999999999884     556789999999999999999999999653222111    11111110000  


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      . .          .......++.+++.+||+.||.+||+++|+++|-
T Consensus       250 ~-~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          250 L-P----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             C-C----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             C-C----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence            0 0          0001123466788899999999999999998764

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.1e-33  Score=324.79  Aligned_cols=266  Identities=19%  Similarity=0.261  Sum_probs=199.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CC-cEEEEEEeeecccccChHHHHHHHHHHhcCCCCc------eeeEeeEEecCCc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PN-AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN------LVRLEDFWLRKDC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  890 (1109)
                      ++|++.+.||+|+||+||+|... ++ +.||+|++..  .......+.+|++++++++|++      ++.+++++...+.
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN--VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS--CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc--cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            67899999999999999999764 34 6899999843  2234557888999999997665      9999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee---------------
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL---------------  955 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll---------------  955 (1109)
                      .++||||+ ++++.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||++               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence            99999999 667777776543 235899999999999999999999   8999999999999999               


Q ss_pred             ----CCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc
Q 001275          956 ----DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031 (1109)
Q Consensus       956 ----~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~ 1031 (1109)
                          +.++.+||+|||+++......     ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... 
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  245 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR-  245 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-
Confidence                567899999999998654322     2357999999999999999999999999999999999999999754221 


Q ss_pred             ccHHHHHHHhhcC-cccc-------c------cccch-----hhhHHh------hhchhHHHHHHHHHHHHhccCCCCCC
Q 001275         1032 TDIVGWVRSVWSD-TEEI-------N------DIVDL-----SLMEEM------LVSSIRDQVIDVLLVALRCTEKKPSN 1086 (1109)
Q Consensus      1032 ~~~~~~~~~~~~~-~~~~-------~------~~~d~-----~~~~~~------~~~~~~~~~~~l~~l~~~cl~~dP~~ 1086 (1109)
                       +....+...... ....       .      ...+.     ......      ..........++.+++.+||+.||++
T Consensus       246 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          246 -EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             -HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             -HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence             111111111100 0000       0      00000     000000      00011233456788999999999999


Q ss_pred             CCCHHHHHHHhh
Q 001275         1087 RPNMRDVVRQLV 1098 (1109)
Q Consensus      1087 RPs~~evl~~L~ 1098 (1109)
                      |||++|+++|-+
T Consensus       325 Rpt~~e~l~hp~  336 (355)
T 2eu9_A          325 RITLAEALLHPF  336 (355)
T ss_dssp             SCCHHHHTTSGG
T ss_pred             CcCHHHHhcChh
Confidence            999999997644

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-34  Score=336.62  Aligned_cols=251  Identities=24%  Similarity=0.304  Sum_probs=184.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+|...++||+|+||+||.....+++.||||++....    ...+.+|+++++++ +|||||++++++.+.+..++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4577889999999999776666779999999984322    22356899999999 899999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-----CCcEEEecccCCccc
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-----EMEPHISDFGIAKLL  972 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DfGla~~~  972 (1109)
                      ++ |+|.+++.....  ...+..+..++.|+++||+|||   +.+|+||||||+||+++.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            97 599999976442  2344456789999999999999   889999999999999953     235889999999876


Q ss_pred             CCCCCC-ceeeecccCcccccccccc---cCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          973 DKSPAS-TTSISVVGTIGYIAPENAF---TTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       973 ~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      ...... .......||+.|+|||++.   ...++.++||||+||++|||++ |+.||.......   ..   ..... ..
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---~~---~~~~~-~~  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---AN---ILLGA-CS  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---HH---HHTTC-CC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---HH---HHhcc-CC
Confidence            543211 2233467999999999987   4567889999999999999999 888885332111   11   11100 00


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      . ....+          .......+.+++.+|++.||++||+++|+++|-
T Consensus       247 ~-~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp  285 (432)
T 3p23_A          247 L-DCLHP----------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP  285 (432)
T ss_dssp             C-TTSCT----------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred             c-cccCc----------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence            0 00000          012223456788899999999999999999764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=4.4e-33  Score=313.24  Aligned_cols=251  Identities=30%  Similarity=0.448  Sum_probs=171.0

Q ss_pred             cccEEEcCCCCCCC--CCCCccccccccceeeccC-cccCCCCCccccCCCCccEEEccCccccccCchHHHhhccccee
Q 001275          312 RLSSLDLSENQLSG--KIPPELGKCKYLTVLHLYA-NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL  388 (1109)
Q Consensus       312 ~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  388 (1109)
                      +++.|+|++|.+++  .+|..++++++|++|++++ |.+.+.+|..++.+++|++|+|++|++++.+|..+.++++|++|
T Consensus        51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L  130 (313)
T 1ogq_A           51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence            45555555555555  5555666666666666663 66665666666666666666666666666666666666666666


Q ss_pred             eccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCC-CCceEEecCCcccccCCCCcccCccceEEECCCccc
Q 001275          389 LVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINS-SLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQF  467 (1109)
Q Consensus       389 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~-~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l  467 (1109)
                      ++++|.+++.+|..+..+++|++|++++|++++.+|..++.++ +|++|++++|.+++.+|..+..++ |++|++++|++
T Consensus       131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l  209 (313)
T 1ogq_A          131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred             eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence            6666666666666677777777777777777767777776666 677777777777777777776665 77777777777


Q ss_pred             ccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhh
Q 001275          468 HGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG  547 (1109)
Q Consensus       468 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  547 (1109)
                      .+.+|..+..+++|+.|++++|++++.+|.+..+++|++|++++|+|++.+|..+..+++|+.|+|++|+++|.+|.. +
T Consensus       210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~  288 (313)
T 1ogq_A          210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-G  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-T
T ss_pred             cCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-c
Confidence            777777766666666666666666666666666777777777777777777777777777777777777777766665 6


Q ss_pred             cccccceeeccccc-ccc
Q 001275          548 NLVSLVTLNISLNH-VEG  564 (1109)
Q Consensus       548 ~l~~L~~L~L~~N~-l~~  564 (1109)
                      .+++|+.|++++|. +.|
T Consensus       289 ~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          289 NLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             TGGGSCGGGTCSSSEEES
T ss_pred             cccccChHHhcCCCCccC
Confidence            67777777777775 443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=5.9e-32  Score=307.29  Aligned_cols=246  Identities=24%  Similarity=0.290  Sum_probs=139.0

Q ss_pred             CCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecc
Q 001275           95 SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFL  174 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  174 (1109)
                      ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.++ .+|..+.          
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~----------  122 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP----------  122 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC----------
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc----------
Confidence            45566666666665555555556666666666666655555555555555666555555555 3443332          


Q ss_pred             cccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEecccccc--CcCchhcccccccccccccCcccC
Q 001275          175 NNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLM--GFLPESLSNLENLVYLDVGDNNLE  252 (1109)
Q Consensus       175 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~  252 (1109)
                                      ++|++|++++|++++..+..|+++++|++|++++|.++  +..+..+..+ +|++|++++|+++
T Consensus       123 ----------------~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~  185 (332)
T 2ft3_A          123 ----------------SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT  185 (332)
T ss_dssp             ----------------TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS
T ss_pred             ----------------ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC
Confidence                            34555555555555444444555555555555555553  2445555555 6666666666665


Q ss_pred             CcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccc
Q 001275          253 GRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELG  332 (1109)
Q Consensus       253 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  332 (1109)
                      +.. ..+  .++|++|++++|++++..+..+..+++|+.|++++|++++..+..++.+++|++|++++|+++ .+|..+.
T Consensus       186 ~l~-~~~--~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~  261 (332)
T 2ft3_A          186 GIP-KDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP  261 (332)
T ss_dssp             SCC-SSS--CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGG
T ss_pred             ccC-ccc--cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhh
Confidence            422 222  145666666666666555556666666666666666666555556666666666666666666 5555666


Q ss_pred             cccccceeeccCcccCCCCCccccCC------CCccEEEccCcccc
Q 001275          333 KCKYLTVLHLYANQLEGEIPDELGQL------SNLQDLELFDNRLT  372 (1109)
Q Consensus       333 ~l~~L~~L~L~~N~l~~~~p~~l~~l------~~L~~L~L~~N~l~  372 (1109)
                      .+++|++|++++|++++..+..|...      .+|+.|++++|++.
T Consensus       262 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~  307 (332)
T 2ft3_A          262 DLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP  307 (332)
T ss_dssp             GCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred             cCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence            66666666666666665444444432      34445555555443

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=5.2e-32  Score=307.74  Aligned_cols=288  Identities=20%  Similarity=0.261  Sum_probs=181.7

Q ss_pred             cccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeecc
Q 001275          312 RLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVY  391 (1109)
Q Consensus       312 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  391 (1109)
                      +++.+++++|.++ .+|..+.  ++|+.|++++|.+++..|..|..+++|++|++++|++++..|..+..+++|++|+++
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            5666666666665 4444442  455666666666655445555556666666666665555445555555555555555


Q ss_pred             CCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccc--c
Q 001275          392 NNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFH--G  469 (1109)
Q Consensus       392 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~--~  469 (1109)
                      +|.++ .+                        |..+.  ++|++|++++|.+++..+..+..+++|++|++++|+++  +
T Consensus       111 ~n~l~-~l------------------------~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~  163 (332)
T 2ft3_A          111 KNHLV-EI------------------------PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG  163 (332)
T ss_dssp             SSCCC-SC------------------------CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGG
T ss_pred             CCcCC-cc------------------------Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCC
Confidence            55554 23                        33222  44555555555554333334445555555555555553  2


Q ss_pred             CCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcc
Q 001275          470 PIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNL  549 (1109)
Q Consensus       470 ~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  549 (1109)
                      ..|..+..+ +|+.|++++|++++.+..+.  ++|++|++++|++++..|..+..+++|+.|++++|++++..|..++.+
T Consensus       164 ~~~~~~~~l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  240 (332)
T 2ft3_A          164 FEPGAFDGL-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL  240 (332)
T ss_dssp             SCTTSSCSC-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred             CCcccccCC-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence            445555555 66666666666665433333  577888888888887777788888888888888888887777778888


Q ss_pred             cccceeecccccccccCCccccCCCCccEEEecCccccCCCCccccc------ccccceecccccccc--CCCcchhhhh
Q 001275          550 VSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRS------WKSLSILKLSENHFT--GGIPTFISEL  621 (1109)
Q Consensus       550 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~--~~~p~~~~~l  621 (1109)
                      ++|++|+|++|+++ .+|..+..+++|+.|++++|+|++..+..|..      ...|+.|++++|.+.  +..|..+..+
T Consensus       241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l  319 (332)
T 2ft3_A          241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV  319 (332)
T ss_dssp             TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTB
T ss_pred             CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccccc
Confidence            88888888888888 67777888888888888888888665566654      356777888888776  4566677777


Q ss_pred             hhhhhhhcccCc
Q 001275          622 EKLLELQLGGNQ  633 (1109)
Q Consensus       622 ~~L~~L~l~~N~  633 (1109)
                      ++|+.|++++|+
T Consensus       320 ~~L~~l~l~~n~  331 (332)
T 2ft3_A          320 TDRLAIQFGNYK  331 (332)
T ss_dssp             CCSTTEEC----
T ss_pred             chhhhhhccccc
Confidence            777777777764

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.98  E-value=3e-33  Score=348.44  Aligned_cols=237  Identities=24%  Similarity=0.312  Sum_probs=189.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC--CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc-----e
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG--PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC-----G  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~  891 (1109)
                      ++|.+.++||+|+||+||+|...  +++.||||++...........+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            67899999999999999999875  5899999988654444455678999999999999999999999987665     6


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      |+||||+++++|.+++..     .+++..++.++.|+++||+|||   +.+|+||||||+||+++.+ .+||+|||+++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            999999999999987754     4899999999999999999999   8899999999999999886 899999999987


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ....      ....||++|+|||++.+.. +.++|||||||++|+|++|..|+......                   .+
T Consensus       231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-------------------~~  284 (681)
T 2pzi_A          231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-------------------GL  284 (681)
T ss_dssp             TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-------------------SC
T ss_pred             cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-------------------cc
Confidence            6433      2357999999999887654 89999999999999999998877532111                   00


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-MRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-~~evl~~L~ 1098 (1109)
                      ....        ........+.+++.+||+.||++||+ ++++.+.+.
T Consensus       285 ~~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 PEDD--------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             CTTC--------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             cccc--------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            0000        00112245677888999999999996 455555444

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.98  E-value=1.9e-31  Score=302.82  Aligned_cols=270  Identities=21%  Similarity=0.303  Sum_probs=166.0

Q ss_pred             CCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCC
Q 001275           57 TPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIP  136 (1109)
Q Consensus        57 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p  136 (1109)
                      +.|+|+.+.|+.            +++. .+|..+.  +.|++|+|++|++++..+..|+++++|++|+|++|++++..|
T Consensus        29 c~c~l~~l~~~~------------~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   93 (330)
T 1xku_A           29 CQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP   93 (330)
T ss_dssp             CEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT
T ss_pred             CcCCCeEEEecC------------CCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCH
Confidence            346677666653            2222 2444332  578888888888887777788888888888888888887778


Q ss_pred             ccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCC--Ccccccccc
Q 001275          137 DNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSG--TIPESIGNC  214 (1109)
Q Consensus       137 ~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~l~~l  214 (1109)
                      ..|+++++|++|+|++|.++ .+|..+.  ++|++|++++|++++..+..++++++|++|++++|.++.  ..+..++++
T Consensus        94 ~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l  170 (330)
T 1xku_A           94 GAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM  170 (330)
T ss_dssp             TTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGC
T ss_pred             HHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCC
Confidence            88888888888888888887 5666554  567777777777666555566666666666666666642  444455555


Q ss_pred             cCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEe
Q 001275          215 YRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDI  294 (1109)
Q Consensus       215 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  294 (1109)
                      ++|++|++++|+++.. |..+.                          ++|++|++++|++++..+..+..+++|+.|++
T Consensus       171 ~~L~~L~l~~n~l~~l-~~~~~--------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  223 (330)
T 1xku_A          171 KKLSYIRIADTNITTI-PQGLP--------------------------PSLTELHLDGNKITKVDAASLKGLNNLAKLGL  223 (330)
T ss_dssp             TTCCEEECCSSCCCSC-CSSCC--------------------------TTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred             CCcCEEECCCCccccC-Ccccc--------------------------ccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            5555555555555432 22111                          34555555555555444455555555555555


Q ss_pred             ecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccC------CCCccEEEccC
Q 001275          295 VGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQ------LSNLQDLELFD  368 (1109)
Q Consensus       295 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~------l~~L~~L~L~~  368 (1109)
                      ++|++++..+..+..+++|++|++++|+++ .+|..+..+++|++|++++|++++..+..|..      .+.++.|++++
T Consensus       224 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~  302 (330)
T 1xku_A          224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS  302 (330)
T ss_dssp             CSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCS
T ss_pred             CCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeec
Confidence            555555555555555566666666666655 45555555666666666666665444444432      24455555555


Q ss_pred             cccc
Q 001275          369 NRLT  372 (1109)
Q Consensus       369 N~l~  372 (1109)
                      |.+.
T Consensus       303 N~~~  306 (330)
T 1xku_A          303 NPVQ  306 (330)
T ss_dssp             SSSC
T ss_pred             Cccc
Confidence            5543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=8.2e-36  Score=355.67  Aligned_cols=352  Identities=22%  Similarity=0.180  Sum_probs=212.8

Q ss_pred             CCccEeecCCCcccccCCCC-CCCCCCCcEeeccCccccC----CCCccccccCccceeccccccccccCCccccc-cc-
Q 001275           95 SKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLSTNGFTG----DIPDNFENLQNLQYLNLYGNLLDGEIPEPLFR-IL-  167 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~Ls~n~l~~----~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~-l~-  167 (1109)
                      ++|++|+|++|+++...... +..+++|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+.. +. 
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~   82 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   82 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence            45666666666665433222 5556667777777776663    23455566677777777777665443333322 33 


Q ss_pred             ---ccceeccccccccc----ccccccCCCcccceeecccccCCCCccccccc-----ccCccEEEeccccccCcC----
Q 001275          168 ---GLQYVFLNNNSLSG----SIPRNVGDLKEVEALWLFSNRLSGTIPESIGN-----CYRLQELYLNENKLMGFL----  231 (1109)
Q Consensus       168 ---~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~~----  231 (1109)
                         +|++|++++|+++.    .++..+..+++|++|+|++|.+++..+..+..     .++|++|+|++|++++..    
T Consensus        83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  162 (461)
T 1z7x_W           83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  162 (461)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence               47777777777663    44666677777777777777766544443332     345777777777776533    


Q ss_pred             chhcccccccccccccCcccCCccccccc-----CCCCcchhccccccccCC----CCcccccccCCcEEEeecCCCCCc
Q 001275          232 PESLSNLENLVYLDVGDNNLEGRINFGSE-----KCKNLTFLDLSYNRFSGG----ISPNLGNCSSLTHLDIVGSKLTGS  302 (1109)
Q Consensus       232 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~  302 (1109)
                      +..+..+++|++|++++|.+++..+..+.     ..++|++|+|++|.+++.    ++..+..+++|++|++++|.+++.
T Consensus       163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~  242 (461)
T 1z7x_W          163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV  242 (461)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred             HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence            44555567777777777776644333332     244677777777776653    345555667777777777776643


Q ss_pred             C-----CccccccccccEEEcCCCCCCCC----CCCccccccccceeeccCcccCCCCCccccC-----CCCccEEEccC
Q 001275          303 I-----PSSFGLLARLSSLDLSENQLSGK----IPPELGKCKYLTVLHLYANQLEGEIPDELGQ-----LSNLQDLELFD  368 (1109)
Q Consensus       303 ~-----~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~-----l~~L~~L~L~~  368 (1109)
                      .     +..+..+++|++|++++|++++.    ++..+..+++|++|++++|.+.+..+..+..     .++|++|++++
T Consensus       243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~  322 (461)
T 1z7x_W          243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS  322 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCC
Confidence            2     22223456777777777776643    4555566677777777777665443333332     25677777777


Q ss_pred             cccccc----CchHHHhhcccceeeccCCccCCCCchhhhc-----cCCCCeEEccCCcCcc----cCCccccCCCCCce
Q 001275          369 NRLTGE----FPVSIWRIASLEYLLVYNNNLLGKLPLEMTE-----LKQLKNISLYNNQFSG----VIPQSLGINSSLMQ  435 (1109)
Q Consensus       369 N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~----~~p~~~~~~~~L~~  435 (1109)
                      |.+++.    ++..+..+++|++|++++|.+++..+..+..     .++|+.|++++|++++    .+|..+..+++|++
T Consensus       323 n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~  402 (461)
T 1z7x_W          323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE  402 (461)
T ss_dssp             SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred             CCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccE
Confidence            777654    3445555677777777777766554444432     4567777777777765    55666666677777


Q ss_pred             EEecCCccccc
Q 001275          436 LDFINNSFTGE  446 (1109)
Q Consensus       436 L~ls~N~l~~~  446 (1109)
                      ||+++|.+++.
T Consensus       403 L~l~~N~i~~~  413 (461)
T 1z7x_W          403 LDLSNNCLGDA  413 (461)
T ss_dssp             EECCSSSCCHH
T ss_pred             EECCCCCCCHH
Confidence            77777776643

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.97  E-value=7.4e-31  Score=298.00  Aligned_cols=289  Identities=21%  Similarity=0.228  Sum_probs=162.8

Q ss_pred             CcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeecc
Q 001275          264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLY  343 (1109)
Q Consensus       264 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~  343 (1109)
                      +++.++++++.++ .+|..+.  ++++.|++++|++++..+..|+.+++|++|++++|++++..|..|+++++|++|+++
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            3445555555554 2333332  456666666666665555566666666666666666665556666666666666666


Q ss_pred             CcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCC--CCchhhhccCCCCeEEccCCcCcc
Q 001275          344 ANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLG--KLPLEMTELKQLKNISLYNNQFSG  421 (1109)
Q Consensus       344 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~  421 (1109)
                      +|+++ .+|..+.  ++|++|++++|++++..+..+..+++|++|++++|.+..  ..+..+..+++|+.|++++|+++.
T Consensus       109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  185 (330)
T 1xku_A          109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  185 (330)
T ss_dssp             SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence            66666 3444433  566677777776666555566666666666666666642  455666667777777777777663


Q ss_pred             cCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCC
Q 001275          422 VIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKN  501 (1109)
Q Consensus       422 ~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~  501 (1109)
                       +|..+.  ++|++|++++|.+++..|..+..+++|+.|++++|++++..+..+..+++|++|++++|+++         
T Consensus       186 -l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~---------  253 (330)
T 1xku_A          186 -IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV---------  253 (330)
T ss_dssp             -CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS---------
T ss_pred             -CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc---------
Confidence             444332  56666666666666555556666666666666666666554444444444444444444444         


Q ss_pred             CCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhc------ccccceeecccccccc--cCCccccCC
Q 001275          502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGN------LVSLVTLNISLNHVEG--SLPSQLSKC  573 (1109)
Q Consensus       502 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~--~~p~~l~~l  573 (1109)
                                     .+|..+..+++|++|++++|++++..+..|..      ..+|+.|++++|.+..  ..|..+..+
T Consensus       254 ---------------~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~  318 (330)
T 1xku_A          254 ---------------KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV  318 (330)
T ss_dssp             ---------------SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred             ---------------cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccc
Confidence                           34444444444444444444444433333322      2445555555555542  344556666


Q ss_pred             CCccEEEecCcc
Q 001275          574 KNLEVFDVSFNL  585 (1109)
Q Consensus       574 ~~L~~L~ls~N~  585 (1109)
                      .+++.++|++|+
T Consensus       319 ~~l~~l~L~~N~  330 (330)
T 1xku_A          319 YVRAAVQLGNYK  330 (330)
T ss_dssp             CCGGGEEC----
T ss_pred             cceeEEEecccC
Confidence            666666666653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=6.4e-32  Score=299.42  Aligned_cols=230  Identities=12%  Similarity=0.089  Sum_probs=178.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||.||+|... +++.||||++.....  ......+.+|++++.+++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888999999999999999775 489999999854332  223367899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++++|.++++..     ....++.+++.|+++||+|||   +.+|+||||||+||+++.++.+||+++|        
T Consensus       111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            999999999999542     355678899999999999999   8899999999999999999999998543        


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                                    |++       .++.++|||||||++|||++|+.||........ +..       ..........  
T Consensus       175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-~~~-------~~~~~~~~~~--  223 (286)
T 3uqc_A          175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-LAP-------AERDTAGQPI--  223 (286)
T ss_dssp             --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-SEE-------CCBCTTSCBC--
T ss_pred             --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-hHH-------HHHHhccCCC--
Confidence                          333       367899999999999999999999975432110 000       0000000000  


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       ......   .....++.+++.+||+.||++| |+.|+++.|+++
T Consensus       224 -~~~~~~---~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          224 -EPADID---RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             -CHHHHC---TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             -Chhhcc---cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence             000000   1122346678889999999999 999999999885

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=5.3e-32  Score=302.83  Aligned_cols=233  Identities=21%  Similarity=0.305  Sum_probs=177.2

Q ss_pred             hCCCCC-ceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHH-hcCCCCceeeEeeEEec----CCce
Q 001275          819 ENLNAK-HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTI-GKIRHRNLVRLEDFWLR----KDCG  891 (1109)
Q Consensus       819 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  891 (1109)
                      ++|.+. ++||+|+||.||+|.. .+++.||+|++..      ...+.+|++++ +..+||||+++++++..    ....
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            456666 7799999999999976 5689999999842      34677888888 55699999999999876    6678


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCcEEEecccC
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EMEPHISDFGI  968 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGl  968 (1109)
                      ++||||+++|+|.+++.... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            99999999999999998743 235899999999999999999999   899999999999999998   78899999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      +....                        +..++.++||||+||++|||++|+.||........     ..   ......
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~---~~~~~~  214 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SP---GMKTRI  214 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------C---CSCCSS
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hH---HHHHHH
Confidence            87542                        13457789999999999999999999964322110     00   000000


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ... ...... .   .......++.+++.+||+.||++||+++|+++|-+
T Consensus       215 ~~~-~~~~~~-~---~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~  259 (299)
T 3m2w_A          215 RMG-QYEFPN-P---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  259 (299)
T ss_dssp             CTT-CCSSCH-H---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             hhc-cccCCc-h---hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence            000 000000 0   00112345677888999999999999999998754

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=4.2e-35  Score=349.54  Aligned_cols=351  Identities=20%  Similarity=0.165  Sum_probs=210.5

Q ss_pred             CCCCcEeeccCccccCCCCcc-ccccCccceeccccccccc----cCCcccccccccceecccccccccccccccC-CCc
Q 001275          118 CSALEYLDLSTNGFTGDIPDN-FENLQNLQYLNLYGNLLDG----EIPEPLFRILGLQYVFLNNNSLSGSIPRNVG-DLK  191 (1109)
Q Consensus       118 l~~L~~L~Ls~n~l~~~~p~~-l~~L~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~  191 (1109)
                      +++|++|||++|+++...... +..+++|++|+|++|.++.    .++..+..+++|++|++++|.++...+..+. .++
T Consensus         2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~   81 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ   81 (461)
T ss_dssp             CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence            357889999999887543333 7788899999999998874    3456667778888888888888765554432 344


Q ss_pred             ----ccceeecccccCCC----CcccccccccCccEEEeccccccCcCchhccc-----ccccccccccCcccCCcc---
Q 001275          192 ----EVEALWLFSNRLSG----TIPESIGNCYRLQELYLNENKLMGFLPESLSN-----LENLVYLDVGDNNLEGRI---  255 (1109)
Q Consensus       192 ----~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~~---  255 (1109)
                          +|++|+|++|+++.    .++..+..+++|++|+|++|.+++..+..+..     .++|++|++++|++++..   
T Consensus        82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  161 (461)
T 1z7x_W           82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  161 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence                58888888888774    45777777888888888888877554444432     456777777777776532   


Q ss_pred             -cccccCCCCcchhccccccccCCCCccccc-----ccCCcEEEeecCCCCCc----CCccccccccccEEEcCCCCCCC
Q 001275          256 -NFGSEKCKNLTFLDLSYNRFSGGISPNLGN-----CSSLTHLDIVGSKLTGS----IPSSFGLLARLSSLDLSENQLSG  325 (1109)
Q Consensus       256 -~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~  325 (1109)
                       +..+..+++|++|++++|.+++..+..+..     .++|++|++++|.+++.    ++..+..+++|++|++++|++++
T Consensus       162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~  241 (461)
T 1z7x_W          162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD  241 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence             344455666777777776665433333321     34666666666666643    34455556666666666666553


Q ss_pred             CC-----CCccccccccceeeccCcccCCC----CCccccCCCCccEEEccCccccccCchHHHhh-----cccceeecc
Q 001275          326 KI-----PPELGKCKYLTVLHLYANQLEGE----IPDELGQLSNLQDLELFDNRLTGEFPVSIWRI-----ASLEYLLVY  391 (1109)
Q Consensus       326 ~~-----p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~l~  391 (1109)
                      ..     +..+..+++|++|++++|++++.    ++..+..+++|++|++++|++++..+..+...     ++|++|+++
T Consensus       242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~  321 (461)
T 1z7x_W          242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK  321 (461)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence            21     11122355666666666666542    34445555666666666666654444444432     456666666


Q ss_pred             CCccCCC----CchhhhccCCCCeEEccCCcCcccCCccccC-----CCCCceEEecCCcccc----cCCCCcccCccce
Q 001275          392 NNNLLGK----LPLEMTELKQLKNISLYNNQFSGVIPQSLGI-----NSSLMQLDFINNSFTG----EIPPNLCFGKQLR  458 (1109)
Q Consensus       392 ~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----~~~L~~L~ls~N~l~~----~~p~~~~~~~~L~  458 (1109)
                      +|.+++.    ++..+..+++|+.|++++|++++..+..++.     .++|++|++++|.+++    .+|..+...++|+
T Consensus       322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~  401 (461)
T 1z7x_W          322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR  401 (461)
T ss_dssp             TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred             CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence            6665543    2344445556666666666555443333321     3455555555555554    4444444455555


Q ss_pred             EEECCCcccc
Q 001275          459 VLNMGQNQFH  468 (1109)
Q Consensus       459 ~L~L~~N~l~  468 (1109)
                      +|++++|+++
T Consensus       402 ~L~l~~N~i~  411 (461)
T 1z7x_W          402 ELDLSNNCLG  411 (461)
T ss_dssp             EEECCSSSCC
T ss_pred             EEECCCCCCC
Confidence            5555555554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=9.8e-33  Score=322.77  Aligned_cols=243  Identities=18%  Similarity=0.185  Sum_probs=176.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCC-Cce---------------e
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRH-RNL---------------V  879 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h-~ni---------------v  879 (1109)
                      ++|...++||+|+||+||+|.+ .+|+.||||++.....  ....+.+.+|+.+++.++| +|.               +
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3466778999999999999975 5789999998853322  2336789999999999987 221               1


Q ss_pred             eE------eeEEec-----CCceeEEEEeccCCCHHHHHhcc----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 001275          880 RL------EDFWLR-----KDCGIIMYRYMENGSLRDVLHSI----TPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV  944 (1109)
Q Consensus       880 ~l------~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  944 (1109)
                      .+      ..++..     ....+++|+++ +|+|.++++..    .....+++..++.++.|+++||+|||   +.+|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence            11      111111     12345566654 67999988521    12334788899999999999999999   89999


Q ss_pred             EeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCccccccccc----------ccCCCCccCcchhhHHHH
Q 001275          945 HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA----------FTTAKSKESDVYSYGVVL 1014 (1109)
Q Consensus       945 H~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvil 1014 (1109)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999865432     233567 999999998          555678999999999999


Q ss_pred             HHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001275         1015 LELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVV 1094 (1109)
Q Consensus      1015 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl 1094 (1109)
                      |||++|+.||........               ...++...          .....++.+++.+||+.||++||++.|++
T Consensus       308 ~elltg~~Pf~~~~~~~~---------------~~~~~~~~----------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG---------------SEWIFRSC----------KNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC---------------SGGGGSSC----------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhhh---------------HHHHHhhc----------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999965322110               00010000          01123466788899999999999988876


Q ss_pred             HH
Q 001275         1095 RQ 1096 (1109)
Q Consensus      1095 ~~ 1096 (1109)
                      ++
T Consensus       363 ~~  364 (413)
T 3dzo_A          363 ET  364 (413)
T ss_dssp             TS
T ss_pred             hC
Confidence            54

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=1.2e-32  Score=313.50  Aligned_cols=246  Identities=14%  Similarity=0.120  Sum_probs=181.7

Q ss_pred             hhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-------ccChHHHHHHHHHHhcCC---------CCceeeE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-------KRGSLSMKREIQTIGKIR---------HRNLVRL  881 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~l  881 (1109)
                      .++|.+.+.||+|+||+||+|+. +++.||||++.....       ......+.+|++++++++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35788899999999999999988 589999999965532       233467889999998886         6666666


Q ss_pred             eeEE-----------------ec-------------CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHH
Q 001275          882 EDFW-----------------LR-------------KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHA  931 (1109)
Q Consensus       882 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~  931 (1109)
                      .+++                 ..             .+..++||||+++|++.+.+..    ..+++..+..++.|++.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            6654                 22             6788999999999977666643    247999999999999999


Q ss_pred             HHHhhcCCCCCeEEeccCCCCeeeCCCC--------------------cEEEecccCCcccCCCCCCceeeecccCcccc
Q 001275          932 LAYLHYDCDPPIVHRDIKPENILLDSEM--------------------EPHISDFGIAKLLDKSPASTTSISVVGTIGYI  991 (1109)
Q Consensus       932 L~~LH~~~~~~ivH~Dlk~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  991 (1109)
                      |+|||.  +.+|+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+
T Consensus       174 L~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTT
T ss_pred             HHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeeccc
Confidence            999992  36899999999999999887                    8999999999876432       247999999


Q ss_pred             cccccccCCCCccCcchhhHHH-HHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHH
Q 001275          992 APENAFTTAKSKESDVYSYGVV-LLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVI 1070 (1109)
Q Consensus       992 aPE~~~~~~~~~~sDvwSlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 1070 (1109)
                      |||++.+.. +.++||||+|++ .+++++|..||...    .............. .......        .........
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~~s~  310 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----LWLHYLTDKMLKQM-TFKTKCN--------TPAMKQIKR  310 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----HHHHHHHHHHHHTC-CCSSCCC--------SHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----hhhhHHHHhhhhhh-ccCcccc--------hhhhhhcCH
Confidence            999988766 899999998777 77888998887311    00000011111000 0000000        001223445


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHH-HH
Q 001275         1071 DVLLVALRCTEKKPSNRPNMRDVV-RQ 1096 (1109)
Q Consensus      1071 ~l~~l~~~cl~~dP~~RPs~~evl-~~ 1096 (1109)
                      ++.+++.+|++.|     |++|++ +|
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHHhccC-----CHHHHHhcC
Confidence            6778888999976     999999 76

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=3.6e-30  Score=295.25  Aligned_cols=285  Identities=20%  Similarity=0.246  Sum_probs=191.9

Q ss_pred             CCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC
Q 001275           56 STPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI  135 (1109)
Q Consensus        56 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (1109)
                      .++|.|.|+ |+..          +++++ .+|..+.  ++|++|++++|++++..+..++++++|++|+|++|++++..
T Consensus        27 ~~~C~~~~~-c~~~----------~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~   92 (353)
T 2z80_A           27 SLSCDRNGI-CKGS----------SGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE   92 (353)
T ss_dssp             CCEECTTSE-EECC----------STTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred             CCCCCCCeE-eeCC----------CCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence            457999888 7643          33333 3555443  47888888888888766668888888888888888888777


Q ss_pred             CccccccCccceeccccccccccCCcccccccccceecccccccccccc-cccCCCcccceeecccc-cCCCCccccccc
Q 001275          136 PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIP-RNVGDLKEVEALWLFSN-RLSGTIPESIGN  213 (1109)
Q Consensus       136 p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~  213 (1109)
                      |..|+++++|++|+|++|++++..+..+.++++|++|++++|++++..+ ..++.+++|++|++++| .+++..+..|++
T Consensus        93 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~  172 (353)
T 2z80_A           93 EDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAG  172 (353)
T ss_dssp             TTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTT
T ss_pred             HhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccC
Confidence            7788888888888888888874333346777777777777777774333 36677777777777777 355555566777


Q ss_pred             ccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEE
Q 001275          214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLD  293 (1109)
Q Consensus       214 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  293 (1109)
                      +++|++|++++|++++..|..|.++++|++|++++|+++......+..+++|++|++++|.+++..+..+..        
T Consensus       173 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~--------  244 (353)
T 2z80_A          173 LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST--------  244 (353)
T ss_dssp             CCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------------
T ss_pred             CCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc--------
Confidence            777777777777777666777777777777777777665444433444556666666666655433322211        


Q ss_pred             eecCCCCCcCCccccccccccEEEcCCCCCCC----CCCCccccccccceeeccCcccCCCCCcc-ccCCCCccEEEccC
Q 001275          294 IVGSKLTGSIPSSFGLLARLSSLDLSENQLSG----KIPPELGKCKYLTVLHLYANQLEGEIPDE-LGQLSNLQDLELFD  368 (1109)
Q Consensus       294 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~L~~  368 (1109)
                                   ......++.++++++.+++    .+|+.+..+++|+.|++++|+++ .+|.. |..+++|++|++++
T Consensus       245 -------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~  310 (353)
T 2z80_A          245 -------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHT  310 (353)
T ss_dssp             ---------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred             -------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeC
Confidence                         1123445566666666554    35566777778888888888887 44544 57788888888888


Q ss_pred             ccccccCc
Q 001275          369 NRLTGEFP  376 (1109)
Q Consensus       369 N~l~~~~~  376 (1109)
                      |++++..|
T Consensus       311 N~~~~~~~  318 (353)
T 2z80_A          311 NPWDCSCP  318 (353)
T ss_dssp             SCBCCCHH
T ss_pred             CCccCcCC
Confidence            88886544

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=3e-30  Score=289.70  Aligned_cols=254  Identities=20%  Similarity=0.235  Sum_probs=154.3

Q ss_pred             CCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccC--
Q 001275           56 STPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTG--  133 (1109)
Q Consensus        56 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~--  133 (1109)
                      .+.|.|.+|.|+...            + ..+|..+  .++|++|+|++|+++...+..|+++++|++|+|++|+++.  
T Consensus         4 ~C~C~~~~l~c~~~~------------l-~~ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~   68 (306)
T 2z66_A            4 RCSCSGTEIRCNSKG------------L-TSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG   68 (306)
T ss_dssp             TCEEETTEEECCSSC------------C-SSCCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred             CCeeCCCEEEcCCCC------------c-ccCCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence            456899999997532            1 1234333  2578888888888875444457888888888888888773  


Q ss_pred             CCCccccccCccceeccccccccccCCcccccccccceecccccccccccc-cccCCCcccceeecccccCCCCcccccc
Q 001275          134 DIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIP-RNVGDLKEVEALWLFSNRLSGTIPESIG  212 (1109)
Q Consensus       134 ~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~  212 (1109)
                      ..|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..|..|+
T Consensus        69 ~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  147 (306)
T 2z66_A           69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN  147 (306)
T ss_dssp             EEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTT
T ss_pred             CcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcc
Confidence            23566667778888888888776 456666667777777777777665443 4556666666666666666655555566


Q ss_pred             cccCccEEEeccccccC-cCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcE
Q 001275          213 NCYRLQELYLNENKLMG-FLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTH  291 (1109)
Q Consensus       213 ~l~~L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  291 (1109)
                      ++++|++|++++|.+++ ..|..+..+++|++|++++|++++..+.                        .+..+++|++
T Consensus       148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~------------------------~~~~l~~L~~  203 (306)
T 2z66_A          148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT------------------------AFNSLSSLQV  203 (306)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT------------------------TTTTCTTCCE
T ss_pred             cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHH------------------------HhcCCCCCCE
Confidence            66666666666666554 3455555555555555555555544444                        4444445555


Q ss_pred             EEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcccccc-ccceeeccCcccCC
Q 001275          292 LDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCK-YLTVLHLYANQLEG  349 (1109)
Q Consensus       292 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~  349 (1109)
                      |++++|++++..+..+..+++|+.|++++|++++..|..+..++ +|++|+|++|.+++
T Consensus       204 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             EECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             EECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            55555555444444455555555555555555555555555542 55555555555543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=3.6e-31  Score=326.14  Aligned_cols=430  Identities=15%  Similarity=0.098  Sum_probs=226.1

Q ss_pred             cCCCCCCCCCCCcEeeccCccc---cCCCCcccc------------ccCccceeccccccccccCCcccccc--ccccee
Q 001275          110 NIPPKLGNCSALEYLDLSTNGF---TGDIPDNFE------------NLQNLQYLNLYGNLLDGEIPEPLFRI--LGLQYV  172 (1109)
Q Consensus       110 ~~p~~l~~l~~L~~L~Ls~n~l---~~~~p~~l~------------~L~~L~~L~L~~n~l~~~~p~~l~~l--~~L~~L  172 (1109)
                      .++..+..+++|++|+|+++..   .+.+|..++            .+++|++|+|++|.+++..+..+...  .+|++|
T Consensus        64 ~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L  143 (592)
T 3ogk_B           64 TPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL  143 (592)
T ss_dssp             CHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEE
T ss_pred             ChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEE
Confidence            3344556788899999987542   134454443            55666666666666655444444443  236666


Q ss_pred             cccccc-ccc-ccccccCCCcccceeecccccCCCC----cccccccccCccEEEeccccccCcCchhcccccccccccc
Q 001275          173 FLNNNS-LSG-SIPRNVGDLKEVEALWLFSNRLSGT----IPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDV  246 (1109)
Q Consensus       173 ~Ls~n~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L  246 (1109)
                      +|++|. ++. .++.....+++|++|+|++|.+++.    ++..+.++++|++|++++|.+++...              
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~--------------  209 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISP--------------  209 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCH--------------
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCH--------------
Confidence            665554 111 1111222344555555555544433    22223344444444444444432111              


Q ss_pred             cCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCC---CcCCccccccccccEEEcCCCCC
Q 001275          247 GDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT---GSIPSSFGLLARLSSLDLSENQL  323 (1109)
Q Consensus       247 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~---~~~~~~~~~l~~L~~L~Ls~N~l  323 (1109)
                            +..+..+..+++|++|++++|.+.+ ++..+..+++|++|+++++...   +..+..+..+++|+.|+++++..
T Consensus       210 ------~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~  282 (592)
T 3ogk_B          210 ------KDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP  282 (592)
T ss_dssp             ------HHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT
T ss_pred             ------HHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch
Confidence                  1122223344555555555555553 3445555566666666543222   22334455666677777766533


Q ss_pred             CCCCCCccccccccceeeccCcccCCCCC-ccccCCCCccEEEccCccccc-cCchHHHhhcccceeeccC---------
Q 001275          324 SGKIPPELGKCKYLTVLHLYANQLEGEIP-DELGQLSNLQDLELFDNRLTG-EFPVSIWRIASLEYLLVYN---------  392 (1109)
Q Consensus       324 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~---------  392 (1109)
                      . .+|..+..+++|++|+|++|.+++... ..+..+++|++|+++ +.+.+ .++.....+++|++|++++         
T Consensus       283 ~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~  360 (592)
T 3ogk_B          283 N-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMED  360 (592)
T ss_dssp             T-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSS
T ss_pred             h-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCcccccccc
Confidence            2 456666667777777777776654332 234567777777777 33332 2333335566777777773         


Q ss_pred             --CccCCCCc-hhhhccCCCCeEEccCCcCcccCCccccC-CCCCceEEec----CCccccc-----CCCCcccCccceE
Q 001275          393 --NNLLGKLP-LEMTELKQLKNISLYNNQFSGVIPQSLGI-NSSLMQLDFI----NNSFTGE-----IPPNLCFGKQLRV  459 (1109)
Q Consensus       393 --N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~~L~~L~ls----~N~l~~~-----~p~~~~~~~~L~~  459 (1109)
                        |.+++... .....+++|+.|+++.|++++..+..++. +++|++|+++    .|.+++.     ++..+..+++|+.
T Consensus       361 ~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~  440 (592)
T 3ogk_B          361 EEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRR  440 (592)
T ss_dssp             TTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCE
T ss_pred             ccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCE
Confidence              44443322 22344667777777777776655555553 5666677665    4555532     1112333455555


Q ss_pred             EECCCcc--cccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCC-CCCCcccccccccEEeccCC
Q 001275          460 LNMGQNQ--FHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISG-AIPSSIGNSINLTSIDFSSN  536 (1109)
Q Consensus       460 L~L~~N~--l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~Ls~N  536 (1109)
                      |++++|.  +++..+..+                      ...+++|++|++++|++++ .++..+..+++|++|++++|
T Consensus       441 L~L~~~~~~l~~~~~~~~----------------------~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n  498 (592)
T 3ogk_B          441 FAFYLRQGGLTDLGLSYI----------------------GQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGC  498 (592)
T ss_dssp             EEEECCGGGCCHHHHHHH----------------------HHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESC
T ss_pred             EEEecCCCCccHHHHHHH----------------------HHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCC
Confidence            5554321  322111111                      1124567777777777764 23444566677777777777


Q ss_pred             cccCC-cchhhhcccccceeecccccccccCCcccc-CCCCccEEEecCc
Q 001275          537 KFSGL-MPQELGNLVSLVTLNISLNHVEGSLPSQLS-KCKNLEVFDVSFN  584 (1109)
Q Consensus       537 ~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~ls~N  584 (1109)
                      ++++. ++..+..+++|++|+|++|++++.-...+. .++.+.+..+..+
T Consensus       499 ~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~  548 (592)
T 3ogk_B          499 CFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR  548 (592)
T ss_dssp             CCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred             CCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence            76644 333445677777777777777754333333 3565655555443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=1.8e-31  Score=328.81  Aligned_cols=450  Identities=15%  Similarity=0.133  Sum_probs=261.0

Q ss_pred             CceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcc---cccCCCCCC------------CCCCCc
Q 001275           58 PCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNF---SGNIPPKLG------------NCSALE  122 (1109)
Q Consensus        58 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l---~~~~p~~l~------------~l~~L~  122 (1109)
                      |++|.++.+..  .+  .+.+..+ .....+..+..+++|++|+|+++..   .+.+|..++            .+++|+
T Consensus        41 ck~W~~~~~~~--~~--~l~~~~~-~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~  115 (592)
T 3ogk_B           41 CRRWFKIDSET--RE--HVTMALC-YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK  115 (592)
T ss_dssp             CHHHHHHHHHH--CC--EEEESCG-GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred             hHHHHHhhhcc--cc--EEEEeec-cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence            45799985432  11  2222221 2222334466789999999988542   245665555            789999


Q ss_pred             EeeccCccccCCCCcccccc--Cccceecccccc-ccc-cCCcccccccccceecccccccccc----cccccCCCcccc
Q 001275          123 YLDLSTNGFTGDIPDNFENL--QNLQYLNLYGNL-LDG-EIPEPLFRILGLQYVFLNNNSLSGS----IPRNVGDLKEVE  194 (1109)
Q Consensus       123 ~L~Ls~n~l~~~~p~~l~~L--~~L~~L~L~~n~-l~~-~~p~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~  194 (1109)
                      +|+|++|.+++..+..+...  ++|++|+|++|. ++. .++.....+++|++|+|++|.+++.    ++..+..+++|+
T Consensus       116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~  195 (592)
T 3ogk_B          116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE  195 (592)
T ss_dssp             EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred             eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence            99999999987777777764  459999999986 321 1233334788999999999998876    445567789999


Q ss_pred             eeecccccCCC----CcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhcc
Q 001275          195 ALWLFSNRLSG----TIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDL  270 (1109)
Q Consensus       195 ~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  270 (1109)
                      +|++++|.+++    .++..+.++++|++|++++|.+.+ ++..+.++++|+.|+++.+......               
T Consensus       196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~---------------  259 (592)
T 3ogk_B          196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGM---------------  259 (592)
T ss_dssp             EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTC---------------
T ss_pred             EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccch---------------
Confidence            99999999983    344556788999999999999886 6788888999999998764322100               


Q ss_pred             ccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCC-CccccccccceeeccCcccCC
Q 001275          271 SYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIP-PELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       271 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                            +..+..+..+++|+.|+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++ +.+.+
T Consensus       260 ------~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~  331 (592)
T 3ogk_B          260 ------PEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGD  331 (592)
T ss_dssp             ------TTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHH
T ss_pred             ------HHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCH
Confidence                  01122333344444554444322 2344444555555555555555432221 223455555555555 32222


Q ss_pred             -CCCccccCCCCccEEEcc-----------CccccccCchH-HHhhcccceeeccCCccCCCCchhhhc-cCCCCeEEcc
Q 001275          350 -EIPDELGQLSNLQDLELF-----------DNRLTGEFPVS-IWRIASLEYLLVYNNNLLGKLPLEMTE-LKQLKNISLY  415 (1109)
Q Consensus       350 -~~p~~l~~l~~L~~L~L~-----------~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~L~  415 (1109)
                       .++..+..+++|++|+++           .|.+++..... ...+++|++|+++.|++++..+..+.. +++|+.|+++
T Consensus       332 ~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~  411 (592)
T 3ogk_B          332 RGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV  411 (592)
T ss_dssp             HHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred             HHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence             122222345566666666           24444332222 334566666666666666555555544 6666666664


Q ss_pred             ----CCcCccc-----CCccccCCCCCceEEecCC--cccccCCCCccc-CccceEEECCCccccc-CCCcccCCCCccc
Q 001275          416 ----NNQFSGV-----IPQSLGINSSLMQLDFINN--SFTGEIPPNLCF-GKQLRVLNMGQNQFHG-PIPSLLGSCPTLW  482 (1109)
Q Consensus       416 ----~N~l~~~-----~p~~~~~~~~L~~L~ls~N--~l~~~~p~~~~~-~~~L~~L~L~~N~l~~-~~p~~~~~l~~L~  482 (1109)
                          .|++++.     ++..+..+++|++|++++|  .+++..+..+.. +++|++|++++|++++ .++..+.      
T Consensus       412 ~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~------  485 (592)
T 3ogk_B          412 LLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSR------  485 (592)
T ss_dssp             ECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHT------
T ss_pred             ecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHh------
Confidence                5555542     2222445666777777643  255444443332 5667777777777653 1222222      


Q ss_pred             hhhccCcccCCCCCCCCCCCCCceEEeecCccCCC-CCCcccccccccEEeccCCcccCCcchhhh-cccccceeeccc
Q 001275          483 RVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGA-IPSSIGNSINLTSIDFSSNKFSGLMPQELG-NLVSLVTLNISL  559 (1109)
Q Consensus       483 ~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~  559 (1109)
                                       .+++|++|++++|.+++. ++..+..+++|++|+|++|++++.....+. .++.+....+..
T Consensus       486 -----------------~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~  547 (592)
T 3ogk_B          486 -----------------GCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPS  547 (592)
T ss_dssp             -----------------CCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred             -----------------cCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence                             334555555555555433 223334455666666666665543222222 344444444443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=9.1e-29  Score=277.60  Aligned_cols=280  Identities=22%  Similarity=0.240  Sum_probs=193.2

Q ss_pred             cEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccc--cCCcccccccccceeccc
Q 001275           98 QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDG--EIPEPLFRILGLQYVFLN  175 (1109)
Q Consensus        98 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls  175 (1109)
                      +.++.+++.++ .+|..+.  ++|++|+|++|+++...+..|+++++|++|+|++|.++.  ..|..+..+++|++|+++
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            46777877777 5565443  678888888888885444457788888888888887762  224445555566666666


Q ss_pred             ccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCc-hhcccccccccccccCcccCCc
Q 001275          176 NNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLP-ESLSNLENLVYLDVGDNNLEGR  254 (1109)
Q Consensus       176 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~  254 (1109)
                      +|.++ .+|..+..+++|++|+++                        +|++++..+ ..+.++++|++|++++|++++.
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~------------------------~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~  141 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQ------------------------HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA  141 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECT------------------------TSEEESSTTTTTTTTCTTCCEEECTTSCCEEC
T ss_pred             CCccc-cChhhcCCCCCCCEEECC------------------------CCcccccccchhhhhccCCCEEECCCCcCCcc
Confidence            66555 234444444444444444                        444444333 3455555555555555555555


Q ss_pred             ccccccCCCCcchhccccccccC-CCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcccc
Q 001275          255 INFGSEKCKNLTFLDLSYNRFSG-GISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGK  333 (1109)
Q Consensus       255 ~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~  333 (1109)
                      .+..+..+++|++|+|++|.+++ ..|..+..+++|++|++++|++++..|..|..+++|++|++++|++++..+..+..
T Consensus       142 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  221 (306)
T 2z66_A          142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC  221 (306)
T ss_dssp             STTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred             chhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence            55555556666666666666664 46777888889999999999999888899999999999999999999777778899


Q ss_pred             ccccceeeccCcccCCCCCccccCCC-CccEEEccCccccccCc--hHHHhhcccceeeccCCccCCCCchhhhc
Q 001275          334 CKYLTVLHLYANQLEGEIPDELGQLS-NLQDLELFDNRLTGEFP--VSIWRIASLEYLLVYNNNLLGKLPLEMTE  405 (1109)
Q Consensus       334 l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  405 (1109)
                      +++|++|++++|++++..|..+..++ +|++|+|++|++++..+  .....+...+.+.+..+.+....|..+.+
T Consensus       222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g  296 (306)
T 2z66_A          222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG  296 (306)
T ss_dssp             CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred             cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence            99999999999999998998898885 89999999999986432  12233444555555556666555555543

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=4.1e-29  Score=286.37  Aligned_cols=277  Identities=21%  Similarity=0.177  Sum_probs=136.8

Q ss_pred             CCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCccccee
Q 001275          117 NCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEAL  196 (1109)
Q Consensus       117 ~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L  196 (1109)
                      .++.....+++++.++ .+|..+.  ++|++|+|++|.+++..+..+.++++|++|++++|++++..|..|+++++|++|
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  105 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL  105 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence            3455555666666666 4555443  356666666666654333355555555555555555554444445555555555


Q ss_pred             ecccccCCCCcccccccccCccEEEeccccccCcCc-hhcccccccccccccCcccCCcccccccCCCCcchhccccc-c
Q 001275          197 WLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLP-ESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN-R  274 (1109)
Q Consensus       197 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~  274 (1109)
                      +|++|++++..+..|+++++|++|+|++|++++..+ ..|.+                        +++|++|++++| .
T Consensus       106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~------------------------l~~L~~L~l~~n~~  161 (353)
T 2z80_A          106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSH------------------------LTKLQILRVGNMDT  161 (353)
T ss_dssp             ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTT------------------------CTTCCEEEEEESSS
T ss_pred             ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhcc------------------------CCCCcEEECCCCcc
Confidence            555555553333334444555555555554443322 23444                        444444444444 2


Q ss_pred             ccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCcc
Q 001275          275 FSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE  354 (1109)
Q Consensus       275 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~  354 (1109)
                      +++..+..|.++++|++|++++|++++..|..++.+++|++|++++|+++...+..+..+++|+.|++++|.+++..+..
T Consensus       162 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~  241 (353)
T 2z80_A          162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE  241 (353)
T ss_dssp             CCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-
T ss_pred             ccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccc
Confidence            33333344455555555555555555444555555555555555555554222122233455555555555555433332


Q ss_pred             cc---CCCCccEEEccCccccc----cCchHHHhhcccceeeccCCccCCCCchh-hhccCCCCeEEccCCcCcc
Q 001275          355 LG---QLSNLQDLELFDNRLTG----EFPVSIWRIASLEYLLVYNNNLLGKLPLE-MTELKQLKNISLYNNQFSG  421 (1109)
Q Consensus       355 l~---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~  421 (1109)
                      +.   ..+.++.++++++.+++    .+|..+..+++|++|++++|+++. +|.. +..+++|+.|++++|++++
T Consensus       242 l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~~N~~~~  315 (353)
T 2z80_A          242 LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWDC  315 (353)
T ss_dssp             -----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCCCCCEEEeeCCCccC
Confidence            22   24456666666666654    234445555555555555555552 3322 3455555555555555543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=1.4e-29  Score=284.63  Aligned_cols=249  Identities=23%  Similarity=0.276  Sum_probs=157.3

Q ss_pred             CCCCCCCcEeeccCccccCCCCccccccCccceeccccccc-cccCCcccc-------cccccceecccccccccccccc
Q 001275          115 LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLL-DGEIPEPLF-------RILGLQYVFLNNNSLSGSIPRN  186 (1109)
Q Consensus       115 l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l-~~~~p~~l~-------~l~~L~~L~Ls~n~l~~~~p~~  186 (1109)
                      ++..++|++|++++|.+  .+|..+...  |++|+|++|.+ .+.+|..+.       ++++|++|+|++|++++.+|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            45566777777777777  566665544  77777777777 345665554       5677777777777777777776


Q ss_pred             c--CCCcccceeecccccCCCCcccccccc-----cCccEEEeccccccCcCchhcccccccccccccCcccCCcc--cc
Q 001275          187 V--GDLKEVEALWLFSNRLSGTIPESIGNC-----YRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRI--NF  257 (1109)
Q Consensus       187 l--~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--~~  257 (1109)
                      +  +.+++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|+.|+++++|++|++++|++.+..  +.
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  193 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS  193 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence            5  7777777777777777766 6777766     77777777777777777777777777777777777766532  22


Q ss_pred             c--ccCCCCcchhccccccccCC--CC-cccccccCCcEEEeecCCCCCcCC-ccccccccccEEEcCCCCCCCCCCCcc
Q 001275          258 G--SEKCKNLTFLDLSYNRFSGG--IS-PNLGNCSSLTHLDIVGSKLTGSIP-SSFGLLARLSSLDLSENQLSGKIPPEL  331 (1109)
Q Consensus       258 ~--~~~l~~L~~L~Ls~N~l~~~--~~-~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l  331 (1109)
                      .  +..+++|++|+|++|++++.  ++ ..+..+++|++|++++|++++.+| ..+..+++|++|+|++|+++ .+|..+
T Consensus       194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~  272 (312)
T 1wwl_A          194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL  272 (312)
T ss_dssp             HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred             HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence            2  25566666666666666521  11 223345566666666666665443 33444556666666666665 455544


Q ss_pred             ccccccceeeccCcccCCCCCccccCCCCccEEEccCccccc
Q 001275          332 GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG  373 (1109)
Q Consensus       332 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  373 (1109)
                      .  ++|++|+|++|++++. |. +..+++|++|++++|++++
T Consensus       273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            4  5556666666666543 43 5555555555555555553

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=5.5e-28  Score=273.27  Aligned_cols=234  Identities=20%  Similarity=0.231  Sum_probs=129.4

Q ss_pred             cccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEc
Q 001275          335 KYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISL  414 (1109)
Q Consensus       335 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  414 (1109)
                      +.++.|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..+..+++|++|++++|.++ .+|..+..+++|+.|++
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            45556666666665 45555555566666666666555 45555555555555555555555 44555555555555555


Q ss_pred             cCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCC
Q 001275          415 YNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGA  494 (1109)
Q Consensus       415 ~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  494 (1109)
                      ++|++.+.+|..++..               ..+..+..+++|++|+|++|+++ .+|..                    
T Consensus       158 ~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~--------------------  201 (328)
T 4fcg_A          158 RACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPAS--------------------  201 (328)
T ss_dssp             EEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGG--------------------
T ss_pred             CCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHh--------------------
Confidence            5555444444433220               00111223444555555555444 33333                    


Q ss_pred             CCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCC
Q 001275          495 LPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCK  574 (1109)
Q Consensus       495 ~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  574 (1109)
                         +..+++|++|++++|++++ +|..++.+++|++|+|++|++.+.+|..++.+++|++|+|++|.+.+.+|..+..++
T Consensus       202 ---l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~  277 (328)
T 4fcg_A          202 ---IANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT  277 (328)
T ss_dssp             ---GGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCT
T ss_pred             ---hcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCC
Confidence               4444555555555555553 444555666666666666666666666666666666666666666666666666666


Q ss_pred             CccEEEecCccccCCCCcccccccccceecccccccc
Q 001275          575 NLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       575 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      +|+.|||++|++.+.+|..++.+++|+.++++.|.+.
T Consensus       278 ~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             TCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             CCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            6666666666666666666666666666666655544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=5.4e-28  Score=268.25  Aligned_cols=255  Identities=22%  Similarity=0.191  Sum_probs=143.9

Q ss_pred             cEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccc
Q 001275          122 EYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSN  201 (1109)
Q Consensus       122 ~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N  201 (1109)
                      ++++.+++.++ .+|..+  .++|++|+|++|.+++..+..+..+++|++|++++|++++..|..|+++++|++|++++|
T Consensus        14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n   90 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence            45666666665 344433  345566666666555444444444555555555555544444444444444444444444


Q ss_pred             cCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCc
Q 001275          202 RLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISP  281 (1109)
Q Consensus       202 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  281 (1109)
                      .                       .++...|..|.++++|++|++++|++++..+..+..+++|++|++++|++++..+.
T Consensus        91 ~-----------------------~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~  147 (285)
T 1ozn_A           91 A-----------------------QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD  147 (285)
T ss_dssp             T-----------------------TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             C-----------------------CccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHh
Confidence            3                       04433344444444444444444444444444444455555555555555544445


Q ss_pred             ccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCc
Q 001275          282 NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNL  361 (1109)
Q Consensus       282 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  361 (1109)
                      .|..+++|++|++++|++++..+..|..+++|+.|++++|++++..|..|..+++|+.|++++|++++..+..+..+++|
T Consensus       148 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  227 (285)
T 1ozn_A          148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL  227 (285)
T ss_dssp             TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred             HhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence            56666666667777666665555566777777777777777776667777777777777777777776555567777777


Q ss_pred             cEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhh
Q 001275          362 QDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEM  403 (1109)
Q Consensus       362 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  403 (1109)
                      ++|++++|++....+.. +-...++.+..+.+.+....|..+
T Consensus       228 ~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          228 QYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             CEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred             CEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHh
Confidence            77777777776533321 222334444455555555555544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.95  E-value=2.2e-27  Score=263.30  Aligned_cols=235  Identities=18%  Similarity=0.165  Sum_probs=136.3

Q ss_pred             CCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcc-cccCCCcccCCCCccchhh
Q 001275          407 KQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQ-FHGPIPSLLGSCPTLWRVI  485 (1109)
Q Consensus       407 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~l~  485 (1109)
                      ++|+.|++++|++++..+..+..+++|++|++++|.+++..|..+..+++|++|++++|+ +....|..+..+++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            345555555555555444455555555555555555555445555555555555555554 4444445555555555555


Q ss_pred             ccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccc
Q 001275          486 LKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEG  564 (1109)
Q Consensus       486 l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  564 (1109)
                      +++|++++..|. +..+++|++|++++|++++..+..++++++|++|+|++|++++..+..+..+++|++|++++|++++
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  191 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence            555555544443 5556666666666666665555556666667777777776665555556666667777777776666


Q ss_pred             cCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCc
Q 001275          565 SLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSI  642 (1109)
Q Consensus       565 ~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~  642 (1109)
                      ..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|++....+.. .-...++.+..+.|.+....|+.+
T Consensus       192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred             cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHh
Confidence            66666666677777777777776554455666666777777777666433321 222344444555555554444433

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=5.8e-28  Score=293.58  Aligned_cols=293  Identities=23%  Similarity=0.289  Sum_probs=163.1

Q ss_pred             cccCCCCCCCCCCceeeeEEecC------CCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCC
Q 001275           46 LIISSWNSSDSTPCQWVGIECDD------DAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCS  119 (1109)
Q Consensus        46 ~~l~sW~~~~~~~c~w~gv~C~~------~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~  119 (1109)
                      ...++|... .+||.|+|..|..      ....++.+++++++++ .+|..+.  ++|++|+|++|+++ .+|.   .++
T Consensus        10 ~~w~~W~~~-~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~   81 (622)
T 3g06_A           10 AVWSAWRRA-APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP   81 (622)
T ss_dssp             CHHHHHHHT-CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred             HHHHHHHhc-CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence            345678654 4579997643321      1123556666666655 4555443  56666666666665 3443   345


Q ss_pred             CCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecc
Q 001275          120 ALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLF  199 (1109)
Q Consensus       120 ~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~  199 (1109)
                      +|++|+|++|++++ +|.   .+++|++|+|++|.++ .+|.   .+.+|+.|++++|++++ +|..   +++|++|+|+
T Consensus        82 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls  149 (622)
T 3g06_A           82 ELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVS  149 (622)
T ss_dssp             TCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred             CCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECc
Confidence            66666666666652 443   4556666666666655 2333   33455555555555553 3322   2444555555


Q ss_pred             cccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCC
Q 001275          200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGI  279 (1109)
Q Consensus       200 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  279 (1109)
                      +|+++                        +. |.   .+++|+.|++++|++++..    ..+++|+.|+|++|.+++ +
T Consensus       150 ~N~l~------------------------~l-~~---~~~~L~~L~L~~N~l~~l~----~~~~~L~~L~Ls~N~l~~-l  196 (622)
T 3g06_A          150 DNQLA------------------------SL-PA---LPSELCKLWAYNNQLTSLP----MLPSGLQELSVSDNQLAS-L  196 (622)
T ss_dssp             SSCCS------------------------CC-CC---CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSC-C
T ss_pred             CCcCC------------------------Cc-CC---ccCCCCEEECCCCCCCCCc----ccCCCCcEEECCCCCCCC-C
Confidence            55444                        32 21   1234445555555554322    234555555555555553 2


Q ss_pred             CcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCC
Q 001275          280 SPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLS  359 (1109)
Q Consensus       280 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  359 (1109)
                      |..   +++|+.|++++|.++. +|..   +++|+.|++++|++++ +|   ..+++|+.|+|++|+|+ .+|.   .++
T Consensus       197 ~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~  261 (622)
T 3g06_A          197 PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPS  261 (622)
T ss_dssp             CCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCT
T ss_pred             CCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccc
Confidence            221   3566666666666663 3322   3567777777777764 44   34466777777777776 3444   456


Q ss_pred             CccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccC
Q 001275          360 NLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELK  407 (1109)
Q Consensus       360 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  407 (1109)
                      +|+.|+|++|+|+ .+|..+.++++|+.|++++|.+++..|..+..++
T Consensus       262 ~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          262 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            6777777777777 5666677777777777777777766666666554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=5.9e-29  Score=280.31  Aligned_cols=265  Identities=18%  Similarity=0.163  Sum_probs=147.0

Q ss_pred             cEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCC
Q 001275          362 QDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN  441 (1109)
Q Consensus       362 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N  441 (1109)
                      +.++++.+.+.......+..+++|++|++++|.+++..|..+..+++|+.|+|++|++++..|  +..+++|++|++++|
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n   90 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN   90 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence            344555555543333333445566666666666666556666666666666666666665443  566666666666666


Q ss_pred             cccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCC
Q 001275          442 SFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPS  520 (1109)
Q Consensus       442 ~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~  520 (1109)
                      .+++..     ..++|++|++++|++++..+..   +++|+.|++++|++++..+. +..+++|++|++++|+|++..|.
T Consensus        91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  162 (317)
T 3o53_A           91 YVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA  162 (317)
T ss_dssp             EEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred             cccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence            666432     2256666666666666543332   33444444555554444332 44555555555555555554444


Q ss_pred             ccc-ccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccc
Q 001275          521 SIG-NSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKS  599 (1109)
Q Consensus       521 ~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~  599 (1109)
                      .+. .+++|++|+|++|++++. |. ...+++|++|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+..+++
T Consensus       163 ~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~  238 (317)
T 3o53_A          163 ELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN  238 (317)
T ss_dssp             GGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTT
T ss_pred             HHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCC
Confidence            442 455566666666665533 21 2235556666666666653 3334555666666666666665 35555556666


Q ss_pred             cceecccccccc-CCCcchhhhhhhhhhhhcc-cCcCCCCCCC
Q 001275          600 LSILKLSENHFT-GGIPTFISELEKLLELQLG-GNQLGGEIPP  640 (1109)
Q Consensus       600 L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~-~N~l~g~ip~  640 (1109)
                      |+.|++++|+++ +.+|.++..+++|+.|+++ .+.++|..|.
T Consensus       239 L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             CCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             CCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            666666666665 4555566666666666655 2334444433

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=8.5e-29  Score=278.35  Aligned_cols=249  Identities=21%  Similarity=0.203  Sum_probs=179.2

Q ss_pred             cccccCccceeccccccccccCCcccccccccceeccccccc-ccccccccC-------CCcccceeecccccCCCCccc
Q 001275          138 NFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSL-SGSIPRNVG-------DLKEVEALWLFSNRLSGTIPE  209 (1109)
Q Consensus       138 ~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l-~~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~  209 (1109)
                      .++..++|++|++++|.+  .+|..+...  |+.|+|++|++ .+.+|..+.       ++++|++|+|++|++++.+|.
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            457788999999999999  788877765  99999999999 456676665       789999999999999999998


Q ss_pred             cc--ccccCccEEEeccccccCcCchhcccc-----cccccccccCcccCCcccccccCCCCcchhccccccccCC--CC
Q 001275          210 SI--GNCYRLQELYLNENKLMGFLPESLSNL-----ENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGG--IS  280 (1109)
Q Consensus       210 ~l--~~l~~L~~L~L~~N~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~  280 (1109)
                      .+  +.+++|++|+|++|++++. |..+..+     ++|++|++++|++++..+..+..+++|++|+|++|++.+.  .+
T Consensus       114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  192 (312)
T 1wwl_A          114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI  192 (312)
T ss_dssp             CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred             HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence            86  8999999999999999987 8888887     7888888888888877777777788888888888876653  22


Q ss_pred             ccc--ccccCCcEEEeecCCCCCc---CCccccccccccEEEcCCCCCCCCCC-CccccccccceeeccCcccCCCCCcc
Q 001275          281 PNL--GNCSSLTHLDIVGSKLTGS---IPSSFGLLARLSSLDLSENQLSGKIP-PELGKCKYLTVLHLYANQLEGEIPDE  354 (1109)
Q Consensus       281 ~~~--~~l~~L~~L~L~~n~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~  354 (1109)
                      ..+  ..+++|++|++++|++++.   ....+..+++|++|++++|++++.+| ..+..+++|++|+|++|+++ .+|..
T Consensus       193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~  271 (312)
T 1wwl_A          193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG  271 (312)
T ss_dssp             HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred             HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence            233  6677777777777777631   11333455677777777777766553 34455666666666666666 45554


Q ss_pred             ccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccC
Q 001275          355 LGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLL  396 (1109)
Q Consensus       355 l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  396 (1109)
                      +.  ++|++|+|++|+|++. |. +..+++|++|++++|+++
T Consensus       272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            44  5566666666666543 33 444555555555555444

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.95  E-value=4.9e-27  Score=278.55  Aligned_cols=249  Identities=24%  Similarity=0.239  Sum_probs=164.2

Q ss_pred             ccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccc
Q 001275           97 LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNN  176 (1109)
Q Consensus        97 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~  176 (1109)
                      .+.++.+++.++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+.++++|++|+|++
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~  132 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD  132 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence            345666666666 4565443  5677777777777766667777777777777777777655555555566666666666


Q ss_pred             cccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCccc
Q 001275          177 NSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRIN  256 (1109)
Q Consensus       177 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  256 (1109)
                      |++++..+..|+.+++|++|+|++|+++...+..|.++++|++|++++|                       |.++...+
T Consensus       133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~-----------------------~~l~~i~~  189 (452)
T 3zyi_A          133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL-----------------------KKLEYISE  189 (452)
T ss_dssp             SCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC-----------------------TTCCEECT
T ss_pred             CcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCC-----------------------CCccccCh
Confidence            6555444444555555555555555555444444444555555555442                       22332333


Q ss_pred             ccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccc
Q 001275          257 FGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKY  336 (1109)
Q Consensus       257 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  336 (1109)
                      ..+..+++|++|+|++|++++.  +.+..+++|+.|++++|++++..|..|..+++|+.|+|++|++++..|..|.++++
T Consensus       190 ~~~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  267 (452)
T 3zyi_A          190 GAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS  267 (452)
T ss_dssp             TTTTTCTTCCEEECTTSCCSSC--CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             hhccCCCCCCEEECCCCccccc--ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCC
Confidence            3455555556666666655532  24667777888888888888777788888888888888888888777788888888


Q ss_pred             cceeeccCcccCCCCCccccCCCCccEEEccCccccc
Q 001275          337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG  373 (1109)
Q Consensus       337 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  373 (1109)
                      |+.|+|++|++++..+..+..+++|++|+|++|.+..
T Consensus       268 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          268 LVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             CCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             CCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            8888888888887666777888888888888888764

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.94  E-value=9.1e-29  Score=278.75  Aligned_cols=236  Identities=25%  Similarity=0.216  Sum_probs=109.3

Q ss_pred             cccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceee
Q 001275          310 LARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLL  389 (1109)
Q Consensus       310 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  389 (1109)
                      +++|++|+|++|++++..|..|+.+++|++|+|++|++++..+  +..+++|++|++++|++++. +    ..++|++|+
T Consensus        33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l-~----~~~~L~~L~  105 (317)
T 3o53_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIETLH  105 (317)
T ss_dssp             GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEE-E----ECTTCCEEE
T ss_pred             CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccc-c----CCCCcCEEE
Confidence            3344444444444443333344444444444444444443222  44444444444444444421 1    113444444


Q ss_pred             ccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcc-cCccceEEECCCcccc
Q 001275          390 VYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLC-FGKQLRVLNMGQNQFH  468 (1109)
Q Consensus       390 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~-~~~~L~~L~L~~N~l~  468 (1109)
                      +++|++++..+.   .+++|+.|++++|++++..|..++.+++|++|++++|.+++..+..+. .+++|++|+|++|+++
T Consensus       106 l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~  182 (317)
T 3o53_A          106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (317)
T ss_dssp             CCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence            444444432222   133455555555555544444444445555555555555544443332 3445555555555554


Q ss_pred             cCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCccc-CCcchhhh
Q 001275          469 GPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFS-GLMPQELG  547 (1109)
Q Consensus       469 ~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~  547 (1109)
                      +. |. ...+++|+.|++++|++++.++.+..+++|++|++++|+|+ .+|..+..+++|+.|++++|+++ +.+|..++
T Consensus       183 ~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~  259 (317)
T 3o53_A          183 DV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS  259 (317)
T ss_dssp             EE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred             cc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence            32 11 11234444444444444433334444555555555555555 34555555555556666665555 44555555


Q ss_pred             cccccceeecc
Q 001275          548 NLVSLVTLNIS  558 (1109)
Q Consensus       548 ~l~~L~~L~L~  558 (1109)
                      .+++|+.|+++
T Consensus       260 ~~~~L~~l~l~  270 (317)
T 3o53_A          260 KNQRVQTVAKQ  270 (317)
T ss_dssp             TCHHHHHHHHH
T ss_pred             ccccceEEECC
Confidence            55555555555

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=1.9e-26  Score=280.33  Aligned_cols=263  Identities=26%  Similarity=0.337  Sum_probs=127.1

Q ss_pred             CCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEcc
Q 001275          288 SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELF  367 (1109)
Q Consensus       288 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~  367 (1109)
                      +++.|++++|.++ .+|..+.  ++|+.|+|++|.++ .+|.   .+++|++|+|++|+++ .+|.   .+++|++|+|+
T Consensus        41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred             CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence            4677777777776 4555443  56777777777776 3444   3566667777777666 3443   45666666666


Q ss_pred             CccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccC
Q 001275          368 DNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEI  447 (1109)
Q Consensus       368 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~  447 (1109)
                      +|++++ +|.   .+++|+.|++++|++++ +|..   +++|+.|++++|++++ +|.   ..                 
T Consensus       110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~-----------------  160 (622)
T 3g06_A          110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LP-----------------  160 (622)
T ss_dssp             SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CC-----------------
T ss_pred             CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---cc-----------------
Confidence            666663 332   33445555555555443 2221   2444444444444442 121   12                 


Q ss_pred             CCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCccccccc
Q 001275          448 PPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSIN  527 (1109)
Q Consensus       448 p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~  527 (1109)
                             .+|+.|++++|+|++ +|   ..+++|+.|++++|++++.++   ..++|+.|++++|.|+ .+|..   +++
T Consensus       161 -------~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~---~~~~L~~L~L~~N~l~-~l~~~---~~~  222 (622)
T 3g06_A          161 -------SELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLASLPT---LPSELYKLWAYNNRLT-SLPAL---PSG  222 (622)
T ss_dssp             -------TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCS-SCCCC---CTT
T ss_pred             -------CCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCC---ccchhhEEECcCCccc-ccCCC---CCC
Confidence                   334444444444442 22   112233333333333332111   1234555555555555 23322   244


Q ss_pred             ccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceecccc
Q 001275          528 LTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSE  607 (1109)
Q Consensus       528 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~  607 (1109)
                      |+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus       223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~  293 (622)
T 3g06_A          223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  293 (622)
T ss_dssp             CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred             CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence            5555555555553 23   23344555555555554 3333   3344555555555555 4444444555555555555


Q ss_pred             ccccCCCcch
Q 001275          608 NHFTGGIPTF  617 (1109)
Q Consensus       608 N~l~~~~p~~  617 (1109)
                      |++++.+|..
T Consensus       294 N~l~~~~~~~  303 (622)
T 3g06_A          294 NPLSERTLQA  303 (622)
T ss_dssp             CCCCHHHHHH
T ss_pred             CCCCCcCHHH
Confidence            5444444433

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=274.30  Aligned_cols=249  Identities=20%  Similarity=0.218  Sum_probs=137.5

Q ss_pred             ccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccC
Q 001275          313 LSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYN  392 (1109)
Q Consensus       313 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  392 (1109)
                      ...++.+++.++ .+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            345555555555 4444443  4555666666666555555566666666666666666554445555555555555555


Q ss_pred             CccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCC
Q 001275          393 NNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIP  472 (1109)
Q Consensus       393 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p  472 (1109)
                      |++++..+..|..+++|+.|+|++|++++..+..+..+++|++|++++|+.                       +....+
T Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~-----------------------l~~i~~  178 (440)
T 3zyj_A          122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR-----------------------LSYISE  178 (440)
T ss_dssp             SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTT-----------------------CCEECT
T ss_pred             CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCC-----------------------cceeCc
Confidence            555544444455555555555555555544444444444455544444222                       211111


Q ss_pred             cccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhccccc
Q 001275          473 SLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSL  552 (1109)
Q Consensus       473 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  552 (1109)
                      ..                       |..+++|++|++++|+++ .+| .+..+++|+.|+|++|++++..|..|.++++|
T Consensus       179 ~~-----------------------~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  233 (440)
T 3zyj_A          179 GA-----------------------FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL  233 (440)
T ss_dssp             TT-----------------------TTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             ch-----------------------hhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccC
Confidence            12                       333344444444444444 233 24455556666666666655555566666666


Q ss_pred             ceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccC
Q 001275          553 VTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG  612 (1109)
Q Consensus       553 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  612 (1109)
                      +.|+|++|+|++..|..|..+++|+.|||++|+|++..+..|..+++|+.|+|++|.+..
T Consensus       234 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             CEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             CEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            666666666666666666666777777777777775555666667777777777777763

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.94  E-value=4.6e-27  Score=278.81  Aligned_cols=234  Identities=23%  Similarity=0.232  Sum_probs=176.2

Q ss_pred             cCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccc
Q 001275           87 LGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRI  166 (1109)
Q Consensus        87 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l  166 (1109)
                      +|..+.  +++++|+|++|++++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..+..+..+
T Consensus        69 iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  146 (452)
T 3zyi_A           69 VPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYL  146 (452)
T ss_dssp             CCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSC
T ss_pred             cCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhccc
Confidence            555443  689999999999999999999999999999999999999888999999999999999999996666778899


Q ss_pred             cccceecccccccccccccccCCCcccceeecccccCCCCc-ccccccccCccEEEeccccccCcCchhccccccccccc
Q 001275          167 LGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTI-PESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLD  245 (1109)
Q Consensus       167 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~  245 (1109)
                      ++|++|+|++|+++...+..|.++++|++|++++|+..+.+ +..|.++++|++|+|++|++++. | .+..+++|+.|+
T Consensus       147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~  224 (452)
T 3zyi_A          147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELE  224 (452)
T ss_dssp             TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEE
T ss_pred             CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEE
Confidence            99999999999999777779999999999999995444444 44688888888888888888754 2 355555555555


Q ss_pred             ccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCC
Q 001275          246 VGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSG  325 (1109)
Q Consensus       246 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  325 (1109)
                      |++|++++..                        +..|.++++|+.|++++|++++..+..|..+++|+.|+|++|++++
T Consensus       225 Ls~N~l~~~~------------------------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  280 (452)
T 3zyi_A          225 MSGNHFPEIR------------------------PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS  280 (452)
T ss_dssp             CTTSCCSEEC------------------------GGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CcCCcCcccC------------------------cccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence            5555555444                        4445555555555555555555555555555666666666666665


Q ss_pred             CCCCccccccccceeeccCcccC
Q 001275          326 KIPPELGKCKYLTVLHLYANQLE  348 (1109)
Q Consensus       326 ~~p~~l~~l~~L~~L~L~~N~l~  348 (1109)
                      ..+..|..+++|+.|+|++|.+.
T Consensus       281 ~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          281 LPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             CCTTSSTTCTTCCEEECCSSCEE
T ss_pred             cChHHhccccCCCEEEccCCCcC
Confidence            55555566666666666666554

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.94  E-value=9.2e-27  Score=275.17  Aligned_cols=249  Identities=22%  Similarity=0.236  Sum_probs=167.8

Q ss_pred             ccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccc
Q 001275           97 LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNN  176 (1109)
Q Consensus        97 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~  176 (1109)
                      .+.++.++++++ .+|..+.  +++++|+|++|++++..+..|.++++|++|+|++|.+++..+..+.++++|++|+|++
T Consensus        45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~  121 (440)
T 3zyj_A           45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD  121 (440)
T ss_dssp             SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred             CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence            356777787877 6676664  6788888888888877777888888888888888877755555555566666666666


Q ss_pred             cccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCccc
Q 001275          177 NSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRIN  256 (1109)
Q Consensus       177 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  256 (1109)
                      |++++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++|                       |.++...+
T Consensus       122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~-----------------------~~l~~i~~  178 (440)
T 3zyj_A          122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL-----------------------KRLSYISE  178 (440)
T ss_dssp             SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC-----------------------TTCCEECT
T ss_pred             CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC-----------------------CCcceeCc
Confidence            6655444444555555555555555555444444445555555555442                       22222233


Q ss_pred             ccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccc
Q 001275          257 FGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKY  336 (1109)
Q Consensus       257 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~  336 (1109)
                      ..|..+++|++|+|++|.++. +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|.++++
T Consensus       179 ~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  256 (440)
T 3zyj_A          179 GAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQS  256 (440)
T ss_dssp             TTTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTT
T ss_pred             chhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCC
Confidence            344555555555555555552 22 3666777888888888887777778888888888888888888777778888888


Q ss_pred             cceeeccCcccCCCCCccccCCCCccEEEccCccccc
Q 001275          337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG  373 (1109)
Q Consensus       337 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  373 (1109)
                      |+.|+|++|++++..+..+..+++|+.|+|++|.+..
T Consensus       257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             CCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             CCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            8888888888887766777888888888888888764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=6.8e-27  Score=278.84  Aligned_cols=233  Identities=19%  Similarity=0.179  Sum_probs=126.6

Q ss_pred             ccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECC
Q 001275          384 SLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMG  463 (1109)
Q Consensus       384 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~  463 (1109)
                      +|++|+|++|.+++..|..|..+++|+.|+|++|.+++.+|  ++.+++|++|+|++|.|++..+     .++|++|+++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence            67777777777777667777777777777777777776555  6677777777777777764332     2567777777


Q ss_pred             CcccccCCCcccCCCCccchhhccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCccc-ccccccEEeccCCcccCC
Q 001275          464 QNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIG-NSINLTSIDFSSNKFSGL  541 (1109)
Q Consensus       464 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~  541 (1109)
                      +|+|.+..+..   +++|+.|++++|++++.+|. +..+++|++|+|++|+|++.+|..+. .+++|+.|+|++|.|++.
T Consensus       108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~  184 (487)
T 3oja_A          108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV  184 (487)
T ss_dssp             SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred             CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence            77776544332   23444444444444444332 44444455555555555444444443 344555555555555433


Q ss_pred             cchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceecccccccc-CCCcchhhh
Q 001275          542 MPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT-GGIPTFISE  620 (1109)
Q Consensus       542 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~  620 (1109)
                       | .+..+++|++|+|++|+|++ +|..+..+++|+.|||++|+|++ +|..+..+++|+.|++++|.+. +.+|.++..
T Consensus       185 -~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~  260 (487)
T 3oja_A          185 -K-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK  260 (487)
T ss_dssp             -E-CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred             -c-ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence             1 12234445555555555543 22234444555555555555542 4444444455555555555544 334444444


Q ss_pred             hhhhhhhhcc
Q 001275          621 LEKLLELQLG  630 (1109)
Q Consensus       621 l~~L~~L~l~  630 (1109)
                      ++.|+.++++
T Consensus       261 l~~L~~l~~~  270 (487)
T 3oja_A          261 NQRVQTVAKQ  270 (487)
T ss_dssp             CHHHHHHHHH
T ss_pred             CCCCcEEecc
Confidence            4444444443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=7.8e-27  Score=278.33  Aligned_cols=237  Identities=22%  Similarity=0.221  Sum_probs=119.6

Q ss_pred             CCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceee
Q 001275          118 CSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALW  197 (1109)
Q Consensus       118 l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~  197 (1109)
                      +++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|  +..+++|++|+|++|.+++..+     .++|++|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~  105 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH  105 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence            3455555555555555444555555555555555555554333  4444555555555555443221     14455555


Q ss_pred             cccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccC
Q 001275          198 LFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG  277 (1109)
Q Consensus       198 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  277 (1109)
                      +++|.+++..+..   +++|+.|+|++|.+++..|..|+++++|++|+|++|.+++.++..+.                 
T Consensus       106 L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-----------------  165 (487)
T 3oja_A          106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA-----------------  165 (487)
T ss_dssp             CCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG-----------------
T ss_pred             CcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh-----------------
Confidence            5555555433322   24455555555555544444444444444444444444443333332                 


Q ss_pred             CCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccC
Q 001275          278 GISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQ  357 (1109)
Q Consensus       278 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~  357 (1109)
                            ..+++|+.|+|++|.+++..+  +..+++|+.|+|++|.+++ +|+.+..+++|+.|+|++|.+++ +|..+..
T Consensus       166 ------~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~  235 (487)
T 3oja_A          166 ------ASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRF  235 (487)
T ss_dssp             ------GGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred             ------hhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhcc
Confidence                  133344444444444443211  1234555555555555553 33335556666666666666653 4555666


Q ss_pred             CCCccEEEccCcccc-ccCchHHHhhcccceeecc
Q 001275          358 LSNLQDLELFDNRLT-GEFPVSIWRIASLEYLLVY  391 (1109)
Q Consensus       358 l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~  391 (1109)
                      +++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus       236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            666666666666665 4556666666677766665

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=1.1e-25  Score=247.36  Aligned_cols=216  Identities=22%  Similarity=0.222  Sum_probs=124.2

Q ss_pred             CCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCC
Q 001275           57 TPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIP  136 (1109)
Q Consensus        57 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p  136 (1109)
                      ++|.|.|+.|+... .++.+++++++++. +|..+.  ++|++|+|++|++++..+..|+++++|++|+|++|+++...+
T Consensus         3 ~~C~~~~~~C~c~~-~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~   78 (270)
T 2o6q_A            3 ALCKKDGGVCSCNN-NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA   78 (270)
T ss_dssp             CCBGGGTCSBEEET-TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred             ccCCCCCCCCEeCC-CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence            57999998886422 34456777766663 554443  456777777777765555566677777777777777665444


Q ss_pred             ccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccC
Q 001275          137 DNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYR  216 (1109)
Q Consensus       137 ~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  216 (1109)
                      ..|.++++|++|+|++|.+++..+..+..+++|++|++++|++++..+..|+.+++|++|+|++|++++..+..|+.+++
T Consensus        79 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~  158 (270)
T 2o6q_A           79 GIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTS  158 (270)
T ss_dssp             TTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcc
Confidence            45566666666666666666444444455555555555555555544444555555555555555555444444455555


Q ss_pred             ccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeec
Q 001275          217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVG  296 (1109)
Q Consensus       217 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  296 (1109)
                      |++|+|++|++++..+..|.                        .+++|++|+|++|++++..+..|..+++|+.|++++
T Consensus       159 L~~L~L~~n~l~~~~~~~~~------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  214 (270)
T 2o6q_A          159 LKELRLYNNQLKRVPEGAFD------------------------KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE  214 (270)
T ss_dssp             CCEEECCSSCCSCCCTTTTT------------------------TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             cceeEecCCcCcEeChhHhc------------------------cCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecC
Confidence            55555555555544444444                        445555555555555544444455555555566655


Q ss_pred             CCCC
Q 001275          297 SKLT  300 (1109)
Q Consensus       297 n~l~  300 (1109)
                      |.+.
T Consensus       215 N~~~  218 (270)
T 2o6q_A          215 NPWD  218 (270)
T ss_dssp             SCBC
T ss_pred             CCee
Confidence            5554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=9.7e-29  Score=304.53  Aligned_cols=132  Identities=10%  Similarity=0.153  Sum_probs=79.5

Q ss_pred             CCCCceEEee--c----CccCCC-----CCCcccccccccEEeccCCcccCCcchhhhc-ccccceeecccccccccCCc
Q 001275          501 NPVLSHLDVS--R----NNISGA-----IPSSIGNSINLTSIDFSSNKFSGLMPQELGN-LVSLVTLNISLNHVEGSLPS  568 (1109)
Q Consensus       501 ~~~L~~L~Ls--~----N~i~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~  568 (1109)
                      +++|++|+++  +    |++++.     ++..+..+++|+.|++++ .+++..+..++. +++|++|+|++|.+++..+.
T Consensus       396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~  474 (594)
T 2p1m_B          396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH  474 (594)
T ss_dssp             CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred             CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence            5566666666  3    444421     111245567777777766 566555555655 67788888888877665444


Q ss_pred             cc-cCCCCccEEEecCccccCCCCc-ccccccccceeccccccccCCCcchh-hhhhhhhhhhcccCc
Q 001275          569 QL-SKCKNLEVFDVSFNLLNGSIPS-SLRSWKSLSILKLSENHFTGGIPTFI-SELEKLLELQLGGNQ  633 (1109)
Q Consensus       569 ~l-~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~l~~N~  633 (1109)
                      .+ ..+++|+.|+|++|.+++..+. .+..+++|+.|++++|+++......+ ..+++|+...+..+.
T Consensus       475 ~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~  542 (594)
T 2p1m_B          475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG  542 (594)
T ss_dssp             HHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred             HHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence            44 5577888888888887544333 33457788888888887753322333 334555444444443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.92  E-value=1.8e-26  Score=278.84  Aligned_cols=185  Identities=16%  Similarity=0.101  Sum_probs=129.8

Q ss_pred             eecccCeEEEEE-EeCCCcEEEEEEeeeccc---------ccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEEE
Q 001275          827 IGRGAHGIVYKA-SLGPNAVFAVKKLAFRGH---------KRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       827 lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      .+.|++|.++.+ +.-.|+.||+|.+.....         +...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            556666666665 334588899999865421         22345699999999999 7999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||++||+|.+++...+.   ++..   +|+.||+.||+|+|   +.+||||||||+|||+++++.+||+|||+|+.....
T Consensus       322 Eyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999987543   5543   58899999999999   999999999999999999999999999999876543


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCC
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKA 1023 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p 1023 (1109)
                      ..  .....+||++|+|||++.+ .+..++|+||+|++.+++.++..+
T Consensus       393 ~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Cc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            22  2234689999999998865 467789999999998887766544

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=1.4e-28  Score=303.14  Aligned_cols=283  Identities=17%  Similarity=0.130  Sum_probs=166.8

Q ss_pred             ccccceeeccCc-ccCCCCCccccCCCCccEEEccC-------ccccccCchHHHhhccccee-eccCCccCCCCchhhh
Q 001275          334 CKYLTVLHLYAN-QLEGEIPDELGQLSNLQDLELFD-------NRLTGEFPVSIWRIASLEYL-LVYNNNLLGKLPLEMT  404 (1109)
Q Consensus       334 l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~-------N~l~~~~~~~~~~l~~L~~L-~l~~N~l~~~~~~~~~  404 (1109)
                      +++|++|++++| .+.+ +|..+..+++|++|+++.       |.+.+ ++..+.++++|+.| .+.+... +.++..+.
T Consensus       210 ~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~  286 (594)
T 2p1m_B          210 CPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYS  286 (594)
T ss_dssp             CTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHH
T ss_pred             CCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHH
Confidence            345555555544 2222 344444455555555322       22332 33345555555555 2322221 22333344


Q ss_pred             ccCCCCeEEccCCcCcccCCc-cccCCCCCceEEecCCcccccCCCCc-ccCccceEEECCCcccccCCCcccCCCCccc
Q 001275          405 ELKQLKNISLYNNQFSGVIPQ-SLGINSSLMQLDFINNSFTGEIPPNL-CFGKQLRVLNMGQNQFHGPIPSLLGSCPTLW  482 (1109)
Q Consensus       405 ~l~~L~~L~L~~N~l~~~~p~-~~~~~~~L~~L~ls~N~l~~~~p~~~-~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~  482 (1109)
                      .+++|+.|++++|.+++.... .+..+++|++|++++| +++.....+ ..+++|+.|+++.+.-.|             
T Consensus       287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g-------------  352 (594)
T 2p1m_B          287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFV-------------  352 (594)
T ss_dssp             HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTC-------------
T ss_pred             hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccc-------------
Confidence            556666666666665432221 1334556666666655 332211111 124555555553321000             


Q ss_pred             hhhccCcccCCCC-CCC-CCCCCCceEEeecCccCCCCCCccc-ccccccEEecc--C----CcccCC-----cchhhhc
Q 001275          483 RVILKQNQLTGAL-PEF-SKNPVLSHLDVSRNNISGAIPSSIG-NSINLTSIDFS--S----NKFSGL-----MPQELGN  548 (1109)
Q Consensus       483 ~l~l~~N~l~~~~-~~~-~~~~~L~~L~Ls~N~i~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~  548 (1109)
                        ....+.+++.. ..+ ..+++|++|+++.|++++..+..+. .+++|+.|+++  +    |++++.     ++..+..
T Consensus       353 --~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~  430 (594)
T 2p1m_B          353 --MEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH  430 (594)
T ss_dssp             --SSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHH
T ss_pred             --cccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhh
Confidence              00122222111 111 2367899999999999877666665 58899999999  4    667632     2233677


Q ss_pred             ccccceeecccccccccCCccccC-CCCccEEEecCccccCCCCccc-ccccccceeccccccccCCCcc-hhhhhhhhh
Q 001275          549 LVSLVTLNISLNHVEGSLPSQLSK-CKNLEVFDVSFNLLNGSIPSSL-RSWKSLSILKLSENHFTGGIPT-FISELEKLL  625 (1109)
Q Consensus       549 l~~L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~  625 (1109)
                      +++|+.|+|++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++..+. .+..+++|+
T Consensus       431 ~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~  509 (594)
T 2p1m_B          431 CKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMR  509 (594)
T ss_dssp             CTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSS
T ss_pred             CCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCC
Confidence            89999999987 777666666666 8999999999999986655555 6789999999999999755443 456689999


Q ss_pred             hhhcccCcCCC
Q 001275          626 ELQLGGNQLGG  636 (1109)
Q Consensus       626 ~L~l~~N~l~g  636 (1109)
                      .|++++|+++.
T Consensus       510 ~L~l~~~~~~~  520 (594)
T 2p1m_B          510 SLWMSSCSVSF  520 (594)
T ss_dssp             EEEEESSCCBH
T ss_pred             EEeeeCCCCCH
Confidence            99999999853

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.92  E-value=1.6e-24  Score=239.01  Aligned_cols=211  Identities=22%  Similarity=0.209  Sum_probs=154.7

Q ss_pred             CCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecc
Q 001275           95 SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFL  174 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  174 (1109)
                      ++|++|+|++|++++..+..++++++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..+.++++|++|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            47899999999998777778899999999999999998777778888999999999999888777777888888888888


Q ss_pred             cccccccccccccCCCcccceeecccccCCCC-cccccccccCccEEEeccccccCcCchhcccccccccccccCcccCC
Q 001275          175 NNNSLSGSIPRNVGDLKEVEALWLFSNRLSGT-IPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEG  253 (1109)
Q Consensus       175 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  253 (1109)
                      ++|++++..+..++.+++|++|++++|++++. +|..|+++++|++|+|++|++++..+..|..+++|+.|.+       
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l-------  180 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL-------  180 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCE-------
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccce-------
Confidence            88888876666788888888888888888763 5777888888888888888887777777776666662211       


Q ss_pred             cccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCC
Q 001275          254 RINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGK  326 (1109)
Q Consensus       254 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  326 (1109)
                                   .|++++|.+++..+..+. ..+|+.|++++|++++..+..|..+++|+.|++++|.+++.
T Consensus       181 -------------~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          181 -------------SLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  239 (276)
T ss_dssp             -------------EEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred             -------------eeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence                         344444444433332222 23566666666666655555566666777777777766643

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.91  E-value=4.1e-24  Score=235.74  Aligned_cols=207  Identities=20%  Similarity=0.193  Sum_probs=143.2

Q ss_pred             CCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhcc
Q 001275          408 QLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK  487 (1109)
Q Consensus       408 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~  487 (1109)
                      +|++|++++|++++..+..+..+++|++|++++|.+++..+..+..+++|++|++++|++++..+..+..+++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            45666666666665555555566666666666666665555556666666666666666666555666666666666666


Q ss_pred             CcccCCCCCC-CCCCCCCceEEeecCccCCC-CCCcccccccccEEeccCCcccCCcchhhhcccccc----eeeccccc
Q 001275          488 QNQLTGALPE-FSKNPVLSHLDVSRNNISGA-IPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLV----TLNISLNH  561 (1109)
Q Consensus       488 ~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~  561 (1109)
                      +|++++..+. +..+++|++|++++|++++. +|..++++++|+.|++++|++++..+..+..+.+|+    .|++++|+
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            6666655553 77778888888888888763 578888888888888888888877777777777777    77888888


Q ss_pred             ccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCc
Q 001275          562 VEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP  615 (1109)
Q Consensus       562 l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  615 (1109)
                      +++..+..+. ..+|+.|++++|++++..+..|..+++|+.|+|++|++++..|
T Consensus       189 l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          189 MNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             ccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            8754444443 3478888888888876555566777788888888887776544

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=1.1e-24  Score=239.48  Aligned_cols=230  Identities=19%  Similarity=0.194  Sum_probs=139.9

Q ss_pred             hcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEE
Q 001275          382 IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLN  461 (1109)
Q Consensus       382 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~  461 (1109)
                      +..+..+++..+.+.+.  .....+++|+.|++++|.++..  ..+..+++|++|++++|.+++.  +.+..+++|++|+
T Consensus        18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~   91 (272)
T 3rfs_A           18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI   91 (272)
T ss_dssp             HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred             HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence            34556667777776643  3356778888888888887632  2356666677777776666542  2444455555555


Q ss_pred             CCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCC
Q 001275          462 MGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGL  541 (1109)
Q Consensus       462 L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~  541 (1109)
                      +++|++++..+..                       |..+++|++|++++|++++..|..++++++|++|++++|++++.
T Consensus        92 L~~n~l~~~~~~~-----------------------~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  148 (272)
T 3rfs_A           92 LTGNQLQSLPNGV-----------------------FDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSL  148 (272)
T ss_dssp             CTTSCCCCCCTTT-----------------------TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             CCCCccCccChhH-----------------------hcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCcc
Confidence            5555554333332                       44555566666666666655555566666666666666666655


Q ss_pred             cchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhh
Q 001275          542 MPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISEL  621 (1109)
Q Consensus       542 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  621 (1109)
                      .|..++.+++|++|++++|++++..|..++.+++|+.|++++|++++..|..+..+++|+.|++++|++.+..|      
T Consensus       149 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------  222 (272)
T 3rfs_A          149 PKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------  222 (272)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT------
T ss_pred             CHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc------
Confidence            55555666666666666666665555556666666666666666666555556666666666666666665433      


Q ss_pred             hhhhhhhcccCcCCCCCCCCchhhhh
Q 001275          622 EKLLELQLGGNQLGGEIPPSIGALQD  647 (1109)
Q Consensus       622 ~~L~~L~l~~N~l~g~ip~~~~~l~~  647 (1109)
                       +|+.|+++.|+++|.+|.+++.+..
T Consensus       223 -~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          223 -GIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             -TTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             -HHHHHHHHHHhCCCcccCcccccCC
Confidence             4566666666666666666665543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=9.4e-26  Score=259.16  Aligned_cols=260  Identities=17%  Similarity=0.178  Sum_probs=145.1

Q ss_pred             EEcCCCCCCCCCCCccccccccceeeccCcccCCCCC----ccccCCC-CccEEEccCccccccCchHHHhh-----ccc
Q 001275          316 LDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIP----DELGQLS-NLQDLELFDNRLTGEFPVSIWRI-----ASL  385 (1109)
Q Consensus       316 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p----~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L  385 (1109)
                      +++++|.+++.+|..+...++|++|+|++|.+++..+    ..+..++ +|++|+|++|++++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            5667777776666666655667777777777765555    5555666 67777777777766666666654     666


Q ss_pred             ceeeccCCccCCCCchhhhcc-----CCCCeEEccCCcCcccCCccccC-----CCCCceEEecCCcccccCCCCcccCc
Q 001275          386 EYLLVYNNNLLGKLPLEMTEL-----KQLKNISLYNNQFSGVIPQSLGI-----NSSLMQLDFINNSFTGEIPPNLCFGK  455 (1109)
Q Consensus       386 ~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~-----~~~L~~L~ls~N~l~~~~p~~~~~~~  455 (1109)
                      ++|++++|.+++..+..+...     ++|+.|+|++|++++..+..++.     .++|++|++++|.+++..+..++   
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~---  159 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI---  159 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH---
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH---
Confidence            666666666665555544332     55666666666655444333221     23444444444444432211110   


Q ss_pred             cceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCC-CCceEEeecCccCCCCCCccccc-----cccc
Q 001275          456 QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNP-VLSHLDVSRNNISGAIPSSIGNS-----INLT  529 (1109)
Q Consensus       456 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~L~~L~Ls~N~i~~~~p~~~~~l-----~~L~  529 (1109)
                                       ..                       +...+ +|++|+|++|+|++..+..+...     ++|+
T Consensus       160 -----------------~~-----------------------l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~  199 (362)
T 3goz_A          160 -----------------QI-----------------------LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT  199 (362)
T ss_dssp             -----------------HH-----------------------HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             -----------------HH-----------------------HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCC
Confidence                             00                       11122 45556666666555444433332     4666


Q ss_pred             EEeccCCcccCC----cchhhhcc-cccceeecccccccccCC----ccccCCCCccEEEecCccccCCC-------Ccc
Q 001275          530 SIDFSSNKFSGL----MPQELGNL-VSLVTLNISLNHVEGSLP----SQLSKCKNLEVFDVSFNLLNGSI-------PSS  593 (1109)
Q Consensus       530 ~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L~~N~l~~~~p----~~l~~l~~L~~L~ls~N~l~~~~-------p~~  593 (1109)
                      +|||++|++++.    ++..+..+ ++|++|+|++|++++..+    ..+..+++|+.|+|++|.+.+..       +..
T Consensus       200 ~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~  279 (362)
T 3goz_A          200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAA  279 (362)
T ss_dssp             EEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTT
T ss_pred             EEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHH
Confidence            666666666642    33444443 366777777776665433    33455677777777777754322       234


Q ss_pred             cccccccceeccccccccCCCcchh
Q 001275          594 LRSWKSLSILKLSENHFTGGIPTFI  618 (1109)
Q Consensus       594 ~~~l~~L~~L~L~~N~l~~~~p~~~  618 (1109)
                      +..+++|+.|++++|++.+..+..+
T Consensus       280 ~~~l~~L~~LdL~~N~l~~~~~~~~  304 (362)
T 3goz_A          280 FPNIQKIILVDKNGKEIHPSHSIPI  304 (362)
T ss_dssp             STTCCEEEEECTTSCBCCGGGCHHH
T ss_pred             hccCCceEEEecCCCcCCCcchHHH
Confidence            5566777777777777765544433

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=2.9e-24  Score=236.26  Aligned_cols=230  Identities=15%  Similarity=0.180  Sum_probs=163.4

Q ss_pred             CCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEE
Q 001275          358 LSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLD  437 (1109)
Q Consensus       358 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~  437 (1109)
                      +.++..+++.++.+.+.  .....+++|+.|++++|.+.. + ..+..+++|+.|++++|++++.  ..++.+++|++|+
T Consensus        18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~   91 (272)
T 3rfs_A           18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI   91 (272)
T ss_dssp             HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEE
T ss_pred             HHHHHHHHhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEE
Confidence            34566677888887754  346789999999999999874 3 3588999999999999999863  4788999999999


Q ss_pred             ecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCC
Q 001275          438 FINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGA  517 (1109)
Q Consensus       438 ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~  517 (1109)
                      +++|.+++..+..+..+++|++|++++|++++..+..++.++                       +|++|++++|++++.
T Consensus        92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-----------------------~L~~L~L~~n~l~~~  148 (272)
T 3rfs_A           92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT-----------------------NLTYLNLAHNQLQSL  148 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT-----------------------TCCEEECCSSCCCCC
T ss_pred             CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCC-----------------------CCCEEECCCCccCcc
Confidence            999999988888889999999999999999866655555544                       455555555555544


Q ss_pred             CCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccc
Q 001275          518 IPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSW  597 (1109)
Q Consensus       518 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l  597 (1109)
                      .+..++.+++|+.|++++|++++..|..++.+++|++|++++|++++..|..+..+++|+.|++++|.+.+.       +
T Consensus       149 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~  221 (272)
T 3rfs_A          149 PKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------C  221 (272)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------T
T ss_pred             CHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------C
Confidence            444555555666666666666555555555666666666666666655555566666666666666666543       3


Q ss_pred             cccceeccccccccCCCcchhhhhhh
Q 001275          598 KSLSILKLSENHFTGGIPTFISELEK  623 (1109)
Q Consensus       598 ~~L~~L~L~~N~l~~~~p~~~~~l~~  623 (1109)
                      ++|+.|+++.|.++|.+|.+++.+..
T Consensus       222 ~~l~~l~~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          222 PGIRYLSEWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             TTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred             cHHHHHHHHHHhCCCcccCcccccCC
Confidence            35666666667777666666655443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=2.5e-25  Score=255.55  Aligned_cols=262  Identities=20%  Similarity=0.157  Sum_probs=144.5

Q ss_pred             hccccccccCCCCcccccccCCcEEEeecCCCCCcCC----ccccccc-cccEEEcCCCCCCCCCCCccccc-----ccc
Q 001275          268 LDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIP----SSFGLLA-RLSSLDLSENQLSGKIPPELGKC-----KYL  337 (1109)
Q Consensus       268 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~L  337 (1109)
                      +++++|.+++.+|..+...++|++|++++|.+++..+    ..|..++ +|++|+|++|++++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4566777776666555555567777777777765555    5555666 67777777776665555555554     666


Q ss_pred             ceeeccCcccCCCCCccccC----C-CCccEEEccCccccccCchHHHhh-----cccceeeccCCccCCCCchhh----
Q 001275          338 TVLHLYANQLEGEIPDELGQ----L-SNLQDLELFDNRLTGEFPVSIWRI-----ASLEYLLVYNNNLLGKLPLEM----  403 (1109)
Q Consensus       338 ~~L~L~~N~l~~~~p~~l~~----l-~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~~----  403 (1109)
                      ++|+|++|++++..+..++.    + ++|++|+|++|++++..+..+...     ++|++|++++|.+++..+..+    
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l  162 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL  162 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence            66666666666555443332    2 566666666666665555444432     466666666666654333322    


Q ss_pred             hccC-CCCeEEccCCcCcccCCcccc----CC-CCCceEEecCCcccccC----CCCccc-CccceEEECCCcccccCCC
Q 001275          404 TELK-QLKNISLYNNQFSGVIPQSLG----IN-SSLMQLDFINNSFTGEI----PPNLCF-GKQLRVLNMGQNQFHGPIP  472 (1109)
Q Consensus       404 ~~l~-~L~~L~L~~N~l~~~~p~~~~----~~-~~L~~L~ls~N~l~~~~----p~~~~~-~~~L~~L~L~~N~l~~~~p  472 (1109)
                      ..++ +|++|+|++|++++..+..++    .+ ++|++|||++|.|++..    +..+.. .++|++|+|++|++++..+
T Consensus       163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~  242 (362)
T 3goz_A          163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL  242 (362)
T ss_dssp             HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred             hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence            3333 566666666666554443332    22 35555555555555421    222222 1244444444444442221


Q ss_pred             cccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCC-------CCCcccccccccEEeccCCcccCCcchh
Q 001275          473 SLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGA-------IPSSIGNSINLTSIDFSSNKFSGLMPQE  545 (1109)
Q Consensus       473 ~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  545 (1109)
                      ..+.                   ..+..+++|++|++++|.+.+.       ++..+.++++|+.||+++|++.+..+..
T Consensus       243 ~~l~-------------------~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~  303 (362)
T 3goz_A          243 ENLK-------------------LLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP  303 (362)
T ss_dssp             HHHH-------------------HTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHH
T ss_pred             HHHH-------------------HHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHH
Confidence            1110                   0145566777777777774432       2335666777777777777777655544


Q ss_pred             hhc
Q 001275          546 LGN  548 (1109)
Q Consensus       546 ~~~  548 (1109)
                      +.+
T Consensus       304 ~~~  306 (362)
T 3goz_A          304 ISN  306 (362)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.90  E-value=6.9e-23  Score=225.03  Aligned_cols=202  Identities=28%  Similarity=0.262  Sum_probs=124.3

Q ss_pred             ceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCc
Q 001275          170 QYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDN  249 (1109)
Q Consensus       170 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  249 (1109)
                      +.+++++++++ .+|..+.  +++++|+|++|++++..+..|+++++|++|+|++|+++...+..|.++++|++|++++|
T Consensus        19 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n   95 (270)
T 2o6q_A           19 NSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDN   95 (270)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSS
T ss_pred             CEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCC
Confidence            34444444444 2333332  34555555555555444455555556666666666655554555555666666666666


Q ss_pred             ccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCC
Q 001275          250 NLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP  329 (1109)
Q Consensus       250 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  329 (1109)
                      ++++..+..+..+++|++|+|++|++++..+..|..+++|++|++++|++++..+..|+.+++|+.|++++|++++..+.
T Consensus        96 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  175 (270)
T 2o6q_A           96 KLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG  175 (270)
T ss_dssp             CCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred             cCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChh
Confidence            66555555555566666666666666655555666667777777777777665555667777777777777777765556


Q ss_pred             ccccccccceeeccCcccCCCCCccccCCCCccEEEccCcccccc
Q 001275          330 ELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGE  374 (1109)
Q Consensus       330 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~  374 (1109)
                      .|..+++|++|+|++|++++..+..+..+++|+.|+|++|.+...
T Consensus       176 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          176 AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             HhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            677777777777777777765555666777777777777776543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=2.1e-25  Score=253.75  Aligned_cols=269  Identities=16%  Similarity=0.181  Sum_probs=142.9

Q ss_pred             CCceeeeEEecCCCCcEEEEEecccCCccccCCcccCC--CCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCC
Q 001275           57 TPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHL--SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGD  134 (1109)
Q Consensus        57 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~  134 (1109)
                      .|.+|.++.|+..  .++.++++++.+.   +..+..+  ++++.|++++|.+++..+. +..+++|++|+|++|.+++.
T Consensus        35 vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~  108 (336)
T 2ast_B           35 VCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS  108 (336)
T ss_dssp             SCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred             HHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence            3567999988642  3556677766554   2334444  6666777777666655444 44566666666666666543


Q ss_pred             -CCccccccCccceeccccccccccCCcccccccccceeccccc-ccccc-cccccCCCcccceeecccc-cCCCC-ccc
Q 001275          135 -IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNN-SLSGS-IPRNVGDLKEVEALWLFSN-RLSGT-IPE  209 (1109)
Q Consensus       135 -~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~~~-~p~  209 (1109)
                       +|..+..+++|++|+|++|.+++..|..+.++++|++|++++| .+++. ++..+..+++|++|++++| .+++. ++.
T Consensus       109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~  188 (336)
T 2ast_B          109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV  188 (336)
T ss_dssp             HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred             HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence             5555666666666666666665555555555555666665555 44432 3444455555555555555 55432 344


Q ss_pred             cccccc-CccEEEeccccccCcCchhcccccccccccccCcccC-CcccccccCCCCcchhcccccc-ccCCCCcccccc
Q 001275          210 SIGNCY-RLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE-GRINFGSEKCKNLTFLDLSYNR-FSGGISPNLGNC  286 (1109)
Q Consensus       210 ~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l  286 (1109)
                      .+..++ +|++|++++|.+                      .++ +.++..+..+++|++|++++|. +++..+..+..+
T Consensus       189 ~~~~l~~~L~~L~l~~~~~----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l  246 (336)
T 2ast_B          189 AVAHVSETITQLNLSGYRK----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL  246 (336)
T ss_dssp             HHHHSCTTCCEEECCSCGG----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC
T ss_pred             HHHhcccCCCEEEeCCCcc----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCC
Confidence            444555 555555555521                      222 2223333444455555555554 443444455555


Q ss_pred             cCCcEEEeecCC-CCCcCCccccccccccEEEcCCCCCCCCCCCccccc-cccceeeccCcccCCCCCccccC
Q 001275          287 SSLTHLDIVGSK-LTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKC-KYLTVLHLYANQLEGEIPDELGQ  357 (1109)
Q Consensus       287 ~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~l~~  357 (1109)
                      ++|++|++++|. ++......++.+++|+.|++++| ++   ...+..+ ..++.|++++|++++..|..+++
T Consensus       247 ~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          247 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             TTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence            555555555553 22111124555566666666665 22   1123333 23555556666666666555543

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.89  E-value=6.3e-23  Score=227.36  Aligned_cols=202  Identities=22%  Similarity=0.202  Sum_probs=104.2

Q ss_pred             hccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccch
Q 001275          404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWR  483 (1109)
Q Consensus       404 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  483 (1109)
                      .++++++.+++++|.++ .+|..+.  +.++.|++++|.+++..|..+..+++|++|+|++|+|++..+           
T Consensus         7 ~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-----------   72 (290)
T 1p9a_G            7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-----------   72 (290)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-----------
T ss_pred             cccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-----------
Confidence            34455555555555555 2333322  345555555555554444444445555555555555443211           


Q ss_pred             hhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeeccccccc
Q 001275          484 VILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE  563 (1109)
Q Consensus       484 l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  563 (1109)
                                    ...+++|++|++++|+|+ .+|..+..+++|++|+|++|+|++..|..|+.+++|++|+|++|+|+
T Consensus        73 --------------~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~  137 (290)
T 1p9a_G           73 --------------DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK  137 (290)
T ss_dssp             --------------CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC
T ss_pred             --------------CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC
Confidence                          133444555555555554 44555555555555555555555444455555555555555555555


Q ss_pred             ccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCC
Q 001275          564 GSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLG  635 (1109)
Q Consensus       564 ~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  635 (1109)
                      +..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|++.
T Consensus       138 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~  208 (290)
T 1p9a_G          138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (290)
T ss_dssp             CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence            444444555555555555555555333334455555555555555555 45555555555666666666654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=8.5e-24  Score=237.35  Aligned_cols=202  Identities=22%  Similarity=0.242  Sum_probs=174.1

Q ss_pred             CCCCceEEeecCccCCCCCCcc--cccccccEEeccCCcccCCcc----hhhhcccccceeecccccccccCCccccCCC
Q 001275          501 NPVLSHLDVSRNNISGAIPSSI--GNSINLTSIDFSSNKFSGLMP----QELGNLVSLVTLNISLNHVEGSLPSQLSKCK  574 (1109)
Q Consensus       501 ~~~L~~L~Ls~N~i~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~  574 (1109)
                      .++|++|++++|++++..|..+  +.+++|++|+|++|++++..|    ..+..+++|++|+|++|++++..|..++.++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            3558999999999999999888  889999999999999997655    4456789999999999999988889999999


Q ss_pred             CccEEEecCccccCC--C--CcccccccccceeccccccccCCCcc----hhhhhhhhhhhhcccCcCCCCCCCCchhh-
Q 001275          575 NLEVFDVSFNLLNGS--I--PSSLRSWKSLSILKLSENHFTGGIPT----FISELEKLLELQLGGNQLGGEIPPSIGAL-  645 (1109)
Q Consensus       575 ~L~~L~ls~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~g~ip~~~~~l-  645 (1109)
                      +|++|||++|++.+.  +  +..+..+++|++|+|++|+++ .+|.    .+..+++|++|||++|++++.+|+.++.+ 
T Consensus       170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~  248 (310)
T 4glp_A          170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM  248 (310)
T ss_dssp             TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred             CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence            999999999998752  2  234578999999999999997 4444    35788999999999999998889888887 


Q ss_pred             --hhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCCCCccccceEEeeecccccc
Q 001275          646 --QDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTG  708 (1109)
Q Consensus       646 --~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~l~~~~~l~~l~~~~n~l~g  708 (1109)
                        ++| ..|+|++|+|+ .+|..+.  ++|++|||++|+|++. |.+..+++|+.|++++|+++.
T Consensus       249 ~~~~L-~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          249 WSSAL-NSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCTTC-CCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTTSC
T ss_pred             CcCcC-CEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCCCC
Confidence              577 57999999999 8898886  8999999999999964 557788999999999999874

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=3.3e-23  Score=224.89  Aligned_cols=191  Identities=19%  Similarity=0.234  Sum_probs=139.3

Q ss_pred             CCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCC
Q 001275           57 TPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIP  136 (1109)
Q Consensus        57 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p  136 (1109)
                      +||.|.|++|....   ..+++++++++ .+|+.+.  +++++|+|++|++++..+..|+++++|++|+|++|++++..|
T Consensus         3 ~Cp~~~gC~C~~~~---~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~   76 (251)
T 3m19_A            3 TCETVTGCTCNEGK---KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA   76 (251)
T ss_dssp             -CHHHHSSEEEGGG---TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred             cCCCCCceEcCCCC---eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence            47899999996432   34677777766 3555554  578888888888887777778888888888888888887777


Q ss_pred             ccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccC
Q 001275          137 DNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYR  216 (1109)
Q Consensus       137 ~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  216 (1109)
                      ..|.++++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..|+.+++
T Consensus        77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  156 (251)
T 3m19_A           77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN  156 (251)
T ss_dssp             TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence            77888888888888888887655566677777777777777777665566677777777777777777666666777777


Q ss_pred             ccEEEeccccccCcCchhcccccccccccccCcccCC
Q 001275          217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEG  253 (1109)
Q Consensus       217 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  253 (1109)
                      |++|+|++|++++..+..|..+++|+.|++++|.++.
T Consensus       157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            7777777777776666666667777777777776654

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.89  E-value=1.2e-22  Score=225.21  Aligned_cols=200  Identities=24%  Similarity=0.199  Sum_probs=94.3

Q ss_pred             CCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchh
Q 001275          189 DLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL  268 (1109)
Q Consensus       189 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  268 (1109)
                      ++++++++++++|.++ .+|..+.  +++++|+|++|++++..+..|.++++|++|+|++|++++..+.  ..+++|++|
T Consensus         8 ~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L   82 (290)
T 1p9a_G            8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTL   82 (290)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEE
T ss_pred             ccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEE
Confidence            3444444444444444 3333332  3455555555555554455555555555555555555443221  344455555


Q ss_pred             ccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccC
Q 001275          269 DLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLE  348 (1109)
Q Consensus       269 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  348 (1109)
                      +|++|+++ .+|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+++
T Consensus        83 ~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  161 (290)
T 1p9a_G           83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (290)
T ss_dssp             ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             ECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence            55555554 33444444555555555555555444444555555555555555555444444444555555555555554


Q ss_pred             CCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCcc
Q 001275          349 GEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL  395 (1109)
Q Consensus       349 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l  395 (1109)
                      +..+..|..+++|++|+|++|+|+ .+|..+....+|+.|++++|.+
T Consensus       162 ~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~  207 (290)
T 1p9a_G          162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (290)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             ccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence            333333444445555555554444 2333333333344444443333

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=3.1e-24  Score=257.83  Aligned_cols=186  Identities=19%  Similarity=0.246  Sum_probs=146.1

Q ss_pred             CCCceeecccCeEEEEEEeCCCcEEEEEEeeeccccc-------ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          822 NAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKR-------GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ...++||+|+||+||+|... ++.+|+|+........       ..+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            44678999999999999544 7788998864332111       134578999999999999999777777777888999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.++++.           +..++.|+++||+|||   +.+|+||||||+||+++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999875           4589999999999999   899999999999999998  999999999997754


Q ss_pred             CCCCc-----eeeecccCccccccccccc--CCCCccCcchhhHHHHHHHHhCCCCC
Q 001275          975 SPAST-----TSISVVGTIGYIAPENAFT--TAKSKESDVYSYGVVLLELITRKKAL 1024 (1109)
Q Consensus       975 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvil~elltg~~p~ 1024 (1109)
                      .....     ......||+.|+|||++..  ..|+..+|+|+..+-..+-+.++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32111     1134689999999999987  66788899999999998888887665

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.88  E-value=3.6e-23  Score=222.89  Aligned_cols=196  Identities=16%  Similarity=0.166  Sum_probs=120.4

Q ss_pred             CccEeecCCCcccccCCCCCCCCCCCcEeeccCcc-ccCCCCccccccCccceecccc-ccccccCCcccccccccceec
Q 001275           96 KLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNG-FTGDIPDNFENLQNLQYLNLYG-NLLDGEIPEPLFRILGLQYVF  173 (1109)
Q Consensus        96 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~-l~~~~p~~l~~L~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~  173 (1109)
                      +|++|+|++|++++..+..|+.+++|++|++++|+ +++..+..|.++++|++|+|++ |++++..+..+..+++|++|+
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            77888888888887666678888888888888886 7765556777788888888877 777754445666666666666


Q ss_pred             ccccccccccccccCCCcccc---eeecccc-cCCCCcccccccccCccEEEeccccccCcCchhcccccccc-cccccC
Q 001275          174 LNNNSLSGSIPRNVGDLKEVE---ALWLFSN-RLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLV-YLDVGD  248 (1109)
Q Consensus       174 Ls~n~l~~~~p~~l~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~-~L~L~~  248 (1109)
                      +++|++++ +|. ++.+++|+   +|++++| +++                        +..+..|.++++|+ .|++++
T Consensus       112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~------------------------~i~~~~~~~l~~L~~~L~l~~  165 (239)
T 2xwt_C          112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT------------------------SIPVNAFQGLCNETLTLKLYN  165 (239)
T ss_dssp             EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC------------------------EECTTTTTTTBSSEEEEECCS
T ss_pred             CCCCCCcc-ccc-cccccccccccEEECCCCcchh------------------------hcCcccccchhcceeEEEcCC
Confidence            66666664 443 55554444   5555555 444                        44444444445555 555555


Q ss_pred             cccCCcccccccCCCCcchhcccccc-ccCCCCcccccc-cCCcEEEeecCCCCCcCCccccccccccEEEcCCC
Q 001275          249 NNLEGRINFGSEKCKNLTFLDLSYNR-FSGGISPNLGNC-SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN  321 (1109)
Q Consensus       249 N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N  321 (1109)
                      |+++...+..+.. ++|++|+|++|+ +++..+..|..+ ++|+.|++++|++++..+.   .+++|+.|+++++
T Consensus       166 n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          166 NGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             CCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            5544322223333 455555666553 554444556666 6666666666666643332   4556667766655

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=7.3e-25  Score=254.33  Aligned_cols=192  Identities=20%  Similarity=0.194  Sum_probs=94.7

Q ss_pred             CCCcccceeecccccCCC----CcccccccccCccEEEeccccccCcCchhccc----c---------cccccccccCcc
Q 001275          188 GDLKEVEALWLFSNRLSG----TIPESIGNCYRLQELYLNENKLMGFLPESLSN----L---------ENLVYLDVGDNN  250 (1109)
Q Consensus       188 ~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~----l---------~~L~~L~L~~N~  250 (1109)
                      ..+++|++|+|++|++++    .+|..+..+++|++|+|++|.++...+..+..    +         ++|++|++++|+
T Consensus        91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~  170 (386)
T 2ca6_A           91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR  170 (386)
T ss_dssp             TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred             hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence            566677777777777665    35666667777777777777765443333332    2         555555555555


Q ss_pred             cCC-ccc---ccccCCCCcchhccccccccC-----CCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCC
Q 001275          251 LEG-RIN---FGSEKCKNLTFLDLSYNRFSG-----GISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSEN  321 (1109)
Q Consensus       251 l~~-~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N  321 (1109)
                      ++. ..+   ..+..+++|++|+|++|+++.     ..+..+..+++|+.|+|++|.++...                  
T Consensus       171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g------------------  232 (386)
T 2ca6_A          171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG------------------  232 (386)
T ss_dssp             CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH------------------
T ss_pred             CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH------------------
Confidence            541 222   223344444444444444441     11223444444444444444443000                  


Q ss_pred             CCCCCCCCccccccccceeeccCcccCCC----CCccc--cCCCCccEEEccCccccc----cCchHH-Hhhcccceeec
Q 001275          322 QLSGKIPPELGKCKYLTVLHLYANQLEGE----IPDEL--GQLSNLQDLELFDNRLTG----EFPVSI-WRIASLEYLLV  390 (1109)
Q Consensus       322 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~l  390 (1109)
                        .+.+|..+..+++|+.|+|++|.+++.    +|..+  +.+++|++|+|++|++++    .+|..+ .++++|++|++
T Consensus       233 --~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l  310 (386)
T 2ca6_A          233 --SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL  310 (386)
T ss_dssp             --HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEEC
T ss_pred             --HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEc
Confidence              023334444444444444444444432    23333  225555555555555554    244444 33455555555


Q ss_pred             cCCccCCCC
Q 001275          391 YNNNLLGKL  399 (1109)
Q Consensus       391 ~~N~l~~~~  399 (1109)
                      ++|.+++..
T Consensus       311 ~~N~l~~~~  319 (386)
T 2ca6_A          311 NGNRFSEED  319 (386)
T ss_dssp             TTSBSCTTS
T ss_pred             cCCcCCcch
Confidence            555555444

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=8.4e-25  Score=253.80  Aligned_cols=272  Identities=21%  Similarity=0.241  Sum_probs=181.0

Q ss_pred             CCcccccccccceeccccccccccc----ccccCCCcccceeecccc---cCCCCccccc-------ccccCccEEEecc
Q 001275          159 IPEPLFRILGLQYVFLNNNSLSGSI----PRNVGDLKEVEALWLFSN---RLSGTIPESI-------GNCYRLQELYLNE  224 (1109)
Q Consensus       159 ~p~~l~~l~~L~~L~Ls~n~l~~~~----p~~l~~l~~L~~L~L~~N---~l~~~~p~~l-------~~l~~L~~L~L~~  224 (1109)
                      ++..+..+++|++|+|++|++++..    +..+..+++|++|+|++|   ++++.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            3334444444444444444444332    233555666666666664   3334445444       5677788888888


Q ss_pred             ccccC----cCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCC
Q 001275          225 NKLMG----FLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLT  300 (1109)
Q Consensus       225 N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  300 (1109)
                      |++++    .+|..+.++++|++|+|++|++++..+..+...  |..  +..|++.+.       .++|++|++++|+++
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~--l~~~~~~~~-------~~~L~~L~L~~n~l~  172 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQE--LAVNKKAKN-------APPLRSIICGRNRLE  172 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHH--HHHHHHHHT-------CCCCCEEECCSSCCT
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHH--Hhhhhhccc-------CCCCcEEECCCCCCC
Confidence            87776    356667777777777777777754333222111  100  011111110       177888888888887


Q ss_pred             -CcCC---ccccccccccEEEcCCCCCC--C---CCCCccccccccceeeccCcccC----CCCCccccCCCCccEEEcc
Q 001275          301 -GSIP---SSFGLLARLSSLDLSENQLS--G---KIPPELGKCKYLTVLHLYANQLE----GEIPDELGQLSNLQDLELF  367 (1109)
Q Consensus       301 -~~~~---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~l~~l~~L~~L~L~~N~l~----~~~p~~l~~l~~L~~L~L~  367 (1109)
                       +.++   ..+..+++|++|++++|+++  |   ..|..+..+++|+.|+|++|.++    +.+|..+..+++|++|+|+
T Consensus       173 ~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~  252 (386)
T 2ca6_A          173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN  252 (386)
T ss_dssp             GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred             cHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC
Confidence             3344   46677889999999999887  2   34557889999999999999996    5678889999999999999


Q ss_pred             Ccccccc----CchHHHh--hcccceeeccCCccCC----CCchhh-hccCCCCeEEccCCcCcccCC--cccc-CCCCC
Q 001275          368 DNRLTGE----FPVSIWR--IASLEYLLVYNNNLLG----KLPLEM-TELKQLKNISLYNNQFSGVIP--QSLG-INSSL  433 (1109)
Q Consensus       368 ~N~l~~~----~~~~~~~--l~~L~~L~l~~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~~~p--~~~~-~~~~L  433 (1109)
                      +|++++.    ++..+..  +++|++|+|++|.+++    .+|..+ .++++|+.|++++|++++..+  ..+. .++.+
T Consensus       253 ~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~  332 (386)
T 2ca6_A          253 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTR  332 (386)
T ss_dssp             TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHH
T ss_pred             CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhc
Confidence            9999876    4556644  8999999999999997    477777 668999999999999997764  3322 23444


Q ss_pred             ceEEecCC
Q 001275          434 MQLDFINN  441 (1109)
Q Consensus       434 ~~L~ls~N  441 (1109)
                      +.+++..+
T Consensus       333 ~~~~l~~~  340 (386)
T 2ca6_A          333 GRGELDEL  340 (386)
T ss_dssp             TCCEECCC
T ss_pred             Ccchhhhc
Confidence            45555443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.88  E-value=6.6e-23  Score=230.05  Aligned_cols=224  Identities=18%  Similarity=0.209  Sum_probs=140.1

Q ss_pred             CccEEEccCccccccCch---HHHhhcccceeeccCCccCCCCchhh--hccCCCCeEEccCCcCcccCC----ccccCC
Q 001275          360 NLQDLELFDNRLTGEFPV---SIWRIASLEYLLVYNNNLLGKLPLEM--TELKQLKNISLYNNQFSGVIP----QSLGIN  430 (1109)
Q Consensus       360 ~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~~  430 (1109)
                      .++.|.+.++.++...-.   .+..+++|++|++++|.+.+..|..+  ..+++|++|+|++|++++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            466777777766532111   12234567777777777777777776  777777777777777776544    233456


Q ss_pred             CCCceEEecCCcccccCCCCcccCccceEEECCCcccccC--C--CcccCCCCccchhhccCcccCCCCCCCCCCCCCce
Q 001275          431 SSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGP--I--PSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSH  506 (1109)
Q Consensus       431 ~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~  506 (1109)
                      ++|++|++++|.+++..|..+..+++|++|+|++|++.+.  +  +..                       +..+++|++
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~-----------------------~~~l~~L~~  201 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALC-----------------------PHKFPAIQN  201 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSC-----------------------TTSSCCCCS
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHh-----------------------hhcCCCCCE
Confidence            6777777777777766666666777777777777766431  1  111                       234455555


Q ss_pred             EEeecCccCCCCCC----cccccccccEEeccCCcccCCcchhhhcc---cccceeecccccccccCCccccCCCCccEE
Q 001275          507 LDVSRNNISGAIPS----SIGNSINLTSIDFSSNKFSGLMPQELGNL---VSLVTLNISLNHVEGSLPSQLSKCKNLEVF  579 (1109)
Q Consensus       507 L~Ls~N~i~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  579 (1109)
                      |+|++|+++ .+|.    .++++++|++|||++|++++..|..++.+   ++|++|+|++|+|+ .+|..+.  ++|+.|
T Consensus       202 L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L  277 (310)
T 4glp_A          202 LALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVL  277 (310)
T ss_dssp             CBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCE
T ss_pred             EECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEE
Confidence            666666654 2222    23455666666666666666656555555   46777777777776 5566554  677777


Q ss_pred             EecCccccCCCCcccccccccceeccccccccC
Q 001275          580 DVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG  612 (1109)
Q Consensus       580 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  612 (1109)
                      ||++|+|++. |. +..+++|+.|+|++|+++.
T Consensus       278 ~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          278 DLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             ECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             ECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            7777777742 33 5666777777777777763

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=7.5e-24  Score=240.93  Aligned_cols=253  Identities=23%  Similarity=0.264  Sum_probs=189.1

Q ss_pred             CcEeeccCccccCCCCcccccc--CccceeccccccccccCCcccccccccceecccccccccc-cccccCCCcccceee
Q 001275          121 LEYLDLSTNGFTGDIPDNFENL--QNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGS-IPRNVGDLKEVEALW  197 (1109)
Q Consensus       121 L~~L~Ls~n~l~~~~p~~l~~L--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~  197 (1109)
                      ++.||+++|.+.   |..+..+  +++++|++++|.+.+..+. ++.+++|++|++++|.+++. ++..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            556666666554   3445555  6677777777766654433 55667777777777777655 666777778888888


Q ss_pred             cccccCCCCcccccccccCccEEEeccc-cccCc-CchhcccccccccccccCc-ccCCc-ccccccCCC-Ccchhcccc
Q 001275          198 LFSNRLSGTIPESIGNCYRLQELYLNEN-KLMGF-LPESLSNLENLVYLDVGDN-NLEGR-INFGSEKCK-NLTFLDLSY  272 (1109)
Q Consensus       198 L~~N~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~Ls~  272 (1109)
                      |++|.+++..|..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence            8888777777777778888888888888 56653 5666788888888888888 88764 466678888 999999999


Q ss_pred             c--ccc-CCCCcccccccCCcEEEeecCC-CCCcCCccccccccccEEEcCCCC-CCCCCCCccccccccceeeccCccc
Q 001275          273 N--RFS-GGISPNLGNCSSLTHLDIVGSK-LTGSIPSSFGLLARLSSLDLSENQ-LSGKIPPELGKCKYLTVLHLYANQL  347 (1109)
Q Consensus       273 N--~l~-~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N~l  347 (1109)
                      |  .++ +.++..+..+++|++|++++|. +++..+..++.+++|++|++++|. +.......++++++|+.|++++| +
T Consensus       205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i  283 (336)
T 2ast_B          205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V  283 (336)
T ss_dssp             CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred             CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence            9  455 4556777889999999999999 787888899999999999999996 33222236889999999999999 5


Q ss_pred             CCCCCccccCC-CCccEEEccCccccccCchHHHh
Q 001275          348 EGEIPDELGQL-SNLQDLELFDNRLTGEFPVSIWR  381 (1109)
Q Consensus       348 ~~~~p~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~  381 (1109)
                      ...   .+..+ .+++.|++++|++++..|..+..
T Consensus       284 ~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          284 PDG---TLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             CTT---CHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CHH---HHHHHHhhCcceEEecccCccccCCcccc
Confidence            432   33333 24677779999999988876554

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.87  E-value=4.1e-22  Score=214.62  Aligned_cols=198  Identities=19%  Similarity=0.188  Sum_probs=153.1

Q ss_pred             CCCcEeeccCccccCCCCccccccCccceecccccc-ccccCCcccccccccceecccccccccccccccCCCcccceee
Q 001275          119 SALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL-LDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALW  197 (1109)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~  197 (1109)
                      ++|++|+|++|++++..+..|+++++|++|+|++|. ++...+..+..                        +++|++|+
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~------------------------l~~L~~L~   86 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYN------------------------LSKVTHIE   86 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEES------------------------CTTCCEEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCC------------------------CcCCcEEE
Confidence            478899999999987666688888888888888886 66333334444                        44555555


Q ss_pred             ccc-ccCCCCcccccccccCccEEEeccccccCcCchhcccccccc---cccccCc-ccCCcccccccCCCCcc-hhccc
Q 001275          198 LFS-NRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLV---YLDVGDN-NLEGRINFGSEKCKNLT-FLDLS  271 (1109)
Q Consensus       198 L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~Ls  271 (1109)
                      +++ |++++..+..|.++++|++|++++|++++ +|. |..+++|+   +|++++| ++++..+..|..+++|+ +|+++
T Consensus        87 l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~  164 (239)
T 2xwt_C           87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY  164 (239)
T ss_dssp             EEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECC
T ss_pred             CCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcC
Confidence            554 55554445566777777777777777776 444 77777777   9999999 99988888899999999 99999


Q ss_pred             cccccCCCCcccccccCCcEEEeecCC-CCCcCCcccccc-ccccEEEcCCCCCCCCCCCccccccccceeeccCcc
Q 001275          272 YNRFSGGISPNLGNCSSLTHLDIVGSK-LTGSIPSSFGLL-ARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQ  346 (1109)
Q Consensus       272 ~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~  346 (1109)
                      +|+++...+..|.. ++|+.|++++|+ +++..+..|..+ ++|+.|++++|++++ +|..  .+++|+.|+++++.
T Consensus       165 ~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          165 NNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNTW  237 (239)
T ss_dssp             SCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC-
T ss_pred             CCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCcc
Confidence            99999444444555 899999999995 997778889999 999999999999995 4443  57889999988763

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=3.1e-22  Score=224.00  Aligned_cols=192  Identities=22%  Similarity=0.299  Sum_probs=94.8

Q ss_pred             ccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchh
Q 001275          405 ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRV  484 (1109)
Q Consensus       405 ~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l  484 (1109)
                      .+++|+.|++++|.++. +| .+..+++|++|++++|.+++..+  +..+++|++|++++|++++.  +.+..+++|+.|
T Consensus        39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence            34444555555554442 22 24444445555555554443222  44444555555555554432  133444444444


Q ss_pred             hccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccc
Q 001275          485 ILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEG  564 (1109)
Q Consensus       485 ~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  564 (1109)
                      ++++|++++. +.+..+++|++|++++|++++..+  ++.+++|+.|++++|++++..+  +..+++|+.|++++|++++
T Consensus       113 ~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  187 (308)
T 1h6u_A          113 DLTSTQITDV-TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISD  187 (308)
T ss_dssp             ECTTSCCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             ECCCCCCCCc-hhhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCc
Confidence            4444444432 225555555555665555554322  5555556666666665554322  5555555555555555553


Q ss_pred             cCCccccCCCCccEEEecCccccCCCCcccccccccceecccccccc
Q 001275          565 SLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       565 ~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      ..+  +..+++|+.|++++|++++..  .+..+++|+.|+|++|+++
T Consensus       188 ~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          188 ISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             CGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred             Chh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence            322  555555555566555555332  2555555555555555555

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=1e-21  Score=213.12  Aligned_cols=158  Identities=17%  Similarity=0.209  Sum_probs=100.3

Q ss_pred             cceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEecc
Q 001275          456 QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFS  534 (1109)
Q Consensus       456 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls  534 (1109)
                      +++.|+|++|++.+..+..+..+++|++|++++|++++..+. |..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            344444444444444444444444444444444444444443 5566667777777777766666666677777777777


Q ss_pred             CCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCC
Q 001275          535 SNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGG  613 (1109)
Q Consensus       535 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  613 (1109)
                      +|+|++..+..++.+++|++|+|++|+|++..|..+..+++|+.|||++|+|++..|..|..+++|+.|+|++|++++.
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            7777765555566777777777777777755555677777777777777777766666677777777777777777654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.86  E-value=2e-21  Score=217.48  Aligned_cols=216  Identities=20%  Similarity=0.309  Sum_probs=132.9

Q ss_pred             ccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEcc
Q 001275          336 YLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLY  415 (1109)
Q Consensus       336 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~  415 (1109)
                      .+..+.+..+.+.+.+  .+..+++|++|++++|.++. ++ .+..+++|++|++++|.+.+..+  +..+++|+.|+++
T Consensus        20 ~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~   93 (308)
T 1h6u_A           20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELS   93 (308)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECC
T ss_pred             HHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEcc
Confidence            3344445555554322  23456666677777666663 33 45566666666666666654333  5566666666666


Q ss_pred             CCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCC
Q 001275          416 NNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGAL  495 (1109)
Q Consensus       416 ~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  495 (1109)
                      +|++++.  ..++.+++|++|++++|.+++. + .                        +..+++|+.|++++|++++..
T Consensus        94 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~------------------------l~~l~~L~~L~l~~n~l~~~~  145 (308)
T 1h6u_A           94 GNPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-P------------------------LAGLSNLQVLYLDLNQITNIS  145 (308)
T ss_dssp             SCCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-G------------------------GTTCTTCCEEECCSSCCCCCG
T ss_pred             CCcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-h------------------------hcCCCCCCEEECCCCccCcCc
Confidence            6666542  2345555555555555555432 1 1                        444455555555555554433


Q ss_pred             CCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCC
Q 001275          496 PEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKN  575 (1109)
Q Consensus       496 ~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  575 (1109)
                      + +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|++|+|++|++++..|  +..+++
T Consensus       146 ~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~  218 (308)
T 1h6u_A          146 P-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSN  218 (308)
T ss_dssp             G-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTT
T ss_pred             c-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCC
Confidence            3 6667778888888888875433  7778888888888888876543  7778888888888888885443  777888


Q ss_pred             ccEEEecCccccCCCCcc
Q 001275          576 LEVFDVSFNLLNGSIPSS  593 (1109)
Q Consensus       576 L~~L~ls~N~l~~~~p~~  593 (1109)
                      |+.|++++|.+++ .|..
T Consensus       219 L~~L~l~~N~i~~-~~~~  235 (308)
T 1h6u_A          219 LFIVTLTNQTITN-QPVF  235 (308)
T ss_dssp             CCEEEEEEEEEEC-CCEE
T ss_pred             CCEEEccCCeeec-CCee
Confidence            8888888888874 4433

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=5.1e-21  Score=201.28  Aligned_cols=187  Identities=22%  Similarity=0.309  Sum_probs=114.5

Q ss_pred             CCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC
Q 001275           56 STPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI  135 (1109)
Q Consensus        56 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (1109)
                      .+.|.|.+|.|+....             ..+|..+  .++|++|++++|++++..+..++.+++|++|+|++|++++..
T Consensus         4 ~C~C~~~~v~c~~~~l-------------~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~   68 (208)
T 2o6s_A            4 RCSCSGTTVECYSQGR-------------TSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP   68 (208)
T ss_dssp             TCEEETTEEECCSSCC-------------SSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred             CCEECCCEEEecCCCc-------------cCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccC
Confidence            4568999999975321             1233322  357888888888888666666778888888888888887665


Q ss_pred             CccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCccccccccc
Q 001275          136 PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCY  215 (1109)
Q Consensus       136 p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  215 (1109)
                      +..|.++++|++|+|++|.+++..+..+..+++|++|++++|++++..+..+..+++|++|++++|++            
T Consensus        69 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l------------  136 (208)
T 2o6s_A           69 NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL------------  136 (208)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC------------
T ss_pred             hhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCcc------------
Confidence            56677777777777777777744444445555555555555555544444444445555555555544            


Q ss_pred             CccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccC
Q 001275          216 RLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSS  288 (1109)
Q Consensus       216 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  288 (1109)
                                  ++..+..|..+++|++|++++|.+.+       .+++|++|+++.|+++|.+|..++.++.
T Consensus       137 ------------~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          137 ------------KSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             ------------SCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             ------------ceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence                        44444444555555555555554432       2345666666666666666666655543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=2.5e-21  Score=232.36  Aligned_cols=187  Identities=28%  Similarity=0.443  Sum_probs=92.6

Q ss_pred             CCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhcc
Q 001275          408 QLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK  487 (1109)
Q Consensus       408 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~  487 (1109)
                      +|+.|++++|.+++ +|..+.  ++|++|+|++|.|+ .+|   ..+++|++|+|++|+|++ +|. +..  +       
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~-------  121 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--S-------  121 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--T-------
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--C-------
Confidence            66667777666665 454442  55666666666666 444   234566666666666654 443 322  3       


Q ss_pred             CcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCC
Q 001275          488 QNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLP  567 (1109)
Q Consensus       488 ~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  567 (1109)
                                      |++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|+|++ +|
T Consensus       122 ----------------L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp  176 (571)
T 3cvr_A          122 ----------------LKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LP  176 (571)
T ss_dssp             ----------------CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred             ----------------CCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cc
Confidence                            3444444444443 232   23444444444444443 232   23444444444444443 33


Q ss_pred             ccccCCCCccEEEecCccccCCCCccccccccc-------ceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCC
Q 001275          568 SQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL-------SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPP  640 (1109)
Q Consensus       568 ~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L-------~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~  640 (1109)
                      . ++  ++|+.|+|++|+|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|.
T Consensus       177 ~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~  248 (571)
T 3cvr_A          177 E-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRE  248 (571)
T ss_dssp             C-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHH
T ss_pred             h-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHH
Confidence            3 33  44555555555554 3444 332  34       55555555555 4555555555555555555555555555


Q ss_pred             Cchhh
Q 001275          641 SIGAL  645 (1109)
Q Consensus       641 ~~~~l  645 (1109)
                      .++.+
T Consensus       249 ~l~~l  253 (571)
T 3cvr_A          249 SLSQQ  253 (571)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            55444

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=1e-21  Score=235.59  Aligned_cols=189  Identities=27%  Similarity=0.407  Sum_probs=130.5

Q ss_pred             CCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeec
Q 001275          432 SLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSR  511 (1109)
Q Consensus       432 ~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~  511 (1109)
                      +++.|++++|+|++ +|..+.  ++|++|+|++|+|+                         .+|  ..+++|++|++++
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-------------------------~ip--~~l~~L~~L~Ls~  109 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-------------------------SLP--ELPASLEYLDACD  109 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-------------------------CCC--CCCTTCCEEECCS
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-------------------------ccc--cccCCCCEEEccC
Confidence            56666666666664 444332  45555555555554                         222  2346788888888


Q ss_pred             CccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCC
Q 001275          512 NNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP  591 (1109)
Q Consensus       512 N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p  591 (1109)
                      |+|++ +|. +.+  +|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|
T Consensus       110 N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp  176 (571)
T 3cvr_A          110 NRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LP  176 (571)
T ss_dssp             SCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC
T ss_pred             CCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cc
Confidence            88886 666 665  88999999999887 565   67888888888888885 665   56788888888888885 67


Q ss_pred             cccccccccceeccccccccCCCcchhhhhhhh-------hhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccC
Q 001275          592 SSLRSWKSLSILKLSENHFTGGIPTFISELEKL-------LELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIP  664 (1109)
Q Consensus       592 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip  664 (1109)
                      . |.  ++|+.|+|++|+|+ .+|. +..  +|       +.|+|++|+|+ .+|..++.+++| ..|+|++|.|+|.+|
T Consensus       177 ~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L-~~L~L~~N~l~~~~p  247 (571)
T 3cvr_A          177 E-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPT-CTIILEDNPLSSRIR  247 (571)
T ss_dssp             C-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTT-EEEECCSSSCCHHHH
T ss_pred             h-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCC-CEEEeeCCcCCCcCH
Confidence            6 65  78888888888888 6776 544  56       66677777766 566666666666 356666666666666


Q ss_pred             cchhhccc
Q 001275          665 SDLEKLSK  672 (1109)
Q Consensus       665 ~~l~~l~~  672 (1109)
                      ..+.+++.
T Consensus       248 ~~l~~l~~  255 (571)
T 3cvr_A          248 ESLSQQTA  255 (571)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHhhc
Confidence            66666544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.84  E-value=5.5e-21  Score=218.20  Aligned_cols=220  Identities=18%  Similarity=0.136  Sum_probs=115.7

Q ss_pred             CccEEEccCccccccCchHHHhhcccceeeccCCccCCCCc-hhhhccCCCCe-EEccCCcCcccCCccccCCCCCceEE
Q 001275          360 NLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLP-LEMTELKQLKN-ISLYNNQFSGVIPQSLGINSSLMQLD  437 (1109)
Q Consensus       360 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~~~~L~~L~  437 (1109)
                      ++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++++. +.+++|+++...|..|..+++|++|+
T Consensus        31 ~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~  110 (350)
T 4ay9_X           31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  110 (350)
T ss_dssp             TCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEE
T ss_pred             CCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccc
Confidence            34444444444443222233444444444444444433332 23455555443 44455666655566666666666666


Q ss_pred             ecCCcccccCCCCcccCccceEEECCC-cccccCCCcccCCCCccchhhccCcccCCCCCCCCCC-CCCceEEeecCccC
Q 001275          438 FINNSFTGEIPPNLCFGKQLRVLNMGQ-NQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKN-PVLSHLDVSRNNIS  515 (1109)
Q Consensus       438 ls~N~l~~~~p~~~~~~~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~-~~L~~L~Ls~N~i~  515 (1109)
                      +++|++++..+..+....++..|++.+ |++....+..                       |..+ ..++.|++++|+|+
T Consensus       111 l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~-----------------------f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X          111 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS-----------------------FVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTS-----------------------STTSBSSCEEEECCSSCCC
T ss_pred             ccccccccCCchhhcccchhhhhhhccccccccccccc-----------------------hhhcchhhhhhcccccccc
Confidence            666666655444455555556666543 3444222222                       2222 24666777777776


Q ss_pred             CCCCCcccccccccEEeccC-CcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCc-cccCCCCcc
Q 001275          516 GAIPSSIGNSINLTSIDFSS-NKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN-LLNGSIPSS  593 (1109)
Q Consensus       516 ~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N-~l~~~~p~~  593 (1109)
                       .+|..+....+|+.|++++ |+++...+..|..+++|++|+|++|+|+...+..+.   +|+.|.+.++ +++ .+| .
T Consensus       168 -~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~-~lP-~  241 (350)
T 4ay9_X          168 -EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLK-KLP-T  241 (350)
T ss_dssp             -EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCC-CCC-C
T ss_pred             -CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcC-cCC-C
Confidence             3444444556677777764 555543334567777777777777777733333343   4444444333 333 566 3


Q ss_pred             cccccccceeccccc
Q 001275          594 LRSWKSLSILKLSEN  608 (1109)
Q Consensus       594 ~~~l~~L~~L~L~~N  608 (1109)
                      +..+++|+.++++++
T Consensus       242 l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          242 LEKLVALMEASLTYP  256 (350)
T ss_dssp             TTTCCSCCEEECSCH
T ss_pred             chhCcChhhCcCCCC
Confidence            667777777777654

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.84  E-value=8.9e-21  Score=216.49  Aligned_cols=240  Identities=18%  Similarity=0.122  Sum_probs=125.9

Q ss_pred             cEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCc-ccccccccce-eccc
Q 001275           98 QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPE-PLFRILGLQY-VFLN  175 (1109)
Q Consensus        98 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~-L~Ls  175 (1109)
                      ++++-++++++ .+|..+  .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .+.++++|++ +.++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            45566666666 556554  35666777777776644444566666666666666666544443 2334444332 3333


Q ss_pred             ccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccC-cccCCc
Q 001275          176 NNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGD-NNLEGR  254 (1109)
Q Consensus       176 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~  254 (1109)
                      +|+++                        ...|..|..+++|++|++++|+++...+..+....++..|++.+ |++...
T Consensus        89 ~N~l~------------------------~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l  144 (350)
T 4ay9_X           89 ANNLL------------------------YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI  144 (350)
T ss_dssp             ETTCC------------------------EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEE
T ss_pred             CCccc------------------------ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccc
Confidence            34444                        33444444444444444444444444444444444444444433 334433


Q ss_pred             ccccccCCC-CcchhccccccccCCCCcccccccCCcEEEeec-CCCCCcCCccccccccccEEEcCCCCCCCCCCCccc
Q 001275          255 INFGSEKCK-NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVG-SKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELG  332 (1109)
Q Consensus       255 ~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~  332 (1109)
                      .+..|..+. .+++|+|++|+|+. ++.......+|+.|++++ |.++...+..|..+++|++|||++|+|+...+..|.
T Consensus       145 ~~~~f~~~~~~l~~L~L~~N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~  223 (350)
T 4ay9_X          145 ERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  223 (350)
T ss_dssp             CTTSSTTSBSSCEEEECCSSCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT
T ss_pred             cccchhhcchhhhhhccccccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc
Confidence            333343332 45556666666653 333333445666666654 455544445667777777777777777744344444


Q ss_pred             cccccceeeccCcccCCCCCccccCCCCccEEEccCc
Q 001275          333 KCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN  369 (1109)
Q Consensus       333 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  369 (1109)
                      ++++|+.+++  +.++ .+| .+..+++|+.+++.++
T Consensus       224 ~L~~L~~l~~--~~l~-~lP-~l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          224 NLKKLRARST--YNLK-KLP-TLEKLVALMEASLTYP  256 (350)
T ss_dssp             TCCEEECTTC--TTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred             cchHhhhccC--CCcC-cCC-CchhCcChhhCcCCCC
Confidence            4444433332  2233 455 3666777777777654

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.83  E-value=1.9e-20  Score=196.91  Aligned_cols=156  Identities=18%  Similarity=0.201  Sum_probs=100.7

Q ss_pred             CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCcc
Q 001275          498 FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLE  577 (1109)
Q Consensus       498 ~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  577 (1109)
                      |..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..++.+++|++|++++|++++..+..+..+++|+
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  127 (208)
T 2o6s_A           48 FDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLK  127 (208)
T ss_dssp             TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCC
Confidence            34455566666666666654445556666666666666666655555566666666666666666655555566777777


Q ss_pred             EEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhccccc
Q 001275          578 VFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKN  657 (1109)
Q Consensus       578 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N  657 (1109)
                      .|++++|++++..+..+..+++|+.|++++|.+.+..       ++|+.|+++.|+++|.+|++++.+..     ++...
T Consensus       128 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~-------~~l~~L~~~~n~~~g~ip~~~~~l~~-----~~~~C  195 (208)
T 2o6s_A          128 DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC-------PGIRYLSEWINKHSGVVRNSAGSVAP-----DSAKC  195 (208)
T ss_dssp             EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCT-------TTTHHHHHHHHHCTTTBBCTTSSBCT-----TCSBB
T ss_pred             EEECCCCccceeCHHHhccCCCccEEEecCCCeecCC-------CCHHHHHHHHHhCCceeeccCccccC-----Ccccc
Confidence            7777777777555555677777777777777776543       35778888888888888888877653     33444


Q ss_pred             ccccccCc
Q 001275          658 GLTGRIPS  665 (1109)
Q Consensus       658 ~l~g~ip~  665 (1109)
                      ...|..+.
T Consensus       196 ~~~~~~~~  203 (208)
T 2o6s_A          196 SGSGKPVR  203 (208)
T ss_dssp             TTTCCBGG
T ss_pred             ccCCCcce
Confidence            44444443

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=4.2e-21  Score=211.26  Aligned_cols=151  Identities=14%  Similarity=0.115  Sum_probs=119.5

Q ss_pred             HHHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccc-----------------cChHHHHHHHHHHhcCCCC
Q 001275          814 VIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHK-----------------RGSLSMKREIQTIGKIRHR  876 (1109)
Q Consensus       814 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~  876 (1109)
                      .......|.+.+.||+|+||.||+|...+|+.||+|.+......                 .....+.+|++++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            33444556677999999999999998877999999998532211                 12346889999999999  


Q ss_pred             ceeeEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          877 NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       877 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      | +++.+++.. +..++||||+++|+|.+ +..         .....++.|+++|++|||   +.+|+||||||+||+++
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE
Confidence            4 666665543 56799999999999988 422         124479999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccc
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF  997 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  997 (1109)
                       ++.+||+|||+|+..               ..|+|||++.
T Consensus       228 -~~~vkl~DFG~a~~~---------------~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVEV---------------GEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence             999999999998733               3568888764

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=9.2e-21  Score=236.16  Aligned_cols=260  Identities=20%  Similarity=0.173  Sum_probs=88.6

Q ss_pred             cCChhhHHHHHHHHHhccCCCCcccCCCCCCCCCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecC
Q 001275           24 NALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLS  103 (1109)
Q Consensus        24 ~~~~~~~~all~~~~~~~~~~~~~l~sW~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~  103 (1109)
                      +....++++|+++..+.....+..-..|.......+.|.+++++.  .+|+.++|.++++... +..     .|+.++|+
T Consensus       128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~-----~l~~l~Ls  199 (727)
T 4b8c_D          128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEA-NQA-----LLQHKKLS  199 (727)
T ss_dssp             ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred             hccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcc-hhh-----HhhcCccC
Confidence            345678899999999886555555567866555668899998865  5688999988777663 322     23444555


Q ss_pred             CCcccc---------cCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecc
Q 001275          104 SNNFSG---------NIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFL  174 (1109)
Q Consensus       104 ~n~l~~---------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  174 (1109)
                      .|.+.+         ..|..+..++.|++|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..+.++++|++|+|
T Consensus       200 ~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L  277 (727)
T 4b8c_D          200 QYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDL  277 (727)
T ss_dssp             ----------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEEC
T ss_pred             cccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeC
Confidence            554432         23444555555555555555555 44544555555555555555555 55555555555555555


Q ss_pred             cccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCc
Q 001275          175 NNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGR  254 (1109)
Q Consensus       175 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  254 (1109)
                      ++|+|+ .+|..|+++++|++|+|++|.++ .+|..|+++++|++|+|++|.|++.+|..+..+..              
T Consensus       278 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~--------------  341 (727)
T 4b8c_D          278 SHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV--------------  341 (727)
T ss_dssp             TTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH--------------
T ss_pred             cCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcch--------------
Confidence            555555 44555555555555555555554 44444555555555555555555554444433321              


Q ss_pred             ccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecC--------CCCCcCCccccccccccEEEcCCCCCC
Q 001275          255 INFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGS--------KLTGSIPSSFGLLARLSSLDLSENQLS  324 (1109)
Q Consensus       255 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n--------~l~~~~~~~~~~l~~L~~L~Ls~N~l~  324 (1109)
                               .+..|+|++|.+++.+|..      |+.|++++|        .+.+..+..+..+..+....+++|-+.
T Consensus       342 ---------~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          342 ---------TGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ---------HHHHHHHHHCCCCCCCCCC-----------------------------------------------CCC
T ss_pred             ---------hhhHHhhccCcccCcCccc------cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence                     1123445555555444432      233334433        333344445556667777788888765

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=4.1e-20  Score=230.25  Aligned_cols=187  Identities=20%  Similarity=0.234  Sum_probs=102.7

Q ss_pred             CCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeec
Q 001275          432 SLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSR  511 (1109)
Q Consensus       432 ~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~  511 (1109)
                      .++.|+|++|.+... +.     ..|+.++|+.|.|.              .++++.|++.-....+..++.|+.|+|++
T Consensus       174 ~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~i~--------------~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~  233 (727)
T 4b8c_D          174 LTPKIELFANGKDEA-NQ-----ALLQHKKLSQYSID--------------EDDDIENRMVMPKDSKYDDQLWHALDLSN  233 (727)
T ss_dssp             --------------------------------------------------------------------CCCCCCEEECTT
T ss_pred             ccceEEeeCCCCCcc-hh-----hHhhcCccCccccc--------------CccccccceecChhhhccCCCCcEEECCC
Confidence            345555555555431 21     22445555555544              22344455542222366777777777777


Q ss_pred             CccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCC
Q 001275          512 NNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP  591 (1109)
Q Consensus       512 N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p  591 (1109)
                      |+|. .+|..+.++++|++|+|++|+|+ .+|..|++|++|++|+|++|+|+ .+|..|+.|++|++|+|++|.|+ .+|
T Consensus       234 n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp  309 (727)
T 4b8c_D          234 LQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLP  309 (727)
T ss_dssp             SCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCC
T ss_pred             CCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccC
Confidence            7777 66766777777888888888777 66777777777888888888777 66777777777888888877776 677


Q ss_pred             cccccccccceeccccccccCCCcchhhhhhh-hhhhhcccCcCCCCCCCCc
Q 001275          592 SSLRSWKSLSILKLSENHFTGGIPTFISELEK-LLELQLGGNQLGGEIPPSI  642 (1109)
Q Consensus       592 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~l~~N~l~g~ip~~~  642 (1109)
                      ..|+.+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.++|.+|.++
T Consensus       310 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l  361 (727)
T 4b8c_D          310 WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER  361 (727)
T ss_dssp             SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred             hhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc
Confidence            77777777777777777777777777655433 2346677777777777655

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.80  E-value=1.2e-21  Score=236.48  Aligned_cols=204  Identities=20%  Similarity=0.142  Sum_probs=116.0

Q ss_pred             CCCCCCcEeeccCccccCCCCccccccCccceecccccc-------------ccccCCcccccccccceec-cccccccc
Q 001275          116 GNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL-------------LDGEIPEPLFRILGLQYVF-LNNNSLSG  181 (1109)
Q Consensus       116 ~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~-------------l~~~~p~~l~~l~~L~~L~-Ls~n~l~~  181 (1109)
                      ..+++|+.|+|++|+++ .+|..++++++|++|++++|.             +.+.+|..+..+.+|+.|+ ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            44566666666666665 456666666666666665553             3445555556666666665 4444332 


Q ss_pred             ccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccC
Q 001275          182 SIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEK  261 (1109)
Q Consensus       182 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~  261 (1109)
                                .|+.+.+.+|.++...+      ..|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..+..
T Consensus       424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~  484 (567)
T 1dce_A          424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA  484 (567)
T ss_dssp             ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred             ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence                      23334444444432211      135556666665554 233 555666666666666665 34455556


Q ss_pred             CCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcC-CccccccccccEEEcCCCCCCCCCCCc---ccccccc
Q 001275          262 CKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI-PSSFGLLARLSSLDLSENQLSGKIPPE---LGKCKYL  337 (1109)
Q Consensus       262 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~---l~~l~~L  337 (1109)
                      +++|++|+|++|++++ +| .++.+++|+.|+|++|+|++.. |..++.+++|+.|+|++|.+++.+|..   +..+++|
T Consensus       485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L  562 (567)
T 1dce_A          485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV  562 (567)
T ss_dssp             CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred             CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence            6666666666666664 34 5666666777777777776655 666777777777777777776543321   2235666


Q ss_pred             ceeec
Q 001275          338 TVLHL  342 (1109)
Q Consensus       338 ~~L~L  342 (1109)
                      +.|++
T Consensus       563 ~~L~l  567 (567)
T 1dce_A          563 SSILT  567 (567)
T ss_dssp             SEEEC
T ss_pred             CccCC
Confidence            66653

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.79  E-value=1.3e-19  Score=219.93  Aligned_cols=188  Identities=21%  Similarity=0.276  Sum_probs=88.7

Q ss_pred             cceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCC
Q 001275          385 LEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQ  464 (1109)
Q Consensus       385 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~  464 (1109)
                      +..+.+..+.+.+..+  +..+++|+.|++++|.++.. | .+..+++|+.|+|++|.|++..|  +..+++|+.|+|++
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            3444444444443222  34455555555555555432 2 34455555555555555554333  45555555555555


Q ss_pred             cccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcch
Q 001275          465 NQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQ  544 (1109)
Q Consensus       465 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  544 (1109)
                      |+|.+ +| .+..+++|+.|+|++|++++ ++.+..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|+|++..| 
T Consensus        97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-  170 (605)
T 1m9s_A           97 NKIKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-  170 (605)
T ss_dssp             SCCCC-CT-TSTTCTTCCEEECTTSCCCC-CGGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred             CCCCC-Ch-hhccCCCCCEEEecCCCCCC-CccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence            55543 11 23333333333333333332 23344445555555555555432  344455555555555555554433 


Q ss_pred             hhhcccccceeecccccccccCCccccCCCCccEEEecCcccc
Q 001275          545 ELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLN  587 (1109)
Q Consensus       545 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~  587 (1109)
                       +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|+++
T Consensus       171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred             -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence             44555555555555555432  23444555555555555554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=7.2e-21  Score=229.77  Aligned_cols=195  Identities=18%  Similarity=0.214  Sum_probs=140.5

Q ss_pred             CCCCCCceEEeecCccCCCCCCcccccccccEEeccCCc-------------ccCCcchhhhcccccceee-cccccccc
Q 001275          499 SKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNK-------------FSGLMPQELGNLVSLVTLN-ISLNHVEG  564 (1109)
Q Consensus       499 ~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~  564 (1109)
                      ..++.|+.|+|++|+++ .+|.+++++++|+.|++++|.             +.+.+|..++.+++|+.|+ ++.|.+..
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~  424 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD  424 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch
Confidence            55677888888888887 788888888888888887775             5677788888888888888 66665431


Q ss_pred             cCCc------cccC--CCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCC
Q 001275          565 SLPS------QLSK--CKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG  636 (1109)
Q Consensus       565 ~~p~------~l~~--l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  636 (1109)
                       ++.      .+..  ...|+.|+|++|+|++ +|. |+.+++|+.|+|++|+++ .+|..++.+++|+.|+|++|+|++
T Consensus       425 -L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~  500 (567)
T 1dce_A          425 -LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN  500 (567)
T ss_dssp             -HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred             -hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC
Confidence             110      0000  1247778888888874 665 777778888888888877 777777777888888888887774


Q ss_pred             CCCCCchhhhhhhhhhccccccccccc-CcchhhcccCCeEEccCCcccccCCCCCc----cccceEEee
Q 001275          637 EIPPSIGALQDLSYALNLSKNGLTGRI-PSDLEKLSKLEQLDISSNNLTGTLSPLSN----IHSLVEVNV  701 (1109)
Q Consensus       637 ~ip~~~~~l~~l~~~L~L~~N~l~g~i-p~~l~~l~~L~~L~Ls~N~l~g~~~~l~~----~~~l~~l~~  701 (1109)
                       +| .++.+++| ..|+|++|+|++.+ |..++++++|+.|||++|+|++.+|....    +++|+.||+
T Consensus       501 -lp-~l~~l~~L-~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          501 -VD-GVANLPRL-QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             -CG-GGTTCSSC-CEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             -Cc-ccCCCCCC-cEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence             66 67777777 36777777777665 77777777777788877777776665322    566666653

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.78  E-value=3.6e-19  Score=197.28  Aligned_cols=171  Identities=23%  Similarity=0.325  Sum_probs=76.9

Q ss_pred             hccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccch
Q 001275          404 TELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWR  483 (1109)
Q Consensus       404 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  483 (1109)
                      ..+++|+.|++++|.+++. + .+..+++|++|++++|.+++..+  +..+++|++|++++|++++ +| .+..+++|+.
T Consensus        43 ~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~  116 (291)
T 1h6t_A           43 NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS  116 (291)
T ss_dssp             HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred             hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence            3455555555555555532 2 24455555555555555554332  4555555555555555543 11 1333333333


Q ss_pred             hhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeeccccccc
Q 001275          484 VILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE  563 (1109)
Q Consensus       484 l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  563 (1109)
                      |++++|++++. +.+..+++|++|++++|++++.  ..++.+++|+.|++++|++++..|  +..+++|+.|++++|+|+
T Consensus       117 L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          117 LSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             EECTTSCCCCC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             EECCCCcCCCC-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            33333333321 2334444444444444444432  334444444444444444443322  444444444444444444


Q ss_pred             ccCCccccCCCCccEEEecCcccc
Q 001275          564 GSLPSQLSKCKNLEVFDVSFNLLN  587 (1109)
Q Consensus       564 ~~~p~~l~~l~~L~~L~ls~N~l~  587 (1109)
                      + +| .+..+++|+.|++++|+++
T Consensus       192 ~-l~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          192 D-LR-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             B-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred             C-Ch-hhccCCCCCEEECcCCccc
Confidence            2 22 2444444444444444444

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=1.5e-18  Score=184.99  Aligned_cols=158  Identities=22%  Similarity=0.259  Sum_probs=110.6

Q ss_pred             CCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC
Q 001275           56 STPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI  135 (1109)
Q Consensus        56 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (1109)
                      .+.|.|.+|.|+...             -+.+|..+.  ++|++|+|++|++++..|..|+.+++|++|+|++|+++...
T Consensus        16 ~~~Cs~~~v~c~~~~-------------l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~   80 (229)
T 3e6j_A           16 QCSCSGTTVDCRSKR-------------HASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP   80 (229)
T ss_dssp             TCEEETTEEECTTSC-------------CSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred             CCEEeCCEeEccCCC-------------cCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcC
Confidence            357999999997532             123454443  77888888888888877888888888888888888887655


Q ss_pred             CccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCccccccccc
Q 001275          136 PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCY  215 (1109)
Q Consensus       136 p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  215 (1109)
                      +..|..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..|..++
T Consensus        81 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  159 (229)
T 3e6j_A           81 VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS  159 (229)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred             hhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCC
Confidence            566788888888888888887554555566667777777777666 5566666666666666666666655555566666


Q ss_pred             CccEEEeccccccC
Q 001275          216 RLQELYLNENKLMG  229 (1109)
Q Consensus       216 ~L~~L~L~~N~l~~  229 (1109)
                      +|+.|+|++|.+..
T Consensus       160 ~L~~L~l~~N~~~c  173 (229)
T 3e6j_A          160 SLTHAYLFGNPWDC  173 (229)
T ss_dssp             TCCEEECTTSCBCT
T ss_pred             CCCEEEeeCCCccC
Confidence            66666666666553

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.77  E-value=6.5e-19  Score=213.90  Aligned_cols=170  Identities=28%  Similarity=0.373  Sum_probs=87.3

Q ss_pred             CcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhc
Q 001275          190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD  269 (1109)
Q Consensus       190 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  269 (1109)
                      +++|+.|++++|.+... | .++.+++|+.|+|++|++++..+  +..+++|+.|+|++|++++..  .+..+++|++|+
T Consensus        42 L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~--~l~~l~~L~~L~  115 (605)
T 1m9s_A           42 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLS--SLKDLKKLKSLS  115 (605)
T ss_dssp             HTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCT--TSTTCTTCCEEE
T ss_pred             CCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCCh--hhccCCCCCEEE
Confidence            33444444444444321 1 34444445555555554444332  444445555555555444321  344455555555


Q ss_pred             cccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCC
Q 001275          270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       270 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                      |++|++++.  +.+..+++|+.|+|++|++++.  ..++.+++|+.|+|++|++++..|  +..+++|+.|+|++|+|++
T Consensus       116 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          116 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             CTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred             ecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC
Confidence            555555532  2355555666666666665543  445556666666666666654433  5566666666666666654


Q ss_pred             CCCccccCCCCccEEEccCccccc
Q 001275          350 EIPDELGQLSNLQDLELFDNRLTG  373 (1109)
Q Consensus       350 ~~p~~l~~l~~L~~L~L~~N~l~~  373 (1109)
                      .  ..+..+++|+.|+|++|++++
T Consensus       190 l--~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          190 L--RALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             C--GGGTTCTTCSEEECCSEEEEC
T ss_pred             C--hHHccCCCCCEEEccCCcCcC
Confidence            2  245566666666666666654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.77  E-value=5.5e-19  Score=195.83  Aligned_cols=170  Identities=28%  Similarity=0.384  Sum_probs=80.2

Q ss_pred             CCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchh
Q 001275          189 DLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFL  268 (1109)
Q Consensus       189 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  268 (1109)
                      .+++|+.|++++|.++.. + .++.+++|++|+|++|++++..+  +.++++|++|++++|++++..  .+..+++|++|
T Consensus        44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L  117 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS--SLKDLKKLKSL  117 (291)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEE
T ss_pred             hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCCCh--hhccCCCCCEE
Confidence            344445555555544422 2 24455555555555555554333  455555555555555554321  14444444444


Q ss_pred             ccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccC
Q 001275          269 DLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLE  348 (1109)
Q Consensus       269 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  348 (1109)
                      +|++|++++.  +.+..+++|+.|++++|++++.  ..++.+++|+.|++++|++++..|  +..+++|+.|++++|+++
T Consensus       118 ~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~  191 (291)
T 1h6t_A          118 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS  191 (291)
T ss_dssp             ECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCC
Confidence            4444444432  2344445555555555555432  344445555555555555543322  444555555555555554


Q ss_pred             CCCCccccCCCCccEEEccCcccc
Q 001275          349 GEIPDELGQLSNLQDLELFDNRLT  372 (1109)
Q Consensus       349 ~~~p~~l~~l~~L~~L~L~~N~l~  372 (1109)
                      + ++ .+..+++|+.|++++|+++
T Consensus       192 ~-l~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          192 D-LR-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             B-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred             C-Ch-hhccCCCCCEEECcCCccc
Confidence            3 22 2444555555555555444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.76  E-value=3.3e-18  Score=181.19  Aligned_cols=158  Identities=23%  Similarity=0.371  Sum_probs=109.8

Q ss_pred             CCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC
Q 001275           56 STPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI  135 (1109)
Q Consensus        56 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (1109)
                      .|.|.|..|.|...            +++ .+|..+.  +.|++|+|++|++++..+..|..+++|++|+|++|++++..
T Consensus         8 ~C~C~~~~v~c~~~------------~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~   72 (220)
T 2v9t_B            8 ACTCSNNIVDCRGK------------GLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELA   72 (220)
T ss_dssp             TSEEETTEEECTTS------------CCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEEC
T ss_pred             CCEECCCEEEcCCC------------CcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcC
Confidence            34467777777542            222 3454443  57888888888888777778888888888888888888777


Q ss_pred             CccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCccccccccc
Q 001275          136 PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCY  215 (1109)
Q Consensus       136 p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  215 (1109)
                      |..|.++++|++|+|++|.++...+..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..++
T Consensus        73 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  152 (220)
T 2v9t_B           73 PDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR  152 (220)
T ss_dssp             TTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             HHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCC
Confidence            88888888888888888888743333455666777777777777666666666666666666666666665555566666


Q ss_pred             CccEEEecccccc
Q 001275          216 RLQELYLNENKLM  228 (1109)
Q Consensus       216 ~L~~L~L~~N~l~  228 (1109)
                      +|++|+|++|.+.
T Consensus       153 ~L~~L~L~~N~~~  165 (220)
T 2v9t_B          153 AIQTMHLAQNPFI  165 (220)
T ss_dssp             TCCEEECCSSCEE
T ss_pred             CCCEEEeCCCCcC
Confidence            6666666666654

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.76  E-value=2.1e-18  Score=182.71  Aligned_cols=117  Identities=21%  Similarity=0.286  Sum_probs=84.0

Q ss_pred             CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCcc
Q 001275          498 FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLE  577 (1109)
Q Consensus       498 ~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~  577 (1109)
                      |..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|+.+++|++|+|++|+|++..|..|..+++|+
T Consensus        53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (220)
T 2v70_A           53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR  132 (220)
T ss_dssp             GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred             hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence            55566677777777777766666777777777777777777766666677777777777777777766677777777777


Q ss_pred             EEEecCccccCCCCcccccccccceeccccccccCCC
Q 001275          578 VFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGI  614 (1109)
Q Consensus       578 ~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  614 (1109)
                      .|+|++|+|++..|..|..+++|+.|+|++|.+++..
T Consensus       133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  169 (220)
T 2v70_A          133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC  169 (220)
T ss_dssp             EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred             EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence            7777777777666777777777777777777776543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.74  E-value=4.5e-18  Score=180.06  Aligned_cols=150  Identities=18%  Similarity=0.188  Sum_probs=90.3

Q ss_pred             EecccCCccccCCcccCCCCccEeecCCCcccccCC-CCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccc
Q 001275           77 NLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIP-PKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLL  155 (1109)
Q Consensus        77 ~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l  155 (1109)
                      +++++.++. +|+.+.  +.+++|+|++|++++..| ..|+.+++|++|+|++|++++..+..|.++++|++|+|++|.+
T Consensus        17 ~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l   93 (220)
T 2v70_A           17 DCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL   93 (220)
T ss_dssp             ECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             EeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCcc
Confidence            333444432 454442  345677777777776544 3466777777777777777766666677777777777777776


Q ss_pred             cccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccC
Q 001275          156 DGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMG  229 (1109)
Q Consensus       156 ~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  229 (1109)
                      ++..|..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|.+..
T Consensus        94 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A           94 ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             CCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             CccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            65555555556666666666666665555555555555555555555555555555555555555555555543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.74  E-value=2e-18  Score=197.84  Aligned_cols=175  Identities=25%  Similarity=0.208  Sum_probs=136.9

Q ss_pred             EEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCC-CCCCCcEeeccCccccCCCCccccccCccceecccccc
Q 001275           76 FNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLG-NCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL  154 (1109)
Q Consensus        76 l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~  154 (1109)
                      ++++++++.. +|..+.  +.+++|+|++|++++..+..+. .+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        23 l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~   99 (361)
T 2xot_A           23 LSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH   99 (361)
T ss_dssp             EECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence            4455555543 555443  4588999999999987777777 89999999999999998777889999999999999999


Q ss_pred             ccccCCcccccccccceecccccccccccccccCCCcccceeecccccCCCCccccc---ccccCccEEEeccccccCcC
Q 001275          155 LDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESI---GNCYRLQELYLNENKLMGFL  231 (1109)
Q Consensus       155 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~L~L~~N~l~~~~  231 (1109)
                      |++..+..+..+.+|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|   ..+++|+.|+|++|+|++..
T Consensus       100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~  179 (361)
T 2xot_A          100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLP  179 (361)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCC
T ss_pred             CCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccC
Confidence            886666678888888888888888887778888888888888888888886544445   56888888888888888777


Q ss_pred             chhcccccc--cccccccCcccCC
Q 001275          232 PESLSNLEN--LVYLDVGDNNLEG  253 (1109)
Q Consensus       232 ~~~l~~l~~--L~~L~L~~N~l~~  253 (1109)
                      +..|..++.  |+.|+|++|.+..
T Consensus       180 ~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          180 LTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             HHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             HHHhhhccHhhcceEEecCCCccC
Confidence            777777776  3777777777763

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.74  E-value=2.4e-18  Score=187.51  Aligned_cols=171  Identities=19%  Similarity=0.237  Sum_probs=114.3

Q ss_pred             hhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEE
Q 001275          381 RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVL  460 (1109)
Q Consensus       381 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L  460 (1109)
                      .+..+..+++++|.+++..  .+..+++|+.|++++|+++. +| .+..+++|++|++++|.+++..+  +..+++|++|
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            4566677777777776432  46677777777777777763 33 45666666666666666664333  5555566666


Q ss_pred             ECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccC
Q 001275          461 NMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG  540 (1109)
Q Consensus       461 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  540 (1109)
                      ++++|++++                         +|.+.. ++|++|++++|+|++ ++ .++.+++|+.|+|++|++++
T Consensus        91 ~L~~N~l~~-------------------------l~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~  142 (263)
T 1xeu_A           91 SVNRNRLKN-------------------------LNGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS  142 (263)
T ss_dssp             ECCSSCCSC-------------------------CTTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB
T ss_pred             ECCCCccCC-------------------------cCcccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC
Confidence            666665542                         122222 667777787777775 33 57777888888888888875


Q ss_pred             CcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCC
Q 001275          541 LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGS  589 (1109)
Q Consensus       541 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~  589 (1109)
                      . | .++.+++|++|+|++|++++.  ..+..+++|+.|++++|.+++.
T Consensus       143 ~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          143 I-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             C-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             C-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            4 3 577777888888888888755  5677778888888888887754

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.74  E-value=5.2e-18  Score=179.61  Aligned_cols=153  Identities=18%  Similarity=0.259  Sum_probs=126.4

Q ss_pred             cEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceeccccc
Q 001275           98 QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNN  177 (1109)
Q Consensus        98 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n  177 (1109)
                      +.++++++.++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..+..+++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            35677888887 5676664  78999999999999877778999999999999999998777888888888888888888


Q ss_pred             ccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCC
Q 001275          178 SLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEG  253 (1109)
Q Consensus       178 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~  253 (1109)
                      +++...+..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            8886666667888888888888888888878888888888888888888887777778888888888888887753

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.74  E-value=4.6e-18  Score=194.80  Aligned_cols=177  Identities=27%  Similarity=0.294  Sum_probs=156.9

Q ss_pred             cEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCcccc-ccCccceeccccccccccCCcccccccccceecccc
Q 001275           98 QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFE-NLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNN  176 (1109)
Q Consensus        98 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~  176 (1109)
                      +.+++++++++ .+|..+.  +.+++|+|++|+|++..+..+. ++++|++|+|++|+|++..|..+..+++|++|+|++
T Consensus        21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   97 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS   97 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence            47899999998 5777664  5689999999999988788887 999999999999999977778899999999999999


Q ss_pred             cccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhc---ccccccccccccCcccCC
Q 001275          177 NSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESL---SNLENLVYLDVGDNNLEG  253 (1109)
Q Consensus       177 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l---~~l~~L~~L~L~~N~l~~  253 (1109)
                      |++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..|   ..+++|+.|+|++|+|++
T Consensus        98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~  177 (361)
T 2xot_A           98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK  177 (361)
T ss_dssp             SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred             CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence            99998878889999999999999999998889999999999999999999998777666   679999999999999998


Q ss_pred             cccccccCCCC--cchhccccccccC
Q 001275          254 RINFGSEKCKN--LTFLDLSYNRFSG  277 (1109)
Q Consensus       254 ~~~~~~~~l~~--L~~L~Ls~N~l~~  277 (1109)
                      ..+..+..++.  ++.|+|++|.+.-
T Consensus       178 l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          178 LPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             CCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             cCHHHhhhccHhhcceEEecCCCccC
Confidence            87777888887  4889999999873

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.72  E-value=2.4e-17  Score=175.72  Aligned_cols=153  Identities=23%  Similarity=0.266  Sum_probs=128.4

Q ss_pred             cEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceeccccc
Q 001275           98 QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNN  177 (1109)
Q Consensus        98 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n  177 (1109)
                      +.++.++++++ .+|..+.  ++|++|+|++|++++..|..|.++++|++|+|++|+++...+..+..+++|++|+|++|
T Consensus        22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N   98 (229)
T 3e6j_A           22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN   98 (229)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence            34677778876 6776554  89999999999999888999999999999999999997554556788889999999999


Q ss_pred             ccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCc
Q 001275          178 SLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGR  254 (1109)
Q Consensus       178 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  254 (1109)
                      ++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|++++|.+...
T Consensus        99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A           99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            998777777888889999999999888 7788888888888888888888887777788888888888888887753

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.72  E-value=3.5e-18  Score=186.24  Aligned_cols=170  Identities=23%  Similarity=0.291  Sum_probs=89.0

Q ss_pred             CCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceee
Q 001275          118 CSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALW  197 (1109)
Q Consensus       118 l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~  197 (1109)
                      +.+++.+++++|.+++ ++ .+..+++|++|++++|.++ .+| .+..+++|++|++++|++++..+  ++.+++|++|+
T Consensus        18 l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~   91 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS   91 (263)
T ss_dssp             HHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred             HHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence            4444444555554442 22 3444555555555555544 233 34444555555555555553322  55555555555


Q ss_pred             cccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccC
Q 001275          198 LFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG  277 (1109)
Q Consensus       198 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  277 (1109)
                      |++|++++. |.. .. ++|++|+|++|++++.  +.+.++++|+.|++++|++++..  .+..+++|++|+|++|++++
T Consensus        92 L~~N~l~~l-~~~-~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A           92 VNRNRLKNL-NGI-PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             CCSSCCSCC-TTC-CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCCCB
T ss_pred             CCCCccCCc-Ccc-cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcCcc
Confidence            555555532 221 11 5666666666666543  24556666666666666665432  35555666666666666654


Q ss_pred             CCCcccccccCCcEEEeecCCCCCc
Q 001275          278 GISPNLGNCSSLTHLDIVGSKLTGS  302 (1109)
Q Consensus       278 ~~~~~~~~l~~L~~L~L~~n~l~~~  302 (1109)
                      .  ..+..+++|+.|++++|.++..
T Consensus       165 ~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          165 T--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             h--HHhccCCCCCEEeCCCCcccCC
Confidence            4  4555666666666666666543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.72  E-value=7.5e-18  Score=175.26  Aligned_cols=153  Identities=16%  Similarity=0.219  Sum_probs=90.5

Q ss_pred             cCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccce
Q 001275           92 GHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQY  171 (1109)
Q Consensus        92 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~  171 (1109)
                      +++++|++|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|+|++|.+++..|..+..+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            44556666666666666 444 4666666666666666554  2335666666666666666666555666666666666


Q ss_pred             ecccccccccccccccCCCcccceeeccccc-CCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcc
Q 001275          172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNR-LSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNN  250 (1109)
Q Consensus       172 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  250 (1109)
                      |++++|++++..|..++.+++|++|++++|+ ++ .+| .++.+++|++|++++|++++..  .+..+++|++|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence            6666666666556666666666666666665 33 333 4556666666666666665422  45555555555555555


Q ss_pred             cC
Q 001275          251 LE  252 (1109)
Q Consensus       251 l~  252 (1109)
                      +.
T Consensus       193 i~  194 (197)
T 4ezg_A          193 IG  194 (197)
T ss_dssp             --
T ss_pred             cC
Confidence            44

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=2e-17  Score=171.15  Aligned_cols=132  Identities=16%  Similarity=0.229  Sum_probs=83.6

Q ss_pred             chhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCC-cccccccccEEeccCCcccCCcchhhhcccccceeecccc
Q 001275          482 WRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPS-SIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLN  560 (1109)
Q Consensus       482 ~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  560 (1109)
                      +.+++++|+++..+..+..  .|++|++++|+|++..+. .++.+++|++|+|++|+|++..|..|+.+++|++|+|++|
T Consensus        11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            4566666666544333332  666666666666654443 3666666666666666666666666666666666666666


Q ss_pred             cccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCc
Q 001275          561 HVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP  615 (1109)
Q Consensus       561 ~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  615 (1109)
                      +|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|++++..+
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            6666666666666666666666666666666666666666666666666665443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.70  E-value=6.7e-17  Score=168.00  Aligned_cols=154  Identities=12%  Similarity=0.164  Sum_probs=109.7

Q ss_pred             ccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccE
Q 001275          284 GNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQD  363 (1109)
Q Consensus       284 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  363 (1109)
                      ..+++|+.|++++|.++ .+| .+..+++|++|++++|.++  .+..+..+++|++|++++|++++..|..++.+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            56677778888887777 444 5777778888888888665  3346777888888888888887767777888888888


Q ss_pred             EEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcc
Q 001275          364 LELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSF  443 (1109)
Q Consensus       364 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l  443 (1109)
                      |++++|++++..|..+..+++|++|++++|.+.+.+| .+..+++|+.|++++|++++. + .+..+++|++|++++|+|
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence            8888888887677777777788888888877333444 577777777777777777652 2 555666666666666665


Q ss_pred             c
Q 001275          444 T  444 (1109)
Q Consensus       444 ~  444 (1109)
                      .
T Consensus       194 ~  194 (197)
T 4ezg_A          194 G  194 (197)
T ss_dssp             -
T ss_pred             C
Confidence            4

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.69  E-value=8.4e-17  Score=166.41  Aligned_cols=132  Identities=19%  Similarity=0.315  Sum_probs=89.3

Q ss_pred             ceEEeecCccCCCCCCcccccccccEEeccCCcccCCcch-hhhcccccceeecccccccccCCccccCCCCccEEEecC
Q 001275          505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQ-ELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSF  583 (1109)
Q Consensus       505 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~  583 (1109)
                      +.+++++|+++ .+|..+..  +|++|++++|+|++..+. .++.+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56677777775 55655543  667777777777655443 366677777777777777766666777777777777777


Q ss_pred             ccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCC
Q 001275          584 NLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIP  639 (1109)
Q Consensus       584 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip  639 (1109)
                      |+|++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|++++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            77776666667777777777777777776666667777777777777777765543

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.68  E-value=7.4e-18  Score=190.54  Aligned_cols=219  Identities=16%  Similarity=0.146  Sum_probs=95.3

Q ss_pred             CcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcc----cCCcccccccCCCCc
Q 001275          190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNN----LEGRINFGSEKCKNL  265 (1109)
Q Consensus       190 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L  265 (1109)
                      +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.++.+.+.+|.+..++..+.+..+.    ........|..+..|
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            55555555555 4444444455555555555555555555555555555444444443321    111122233333333


Q ss_pred             c-hhcccccc-ccCCCCcccccccCCcEEEeecCCCCCcCCccc-cccccccEEEcCCCCCCCCCCCccccccccceeec
Q 001275          266 T-FLDLSYNR-FSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSF-GLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHL  342 (1109)
Q Consensus       266 ~-~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L  342 (1109)
                      + .+.+.... +.......-....+++.+.+.++-.. .....+ ..+++|+.|+|++|+++...+..|.++++|+.+++
T Consensus       179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l  257 (329)
T 3sb4_A          179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKL  257 (329)
T ss_dssp             EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred             ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence            3 22222110 00000000012334444444443211 111111 12455566666655555444445555555555555


Q ss_pred             cCcccCCCCCccccCCCCcc-EEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeE
Q 001275          343 YANQLEGEIPDELGQLSNLQ-DLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNI  412 (1109)
Q Consensus       343 ~~N~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  412 (1109)
                      .+| ++...+.+|.++++|+ .+++.+ .++...+..|.++++|+.+++++|+++...+..|.++++|+.+
T Consensus       258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l  326 (329)
T 3sb4_A          258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI  326 (329)
T ss_dssp             CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred             Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence            555 4444444555555555 555555 4443334444444444444444444444444444444444444

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.66  E-value=7.3e-17  Score=175.23  Aligned_cols=138  Identities=16%  Similarity=0.165  Sum_probs=106.0

Q ss_pred             CCCCceeecccCeEEEEEEe-CCCcE--EEEEEeeecccc-----------------------cChHHHHHHHHHHhcCC
Q 001275          821 LNAKHVIGRGAHGIVYKASL-GPNAV--FAVKKLAFRGHK-----------------------RGSLSMKREIQTIGKIR  874 (1109)
Q Consensus       821 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~  874 (1109)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||++......                       .....+.+|++++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999987 67888  999987432111                       01136789999999998


Q ss_pred             CCce--eeEeeEEecCCceeEEEEeccC-C----CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEec
Q 001275          875 HRNL--VRLEDFWLRKDCGIIMYRYMEN-G----SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRD  947 (1109)
Q Consensus       875 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  947 (1109)
                      |+++  ..++++    +..++||||+.+ |    +|.++...      .++..+..++.|++.|++|||.  +.+|+|||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHrD  196 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHAD  196 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCC
Confidence            8764  333332    367899999942 4    77776543      1234567899999999999994  46899999


Q ss_pred             cCCCCeeeCCCCcEEEecccCCccc
Q 001275          948 IKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       948 lk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999865

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.65  E-value=2.7e-16  Score=177.63  Aligned_cols=280  Identities=14%  Similarity=0.059  Sum_probs=121.6

Q ss_pred             CcccceeecccccCCCCccccccc-ccCccEEEecccccc--CcCchhcccccccccccccCcccCCcccccccC-----
Q 001275          190 LKEVEALWLFSNRLSGTIPESIGN-CYRLQELYLNENKLM--GFLPESLSNLENLVYLDVGDNNLEGRINFGSEK-----  261 (1109)
Q Consensus       190 l~~L~~L~L~~N~l~~~~p~~l~~-l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----  261 (1109)
                      +.++++|.++++ +.......+.. +++|++|+|++|++.  ...+..+   +.+..+.+..|.|.   ...|..     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhccccccc
Confidence            556777777654 22111122333 566777777777766  2221111   22333334444222   233444     


Q ss_pred             ---CCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCC----CCCCCCCccccc
Q 001275          262 ---CKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQ----LSGKIPPELGKC  334 (1109)
Q Consensus       262 ---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~----l~~~~p~~l~~l  334 (1109)
                         +++|+.|+|++ .++...+.+|.++++|+.|++++|.++...+.+|....++..+.+..+.    ........|.++
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~  175 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEG  175 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEES
T ss_pred             ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccc
Confidence               56666666655 5554444555555666666666555554455555554444444444321    111222233344


Q ss_pred             cccc-eeeccCcccCCCCCccc----cCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCC
Q 001275          335 KYLT-VLHLYANQLEGEIPDEL----GQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQL  409 (1109)
Q Consensus       335 ~~L~-~L~L~~N~l~~~~p~~l----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  409 (1109)
                      ..|+ .+.+....   .++..+    ....+++.+.+.++-....+......+++|+.+++++|+++...+..|.++++|
T Consensus       176 ~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L  252 (329)
T 3sb4_A          176 EPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYL  252 (329)
T ss_dssp             CCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTC
T ss_pred             cccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCC
Confidence            4444 22222110   111111    012333444443331111111111124455555555555554444445555555


Q ss_pred             CeEEccCCcCcccCCccccCCCCCc-eEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccc
Q 001275          410 KNISLYNNQFSGVIPQSLGINSSLM-QLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLW  482 (1109)
Q Consensus       410 ~~L~L~~N~l~~~~p~~~~~~~~L~-~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~  482 (1109)
                      +.|+|.+| ++...+..|..+.+|+ .+++.+ +++...+..|..+++|+.++++.|+++...+.+|.+|++|+
T Consensus       253 ~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~  324 (329)
T 3sb4_A          253 LKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSK  324 (329)
T ss_dssp             CEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCC
T ss_pred             CEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchh
Confidence            55555554 4434444444555555 555544 44433344444444444444444444433333444444333

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.63  E-value=2.3e-16  Score=159.34  Aligned_cols=137  Identities=22%  Similarity=0.195  Sum_probs=95.2

Q ss_pred             CCCceEEeecCccC-CCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEE
Q 001275          502 PVLSHLDVSRNNIS-GAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFD  580 (1109)
Q Consensus       502 ~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  580 (1109)
                      ++|++|++++|+++ +.+|..+..+++|++|++++|++++.  ..++.+++|++|+|++|++++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            56777777777776 56677777777777777777777754  5667777777777777777766666666677777777


Q ss_pred             ecCccccCCC-CcccccccccceeccccccccCCCc---chhhhhhhhhhhhcccCcCCCCCCCC
Q 001275          581 VSFNLLNGSI-PSSLRSWKSLSILKLSENHFTGGIP---TFISELEKLLELQLGGNQLGGEIPPS  641 (1109)
Q Consensus       581 ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~g~ip~~  641 (1109)
                      +++|+|++.. +..+..+++|+.|++++|++++..+   ..+..+++|+.|++++|.+. ++|++
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~  165 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS  165 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence            7777777431 1567777777777777777774433   36677777777777777766 55543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.61  E-value=7.9e-16  Score=155.46  Aligned_cols=108  Identities=19%  Similarity=0.155  Sum_probs=54.1

Q ss_pred             CCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccC-CccccCCCCccEEE
Q 001275          502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL-PSQLSKCKNLEVFD  580 (1109)
Q Consensus       502 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~  580 (1109)
                      ++|++|++++|.|++.  ..+..+++|++|+|++|++++.+|..++.+++|++|+|++|++++.. +..+..+++|+.|+
T Consensus        49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~  126 (168)
T 2ell_A           49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD  126 (168)
T ss_dssp             GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred             CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence            3344444444444432  44444445555555555554444444444555555555555555321 14555555555555


Q ss_pred             ecCccccCCCC---cccccccccceecccccccc
Q 001275          581 VSFNLLNGSIP---SSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       581 ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      +++|.+++..+   ..+..+++|+.|++++|.+.
T Consensus       127 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          127 LFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             eeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            55555553332   25555566666666666555

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.59  E-value=4.6e-15  Score=151.19  Aligned_cols=134  Identities=21%  Similarity=0.284  Sum_probs=80.0

Q ss_pred             CCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC
Q 001275           56 STPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI  135 (1109)
Q Consensus        56 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (1109)
                      .+.|.|.+|.|+...            +. .+|..+  .++|++|++++|++++..+..++.+++|++|+|++|++++..
T Consensus         4 ~C~C~~~~l~~~~~~------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~   68 (177)
T 2o6r_A            4 RCSCSGTEIRCNSKG------------LT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLP   68 (177)
T ss_dssp             TCEEETTEEECCSSC------------CS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred             CCEeCCCEEEecCCC------------Cc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeC
Confidence            355889999996532            11 233322  357778888888777666666777777777777777777655


Q ss_pred             CccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCC
Q 001275          136 PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS  204 (1109)
Q Consensus       136 p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~  204 (1109)
                      +..|.++++|++|+|++|.+++..+..+..+++|++|++++|++++..+..+..+++|++|++++|.++
T Consensus        69 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A           69 DGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             hhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence            556677777777777777776444444445555555555555554333333344444444444444443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.58  E-value=1.4e-15  Score=150.19  Aligned_cols=127  Identities=21%  Similarity=0.259  Sum_probs=66.9

Q ss_pred             CCccEeecCCCccc-ccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceec
Q 001275           95 SKLQTIDLSSNNFS-GNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVF  173 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  173 (1109)
                      ++|++|++++|.++ +.+|..++.+++|++|++++|.+++.  ..++++++|++|+|++|.+++.+              
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~--------------   80 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGL--------------   80 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCT--------------
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchH--------------
Confidence            45555555555555 45555555555555555555555533  44555555555555555554333              


Q ss_pred             ccccccccccccccCCCcccceeecccccCCCC-cccccccccCccEEEeccccccCcCc---hhccccccccccccc
Q 001275          174 LNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGT-IPESIGNCYRLQELYLNENKLMGFLP---ESLSNLENLVYLDVG  247 (1109)
Q Consensus       174 Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~---~~l~~l~~L~~L~L~  247 (1109)
                                |..++.+++|++|++++|++++. .+..++.+++|++|++++|.+++..+   ..+..+++|++|+++
T Consensus        81 ----------~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           81 ----------EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ----------HHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ----------HHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence                      33344444444444444444432 23455555666666666666655444   355666666666554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.56  E-value=4.1e-15  Score=153.62  Aligned_cols=126  Identities=23%  Similarity=0.280  Sum_probs=61.1

Q ss_pred             hhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccc
Q 001275          483 RVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHV  562 (1109)
Q Consensus       483 ~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  562 (1109)
                      .+++++|+++..+..+.  +.|++|++++|+|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus        14 ~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l   90 (193)
T 2wfh_A           14 VVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL   90 (193)
T ss_dssp             EEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence            34455555553322221  34555555555554 3444555555555555555555544444455555555555555555


Q ss_pred             cccCCccccCCCCccEEEecCccccCCCCcccccccccceecccccccc
Q 001275          563 EGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       563 ~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      ++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus        91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            5444444555555555555555555333334444445555555544444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.56  E-value=6.7e-15  Score=145.31  Aligned_cols=127  Identities=23%  Similarity=0.282  Sum_probs=74.7

Q ss_pred             ccccEEEcCCCCCC-CCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceee
Q 001275          311 ARLSSLDLSENQLS-GKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLL  389 (1109)
Q Consensus       311 ~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  389 (1109)
                      ++|+.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..++.+++|++|++++|++++.+|..+..+++|++|+
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45555555555555 45555555566666666666666543  4555666666666666666655555555566666666


Q ss_pred             ccCCccCCC-CchhhhccCCCCeEEccCCcCcccCC---ccccCCCCCceEEec
Q 001275          390 VYNNNLLGK-LPLEMTELKQLKNISLYNNQFSGVIP---QSLGINSSLMQLDFI  439 (1109)
Q Consensus       390 l~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~~~~L~~L~ls  439 (1109)
                      +++|.+++. .+..+..+++|+.|++++|++++..+   ..++.+++|++||++
T Consensus        95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            666666542 23556666666666666666665444   345555566655554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.56  E-value=9.6e-15  Score=148.84  Aligned_cols=114  Identities=18%  Similarity=0.225  Sum_probs=77.6

Q ss_pred             CCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEe
Q 001275          502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDV  581 (1109)
Q Consensus       502 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l  581 (1109)
                      ++|++|++++|++++..+..++.+++|++|++++|++++..+..++.+++|++|+|++|+|++..+..+..+++|+.|++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            45677777777777655566677777777777777777655555677777777777777777655556677777777777


Q ss_pred             cCccccCCCCcccccccccceeccccccccCCCc
Q 001275          582 SFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP  615 (1109)
Q Consensus       582 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  615 (1109)
                      ++|+|++..+..+..+++|+.|+|++|++++..|
T Consensus       108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             cCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            7777775444455667777777777777765443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.55  E-value=9e-15  Score=151.06  Aligned_cols=128  Identities=25%  Similarity=0.366  Sum_probs=105.1

Q ss_pred             ceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCc
Q 001275          505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN  584 (1109)
Q Consensus       505 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N  584 (1109)
                      +.+++++|+++ .+|..+.  .+|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            57888888887 5676553  57888888888888 56788888888888888888888777778888888888888888


Q ss_pred             cccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCC
Q 001275          585 LLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGG  636 (1109)
Q Consensus       585 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g  636 (1109)
                      +|++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++..
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence            8887777788888888888888888886555568888888888888888874

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=1.6e-16  Score=165.37  Aligned_cols=153  Identities=25%  Similarity=0.299  Sum_probs=92.5

Q ss_pred             hcccccceeecccccccccCCc------cccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhh
Q 001275          547 GNLVSLVTLNISLNHVEGSLPS------QLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISE  620 (1109)
Q Consensus       547 ~~l~~L~~L~L~~N~l~~~~p~------~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  620 (1109)
                      .....++.++++.|.++|.+|.      .++.+++|++|++++|++++ +| .+..+++|+.|++++|+++ .+|..+..
T Consensus        15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~   91 (198)
T 1ds9_A           15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV   91 (198)
T ss_dssp             HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred             HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence            3344455555555555555444      55555666666666666653 44 5555666666666666665 45555556


Q ss_pred             hhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccC-cchhhcccCCeEEccCCcccccCCC----------
Q 001275          621 LEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIP-SDLEKLSKLEQLDISSNNLTGTLSP----------  689 (1109)
Q Consensus       621 l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip-~~l~~l~~L~~L~Ls~N~l~g~~~~----------  689 (1109)
                      +++|+.|+|++|++++ +| .++.+++| ..|+|++|++++..+ ..+.++++|++|++++|++++.+|.          
T Consensus        92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L-~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~  168 (198)
T 1ds9_A           92 ADTLEELWISYNQIAS-LS-GIEKLVNL-RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE  168 (198)
T ss_dssp             HHHCSEEEEEEEECCC-HH-HHHHHHHS-SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred             CCcCCEEECcCCcCCc-CC-ccccCCCC-CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence            6666666666666653 44 45666666 356666666663211 3677788888888888888777664          


Q ss_pred             -CCccccceEEeeeccccc
Q 001275          690 -LSNIHSLVEVNVSYNLFT  707 (1109)
Q Consensus       690 -l~~~~~l~~l~~~~n~l~  707 (1109)
                       +..+++|+.||  +|.++
T Consensus       169 ~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          169 VVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHCSSCSEEC--CGGGT
T ss_pred             HHHhCCCcEEEC--CcccC
Confidence             56677777765  55544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=1.1e-16  Score=166.58  Aligned_cols=132  Identities=25%  Similarity=0.311  Sum_probs=88.7

Q ss_pred             hhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhh
Q 001275          545 ELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKL  624 (1109)
Q Consensus       545 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  624 (1109)
                      .++.+++|++|+|++|++++ +| .+..+++|+.|++++|+|+ .+|..+..+++|+.|+|++|++++ +| .+..+++|
T Consensus        43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L  117 (198)
T 1ds9_A           43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred             HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence            66666666666666666664 55 6666666666666666666 566666666667777777776664 44 46667777


Q ss_pred             hhhhcccCcCCCCCC--CCchhhhhhhhhhcccccccccccCcc----------hhhcccCCeEEccCCcccc
Q 001275          625 LELQLGGNQLGGEIP--PSIGALQDLSYALNLSKNGLTGRIPSD----------LEKLSKLEQLDISSNNLTG  685 (1109)
Q Consensus       625 ~~L~l~~N~l~g~ip--~~~~~l~~l~~~L~L~~N~l~g~ip~~----------l~~l~~L~~L~Ls~N~l~g  685 (1109)
                      +.|++++|++++ +|  ..++.+++| ..|++++|.+++.+|..          +..+++|+.||  +|.++.
T Consensus       118 ~~L~l~~N~i~~-~~~~~~l~~l~~L-~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          118 RVLYMSNNKITN-WGEIDKLAALDKL-EDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             SEEEESEEECCC-HHHHHHHTTTTTC-SEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             CEEECCCCcCCc-hhHHHHHhcCCCC-CEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            777777777763 33  256666666 36777777777766653          88999999997  777763

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.54  E-value=5.7e-14  Score=162.02  Aligned_cols=261  Identities=11%  Similarity=0.076  Sum_probs=114.5

Q ss_pred             CCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecc
Q 001275           95 SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFL  174 (1109)
Q Consensus        95 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L  174 (1109)
                      ..++.+.+.+ .++..-..+|.++ +|+.+++..+ ++..-..+|.+. +|+.+.|.. .++..-+..+..+.+|+.+++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l  187 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL  187 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence            4445555542 3443334455553 5666666544 443444455552 455555554 333233344445555555555


Q ss_pred             cccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCc
Q 001275          175 NNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGR  254 (1109)
Q Consensus       175 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~  254 (1109)
                      ++|+++......|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .+.++..
T Consensus       188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I  262 (401)
T 4fdw_A          188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNI  262 (401)
T ss_dssp             TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEE
T ss_pred             CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEE
Confidence            55555533333333 245555555422 43333444555555555555442 33334444444 44444444 2334333


Q ss_pred             ccccccCCCCcchhcccccccc-----CCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCC
Q 001275          255 INFGSEKCKNLTFLDLSYNRFS-----GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP  329 (1109)
Q Consensus       255 ~~~~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  329 (1109)
                      ....|..+++|+.+++..|.+.     .....+|.++++|+.+++. +.++.....+|..+++|+.++|..| ++.....
T Consensus       263 ~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~  340 (401)
T 4fdw_A          263 ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFS  340 (401)
T ss_dssp             CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred             ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence            3444444444444444444332     1223344444444444444 2233333344444444444444332 3323333


Q ss_pred             ccccccccceeeccCcccCCCCCccccCCC-CccEEEccC
Q 001275          330 ELGKCKYLTVLHLYANQLEGEIPDELGQLS-NLQDLELFD  368 (1109)
Q Consensus       330 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~L~~  368 (1109)
                      +|.++ +|+.+++++|.+....+..|..++ +++.|++..
T Consensus       341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~  379 (401)
T 4fdw_A          341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPA  379 (401)
T ss_dssp             SSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECG
T ss_pred             hCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCH
Confidence            44444 444444444444333333333332 334444433

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.53  E-value=1e-13  Score=159.99  Aligned_cols=247  Identities=14%  Similarity=0.125  Sum_probs=208.3

Q ss_pred             cccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCccccccccc
Q 001275           90 EIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGL  169 (1109)
Q Consensus        90 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L  169 (1109)
                      ++.+ .+|+.++|..+ ++..-..+|.++ +|+.+++.. .++..-+.+|.++++|+.++|..|.++ .++...+...+|
T Consensus       131 aF~~-~~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L  205 (401)
T 4fdw_A          131 AFRN-SQIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGI  205 (401)
T ss_dssp             TTTT-CCCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCC
T ss_pred             hccc-CCccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeeccc
Confidence            4566 47999999866 776666778885 799999986 677666789999999999999999998 667666668999


Q ss_pred             ceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCc
Q 001275          170 QYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDN  249 (1109)
Q Consensus       170 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N  249 (1109)
                      +.+.+.++ ++......|.++++|+.+.+..| ++.+...+|.+ .+|+.+.+ .+.++.+...+|.++++|+.+++.+|
T Consensus       206 ~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~  281 (401)
T 4fdw_A          206 EEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGS  281 (401)
T ss_dssp             SEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred             CEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCc
Confidence            99999855 77677789999999999999975 66566677877 89999999 56688788899999999999999998


Q ss_pred             ccC-----CcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCC
Q 001275          250 NLE-----GRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLS  324 (1109)
Q Consensus       250 ~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  324 (1109)
                      .+.     ......|..|++|+.++|. +.++.....+|.++++|+.+.+..| ++.....+|..+ +|+.+++++|.+.
T Consensus       282 ~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~  358 (401)
T 4fdw_A          282 TFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP  358 (401)
T ss_dssp             CCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred             cccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence            876     4667889999999999999 4577677789999999999999655 776778899999 9999999999998


Q ss_pred             CCCCCcccccc-ccceeeccCcccC
Q 001275          325 GKIPPELGKCK-YLTVLHLYANQLE  348 (1109)
Q Consensus       325 ~~~p~~l~~l~-~L~~L~L~~N~l~  348 (1109)
                      ...+..|.+++ .++.|++..+.+.
T Consensus       359 ~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          359 QVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             BCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             ccccccccCCCCCccEEEeCHHHHH
Confidence            77777888884 7899999887654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.52  E-value=3.3e-15  Score=167.83  Aligned_cols=139  Identities=14%  Similarity=0.112  Sum_probs=101.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeeccc-------------ccChH--------HHHHHHHHHhcCCCCc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGH-------------KRGSL--------SMKREIQTIGKIRHRN  877 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------~~~~~--------~~~~E~~~l~~l~h~n  877 (1109)
                      .-|.+.+.||+|+||.||+|...+|+.||||+++....             .....        ...+|+..+.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            34888999999999999999999999999998743210             00011        1245677777775444


Q ss_pred             ee--eEeeEEecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeee
Q 001275          878 LV--RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILL  955 (1109)
Q Consensus       878 iv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll  955 (1109)
                      +.  ..+++    ...++||||++|++|.++...         +....++.|++.++.|||   ..+||||||||.|||+
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl  238 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILI  238 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEE
Confidence            32  22222    234799999999888654321         123568899999999999   8899999999999999


Q ss_pred             CCCC----------cEEEecccCCcccC
Q 001275          956 DSEM----------EPHISDFGIAKLLD  973 (1109)
Q Consensus       956 ~~~~----------~~kl~DfGla~~~~  973 (1109)
                      ++++          .+.|+||+-+....
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             eCCCCcccccccccceEEEEeCCcccCC
Confidence            8776          38999999877543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.50  E-value=8.3e-15  Score=149.13  Aligned_cols=131  Identities=23%  Similarity=0.262  Sum_probs=69.8

Q ss_pred             CCCCCCCceEEeecCccCCCCCCcccccc-cccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCc
Q 001275          498 FSKNPVLSHLDVSRNNISGAIPSSIGNSI-NLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL  576 (1109)
Q Consensus       498 ~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  576 (1109)
                      +...++|++|++++|+++ .+|. +..+. +|++|++++|++++.  ..++.+++|++|+|++|+|++..|..+..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            344455555555555555 2333 33333 555555655555543  345555555555555555553333333555566


Q ss_pred             cEEEecCccccCCCCc--ccccccccceeccccccccCCCcch----hhhhhhhhhhhcccCcC
Q 001275          577 EVFDVSFNLLNGSIPS--SLRSWKSLSILKLSENHFTGGIPTF----ISELEKLLELQLGGNQL  634 (1109)
Q Consensus       577 ~~L~ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l  634 (1109)
                      ++|++++|+|+ .+|.  .+..+++|+.|++++|+++ .+|..    +..+++|+.||+++|++
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence            66666666654 3443  5555556666666666655 34443    55555666666655554

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.48  E-value=1.8e-14  Score=146.69  Aligned_cols=105  Identities=15%  Similarity=0.146  Sum_probs=82.2

Q ss_pred             CCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCc--cccCCCCccEEE
Q 001275          503 VLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPS--QLSKCKNLEVFD  580 (1109)
Q Consensus       503 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~  580 (1109)
                      +|++|++++|+|++.  ..++.+++|++|+|++|+|++..|..++.+++|++|+|++|+|+ .+|.  .+..+++|+.|+
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            777888888888754  57777888888888888888654455578888888888888886 5665  778888888888


Q ss_pred             ecCccccCCCCcc----cccccccceecccccccc
Q 001275          581 VSFNLLNGSIPSS----LRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       581 ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~  611 (1109)
                      +++|.++ .+|..    +..+++|+.|++++|...
T Consensus       120 l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          120 ILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             ecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            8888887 55664    888888999998888776

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.48  E-value=1.5e-12  Score=150.84  Aligned_cols=314  Identities=13%  Similarity=0.049  Sum_probs=181.7

Q ss_pred             cCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCC
Q 001275          110 NIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGD  189 (1109)
Q Consensus       110 ~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~  189 (1109)
                      +-..+|.++++|+.+.|..+ ++..-..+|.++++|+.++|..+ ++..-...+..+.+|+.+.+..+ +.......|.+
T Consensus        62 Ig~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~  138 (394)
T 4fs7_A           62 IGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKG  138 (394)
T ss_dssp             ECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred             hHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeec
Confidence            33445666666666666532 44334445666666666666543 33223344555556665555433 22233444554


Q ss_pred             CcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhc
Q 001275          190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD  269 (1109)
Q Consensus       190 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  269 (1109)
                      ...++......  .......+|.++++|+.+.+.++. ..+...+|.++++|+.+++..| ++......|..+..|+.+.
T Consensus       139 ~~~~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~  214 (394)
T 4fs7_A          139 CDFKEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENME  214 (394)
T ss_dssp             CCCSEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCC
T ss_pred             ccccccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceee
Confidence            44333332222  222334567788888888887553 4456677888888888888765 5555666777888888887


Q ss_pred             cccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCC
Q 001275          270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       270 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                      +..+...  +...+....+|+.+.+..+ ++......|.....|+.+.+..+... .....|..+..++.+....+.+. 
T Consensus       215 ~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~-  289 (394)
T 4fs7_A          215 FPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP-  289 (394)
T ss_dssp             CCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC-
T ss_pred             cCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec-
Confidence            7766443  2233444567777777543 33344556777777777777776544 45556777777777776665443 


Q ss_pred             CCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccC
Q 001275          350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI  429 (1109)
Q Consensus       350 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  429 (1109)
                        ...|..+.+|+.+.+.++ ++......|.++.+|+.+++.++ ++......|.++++|+.+++..| ++..-...|..
T Consensus       290 --~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~  364 (394)
T 4fs7_A          290 --EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQG  364 (394)
T ss_dssp             --TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTT
T ss_pred             --cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhC
Confidence              235666677777777654 44344455666666666666533 44444555666666666666554 44344445555


Q ss_pred             CCCCceEEecC
Q 001275          430 NSSLMQLDFIN  440 (1109)
Q Consensus       430 ~~~L~~L~ls~  440 (1109)
                      +.+|+.+++..
T Consensus       365 C~~L~~i~lp~  375 (394)
T 4fs7_A          365 CINLKKVELPK  375 (394)
T ss_dssp             CTTCCEEEEEG
T ss_pred             CCCCCEEEECC
Confidence            55555555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.45  E-value=8.9e-13  Score=152.72  Aligned_cols=335  Identities=13%  Similarity=0.107  Sum_probs=171.3

Q ss_pred             cccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCc
Q 001275          226 KLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS  305 (1109)
Q Consensus       226 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  305 (1109)
                      .++.+...+|.++++|+.+.+.. .++.....+|..+++|+.+++..+ ++.....+|.++.+|+.+.+..+ ++.....
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~  134 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVE  134 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecce
Confidence            35556667788888888888864 366666667777777777777654 44344556667777776655433 3333344


Q ss_pred             cccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhccc
Q 001275          306 SFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASL  385 (1109)
Q Consensus       306 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  385 (1109)
                      +|.....+........  ......+|.++++|+.+.+..+.. ......|..+.+|+.+++..| ++......       
T Consensus       135 aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~-~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~-------  203 (394)
T 4fs7_A          135 AFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVSLPDSME-TLHNGLFSGCGKLKSIKLPRN-LKIIRDYC-------  203 (394)
T ss_dssp             TTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCBCCCCTT-CCEECTTT-------
T ss_pred             eeecccccccccCccc--cccchhhhcccCCCcEEecCCccc-eeccccccCCCCceEEEcCCC-ceEeCchh-------
Confidence            4544433222222211  112233455555555555544322 133344445555555555443 22222333       


Q ss_pred             ceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCc
Q 001275          386 EYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQN  465 (1109)
Q Consensus       386 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N  465 (1109)
                                       |.+...|+.+.+..+...  +.+......+|+.+.+..+ ++......+.....|+.+.+..+
T Consensus       204 -----------------F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~  263 (394)
T 4fs7_A          204 -----------------FAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNN  263 (394)
T ss_dssp             -----------------TTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCT
T ss_pred             -----------------hccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCC
Confidence                             444444444444333221  1222223344455444322 22223333444455555555544


Q ss_pred             ccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchh
Q 001275          466 QFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQE  545 (1109)
Q Consensus       466 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  545 (1109)
                      ... .....+..+..+..+....+.+..  ..|..+.+|+.+.+..+ ++.....+|.++.+|+.+++..+ ++......
T Consensus       264 ~~~-i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a  338 (394)
T 4fs7_A          264 KLR-IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS  338 (394)
T ss_dssp             TCE-ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             cce-eeccccccccccceeccCceeecc--ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence            322 333445555555554444332211  12566667777777544 54444556777777777777643 55344556


Q ss_pred             hhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccce
Q 001275          546 LGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI  602 (1109)
Q Consensus       546 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  602 (1109)
                      |.++.+|+.+++..| ++..-..+|.+|.+|+.+++..+ ++ .+..+|.++++|+.
T Consensus       339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~  392 (394)
T 4fs7_A          339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKW  392 (394)
T ss_dssp             TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEE
T ss_pred             ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcE
Confidence            666777777776655 55344556666677777766543 22 22345555555543

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.42  E-value=5.1e-13  Score=135.29  Aligned_cols=104  Identities=19%  Similarity=0.288  Sum_probs=78.2

Q ss_pred             ceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCc
Q 001275          505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN  584 (1109)
Q Consensus       505 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N  584 (1109)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|||++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            57788888876 5666654  67888888888888777777888888888888888887655556677888888888888


Q ss_pred             cccCCCCcccccccccceecccccccc
Q 001275          585 LLNGSIPSSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       585 ~l~~~~p~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      +|++..+..|..+++|+.|+|++|++.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            887554455777777777777777777

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.41  E-value=6e-13  Score=134.32  Aligned_cols=107  Identities=19%  Similarity=0.257  Sum_probs=79.4

Q ss_pred             CceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecC
Q 001275          504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSF  583 (1109)
Q Consensus       504 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~  583 (1109)
                      .+.|++++|+++ .+|..+.  ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            457777777777 4666553  6777888888888877777777787888888888887766666677778888888888


Q ss_pred             ccccCCCCcccccccccceeccccccccCC
Q 001275          584 NLLNGSIPSSLRSWKSLSILKLSENHFTGG  613 (1109)
Q Consensus       584 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  613 (1109)
                      |+|++..|..|..+++|+.|+|++|+++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            888765556677777777777777777744

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.35  E-value=1.5e-12  Score=131.28  Aligned_cols=104  Identities=17%  Similarity=0.172  Sum_probs=85.0

Q ss_pred             hhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeeccccccc
Q 001275          484 VILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVE  563 (1109)
Q Consensus       484 l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  563 (1109)
                      +++++|+++..+..+  .+.|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|+
T Consensus        14 l~~s~n~l~~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~   91 (170)
T 3g39_A           14 VDCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLK   91 (170)
T ss_dssp             EECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EEeCCCCcCccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccC
Confidence            344444444333223  267889999999999888899999999999999999999877777899999999999999999


Q ss_pred             ccCCccccCCCCccEEEecCccccCC
Q 001275          564 GSLPSQLSKCKNLEVFDVSFNLLNGS  589 (1109)
Q Consensus       564 ~~~p~~l~~l~~L~~L~ls~N~l~~~  589 (1109)
                      +..+..|..+++|++|+|++|.++..
T Consensus        92 ~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           92 SIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             EeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            77777899999999999999999843

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.34  E-value=1.4e-12  Score=131.98  Aligned_cols=92  Identities=20%  Similarity=0.249  Sum_probs=78.6

Q ss_pred             CCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEe
Q 001275          502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDV  581 (1109)
Q Consensus       502 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l  581 (1109)
                      +.|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            67889999999999888889999999999999999999776666789999999999999999666666999999999999


Q ss_pred             cCccccCCCCccc
Q 001275          582 SFNLLNGSIPSSL  594 (1109)
Q Consensus       582 s~N~l~~~~p~~~  594 (1109)
                      ++|.+. ..+..+
T Consensus       113 ~~N~~~-c~~~~~  124 (174)
T 2r9u_A          113 YNNPWD-CECRDI  124 (174)
T ss_dssp             CSSCBC-TTBGGG
T ss_pred             CCCCcc-cccccH
Confidence            999998 344433

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.23  E-value=1.1e-13  Score=158.12  Aligned_cols=134  Identities=22%  Similarity=0.161  Sum_probs=57.1

Q ss_pred             CCCcEeeccCccccCCCCcccccc-----CccceeccccccccccCCcccc-cccccceeccccccccccccccc-----
Q 001275          119 SALEYLDLSTNGFTGDIPDNFENL-----QNLQYLNLYGNLLDGEIPEPLF-RILGLQYVFLNNNSLSGSIPRNV-----  187 (1109)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~p~~l~~L-----~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l-----  187 (1109)
                      +.|++|+|++|.++......+...     ++|++|+|++|.++......+. .+.+|++|+|++|.++......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            345555555555543222222222     4555555555555432222221 23445555555555543333322     


Q ss_pred             CCCcccceeecccccCCCC----cccccccccCccEEEeccccccCcC----chhcccccccccccccCcccC
Q 001275          188 GDLKEVEALWLFSNRLSGT----IPESIGNCYRLQELYLNENKLMGFL----PESLSNLENLVYLDVGDNNLE  252 (1109)
Q Consensus       188 ~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~  252 (1109)
                      ...++|++|+|++|.++..    ++..+..+++|++|+|++|.|+...    ++.+...++|+.|+|++|.|+
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~  224 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG  224 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence            1234455555555554421    2222334445555555555544321    233333444444444444443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.23  E-value=1.8e-13  Score=156.28  Aligned_cols=141  Identities=20%  Similarity=0.157  Sum_probs=73.6

Q ss_pred             ccccEEEcCCCCCCCCCCCcc-ccccccceeeccCcccCCCCCccc-----cCCCCccEEEccCcccccc----CchHHH
Q 001275          311 ARLSSLDLSENQLSGKIPPEL-GKCKYLTVLHLYANQLEGEIPDEL-----GQLSNLQDLELFDNRLTGE----FPVSIW  380 (1109)
Q Consensus       311 ~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~----~~~~~~  380 (1109)
                      ++|++|+|++|.++......+ ..+++|+.|+|++|.+++.....+     ...++|++|+|++|.|++.    ++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            355555555555542221122 224455566666665554333322     2345666666666666542    222334


Q ss_pred             hhcccceeeccCCccCCCC----chhhhccCCCCeEEccCCcCccc----CCccccCCCCCceEEecCCcccccCCCCc
Q 001275          381 RIASLEYLLVYNNNLLGKL----PLEMTELKQLKNISLYNNQFSGV----IPQSLGINSSLMQLDFINNSFTGEIPPNL  451 (1109)
Q Consensus       381 ~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~~~~L~~L~ls~N~l~~~~p~~~  451 (1109)
                      .+++|++|+|++|.+++..    +..+...++|+.|+|++|.|++.    ++..+..+++|++|||++|.|++.....+
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L  259 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL  259 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence            4566666666666665322    33445556677777777776642    22333345667777777777665444333

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.22  E-value=1.4e-11  Score=139.98  Aligned_cols=105  Identities=21%  Similarity=0.256  Sum_probs=84.3

Q ss_pred             eEEeecC-ccCCCCCCcccccccccEEeccC-CcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecC
Q 001275          506 HLDVSRN-NISGAIPSSIGNSINLTSIDFSS-NKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSF  583 (1109)
Q Consensus       506 ~L~Ls~N-~i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~  583 (1109)
                      .++++++ +|+ .+|. +..+++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|||++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4677777 787 4777 88888888888885 888877778888888888888888888888888888888888888888


Q ss_pred             ccccCCCCcccccccccceeccccccccCC
Q 001275          584 NLLNGSIPSSLRSWKSLSILKLSENHFTGG  613 (1109)
Q Consensus       584 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  613 (1109)
                      |+|++..|..|..++ |+.|+|.+|.+...
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence            888865555565555 88888888888743

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.18  E-value=5e-10  Score=129.50  Aligned_cols=110  Identities=13%  Similarity=0.160  Sum_probs=49.9

Q ss_pred             ccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcc
Q 001275          305 SSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIAS  384 (1109)
Q Consensus       305 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  384 (1109)
                      .+|.....|+.+.+..+..+ .....|.+++.|+.+.+. +.++......|.++.+|+.+++..+ ++.....+|.++.+
T Consensus       259 ~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~  335 (394)
T 4gt6_A          259 HAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQ  335 (394)
T ss_dssp             TTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTT
T ss_pred             ceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCC
Confidence            34445555555555443322 333445555555555553 2233233344555555555555433 33233344444555


Q ss_pred             cceeeccCCccCCCCchhhhccCCCCeEEccCCc
Q 001275          385 LEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ  418 (1109)
Q Consensus       385 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~  418 (1109)
                      |+.+.+..+ ++......|.++++|+.+++.+|.
T Consensus       336 L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          336 LERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             CCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred             CCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence            555555332 333334444555555555554443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.14  E-value=7.2e-10  Score=128.18  Aligned_cols=328  Identities=12%  Similarity=0.138  Sum_probs=172.4

Q ss_pred             cccCCCc-ccceeecccccCCCCcccccccccCccEEEecccc---ccCcCchhcccccccccccccCcccCCccccccc
Q 001275          185 RNVGDLK-EVEALWLFSNRLSGTIPESIGNCYRLQELYLNENK---LMGFLPESLSNLENLVYLDVGDNNLEGRINFGSE  260 (1109)
Q Consensus       185 ~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~---l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  260 (1109)
                      .+|.+.+ .|+.+.+..+ ++.+-..+|.++++|+.+.+..|.   ++.+...+|.++.+|+.+.+..+ ++......|.
T Consensus        57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~  134 (394)
T 4gt6_A           57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH  134 (394)
T ss_dssp             TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred             hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence            4454442 4666666543 444556677777777777777664   55556677777777777776554 5545556677


Q ss_pred             CCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcccccccccee
Q 001275          261 KCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVL  340 (1109)
Q Consensus       261 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L  340 (1109)
                      .+.+|+.+.+..+. .......|..+.+|+.+.+..+ ++.....+|.. .+|+.+.+..+-.. .....|..+.+++..
T Consensus       135 ~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~  210 (394)
T 4gt6_A          135 HCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTI  210 (394)
T ss_dssp             TCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred             hhccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccccee
Confidence            77777777776443 3244556777777777777654 44344455543 56777777655433 445566677777766


Q ss_pred             eccCcccCCCCCcccc-CCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcC
Q 001275          341 HLYANQLEGEIPDELG-QLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQF  419 (1109)
Q Consensus       341 ~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  419 (1109)
                      ....+.... +...+. .......-...           +.....+..+.+. +.+.......|.++..|+.+.+.++..
T Consensus       211 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~  277 (394)
T 4gt6_A          211 TSDSESYPA-IDNVLYEKSANGDYALIR-----------YPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV  277 (394)
T ss_dssp             EECCSSSCB-SSSCEEEECTTSCEEEEE-----------CCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC
T ss_pred             ccccccccc-ccceeecccccccccccc-----------cccccccceEEcC-CcceEcccceeeecccccEEecccccc
Confidence            665544431 111111 00000000000           0001111112111 112222233455555555555544433


Q ss_pred             cccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCC-C
Q 001275          420 SGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-F  498 (1109)
Q Consensus       420 ~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~  498 (1109)
                      + .....|..+.+|+.+++. +.++......|..+.+|+.+++..+ ++.....+|.+|.+|+.+.+..+ ++..-.. |
T Consensus       278 ~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF  353 (394)
T 4gt6_A          278 S-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAF  353 (394)
T ss_dssp             E-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGG
T ss_pred             e-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHh
Confidence            2 333445555566666664 3344344445555566666666543 44444556777777777776543 4422222 7


Q ss_pred             CCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcc
Q 001275          499 SKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKF  538 (1109)
Q Consensus       499 ~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l  538 (1109)
                      ..+.+|+.+++.+|....   ..+....+|+.+.+..|.+
T Consensus       354 ~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          354 SNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             TTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             hCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            788888888888776531   3566677788887776654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.13  E-value=4.2e-11  Score=136.11  Aligned_cols=103  Identities=15%  Similarity=0.118  Sum_probs=84.3

Q ss_pred             hhccCc-ccCCCCCCCCCCCCCceEEeec-CccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeeccccc
Q 001275          484 VILKQN-QLTGALPEFSKNPVLSHLDVSR-NNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH  561 (1109)
Q Consensus       484 l~l~~N-~l~~~~~~~~~~~~L~~L~Ls~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  561 (1109)
                      ++.+++ +|++.++ +..+++|++|+|++ |+|++..|..|+++++|+.|+|++|+|++..|..|++|++|+.|+|++|+
T Consensus        13 v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~   91 (347)
T 2ifg_A           13 LRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (347)
T ss_dssp             EECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence            455555 6665444 77778889999986 99987777889999999999999999998888889999999999999999


Q ss_pred             ccccCCccccCCCCccEEEecCccccC
Q 001275          562 VEGSLPSQLSKCKNLEVFDVSFNLLNG  588 (1109)
Q Consensus       562 l~~~~p~~l~~l~~L~~L~ls~N~l~~  588 (1109)
                      |++..+..+..++ |+.|+|++|.|..
T Consensus        92 l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           92 LESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             CSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             cceeCHHHcccCC-ceEEEeeCCCccC
Confidence            9966666666665 9999999999873

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.03  E-value=4e-10  Score=122.47  Aligned_cols=145  Identities=14%  Similarity=0.071  Sum_probs=111.8

Q ss_pred             HHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEE
Q 001275          816 EATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       816 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .....|......+.|+.+.||++... ++.+++|+..... ......+.+|+++++.+. +..+.++++++...+..++|
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~-~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCccc-CCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            34467877888888999999999765 6889999874321 123346889999999884 67788899999888889999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD------------------------------------  938 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------  938 (1109)
                      |||++|.++.+.+..        ......++.+++++++.||..                                    
T Consensus        89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            999999999876321        112347888999999999951                                    


Q ss_pred             --------------------CCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          939 --------------------CDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       939 --------------------~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                                          ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                01458999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.90  E-value=1.7e-09  Score=117.16  Aligned_cols=136  Identities=15%  Similarity=0.054  Sum_probs=98.4

Q ss_pred             CCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCc--eeeEeeEEecCCceeEEEEe
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN--LVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~  897 (1109)
                      .+....+.+.|..+.||++...+|+.+++|.....    ....+.+|+++++.+.+.+  +.+++++....+..++||||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            34433333456669999998877888999986332    2345788999999885444  55688888877788999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC--------------------------------------  939 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------  939 (1109)
                      ++|.++.  ...      .+   ...++.++++.++.||...                                      
T Consensus        97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9998874  211      11   2356778888888888421                                      


Q ss_pred             -----------------CCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          940 -----------------DPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       940 -----------------~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                                       ...++|+|++|.||++++++.+.|+|||.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                             1129999999999999877667799999875

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.85  E-value=2.9e-10  Score=128.51  Aligned_cols=161  Identities=15%  Similarity=0.158  Sum_probs=75.0

Q ss_pred             ccccccCccceeccccccccccCCcccccccccceecccccccccccccccC--CCcccceeeccc--ccCCCC-----c
Q 001275          137 DNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVG--DLKEVEALWLFS--NRLSGT-----I  207 (1109)
Q Consensus       137 ~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~--~l~~L~~L~L~~--N~l~~~-----~  207 (1109)
                      ..+..+++|+.|+|++|.-. .++. + .+++|++|+|..|.++......++  .+++|++|+|+.  |...+.     +
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l  242 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF  242 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred             HHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence            33455566666666665211 2222 2 255666666666665544333333  566666666642  111111     0


Q ss_pred             cccc--ccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCC----CCc
Q 001275          208 PESI--GNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGG----ISP  281 (1109)
Q Consensus       208 p~~l--~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~  281 (1109)
                      ...+  ..+++|++|+|.+|.+++..+..+..                     ...+++|++|+|+.|.+++.    ++.
T Consensus       243 ~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~---------------------a~~~~~L~~LdLs~n~L~d~G~~~L~~  301 (362)
T 2ra8_A          243 RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE---------------------SDILPQLETMDISAGVLTDEGARLLLD  301 (362)
T ss_dssp             GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHH---------------------CSSGGGCSEEECCSSCCBHHHHHHHHT
T ss_pred             HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHh---------------------CccCCCCCEEECCCCCCChHHHHHHHh
Confidence            0111  23456666666666555333222221                     01234445555555544432    122


Q ss_pred             ccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCC
Q 001275          282 NLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQ  322 (1109)
Q Consensus       282 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~  322 (1109)
                      .+..+++|+.|++++|.++...-..+...- ...+++++++
T Consensus       302 ~L~~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          302 HVDKIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             THHHHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred             hcccCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence            233456666666666666543333333200 3556777766

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.81  E-value=2.5e-11  Score=129.98  Aligned_cols=152  Identities=20%  Similarity=0.155  Sum_probs=70.4

Q ss_pred             ChhhHHHHHHHHHhccCCCCcccCCCCC---------C----CCCCceeeeEEecCCCCcEEEEEecc---cCCccccCC
Q 001275           26 LNGDGVALLSLMRHWNSVPPLIISSWNS---------S----DSTPCQWVGIECDDDAHNVVSFNLSS---YGVSGQLGP   89 (1109)
Q Consensus        26 ~~~~~~all~~~~~~~~~~~~~l~sW~~---------~----~~~~c~w~gv~C~~~~~~v~~l~l~~---~~l~~~~~~   89 (1109)
                      ..-|++-|+.+-......| -.-..|.-         .    ....|+|.|+.|+.+..+|+.+...+   ..+.+.+.+
T Consensus        33 ~ky~k~~ll~~i~~~~~~~-f~p~~~~~~~~~~~ffV~~~~~A~~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~  111 (267)
T 3rw6_A           33 RKYDKAWLLSMIQSKCSVP-FTPIEFHYENTRAQFFVEDASTASALKAVNYKILDRENRRISIIINSSAPPHTILNELKP  111 (267)
T ss_dssp             GGSCHHHHHHHHHHTCSSC-CCCEEEEEETTEEEEEESCHHHHHHHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCH
T ss_pred             cccCHHHHHHHHHHhCCCC-cEeEEEEEeCCEEEEEeCChHHHHHHHhcCcEEECCCCCEEEEEEecCCCcccccccCCH
Confidence            4456677777766654333 11223320         0    11247899999998776776665544   334444432


Q ss_pred             c-ccCCCCccEeecCCCcccccCC-CCCCCCCCCcE--eeccCcccc---CCCCccccccCccceeccccccccc--cCC
Q 001275           90 E-IGHLSKLQTIDLSSNNFSGNIP-PKLGNCSALEY--LDLSTNGFT---GDIPDNFENLQNLQYLNLYGNLLDG--EIP  160 (1109)
Q Consensus        90 ~-l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~--L~Ls~n~l~---~~~p~~l~~L~~L~~L~L~~n~l~~--~~p  160 (1109)
                      + +..++.  .|..++|.-++.++ ..+...+.|+.  ++++.|...   +.++....++++|++|+|++|+|++  .+|
T Consensus       112 ~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~  189 (267)
T 3rw6_A          112 EQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMS  189 (267)
T ss_dssp             HHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGT
T ss_pred             HHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccch
Confidence            2 222211  12222222222211 11333444444  455555322   1111112345566666666666654  333


Q ss_pred             cccccccccceecccccccc
Q 001275          161 EPLFRILGLQYVFLNNNSLS  180 (1109)
Q Consensus       161 ~~l~~l~~L~~L~Ls~n~l~  180 (1109)
                      ..+..+++|+.|+|++|+|+
T Consensus       190 ~~~~~l~~L~~L~Ls~N~i~  209 (267)
T 3rw6_A          190 SIVQKAPNLKILNLSGNELK  209 (267)
T ss_dssp             THHHHSTTCCEEECTTSCCC
T ss_pred             hHHhhCCCCCEEECCCCccC
Confidence            44444455555555555544

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.80  E-value=1.4e-09  Score=122.94  Aligned_cols=84  Identities=19%  Similarity=0.180  Sum_probs=48.5

Q ss_pred             CCCCccEEEccCccccccCchHHH---hhcccceeeccCCccCCCC----chhhhccCCCCeEEccCCcCcccCCccccC
Q 001275          357 QLSNLQDLELFDNRLTGEFPVSIW---RIASLEYLLVYNNNLLGKL----PLEMTELKQLKNISLYNNQFSGVIPQSLGI  429 (1109)
Q Consensus       357 ~l~~L~~L~L~~N~l~~~~~~~~~---~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  429 (1109)
                      .+++|++|+|++|.+++..+..+.   .+++|++|+|+.|.+.+..    +..+..+++|+.|+|++|.|+...-..+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~  329 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK  329 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHH
Confidence            356677777777666654444443   2566777777777766532    223345677777777777766433322221


Q ss_pred             -CCCCceEEecCCc
Q 001275          430 -NSSLMQLDFINNS  442 (1109)
Q Consensus       430 -~~~L~~L~ls~N~  442 (1109)
                       +  ...+++++|.
T Consensus       330 al--g~~~~~~~~~  341 (362)
T 2ra8_A          330 SL--PMKIDVSDSQ  341 (362)
T ss_dssp             HC--CSEEECCSBC
T ss_pred             Hc--CCEEEecCCc
Confidence             1  3456777765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.80  E-value=6.5e-09  Score=118.50  Aligned_cols=142  Identities=13%  Similarity=0.173  Sum_probs=104.7

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEee--ecccccChHHHHHHHHHHhcCC--CCceeeEeeEEecC---CceeEEEE
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLA--FRGHKRGSLSMKREIQTIGKIR--HRNLVRLEDFWLRK---DCGIIMYR  896 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e  896 (1109)
                      .+.++.|.++.||+.+..+ ..+++|+..  ..........+.+|+.+++.+.  +..+.+++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            5678999999999998764 577888764  2222223456889999999996  45678888888766   34799999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC-------------------------------------  939 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  939 (1109)
                      |++|..+.+.     ....++...+..++.+++++|+.||...                                     
T Consensus       122 ~v~G~~l~~~-----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQ-----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCT-----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCC-----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9999776431     1123678888899999999999999520                                     


Q ss_pred             ------------------CCCeEEeccCCCCeeeCCCCc--EEEecccCCcc
Q 001275          940 ------------------DPPIVHRDIKPENILLDSEME--PHISDFGIAKL  971 (1109)
Q Consensus       940 ------------------~~~ivH~Dlk~~NIll~~~~~--~kl~DfGla~~  971 (1109)
                                        ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              256899999999999987753  68999998864

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.75  E-value=1.6e-07  Score=107.84  Aligned_cols=313  Identities=12%  Similarity=0.066  Sum_probs=161.6

Q ss_pred             ccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccc
Q 001275           91 IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQ  170 (1109)
Q Consensus        91 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~  170 (1109)
                      +..-.+|+.+.+.. .++.+-..+|.++.+|+.++|..+ ++..-..+|.+. +|+.+.+..+ ++ .+....+...+|+
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~-~I~~~aF~~~~L~  116 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VK-KFGDYVFQGTDLD  116 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CC-EECTTTTTTCCCS
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-ee-EeccceeccCCcc
Confidence            44456677777764 466555667888888888888654 554445667776 5666666543 33 3333333444677


Q ss_pred             eecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcc
Q 001275          171 YVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNN  250 (1109)
Q Consensus       171 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~  250 (1109)
                      .+.+..+- +......|.+. +|+.+.+..+ ++......|..+.+++.+.+..+.........+ ..          +.
T Consensus       117 ~i~lp~~~-~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~-~~----------~~  182 (379)
T 4h09_A          117 DFEFPGAT-TEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYV-LY----------NK  182 (379)
T ss_dssp             EEECCTTC-CEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTE-EE----------ET
T ss_pred             cccCCCcc-ccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccce-ec----------cc
Confidence            77765442 21223333332 4555444332 333444556666666666665443321111000 00          00


Q ss_pred             cCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCc
Q 001275          251 LEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE  330 (1109)
Q Consensus       251 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  330 (1109)
                       .......+.....+..+.+..+. .......+....+|+.+.+..+ ++.....+|.....|+.+.+..+ ++......
T Consensus       183 -~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~a  258 (379)
T 4h09_A          183 -NKTILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFL  258 (379)
T ss_dssp             -TSSEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTT
T ss_pred             -ccceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccc
Confidence             00011112222333333322221 1122344455556666665433 33344455566666666666554 44344455


Q ss_pred             cccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCC
Q 001275          331 LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLK  410 (1109)
Q Consensus       331 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  410 (1109)
                      |.++.+|+.+.+..+ +.......|..+++|+.+.+.++.++......|.++.+|+.+.+..+ ++......|.++++|+
T Consensus       259 F~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~  336 (379)
T 4h09_A          259 LQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALS  336 (379)
T ss_dssp             TTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             cceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCC
Confidence            666666666666543 43334445666667777777666666555556666777777777543 5444455677777777


Q ss_pred             eEEccCCcCcccCCccccC
Q 001275          411 NISLYNNQFSGVIPQSLGI  429 (1109)
Q Consensus       411 ~L~L~~N~l~~~~p~~~~~  429 (1109)
                      .+.+..+ ++..-...|..
T Consensus       337 ~i~ip~~-v~~I~~~aF~~  354 (379)
T 4h09_A          337 TISYPKS-ITLIESGAFEG  354 (379)
T ss_dssp             CCCCCTT-CCEECTTTTTT
T ss_pred             EEEECCc-cCEEchhHhhC
Confidence            7776544 44333344433

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.73  E-value=2.5e-07  Score=106.08  Aligned_cols=107  Identities=12%  Similarity=0.123  Sum_probs=48.7

Q ss_pred             HHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccce
Q 001275          379 IWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLR  458 (1109)
Q Consensus       379 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~  458 (1109)
                      +..+..|+.+.+..+ ++......|.+..+|+.+.+..+ ++......|..+.+|+.+++.++.++......|..+.+|+
T Consensus       236 f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~  313 (379)
T 4h09_A          236 FYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLS  313 (379)
T ss_dssp             TTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCC
T ss_pred             ccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCC
Confidence            333444444444332 22223333444444444444332 3323333344445555555555545444444444555555


Q ss_pred             EEECCCcccccCCCcccCCCCccchhhccC
Q 001275          459 VLNMGQNQFHGPIPSLLGSCPTLWRVILKQ  488 (1109)
Q Consensus       459 ~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~  488 (1109)
                      .+.|..+ ++.....+|.+|.+|+.+.+..
T Consensus       314 ~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~  342 (379)
T 4h09_A          314 SVTLPTA-LKTIQVYAFKNCKALSTISYPK  342 (379)
T ss_dssp             EEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred             EEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence            5555433 4434445566666666665543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.53  E-value=1.7e-08  Score=112.01  Aligned_cols=187  Identities=18%  Similarity=0.205  Sum_probs=118.9

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCc--eeeEeeEEecCC---ceeEEEEe
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRN--LVRLEDFWLRKD---CGIIMYRY  897 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~  897 (1109)
                      .+.++.|....||+..    ..+++|+...   ......+.+|+++++.+. +..  +.+.+.+....+   ..|+||||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~---~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH---SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS---HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC---cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999974    5578886521   233457889999998873 332  334444433332   34899999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD---------------------------------------  938 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------  938 (1109)
                      ++|.++.+....     .++.+++..++.++++.++.||..                                       
T Consensus        98 i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           98 IKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             cCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999887653321     256677778888888888888841                                       


Q ss_pred             ----------------CCCCeEEeccCCCCeeeCC--CCcEEEecccCCcccCCCCCCceee------------ecccCc
Q 001275          939 ----------------CDPPIVHRDIKPENILLDS--EMEPHISDFGIAKLLDKSPASTTSI------------SVVGTI  988 (1109)
Q Consensus       939 ----------------~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~------------~~~gt~  988 (1109)
                                      ....++|+|++|.||++++  +..+.|+||+.+..-+.........            ......
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                            1245799999999999988  4567899999887542211000000            000001


Q ss_pred             cccc-ccccccCCCCccCcchhhHHHHHHHHhCCCCC
Q 001275          989 GYIA-PENAFTTAKSKESDVYSYGVVLLELITRKKAL 1024 (1109)
Q Consensus       989 ~y~a-PE~~~~~~~~~~sDvwSlGvil~elltg~~p~ 1024 (1109)
                      ++.. |+.....  ....+.|++|.++|.+.+|+.++
T Consensus       253 ~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          253 KHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence            1111 2221111  22368999999999999998654

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.36  E-value=5.6e-08  Score=103.99  Aligned_cols=67  Identities=28%  Similarity=0.348  Sum_probs=40.5

Q ss_pred             hcccccceeecccccccc--cCCccccCCCCccEEEecCccccCCCCccccccc--ccceeccccccccCCCc
Q 001275          547 GNLVSLVTLNISLNHVEG--SLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWK--SLSILKLSENHFTGGIP  615 (1109)
Q Consensus       547 ~~l~~L~~L~L~~N~l~~--~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p  615 (1109)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|||++|+|++.  ..+..++  +|+.|+|++|.+.+.+|
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence            345666666666666665  3445556666777777777776643  3344444  66666666666665554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.30  E-value=1.3e-07  Score=96.43  Aligned_cols=15  Identities=7%  Similarity=0.217  Sum_probs=7.4

Q ss_pred             CCCccEEEccCcccc
Q 001275          358 LSNLQDLELFDNRLT  372 (1109)
Q Consensus       358 l~~L~~L~L~~N~l~  372 (1109)
                      .++|++|+|++|+|.
T Consensus        64 ~~~L~~L~Ls~n~i~   78 (185)
T 1io0_A           64 NTYVKKFSIVGTRSN   78 (185)
T ss_dssp             CCSCCEEECTTSCCC
T ss_pred             CCCcCEEECcCCCCC
Confidence            344555555555544

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.27  E-value=1.2e-07  Score=96.55  Aligned_cols=116  Identities=13%  Similarity=0.098  Sum_probs=86.3

Q ss_pred             ccccCCCCccEEEccCc-cccccCc----hHHHhhcccceeeccCCccCCCC----chhhhccCCCCeEEccCCcCccc-
Q 001275          353 DELGQLSNLQDLELFDN-RLTGEFP----VSIWRIASLEYLLVYNNNLLGKL----PLEMTELKQLKNISLYNNQFSGV-  422 (1109)
Q Consensus       353 ~~l~~l~~L~~L~L~~N-~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-  422 (1109)
                      ..+...++|++|+|++| .+.....    ..+...++|++|+|++|.+....    ...+...+.|++|+|++|+|+.. 
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g  109 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG  109 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence            44566788999999998 8875433    33445688999999999987543    33455668899999999999864 


Q ss_pred             ---CCccccCCCCCceEEe--cCCcccccCCC----CcccCccceEEECCCcccc
Q 001275          423 ---IPQSLGINSSLMQLDF--INNSFTGEIPP----NLCFGKQLRVLNMGQNQFH  468 (1109)
Q Consensus       423 ---~p~~~~~~~~L~~L~l--s~N~l~~~~p~----~~~~~~~L~~L~L~~N~l~  468 (1109)
                         +...+..+++|++|+|  ++|.|+.....    .+...+.|+.|+|++|++.
T Consensus       110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence               4556677888999999  88998865433    3334478899999988875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.96  E-value=2e-05  Score=87.04  Aligned_cols=136  Identities=19%  Similarity=0.249  Sum_probs=91.4

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCC---ceeeEeeEEe-cCCceeEEEEecc
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR---NLVRLEDFWL-RKDCGIIMYRYME  899 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~  899 (1109)
                      .+.++.|....||+.    +..+++|+-   ........+.+|+++++.+.+.   .+.+.+.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~---~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFP---KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEE---SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEec---CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456888999999998    566788863   1223345788999999999642   3556666664 3456789999999


Q ss_pred             CCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 001275          900 NGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD-----------------------------------------  938 (1109)
Q Consensus       900 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----------------------------------------  938 (1109)
                      |.++.+..-.     .++......++.++++.++.||..                                         
T Consensus        97 G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           97 GQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             SEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             CeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            9887653211     123344444444444444444421                                         


Q ss_pred             ----------------CCCCeEEeccCCCCeeeCC---CCc-EEEecccCCcc
Q 001275          939 ----------------CDPPIVHRDIKPENILLDS---EME-PHISDFGIAKL  971 (1109)
Q Consensus       939 ----------------~~~~ivH~Dlk~~NIll~~---~~~-~kl~DfGla~~  971 (1109)
                                      ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            2345799999999999987   455 48999997763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.95  E-value=2.4e-05  Score=84.76  Aligned_cols=134  Identities=16%  Similarity=0.122  Sum_probs=95.2

Q ss_pred             eeecccCe-EEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEEEEeccCCC
Q 001275          826 VIGRGAHG-IVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIMYRYMENGS  902 (1109)
Q Consensus       826 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  902 (1109)
                      .+..|..| .||+.... ++..+++|+-..    ....++.+|...++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            35556655 69998765 456788887532    23456888999998884 3346678888888889999999999988


Q ss_pred             HHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 001275          903 LRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD--------------------------------------------  938 (1109)
Q Consensus       903 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------  938 (1109)
                      +.+......       .....+..++++.++.||..                                            
T Consensus       107 ~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            877654311       12334566666667767621                                            


Q ss_pred             -----------CCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          939 -----------CDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       939 -----------~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                                 ....++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       01237899999999999987777899998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.67  E-value=5.5e-05  Score=85.65  Aligned_cols=80  Identities=6%  Similarity=-0.002  Sum_probs=54.0

Q ss_pred             cee-ecccCeEEEEEEeC-------CCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCC-C--CceeeEeeEEecC---
Q 001275          825 HVI-GRGAHGIVYKASLG-------PNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIR-H--RNLVRLEDFWLRK---  888 (1109)
Q Consensus       825 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~---  888 (1109)
                      +.| +.|....+|+....       +++.+++|.......  ......+.+|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            557 78889999998654       266788886532210  112246788988888884 2  3566777777654   


Q ss_pred             CceeEEEEeccCCCHH
Q 001275          889 DCGIIMYRYMENGSLR  904 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~  904 (1109)
                      +..++||||++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999986653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.66  E-value=2.3e-05  Score=77.59  Aligned_cols=84  Identities=10%  Similarity=0.090  Sum_probs=53.7

Q ss_pred             cccceeeccCcccCCCCCccccCCCCccEEEccCcc-ccccCchHHHhh----cccceeeccCCc-cCCCCchhhhccCC
Q 001275          335 KYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNR-LTGEFPVSIWRI----ASLEYLLVYNNN-LLGKLPLEMTELKQ  408 (1109)
Q Consensus       335 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~~~~~~~l~~  408 (1109)
                      ..|+.||++++.+++..-..+..+++|++|+|++|. +++..-..+..+    ++|++|+|++|. +++..-..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356666666666665555556667777777777774 665444445543    367777777764 66555555666777


Q ss_pred             CCeEEccCCc
Q 001275          409 LKNISLYNNQ  418 (1109)
Q Consensus       409 L~~L~L~~N~  418 (1109)
                      |+.|+++++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            7777777664

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.53  E-value=2.3e-05  Score=77.56  Aligned_cols=34  Identities=21%  Similarity=0.160  Sum_probs=16.5

Q ss_pred             CccEEEecccc-ccCcCchhcccccccccccccCc
Q 001275          216 RLQELYLNENK-LMGFLPESLSNLENLVYLDVGDN  249 (1109)
Q Consensus       216 ~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N  249 (1109)
                      +|++|+|++|. ||...-..+.++++|++|+++++
T Consensus       115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c  149 (176)
T 3e4g_A          115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDL  149 (176)
T ss_dssp             HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESC
T ss_pred             CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCC
Confidence            45555555542 44433344444555555555544

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.49  E-value=0.00023  Score=79.89  Aligned_cols=140  Identities=15%  Similarity=0.210  Sum_probs=79.2

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC--CCceeeEee------EEecCCceeEEEE
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR--HRNLVRLED------FWLRKDCGIIMYR  896 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~e  896 (1109)
                      +.++.|..+.||+....+| .+++|+...     ...++..|+.++..+.  .-.+.+++.      +....+..++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECS-----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCC-----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3466677899999987755 488888743     1234445556555552  112333332      1223566789999


Q ss_pred             eccCCCHH--------------HHHhccCC----C-------CCCCHHHHH-----------------------------
Q 001275          897 YMENGSLR--------------DVLHSITP----P-------PTLEWNVRY-----------------------------  922 (1109)
Q Consensus       897 ~~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~~-----------------------------  922 (1109)
                      |++|.++.              ..+|....    +       ..-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986532              11222110    1       012332211                             


Q ss_pred             --HHHHHHHHHHHHhhc----------CCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          923 --KIALGAAHALAYLHY----------DCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       923 --~i~~~i~~~L~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                        .+...+.+++++|+.          .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111123345666652          025789999999999999888899999999765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.43  E-value=0.00034  Score=80.31  Aligned_cols=76  Identities=9%  Similarity=0.018  Sum_probs=49.6

Q ss_pred             CceeecccCeEEEEEEeC-CCcEEEEEEeeeccc------ccChHHHHHHHHHHhcCCC--C-ceeeEeeEEecCCceeE
Q 001275          824 KHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH------KRGSLSMKREIQTIGKIRH--R-NLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  893 (1109)
                      .+.+|.|..+.||+++.. +++.++||.......      .....++..|.++++.+..  + .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            456999999999999754 467899997642211      1234467789888887732  3 34455543  3456789


Q ss_pred             EEEeccCC
Q 001275          894 MYRYMENG  901 (1109)
Q Consensus       894 v~e~~~~g  901 (1109)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.18  E-value=0.0011  Score=72.34  Aligned_cols=78  Identities=12%  Similarity=0.131  Sum_probs=55.6

Q ss_pred             CCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCC---CceeeEeeEEecCCceeEEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH---RNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .....+.+|.|..+.||+.+..+|+.|++|+-... .......|.+|+..|+.+.-   --+.+.+++    +..++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDD-APALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTT-CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCC-CcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence            34446679999999999999999999999975322 23334568899999888742   234445544    23578999


Q ss_pred             eccCCC
Q 001275          897 YMENGS  902 (1109)
Q Consensus       897 ~~~~gs  902 (1109)
                      |++++.
T Consensus        91 ~l~~~~   96 (288)
T 3f7w_A           91 WVDERP   96 (288)
T ss_dssp             CCCCCC
T ss_pred             eecccC
Confidence            998764

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.11  E-value=0.00011  Score=74.15  Aligned_cols=63  Identities=10%  Similarity=0.104  Sum_probs=28.3

Q ss_pred             ccCCCCeEEccCCcCccc----CCccccCCCCCceEEecCC---ccccc----CCCCcccCccceEEECCCccc
Q 001275          405 ELKQLKNISLYNNQFSGV----IPQSLGINSSLMQLDFINN---SFTGE----IPPNLCFGKQLRVLNMGQNQF  467 (1109)
Q Consensus       405 ~l~~L~~L~L~~N~l~~~----~p~~~~~~~~L~~L~ls~N---~l~~~----~p~~~~~~~~L~~L~L~~N~l  467 (1109)
                      .-+.|+.|+|++|+|...    +.+.+..++.|++|+|++|   .+...    +...+..-+.|+.|+++.|.+
T Consensus        96 ~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A           96 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             cCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            334455555555555432    2223334455666666543   22221    122233335566666665554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.02  E-value=0.0052  Score=67.43  Aligned_cols=138  Identities=13%  Similarity=0.139  Sum_probs=92.2

Q ss_pred             CceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC---CCceeeEeeEEecCCceeEEEEeccC
Q 001275          824 KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR---HRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      .+.++.|....+|+.... +..+++|+...    .....+.+|++.++.+.   ...+.++++++...+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINER----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEG----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCc----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            466899999999999864 67788887632    23557889999888883   36688888888878889999999998


Q ss_pred             CCHH-----------HHHhccCCCC-------------------CCCHHHHH---HHHH----------------HHHHH
Q 001275          901 GSLR-----------DVLHSITPPP-------------------TLEWNVRY---KIAL----------------GAAHA  931 (1109)
Q Consensus       901 gsL~-----------~~l~~~~~~~-------------------~l~~~~~~---~i~~----------------~i~~~  931 (1109)
                      ..+.           ..+|.....+                   .-+|....   ++..                .+++.
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7641           1234332200                   12465432   1111                11111


Q ss_pred             -HHHhh-cCCCCCeEEeccCCCCeeeCCCCcEEEeccc
Q 001275          932 -LAYLH-YDCDPPIVHRDIKPENILLDSEMEPHISDFG  967 (1109)
Q Consensus       932 -L~~LH-~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfG  967 (1109)
                       ...|. ....+.++|+|+.+.||+++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             22332 12256799999999999999887 8899973

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.00  E-value=0.00014  Score=73.35  Aligned_cols=116  Identities=14%  Similarity=0.124  Sum_probs=54.4

Q ss_pred             ccccccEEEcCCC-CCCCC----CCCccccccccceeeccCcccCCCCCccc----cCCCCccEEEccCccccccCchHH
Q 001275          309 LLARLSSLDLSEN-QLSGK----IPPELGKCKYLTVLHLYANQLEGEIPDEL----GQLSNLQDLELFDNRLTGEFPVSI  379 (1109)
Q Consensus       309 ~l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l----~~l~~L~~L~L~~N~l~~~~~~~~  379 (1109)
                      .-+.|++|+|++| +|...    +.+.+..-+.|+.|+|++|+|.+.....+    ..-+.|++|+|++|.|++..-..+
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al  118 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL  118 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence            3355666666664 55421    22233344555555555555543222222    223444555555554443222222


Q ss_pred             HhhcccceeeccCCccCCCCchhhhccCCCCeEEccCC---cCcc----cCCccccCCCCCceEEecCCccc
Q 001275          380 WRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNN---QFSG----VIPQSLGINSSLMQLDFINNSFT  444 (1109)
Q Consensus       380 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N---~l~~----~~p~~~~~~~~L~~L~ls~N~l~  444 (1109)
                      .                    ..+..-+.|+.|+|++|   ++..    .+.+.+..+++|+.|+++.|.+.
T Consensus       119 a--------------------~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          119 L--------------------RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             H--------------------HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             H--------------------HHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            2                    22333445666666543   3332    13334456677777777766543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.62  E-value=0.006  Score=70.38  Aligned_cols=80  Identities=9%  Similarity=0.092  Sum_probs=48.7

Q ss_pred             CCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccC---CCCccCcchhhHHHHHH
Q 001275          940 DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT---AKSKESDVYSYGVVLLE 1016 (1109)
Q Consensus       940 ~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvil~e 1016 (1109)
                      ...++|||+++.||+++.++ ++++||+.+..-.......... ..-...|.+|+.....   ......++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHH-HHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            67899999999999998876 9999999887432110000000 0011346666644311   11233555678888888


Q ss_pred             HHhCC
Q 001275         1017 LITRK 1021 (1109)
Q Consensus      1017 lltg~ 1021 (1109)
                      .++++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.53  E-value=0.0053  Score=67.30  Aligned_cols=72  Identities=10%  Similarity=0.153  Sum_probs=44.5

Q ss_pred             CCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCce-eeEeeEEecCCceeEEEEec-cC
Q 001275          823 AKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL-VRLEDFWLRKDCGIIMYRYM-EN  900 (1109)
Q Consensus       823 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~  900 (1109)
                      -.+.++.|....+|+.     ..+++|+.....  ....+..+|+.+++.+....+ .+++++  ..+..++|+||+ ++
T Consensus        22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g   92 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGT--EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGA   92 (301)
T ss_dssp             SCEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTC
T ss_pred             ceeEcCCcccccccee-----eeEEEECCCCCc--cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCC
Confidence            3678999999999999     557888764321  111234568777777642223 344443  344568999999 55


Q ss_pred             CCH
Q 001275          901 GSL  903 (1109)
Q Consensus       901 gsL  903 (1109)
                      .++
T Consensus        93 ~~l   95 (301)
T 3dxq_A           93 QTM   95 (301)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            443

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.49  E-value=0.0071  Score=66.92  Aligned_cols=158  Identities=11%  Similarity=0.091  Sum_probs=85.7

Q ss_pred             ccHHHHHHHhhCCCCC-----ceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCc--eeeE
Q 001275          809 YLLKQVIEATENLNAK-----HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN--LVRL  881 (1109)
Q Consensus       809 ~~~~~~~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l  881 (1109)
                      .+.+++...-+.|...     +.++.|....+|+....++ .+++|.....   .....+..|+.++..+....  +.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~---~~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR---VEKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC---CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3344555555556542     3466788899999987766 5778877432   12335667777777763212  2333


Q ss_pred             eeE------EecCCceeEEEEeccCCCHH--------------HHHhccC----CCC--C---CCHHHHHHH--------
Q 001275          882 EDF------WLRKDCGIIMYRYMENGSLR--------------DVLHSIT----PPP--T---LEWNVRYKI--------  924 (1109)
Q Consensus       882 ~~~------~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~----~~~--~---l~~~~~~~i--------  924 (1109)
                      +..      ....+..+++++|++|..+.              ..+|...    ...  .   ..|...+.-        
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      12235568999999986431              0122211    110  0   123321110        


Q ss_pred             ----HHHHHHHHHHhhc----CCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          925 ----ALGAAHALAYLHY----DCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       925 ----~~~i~~~L~~LH~----~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                          ...+.+.+++++.    .....++|+|+.+.||+++++..+.++||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                0113344555542    123568999999999999887666899998765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.45  E-value=0.0049  Score=68.63  Aligned_cols=141  Identities=16%  Similarity=0.128  Sum_probs=71.8

Q ss_pred             ceeecccCeE-EEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCC--CceeeEeeEEecCCceeEEEEeccCC
Q 001275          825 HVIGRGAHGI-VYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH--RNLVRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       825 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      +.++.|+... +|+....+++.+++|......    ..++..|+.++..+..  -.+.+++.+...  ..+++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE----GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT----TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC----CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCc
Confidence            3465555444 667766446677776542211    1234556666666632  234556665333  237899999877


Q ss_pred             CHHHHHhcc---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHhh--
Q 001275          902 SLRDVLHSI---------------------TPP--PTLEWNVRY-------K-------------IALGAAHALAYLH--  936 (1109)
Q Consensus       902 sL~~~l~~~---------------------~~~--~~l~~~~~~-------~-------------i~~~i~~~L~~LH--  936 (1109)
                      ++.+++...                     ...  +.++.....       .             ....+.+.++.+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            775544221                     100  112111100       0             0001112222221  


Q ss_pred             -cCCCCCeEEeccCCCCeeeCCC----CcEEEecccCCcc
Q 001275          937 -YDCDPPIVHRDIKPENILLDSE----MEPHISDFGIAKL  971 (1109)
Q Consensus       937 -~~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfGla~~  971 (1109)
                       ......++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1124578999999999999875    6799999998763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.41  E-value=0.021  Score=63.28  Aligned_cols=141  Identities=16%  Similarity=0.129  Sum_probs=80.4

Q ss_pred             ceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCC--ceeeEeeE-----EecCCceeEEEEe
Q 001275          825 HVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR--NLVRLEDF-----WLRKDCGIIMYRY  897 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~  897 (1109)
                      +.++ |....||+....+|+.+++|.....  ......+..|..++..+...  .+.+++..     ....+..++|+||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~--~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCC--CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4566 8888999998777878899987422  12345677788888777421  23444443     1223455789999


Q ss_pred             ccCCCHH-----H------H---HhccCC------CCCCCHHHH----------------------HHHHHHHHHHHHHh
Q 001275          898 MENGSLR-----D------V---LHSITP------PPTLEWNVR----------------------YKIALGAAHALAYL  935 (1109)
Q Consensus       898 ~~~gsL~-----~------~---l~~~~~------~~~l~~~~~----------------------~~i~~~i~~~L~~L  935 (1109)
                      ++|.++.     .      .   +|....      ....++...                      ...+..++..++-.
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875421     1      1   121100      112222211                      01111112222211


Q ss_pred             hc-CCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          936 HY-DCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       936 H~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      -. .....++|+|+++.||+++ + .+.++||+.+.
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            11 1245578999999999999 4 89999998775

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=95.98  E-value=0.0067  Score=57.02  Aligned_cols=56  Identities=18%  Similarity=0.225  Sum_probs=31.8

Q ss_pred             eeeccccccc-ccCCccccCCCCccEEEecCccccCCCCcccccccccceecccccccc
Q 001275          554 TLNISLNHVE-GSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       554 ~L~L~~N~l~-~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      .++-++++++ ..+|..+.  .+|+.|||++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3444444443 23444333  45667777777776444455666666666666666665

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=95.96  E-value=0.0088  Score=56.22  Aligned_cols=38  Identities=24%  Similarity=0.177  Sum_probs=28.2

Q ss_pred             CCCcEeeccCccccCCCCccccccCccceecccccccc
Q 001275          119 SALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD  156 (1109)
Q Consensus       119 ~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~  156 (1109)
                      ++|++|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus        31 ~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            45777788888877665667777888888888888664

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.67  E-value=0.011  Score=68.25  Aligned_cols=72  Identities=11%  Similarity=0.110  Sum_probs=47.6

Q ss_pred             CceeecccCeEEEEEEeCC--------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCce-eeEeeEEecCCceeEE
Q 001275          824 KHVIGRGAHGIVYKASLGP--------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL-VRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  894 (1109)
                      .+.|+.|....||++...+        +..+++|+....   .....+.+|..+++.+...++ .++++.+..    .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            3568888899999998753        477888876221   111456689988888843333 556665432    389


Q ss_pred             EEeccCCC
Q 001275          895 YRYMENGS  902 (1109)
Q Consensus       895 ~e~~~~gs  902 (1109)
                      +||++|.+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99998643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.41  E-value=0.019  Score=64.67  Aligned_cols=141  Identities=16%  Similarity=0.149  Sum_probs=81.3

Q ss_pred             CceeecccCeEEEEEEeC--------CCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCceeEE
Q 001275          824 KHVIGRGAHGIVYKASLG--------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  894 (1109)
                      .+.+..|-...+|+....        +++.+++|+...  .......+.+|.++++.+. +.-..++++++.+    .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence            345777888999999875        246788887522  2234556778999998884 2223556665543    289


Q ss_pred             EEeccCCCHHH-----------------HHhccCC--CCCC--CHHHHHHHHHHHHH-------------------HHHH
Q 001275          895 YRYMENGSLRD-----------------VLHSITP--PPTL--EWNVRYKIALGAAH-------------------ALAY  934 (1109)
Q Consensus       895 ~e~~~~gsL~~-----------------~l~~~~~--~~~l--~~~~~~~i~~~i~~-------------------~L~~  934 (1109)
                      +||++|.++..                 -+|....  ....  -|..+.++..++..                   .++.
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99998755421                 1122211  1112  24444444433321                   1222


Q ss_pred             h----hc-CCCCCeEEeccCCCCeeeCCC----CcEEEecccCCc
Q 001275          935 L----HY-DCDPPIVHRDIKPENILLDSE----MEPHISDFGIAK  970 (1109)
Q Consensus       935 L----H~-~~~~~ivH~Dlk~~NIll~~~----~~~kl~DfGla~  970 (1109)
                      |    .. .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2    21 123468899999999999876    789999998775

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.24  E-value=0.012  Score=66.50  Aligned_cols=72  Identities=8%  Similarity=0.074  Sum_probs=42.2

Q ss_pred             ceeecccCeEEEEEEeCC---------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCc-eeeEeeEEecCCceeEE
Q 001275          825 HVIGRGAHGIVYKASLGP---------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN-LVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  894 (1109)
                      +.++.|....+|+....+         ++.+++|+....  .....+...|.++++.+...+ +.++++..    ..++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH--VDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT--GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC--ccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            457788889999998764         267778765321  111123467888888774333 34555443    23789


Q ss_pred             EEeccCCC
Q 001275          895 YRYMENGS  902 (1109)
Q Consensus       895 ~e~~~~gs  902 (1109)
                      |||++|.+
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.94  E-value=0.042  Score=63.61  Aligned_cols=74  Identities=15%  Similarity=0.221  Sum_probs=47.0

Q ss_pred             CceeecccCeEEEEEEeCC-CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCce-eeEeeEEecCCceeEEEEeccCC
Q 001275          824 KHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL-VRLEDFWLRKDCGIIMYRYMENG  901 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  901 (1109)
                      .+.|+.|-...+|+....+ +..+++|+.....  ....+..+|..++..+...++ .++++++.  +  ..|+||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCc
Confidence            3568888899999998875 4778888763221  112233688888888864444 45666652  2  3599999874


Q ss_pred             CH
Q 001275          902 SL  903 (1109)
Q Consensus       902 sL  903 (1109)
                      ++
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.93  E-value=0.073  Score=59.17  Aligned_cols=32  Identities=28%  Similarity=0.361  Sum_probs=27.8

Q ss_pred             CCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          940 DPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       940 ~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      ...++|+|+.+.||++++++.+.++||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45689999999999999888899999987653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.27  E-value=0.16  Score=51.37  Aligned_cols=120  Identities=10%  Similarity=0.120  Sum_probs=73.1

Q ss_pred             CHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCcee
Q 001275          902 SLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS  981 (1109)
Q Consensus       902 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  981 (1109)
                      +|.++|...+.  +++++++|.++.|.+++|.-.-....+  ..+=..|..|++..+|.|...+ +.+.           
T Consensus        34 SL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence            79999988664  599999999999999998876211011  1222346889999999988764 1111           


Q ss_pred             eecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHh
Q 001275          982 ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041 (1109)
Q Consensus       982 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1109)
                         .....+.|||... ...+.+.=|||+|+++|..+--..|-+....-..++...+..+
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHM  153 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHH
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHH
Confidence               1122466888653 3456788899999999999976655332222233344444333

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=90.34  E-value=0.5  Score=53.84  Aligned_cols=74  Identities=9%  Similarity=0.036  Sum_probs=47.4

Q ss_pred             CceeecccCeEEEEEEeCC--------CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCc-eeeEeeEEecCCceeEE
Q 001275          824 KHVIGRGAHGIVYKASLGP--------NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN-LVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  894 (1109)
                      .+.+..|-...+|+....+        ++.|++|+....  .....+..+|.++++.+...+ ..++++.+    ..+.|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~--t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH--VGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC--C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC--cchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEE
Confidence            3457778889999998763        577888875322  122234567888888874222 34455433    23789


Q ss_pred             EEeccCCCH
Q 001275          895 YRYMENGSL  903 (1109)
Q Consensus       895 ~e~~~~gsL  903 (1109)
                      +||++|.++
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1109
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-60
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-54
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-52
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-51
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-50
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-49
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-46
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-43
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-40
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-36
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-36
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-30
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-28
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-11
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	9e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-12
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-20
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	9e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-19
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-15
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-12
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	0.004
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	3e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-08
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	4e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	2e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.004
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	5e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (524), Expect = 2e-60
 Identities = 71/283 (25%), Positives = 113/283 (39%), Gaps = 27/283 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRN 877
              +     IG G+ G VYK     +   AVK L         L + K E+  + K RH N
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            ++    +       I+   + E  SL   LH I      E      IA   A  + YLH 
Sbjct: 66   ILLFMGYSTAPQLAIVTQ-WCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHA 122

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I+HRD+K  NI L  ++   I DFG+A +  +   S     + G+I ++APE   
Sbjct: 123  ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 998  TTAK---SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054
               K   S +SDVY++G+VL EL+T +                     ++ ++I  +V  
Sbjct: 180  MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI---------------NNRDQIIFMVGR 224

Query: 1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              +   L     +    +  +   C +KK   RP    ++  +
Sbjct: 225  GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-55
 Identities = 67/292 (22%), Positives = 110/292 (37%), Gaps = 25/292 (8%)

Query: 824  KHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
            +  IG+G  G V++         AVK       +  S   + EI     +RH N++    
Sbjct: 8    QESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIA 64

Query: 884  FWLRKDCGI----IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
               + +       ++  Y E+GSL D L+      T+      K+AL  A  LA+LH + 
Sbjct: 65   ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 940  -----DPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP--ASTTSISVVGTIGYIA 992
                  P I HRD+K +NIL+       I+D G+A   D +           VGT  Y+A
Sbjct: 121  VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 993  PENAFTTAK------SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046
            PE    +         K +D+Y+ G+V  E+  R          +      V S  S  E
Sbjct: 181  PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 1047 EINDIVDLSLMEEMLVSSIRDQVIDVLL-VALRCTEKKPSNRPNMRDVVRQL 1097
                + +  L   +       + + V+  +   C     + R     + + L
Sbjct: 241  MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-54
 Identities = 65/279 (23%), Positives = 121/279 (43%), Gaps = 27/279 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            E L     +G G  G V+      +   AVK L  +       +   E   + +++H+ L
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            VRL     ++   II   YMENGSL D L + +    L  N    +A   A  +A++   
Sbjct: 71   VRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE-- 126

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
             +   +HRD++  NIL+   +   I+DFG+A+L++ +  +         I + APE    
Sbjct: 127  -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINY 184

Query: 999  TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058
               + +SDV+S+G++L E++T  +   P                ++ E I ++     M 
Sbjct: 185  GTFTIKSDVWSFGILLTEIVTHGRIPYPG--------------MTNPEVIQNLERGYRMV 230

Query: 1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                 +  +++  ++     C +++P +RP    +   L
Sbjct: 231  --RPDNCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 6e-53
 Identities = 49/281 (17%), Positives = 104/281 (37%), Gaps = 27/281 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            ++L     +G G  G+V           A+K +  +           E + +  + H  L
Sbjct: 4    KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLSHEKL 61

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            V+L     ++    I+  YM NG L + L  +      +     ++      A+ YL   
Sbjct: 62   VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLES- 118

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
                 +HRD+   N L++ +    +SDFG+++ +      T+S+     + +  PE    
Sbjct: 119  --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMY 175

Query: 999  TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058
            +  S +SD++++GV++ E+ +  K     Y+  T+                 +    +  
Sbjct: 176  SKFSSKSDIWAFGVLMWEIYSLGK---MPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 232

Query: 1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099
                            +   C  +K   RP  + ++  ++D
Sbjct: 233  ----------------IMYSCWHEKADERPTFKILLSNILD 257

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 1e-52
 Identities = 58/279 (20%), Positives = 113/279 (40%), Gaps = 27/279 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
              L     IG G  G+V+          A+K +  R           E + + K+ H  L
Sbjct: 5    SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKL 62

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            V+L    L +    +++ +ME+G L D  +  T            + L     +    Y 
Sbjct: 63   VQLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGM---AYL 117

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
             +  ++HRD+   N L+       +SDFG+ + +      T+S      + + +PE    
Sbjct: 118  EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSF 176

Query: 999  TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058
            +  S +SDV+S+GV++ E+ +  K    + +  +++V  + + +             L +
Sbjct: 177  SRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGF------------RLYK 223

Query: 1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              L S+       V  +   C +++P +RP    ++RQL
Sbjct: 224  PRLAST------HVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-52
 Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 27/279 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            E+L  +  +G+G  G V+  +       A+K L  +       +  +E Q + K+RH  L
Sbjct: 17   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 74

Query: 879  VRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            V+L      +   I+   YM  GSL D L   T            +A   A  +AY+   
Sbjct: 75   VQLYAVVSEEPIYIVTE-YMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM 132

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
                 VHRD++  NIL+   +   ++DFG+A+L++ +  +         I + APE A  
Sbjct: 133  N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALY 188

Query: 999  TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058
               + +SDV+S+G++L EL T+ +   P                    E+ D V+     
Sbjct: 189  GRFTIKSDVWSFGILLTELTTKGRVPYPGM---------------VNREVLDQVERGYRM 233

Query: 1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
                    + + D++    +C  K+P  RP    +   L
Sbjct: 234  P-CPPECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 268

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (468), Expect = 1e-52
 Identities = 70/306 (22%), Positives = 121/306 (39%), Gaps = 49/306 (16%)

Query: 819  ENLNAKHVIGRGAHGIVYKA------SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
             N+     IG GA G V++A         P  + AVK L            +RE   + +
Sbjct: 13   NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITP-------------------- 912
              + N+V+L           +++ YM  G L + L S++P                    
Sbjct: 73   FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 913  -PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
             PP L    +  IA   A  +AYL    +   VHRD+   N L+   M   I+DFG+++ 
Sbjct: 133  GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 972  LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            +  +       +    I ++ PE+ F    + ESDV++YGVVL E+ +        Y   
Sbjct: 190  IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL---QPYYGM 246

Query: 1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
                       +  E I  + D +++      +   ++ +++     C  K P++RP+  
Sbjct: 247  -----------AHEEVIYYVRDGNILA--CPENCPLELYNLM---RLCWSKLPADRPSFC 290

Query: 1092 DVVRQL 1097
             + R L
Sbjct: 291  SIHRIL 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-52
 Identities = 65/303 (21%), Positives = 115/303 (37%), Gaps = 33/303 (10%)

Query: 817  ATENLNAKHVIGRGAHGIVYKASLGP-NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH 875
              ++      +G G  G+V+K S  P   V A K +           + RE+Q + +   
Sbjct: 4    KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
              +V     +       I   +M+ GSL  VL        +   +  K+++     L YL
Sbjct: 64   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
                   I+HRD+KP NIL++S  E  + DFG++  L  S A++     VGT  Y++PE 
Sbjct: 121  REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRSYMSPER 174

Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPS---------------------YKERTDI 1034
               T  S +SD++S G+ L+E+   +  + P                       + RT  
Sbjct: 175  LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 1035 VGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVAL--RCTEKKPSNRPNMRD 1092
                         +     L  +       +   V  +       +C  K P+ R +++ 
Sbjct: 235  RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 1093 VVR 1095
            ++ 
Sbjct: 295  LMV 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-51
 Identities = 57/306 (18%), Positives = 105/306 (34%), Gaps = 48/306 (15%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
            ENL    V+G GA G V  A+       G +   AVK L  +       ++  E++ + +
Sbjct: 37   ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 873  I-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS--------------------IT 911
            +  H N+V L           +++ Y   G L + L S                      
Sbjct: 97   LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 912  PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL 971
                L +      A   A  + +L        VHRD+   N+L+       I DFG+A+ 
Sbjct: 157  DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 972  LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER 1031
            +          +    + ++APE+ F    + +SDV+SYG++L E+ +      P     
Sbjct: 214  IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 1032 TDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
             +    +++ +    +        +                  +   C       RP+  
Sbjct: 274  ANFYKLIQNGF--KMDQPFYATEEIYI----------------IMQSCWAFDSRKRPSFP 315

Query: 1092 DVVRQL 1097
            ++   L
Sbjct: 316  NLTSFL 321

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 4e-51
 Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 29/284 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSM-KREIQTIGKIRHR 876
            E+    + IG G++G   K        +   K+L +         M   E+  + +++H 
Sbjct: 4    EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 877  NLVRLEDFWLRKDCGI--IMYRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALA 933
            N+VR  D  + +      I+  Y E G L  V+   T     L+     ++      AL 
Sbjct: 64   NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 934  YLHY--DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYI 991
              H   D    ++HRD+KP N+ LD +    + DFG+A++L+   +     + VGT  Y+
Sbjct: 124  ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYM 181

Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051
            +PE     + +++SD++S G +L EL                        +S  E    I
Sbjct: 182  SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA---------------FSQKELAGKI 226

Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
             +       +     D++ +++    R    K  +RP++ +++ 
Sbjct: 227  REGKFRR--IPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 6e-51
 Identities = 62/301 (20%), Positives = 105/301 (34%), Gaps = 30/301 (9%)

Query: 812  KQVIEATENLNAKHV-IGRGAHGIVYKA---SLGPNAVFAVKKLAFRGHKRGSLSMKREI 867
            K++    +NL    + +G G  G V +            A+K L     K  +  M RE 
Sbjct: 1    KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 868  QTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALG 927
            Q + ++ +  +VRL      +   ++M      G L   L        +  +   ++   
Sbjct: 61   QIMHQLDNPYIVRLIGVCQAEALMLVME-MAGGGPLHKFLVG--KREEIPVSNVAELLHQ 117

Query: 928  AAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK-SPASTTSISVVG 986
             +  + YL        VHRD+   N+LL +     ISDFG++K L       T   +   
Sbjct: 118  VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 987  TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046
             + + APE       S  SDV+SYGV + E ++  +     YK+                
Sbjct: 175  PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ---KPYKKMKGPEVMAFIEQGKRM 231

Query: 1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTS 1106
            E        L                  +   C   K  +RP+   V +++      + S
Sbjct: 232  ECPPECPPELYA----------------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275

Query: 1107 K 1107
            K
Sbjct: 276  K 276

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (455), Expect = 7e-51
 Identities = 69/305 (22%), Positives = 122/305 (40%), Gaps = 40/305 (13%)

Query: 809  YLLKQVIEATENLNAK---------HVIGRGAHGIVYKASL----GPNAVFAVKKLAFRG 855
            +  +   EA      +          VIG G  G V    L          A+K L    
Sbjct: 7    FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 856  HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPT 915
             ++       E   +G+  H N++ LE    +    +I+  +MENGSL   L       T
Sbjct: 67   TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 916  LEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
                    +  G A  + YL        VHRD+   NIL++S +   +SDFG+++ L+  
Sbjct: 127  --VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 976  PASTTSISVVG---TIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERT 1032
             +  T  S +G    I + APE       +  SDV+SYG+V+ E+++  +     Y + T
Sbjct: 182  TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---RPYWDMT 238

Query: 1033 DIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRD 1092
            +            +++ + ++    ++  +    D    +  + L C +K  ++RP    
Sbjct: 239  N------------QDVINAIE----QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 1093 VVRQL 1097
            +V  L
Sbjct: 283  IVNTL 287

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-50
 Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 34/277 (12%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED 883
             IGRG+   VYK          A  +L  R   +      K E + +  ++H N+VR  D
Sbjct: 16   EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75

Query: 884  FWL----RKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
             W      K C +++   M +G+L+  L        ++  V           L +LH   
Sbjct: 76   SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTRT 132

Query: 940  DPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFT 998
             PPI+HRD+K +NI +        I D G+A L   S A      V+GT  ++APE  + 
Sbjct: 133  -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPE-MYE 186

Query: 999  TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058
                +  DVY++G+ +LE+ T +      Y E  +     R V S        V  +  +
Sbjct: 187  EKYDESVDVYAFGMCMLEMATSE----YPYSECQNAAQIYRRVTSG-------VKPASFD 235

Query: 1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
            ++ +  +++       +   C  +    R +++D++ 
Sbjct: 236  KVAIPEVKE-------IIEGCIRQNKDERYSIKDLLN 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (450), Expect = 2e-50
 Identities = 62/280 (22%), Positives = 117/280 (41%), Gaps = 27/280 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN 877
             ++  KH +G G +G VY+      +   AVK L  +          +E   + +I+H N
Sbjct: 17   TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPN 74

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            LV+L     R+    I+  +M  G+L D L        +   V   +A   + A+ YL  
Sbjct: 75   LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE- 132

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                  +HRD+   N L+       ++DFG+++L+      T        I + APE+  
Sbjct: 133  --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLA 189

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057
                S +SDV+++GV+L E+ T   +  P                 D  ++ ++++    
Sbjct: 190  YNKFSIKSDVWAFGVLLWEIATYGMSPYPG---------------IDLSQVYELLEKDYR 234

Query: 1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             E       ++V +++     C +  PS+RP+  ++ +  
Sbjct: 235  MER-PEGCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 270

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-50
 Identities = 63/284 (22%), Positives = 115/284 (40%), Gaps = 31/284 (10%)

Query: 821  LNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHR 876
            ++   VIGRG  G VY  +L    G     AVK L              E   +    H 
Sbjct: 29   VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88

Query: 877  NLVRLEDFWLRKD-CGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
            N++ L    LR +   +++  YM++G LR+ + + T  PT++  + + + +        +
Sbjct: 89   NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----M 143

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTT--SISVVGTIGYIAP 993
             +      VHRD+   N +LD +    ++DFG+A+ +      +          + ++A 
Sbjct: 144  KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053
            E+  T   + +SDV+S+GV+L EL+TR     P      +       +            
Sbjct: 204  ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD----VNTFDITVYLLQGRRL------ 253

Query: 1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              L  E     + +       V L+C   K   RP+  ++V ++
Sbjct: 254  --LQPEYCPDPLYE-------VMLKCWHPKAEMRPSFSELVSRI 288

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 8e-50
 Identities = 60/301 (19%), Positives = 106/301 (35%), Gaps = 43/301 (14%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
              L+    +G GA G V +A+             AVK L    H     ++  E++ +  
Sbjct: 23   NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 873  I-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHS---------------ITPPPTL 916
            +  H N+V L          +++  Y   G L + L                       L
Sbjct: 83   LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 917  EWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
            +       +   A  +A+L        +HRD+   NILL       I DFG+A+ +    
Sbjct: 143  DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVG 1036
                  +    + ++APE+ F    + ESDV+SYG+ L EL +   +  P     +    
Sbjct: 200  NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 1037 WVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
             ++  +             L  E   + + D       +   C +  P  RP  + +V+ 
Sbjct: 260  MIKEGFRM-----------LSPEHAPAEMYD-------IMKTCWDADPLKRPTFKQIVQL 301

Query: 1097 L 1097
            +
Sbjct: 302  I 302

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-49
 Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 26/279 (9%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN 877
            E+ +    +G GA+G V  A +       AVK +  +       ++K+EI     + H N
Sbjct: 5    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            +V+        +   +   Y   G L D +        +      +        + YLH 
Sbjct: 65   VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH- 120

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I HRDIKPEN+LLD      ISDFG+A +   +        + GT+ Y+APE   
Sbjct: 121  --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 998  TTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056
                 ++  DV+S G+VL  ++  +      + + +D              +N    +  
Sbjct: 179  RREFHAEPVDVWSCGIVLTAMLAGE----LPWDQPSDSCQEYSDWKEKKTYLNPWKKID- 233

Query: 1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                         + +L    +   + PS R  + D+ +
Sbjct: 234  ----------SAPLALL---HKILVENPSARITIPDIKK 259

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-49
 Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 33/280 (11%)

Query: 819  ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL 878
            + L     IG+G  G V           AVK +      +   +   E   + ++RH NL
Sbjct: 7    KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNL 62

Query: 879  VRLEDFWLRKDCGI-IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            V+L    + +  G+ I+  YM  GSL D L S      L  +   K +L    A+ YL  
Sbjct: 63   VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE- 120

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                  VHRD+   N+L+  +    +SDFG+ K       S+T  +    + + APE   
Sbjct: 121  --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALR 173

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057
                S +SDV+S+G++L E+ +  +   P                   + +  +     M
Sbjct: 174  EKKFSTKSDVWSFGILLWEIYSFGRVPYPR--------------IPLKDVVPRVEKGYKM 219

Query: 1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +          V +V+     C     + RP+   +  QL
Sbjct: 220  D--APDGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQL 254

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 2e-49
 Identities = 65/285 (22%), Positives = 118/285 (41%), Gaps = 30/285 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL-----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI 873
              +  + VIG G  G VYK  L           A+K L     ++  +    E   +G+ 
Sbjct: 7    SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 874  RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALA 933
             H N++RLE    +    +I+  YMENG+L                    +  G A  + 
Sbjct: 67   SHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGM- 123

Query: 934  YLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST-TSISVVGTIGYIA 992
               Y  +   VHRD+   NIL++S +   +SDFG++++L+  P +T T+      I + A
Sbjct: 124  --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 993  PENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052
            PE       +  SDV+S+G+V+ E++T  +                        E+   +
Sbjct: 182  PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---------------HEVMKAI 226

Query: 1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            +    +   + +  D    +  + ++C +++ + RP   D+V  L
Sbjct: 227  N----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-49
 Identities = 53/277 (19%), Positives = 97/277 (35%), Gaps = 31/277 (11%)

Query: 826  VIGRGAHGIVYKASL---GPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRL 881
             +G G  G V K            AVK L    +       +  E   + ++ +  +VR+
Sbjct: 14   ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 882  EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
                  +   ++M    E G L   L        ++     ++    +  + YL      
Sbjct: 74   IGICEAESWMLVME-MAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE---S 126

Query: 942  PIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP-ASTTSISVVGTIGYIAPENAFTTA 1000
              VHRD+   N+LL ++    ISDFG++K L                + + APE      
Sbjct: 127  NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 1001 KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM 1060
             S +SDV+S+GV++ E  +  +     Y+                 E+  +++       
Sbjct: 187  FSSKSDVWSFGVLMWEAFSYGQ---KPYRGMKG------------SEVTAMLEKGERMG- 230

Query: 1061 LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              +    ++ D++     C      NRP    V  +L
Sbjct: 231  CPAGCPREMYDLM---NLCWTYDVENRPGFAAVELRL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 5e-49
 Identities = 62/296 (20%), Positives = 111/296 (37%), Gaps = 42/296 (14%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL---GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-R 874
             ++  + VIG G  G V KA +   G     A+K++     K        E++ + K+  
Sbjct: 10   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPT-------------LEWNVR 921
            H N++ L      +    +   Y  +G+L D L       T             L     
Sbjct: 70   HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 922  YKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTS 981
               A   A  +    Y      +HRD+   NIL+       I+DFG+++  +     T  
Sbjct: 130  LHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM- 185

Query: 982  ISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSV 1041
                  + ++A E+   +  +  SDV+SYGV+L E+++        Y             
Sbjct: 186  --GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---TPYCG----------- 229

Query: 1042 WSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             +  E    +     +E+ L     D+V D++    +C  +KP  RP+   ++  L
Sbjct: 230  MTCAELYEKLPQGYRLEKPLNCD--DEVYDLM---RQCWREKPYERPSFAQILVSL 280

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 6e-49
 Identities = 63/280 (22%), Positives = 114/280 (40%), Gaps = 34/280 (12%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRH 875
            E+      +G+G  G VY A       + A+K L  A          ++RE++    +RH
Sbjct: 6    EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
             N++RL  ++       ++  Y   G++   L  ++     +           A+AL+Y 
Sbjct: 66   PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
            H      ++HRDIKPEN+LL S  E  I+DFG +        S+   ++ GT+ Y+ PE 
Sbjct: 123  H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 175

Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                   ++ D++S GV+  E +                    +  +           +S
Sbjct: 176  IEGRMHDEKVDLWSLGVLCYEFLVG------------------KPPFEANTYQETYKRIS 217

Query: 1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
             +E      + +   D++    R  +  PS RP +R+V+ 
Sbjct: 218  RVEFTFPDFVTEGARDLI---SRLLKHNPSQRPMLREVLE 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-47
 Identities = 61/276 (22%), Positives = 108/276 (39%), Gaps = 32/276 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +G GA G VYKA +   + + A K +     +        EI  +    H N+V+L D 
Sbjct: 19   ELGDGAFGKVYKAQNKETSVLAAAKVID-TKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +  ++   I+  +   G++  V+  +  P  L  +    +      AL YLH   D  I+
Sbjct: 78   FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLH---DNKII 132

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK--- 1001
            HRD+K  NIL   + +  ++DFG++    ++       S +GT  ++APE          
Sbjct: 133  HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD--SFIGTPYWMAPEVVMCETSKDR 190

Query: 1002 --SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059
                ++DV+S G+ L+E+   +    P + E   +             +  I        
Sbjct: 191  PYDYKADVWSLGITLIEMAEIE----PPHHELNPM-----------RVLLKIAKSEPPTL 235

Query: 1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
               S       D L    +C EK    R     +++
Sbjct: 236  AQPSRWSSNFKDFL---KKCLEKNVDARWTTSQLLQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 6e-47
 Identities = 64/289 (22%), Positives = 106/289 (36%), Gaps = 31/289 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGK 872
            ++L     +G G+ G+V +       G     AVK L               RE+  +  
Sbjct: 8    KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHAL 932
            + HRNL+RL    L     ++       GSL D L        L    RY  A+  A  +
Sbjct: 68   LDHRNLIRLYGVVLTPPMKMVTE-LAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGM 124

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS-TTSISVVGTIGYI 991
             YL        +HRD+   N+LL +     I DFG+ + L ++               + 
Sbjct: 125  GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 992  APENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051
            APE+  T   S  SD + +GV L E+ T  +     +         +  +  + E +   
Sbjct: 182  APESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNG-SQILHKIDKEGERLPRP 237

Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
             D               + +V+   ++C   KP +RP    +   L++A
Sbjct: 238  EDCP-----------QDIYNVM---VQCWAHKPEDRPTFVALRDFLLEA 272

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (427), Expect = 6e-47
 Identities = 62/276 (22%), Positives = 113/276 (40%), Gaps = 37/276 (13%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL--SMKREIQTIGKIRHRNLVRLE 882
             IG G+ G VY A  +  + V A+KK+++ G +       + +E++ + K+RH N ++  
Sbjct: 22   EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +LR+    ++  Y    +   +     P   L+      +  GA   LAYLH      
Sbjct: 82   GCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH---SHN 135

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK- 1001
            ++HRD+K  NILL       + DFG A ++        + S VGT  ++APE      + 
Sbjct: 136  MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189

Query: 1002 --SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059
                + DV+S G+  +EL  RK    P       +        +++  +           
Sbjct: 190  QYDGKVDVWSLGITCIELAERK----PPLFNMNAMSALYHIAQNESPALQS--------- 236

Query: 1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                   +   + +     C +K P +RP    +++
Sbjct: 237  ---GHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 7e-47
 Identities = 59/283 (20%), Positives = 101/283 (35%), Gaps = 30/283 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR 874
            E +     IG G  G V++        P    A+K               +E  T+ +  
Sbjct: 7    ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            H ++V+L          IIM      G LR          +L+       A   + ALAY
Sbjct: 67   HPHIVKLIGVITENPVWIIME-LCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            L        VHRDI   N+L+ S     + DFG+++ ++ S     S      I ++APE
Sbjct: 124  LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPE 179

Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054
            +      +  SDV+ +GV + E++                         + + I  I + 
Sbjct: 180  SINFRRFTSASDVWMFGVCMWEILMHGVKPFQG--------------VKNNDVIGRIENG 225

Query: 1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
              +   +  +    +  ++    +C    PS RP   ++  QL
Sbjct: 226  ERLP--MPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 263

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-46
 Identities = 65/292 (22%), Positives = 112/292 (38%), Gaps = 31/292 (10%)

Query: 811  LKQVIEATENLNAKHVIGRGAHGIVYKASLGPN-----AVFAVKKLAFRGHKRGSLSMKR 865
            L ++++ TE      V+G GA G VYK    P         A+K+L      + +  +  
Sbjct: 2    LLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60

Query: 866  EIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIA 925
            E   +  + + ++ RL    L     +I    M  G L D +                  
Sbjct: 61   EAYVMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIG--SQYLLNWC 117

Query: 926  LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
            +  A  + YL       +VHRD+   N+L+ +     I+DFG+AKLL        +    
Sbjct: 118  VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045
              I ++A E+      + +SDV+SYGV + EL+T        Y                 
Sbjct: 175  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS---KPYDGIPA------------ 219

Query: 1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
             EI+ I++                IDV ++ ++C      +RP  R+++ + 
Sbjct: 220  SEISSILEKGERLPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 6e-46
 Identities = 53/292 (18%), Positives = 115/292 (39%), Gaps = 35/292 (11%)

Query: 819  ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
            E +     +G+G+ G+VY+          P    A+K +      R  +    E   + +
Sbjct: 20   EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPP-------PTLEWNVRYKIA 925
                ++VRL     +    +++   M  G L+  L S+ P             +   ++A
Sbjct: 80   FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 926  LGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVV 985
               A  +AYL        VHRD+   N ++  +    I DFG+ + + ++         +
Sbjct: 140  GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 986  GTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045
              + +++PE+      +  SDV+S+GVVL E+ T  +                    S+ 
Sbjct: 197  LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------------LSNE 242

Query: 1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            + +  +++  L++     +  D + +++     C +  P  RP+  +++  +
Sbjct: 243  QVLRFVMEGGLLD--KPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSI 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 6e-46
 Identities = 66/310 (21%), Positives = 119/310 (38%), Gaps = 45/310 (14%)

Query: 819  ENLNAKHVIGRGAHGIVYKA--------SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTI 870
            + L     +G GA G V  A                AVK L     ++    +  E++ +
Sbjct: 13   DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 871  GKI-RHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPP-------------TL 916
              I +H+N++ L     +     ++  Y   G+LR+ L +  PP               L
Sbjct: 73   KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 917  EWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP 976
                    A   A  + YL        +HRD+   N+L+  +    I+DFG+A+ +    
Sbjct: 133  SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 977  ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVG 1036
                + +    + ++APE  F    + +SDV+S+GV+L E+ T   +  P          
Sbjct: 190  YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------- 240

Query: 1037 WVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
                     EE+  ++      +   S+  +++  ++     C    PS RP  + +V  
Sbjct: 241  ------VPVEELFKLLKEGHRMD-KPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVED 290

Query: 1097 LVDASVPMTS 1106
            L D  V +TS
Sbjct: 291  L-DRIVALTS 299

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 7e-46
 Identities = 62/271 (22%), Positives = 115/271 (42%), Gaps = 29/271 (10%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             IG+GA G VY A  +      A++++  +   +  L +  EI  + + ++ N+V   D 
Sbjct: 27   KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNPNIVNYLDS 85

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +L  D   ++  Y+  GSL DV+                +      AL +LH      ++
Sbjct: 86   YLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLH---SNQVI 138

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKE 1004
            HRDIK +NILL  +    ++DFG    +    +  +++  VGT  ++APE     A   +
Sbjct: 139  HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVTRKAYGPK 196

Query: 1005 SDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSS 1064
             D++S G++ +E+I  +    P Y     +        + T E+ +   LS         
Sbjct: 197  VDIWSLGIMAIEMIEGE----PPYLNENPLRALYLIATNGTPELQNPEKLS--------- 243

Query: 1065 IRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                  D L    RC +     R + +++++
Sbjct: 244  --AIFRDFL---NRCLDMDVEKRGSAKELLQ 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 8e-43
 Identities = 62/300 (20%), Positives = 106/300 (35%), Gaps = 42/300 (14%)

Query: 819  ENLNAKHVIGRGAHGIVYKA------SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGK 872
            + L     +GRGA G V +A              AVK L          ++  E++ +  
Sbjct: 13   DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 873  IRHR-NLVRLEDFWLRKDCGI-IMYRYMENGSLRDVLHS-------------ITPPPTLE 917
            I H  N+V L     +    + ++  + + G+L   L S                   L 
Sbjct: 73   IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 918  WNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA 977
                   +   A  + +L        +HRD+   NILL  +    I DFG+A+ + K P 
Sbjct: 133  LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 978  STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGW 1037
                      + ++APE  F    + +SDV+S+GV+L E+ +   +  P  K   +    
Sbjct: 190  YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 1038 VRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
            ++          D     + +                  L C   +PS RP   ++V  L
Sbjct: 250  LKE--GTRMRAPDYTTPEMYQ----------------TMLDCWHGEPSQRPTFSELVEHL 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  156 bits (396), Expect = 2e-42
 Identities = 57/272 (20%), Positives = 108/272 (39%), Gaps = 31/272 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +G GA G+V++         FA K +    H+    ++++EIQT+  +RH  LV L D 
Sbjct: 33   ELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +   +  +++Y +M  G L + +        +  +   +        L ++H +     V
Sbjct: 92   FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YV 146

Query: 945  HRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            H D+KPENI+  ++    +   DFG+   LD      +     GT  + APE A      
Sbjct: 147  HLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVG 203

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL-MEEML 1061
              +D++S GV+   L++        +    D            E + ++      M++  
Sbjct: 204  YYTDMWSVGVLSYILLSGL----SPFGGENDD-----------ETLRNVKSCDWNMDDSA 248

Query: 1062 VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             S I +   D +    +     P+ R  +   
Sbjct: 249  FSGISEDGKDFI---RKLLLADPNTRMTIHQA 277

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 4e-42
 Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 30/278 (10%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRH 875
            E+     ++G G+   V  A  L  +  +A+K L  R    +     + RE   + ++ H
Sbjct: 8    EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 876  RNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
               V+L   +   +       Y +NG L   +  I                  A  ++ L
Sbjct: 68   PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC------TRFYTAEIVSAL 121

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
             Y     I+HRD+KPENILL+ +M   I+DFG AK+L        + S VGT  Y++PE 
Sbjct: 122  EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                +  K SD+++ G ++ +L+       P ++   +                 I+   
Sbjct: 182  LTEKSACKSSDLWALGCIIYQLVAGL----PPFRAGNEY-----------LIFQKIIK-- 224

Query: 1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             +E         +  D++    +      + R    ++
Sbjct: 225  -LEYDFPEKFFPKARDLV---EKLLVLDATKRLGCEEM 258

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  149 bits (377), Expect = 6e-40
 Identities = 55/274 (20%), Positives = 107/274 (39%), Gaps = 31/274 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +G GA G+V++        VF  K +    +     ++K EI  + ++ H  L+ L D 
Sbjct: 36   ELGSGAFGVVHRCVEKATGRVFVAKFI-NTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +  K   +++  ++  G L D + +      +           A   L ++H   +  IV
Sbjct: 95   FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149

Query: 945  HRDIKPENILLDSEMEPHI--SDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            H DIKPENI+ +++    +   DFG+A  L+             T  + APE        
Sbjct: 150  HLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVG 206

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL-MEEML 1061
              +D+++ GV+   L++        +    D+           E + ++       +E  
Sbjct: 207  FYTDMWAIGVLGYVLLSGL----SPFAGEDDL-----------ETLQNVKRCDWEFDEDA 251

Query: 1062 VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
             SS+  +  D +       +K+P  R  + D + 
Sbjct: 252  FSSVSPEAKDFI---KNLLQKEPRKRLTVHDALE 282

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 7e-40
 Identities = 51/274 (18%), Positives = 106/274 (38%), Gaps = 32/274 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             +GRG  GIV++         +  K +  +G  +  +  K+EI  +   RHRN++ L + 
Sbjct: 12   DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV--KKEISILNIARHRNILHLHES 69

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
            +   +  ++++ ++    + + +++      L              AL +LH      I 
Sbjct: 70   FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124

Query: 945  HRDIKPENILLDSEMEPH--ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            H DI+PENI+  +       I +FG A+ L           +     Y APE       S
Sbjct: 125  HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL-MEEML 1061
              +D++S G ++  L++                       ++ + I +I++     +E  
Sbjct: 182  TATDMWSLGTLVYVLLSGINPFLAE---------------TNQQIIENIMNAEYTFDEEA 226

Query: 1062 VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
               I  + +D +    R   K+  +R    + ++
Sbjct: 227  FKEISIEAMDFV---DRLLVKERKSRMTASEALQ 257

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  145 bits (367), Expect = 2e-39
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 32/282 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            ++G G    V+ A  L  +   AVK L           L  +RE Q    + H  +V + 
Sbjct: 14   ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 883  DFWLRKDCGI----IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            D    +        I+  Y++  +LRD++H+  P   +      ++   A  AL +    
Sbjct: 74   DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFS--- 127

Query: 939  CDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSI-SVVGTIGYIAPENAF 997
                I+HRD+KP NI++ +     + DFGIA+ +  S  S T   +V+GT  Y++PE A 
Sbjct: 128  HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057
              +    SDVYS G VL E++T +    P +   + +    + V  D    +   +    
Sbjct: 188  GDSVDARSDVYSLGCVLYEVLTGE----PPFTGDSPVSVAYQHVREDPIPPSARHE---- 239

Query: 1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-NMRDVVRQLV 1098
                   +   +  V+   L+   K P NR     ++   LV
Sbjct: 240  ------GLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (368), Expect = 4e-39
 Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 30/276 (10%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            + V+G GA   V  A       + A+K +A +  +    SM+ EI  + KI+H N+V L+
Sbjct: 14   RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
            D +       ++ + +  G L D +               ++      A+ YLH      
Sbjct: 74   DIYESGGHLYLIMQLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG--- 127

Query: 943  IVHRDIKPENILL---DSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTT 999
            IVHRD+KPEN+L    D + +  ISDFG++K+ D     +T     GT GY+APE     
Sbjct: 128  IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---ACGTPGYVAPEVLAQK 184

Query: 1000 AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059
              SK  D +S GV+   L+       P + +  D   + + + ++ E           + 
Sbjct: 185  PYSKAVDCWSIGVIAYILLCGY----PPFYDENDAKLFEQILKAEYE----------FDS 230

Query: 1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                 I D   D +       EK P  R      ++
Sbjct: 231  PYWDDISDSAKDFI---RHLMEKDPEKRFTCEQALQ 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  144 bits (364), Expect = 6e-39
 Identities = 72/291 (24%), Positives = 114/291 (39%), Gaps = 42/291 (14%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSM--------KREIQT 869
            EN   K ++GRG   +V +         +AVK +   G    S            +E+  
Sbjct: 3    ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 870  IGKIR-HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGA 928
            + K+  H N+++L+D +       +++  M+ G L D L       TL      KI    
Sbjct: 63   LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRAL 119

Query: 929  AHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTI 988
               +  LH      IVHRD+KPENILLD +M   ++DFG +  LD          V GT 
Sbjct: 120  LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCGTP 173

Query: 989  GYIAPE------NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042
             Y+APE      N       KE D++S GV++  L+       P +  R  ++     + 
Sbjct: 174  SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS----PPFWHRKQMLMLRMIMS 229

Query: 1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + +  +   D             D V D++    R    +P  R    + 
Sbjct: 230  GNYQFGSPEWD----------DYSDTVKDLV---SRFLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-38
 Identities = 59/282 (20%), Positives = 105/282 (37%), Gaps = 33/282 (11%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGK-IR 874
            E+     ++G+G+ G V+ A     N  FA+K L                E + +     
Sbjct: 2    EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 875  HRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAY 934
            H  L  +   +  K+    +  Y+  G L   + S       + +     A      L +
Sbjct: 62   HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 935  LHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPE 994
            L       IV+RD+K +NILLD +    I+DFG+ K          + +  GT  YIAPE
Sbjct: 119  L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--MLGDAKTNTFCGTPDYIAPE 173

Query: 995  NAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054
                   +   D +S+GV+L E++                    +S +   +E      +
Sbjct: 174  ILLGQKYNHSVDWWSFGVLLYEMLIG------------------QSPFHGQDEEELFHSI 215

Query: 1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096
             +        +  +  D+L   ++   ++P  R  +R  +RQ
Sbjct: 216  RMDNPFYPRWLEKEAKDLL---VKLFVREPEKRLGVRGDIRQ 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 1e-37
 Identities = 58/299 (19%), Positives = 113/299 (37%), Gaps = 22/299 (7%)

Query: 813  QVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIG 871
            QV +          IG GA+G+V  A         A+KK++   H+       REI+ + 
Sbjct: 2    QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 872  KIRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHA 931
            + RH N++ + D         +   Y+    +   L+ +     L  +            
Sbjct: 62   RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 932  LAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS-TTSISVVGTIGY 990
            L Y+H      ++HRD+KP N+LL++  +  I DFG+A++ D            V T  Y
Sbjct: 122  LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 991  IAPENAFTTAK-SKESDVYSYGVVLLELITRK-------------KALDPSYKERTDIVG 1036
             APE    +   +K  D++S G +L E+++ +               L        + + 
Sbjct: 179  RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238

Query: 1037 WVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
             + ++ +    ++      +    L  +   + +D+L    +     P  R  +   + 
Sbjct: 239  CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL---DKMLTFNPHKRIEVEQALA 294

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 61/269 (22%), Positives = 99/269 (36%), Gaps = 35/269 (13%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
             +G G+ G V+   S      +A+K L        +       E   +  + H  ++R+ 
Sbjct: 11   TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +       ++  Y+E G L  +L      P             AA     L Y     
Sbjct: 71   GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLALEYLHSKD 124

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            I++RD+KPENILLD      I+DFG AK +          ++ GT  YIAPE   T   +
Sbjct: 125  IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPYN 179

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
            K  D +S+G+++ E++       P Y              +  +    I++    E    
Sbjct: 180  KSIDWWSFGILIYEMLAGYT---PFYDS------------NTMKTYEKILN---AELRFP 221

Query: 1063 SSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
                + V D+L    R   +  S R    
Sbjct: 222  PFFNEDVKDLL---SRLITRDLSQRLGNL 247

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  138 bits (348), Expect = 8e-37
 Identities = 64/283 (22%), Positives = 116/283 (40%), Gaps = 24/283 (8%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHRNLVRLEDF 884
             IG G +G+VYKA       FA+KK+       G  S   REI  + +++H N+V+L D 
Sbjct: 9    KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
               K   ++++ +++    + +         LE        L   + +AY H   D  ++
Sbjct: 69   IHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCH---DRRVL 122

Query: 945  HRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SK 1003
            HRD+KP+N+L++ E E  I+DFG+A+              + T+ Y AP+    + K S 
Sbjct: 123  HRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERT-----------DIVGWVRSVWSDTEEINDIV 1052
              D++S G +  E++          +              +   W         + N  V
Sbjct: 181  TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
               L  E  +  + +  ID+L    +  +  P+ R   +  + 
Sbjct: 241  YEPLPWESFLKGLDESGIDLL---SKMLKLDPNQRITAKQALE 280

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-36
 Identities = 65/286 (22%), Positives = 107/286 (37%), Gaps = 27/286 (9%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSM----KREIQTIGKIRHRNLVR 880
             +G G    VYKA     N + A+KK+           +     REI+ + ++ H N++ 
Sbjct: 5    FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 881  LEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD 940
            L D +  K    +++ +ME       +   +   T      Y         L  L Y   
Sbjct: 65   LLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAY-----MLMTLQGLEYLHQ 118

Query: 941  PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
              I+HRD+KP N+LLD      ++DFG+AK       + T    V T  Y APE  F   
Sbjct: 119  HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--HQVVTRWYRAPELLFGAR 176

Query: 1001 K-SKESDVYSYGVVLLELITRK------KALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053
                  D+++ G +L EL+ R         LD   +    +       W D   + D V 
Sbjct: 177  MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 1054 LSLMEEM----LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                  +    + S+  D ++D++          P  R      ++
Sbjct: 237  FKSFPGIPLHHIFSAAGDDLLDLI---QGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-36
 Identities = 61/289 (21%), Positives = 115/289 (39%), Gaps = 24/289 (8%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLS-MKREIQTIGKIRHR 876
            EN      IG G +G+VYKA +     V A+KK+       G  S   REI  + ++ H 
Sbjct: 2    ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
            N+V+L D    ++   +++ ++     + +  S      +   +           LA+  
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFC- 118

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
                  ++HRD+KP+N+L+++E    ++DFG+A+         T    V T+ Y APE  
Sbjct: 119  --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEIL 174

Query: 997  FTTAK-SKESDVYSYGVVLLELITRKK------ALDPSYKERTDIVGWVRSVWSDTEEIN 1049
                  S   D++S G +  E++TR+        +D  ++    +      VW     + 
Sbjct: 175  LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 1050 DIVD-----LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
            D               +V  + +    +L    +     P+ R + +  
Sbjct: 235  DYKPSFPKWARQDFSKVVPPLDEDGRSLL---SQMLHYDPNKRISAKAA 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  137 bits (346), Expect = 2e-36
 Identities = 44/284 (15%), Positives = 87/284 (30%), Gaps = 30/284 (10%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
             IG G+ G +Y    +      A+K    +        +  E +    ++    +    +
Sbjct: 14   KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRW 70

Query: 885  WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIV 944
               +    +M   +   SL D+ +  +            +A      + Y+H       +
Sbjct: 71   CGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFI 125

Query: 945  HRDIKPENIL---LDSEMEPHISDFGIAKLLDKSPASTTSI-----SVVGTIGYIAPENA 996
            HRD+KP+N L          +I DFG+AK    +            ++ GT  Y +    
Sbjct: 126  HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056
                +S+  D+ S G VL+                               E      +S 
Sbjct: 186  LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR----------QKYERISEKKMST 235

Query: 1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
              E+L      +    L     C   +  ++P+   + +   + 
Sbjct: 236  PIEVLCKGYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFRNL 276

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-36
 Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 31/288 (10%)

Query: 826  VIGRGAHGIVYKA--SLGPNAVFAVKKLAFRGHKRG-SLSMKREI---QTIGKIRHRNLV 879
             IG GA+G V+KA          A+K++  +  + G  LS  RE+   + +    H N+V
Sbjct: 14   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 880  RLEDFWLRKDCGIIMYRYMENGSLR---DVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
            RL D              +    +           P P +       +       L +LH
Sbjct: 74   RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
                  +VHRD+KP+NIL+ S  +  ++DFG+A++     A T+   VV T+ Y APE  
Sbjct: 134  ---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRAPEVL 187

Query: 997  FTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056
              ++ +   D++S G +  E+  RK           D +G +  V     E +   D++L
Sbjct: 188  LQSSYATPVDLWSVGCIFAEMFRRKPLFRG--SSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 1057 MEEM-----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
              +             V+ I +   D+L   L+C    P+ R +    
Sbjct: 246  PRQAFHSKSAQPIEKFVTDIDELGKDLL---LKCLTFNPAKRISAYSA 290

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-35
 Identities = 59/281 (20%), Positives = 109/281 (38%), Gaps = 38/281 (13%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKL---AFRGHKRGSL--SMKREIQTIGKIRHRNLV 879
             +G G   +V K         +A K +     +  +RG     ++RE+  + +I+H N++
Sbjct: 17   ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 880  RLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDC 939
             L + +  K   I++   +  G L D L       +L      +        L  ++Y  
Sbjct: 77   TLHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEF---LKQILNGVYYLH 130

Query: 940  DPPIVHRDIKPENILLDSEMEP----HISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN 995
               I H D+KPENI+L     P     I DFG+A  +D         ++ GT  ++APE 
Sbjct: 131  SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPEFVAPEI 187

Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
                    E+D++S GV+   L++                       +  E + ++  ++
Sbjct: 188  VNYEPLGLEADMWSIGVITYILLSGASPFLGD---------------TKQETLANVSAVN 232

Query: 1056 L-MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
               E+   S+      D +    R   K P  R  ++D ++
Sbjct: 233  YEFEDEYFSNTSALAKDFI---RRLLVKDPKKRMTIQDSLQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-35
 Identities = 50/278 (17%), Positives = 105/278 (37%), Gaps = 29/278 (10%)

Query: 824  KHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRL 881
              V+G G +G V +  +      FA+K L      +     +RE++   +  +  ++VR+
Sbjct: 17   SQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRI 70

Query: 882  ----EDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
                E+ +  + C +I+   ++ G L   +               +I      A+ YLH 
Sbjct: 71   VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH- 128

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I HRD+KPEN+L  S+    I          ++ +  +  +   T  Y+APE   
Sbjct: 129  --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 998  TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057
                 K  D++S GV++  L+       P +     +     ++    +    +      
Sbjct: 187  PEKYDKSCDMWSLGVIMYILLCGY----PPFYSNHGL-----AISPGMKTRIRMGQYEFP 237

Query: 1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                 S + ++V  ++       + +P+ R  + + + 
Sbjct: 238  NPEW-SEVSEEVKMLI---RNLLKTEPTQRMTITEFMN 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  136 bits (343), Expect = 3e-35
 Identities = 56/280 (20%), Positives = 97/280 (34%), Gaps = 35/280 (12%)

Query: 819  ENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKL-----AFRGHKRGSLSMKREIQTIGK 872
             + +   +IGRG  G VY         ++A+K L       +  +  +L+ +  +  +  
Sbjct: 4    NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 873  IRHRNLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHAL 932
                 +V +   +   D    +   M  G L   L                 A      L
Sbjct: 64   GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGL 120

Query: 933  AYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIA 992
             ++H   +  +V+RD+KP NILLD      ISD G+A    K     +    VGT GY+A
Sbjct: 121  EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMA 173

Query: 993  PENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051
            PE           +D +S G +L +L+       P  + +T     +  +          
Sbjct: 174  PEVLQKGVAYDSSADWFSLGCMLFKLLRGH---SPFRQHKTKDKHEIDRMTLT------- 223

Query: 1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
                 M   L  S   ++  +L       ++  + R    
Sbjct: 224  -----MAVELPDSFSPELRSLL---EGLLQRDVNRRLGCL 255

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-35
 Identities = 69/285 (24%), Positives = 110/285 (38%), Gaps = 28/285 (9%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDF 884
            VIG G+ G+VY+A       + A+KK+      +      RE+Q + K+ H N+VRL  F
Sbjct: 27   VIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 885  WLRKDCG------IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD 938
            +             ++  Y+     R   H      TL              +LAY+H  
Sbjct: 82   FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-- 139

Query: 939  CDPPIVHRDIKPENILLDSEMEPH-ISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                I HRDIKP+N+LLD +     + DFG AK L +      ++S + +  Y APE  F
Sbjct: 140  -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYICSRYYRAPELIF 195

Query: 998  TTAK-SKESDVYSYGVVLLELITRKK------ALDPSYKERTDIVGWVRSVWSDTEEIND 1050
                 +   DV+S G VL EL+  +        +D   +    +    R    +      
Sbjct: 196  GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 1051 IVDLSLMEEMLVSSIRDQVIDVLLVAL--RCTEKKPSNRPNMRDV 1093
                  ++    + +         +AL  R  E  P+ R    + 
Sbjct: 256  EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-35
 Identities = 54/284 (19%), Positives = 105/284 (36%), Gaps = 24/284 (8%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED 883
             IG G +G V+KA +   + + A+K++       G   S  REI  + +++H+N+VRL D
Sbjct: 9    KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
                     +++ + +    +                   +       L  L +     +
Sbjct: 69   VLHSDKKLTLVFEFCDQDLKKY------FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 944  VHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSK 1003
            +HRD+KP+N+L++   E  +++FG+A+     P    S  VV                S 
Sbjct: 123  LHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 1004 ESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV----------- 1052
              D++S G +  EL    + L P       +    R + + TEE    +           
Sbjct: 182  SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 1053 -DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
               +     +V  +     D+L       +  P  R +  + ++
Sbjct: 242  YPATTSLVNVVPKLNATGRDLL---QNLLKCNPVQRISAEEALQ 282

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  133 bits (334), Expect = 6e-35
 Identities = 38/287 (13%), Positives = 85/287 (29%), Gaps = 34/287 (11%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN-LVRLED 883
             IG G+ G++++  +L  N   A+K    R        ++ E +T   +     +  +  
Sbjct: 12   RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYY 68

Query: 884  FWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPI 943
            F       +++   +                          A      +  +H   +  +
Sbjct: 69   FGQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 122

Query: 944  VHRDIKPENILLDSEMEPH-----ISDFGIAKLLDKSPASTTSI-----SVVGTIGYIAP 993
            V+RDIKP+N L+      +     + DFG+ K                 ++ GT  Y++ 
Sbjct: 123  VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 994  ENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053
                   +S+  D+ + G V +  +                     +     E I +   
Sbjct: 183  NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL---------KAATNKQKYERIGEKKQ 233

Query: 1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100
             + + E L +   ++    +              P+   +       
Sbjct: 234  STPLRE-LCAGFPEEFYKYM---HYARNLAFDATPDYDYLQGLFSKV 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 2e-34
 Identities = 53/281 (18%), Positives = 101/281 (35%), Gaps = 48/281 (17%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFR-----GHKRGSLSMKREIQTIGKIR--HRN 877
            ++G G  G VY    +  N   A+K +        G       +  E+  + K+      
Sbjct: 11   LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 878  LVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
            ++RL D++ R D  +++    E          IT    L+  +          A+ +   
Sbjct: 71   VIRLLDWFERPDSFVLILERPEPVQDLFDF--ITERGALQEELARSFFWQVLEAVRHC-- 126

Query: 938  DCDPPIVHRDIKPENILLD-SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPEN- 995
              +  ++HRDIK ENIL+D +  E  + DFG   LL  +  +       GT  Y  PE  
Sbjct: 127  -HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYSPPEWI 181

Query: 996  AFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-TEEINDIVDL 1054
             +     + + V+S G++L +++         ++   +I+          + E   ++  
Sbjct: 182  RYHRYHGRSAAVWSLGILLYDMVCGD----IPFEHDEEIIRGQVFFRQRVSSECQHLIR- 236

Query: 1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095
                                    C   +PS+RP   ++  
Sbjct: 237  -----------------------WCLALRPSDRPTFEEIQN 254

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (326), Expect = 2e-33
 Identities = 57/292 (19%), Positives = 110/292 (37%), Gaps = 30/292 (10%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRG-SLSMKREIQTIGKIRHRNLVRLED 883
             IG+G  G V+KA         A+KK+     K G  ++  REI+ +  ++H N+V L +
Sbjct: 17   KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76

Query: 884  FWLRKDCGI--------IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYL 935
                K            +++ + E+     + + +      E      I       L  L
Sbjct: 77   ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE------IKRVMQMLLNGL 130

Query: 936  HYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS--TTSISVVGTIGYIAP 993
            +Y     I+HRD+K  N+L+  +    ++DFG+A+    +  S      + V T+ Y  P
Sbjct: 131  YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190

Query: 994  ENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERT---------DIVGWVRSVWS 1043
            E            D++  G ++ E+ TR   +  + ++            I   V     
Sbjct: 191  ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250

Query: 1044 DTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVAL--RCTEKKPSNRPNMRDV 1093
            + E    +  +   +  +   ++  V D   + L  +     P+ R +  D 
Sbjct: 251  NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 5e-33
 Identities = 58/270 (21%), Positives = 96/270 (35%), Gaps = 34/270 (12%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
            ++G+G  G V           +A+K L       K        E + +   RH  L  L+
Sbjct: 12   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +   D    +  Y   G L   L         E   R+      A  ++ L Y     
Sbjct: 72   YAFQTHDRLCFVMEYANGGELFFHLSRERVFT--EERARF----YGAEIVSALEYLHSRD 125

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +V+RDIK EN++LD +    I+DFG+ K         T  +  GT  Y+APE        
Sbjct: 126  VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEM-L 1061
            +  D +  GVV+ E++  +      +  +                   + +L LMEE+  
Sbjct: 184  RAVDWWGLGVVMYEMMCGR----LPFYNQDH---------------ERLFELILMEEIRF 224

Query: 1062 VSSIRDQVIDVLLVALRCTEKKPSNRPNMR 1091
              ++  +   +L       +K P  R    
Sbjct: 225  PRTLSPEAKSLL---AGLLKKDPKQRLGGG 251

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 3e-30
 Identities = 61/280 (21%), Positives = 99/280 (35%), Gaps = 34/280 (12%)

Query: 819  ENLNAKHVIGRGAHGIVYKA----SLGPNAVFAVKKL---AFRGHKRGSLSMKREIQTIG 871
            EN     V+G GA+G V+            ++A+K L         + +   + E Q + 
Sbjct: 24   ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 872  KIRHR-NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH 930
             IR    LV L   +  +    ++  Y+  G L   L         E  +          
Sbjct: 84   HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGY 990
             +  L +     I++RDIK ENILLDS     ++DFG++K    +  +  +    GTI Y
Sbjct: 138  IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEY 196

Query: 991  IAPENAFTTAK--SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048
            +AP+          K  D +S GV++ EL+T          E+       R +       
Sbjct: 197  MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSEPPY 255

Query: 1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP 1088
                            +     D++    R   K P  R 
Sbjct: 256  PQ-------------EMSALAKDLI---QRLLMKDPKKRL 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (300), Expect = 7e-30
 Identities = 50/276 (18%), Positives = 96/276 (34%), Gaps = 36/276 (13%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKL--AFRGHKRGSLSMKREIQTIGKIRHRNLVRLE 882
             +G G+ G V           +A+K L        +       E + +  +    LV+LE
Sbjct: 48   TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 883  DFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
              +       ++  Y+  G +   L  I              A        YLH      
Sbjct: 108  FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH---SLD 161

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKS 1002
            +++RD+KPEN+L+D +    ++DFG AK          + ++ GT   +APE   +   +
Sbjct: 162  LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYN 216

Query: 1003 KESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLV 1062
            K  D ++ GV++ E+                        +   + I     +   +    
Sbjct: 217  KAVDWWALGVLIYEMAAG------------------YPPFFADQPIQIYEKIVSGKVRFP 258

Query: 1063 SSIRDQVIDVLLVALRCTEKKPSNR-PNMRDVVRQL 1097
            S     + D+L       +   + R  N+++ V  +
Sbjct: 259  SHFSSDLKDLL---RNLLQVDLTKRFGNLKNGVNDI 291

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  114 bits (285), Expect = 5e-28
 Identities = 55/278 (19%), Positives = 112/278 (40%), Gaps = 23/278 (8%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLED 883
             +GRG +  V++A ++  N    VK L     K+    +KREI+ +  +R   N++ L D
Sbjct: 42   KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK----IKREIKILENLRGGPNIITLAD 97

Query: 884  FWLRKDCG--IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDP 941
                       +++ ++ N   + +  ++T     ++++R         AL Y H     
Sbjct: 98   IVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIR-FYMYEILKALDYCHSMG-- 149

Query: 942  PIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTA 1000
             I+HRD+KP N+++D E  +  + D+G+A+              V +  +  PE      
Sbjct: 150  -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKGPELLVDYQ 205

Query: 1001 K-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLMEE 1059
                  D++S G +L  +I RK+     +    D +  +  V    +  + I   ++  +
Sbjct: 206  MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 1060 MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097
               + I  +           +E +    P   D + +L
Sbjct: 265  PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 1e-27
 Identities = 56/285 (19%), Positives = 104/285 (36%), Gaps = 28/285 (9%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED 883
             +G GA+G V  A      A  A+KKL              RE++ +  +RH N++ L D
Sbjct: 25   PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 884  FWLRKDC-GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP 942
             +   +        Y+    +   L  +     L  +    +       L Y+H      
Sbjct: 85   VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141

Query: 943  IVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAK- 1001
            I+HRD+KP N+ ++ + E  I DFG+A+  D     +     V T  Y APE      + 
Sbjct: 142  IIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWYRAPEVILNWMRY 196

Query: 1002 SKESDVYSYGVVLLELITRK------KALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055
            ++  D++S G ++ E+IT K        LD   +                +       + 
Sbjct: 197  TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 1056 LMEEM-------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDV 1093
             + E+       ++++     +++L    +        R    + 
Sbjct: 257  GLPELEKKDFASILTNASPLAVNLL---EKMLVLDAEQRVTAGEA 298

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  112 bits (280), Expect = 1e-27
 Identities = 80/329 (24%), Positives = 132/329 (40%), Gaps = 32/329 (9%)

Query: 29  DGVALLSLMRHWNSVPPLIISSWN-SSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQL 87
           D  ALL + +   +  P  +SSW  ++D     W+G+ CD D                  
Sbjct: 7   DKQALLQIKKDLGN--PTTLSSWLPTTDCCNRTWLGVLCDTD------------------ 46

Query: 88  GPEIGHLSKLQTIDLSSNNFSGN--IPPKLGNCSALEYLDLSTN-GFTGDIPDNFENLQN 144
                   ++  +DLS  N      IP  L N   L +L +       G IP     L  
Sbjct: 47  ----TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102

Query: 145 LQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS 204
           L YL +    + G IP+ L +I  L  +  + N+LSG++P ++  L  +  +    NR+S
Sbjct: 103 LHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS 162

Query: 205 GTIPESIGNCYRLQE-LYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCK 263
           G IP+S G+  +L   + ++ N+L G +P + +NL           N+            
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVLFGSD 220

Query: 264 NLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQL 323
             T                +G   +L  LD+  +++ G++P     L  L SL++S N L
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 324 SGKIPPELGKCKYLTVLHLYANQLEGEIP 352
            G+I P+ G  +   V     N+     P
Sbjct: 281 CGEI-PQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 94.8 bits (234), Expect = 1e-21
 Identities = 73/265 (27%), Positives = 111/265 (41%), Gaps = 6/265 (2%)

Query: 312 RLSSLDLSENQLSGK--IPPELGKCKYLTVLHLYAN-QLEGEIPDELGQLSNLQDLELFD 368
           R+++LDLS   L     IP  L    YL  L++     L G IP  + +L+ L  L +  
Sbjct: 51  RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110

Query: 369 NRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLG 428
             ++G  P  + +I +L  L    N L G LP  ++ L  L  I+   N+ SG IP S G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170

Query: 429 INSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQ 488
             S L     I+ +      P       L  +++ +N   G    L GS     ++ L +
Sbjct: 171 SFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230

Query: 489 NQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGN 548
           N L   L +   +  L+ LD+  N I G +P  +     L S++ S N   G +P + GN
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGN 289

Query: 549 LVSLVTLNISLNHVEGSLPSQLSKC 573
           L        + N      P  L  C
Sbjct: 290 LQRFDVSAYANNKCLCGSP--LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.8 bits (182), Expect = 7e-15
 Identities = 50/261 (19%), Positives = 90/261 (34%), Gaps = 6/261 (2%)

Query: 385 LEYLLVYNNNLLGKLPL--EMTELKQLKNISLYNN-QFSGVIPQSLGINSSLMQLDFINN 441
           +  L +   NL    P+   +  L  L  + +       G IP ++   + L  L   + 
Sbjct: 52  VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111

Query: 442 SFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKN 501
           + +G IP  L   K L  L+   N   G +P  + S P L  +    N+++GA+P+   +
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171

Query: 502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNH 561
                  ++ +            +    +    S          L              +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231

Query: 562 VEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISEL 621
                  ++   KNL   D+  N + G++P  L   K L  L +S N+  G IP     L
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNL 290

Query: 622 EKLLELQLGGNQL--GGEIPP 640
           ++        N+   G  +P 
Sbjct: 291 QRFDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 71.7 bits (174), Expect = 7e-14
 Identities = 59/281 (20%), Positives = 107/281 (38%), Gaps = 8/281 (2%)

Query: 437 DFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHG--PIPSLLGSCPTLWRVILK--QNQLT 492
           D  N ++ G +        ++  L++         PIPS L + P L  + +    N + 
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 493 GALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSL 552
              P  +K   L +L ++  N+SGAIP  +     L ++DFS N  SG +P  + +L +L
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151

Query: 553 VTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG 612
           V +    N + G++P        L          N        ++ +L++  +  +    
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISR--NRLTGKIPPTFANLNLAFVDLSRNML 209

Query: 613 GIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSK 672
                +         ++   +           L      L+L  N + G +P  L +L  
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKF 269

Query: 673 LEQLDISSNNLTGTLSPLSNIHSLVEVNVSYN--LFTGPVP 711
           L  L++S NNL G +    N+        + N  L   P+P
Sbjct: 270 LHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 71.7 bits (174), Expect = 8e-14
 Identities = 73/281 (25%), Positives = 111/281 (39%), Gaps = 10/281 (3%)

Query: 416 NNQFSGVIPQSLGINSSLMQLDFINNSFTG--EIPPNLCFGKQLRVLNMGQN-QFHGPIP 472
           N  + GV+  +      +  LD    +      IP +L     L  L +G      GPIP
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94

Query: 473 SLLGSCPTLWRVILKQNQLTGALP-EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSI 531
             +     L  + +    ++GA+P   S+   L  LD S N +SG +P SI +  NL  I
Sbjct: 95  PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154

Query: 532 DFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIP 591
            F  N+ SG +P   G+   L T      +             NL   D+S N+L G   
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS 214

Query: 592 SSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYA 651
               S K+   + L++N     +              L  N++ G +P  +  L+ L   
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFLHS- 272

Query: 652 LNLSKNGLTGRIPSDLEKLSKLEQLDISSNN-LTGTLSPLS 691
           LN+S N L G IP     L + +    ++N  L G  SPL 
Sbjct: 273 LNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCG--SPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 67.9 bits (164), Expect = 1e-12
 Identities = 66/260 (25%), Positives = 108/260 (41%), Gaps = 27/260 (10%)

Query: 499 SKNPVLSHLDVSRNNISGA--IPSSIGNSINLTSIDFSSN-KFSGLMPQELGNLVSLVTL 555
           ++   +++LD+S  N+     IPSS+ N   L  +         G +P  +  L  L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 556 NISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIP 615
            I+  +V G++P  LS+ K L   D S+N L+G++P S+ S  +L  +    N  +G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 616 TFISELEKLLE-LQLGGNQLGGEIPPSIGALQDLSY---------------------ALN 653
                  KL   + +  N+L G+IPP+   L                             
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 654 LSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSP-LSNIHSLVEVNVSYNLFTGPVPE 712
                        +     L  LD+ +N + GTL   L+ +  L  +NVS+N   G +P+
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 713 TLMNLLGPSPSSFSGNPSLC 732
              NL     S+++ N  LC
Sbjct: 287 -GGNLQRFDVSAYANNKCLC 305

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 67.1 bits (162), Expect = 2e-12
 Identities = 72/263 (27%), Positives = 103/263 (39%), Gaps = 8/263 (3%)

Query: 404 TELKQLKNISLYNNQFSGV--IPQSLGINSSLMQLDFINN-SFTGEIPPNLCFGKQLRVL 460
           T+  ++ N+ L          IP SL     L  L      +  G IPP +    QL  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 461 NMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIP 519
            +      G IP  L    TL  +    N L+G LP   S  P L  +    N ISGAIP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 520 SSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVF 579
            S G+   L +    S              ++L  +++S N +EG         KN +  
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 580 DVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIP 639
            ++ N L   +       K+L+ L L  N   G +P  +++L+ L  L +  N L GEI 
Sbjct: 227 HLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI- 284

Query: 640 PSIGALQDLSYALNLSKN-GLTG 661
           P  G LQ        + N  L G
Sbjct: 285 PQGGNLQRFDV-SAYANNKCLCG 306

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 63.6 bits (153), Expect = 3e-11
 Identities = 22/126 (17%), Positives = 35/126 (27%), Gaps = 1/126 (0%)

Query: 37  MRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSK 96
           +          ++      S             +         +         ++G    
Sbjct: 186 LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKN 245

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD 156
           L  +DL +N   G +P  L     L  L++S N   G+IP    NLQ         N   
Sbjct: 246 LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCL 304

Query: 157 GEIPEP 162
              P P
Sbjct: 305 CGSPLP 310

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 2e-26
 Identities = 56/299 (18%), Positives = 108/299 (36%), Gaps = 41/299 (13%)

Query: 826  VIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL-SMKREIQTIGKIRHRNLVRLED 883
             IG GA GIV  A     +   A+KKL+     +       RE+  +  + H+N++ L +
Sbjct: 24   PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 884  FWLRKDCG------IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY 937
             +  +          ++   M+    + +   +             +       + +LH 
Sbjct: 84   VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137

Query: 938  DCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAF 997
                 I+HRD+KP NI++ S+    I DFG+A+    S   T     V T  Y APE   
Sbjct: 138  AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRAPEVIL 191

Query: 998  TTAKSKESDVYSYGVVLLELITRK-----------------KALDPSYKERTDIVGWVRS 1040
                 +  D++S G ++ E++  K                 +   P  +    +   VR+
Sbjct: 192  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVAL----RCTEKKPSNRPNMRDVVR 1095
               +  +   +    L  + L  +  +        A     +     P+ R ++ D ++
Sbjct: 252  YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (267), Expect = 2e-25
 Identities = 42/224 (18%), Positives = 81/224 (36%), Gaps = 19/224 (8%)

Query: 825  HVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLED 883
              +G G    V+ A  +  N   A+K +  RG K  + + + EI+ + ++   +  + + 
Sbjct: 19   RKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 884  FWLR-------------KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAH 930
                              +   ++  +   G     L        +      +I+     
Sbjct: 77   MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 931  ALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGIAKLLDKSPASTTSISVVGTIG 989
             L Y+H  C   I+H DIKPEN+L++      ++    IA L +         + + T  
Sbjct: 137  GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 990  YIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTD 1033
            Y +PE          +D++S   ++ ELIT     +P       
Sbjct: 195  YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 4e-24
 Identities = 61/313 (19%), Positives = 112/313 (35%), Gaps = 42/313 (13%)

Query: 807  PSY----LLKQVIEATENLNAKHVIGRGAHGIVYKA-SLGPNAVFAVKKLAFRGHKRGSL 861
            P++    L K + E  E       +G GA+G V  A         AVKKL+         
Sbjct: 2    PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61

Query: 862  -SMKREIQTIGKIRHRNLVRLEDFW-----LRKDCGIIMYRYMENGSLRDVLHSITPPPT 915
                RE++ +  ++H N++ L D +     L +   + +  ++    L +++        
Sbjct: 62   KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QK 117

Query: 916  LEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS 975
            L  +    +       L Y+H      I+HRD+KP N+ ++ + E  I DFG+A+  D  
Sbjct: 118  LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

Query: 976  PASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDI 1034
                 +     T  Y APE        ++  D++S G ++ EL+T  + L P       +
Sbjct: 175  MTGYVA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHIDQL 228

Query: 1035 VGWVRSVWSDTEEINDIVDLSLMEEM--------------LVSSIRDQVIDVLLVALRCT 1080
               +R V +   E+   +                      +        +D+L    +  
Sbjct: 229  KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL---EKML 285

Query: 1081 EKKPSNRPNMRDV 1093
                  R      
Sbjct: 286  VLDSDKRITAAQA 298

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  102 bits (255), Expect = 9e-24
 Identities = 71/380 (18%), Positives = 133/380 (35%), Gaps = 32/380 (8%)

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS 276
             +  L +  +   +  S ++L+ +  L      ++       E   NLT ++ S N+ +
Sbjct: 24  KMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSIDGV--EYLNNLTQINFSNNQLT 79

Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP------- 329
                 L N + L  + +  +++    P +        +L  ++      +         
Sbjct: 80  D--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 137

Query: 330 -----ELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIAS 384
                 +     L+ L        G    +L  L+NL  LE  D        +S+    +
Sbjct: 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT 197

Query: 385 LEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFT 444
               L+  NN +  +   +  L  L  +SL  NQ       +L   ++L  LD  NN  +
Sbjct: 198 NLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS 254

Query: 445 GEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVL 504
              P  L    +L  L +G NQ     P    +  T   +   Q +        S    L
Sbjct: 255 NLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI---SPISNLKNL 309

Query: 505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEG 564
           ++L +  NNIS   P  + +   L  + F++NK S      L NL ++  L+   N +  
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365

Query: 565 SLPSQLSKCKNLEVFDVSFN 584
             P  L+    +    ++  
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  102 bits (254), Expect = 1e-23
 Identities = 72/396 (18%), Positives = 135/396 (34%), Gaps = 34/396 (8%)

Query: 310 LARLSSLDLSENQLSGKIPP-ELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFD 368
           LA      L +  ++  +   +L +   L    L    ++G     +  L+NL  +   +
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFSN 75

Query: 369 NRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLG 428
           N+LT   P     + +L  L+    N      +               N     I     
Sbjct: 76  NQLTDITP-----LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 429 INSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQ 488
           + +        N         ++     L  L              L +  TL R+ +  
Sbjct: 131 LTNLNRLELSSNT------ISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184

Query: 489 NQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGN 548
           N+++      +K   L  L  + N IS   P  I    NL  +  + N+        L +
Sbjct: 185 NKVSDI-SVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLAS 239

Query: 549 LVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSEN 608
           L +L  L+++ N +    P  LS    L    +  N ++   P         ++  L  N
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL----AGLTALTNLELN 293

Query: 609 HFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLE 668
                  + IS L+ L  L L  N +    P  + +L  L   L  + N ++    S L 
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFANNKVSD--VSSLA 348

Query: 669 KLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYN 704
            L+ +  L    N ++  L+PL+N+  + ++ ++  
Sbjct: 349 NLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  101 bits (251), Expect = 3e-23
 Identities = 66/388 (17%), Positives = 133/388 (34%), Gaps = 38/388 (9%)

Query: 236 SNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGIS--PNLGNCSSLTHLD 293
           + L   +   +G  N+   ++        +T L         GI     +   ++LT ++
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRL----GIKSIDGVEYLNNLTQIN 72

Query: 294 IVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPE------LGKCKYLTVLHLYANQL 347
              ++LT   P     L +L  + ++ NQ++   P                +  +   + 
Sbjct: 73  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 348 EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL-------LVYNNNLLGKLP 400
              +       + + D+       + +      ++  L+ L        +  ++      
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190

Query: 401 LEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVL 460
             + +L  L+++   NNQ S + P    I ++L +L    N         L     L  L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDL 246

Query: 461 NMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPS 520
           ++  NQ     P  L     L  + L  NQ++   P      + +  ++  N       S
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAG---LTALTNLELNENQLEDIS 301

Query: 521 SIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFD 580
            I N  NLT +    N  S + P  + +L  L  L  + N V     S L+   N+    
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357

Query: 581 VSFNLLNGSIPSSLRSWKSLSILKLSEN 608
              N ++   P  L +   ++ L L++ 
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 97.0 bits (240), Expect = 6e-22
 Identities = 68/370 (18%), Positives = 130/370 (35%), Gaps = 47/370 (12%)

Query: 68  DDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLS 127
            D   V +      G+    G  + +L+ L  I+ S+N  +   P  L N + L  + ++
Sbjct: 41  TDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMN 96

Query: 128 TNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV 187
            N      P           L          +            + L++N++S     + 
Sbjct: 97  NNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL----NRLELSSNTISDISALSG 152

Query: 188 GDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVG 247
               +  +             + + N   L+ L ++ NK+        + L NL  L   
Sbjct: 153 LTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIAT 205

Query: 248 DNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSF 307
           +N +            NL  L L+ N+        L + ++LT LD+  ++++   P   
Sbjct: 206 NNQISDITPL--GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259

Query: 308 GLLARLSSLDLSENQLSGKIP--------------------PELGKCKYLTVLHLYANQL 347
             L +L+ L L  NQ+S   P                      +   K LT L LY N +
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319

Query: 348 EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELK 407
               P  +  L+ LQ L   +N+++     S+  + ++ +L   +N +    PL    L 
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NLT 373

Query: 408 QLKNISLYNN 417
           ++  + L + 
Sbjct: 374 RITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.1 bits (235), Expect = 3e-21
 Identities = 81/397 (20%), Positives = 138/397 (34%), Gaps = 35/397 (8%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
           L++     L   N +  +     +   +  L     G    I D  E L NL  +N   N
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 76

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
            L      PL  +  L  + +NNN ++   P                  L+G    +   
Sbjct: 77  QLTDIT--PLKNLTKLVDILMNNNQIADITP------------LANLTNLTGLTLFNNQI 122

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
                   L     +     ++S++  L  L        G      +   NLT L+    
Sbjct: 123 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDI 182

Query: 274 RFS-GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELG 332
             +       L   ++L  L    ++++   P        L  L L+ NQL       L 
Sbjct: 183 SSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLA 238

Query: 333 KCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYN 392
               LT L L  NQ+    P  L  L+ L +L+L  N+++   P  +  + +L  L +  
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNE 294

Query: 393 NNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLC 452
           N    +    ++ LK L  ++LY N  S + P  +   + L +L F NN  +     +L 
Sbjct: 295 NQ--LEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348

Query: 453 FGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
               +  L+ G NQ     P  L +   + ++ L   
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 88.5 bits (218), Expect = 4e-19
 Identities = 73/403 (18%), Positives = 140/403 (34%), Gaps = 36/403 (8%)

Query: 135 IPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVE 194
             D    L       L    +   + +    +  +  +  +   +  SI   V  L  + 
Sbjct: 16  FTD--TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLT 69

Query: 195 ALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGR 254
            +   +N+L+   P  + N  +L ++ +N N++                      NL G 
Sbjct: 70  QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI------------TPLANLTNLTGL 115

Query: 255 INFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLS 314
             F ++        +L+        S  + + S+L+ L  +     G+  +    LA L+
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175

Query: 315 SLDLSENQLS-GKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTG 373
           +L+  +   +       L K   L  L    NQ+    P  +   +NL +L L  N+L  
Sbjct: 176 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD 233

Query: 374 EFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSL 433
               ++  + +L  L + NN +    PL    L +L  + L  NQ S + P + G+ +  
Sbjct: 234 --IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISPLA-GLTALT 288

Query: 434 MQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTG 493
                 N         NL     L  L +  N      P  + S   L R+    N+++ 
Sbjct: 289 NLELNENQLEDISPISNLKN---LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343

Query: 494 ALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSN 536
            +   +    ++ L    N IS   P  + N   +T +  +  
Sbjct: 344 -VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 68.1 bits (165), Expect = 2e-12
 Identities = 23/120 (19%), Positives = 42/120 (35%), Gaps = 6/120 (5%)

Query: 34  LSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGH 93
           L   +  N  P   +++  + +    Q   I    +  N+    L    +S      +  
Sbjct: 270 LGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI--SPVSS 327

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
           L+KLQ +  ++N  S      L N + + +L    N  +   P    NL  +  L L   
Sbjct: 328 LTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  100 bits (250), Expect = 1e-23
 Identities = 53/312 (16%), Positives = 92/312 (29%), Gaps = 38/312 (12%)

Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKY 336
           G + P    C  L  +      L   +P    L    + LDL  N+++     +    K 
Sbjct: 1   GPVCPFRCQCH-LRVVQCSDLGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKN 56

Query: 337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLE---------- 386
           L  L L  N++    P     L  L+ L L  N+L          +  L           
Sbjct: 57  LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 116

Query: 387 -------------YLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSL 433
                         L        G        +K+L  I + +   + +     G+  SL
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSL 173

Query: 434 MQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTG 493
            +L    N  T     +L     L  L +  N         L + P L  + L  N+L  
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233

Query: 494 ALPEFSKNPVLSHLDVSRNNISG------AIPSSIGNSINLTSIDFSSNK--FSGLMPQE 545
                + +  +  + +  NNIS         P       + + +   SN   +  + P  
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 293

Query: 546 LGNLVSLVTLNI 557
              +     + +
Sbjct: 294 FRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 99.0 bits (245), Expect = 5e-23
 Identities = 52/278 (18%), Positives = 93/278 (33%), Gaps = 13/278 (4%)

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD 156
              +DL +N  +        N   L  L L  N  +   P  F  L  L+ L L  N L 
Sbjct: 33  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92

Query: 157 GEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYR 216
               +    +  L+        +  S+   +  +  VE L     + SG    +     +
Sbjct: 93  ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKK 151

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS 276
           L  + + +  +         +L     L +  N +        +   NL  L LS+N  S
Sbjct: 152 LSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208

Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSG------KIPPE 330
              + +L N   L  L +  +KL   +P        +  + L  N +S         P  
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267

Query: 331 LGKCKYLTVLHLYANQLE-GEI-PDELGQLSNLQDLEL 366
             K    + + L++N ++  EI P     +     ++L
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.0 bits (227), Expect = 1e-20
 Identities = 55/269 (20%), Positives = 110/269 (40%), Gaps = 13/269 (4%)

Query: 158 EIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRL 217
           ++P+ L        + L NN ++     +  +LK +  L L +N++S   P +     +L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG 277
           + LYL++N+L     +    L+ L   +     +   + F       +  L  +  + SG
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV-FNGLNQMIVVELGTNPLKSSG 140

Query: 278 GISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYL 337
             +        L+++ I  + +T +IP   GL   L+ L L  N+++      L     L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNL 197

Query: 338 TVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL-- 395
             L L  N +       L    +L++L L +N+L  + P  +     ++ + ++NNN+  
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256

Query: 396 ----LGKLPLEMTELKQLKNISLYNNQFS 420
                   P   T+      +SL++N   
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 81.6 bits (200), Expect = 3e-17
 Identities = 52/277 (18%), Positives = 96/277 (34%), Gaps = 15/277 (5%)

Query: 428 GINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK 487
            +      LD  NN  T     +    K L  L +  N+     P        L R+ L 
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87

Query: 488 QNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSS--NKFSGLMPQE 545
           +NQL     +  K      L V  N I+    S       +  ++  +   K SG+    
Sbjct: 88  KNQLKELPEKMPKTL--QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 145

Query: 546 LGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKL 605
              +  L  + I+  ++  ++P  L    +L    +  N +     +SL+   +L+ L L
Sbjct: 146 FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202

Query: 606 SENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTG---- 661
           S N  +      ++    L EL L  N+L  ++P  +   + +   + L  N ++     
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQV-VYLHNNNISAIGSN 260

Query: 662 --RIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSL 696
               P    K +    + + SN +       S    +
Sbjct: 261 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (219), Expect = 8e-20
 Identities = 56/254 (22%), Positives = 85/254 (33%), Gaps = 29/254 (11%)

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI--------------------- 135
            Q I L  N  S         C  L  L L +N                           
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 136 ----PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLK 191
               P  F  L  L  L+L    L    P     +  LQY++L +N+L         DL 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 192 EVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
            +  L+L  NR+S     +    + L  L L++N++    P +  +L  L+ L +  NNL
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 252 EGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLA 311
                      + L +L L+ N +           + L       S++  S+P     LA
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQR---LA 269

Query: 312 RLSSLDLSENQLSG 325
                 L+ N L G
Sbjct: 270 GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.9 bits (203), Expect = 9e-18
 Identities = 57/279 (20%), Positives = 94/279 (33%), Gaps = 28/279 (10%)

Query: 263 KNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQ 322
                + L  NR S   + +   C +LT L +  + L     ++F  LA L  LDLS+N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 323 LSGKIPP-ELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWR 381
               + P        L  LHL    L+   P     L+ LQ L L DN L      +   
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 382 IASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN 441
           + +L +L ++ N +          L  L  + L+ N+ + V P +      LM L    N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 442 SFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKN 501
           + +      L   + L+ L +  N +          C       L               
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVC-------DCRARP---LWAW------------ 249

Query: 502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
             L     S + +  ++P  +           ++N   G
Sbjct: 250 --LQKFRGSSSEVPCSLPQRLA---GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (195), Expect = 9e-17
 Identities = 62/275 (22%), Positives = 95/275 (34%), Gaps = 8/275 (2%)

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
                 G    +P         Q + L+GN +             L  ++L++N L+   
Sbjct: 16  TSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 184 PRNVGDLKEVEALWLFSNRLSGTI-PESIGNCYRLQELYLNENKLMGFLPESLSNLENLV 242
                 L  +E L L  N    ++ P +     RL  L+L+   L    P     L  L 
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132

Query: 243 YLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGS 302
           YL + DN L+   +       NLT L L  NR S           SL  L +  +++   
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 303 IPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQ 362
            P +F  L RL +L L  N LS      L   + L  L L  N    +        + LQ
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQ 251

Query: 363 DLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLG 397
                 + +    P     +A  +   +  N+L G
Sbjct: 252 KFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (192), Expect = 2e-16
 Identities = 42/265 (15%), Positives = 86/265 (32%), Gaps = 9/265 (3%)

Query: 423 IPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLW 482
           +P   GI ++  ++    N  +     +    + L +L +  N       +       L 
Sbjct: 26  VPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 483 RVILKQNQLTGAL--PEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG 540
           ++ L  N    ++    F     L  L + R  +    P        L  +    N    
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 541 LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSL 600
           L      +L +L  L +  N +            +L+   +  N +    P + R    L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 601 SILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT 660
             L L  N+ +      ++ L  L  L+L  N    +       L         S + + 
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVP 261

Query: 661 GRIPSDLEKLSKLEQLDISSNNLTG 685
             +P   ++L+  +   +++N+L G
Sbjct: 262 CSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.1 bits (180), Expect = 8e-15
 Identities = 45/251 (17%), Positives = 74/251 (29%), Gaps = 28/251 (11%)

Query: 504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKF------------------------- 538
              + +  N IS    +S     NLT +   SN                           
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 539 SGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWK 598
             + P     L  L TL++    ++   P        L+   +  N L      + R   
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 599 SLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNG 658
           +L+ L L  N  +         L  L  L L  N++    P +   L  L     L  N 
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL-YLFANN 212

Query: 659 LTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVPETL--MN 716
           L+      L  L  L+ L ++ N              L +   S +     +P+ L   +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272

Query: 717 LLGPSPSSFSG 727
           L   + +   G
Sbjct: 273 LKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.5 bits (176), Expect = 2e-14
 Identities = 43/187 (22%), Positives = 70/187 (37%), Gaps = 4/187 (2%)

Query: 91  IGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNL 150
              L +L T+ L         P      +AL+YL L  N       D F +L NL +L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160

Query: 151 YGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
           +GN +          +  L  + L+ N ++   P    DL  +  L+LF+N LS    E+
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220

Query: 211 IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDL 270
           +     LQ L LN+N  +     +      L       + +   +    ++        L
Sbjct: 221 LAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSL---PQRLAGRDLKRL 276

Query: 271 SYNRFSG 277
           + N   G
Sbjct: 277 AANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (151), Expect = 4e-11
 Identities = 35/183 (19%), Positives = 67/183 (36%), Gaps = 4/183 (2%)

Query: 71  HNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNG 130
             + + +L   G+          L+ LQ + L  N           +   L +L L  N 
Sbjct: 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164

Query: 131 FTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDL 190
            +      F  L +L  L L+ N +    P     +  L  ++L  N+LS      +  L
Sbjct: 165 ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224

Query: 191 KEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNN 250
           + ++ L L  N        +      LQ+   + +++   LP+ L+  +      +  N+
Sbjct: 225 RALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRD---LKRLAAND 280

Query: 251 LEG 253
           L+G
Sbjct: 281 LQG 283

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.6 bits (211), Expect = 1e-19
 Identities = 30/200 (15%), Positives = 54/200 (27%), Gaps = 24/200 (12%)

Query: 826  VIGRGAHGIVYKASLGPNAVFAVKKL---------AFRGHKRGSLSMKREIQTIGKIRHR 876
            ++G G    V+           VK                  G L          +   R
Sbjct: 7    LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 877  NLVRLEDFWLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLH 936
             L +L      +   +      E  ++   L        +      ++       +A  +
Sbjct: 67   ALQKL------QGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 937  YDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENA 996
                  IVH D+   N+L+  E    I DF  +  + +          V  I        
Sbjct: 121  ---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNI-----ITY 171

Query: 997  FTTAKSKESDVYSYGVVLLE 1016
            F+     E D+ S    +L+
Sbjct: 172  FSRTYRTEKDINSAIDRILQ 191

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.0 bits (180), Expect = 7e-15
 Identities = 44/273 (16%), Positives = 83/273 (30%), Gaps = 15/273 (5%)

Query: 268 LDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKI 327
           LDL+       ++  L +   +       S +   +   F    R+  +DLS + +    
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62

Query: 328 PPE-LGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLE 386
               L +C  L  L L   +L   I + L + SNL  L L       EF +     +   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 387 YLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDF-------- 438
              +  +         +       + ++     SG        + S +            
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 439 -INNSFTGEIPPNLCFGKQLRVLNM-GQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALP 496
             +     +          L+ L++             LG  PTL  + +      G L 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 497 EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLT 529
              +   L HL ++ ++ +     +IGN  N  
Sbjct: 243 LLKEA--LPHLQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (163), Expect = 1e-12
 Identities = 45/272 (16%), Positives = 79/272 (29%), Gaps = 21/272 (7%)

Query: 70  AHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPK-LGNCSALEYLDLST 128
           +  V++F      +   L  E     ++Q +DLS++    +     L  CS L+ L L  
Sbjct: 22  SQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80

Query: 129 NGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVG 188
              +  I +      NL  LNL G     E           +   LN +       ++V 
Sbjct: 81  LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 140

Query: 189 DLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGD 248
                 +  +    LSG       +              +                    
Sbjct: 141 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD---------------S 185

Query: 249 NNLEGRINFGSEKCKNLTFLDLSYNRFSGGISP-NLGNCSSLTHLDIVGSKLTGSIPSSF 307
             L+        +   L  L LS        +   LG   +L  L + G    G++    
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL-- 243

Query: 308 GLLARLSSLDLSENQLSGKIPPELGKCKYLTV 339
            L   L  L ++ +  +    P +G  K   +
Sbjct: 244 -LKEALPHLQINCSHFTTIARPTIGNKKNQEI 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.1 bits (131), Expect = 2e-08
 Identities = 32/290 (11%), Positives = 83/290 (28%), Gaps = 21/290 (7%)

Query: 315 SLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGE 374
           +LDL+   L   +   L   + +       + ++  +  E      +Q ++L ++ +   
Sbjct: 4   TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61

Query: 375 -FPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSL 433
                + + + L+ L +    L   +   + +   L  ++L                +  
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSG-------FSEFALQ 114

Query: 434 MQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTG 493
             L   +      +     F ++   + +          +L G    L +  L       
Sbjct: 115 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV--- 171

Query: 494 ALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSS-NKFSGLMPQELGNLVSL 552
                    ++         +             L  +  S           ELG + +L
Sbjct: 172 ----RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227

Query: 553 VTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI 602
            TL +     +G+L        +L    ++ +        ++ + K+  I
Sbjct: 228 KTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGNKKNQEI 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 47/278 (16%), Positives = 93/278 (33%), Gaps = 44/278 (15%)

Query: 196 LW----LFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
           LW    L    L   +   + +   +       + +   L E  S    + ++D+ ++ +
Sbjct: 1   LWQTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVI 58

Query: 252 EGR-INFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKL--TGSIPSSFG 308
           E   ++    +C  L  L L   R S  I   L   S+L  L++ G       ++ +   
Sbjct: 59  EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 118

Query: 309 LLARLSSLDLSE-------------------------------NQLSGKIPPELGKCKYL 337
             +RL  L+LS                                 Q S            +
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178

Query: 338 TVLHLYANQLEGEIPDELGQLSNLQDLELFD-NRLTGEFPVSIWRIASLEYLLVYNNNLL 396
            +    +  L+ +   E  QL+ LQ L L     +  E  + +  I +L+ L V+     
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238

Query: 397 GKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLM 434
           G L L     + L ++ +  + F+ +   ++G   +  
Sbjct: 239 GTLQL---LKEALPHLQINCSHFTTIARPTIGNKKNQE 273

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 3e-06
 Identities = 16/99 (16%), Positives = 40/99 (40%), Gaps = 3/99 (3%)

Query: 506 HLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEG- 564
            LD++  N+   +   +  S  + +     +     + +       +  +++S + +E  
Sbjct: 4   TLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVS 61

Query: 565 SLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSIL 603
           +L   LS+C  L+   +    L+  I ++L    +L  L
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 2e-04
 Identities = 20/169 (11%), Positives = 52/169 (30%), Gaps = 5/169 (2%)

Query: 37  MRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSK 96
                     +   ++ ++      V    +      +S    +   S          + 
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLS-TNGFTGDIPDNFENLQNLQYLNLYGNLL 155
           +      S     +   +    + L++L LS       +       +  L+ L ++G + 
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237

Query: 156 DGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS 204
           DG +         L ++ +N +  +      +G+ K  + +W    RL+
Sbjct: 238 DGTLQL---LKEALPHLQINCSHFTTIARPTIGNKKN-QEIWGIKCRLT 282

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.004
 Identities = 12/93 (12%), Positives = 36/93 (38%), Gaps = 5/93 (5%)

Query: 627 LQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGT 686
           L L G  L  ++   + +   ++      ++ +   +        +++ +D+S++ +  +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIA--FRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVS 61

Query: 687 --LSPLSNIHSLVEVNVSYNLFTGPVPETLMNL 717
                LS    L  +++     + P+  TL   
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN 94

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.4 bits (163), Expect = 1e-12
 Identities = 44/207 (21%), Positives = 68/207 (32%), Gaps = 25/207 (12%)

Query: 90  EIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLN 149
           E+  ++    ++    N +  +PP L        L LS N               L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 150 LYGNLLDGEIPEPLFRILGLQYVFLNNN---------------------SLSGSIPRNVG 188
           L    L     +    +LG   +  N                        L+      + 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 189 DLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGD 248
            L E++ L+L  N L    P  +    +L++L L  N L       L+ LENL  L + +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 249 NNLEGRINFGSEKCKNLTFLDLSYNRF 275
           N+L   I  G      L F  L  N +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.6 bits (153), Expect = 2e-11
 Identities = 43/203 (21%), Positives = 74/203 (36%), Gaps = 6/203 (2%)

Query: 310 LARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
           +A    ++  +  L+  +PP+L K    T+LHL  N L       L   + L  L L   
Sbjct: 9   VASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 370 RLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI 429
                  + +     +   L  ++N L  LPL    L  L  + +  N+ + +   +L  
Sbjct: 66  E---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
              L +L    N      P  L    +L  L++  N        LL     L  ++L++N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

Query: 490 QLTGALPEFSKNPVLSHLDVSRN 512
            L      F  + +L    +  N
Sbjct: 183 SLYTIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 3e-09
 Identities = 38/210 (18%), Positives = 63/210 (30%), Gaps = 7/210 (3%)

Query: 497 EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLN 556
           E SK      ++  + N++ A+P  +    + T +  S N         L     L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 557 ISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPT 616
             L+  E +          L   D+S N L               +      +    +P 
Sbjct: 62  --LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV--SFNRLTSLPL 117

Query: 617 FISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQL 676
                   L+           +PP +         L+L+ N LT      L  L  L+ L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 677 DISSNNLTGTLSPLSNIHSLVEVNVSYNLF 706
            +  N+L          H L    +  N +
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 3e-09
 Identities = 45/208 (21%), Positives = 70/208 (33%), Gaps = 29/208 (13%)

Query: 284 GNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLY 343
              +S   ++     LT ++P    L    + L LSEN L       L     LT L+L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL- 62

Query: 344 ANQLEGEIPDELGQLSNLQDLELFDNR-----------------------LTGEFPVSIW 380
            ++ E       G L  L  L+L  N+                       LT     ++ 
Sbjct: 63  -DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 381 RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFIN 440
            +  L+ L +  N L    P  +T   +L+ +SL NN  + +    L    +L  L    
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 441 NSFTGEIPPNLCFGKQLRVLNMGQNQFH 468
           NS    IP        L    +  N + 
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.0 bits (136), Expect = 3e-09
 Identities = 47/212 (22%), Positives = 74/212 (34%), Gaps = 11/212 (5%)

Query: 234 SLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLD 293
            +S + + + ++    NL        +  K+ T L LS N         L   + LT L+
Sbjct: 5   EVSKVASHLEVNCDKRNLT---ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 294 IVGSKLTGSIPSSFGLLARLSSLDLSENQLSGK--IPPELGKCKYLTVLHLYANQLEGEI 351
                L  +  +   +   L  L   +   +    +P        LTVL +  N+L    
Sbjct: 62  -----LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLP 116

Query: 352 PDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKN 411
              L  L  LQ+L L  N L    P  +     LE L + NNNL       +  L+ L  
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT 176

Query: 412 ISLYNNQFSGVIPQSLGINSSLMQLDFINNSF 443
           + L  N     IP+    +  L       N +
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.6 bits (109), Expect = 8e-06
 Identities = 31/180 (17%), Positives = 60/180 (33%), Gaps = 4/180 (2%)

Query: 72  NVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGF 131
           +    +LS   +       +   ++L  ++L     +            +      ++  
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD---GTLPVLGTLDLSHNQ 88

Query: 132 TGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLK 191
              +P   + L  L  L++  N L       L  +  LQ ++L  N L    P  +    
Sbjct: 89  LQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148

Query: 192 EVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNL 251
           ++E L L +N L+      +     L  L L EN L   +P+       L +  +  N  
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 8e-05
 Identities = 14/54 (25%), Positives = 20/54 (37%), Gaps = 1/54 (1%)

Query: 103 SSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD 156
           ++NN +      L     L+ L L  N     IP  F     L +  L+GN   
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.8 bits (140), Expect = 2e-09
 Identities = 49/451 (10%), Positives = 112/451 (24%), Gaps = 21/451 (4%)

Query: 192 EVEALWLFSNRLSGT-IPESIGNCYRLQELYLNENKL----MGFLPESLSNLENLVYLDV 246
           ++++L +    LS     E +    + Q + L++  L       +  +L     L  L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 247 GDNNL--EGRINFGS---EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTG 301
             N L   G              +  L L     +G     L +                
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 302 SIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNL 361
            +  +   L     LD        ++            L              +      
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 182

Query: 362 QDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSG 421
           +       +   + P  +  +      +  +N       +      +   +        G
Sbjct: 183 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242

Query: 422 VIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTL 481
           +     G+     +L  +     G          ++        +       L      L
Sbjct: 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302

Query: 482 WRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGL 541
               L +                +      +++       +   I+   ++ +  +    
Sbjct: 303 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL-- 360

Query: 542 MPQELGNLVSLVTLNISLNHVEG----SLPSQLSKCKNLEVFDVSFNLLNGSIPSSL--- 594
                     L  L ++   V      SL + L    +L   D+S N L  +    L   
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420

Query: 595 --RSWKSLSILKLSENHFTGGIPTFISELEK 623
             +    L  L L + +++  +   +  LEK
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (128), Expect = 6e-08
 Identities = 17/90 (18%), Positives = 27/90 (30%), Gaps = 5/90 (5%)

Query: 97  LQTIDLSSNNFSGNIPPKL-GNCSALEYLDLSTNGFTGD----IPDNFENLQNLQYLNLY 151
           +Q++D+     S     +L       + + L   G T      I         L  LNL 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 152 GNLLDGEIPEPLFRILGLQYVFLNNNSLSG 181
            N L       + + L      +   SL  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 3e-07
 Identities = 18/165 (10%), Positives = 40/165 (24%), Gaps = 9/165 (5%)

Query: 37  MRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSK 96
                        +    ++       +E         +    S+  S           +
Sbjct: 287 ELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 346

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGD----IPDNFENLQNLQYLNLYG 152
           +    L                S L  L L+    +      +        +L+ L+L  
Sbjct: 347 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 406

Query: 153 NLLDGEIPEPLFRIL-----GLQYVFLNNNSLSGSIPRNVGDLKE 192
           N L       L   +      L+ + L +   S  +   +  L++
Sbjct: 407 NCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (115), Expect = 2e-06
 Identities = 16/92 (17%), Positives = 30/92 (32%), Gaps = 10/92 (10%)

Query: 72  NVVSFNLSSYGVSGQLGPEI-GHLSKLQTIDLSSNNFSG----NIPPKLGNCSALEYLDL 126
           ++ S ++    +S     E+   L + Q + L     +     +I   L    AL  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 127 STNGFTGDIPDNF-----ENLQNLQYLNLYGN 153
            +N                    +Q L+L   
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 3e-06
 Identities = 13/86 (15%), Positives = 26/86 (30%), Gaps = 5/86 (5%)

Query: 525 SINLTSIDFSSNKFSGLMPQEL-GNLVSLVTLNISLNHVEG----SLPSQLSKCKNLEVF 579
           S+++ S+D    + S     EL   L     + +    +       + S L     L   
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 580 DVSFNLLNGSIPSSLRSWKSLSILKL 605
           ++  N L       +         K+
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 1e-05
 Identities = 17/99 (17%), Positives = 32/99 (32%), Gaps = 9/99 (9%)

Query: 591 PSSLRSWKSLSILKLSENHFTG----GIPTFISELEKLLELQLGGNQLGGEIPPSIG-AL 645
               +    L +L L++   +      +   +     L EL L  N LG      +  ++
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 646 QDLSYA---LNLSKNGLTGRIPSDLEKLSK-LEQLDISS 680
           +        L L     +  +   L+ L K    L + S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 24/148 (16%), Positives = 46/148 (31%), Gaps = 12/148 (8%)

Query: 624 LLELQLGGNQLGGEIPPSI-GALQDLSYALNLSKNGLTGR----IPSDLEKLSKLEQLDI 678
           +  L +   +L       +   LQ     + L   GLT      I S L     L +L++
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQV-VRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 679 SSNNLTGTLSPL------SNIHSLVEVNVSYNLFTGPVPETLMNLLGPSPSSFSGNPSLC 732
            SN L             +    + ++++     TG     L + L   P+    + S  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122

Query: 733 VKCLSSTDSSCFGTSNLRPCDYHSSHQQ 760
           +   +     C G  + +        + 
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEY 150

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 6e-05
 Identities = 16/84 (19%), Positives = 32/84 (38%), Gaps = 6/84 (7%)

Query: 575 NLEVFDVSFNLLNGS-IPSSLRSWKSLSILKLSENHFTG----GIPTFISELEKLLELQL 629
           +++  D+    L+ +     L   +   +++L +   T      I + +     L EL L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 630 GGNQLGGEIPPSIG-ALQDLSYAL 652
             N+LG      +   LQ  S  +
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKI 86

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 2e-04
 Identities = 17/93 (18%), Positives = 31/93 (33%), Gaps = 10/93 (10%)

Query: 213 NCYRLQELYLNENKL----MGFLPESLSNLENLVYLDVGDNNL--EGRINFGS---EKCK 263
               L+ L+L +  +       L  +L    +L  LD+ +N L   G +       +   
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 264 NLTFLDLSYNRFSGGISPNLGNCS-SLTHLDIV 295
            L  L L    +S  +   L         L ++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 16/87 (18%), Positives = 33/87 (37%), Gaps = 9/87 (10%)

Query: 334 CKYLTVLHLYANQLEGE----IPDELGQLSNLQDLELFDNRLTGEFPVSIWRI-----AS 384
              L VL L    +       +   L    +L++L+L +N L     + +          
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 385 LEYLLVYNNNLLGKLPLEMTELKQLKN 411
           LE L++Y+     ++   +  L++ K 
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKP 454

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 15/82 (18%), Positives = 31/82 (37%), Gaps = 10/82 (12%)

Query: 652 LNLSKNGLTGR----IPSDLEKLSKLEQLDISSNNLTGT-----LSPLSNIHSLVEV-NV 701
           L L+   ++      + + L     L +LD+S+N L        +  +     L+E   +
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433

Query: 702 SYNLFTGPVPETLMNLLGPSPS 723
               ++  + + L  L    PS
Sbjct: 434 YDIYWSEEMEDRLQALEKDKPS 455

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.002
 Identities = 19/90 (21%), Positives = 33/90 (36%), Gaps = 10/90 (11%)

Query: 144 NLQYLNLYGN-LLDGEIPEPLFRILGLQYVFLNNNSLSG----SIPRNVGDLKEVEALWL 198
           ++Q L++    L D    E L  +   Q V L++  L+      I   +     +  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 199 FSNRLSGTIPESIG-----NCYRLQELYLN 223
            SN L       +         ++Q+L L 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 58.3 bits (139), Expect = 2e-09
 Identities = 58/339 (17%), Positives = 96/339 (28%), Gaps = 26/339 (7%)

Query: 286 CSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYAN 345
                 L++    L+ S+P    L   L SL  S N L+ ++P      K L V +    
Sbjct: 37  DRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91

Query: 346 QLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTE 405
            L    P           LE           +   + +S   ++  +NN L KLP     
Sbjct: 92  ALSDLPP----------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPP- 140

Query: 406 LKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQN 465
                  +  N        Q+L   +++   +                     +L     
Sbjct: 141 -SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199

Query: 466 QFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNS 525
             + P  + + +   L + +        AL                        +     
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259

Query: 526 INLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNL 585
             L    +  N  S  +        SL  LN+S N +   LP+       LE    SFN 
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNH 315

Query: 586 LNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKL 624
           L   +P      ++L  L +  N      P     +E L
Sbjct: 316 LA-EVPELP---QNLKQLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.9 bits (125), Expect = 1e-07
 Identities = 57/340 (16%), Positives = 89/340 (26%), Gaps = 27/340 (7%)

Query: 334 CKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNN 393
            +    L L    L   +P+      +L+ L    N LT E P       SL+ LLV NN
Sbjct: 37  DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQ---SLKSLLVDNN 88

Query: 394 NLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCF 453
           NL     L            L     S    + L    +   L  I+             
Sbjct: 89  NLKALSDLPP---------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP 139

Query: 454 GKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNN 513
                +          P    L     ++       +L             +++      
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199

Query: 514 ISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKC 573
           +      +   + N           S        N ++ +              +  S  
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259

Query: 574 KNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQ 633
             L       N  +  I S      SL  L +S N     +P     LE+   L    N 
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNH 315

Query: 634 LGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKL 673
           L  E+P     L+     L++  N L    P   E +  L
Sbjct: 316 L-AEVPELPQNLKQ----LHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 3e-07
 Identities = 23/114 (20%), Positives = 37/114 (32%), Gaps = 33/114 (28%)

Query: 249 NNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFG 308
           N     I    +   +L  L++S N+                            +P+   
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-------------------------ELPALPP 304

Query: 309 LLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQ 362
              RL  L  S N L+ ++P        L  LH+  N L  E PD    + +L+
Sbjct: 305 ---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 7e-07
 Identities = 25/140 (17%), Positives = 46/140 (32%), Gaps = 12/140 (8%)

Query: 37  MRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSK 96
           +   N     +        S     V          +          S ++         
Sbjct: 226 LEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPS 285

Query: 97  LQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLD 156
           L+ +++S+N     +P        LE L  S N    ++P   E  QNL+ L++  N L 
Sbjct: 286 LEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVP---ELPQNLKQLHVEYNPLR 337

Query: 157 GEIPEPLFRILGLQYVFLNN 176
            E P+    +  L+   +N+
Sbjct: 338 -EFPDIPESVEDLR---MNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.4 bits (108), Expect = 1e-05
 Identities = 52/338 (15%), Positives = 98/338 (28%), Gaps = 26/338 (7%)

Query: 359 SNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQ 418
               +LEL +  L+   P        LE L+   N+L  +LP      + LK++ + NN 
Sbjct: 38  RQAHELELNNLGLS-SLPELP---PHLESLVASCNSL-TELP---ELPQSLKSLLVDNNN 89

Query: 419 FSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSC 478
                 ++L     L++   ++N+   ++P          +     +    P        
Sbjct: 90  L-----KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144

Query: 479 PTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKF 538
                  L++      LP  +     ++      ++      SI    N+          
Sbjct: 145 IAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPL-SLESIVAGNNILEELPELQNL 203

Query: 539 SGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWK 598
             L      N +     ++  +       +                       +      
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEA---LNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260

Query: 599 SLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNG 658
            L       N  +  I +       L EL +  N+L  E+P     L+ L      S N 
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL----IASFNH 315

Query: 659 LTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSL 696
           L   +P   E    L+QL +  N L        ++  L
Sbjct: 316 LA-EVP---ELPQNLKQLHVEYNPLREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 2e-05
 Identities = 55/332 (16%), Positives = 101/332 (30%), Gaps = 28/332 (8%)

Query: 72  NVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGF 131
                 L++ G+S  L     HL  L     S N+ +  +P    +  +L   + +    
Sbjct: 39  QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

Query: 132 TGDIP---DNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVG 188
           +   P       +   L+ L    N    +I +     L        +     +    + 
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 189 DLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGD 248
           +L E++ L   +   +            L    +     +      L NL  L  +   +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 249 NNLEGRINFGSEKCKNLTFLDLSYNRFSG--------GISPNLGNCSSLTHLDIVGSKLT 300
           N L+   +            +   +                     S L       +  +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 301 GSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSN 360
             I S   L   L  L++S N+L  ++P    +   L  L    N L  E+P+      N
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQ---N 325

Query: 361 LQDLELFDNRLTGEFPVSIWRIASLEYLLVYN 392
           L+ L +  N L  EFP       S+E L + +
Sbjct: 326 LKQLHVEYNPLR-EFPDI---PESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 2e-05
 Identities = 57/336 (16%), Positives = 95/336 (28%), Gaps = 26/336 (7%)

Query: 217 LQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS 276
             EL LN   L   LPE   +LE    L    N+L        E  ++L  L +  N   
Sbjct: 40  AHELELNNLGLSS-LPELPPHLE---SLVASCNSLTEL----PELPQSLKSLLVDNNNL- 90

Query: 277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKY 336
                 L +   L     V +     +P          S     +  +  +         
Sbjct: 91  ----KALSDLPPLLEYLGVSNNQLEKLPELQNS-----SFLKIIDVDNNSLKKLPDLPPS 141

Query: 337 LTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLL 396
           L  +    NQLE     +          +    +   + P+S+  I +   +L     L 
Sbjct: 142 LEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQ 201

Query: 397 GKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQ 456
               L           +L +   S           + +     + +F            +
Sbjct: 202 NLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 261

Query: 457 LRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISG 516
           L       N     I SL    P+L  + +  N+L   LP       L  L  S N+++ 
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR--LERLIASFNHLA- 317

Query: 517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSL 552
            +P    N   L  +    N      P    ++  L
Sbjct: 318 EVPELPQN---LKQLHVEYNPLREF-PDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 1e-04
 Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 9/93 (9%)

Query: 318 LSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPV 377
              N  S +I         L  L++  N+L  E+P        L+ L    N L  E P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPE 321

Query: 378 SIWRIASLEYLLVYNNNLLGKLPLEMTELKQLK 410
                 +L+ L V  N L  + P     ++ L+
Sbjct: 322 L---PQNLKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.6 bits (135), Expect = 3e-09
 Identities = 36/215 (16%), Positives = 56/215 (26%), Gaps = 22/215 (10%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
           L+    I    +N +  +     +   +  L     G T  I    + L NL  L L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDN 73

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFS------------- 200
            +    P      +    +  N      +I                +             
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 201 -NRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGS 259
                  I             YL+           L+NL  L  L   DN +       S
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLAS 193

Query: 260 EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDI 294
               NL  + L  N+ S      L N S+L  + +
Sbjct: 194 --LPNLIEVHLKNNQISD--VSPLANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 4e-08
 Identities = 33/221 (14%), Positives = 65/221 (29%), Gaps = 26/221 (11%)

Query: 67  DDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDL 126
           D    N +        V+  +      L  + T+       +  I   +   + L  L+L
Sbjct: 15  DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70

Query: 127 STNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGS---- 182
             N          +NL  +  L L GN L         + +    +     +        
Sbjct: 71  KDNQI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 183 ------------IPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGF 230
                       I             +L       +    + N  +L  L  ++NK+   
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI 188

Query: 231 LPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLS 271
            P  L++L NL+ + + +N +       +    NL  + L+
Sbjct: 189 SP--LASLPNLIEVHLKNNQISDVSPLAN--TSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 8e-08
 Identities = 28/225 (12%), Positives = 68/225 (30%), Gaps = 17/225 (7%)

Query: 310 LARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
           LA    +   ++ ++  +         +T L  +   +     + +  L+NL  LEL DN
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 370 RLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI 429
           ++T   P+                  L      +  +  +  +             +   
Sbjct: 74  QITDLAPLKNL----------TKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
             + +    +      +I           +  +          + L +   L  +    N
Sbjct: 124 PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 490 QLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFS 534
           +++  +   +  P L  + +  N IS   P  + N+ NL  +  +
Sbjct: 184 KISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 35/223 (15%), Positives = 67/223 (30%), Gaps = 25/223 (11%)

Query: 351 IPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLK 410
            PD    L+N   +    + +T    V+   +  +  L  +   +     ++   L  L 
Sbjct: 13  FPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQY--LNNLI 66

Query: 411 NISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGP 470
            + L +NQ + + P       + ++L          I                 +     
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 471 IPSLLGSCPTLWRVILKQNQLTGA---------------LPEFSKNPVLSHLDVSRNNIS 515
             S L         I   + L G                L   +    L+ L    N IS
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186

Query: 516 GAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNIS 558
              P  + +  NL  +   +N+ S + P  L N  +L  + ++
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 36/223 (16%), Positives = 64/223 (28%), Gaps = 19/223 (8%)

Query: 124 LDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSI 183
           +    +  T  +     +L  +  L+ +G  +     E +  +  L  + L +N ++   
Sbjct: 24  IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA 79

Query: 184 PRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVY 243
           P             L            + N   +  L   +   +     +       + 
Sbjct: 80  PLK----------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129

Query: 244 LDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI 303
                     +I   S          LS           L N S LT L    +K++   
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189

Query: 304 PSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQ 346
           P     L  L  + L  NQ+S   P  L     L ++ L  NQ
Sbjct: 190 P--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL-TNQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 8e-05
 Identities = 26/209 (12%), Positives = 68/209 (32%), Gaps = 20/209 (9%)

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
           +   ++N++  +  +  +   +T++       + +  + +  L +L+ L +  N +    
Sbjct: 24  IAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA 79

Query: 567 PSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLE 626
           P +            +      +I                 +       + +  L   L 
Sbjct: 80  PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139

Query: 627 LQLGGNQLGGEIPPSIGALQ--------DLSYALNL-----SKNGLTGRIPSDLEKLSKL 673
                + L G       ++          L+    L       N ++   P  L  L  L
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNL 197

Query: 674 EQLDISSNNLTGTLSPLSNIHSLVEVNVS 702
            ++ + +N ++  +SPL+N  +L  V ++
Sbjct: 198 IEVHLKNNQISD-VSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.002
 Identities = 8/56 (14%), Positives = 22/56 (39%), Gaps = 3/56 (5%)

Query: 651 ALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLF 706
            +   K+ +T  +      L  +  L      +T T+  +  +++L+ + +  N  
Sbjct: 23  KIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQI 75

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.5 bits (120), Expect = 5e-08
 Identities = 28/126 (22%), Positives = 47/126 (37%), Gaps = 9/126 (7%)

Query: 268 LDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKI 327
           L L++   +  +  +L     +THLD+  ++L    P+    L  L  L  S+N    + 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LEN 57

Query: 328 PPELGKCKYLTVLHLYANQLEG-EIPDELGQLSNLQDLELFDNRLTGEFPVS---IWRIA 383
              +     L  L L  N+L+       L     L  L L  N L  E  +       + 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 384 SLEYLL 389
           S+  +L
Sbjct: 118 SVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.7 bits (118), Expect = 8e-08
 Identities = 29/127 (22%), Positives = 53/127 (41%), Gaps = 12/127 (9%)

Query: 123 YLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGS 182
            L L+    T  +  + E L  + +L+L  N L    P  L  +  L+ +    +  +  
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALE 56

Query: 183 IPRNVGDLKEVEALWLFSNRLSGT-IPESIGNCYRLQELYLNENKLMG------FLPESL 235
               V +L  ++ L L +NRL  +   + + +C RL  L L  N L         L E L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 236 SNLENLV 242
            ++ +++
Sbjct: 117 PSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.9 bits (116), Expect = 2e-07
 Identities = 31/126 (24%), Positives = 45/126 (35%), Gaps = 9/126 (7%)

Query: 243 YLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGS 302
            L +   +L    +    +   +T LDLS+NR    + P L     L  L    + L   
Sbjct: 2   VLHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-- 56

Query: 303 IPSSFGLLARLSSLDLSENQL-SGKIPPELGKCKYLTVLHLYANQL---EGEIPDELGQL 358
                  L RL  L L  N+L        L  C  L +L+L  N L   EG        L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 359 SNLQDL 364
            ++  +
Sbjct: 117 PSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 23/123 (18%), Positives = 40/123 (32%), Gaps = 8/123 (6%)

Query: 316 LDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEF 375
           L L+   L+  +   L +   +T L L  N+L    P     L+ L+ LE+         
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALE 56

Query: 376 PVSIWRIASLEYLLVYNNNLLGKLPL--EMTELKQLKNISLYNNQFSGVIPQSLGINSSL 433
            V           L+  NN L +      +    +L  ++L  N           +   L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 434 MQL 436
             +
Sbjct: 117 PSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 6/110 (5%)

Query: 218 QELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG 277
           + L+L    L       L  L  + +LD+  N L           + L  L    +  + 
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNAL 55

Query: 278 GISPNLGNCSSLTHLDIVGSKLTG-SIPSSFGLLARLSSLDLSENQLSGK 326
                + N   L  L +  ++L   +         RL  L+L  N L  +
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 42.8 bits (100), Expect = 2e-05
 Identities = 20/121 (16%), Positives = 35/121 (28%), Gaps = 7/121 (5%)

Query: 578 VFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGE 637
           V  ++   L  ++   L     ++ L LS N      P        L  L++        
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPAL----AALRCLEVLQASDNAL 55

Query: 638 IPPSIGALQDLSYALNLSKNGLTG-RIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSL 696
                 A       L L  N L        L    +L  L++  N+L         +  +
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 697 V 697
           +
Sbjct: 116 L 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 1e-04
 Identities = 22/114 (19%), Positives = 40/114 (35%), Gaps = 7/114 (6%)

Query: 486 LKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQE 545
           L    LT  L    +  +++HLD+S N +    P ++     L  +  S N    +    
Sbjct: 5   LAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVA 62

Query: 546 LGNLVSLVTLNISLNHVEG-SLPSQLSKCKNLEVFDVSFNLLNG--SIPSSLRS 596
               +    L +  N ++  +    L  C  L + ++  N L     I   L  
Sbjct: 63  NLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 27/94 (28%), Positives = 34/94 (36%), Gaps = 4/94 (4%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYL 148
             +  L  +  +DLS N      PP L     LE L    +    +  D   NL  LQ L
Sbjct: 14  CHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ--ASDNALENVDGVANLPRLQEL 70

Query: 149 NLYGNLL-DGEIPEPLFRILGLQYVFLNNNSLSG 181
            L  N L      +PL     L  + L  NSL  
Sbjct: 71  LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.4 bits (86), Expect = 0.002
 Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 14/99 (14%)

Query: 652 LNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNVSYNLFTGPVP 711
           L+L+   LT  +   LE+L  +  LD+S N L      L+ +  L  +  S N       
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 712 ETLM----------NLL--GPSPSSFSGNPSLCVKCLSS 738
              +          N L    +       P L +  L  
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 99

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 53.3 bits (126), Expect = 8e-08
 Identities = 35/338 (10%), Positives = 93/338 (27%), Gaps = 30/338 (8%)

Query: 313 LSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGE----IPDELGQLSNLQDLELFD 368
           L    ++       +   L +   +  + L  N +  E    + + +    +L+  E  D
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 369 N---RLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQ 425
               R+  E P ++  +          + +           ++     L  +     +  
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 426 SLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVI 485
                                +         LR +  G+N+                R+ 
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL- 187

Query: 486 LKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQE 545
                    L            +   + +   +       +     +  ++  S  +   
Sbjct: 188 ---------LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238

Query: 546 LGNLVSLVTLNISLNHVEG----SLPSQLSKCKN--LEVFDVSFNLLNGSIPSSLRSW-- 597
           L +  +L  L ++   +      ++    SK +N  L+   + +N +      +L++   
Sbjct: 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298

Query: 598 ---KSLSILKLSENHFTGGIPTFISELEKLLELQLGGN 632
                L  L+L+ N F       + E+ ++   +  G 
Sbjct: 299 EKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.8 bits (122), Expect = 2e-07
 Identities = 35/334 (10%), Positives = 83/334 (24%), Gaps = 31/334 (9%)

Query: 239 ENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSG----GISPNLGNCSSLTHLDI 294
           ++L    +   + +        +  ++  + LS N         +S N+ +   L   + 
Sbjct: 8   KSLKLDAITTEDEKSVFA-VLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 295 VGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE 354
                          L  L    L   +L      +           +        +   
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 355 LGQLSNLQDLELFDNRLTGEFPVSIWRIA--SLEYLLVYNNNLLGKLPLEMTELKQLKNI 412
               + L            +      +         ++   N L    ++        + 
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 413 SLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIP 472
            L+  +               ++ + I +     +             N   +     + 
Sbjct: 187 LLHTVKMVQNG----------IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236

Query: 473 SLLGSCPTLWRVILKQNQLTGALPE-------FSKNPVLSHLDVSRNNISGAIPSSIGNS 525
             L S P L  + L    L+              +N  L  L +  N I      ++   
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296

Query: 526 I-----NLTSIDFSSNKFS--GLMPQELGNLVSL 552
           I     +L  ++ + N+FS    +  E+  + S 
Sbjct: 297 IDEKMPDLLFLELNGNRFSEEDDVVDEIREVFST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.0 bits (120), Expect = 4e-07
 Identities = 45/322 (13%), Positives = 97/322 (30%), Gaps = 32/322 (9%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGD----IPDNFENLQNLQYLNL 150
            K   +D  +     ++   L    +++ + LS N    +    + +N  + ++L+    
Sbjct: 7   GKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 151 YGN---LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTI 207
                  +  EIPE L  +L         +++  S        +E    +L  +     +
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 208 PESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE----GRINFGSEKCK 263
                         +        + +   N   L  +  G N LE           +  +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 264 NLTFLDLSYNRFSG---------GISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLS 314
            L  + +  N             G++            +      + ++  +      L 
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 315 SLDLSENQLSGKIPPELGKC------KYLTVLHLYANQLEGEIPDEL-----GQLSNLQD 363
            L L++  LS +    +           L  L L  N++E +    L      ++ +L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 364 LELFDNRLTGEFPVSIWRIASL 385
           LEL  NR + E    +  I  +
Sbjct: 307 LELNGNRFSEE-DDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 44/322 (13%), Positives = 90/322 (27%), Gaps = 42/322 (13%)

Query: 86  QLGPEIGHLSKLQTIDLSSNNFSGN----IPPKLGNCSALEYLDLSTNG---FTGDIPDN 138
            +   +     ++ I LS N         +   + +   LE  + S         +IP+ 
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 139 FENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWL 198
              L          + +                 FL+ ++    +  +   L       +
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 199 FSNRLSGTIPESIGNCYRLQELYLNENKL----MGFLPESLSNLENLVYLDVGDNNLEGR 254
                   + +   N   L+ +    N+L    M    ++  +   L  + +  N +   
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201

Query: 255 INFGSEKCKNLTFLDLSYNRFS---------GGISPNLGNCSSLTHLDIVGSKLTGSIPS 305
                         +L                 ++  L +  +L  L +    L+    +
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261

Query: 306 ------SFGLLARLSSLDLSENQLSGKIPPEL-----GKCKYLTVLHLYANQL--EGEIP 352
                 S      L +L L  N++       L      K   L  L L  N+   E ++ 
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV 321

Query: 353 DEL---------GQLSNLQDLE 365
           DE+         G+L  L D+E
Sbjct: 322 DEIREVFSTRGRGELDELDDME 343

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.7 bits (101), Expect = 8e-05
 Identities = 20/132 (15%), Positives = 38/132 (28%), Gaps = 11/132 (8%)

Query: 36  LMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGP-EIGHL 94
           L               ++       W  +             LS+ G +  +        
Sbjct: 217 LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC----LLSARGAAAVVDAFSKLEN 272

Query: 95  SKLQTIDLSSNNFSGNIPPKL-----GNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLN 149
             LQT+ L  N    +    L          L +L+L+ N F  +  D  + ++ +    
Sbjct: 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTR 331

Query: 150 LYGNLLDGEIPE 161
             G L + +  E
Sbjct: 332 GRGELDELDDME 343

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 0.001
 Identities = 38/328 (11%), Positives = 90/328 (27%), Gaps = 33/328 (10%)

Query: 121 LEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILG----LQYVFLNN 176
           L+   ++T      +        +++ + L GN +  E    L   +     L+    ++
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 177 NS---LSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPE 233
                +   IP  +  L +        + +  +              +L+++  +  L  
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 234 SLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNC------- 286
             + L       +     E  +N  ++    L  +    NR   G               
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 287 ------SSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVL 340
                  +    + +   L   +     L       +   +  S  +   L     L  L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 341 HLYANQLEGEIPDELGQ------LSNLQDLELFDNRLTGEFPVSIWRIA-----SLEYLL 389
            L    L       +           LQ L L  N +  +   ++  +       L +L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 390 VYNNNLLGKLPLEMTELKQLKNISLYNN 417
           + N N   +    + E++++ +      
Sbjct: 309 L-NGNRFSEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 38/325 (11%), Positives = 77/325 (23%), Gaps = 32/325 (9%)

Query: 405 ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGE----IPPNLCFGKQLRVL 460
           E K LK  ++        +   L  + S+ ++    N+   E    +  N+   K L + 
Sbjct: 6   EGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 461 NMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPS 520
                        +  +   L + +LK  +L       +     +   +           
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124

Query: 521 SIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL--------PSQLSK 572
            +    N       +     L    +           S+      L              
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184

Query: 573 CKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFT---------GGIPTFISELEK 623
            + L    +  N +       L         +L                 +   +     
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244

Query: 624 LLELQLGGNQLGGEIPPSIGALQDLSYA-----LNLSKNGLTGRIPSDL-----EKLSKL 673
           L EL L    L      ++              L L  N +       L     EK+  L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304

Query: 674 EQLDISSNNLTGTLSPLSNIHSLVE 698
             L+++ N  +     +  I  +  
Sbjct: 305 LFLELNGNRFSEEDDVVDEIREVFS 329

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 1e-06
 Identities = 27/236 (11%), Positives = 58/236 (24%), Gaps = 10/236 (4%)

Query: 98  QTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDG 157
           +      +  +  IP  L        L              F    +L+ + +  N +  
Sbjct: 11  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 158 EIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNR--LSGTIPESIGNCY 215
            I   +F  L   +      + +                +L  +   +         +  
Sbjct: 68  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127

Query: 216 RLQELYLNE--NKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
           +   L + +  N         +      V L +  N ++   N      +         N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187

Query: 274 RFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPP 329
                 +      S    LDI  +++          L +L +       L  K+P 
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 4e-05
 Identities = 29/239 (12%), Positives = 59/239 (24%), Gaps = 8/239 (3%)

Query: 112 PPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQY 171
             ++ +CS         +  T +IP +    +N   L      L             L+ 
Sbjct: 2   HHRICHCS-NRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 57

Query: 172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFL 231
           + ++ N +   I  +V                +                YL  +      
Sbjct: 58  IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117

Query: 232 PESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTF----LDLSYNRFSGGISPNLGNCS 287
              +  + +L  + +   +              L+F    L L+ N      +       
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177

Query: 288 SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQ 346
                    + L       F   +    LD+S  ++       L   K L     Y  +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (101), Expect = 6e-05
 Identities = 15/121 (12%), Positives = 27/121 (22%)

Query: 33  LLSLMRHWNSVPPLIISSWNSSDSTPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIG 92
           +  L           +      +              +   V   L+  G+         
Sbjct: 115 IKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN 174

Query: 93  HLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYG 152
                +     +NN            S    LD+S            ENL+ L+  + Y 
Sbjct: 175 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234

Query: 153 N 153
            
Sbjct: 235 L 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 7e-05
 Identities = 33/233 (14%), Positives = 71/233 (30%), Gaps = 10/233 (4%)

Query: 172 VFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFL 231
                + ++  IP ++   +    L     +L      +      L+++ +++N ++  +
Sbjct: 13  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69

Query: 232 PESLSNLENLVYLDVGD--NNLEGRINFGSEKCKNLTFLDLSYNRFSGGI--SPNLGNCS 287
              + +    ++    +  NNL        +   NL +L +S                  
Sbjct: 70  EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129

Query: 288 SLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQL 347
            L  +    +  T    S  GL      L L++N +           +   +     N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189

Query: 348 EGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLP 400
           E    D     S    L++   R+       +  +  L      +   L KLP
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR---STYNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 30/229 (13%), Positives = 68/229 (29%), Gaps = 8/229 (3%)

Query: 314 SSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNR--- 370
                 E++++ +IP +L   +    L     +L            +L+ +E+  N    
Sbjct: 11  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 371 -LTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI 429
            +  +   ++ ++  +      N   +     +     Q   IS    +    + +   +
Sbjct: 68  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
              L+ +    N  T E    +    +  +L + +N                   +   N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187

Query: 490 QLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNK 537
            L     + F        LD+SR  I       + N   L +    + K
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (97), Expect = 2e-04
 Identities = 29/215 (13%), Positives = 57/215 (26%), Gaps = 7/215 (3%)

Query: 95  SKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNL 154
                +                    LE +++S N     I  +  +     +       
Sbjct: 29  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88

Query: 155 LDGEIPEPLFRILGLQYVFLNNNSLS----GSIPRNVGDLKEVEALWLFSNRLSGTIPES 210
            +     P          +L  ++        + +     K +  +    N  +      
Sbjct: 89  NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148

Query: 211 IGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDL 270
           +G  +    L+LN+N +      + +  +        +NNLE   N           LD+
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208

Query: 271 SYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPS 305
           S  R     S  L N   L        K    +P+
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 6e-04
 Identities = 32/236 (13%), Positives = 65/236 (27%), Gaps = 11/236 (4%)

Query: 338 TVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLG 397
            V     +++  EIP +L    N  +L     +L      +      LE + +  N++L 
Sbjct: 11  RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67

Query: 398 KLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINN--SFTGEIPPNLCFGK 455
            +  ++       +        + +        +       + +          +     
Sbjct: 68  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127

Query: 456 QLRVLNMGQNQFHGPIPSLLGSCPTLWRVIL---KQNQLTGALPEFSKNPVLSHLDVSRN 512
           Q  +L++  N     I        +   VIL   K          F+   +        N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187

Query: 513 NISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPS 568
           N+          +     +D S  +   L    L NL  L   +         LP+
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL---KKLPT 240

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 25/201 (12%), Positives = 56/201 (27%), Gaps = 16/201 (7%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
            ++    +L   + +  +       ++++ +  + +          + L N+  L L GN
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
            L          +  L+ +       +     +     +        +     I   +  
Sbjct: 79  KLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133

Query: 214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYN 273
                    N       +   L+ L+ L      DN +   +         L  L LS N
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSL---EDNQISDIVPLA--GLTKLQNLYLSKN 188

Query: 274 RFSGGISPNLGNCSSLTHLDI 294
             S      L    +L  L++
Sbjct: 189 HISD--LRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 6e-06
 Identities = 25/200 (12%), Positives = 65/200 (32%), Gaps = 23/200 (11%)

Query: 351 IPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLK 410
             D+    +      L    +T    V+   + S++ ++  N+++     ++   L  + 
Sbjct: 18  FSDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQY--LPNVT 71

Query: 411 NISLYNNQFSGVIPQS---------------LGINSSLMQLDFINNSFTGEIPPNLCFGK 455
            + L  N+ + + P +                 ++S        + S       ++    
Sbjct: 72  KLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131

Query: 456 QLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNIS 515
            L  L       +      + S  T    +  ++     +   +    L +L +S+N+IS
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS 191

Query: 516 GAIPSSIGNSINLTSIDFSS 535
                ++    NL  ++  S
Sbjct: 192 D--LRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 40/216 (18%), Positives = 71/216 (32%), Gaps = 32/216 (14%)

Query: 174 LNNNSLSGSIPRNVGD------LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKL 227
           L + +++  +P  +          E     L    ++  + ++      + ++  N + +
Sbjct: 3   LGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI 58

Query: 228 MGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD----------------LS 271
                  +  L N+  L +  N L       + K     FLD                 S
Sbjct: 59  KSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS 116

Query: 272 YNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPEL 331
            +    GIS   G         +       +  +    L +L +L L +NQ+S  +P  L
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--L 174

Query: 332 GKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELF 367
                L  L+L  N +       L  L NL  LELF
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 3e-05
 Identities = 27/201 (13%), Positives = 61/201 (30%), Gaps = 15/201 (7%)

Query: 310 LARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDN 369
            A     +L +  ++  +     +   +  +    + ++      +  L N+  L L  N
Sbjct: 23  FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 370 RLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI 429
           +LT      I  +A+L+ L     +      L   +  +        +     I   + +
Sbjct: 79  KLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133

Query: 430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQN 489
                     N      +   L     L + +    Q    +P  L     L  + L +N
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDN---QISDIVP--LAGLTKLQNLYLSKN 188

Query: 490 QLTGALPEFSKNPVLSHLDVS 510
            ++  L   +    L  L++ 
Sbjct: 189 HISD-LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.8 bits (102), Expect = 4e-05
 Identities = 34/189 (17%), Positives = 70/189 (37%), Gaps = 25/189 (13%)

Query: 174 LNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPE 233
           L   S++ ++ +N  +L  ++ +   ++ +       I     + +L+LN NKL    P 
Sbjct: 31  LKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPL 86

Query: 234 S---------LSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLG 284
           +         L   +      + D      ++       ++  L       S  +  N  
Sbjct: 87  ANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKI 146

Query: 285 -------NCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYL 337
                    + L  L +  ++++  +P     L +L +L LS+N +S      L   K L
Sbjct: 147 TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNL 202

Query: 338 TVLHLYANQ 346
            VL L+ +Q
Sbjct: 203 DVLELF-SQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 27/179 (15%), Positives = 63/179 (35%), Gaps = 14/179 (7%)

Query: 68  DDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLS 127
           ++ +++     ++  +    G  I +L  +  + L+ N  +          + L+ L   
Sbjct: 43  NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK-----PLANLKNLGWL 95

Query: 128 TNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNV 187
                     +              +    +I   +           NN          +
Sbjct: 96  FLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITD---ITVL 152

Query: 188 GDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDV 246
             L +++ L L  N++S  +P  +    +LQ LYL++N +      +L+ L+NL  L++
Sbjct: 153 SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 25/196 (12%), Positives = 63/196 (32%), Gaps = 16/196 (8%)

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
            ++ + +++ A+  +     ++  I  +++    +    +  L ++  L ++ N +    
Sbjct: 29  DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDI- 83

Query: 567 PSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLE 626
                   NL+     F   N     S             E++    I   +   +    
Sbjct: 84  ----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139

Query: 627 LQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGT 686
                      +         L+    LS           L  L+KL+ L +S N+++  
Sbjct: 140 YLGNNKITDITVL------SRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-D 192

Query: 687 LSPLSNIHSLVEVNVS 702
           L  L+ + +L  + + 
Sbjct: 193 LRALAGLKNLDVLELF 208

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (106), Expect = 7e-06
 Identities = 21/137 (15%), Positives = 38/137 (27%), Gaps = 7/137 (5%)

Query: 113 PKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYV 172
            +  N      LDL        I +    L     ++   N +      PL R   L+ +
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRR--LKTL 68

Query: 173 FLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLP 232
            +NNN +          L ++  L L +N L            +           +    
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 233 ----ESLSNLENLVYLD 245
                 +  +  +  LD
Sbjct: 129 HYRLYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 19/93 (20%), Positives = 37/93 (39%), Gaps = 3/93 (3%)

Query: 280 SPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTV 339
           +    N      LD+ G K+   I +    L +  ++D S+N++  +        + L  
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67

Query: 340 LHLYANQLEGEIPDELGQLSNLQDLELFDNRLT 372
           L +  N++          L +L +L L +N L 
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.003
 Identities = 27/140 (19%), Positives = 51/140 (36%), Gaps = 4/140 (2%)

Query: 490 QLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNL 549
           +L     +++       LD+    I   I +         +IDFS N+   L       L
Sbjct: 6   ELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LL 62

Query: 550 VSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVS-FNLLNGSIPSSLRSWKSLSILKLSEN 608
             L TL ++ N +            +L    ++  +L+       L S KSL+ L +  N
Sbjct: 63  RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122

Query: 609 HFTGGIPTFISELEKLLELQ 628
             T      +  + K+ +++
Sbjct: 123 PVTNKKHYRLYVIYKVPQVR 142

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 2e-05
 Identities = 23/155 (14%), Positives = 46/155 (29%), Gaps = 4/155 (2%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDN-FENLQNLQY 147
           P+         +  + +    +    L     L  L +        +       L  L+ 
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 148 LNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTI 207
           L +  + L    P+       L  + L+ N+L  S+         ++ L L  N L  + 
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119

Query: 208 -PESIGNCYRLQELYLNENKLMGFLPESLSNLENL 241
               +          + E KL       L+++ N 
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 0.001
 Identities = 25/134 (18%), Positives = 41/134 (30%), Gaps = 3/134 (2%)

Query: 200 SNRLSGTIPESIGNCYRLQELYLNENKLMGFLP-ESLSNLENLVYLDVGDNNLEGRINFG 258
           +   +      +     L ELY+   + +  L    L  L  L  L +  + L       
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 259 SEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI-PSSFGLLARLSSLD 317
                 L+ L+LS+N     +S       SL  L + G+ L  S                
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGG 134

Query: 318 LSENQLSGKIPPEL 331
           + E +L       L
Sbjct: 135 VPEQKLQCHGQGPL 148

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.002
 Identities = 19/148 (12%), Positives = 36/148 (24%), Gaps = 2/148 (1%)

Query: 281 PNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPEL-GKCKYLTV 339
           P+       + L                    L+ L +   Q    +          L  
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 340 LHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKL 399
           L +  + L    PD       L  L L  N L      ++  ++  E +L  N       
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120

Query: 400 PLEMTELKQLKNISLYNNQFSGVIPQSL 427
              +   ++     +   +        L
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPL 148

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 24/189 (12%), Positives = 58/189 (30%), Gaps = 20/189 (10%)

Query: 190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDN 249
           L E     L    ++ T+ ++  +  ++  L  +   +     + +  L NL  ++  +N
Sbjct: 17  LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72

Query: 250 NLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGL 309
            L       +        ++ +       ++            + +         ++   
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132

Query: 310 LARLSSLDLSENQLSGKI--------------PPELGKCKYLTVLHLYANQLEGEIPDEL 355
           L   S+     + LSG                   L     L  L + +N++       L
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190

Query: 356 GQLSNLQDL 364
            +L+NL+ L
Sbjct: 191 AKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.2 bits (95), Expect = 3e-04
 Identities = 34/195 (17%), Positives = 52/195 (26%), Gaps = 32/195 (16%)

Query: 94  LSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGN 153
           L++     L   N +  +     +   +  L     G    I D  E L NL  +N   N
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 72

Query: 154 LLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGN 213
            L           L      ++    +  I              L       T  + + N
Sbjct: 73  QLTD------ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 126

Query: 214 CYRLQELYLNENKLMGFL--------------------PESLSNLENLVYLDVGDNNLEG 253
              L  L L+ N +                         + L+NL  L  LD+  N +  
Sbjct: 127 LTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD 186

Query: 254 RINFGSEKCKNLTFL 268
                  K  NL  L
Sbjct: 187 ISVLA--KLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.002
 Identities = 28/190 (14%), Positives = 63/190 (33%), Gaps = 16/190 (8%)

Query: 507 LDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSL 566
             + + N++  +  +  +   +T++         +    +  L +L  +N S N +    
Sbjct: 23  TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT 78

Query: 567 PSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLE 626
           P +        + + +       + +             +  +        +  L  L  
Sbjct: 79  PLKNLTKLVDILMNNNQIADITPLANLTNLTGL------TLFNNQITDIDPLKNLTNLNR 132

Query: 627 LQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGT 686
           L+L  N +      S           +     L       L  L+ LE+LDISSN ++  
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDL-----KPLANLTTLERLDISSNKVSD- 186

Query: 687 LSPLSNIHSL 696
           +S L+ + +L
Sbjct: 187 ISVLAKLTNL 196

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.9 bits (89), Expect = 0.002
 Identities = 26/192 (13%), Positives = 50/192 (26%), Gaps = 20/192 (10%)

Query: 67  DDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDL 126
           D      +   L    V+         L ++ T+         +I   +   + L  ++ 
Sbjct: 14  DTALAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINF 69

Query: 127 STNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRN 186
           S N  T   P           +N         +           +     +        N
Sbjct: 70  SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129

Query: 187 VGDLKEVEAL--------------WLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLP 232
           +  L+                    L  +    T  + + N   L+ L ++ NK+     
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--I 187

Query: 233 ESLSNLENLVYL 244
             L+ L NL  L
Sbjct: 188 SVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 36/205 (17%), Positives = 60/205 (29%), Gaps = 17/205 (8%)

Query: 351 IPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLK 410
             D    L+      L    +T    VS   +  +  L      +     +E   L  L 
Sbjct: 12  FTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSIDGVE--YLNNLT 65

Query: 411 NISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGP 470
            I+  NNQ + + P         + ++    +    +             N   +     
Sbjct: 66  QINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 125

Query: 471 IPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTS 530
             + L         I             S    L  L+ S N ++   P  + N   L  
Sbjct: 126 NLTNLNRLELSSNTISDI-------SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLER 176

Query: 531 IDFSSNKFSGLMPQELGNLVSLVTL 555
           +D SSNK S +    L  L +L +L
Sbjct: 177 LDISSNKVSDI--SVLAKLTNLESL 199

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 43.5 bits (101), Expect = 5e-05
 Identities = 31/168 (18%), Positives = 55/168 (32%), Gaps = 20/168 (11%)

Query: 94  LSKLQTIDLSSNNFSGNIPP------KLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQY 147
              +   +       G IPP       L    A ++L LSTN     I  +   ++NL+ 
Sbjct: 17  RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRI 74

Query: 148 LNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTI 207
           L+L  N    +  E L  +         + +   S+      +         +   +   
Sbjct: 75  LSLGRN--LIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGE 132

Query: 208 PESIGNCYRLQELYLNENKLMGFLPES----------LSNLENLVYLD 245
            + +    +L++L L  N L     E+          +  L NL  LD
Sbjct: 133 IDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (97), Expect = 1e-04
 Identities = 29/168 (17%), Positives = 45/168 (26%), Gaps = 29/168 (17%)

Query: 207 IPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLT 266
           +   +   Y   +  L+   L       L      V L+   +++   +    E    L 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELL 68

Query: 267 FLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGK 326
            L+LS NR                            + S       L  L+LS N+L  +
Sbjct: 69  SLNLSNNRLYR----------------------LDDMSSIVQKAPNLKILNLSGNELKSE 106

Query: 327 IPPELGKCKYLTVLHLYANQLEGEIPDELGQ----LSNLQDLELFDNR 370
              +  K   L  L L  N L     D+             L   D  
Sbjct: 107 RELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGH 154

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 1e-04
 Identities = 24/107 (22%), Positives = 45/107 (42%), Gaps = 3/107 (2%)

Query: 89  PEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTG--DIPDNFENLQNLQ 146
           P++   +    ++   ++ +  +     N   L  L+LS N      D+    +   NL+
Sbjct: 36  PDLVAQNIDVVLNRR-SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94

Query: 147 YLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEV 193
            LNL GN L  E      + L L+ ++L+ NSLS +       +  +
Sbjct: 95  ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 0.001
 Identities = 26/116 (22%), Positives = 44/116 (37%), Gaps = 7/116 (6%)

Query: 96  KLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLL 155
             Q +DL          P L   +    L+  ++     +    EN+  L  LNL  N L
Sbjct: 23  SQQALDLKGLRS----DPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRL 77

Query: 156 DG--EIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPE 209
               ++   + +   L+ + L+ N L      +     ++E LWL  N LS T  +
Sbjct: 78  YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 30/166 (18%), Positives = 59/166 (35%), Gaps = 7/166 (4%)

Query: 231 LPESLSNLENLVYLDVGDNNLEGRINFGSE-KCKNLTFLDLSYNRFSGGISPNLGNCSSL 289
           +P  +    +   L + DN L    + G   +  +L  L+L  N+ +G         S +
Sbjct: 23  IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80

Query: 290 THLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG 349
             L +  +K+       F  L +L +L+L +NQ+S  +P        LT L+  A+    
Sbjct: 81  QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFN 139

Query: 350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNL 395
                      L+   L         P     +  ++   + ++  
Sbjct: 140 CNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1109
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.93
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.87
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.87
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.82
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.82
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.81
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.73
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.73
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.72
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.72
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.72
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.71
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.69
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.68
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.67
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.47
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.47
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.44
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.44
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.44
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.42
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.31
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.27
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.26
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.15
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.32
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.28
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.06
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.58
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.35
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.34
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.07
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.32
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.21
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.98
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.2
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.96

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=417.76  Aligned_cols=260  Identities=27%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|.+.++||+|+||+||+|+.+.  .||||++.... .....+.|.+|++++++++|||||++++++.+ +..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence            578899999999999999998653  59999985443 33445689999999999999999999998754 568999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.++++...  ..+++..+..++.|+++||+|||   +++||||||||+|||++.++.+||+|||+|+.......
T Consensus        85 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          85 CEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             CCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             CCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            99999999997643  35899999999999999999999   88999999999999999999999999999987755444


Q ss_pred             CceeeecccCccccccccccc---CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          978 STTSISVVGTIGYIAPENAFT---TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ........||+.|+|||++.+   ..|+.++|||||||++|||+||+.||...... ..+...+.....         .+
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-~~~~~~~~~~~~---------~p  229 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIFMVGRGYL---------SP  229 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-HHHHHHHHHTSC---------CC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-HHHHHHHhcCCC---------CC
Confidence            444455689999999998864   35799999999999999999999999643221 111111111110         00


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                      ....     .......++.+++.+||+.||++||||+|++++|+.+.
T Consensus       230 ~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         230 DLSK-----VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             CGGG-----SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchh-----ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            0000     01122345677888999999999999999999998763

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=415.75  Aligned_cols=256  Identities=24%  Similarity=0.319  Sum_probs=203.5

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5788899999999999999977 468999999996655444556789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+|+.......
T Consensus        85 ~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999987533   4899999999999999999999   89999999999999999999999999999997754433


Q ss_pred             CceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                      .......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+.    ......    .   
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~----~~~~~~----~---  227 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTYL----N---  227 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH----TTCTTS----T---
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCC----C---
Confidence            333445689999999999988876 6789999999999999999999965432221111111    000000    0   


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                          .....   ..++.+++.+||+.||++|||++|+++|=+
T Consensus       228 ----~~~~~---s~~~~~li~~~L~~dP~~R~t~~eil~hpw  262 (271)
T d1nvra_         228 ----PWKKI---DSAPLALLHKILVENPSARITIPDIKKDRW  262 (271)
T ss_dssp             ----TGGGS---CHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             ----ccccC---CHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence                00011   234556778999999999999999998743

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-47  Score=412.18  Aligned_cols=255  Identities=22%  Similarity=0.357  Sum_probs=198.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|+..+.||+|+||+||+|.+.+++.||||++..  .....++|.+|++++++++|||||+++|+|...+..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCS--SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECC--CcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46778899999999999999998899999999853  3344578999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++....  ..++|+.++.++.|+|+||+|||   +.+|+||||||+||++++++.+||+|||+|+....... 
T Consensus        83 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  156 (263)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence            9999999987643  45899999999999999999999   89999999999999999999999999999987654322 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      .......||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ..+...+.....       ...+    
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~-------~~~p----  224 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFR-------LYKP----  224 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTCC-------CCCC----
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhcCC-------CCCc----
Confidence            2233467999999999999999999999999999999999966555433211 122222211110       0011    


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .....++.+++.+||+.||++||||+|++++|+++
T Consensus       225 -------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         225 -------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                   11123567788899999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-46  Score=416.58  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=195.4

Q ss_pred             CCCCCceeecccCeEEEEEEeCC-C---cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          820 NLNAKHVIGRGAHGIVYKASLGP-N---AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +|+..++||+|+||+||+|++.. +   ..||||++.........++|.+|++++++++|||||+++|+|...+..++||
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~  106 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT  106 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            45556899999999999997742 2   3588998865555555678999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....  ..++|.++.+++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus       107 Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         107 EFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             ECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            9999999999887643  35899999999999999999999   899999999999999999999999999999877543


Q ss_pred             CCCc---eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          976 PAST---TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       976 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      ....   ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.....  .++...+..   ... .   
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--~~~~~~i~~---~~~-~---  252 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--QDVINAIEQ---DYR-L---  252 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHT---TCC-C---
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CCC-C---
Confidence            3222   2223568999999999999999999999999999999998 8988864321  122222211   100 0   


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                       .          ...+...++.+++.+||+.||++||||+|++++|+++
T Consensus       253 -~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         253 -P----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             -C----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -C----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             0          0111234466788899999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-46  Score=401.01  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=204.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++....  .......+.+|++++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999774 68999999985432  2334567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++....   .+++..+..++.|+++||+|||   +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999998654   3899999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .    .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ...............+     
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~~p~-----  225 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRVEFTFPD-----  225 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCCCCCT-----
T ss_pred             c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCCCc-----
Confidence            2    2346899999999999999999999999999999999999999964321     1112211111111110     


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                              ..   ..++.+++.+|++.||++|||++|+++|=
T Consensus       226 --------~~---s~~~~~li~~~L~~dp~~R~t~~eil~hp  256 (263)
T d2j4za1         226 --------FV---TEGARDLISRLLKHNPSQRPMLREVLEHP  256 (263)
T ss_dssp             --------TS---CHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred             --------cC---CHHHHHHHHHHccCCHhHCcCHHHHHcCc
Confidence                    11   23455677899999999999999999853

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-46  Score=400.47  Aligned_cols=254  Identities=19%  Similarity=0.320  Sum_probs=210.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|+..++||+|+||+||+|++++++.||||++...  .....+|.+|++++++++|||||+++|+|.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC--cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            578899999999999999999998999999998543  334568999999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|++.+++....  ..+++..+++++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++....... 
T Consensus        82 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-  155 (258)
T d1k2pa_          82 ANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  155 (258)
T ss_dssp             TTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred             CCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence            9999999976543  34889999999999999999999   88999999999999999999999999999987654432 


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                      .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....  .++...+.   ...    ....+.  
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--~~~~~~i~---~~~----~~~~p~--  224 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIA---QGL----RLYRPH--  224 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHH---TTC----CCCCCT--
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH--HHHHHHHH---hCC----CCCCcc--
Confidence            23344679999999999999999999999999999999998 7888865422  12222111   110    000111  


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                               ....++.+++.+||+.||++|||++|++++|.++
T Consensus       225 ---------~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         225 ---------LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             ---------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ---------cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                     1123567788899999999999999999999764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-46  Score=407.10  Aligned_cols=251  Identities=21%  Similarity=0.324  Sum_probs=204.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|+..+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG-GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc-cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4799999999999999999976 56899999998543 334456799999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus        99 ~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1          99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             cCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            9999999988753    3899999999999999999999   89999999999999999999999999999997754322


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLM 1057 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 1057 (1109)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+........   .   ....    
T Consensus       172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~---~---~~~~----  238 (293)
T d1yhwa1         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGT---P---ELQN----  238 (293)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCS---C---CCSS----
T ss_pred             --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCC---C---CCCC----
Confidence              223467999999999999999999999999999999999999999643211 11111111100   0   0000    


Q ss_pred             HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1058 EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1058 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                             ......++.+++.+||+.||++|||++|+++|=
T Consensus       239 -------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp  271 (293)
T d1yhwa1         239 -------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (293)
T ss_dssp             -------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred             -------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence                   011123455678899999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-46  Score=412.66  Aligned_cols=259  Identities=23%  Similarity=0.326  Sum_probs=210.6

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|+..+.||+|+||+||+|.+. +++.||||++..  .....++|.+|++++++++|||||+++++|.+++..++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT--TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECC--ccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            357888899999999999999775 588999998843  33456789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+++|+|.+++.... ...+++..+..++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        94 ~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             cccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            999999999997643 346899999999999999999999   8899999999999999999999999999999765432


Q ss_pred             CCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                       ........||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ..+...+....    ..      . 
T Consensus       170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~~~----~~------~-  236 (287)
T d1opja_         170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDY----RM------E-  236 (287)
T ss_dssp             -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTC----CC------C-
T ss_pred             -ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHHHhcCC----CC------C-
Confidence             23333456899999999999999999999999999999999988877543221 11211111100    00      0 


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASV 1102 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~ 1102 (1109)
                             .......++.+++.+||+.||++||||+|+++.|+.+..
T Consensus       237 -------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         237 -------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             -------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   001122356778889999999999999999999988743

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=407.15  Aligned_cols=255  Identities=25%  Similarity=0.383  Sum_probs=205.3

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|++.+.||+|+||+||+|.+++++.||||++..  .....+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECT--TSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEcc--CcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            57888899999999999999999889999999843  33456689999999999999999999998854 5679999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.+++.... ...++|..+++++.||++||+|||   +.+|+||||||+|||+++++.+||+|||+|+...... .
T Consensus        90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~  164 (272)
T d1qpca_          90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (272)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence            9999999876533 234899999999999999999999   8899999999999999999999999999999775432 2


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      .......||+.|+|||++.+..++.++|||||||++|||+||+.|+...... .+....+.   ....    ...+    
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~---~~~~----~~~p----  232 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLE---RGYR----MVRP----  232 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHH---TTCC----CCCC----
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHH---hcCC----CCCc----
Confidence            2233457899999999999999999999999999999999977766443221 11221111   1100    0000    


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                             .....++.+++.+||+.||++||||+|+++.|+++
T Consensus       233 -------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         233 -------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                   01123466788899999999999999999998864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-46  Score=416.75  Aligned_cols=258  Identities=22%  Similarity=0.309  Sum_probs=205.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-C-----cEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-N-----AVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      ++|++.++||+|+||+||+|+... +     ..||||++...........+.+|+.++.++ +|||||++++++.+.+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578889999999999999997642 2     368999986665666677899999999998 899999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCC
Q 001275          892 IIMYRYMENGSLRDVLHSITP--------------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPE  951 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~  951 (1109)
                      ++||||+++|+|.++++....                    ...+++..++.++.|+++||+|||   +++||||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchh
Confidence            999999999999999976432                    135899999999999999999999   889999999999


Q ss_pred             CeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccc
Q 001275          952 NILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKE 1030 (1109)
Q Consensus       952 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~ 1030 (1109)
                      ||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||..... 
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~-  272 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV-  272 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999987755544444445678999999999999999999999999999999998 8999864322 


Q ss_pred             cccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1031 RTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                      ...+...+.....    .    +          .......++.+++.+||+.||++|||++|++++|.
T Consensus       273 ~~~~~~~~~~~~~----~----~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFYKLIQNGFK----M----D----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHHHHHHTTCC----C----C----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCC----C----C----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1222222221110    0    0          00111235667888999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-46  Score=417.81  Aligned_cols=200  Identities=28%  Similarity=0.416  Sum_probs=178.2

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      .++|++.++||+|+||+||+|+. .+|+.||+|++...........+.+|++++++++|||||+++++|.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46789999999999999999976 46899999999665555556789999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCD-PPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      |+++|+|.+++.+.+   .+++..+..++.|+++||+|||   + .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999998654   3899999999999999999999   6 48999999999999999999999999999866432


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCC
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPS 1027 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~ 1027 (1109)
                      .    ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus       159 ~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         159 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             T----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             c----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            1    22468999999999999999999999999999999999999999764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=405.32  Aligned_cols=258  Identities=25%  Similarity=0.399  Sum_probs=200.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCC-----cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPN-----AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      +.|+..++||+|+||+||+|.+..+     ..||||++.....+....+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4577789999999999999976532     47999998655555556679999999999999999999999999999999


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ||||+.+|++.+++....  ..++|..+..++.|++.|++|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999887643  35899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCC-CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPA-STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      .... ........||+.|+|||++.++.++.++|||||||++|||++|+.|+...... .++...+....   . .    
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~---~-~----  232 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGF---R-L----  232 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC---C-C----
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccC---C-C----
Confidence            4322 22333457899999999999999999999999999999999987776543222 12222211110   0 0    


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                        .        .......++.+++.+||+.||++||+|+|++++|+++
T Consensus       233 --~--------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         233 --P--------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             --C--------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --C--------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence              0        0011224567788899999999999999999999865

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=404.25  Aligned_cols=256  Identities=21%  Similarity=0.297  Sum_probs=204.7

Q ss_pred             hCCCCCc-eeecccCeEEEEEEeC---CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKH-VIGRGAHGIVYKASLG---PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|...+ +||+|+||+||+|.+.   ++..||||++.....+...++|.+|++++++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            3455556 4999999999999663   3557999999665555566789999999999999999999999865 568999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.+++...+  ..+++..+.+++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+|+.+..
T Consensus        87 mE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999986533  35899999999999999999999   89999999999999999999999999999998755


Q ss_pred             CCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          975 SPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       975 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....  .++...+..   . ... .. 
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~---~-~~~-~~-  233 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ---G-KRM-EC-  233 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT---T-CCC-CC-
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---C-CCC-CC-
Confidence            43222 2234578999999999999999999999999999999998 8999865321  222222211   0 000 00 


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                  ......++.+++.+||+.||++||++.++++.|+.+
T Consensus       234 ------------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         234 ------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                        011224567788899999999999999999988754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=404.16  Aligned_cols=256  Identities=23%  Similarity=0.367  Sum_probs=191.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEec--CCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--KDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  894 (1109)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++..... +...+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6789999999999999999976 4689999999865432 3334568999999999999999999999865  3457999


Q ss_pred             EEeccCCCHHHHHhccC-CCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          895 YRYMENGSLRDVLHSIT-PPPTLEWNVRYKIALGAAHALAYLHYDC--DPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      |||+++|+|.+++.... ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999986532 2345999999999999999999999421  23599999999999999999999999999997


Q ss_pred             cCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      +.....  ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....  .++...+...  .   ...+
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--~~~~~~i~~~--~---~~~~  234 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--KELAGKIREG--K---FRRI  234 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHT--C---CCCC
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--HHHHHHHHcC--C---CCCC
Confidence            754322  22346899999999999999999999999999999999999999964321  1121111110  0   0000


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                                +...   ..++.+++.+||+.||++|||++|+++|
T Consensus       235 ----------~~~~---s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         235 ----------PYRY---SDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ----------CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----------Cccc---CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                      0011   2345667889999999999999999876

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=401.50  Aligned_cols=250  Identities=22%  Similarity=0.331  Sum_probs=201.3

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||+||+|+. .+++.||||++....  .......+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5689999999999999999977 568999999985432  2344567999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999988654   3899999999999999999999   899999999999999999999999999999987654


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .............+.      
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~~~~p------  230 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIKLEYDFP------  230 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHTTCCCCC------
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHHHHcCCCCCC------
Confidence            443344456899999999999999999999999999999999999999965321     111111111111110      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVR 1095 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~ 1095 (1109)
                             ...   ..++.+++.+||+.||++|||++|+++
T Consensus       231 -------~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         231 -------EKF---FPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -------TTC---CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -------ccC---CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                   011   223566788999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=395.63  Aligned_cols=246  Identities=26%  Similarity=0.392  Sum_probs=193.9

Q ss_pred             CCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEec----CCceeEEE
Q 001275          822 NAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR----KDCGIIMY  895 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~  895 (1109)
                      +..++||+|+||+||+|... +++.||+|++.... .....+.+.+|++++++++|||||++++++..    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45668999999999999765 68899999986543 23345678999999999999999999999865    34579999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEEeccCCCCeeeC-CCCcEEEecccCCccc
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPP--IVHRDIKPENILLD-SEMEPHISDFGIAKLL  972 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~kl~DfGla~~~  972 (1109)
                      ||+++|+|.++++...   .+++..+..++.|+++||+|||   +.+  |+||||||+|||++ +++.+||+|||+|+..
T Consensus        92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            9999999999998654   4899999999999999999999   766  99999999999996 5789999999999865


Q ss_pred             CCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ...    ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.....    ..............     
T Consensus       166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~----~~~~~~~i~~~~~~-----  231 (270)
T d1t4ha_         166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----AAQIYRRVTSGVKP-----  231 (270)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----HHHHHHHHTTTCCC-----
T ss_pred             cCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc----HHHHHHHHHcCCCC-----
Confidence            332    2234689999999998765 699999999999999999999999964321    11122221111100     


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                       .. .    .   .....++.+++.+||+.||++|||++|+++|
T Consensus       232 -~~-~----~---~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         232 -AS-F----D---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -GG-G----G---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -cc-c----C---ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence             00 0    0   0112345668889999999999999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=400.69  Aligned_cols=263  Identities=26%  Similarity=0.370  Sum_probs=206.1

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      ++|++.+.||+|+||+||+|+.++++.||||++..  .....+.|.+|+.++++++|||||+++++|. .+..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~--~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCT--TSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECc--ccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            57899999999999999999999888999999843  3344578999999999999999999999985 45689999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|..++.... ...++|.+++.++.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... .
T Consensus        94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~  168 (285)
T d1fmka3          94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  168 (285)
T ss_dssp             TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-c
Confidence            9999999987633 234899999999999999999999   8899999999999999999999999999998764332 2


Q ss_pred             ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          979 TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      .......||+.|+|||++.++.++.++|||||||++|||++|+.|+...... ......+....  ....    .     
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~--~~~~----~-----  236 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGY--RMPC----P-----  236 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTC--CCCC----C-----
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcC--CCCC----C-----
Confidence            2334467999999999999999999999999999999999987776543322 11222221110  0000    0     


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCCCCC
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMTSKY 1108 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 1108 (1109)
                             .....++.+++.+||+.||++||+|+||+++|++......++|
T Consensus       237 -------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~  279 (285)
T d1fmka3         237 -------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY  279 (285)
T ss_dssp             -------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred             -------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence                   1112346678889999999999999999999998766655554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-45  Score=398.63  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=201.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.|++.+.||+|+||+||+|+. .+++.||||++... .....+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            4578889999999999999976 46899999998543 344556789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        91 ~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-  164 (288)
T d2jfla1          91 CAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  164 (288)
T ss_dssp             CTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence            99999999986543  24899999999999999999999   8999999999999999999999999999997553211 


Q ss_pred             CceeeecccCcccccccccc-----cCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          978 STTSISVVGTIGYIAPENAF-----TTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                       .......||+.|+|||++.     +..|+.++||||+||++|||++|+.||......  +...   .......  ....
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~---~i~~~~~--~~~~  236 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLL---KIAKSEP--PTLA  236 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHH---HHHHSCC--CCCS
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHH---HHHcCCC--CCCC
Confidence             1122457999999999874     556799999999999999999999999653221  1111   1111100  0000


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .           ......++.+++.+||+.||++|||++|+++|=
T Consensus       237 ~-----------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp  270 (288)
T d2jfla1         237 Q-----------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHP  270 (288)
T ss_dssp             S-----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             c-----------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            0           011123456678899999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-45  Score=396.46  Aligned_cols=248  Identities=20%  Similarity=0.259  Sum_probs=195.1

Q ss_pred             ceeecccCeEEEEEEeC---CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEeccC
Q 001275          825 HVIGRGAHGIVYKASLG---PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYMEN  900 (1109)
Q Consensus       825 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  900 (1109)
                      ++||+|+||+||+|.+.   .++.||||++..... ....+++.+|++++++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            56999999999999753   346899999854432 3335679999999999999999999999864 567899999999


Q ss_pred             CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCCc-
Q 001275          901 GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAST-  979 (1109)
Q Consensus       901 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~-  979 (1109)
                      |+|.++++...   .+++..++.++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+|+......... 
T Consensus        92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999998644   4899999999999999999999   8899999999999999999999999999998775443322 


Q ss_pred             eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhhhH
Q 001275          980 TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSLME 1058 (1109)
Q Consensus       980 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 1058 (1109)
                      ......||++|+|||.+.+..++.++|||||||++|||+| |+.||.....  .++...+..   .. .. ..       
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~---~~-~~-~~-------  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEK---GE-RM-GC-------  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT---TC-CC-CC-------
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHc---CC-CC-CC-------
Confidence            2234579999999999999999999999999999999998 8999864321  122222211   10 00 00       


Q ss_pred             HhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhh
Q 001275         1059 EMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVD 1099 (1109)
Q Consensus      1059 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~ 1099 (1109)
                            ......++.+++.+||+.||++|||++|+++.|+.
T Consensus       232 ------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 ------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                  01122346678889999999999999999988765

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-44  Score=400.41  Aligned_cols=253  Identities=26%  Similarity=0.343  Sum_probs=188.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      +.|++.+.||+|+||+||+|+.. +++.||||++...........+.+|++++++++|||||++++++.+++..|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56889999999999999999764 68999999997655445556788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC---CCCcEEEecccCCcccCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD---SEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~DfGla~~~~~  974 (1109)
                      +++|+|.+++...+   .+++..+..++.|++.||+|||   +.+|+||||||+||++.   +++.+||+|||+|+....
T Consensus        89 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          89 VSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             cCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999997643   4999999999999999999999   89999999999999994   578999999999986643


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..   .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||......  ..   .............    
T Consensus       163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~---~~~i~~~~~~~~~----  230 (307)
T d1a06a_         163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--KL---FEQILKAEYEFDS----  230 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HH---HHHHHTTCCCCCT----
T ss_pred             CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--HH---HHHHhccCCCCCC----
Confidence            32   223467999999999999999999999999999999999999999653211  11   1111111111100    


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ..        ......++.+++.+|++.||++|||++|+++|-
T Consensus       231 ~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  265 (307)
T d1a06a_         231 PY--------WDDISDSAKDFIRHLMEKDPEKRFTCEQALQHP  265 (307)
T ss_dssp             TT--------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             cc--------ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence            00        011123466678899999999999999999973

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-45  Score=403.66  Aligned_cols=261  Identities=26%  Similarity=0.413  Sum_probs=210.3

Q ss_pred             HhhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc
Q 001275          817 ATENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       817 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  890 (1109)
                      ..++|++.+.||+|+||+||+|+..      +++.||||++..........+|.+|++++++++||||++++++|...+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            3467999999999999999999763      4578999998655555556789999999999999999999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccC
Q 001275          891 GIIMYRYMENGSLRDVLHSITP---------------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIK  949 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  949 (1109)
                      .++||||+++|+|.++++....                     ...+++..++.++.|+++||+|||   +.+|||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEc
Confidence            9999999999999999975321                     234899999999999999999999   8999999999


Q ss_pred             CCCeeeCCCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCC-CCCCCc
Q 001275          950 PENILLDSEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKK-ALDPSY 1028 (1109)
Q Consensus       950 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~-p~~~~~ 1028 (1109)
                      |+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|.. ||... 
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-  246 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-  246 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-
Confidence            9999999999999999999987655444444445678999999999999999999999999999999999975 55432 


Q ss_pred             cccccHHHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1029 KERTDIVGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .. .++...+..   ..  ....             ......++.+++.+||+.||++||||.||+++|+++
T Consensus       247 ~~-~e~~~~v~~---~~--~~~~-------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         247 AH-EEVIYYVRD---GN--ILAC-------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             CH-HHHHHHHHT---TC--CCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CH-HHHHHHHHc---CC--CCCC-------------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            11 122222211   10  0000             011223577789999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-45  Score=401.72  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=198.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc--cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK--RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      +.|+..+.||+|+||+||+|+. .+++.||||++......  ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4588899999999999999976 56889999998654322  23457889999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|++..++....   .+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus        95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            9999999987765533   4899999999999999999999   899999999999999999999999999999865432


Q ss_pred             CCCceeeecccCccccccccccc---CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          976 PASTTSISVVGTIGYIAPENAFT---TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                            ....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||......     ...........  ....
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-----~~~~~i~~~~~--~~~~  235 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNES--PALQ  235 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCC--CCCS
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhCCC--CCCC
Confidence                  23579999999998864   45899999999999999999999998643211     11111111100  0000


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .         ...   ..++.+++.+||+.||++|||++|+++|
T Consensus       236 ~---------~~~---s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         236 S---------GHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             C---------TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C---------CCC---CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            0         011   2345667889999999999999999885

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-44  Score=400.13  Aligned_cols=256  Identities=23%  Similarity=0.355  Sum_probs=199.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCc----EEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNA----VFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  893 (1109)
                      .+|++.++||+|+||+||+|.+. +|+    +||+|++.........++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            35888999999999999999764 343    58899886555566678899999999999999999999999864 5678


Q ss_pred             EEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccC
Q 001275          894 MYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLD  973 (1109)
Q Consensus       894 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~  973 (1109)
                      ++||+.+|+|.+++....  ..+++..+++++.||++||+|||   +++||||||||+||+++.++.+||+|||+|+...
T Consensus        88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            899999999999887643  35899999999999999999999   8899999999999999999999999999999876


Q ss_pred             CCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccccc
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIV 1052 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1109)
                      ............||+.|+|||++.++.++.++|||||||++|||+| |+.||+...  ...+...+.....    .    
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~i~~~~~----~----  232 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEKGER----L----  232 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHHHHHTCC----C----
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCC----C----
Confidence            5544444445679999999999999999999999999999999999 677775432  1222222221100    0    


Q ss_pred             chhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1053 DLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1053 d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                ........++.+++.+||+.||++|||++|++++|..+
T Consensus       233 ----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 ----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                      00011224567788899999999999999999998754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=389.06  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=204.6

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc-----cChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK-----RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++......     ...+.+.+|++++++++|||||++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5789999999999999999977 57899999998654322     23567999999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC----cEEEecccC
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM----EPHISDFGI  968 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~DfGl  968 (1109)
                      +||||+++|+|.+++...+   .+++..+..++.|++.||+|||   +.+||||||||+||+++.++    .+|++|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999997654   4899999999999999999999   89999999999999998776    499999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      |+.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||......     .............
T Consensus       164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~~~~~~  235 (293)
T d1jksa_         164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANVSAVNYEF  235 (293)
T ss_dssp             CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHTTCCCC
T ss_pred             hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcCCCC
Confidence            987754322   23457999999999999999999999999999999999999999653211     1111111111000


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                          ...    .    ......++.+++.+||+.||++|||++|+++|-
T Consensus       236 ----~~~----~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  272 (293)
T d1jksa_         236 ----EDE----Y----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  272 (293)
T ss_dssp             ----CHH----H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             ----Cch----h----cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence                000    0    011123456678899999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-43  Score=399.23  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=204.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5799999999999999999976 56899999998543 334456789999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC--CCcEEEecccCCcccCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS--EMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~DfGla~~~~~~  975 (1109)
                      +++|+|.+++....  ..+++..+..++.||+.||+|||   +.+||||||||+|||++.  ++.+||+|||+|+.....
T Consensus       105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999996532  34899999999999999999999   899999999999999964  578999999999977543


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  .+.   ...........    +..
T Consensus       180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--~~~---~~~i~~~~~~~----~~~  247 (350)
T d1koaa2         180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--DET---LRNVKSCDWNM----DDS  247 (350)
T ss_dssp             S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HHH---HHHHHHTCCCS----CCG
T ss_pred             c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--HHH---HHHHHhCCCCC----Ccc
Confidence            2   23446899999999999999999999999999999999999999964321  111   11111111000    000


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .        ......++.+++.+||+.||++|||++|+++|
T Consensus       248 ~--------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 A--------FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             G--------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             c--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0        01112345667889999999999999999997

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-44  Score=396.02  Aligned_cols=261  Identities=23%  Similarity=0.320  Sum_probs=198.1

Q ss_pred             hhCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC-
Q 001275          818 TENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD-  889 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-  889 (1109)
                      .++|+..++||+|+||+||+|++.      +++.||||++.........+.+.+|...+.++ +|+|||++++++...+ 
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            367889999999999999999753      34689999986555555566788888888887 6899999999987654 


Q ss_pred             ceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ..++||||+++|+|.++++....             ...+++..+..++.||++||+|||   +++||||||||+|||++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEC
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeEC
Confidence            67999999999999999975431             235899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCC-CCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKK-ALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~-p~~~~~~~~~~~~ 1035 (1109)
                      +++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||.. ||... .....+.
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~-~~~~~~~  247 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFC  247 (299)
T ss_dssp             GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CCSHHHH
T ss_pred             CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence            999999999999987755544444445689999999999999999999999999999999999765 55432 2222222


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..+.....    . ..             ......++.+++.+||+.||++|||++|+++||+++
T Consensus       248 ~~~~~~~~----~-~~-------------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         248 RRLKEGTR----M-RA-------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HHHHHTCC----C-CC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcCCC----C-CC-------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            22221110    0 00             011123467788899999999999999999999865

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.9e-43  Score=396.88  Aligned_cols=252  Identities=21%  Similarity=0.283  Sum_probs=204.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++.... ......+.+|++++++++|||||++++++.+++..|+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4689999999999999999976 579999999985432 33456788999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC--CCCcEEEecccCCcccCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD--SEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~kl~DfGla~~~~~~  975 (1109)
                      +++|+|.+++....  ..+++.++..++.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+|+.+...
T Consensus       108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            99999999876533  34899999999999999999999   89999999999999997  6789999999999987543


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .   ......||+.|+|||++.+..++.++||||+||++|||+||+.||......  ..   .............    .
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~---~~~i~~~~~~~~~----~  250 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ET---LQNVKRCDWEFDE----D  250 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HH---HHHHHHCCCCCCS----S
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HH---HHHHHhCCCCCCc----c
Confidence            2   234468999999999999999999999999999999999999999643211  11   1111111100000    0


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .        ......++.+++.+||+.||++|||++|+++|
T Consensus       251 ~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         251 A--------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             T--------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             c--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0        01112345667889999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-44  Score=397.58  Aligned_cols=270  Identities=24%  Similarity=0.293  Sum_probs=199.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC----ceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD----CGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  894 (1109)
                      ++|...+.||+|+||+||+|+.+ |+.||||++...  .......+.|+..+.+++|||||+++++|...+    ..++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~--~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc--chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            56777889999999999999875 889999988432  222223445666667889999999999998654    46899


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEEeccCCCCeeeCCCCcEEEecccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD-----CDPPIVHRDIKPENILLDSEMEPHISDFGIA  969 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla  969 (1109)
                      |||+++|+|.+++++.    .++|..+++++.|+|.|++|+|..     .+++||||||||+|||++.++.+||+|||++
T Consensus        80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999864    389999999999999999999942     1469999999999999999999999999999


Q ss_pred             cccCCCCCC--ceeeecccCcccccccccccCC------CCccCcchhhHHHHHHHHhCCCCCCCCccccccH-------
Q 001275          970 KLLDKSPAS--TTSISVVGTIGYIAPENAFTTA------KSKESDVYSYGVVLLELITRKKALDPSYKERTDI------- 1034 (1109)
Q Consensus       970 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~------- 1034 (1109)
                      +........  .......||++|+|||++.+..      ++.++|||||||++|||+||..|+..........       
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            877543322  1233468999999999887643      5779999999999999999998874322111100       


Q ss_pred             --HHHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCC
Q 001275         1035 --VGWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVP 1103 (1109)
Q Consensus      1035 --~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~ 1103 (1109)
                        ..........     .-.++......   ...+....+.+++.+||+.||++|||+.||+++|+++..+
T Consensus       236 ~~~~~~~~~~~~-----~~~~p~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         236 PSVEEMRKVVCE-----QKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTT-----SCCCCCCCGGG---GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhc-----cccCCCCCccc---CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence              0111111100     00111111111   1234556688899999999999999999999999887443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=394.33  Aligned_cols=261  Identities=22%  Similarity=0.336  Sum_probs=214.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe------CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCce
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL------GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  891 (1109)
                      ++|+..++||+|+||.||+|++      .+++.||||++..........++.+|+.+++++ +|||||+++++|.+.+..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5788899999999999999975      356789999996655555666899999999999 699999999999999999


Q ss_pred             eEEEEeccCCCHHHHHhccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          892 IIMYRYMENGSLRDVLHSITP---------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ++||||+++|+|.++++....               ...+++..+.+++.||++|++|||   +++||||||||+||+++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccccc
Confidence            999999999999999976432               235899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVG 1036 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~ 1036 (1109)
                      .++.+|++|||.++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+.........+..
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999999876655555555678999999999999999999999999999999999966665444333333333


Q ss_pred             HHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1037 WVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1037 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      .+.......       .           ......++.+++.+||+.||++||||+|++++|++.
T Consensus       260 ~i~~~~~~~-------~-----------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         260 MIKEGFRML-------S-----------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHHTCCCC-------C-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcCCCCC-------C-----------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            332211000       0           011224567788899999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-44  Score=389.78  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=193.8

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC----CcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP----NAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|++.+.||+|+||+||+|.+..    +..||||++...........+.+|++++++++|||||++++++. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            578889999999999999997642    35688888755444555667999999999999999999999986 4678999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|++.+++....  ..+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+|+....
T Consensus        86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999999886543  35899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccc
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVD 1053 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 1053 (1109)
                      ... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....  .++...+..   ... . ..  
T Consensus       161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~~---~~~-~-~~--  230 (273)
T d1mp8a_         161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIEN---GER-L-PM--  230 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHT---TCC-C-CC--
T ss_pred             Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHHHc---CCC-C-CC--
Confidence            322 22334578999999999999999999999999999999998 7888764322  222222211   100 0 00  


Q ss_pred             hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1054 LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1054 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                 ......++.+++.+||+.||++|||++|++++|+.+
T Consensus       231 -----------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         231 -----------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             -----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                       011123466788899999999999999999999865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=388.56  Aligned_cols=250  Identities=22%  Similarity=0.262  Sum_probs=205.4

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.++||+|+||+||+|+. .+|+.||||++....  .......+.+|+.++++++|||||++++++.+.+..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5688999999999999999976 578999999996442  2344567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999998754   3889999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      ..  .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....     ...........-...      
T Consensus       159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~i~~~~~~~p------  225 (337)
T d1o6la_         159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEEIRFP------  225 (337)
T ss_dssp             TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC------
T ss_pred             Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHHHhcCCCCCC------
Confidence            22  23346899999999999999999999999999999999999999965421     111111111111110      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQL 1097 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L 1097 (1109)
                             ....   .++.+++.+|++.||++||+     ++|+++|-
T Consensus       226 -------~~~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp  262 (337)
T d1o6la_         226 -------RTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             -------TTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             -------ccCC---HHHHHHHHhhccCCchhhcccccccHHHHHcCc
Confidence                   0112   23556778999999999994     89999873

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-43  Score=390.81  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             CceeecccCeEEEEEEeCCC----cEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec-CCceeEEEEec
Q 001275          824 KHVIGRGAHGIVYKASLGPN----AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR-KDCGIIMYRYM  898 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  898 (1109)
                      .++||+|+||+||+|++.++    ..||||++..........+|.+|++++++++|||||+++|++.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999976432    36899998655555556789999999999999999999999875 45789999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      ++|+|.++++...  ...++..+++++.|+++||.|+|   +.+|+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999987643  35788999999999999999999   899999999999999999999999999999876543322


Q ss_pred             --ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          979 --TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       979 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                        .......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .++...+..   ...    ...+  
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~---g~~----~~~p--  256 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQ---GRR----LLQP--  256 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHT---TCC----CCCC--
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHc---CCC----CCCc--
Confidence              2223457899999999999999999999999999999999998887654322 222222211   110    0011  


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                               .....++.+++.+||+.||++||+|+||+++|+++.
T Consensus       257 ---------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~  292 (311)
T d1r0pa_         257 ---------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  292 (311)
T ss_dssp             ---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                     011234667888999999999999999999998763

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-44  Score=385.36  Aligned_cols=249  Identities=26%  Similarity=0.344  Sum_probs=193.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEec-CCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLR-KDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~  897 (1109)
                      ++|+..++||+|+||.||+|+++ |+.||||++..   ....+.+.+|++++++++|||||+++|+|.+ .+..++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC---CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            45778899999999999999986 78899999843   2345679999999999999999999999865 4567999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +++|+|.++++... ...++|..+++++.||++||+|||   +.+|+||||||+||+++.++.+|++|||+++...... 
T Consensus        83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence            99999999997532 224899999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCccccccccchhh
Q 001275          978 STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLSL 1056 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 1056 (1109)
                          ....+|..|+|||++.+..++.++|||||||++|||+| |+.||...  ...++...+....          .+..
T Consensus       158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~----------~~~~  221 (262)
T d1byga_         158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY----------KMDA  221 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTC----------CCCC
T ss_pred             ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCC----------CCCC
Confidence                23468899999999999999999999999999999998 56666432  2223333322110          0000


Q ss_pred             hHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1057 MEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1057 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                              ......++.+++.+||+.||++||||+|++++|+++
T Consensus       222 --------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         222 --------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                    011123466788899999999999999999999865

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-42  Score=385.34  Aligned_cols=246  Identities=24%  Similarity=0.313  Sum_probs=202.9

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....  .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688899999999999999986 568999999986432  3344677999999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||++||++..++....   .+++..+..++.|++.|++|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999987654   3788899999999999999999   999999999999999999999999999999876433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .     ...+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....     ................     
T Consensus       158 ~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~~~~~p~-----  222 (316)
T d1fota_         158 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILNAELRFPP-----  222 (316)
T ss_dssp             B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHCCCCCCT-----
T ss_pred             c-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHHHHcCCCCCCC-----
Confidence            2     236899999999999999999999999999999999999999965321     1111111111111100     


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1096 (1109)
                              ..   ..++.+++.+|++.||++|+     +++|+++|
T Consensus       223 --------~~---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         223 --------FF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --------TS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --------CC---CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                    11   12355677899999999996     89999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=393.60  Aligned_cols=256  Identities=21%  Similarity=0.310  Sum_probs=199.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeCC-Cc--EEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGP-NA--VFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|+..++||+|+||+||+|++.+ +.  .||||++.........+++.+|+++++++ +|||||+++++|..++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            578888999999999999997653 43  47888876555555667899999999999 799999999999999999999


Q ss_pred             EEeccCCCHHHHHhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcE
Q 001275          895 YRYMENGSLRDVLHSIT-------------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEP  961 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  961 (1109)
                      |||+++|+|.++++...             ....+++..+..++.||++|+.|+|   +.+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            99999999999997542             2356899999999999999999999   8999999999999999999999


Q ss_pred             EEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCC-CCCCccccccHHHHHHH
Q 001275          962 HISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKA-LDPSYKERTDIVGWVRS 1040 (1109)
Q Consensus       962 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p-~~~~~~~~~~~~~~~~~ 1040 (1109)
                      ||+|||+|+......   ......||..|+|||.+.+..++.++|||||||++|||++|..| |...  .   .......
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~---~~~~~~~  238 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--T---CAELYEK  238 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--C---HHHHHHH
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--C---HHHHHHH
Confidence            999999998654322   12235689999999999999999999999999999999998764 4322  1   1112211


Q ss_pred             hhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1041 VWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1041 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..... ..      .        .......++.+++.+||+.||++||||+||+++|+++
T Consensus       239 i~~~~-~~------~--------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         239 LPQGY-RL------E--------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             GGGTC-CC------C--------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcC-CC------C--------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11110 00      0        0011223566788899999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=391.02  Aligned_cols=261  Identities=20%  Similarity=0.313  Sum_probs=209.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC------CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|...++||+|+||+||+|.+.      +++.||||++...........|.+|++++++++|||||+++++|...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            67888999999999999999763      357899999865555555567899999999999999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEec
Q 001275          893 IMYRYMENGSLRDVLHSIT-------PPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISD  965 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  965 (1109)
                      +||||+++|+|.++++...       ....+++..+.+++.|+++||+|||   +.+|+||||||+|||+++++.+||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEee
Confidence            9999999999999986432       2235789999999999999999999   88999999999999999999999999


Q ss_pred             ccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          966 FGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       966 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      ||+|+...............||+.|+|||.+.+..++.++||||||+++|||+||+.|+......    ...........
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~----~~~~~~i~~~~  252 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN----EQVLRFVMEGG  252 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH----HHHHHHHHTTC
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhCC
Confidence            99998775544433344457899999999999999999999999999999999996443322211    11221111110


Q ss_pred             cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCC
Q 001275         1046 EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDAS 1101 (1109)
Q Consensus      1046 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~ 1101 (1109)
                       .. ..             .......+.+++.+||+.||++||||+||+++|++..
T Consensus       253 -~~-~~-------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         253 -LL-DK-------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             -CC-CC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -CC-CC-------------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             00 00             0112235777888999999999999999999998863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=391.69  Aligned_cols=259  Identities=22%  Similarity=0.349  Sum_probs=205.9

Q ss_pred             hCCCCCceeecccCeEEEEEEeC--------CCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEecCC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG--------PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLRKD  889 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  889 (1109)
                      ++|.+.+.||+|+||.||+|+..        ++..||||++..........++.+|+..+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            57888899999999999999652        23579999986655555667888999999888 8999999999999999


Q ss_pred             ceeEEEEeccCCCHHHHHhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeC
Q 001275          890 CGIIMYRYMENGSLRDVLHSITP-------------PPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLD  956 (1109)
Q Consensus       890 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~  956 (1109)
                      ..++||||+++|+|.++++....             ...+++.++++++.|++.||+|||   +.+||||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeec
Confidence            99999999999999999976542             245899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHH
Q 001275          957 SEMEPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIV 1035 (1109)
Q Consensus       957 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1109)
                      .++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |+.||.....  ..+.
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--~~~~  247 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EELF  247 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--HHHH
Confidence            999999999999997765554444455689999999999999999999999999999999998 5777643221  1122


Q ss_pred             HHHHHhhcCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1036 GWVRSVWSDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1036 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                      ..+..    ..... . .            .....++.+++.+||+.||++||||+||++.|+++
T Consensus       248 ~~i~~----~~~~~-~-p------------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         248 KLLKE----GHRMD-K-P------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHT----TCCCC-C-C------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHc----CCCCC-C-C------------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            22111    11000 0 0            01123467788899999999999999999999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=385.73  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=194.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC--CC--cEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG--PN--AVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|++.+.||+|+||+||+|+..  ++  ..||||++....  .....++|.+|++++++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56888999999999999999753  22  468999885433  23335679999999999999999999999965 5678


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +||||+++|++.+++....  ..+++..++.++.|+|+||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999999887643  34899999999999999999999   889999999999999999999999999999987


Q ss_pred             CCCCCCc-eeeecccCcccccccccccCCCCccCcchhhHHHHHHHHh-CCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          973 DKSPAST-TSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELIT-RKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       973 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ....... ......||..|+|||++.+..++.++|||||||++|||+| |+.||.....  .+.   .............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--~~~---~~~i~~~~~~~~~  236 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQI---LHKIDKEGERLPR  236 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHH---HHHHHTSCCCCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--HHH---HHHHHhCCCCCCC
Confidence            5543322 2234568889999999999999999999999999999998 8999864321  111   1222111111100


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                                    ......++.+++.+||+.||++||||+|+++.|.++
T Consensus       237 --------------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         237 --------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                          011123466788899999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.7e-42  Score=374.96  Aligned_cols=252  Identities=27%  Similarity=0.372  Sum_probs=201.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccccc--------ChHHHHHHHHHHhcCC-CCceeeEeeEEecC
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKR--------GSLSMKREIQTIGKIR-HRNLVRLEDFWLRK  888 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  888 (1109)
                      ++|++.+.||+|+||+||+|+. .+++.||||++.......        ....+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788999999999999999976 578999999986543221        1235889999999996 99999999999999


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      +..|+||||+++|+|.++++..+   .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997644   4899999999999999999999   88999999999999999999999999999


Q ss_pred             CcccCCCCCCceeeecccCccccccccccc------CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFT------TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW 1042 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1109)
                      ++.......   .....||+.|+|||.+.+      ..++.++||||+||++|||++|+.||......  .....+   .
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--~~~~~i---~  228 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--LMLRMI---M  228 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH---H
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--HHHHHH---H
Confidence            997754322   234689999999998753      34688999999999999999999999754211  111111   1


Q ss_pred             cCccccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1043 SDTEEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1043 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ......    ...        .......++.+++.+|++.||++||+++|+++|
T Consensus       229 ~~~~~~----~~~--------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         229 SGNYQF----GSP--------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HTCCCC----CTT--------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hCCCCC----CCc--------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            111000    000        011122346667889999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.5e-42  Score=388.63  Aligned_cols=252  Identities=23%  Similarity=0.273  Sum_probs=199.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHH---HHHHHHhcCCCCceeeEeeEEecCCcee
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMK---REIQTIGKIRHRNLVRLEDFWLRKDCGI  892 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~  892 (1109)
                      ++|++.++||+|+||+||+|+.. +|+.||||++....  .......+.   +|+++++.++|||||++++++...+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            47889999999999999999764 68999999985432  122223333   4577788889999999999999999999


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      +||||+++|+|.+++....   .+++..+..++.||+.||+|||   +.+||||||||+|||+++++.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999997654   3789999999999999999999   899999999999999999999999999999977


Q ss_pred             CCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccc
Q 001275          973 DKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDI 1051 (1109)
Q Consensus       973 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1109)
                      .....    ....||+.|+|||++.. ..|+.++||||+||++|||+||+.||......  +.....+........... 
T Consensus       158 ~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~-  230 (364)
T d1omwa3         158 SKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK--DKHEIDRMTLTMAVELPD-  230 (364)
T ss_dssp             SSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS--CHHHHHHHSSSCCCCCCS-
T ss_pred             CCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhcccCCCCCCC-
Confidence            54322    23579999999999875 56899999999999999999999999754221  222222221111111111 


Q ss_pred             cchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHhh
Q 001275         1052 VDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPN-----MRDVVRQLV 1098 (1109)
Q Consensus      1052 ~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs-----~~evl~~L~ 1098 (1109)
                                  ..   ..++.+++.+||+.||++||+     ++|+++|=+
T Consensus       231 ------------~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~  267 (364)
T d1omwa3         231 ------------SF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  267 (364)
T ss_dssp             ------------SS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred             ------------CC---CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence                        11   123566778999999999999     799988643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.5e-42  Score=384.88  Aligned_cols=247  Identities=19%  Similarity=0.252  Sum_probs=203.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc--cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG--HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMY  895 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  895 (1109)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....  .......+.+|++++++++|||||++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5789999999999999999976 469999999985432  2344567899999999999999999999999999999999


Q ss_pred             EeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCC
Q 001275          896 RYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       896 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~  975 (1109)
                      ||+.+|+|.+++...+   .+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999997754   3899999999999999999999   899999999999999999999999999999977532


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                      .     ....||+.|||||++.+..++.++||||+||++|||+||+.||.....     ...............      
T Consensus       195 ~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~~~~~p------  258 (350)
T d1rdqe_         195 T-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEKIVSGKVRFP------  258 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC------
T ss_pred             c-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----HHHHHHHhcCCCCCC------
Confidence            2     235799999999999999999999999999999999999999964321     111111111110000      


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQL 1097 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~L 1097 (1109)
                             .   ....++.+++.+|++.||++|+     +++|+++|=
T Consensus       259 -------~---~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp  295 (350)
T d1rdqe_         259 -------S---HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             -------T---TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             -------c---cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCc
Confidence                   0   1123456678899999999994     899999864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6e-42  Score=375.44  Aligned_cols=259  Identities=25%  Similarity=0.327  Sum_probs=197.9

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc--ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCc----e
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH--KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDC----G  891 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~  891 (1109)
                      ++|++.+.||+|+||+||+|.. .+++.||||++.....  ......+.+|++++++++|||||++++++...+.    .
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5789999999999999999976 5789999999864432  2334578999999999999999999999876543    7


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcc
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKL  971 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~  971 (1109)
                      |+||||+++|+|.+++...+   .+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.++++|||.+..
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            89999999999999987654   4899999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCC-CceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccccc
Q 001275          972 LDKSPA-STTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIND 1050 (1109)
Q Consensus       972 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1109)
                      ...... ........||+.|+|||++.+..++.++||||+||++|||+||+.||......     ...............
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~~~~~~~~~~  235 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIPPS  235 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCCGG
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHHHHhcCCCCCc
Confidence            543322 22334468999999999999999999999999999999999999999643211     111111111100000


Q ss_pred             ccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhhhC
Q 001275         1051 IVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-NMRDVVRQLVDA 1100 (1109)
Q Consensus      1051 ~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-s~~evl~~L~~~ 1100 (1109)
                               ...   .....++.+++.+|++.||++|| +++|+++.|.++
T Consensus       236 ---------~~~---~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         236 ---------ARH---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ---------GTS---SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---------hhc---cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                     000   11123466678899999999999 899999888764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-42  Score=381.32  Aligned_cols=251  Identities=20%  Similarity=0.312  Sum_probs=202.2

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|.+.+.||+|+||+||+|... +++.||||.+....  .....+.+|++++++++|||||++++++.+.+..|+||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            57889999999999999999764 68899999985432  2345688999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC--CcEEEecccCCcccCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE--MEPHISDFGIAKLLDKS  975 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~DfGla~~~~~~  975 (1109)
                      +++|+|.+++...+  ..+++.++..++.|+++||+|||   +.+|+||||||+|||++.+  ..+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            99999999997643  24899999999999999999999   8999999999999999854  47999999999876433


Q ss_pred             CCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccchh
Q 001275          976 PASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDLS 1055 (1109)
Q Consensus       976 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 1055 (1109)
                         .......+|+.|+|||...+..++.++||||+||++|+|++|+.||......  +   ............    +..
T Consensus       158 ---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~---~~~~i~~~~~~~----~~~  225 (321)
T d1tkia_         158 ---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--Q---IIENIMNAEYTF----DEE  225 (321)
T ss_dssp             ---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--H---HHHHHHHTCCCC----CHH
T ss_pred             ---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--H---HHHHHHhCCCCC----Chh
Confidence               2233467999999999999999999999999999999999999999654211  1   111111111000    000


Q ss_pred             hhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1056 LMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1056 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .        ......++.+++.+|++.||++|||++|+++|
T Consensus       226 ~--------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         226 A--------FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             H--------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             h--------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0        01112345667889999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-42  Score=383.37  Aligned_cols=252  Identities=21%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             hCCCCC-ceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcC-CCCceeeEeeEEec----CCce
Q 001275          819 ENLNAK-HVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKI-RHRNLVRLEDFWLR----KDCG  891 (1109)
Q Consensus       819 ~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  891 (1109)
                      ++|.+. ++||+|+||+||+|+. .+++.||||++..      ...+.+|++++.++ +|||||++++++.+    ....
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            578776 4699999999999976 5789999999842      34678899987655 89999999999865    3567


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCcEEEecccC
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EMEPHISDFGI  968 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGl  968 (1109)
                      |+|||||+||+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence            99999999999999998643 345899999999999999999999   899999999999999975   56799999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      |+.......   .....||+.|+|||++.+..|+.++||||+||++|+|+||+.||.......  ...........    
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~--~~~~~~~~i~~----  231 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--ISPGMKTRIRM----  231 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS----
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH--HHHHHHHHHhc----
Confidence            987654332   234689999999999999999999999999999999999999995432111  11111000000    


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ...--+.       ........++.+++.+|++.||++|||+.|+++|
T Consensus       232 ~~~~~~~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 GQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CSSSCCT-------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCCC-------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            0000000       0011223456778889999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-42  Score=377.89  Aligned_cols=278  Identities=21%  Similarity=0.332  Sum_probs=204.0

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|++.+.||+|+||+||+|.. .+|+.||||++..... +.....+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788999999999999999976 5789999999854432 2345689999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      |+.++ +.+++.... ...+++..+..++.|++.||+|||   +.+||||||||+|||++.++.+||+|||.|+......
T Consensus        82 ~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99764 444444322 345899999999999999999999   8999999999999999999999999999998765432


Q ss_pred             CCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc-cccc-c
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI-NDIV-D 1053 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-d 1053 (1109)
                        .......||+.|+|||......+ +.++||||+||++|+|++|+.||..... ...+...........+.. .... .
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-HHHHHHHHHhcCCCchhhccccccc
Confidence              22234579999999998776664 8899999999999999999999965321 111222222111111000 0000 0


Q ss_pred             hhhhHH---hh----hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH--hhhCCCCC
Q 001275         1054 LSLMEE---ML----VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ--LVDASVPM 1104 (1109)
Q Consensus      1054 ~~~~~~---~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~--L~~~~~~~ 1104 (1109)
                      +.....   ..    .........++.+++.+|++.||++|||++|+++|  +.++..|.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~  293 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV  293 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCC
Confidence            000000   00    00011112456778889999999999999999998  66665443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-42  Score=380.27  Aligned_cols=249  Identities=22%  Similarity=0.317  Sum_probs=200.0

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecc--cccChHHHHHHHHHHh-cCCCCceeeEeeEEecCCceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRG--HKRGSLSMKREIQTIG-KIRHRNLVRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  894 (1109)
                      ++|.+.++||+|+||+||+|+.. +++.||||++....  .......+.+|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57888999999999999999764 68999999996432  2334456677777665 68999999999999999999999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDK  974 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~  974 (1109)
                      |||+++|+|.++++...   .+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999998754   3889999999999999999999   88999999999999999999999999999986643


Q ss_pred             CCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccccccch
Q 001275          975 SPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEINDIVDL 1054 (1109)
Q Consensus       975 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 1054 (1109)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....  ..+...+   ........     
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--~~~~~~i---~~~~~~~p-----  223 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--EELFHSI---RMDNPFYP-----  223 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHH---HHCCCCCC-----
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--HHHHHHH---HcCCCCCC-----
Confidence            32  223346899999999999999999999999999999999999999965321  1111111   11110000     


Q ss_pred             hhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHH-HHHHH
Q 001275         1055 SLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMR-DVVRQ 1096 (1109)
Q Consensus      1055 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~-evl~~ 1096 (1109)
                              ...   ..++.+++.+||+.||++||++. |+++|
T Consensus       224 --------~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         224 --------RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             --------TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --------ccC---CHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                    011   23356677899999999999995 78654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-42  Score=378.45  Aligned_cols=264  Identities=24%  Similarity=0.290  Sum_probs=193.8

Q ss_pred             CceeecccCeEEEEEEe-CCCcEEEEEEeeeccccc----ChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEec
Q 001275          824 KHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKR----GSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRYM  898 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  898 (1109)
                      .++||+|+||+||+|+. .+|+.||||++.......    ....+.+|++++++++|||||++++++..++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            47899999999999976 468999999985433221    2356889999999999999999999999999999999999


Q ss_pred             cCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCCC
Q 001275          899 ENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPAS  978 (1109)
Q Consensus       899 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~  978 (1109)
                      +++++..+....   ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....... 
T Consensus        83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            998777665432   34888899999999999999999   89999999999999999999999999999987654322 


Q ss_pred             ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc-------cccc
Q 001275          979 TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE-------EIND 1050 (1109)
Q Consensus       979 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~ 1050 (1109)
                       .....+||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+............       ....
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-HHHHHHHHHhcCCCChhhccchhccch
Confidence             22345799999999988654 579999999999999999999999864322 1111222211110000       0000


Q ss_pred             ccchhhhHH-hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1051 IVDLSLMEE-MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1051 ~~d~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ......... ...........++.+++.+|++.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000000000 0000001122456778889999999999999999997

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1e-41  Score=381.67  Aligned_cols=296  Identities=27%  Similarity=0.468  Sum_probs=214.4

Q ss_pred             cCChhhHHHHHHHHHhccCCCCcccCCCCCCCCCCc--eeeeEEecCCC--CcEEEEEecccCCcc--ccCCcccCCCCc
Q 001275           24 NALNGDGVALLSLMRHWNSVPPLIISSWNSSDSTPC--QWVGIECDDDA--HNVVSFNLSSYGVSG--QLGPEIGHLSKL   97 (1109)
Q Consensus        24 ~~~~~~~~all~~~~~~~~~~~~~l~sW~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L   97 (1109)
                      -|.++|++||++||+++.+ | ..+++|..+ .|||  .|+||+|+..+  +||++|+|++++++|  .+|+++++|++|
T Consensus         2 ~c~~~e~~aLl~~k~~~~~-~-~~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L   78 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGN-P-TTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTC-C-GGGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCCHHHHHHHHHHHHHCCC-C-CcCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence            3999999999999999975 3 468999864 4788  49999998754  489999999999988  577888888999


Q ss_pred             cEeecCC-CcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccc
Q 001275           98 QTIDLSS-NNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNN  176 (1109)
Q Consensus        98 ~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~  176 (1109)
                      ++|+|++ |+++|.+|++|+++++|++|+|++|++.+..|..+..+.+|+++++++|.+.+.+|..+.++++|+++++++
T Consensus        79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~  158 (313)
T d1ogqa_          79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG  158 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccc
Confidence            9998886 788888888888888888888888888888888888888888888888888877777777777777777777


Q ss_pred             cccccccccccCCCccc-ceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcc
Q 001275          177 NSLSGSIPRNVGDLKEV-EALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRI  255 (1109)
Q Consensus       177 n~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~  255 (1109)
                      |.+++.+|..+..+.++ +.++++.|++++..|..++++..+ .+++++|...+.+|..+..+++|+.+++++|.+++.+
T Consensus       159 n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~  237 (313)
T d1ogqa_         159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL  237 (313)
T ss_dssp             SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred             cccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence            77777777766666554 566666666666666555555433 4555555555555555555555555555555544332


Q ss_pred             cccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcccccc
Q 001275          256 NFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCK  335 (1109)
Q Consensus       256 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~  335 (1109)
                                               +.++.+++|+.|+|++|+++|.+|..|+.+++|++|+|++|+|+|.+|. +++++
T Consensus       238 -------------------------~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~  291 (313)
T d1ogqa_         238 -------------------------GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQ  291 (313)
T ss_dssp             -------------------------GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGG
T ss_pred             -------------------------cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCC
Confidence                                     2345556666666666666666666666666666666666666666653 46666


Q ss_pred             ccceeeccCcc-cCC
Q 001275          336 YLTVLHLYANQ-LEG  349 (1109)
Q Consensus       336 ~L~~L~L~~N~-l~~  349 (1109)
                      +|+.+++++|+ +.|
T Consensus       292 ~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         292 RFDVSAYANNKCLCG  306 (313)
T ss_dssp             GSCGGGTCSSSEEES
T ss_pred             CCCHHHhCCCccccC
Confidence            67777777665 444

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-42  Score=372.98  Aligned_cols=242  Identities=21%  Similarity=0.321  Sum_probs=194.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc-----cChHHHHHHHHHHhcCC--CCceeeEeeEEecCCc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK-----RGSLSMKREIQTIGKIR--HRNLVRLEDFWLRKDC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  890 (1109)
                      .+|++.++||+|+||+||+|.. .+|+.||||++......     ....++.+|++++++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            4688899999999999999976 46899999998543211     12234678999999986  8999999999999999


Q ss_pred             eeEEEEeccC-CCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCC-CcEEEecccC
Q 001275          891 GIIMYRYMEN-GSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSE-MEPHISDFGI  968 (1109)
Q Consensus       891 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~DfGl  968 (1109)
                      .++||||+.+ +++.+++....   .+++..+..++.|+++||+|||   +++|+||||||+||+++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 68888887643   4899999999999999999999   8999999999999999854 7999999999


Q ss_pred             CcccCCCCCCceeeecccCcccccccccccCCC-CccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc
Q 001275          969 AKLLDKSPASTTSISVVGTIGYIAPENAFTTAK-SKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE 1047 (1109)
Q Consensus       969 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1109)
                      |+......    .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....       ...+    ....
T Consensus       158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~----~~~~  222 (273)
T d1xwsa_         158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIR----GQVF  222 (273)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHH----CCCC
T ss_pred             ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhh----cccC
Confidence            98664332    234679999999999987766 678999999999999999999996421       0110    0000


Q ss_pred             cccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1048 INDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1048 ~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .    .+         ..+   .++.+++.+|++.||++|||++|+++|-
T Consensus       223 ~----~~---------~~s---~~~~~li~~~L~~dp~~R~s~~eil~hp  256 (273)
T d1xwsa_         223 F----RQ---------RVS---SECQHLIRWCLALRPSDRPTFEEIQNHP  256 (273)
T ss_dssp             C----SS---------CCC---HHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             C----CC---------CCC---HHHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence            0    10         111   3456677899999999999999999973

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.7e-41  Score=370.52  Aligned_cols=268  Identities=22%  Similarity=0.317  Sum_probs=200.6

Q ss_pred             hCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEEe
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYRY  897 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  897 (1109)
                      ++|+..++||+|+||+||+|+..+|+.||||++.... .+.....+.+|+.++++++|||||++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5788899999999999999999999999999985543 333467899999999999999999999999999999999999


Q ss_pred             ccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCCC
Q 001275          898 MENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSPA  977 (1109)
Q Consensus       898 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~  977 (1109)
                      +.++.+..+....   ..+++..+..++.|++.||+|||   +.+||||||||+|||++.++.+|++|||.|........
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9987777766543   35999999999999999999999   88999999999999999999999999999987654322


Q ss_pred             CceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC-------ccccc
Q 001275          978 STTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD-------TEEIN 1049 (1109)
Q Consensus       978 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 1049 (1109)
                        ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+..........       .....
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCChhhccchhhhh
Confidence              22345789999999988764 4699999999999999999999999654221 1111111111100       00000


Q ss_pred             cccchhhh---HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1050 DIVDLSLM---EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1050 ~~~d~~~~---~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .. +....   .............++.+++.+|++.||++|||++|+++|
T Consensus       233 ~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         233 KY-DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             TC-CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hc-ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00 00000   000000011112356678889999999999999999976

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=370.75  Aligned_cols=271  Identities=23%  Similarity=0.290  Sum_probs=197.1

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CC-CcEEEEEEeeecccc-cChHHHHHHHHHHhcC---CCCceeeEeeEEec----
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GP-NAVFAVKKLAFRGHK-RGSLSMKREIQTIGKI---RHRNLVRLEDFWLR----  887 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  887 (1109)
                      .++|++.++||+|+||+||+|+. .+ ++.||||++...... .....+.+|+++++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36899999999999999999986 34 667999998654332 2344567788877666   79999999999853    


Q ss_pred             -CCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecc
Q 001275          888 -KDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDF  966 (1109)
Q Consensus       888 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  966 (1109)
                       ....++++||+++|++......  ....+++..+..++.|++.||+|||   +.+||||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence             3467999999998877655443  2345899999999999999999999   899999999999999999999999999


Q ss_pred             cCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-
Q 001275          967 GIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT- 1045 (1109)
Q Consensus       967 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~- 1045 (1109)
                      |+++.....   .......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ...+........... 
T Consensus       161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCG
T ss_pred             hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCch
Confidence            998865332   233456899999999999999999999999999999999999999975422 111222211111100 


Q ss_pred             cccc------cccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1046 EEIN------DIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1046 ~~~~------~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ....      ......................+.+++.+|++.||++|||++|+++|-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp  294 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  294 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence            0000      000000000000000111123456678899999999999999999973

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-40  Score=370.87  Aligned_cols=270  Identities=21%  Similarity=0.311  Sum_probs=197.4

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecCC----cee
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD----CGI  892 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  892 (1109)
                      +++|++.++||+|+||+||+|.. .+|+.||||++.........+.+.+|++++++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45788999999999999999965 5799999999965444445667899999999999999999999987654    235


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCccc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLL  972 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~  972 (1109)
                      ++++|+.+|+|.+++...    .+++..+..++.|+++||+|||   +.+||||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            666778899999999753    3899999999999999999999   899999999999999999999999999999866


Q ss_pred             CCCCCC-ceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc--cc
Q 001275          973 DKSPAS-TTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE--EI 1048 (1109)
Q Consensus       973 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 1048 (1109)
                      ...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......  +.............  ..
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL--DQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH--HHHHHHhhhccCCChhhh
Confidence            433221 12234679999999998854 56689999999999999999999999654221  11111111111000  00


Q ss_pred             ccccchhhhHHhh----------hchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1049 NDIVDLSLMEEML----------VSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~----------~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      .............          .........++.+++.+|++.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000000000          00000111356778889999999999999999998

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-39  Score=362.78  Aligned_cols=280  Identities=20%  Similarity=0.259  Sum_probs=200.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEec--------C
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLR--------K  888 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  888 (1109)
                      ++|++.++||+|+||+||+|+. .+|+.||||++..... +....++.+|++++++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999986 5799999999854433 3445678999999999999999999998865        3


Q ss_pred             CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccC
Q 001275          889 DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGI  968 (1109)
Q Consensus       889 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGl  968 (1109)
                      +..++||||++++.+..+...   ...++...+..++.|+++||+|||   +.+|+||||||+|||++.++.+|++|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecce
Confidence            457899999988776655443   234888999999999999999999   89999999999999999999999999999


Q ss_pred             CcccCCCCCC--ceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc
Q 001275          969 AKLLDKSPAS--TTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT 1045 (1109)
Q Consensus       969 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1109)
                      ++........  .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ........+......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~  242 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSIT  242 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhcCCCC
Confidence            9876543221  122335799999999988765 689999999999999999999999965321 111111111111111


Q ss_pred             ccc-ccccchhhhHHh-----hhchh------HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhCCCCCC
Q 001275         1046 EEI-NDIVDLSLMEEM-----LVSSI------RDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDASVPMT 1105 (1109)
Q Consensus      1046 ~~~-~~~~d~~~~~~~-----~~~~~------~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 1105 (1109)
                      ... ............     .....      .....++++++.+|++.||++|||++|+++|=+--..+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p  314 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  314 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence            000 000000000000     00000      0112356678889999999999999999999664434443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-39  Score=365.33  Aligned_cols=261  Identities=27%  Similarity=0.354  Sum_probs=192.3

Q ss_pred             CCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCceeeEeeEEecC------Ccee
Q 001275          820 NLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------DCGI  892 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  892 (1109)
                      +|+..++||+|+||+||+|+.. +|+.||||++.....     ...+|++++++++|||||++++++...      ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            5778899999999999999774 689999999854322     234799999999999999999998543      2468


Q ss_pred             EEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecccCCcc
Q 001275          893 IMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKL  971 (1109)
Q Consensus       893 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~  971 (1109)
                      +||||+++|.+....+.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            99999987654444433334456999999999999999999999   99999999999999999775 899999999987


Q ss_pred             cCCCCCCceeeecccCccccccccccc-CCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCc-----
Q 001275          972 LDKSPASTTSISVVGTIGYIAPENAFT-TAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDT----- 1045 (1109)
Q Consensus       972 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 1045 (1109)
                      .......   ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ...+...+.......     
T Consensus       173 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~-~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         173 LVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-VDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred             ccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH-HHHHHHHHHHhCCChHHhhh
Confidence            7543322   23579999999998765 5689999999999999999999999965422 111222211110000     


Q ss_pred             --------cccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1046 --------EEINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1046 --------~~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                              ........... ....   ......++.+++.+|++.||++|||++|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~-~~~~---~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPW-TKVF---RPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHCC---CCCCCCCCCCCG-GGTS---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccchhhccccccccCch-hhhc---ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    00000000000 0000   11123346678889999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-39  Score=356.74  Aligned_cols=271  Identities=20%  Similarity=0.306  Sum_probs=204.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccc-cChHHHHHHHHHHhcCCCCceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHK-RGSLSMKREIQTIGKIRHRNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|++.++||+|+||+||+|+. .+++.||||++...... .....+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4788999999999999999976 57899999999654433 335678999999999999999999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCcccCCCC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAKLLDKSP  976 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~~~~~~~  976 (1109)
                      ++.++++..+++..+   .+++..+..++.|+++||+|||   +.+||||||||+||+++.++.+|++|||.|+......
T Consensus        82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988877543   4789999999999999999999   8999999999999999999999999999998775433


Q ss_pred             CCceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccc-------c
Q 001275          977 ASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEE-------I 1048 (1109)
Q Consensus       977 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~ 1048 (1109)
                      .  ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.......................       .
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            2  223356788999999887665 58999999999999999999999865433222222211111111000       0


Q ss_pred             ccccchhhh--HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1049 NDIVDLSLM--EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1049 ~~~~d~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      .+..+....  ..............+.+++.+|++.||++||||+|+++|=
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp  284 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcCh
Confidence            000000000  0000000111123456678899999999999999999863

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.7e-39  Score=360.55  Aligned_cols=264  Identities=20%  Similarity=0.243  Sum_probs=196.8

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecC--CceeEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRK--DCGIIM  894 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  894 (1109)
                      ++|++.++||+|+||+||+|+. .+++.||||++..    ...+++.+|++++++++ ||||+++++++...  ...++|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            5799999999999999999976 5689999999842    33567899999999995 99999999998754  468999


Q ss_pred             EEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC-cEEEecccCCcccC
Q 001275          895 YRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM-EPHISDFGIAKLLD  973 (1109)
Q Consensus       895 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~DfGla~~~~  973 (1109)
                      |||+++|+|.++.+      .+++..+..++.||++||+|||   +.+||||||||+|||++.++ .+||+|||+|+...
T Consensus       111 ~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceecc
Confidence            99999999876543      3899999999999999999999   89999999999999998655 69999999998775


Q ss_pred             CCCCCceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhh----------
Q 001275          974 KSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVW---------- 1042 (1109)
Q Consensus       974 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 1042 (1109)
                      ....   .....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||..................          
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            4432   23457899999999887654 799999999999999999999999765432221111111000          


Q ss_pred             ---cCccccccccc----hhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhh
Q 001275         1043 ---SDTEEINDIVD----LSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLV 1098 (1109)
Q Consensus      1043 ---~~~~~~~~~~d----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~ 1098 (1109)
                         ...........    .................++.+++.+|++.||++|||++|+++|=+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence               00000000000    000000000001112245677888999999999999999998754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-39  Score=364.70  Aligned_cols=264  Identities=21%  Similarity=0.253  Sum_probs=192.2

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecc-cccChHHHHHHHHHHhcCCCCceeeEeeEEecCC------c
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRG-HKRGSLSMKREIQTIGKIRHRNLVRLEDFWLRKD------C  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  890 (1109)
                      ++|++.++||+|+||+||+|.. .+|+.||||++.... .+...+.+.+|++++++++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            5788999999999999999976 469999999985432 2233457889999999999999999999997655      4


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .|+||||+ +++|..+.+..    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+|+
T Consensus        98 ~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            69999999 56888877653    3999999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccC-CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTT-AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      ......     ....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ...+...............
T Consensus       170 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         170 QADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-LDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             ECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHH
T ss_pred             ccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-HHHHHHHHhccCCCcHHHH
Confidence            764332     345799999999988764 568999999999999999999999965421 1111111111111100000


Q ss_pred             cccchhhhHH-----------hhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 001275         1050 DIVDLSLMEE-----------MLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQ 1096 (1109)
Q Consensus      1050 ~~~d~~~~~~-----------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~ 1096 (1109)
                      ..........           ...........++.+++.+|++.||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000000           0000001112345678889999999999999999998

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.3e-38  Score=347.86  Aligned_cols=260  Identities=15%  Similarity=0.190  Sum_probs=200.5

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeecccccChHHHHHHHHHHhcCCC-CceeeEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRH-RNLVRLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|++.++||+|+||+||+|+.. +|+.||||++....   ....+.+|++.++.++| +|++.+++++......++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            57889999999999999999764 68999999875432   23357789999999965 899999999999999999999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC-----CCcEEEecccCCcc
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS-----EMEPHISDFGIAKL  971 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~kl~DfGla~~  971 (1109)
                      |+ +|+|.++++...  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 689999987643  34899999999999999999999   999999999999999974     56899999999987


Q ss_pred             cCCCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcc
Q 001275          972 LDKSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTE 1046 (1109)
Q Consensus       972 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1109)
                      .......     .......||+.|+|||.+.+..++.++||||+||++|||+||+.||.........  .......... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~--~~~~~i~~~~-  232 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--QKYERIGEKK-  232 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHHHH-
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH--HHHHHHHhcc-
Confidence            6543211     1233467999999999999999999999999999999999999999654222111  1111000000 


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                         ....   ..+. .   .....++.+++..|++.+|++||+++.+.+.+.++
T Consensus       233 ---~~~~---~~~l-~---~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         233 ---QSTP---LREL-C---AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             ---HHSC---HHHH-T---TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ---CCCC---hHHh-c---CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence               0000   0000 0   11224567778899999999999998888877654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-38  Score=351.31  Aligned_cols=258  Identities=16%  Similarity=0.209  Sum_probs=192.7

Q ss_pred             hCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCcee-eEeeEEecCCceeEEEE
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNLV-RLEDFWLRKDCGIIMYR  896 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e  896 (1109)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.....   ..++.+|++++++++|++++ .+.+++...+..++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4688999999999999999976 5689999998754332   23578899999999877655 45555677778899999


Q ss_pred             eccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCC---CCcEEEecccCCcccC
Q 001275          897 YMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDS---EMEPHISDFGIAKLLD  973 (1109)
Q Consensus       897 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~DfGla~~~~  973 (1109)
                      |+. |++.+.+....  ..+++..+..++.|+++||+|||   +++|+||||||+||+++.   +..+|++|||+|+...
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            995 56766665433  34899999999999999999999   899999999999999864   5579999999999775


Q ss_pred             CCCCC-----ceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHH--HHHHHhhcCcc
Q 001275          974 KSPAS-----TTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIV--GWVRSVWSDTE 1046 (1109)
Q Consensus       974 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~ 1046 (1109)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........  .........  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~--  235 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST--  235 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC--
Confidence            43321     123346799999999999999999999999999999999999999965432211100  000000000  


Q ss_pred             ccccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhhhC
Q 001275         1047 EINDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQLVDA 1100 (1109)
Q Consensus      1047 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L~~~ 1100 (1109)
                            .    ....   ......++.+++..||+.+|++||+++++.+.|+.+
T Consensus       236 ------~----~~~~---~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         236 ------P----IEVL---CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             ------C----HHHH---TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ------C----hhHh---ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                  0    0000   111234567788899999999999999888777653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-39  Score=356.31  Aligned_cols=254  Identities=24%  Similarity=0.292  Sum_probs=200.1

Q ss_pred             hCCCCCceeecccCeEEEEEEe----CCCcEEEEEEeeecc---cccChHHHHHHHHHHhcCCC-CceeeEeeEEecCCc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASL----GPNAVFAVKKLAFRG---HKRGSLSMKREIQTIGKIRH-RNLVRLEDFWLRKDC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  890 (1109)
                      ++|++.++||+|+||+||+|..    .+|+.||||.+....   .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999965    257899999985432   23345678899999999966 899999999999999


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++||||+.+|+|.+++...+.   +....+..++.|++.|++|+|   +.+||||||||+||+++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999999987553   678889999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCCCceeeecccCcccccccccccC--CCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCcccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTT--AKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEI 1048 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1109)
                      .+.... ........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||...... .................
T Consensus       178 ~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-~~~~~i~~~~~~~~~~~  255 (322)
T d1vzoa_         178 EFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQAEISRRILKSEPPY  255 (322)
T ss_dssp             ECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCHHHHHHHHHHCCCCC
T ss_pred             hhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcccCCCCC
Confidence            764332 2223346899999999988765  4588999999999999999999999654322 12222222211111000


Q ss_pred             ccccchhhhHHhhhchhHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 001275         1049 NDIVDLSLMEEMLVSSIRDQVIDVLLVALRCTEKKPSNRP-----NMRDVVRQ 1096 (1109)
Q Consensus      1049 ~~~~d~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----s~~evl~~ 1096 (1109)
                                      ......++.+++.+||+.||++||     +++|+++|
T Consensus       256 ----------------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         256 ----------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ----------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----------------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                            011234466677899999999999     58999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-38  Score=358.35  Aligned_cols=266  Identities=20%  Similarity=0.236  Sum_probs=189.7

Q ss_pred             hCCCCCceeecccCeEEEEEEeC-CCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecC------Cc
Q 001275          819 ENLNAKHVIGRGAHGIVYKASLG-PNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK------DC  890 (1109)
Q Consensus       819 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  890 (1109)
                      ++|++.++||+|+||+||+|.+. +|+.||||++..... .....++.+|+.++++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57889999999999999999765 699999999965433 23345788999999999999999999999643      56


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .|+||||+.++.+ +.+..     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence            7999999976544 44432     3789999999999999999999   8999999999999999999999999999988


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcC------
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSD------ 1044 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 1044 (1109)
                      ......   ......+|+.|+|||++.+..++.++||||+||++|||++|+.||..... ..............      
T Consensus       168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~-~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-IDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHT
T ss_pred             cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH-HHHHHHHHHhccCCCHHHHH
Confidence            654332   23346799999999999999999999999999999999999999864321 11111111111100      


Q ss_pred             ------------ccccccccchhhhHHh----hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1045 ------------TEEINDIVDLSLMEEM----LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1045 ------------~~~~~~~~d~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                                  .......-.+......    ..........++.+++.+|++.||++||||+|+++|=
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp  312 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  312 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence                        0000000000000000    0011223445678889999999999999999999884

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-38  Score=356.15  Aligned_cols=267  Identities=20%  Similarity=0.239  Sum_probs=194.8

Q ss_pred             hhCCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeeccc-ccChHHHHHHHHHHhcCCCCceeeEeeEEecC-----Cc
Q 001275          818 TENLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGH-KRGSLSMKREIQTIGKIRHRNLVRLEDFWLRK-----DC  890 (1109)
Q Consensus       818 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  890 (1109)
                      +++|++.++||+|+||+||+|.. .+|+.||||++..... ....+.+.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999975 5799999999854332 23345788999999999999999999998643     34


Q ss_pred             eeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          891 GIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       891 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      .++++||+.+|+|.++++..    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|++|||.+.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence            57788889999999999653    3999999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCCCCceeeecccCcccccccccccCC-CCccCcchhhHHHHHHHHhCCCCCCCCccccccHHHHHHHhhcCccccc
Q 001275          971 LLDKSPASTTSISVVGTIGYIAPENAFTTA-KSKESDVYSYGVVLLELITRKKALDPSYKERTDIVGWVRSVWSDTEEIN 1049 (1109)
Q Consensus       971 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1109)
                      .....     .....||+.|+|||...+.. ++.++||||+||++|+|++|+.||...... ..................
T Consensus       170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred             ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHh
Confidence            55322     23357999999999877654 589999999999999999999999653211 111111111111110000


Q ss_pred             cccchhhhHHh-----------hhchhHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 001275         1050 DIVDLSLMEEM-----------LVSSIRDQVIDVLLVALRCTEKKPSNRPNMRDVVRQL 1097 (1109)
Q Consensus      1050 ~~~d~~~~~~~-----------~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~evl~~L 1097 (1109)
                      ...........           ..........++.+++.+|++.||++|||++|+++|=
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp  302 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  302 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCH
Confidence            00000000000           0000011123466788899999999999999999963

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-33  Score=323.20  Aligned_cols=269  Identities=19%  Similarity=0.193  Sum_probs=190.5

Q ss_pred             CCCCCceeecccCeEEEEEEe-CCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-----------CCceeeEeeEEec
Q 001275          820 NLNAKHVIGRGAHGIVYKASL-GPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-----------HRNLVRLEDFWLR  887 (1109)
Q Consensus       820 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  887 (1109)
                      +|++.++||+|+||+||+|+. .+|+.||||++...  ......+.+|++++++++           |+||+++++++..
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            588999999999999999976 57999999998532  223456788999888875           5789999998865


Q ss_pred             C--CceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCC------
Q 001275          888 K--DCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEM------  959 (1109)
Q Consensus       888 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~------  959 (1109)
                      .  ...+++++++..+..............+++..+..++.|++.|++|||+  ..+|+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence            3  4556777776655443333333445568899999999999999999993  37899999999999997655      


Q ss_pred             cEEEecccCCcccCCCCCCceeeecccCcccccccccccCCCCccCcchhhHHHHHHHHhCCCCCCCCcccc--cc---H
Q 001275          960 EPHISDFGIAKLLDKSPASTTSISVVGTIGYIAPENAFTTAKSKESDVYSYGVVLLELITRKKALDPSYKER--TD---I 1034 (1109)
Q Consensus       960 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvil~elltg~~p~~~~~~~~--~~---~ 1034 (1109)
                      .++++|||.+.......     ....||+.|+|||++.+..++.++||||+||++++|++|+.||.+.....  .+   .
T Consensus       170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            39999999998654322     23579999999999999999999999999999999999999997542211  01   1


Q ss_pred             HHHHHHhhcC-----------------ccc---cccccchhhh--HHhhhchhHHHHHHHHHHHHhccCCCCCCCCCHHH
Q 001275         1035 VGWVRSVWSD-----------------TEE---INDIVDLSLM--EEMLVSSIRDQVIDVLLVALRCTEKKPSNRPNMRD 1092 (1109)
Q Consensus      1035 ~~~~~~~~~~-----------------~~~---~~~~~d~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPs~~e 1092 (1109)
                      ...+......                 ...   ..........  .............++.+++.+|++.||++|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            1111110000                 000   0000000000  00011123455677888999999999999999999


Q ss_pred             HHHHh
Q 001275         1093 VVRQL 1097 (1109)
Q Consensus      1093 vl~~L 1097 (1109)
                      +++|=
T Consensus       325 ~L~Hp  329 (362)
T d1q8ya_         325 LVNHP  329 (362)
T ss_dssp             HHTCG
T ss_pred             HhcCc
Confidence            99983

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=4.7e-31  Score=294.48  Aligned_cols=248  Identities=30%  Similarity=0.438  Sum_probs=184.9

Q ss_pred             cccEEEcCCCCCCC--CCCCccccccccceeeccC-cccCCCCCccccCCCCccEEEccCccccccCchHHHhhccccee
Q 001275          312 RLSSLDLSENQLSG--KIPPELGKCKYLTVLHLYA-NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL  388 (1109)
Q Consensus       312 ~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  388 (1109)
                      +++.|+|++|.++|  .+|+.++++++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+..|+++
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46666666666665  3667777777777777775 67777777777778888888888888777777777777788888


Q ss_pred             eccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCC-ceEEecCCcccccCCCCcccCccceEEECCCccc
Q 001275          389 LVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSL-MQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQF  467 (1109)
Q Consensus       389 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L-~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l  467 (1109)
                      ++++|.+.+.+|..+.++++++.+++++|.+++.+|..++.+..+ +.+++++|++++..|..+..+..+ .+++++|.+
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred             ccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence            888888877888888888888888888888888888877777665 778888888888877777666544 688888888


Q ss_pred             ccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhh
Q 001275          468 HGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG  547 (1109)
Q Consensus       468 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  547 (1109)
                      .+.+|..++.+++++.+++++|.+++.+|.+..+++|++|+|++|+++|.+|..|+++++|++|||++|+|+|.+| +++
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~  288 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGG  288 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CST
T ss_pred             cccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC-Ccc
Confidence            8888877777777777777777777766666666777777777777777777777777777777777777776666 346


Q ss_pred             cccccceeeccccc
Q 001275          548 NLVSLVTLNISLNH  561 (1109)
Q Consensus       548 ~l~~L~~L~L~~N~  561 (1109)
                      ++++|+.+++++|+
T Consensus       289 ~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         289 NLQRFDVSAYANNK  302 (313)
T ss_dssp             TGGGSCGGGTCSSS
T ss_pred             cCCCCCHHHhCCCc
Confidence            66666666666665

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=5.2e-28  Score=277.90  Aligned_cols=341  Identities=23%  Similarity=0.282  Sum_probs=140.1

Q ss_pred             CcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhc
Q 001275          190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD  269 (1109)
Q Consensus       190 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  269 (1109)
                      +.+|++|++++|.++..  +.++.+++|++|+|++|+|++..  .++++++|++|++++|++++..+  +..+++|+.|+
T Consensus        43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~  116 (384)
T d2omza2          43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLT  116 (384)
T ss_dssp             HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             hCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccccc--ccccccccccc
Confidence            33444444444444421  23444555555555555554432  14455555555555555543322  34445555555


Q ss_pred             cccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCC
Q 001275          270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       270 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                      +++|.+++..+  ......+..+....|.+....+..................+     ..+...+.........|... 
T Consensus       117 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~-  188 (384)
T d2omza2         117 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVS-  188 (384)
T ss_dssp             CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCC-
T ss_pred             ccccccccccc--ccccccccccccccccccccccccccccccccccccccchh-----hhhccccccccccccccccc-
Confidence            55554443221  22233444444444444432222221111111111111111     12233333333444444332 


Q ss_pred             CCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccC
Q 001275          350 EIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGI  429 (1109)
Q Consensus       350 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  429 (1109)
                       ....+..+++++.+++++|.+++..|  +..+++|+.|++++|.+++ + ..+..+++|+.|++++|++++..+  ++.
T Consensus       189 -~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~  261 (384)
T d2omza2         189 -DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSG  261 (384)
T ss_dssp             -CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred             -cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccc
Confidence             22334445555555555555553322  2334445555555554442 1 234444555555555555543221  333


Q ss_pred             CCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEe
Q 001275          430 NSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDV  509 (1109)
Q Consensus       430 ~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~L  509 (1109)
                      ++                        +|++|++++|++.+..+  +..++.++.+.++.|++++ ++.+..++.+++|++
T Consensus       262 ~~------------------------~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~l  314 (384)
T d2omza2         262 LT------------------------KLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTL  314 (384)
T ss_dssp             CT------------------------TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEEC
T ss_pred             cc------------------------cCCEeeccCcccCCCCc--ccccccccccccccccccc-ccccchhcccCeEEC
Confidence            33                        44444444444432111  2222222333333333332 122334444445555


Q ss_pred             ecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCc
Q 001275          510 SRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN  584 (1109)
Q Consensus       510 s~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N  584 (1109)
                      ++|+|++..  .+..+++|+.|++++|+|++ +| .++++++|++|++++|+|++..|  +.++++|+.|+|++|
T Consensus       315 s~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         315 YFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            555554322  14444455555555555442 22 34444444444444444443322  444444444444444

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=4.4e-28  Score=278.51  Aligned_cols=356  Identities=21%  Similarity=0.266  Sum_probs=170.0

Q ss_pred             ecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhcccccccc
Q 001275          197 WLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFS  276 (1109)
Q Consensus       197 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  276 (1109)
                      .+..+.+++.++  ...+.+|++|++++|.|+..  +.+..+++|++|++++|+|++..+                    
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--------------------   83 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--------------------   83 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--------------------
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--------------------
Confidence            344444444332  23455566666666665532  234455555555555555543221                    


Q ss_pred             CCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCcccc
Q 001275          277 GGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELG  356 (1109)
Q Consensus       277 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~  356 (1109)
                            ++++++|++|++++|++++..  .++.+++|+.|++++|.+++..+  ......+..+....|.+....+....
T Consensus        84 ------l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~  153 (384)
T d2omza2          84 ------LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGL  153 (384)
T ss_dssp             ------GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTC
T ss_pred             ------ccCCccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccccccc
Confidence                  444444444444444444322  14445555555555555543221  22334444555555554432222211


Q ss_pred             CCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceE
Q 001275          357 QLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQL  436 (1109)
Q Consensus       357 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L  436 (1109)
                      ..............+     ..+.............|...  ....+..+++++.+++++|.+++..|  ++..++|++|
T Consensus       154 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L  224 (384)
T d2omza2         154 TSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL  224 (384)
T ss_dssp             TTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             ccccccccccccchh-----hhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEE
Confidence            111222111111111     12223333344444444332  23445556666666666666665433  3345566666


Q ss_pred             EecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCC
Q 001275          437 DFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISG  516 (1109)
Q Consensus       437 ~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~  516 (1109)
                      ++++|.+++ + +.+..+++|+.|++++|++++..+  ++.+++|+.+++++|++++.. .+..++.++.+++++|++++
T Consensus       225 ~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~-~~~~~~~l~~l~~~~n~l~~  299 (384)
T d2omza2         225 SLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLELNENQLED  299 (384)
T ss_dssp             ECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCSC
T ss_pred             ECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC-cccccccccccccccccccc
Confidence            666666653 2 245555666666666666664332  445555555555555555332 34455555555555555543


Q ss_pred             CCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCccccc
Q 001275          517 AIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRS  596 (1109)
Q Consensus       517 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~  596 (1109)
                        ...+..+.+++.|++++|++++..  .+..+++|++|++++|+|++ +| .++++++|++||+++|+|++..|  +.+
T Consensus       300 --~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~  371 (384)
T d2omza2         300 --ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LAN  371 (384)
T ss_dssp             --CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTT
T ss_pred             --ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hcc
Confidence              123445555555555555555432  24555555555555555552 22 35555555555555555553322  445


Q ss_pred             ccccceeccccc
Q 001275          597 WKSLSILKLSEN  608 (1109)
Q Consensus       597 l~~L~~L~L~~N  608 (1109)
                      +++|+.|+|++|
T Consensus       372 l~~L~~L~L~~N  383 (384)
T d2omza2         372 LTRITQLGLNDQ  383 (384)
T ss_dssp             CTTCSEEECCCE
T ss_pred             CCCCCEeeCCCC
Confidence            555555555544

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.93  E-value=2.7e-25  Score=246.37  Aligned_cols=271  Identities=21%  Similarity=0.290  Sum_probs=177.8

Q ss_pred             CCCceeeeEEecCCCCcEEEEEecccCCccccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC
Q 001275           56 STPCQWVGIECDDDAHNVVSFNLSSYGVSGQLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI  135 (1109)
Q Consensus        56 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~  135 (1109)
                      .|-|.|.+|.|+..            +++ .+|+.+.  +.+++|+|++|+|+...+.+|.++++|++|++++|.+....
T Consensus         7 ~c~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~   71 (305)
T d1xkua_           7 RCQCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS   71 (305)
T ss_dssp             TCEEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBC
T ss_pred             CCEecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccc
Confidence            34578889988752            222 4566553  67899999999998655567899999999999999999777


Q ss_pred             CccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeecccccCC--CCccccccc
Q 001275          136 PDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLS--GTIPESIGN  213 (1109)
Q Consensus       136 p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~  213 (1109)
                      |..|.++++|++|++++|+++ .+|..+.  ..++.|++++|.+.+..+..+.....+..++...|...  ...+..+..
T Consensus        72 ~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~  148 (305)
T d1xkua_          72 PGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG  148 (305)
T ss_dssp             TTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGG
T ss_pred             hhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccc
Confidence            888999999999999999888 5665433  46677777777777655555555566666666655433  122334444


Q ss_pred             ccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEE
Q 001275          214 CYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLD  293 (1109)
Q Consensus       214 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  293 (1109)
                      +++|+.+++++|.++.. |..                          .+++|+.|++++|..++..+..|.+++.++.|+
T Consensus       149 l~~L~~l~l~~n~l~~l-~~~--------------------------~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~  201 (305)
T d1xkua_         149 MKKLSYIRIADTNITTI-PQG--------------------------LPPSLTELHLDGNKITKVDAASLKGLNNLAKLG  201 (305)
T ss_dssp             CTTCCEEECCSSCCCSC-CSS--------------------------CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEE
T ss_pred             ccccCccccccCCcccc-Ccc--------------------------cCCccCEEECCCCcCCCCChhHhhccccccccc
Confidence            55555555555544422 111                          134555566666665555555666666666666


Q ss_pred             eecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCcc------ccCCCCccEEEcc
Q 001275          294 IVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDE------LGQLSNLQDLELF  367 (1109)
Q Consensus       294 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~------l~~l~~L~~L~L~  367 (1109)
                      +++|++++..+..+..+++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+......      ...+.+|+.|+|+
T Consensus       202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~  280 (305)
T d1xkua_         202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF  280 (305)
T ss_dssp             CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred             cccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECC
Confidence            6666666666666666666777777777666 45666666777777777777766432222      3345678888888


Q ss_pred             Ccccc
Q 001275          368 DNRLT  372 (1109)
Q Consensus       368 ~N~l~  372 (1109)
                      +|+++
T Consensus       281 ~N~~~  285 (305)
T d1xkua_         281 SNPVQ  285 (305)
T ss_dssp             SSSSC
T ss_pred             CCcCc
Confidence            88775

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.92  E-value=4.4e-24  Score=236.51  Aligned_cols=242  Identities=24%  Similarity=0.260  Sum_probs=150.8

Q ss_pred             cchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccC
Q 001275          265 LTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYA  344 (1109)
Q Consensus       265 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~  344 (1109)
                      ++++|-+++.++ .+|..+.  +++++|+|++|+|+...+.+|..+++|++|++++|.+....|..|.++++|+.|++++
T Consensus        12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~   88 (305)
T d1xkua_          12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK   88 (305)
T ss_dssp             TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence            344555555555 3444442  4677777777777755555677777777777777777766666777777777777777


Q ss_pred             cccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccC--CCCchhhhccCCCCeEEccCCcCccc
Q 001275          345 NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLL--GKLPLEMTELKQLKNISLYNNQFSGV  422 (1109)
Q Consensus       345 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~  422 (1109)
                      |+++ .+|..+  ...++.|++.+|.+.+..+..+.....+..++...|...  ...+..+..+++|+.+++++|.++. 
T Consensus        89 n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-  164 (305)
T d1xkua_          89 NQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-  164 (305)
T ss_dssp             SCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-
T ss_pred             CccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-
Confidence            7776 344332  346777777777777655555556666677777666543  2334556677777777777777763 


Q ss_pred             CCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCC
Q 001275          423 IPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNP  502 (1109)
Q Consensus       423 ~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~  502 (1109)
                      +|..+  .++|++|++++|.+++..+..+..++.+++|++++|++.+..+.++..+++|++|+|++|+++..++.|..++
T Consensus       165 l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~  242 (305)
T d1xkua_         165 IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK  242 (305)
T ss_dssp             CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCS
T ss_pred             cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccccccccccc
Confidence            44332  4667777777777776666666666677777777777766555555555555555555555543333344455


Q ss_pred             CCceEEeecCccC
Q 001275          503 VLSHLDVSRNNIS  515 (1109)
Q Consensus       503 ~L~~L~Ls~N~i~  515 (1109)
                      +|++|+|++|+|+
T Consensus       243 ~L~~L~Ls~N~i~  255 (305)
T d1xkua_         243 YIQVVYLHNNNIS  255 (305)
T ss_dssp             SCCEEECCSSCCC
T ss_pred             CCCEEECCCCccC
Confidence            5555555555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8e-25  Score=239.76  Aligned_cols=234  Identities=18%  Similarity=0.165  Sum_probs=136.9

Q ss_pred             CCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECC-CcccccCCCcccCCCCccchhhc
Q 001275          408 QLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMG-QNQFHGPIPSLLGSCPTLWRVIL  486 (1109)
Q Consensus       408 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~l~l  486 (1109)
                      .+++|+|++|+|+...+.+|..++.|++||+++|.+....+..+.....++.++.. .|.++...|..+.++++|+.|++
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l  112 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL  112 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence            34555555555554444445555555555555555554444444444445444432 33444444445555555555555


Q ss_pred             cCcccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeeccccccccc
Q 001275          487 KQNQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGS  565 (1109)
Q Consensus       487 ~~N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  565 (1109)
                      ++|.+....+. +.....|+.+++++|+|++..+..|.++++|+.|++++|++++..|..|.++++|+++++++|++++.
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i  192 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV  192 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence            55555444333 55566677777777777655566666677777777777777766666667777777777777777766


Q ss_pred             CCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCc
Q 001275          566 LPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSI  642 (1109)
Q Consensus       566 ~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~  642 (1109)
                      .|..|..+++|++||+++|++++..|..|..+++|++|++++|++.+..+. ..-...++.+....+++....|.++
T Consensus       193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l  268 (284)
T d1ozna_         193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL  268 (284)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred             ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHH
Confidence            677777777777777777777766666666777777777777777654331 1122345555555555554444444

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7.1e-25  Score=240.19  Aligned_cols=268  Identities=16%  Similarity=0.157  Sum_probs=227.9

Q ss_pred             CeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchhhcc-C
Q 001275          410 KNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRVILK-Q  488 (1109)
Q Consensus       410 ~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~-~  488 (1109)
                      ..++.++++++ .+|..+.  +++++|+|++|+|+...+..|..+++|++|++++|++....+..+..++.+..+... .
T Consensus        14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            34567777777 5676553  678999999999997777789999999999999999999999999999999888654 6


Q ss_pred             cccCCCCCC-CCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCC
Q 001275          489 NQLTGALPE-FSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLP  567 (1109)
Q Consensus       489 N~l~~~~~~-~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  567 (1109)
                      |.++...+. |..+++|++|++++|.+....+..+....+|+.+++++|+|++..+..|..+++|+.|++++|++++..|
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence            667666555 8999999999999999998888889999999999999999998778889999999999999999998888


Q ss_pred             ccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhh
Q 001275          568 SQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQD  647 (1109)
Q Consensus       568 ~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~  647 (1109)
                      ..|..+++|+.+++++|++++..|..|..+++|++|++++|++++..|..|+.+.+|+.|+|++|++.+.-+  +..+..
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~--~~~l~~  248 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWA  248 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG--GHHHHH
T ss_pred             hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc--chHHHH
Confidence            999999999999999999999999999999999999999999998888999999999999999999986543  222222


Q ss_pred             hhhhhcccccccccccCcchhhcccCCeEEccCCcccc
Q 001275          648 LSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTG  685 (1109)
Q Consensus       648 l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g  685 (1109)
                      -...+....+++....|..+.+   ...++|+.+.|+|
T Consensus       249 ~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g  283 (284)
T d1ozna_         249 WLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG  283 (284)
T ss_dssp             HHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred             HHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence            2245677778888788877654   4556677777766

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.9e-22  Score=218.21  Aligned_cols=201  Identities=23%  Similarity=0.213  Sum_probs=106.6

Q ss_pred             ccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCcccccCCCcccCCCCccchh
Q 001275          405 ELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQFHGPIPSLLGSCPTLWRV  484 (1109)
Q Consensus       405 ~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l  484 (1109)
                      +...+.+++.+++.++ .+|+.+.  +++++|||++|.|++..+..|..+++|++|+|++|+|+.               
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~---------------   69 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK---------------   69 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE---------------
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc---------------
Confidence            3445566677777776 3555443  456666666666665555556666666666666666652               


Q ss_pred             hccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccc
Q 001275          485 ILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEG  564 (1109)
Q Consensus       485 ~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  564 (1109)
                                +|.+..+++|++|+|++|+++ ..+..+.++++|++|++++|++.+..+..+..+.++++|++++|.++.
T Consensus        70 ----------l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~  138 (266)
T d1p9ag_          70 ----------LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT  138 (266)
T ss_dssp             ----------EECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred             ----------ccccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccce
Confidence                      222334444555555555554 234444445555555555555544444444445555555555555554


Q ss_pred             cCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCC
Q 001275          565 SLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLG  635 (1109)
Q Consensus       565 ~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  635 (1109)
                      ..+..+..+++|+.+++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.
T Consensus       139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             eccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            44444444555555555555555444444555555555555555555 45554545555555555555543

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=5.1e-22  Score=214.76  Aligned_cols=202  Identities=21%  Similarity=0.180  Sum_probs=163.1

Q ss_pred             hhcccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEE
Q 001275          381 RIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVL  460 (1109)
Q Consensus       381 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L  460 (1109)
                      +..++..++.++++++ .+|..+.  +.+++|+|++|+|++..+..|..+++|++|+|++|+|+. +| .+..+++|++|
T Consensus         8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L   82 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTL   82 (266)
T ss_dssp             CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEE
T ss_pred             ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccc
Confidence            3456777899999998 4676664  579999999999998878889999999999999999984 44 24567788888


Q ss_pred             ECCCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccC
Q 001275          461 NMGQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSG  540 (1109)
Q Consensus       461 ~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~  540 (1109)
                      +|++|++++                        ..+.+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++.
T Consensus        83 ~Ls~N~l~~------------------------~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~  138 (266)
T d1p9ag_          83 DLSHNQLQS------------------------LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT  138 (266)
T ss_dssp             ECCSSCCSS------------------------CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC
T ss_pred             ccccccccc------------------------cccccccccccccccccccccceeeccccccccccccccccccccce
Confidence            888887763                        22335566777788888888877777777788888888888888887


Q ss_pred             CcchhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccC
Q 001275          541 LMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTG  612 (1109)
Q Consensus       541 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  612 (1109)
                      ..+..+..+++|+.|++++|++++..+..|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus       139 l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             eccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            76777777888888888888888777777888888889999988888 788888888889999999998874

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.82  E-value=3.5e-19  Score=200.61  Aligned_cols=68  Identities=28%  Similarity=0.333  Sum_probs=39.9

Q ss_pred             hhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccccCcchhhcccCCeEEccCCcccccCCCCCccccceEEee
Q 001275          622 EKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGRIPSDLEKLSKLEQLDISSNNLTGTLSPLSNIHSLVEVNV  701 (1109)
Q Consensus       622 ~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~~~~l~~~~~l~~l~~  701 (1109)
                      ++|++|+|++|+++ .+|..++++    ..|+|++|+|+ .+|..   +++|++|+|++|+|+ .+|.+  ...|+.|.+
T Consensus       284 ~~L~~L~Ls~N~l~-~lp~~~~~L----~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~--~~~L~~L~~  351 (353)
T d1jl5a_         284 PSLEELNVSNNKLI-ELPALPPRL----ERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDI--PESVEDLRM  351 (353)
T ss_dssp             TTCCEEECCSSCCS-CCCCCCTTC----CEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCC--CTTCCEEEC
T ss_pred             CCCCEEECCCCccC-ccccccCCC----CEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCcc--ccccCeeEC
Confidence            45556666666665 556544433    24667777776 56643   346778888888877 56653  123555544

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.82  E-value=3.7e-21  Score=196.57  Aligned_cols=165  Identities=15%  Similarity=0.143  Sum_probs=120.4

Q ss_pred             CCCceeecccCeEEEEEEeCCCcEEEEEEeeecccc-----------------cChHHHHHHHHHHhcCCCCceeeEeeE
Q 001275          822 NAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHK-----------------RGSLSMKREIQTIGKIRHRNLVRLEDF  884 (1109)
Q Consensus       822 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~niv~l~~~  884 (1109)
                      .+.++||+|+||+||+|...+|+.||||++......                 .......+|+..+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            356889999999999999888999999986432110                 011245678999999999999988765


Q ss_pred             EecCCceeEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEEeccCCCCeeeCCCCcEEEe
Q 001275          885 WLRKDCGIIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYDCDPPIVHRDIKPENILLDSEMEPHIS  964 (1109)
Q Consensus       885 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  964 (1109)
                      .    ..+++|||++++.+.+          ++......++.|+++|++|||   +.+|+||||||+|||++++ .++++
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence            3    3479999998864432          333445689999999999999   8999999999999999865 58999


Q ss_pred             cccCCcccCCCCCCceeeecccCccccccc-----ccccCCCCccCcchhhHHHH
Q 001275          965 DFGIAKLLDKSPASTTSISVVGTIGYIAPE-----NAFTTAKSKESDVYSYGVVL 1014 (1109)
Q Consensus       965 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~sDvwSlGvil 1014 (1109)
                      |||.|+....+...          .|....     ....+.|..++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99999865432211          111110     01246678899999975443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.81  E-value=1.3e-18  Score=195.91  Aligned_cols=137  Identities=24%  Similarity=0.285  Sum_probs=78.0

Q ss_pred             CccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceeccc
Q 001275           96 KLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLN  175 (1109)
Q Consensus        96 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls  175 (1109)
                      ++++|||++|.++ .+|+.   +++|++|+|++|+|+ .+|+.+   .+|++|++++|+++ .++.-   ...|++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS  106 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence            5778888888887 56753   467888888888888 567653   56778888888776 33321   1246666666


Q ss_pred             ccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccC
Q 001275          176 NNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE  252 (1109)
Q Consensus       176 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  252 (1109)
                      +|.+. .+|. ++.+++|++|++++|.+... +..   ...+..+.+..+...  .+..+..++.++.|++++|...
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             ccccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc--ccccccccccceeccccccccc
Confidence            66665 3332 45556666666666555422 211   233444444444332  1223344444444444444443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=2.3e-21  Score=227.17  Aligned_cols=374  Identities=22%  Similarity=0.166  Sum_probs=189.7

Q ss_pred             CccEeecCCCccccc-CCCCCCCCCCCcEeeccCccccC----CCCccccccCccceecccccccccc----CCccccc-
Q 001275           96 KLQTIDLSSNNFSGN-IPPKLGNCSALEYLDLSTNGFTG----DIPDNFENLQNLQYLNLYGNLLDGE----IPEPLFR-  165 (1109)
Q Consensus        96 ~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~L~~L~~L~L~~n~l~~~----~p~~l~~-  165 (1109)
                      +|++||+++|++++. +.+-+..++++++|+|++|+++.    .++..+..+++|++|||++|.|+..    +...+.. 
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            355566666665532 12223445566666666665552    2233445556666666666655421    1111211 


Q ss_pred             ccccceecccccccccc----cccccCCCcccceeecccccCCCCcccccc-----cccCccEEEeccccccCcC----c
Q 001275          166 ILGLQYVFLNNNSLSGS----IPRNVGDLKEVEALWLFSNRLSGTIPESIG-----NCYRLQELYLNENKLMGFL----P  232 (1109)
Q Consensus       166 l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~~----~  232 (1109)
                      ..+|++|+|++|+++..    ++..+..+++|++|++++|.++......+.     ..............+....    .
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  162 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence            23466666666665532    334455566666666666665532211111     1112222333333222111    1


Q ss_pred             hhcccccccccccccCcccCCcccc----cc-cCCCCcchhccccccccCCC----CcccccccCCcEEEeecCCCCCc-
Q 001275          233 ESLSNLENLVYLDVGDNNLEGRINF----GS-EKCKNLTFLDLSYNRFSGGI----SPNLGNCSSLTHLDIVGSKLTGS-  302 (1109)
Q Consensus       233 ~~l~~l~~L~~L~L~~N~l~~~~~~----~~-~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~-  302 (1109)
                      ..+.....++.++++++........    .+ ........+++..+.+....    ...+...+.++.+++++|++... 
T Consensus       163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~  242 (460)
T d1z7xw1         163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  242 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence            1223344555566655554321100    00 11123344555555443211    12233456677777777765421 


Q ss_pred             ----CCccccccccccEEEcCCCCCCCC----CCCccccccccceeeccCcccCCCCCccc-----cCCCCccEEEccCc
Q 001275          303 ----IPSSFGLLARLSSLDLSENQLSGK----IPPELGKCKYLTVLHLYANQLEGEIPDEL-----GQLSNLQDLELFDN  369 (1109)
Q Consensus       303 ----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N  369 (1109)
                          .+..+.....++.+++++|.+...    ....+...+.++.+++++|.+.+.....+     .....|+.+++++|
T Consensus       243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~  322 (460)
T d1z7xw1         243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC  322 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence                222334456677777777776532    12234456677777777777754222221     12356778888888


Q ss_pred             cccccCchHHH----hhcccceeeccCCccCCCCc----hhhh-ccCCCCeEEccCCcCccc----CCccccCCCCCceE
Q 001275          370 RLTGEFPVSIW----RIASLEYLLVYNNNLLGKLP----LEMT-ELKQLKNISLYNNQFSGV----IPQSLGINSSLMQL  436 (1109)
Q Consensus       370 ~l~~~~~~~~~----~l~~L~~L~l~~N~l~~~~~----~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~~~~L~~L  436 (1109)
                      .++......+.    ...+|++|+|++|++++...    ..+. ..+.|++|+|++|.|+..    +++.+..+++|++|
T Consensus       323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L  402 (460)
T d1z7xw1         323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL  402 (460)
T ss_dssp             CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred             chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence            77755444333    34577788888777754322    2222 345677788888877642    33445556777777


Q ss_pred             EecCCcccccCCCCcc-----cCccceEEECCCccccc
Q 001275          437 DFINNSFTGEIPPNLC-----FGKQLRVLNMGQNQFHG  469 (1109)
Q Consensus       437 ~ls~N~l~~~~p~~~~-----~~~~L~~L~L~~N~l~~  469 (1109)
                      |+++|+|+......+.     +...|+.|++.+|++..
T Consensus       403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            7777777654433332     23357777777777653

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=2.1e-21  Score=227.46  Aligned_cols=383  Identities=20%  Similarity=0.146  Sum_probs=179.7

Q ss_pred             ccceeecccccCCCCc-ccccccccCccEEEeccccccCc----CchhcccccccccccccCcccCCcc----ccccc-C
Q 001275          192 EVEALWLFSNRLSGTI-PESIGNCYRLQELYLNENKLMGF----LPESLSNLENLVYLDVGDNNLEGRI----NFGSE-K  261 (1109)
Q Consensus       192 ~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~----~~~~~-~  261 (1109)
                      +|+.|+++.|++++.. .+-+..+++++.|+|++|.++..    ++.++...++|+.|||++|+|+...    ...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            5777888888877532 33356677777778877777632    3344566677777777777765321    11121 1


Q ss_pred             CCCcchhccccccccCC----CCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCcccccccc
Q 001275          262 CKNLTFLDLSYNRFSGG----ISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYL  337 (1109)
Q Consensus       262 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  337 (1109)
                      ..+|++|+|++|++++.    ++..+..+++|++|++++|.++......+...  +                 .......
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~--l-----------------~~~~~~~  143 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG--L-----------------LDPQCRL  143 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH--H-----------------TSTTCCC
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhc--c-----------------ccccccc
Confidence            23455555555555432    22334444555555555555442211111100  0                 0000111


Q ss_pred             ceeeccCcccCCC----CCccccCCCCccEEEccCccccccCchHHH-----hhcccceeeccCCccCCCC----chhhh
Q 001275          338 TVLHLYANQLEGE----IPDELGQLSNLQDLELFDNRLTGEFPVSIW-----RIASLEYLLVYNNNLLGKL----PLEMT  404 (1109)
Q Consensus       338 ~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~~----~~~~~  404 (1109)
                      .........+...    ....+.....++.++++++......-..+.     .......+++..+.+....    ...+.
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~  223 (460)
T d1z7xw1         144 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA  223 (460)
T ss_dssp             CEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHH
T ss_pred             ccccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccccccc
Confidence            1122221111100    001122345566666666654421111111     1123445555555543221    11234


Q ss_pred             ccCCCCeEEccCCcCccc-----CCccccCCCCCceEEecCCcccccCC----CCcccCccceEEECCCcccccCCCccc
Q 001275          405 ELKQLKNISLYNNQFSGV-----IPQSLGINSSLMQLDFINNSFTGEIP----PNLCFGKQLRVLNMGQNQFHGPIPSLL  475 (1109)
Q Consensus       405 ~l~~L~~L~L~~N~l~~~-----~p~~~~~~~~L~~L~ls~N~l~~~~p----~~~~~~~~L~~L~L~~N~l~~~~p~~~  475 (1109)
                      ..+.++.+++++|++...     .+........++.+++++|.+.....    ..+...+.++.+++++|++.......+
T Consensus       224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l  303 (460)
T d1z7xw1         224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL  303 (460)
T ss_dssp             HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred             ccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchh
Confidence            456666677766665321     12222334566666666666553211    122334556666666666542111110


Q ss_pred             CCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcc----cccccccEEeccCCcccCCc----chhhh
Q 001275          476 GSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSI----GNSINLTSIDFSSNKFSGLM----PQELG  547 (1109)
Q Consensus       476 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~----p~~~~  547 (1109)
                      ..                .+  ......|+.+++++|.++......+    ....+|++|||++|++++..    +..+.
T Consensus       304 ~~----------------~l--~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~  365 (460)
T d1z7xw1         304 CE----------------TL--LEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLG  365 (460)
T ss_dssp             HH----------------HH--TSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred             hc----------------cc--cccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhh
Confidence            00                00  1122456677777776664432322    23346777777777765432    22222


Q ss_pred             -cccccceeeccccccccc----CCccccCCCCccEEEecCccccCCCCccc----c-cccccceecccccccc
Q 001275          548 -NLVSLVTLNISLNHVEGS----LPSQLSKCKNLEVFDVSFNLLNGSIPSSL----R-SWKSLSILKLSENHFT  611 (1109)
Q Consensus       548 -~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~ls~N~l~~~~p~~~----~-~l~~L~~L~L~~N~l~  611 (1109)
                       ..+.|++|+|++|+|++.    ++..+..+++|++|||++|+|+......+    . ....|+.|++++|++.
T Consensus       366 ~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             STTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             cccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence             234566777777766532    33445556667777777776654322222    1 1224566666665555

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=4.5e-18  Score=178.73  Aligned_cols=77  Identities=23%  Similarity=0.306  Sum_probs=31.6

Q ss_pred             ccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhccccee
Q 001275          309 LLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYL  388 (1109)
Q Consensus       309 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  388 (1109)
                      ..++|+.|++++|.+++.  ..++++++|+.|+|++|++++ ++ .++++++|++|+|++|++++ ++ .+.++++|++|
T Consensus       149 ~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~-i~-~l~~l~~L~~L  222 (227)
T d1h6ua2         149 GLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD-VS-PLANTSNLFIV  222 (227)
T ss_dssp             GCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB-CG-GGTTCTTCCEE
T ss_pred             cccccccccccccccccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC-Cc-ccccCCCCCEE
Confidence            334444444444444321  123444444444444444442 21 14444444444444444442 22 13444444444


Q ss_pred             ecc
Q 001275          389 LVY  391 (1109)
Q Consensus       389 ~l~  391 (1109)
                      +++
T Consensus       223 ~ls  225 (227)
T d1h6ua2         223 TLT  225 (227)
T ss_dssp             EEE
T ss_pred             Eee
Confidence            443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.73  E-value=8e-18  Score=171.56  Aligned_cols=154  Identities=16%  Similarity=0.236  Sum_probs=109.4

Q ss_pred             CCCceEEeecCccCCCC-CCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEE
Q 001275          502 PVLSHLDVSRNNISGAI-PSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFD  580 (1109)
Q Consensus       502 ~~L~~L~Ls~N~i~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  580 (1109)
                      +.+++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..+..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            46778888888887544 55667788888888888888877778888888888888888888877777788888888888


Q ss_pred             ecCccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccc
Q 001275          581 VSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLT  660 (1109)
Q Consensus       581 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~  660 (1109)
                      |++|+|++..|..|..+++|++|+|++|.+....+ ...-...++.+.+..|.++...|..+.+   + ..++|+.|.|+
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l~~---~-~l~~L~~n~l~  183 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVRD---V-QIKDLPHSEFK  183 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTTTT---S-BGGGSCTTTCC
T ss_pred             cCCccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCChhhcC---C-EeeecCHhhCc
Confidence            88888887777778888888888888888874332 2222334666666666666555544333   2 23555555554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=6.2e-18  Score=177.63  Aligned_cols=144  Identities=22%  Similarity=0.284  Sum_probs=87.5

Q ss_pred             cCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccce
Q 001275          260 EKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTV  339 (1109)
Q Consensus       260 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  339 (1109)
                      ..+++|+++++++|.++. + ..+..+++|+.++++++...+.  ..+...+.++.+.++.+.+...  ..+..+++|+.
T Consensus        82 ~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~  155 (227)
T d1h6ua2          82 KNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQY  155 (227)
T ss_dssp             TTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCE
T ss_pred             cccccccccccccccccc-c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhcccccccc
Confidence            333444444444444432 1 2344555556666655555432  2244556667777777776532  33566777777


Q ss_pred             eeccCcccCCCCCccccCCCCccEEEccCccccccCchHHHhhcccceeeccCCccCCCCchhhhccCCCCeEEcc
Q 001275          340 LHLYANQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASLEYLLVYNNNLLGKLPLEMTELKQLKNISLY  415 (1109)
Q Consensus       340 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~  415 (1109)
                      |++++|.+.+.  ..++++++|++|+|++|++++ ++ .+..+++|++|++++|++++..  .+.++++|+.|+++
T Consensus       156 L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         156 LSIGNAQVSDL--TPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT  225 (227)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred             ccccccccccc--hhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence            77777777643  236777777778887777774 33 3667777777888777777533  26677777777775

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.72  E-value=3.9e-18  Score=173.92  Aligned_cols=173  Identities=17%  Similarity=0.278  Sum_probs=145.5

Q ss_pred             CceEEeecCccCCCCCCcccccccccEEeccCCcccCCc-chhhhcccccceeecccccccccCCccccCCCCccEEEec
Q 001275          504 LSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLM-PQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVS  582 (1109)
Q Consensus       504 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls  582 (1109)
                      .+.++.++|+++ .+|..+.  +++++|+|++|+|++.+ +..|+++++|+.|+|++|++.+..+..+..+++|+.|+|+
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            357899999998 6787764  68999999999998644 5678999999999999999999999999999999999999


Q ss_pred             CccccCCCCcccccccccceeccccccccCCCcchhhhhhhhhhhhcccCcCCCCCCCCchhhhhhhhhhcccccccccc
Q 001275          583 FNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELEKLLELQLGGNQLGGEIPPSIGALQDLSYALNLSKNGLTGR  662 (1109)
Q Consensus       583 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~l~~~L~L~~N~l~g~  662 (1109)
                      +|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++....+  +..+......+.+..|.++..
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~--~~~~~~~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH--LAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG--GHHHHHHHHHHCCSGGGCBBC
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc--hHHHhhhhhhhcccCCCeEeC
Confidence            999998878899999999999999999998778889999999999999999985432  222222224678888888877


Q ss_pred             cCcchhhcccCCeEEccCCccc
Q 001275          663 IPSDLEKLSKLEQLDISSNNLT  684 (1109)
Q Consensus       663 ip~~l~~l~~L~~L~Ls~N~l~  684 (1109)
                      .|..+   .+++.+||+.|+|+
T Consensus       165 ~p~~l---~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         165 APSKV---RDVQIKDLPHSEFK  183 (192)
T ss_dssp             SSTTT---TTSBGGGSCTTTCC
T ss_pred             CChhh---cCCEeeecCHhhCc
Confidence            77654   45667788888876

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=1.5e-17  Score=176.62  Aligned_cols=210  Identities=15%  Similarity=0.121  Sum_probs=120.0

Q ss_pred             ccCCcccCCCCccEeecCCCcccccCCCCCCCCCCCcEeeccCccccCCC-CccccccCccceecccc-ccccccCCccc
Q 001275           86 QLGPEIGHLSKLQTIDLSSNNFSGNIPPKLGNCSALEYLDLSTNGFTGDI-PDNFENLQNLQYLNLYG-NLLDGEIPEPL  163 (1109)
Q Consensus        86 ~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~L~~L~~L~L~~-n~l~~~~p~~l  163 (1109)
                      .+|+.+.  +++++|+|++|+++...+..|.++++|++|+|++|.+...+ +..|.+++++++|++.. |.+....+..+
T Consensus        22 ~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~   99 (242)
T d1xwdc1          22 EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF   99 (242)
T ss_dssp             SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSE
T ss_pred             CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccc
Confidence            4555442  46777888877777554556777777777777777776543 34567777777777653 45554455555


Q ss_pred             ccccccceecccccccccccccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhccccc-ccc
Q 001275          164 FRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLE-NLV  242 (1109)
Q Consensus       164 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~  242 (1109)
                      ..+++|++|++++|++....+.                       ..+..++.++.+..+++++....+..|.+++ .++
T Consensus       100 ~~l~~L~~l~l~~~~l~~~~~~-----------------------~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~  156 (242)
T d1xwdc1         100 QNLPNLQYLLISNTGIKHLPDV-----------------------HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV  156 (242)
T ss_dssp             ECCTTCCEEEEESCCCCSCCCC-----------------------TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCE
T ss_pred             cccccccccccchhhhcccccc-----------------------cccccccccccccccccccccccccccccccccce
Confidence            5555666666655555422111                       1123334444444455555544444444443 455


Q ss_pred             cccccCcccCCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCC
Q 001275          243 YLDVGDNNLEGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSE  320 (1109)
Q Consensus       243 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  320 (1109)
                      .|++++|+++...+..+....-++.+++++|+++...+..|.++++|++|++++|+++...+..|..+++|+.+++.+
T Consensus       157 ~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             EEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             eeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            566666666544333333222233334566666654445567777777777777777755555666666666666543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=3.2e-17  Score=174.02  Aligned_cols=198  Identities=11%  Similarity=0.007  Sum_probs=109.0

Q ss_pred             CCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCC-CCcccCccceEEECC-CcccccCCCcccCCCCccchhh
Q 001275          408 QLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIP-PNLCFGKQLRVLNMG-QNQFHGPIPSLLGSCPTLWRVI  485 (1109)
Q Consensus       408 ~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p-~~~~~~~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~l~  485 (1109)
                      ++++|++++|+|+...+..|..+++|++|++++|.+...++ ..|..+.+++++++. .|++....+..+.++++|+.++
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            44555555555544333344445555555555555443322 233444455555443 2444444445555555555555


Q ss_pred             ccCcccCCCCCC--CCCCCCCceEEeecCccCCCCCCcccccc-cccEEeccCCcccCCcchhhhcccccce-eeccccc
Q 001275          486 LKQNQLTGALPE--FSKNPVLSHLDVSRNNISGAIPSSIGNSI-NLTSIDFSSNKFSGLMPQELGNLVSLVT-LNISLNH  561 (1109)
Q Consensus       486 l~~N~l~~~~~~--~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~L~~N~  561 (1109)
                      +++|+++...+.  +..+..+..+..+++++....+..+.++. .++.|++++|+++.. +....+..+++. +++++|+
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i-~~~~~~~~~l~~~~~l~~n~  188 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI-HNCAFNGTQLDELNLSDNNN  188 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEE-CTTTTTTCCEEEEECTTCTT
T ss_pred             cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccc-ccccccchhhhccccccccc
Confidence            555555432221  33445555666666677655556666554 677778888877743 333344444443 3567777


Q ss_pred             ccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccc
Q 001275          562 VEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS  606 (1109)
Q Consensus       562 l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~  606 (1109)
                      ++...+..|.++++|++|||++|+|+...+..|.++++|+.+++.
T Consensus       189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            774444557777788888888777774434556677777666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.69  E-value=2.3e-17  Score=170.66  Aligned_cols=180  Identities=22%  Similarity=0.255  Sum_probs=87.2

Q ss_pred             eeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEECCCccc
Q 001275          388 LLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNMGQNQF  467 (1109)
Q Consensus       388 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l  467 (1109)
                      ..+..+.+++.++.  ..+.+|+.|++++|.+++..  .+..+++|++|++++|+|++..  .+..+++|++|++++|+|
T Consensus        29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i  102 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKV  102 (210)
T ss_dssp             HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred             HHhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccc
Confidence            34444555443332  23455566666666655321  2445555555555555555322  234455555555555555


Q ss_pred             ccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhh
Q 001275          468 HGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELG  547 (1109)
Q Consensus       468 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  547 (1109)
                      ++                         +|.+..+++|+.|++++|.+.. + ..+..+++++.+++++|++++  +..+.
T Consensus       103 ~~-------------------------l~~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~  153 (210)
T d1h6ta2         103 KD-------------------------LSSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLS  153 (210)
T ss_dssp             CC-------------------------GGGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGG
T ss_pred             cc-------------------------cccccccccccccccccccccc-c-ccccccccccccccccccccc--ccccc
Confidence            42                         1223344444445554444431 1 234444555555555555542  22344


Q ss_pred             cccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccc
Q 001275          548 NLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLS  606 (1109)
Q Consensus       548 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~  606 (1109)
                      .+++|+++++++|++++ ++ .++++++|+.|+|++|+|+ .+| .+.++++|++|+|+
T Consensus       154 ~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         154 RLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             GCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEE
T ss_pred             ccccccccccccccccc-cc-cccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEcc
Confidence            45555555555555553 22 1455555555555555555 233 35555555555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=4.8e-17  Score=166.74  Aligned_cols=181  Identities=25%  Similarity=0.314  Sum_probs=92.3

Q ss_pred             cccceeeccCCccCCCCchhhhccCCCCeEEccCCcCcccCCccccCCCCCceEEecCCcccccCCCCcccCccceEEEC
Q 001275          383 ASLEYLLVYNNNLLGKLPLEMTELKQLKNISLYNNQFSGVIPQSLGINSSLMQLDFINNSFTGEIPPNLCFGKQLRVLNM  462 (1109)
Q Consensus       383 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~L  462 (1109)
                      .....+.++.+.+++.++  ...+.+++.|++++|.++..  +.+..+++|++|++++|++++..|  +..+++|+.|++
T Consensus        18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l   91 (199)
T d2omxa2          18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM   91 (199)
T ss_dssp             HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence            334444566666654332  24556666777777666532  224445555555555555553221  444444555555


Q ss_pred             CCcccccCCCcccCCCCccchhhccCcccCCCCCCCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCc
Q 001275          463 GQNQFHGPIPSLLGSCPTLWRVILKQNQLTGALPEFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLM  542 (1109)
Q Consensus       463 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  542 (1109)
                      ++|.+..                         ++.+..++.|++|++++|.+...  ..+..+++|+.|++++|++.. +
T Consensus        92 ~~n~~~~-------------------------~~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~  143 (199)
T d2omxa2          92 NNNQIAD-------------------------ITPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I  143 (199)
T ss_dssp             CSSCCCC-------------------------CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C
T ss_pred             ccccccc-------------------------ccccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c
Confidence            5444431                         22244455555555555555432  234455556666666665552 2


Q ss_pred             chhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccce
Q 001275          543 PQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSI  602 (1109)
Q Consensus       543 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~  602 (1109)
                      | .+..+++|++|++++|++++. + .++++++|+.|++++|++++ +| .++.+++|+.
T Consensus       144 ~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~  198 (199)
T d2omxa2         144 S-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVSD-IS-VLAKLTNLES  198 (199)
T ss_dssp             G-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSE
T ss_pred             c-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCc
Confidence            2 355555566666666655532 2 25555666666666666653 32 3455555544

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.68  E-value=4.7e-17  Score=168.33  Aligned_cols=163  Identities=28%  Similarity=0.350  Sum_probs=73.3

Q ss_pred             CcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhc
Q 001275          190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD  269 (1109)
Q Consensus       190 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  269 (1109)
                      +.+|++|++++|.++..  ..+..+++|++|+|++|++++..  .++++++|++|++++|++++..  .+..+++|+.|+
T Consensus        45 L~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~  118 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLS  118 (210)
T ss_dssp             HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEE
T ss_pred             hcCccEEECcCCCCCCc--hhHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc--cccccccccccc
Confidence            44555555555555432  12455555555555555555432  2344555555555555554321  234444444444


Q ss_pred             cccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceeeccCcccCC
Q 001275          270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLHLYANQLEG  349 (1109)
Q Consensus       270 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~  349 (1109)
                      +++|.+..  ...+..+++++.+++++|.+++  +..+..+++|+.+++++|++++. + .++++++|+.|+|++|++++
T Consensus       119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~  192 (210)
T d1h6ta2         119 LEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD  192 (210)
T ss_dssp             CTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB
T ss_pred             cccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC
Confidence            44444432  1234444444444444444442  12233444444444444444421 1 14444444444444444442


Q ss_pred             CCCccccCCCCccEEEc
Q 001275          350 EIPDELGQLSNLQDLEL  366 (1109)
Q Consensus       350 ~~p~~l~~l~~L~~L~L  366 (1109)
                       +| .+..+++|++|+|
T Consensus       193 -l~-~l~~l~~L~~L~L  207 (210)
T d1h6ta2         193 -LR-ALAGLKNLDVLEL  207 (210)
T ss_dssp             -CG-GGTTCTTCSEEEE
T ss_pred             -Ch-hhcCCCCCCEEEc
Confidence             22 2444444444444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.67  E-value=8.3e-17  Score=164.94  Aligned_cols=125  Identities=25%  Similarity=0.335  Sum_probs=51.6

Q ss_pred             CcccceeecccccCCCCcccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCcccccccCCCCcchhc
Q 001275          190 LKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSEKCKNLTFLD  269 (1109)
Q Consensus       190 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  269 (1109)
                      +.++++|++++|.++..  +.++.+++|++|++++|++++..|  +.++++|++|++++|.+....  .+..+++|+.|+
T Consensus        39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~  112 (199)
T d2omxa2          39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT  112 (199)
T ss_dssp             HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred             hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccccc--cccccccccccc
Confidence            34444555555544421  234445555555555555544322  444444555544444443221  133344444444


Q ss_pred             cccccccCCCCcccccccCCcEEEeecCCCCCcCCccccccccccEEEcCCCCCC
Q 001275          270 LSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSIPSSFGLLARLSSLDLSENQLS  324 (1109)
Q Consensus       270 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  324 (1109)
                      +++|.+...  ..+..+++|+.|++++|++.. + +.+..+++|+.|++++|+++
T Consensus       113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~  163 (199)
T d2omxa2         113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVT  163 (199)
T ss_dssp             CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC
T ss_pred             ccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccccccccccccccc
Confidence            444433321  123333444444444444331 1 12333344444444444443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=1.6e-15  Score=164.42  Aligned_cols=94  Identities=21%  Similarity=0.206  Sum_probs=51.8

Q ss_pred             cccccccEEEcCCC-CCCCCCCCccccccccceeeccC-cccCCCCCccccCCCCccEEEccCccccccCchHHHhhccc
Q 001275          308 GLLARLSSLDLSEN-QLSGKIPPELGKCKYLTVLHLYA-NQLEGEIPDELGQLSNLQDLELFDNRLTGEFPVSIWRIASL  385 (1109)
Q Consensus       308 ~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  385 (1109)
                      ..+++|++|++++| .+++.....+.++++|++|++++ +.+++.....++++++|++|+++++ +++..-..+.  ..+
T Consensus       172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~--~~l  248 (284)
T d2astb2         172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLK--EAL  248 (284)
T ss_dssp             HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHH--HHS
T ss_pred             cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHH--HhC
Confidence            34556666666654 34544555566666666666666 3455555556666777777777766 3322222221  234


Q ss_pred             ceeeccCCccCCCCchhhh
Q 001275          386 EYLLVYNNNLLGKLPLEMT  404 (1109)
Q Consensus       386 ~~L~l~~N~l~~~~~~~~~  404 (1109)
                      ..|.+..+++++..+..++
T Consensus       249 p~L~i~~~~ls~~~~~~~~  267 (284)
T d2astb2         249 PHLQINCSHFTTIARPTIG  267 (284)
T ss_dssp             TTSEESCCCSCCTTCSSCS
T ss_pred             ccccccCccCCCCCCCccC
Confidence            4445566666655554444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=3.2e-15  Score=162.00  Aligned_cols=179  Identities=20%  Similarity=0.236  Sum_probs=72.4

Q ss_pred             Cccceecccccccccc-CCcccccccccceecccccccccccccccCCCcccceeecccc-cCCCC-cccccccccCccE
Q 001275          143 QNLQYLNLYGNLLDGE-IPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSN-RLSGT-IPESIGNCYRLQE  219 (1109)
Q Consensus       143 ~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~  219 (1109)
                      .+|++|||++|.++.. ++..+..+++|++|++++|.+++..+..++.+++|++|+++++ .++.. +..-+.++++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            3455555555444322 2222334444555555555444444444555555555555553 23211 1111234455555


Q ss_pred             EEeccc-cccCc-Cchhccc-ccccccccccCc--ccCCc-ccccccCCCCcchhccccc-cccCCCCcccccccCCcEE
Q 001275          220 LYLNEN-KLMGF-LPESLSN-LENLVYLDVGDN--NLEGR-INFGSEKCKNLTFLDLSYN-RFSGGISPNLGNCSSLTHL  292 (1109)
Q Consensus       220 L~L~~N-~l~~~-~~~~l~~-l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L  292 (1109)
                      |+++++ .++.. ....+.. .++|+.|+++++  .++.. +...+..+++|++|++++| .+++.....+..+++|++|
T Consensus       126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L  205 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL  205 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred             cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence            555553 22211 1112222 234555555432  22211 1111223444444444443 2333333344444444444


Q ss_pred             EeecC-CCCCcCCccccccccccEEEcCCC
Q 001275          293 DIVGS-KLTGSIPSSFGLLARLSSLDLSEN  321 (1109)
Q Consensus       293 ~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N  321 (1109)
                      ++++| .+++.....++.+++|+.|+++++
T Consensus       206 ~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         206 SLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             ECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            44442 333333333444444444444443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.44  E-value=7.7e-14  Score=129.92  Aligned_cols=102  Identities=23%  Similarity=0.309  Sum_probs=68.6

Q ss_pred             ceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCccEEEecCc
Q 001275          505 SHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFN  584 (1109)
Q Consensus       505 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N  584 (1109)
                      +.|+|++|+|+ .++ .++.+++|++||+++|+|+ .+|..++.+++|++|++++|+|++ +| .++.+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            35777777776 344 3677777777777777776 356667777777777777777773 44 3677777777777777


Q ss_pred             cccCCC-Ccccccccccceecccccccc
Q 001275          585 LLNGSI-PSSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       585 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      +|++.. +..+..+++|+.|++++|+++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            776332 145666677777777777766

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.44  E-value=1.9e-15  Score=169.12  Aligned_cols=258  Identities=18%  Similarity=0.186  Sum_probs=128.4

Q ss_pred             CCCCCCCCCCcEeeccCccccC----CCCccccccCccceecccccccccc---CCcccccccccceecccccccccccc
Q 001275          112 PPKLGNCSALEYLDLSTNGFTG----DIPDNFENLQNLQYLNLYGNLLDGE---IPEPLFRILGLQYVFLNNNSLSGSIP  184 (1109)
Q Consensus       112 p~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~L~~L~~L~L~~n~l~~~---~p~~l~~l~~L~~L~Ls~n~l~~~~p  184 (1109)
                      ...+.....|++|+|++|.+..    .+...+...++|+.|+++++.....   .|..+                 ..+.
T Consensus        24 ~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~-----------------~~l~   86 (344)
T d2ca6a1          24 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL-----------------RLLL   86 (344)
T ss_dssp             SHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHH-----------------HHHH
T ss_pred             HHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHH-----------------HHHH
Confidence            3445556667777777776642    1223455566666666666543211   01000                 0122


Q ss_pred             cccCCCcccceeecccccCCCC----cccccccccCccEEEeccccccCcCchhcccccccccccccCcccCCccccccc
Q 001275          185 RNVGDLKEVEALWLFSNRLSGT----IPESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLEGRINFGSE  260 (1109)
Q Consensus       185 ~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~  260 (1109)
                      ..+...++|++|+|++|.++..    +...+...++|++|++++|.++......++.  .|..+...         ....
T Consensus        87 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~~~~---------~~~~  155 (344)
T d2ca6a1          87 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQELAVN---------KKAK  155 (344)
T ss_dssp             HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHHHHH---------HHHH
T ss_pred             HHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccc--cccccccc---------cccc
Confidence            3445556677777777766653    2233445667777777777664322111111  00000000         0011


Q ss_pred             CCCCcchhccccccccCC----CCcccccccCCcEEEeecCCCCCc-----CCccccccccccEEEcCCCCCCCC----C
Q 001275          261 KCKNLTFLDLSYNRFSGG----ISPNLGNCSSLTHLDIVGSKLTGS-----IPSSFGLLARLSSLDLSENQLSGK----I  327 (1109)
Q Consensus       261 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~  327 (1109)
                      ..+.|+.+++++|.++..    +...+...+.|+.|++++|+++..     +...+...++|+.|+|++|.++..    +
T Consensus       156 ~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L  235 (344)
T d2ca6a1         156 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL  235 (344)
T ss_dssp             TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHH
T ss_pred             cCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccc
Confidence            223344444444444321    112233345555555555555421     223345556666666666665421    2


Q ss_pred             CCccccccccceeeccCcccCCCCCccc----cC--CCCccEEEccCccccccCc----hHHH-hhcccceeeccCCccC
Q 001275          328 PPELGKCKYLTVLHLYANQLEGEIPDEL----GQ--LSNLQDLELFDNRLTGEFP----VSIW-RIASLEYLLVYNNNLL  396 (1109)
Q Consensus       328 p~~l~~l~~L~~L~L~~N~l~~~~p~~l----~~--l~~L~~L~L~~N~l~~~~~----~~~~-~l~~L~~L~l~~N~l~  396 (1109)
                      ...+..+++|++|+|++|.|++.....+    ..  .+.|++|++++|+|+....    ..+. +.++|++|++++|++.
T Consensus       236 ~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             cccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            2344556666666766666654322222    22  3567778888877765322    2232 3567888888888876


Q ss_pred             C
Q 001275          397 G  397 (1109)
Q Consensus       397 ~  397 (1109)
                      .
T Consensus       316 ~  316 (344)
T d2ca6a1         316 E  316 (344)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=2.4e-14  Score=140.37  Aligned_cols=127  Identities=21%  Similarity=0.181  Sum_probs=78.2

Q ss_pred             CCCCCCCCceEEeecCccCCCCCCcccccccccEEeccCCcccCCcchhhhcccccceeecccccccccCCccccCCCCc
Q 001275          497 EFSKNPVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSNKFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNL  576 (1109)
Q Consensus       497 ~~~~~~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L  576 (1109)
                      .|.+...|++|+|++|+|+ .+|..+..+++|+.||||+|+|+. ++ .+..+++|++|++++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3445556677777777776 445555666677777777777763 22 46666677777777777764444444556777


Q ss_pred             cEEEecCccccCCCC--cccccccccceeccccccccCCCcc----hhhhhhhhhhhh
Q 001275          577 EVFDVSFNLLNGSIP--SSLRSWKSLSILKLSENHFTGGIPT----FISELEKLLELQ  628 (1109)
Q Consensus       577 ~~L~ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~  628 (1109)
                      +.|++++|+|+ .++  ..+..+++|+.|++++|+++ ..|.    .+..+++|+.||
T Consensus        90 ~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             ccceecccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            77777777766 333  34566667777777777666 3332    355566666555

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.44  E-value=3.6e-15  Score=166.89  Aligned_cols=225  Identities=19%  Similarity=0.200  Sum_probs=149.3

Q ss_pred             ccCCCcccceeecccccCCCC----------cccccccccCccEEEeccccccCcC----chhcccccccccccccCccc
Q 001275          186 NVGDLKEVEALWLFSNRLSGT----------IPESIGNCYRLQELYLNENKLMGFL----PESLSNLENLVYLDVGDNNL  251 (1109)
Q Consensus       186 ~l~~l~~L~~L~L~~N~l~~~----------~p~~l~~l~~L~~L~L~~N~l~~~~----~~~l~~l~~L~~L~L~~N~l  251 (1109)
                      .+...++|+.|+++++.....          +...+..+++|++|+|++|.++...    ...+...++|++|++++|.+
T Consensus        54 ~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l  133 (344)
T d2ca6a1          54 NIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL  133 (344)
T ss_dssp             TTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred             HHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheecccccc
Confidence            344556666666665544321          1223445677888888888776542    23344567777777777766


Q ss_pred             CCcccccccCCCCcchhccccccccCCCCcccccccCCcEEEeecCCCCCcC----CccccccccccEEEcCCCCCCCC-
Q 001275          252 EGRINFGSEKCKNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGSKLTGSI----PSSFGLLARLSSLDLSENQLSGK-  326 (1109)
Q Consensus       252 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~-  326 (1109)
                      +......+.  ..+..+....         .....+.|+.+++++|+++...    ...+...+.|+.|+|++|+++.. 
T Consensus       134 ~~~~~~~l~--~~l~~~~~~~---------~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g  202 (344)
T d2ca6a1         134 GPQAGAKIA--RALQELAVNK---------KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG  202 (344)
T ss_dssp             HHHHHHHHH--HHHHHHHHHH---------HHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHH
T ss_pred             ccccccccc--cccccccccc---------ccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccc
Confidence            422111111  1122221111         1234568999999999987432    33456678999999999998732 


Q ss_pred             ----CCCccccccccceeeccCcccCCC----CCccccCCCCccEEEccCccccccCchHHHh------hcccceeeccC
Q 001275          327 ----IPPELGKCKYLTVLHLYANQLEGE----IPDELGQLSNLQDLELFDNRLTGEFPVSIWR------IASLEYLLVYN  392 (1109)
Q Consensus       327 ----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~l~~  392 (1109)
                          +...+..+++|+.|+|++|.++..    +...+...++|++|+|++|.|++.....++.      ...|+.|++++
T Consensus       203 ~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~  282 (344)
T d2ca6a1         203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY  282 (344)
T ss_dssp             HHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCS
T ss_pred             cccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCC
Confidence                345678889999999999998643    3345678899999999999998765554432      35799999999


Q ss_pred             CccCCCCc----hhhh-ccCCCCeEEccCCcCcc
Q 001275          393 NNLLGKLP----LEMT-ELKQLKNISLYNNQFSG  421 (1109)
Q Consensus       393 N~l~~~~~----~~~~-~l~~L~~L~L~~N~l~~  421 (1109)
                      |+++....    ..+. ++++|+.|+|++|+|..
T Consensus       283 N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             SCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             CcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            99875432    3332 57899999999999974

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=4e-14  Score=138.83  Aligned_cols=128  Identities=16%  Similarity=0.119  Sum_probs=63.4

Q ss_pred             CCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccc
Q 001275          115 LGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVE  194 (1109)
Q Consensus       115 l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~  194 (1109)
                      +.++.+|++|||++|+|+ .+|..+..+++|++|+|++|+|+ .++ .+..+++|++|++++|+++...+..+..+++|+
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~   90 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT   90 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence            334445555555555555 23444445555555555555554 222 344445555555555555433333334455555


Q ss_pred             eeecccccCCCCcc-cccccccCccEEEeccccccCcC---chhccccccccccc
Q 001275          195 ALWLFSNRLSGTIP-ESIGNCYRLQELYLNENKLMGFL---PESLSNLENLVYLD  245 (1109)
Q Consensus       195 ~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~---~~~l~~l~~L~~L~  245 (1109)
                      +|++++|+++.... ..+..+++|++|++++|.++...   +..+..+++|++||
T Consensus        91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            55555555543211 24555566666666666655322   12345555555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.42  E-value=1.9e-13  Score=127.26  Aligned_cols=101  Identities=28%  Similarity=0.385  Sum_probs=51.2

Q ss_pred             EeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCcccceeeccccc
Q 001275          123 YLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEVEALWLFSNR  202 (1109)
Q Consensus       123 ~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~  202 (1109)
                      +|||++|+++ .++ .++++++|++|++++|+++ .+|..++.+++|+.|++++|+|++ +| .++.+++|++|++++|+
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            4444444444 222 2444445555555555444 344444444444444444444442 22 25555666666666666


Q ss_pred             CCCCc-ccccccccCccEEEecccccc
Q 001275          203 LSGTI-PESIGNCYRLQELYLNENKLM  228 (1109)
Q Consensus       203 l~~~~-p~~l~~l~~L~~L~L~~N~l~  228 (1109)
                      ++... ...++.+++|++|++++|.++
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            65332 234566666666666666665

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.31  E-value=5e-14  Score=143.21  Aligned_cols=87  Identities=25%  Similarity=0.318  Sum_probs=39.3

Q ss_pred             chhhhcccccceeecccccccccCCccccCCCCccEEEecCccccCCCCcccccccccceeccccccccCCCcchhhhhh
Q 001275          543 PQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFDVSFNLLNGSIPSSLRSWKSLSILKLSENHFTGGIPTFISELE  622 (1109)
Q Consensus       543 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  622 (1109)
                      |..+..+++|++|+|++|+|+ .++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++ .++ .+..++
T Consensus        41 ~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~  115 (198)
T d1m9la_          41 DATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHH
T ss_pred             hhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccccc
Confidence            444555555555555555554 222 2444555555555555554 33433333444444455444444 221 233444


Q ss_pred             hhhhhhcccCcC
Q 001275          623 KLLELQLGGNQL  634 (1109)
Q Consensus       623 ~L~~L~l~~N~l  634 (1109)
                      +|+.|++++|++
T Consensus       116 ~L~~L~L~~N~i  127 (198)
T d1m9la_         116 NLRVLYMSNNKI  127 (198)
T ss_dssp             HSSEEEESEEEC
T ss_pred             cccccccccchh
Confidence            444444444443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.27  E-value=7.9e-14  Score=141.67  Aligned_cols=110  Identities=28%  Similarity=0.400  Sum_probs=51.3

Q ss_pred             CCCCCCCCcEeeccCccccCCCCccccccCccceeccccccccccCCcccccccccceecccccccccccccccCCCccc
Q 001275          114 KLGNCSALEYLDLSTNGFTGDIPDNFENLQNLQYLNLYGNLLDGEIPEPLFRILGLQYVFLNNNSLSGSIPRNVGDLKEV  193 (1109)
Q Consensus       114 ~l~~l~~L~~L~Ls~n~l~~~~p~~l~~L~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L  193 (1109)
                      +++.+++|++|+|++|+|+. ++ .+.++++|++|+|++|.++ .+|.....                        +++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~------------------------~~~L   95 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV------------------------ADTL   95 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHH------------------------HHHC
T ss_pred             HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccc------------------------cccc
Confidence            34445555555555555542 22 2455555555555555544 33332233                        3344


Q ss_pred             ceeecccccCCCCcccccccccCccEEEeccccccCcCc-hhcccccccccccccCcccC
Q 001275          194 EALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLP-ESLSNLENLVYLDVGDNNLE  252 (1109)
Q Consensus       194 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~  252 (1109)
                      ++|++++|+++..  ..+..+++|++|++++|+|+.... ..+..+++|+.|++++|.+.
T Consensus        96 ~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_          96 EELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             CEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            4444444444421  224445555555555555543321 33455555555555555443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=6.2e-12  Score=122.04  Aligned_cols=108  Identities=23%  Similarity=0.198  Sum_probs=82.9

Q ss_pred             CCCceEEeecCccCCCCCCcccccccccEEeccCC-cccCCcchhhhcccccceeecccccccccCCccccCCCCccEEE
Q 001275          502 PVLSHLDVSRNNISGAIPSSIGNSINLTSIDFSSN-KFSGLMPQELGNLVSLVTLNISLNHVEGSLPSQLSKCKNLEVFD  580 (1109)
Q Consensus       502 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  580 (1109)
                      ...+.++.++++++ ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++||
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            34456777777777 56777878888888888665 47766667788888888888888888877777888888888888


Q ss_pred             ecCccccCCCCcccccccccceecccccccc
Q 001275          581 VSFNLLNGSIPSSLRSWKSLSILKLSENHFT  611 (1109)
Q Consensus       581 ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  611 (1109)
                      |++|+|+ .+|.......+|+.|+|++|++.
T Consensus        87 Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          87 LSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccCCCCc-ccChhhhccccccccccCCCccc
Confidence            8888888 55554444457888888888886

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=7.1e-11  Score=114.37  Aligned_cols=108  Identities=23%  Similarity=0.136  Sum_probs=81.7

Q ss_pred             CCcchhccccccccCCCCcccccccCCcEEEeecC-CCCCcCCccccccccccEEEcCCCCCCCCCCCccccccccceee
Q 001275          263 KNLTFLDLSYNRFSGGISPNLGNCSSLTHLDIVGS-KLTGSIPSSFGLLARLSSLDLSENQLSGKIPPELGKCKYLTVLH  341 (1109)
Q Consensus       263 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~  341 (1109)
                      ...+.++.+++.+. ..|..+..+++|++|++++| .++...+..|..+++|+.|+|++|+|+...|..|..+++|++|+
T Consensus         8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            34455667777666 35666777888888888766 47766677888888888888888888877778888888888888


Q ss_pred             ccCcccCCCCCccccCCCCccEEEccCcccc
Q 001275          342 LYANQLEGEIPDELGQLSNLQDLELFDNRLT  372 (1109)
Q Consensus       342 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  372 (1109)
                      |++|+|+. +|.......+|++|+|++|.+.
T Consensus        87 Ls~N~l~~-l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          87 LSFNALES-LSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSSCCSC-CCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccCCCCcc-cChhhhccccccccccCCCccc
Confidence            88888884 4444334447888999988885

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.32  E-value=5e-08  Score=94.55  Aligned_cols=65  Identities=23%  Similarity=0.115  Sum_probs=31.0

Q ss_pred             CCCcccceeecccccCCCCc--ccccccccCccEEEeccccccCcCchhcccccccccccccCcccC
Q 001275          188 GDLKEVEALWLFSNRLSGTI--PESIGNCYRLQELYLNENKLMGFLPESLSNLENLVYLDVGDNNLE  252 (1109)
Q Consensus       188 ~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~  252 (1109)
                      ..+++|++|+|++|+++...  +..+..+++|+.|+|++|+|+...+-.+.....|+.|++++|.+.
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            34455555555555555321  233445555555555555555433322223334555555555544

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=4.4e-08  Score=94.96  Aligned_cols=81  Identities=25%  Similarity=0.243  Sum_probs=39.0

Q ss_pred             cccccceecccccccccc--cccccCCCcccceeecccccCCCCcccccccccCccEEEeccccccCcCch-------hc
Q 001275          165 RILGLQYVFLNNNSLSGS--IPRNVGDLKEVEALWLFSNRLSGTIPESIGNCYRLQELYLNENKLMGFLPE-------SL  235 (1109)
Q Consensus       165 ~l~~L~~L~Ls~n~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-------~l  235 (1109)
                      .+++|++|+|++|+|+..  ++..+..+++|+.|+|++|+++...+-.+....+|++|++++|.++....+       .+
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~  142 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR  142 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHH
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHH
Confidence            344444444444444432  123344455555555555555533222222334566666666666543321       23


Q ss_pred             cccccccccc
Q 001275          236 SNLENLVYLD  245 (1109)
Q Consensus       236 ~~l~~L~~L~  245 (1109)
                      ..+|+|+.||
T Consensus       143 ~~~P~L~~LD  152 (162)
T d1koha1         143 ERFPKLLRLD  152 (162)
T ss_dssp             TTSTTCCEET
T ss_pred             HHCCCCCEEC
Confidence            4455666554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.06  E-value=8.1e-06  Score=85.51  Aligned_cols=148  Identities=14%  Similarity=0.065  Sum_probs=98.8

Q ss_pred             HHHHHhhCCCCCceeecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC-CCceeeEeeEEecCCce
Q 001275          813 QVIEATENLNAKHVIGRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR-HRNLVRLEDFWLRKDCG  891 (1109)
Q Consensus       813 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  891 (1109)
                      ++.+.-+.|+..+..+.++.+.||+...+ ++.+++|+... ........+.+|...+..+. +--+.+++.++..++..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~-~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDS-RYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECG-GGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCC-CcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45555567766655444555789998754 55667887632 23333446788888877763 43456777888788888


Q ss_pred             eEEEEeccCCCHHHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 001275          892 IIMYRYMENGSLRDVLHSITPPPTLEWNVRYKIALGAAHALAYLHYD---------------------------------  938 (1109)
Q Consensus       892 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------  938 (1109)
                      ++||++++|.++.+.....     ..   ...++.++++.++.||..                                 
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            9999999998886644221     11   223455555566666621                                 


Q ss_pred             -----------------------CCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          939 -----------------------CDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       939 -----------------------~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                                             ....++|+|+.|.||++++++.+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                   02237899999999999987767799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.58  E-value=4.9e-05  Score=78.82  Aligned_cols=129  Identities=16%  Similarity=0.072  Sum_probs=83.8

Q ss_pred             eecccC-eEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCC--CCceeeEeeEEecCCceeEEEEeccCCCH
Q 001275          827 IGRGAH-GIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIR--HRNLVRLEDFWLRKDCGIIMYRYMENGSL  903 (1109)
Q Consensus       827 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL  903 (1109)
                      +..|.. +.||+...+++..+++|.-...    ....+.+|...++.+.  .-.+.++++++.+.+..++||+|++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCcc----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444543 6899999888888888865322    2234677888877763  33356778888888888999999988654


Q ss_pred             HHHHhccCCCCCCCHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 001275          904 RDVLHSITPPPTLEWNVRYKIALGAAHALAYLHY----------------------------------------------  937 (1109)
Q Consensus       904 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~----------------------------------------------  937 (1109)
                      .+..        ...   ...+.++++.++-||.                                              
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            2210        110   1112233333333331                                              


Q ss_pred             ---------CCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          938 ---------DCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       938 ---------~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                               .....++|+|+.|.||+++++..+.|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                     012347999999999999987777899998764

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.35  E-value=3e-05  Score=74.76  Aligned_cols=15  Identities=7%  Similarity=0.324  Sum_probs=7.1

Q ss_pred             CCCccEEEccCcccc
Q 001275          358 LSNLQDLELFDNRLT  372 (1109)
Q Consensus       358 l~~L~~L~L~~N~l~  372 (1109)
                      .++|++|+|++|.++
T Consensus        43 n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          43 SKHIEKFSLANTAIS   57 (167)
T ss_dssp             CSCCCEEECTTSCCB
T ss_pred             CCccceeeccccccc
Confidence            344455555555444

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.34  E-value=3.7e-05  Score=74.10  Aligned_cols=111  Identities=10%  Similarity=0.081  Sum_probs=74.6

Q ss_pred             CCCCccEEEccCc-ccccc----CchHHHhhcccceeeccCCccCCCC----chhhhccCCCCeEEccCCcCccc----C
Q 001275          357 QLSNLQDLELFDN-RLTGE----FPVSIWRIASLEYLLVYNNNLLGKL----PLEMTELKQLKNISLYNNQFSGV----I  423 (1109)
Q Consensus       357 ~l~~L~~L~L~~N-~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~  423 (1109)
                      +.++|++|+|+++ .++..    +-..+...+.|+.|++++|.+....    ...+...+.|+.|+|++|.|+..    +
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            4577888888874 46543    2223445678999999999887432    33455678899999999998763    2


Q ss_pred             CccccCCCCCceEEecCCccccc-------CCCCcccCccceEEECCCccc
Q 001275          424 PQSLGINSSLMQLDFINNSFTGE-------IPPNLCFGKQLRVLNMGQNQF  467 (1109)
Q Consensus       424 p~~~~~~~~L~~L~ls~N~l~~~-------~p~~~~~~~~L~~L~L~~N~l  467 (1109)
                      -..+..+++|++|++++|.+...       +...+...+.|+.|+++.+..
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            33455778899999988876532       223333456778888876654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.07  E-value=0.00049  Score=75.92  Aligned_cols=77  Identities=10%  Similarity=0.045  Sum_probs=49.4

Q ss_pred             CceeecccCeEEEEEEeCC-CcEEEEEEeeec------ccccChHHHHHHHHHHhcCC-C--CceeeEeeEEecCCceeE
Q 001275          824 KHVIGRGAHGIVYKASLGP-NAVFAVKKLAFR------GHKRGSLSMKREIQTIGKIR-H--RNLVRLEDFWLRKDCGII  893 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  893 (1109)
                      .+.||.|....||+.+..+ ++.++||.-...      .......+...|++.++.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3468999999999997654 677888864321      12223445667888887662 2  345555544  4566789


Q ss_pred             EEEeccCCC
Q 001275          894 MYRYMENGS  902 (1109)
Q Consensus       894 v~e~~~~gs  902 (1109)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.32  E-value=0.00039  Score=66.51  Aligned_cols=16  Identities=6%  Similarity=0.204  Sum_probs=7.4

Q ss_pred             CCCCccEEEccCcccc
Q 001275          357 QLSNLQDLELFDNRLT  372 (1109)
Q Consensus       357 ~l~~L~~L~L~~N~l~  372 (1109)
                      ..++|++|++++|.++
T Consensus        44 ~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TCCSCCEEECTTSCCC
T ss_pred             cCCccCeeeccCCccc
Confidence            3444444444444444

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.21  E-value=0.00053  Score=65.57  Aligned_cols=112  Identities=13%  Similarity=0.128  Sum_probs=74.3

Q ss_pred             cCCCCccEEEccC-ccccccCc----hHHHhhcccceeeccCCccCCCCc----hhhhccCCCCeEEccCCcCccc----
Q 001275          356 GQLSNLQDLELFD-NRLTGEFP----VSIWRIASLEYLLVYNNNLLGKLP----LEMTELKQLKNISLYNNQFSGV----  422 (1109)
Q Consensus       356 ~~l~~L~~L~L~~-N~l~~~~~----~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~----  422 (1109)
                      .+.++|++|+|++ +.++...-    ..+...+.|+.|++++|.++....    ..+...+.++.+++++|.++..    
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence            4567888888887 45654332    233456889999999998875433    3445678899999999988653    


Q ss_pred             CCccccCCCCCceEEe--cCCcccccC----CCCcccCccceEEECCCccc
Q 001275          423 IPQSLGINSSLMQLDF--INNSFTGEI----PPNLCFGKQLRVLNMGQNQF  467 (1109)
Q Consensus       423 ~p~~~~~~~~L~~L~l--s~N~l~~~~----p~~~~~~~~L~~L~L~~N~l  467 (1109)
                      +...+..+++|+.++|  ++|.+....    ...+...++|+.|+++.++.
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            2345567778876444  567776432    23344557788888876654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.98  E-value=0.016  Score=61.54  Aligned_cols=135  Identities=16%  Similarity=0.120  Sum_probs=75.7

Q ss_pred             CeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCce--eeEee-----EEecCCceeEEEEeccCCCH-
Q 001275          832 HGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL--VRLED-----FWLRKDCGIIMYRYMENGSL-  903 (1109)
Q Consensus       832 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL-  903 (1109)
                      --.||+++.++|+.|++|.....  .....++..|...+..+....+  +..+.     .....+..+.++++++|..+ 
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~--~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE--RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT--TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC--CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            46899999999999999986322  2245667888888877742221  11111     12335567889999876432 


Q ss_pred             ----HHH---------Hhc----cCC--CCCCCHH----------------------HHHHHHHHHHHHHHHh-hcCCCC
Q 001275          904 ----RDV---------LHS----ITP--PPTLEWN----------------------VRYKIALGAAHALAYL-HYDCDP  941 (1109)
Q Consensus       904 ----~~~---------l~~----~~~--~~~l~~~----------------------~~~~i~~~i~~~L~~L-H~~~~~  941 (1109)
                          ..+         +|.    ...  ....++.                      .....+..+...+.-. ......
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                100         111    100  0111111                      1122223333222222 112245


Q ss_pred             CeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          942 PIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       942 ~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      +++|+|+.+.||+++++  ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhcc
Confidence            68999999999999743  4589999776

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.20  E-value=0.034  Score=60.67  Aligned_cols=72  Identities=13%  Similarity=0.160  Sum_probs=47.8

Q ss_pred             CceeecccCeEEEEEEeCCC--------cEEEEEEeeecccccChHHHHHHHHHHhcCCCCce-eeEeeEEecCCceeEE
Q 001275          824 KHVIGRGAHGIVYKASLGPN--------AVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRNL-VRLEDFWLRKDCGIIM  894 (1109)
Q Consensus       824 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  894 (1109)
                      .+.|+.|-.-.+|++...++        +.|.+++..   ......+..+|..+++.+.-.++ .++++++.    -..|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g---~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF---NPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC---SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC---CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceE
Confidence            35688899999999987543        445555442   23334567789999888843333 46777664    2688


Q ss_pred             EEeccCCC
Q 001275          895 YRYMENGS  902 (1109)
Q Consensus       895 ~e~~~~gs  902 (1109)
                      +||++|.+
T Consensus       120 ~efi~g~~  127 (395)
T d1nw1a_         120 EEYIPSRP  127 (395)
T ss_dssp             ECCCCEEE
T ss_pred             EEEecccc
Confidence            99998744

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.96  E-value=0.12  Score=54.01  Aligned_cols=157  Identities=10%  Similarity=0.025  Sum_probs=82.6

Q ss_pred             cHHHHHHHhhCCCCCcee-----ecccCeEEEEEEeCCCcEEEEEEeeecccccChHHHHHHHHHHhcCCCCc--eeeEe
Q 001275          810 LLKQVIEATENLNAKHVI-----GRGAHGIVYKASLGPNAVFAVKKLAFRGHKRGSLSMKREIQTIGKIRHRN--LVRLE  882 (1109)
Q Consensus       810 ~~~~~~~~~~~~~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  882 (1109)
                      +.+++.....+|...+..     ..|---+.|+.+.++|+ +++|+....   ....++..|++.+..+...+  +...+
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~---~~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR---VEKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC---CCHHHHHHHHHHHHhhhhccccccccc
Confidence            456677777788775543     35666788999888665 788876332   23345666777777763222  11111


Q ss_pred             e------EEecCCceeEEEEeccCCCHH--------------HHHhcc----CCC--CCC------------------CH
Q 001275          883 D------FWLRKDCGIIMYRYMENGSLR--------------DVLHSI----TPP--PTL------------------EW  918 (1109)
Q Consensus       883 ~------~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~----~~~--~~l------------------~~  918 (1109)
                      .      +.........++.+..+....              ..++..    ...  ...                  ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            1      112234456666666553221              011100    000  000                  00


Q ss_pred             HHHHHHHHHHHHHHHHhhc-CCCCCeEEeccCCCCeeeCCCCcEEEecccCCc
Q 001275          919 NVRYKIALGAAHALAYLHY-DCDPPIVHRDIKPENILLDSEMEPHISDFGIAK  970 (1109)
Q Consensus       919 ~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~DfGla~  970 (1109)
                      ......+......+...+. ....+++|+|+.++||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            0111222222222333221 235679999999999999988777899999775